PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Saenz, A; Lopez-Sanchez, A; Mojica-Lazaro, J; Martinez-Caro, L; Nin, N; Bagatolli, LA; Casals, C				Saenz, Alejandra; Lopez-Sanchez, Almudena; Mojica-Lazaro, Jonas; Martinez-Caro, Leticia; Nin, Nicolas; Bagatolli, Luis A.; Casals, Cristina			Fluidizing effects of C-reactive protein on lung surfactant membranes: protective role of surfactant protein A	FASEB JOURNAL			English	Article						membrane fluidity; lipid domains; fluorescence; lipid-protein interaction; protein-protein interaction; lung injury	PULMONARY SURFACTANT; EXPRESSION; TRANSPLANTATION; DISEASE; OLIGOMERIZATION; FLUORESCENCE; INFLAMMATION; INHIBITION; PRESSURE; PHASES	The purpose of this study was to investigate how surfactant membranes can be perturbed by C-reactive protein (CRP) and whether surfactant protein A (SP-A) might overcome CRP-induced surfactant membrane alterations. The effect of CRP on surfactant surface adsorption was evaluated in vivo after intratracheal instillation of CRP into rat lungs. Insertion of CRP into surfactant membranes was investigated through monolayer techniques. The effect of CRP on membrane structure was studied through differential scanning calorimetry and fluorescence spectroscopy and microscopy using large and giant unilamellar vesicles. Our results indicate that CRP inserts into surfactant membranes and drastically increases membrane fluidity, resulting in surfactant inactivation. At 10% CRP/phospholipid weight ratio, CRP causes disappearance of liquid-ordered/ liquid-disordered phase coexistence distinctive of surfactant membranes. SP-A, the most abundant surfactant lipoprotein structurally similar to C1q, binds to CRP (K-d=56+/-8 nM), as determined by solid-phase binding assays and dynamic light scattering. This novel SP-A/ CRP interaction reduces CRP insertion and blocks CRP effects on surfactant membranes. In addition, intratracheal coinstillation of SP-A+CRP into rat lungs prevents surfactant inhibition induced by CRP, indicating that SP-A/ CRP interactions might be an important factor in vivo in controlling harmful CRP effects in the alveolus.-Saenz, A., Lopez-Sanchez, A., Mojica-Lazaro, J., Martinez-Caro, L., Nin, N., Bagatolli, L. A., Casals, C. Fluidizing effects of C-reactive protein on lung surfactant membranes: protective role of surfactant protein A. FASEB J. 24, 3662-3673 (2010). www.fasebj.org	[Saenz, Alejandra; Lopez-Sanchez, Almudena; Mojica-Lazaro, Jonas; Casals, Cristina] Univ Complutense Madrid, Fac Biol, Dept Bioquim & Biol Mol 1, Ctr Invest Biomed Red CIBER Enfermedades Resp, E-28040 Madrid, Spain; [Saenz, Alejandra; Lopez-Sanchez, Almudena; Mojica-Lazaro, Jonas; Casals, Cristina] Univ Complutense Madrid, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain; [Martinez-Caro, Leticia; Nin, Nicolas] Hosp Univ Getafe, Serv Cuidados Intens, Madrid, Spain; [Martinez-Caro, Leticia; Nin, Nicolas] Hosp Univ Getafe, CIBER Enfermedades Resp, Madrid, Spain; [Bagatolli, Luis A.] Univ So Denmark, Dept Biochem & Mol Biol, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario de Getafe; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitario de Getafe; University of Southern Denmark	Casals, C (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Bioquim & Biol Mol 1, Ctr Invest Biomed Red CIBER Enfermedades Resp, E-28040 Madrid, Spain.	ccasalsc@bio.ucm.es	Casals, Cristina/H-4658-2015; Saenz, Alejandra/G-7275-2015; Martinez-Caro, Leticia/AAD-9010-2019; Nin, Nicolas/X-4938-2019; Bagatolli, Luis/L-5159-2016	Casals, Cristina/0000-0003-2696-0918; Saenz, Alejandra/0000-0001-8439-2985; Bagatolli, Luis/0000-0002-4727-8611; NIN, NICOLAS/0000-0001-6037-2357	Ministerio de Educacion y Ciencia [SAF2006-04434, SAF2009-07810]; Instituto de Salud Carlos III (CIBERES); Comunidad de Madrid [S-BIO-0260-2006]; Fundacion Medica MM	Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III (CIBERES)(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Fundacion Medica MM	This work was supported by Ministerio de Educacion y Ciencia (SAF2006-04434 and SAF2009-07810), Instituto de Salud Carlos III (CIBERES), Comunidad de Madrid (S-BIO-0260-2006), and Fundacion Medica MM. Experiments in the laboratory of L.A.B. were supported by Forskningsradet for Natur og Univers (FNU; Denmark) and the Danish National Research Foundation.	AMIRKHANIAN JD, 1993, BIOCHIM BIOPHYS ACTA, V1165, P321, DOI 10.1016/0005-2760(93)90143-W; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Calvez P, 2009, BIOCHIMIE, V91, P718, DOI 10.1016/j.biochi.2009.03.018; Canadas O, 2008, BIOPHYS J, V95, P3287, DOI 10.1529/biophysj.108.137323; Casals C, 2003, AM J PHYSIOL-LUNG C, V284, pL466, DOI 10.1152/ajplung.00325.2002; Casals C, 1998, AM J RESP CRIT CARE, V157, P43, DOI 10.1164/ajrccm.157.1.9611106; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Christopeit T, 2009, ANAL BIOCHEM, V391, P39, DOI 10.1016/j.ab.2009.04.037; Dahl M, 2007, AM J RESP CRIT CARE, V175, P250, DOI 10.1164/rccm.200605-713OC; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; Dong Q, 1996, J IMMUNOL, V156, P4815; Gould JM, 2001, INFECT IMMUN, V69, P1747, DOI 10.1128/IAI.69.3.1747-1754.2001; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; *I AN LAB RES, 1996, GUID CAR US LAB AN; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Levy H, 2007, PEDIATR PULM, V42, P256, DOI 10.1002/ppul.20563; LI JJ, 1989, J TRAUMA, V29, P1690, DOI 10.1097/00005373-198912000-00019; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; MCEACHREN TM, 1995, AM J PHYSIOL-LUNG C, V269, pL492, DOI 10.1152/ajplung.1995.269.4.L492; MCELHANEY RN, 1986, BIOCHIM BIOPHYS ACTA, V864, P361, DOI 10.1016/0304-4157(86)90004-3; Nag K, 2004, AM J PHYSIOL-LUNG C, V287, pL1145, DOI 10.1152/ajplung.00408.2003; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Ramage L, 2004, INHAL TOXICOL, V16, P607, DOI 10.1080/08958370490464599; Rasmussen F, 2009, EUR RESPIR J, V33, P382, DOI 10.1183/09031936.00040708; Ruano MLF, 2000, BIOCHEMISTRY-US, V39, P6529, DOI 10.1021/bi000188z; Saenz A, 2007, BIOPHYS J, V92, P482, DOI 10.1529/biophysj.106.090217; Sanchez-Barbero F, 2005, J BIOL CHEM, V280, P7659, DOI 10.1074/jbc.M410266200; Sanchez-Barbero F, 2007, BIOCHEM J, V406, P479, DOI 10.1042/BJ20070275; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Valino F, 2004, TRANSPLANTATION, V77, P812, DOI 10.1097/01.TP.0000116421.57232.81; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Vos R, 2009, J HEART LUNG TRANSPL, V28, pS108, DOI 10.1016/j.healun.2008.11.799; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	38	22	23	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3662	3673		10.1096/fj.09-142646	http://dx.doi.org/10.1096/fj.09-142646			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20484671				2022-12-25	WOS:000285005900007
J	Chen, J; Miller, EM; Gallo, KA				Chen, J.; Miller, E. M.; Gallo, K. A.			MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells	ONCOGENE			English	Article						MLK3; JNK; migration; invasion; Bim; AP-1; breast cancer	MIXED-LINEAGE KINASE; BASEMENT-MEMBRANE CULTURES; GENE-EXPRESSION PROFILES; P38 MAPK PATHWAYS; N-TERMINAL KINASE; PROTEIN-KINASE; C-JUN; SRC-HOMOLOGY-3 DOMAIN; SIGNALING PATHWAYS; DEPENDENT PATHWAY	The malignant phenotype in breast cancer is driven by aberrant signal transduction pathways. Mixed-lineage kinase-3 (MLK3) is a mammalian mitogen-activated protein kinase kinase kinase (MAP3K) that activates multiple MAPK pathways. Depending on the cellular context, MLK3 has been implicated in apoptosis, proliferation, migration and differentiation. Here we investigated the effect of MLK3 and its signaling to MAPKs in the acquisition of malignancy in breast cancer. We show that MLK3 is highly expressed in breast cancer cells. We provide evidence that MLK3's catalytic activity and signaling to c-jun N-terminal kinase (JNK) is required for migration of highly invasive breast cancer cells and for MLK3-induced migration of mammary epithelial cells. Expression of active MLK3 is sufficient to induce the invasion of mammary epithelial cells, which requires AP-1 activity and is accompanied by the expression of several proteins corresponding to AP-1-regulated invasion genes. To assess MLK3's contribution to the breast cancer malignant phenotype in a more physiological setting, we implemented a strategy to inducibly express active MLK3 in the preformed acini of MCF10A cells grown in 3D Matrigel. Induction of MLK3 expression dramatically increases acinar size and modestly perturbs apicobasal polarity. Remarkably, MLK3 expression induces luminal repopulation and suppresses the expression of the pro-apoptotic protein BimEL, as has been observed in Her2/Neu-expressing acini. Taken together, our data show that MLK3-JNK-AP-1 signaling is critical for breast cancer cell migration and invasion. Our current study uncovers both a proliferative and novel antiapoptotic role for MLK3 in the acquisition of a malignant phenotype in mammary epithelial cells. Thus, MLK3 may be an important therapeutic target for the treatment of invasive breast cancer. Oncogene (2010) 29, 4399-4411; doi: 10.1038/onc.2010.198; published online 31 May 2010	[Miller, E. M.; Gallo, K. A.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Chen, J.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Gallo, K. A.] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Gallo, KA (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	gallok@msu.edu	Wang, Limin/O-3724-2015		MSU-Health and Biomedical Research Institute [HBRI-729]; DoD [BC085020]	MSU-Health and Biomedical Research Institute; DoD(United States Department of Defense)	This work was supported by an MSU-Health and Biomedical Research Institute seed grant (KAG HBRI-729) and a DoD Breast Cancer Idea Award (KAG BC085020). Confocal microscopes were provided through the MSU Center for Advanced Microscopy. We are grateful to Cephalon Inc. for CEP-11004; Ariad Pharmaceuticals for AP21967 and for parental inducible expression vectors; Richard Mulligan (Harvard Medical School) for the 293GPG packaging cell line and Daniel DiMaio (Yale Cancer Center) for the pBabe-Tam67 construct. We thank Mauricio Reginato (Drexel University) for advice on Bim immunoblotting and Bradley Smith (Department of Physiology, MSU) for help with the morphometric analysis of the MCF10A cells grown in 3D culture. We appreciate the constructive input from the members of the MSU-Breast Cancer Signaling Networks Consortium.	BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; BROWN PH, 1993, ONCOGENE, V8, P877; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Cui XJ, 2006, CANCER RES, V66, P5304, DOI 10.1158/0008-5472.CAN-05-2858; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Hall JP, 2002, J CELL BIOCHEM, V86, P1, DOI 10.1002/jcb.10187; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lester RD, 2005, J BIOL CHEM, V280, P39273, DOI 10.1074/jbc.M509446200; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Minet E, 2001, EXP CELL RES, V265, P114, DOI 10.1006/excr.2001.5180; Murakata C, 2002, BIOORG MED CHEM LETT, V12, P147, DOI 10.1016/S0960-894X(01)00690-4; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nielsen DL, 2009, CANCER TREAT REV, V35, P121, DOI 10.1016/j.ctrv.2008.09.003; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; RITTLING SR, 1989, NUCLEIC ACIDS RES, V17, P1619, DOI 10.1093/nar/17.4.1619; Rizki A, 2007, CANCER RES, V67, P11106, DOI 10.1158/0008-5472.CAN-07-2348; Schachter KA, 2006, J BIOL CHEM, V281, P19134, DOI 10.1074/jbc.M603324200; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1506, DOI 10.1038/sj.cdd.4401831; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; SOMMERS CL, 1994, CELL GROWTH DIFFER, V5, P839; SOMMERS CL, 1994, BREAST CANCER RES TR, V31, P325, DOI 10.1007/BF00666165; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Swenson-Fields KI, 2008, MOL CELL, V32, P43, DOI 10.1016/j.molcel.2008.09.007; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; Vacratsis PO, 2000, J BIOL CHEM, V275, P27893; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wilsbacher Julie L, 2006, Cell Commun Signal, V4, P5, DOI 10.1186/1478-811X-4-5; Yeh YT, 2006, INT J CANCER, V118, P2678, DOI 10.1002/ijc.21707; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zhang H, 2001, J BIOL CHEM, V276, P45598, DOI 10.1074/jbc.M107176200; Zhang H, 2004, J BIOL CHEM, V279, P19457, DOI 10.1074/jbc.M311377200; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	59	52	54	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 5	2010	29	31					4399	4411		10.1038/onc.2010.198	http://dx.doi.org/10.1038/onc.2010.198			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	634DG	20514022				2022-12-25	WOS:000280559100004
J	Craft, CS; Zou, W; Watkins, M; Grimston, S; Brodt, MD; Broekelmann, TJ; Weinbaum, JS; Teitelbaum, SL; Pierce, RA; Civitelli, R; Silva, MJ; Mecham, RP				Craft, Clarissa S.; Zou, Wei; Watkins, Marcus; Grimston, Susan; Brodt, Michael D.; Broekelmann, Thomas J.; Weinbaum, Justin S.; Teitelbaum, Steven L.; Pierce, Richard A.; Civitelli, Roberto; Silva, Matthew J.; Mecham, Robert P.			Microfibril-associated Glycoprotein-1, an Extracellular Matrix Regulator of Bone Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLIN-CONTAINING MICROFIBRILS; QUANTITATIVE TRAIT LOCI; TGF-BETA ACTIVATION; MARFAN-SYNDROME; AORTIC DEVELOPMENT; RICH MICROFIBRILS; IN-VIVO; EXPRESSION; RECEPTOR; PROTEIN	MAGP1 is an extracellular matrix protein that, in vertebrates, is a ubiquitous component of fibrillin-rich microfibrils. We previously reported that aged MAGP1-deficient mice (MAGP1 Delta) develop lesions that are the consequence of spontaneous bone fracture. We now present a more defined bone phenotype found in MAGP1 Delta mice. A longitudinal DEXA study demonstrated age-associated osteopenia in MAGP1 Delta animals and mu CT confirmed reduced bone mineral density in the trabecular and cortical bone. Further, MAGP1 Delta mice have significantly less trabecular bone, the trabecular microarchitecture is more fragmented, and the diaphyseal cross-sectional area is significantly reduced. There modeling defect seen in MAGP1 Delta mice is likely not due to an osteoblast defect, because MAGP1 Delta bone marrow stromal cells undergo osteoblastogenesis and form mineralized nodules. In vivo, MAGP1 Delta mice exhibit normal osteoblast number, mineralized bone surface, and bone formation rate. Instead, our findings suggest increased bone resorption is responsible for the osteopenia. The number of osteoclasts derived from MAGP1 Delta bone marrow macrophage cells is increased relative to the wild type, and osteoclast differentiation markers are expressed at earlier time points in MAGP1 Delta cells. In vivo, MAGP1 Delta mice have more osteoclasts lining the bone surface. RANKL(receptor activator of NF-kappa B ligand) expression is significantly higher in MAGP1 Delta bone, and likely contributes to enhanced osteoclastogenesis. However, bone marrow macrophage cells from MAGP1 Delta mice show a higher propensity than do wildtype cells to differentiate to osteoclasts in response to RANKL, suggesting that they are also primed to respond to osteoclast-promoting signals. Together, our findings suggest that MAGP1 is a regulator of bone remodeling, and its absence results in osteopenia associated with an increase in osteoclast number.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Zou, Wei; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Anat & Mol Pathol, St Louis, MO 63110 USA; [Watkins, Marcus; Grimston, Susan; Pierce, Richard A.; Civitelli, Roberto] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Brodt, Michael D.; Silva, Matthew J.] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63110 USA; [Weinbaum, Justin S.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities	Mecham, RP (corresponding author), Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	bmecham@wustl.edu	Weinbaum, Justin S/C-3192-2009; Civitelli, Roberto/AAA-8260-2019; Watkins, Marcus/V-8817-2019	Weinbaum, Justin S/0000-0002-0626-6083; Civitelli, Roberto/0000-0003-4076-4315; Watkins, Marcus/0000-0002-1224-3478; Silva, Matthew/0000-0001-7375-4522; Teitelbaum, Steven/0000-0002-4054-6679; Zou, Wei/0000-0001-8081-268X	National Institutes of Health [HL71960, HL084922, T32-HL007275-30, AR0327888, AR046523, AR057037, AR054618, P30AR057235]; National Marfan Foundation; Washington University Core Center for Musculoskeletal Biology and Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105314, P50HL084922, T32HL007275, R01HL053325, R01HL071960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR046523, R01AR054618, R01AR047867, P30AR057235, R01AR046523, R01AR057037, R01AR032788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation; Washington University Core Center for Musculoskeletal Biology and Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL71960 and HL084922 (to R.P.M.), T32-HL007275-30 (to C.S.C.), AR0327888, AR046523, AR057037, and AR054618 (to S.L.T.), and P30AR057235. This work was also supported by a National Marfan Foundation Research Grant (to R.P.M.) and by the Washington University Core Center for Musculoskeletal Biology and Medicine.	Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Arteage-Solis E, 2008, PRIMER METABOLIC BON, P450; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Barisic-Dujmovic T, 2007, CALCIFIED TISSUE INT, V81, P305, DOI 10.1007/s00223-007-9059-4; Beamer WG, 2001, J BONE MINER RES, V16, P1195, DOI 10.1359/jbmr.2001.16.7.1195; Bona C A, 1997, DNA Res, V4, P267, DOI 10.1093/dnares/4.4.267; Bouxsein ML, 2004, J BONE MINER RES, V19, P587, DOI 10.1359/JBMR.0301255; Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; CHEN YP, 1993, J BIOL CHEM, V268, P27381; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; GOLTZMAN D, 2008, PRIMER METABOLIC BON, V7th, ppp104; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Ishida A, 2002, J BIOL CHEM, V277, P26217, DOI 10.1074/jbc.M111093200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Jurado S, 2010, J CELL BIOCHEM, V110, P304, DOI 10.1002/jcb.22538; Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331; Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; Kelleher CM, 2004, CURR TOP DEV BIOL, V62, P153; Kitahama S, 2000, BONE, V27, P61, DOI 10.1016/S8756-3282(00)00292-1; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; Mc Donnell P, 2007, ANN BIOMED ENG, V35, P170, DOI 10.1007/s10439-006-9239-9; MCLEAN SE, 2005, EXTRACELLULAR MATRIC, P82; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Ramirez F, 2008, CONNECT TISSUE RES, V49, P1, DOI 10.1080/03008200701820708; Reeve JL, 2009, J IMMUNOL, V183, P1804, DOI 10.4049/jimmunol.0804206; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Segade F, 2009, GENE, V439, P43, DOI 10.1016/j.gene.2009.03.013; Silva MJ, 2002, J BONE MINER RES, V17, P1597, DOI 10.1359/jbmr.2002.17.9.1597; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Werneck CC, 2008, BLOOD, V111, P4137, DOI 10.1182/blood-2007-07-101733; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; Zhang J, 2004, PROSTATE, V59, P360, DOI 10.1002/pros.20019	56	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23858	23867		10.1074/jbc.M110.113019	http://dx.doi.org/10.1074/jbc.M110.113019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501659	Green Published, hybrid			2022-12-25	WOS:000280291400036
J	Dulic, M; Cvetesic, N; Perona, JJ; Gruic-Sovulj, I				Dulic, Morana; Cvetesic, Nevena; Perona, John J.; Gruic-Sovulj, Ita			Partitioning of tRNA-dependent Editing between Pre- and Post-transfer Pathways in Class I Aminoacyl-tRNA Synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLEUCYL-TRANSFER-RNA; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA-POLYMERASES; QUALITY-CONTROL; MECHANISM; HYDROLYSIS; ADENYLATE	Hydrolytic editing activities are present in aminoacyl-tRNA synthetases possessing reduced amino acid discrimination in the synthetic reactions. Post-transfer hydrolysis of misacylated tRNA in class I editing enzymes occurs in a spatially separate domain inserted into the catalytic Rossmann fold, but the location and mechanisms of pre-transfer hydrolysis of misactivated amino acids have been uncertain. Here, we use novel kinetic approaches to distinguish among three models for pre-transfer editing by Escherichia coli isoleucyl-tRNA synthetase (IleRS). We demonstrate that tRNA-dependent hydrolysis of noncognate valyl-adenylate by IleRS is largely insensitive to mutations in the editing domain of the enzyme and that noncatalytic hydrolysis after release is too slow to account for the observed rate of clearing. Measurements of the microscopic rate constants for amino acid transfer to tRNA in IleRS and the related valyl-tRNA synthetase (ValRS) further suggest that pre-transfer editing in IleRS is an enzyme-catalyzed activity residing in the synthetic active site. In this model, the balance between pre-transfer and post-transfer editing pathways is controlled by kinetic partitioning of the noncognate aminoacyl-adenylate. Rate constants for hydrolysis and transfer of a noncognate intermediate are roughly equal in IleRS, whereas in ValRS transfer to tRNA is 200-fold faster than hydrolysis. In consequence, editing by ValRS occurs nearly exclusively by post-transfer hydrolysis in the editing domain, whereas in IleRS both pre- and post-transfer editing are important. In both enzymes, the rates of amino acid transfer to tRNA are similar for cognate and noncognate aminoacyl-adenylates, providing a significant contrast with editing DNA polymerases.	[Dulic, Morana; Cvetesic, Nevena; Gruic-Sovulj, Ita] Univ Zagreb, Dept Chem, Fac Sci, Zagreb 10000, Croatia; [Perona, John J.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of Zagreb; University of California System; University of California Santa Barbara	Gruic-Sovulj, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, Zagreb 10000, Croatia.	gruic@chem.pmf.hr		Cvetesic, Nevena/0000-0002-1575-5612	National Institutes of Health [1R03TW008024, GM63713]; Ministry of Science, Education, and Sports of the Republic of Croatia [119-0982913-1358]; FOGARTY INTERNATIONAL CENTER [R03TW008024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Education, and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03TW008024 (to J.J.P. and I.G.-S.) and GM63713 (to J.J.P.). This work was also supported by the Ministry of Science, Education, and Sports of the Republic of Croatia Grant 119-0982913-1358 (to Ivana Weygand-Durasevic).	BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Fersht A.R., 1999, STRUCTURE MECH PROTE, P384; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P818, DOI 10.1021/bi00649a014; Francklyn CS, 2008, BIOCHEMISTRY-US, V47, P11695, DOI 10.1021/bi801500z; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J BIOL CHEM, V280, P29937, DOI 10.1074/jbc.M502668200; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; GRUICSOVULJ I, 2010, CROAT CHEM IN PRESS; Hale SP, 1996, P NATL ACAD SCI USA, V93, P2755, DOI 10.1073/pnas.93.7.2755; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1980, BIOCHEMISTRY-US, V19, P5071, DOI 10.1021/bi00563a021; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; JOHNSSON MSA, 1992, CRIT REV ORAL BIOL M, V3, P61, DOI 10.1177/10454411920030010601; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Salazar JC, 2004, P NATL ACAD SCI USA, V101, P7536, DOI 10.1073/pnas.0401982101; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P1, DOI 10.1016/S0968-0004(00)88937-9; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	45	58	60	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23799	23809		10.1074/jbc.M110.133553	http://dx.doi.org/10.1074/jbc.M110.133553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498377	Green Published, hybrid			2022-12-25	WOS:000280291400030
J	Maeda, K; Singh, SK; Eda, K; Kitabatake, M; Pham, P; Goodman, MF; Sakaguchi, N				Maeda, Kazuhiko; Singh, Shailendra Kumar; Eda, Kazufumi; Kitabatake, Masahiro; Pham, Phuong; Goodman, Myron F.; Sakaguchi, Nobuo			GANP-mediated Recruitment of Activation-induced Cytidine Deaminase to Cell Nuclei and to Immunoglobulin Variable Region DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; SOMATIC HYPERMUTATION; GERMINAL CENTER; DIVERSIFICATION ENZYME; AFFINITY-MATURATION; PROTEIN; AID; RNA; ANTIBODY	AID (activation-induced cytidine deaminase) catalyzes transcription-dependent deamination of C 3 U in immunoglobulin variable (IgV) regions to initiate somatic hypermutation (SHM) in germinal center B-cells. SHM is essential in generating high affinity antibodies. Here we show that when coexpressed with GANP ( germinal center-associated nuclear protein) in COS-7 cells, AID is transported from the cytoplasm and concentrated in the nucleus. GANP forms a complex with AID in cotransfected cells in vivo and in vitro. We have isolated AID mutants that bind with reduced affinity to GANP compared with wild type AID. One of these mutants, AID (D143A) binds GANP with a 10-fold lower affinity compared with wild type AID yet retains substantial C-deamination activity in vitro. Mutant AID (D143A) remains localized predominantly in the cytoplasm when coexpressed with GANP. Exogenous expression of GANP in Ramos B-cells promotes binding of AID to IgV DNA and mRNA and increases SHM frequency. These data suggest that GANP may serve as an essential link required to transport AID to B-cell nuclei and to target AID to actively transcribed IgV regions.	[Maeda, Kazuhiko; Singh, Shailendra Kumar; Eda, Kazufumi; Kitabatake, Masahiro; Sakaguchi, Nobuo] Kumamoto Univ, Dept Immunol, Grad Sch Life Sci, Kumamoto 8608556, Japan; [Pham, Phuong; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Pham, Phuong; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Kumamoto University; University of Southern California; University of Southern California	Sakaguchi, N (corresponding author), Kumamoto Univ, Dept Immunol, Grad Sch Life Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	nobusaka@kumamoto-u.ac.jp			National Institutes of Health [ES013192, GM21422]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Founding Research Centers for Emerging and Reemerging Infectious Diseases; Global Centers of Excellence (COE); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021422, R37GM021422] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22590436] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Centers of Excellence (COE); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants ES013192 (to M.F.G.) and GM21422 (to P.P.). This work was also supported by a grant-in-aid for scientific research in priority areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, and by the Global Centers of Excellence (COE) program Global Education Research Center Aiming at the Control of AIDS (to N.S.).	Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Fujimura S, 2005, CANCER RES, V65, P5925, DOI 10.1158/0008-5472.CAN-04-3259; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Kawatani Y, 2005, J IMMUNOL, V175, P5615, DOI 10.4049/jimmunol.175.9.5615; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kuwahara K, 2000, BLOOD, V95, P2321, DOI 10.1182/blood.V95.7.2321.007k33_2321_2328; Kuwahara K, 2004, P NATL ACAD SCI USA, V101, P1010, DOI 10.1073/pnas.0307609100; Kuwahara K, 2001, P NATL ACAD SCI USA, V98, P10279, DOI 10.1073/pnas.181335698; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Osman W, 2006, BIOCHEM BIOPH RES CO, V348, P1239, DOI 10.1016/j.bbrc.2006.07.182; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Takei Y, 1998, J BIOL CHEM, V273, P22177, DOI 10.1074/jbc.273.35.22177; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026	28	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23945	23953		10.1074/jbc.M110.131441	http://dx.doi.org/10.1074/jbc.M110.131441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507984	Green Published, hybrid			2022-12-25	WOS:000280291400045
J	Yu, F; Deng, H; Yao, H; Liu, Q; Su, F; Song, E				Yu, F.; Deng, H.; Yao, H.; Liu, Q.; Su, F.; Song, E.			Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells	ONCOGENE			English	Article						microRNA; cancer stem cell; breast cancer; Ubc9; ITGB3	CANCER STEM-CELLS; IN-VITRO PROPAGATION; EXPRESSION; UBC9; MECHANISMS; INTEGRINS; ANOIKIS	Accumulating evidence indicates that a sub-population of cancer cells with stem-like properties, termed tumor-initiating cells (T-ICs), exist in many different kinds of malignancies, which have a pivotal role in tumorigenesis, tumor progression, metastasis and post-treatment relapse. However, how the stem-like properties of T-ICs are regulated remains obscure. Our previous study showed that reduction of let-7 microRNA ( miRNA) in breast tumor-initiating cells (BT-ICs) contributes to the maintenance of their self-renewal capacity and undifferentiated status. In this study we show the effect of mir-30 reduction on the stem-like features of BT-ICs. Similar to let-7, mir-30 is reduced in BT-ICs, and the protein level of Ubc9 (ubiquitin-conjugating enzyme 9) and ITGB3 ( integrin b3), the target genes of mir-30, is markedly upregulated. Enforced constitutive expression of mir-30 in BT-ICs inhibits their self-renewal capacity by reducing Ubc9, and induces apoptosis through silencing ITGB3. On the contrary, blocking the miRNA with a specific antisense oligonucleotide (ASO) in differentiated breast cancer cells revived their self-renewal capacity. Furthermore, ectopic expression of mir-30 in BT-IC xenografts reduces tumorigenesis and lung metastasis in nonobese diabetic/severe combined immunodeficient mice, whereas blocking mir-30 expression enhances tumorigenesis and metastasis. Together, our data suggest mir-30 as one of the important miRNAs in regulating the stem-like features of T-ICs. Oncogene ( 2010) 29, 4194-4204; doi: 10.1038/onc.2010.167; published online 24 May 2010	[Yu, F.; Deng, H.; Liu, Q.; Su, F.; Song, E.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Guangzhou 510120, Guangdong, Peoples R China; [Yao, H.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Guangzhou 510120, Guangdong, Peoples R China; [Liu, Q.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Song, E.] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Harvard University; Dana-Farber Cancer Institute; Sun Yat Sen University	Song, E (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 2, Dept Breast Surg, 107 Yanjiang W Rd, Guangzhou 510120, Guangdong, Peoples R China.	songerwei02@yahoo.com.cn		Liu, Qiang/0000-0002-5451-4862	Natural Science Foundation of China [30921140312, 30830110, 30772550, 30973396, 30525022, 30671930, 30973505]; Ministry of Science and Technology of China [2010CB912800, 2009CB521706, 2005CB724605]; Natural Science Foundation of Guangdong Province [8251008901000011]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the Natural Science Foundation of China Grant (30921140312, 30830110, 30772550, 30973396, 30525022, 30671930, 30973505), 973 (2010CB912800, 2009CB521706, 2005CB724605) Projects from the Ministry of Science and Technology of China, and Natural Science Foundation of Guangdong Province (8251008901000011).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Park SW, 2007, NAT STRUCT MOL BIOL, V14, P68, DOI 10.1038/nsmb1185; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Watanabe M, 2008, ACTA BIOCHIM POL, V55, P681; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com	24	253	277	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 22	2010	29	29					4194	4204		10.1038/onc.2010.167	http://dx.doi.org/10.1038/onc.2010.167			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20498642				2022-12-25	WOS:000280151500007
J	Al Safadi, R; Amor, S; Hery-Arnaud, G; Spellerberg, B; Lanotte, P; Mereghetti, L; Gannier, F; Quentin, R; Rosenau, A				Al Safadi, Rim; Amor, Souheila; Hery-Arnaud, Genevieve; Spellerberg, Barbara; Lanotte, Philippe; Mereghetti, Laurent; Gannier, Francois; Quentin, Roland; Rosenau, Agnes			Enhanced Expression of lmb Gene Encoding Laminin-Binding Protein in Streptococcus agalactiae Strains Harboring IS1548 in scpB-lmb Intergenic Region	PLOS ONE			English	Article							GROUP-B-STREPTOCOCCUS; INVASIVE NEONATAL DISEASE; MICROVASCULAR ENDOTHELIAL-CELLS; GROUP-II INTRON; C5A PEPTIDASE; MOLECULAR CHARACTERIZATION; INSERTIONAL ACTIVATION; POPULATION-STRUCTURE; BIOFILM FORMATION; EPITHELIAL-CELLS	Group B streptococcus (GBS) is the main cause of neonatal sepsis and meningitis. Bacterial surface proteins play a major role in GBS binding to and invasion of different host surfaces. The scpB and lmb genes, coding for fibronectin-binding and laminin-binding surface proteins, are present in almost all human GBS isolates. The scpB-lmb intergenic region is a hot spot for integration of two mobile genetic elements (MGEs): the insertion element IS1548 or the group II intron GBSi1. We studied the structure of scpB-lmb intergenic region in 111 GBS isolates belonging to the intraspecies major clonal complexes (CCs). IS1548 was mostly found (72.2%) in CC19 serotype III strains recovered more specifically (92.3%) from neonatal meningitis. GBSi1 was principally found (70.6%) in CC17 strains, mostly (94.4%) of serotype III, but also (15.7%) in CC19 strains, mostly (87.5%) of serotype II. No MGE was found in most strains of the other CCs (76.0%), notably CC23, CC10 and CC1. Twenty-six strains representing these three genetic configurations were selected to investigate the transcription and expression levels of scpB and lmb genes. Quantitative RT-PCR showed that lmb transcripts were 5.0- to 9.6-fold higher in the group of strains with IS1548 than in the other two groups of strains (P<0.001). Accordingly, the binding ability to laminin was 3.8- to 6.6-fold higher in these strains (P <= 0.001). Moreover, Lmb amount expressed on the cell surface was 2.4- to 2.7-fold greater in these strains (P<0.001). By contrast, scpB transcript levels and fibronectin binding ability were similar in the three groups of strains. Deletion of the IS1548 sequence between scpB and lmb genes in a CC19 serotype III GBS strain substantially reduced the transcription of lmb gene (13.5-fold), the binding ability to laminin (6.2-fold), and the expression of Lmb protein (5.0-fold). These data highlight the importance of MGEs in bacterial virulence and demonstrate the up-regulation of lmb gene by IS1548; the increased lmb gene expression observed in CC19 serotype III strains with IS1548 may play a role in their ability to cause neonatal meningitis and endocarditis.	[Al Safadi, Rim; Amor, Souheila; Hery-Arnaud, Genevieve; Lanotte, Philippe; Mereghetti, Laurent; Quentin, Roland; Rosenau, Agnes] Univ Tours, UFR Med, Equipe Accueil Bacteries & Risque Maternofoetal 3, Inst Federatif Rech Agents Transmissibles & Infec, Tours, France; [Spellerberg, Barbara] Univ Ulm Klinikum, Inst Med Mikrobiol & Hyg, Ulm, Germany; [Gannier, Francois] Univ Tours, UFR Sci, UMR CNRS FRE Physiol Cellules Cardiaques & Vasc 3, Tours, France; [Quentin, Roland] CHRU Tours, Hop Trousseau, Serv Bacteriol & Hyg Hosp, Tours, France	Universite de Tours; Ulm University; Universite de Tours; CHU Tours	Al Safadi, R (corresponding author), Univ Tours, UFR Med, Equipe Accueil Bacteries & Risque Maternofoetal 3, Inst Federatif Rech Agents Transmissibles & Infec, Tours, France.	rosenau@univ-tours.fr	Spellerberg, Barbara/D-3443-2011; Gannier, François/P-5036-2016; Gannier, François/AAD-7372-2020	Spellerberg, Barbara/0000-0001-7552-8764; Gannier, François/0000-0001-9383-7229; 	Region Centre, France [200700025461]	Region Centre, France(Region Centre-Val de Loire)	Funding: This work was supported by grant no. 200700025461 from the Region Centre, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Bidet P, 2003, J INFECT DIS, V188, P1132, DOI 10.1086/378517; Bisharat N, 2005, MICROBIOL-SGM, V151, P1875, DOI 10.1099/mic.0.27826-0; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Bohnsack JF, 2004, EMERG INFECT DIS, V10, P1412, DOI 10.3201/eid1008.030917; Bohnsack JF, 2008, J CLIN MICROBIOL, V46, P1285, DOI 10.1128/JCM.02105-07; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Broker G, 2004, INT J MED MICROBIOL, V294, P169, DOI 10.1016/j.ijmm.2004.06.018; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Davies HD, 2004, J INFECT DIS, V189, P1097, DOI 10.1086/382087; deFelipe FL, 1996, MOL GEN GENET, V250, P428, DOI 10.1007/s004380050095; Depardieu F, 2007, CLIN MICROBIOL REV, V20, P79, DOI 10.1128/CMR.00015-06; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Dmitriev A, 2004, ACTA VET BRNO, V73, P215, DOI 10.2754/avb200473020215; Domelier AS, 2009, J BACTERIOL, V191, P4776, DOI 10.1128/JB.00426-09; Elsner A, 2002, INFECT IMMUN, V70, P4859, DOI 10.1128/IAI.70.9.4859-4869.2002; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Franken C, 2001, MOL MICROBIOL, V41, P925, DOI 10.1046/j.1365-2958.2001.02563.x; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gleich-Theurer U, 2009, INFECT IMMUN, V77, P3817, DOI 10.1128/IAI.00826-08; Granlund M, 1998, J INFECT DIS, V177, P967, DOI 10.1086/515233; Granlund M, 2001, J BACTERIOL, V183, P2560, DOI 10.1128/JB.183.8.2560-2569.2001; Gutekunst H, 2003, INFECT IMMUN, V71, P5056, DOI 10.1128/IAI.71.9.5056-5064.2003; Hery-Arnaud G, 2005, J BACTERIOL, V187, P6248, DOI 10.1128/JB.187.17.6248-6252.2005; Hery-Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4668, DOI 10.1128/AEM.02604-06; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kling DE, 1999, BIOTECHNIQUES, V27, P24, DOI 10.2144/99271bm03; Lamy MC, 2006, MICROBES INFECT, V8, P1714, DOI 10.1016/j.micinf.2006.02.008; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Luan SL, 2003, GENE, V312, P305, DOI 10.1016/S0378-1119(03)00634-6; MOREILLON P, 1999, INFECT DIS MOSBY, P501; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Olliver A, 2005, ANTIMICROB AGENTS CH, V49, P289, DOI 10.1128/AAC.49.1.289-301.2005; PREISSNER KT, 2005, CELLULAR MICROBIOLOG, P87; QUENTIN R, 1995, J CLIN MICROBIOL, V33, P2576, DOI 10.1128/JCM.33.10.2576-2581.1995; ROGERS MB, 1994, J BACTERIOL, V176, P4376, DOI 10.1128/jb.176.14.4376-4384.1994; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; RUBENS CE, 1989, J BACTERIOL, V171, P5531, DOI 10.1128/jb.171.10.5531-5535.1989; Sambrook J., 2002, MOL CLONING LAB MANU; Samen UM, 2006, INFECT IMMUN, V74, P5625, DOI 10.1128/IAI.00667-06; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Takahashi S, 2002, J INFECT DIS, V186, P1034, DOI 10.1086/342950; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Terao Y, 2002, INFECT IMMUN, V70, P993; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; YILIRIM AO, 2002, RES VET SCI, V2, P131	53	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10794	10.1371/journal.pone.0010794	http://dx.doi.org/10.1371/journal.pone.0010794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520730	gold, Green Published, Green Submitted			2022-12-25	WOS:000278034600018
J	Hagglof, C; Hammarsten, P; Josefsson, A; Stattin, P; Paulsson, J; Bergh, A; Ostman, A				Hagglof, Christina; Hammarsten, Peter; Josefsson, Andreas; Stattin, Par; Paulsson, Janna; Bergh, Anders; Ostman, Arne			Stromal PDGFR beta Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; INHIBITION; CARCINOMA; MICROENVIRONMENT; HETEROGENEITY; CHEMOTHERAPY; TARGETS; MARKERS	Background: The identification of new prognostic markers for prostate cancer is highly warranted, since it is difficult to identify patients requiring curative treatment. Data from both experimental models and clinical samples have identified important functions of PDGFR beta on pericytes and fibroblasts in the tumor stroma. Methodology/Principal Findings: In this study the prognostic significance of PDGFRb in prostate cancer stroma, and in matched non-malignant tissue, was evaluated with immunohistochemistry. PDGFRb expression was analyzed in normal and tumor stroma from more than 300 prostate cancer patients. High PDGFR beta expression in tumor stroma was associated with large tumor size, advanced stage, high Gleason score and high vessel density. Perivascular PDGFR beta staining in tumors was also correlated with high Gleason score. Correlations were also observed between PDGFR beta status in tumor stroma and nonmalignant stroma. Similarly, high PDGFR beta expression in adjacent non-malignant tissue stroma correlated with large tumor size, advanced stage, high Gleason score and proliferation in non-malignant epithelium. Interestingly, high levels of PDGFR beta in the stroma of tumor and non-malignant tissue were associated with shorter cancer specific survival in prostate cancer patients. Conclusions/Significance: The study revealed a number of novel associations between stromal PDGFR beta expression in prostate tumors and several important clinical characteristics, including survival.	[Hagglof, Christina; Paulsson, Janna; Ostman, Arne] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hammarsten, Peter; Josefsson, Andreas; Bergh, Anders] Umea Univ, Dept Med Biosci, Umea, Sweden; [Stattin, Par] Umea Univ, Dept Surg, Umea, Sweden; [Stattin, Par] Umea Univ, Dept Perioperat Sci Urol & Androl, Umea, Sweden	Karolinska Institutet; Umea University; Umea University; Umea University	Hagglof, C (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	arne.ostman@ki.se	Josefsson, Andreas/T-2311-2019	Josefsson, Andreas/0000-0002-2013-0887	Swedish Research Council; Swedish Cancer Society; Konung Gustaf V.s Jubileumsfond	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Konung Gustaf V.s Jubileumsfond	This study was funded by unrestricted grants from a Linna grant to the STARGET network from the Swedish Research Council and grants from Swedish Cancer Society and Konung Gustaf V.s Jubileumsfond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Fleischmann A, 2009, PROSTATE, V69, P976, DOI 10.1002/pros.20948; FORSBERG K, 1993, P NATL ACAD SCI USA, V90, P393, DOI 10.1073/pnas.90.2.393; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Johansson A, 2007, PROSTATE, V67, P1664, DOI 10.1002/pros.20657; Josefsson A, 2005, EUR UROL, V48, P577, DOI 10.1016/j.eururo.2005.05.016; Karja V, 2005, ANTICANCER RES, V25, P4435; Kitadai Y, 2006, AM J PATHOL, V169, P2054, DOI 10.2353/ajpath.2006.060653; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Lissbrant IF, 2001, SCAND J UROL NEPHROL, V35, P437; Mathew P, 2007, CLIN CANCER RES, V13, P5816, DOI 10.1158/1078-0432.CCR-07-1269; Mathew P, 2009, J UROLOGY, V181, P81, DOI 10.1016/j.juro.2008.09.006; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Nupponen NN, 2008, MODERN PATHOL, V21, P265, DOI 10.1038/modpathol.3800989; Orimo A, 2007, CANCER BIOL THER, V6, P618, DOI 10.4161/cbt.6.4.4255; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Pietras K, 2002, CANCER RES, V62, P5476; Pietras K, 2001, CANCER RES, V61, P2929; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Skobe M, 1998, P NATL ACAD SCI USA, V95, P1050, DOI 10.1073/pnas.95.3.1050; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Yanagisawa N, 2007, HUM PATHOL, V38, P1611, DOI 10.1016/j.humpath.2007.04.008	28	77	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10747	10.1371/journal.pone.0010747	http://dx.doi.org/10.1371/journal.pone.0010747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505768	Green Submitted, Green Published, gold			2022-12-25	WOS:000278017300018
J	Horner, V; Proctor, D; Bonnie, KE; Whiten, A; de Waal, FBM				Horner, Victoria; Proctor, Darby; Bonnie, Kristin E.; Whiten, Andrew; de Waal, Frans B. M.			Prestige Affects Cultural Learning in Chimpanzees	PLOS ONE			English	Article							PAN-TROGLODYTES; WILD CHIMPANZEES; TOOL USE; TRANSMISSION; RANK; INNOVATION; STRATEGIES; BEHAVIOR; CHILDREN; SKILLS	Humans follow the example of prestigious, high-status individuals much more readily than that of others, such as when we copy the behavior of village elders, community leaders, or celebrities. This tendency has been declared uniquely human, yet remains untested in other species. Experimental studies of animal learning have typically focused on the learning mechanism rather than on social issues, such as who learns from whom. The latter, however, is essential to understanding how habits spread. Here we report that when given opportunities to watch alternative solutions to a foraging problem performed by two different models of their own species, chimpanzees preferentially copy the method shown by the older, higher-ranking individual with a prior track-record of success. Since both solutions were equally difficult, shown an equal number of times by each model and resulted in equal rewards, we interpret this outcome as evidence that the preferred model in each of the two groups tested enjoyed a significant degree of prestige in terms of whose example other chimpanzees chose to follow. Such prestige-based cultural transmission is a phenomenon shared with our own species. If similar biases operate in wild animal populations, the adoption of culturally transmitted innovations may be significantly shaped by the characteristics of performers.	[Horner, Victoria; Proctor, Darby; de Waal, Frans B. M.] Emory Univ, Yerkes Natl Primate Res Ctr, Lawrenceville, GA USA; [Bonnie, Kristin E.] Beloit Coll, Dept Psychol, Beloit, WI 53511 USA; [Whiten, Andrew] Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9AJ, Fife, Scotland	Emory University; Beloit College; University of St Andrews	Horner, V (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Lawrenceville, GA USA.	vhorner@emory.edu	Proctor, Darby/AAB-2749-2019	Proctor, Darby/0000-0002-5465-6705; Whiten, Andrew/0000-0003-2426-5890	Living Links Center of Emory University; Emory University's College of Arts Sciences; National Institutes of Health [RR-00165]; Royal Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER	Living Links Center of Emory University; Emory University's College of Arts Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the Living Links Center of Emory University, Emory University's College of Arts & Sciences, and by a base grant from the National Institutes of Health (RR-00165) to Yerkes National Primate Research Center (YNPRC). A. Whiten was supported by a Royal Society Leverhulme Trust Senior Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKOW JH, 1975, CURR ANTHROPOL, V16, P553, DOI 10.1086/201619; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; BOESCH C, 1995, INT J PRIMATOL, V16, P1, DOI 10.1007/BF02700150; Boesch C, 1998, CURR ANTHROPOL, V39, P591, DOI 10.1086/204785; Boesch C, 2007, J COMP PSYCHOL, V121, P227, DOI 10.1037/0735-7036.121.3.227; Bonnie KE, 2006, PRIMATES, V47, P27, DOI 10.1007/s10329-005-0141-0; Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; CHANCE MRA, 1967, MAN, V2, P503, DOI 10.2307/2799336; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; de Waal FBM, 2001, APE SUSHI MASTER; De Waal FBM, 2008, SCIENCE, V319, P569, DOI 10.1126/science.319.5863.569c; Durham WH., 1991, COEVOLUTION GENES CU; Goodall J., 1963, S ZOOL SOC LOND, V10, P39; GOODALL J, 1973, PRECULTURAL PRIMATE, V1; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Horner V, 2010, MIND CHIMPANZEE; Horner V, 2006, P NATL ACAD SCI USA, V103, P13878, DOI 10.1073/pnas.0606015103; Hrubesch C, 2009, ANIM COGN, V12, P209, DOI 10.1007/s10071-008-0183-y; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; Laland KN, 2004, LEARN BEHAV, V32, P4; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew WC, 1997, INT J PRIMATOL, V18, P353, DOI 10.1023/A:1026382316131; MENZEL EWJ, 1973, PRECULTURAL PRIMATE; Murray CM, 2006, BEHAV ECOL, V17, P1020, DOI 10.1093/beheco/arl042; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; Nishida T, 2009, PRIMATES, V50, P23, DOI 10.1007/s10329-008-0109-y; Ottoni EB, 2005, ANIM COGN, V8, P215, DOI 10.1007/s10071-004-0245-8; Pongracz P, 2008, ANIM COGN, V11, P75, DOI 10.1007/s10071-007-0090-7; Reader SM, 2001, INT J PRIMATOL, V22, P787, DOI 10.1023/A:1012069500899; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	34	113	113	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10625	10.1371/journal.pone.0010625	http://dx.doi.org/10.1371/journal.pone.0010625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502702	gold, Green Published, Green Submitted			2022-12-25	WOS:000277845400001
J	Li, J; Ribeiro, JMC; Yan, GY				Li, Jun; Ribeiro, Jose M. C.; Yan, Guiyun			Allelic Gene Structure Variations in Anopheles gambiae Mosquitoes	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE SURVEY; MESSENGER-RNA; AB-INITIO; SEQUENCE; PREDICTION; EXON; REFRACTORINESS; IDENTIFICATION; ISOFORMS	Background: Allelic gene structure variations and alternative splicing are responsible for transcript structure variations. More than 75% of human genes have structural isoforms of transcripts, but to date few studies have been conducted to verify the alternative splicing systematically. Methodology/Principal Findings: The present study used expressed sequence tags (ESTs) and EST tagged SNP patterns to examine the transcript structure variations resulting from allelic gene structure variations in the major human malaria vector, Anopheles gambiae. About 80% of 236,004 available A. gambiae ESTs were successfully aligned to A. gambiae reference genomes. More than 2,340 transcript structure variation events were detected. Because the current A. gambiae annotation is incomplete, we re-annotated the A. gambiae genome with an A. gambiae-specific gene model so that the effect of variations on gene coding could be better evaluated. A total of 15,962 genes were predicted. Among them, 3,873 were novel genes and 12,089 were previously identified genes. The gene completion rate improved from 60% to 84%. Based on EST support, 82.5% of gene structures were predicted correctly. In light of the new annotation, we found that similar to 78% of transcript structure variations were located within the coding sequence (CDS) regions, and >65% of variations in the CDS regions have the same open-reading-frame. The association between transcript structure isoforms and SNPs indicated that more than 28% of transcript structure variation events were contributed by different gene alleles in A. gambiae. Conclusions/Significance: We successfully expanded the A. gambiae genome annotation. We predicted and analyzed transcript structure variations in A. gambiae and found that allelic gene structure variation plays a major role in transcript diversity in this important human malaria vector.	[Li, Jun] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA; [Ribeiro, Jose M. C.] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Irvine	Li, J (corresponding author), Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA.	junli@umn.edu		Ribeiro, Jose/0000-0002-9107-0818	National Institutes of Health [R56AI081829]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, R56AI081829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by a grant from the National Institutes of Health (R56AI081829 to Jun Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; ESTES PA, 1992, J BIOL CHEM, V267, P14902; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gomez SM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r39; Gorman MJ, 1997, GENETICS, V146, P965; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kriventseva EV, 2005, GENOME RES, V15, P893, DOI 10.1101/gr.3756405; Li J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r24; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Malko DB, 2006, GENOME RES, V16, P505, DOI 10.1101/gr.4236606; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; Menge DM, 2006, GENETICS, V173, P235, DOI 10.1534/genetics.105.055129; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nembaware V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-265; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; RIBEIRO JMC, 2007, ANOGOLD; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; SAMBROOK J, 1977, NATURE, V268, P101, DOI 10.1038/268101a0; Schlueter SD, 2003, NUCLEIC ACIDS RES, V31, P3597, DOI 10.1093/nar/gkg533; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Swart EC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-8; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; WANG Z, 2008, SPLICING REGULATION; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	41	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10699	10.1371/journal.pone.0010699	http://dx.doi.org/10.1371/journal.pone.0010699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502664	gold, Green Published, Green Submitted			2022-12-25	WOS:000277845400009
J	Bhaskaran, MD; Smith, BN				Bhaskaran, Muthu D.; Smith, Bret N.			Cannabinoid-Mediated Inhibition of Recurrent Excitatory Circuitry in the Dentate Gyrus in a Mouse Model of Temporal Lobe Epilepsy	PLOS ONE			English	Article							CA1 PYRAMIDAL CELLS; KAINIC ACID; HIPPOCAMPAL SLICES; MOSSY FIBERS; SYNAPTIC REORGANIZATION; GABAERGIC INTERNEURONS; SPONTANEOUS SEIZURES; NEUROPEPTIDE-Y; GRANULE CELLS; RECEPTOR	Temporal lobe epilepsy (TLE) is a neurological condition associated with neuron loss, axon sprouting, and hippocampal sclerosis, which results in modified synaptic circuitry. Cannabinoids appear to be anti-convulsive in patients and animal models of TLE, but the mechanisms of this effect are not known. A pilocarpine-induced status epilepticus mouse model of TLE was used to study the effect of cannabinoid agonists on recurrent excitatory circuits of the dentate gyrus using electrophysiological recordings in hippocampal slices isolated from control mice and mice with TLE. Cannabinoid agonists WIN 55,212-2, anandamide (AEA), or 2-arachydonoylglycerol (2-AG) reduced the frequency of spontaneous and tetrodotoxin-resistant excitatory postsynaptic currents (EPSCs) in mice with TLE, but not in controls. WIN 55,212-2 also reduced the frequency of EPSCs evoked by glutamate-photolysis activation of other granule cells in epileptic mice. Secondary population discharges evoked after antidromic electrical stimulation of mossy fibers in the hilus were also attenuated by cannabinoid agonists. Agonist effects were blocked by the cannabinoid type 1 receptor (CB1R) antagonist AM251. No change in glutamate release was observed in slices from mice that did not undergo status epilepticus. Western blot analysis suggested an up-regulation of CB1R in the dentate gyrus of animals with TLE. These findings indicate that activation of CB1R present on nerve terminals can suppress recurrent excitation in the dentate gyrus of mice with TLE. This suggests a mechanism for the anti-convulsive role of cannabinoids aimed at modulating receptors on synaptic terminals expressed de novo after epileptogenesis.	[Bhaskaran, Muthu D.; Smith, Bret N.] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Bhaskaran, Muthu D.; Smith, Bret N.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	University of Kentucky; Tulane University	Bhaskaran, MD (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA.	bret.smith@uky.edu			National Institutes of Health [R21 NS052302]; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from National Institutes of Health (R21 NS052302) and the Epilepsy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Baker D, 2003, EXPERT OPIN INV DRUG, V12, P561; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; BHASKARAN M, 2010, EXP NEUROL; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Braakman H, 2009, EPILEPSIA, V50, P129; BUCKMASTER PS, 1992, HIPPOCAMPUS, V2, P349, DOI 10.1002/hipo.450020403; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chen J, 2007, SHOCK, V27, P58; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Chiu CYQ, 2008, NEUROPHARMACOLOGY, V54, P68, DOI 10.1016/j.neuropharm.2007.06.026; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; CRONIN J, 1988, BRAIN RES, V474, P181, DOI 10.1016/0006-8993(88)90681-6; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Deshpande LS, 2007, NEUROSCI LETT, V411, P11, DOI 10.1016/j.neulet.2006.09.046; Dudek FE, 1997, J CLIN NEUROPHYSIOL, V14, P90, DOI 10.1097/00004691-199703000-00002; Epsztein J, 2005, J NEUROSCI, V25, P8229, DOI 10.1523/JNEUROSCI.1469-05.2005; Falenski KW, 2007, NEUROSCIENCE, V146, P1232, DOI 10.1016/j.neuroscience.2007.01.065; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Gordon E, 2001, EPILEPSIA, V42, P1266, DOI 10.1046/j.1528-1157.2001.19301.x; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hendriksen H, 2001, EUR J NEUROSCI, V14, P1475, DOI 10.1046/j.0953-816x.2001.01778.x; HOUSER CR, 1990, J NEUROSCI, V10, P267; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katona I, 2000, NEUROSCIENCE, V100, P797, DOI 10.1016/S0306-4522(00)00286-4; Katona I, 1999, J NEUROSCI, V19, P4544; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Lynch M, 2000, J NEUROPHYSIOL, V83, P693, DOI 10.1152/jn.2000.83.2.693; Magloczky Z, 2000, NEUROSCIENCE, V96, P7, DOI 10.1016/S0306-4522(99)00474-1; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MATHERN GW, 1995, J NEUROSCI, V15, P3990; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; NADLER JV, 1980, BRAIN RES, V182, P1; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nakajima S, 1991, Hippocampus, V1, P67, DOI 10.1002/hipo.450010107; Patrylo PR, 1998, J NEUROPHYSIOL, V79, P418, DOI 10.1152/jn.1998.79.1.418; Perez Y, 1996, EUR J NEUROSCI, V8, P736, DOI 10.1111/j.1460-9568.1996.tb01259.x; RACINE R, 1972, ELECTROEN CLIN NEURO, V32, P295, DOI 10.1016/0013-4694(72)90178-2; SCHARFMAN HE, 1994, J NEUROPHYSIOL, V72, P2167, DOI 10.1152/jn.1994.72.5.2167; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; SLOVITER RS, 1991, J COMP NEUROL, V308, P381, DOI 10.1002/cne.903080306; Smith BN, 1997, NEUROSCI LETT, V222, P1, DOI 10.1016/S0304-3940(97)13326-2; Smith BN, 2002, J NEUROPHYSIOL, V87, P1655, DOI 10.1152/jn.00581.2001; Smith BN, 2001, J NEUROPHYSIOL, V85, P1, DOI 10.1152/jn.2001.85.1.1; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; SWARTZWELDER HS, 1987, BRAIN RES, V410, P362; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Tu B, 2005, J NEUROSCI, V25, P1718, DOI 10.1523/JNEUROSCI.4835-04.2005; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Winokur RS, 2004, EPILEPSY RES, V58, P93, DOI 10.1016/j.eplepsyres.2004.01.002; Wuarin JP, 1996, J NEUROSCI, V16, P4438; Wuarin JP, 2001, J NEUROPHYSIOL, V85, P1067, DOI 10.1152/jn.2001.85.3.1067; Zhu ZQ, 1997, J NEUROPATH EXP NEUR, V56, P988, DOI 10.1097/00005072-199709000-00004	64	58	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10683	10.1371/journal.pone.0010683	http://dx.doi.org/10.1371/journal.pone.0010683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498848	Green Published, gold, Green Submitted			2022-12-25	WOS:000277773700019
J	Tolimieri, N; Anderson, MJ				Tolimieri, Nick; Anderson, Marti J.			Taxonomic Distinctness of Demersal Fishes of the California Current: Moving Beyond Simple Measures of Diversity for Marine Ecosystem-Based Management	PLOS ONE			English	Article							LARGE-SCALE PATTERNS; GROUNDFISH ASSEMBLAGES; SPECIES-DIVERSITY; COMMUNITY DIVERSITY; BIODIVERSITY; SEA; HABITATS; RICHNESS; HOTSPOTS; AREAS	Background: Large-scale patterns or trends in species diversity have long interested ecologists. The classic pattern is for diversity (e. g., species richness) to decrease with increasing latitude. Taxonomic distinctness is a diversity measure based on the relatedness of the species within a sample. Here we examined patterns of taxonomic distinctness in relation to latitude (ca. 32-48 degrees N) and depth (ca. 50-1220 m) for demersal fishes on the continental shelf and slope of the US Pacific coast. Methodology/Principal Findings: Both average taxonomic distinctness (AvTD) and variation in taxonomic distinctness (VarTD) changed with latitude and depth. AvTD was highest at approximately 500 m and lowest at around 200 m bottom depth. Latitudinal trends in AvTD were somewhat weaker and were depth-specific. AvTD increased with latitude on the shelf (50-150 m) but tended to decrease with latitude at deeper depths. Variation in taxonomic distinctness (VarTD) was highest around 300 m. As with AvTD, latitudinal trends in VarTD were depth-specific. On the shelf (50-150 m), VarTD increased with latitude, while in deeper areas the patterns were more complex. Closer inspection of the data showed that the number and distribution of species within the class Chondrichthyes were the primary drivers of the overall patterns seen in AvTD and VarTD, while the relatedness and distribution of species in the order Scorpaeniformes appeared to cause the relatively low observed values of AvTD at around 200 m. Conclusions/Significance: These trends contrast to some extent the patterns seen in earlier studies for species richness and evenness in demersal fishes along this coast and add to our understanding of diversity of the demersal fishes of the California Current.	[Tolimieri, Nick] NOAA, NW Fisheries Sci Ctr, Seattle, WA USA; [Anderson, Marti J.] Massey Univ, Inst Informat & Math Sci, Auckland, New Zealand	National Oceanic Atmospheric Admin (NOAA) - USA; Massey University	Tolimieri, N (corresponding author), NOAA, NW Fisheries Sci Ctr, Seattle, WA USA.	nick.tolimieri@noaa.gov	Anderson, Marti J./AAQ-9038-2021	Anderson, Marti J./0000-0002-4018-4049	NOAA Fisheries (Northwest Fisheries Science Center); Royal Society of New Zealand Marsden [MAU0713]	NOAA Fisheries (Northwest Fisheries Science Center)(National Oceanic Atmospheric Admin (NOAA) - USA); Royal Society of New Zealand Marsden(Royal Society of New ZealandMarsden Fund (NZ))	This research was supported in part by NOAA Fisheries (Northwest Fisheries Science Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M.J. Anderson was partially supported by a Royal Society of New Zealand Marsden Grant, no. MAU0713 and also by a Research Associateship from the US National Research Council, through C. Jordan at NOAA.	Arvanitidis C, 2009, MAR ECOL PROG SER, V382, P265, DOI 10.3354/meps07955; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Brewin PE, 2009, MAR ECOL PROG SER, V383, P225, DOI 10.3354/meps07987; Brown BE, 2002, MAR BIOL, V141, P21, DOI 10.1007/s00227-002-0810-0; Builder-Ramsey T, 2002, NMFSNWFSC55 NOAA US; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carr MH, 2002, P NATL ACAD SCI USA, V99, P11241, DOI 10.1073/pnas.162653499; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cowling RM, 1995, BIODIVERSITY LETT, V2, P127; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Ellingsen KE, 2005, J ANIM ECOL, V74, P1069, DOI 10.1111/j.1365-2656.2005.01004.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FAITH DP, 1994, PHILOS T R SOC B, V345, P45, DOI 10.1098/rstb.1994.0085; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gristina M, 2006, FISH RES, V81, P60, DOI 10.1016/j.fishres.2006.05.010; Guo Y, 2001, J MAR BIOL ASSOC UK, V81, P755, DOI 10.1017/S0025315401004568; Hastie T., 1999, GEN ADDITIVE MODELS; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HORN MH, 1978, J BIOGEOGR, V5, P23, DOI 10.2307/3038105; Horn MH, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P3; Jagielo T, 2003, FISH B-NOAA, V101, P545; Juan-Jorda MJ, 2009, FISH OCEANOGR, V18, P1, DOI 10.1111/j.1365-2419.2008.00489.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Keller AA, 2007, 2003 US W COAST BOTT; KRIEGER KJ, 1993, FISH B-NOAA, V91, P87; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Levin PS, 2009, J APPL ECOL, V46, P735, DOI 10.1111/j.1365-2664.2009.01667.x; Levin PS, 2002, AM SCI, V90, P6, DOI 10.1511/2002.1.6; Love M. S., 2002, ROCKFISHES NE PACIFI; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; McClatchie S, 1997, DEEP-SEA RES PT I, V44, P647, DOI 10.1016/S0967-0637(96)00096-9; Merigot B, 2007, FISH RES, V88, P120, DOI 10.1016/j.fishres.2007.08.003; Merigot B, 2007, ESTUAR COAST SHELF S, V73, P123, DOI 10.1016/j.ecss.2006.12.017; MERRETT NR, 1994, ENVIRON BIOL FISH, V41, P207, DOI 10.1007/BF02197846; MURRAY SN, 1981, J BIOGEOGR, V8, P339, DOI 10.2307/2844755; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Nelson JS, 1984, FISHES WORLD; NEWELL IRWIN M., 1948, PROC AMER PHIL SOC, V92, P155; PEARCY W G, 1982, Biological Oceanography, V1, P375; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Renaud PE, 2009, MAR ECOL PROG SER, V382, P239, DOI 10.3354/meps07963; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Rogers SI, 1999, J ANIM ECOL, V68, P769, DOI 10.1046/j.1365-2656.1999.00327.x; Rogers SI, 2008, MAR POLLUT BULL, V56, P880, DOI 10.1016/j.marpolbul.2008.01.035; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Somerfield PJ, 2008, ICES J MAR SCI, V65, P1462, DOI 10.1093/icesjms/fsn118; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tolimieri N, 2007, ENVIRON BIOL FISH, V78, P241, DOI 10.1007/s10641-006-9093-5; Tolimieri N, 2006, T AM FISH SOC, V135, P317, DOI 10.1577/T05-092.1; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wildsmith MD, 2009, MAR POLLUT BULL, V58, P1250, DOI 10.1016/j.marpolbul.2009.06.008; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WILLIG RM, 2000, ENCY BIODIVERSITY, P701; Wood S.N., 2017, GEN ADDITIVE MODELS, V2, P1, DOI [DOI 10.1201/9781315370279, 10.1201/9781315370279]; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	73	51	55	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10653	10.1371/journal.pone.0010653	http://dx.doi.org/10.1371/journal.pone.0010653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498727	gold, Green Submitted, Green Published			2022-12-25	WOS:000277773700006
J	Yu, JJ; Fu, PF; Pink, JJ; Dawson, D; Wasman, J; Orem, J; Mwanda, WO; Zhu, HL; Liang, XB; Guo, Y; Petros, WP; Mitsuyasu, RT; Wabinga, H; Remick, SC				Yu, Jing Jie; Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay; Orem, Jackson; Mwanda, Walter O.; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Mitsuyasu, Ronald T.; Wabinga, Henry; Remick, Scot C.			HPV Infection and EGFR Activation/Alteration in HIV-Infected East African Patients with Conjunctival Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS TYPE-16; GROWTH-FACTOR RECEPTOR; CERVICAL-CANCER; LUNG-CANCER; E5 GENE; EXPRESSION; UGANDA; HEAD; NECK	Background: There has been substantial growth in the numbers of patients with conjunctival squamous cell carcinoma infected with HIV in East Africa. The natural history of the conjunctival squamous cell carcinoma appears to be unique in this region of the world, but the etiologic mechanism unclear and therapeutic options limited. This research was carried out to determine if conjunctival squamous cell carcinoma harbors human papillomavirus DNA and is associated with activation of the EGFR signaling pathway. Positive findings would identify etiologic causes and provide clinical guidance to improve treatment. Methods/Findings: Expression of p-MAPK/MAPK, p-Akt/Akt and p-EGFR/EGFR in cell nuclei and cytoplasm of 38 FFPE specimens were assessed by immunohistochemistry; HPV genotype was detected by qPCR assay; EGFR mutation was assessed by DNA sequencing analysis; and EGFR mRNA expression was measured using relative qPCR. Statistical analyses included two-sided Fisher exact test or chi-square test, Spearman correlation coefficient and ANOVA. HPV 18 was found in 61% of samples, with HPV 16 double-genotype in 6 patients (16%). Immunohistochemistry and qPCR data suggest that activation and expression of the EGFR signaling pathway is related to disease progression of conjunctival cancer. The associations between cytoplasmic p-MAPK, cytoplasmic p-Akt and tumor invasiveness were significant (p = 0.05 or 0.028). Nuclear p-EGFR appeared only in invasive tumors. A significant positive association between EGFR expression and disease invasiveness was observed (p = 0.01). A SNP in 10 patients and one missense mutation were found within EGFR tyrosine kinase domain. Statistical analysis indicates that patients with measurable EGFR expression more likely harbor EGFR mutations, compared to those with negative EGFR expression 935.3% vs. 0%). Conclusions/Significance: We conclude that HPV types 16/18 infection is frequent in East African patients with AIDS-associated squamous cell carcinoma of the conjunctiva. EGFR activation/alteration may contribute to and sustain the high prevalence of this cancer. Our findings hint that adoption of HPV vaccination strategies may impact the incidence of conjunctival carcinoma. Agents that target the EGFR pathway may have potential therapeutic benefit.	[Yu, Jing Jie; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Remick, Scot C.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA; [Yu, Jing Jie; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Remick, Scot C.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Pharm, Morgantown, WV 26506 USA; [Yu, Jing Jie; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Remick, Scot C.] W Virginia Univ, Mol Med Core Facil, Sch Med, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA; [Yu, Jing Jie; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Remick, Scot C.] W Virginia Univ, Mol Med Core Facil, Sch Pharm, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA; [Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay] Case Western Reserve Univ, Ctr AIDS Res, Dept Biostat & Epidemiol, Cleveland, OH 44106 USA; [Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay] Case Western Reserve Univ, Ctr AIDS Res, Dept Med, Cleveland, OH 44106 USA; [Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay] Case Western Reserve Univ, Ctr AIDS Res, Dept Pathol, Cleveland, OH 44106 USA; [Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Orem, Jackson] Makerere Univ, Uganda Canc Inst, Sch Med, Kampala, Uganda; [Wabinga, Henry] Makerere Univ, Dept Pathol, Sch Med, Kampala, Uganda; [Mwanda, Walter O.] Univ Nairobi, Kenyatta Natl Hosp, Dept Pathol, Nairobi, Kenya; [Mitsuyasu, Ronald T.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Makerere University; Makerere University; Kenyatta National Hospital; University of Nairobi; University of California System; University of California Los Angeles	Yu, JJ (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA.	jyu@hsc.wvu.edu	Fu, Pingfu/O-5415-2019	Fu, Pingfu/0000-0002-2334-5218	National Institutes of Health [CA70091, CA43703, CA70081, CA121947, P30 CA43703]; NATIONAL CANCER INSTITUTE [T32CA070091, P30CA043703, U01CA070081, U01CA121947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (CA70091, CA43703, CA70081, CA121947 and P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar LV, 2006, SEX TRANSM INFECT, V82, P31, DOI 10.1136/sti.2005.015131; ATEENYIAGABA C, 1995, LANCET, V345, P695, DOI 10.1016/S0140-6736(95)90870-6; Begum S, 2007, CLIN CANCER RES, V13, P1186, DOI 10.1158/1078-0432.CCR-06-1690; Bertelsen BI, 2006, VIRCHOWS ARCH, V449, P141, DOI 10.1007/s00428-006-0232-3; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Cheng YH, 2007, COMM COM INF SC, V2, P1; de Koning Maurits Nc, 2008, Infect Agent Cancer, V3, P12, DOI 10.1186/1750-9378-3-12; Ferenczy A, 2002, LANCET ONCOL, V3, P11, DOI 10.1016/S1470-2045(01)00617-9; Gillison ML, 2006, J CLIN ONCOL, V24, P5623, DOI 10.1200/JCO.2006.07.1829; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Grunwald V, 2003, JNCI-J NATL CANCER I, V95, P851, DOI 10.1093/jnci/95.12.851; GU ZM, 1995, J VIROL, V69, P8051, DOI 10.1128/JVI.69.12.8051-8056.1995; Ha PK, 2002, CLIN CANCER RES, V8, P1203; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kenny D, 2002, J HISTOCHEM CYTOCHEM, V50, P1219, DOI 10.1177/002215540205000909; Kohrenhagen N, 2008, J OBSTET GYNAECOL RE, V34, P293, DOI 10.1111/j.1447-0756.2008.00749.x; Lindh M, 2007, J CLIN VIROL, V40, P321, DOI 10.1016/j.jcv.2007.09.009; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Moubayed P, 2004, AM J CLIN PATHOL, V122, P938, DOI [10.1309/T189UWWVB71M9VRC, 10.1309/T189UwVVVB71M9VRC]; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Newton R, 2002, BRIT J CANCER, V87, P301, DOI 10.1038/sj.bjc.6600451; Orem J, 2004, CURR OPIN ONCOL, V16, P468, DOI 10.1097/00001622-200409000-00010; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PIM D, 1992, ONCOGENE, V7, P27; Sanclemente G, 2002, J EUR ACAD DERMATOL, V16, P231, DOI 10.1046/j.1473-2165.2002.00419.x; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shepler TR, 2006, OPHTHAL PLAST RECONS, V22, P113, DOI 10.1097/01.iop.0000202609.92772.c3; Stoppler MC, 1996, VIROLOGY, V223, P251, DOI 10.1006/viro.1996.0475; Waddell KM, 1996, BRIT J OPHTHALMOL, V80, P503, DOI 10.1136/bjo.80.6.503; Zhang BY, 2005, ONCOGENE, V24, P2585, DOI 10.1038/sj.onc.1208453	31	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10477	10.1371/journal.pone.0010477	http://dx.doi.org/10.1371/journal.pone.0010477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498858	Green Published, gold, Green Submitted			2022-12-25	WOS:000277773700001
J	Cohen, J; Dibner, MS; Wilson, A				Cohen, Joshua; Dibner, Maria Staroselsky; Wilson, Andrew			Development of and Access to Products for Neglected Diseases	PLOS ONE			English	Article							DRUG DEVELOPMENT; MARKET	Introduction: Prior research on neglected disease drug development suggested inadequate funding was responsible for relatively few new approvals. In response, significantly more resources have been allocated towards development of drugs targeting neglected diseases. Our objective was to reassess drug development between1975 and 1999, evaluate progress in neglected disease drug development since 2000, and explain how increased numbers of approvals are a necessary but insufficient condition to improving access. Methods: To assess numbers of approvals targeting neglected diseases, we employed two distinct methodologies: First, to revisit numbers published in Trouiller et al. (2002) we used their method to count marketed new chemical entities (NCEs) between 1975 and 1999. Second, using the G-Finder report as a benchmark, we identified which diseases are currently considered "neglected'' to tally approvals in the 1975-1999 and 2000-2009 periods. Searching PharmaProjects and IMS R&D Focus databases as well as websites from numerous drug regulatory agencies, we identified new drug approvals and indications. Also, we examined the World Health Organization's (WHO) Essential Drug List (EDL) to see which drugs and indications were on the list. Findings: Upon recount, using Trouiller et al. methodology, we found that between 1975 and 1999 more NCEs (n = 32) targeting tropical diseases and tuberculosis were approved than reported in Trouiller et al. (n = 16). Using the G-Finder method of defining neglected diseases, we found 46 new drug approvals between 1975 and 1999. WHO included 85% of these drugs on the EDL. In the period 2000 to May 2009, despite much greater funding, only 26 new drugs and vaccines for neglected diseases were marketed. Of these, WHO placed 50% on the EDL. Conclusions: Product approvals for neglected diseases have increased, though progress has been uneven, with malaria appearing to benefit most in the short run from increased funding, while less success has been booked in other disease categories. Uneven progress suggests funding could be better targeted, particularly with regard to neglected diseases that have hitherto received scant attention. In addition, policymakers should focus on other aspects related to access. Besides drug development, there are the issues of EDL listing, architecture, availability, affordability, and adoption.	[Cohen, Joshua; Wilson, Andrew] Tufts Univ, Ctr Study Drug Dev, Boston, MA 02111 USA; [Dibner, Maria Staroselsky] Lahey Clin Fdn, Dept Med, Burlington, MA USA	Tufts University; Lahey Hospital & Medical Center	Cohen, J (corresponding author), Tufts Univ, Ctr Study Drug Dev, Boston, MA 02111 USA.	joshua.cohen@tufts.edu						Chirac P, 2006, LANCET, V367, P1560, DOI 10.1016/S0140-6736(06)68672-8; Dentzer S, 2009, HEALTH AFFAIR, V28, pW411, DOI 10.1377/hlthaff.28.3.w411; Fehr A, 2006, TROP MED INT HEALTH, V11, P1335, DOI 10.1111/j.1365-3156.2006.01714.x; Frost LJ, 2009, HEALTH AFFAIR, V28, P962, DOI 10.1377/hlthaff.28.4.962; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Moran M, 2009, PLOS MED, V6, P137, DOI 10.1371/journal.pmed.1000030; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; REICH M, 2008, ACCESS DO GOOD TECHN; Robertson J, 2007, CLIN PHARMACOL THER, V82, P498, DOI 10.1038/sj.clpt.6100392; Trouiller P, 2001, TROP MED INT HEALTH, V6, P945, DOI 10.1046/j.1365-3156.2001.00803.x; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; WHO Model List of Essential Medicines, 2007, WHO MOD LIST ESS MED; REVISED PROCEDURES U; ENSURING SUCCESS TAR; 2009, ECONOMIST       0515	15	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10610	10.1371/journal.pone.0010610	http://dx.doi.org/10.1371/journal.pone.0010610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485552	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563400015
J	Singh, SK; Kurfurst, R; Nizard, C; Schnebert, S; Perrier, E; Tobin, DJ				Singh, Suman K.; Kurfurst, Robin; Nizard, Carine; Schnebert, Sylvianne; Perrier, Eric; Tobin, Desmond J.			Melanin transfer in human skin cells is mediated by filopodia-a model for homotypic and heterotypic lysosome-related organelle transfer	FASEB JOURNAL			English	Article						pigmentation; myosin-X; Cdc42; phagocytosis; UV	MYOSIN-X; MELANOSOME TRANSFER; ACTIN CYTOSKELETON; HUMAN MELANOCYTES; MOLECULAR MOTOR; CYTOCHALASIN-B; CUTTING EDGE; PIGMENTATION; RECEPTOR; MOTILITY	Transfer of the melanocyte-specific and lysosome-related organelle, the melanosome, from melanocytes to keratinocytes is crucial for the protection of the skin against harmful ultraviolet radiation (UVR)-our main physiological cutaneous stressor. However, this commonplace event remains a most enigmatic process despite several early hypotheses. Recently, we and others have proposed a role for filopodia in melanin transfer, although conclusive experimental proof remained elusive. Using known filopodial markers (MyoX/Cdc42) and the filopodial disrupter, low-dose cytochalasin-B, we demonstrate here a requirement for filopodia in melanosome transfer from melanocytes to keratinocytes and also, unexpectedly, between keratinocytes. Melanin distribution throughout the skin represents the key phenotypic event in skin pigmentation. Melanocyte filopodia were also necessary for UVR-stimulated melanosome transfer, as this was also inhibited by MyoX knockdown and low-dose cytochalasin-B. Knockdown of keratinocyte MyoX protein, in its capacity as a phagocytosis effector, resulted in the inhibition of melanin uptake by keratinocytes. This indicates a central role for phagocytosis by keratinocytes of melanocyte filopodia. In summary, we propose a new model for the regulation of pigmentation in human skin cells under both constitutive and facultative (post-UVR) conditions, which we call the "filopodial-phagocytosis model." This model also provides a unique and highly accessible way to study lysosome-related organelle movement between mammalian cells.-Singh, S. K., Kurfurst, R., Nizard, C., Schnebert, S., Perrier, E., Tobin, D. J. Melanin transfer in human skin cells is mediated by filopodia-a model for homotypic and heterotypic lysosomerelated organelle transfer. FASEB J. 24, 3756-3769 (2010). www.fasebj.org	[Singh, Suman K.; Tobin, Desmond J.] Univ Bradford, Ctr Skin Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Kurfurst, Robin; Nizard, Carine; Schnebert, Sylvianne; Perrier, Eric] LVMH Rech, St Jean De Braye, France	University of Bradford	Tobin, DJ (corresponding author), Univ Bradford, Ctr Skin Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England.	d.tobin@bradford.ac.uk	Tobin, Desmond/A-5228-2009	Tobin, Desmond/0000-0003-4566-9392				Baluska F, 2004, TRENDS CELL BIOL, V14, P404, DOI 10.1016/j.tcb.2004.07.001; Berens W, 2005, PIGM CELL RES, V18, P370, DOI 10.1111/j.1600-0749.2005.00263.x; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; BOUSQUET PF, 1990, CANCER RES, V50, P1431; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Byers HR, 2000, J INVEST DERMATOL, V114, P990, DOI 10.1046/j.1523-1747.2000.00957.x; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; FITZPATRICK T B, 1963, Dermatol Wochenschr, V147, P481; Fitzpatrick T. B., 1971, MOD TRENDS DERMATOL, V4, P122; FLAXMAN BA, 1973, J INVEST DERMATOL, V60, P321, DOI 10.1111/1523-1747.ep12723167; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; Hessen DO, 2008, SOLAR RAD HUMAN HLTH, P123, DOI DOI 10.1038/NRG2897; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Kauser S, 2003, J INVEST DERMATOL, V120, P1073, DOI 10.1046/j.1523-1747.2003.12242.x; Kawakami A, 2008, J INVEST DERMATOL, V128, P143, DOI 10.1038/sj.jid.5700964; Linch CA, 2001, J FORENSIC SCI, V46, P844; Ma HJ, 2010, EXP DERMATOL, V19, pE282, DOI 10.1111/j.1600-0625.2009.00956.x; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; Menna E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000138; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Rhodes LE, 2009, FASEB J, V23, P3947, DOI 10.1096/fj.09-136077; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Scott G, 2001, J INVEST DERMATOL, V117, P1412, DOI 10.1046/j.0022-202x.2001.01575.x; Scott G, 2002, J CELL SCI, V115, P1441; Seiberg M, 2000, EXP CELL RES, V254, P25, DOI 10.1006/excr.1999.4692; SEIJI M, 1963, NATURE, V197, P1082, DOI 10.1038/1971082a0; Singh SK, 2008, EXP DERMATOL, V17, P418, DOI 10.1111/j.1600-0625.2008.00702.x; SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Thong HY, 2003, BRIT J DERMATOL, V149, P498, DOI 10.1046/j.1365-2133.2003.05473.x; Tobin DJ, 2006, CHEM SOC REV, V35, P52, DOI 10.1039/b505793k; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Vancoillie G, 2000, J INVEST DERMATOL, V114, P421, DOI 10.1046/j.1523-1747.2000.00897.x; Vidulescu C, 2004, J CELL MOL MED, V8, P388, DOI 10.1111/j.1582-4934.2004.tb00328.x; Virador VM, 2001, FASEB J, V15, P105, DOI 10.1096/fj.01-0518fje; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yonezawa S, 2003, DEV GROWTH DIFFER, V45, P175; Zhang RZ, 2004, PIGM CELL RES, V17, P62, DOI 10.1046/j.1600-0749.2003.00111.x; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zhuravlev PI, 2009, P NATL ACAD SCI USA, V106, P11570, DOI 10.1073/pnas.0812746106; ZURIER RB, 1973, P NATL ACAD SCI USA, V70, P844, DOI 10.1073/pnas.70.3.844	60	84	89	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3756	3769		10.1096/fj.10-159046	http://dx.doi.org/10.1096/fj.10-159046			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20501793				2022-12-25	WOS:000285005900015
J	Singh, G; Singh, SK; Konig, A; Reutlinger, K; Nye, MD; Adhikary, T; Eilers, M; Gress, TM; Fernandez-Zapico, ME; Ellenrieder, V				Singh, Garima; Singh, Shiv K.; Koenig, Alexander; Reutlinger, Kristina; Nye, Monica D.; Adhikary, Tillman; Eilers, Martin; Gress, Thomas M.; Fernandez-Zapico, Martin E.; Ellenrieder, Volker			Sequential Activation of NFAT and c-Myc Transcription Factors Mediates the TGF-beta Switch from a Suppressor to a Promoter of Cancer Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SIGNALING PATHWAY; GENE-EXPRESSION; SMAD PROTEINS; REPRESSION; P15(INK4B); CARCINOGENESIS; MECHANISMS; RESPONSES; ARREST	Transforming growth factor beta (TGF-beta) has a dual role in carcinogenesis, acting as a growth inhibitor in early tumor stages and a promoter of cell proliferation in advanced diseases. Although this cellular phenomenon is well established, the underlying molecular mechanisms remain elusive. Here, we report that sequential induction of NFAT and c-Myc transcription factors is sufficient and required for the TGF-beta switch from a cell cycle inhibitor to a growth promoter pathway in cancer cells. Mechanistically, TGF-beta induces in a calcineurin-dependent manner the expression and activation of NFAT factors, which then translocate into the nucleus to promote c-Myc expression. In response to TGF-beta, activated NFAT factors bind to and displace Smad3 repressor complexes from the previously identified TGF-beta inhibitory element (TIE) to transactivate the c-Myc promoter. c-Myc in turn stimulates cell cycle progression and growth through up-regulation of D-type cyclins. Most importantly, NFAT knockdown not only prevents c-Myc activation and cell proliferation, but also partially restores TGF-beta-induced cell cycle arrest and growth suppression. Taken together, this study provides the first evidence for a Smad-independent master regulatory pathway in TGF-beta-promoted cell growth that is defined by sequential transcriptional activation of NFAT and c-Myc factors.	[Nye, Monica D.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Singh, Garima; Singh, Shiv K.; Koenig, Alexander; Reutlinger, Kristina; Gress, Thomas M.; Ellenrieder, Volker] Univ Marburg, Signal Transduct & Transcript Lab, Dept Gastroenterol & Endocrinol, D-35043 Marburg, Germany; [Adhikary, Tillman] Univ Marburg, Inst Mol Biol & Tumor Res, D-35032 Marburg, Germany; [Eilers, Martin] Univ Wurzburg, Dept Physiol Chem 2, Theodor Boveri Inst, D-97074 Wurzburg, Germany	Mayo Clinic; Philipps University Marburg; Philipps University Marburg; University of Wurzburg	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu; ellenrie@med.uni-marburg.de		Gress, Thomas/0000-0002-9333-5461; Eilers, Martin/0000-0002-0376-6533	Deutsche Forschungsgemeinschaft (DFG) [SFB-TR17, KFO 210]; German Cancer Research Foundation (Deutsche Krebshilfe) [70-3022-El I]; Division of Oncology Research, Mayo Clinic Cancer Center, Miles and Shirley Fiterman Center for Digestive Disease [CA136526]; Carole and Bob Daly AACR-PANCAN Career Development Award for Pancreatic Cancer Research, Mayo Clinic Pancreatic SPORE [P50 CA102701]; NIDDK [P30DK084567]; Leukemia and Lymphoma Society Translational Research Program; NATIONAL CANCER INSTITUTE [R01CA136526, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Cancer Research Foundation (Deutsche Krebshilfe)(Deutsche Krebshilfe); Division of Oncology Research, Mayo Clinic Cancer Center, Miles and Shirley Fiterman Center for Digestive Disease; Carole and Bob Daly AACR-PANCAN Career Development Award for Pancreatic Cancer Research, Mayo Clinic Pancreatic SPORE; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, SFB-TR17, and KFO 210) and the Max Eder programme of the German Cancer Research Foundation (Deutsche Krebshilfe, 70-3022-El I) (to V. E.). This work was also supported by the Division of Oncology Research, Mayo Clinic Cancer Center, Miles and Shirley Fiterman Center for Digestive Disease, CA136526, Carole and Bob Daly AACR-PANCAN Career Development Award for Pancreatic Cancer Research, Mayo Clinic Pancreatic SPORE P50 CA102701, Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK P30DK084567), and Leukemia and Lymphoma Society Translational Research Program (to M. E. F.-Z.).	Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ellenrieder V, 2008, ANTICANCER RES, V28, P1531; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Im SH, 2004, MOL CELLS, V18, P1; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jonson T, 2001, INT J ONCOL, V19, P71; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; ORIAN A, 2001, SCI STKE, V26, P88; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; SERFLING E, 2007, SCI STKE, V398, P42; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Yan ZF, 2002, J BIOL CHEM, V277, P9870, DOI 10.1074/jbc.M107646200; Yoeli-Lerner M, 2009, MOL CANCER RES, V7, P425, DOI 10.1158/1541-7786.MCR-08-0342	41	71	72	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27241	27250		10.1074/jbc.M110.100438	http://dx.doi.org/10.1074/jbc.M110.100438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20516082	Green Published, hybrid			2022-12-25	WOS:000281172700055
J	Stalnaker, SH; Hashmi, S; Lim, JM; Aoki, K; Porterfield, M; Gutierrez-Sanchez, G; Wheeler, J; Ervasti, JM; Bergmann, C; Tiemeyer, M; Wells, L				Stalnaker, Stephanie H.; Hashmi, Sana; Lim, Jae-Min; Aoki, Kazuhiro; Porterfield, Mindy; Gutierrez-Sanchez, Gerardo; Wheeler, James; Ervasti, James M.; Bergmann, Carl; Tiemeyer, Michael; Wells, Lance			Site Mapping and Characterization of O-Glycan Structures on alpha-Dystroglycan Isolated from Rabbit Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMININ-BINDING; MANNOSYLATION; BRAIN; SEQUENCES	The main extracellular matrix binding component of the dystrophin- glycoprotein complex, alpha-dystroglycan (alpha-DG), which was originally isolated from rabbit skeletal muscle, is an extensively O-glycosylated protein. Previous studies have shown alpha-DG to be modified by both O-GalNAc- and O-mannose-initiated glycan structures. O-Mannosylation, which accounts for up to 30% of the reportedO-linked structures in certain tissues, has been rarely observed on mammalian proteins. Mutations in multiple genes encoding defined or putative glycosyltransferases involved in O-mannosylation are causal for various forms of congenital muscular dystrophy. Here, we explore the glycosylation of purified rabbit skeletal muscle alpha-DG in detail. Using tandem mass spectrometry approaches, we identify 4 O-mannose-initiated and 17 O-GalNAc-initiated structures on alpha-DG isolated from rabbit skeletal muscle. Additionally, we demonstrate the use of tandem mass spectrometry-based workflows to directly analyze glycopeptides generated from the purified protein. By combining glycomics and tandem mass spectrometry analysis of 91 glycopeptides from alpha-DG, we were able to assign 21 different residues as being modified by O-glycosylation with differing degrees of microheterogeneity; 9 sites of O-mannosylation and 14 sites of O-GalNAcylation were observed with only two sites definitively exhibiting occupancy by either type of glycan. The distribution of identified sites of O-mannosylation suggests a limited role for local primary sequence in dictating sites of attachment.	[Gutierrez-Sanchez, Gerardo; Wheeler, James; Bergmann, Carl; Tiemeyer, Michael; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Bergmann, Carl; Tiemeyer, Michael; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Stalnaker, Stephanie H.; Porterfield, Mindy; Wells, Lance] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu	Aoki, Kazuhiro/H-8283-2014; Wells, Lance/H-3118-2013; Ervasti, James/AAZ-4786-2020	Wells, Lance/0000-0003-4956-5363; Aoki, Kazuhiro/0000-0003-0029-4291	National Institutes of Health [P41 RR018502]; NCRR; Muscular Dystrophy Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P41 RR018502 from NCRR (to L.W. and M.T.). This work was also supported by the Muscular Dystrophy Association (to J.M.E. and L.W.).	Aebi M, 1999, Glycoconj J, V16, P669; Alvarez-Manilla G, 2010, GLYCOBIOLOGY, V20, P166, DOI 10.1093/glycob/cwp158; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cohn RD, 2005, NEUROMUSCULAR DISORD, V15, P207, DOI 10.1016/j.nmd.2004.11.005; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Endo Tamao, 2006, V347, P43; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINNE J, 1979, J BIOL CHEM, V254, P295; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Jaeken J, 2008, J INHERIT METAB DIS, V31, P669, DOI 10.1007/s10545-008-0983-x; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Martin PT, 2007, CURR MOL MED, V7, P417, DOI 10.2174/156652407780831601; NILSSON J, 2010, GLYCOBIOLOGY, DOI DOI 10.1093/GLYCOB/CWG082; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	25	78	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24882	24891		10.1074/jbc.M110.126474	http://dx.doi.org/10.1074/jbc.M110.126474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507986	Green Published, hybrid			2022-12-25	WOS:000280542100061
J	Chen, H; Xiong, LM				Chen, Hao; Xiong, Liming			myo-Inositol-1-phosphate Synthase Is Required for Polar Auxin Transport and Organ Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT CAP CELLS; ARABIDOPSIS-THALIANA; EFFLUX CARRIER; ARF-GAP; INOSITOL HEXAKISPHOSPHATE; MYOINOSITOL METABOLISM; ABSCISIC-ACID; LOCALIZATION; PLANTS; PIN2	myo-Inositol-1-phosphate synthase is a conserved enzyme that catalyzes the first committed and rate-limiting step in inositol biosynthesis. Despite its wide occurrence in all eukaryotes, the role of myo-inositol-1-phosphate synthase and de novo inositol biosynthesis in cell signaling and organism development has been unclear. In this study, we isolated loss-of-function mutants in the Arabidopsis MIPS1 gene from different ecotypes. It was found that all null mips1 mutants are defective in embryogenesis, cotyledon venation patterning, root growth, and root cap development. The mutant roots are also agravitropic and have reduced basipetal auxin transport. mips1 mutants have significantly reduced levels of major phosphatidylinositols and exhibit much slower rates of endocytosis. Treatment with brefeldin A induces slower PIN2 protein aggregation in mips1, indicating altered PIN2 trafficking. Our results demonstrate that MIPS1 is critical for maintaining phosphatidylinositol levels and affects pattern formation in plants likely through regulation of auxin distribution.	[Xiong, Liming] King Abdullah Univ Sci & Technol, Plant Stress Genom Res Ctr, Thuwal 239556900, Saudi Arabia; [Xiong, Liming] King Abdullah Univ Sci & Technol, Div Chem & Life Sci & Engn, Thuwal 239556900, Saudi Arabia; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Donald Danforth Plant Science Center	Xiong, LM (corresponding author), King Abdullah Univ Sci & Technol, Plant Stress Genom Res Ctr, Thuwal 239556900, Saudi Arabia.	liming.xiong@kaust.edu.sa	Chen, Hao/AAF-3704-2020	Xiong, Liming/0000-0001-8099-0806	National Science Foundation [0446359]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 0446359 (to L. X.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blancaflor EB, 1999, ADV SPACE RES-SERIES, V24, P731, DOI 10.1016/S0273-1177(99)00406-8; Carland FM, 2004, PLANT CELL, V16, P1263, DOI 10.1105/tpc.021030; Carland F, 2009, PLANT J, V59, P895, DOI 10.1111/j.1365-313X.2009.03920.x; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Chen R, 2002, PLANT MOL BIOL, V49, P305, DOI 10.1023/A:1015294711391; CULBERTSON MR, 1976, J BACTERIOL, V126, P232, DOI 10.1128/JB.126.1.232-242.1976; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donahue JL, 2010, PLANT CELL, V22, P888, DOI 10.1105/tpc.109.071779; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; JOHNSON MD, 1995, PLANT PHYSIOL, V107, P613, DOI 10.1104/pp.107.2.613; Keller R, 1998, PLANT J, V16, P403, DOI 10.1046/j.1365-313x.1998.00309.x; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Koizumi K, 2005, DEVELOPMENT, V132, P1699, DOI 10.1242/dev.01716; Kutter C, 2007, PLANT CELL, V19, P2417, DOI 10.1105/tpc.107.050377; Lackey KH, 2003, PLANT PHYSIOL, V132, P2240, DOI 10.1104/pp.103.020610; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Lemtiri-Chlieh F, 2003, P NATL ACAD SCI USA, V100, P10091, DOI 10.1073/pnas.1133289100; Li G, 2007, PLANT CELL, V19, P281, DOI 10.1105/tpc.106.041426; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; Martin KL, 2006, MOL MICROBIOL, V61, P89, DOI 10.1111/j.1365-2958.2006.05216.x; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Meng PH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007364; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Mitsuhashi N, 2008, J EXP BOT, V59, P3069, DOI 10.1093/jxb/ern161; Muday GK, 2001, TRENDS PLANT SCI, V6, P535, DOI 10.1016/S1360-1385(01)02101-X; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; Nagy R, 2009, J BIOL CHEM, V284, P33614, DOI 10.1074/jbc.M109.030247; Naramoto S, 2009, DEVELOPMENT, V136, P1529, DOI 10.1242/dev.030098; Nelson DE, 1998, PLANT CELL, V10, P753; Nunes ACS, 2006, PLANTA, V224, P125, DOI 10.1007/s00425-005-0201-0; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Pilu R, 2005, CROP SCI, V45, P2096, DOI 10.2135/cropsci2004.0651; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Sieburth LE, 2006, PLANT CELL, V18, P1396, DOI 10.1105/tpc.105.039008; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Stevenson JM, 2000, TRENDS PLANT SCI, V5, P252, DOI 10.1016/S1360-1385(00)01652-6; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	53	44	46	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24238	24247		10.1074/jbc.M110.123661	http://dx.doi.org/10.1074/jbc.M110.123661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516080	Green Published, hybrid			2022-12-25	WOS:000280291400073
J	Yang, KS; Macdonald-Obermann, JL; Piwnica-Worms, D; Pike, LJ				Yang, Katherine S.; Macdonald-Obermann, Jennifer L.; Piwnica-Worms, David; Pike, Linda J.			Asp-960/Glu-961 Controls the Movement of the C-terminal Tail of the Epidermal Growth Factor Receptor to Regulate Asymmetric Dimer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; KINASE DOMAIN; CRYSTAL-STRUCTURE; ACTIVATION; PHOSPHORYLATION; CELLS; INHIBITOR; MECHANISM; COMPLEX	The epidermal growth factor (EGF) receptor is a tyrosine kinase that dimerizes in response to ligand binding. Ligand-induced dimerization of the extracellular domain of the receptor promotes formation of an asymmetric dimer of the intracellular kinase domains, leading to stimulation of the tyrosine kinase activity of the receptor. We recently monitored ligand-promoted conformational changes within the EGF receptor in real time using luciferase fragment complementation imaging and showed that there was significant movement of the C-terminal tail of the EGF receptor following EGF binding (Yang, K. S., Ilagan, M. X. G., Piwnica-Worms, D., and Pike, L. J. (2009) J. Biol. Chem. 284, 7474-7482). To investigate the structural basis for this conformational change, we analyzed the effect of several mutations on the kinase activity and luciferase fragment complementation activity of the EGF receptor. Mutation of Asp-960 and Glu-961, two residues at the beginning of the C-terminal tail, to alanine resulted in a marked enhancement of EGF-stimulated kinase activity as well as enhanced downstream signaling. The side chain of Asp-960 interacts with that of Ser-787. Mutation of Ser-787 to Phe, which precludes this interaction, also leads to enhanced receptor kinase activity. Our data are consistent with the hypothesis that Asp-960/Glu-961 represents a hinge or fulcrum for the movement of the C-terminal tail of the EGF receptor. Mutation of these residues destabilizes this hinge, facilitating the formation of the activating asymmetric dimer and leading to enhanced receptor signaling.	[Yang, Katherine S.; Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu			National Institutes of Health [R01 GM064491, P50 CA94056]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM064491 (to L.J.P.) and P50 CA94056 (to D. P. W.).	Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HEISERMANN GJ, 1990, J BIOL CHEM, V265, P12820; Il Na I, 2007, LUNG CANCER, V57, P96, DOI 10.1016/j.lungcan.2007.01.027; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	29	6	6	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24014	24022		10.1074/jbc.M110.103317	http://dx.doi.org/10.1074/jbc.M110.103317			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507979	Green Published, hybrid			2022-12-25	WOS:000280291400052
J	Xu, YL; Toure, F; Qu, W; Lin, LL; Song, F; Shen, XP; Rosario, R; Garcia, J; Schmidt, AM; Yan, SF				Xu, Yunlu; Toure, Fatouma; Qu, Wu; Lin, Lili; Song, Fei; Shen, Xiaoping; Rosario, Rosa; Garcia, Joel; Schmidt, Ann Marie; Yan, Shi-Fang			Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY GROWTH RESPONSE-1; GENE-EXPRESSION; ISCHEMIC-INJURY; RECEPTOR; ACTIVATION; DISEASE; OXYGEN; CELLS; ATHEROSCLEROSIS; PATHOGENESIS	Receptor for advanced glycation end product (RAGE)-dependent signaling has been implicated in ischemia/reperfusion injury in the heart, lung, liver, and brain. Because macrophages contribute to vascular perturbation and tissue injury in hypoxic settings, we tested the hypothesis that RAGE regulates early growth response-1 (Egr-1) expression in hypoxia-exposed macrophages. Molecular analysis, including silencing of RAGE, or blockade of RAGE with sRAGE (the extracellular ligand-binding domain of RAGE), anti-RAGE IgG, or anti-AGE IgG in THP-1 cells, and genetic deletion of RAGE in peritoneal macrophages, revealed that hypoxia-induced up-regulation of Egr-1 is mediated by RAGE signaling. In addition, the observation of increased cellular release of RAGE ligand AGEs in hypoxic THP-1 cells suggests that recruitment of RAGE in hypoxia is stimulated by rapid production of RAGE ligands in this setting. Finally, we show that mDia-1, previously shown to interact with the RAGE cytoplasmic domain, is essential for hypoxia-stimulated regulation of Egr-1, at least in part through protein kinase C beta II, ERK1/2, and c-Jun NH2-terminal kinase signaling triggered by RAGE ligands. Our findings highlight a novel mechanism by which an extracellular signal initiated by RAGE ligand AGEs regulates Egr-1 in a manner requiring mDia-1.	[Xu, Yunlu; Toure, Fatouma; Qu, Wu; Lin, Lili; Song, Fei; Shen, Xiaoping; Rosario, Rosa; Garcia, Joel; Schmidt, Ann Marie; Yan, Shi-Fang] Columbia Univ, Med Ctr, Dept Surg, Div Surg Sci, New York, NY 10032 USA	Columbia University	Yan, SF (corresponding author), Columbia Univ Coll Phys & Surg, Dept Surg, Div Surg Sci, 630 W 168th St, New York, NY 10032 USA.	sy18@columbia.edu			National Institutes of Health, NHLBI [HL60901]; U.S. Public Health Service; Juvenile Diabetes Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060901] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL60901 through the NHLBI. This work was also supported by the U.S. Public Health Service and the Juvenile Diabetes Research Foundation.	Albina JE, 2003, WOUND REPAIR REGEN, V11, P445, DOI 10.1046/j.1524-475X.2003.11619.x; Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; BANKA CL, 1991, J LIPID RES, V32, P35; BIANCO C, 1975, J EXP MED, V141, P1278, DOI 10.1084/jem.141.6.1278; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; BROWNLEE M, 1992, DIABETES CARE, V15, P1835, DOI 10.2337/diacare.15.12.1835; Bucciarelli LG, 2006, CIRCULATION, V113, P1226, DOI 10.1161/CIRCULATIONAHA.105.575993; Bucciarelli LG, 2008, DIABETES, V57, P1941, DOI 10.2337/db07-0326; Chang JS, 2008, CIRC RES, V102, P905, DOI 10.1161/CIRCRESAHA.107.165308; Davies MG, 1996, J SURG RES, V63, P474, DOI 10.1006/jsre.1996.0295; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ikeda E, 2005, PATHOL INT, V55, P603, DOI 10.1111/j.1440-1827.2005.01877.x; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy AD, 1997, MOL CELL BIOCHEM, V170, P43, DOI 10.1023/A:1006816223292; Miyata T, 1996, NEPHROL DIAL TRANSPL, V11, P54; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; STEVENS CR, 1991, ANN RHEUM DIS, V50, P124, DOI 10.1136/ard.50.2.124; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Takagi M, 1997, J BONE MINER RES, V12, P439, DOI 10.1359/jbmr.1997.12.3.439; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298; Yan SF, 1999, ARTERIOSCL THROM VAS, V19, P2029, DOI 10.1161/01.ATV.19.9.2029; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yan SF, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S146239940900101X; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495	36	86	93	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23231	23238		10.1074/jbc.M110.117457	http://dx.doi.org/10.1074/jbc.M110.117457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20507991	Green Published, hybrid			2022-12-25	WOS:000279999900057
J	Lock, FE; Underhill-Day, N; Dunwell, T; Matallanas, D; Cooper, W; Hesson, L; Recino, A; Ward, A; Pavlova, T; Zabarovsky, E; Grant, MM; Maher, ER; Chalmers, AD; Kolch, W; Latif, F				Lock, F. E.; Underhill-Day, N.; Dunwell, T.; Matallanas, D.; Cooper, W.; Hesson, L.; Recino, A.; Ward, A.; Pavlova, T.; Zabarovsky, E.; Grant, M. M.; Maher, E. R.; Chalmers, A. D.; Kolch, W.; Latif, F.			The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappa B signaling pathways	ONCOGENE			English	Article						RASSF8; adherens junctions; lung cancer	BETA-CATENIN; GENE; INTERACTS; ADHESION; PROTEINS; DOMAIN; FAMILY	The Ras-assocation domain family (RASSF) of tumor suppressor proteins until recently contained six proteins named RASSF1-6. Recently, four novel family members, RASSF7-10, have been identified by homology searches for RA-domain-containing proteins. These additional RASSF members are divergent and structurally distinct from RASSF1-6, containing an N-terminal RA domain and lacking the Sav/RASSF/Hpo (SARAH) domain. Here, we show that RASSF8 is ubiquitously expressed throughout the murine embryo and in normal human adult tissues. Functionally, RNAi-mediated knockdown of RASSF8 in non-small-cell lung cancer (NSCLC) cell lines, increased anchorage-independent growth in soft agar and enhanced tumor growth in severe combined immunodeficiency (SCID) mice. Furthermore, EdU staining of RASSF8-depleted cells showed growth suppression in a manner dependent on contact inhibition. We show that endogenous RASSF8 is not only found in the nucleus, but is also membrane associated at sites of cell-cell adhesion, co-localizing with the adherens junction (AJ) component beta-catenin and binding to E-cadherin. Following RASSF8 depletion in two different lung cancer cell lines using alternative small interfering RNA (siRNA) sequences, we show that AJs are destabilized and E-cadherin is lost from the cell membrane. The AJ components beta-catenin and p65 are also lost from sites of cell-cell contact and are relocalized to the nucleus with a concomitant increase in beta-catenin-dependent and nuclear factor-kappa B (NF-kappa B)-dependent signaling following RASSF8 depletion. RASSF8 may also be required to maintain actin -cytoskeletal organization since immunofluorescence analysis shows a striking disorganization of the actincytoskeleton following RASSF8 depletion. Accordingly, scratch wound healing studies show increased cellular migration in RASSF8-deficient cells. These results implicate RASSF8 as a tumor suppressor gene that is essential for maintaining AJs function in epithelial cells and have a role in epithelial cell migration. Oncogene (2010) 29, 4307-4316; doi: 10.1038/onc.2010.192; published online 31 May 2010	[Lock, F. E.; Underhill-Day, N.; Dunwell, T.; Cooper, W.; Hesson, L.; Maher, E. R.; Latif, F.] Univ Birmingham, Dept Med & Mol Genet, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Matallanas, D.; Kolch, W.] Univ Coll Dublin, Dublin 2, Ireland; [Recino, A.; Ward, A.; Chalmers, A. D.] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Pavlova, T.; Zabarovsky, E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Grant, M. M.] Univ Birmingham, Sch Dent, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University College Dublin; University of Bath; Karolinska Institutet; University of Birmingham	Latif, F (corresponding author), Univ Birmingham, Dept Med & Mol Genet, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	f.latif@bham.ac.uk	Kolch, Walter/ABF-2102-2021; MAHER, EAMONN R/A-9507-2008; Chalmers, Andrew/D-4103-2009; Grant, Melissa/A-5590-2010; gomez, david/U-9465-2019; Hesson, Luke/HDM-0311-2022; Admin, SBI/HGB-2738-2022; Zabarovsky, Eugene R/A-6645-2010	MAHER, EAMONN R/0000-0002-6226-6918; Chalmers, Andrew/0000-0003-4182-6717; Grant, Melissa/0000-0003-1154-7266; gomez, david/0000-0002-2360-3141; Ward, Andrew/0000-0001-8311-5695; Kolch, Walter/0000-0001-5777-5016; Pavlova, Tatiana/0000-0002-2857-5696; Dunwell, Thomas/0000-0001-9985-3828	Cancer Research UK; Breast Cancer Campaign; Sport Aiding Medical Research for Kids (SPARKS); MRC; Swedish Cancer Society; Swedish Research Council; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Instituteand Karolinska Institute	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Sport Aiding Medical Research for Kids (SPARKS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Instituteand Karolinska Institute(Karolinska Institutet)	Work in FL's laboratory is supported by Cancer Research UK, Breast Cancer Campaign and Sport Aiding Medical Research for Kids (SPARKS). Work in ADC's laboratory is funded by MRC and Cancer Research UK, and AR by a Marie Curie PhD studentship. EZ was supported by research grants from the Swedish Cancer Society, the Swedish Research Council and the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Swedish Instituteand Karolinska Institute.	Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Chen LH, 1998, J BIOL CHEM, V273, P33524, DOI 10.1074/jbc.273.50.33524; Dallol A, 2005, CANCER RES, V65, P7653, DOI 10.1158/0008-5472.CAN-05-0247; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dallol A, 2009, CURR BIOL, V19, P1227, DOI 10.1016/j.cub.2009.05.064; Debeer P, 2002, J MED GENET, V39, P98, DOI 10.1136/jmg.39.2.98; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Downward J, 2009, NATURE, V462, P44, DOI 10.1038/462044a; Falvella FS, 2006, ONCOGENE, V25, P3934, DOI 10.1038/sj.onc.1209422; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Langton PF, 2009, CURR BIOL, V19, P1969, DOI 10.1016/j.cub.2009.10.027; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rudini N, 2008, CURR BIOL, V18, pR1080, DOI 10.1016/j.cub.2008.09.018; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Wang FL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003031	26	64	68	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2010	29	30					4307	4316		10.1038/onc.2010.192	http://dx.doi.org/10.1038/onc.2010.192			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20514026	Green Submitted			2022-12-25	WOS:000280547900007
J	Deribew, A; Alemseged, F; Tessema, F; Sena, L; Birhanu, Z; Zeynudin, A; Sudhakar, M; Abdo, N; Deribe, K; Biadgilign, S				Deribew, Amare; Alemseged, Fessehaye; Tessema, Fasil; Sena, Lelisa; Birhanu, Zewdie; Zeynudin, Ahmed; Sudhakar, Morankar; Abdo, Nasir; Deribe, Kebede; Biadgilign, Sibhatu			Malaria and Under-Nutrition: A Community Based Study Among Under-Five Children at Risk of Malaria, South-West Ethiopia	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; AFRICAN CHILDREN; IRON STATUS; MALNUTRITION; MORBIDITY; DETERMINANTS; MORTALITY; PROVINCE; REGION	Background: The interaction between malaria and under-nutrition is not well elucidated in Ethiopia. The objective of this study was to assess the magnitude of under-nutrition and its correlation with malaria among under-five children in southwest Ethiopia. Methods: This cross-sectional study was undertaken during March-February, 2009 as part of the baseline assessment of a cluster randomized trial around Gilgel Gibe Hydroelectric dam, south-west Ethiopia. A total of 2410 under-five children were included for anthropometric measurement and blood investigation for the diagnosis of malaria and anemia. The nutritional status of children was determined using the International Reference Population defined by the U.S National Center for Health Statistics (NCHS). Blood film was used to identify malaria parasite and haemoglobin concentration was determined by Hemo Cue analyzer (HemoCue Hb 301, Sweden). Results: Significant proportion (40.4%) of under-five children were stunted (height-for-age <-22SD). The prevalence of under-weight was 34.2%. One third and one tenth of the children had anemia and malaria parasite respectively. Older children were more likely to have under-nutrition. There was no association between malaria and under-nutrition. Children who had malaria parasite were 1.5 times more likely to become anaemic compare to children who had no malaria parasite, [OR = 1.5, (95% CI: 1.1-2.0)]. Conclusion: In this study, there is no association between malaria and under-nutrition. Children who have malaria are more likely to be anaemic. Malaria prevention and control program should consider nutrition interventions particularly anemia.	[Deribew, Amare; Alemseged, Fessehaye; Tessema, Fasil; Sena, Lelisa] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Birhanu, Zewdie; Sudhakar, Morankar] Jimma Univ, Dept Hlth Educ & Behav Sci, Jimma, Ethiopia; [Zeynudin, Ahmed] Jimma Univ, Dept Lab Med & Pathol, Jimma, Ethiopia; [Abdo, Nasir] Jimma Zone Hlth Dept, Jimma, Ethiopia; [Deribe, Kebede] Fayyaa Integrated Dev Assoc NCMI, Addis Ababa, Ethiopia; [Biadgilign, Sibhatu] Johns Hopkins Univ, Tech Support Ethiopian HIV AIDS ART Initiat, Addis Ababa, Ethiopia	Jimma University; Jimma University; Jimma University	Deribew, A (corresponding author), Jimma Univ, Dept Epidemiol, Jimma, Ethiopia.	amare_deribew@yahoo.com	Dadi, Lelisa Sena/AAC-5641-2019; Deribe, Kebede/I-5422-2019; Birhanu, Zewdie/L-5983-2019; Deribe, Kebede/K-7055-2019	Dadi, Lelisa Sena/0000-0002-5232-3771; Deribe, Kebede/0000-0002-8526-6996; Deribew, Amare/0000-0003-2031-6080; Kasim, Ahmed Zeynudin/0000-0002-0552-1783; Biadgilign, Sibhatu/0000-0002-7582-5977	UNICEF/UNDP/WorldBank/WHO	UNICEF/UNDP/WorldBank/WHO(World Health Organization)	The study is funded by the UNICEF/UNDP/WorldBank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breman JG, 2001, AM J TROP MED HYG, V64, P1; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Central Statistics Agency (CSA) [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Deen JL, 2002, J TROP PEDIATRICS, V48, P78, DOI 10.1093/tropej/48.2.78; DERIBEW A, 2009, EFFECT TRAI IN PRESS; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Fillol F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-116; Fillol F, 2009, AM J TROP MED HYG, V80, P202, DOI 10.4269/ajtmh.2009.80.202; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Genton B, 1998, AM J CLIN NUTR, V68, P734, DOI 10.1093/ajcn/68.3.734; Hadley C, 2008, J EPIDEMIOL COMMUN H, V62, P980, DOI 10.1136/jech.2007.068460; HENDRICKSE RG, 1971, ANN TROP MED PARASIT, V65, P1; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; MEDHIN G, BMC PUBLIC HLTH, V10, P27; MURRAY MJ, 1975, LANCET, V1, P653; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Phengxay M, 2007, PEDIATR INT, V49, P260, DOI 10.1111/j.1442-200X.2007.02354.x; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; SNOW RW, 1991, T ROY SOC TROP MED H, V85, P584, DOI 10.1016/0035-9203(91)90351-X; Snow RW, 1997, ACTA TROP, V65, P1, DOI 10.1016/S0001-706X(96)00601-8; Wamani H., 2007, BMC Pediatrics, V7; *WHO, 2008, WHOHTMGMP20081; WOLDEGEBRIEL Z, 1993, BRIT J NUTR, V70, P593, DOI 10.1079/BJN19930151; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21	28	51	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10775	10.1371/journal.pone.0010775	http://dx.doi.org/10.1371/journal.pone.0010775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505829	Green Published, gold, Green Submitted			2022-12-25	WOS:000278017400022
J	Lacerda, SMSN; Batlouni, SR; Costa, GMJ; Segatelli, TM; Quirino, BR; Queiroz, BM; Kalapothakis, E; Franca, LR				Lacerda, Samyra M. S. N.; Batlouni, Sergio R.; Costa, Guilherme M. J.; Segatelli, Tania M.; Quirino, Bruno R.; Queiroz, Bruno M.; Kalapothakis, Evanguedes; Franca, Luiz R.			A New and Fast Technique to Generate Offspring after Germ Cells Transplantation in Adult Fish: The Nile Tilapia (Oreochromis niloticus) Model	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; LINE CHIMERAS; RAINBOW-TROUT; SPERMATOGENESIS; PROLIFERATION; COLONIZATION; ZEBRAFISH; CULTURE; TESTIS; MOUSE	Background: Germ cell transplantation results in fertile recipients and is the only available approach to functionally investigate the spermatogonial stem cell biology in mammals and probably in other vertebrates. In the current study, we describe a novel non-surgical methodology for efficient spermatogonial transplantation into the testes of adult tilapia (O. niloticus), in which endogenous spermatogenesis had been depleted with the cytostatic drug busulfan. Methodology/Principal Findings: Using two different tilapia strains, the production of fertile spermatozoa with donor characteristics was demonstrated in adult recipient, which also sired progeny with the donor genotype. Also, after cryopreservation tilapia spermatogonial cells were able to differentiate to spermatozoa in the testes of recipient fishes. These findings indicate that injecting germ cells directly into adult testis facilitates and enable fast generation of donor spermatogenesis and offspring compared to previously described methods. Conclusion: Therefore, a new suitable methodology for biotechnological investigations in aquaculture was established, with a high potential to improve the production of commercially valuable fish, generate transgenic animals and preserve endangered fish species.	[Lacerda, Samyra M. S. N.; Batlouni, Sergio R.; Costa, Guilherme M. J.; Segatelli, Tania M.; Quirino, Bruno R.; Franca, Luiz R.] Univ Fed Minas Gerais, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil; [Batlouni, Sergio R.] Sao Paulo State Univ, Aquaculture Ctr CAUNESP, Sao Paulo, Brazil; [Queiroz, Bruno M.] GM Alevinos LTDA, Contagem, MG, Brazil; [Kalapothakis, Evanguedes] Univ Fed Minas Gerais, Dept Gen Biol, Lab Biotechnol & Mol Markers, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual Paulista; Universidade Federal de Minas Gerais	Lacerda, SMSN (corresponding author), Univ Fed Minas Gerais, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil.	lrfranca@icb.ufmg.br	Lacerda, Samyra/A-7756-2016; Batlouni, Sergio r/F-6357-2010; Lacerda, Samyra/AAG-8948-2021; Mattos Jardim Costa, Guilherme/A-7369-2016; Batlouni, Sergio r/D-2324-2017; Nassif, Samyra/AAR-5947-2020; DE FRANCA, LUIZ/AAA-6923-2021	Lacerda, Samyra/0000-0003-4577-6243; Batlouni, Sergio r/0000-0003-3579-2530; Lacerda, Samyra/0000-0003-4577-6243; Mattos Jardim Costa, Guilherme/0000-0002-2907-7760; Batlouni, Sergio r/0000-0003-3579-2530; 	Brazilian National Council for Research (CNPq); Minas Gerais State Foundation (FAPEMIG); Coordination for the Improvement of Higher Level Personnel (CAPES)	Brazilian National Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support was provided by the Brazilian National Council for Research (CNPq); Minas Gerais State Foundation (FAPEMIG); Coordination for the Improvement of Higher Level Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; De Rooij DG, 2000, J ANDROL, V21, P776; Dobrinski I, 2008, REPROD DOMEST ANIM, V43, P288, DOI 10.1111/j.1439-0531.2008.01176.x; Dobrinski I, 1999, MOL REPROD DEV, V53, P142, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;142::AID-MRD3&gt;3.0.CO;2-O; FAO, 2007, CULT AQ SPEC INF PRO; Herrid M, 2006, REPRODUCTION, V132, P617, DOI 10.1530/rep.1.01125; Herrid M, 2009, REPROD FERT DEVELOP, V21, P393, DOI 10.1071/RD08129; Hilsdorf AWS, 2002, PIGM CELL RES, V15, P57, DOI 10.1034/j.1600-0749.2002.00058.x; Honaramooz A, 2002, BIOL REPROD, V66, P21, DOI 10.1095/biolreprod66.1.21; Horan P K, 1990, Methods Cell Biol, V33, P469; Hussain M.G., 1994, Asian Fisheries Science, V7, P215; Kobayashi T, 2007, MOL REPROD DEV, V74, P207, DOI 10.1002/mrd.20577; Lacerda S. M. S. N., 2006, Animal Reproduction, V3, P146; LIN S, 1992, P NATL ACAD SCI USA, V89, P4519, DOI 10.1073/pnas.89.10.4519; Luo JP, 2006, MOL REPROD DEV, V73, P1531, DOI 10.1002/mrd.20529; Majhi SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006132; Melo DC, 2006, ARQ BRAS MED VET ZOO, V58, P87, DOI 10.1590/S0102-09352006000100013; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nobrega RH, 2009, FISH PHYSIOL BIOCHEM, V35, P197, DOI 10.1007/s10695-008-9252-z; Ohta H, 2000, DEV GROWTH DIFFER, V42, P105; Okutsu T, 2006, P NATL ACAD SCI USA, V103, P2725, DOI 10.1073/pnas.0509218103; Okutsu T, 2007, SCIENCE, V317, P1517, DOI 10.1126/science.1145626; Okutsu T, 2006, J REPROD DEVELOP, V52, P685, DOI 10.1262/jrd.18096; Parreira GG, 1998, BIOL REPROD, V59, P1360, DOI 10.1095/biolreprod59.6.1360; REICH L, 1990, GENETICA, V80, P195, DOI 10.1007/BF00137326; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Schulz RW, 2005, BIOL REPROD, V73, P891, DOI 10.1095/biolreprod.105.039891; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Shikina S, 2008, MOL REPROD DEV, V75, P529, DOI 10.1002/mrd.20771; STICKNEY RR, 2000, ENCY AQUACULTURE, P934; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Takeuchi Y, 2001, MOL REPROD DEV, V59, P380, DOI 10.1002/mrd.1044; Takeuchi Y, 2009, BIOL REPROD, V81, P1055, DOI 10.1095/biolreprod.109.077701; VANBEEK MEAB, 1990, CELL TISSUE KINET, V23, P1; WITTE F, 1992, ENVIRON BIOL FISH, V34, P1, DOI 10.1007/BF00004782	42	95	103	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10740	10.1371/journal.pone.0010740	http://dx.doi.org/10.1371/journal.pone.0010740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505774	gold, Green Published, Green Submitted			2022-12-25	WOS:000278017300013
J	Elsaba, TMA; Martinez-Pomares, L; Robins, AR; Crook, S; Seth, R; Jackson, D; McCart, A; Silver, AR; Tomlinson, IPM; Ilyas, M				Elsaba, Tarek M. A.; Martinez-Pomares, Luisa; Robins, Adrian R.; Crook, Simon; Seth, Rashmi; Jackson, Darryl; McCart, Amy; Silver, Andrew R.; Tomlinson, Ian P. M.; Ilyas, Mohammad			The Stem Cell Marker CD133 Associates with Enhanced Colony Formation and Cell Motility in Colorectal Cancer	PLOS ONE			English	Article							IDENTIFICATION; ANTIGEN; TUMORS	CD133 is a membrane molecule that has been, controversially, reported as a CSC marker in colorectal cancer (CRC). In this study, we sought to clarify the expression and role of CD133 in CRC. Initially the size of the CD133-expressing (CD133+) population in eight well-described CRC cell lines was measured by flow cytometry and was found to range from 0% to >95%. The cell line HT29 has a CD133+ population of >95% and was chosen for functional evaluation of CD133 after gene knockdown by RNA interference. A time course assay showed that CD133 inhibition had no significant effect on cell proliferation or apoptosis. However, CD133 knockdown did result in greater susceptibility to staurosporine-induced apoptosis (p = 0.01) and reduction in cell motility (p<0.04). Since gene knockdown may cause "off-target" effects, the cell line SW480 (which has a CD133+ population of 40%) was sorted into pure CD133+ and CD133- populations to allow functional comparison of isogenic populations separated only by CD133 expression. In concordance with the knockdown experiments, a time course assay showed no significant proliferative differences between the CD133+/CD133- populations. Also greater resistance to staurosporine-induced apoptosis (p = 0.008), greater cell motility (p = 0.03) and greater colony forming efficiency was seen in the CD133+ population than the CD133- population in both 2D and 3D culture (p<0.0001 and p<0.003 respectively). Finally, the plasticity of CD133 expression in tumour cells was tested. Quantitative PCR analysis showed there was transcriptional repression in the CD133- population of SW480. Prolonged culture of a pure CD133- population resulted in re-emergence of CD133+ cells. We conclude that CD133 expression in CRCs is associated with some features attributable to stemness and that there is plasticity of CD133 expression. Further studies are necessary to delineate the mechanistic basis of these features.	[Elsaba, Tarek M. A.; Crook, Simon; Seth, Rashmi; Jackson, Darryl; Ilyas, Mohammad] Univ Nottingham, Queens Med Ctr, Div Pathol, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Elsaba, Tarek M. A.] Assiut Univ, S Egypt Canc Inst, Dept Pathol, Assiut, Egypt; [Martinez-Pomares, Luisa; Robins, Adrian R.] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Inst Infect Immun & Inflammat, Nottingham, England; [McCart, Amy; Silver, Andrew R.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Acad Surg, London, England; [Tomlinson, Ian P. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ilyas, Mohammad] Queens Med Ctr, Nottingham Digest Dis Ctr, Biol Res Unit, Nottingham NG7 2UH, England	University of Nottingham; Egyptian Knowledge Bank (EKB); Assiut University; University of Nottingham; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Nottingham	Elsaba, TMA (corresponding author), Univ Nottingham, Queens Med Ctr, Div Pathol, Sch Mol Med Sci, Nottingham NG7 2RD, England.	Mohammad.Ilyas@nottingham.ac.uk	Jackson, Darryl/GVS-2243-2022; Reed, Amy E McCart/C-6192-2011; Elsaba, Tarek/AAF-1286-2021	Reed, Amy E McCart/0000-0001-5387-2791; Elsaba, Tarek/0000-0001-5670-7038; Martinez-Pomares, Luisa/0000-0002-2331-127X	University of Nottingham; CR-UK; Egyptian government	University of Nottingham; CR-UK(Cancer Research UK); Egyptian government	This work was funded by the University of Nottingham and CR-UK. Tarek Elsaba is a recipient of a PhD scholarship which has been provided by the Egyptian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULKADER A, 2009, C TERMINAL TENSIN LI, P57; ADDLA SK, 2008, CHARACTERIZATION HOE, pF680; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2009, J PATHOL, V217, P144, DOI 10.1002/path.2498; Arango M, 2005, Dermatol Online J, V11, P2; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; DAVID H, 2009, J PATHOL, V219, P427; GERMANA R, 2008, STEM CELL ASS ANTIGE, P3008; GIEBEL B, 2004, SEGREGATION LIPID RA, P2332; HADAS DS, 2007, SUPPRESSION GASTRIC, P188; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; LI C, 2007, IDENTIFICATION PANCR, P1030; LIU G, 2006, ANAL GENE EXPRESSION, P67; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; MIRAGLIA S, 1997, NOVEL 5 TRANSMEMBRAN, P5013; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; OLIVER MH, 1989, RAPID CONVENIENT ASS, P513; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Rasband W.S., 1997, IMAGE J; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2003, CANCER RES, V63, P5821; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; TETSUHIRO C, 2006, SIDE POPULATION PURI, P240; WRIGHT M, 2008, BRCAL BREAST TUMORS, pR10; YI JM, 2008, ABNORMAL DNA METHYLA, P8094; YIN AH, 1997, AC133 NOVEL MARKER H, P5002; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	33	72	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10714	10.1371/journal.pone.0010714	http://dx.doi.org/10.1371/journal.pone.0010714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502714	gold, Green Published, Green Submitted			2022-12-25	WOS:000277845400016
J	Landsverk, ML; Weiser, DC; Hannibal, MC; Kimelman, D				Landsverk, Megan L.; Weiser, Douglas C.; Hannibal, Mark C.; Kimelman, David			Alternative Splicing of sept9a and sept9b in Zebrafish Produces Multiple mRNA Transcripts Expressed Throughout Development	PLOS ONE			English	Article							HEREDITARY NEURALGIC AMYOTROPHY; MAMMALIAN SEPTIN; MSF-A; GENE; MICROTUBULES; ISOFORMS; DISEASE; TUMORS; CELLS	Background: Septins are involved in a number of cellular processes including cytokinesis and organization of the cytoskeleton. Alterations in human septin-9 (SEPT9) levels have been linked to multiple cancers, whereas mutations in SEPT9 cause the episodic neuropathy, hereditary neuralgic amyotrophy (HNA). Despite its important function in human health, the in vivo role of SEPT9 is unknown. Methodology/Principal Findings: Here we utilize zebrafish to study the role of SEPT9 in early development. We show that zebrafish possess two genes, sept9a and sept9b that, like humans, express multiple transcripts. Knockdown or overexpression of sept9a transcripts results in specific developmental alterations including circulation defects and aberrant epidermal development. Conclusions/Significance: Our work demonstrates that sept9 plays an important role in zebrafish development, and establishes zebrafish as a valuable model organism for the study of SEPT9.	[Landsverk, Megan L.; Hannibal, Mark C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Weiser, Douglas C.; Kimelman, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Landsverk, Megan L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Weiser, Douglas C.] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Baylor College of Medicine; University of the Pacific	Landsverk, ML (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	kimelman@uw.edu		Hannibal, Mark/0000-0002-9077-3837	NIH [GM079203, NS38181]; NRSA [F32HD053189]; University of the Pacific Start-up funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD053189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038181] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of the Pacific Start-up funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant (GM079203) to D. K. and NIH grant (NS38181) to Phillip Chance and an NRSA fellowship (F32HD053189) and University of the Pacific Start-up funds to D. C. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2006, CANCER RES, V66, P856, DOI 10.1158/0008-5472.CAN-05-2738; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Gomez GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004994; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hentschel DM, 2005, AM J PHYSIOL-RENAL, V288, pF923, DOI 10.1152/ajprenal.00386.2004; Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056; Kiener TK, 2008, DEV BIOL, V316, P36, DOI 10.1016/j.ydbio.2007.12.047; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Landsverk ML, 2009, HUM MOL GENET, V18, P1200, DOI 10.1093/hmg/ddp014; McDade SS, 2007, HUM MOL GENET, V16, P742, DOI 10.1093/hmg/ddm003; McIlhatton MA, 2001, ONCOGENE, V20, P5930, DOI 10.1038/sj.onc.1204752; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Robertson C, 2004, J PATHOL, V203, P519, DOI 10.1002/path.1551; Russell SEH, 2000, CANCER RES, V60, P4729; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Sudo K, 2007, HUM MUTAT, V28, P1005, DOI 10.1002/humu.20554; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Webb AE, 2008, DEV DYNAM, V237, P1153, DOI 10.1002/dvdy.21509; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	25	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10712	10.1371/journal.pone.0010712	http://dx.doi.org/10.1371/journal.pone.0010712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502708	gold, Green Submitted, Green Published			2022-12-25	WOS:000277845400015
J	Yang, M; Gao, CH; Wang, Y; Zhang, H; He, ZG				Yang, Min; Gao, Chunhui; Wang, Yi; Zhang, Hua; He, Zheng-Guo			Characterization of the Interaction and Cross-Regulation of Three Mycobacterium tuberculosis RelBE Modules	PLOS ONE			English	Article							TOXIN-ANTITOXIN MODULES; ESCHERICHIA-COLI; DNA-POLYMERASE; PLASMID; PROKARYOTES; SYSTEMS; STRESS; GROWTH; CELLS; LOCI	RelBE represents a typical bacterial toxin-antitoxin (TA) system. Mycobacterium tuberculosis H37Rv, the pathogen responsible for human tuberculosis, contains three RelBE-like modules, RelBE, RelFG, and RelJK, which are at least partly expressed in human macrophages during infection. RelBE modules appear to be autoregulated in an atypical manner compared to other TA systems; however, the molecular mechanisms and potential interactions between different RelBE modules remain to be elucidated. In the present study, we characterized the interaction and cross-regulation of these Rel toxin-antitoxin modules from this unique pathogen. The physical interactions between the three pairs of RelBE proteins were confirmed and the DNA-binding domain recognized by three RelBE-like pairs and domain structure characteristics were described. The three RelE-like proteins physically interacted with the same RelB-like protein, and could conditionally regulate its binding with promoter DNA. The RelBE-like modules exerted complex cross-regulation effects on mycobacterial growth. The relB antitoxin gene could replace relF in cross-neutralizing the relG toxin gene. Conversely, relF enhanced the toxicity of the relE toxin gene, while relB increased the toxicity of relK. This is the first report of interactions between different pairs of RelBE modules of M. tuberculosis.	[Yang, Min; Gao, Chunhui; Wang, Yi; Zhang, Hua; He, Zheng-Guo] Huazhong Agr Univ, Ctr Prote Res, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Ctr Prote Res, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China.	he.zhengguo@hotmail.com	Gao, Chun-Hui/B-3667-2016; He, Zheng-Guo/P-3647-2014; Gao, Chun-Hui/B-4111-2008	Gao, Chun-Hui/0000-0002-1445-7939; Gao, Chun-Hui/0000-0002-1445-7939; Yang, Min/0000-0003-2924-5717	973 Program [2006CB504402]; National Natural Science Foundation of China [30930003]; National Special Key Project of China on Major Infectious Diseases [2008ZX10003-005, 2008ZX10003-006]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Key Project of China on Major Infectious Diseases	This work was supported by 973 Program (2006CB504402), the National Natural Science Foundation of China (30930003) and the National Special Key Project of China on Major Infectious Diseases (2008ZX10003-005 and 2008ZX10003-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Galvani C, 2001, J BACTERIOL, V183, P2700, DOI 10.1128/JB.183.8.2700-2703.2001; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GOSSEN M, 1993, NUCLEIC ACIDS RES, V21, P4411, DOI 10.1093/nar/21.18.4411; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gronlund H, 1999, J MOL BIOL, V285, P1401, DOI 10.1006/jmbi.1998.2416; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; JAFFE A, 1985, J BACTERIOL, V163, P841; Korch SB, 2009, J BACTERIOL, V191, P1618, DOI 10.1128/JB.01318-08; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Wang J, 2007, BIOCHEM BIOPH RES CO, V363, P63, DOI 10.1016/j.bbrc.2007.08.125; WHO, 2009, GLOB TUB CONTR 2009; Zhang L, 2009, P NATL ACAD SCI USA, V106, P7792, DOI 10.1073/pnas.0813056106	28	62	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10672	10.1371/journal.pone.0010672	http://dx.doi.org/10.1371/journal.pone.0010672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498855	Green Published, gold, Green Submitted			2022-12-25	WOS:000277773700015
J	Lari, M; Rizzi, E; Milani, L; Corti, G; Balsamo, C; Vai, S; Catalano, G; Pilli, E; Longo, L; Condemi, S; Giunti, P; Hanni, C; De Bellis, G; Orlando, L; Barbujani, G; Caramelli, D				Lari, Martina; Rizzi, Ermanno; Milani, Lucio; Corti, Giorgio; Balsamo, Carlotta; Vai, Stefania; Catalano, Giulio; Pilli, Elena; Longo, Laura; Condemi, Silvana; Giunti, Paolo; Haenni, Catherine; De Bellis, Gianluca; Orlando, Ludovic; Barbujani, Guido; Caramelli, David			The Microcephalin Ancestral Allele in a Neanderthal Individual	PLOS ONE			English	Article							REGULATING BRAIN SIZE; X-CHROMOSOME; POPULATION-STRUCTURE; GENETIC DIVERSITY; MODERN HUMANS; HOMO-SAPIENS; DNA; EVOLUTION; SEQUENCE; SELECTION	Background: The high frequency (around 0.70 worlwide) and the relatively young age (between 14,000 and 62,000 years) of a derived group of haplotypes, haplogroup D, at the microcephalin (MCPH1) locus led to the proposal that haplogroup D originated in a human lineage that separated from modern humans>1 million years ago, evolved under strong positive selection, and passed into the human gene pool by an episode of admixture circa 37,000 years ago. The geographic distribution of haplogroup D, with marked differences between Africa and Eurasia, suggested that the archaic human form admixing with anatomically modern humans might have been Neanderthal. Methodology/Principal Findings: Here we report the first PCR amplification and high-throughput sequencing of nuclear DNA at the microcephalin (MCPH1) locus from Neanderthal individual from Mezzena Rockshelter (Monti Lessini, Italy). We show that a well-preserved Neanderthal fossil dated at approximately 50,000 years B. P., was homozygous for the ancestral, non-D, allele. The high yield of Neanderthal mtDNA sequences of the studied specimen, the pattern of nucleotide misincorporation among sequences consistent with post-mortem DNA damage and an accurate control of the MCPH1 alleles in all personnel that manipulated the sample, make it extremely unlikely that this result might reflect modern DNA contamination. Conclusions/Significance: The MCPH1 genotype of the Monti Lessini (MLS) Neanderthal does not prove that there was no interbreeding between anatomically archaic and modern humans in Europe, but certainly shows that speculations on a possible Neanderthal origin of what is now the most common MCPH1 haplogroup are not supported by empirical evidence from ancient DNA.	[Lari, Martina; Milani, Lucio; Balsamo, Carlotta; Vai, Stefania; Catalano, Giulio; Pilli, Elena; Caramelli, David] Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Florence, Italy; [Rizzi, Ermanno; Corti, Giorgio; De Bellis, Gianluca] CNR, ITB, Segrate, MI, Italy; [Longo, Laura] Univ Siena, Dipartimento Sci Ambientali G Sarfatti, UR Ecol Preistor, I-53100 Siena, Italy; [Longo, Laura; Giunti, Paolo] Museo Storia Nat Verona, Sez Preistoria, Verona, Italy; [Condemi, Silvana] Univ Mediterranee, CNRS EFS, Lab Anthropol Bioculturelle, UMR6578, Marseille, France; [Haenni, Catherine; Orlando, Ludovic] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon,INRA, F-69365 Lyon, France; [Barbujani, Guido] Univ Ferrara, Dipartimento Biol & Evoluz, I-44100 Ferrara, Italy	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Siena; UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Ferrara	Lari, M (corresponding author), Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Florence, Italy.	david.caramelli@unifi.it	De Bellis, Gianluca/H-9725-2013; Longo, Laura/G-2797-2011; Orlando, Ludovic/A-8932-2013; Condemi, Silvana/ABE-2701-2021; Rizzi, Ermanno/J-7448-2012; rizzi, ermanno/Q-3399-2016; Catalano, Giulio/AAT-2749-2020; Lari, Martina/A-4085-2009; Barbujani, Guido/ABE-9998-2020	De Bellis, Gianluca/0000-0002-1622-4477; Longo, Laura/0000-0001-6562-3047; Orlando, Ludovic/0000-0003-3936-1850; Condemi, Silvana/0000-0002-6516-0879; rizzi, ermanno/0000-0002-9898-2326; Catalano, Giulio/0000-0002-2564-5775; Barbujani, Guido/0000-0001-7854-6669; Corti, Giorgio/0000-0001-6379-4117; Caramelli, David/0000-0001-6468-1675; VAI, STEFANIA/0000-0003-3844-5147; Pilli, Elena/0000-0002-3150-5082	Italian Ministry of Universities (MIUR); PRIN; FIRB [n RBLA03ER38]	Italian Ministry of Universities (MIUR)(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This study was supported by the Italian Ministry of Universities (MIUR http://www.miur.it) PRIN funds to G. B. and D. C. Grant FIRB (http://firb.miur.it/) n RBLA03ER38 funds to E. R., G. D. B. and G. Corti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Coop G, 2008, MOL BIOL EVOL, V25, P1257, DOI 10.1093/molbev/msn091; Cox MP, 2008, GENETICS, V178, P427, DOI 10.1534/genetics.107.080432; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Currat M, 2006, SCIENCE, V313, P172, DOI 10.1126/science.1122712; Donnelly MP, 2010, AM J HUM GENET, V86, P161, DOI 10.1016/j.ajhg.2010.01.007; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Evans PD, 2006, P NATL ACAD SCI USA, V103, P18178, DOI 10.1073/pnas.0606966103; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Garrigan D, 2005, MOL BIOL EVOL, V22, P189, DOI 10.1093/molbev/msi013; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert M Thomas P, 2006, Med Secoli, V18, P701; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Giunti Paolo, 2008, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V32, P39; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Gunz P, 2009, P NATL ACAD SCI USA, V106, P6094, DOI 10.1073/pnas.0808160106; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hawks J, 2008, TRENDS GENET, V24, P19, DOI 10.1016/j.tig.2007.10.003; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lalueza-Fox C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-342; Linderholm A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002316; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Marth G, 2003, P NATL ACAD SCI USA, V100, P376, DOI 10.1073/pnas.222673099; Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x; Sabater-Lleal M, 2006, HUM GENET, V118, P741, DOI 10.1007/s00439-005-0045-5; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; Yotova V, 2007, HUM GENET, V122, P431, DOI 10.1007/s00439-007-0413-4; Zietkiewicz E, 2003, AM J HUM GENET, V73, P994, DOI 10.1086/378777	50	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10648	10.1371/journal.pone.0010648	http://dx.doi.org/10.1371/journal.pone.0010648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498832	gold, Green Published, Green Submitted			2022-12-25	WOS:000277771600012
J	Unni, VK; Weissman, TA; Rockenstein, E; Masliah, E; McLean, PJ; Hyman, BT				Unni, Vivek K.; Weissman, Tamily A.; Rockenstein, Edward; Masliah, Eliezer; McLean, Pamela J.; Hyman, Bradley T.			In Vivo Imaging of alpha-Synuclein in Mouse Cortex Demonstrates Stable Expression and Differential Subcellular Compartment Mobility	PLOS ONE			English	Article							CELL-DEATH; LONG-TERM; ACCUMULATION; AGGREGATION; DEGRADATION; APPEARANCE; DOPAMINE; DYNAMICS; PLAQUES; MODELS	Background: Regulation of alpha-synuclein levels within cells is thought to play a critical role in Parkinson's Disease (PD) pathogenesis and in other related synucleinopathies. These processes have been studied primarily in reduced preparations, including cell culture. We now develop methods to measure alpha-synuclein levels in the living mammalian brain to study in vivo protein mobility, turnover and degradation with subcellular specificity. Methodology/Principal Findings: We have developed a system using enhanced Green Fluorescent Protein (GFP)-tagged human alpha-synuclein (Syn-GFP) transgenic mice and in vivo multiphoton imaging to measure alpha-synuclein levels with subcellular resolution. This new experimental paradigm allows individual Syn-GFP-expressing neurons and presynaptic terminals to be imaged in the living mouse brain over a period of months. We find that Syn-GFP is stably expressed by neurons and presynaptic terminals over this time frame and further find that different presynaptic terminals can express widely differing levels of Syn-GFP. Using the fluorescence recovery after photobleaching (FRAP) technique in vivo we provide evidence that at least two pools of Syn-GFP exist in terminals with lower levels of mobility than measured previously. These results demonstrate that multiphoton imaging in Syn-GFP mice is an excellent new strategy for exploring the biology of alpha-synuclein and related mechanisms of neurodegeneration. Conclusions/Significance: In vivo multiphoton imaging in Syn-GFP transgenic mice demonstrates stable alpha-synuclein expression and differential subcellular compartment mobility within cortical neurons. This opens new avenues for studying alpha-synuclein biology in the living brain and testing new therapeutics for PD and related disorders.	[Unni, Vivek K.; McLean, Pamela J.; Hyman, Bradley T.] MGH Harvard Med Sch, Alzheimers Res Unit, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA; [Weissman, Tamily A.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Weissman, Tamily A.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Harvard University; University of California System; University of California San Diego	Unni, VK (corresponding author), MGH Harvard Med Sch, Alzheimers Res Unit, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA.	bhyman@partners.org		Weissman, Tamily/0000-0001-9361-6071; McLean, Pamela/0000-0003-4870-5715	National Institutes of Health [NS038372, NS063963, T32AG000222, T32NS048005, AG18440, AG022074]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063963, T32NS048005, P50NS038372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, R37AG018440, R01AG018440, T32AG000222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants NS038372, NS063963, T32AG000222, T32NS048005, AG18440 and AG022074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Dawson TM, 2002, NEURON, V35, P219, DOI 10.1016/S0896-6273(02)00780-8; DECALIGNON A, 2010, NATURE IN PRESS; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; George JM, 2002, GENOME BIOL, V3; Gomez-Santos C, 2005, BRAIN RES BULL, V65, P87, DOI 10.1016/j.brainresbull.2004.11.008; Grutzendler Jaime, 2006, NeuroRx, V3, P489, DOI 10.1016/j.nurx.2006.07.005; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Lee IH, 2008, NEUROCHEM RES, V33, P1393, DOI 10.1007/s11064-008-9598-8; Liang TB, 2006, J NEUROCHEM, V99, P470, DOI 10.1111/j.1471-4159.2006.04111.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Schwach G, 2010, J MOL NEUROSCI, V41, P80, DOI 10.1007/s12031-009-9289-1; Skoch Jesse, 2004, V299, P349; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009; Yang YX, 2008, NEUROREPORT, V19, P867, DOI 10.1097/WNR.0b013e3282ffda48	36	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10589	10.1371/journal.pone.0010589	http://dx.doi.org/10.1371/journal.pone.0010589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485674	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563200020
J	Cavanaugh, NA; Beard, WA; Wilson, SH				Cavanaugh, Nisha A.; Beard, William A.; Wilson, Samuel H.			DNA Polymerase beta Ribonucleotide Discrimination INSERTION, MISINSERTION, EXTENSION, AND CODING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; I KLENOW FRAGMENT; ESCHERICHIA-COLI; NUCLEOTIDE INCORPORATION; TERNARY COMPLEXES; SINGLE RESIDUE; MINOR-GROOVE; ABASIC SITE; FIDELITY; REPLICATION	DNA polymerases must select nucleotides that preserve Watson-Crick base pairing rules and choose substrates with the correct (deoxyribose) sugar. Sugar discrimination represents a great challenge because ribonucleotide triphosphates are present at much higher cellular concentrations than their deoxy-counterparts. Although DNA polymerases discriminate against ribonucleotides, many therapeutic nucleotide analogs that target polymerases have sugar modifications, and their efficacy depends on their ability to be incorporated into DNA. Here, we investigate the ability of DNA polymerase beta to utilize nucleotides with modified sugars. DNA polymerase beta readily inserts dideoxynucleoside triphosphates but inserts ribonucleotides nearly 4 orders of magnitude less efficiently than natural deoxynucleotides. The efficiency of ribonucleotide insertion is similar to that reported for other DNA polymerases. The poor polymerase-dependent insertion represents a key step in discriminating against ribonucleotides because, once inserted, a ribonucleotide is easily extended. Likewise, a templating ribonucleotide has little effect on insertion efficiency or fidelity. In contrast to insertion and extension of a ribonucleotide, the chemotherapeutic drug arabinofuranosylcytosine triphosphate is efficiently inserted but poorly extended. These results suggest that the sugar pucker at the primer terminus plays a crucial role in DNA synthesis; a 3'-endo sugar pucker facilitates nucleotide insertion, whereas a 2'-endo conformation inhibits insertion.	[Cavanaugh, Nisha A.; Beard, William A.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Beard, WA (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233,MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	National Institutes of Health [Z01-ES050158, P41 RR-01081]; NIEHS [Z01-ES050161, 1U19CA105010]; NATIONAL CANCER INSTITUTE [U19CA105010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, Z01ES050161, Z01ES050158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01-ES050158 and Z01-ES050161 Intramural Research Program, NIEHS (to S. H. W.), and was in association with Grant 1U19CA105010.; Molecular graphics images were produced using the Chimera package (58) from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR-01081).	Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2005, STRUCTURE, V13, P1225, DOI 10.1016/j.str.2005.05.010; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 1998, CHEM BIOL, V5, pR7, DOI 10.1016/S1074-5521(98)90081-3; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Bergoglio V, 2003, J MOL BIOL, V331, P1017, DOI 10.1016/S0022-2836(03)00837-4; BISWAS G, 1988, ACTA CRYSTALLOGR C, V44, P1269, DOI 10.1107/S0108270188002264; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Boyer PL, 2000, P NATL ACAD SCI USA, V97, P3056, DOI 10.1073/pnas.97.7.3056; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; FERSHT AR, 1982, J MOL BIOL, V156, P37, DOI 10.1016/0022-2836(82)90457-0; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gardner AF, 2004, J BIOL CHEM, V279, P11834, DOI 10.1074/jbc.M308286200; GOODMAN MF, 1983, J BIOL CHEM, V258, P3469; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; HARRINGTON C, 1995, J BIOL CHEM, V270, P26664, DOI 10.1074/jbc.270.44.26664; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kirk BW, 1999, BIOCHEMISTRY-US, V38, P7727, DOI 10.1021/bi990247c; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KUCHTA RD, 1992, BIOCHEMISTRY-US, V31, P4720, DOI 10.1021/bi00134a027; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Liang FT, 2008, J MED CHEM, V51, P6460, DOI 10.1021/jm800692a; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; McKenna CE, 2007, J AM CHEM SOC, V129, P15412, DOI 10.1021/ja072127v; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Nakamura J, 1999, CANCER RES, V59, P2522; Osheroff WP, 1999, J BIOL CHEM, V274, P20749, DOI 10.1074/jbc.274.30.20749; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REID R, 1988, J BIOL CHEM, V263, P3898; Roettger MP, 2004, BIOCHEMISTRY-US, V43, P13827, DOI 10.1021/bi048782m; Ruiz JF, 2003, NUCLEIC ACIDS RES, V31, P4441, DOI 10.1093/nar/gkg637; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Sharma B, 2008, PROTEINS, V71, P715, DOI 10.1002/prot.21829; Sucato CA, 2008, BIOCHEMISTRY-US, V47, P870, DOI 10.1021/bi7014162; Sucato CA, 2007, BIOCHEMISTRY-US, V46, P461, DOI 10.1021/bi061517b; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Upton TG, 2009, ORG LETT, V11, P1883, DOI 10.1021/ol701755k; Urban M, 2010, BIOCHEMISTRY-US, V49, P727, DOI 10.1021/bi9019516; Williams AA, 2009, BIOCHEMISTRY-US, V48, P11994, DOI 10.1021/bi9014133; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171	63	51	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24457	24465		10.1074/jbc.M110.132407	http://dx.doi.org/10.1074/jbc.M110.132407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519499	Green Published, hybrid			2022-12-25	WOS:000280542100018
J	Boudko, SP; Zientek, KD; Vance, J; Hacker, JL; Engel, J; Bachinger, HP				Boudko, Sergei P.; Zientek, Keith D.; Vance, Jesse; Hacker, Jessica L.; Engel, Juergen; Baechinger, Hans Peter			The NC2 Domain of Collagen IX Provides Chain Selection and Heterotrimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; CARTILAGE FIBRILS; CRYSTAL-STRUCTURE; TRIPLE-HELIX; ALPHA-CHAINS; ARTHRITIS; SEQUENCE; GLYCOSAMINOGLYCANS; TRIMERIZATION; PROTEOGLYCAN	The mechanism of chain selection and trimerization of fibril-associated collagens with interrupted triple helices (FACITs) differs from that of fibrillar collagens that have special C-propeptides. We recently showed that the second carboxyl-terminal non-collagenous domain (NC2) of homotrimeric collagen XIX forms a stable trimer and substantially stabilizes a collagen triple helix attached to either end. We then hypothesized a general trimerizing role for the NC2 domain in other FACITs. Here we analyzed the NC2 domain of human heterotrimeric collagen IX, the only member of FACITs with all three chains encoded by distinct genes. Upon oxidative folding of equimolar amounts of the alpha 1, alpha 2, and alpha 3 chains of NC2, a stable heterotrimer with a disulfide bridge between alpha 1 and alpha 3 chains is formed. Our experiments show that this heterotrimerization domain can stabilize a short triple helix attached at the carboxyl-terminal end and allows for the proper oxidation of the cystine knot of type III collagen after the short triple helix.	Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Boudko, Sergei P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Oregon Health & Science University; University of Basel	Bachinger, HP (corresponding author), 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Boudko, Sergei/0000-0003-3856-4859	Shriners Hospital for Children	Shriners Hospital for Children	This work was supported by a grant from the Shriners Hospital for Children.	Asamura K, 2005, NEUROSCIENCE, V132, P493, DOI 10.1016/j.neuroscience.2005.01.013; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200; Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054; Boyd LM, 2008, ARTHRITIS RHEUM, V58, P164, DOI 10.1002/art.23231; BRUCKNER P, 1988, J BIOL CHEM, V263, P16911; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5; Diab M, 1993, Orthop Rev, V22, P165; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; EYRE DR, 1995, J RHEUMATOL, V22, P82; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Fresquet M, 2007, J BIOL CHEM, V282, P34634, DOI 10.1074/jbc.M705301200; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Jaalinoja J, 2008, J RHEUMATOL, V35, P745; Jaalinoja J, 2008, BIOCHEM J, V409, P545, DOI 10.1042/BJ20070984; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; LABOURDETTE L, 1993, FEBS LETT, V320, P211, DOI 10.1016/0014-5793(93)80588-L; Leppanen VM, 2007, J BIOL CHEM, V282, P23219, DOI 10.1074/jbc.M702514200; Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p; MAZZORANA M, 1993, J BIOL CHEM, V268, P3029; Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; Mechling DE, 1996, J BIOL CHEM, V271, P13781, DOI 10.1074/jbc.271.23.13781; MORGELIN M, 1994, BIOPHYS CHEM, V50, P113, DOI 10.1016/0301-4622(94)85024-0; Munakata H, 1999, GLYCOBIOLOGY, V9, P1023, DOI 10.1093/glycob/9.10.1023; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; OKADA Y, 1989, FEBS LETT, V244, P473, DOI 10.1016/0014-5793(89)80586-1; Paassilta P, 1999, J BIOL CHEM, V274, P22469, DOI 10.1074/jbc.274.32.22469; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Rowley MJ, 2008, MOD RHEUMATOL, V18, P429, DOI 10.1007/s10165-008-0080-x; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; WU JJ, 1991, J BIOL CHEM, V266, P5625	39	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23721	23731		10.1074/jbc.M110.128405	http://dx.doi.org/10.1074/jbc.M110.128405			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507993	Green Published, hybrid			2022-12-25	WOS:000280291400022
J	D'Alessio, A; Kluger, MS; Li, JH; Al-Lamki, R; Bradley, JR; Pober, JS				D'Alessio, Alessio; Kluger, Martin S.; Li, Jie H.; Al-Lamki, Rafia; Bradley, John R.; Pober, Jordan S.			Targeting of Tumor Necrosis Factor Receptor 1 to Low Density Plasma Membrane Domains in Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA B ACTIVATION; DEATH DOMAIN; TNF; ENDOCYTOSIS; CAVEOLIN-1; LOCALIZATION; PROTEINS; SIGNAL; INTERNALIZATION; APOPTOSIS	TNFR1 ( tumor necrosis factor receptor 1) localizes to caveolae of human endothelial-derived EA.hy926 cells. Transduced TNFR1 molecules lacking amino acid residues 229-244 ( spanning the transmembrane/intercellular boundary) are expressed on the cell surface equivalently to full-length TNFR1 molecules but incompletely localize to caveolae. A peptide containing this sequence pulls down CAV-1 (caveolin-1) and TNFR1 from cell lysates but fails to do so following disruption of caveolae with methyl-beta-cyclodextrin. We previously reported that methyl-beta-cyclodextrin eliminates caveolae and blocks tumor necrosis factor (TNF)-induced internalization of TNFR1 but not TNF-induced activation of NF-kappa B in EA.hy926 cells. Both CAV-1 and FLOT-2 (flotillin-2), organizing proteins of caveolae and lipid rafts, respectively, associate with caveolae in EA.hy926 cells. Small interfering RNA-mediated knockdown of CAV-1 but not FLOT-2 strikingly reduces caveolae number. Both knockdowns reduce total TNFR1 protein expression, but neither prevents TNFR1 localization to low density membrane domains, TNF-induced internalization of TNFR1, or NF-kappa B activation by TNF. Both CAV-1 and FLOT-2 knockdowns reduce TNF-mediated activation of stress-activated protein kinase ( SAPK). However, both knockdowns reduce expression of TRAF2 (TNF receptor-associated factor-2) protein, and small interfering RNA targeting of TRAF2 also selectively inhibits SAPK activation. We conclude that TNFR1 contains a membrane-proximal sequence that targets the receptor to caveolae/lipid rafts. Neither TNFR1 targeting to nor internalization from these low density membrane domains depends upon CAV-1 or FLOT-2. Furthermore, both NF-kappa B and SAPK activation appear independent of both TNFR1 localization to low density membrane domains and to TNF-induced receptor internalization.	[D'Alessio, Alessio; Kluger, Martin S.; Li, Jie H.; Pober, Jordan S.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [D'Alessio, Alessio; Li, Jie H.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kluger, Martin S.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Pober, Jordan S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Al-Lamki, Rafia; Bradley, John R.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Al-Lamki, Rafia; Bradley, John R.] Addenbrookes Hosp, Cambridge CB2 2QQ, England; [D'Alessio, Alessio] Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00161 Rome, Italy	Yale University; Yale University; Yale University; Yale University; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Sapienza University Rome	Pober, JS (corresponding author), Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, 10 Amistad St,Rm 401D, New Haven, CT 06520 USA.	jordan.pober@yale.edu	D'Alessio, Alessio/F-3778-2010	D'Alessio, Alessio/0000-0002-3340-2634; Bradley, John/0000-0002-7774-8805	National Institutes of Health [RO1-HL36003, NO1-HV28186]; Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR); British Heart Foundation; National Institute for Health Research Cambridge Biomedical Research Centre; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); British Heart Foundation(British Heart Foundation); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL36003 and NO1-HV28186. This work was also supported by the Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR), the British Heart Foundation, and the National Institute for Health Research Cambridge Biomedical Research Centre.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bilderback TR, 2001, J NEUROCHEM, V76, P1540, DOI 10.1046/j.1471-4159.2001.00171.x; BRADLEY JR, 1995, AM J PATHOL, V146, P27; BRADLEY JR, 1993, J IMMUNOL, V150, P5544; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Gaeta ML, 2000, LAB INVEST, V80, P1185, DOI 10.1038/labinvest.3780126; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; HIGUCHI M, 1994, J IMMUNOL, V152, P3550; Jadot M, 2001, EUR J BIOCHEM, V268, P1392, DOI 10.1046/j.1432-1327.2001.02006.x; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Ledgerwood EC, 1999, LAB INVEST, V79, P1041; Ledgerwood EC, 1998, LAB INVEST, V78, P1583; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; LOETSCHER H, 1993, J BIOL CHEM, V268, P26350; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; SLOWIK MR, 1993, AM J PATHOL, V143, P1724; Storey H, 2002, BIOCHEM J, V366, P15, DOI 10.1042/BJ20020048; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Vasile E, 1999, J HISTOCHEM CYTOCHEM, V47, P159, DOI 10.1177/002215549904700205; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200	41	28	28	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23868	23879		10.1074/jbc.M110.122853	http://dx.doi.org/10.1074/jbc.M110.122853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511226	Green Published, hybrid			2022-12-25	WOS:000280291400037
J	de Jesus, TCL; Tonelli, RR; Nardelli, SC; Augusto, LD; Motta, MCM; Girard-Dias, W; Miranda, K; Ulrich, P; Jimenez, V; Barquilla, A; Navarro, M; Docampo, R; Schenkman, S				Leandro de Jesus, Teresa Cristina; Tonelli, Renata Rosito; Nardelli, Sheila C.; Augusto, Leonardo da Silva; Motta, Maria Cristina M.; Girard-Dias, Wendell; Miranda, Kildare; Ulrich, Paul; Jimenez, Veronica; Barquilla, Antonio; Navarro, Miguel; Docampo, Roberto; Schenkman, Sergio			Target of Rapamycin (TOR)-like 1 Kinase Is Involved in the Control of Polyphosphate Levels and Acidocalcisome Maintenance in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE EXPRESSION SYSTEM; INORGANIC POLYPHOSPHATE; CELL-GROWTH; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; RNA INTERFERENCE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; ACIDIC VACUOLES; GENE-EXPRESSION; OSMOTIC-STRESS	Target of rapamycin (TOR) kinases are highly conserved protein kinases that integrate signals from nutrients and growth factors to coordinate cell growth and cell cycle progression. It has been previously described that two TOR kinases control cell growth in the protozoan parasite Trypanosoma brucei, the causative agent of African trypanosomiasis. Here we studied an unusual TOR-like protein named TbTOR-like 1 containing a PDZ domain and found exclusively in kinetoplastids. TbTOR-like 1 localizes to unique cytosolic granules. After hyperosmotic stress, the localization of the protein shifts to the cell periphery, different from other organelle markers. Ablation of TbTOR-like 1 causes a progressive inhibition of cell proliferation, producing parasites accumulating in the S/G(2) phase of the cell cycle. TbTOR-like 1 knocked down cells have an increased area occupied by acidic vacuoles, known as acidocalcisomes, and are enriched in polyphosphate and pyrophosphate. These results suggest that TbTOR-like 1 might be involved in the control of acidocalcisome and polyphosphate metabolism in T. brucei.	[Leandro de Jesus, Teresa Cristina; Ulrich, Paul; Jimenez, Veronica; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Leandro de Jesus, Teresa Cristina; Ulrich, Paul; Jimenez, Veronica; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Leandro de Jesus, Teresa Cristina; Tonelli, Renata Rosito; Nardelli, Sheila C.; Augusto, Leonardo da Silva; Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Motta, Maria Cristina M.; Girard-Dias, Wendell; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; [Miranda, Kildare] Inst Nacl Metrol Normalizacao & Qualidade Ind, Diretoria Programas, BR-25250020 Rio De Janeiro, Brazil; [Barquilla, Antonio; Navarro, Miguel] Consejo Super Invest Cient, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@cb.uga.edu; sschenkman@unifesp.br	Motta, Maria Cristina M/I-3140-2014; Nardelli, Sheila/E-7787-2013; Schenkman, Sergio/A-9227-2013; Navarro, Miguel/C-3685-2009; Tonelli, Renata R/H-1334-2012; Nardelli, Sheila/D-4809-2018	Schenkman, Sergio/0000-0001-9353-8480; Navarro, Miguel/0000-0003-2301-2699; Tonelli, Renata R/0000-0002-1685-9042; Motta, Maria Cristina/0000-0002-0947-4830; da Silva Augusto, Leonardo/0000-0003-0430-8216	National Institutes of Health [AI-077538]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico e Instituto Nacional de Ciencia e Tecnologia de Vacinas do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico e Instituto Nacional de Ciencia e Tecnologia de Vacinas do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases(Lawrence Ellison Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-077538 (to R. D.). This work was also supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico e Instituto Nacional de Ciencia e Tecnologia de Vacinas do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. Supported in part by a training grant from the Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases.; Supported by a postdoctoral fellowship from the American Heart Association.	Abuin G, 1999, J BIOL CHEM, V274, P13041, DOI 10.1074/jbc.274.19.13041; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BANGS JD, 1993, J CELL SCI, V105, P1101; Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105; Barquilla A, 2009, AUTOPHAGY, V5, P256, DOI 10.4161/auto.5.2.7591; Barquilla A, 2009, CELL CYCLE, V8, P697, DOI 10.4161/cc.8.5.7808; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; CASTRO CD, 1995, APPL ENVIRON MICROB, V61, P4448, DOI 10.1128/AEM.61.12.4448-4453.1995; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Clayton CE, 2005, METH MOL B, V309, P39; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gull K, 2001, INT J PARASITOL, V31, P443, DOI 10.1016/S0020-7519(01)00154-0; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; HAROLD FM, 1965, J BACTERIOL, V89, P1262, DOI 10.1128/JB.89.5.1262-1270.1965; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kocic I, 2001, CARDIOVASC RES, V51, P59, DOI 10.1016/S0008-6363(01)00279-6; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lopez-Aviles S, 2005, MOL CELL, V17, P49, DOI 10.1016/j.molcel.2004.11.043; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Monnerat Severine, 2009, BMC Res Notes, V2, P46, DOI 10.1186/1756-0500-2-46; Petersen J, 2009, BIOCHEM SOC T, V37, P273, DOI 10.1042/BST0370273; PICK U, 1991, PLANT PHYSIOL, V97, P1234, DOI 10.1104/pp.97.3.1234; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Ruiz FA, 2004, MICROSC MICROANAL, V10, P563, DOI 10.1017/S1431927604040875; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Schoneck R, 1997, EUR J BIOCHEM, V243, P739, DOI 10.1111/j.1432-1033.1997.00739.x; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Vieira LL, 1998, BBA-REV BIOMEMBRANES, V1376, P221, DOI 10.1016/S0304-4157(98)00007-0; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YANG YC, 1993, BIOCHIM BIOPHYS ACTA, V1179, P141, DOI 10.1016/0167-4889(93)90135-C	58	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24131	24140		10.1074/jbc.M110.120212	http://dx.doi.org/10.1074/jbc.M110.120212			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20495004	Green Published, hybrid			2022-12-25	WOS:000280291400063
J	Rajapaksa, TE; Bennett, KM; Hamer, M; Lytle, C; Rodgers, VGJ; Lo, DD				Rajapaksa, Thejani E.; Bennett, Kaila M.; Hamer, Mary; Lytle, Christian; Rodgers, Victor G. J.; Lo, David D.			Intranasal M Cell Uptake of Nanoparticles Is Independently Influenced by Targeting Ligands and Buffer Ionic Strength	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEYERS PATCH; HUMAN MUCUS; POLOXAMER; DELIVERY; PLGA; DRUG; IMMUNIZATION; MUCOSAL; PROTEIN; SURFACE	In mucosal tissues, epithelial M cells capture and transport microbes across the barrier to underlying immune cells. Previous studies suggested that high affinity ligands targeting M cells may be used to deliver mucosal vaccines; here, we show that particle composition and dispersion buffer ionic strength can independently influence their uptake in vivo. First, addition of a poloxamer 188 to nanoparticle formulations increased uptake of intranasally administered nanoparticles in vivo, but the effect was dependent on the presence of the M cell-targeting ligand. Second, solvent ionic strength is known to effect electrostatic interactions; accordingly, reduced ionic strength increased the electrostatic potential between the epithelium and the particles. Interestingly, below a critical ionic strength, intranasal particle uptake in vivo significantly was increased even when controlled for osmolarity. Similar results were obtained for uptake of bacterial particles. Surprisingly, at low ionic strength, the specific enhancement effect by the targeting peptide was negligible. Modeling of the electrostatic forces predicted that the enhancing effects of the M cell-targeting ligand only are enabled at high ionic strength, as particle electrostatic forces are reduced through Debye screening. Thus, electrostatic forces can have a dramatic effect on the in vivo M cell particle uptake independent of the action of targeting ligands. Examination of these forces will be helpful to optimizing mucosal vaccine and drug delivery.	[Lo, David D.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Bennett, Kaila M.; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Lo, DD (corresponding author), Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA.	david.lo@ucr.edu	Lytle, Christian/X-2836-2019; Rodgers, Victor G. J./AAF-3838-2021; Rodgers, Victor G/G-3652-2016	Lytle, Christian/0000-0001-5442-1546; Rodgers, Victor G. J./0000-0002-1857-8025; Rodgers, Victor G/0000-0002-1857-8025	National Institutes of Health [AI63426, AI73689]; Foundation for the National Institutes of Health; Grand Challenges in Global Health; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073689, R01AI063426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Challenges in Global Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI63426 and AI73689 and the Foundation for the National Institutes of Health. This work was also supported by an award from the Grand Challenges in Global Health and the Bill and Melinda Gates Foundation.	Al Haushey L, 2007, INT J PHARMACEUT, V344, P16, DOI 10.1016/j.ijpharm.2007.05.067; Allen MJ, 2004, INT J FOOD MICROBIOL, V92, P265, DOI 10.1016/j.ijfoodmicro.2003.08.017; BESHEER A, 2009, MOL PHARM IN PRESS; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Bonferoni M C, 2000, AAPS PharmSciTech, V1, pE15, DOI 10.1208/pt010215; Busscher HJ, 2008, LANGMUIR, V24, P10968, DOI 10.1021/la8016968; Busscher HJ, 2006, ENVIRON SCI TECHNOL, V40, P6799, DOI 10.1021/es061282r; Clark MA, 2001, ADV DRUG DELIVER REV, V50, P81, DOI 10.1016/S0169-409X(01)00149-1; Csaba N, 2006, J CONTROL RELEASE, V113, P164, DOI 10.1016/j.jconrel.2006.03.017; Cu Y, 2009, MOL PHARMACEUT, V6, P173, DOI 10.1021/mp8001254; Doble MA, 2002, J GASTROINTEST SURG, V6, P387, DOI 10.1016/S1091-255X(01)00049-X; ELDRIDGE JH, 1989, CURR TOP MICROBIOL, V146, P59; Florence Alexander T, 2005, Drug Discov Today Technol, V2, P75, DOI 10.1016/j.ddtec.2005.05.019; Florence AT, 2004, J DRUG TARGET, V12, P65, DOI 10.1080/10611860410001693706; Foster N, 1998, VACCINE, V16, P536, DOI 10.1016/S0264-410X(97)00222-3; Gregory J., 2005, PARTICLES WATER PROP, DOI DOI 10.1201/9780203508459; Gupta PN, 2007, J DRUG TARGET, V15, P701, DOI 10.1080/10611860701637982; Gurtovenko AA, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166396; Helander A, 2003, J VIROL, V77, P7964, DOI 10.1128/JVI.77.14.7964-7977.2003; Hillery AM, 1996, INT J PHARM, V132, P123, DOI 10.1016/0378-5173(95)04353-5; Jepson MA, 1996, J ANAT, V189, P507; Kharenko EA, 2009, PHARM CHEM J, V43, P200, DOI 10.1007/s11094-009-0271-6; Kimura J, 2010, J BIOL CHEM, V285, P401, DOI 10.1074/jbc.M109.051417; Kondoh M, 2006, BIOL PHARM BULL, V29, P1783, DOI 10.1248/bpb.29.1783; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lavelle EC, 1999, VACCINE, V17, P512, DOI 10.1016/S0264-410X(98)00229-1; Li Q, 1999, WATER RES, V33, P1090, DOI 10.1016/S0043-1354(98)00291-7; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; Lo D, 2004, INT IMMUNOL, V16, P91, DOI 10.1093/intimm/dxh011; Manocha M, 2005, VACCINE, V23, P5599, DOI 10.1016/j.vaccine.2005.06.031; Moghimi SM, 2000, TRENDS BIOTECHNOL, V18, P412, DOI 10.1016/S0167-7799(00)01485-2; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Neutra MR, 1999, SEMIN IMMUNOL, V11, P171, DOI 10.1006/smim.1999.0173; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Rajapaksa Thejani E., 2010, Current Immunology Reviews, V6, P29; RYAN JN, 1994, J COLLOID INTERF SCI, V165, P536; Santander-Ortega MJ, 2007, COLLOID SURFACE A, V296, P132, DOI 10.1016/j.colsurfa.2006.09.036; Shahiwala Aliasgar, 2007, Recent Pat Drug Deliv Formul, V1, P1, DOI 10.2174/187221107779814140; Shakweh Monjed, 2004, Expert Opin Drug Deliv, V1, P141, DOI 10.1517/17425247.1.1.141; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Tang BC, 2009, P NATL ACAD SCI USA, V106, P19268, DOI 10.1073/pnas.0905998106; Tobio M, 1999, PHARMACEUT RES, V16, P682, DOI 10.1023/A:1018820507379; Tsao HK, 2001, J COLLOID INTERF SCI, V233, P124, DOI 10.1006/jcis.2000.7261; van Merode AEJ, 2008, COLLOID SURFACE B, V64, P302, DOI 10.1016/j.colsurfb.2008.02.004; Wu YP, 2001, P NATL ACAD SCI USA, V98, P9318, DOI 10.1073/pnas.161204098; Zhang Y, 2008, BIOMED MICRODEVICES, V10, P321, DOI 10.1007/s10544-007-9139-2	48	43	48	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23739	23746		10.1074/jbc.M110.126359	http://dx.doi.org/10.1074/jbc.M110.126359			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511224	Green Published, hybrid			2022-12-25	WOS:000280291400024
J	Saga, G; Giorgetti, A; Fufezan, C; Giacometti, GM; Bassi, R; Morosinotto, T				Saga, Giorgia; Giorgetti, Alejandro; Fufezan, Christian; Giacometti, Giorgio M.; Bassi, Roberto; Morosinotto, Tomas			Mutation Analysis of Violaxanthin De-epoxidase Identifies Substrate-binding Sites and Residues Involved in Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHOPHYLL-CYCLE ENZYME; CRYSTAL-STRUCTURE; ZEAXANTHIN FORMATION; ESCHERICHIA-COLI; EXCESS LIGHT; PROTEIN; LIPOCALIN; ENERGY; PH; MEMBRANE	Plants are able to deal with variable environmental conditions; when exposed to strong illumination, they safely dissipate excess energy as heat and increase their capacity for scavenging reacting oxygen species. Both these protection mechanisms involve activation of the xanthophyll cycle, in which the carotenoid violaxanthin is converted to zeaxanthin by violaxanthin de-epoxidase, using ascorbate as the source of reducing power. In this work, following determination of the three-dimensional structure of the violaxanthin de-epoxidase catalytic domain, we identified the putative binding sites for violaxanthin and ascorbate by in silico docking. Amino acid residues lying in close contact with the two substrates were analyzed for their involvement in the catalytic mechanism. Experimental results supported the proposed substrate-binding sites and point to two residues, Asp-177 and Tyr-198, which are suggested to participate in the catalytic mechanism, based on complete loss of activity in mutant proteins. The role of other residues and the mechanistic similarity to aspartic proteases and epoxide hydrolases are discussed.	[Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35121 Padua, Italy; [Saga, Giorgia; Giorgetti, Alejandro; Bassi, Roberto] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Fufezan, Christian] Univ Munster, Inst Biochem & Biotechnol Pflanzen, D-48143 Munster, Germany	University of Padua; University of Verona; University of Munster	Morosinotto, T (corresponding author), Univ Padua, Dipartimento Biol, Via Ugo Bassi 58 B, I-35121 Padua, Italy.	tomas.morosinotto@unipd.it	Morosinotto, Tomas/AAC-3188-2019	Morosinotto, Tomas/0000-0002-0803-7591; Giorgetti, Alejandro/0000-0001-8738-6150; bassi, roberto/0000-0002-4140-8446; Fufezan, Christian/0000-0002-7048-6822	MIUR [PRIN 20073YHRLE]; University of Padova [CPDA089403]	MIUR(Ministry of Education, Universities and Research (MIUR)); University of Padova	This work was supported in part by MIUR Grant PRIN 20073YHRLE and the University of Padova Grant CPDA089403 (to T.M.).	Arand M, 2003, DRUG METAB REV, V35, P365, DOI 10.1081/DMR-120026498; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BRATT CE, 1995, PHOTOSYNTH RES, V45, P169, DOI 10.1007/BF00032588; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; Bugos RC, 1998, J BIOL CHEM, V273, P15321, DOI 10.1074/jbc.273.25.15321; Campanacci V, 2006, FEBS LETT, V580, P4877, DOI 10.1016/j.febslet.2006.07.086; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; Fufezan C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-258; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Garcia-Martin A, 2008, J MOL BIOL, V382, P154, DOI 10.1016/j.jmb.2008.07.002; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Gisselsson A, 2004, PHYSIOL PLANTARUM, V122, P337, DOI 10.1111/j.1399-3054.2004.00415.x; HAGER A, 1994, PLANTA, V192, P581, DOI 10.1007/BF00203597; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Havir EA, 1997, PLANT SCI, V123, P57, DOI 10.1016/S0168-9452(97)04579-2; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Hieber AD, 2002, PLANTA, V214, P476, DOI 10.1007/s00425-001-0704-2; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Kawano M, 2000, FEBS LETT, V481, P101, DOI 10.1016/S0014-5793(00)01991-8; Kerfeld CA, 2003, STRUCTURE, V11, P55, DOI 10.1016/S0969-2126(02)00936-X; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Kuwabara T, 1999, PLANT CELL PHYSIOL, V40, P1119, DOI 10.1093/oxfordjournals.pcp.a029496; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; Latowski D, 2004, BIOCHEMISTRY-US, V43, P4417, DOI 10.1021/bi049652g; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NEUBAUER C, 1994, PHOTOSYNTH RES, V39, P137, DOI 10.1007/BF00029381; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rockholm DC, 1996, PLANT PHYSIOL, V110, P697, DOI 10.1104/pp.110.2.697; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; YAMAMOTO HY, 1978, ARCH BIOCHEM BIOPHYS, V190, P514, DOI 10.1016/0003-9861(78)90305-3; YAMAMOTO HY, 1971, BIOCHEM BIOPH RES CO, V42, P37, DOI 10.1016/0006-291X(71)90358-5	48	42	44	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23763	23778		10.1074/jbc.M110.115097	http://dx.doi.org/10.1074/jbc.M110.115097			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507981	Green Published, hybrid			2022-12-25	WOS:000280291400027
J	Stuible, M; Abella, JV; Feldhammer, M; Nossov, M; Sangwan, V; Blagoev, B; Park, M; Tremblay, ML				Stuible, Matthew; Abella, Jasmine V.; Feldhammer, Matthew; Nossov, Misha; Sangwan, Veena; Blagoev, Blagoy; Park, Morag; Tremblay, Michel L.			PTP1B Targets the Endosomal Sorting Machinery DEPHOSPHORYLATION OF REGULATORY SITES ON THE ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT COMPONENT STAM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; INSULIN SENSITIVITY; SIGNALING NETWORKS; CELL DEVELOPMENT; MOLECULAR-BASIS; DOWN-REGULATION; MICE LACKING; 1B; HRS	Dephosphorylation and endocytic down-regulation are distinct processes that together control the signaling output of a variety of receptor tyrosine kinases (RTKs). PTP1B can directly dephosphorylate several RTKs, but it can also promote activation of downstream pathways through largely unknown mechanisms. These positive signaling functions likely contribute to the tumor-promoting effect of PTP1B in mouse cancer models. Here, we have identified STAM2, an endosomal protein involved in sorting activated RTKs for lysosomal degradation, as a substrate of PTP1B. PTP1B interacts with STAM2 at defined phosphotyrosine sites, and knockdown of PTP1B expression augments STAM2 phosphorylation. Intriguingly, manipulating the expression and phosphorylation state of STAM2 did not have a general effect on epidermal growth factor (EGF)-induced EGF receptor trafficking, degradation, or signaling. Instead, phosphorylated STAM2 specifically suppressed Akt activation, and a phosphorylation-deficient STAM2 mutant displayed prolonged localization on endosomes following EGF stimulation. These results reveal a novel link between the dephosphorylation and endocytic machinery and suggest that PTP1B can affect RTK signaling in a previously unrecognized manner.	[Park, Morag; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Tremblay, Michel L.] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Blagoev, Blagoy] Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt BioInformat, DK-5230 Odense, Denmark	McGill University; McGill University; McGill University; University of Southern Denmark	Tremblay, ML (corresponding author), McGill Univ, Dept Biochem, 1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	michel.tremblay@mcgill.ca		Blagoev, Blagoy/0000-0002-3596-0066	Canadian Institutes of Health Research [MOP-62887, MOP-1154]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants MOP-62887 (to M.L.T.) and MOP-1154 (to M.P.).	Abella JV, 2009, AM J PHYSIOL-ENDOC M, V296, pE973, DOI 10.1152/ajpendo.90857.2008; Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Burz DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002571; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Lohi O, 1998, FEBS LETT, V432, P225, DOI 10.1016/S0014-5793(98)00874-6; Mizuno E, 2004, J BIOCHEM, V135, P385, DOI 10.1093/jb/mvh046; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pandey A, 2000, J BIOL CHEM, V275, P38633, DOI 10.1074/jbc.M007849200; Parachoniak CA, 2009, J BIOL CHEM, V284, P8382, DOI 10.1074/jbc.M807607200; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkina T, 2002, J BIOL CHEM, V277, P27433, DOI 10.1074/jbc.M201595200; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Stuible M, 2007, CHEMBIOCHEM, V8, P179, DOI 10.1002/cbic.200600287; Uetani N, 2009, J CLIN INVEST, V119, P924, DOI 10.1172/JCI37196; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Yamada M, 2002, MOL CELL BIOL, V22, P8648, DOI 10.1128/MCB.22.24.8648-8658.2002; Yamada M, 2001, MOL CELL BIOL, V21, P3807, DOI 10.1128/MCB.21.11.3807-3819.2001	44	39	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23899	23907		10.1074/jbc.M110.115295	http://dx.doi.org/10.1074/jbc.M110.115295			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504764	Green Published, hybrid			2022-12-25	WOS:000280291400040
J	Kim, J; Lilliehook, C; Dudak, A; Prox, J; Saftig, P; Federoff, HJ; Lim, ST				Kim, Jinsook; Lilliehook, Christina; Dudak, Amanda; Prox, Johannes; Saftig, Paul; Federoff, Howard J.; Lim, Seung T.			Activity-dependent alpha-Cleavage of Nectin-1 Is Mediated by A Disintegrin and Metalloprotease 10 (ADAM10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; MOSSY FIBER TERMINALS; AMYLOID PRECURSOR PROTEIN; ADULT-MOUSE HIPPOCAMPUS; N-CADHERIN; PRESENILIN/GAMMA-SECRETASE; PYRAMIDAL CELLS; BETA-CATENIN; SYNAPTIC PLASTICITY; ADHERENS JUNCTIONS	Nectin-1 is known to undergo ectodomain shedding by alpha-secretase and subsequent proteolytic processing by gamma-secretase. How secretase-mediated cleavage of nectin-1 is regulated in neuronal cells and how nectin-1 cleavage affects synaptic adhesion is poorly understood. We have investigated alpha-and gamma-secretase-mediated processing of nectin-1 in primary cortical neurons and identified which protease acts as a alpha-secretase. We report here that NMDA receptor activation, but not stimulation of AMPA or metabotropic glutamate receptors, resulted in robust alpha- and gamma-secretase cleavage of nectin-1 in mature cortical neurons. Cleavage of nectin-1 required influx of Ca2+ through the NMDA receptor, and activation of calmodulin, but was not dependent on calcium/calmodulin-dependent protein kinase II (CaMKII) activation. We found that ADAM10 is the major secretase responsible for nectin-1 ectodomain cleavage in neurons and the brain. These observations suggest that alpha- and gamma-secretase processing of nectin-1 is a Ca2+/calmodulin-regulated event that occurs under conditions of activity-dependent synaptic plasticity and ADAM10 and gamma-secretase are responsible for these cleavage events.	[Lim, Seung T.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Lilliehook, Christina] Univ Rochester, Sch Med & Dent, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; [Prox, Johannes; Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	Georgetown University; University of Rochester; University of Kiel	Lim, ST (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	ls379@georgetown.edu	Saftig, Paul/A-7966-2010		National Institutes of Health [R01 AG027233]; NATIONAL INSTITUTE ON AGING [R01AG027233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG027233.	Benson DL, 1998, J NEUROSCI, V18, P6892; Buchert M, 2007, J CELL PHYSIOL, V210, P212, DOI 10.1002/jcp.20853; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dihne M, 2003, J NEUROSCI, V23, P6638; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Haarr L, 2001, VIROLOGY, V287, P301, DOI 10.1006/viro.2001.1041; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Inagaki M, 2003, J COMP NEUROL, V460, P514, DOI 10.1002/cne.10653; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; Lee TW, 2008, NEURON GLIA BIOL, V4, P223, DOI 10.1017/S1740925X09990172; Li T, 2003, J NEUROSCI, V23, P3272; Li Y, 2009, J CELL BIOL, V185, P1065, DOI 10.1083/jcb.200811033; Lim ST, 2008, J COMP NEUROL, V507, P1228, DOI 10.1002/cne.21608; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nishioka H, 2000, J COMP NEUROL, V424, P297, DOI 10.1002/1096-9861(20000821)424:2<297::AID-CNE8>3.0.CO;2-J; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Saito S, 1998, DNA Res, V5, P115, DOI 10.1093/dnares/5.2.115; Sakisaka T, 2007, CURR OPIN CELL BIOL, V19, P593, DOI 10.1016/j.ceb.2007.09.007; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; Sugawa M, 1997, NEUROREPORT, V8, P3157, DOI 10.1097/00001756-199709290-00030; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, CURR OPIN NEUROBIOL, V13, P520, DOI 10.1016/j.conb.2003.09.003; Tanaka Y, 2002, BIOCHEM BIOPH RES CO, V299, P472, DOI 10.1016/S0006-291X(02)02681-5; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Uemura K, 2006, BIOCHEM BIOPH RES CO, V345, P951, DOI 10.1016/j.bbrc.2006.04.157; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yamada A, 2003, GENES CELLS, V8, P985, DOI 10.1046/j.1356-9597.2003.00690.x; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	46	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22917	22924		10.1074/jbc.M110.126649	http://dx.doi.org/10.1074/jbc.M110.126649			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501653	hybrid, Green Published			2022-12-25	WOS:000279999900025
J	Salameh, A; Galvagni, F; Anselmi, F; De Clemente, C; Orlandini, M; Oliviero, S				Salameh, Ahmad; Galvagni, Federico; Anselmi, Francesca; De Clemente, Caterina; Orlandini, Maurizio; Oliviero, Salvatore			Growth Factor Stimulation Induces Cell Survival by c-Jun center dot ATF2-dependent Activation of Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; GENE; APOPTOSIS; PHOSPHORYLATION; PROMOTER; JNK; PROLIFERATION; LYMPHOCYTES; EXPRESSION; AP-1	Growth factor stimulation induces c-Jun-dependent survival of primary endothelial cells. However, the mechanism of c-Jun anti-apoptotic activity has not been identified. We here demonstrate that in response to growth factor treatment, primary human endothelial cells as well as mouse fibroblasts respond with an increased expression of c-Jun that forms a complex with ATF2. This complex activates the expression of the anti-apoptotic protein Bcl-XL. By site-directed mutagenesis experiments, we identified two AP-1-binding sites located within the proximal promoter of the Bcl-X gene. Site-directed mutagenesis demonstrated that these AP-1 sites are required for the transcriptional activation of the promoter. Chromatin immunoprecipitation experiments show that in response to growth factor treatment, the heterodimer c-Jun center dot ATF2 binds to these functional AP-1 sites. Silencing of either c-Jun or ATF2 demonstrated that both nuclear factors are required for the activation of the proximal Bcl-X promoter. Taken together, our experiments provide evidence that growth factor-independent signaling pathways converge in the formation of an active c-Jun center dot AFT2 dimer, which induces the expression of the anti-apoptotic factor Bcl-XL that mediates a pro-survival response.	[Salameh, Ahmad; Galvagni, Federico; Anselmi, Francesca; De Clemente, Caterina; Orlandini, Maurizio; Oliviero, Salvatore] Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy	University of Siena	Oliviero, S (corresponding author), Via Fiorentina 1, I-53100 Siena, Italy.	Oliviero@unisi.it	Orlandini, Maurizio/AAF-8247-2020; oliviero, salvatore/R-6657-2019; Galvagni, Federico/F-9186-2013	Orlandini, Maurizio/0000-0002-6112-4889; oliviero, salvatore/0000-0002-3405-765X; 	Associazione Italiana Ricerca sul Cancro, Istituto Tosscano Tumori; Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca	Associazione Italiana Ricerca sul Cancro, Istituto Tosscano Tumori(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from Associazione Italiana Ricerca sul Cancro, Istituto Tosscano Tumori, and Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Ezzat S, 2006, MOL ENDOCRINOL, V20, P2976, DOI 10.1210/me.2006-0265; FANG W, 1994, J IMMUNOL, V153, P4388; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Habens F, 2007, ONCOGENE, V26, P1910, DOI 10.1038/sj.onc.1209979; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Pecci A, 2001, J BIOL CHEM, V276, P21062, DOI 10.1074/jbc.M008665200; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Viegas LR, 2004, J BIOL CHEM, V279, P9831, DOI 10.1074/jbc.M312402200; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Yang XF, 1997, IMMUNITY, V7, P629, DOI 10.1016/S1074-7613(00)80384-2; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08; Zippo A, 2004, BLOOD, V103, P4536, DOI 10.1182/blood-2003-11-3827; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	30	36	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23094	23102		10.1074/jbc.M109.087221	http://dx.doi.org/10.1074/jbc.M109.087221			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20507983	Green Published, hybrid			2022-12-25	WOS:000279999900044
J	Zong, HL; Madden, A; Ward, M; Mooney, MH; Elliott, CT; Stitt, AW				Zong, Hongliang; Madden, Angelina; Ward, Micheal; Mooney, Mark H.; Elliott, Christopher T.; Stitt, Alan W.			Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CELL-SURFACE RECEPTOR; ENDPRODUCTS RAGE; PATTERN-RECOGNITION; CYTOPLASMIC DOMAIN; NEURITE OUTGROWTH; ACTIVATION; EXPRESSION; GLYCOSYLATION; NEUROTOXICITY	The receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor that binds to diverse ligands and initiates a downstream proinflammatory signaling cascade. RAGE activation has been linked to diabetic complications, Alzheimer disease, infections, and cancers. RAGE is known to mediate cell signaling and downstream proinflammatory gene transcription activation, although the precise mechanism surrounding receptor-ligand interactions is still being elucidated. Recent fluorescence resonance energy transfer evidence indicates that RAGE may form oligomers on the cell surface and that this could be related to signal transduction. To investigate whether RAGE forms oligomers, protein-protein interaction assays were carried out. Here, we demonstrate the interaction between RAGE molecules via their N-terminal V domain, which is an important region involved in ligand recognition. By protein cross-linking using water-soluble and membrane-impermeable cross-linker bis(sulfosuccinimidyl) suberate and nondenaturing gels, we show that RAGE forms homodimers at the plasma membrane, a process potentiated by S100B and advanced glycation end products. Soluble RAGE, the RAGE inhibitor, is also capable of binding to RAGE, similar to V peptide, as shown by surface plasmon resonance. Incubation of cells with soluble RAGE or RAGE V domain peptide inhibits RAGE dimerization, subsequent phosphorylation of intracellular MAPK proteins, and activation of NF-kappa B pathways. Thus, the data indicate that dimerization of RAGE represents an important component of RAGE-mediated cell signaling.	[Zong, Hongliang; Madden, Angelina; Ward, Micheal; Stitt, Alan W.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland; [Mooney, Mark H.; Elliott, Christopher T.] Queens Univ Belfast, Sch Biol Sci, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Stitt, AW (corresponding author), Queens Univ Belfast, Royal Victoria Hosp, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland.	a.stitt@qub.ac.uk	Ward, Micheal/G-1379-2012; Stitt, Alan/A-9842-2009; Zong, Hongliang/F-9366-2013	Ward, Micheal/0000-0001-8988-5797; Stitt, Alan/0000-0002-8647-9918; Zong, Hongliang/0000-0002-5855-5733	Juvenile Diabetes Research Foundation; Fight for Sight (United Kingdom)	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fight for Sight (United Kingdom)	This work was supported by the Juvenile Diabetes Research Foundation and Fight for Sight (United Kingdom).	Bhatwadekar A, 2007, EXPERT REV OPHTHALMO, V2, P105, DOI 10.1586/17469899.2.1.105; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BRETT J, 1993, AM J PATHOL, V143, P1699; Chaney MO, 2005, BBA-MOL BASIS DIS, V1741, P199, DOI 10.1016/j.bbadis.2005.03.014; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; CHUONG C, 2009, J CELL PHYSL; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Sasahira T, 2005, VIRCHOWS ARCH, V446, P411, DOI 10.1007/s00428-005-1210-x; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Stitt AW, 1999, BIOCHEM BIOPH RES CO, V256, P549, DOI 10.1006/bbrc.1999.0291; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van Zoelen MAD, 2009, VIROLOGY, V391, P265, DOI 10.1016/j.virol.2009.05.032; Wang LY, 2008, J NEUROSCI RES, V86, P1254, DOI 10.1002/jnr.21578; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S146239940900101X; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495	40	97	98	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23135	23144		10.1074/jbc.M110.133827	http://dx.doi.org/10.1074/jbc.M110.133827			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504772	Green Published, hybrid			2022-12-25	WOS:000279999900048
J	Chen, SG; Owens, GC; Makarenkova, H; Edelman, DB				Chen, Sigeng; Owens, Geoffrey C.; Makarenkova, Helen; Edelman, David B.			HDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons	PLOS ONE			English	Article							KINESIN-HEAVY-CHAIN; AXONAL-TRANSPORT; MICROTUBULE ACETYLATION; ALZHEIMERS-DISEASE; TUBULIN; DEACETYLASE; BINDING; INTERACTS; PARKIN; MILTON	Background: Tubulin is a major substrate of the cytoplasmic class II histone deacetylase HDAC6. Inhibition of HDAC6 results in higher levels of acetylated tubulin and enhanced binding of the motor protein kinesin-1 to tubulin, which promotes transport of cargoes along microtubules. Microtubule-dependent intracellular trafficking may therefore be regulated by modulating the activity of HDAC6. We have shown previously that the neuromodulator serotonin increases mitochondrial movement in hippocampal neurons via the Akt-GSK3 beta signaling pathway. Here, we demonstrate a role for HDAC6 in this signaling pathway. Methodology/Principal Findings: We found that the presence of tubacin, a specific HDAC6 inhibitor, dramatically enhanced mitochondrial movement in hippocampal neurons, whereas niltubacin, an inactive tubacin analog, had no effect. Compared to control cultures, higher levels of acetylated tubulin were found in neurons treated with tubacin, and more kinesin-1 was associated with mitochondria isolated from these neurons. Inhibition of GSK3 beta decreased cytoplasmic deacetylase activity and increased tubulin acetylation, whereas blockade of Akt, which phosphorylates and down-regulates GSK3 beta, increased cytoplasmic deacetylase activity and decreased tubulin acetylation. Concordantly, the administration of 5-HT, 8-OH-DPAT (a specific 5-HT1A receptor agonist), or fluoxetine (a 5-HT reuptake inhibitor) increased tubulin acetylation. GSK3 beta was found to co-localize with HDAC6 in hippocampal neurons, and inhibition of GSK3 beta resulted in decreased binding of antibody to phosphoserine-22, a potential GSK3 beta phosphorylation site in HDAC6. GSK3 beta may therefore regulate HDAC6 activity by phosphorylation. Conclusions/Significance: This study demonstrates that HDAC6 plays an important role in the modulation of mitochondrial transport. The link between HDAC6 and GSK3 beta, established here, has important implications for our understanding of neurodegenerative disorders. In particular, abnormal mitochondrial transport, which has been observed in such disorders as Alzheimer's disease and Parkinson's disease, could result from the misregulation of HDAC6 by GSK3 beta. HDAC6 may therefore constitute an attractive target in the treatment of these disorders.	[Chen, Sigeng; Owens, Geoffrey C.; Makarenkova, Helen; Edelman, David B.] Inst Neurosci, San Diego, CA USA		Chen, SG (corresponding author), Inst Neurosci, San Diego, CA USA.	schen@nsi.edu	Chen, Sigeng/G-1678-2014		Neurosciences Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053163] Funding Source: NIH RePORTER	Neurosciences Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the Neurosciences Research Foundation. The Neurosciences Research Foundation did not have any role in study design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.	Beal M Flint, 2007, Novartis Found Symp, V287, P183; Bendiske J, 2002, J NEUROPATH EXP NEUR, V61, P640, DOI 10.1093/jnen/61.7.640; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Chen J, 2008, GENOME RES, V18, P123, DOI 10.1101/gr.6940108; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; DING H, 2008, J NEUROCHEM; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jiang Q, 2008, J NEUROSCI, V28, P12993, DOI 10.1523/JNEUROSCI.2860-08.2008; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Leroy K, 2007, NEUROPATH APPL NEURO, V33, P43, DOI 10.1111/j.1365-2990.2006.00795.x; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2002, NEUROMOL MED, V2, P89, DOI 10.1385/NMM:2:2:089; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Pigino G, 2003, J NEUROSCI, V23, P4499; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Reynolds IJ, 2004, J BIOENERG BIOMEMBR, V36, P283, DOI 10.1023/B:JOBB.0000041754.78313.c2; Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071; Schlager MA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-25; Sigala R, 2007, CURR BIOL, V17, pR18, DOI 10.1016/j.cub.2006.11.036; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Trejo HE, 2010, FASEB J, V24, P374, DOI 10.1096/fj.09-137802; Trimmer PA, 2005, ANTIOXID REDOX SIGN, V7, P1101, DOI 10.1089/ars.2005.7.1101; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vaughan EE, 2008, MOL THER, V16, P1841, DOI 10.1038/mt.2008.190; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	43	271	280	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10848	10.1371/journal.pone.0010848	http://dx.doi.org/10.1371/journal.pone.0010848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520769	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221500033
J	Cohen, H; Voss, P; Lepore, F; Scherzer, P				Cohen, Henri; Voss, Patrice; Lepore, Franco; Scherzer, Peter			The Nature of Working Memory for Braille	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; EARLY VISUAL-CORTEX; TACTILE ACUITY; LATE BLIND; CONGENITALLY BLIND; ADAPTIVE-CHANGES; DISCRIMINATION; RECOGNITION; PERFORMANCE; ACTIVATION	Blind individuals have been shown on multiple occasions to compensate for their loss of sight by developing exceptional abilities in their remaining senses. While most research has been focused on perceptual abilities per se in the auditory and tactile modalities, recent work has also investigated higher-order processes involving memory and language functions. Here we examined tactile working memory for Braille in two groups of visually challenged individuals (completely blind subjects, CBS; blind with residual vision, BRV). In a first experimental procedure both groups were given a Braille tactile memory span task with and without articulatory suppression, while the BRV and a sighted group performed a visual version of the task. It was shown that the Braille tactile working memory (BrWM) of CBS individuals under articulatory suppression is as efficient as that of sighted individuals' visual working memory in the same condition. Moreover, the results suggest that BrWM may be more robust in the CBS than in the BRV subjects, thus pointing to the potential role of visual experience in shaping tactile working memory. A second experiment designed to assess the nature (spatial vs. verbal) of this working memory was then carried out with two new CBS and BRV groups having to perform the Braille task concurrently with a mental arithmetic task or a mental displacement of blocks task. We show that the disruption of memory was greatest when concurrently carrying out the mental displacement of blocks, indicating that the Braille tactile subsystem of working memory is likely spatial in nature in CBS. The results also point to the multimodal nature of working memory and show how experience can shape the development of its subcomponents.	[Cohen, Henri] Univ Paris 05, CNRS, Lab Psychol & Neuropsychol Cognit, FRE 3292, Boulogne Billancourt, France; [Cohen, Henri; Scherzer, Peter] Univ Quebec, Inst Cognit Sci, Montreal, PQ H3C 3P8, Canada; [Cohen, Henri] Clin St Anne, Quebec Memory & Motor Skills Disorders Res Ctr, Quebec City, PQ, Canada; [Voss, Patrice; Lepore, Franco] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Quebec; University of Quebec Montreal; Universite de Montreal	Cohen, H (corresponding author), Univ Paris 05, CNRS, Lab Psychol & Neuropsychol Cognit, FRE 3292, Boulogne Billancourt, France.	henri.cohen@parisdescartes.fr	voss, patrice/I-7026-2019	voss, patrice/0000-0001-8698-7130	FQRSC (Fonds de recherche sur la societe et la culture) (Quebec)	FQRSC (Fonds de recherche sur la societe et la culture) (Quebec)	This study was aided in part by a grant from FQRSC (Fonds de recherche sur la societe et la culture) (Quebec). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary F, 2008, EXP BRAIN RES, V187, P587, DOI 10.1007/s00221-008-1327-7; Alary F, 2009, NEUROPSYCHOLOGIA, V47, P2037, DOI 10.1016/j.neuropsychologia.2009.03.014; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; AXELROD S, 1959, RES SERIES AM FDN BL, V7; BADDELEY A, 1992, Q J EXP PSYCHOL-A, V44, P1, DOI 10.1080/14640749208401281; Baddeley A., 2007, WORKING MEMORY THOUG; Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851; Baddeley AD, 1974, RECENT ADV LEARNING, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Bliss I, 2004, COGNITIVE BRAIN RES, V18, P273, DOI 10.1016/j.cogbrainres.2003.10.012; BORINO D, 2008, ARCH ITAL BIOL, V146, P133; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Cornoldi C., 2003, VISUO SPATIAL WORKIN; D'Angiulli A, 2002, INT J REHABIL RES, V25, P143, DOI 10.1097/00004356-200206000-00008; Deibert E, 1999, NEUROLOGY, V52, P1413, DOI 10.1212/WNL.52.7.1413; Facchini S, 2003, NEUROLOGY, V60, P1998, DOI 10.1212/01.WNL.0000068026.15208.D0; GILSON EQ, 1969, Q J EXP PSYCHOL, V21, P180, DOI 10.1080/14640746908400211; Goldreich D, 2003, J NEUROSCI, V23, P3439; JONES B, 1975, BRIT J PSYCHOL, V66, P461, DOI 10.1111/j.2044-8295.1975.tb01481.x; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewald J, 2002, NEUROPSYCHOLOGIA, V40, P1868, DOI 10.1016/S0028-3932(02)00071-4; LOGIE RH, 1990, ACTA PSYCHOL, V75, P55, DOI 10.1016/0001-6918(90)90066-O; Mahrer P, 2002, MEMORY, V10, P7, DOI 10.1080/09658210143000128; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; Miles C, 1996, MEMORY, V4, P655, DOI 10.1080/741940995; Ricciardi E, 2006, NEUROSCIENCE, V139, P339, DOI 10.1016/j.neuroscience.2005.08.045; RICE C, 1970, AM F BLIND RES B, V22, P1, DOI DOI 10.3758/S13414-011-0160-4; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Roder B, 2000, NEUROPSYCHOLOGIA, V38, P1482, DOI 10.1016/S0028-3932(00)00057-9; Roder B, 2003, INT J PSYCHOPHYSIOL, V50, P27, DOI 10.1016/S0167-8760(03)00122-3; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B, 1996, COGNITIVE BRAIN RES, V4, P77, DOI 10.1016/0926-6410(96)00024-9; Roder B, 2001, COGNITIVE BRAIN RES, V11, P289, DOI 10.1016/S0926-6410(01)00002-7; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Saito DN, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-79; SULLIVAN EV, 1972, Q J EXP PSYCHOL, V24, P253, DOI 10.1080/14640747208400278; Theoret H, 2004, J PHYSIOL-PARIS, V98, P221, DOI 10.1016/j.jphysparis.2004.03.009; Vecchi T, 2004, NEUROREPORT, V15, P2787; Vecchi T, 1998, MEMORY, V6, P91, DOI 10.1080/741941601; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; VOSS P, 2010, WILEY INTER IN PRESS; Zhou YD, 1997, EXP BRAIN RES, V116, P551, DOI 10.1007/PL00005783; Zwiers MP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-09-j0002.2001	45	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10833	10.1371/journal.pone.0010833	http://dx.doi.org/10.1371/journal.pone.0010833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	603PW	20520807	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221500019
J	Safdar, A; Hamadeh, MJ; Kaczor, JJ; Raha, S; Debeer, J; Tarnopolsky, MA				Safdar, Adeel; Hamadeh, Mazen J.; Kaczor, Jan J.; Raha, Sandeep; deBeer, Justin; Tarnopolsky, Mark A.			Aberrant Mitochondrial Homeostasis in the Skeletal Muscle of Sedentary Older Adults	PLOS ONE			English	Article							DNA-DELETION MUTATIONS; CONJUGATED LINOLEIC-ACID; C-REACTIVE PROTEIN; NITRIC-OXIDE; RESISTANCE EXERCISE; PHYSICAL-ACTIVITY; OXIDATIVE DAMAGE; CREATINE MONOHYDRATE; SUPEROXIDE-DISMUTASE; INFLAMMATORY MARKERS	The role of mitochondrial dysfunction and oxidative stress has been extensively characterized in the aetiology of sarcopenia (aging-associated loss of muscle mass) and muscle wasting as a result of muscle disuse. What remains less clear is whether the decline in skeletal muscle mitochondrial oxidative capacity is purely a function of the aging process or if the sedentary lifestyle of older adult subjects has confounded previous reports. The objective of the present study was to investigate if a recreationally active lifestyle in older adults can conserve skeletal muscle strength and functionality, chronic systemic inflammation, mitochondrial biogenesis and oxidative capacity, and cellular antioxidant capacity. To that end, muscle biopsies were taken from the vastus lateralis of young and age-matched recreationally active older and sedentary older men and women (N = 10/group; R female = male). We show that a physically active lifestyle is associated with the partial compensatory preservation of mitochondrial biogenesis, and cellular oxidative and antioxidant capacity in skeletal muscle of older adults. Conversely a sedentary lifestyle, associated with osteoarthritis-mediated physical inactivity, is associated with reduced mitochondrial function, dysregulation of cellular redox status and chronic systemic inflammation that renders the skeletal muscle intracellular environment prone to reactive oxygen species-mediated toxicity. We propose that an active lifestyle is an important determinant of quality of life and molecular progression of aging in skeletal muscle of the elderly, and is a viable therapy for attenuating and/or reversing skeletal muscle strength declines and mitochondrial abnormalities associated with aging.	[Safdar, Adeel] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Safdar, Adeel; Hamadeh, Mazen J.; Kaczor, Jan J.; Raha, Sandeep; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [deBeer, Justin] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Hamadeh, Mazen J.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	McMaster University; McMaster University; McMaster University; McMaster University; York University - Canada	Safdar, A (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Raha, Sandeep/AAF-3655-2020; Kaczor, Jan/ABC-6283-2021; Kaczor, Jan/AAH-5078-2021; Kaczor, Jan/A-1990-2008	Raha, Sandeep/0000-0001-7307-3292; Kaczor, Jan/0000-0002-6370-2160; Safdar, Adeel/0000-0002-7453-7770; Hamadeh, Mazen/0000-0002-3511-4345; Safdar, Adeel/0000-0003-2469-0467	Canadian Institute of Health Research (CIHR); Physician Services Incorporated; CIHR - Institute of Aging	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Physician Services Incorporated; CIHR - Institute of Aging(Canadian Institutes of Health Research (CIHR))	Funding: Funding for this work was primarily from grants to MAT from the Canadian Institute of Health Research (CIHR), the Physician Services Incorporated, and a donation from Mr. Warren Lammert and Family. AS was funded by CIHR - Institute of Aging Doctoral Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatecola AM, 2004, J AM GERIATR SOC, V52, P399, DOI 10.1111/j.1532-5415.2004.52112.x; Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x; Albert MA, 2004, AM J CARDIOL, V93, P221, DOI 10.1016/j.amjcard.2003.09.046; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Barrientos A, 1996, BIOCHEM BIOPH RES CO, V229, P536, DOI 10.1006/bbrc.1996.1839; Bauer JM, 2008, EXP GERONTOL, V43, P674, DOI 10.1016/j.exger.2008.03.007; Berk DR, 2006, J GERONTOL A-BIOL, V61, P97, DOI 10.1093/gerona/61.1.97; Bijlsma JWJ, 2007, BEST PRACT RES CL RH, V21, P59, DOI 10.1016/j.berh.2006.08.013; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Bosomworth NJ, 2009, CAN FAM PHYSICIAN, V55, P871; Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; BUFORD TW, J GERONTOL A; Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502; Capasso M, 2008, MUSCLE NERVE, V37, P196, DOI 10.1002/mus.20907; CARDELLACH F, 1989, LANCET, V2, P44; Cesari M, 2006, AM J CLIN NUTR, V83, P1142, DOI 10.1093/ajcn/83.5.1142; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865; Chokshi NK, 2008, SEMIN PERINATOL, V32, P92, DOI 10.1053/j.semperi.2008.01.002; Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Fakhrzadeh L, 2008, TOXICOL APPL PHARM, V227, P380, DOI 10.1016/j.taap.2007.11.012; Ferrucci L, 1999, AM J EPIDEMIOL, V149, P645, DOI 10.1093/oxfordjournals.aje.a009865; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Fischer CP, 2007, SCAND J MED SCI SPOR, V17, P580, DOI 10.1111/j.1600-0838.2006.00602.x; Franceschi C, 2001, AGING-CLIN EXP RES, V13, P163, DOI 10.1007/BF03351475; FRANSEN M, OSTEOARTHRITIS CARTI; Frontera WR, 2008, J APPL PHYSIOL, V105, P637, DOI 10.1152/japplphysiol.90332.2008; Frontera WR, 2003, MUSCLE NERVE, V28, P601, DOI 10.1002/mus.10480; Frontera WR, 2001, INT J SPORT NUTR EXE, V11, pS16, DOI 10.1123/ijsnem.11.s1.s16; Frontera WR, 2000, AM J PHYSIOL-CELL PH, V279, pC611, DOI 10.1152/ajpcell.2000.279.3.C611; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202; Hepple Russell T, 2003, Sci Aging Knowledge Environ, V2003, ppe31; HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281; Hollmann W, 2007, EUR J CARDIOV PREV R, V14, P730, DOI 10.1097/HJR.0b013e32828622f9; HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009; Hubbard RE, 2008, J AM GERIATR SOC, V56, P279, DOI 10.1111/j.1532-5415.2007.01548.x; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Humphries KM, 2006, FREE RADICAL RES, V40, P1239, DOI 10.1080/10715760600913184; Ji LL, 1998, ANN NY ACAD SCI, V854, P102, DOI 10.1111/j.1749-6632.1998.tb09896.x; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lee HC, 1997, J FORMOS MED ASSOC, V96, P770; Leeuwenburgh C, 2006, ANTIOXID REDOX SIGN, V8, P503, DOI 10.1089/ars.2006.8.503; Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x; Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001; Leveille SG, 1999, AM J EPIDEMIOL, V149, P654; LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Loeser RF, 2008, CURR OPIN RHEUMATOL, V20, P581, DOI 10.1097/BOR.0b013e3283090463; Loeser RF, 2006, ARTHRITIS RHEUM-US, V54, P1357, DOI 10.1002/art.21813; Mahler D A, 1986, Clin Geriatr Med, V2, P433; MANTON KG, 1995, NEW ENGL J MED, V333, P1232, DOI 10.1056/NEJM199511023331824; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465; Melton L J 3rd, 2000, Mayo Clin Proc, V75 Suppl, pS10; Melton LJ, 2000, MAYO CLIN P S, V75, pS12, DOI DOI 10.1016/S0025-6196(19)30635-4; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Rasmussen UF, 2003, PFLUG ARCH EUR J PHY, V446, P270, DOI 10.1007/s00424-003-1022-2; Roddy E, 2005, ANN RHEUM DIS, V64, P544, DOI 10.1136/ard.2004.028746; ROGERS MA, 1990, J APPL PHYSIOL, V68, P2195, DOI 10.1152/jappl.1990.68.5.2195; Rooyackers OE, 1997, MUSCLE NERVE, pS93; Roy BD, 2005, ARCH PHYS MED REHAB, V86, P1293, DOI 10.1016/j.apmr.2005.01.005; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Safdar A, 2008, PHYSIOL GENOMICS, V32, P219, DOI 10.1152/physiolgenomics.00157.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Shi X, 2007, FREE RADICAL RES, V41, P1313, DOI 10.1080/10715760701687117; Sohal RS, 1997, FASEB J, V11, P1269, DOI 10.1096/fasebj.11.14.9409545; SONG R, J ALTERN COMPLEMENT, V16, P227; Spector TD, 1997, ARTHRITIS RHEUM, V40, P723, DOI 10.1002/art.1780400419; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Strawbridge WJ, 1996, AM J EPIDEMIOL, V144, P135, DOI 10.1093/oxfordjournals.aje.a008900; Tarnopolsky M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000991; Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P213, DOI 10.1139/H07-142; THOMAS NE, 2008, SCAND J MED SCI SPOR; THOMPSON LV, 2008, EXP GERONTOL; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Trappe SW, 1996, J APPL PHYSIOL, V80, P285, DOI 10.1152/jappl.1996.80.1.285; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; TSENG BS, 1995, J GERONTOL A-BIOL, V50, P113; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wilkie R, 2007, ARTHRIT RHEUM-ARTHR, V57, P1381, DOI 10.1002/art.23083; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Zucchini C, 1995, BIOCHEM MOL BIOL INT, V37, P607	98	129	130	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10778	10.1371/journal.pone.0010778	http://dx.doi.org/10.1371/journal.pone.0010778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520725	gold, Green Submitted, Green Published			2022-12-25	WOS:000278034600009
J	Love, W; Dobbs, N; Tabor, L; Simecka, JW				Love, Wees; Dobbs, Nicole; Tabor, Leslie; Simecka, Jerry W.			Toll-Like Receptor 2 (TLR2) Plays a Major Role in Innate Resistance in the Lung against Murine Mycoplasma	PLOS ONE			English	Article							NF-KAPPA-B; ALVEOLAR MACROPHAGES; RESPIRATORY-INFECTIONS; GAMMA-INTERFERON; IMMUNE-RESPONSE; CUTTING EDGE; HOST-DEFENSE; PNEUMONIAE; EXPRESSION; PULMONIS	Mycoplasma lipoproteins are recognized by Toll-like receptors (TLR), but TLRs' role in responses to infection are unknown. Mycoplasma pulmonis is a naturally occurring respiratory pathogen in mice. In the current study, we used TLR-transfected HEK cells and TLR2(-/-) bone marrow-derived dendritic cells to demonstrate TLR2-mediated events are important in the initial host-mycoplasma interactions promoting cytokine responses. As we found alveolar macrophages expressed TLR1, TLR2 and TLR6 mRNAs, a role for TLR2 in innate immune clearance in lungs was examined. Three days post-infection, TLR2(-/-) mice had higher M. pulmonis numbers in lungs, but not in nasal passages. However, TLR2(-/-) mice had higher lung cytokine levels, indicating TLR2-independent mechanisms are also involved in host responses. Thus, TLR2 plays a critical role in the ability of innate immunity to determine M. pulmonis numbers in the lung, and it is likely that early after respiratory infection that TLR2 recognition of M. pulmonis triggers initial cytokine responses of host cells.	[Love, Wees; Dobbs, Nicole; Tabor, Leslie; Simecka, Jerry W.] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Mol Biol & Immunol, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Love, W (corresponding author), Univ N Texas Hlth Sci Ctr Ft Worth, Dept Mol Biol & Immunol, Ft Worth, TX USA.	jsimecka@hsc.unt.edu			Public Health Service [1R01HL069431]; National Heart Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069431] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Heart Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Public Health Service Grant 1R01HL069431 (to J.W.S.). Wees Love, Ph. D. was supported by National Heart Institute Minority Research Supplement for this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Becker S, 2002, AM J RESP CELL MOL, V27, P611, DOI 10.1165/rcmb.4868; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; CASSELL GH, 1982, REV INFECT DIS, V4, pS18; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; DAVIDSON MK, 1988, INFECT IMMUN, V56, P2163, DOI 10.1128/IAI.56.8.2163-2168.1988; DAVIS JK, 1992, AM REV RESPIR DIS, V145, P406, DOI 10.1164/ajrccm/145.2_Pt_1.406; DAVIS JK, 1980, INFECT IMMUN, V29, P590; Davison P. A., 1991, Seed Science Research, V1, P29; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Echchannaoui H, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-25; ERB P, 1979, INFECT IMMUN, V25, P11, DOI 10.1128/IAI.25.1.11-15.1979; FAULKNER CB, 1995, INFECT IMMUN, V63, P4084, DOI 10.1128/IAI.63.10.4084-4090.1995; FOY HM, 1993, CLIN INFECT DIS, V17, pS37, DOI 10.1093/clinids/17.Supplement_1.S37; FOY HM, 1979, J INFECT DIS, V139, P681, DOI 10.1093/infdis/139.6.681; Fulton SA, 2004, INFECT IMMUN, V72, P2101, DOI 10.1128/IAI.72.4.2101-2110.2004; Fuse ET, 2007, J MED MICROBIOL, V56, P305, DOI 10.1099/jmm.0.46913-0; He J, 2009, CLIN VACCINE IMMUNOL, V16, P1750, DOI 10.1128/CVI.00281-09; HickmanDavis JM, 1997, INFECT IMMUN, V65, P2278, DOI 10.1128/IAI.65.6.2278-2282.1997; HICKMANDAVIS JM, 1998, AM J PHYSL LUNG CELL, V18; Hodge LM, 2002, J INFECT DIS, V186, P290, DOI 10.1086/341280; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Isaacs D, 2002, MED J AUSTRALIA, V177, pS50; Jones HP, 2003, FRONT BIOSCI-LANDMRK, V8, pD930, DOI 10.2741/1098; Jones HP, 2002, J IMMUNOL, V168, P3493, DOI 10.4049/jimmunol.168.7.3493; Kraft M, 2006, J ALLERGY CLIN IMMUN, V117, P1197, DOI 10.1016/j.jaci.2006.03.001; KRAUSE DC, 1993, MYCOPLASMAS MOL BIOL, P417; KRUISBEEK A, 1999, CURRENT PROTOCOLS IM; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mitsunari M, 2006, J REPROD IMMUNOL, V72, P46, DOI 10.1016/j.jri.2006.02.003; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Powell Jonathan D, 2004, Clin Dev Immunol, V11, P77, DOI 10.1080/10446670410001670535; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sato M, 1999, IMMUNOL LETT, V67, P63, DOI 10.1016/S0165-2478(98)00186-2; Shimizu T, 2005, J IMMUNOL, V175, P4641, DOI 10.4049/jimmunol.175.7.4641; Shimizu T, 2004, IMMUNOLOGY, V113, P121, DOI 10.1111/j.1365-2567.2004.01937.x; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Simecka Jerry W., 1992, P391; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Weinberger M, 2004, DRUG DISCOV TODAY, V9, P831, DOI 10.1016/S1359-6446(04)03239-8; Woolard MD, 2005, INFECT IMMUN, V73, P6742, DOI 10.1128/IAI.73.10.6742-6751.2005; Wooten RM, 2002, VECTOR-BORNE ZOONOT, V2, P275, DOI 10.1089/153036602321653860; Wu Q, 2008, AM J RESP CRIT CARE, V177, P720, DOI 10.1164/rccm.200709-1387OC; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011	50	30	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10739	10.1371/journal.pone.0010739	http://dx.doi.org/10.1371/journal.pone.0010739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505832	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017300012
J	Tun, HW; Marlow, LA; von Roemeling, CA; Cooper, SJ; Kreinest, P; Wu, K; Luxon, BA; Sinha, M; Anastasiadis, PZ; Copland, JA				Tun, Han W.; Marlow, Laura A.; von Roemeling, Christina A.; Cooper, Simon J.; Kreinest, Pamela; Wu, Kevin; Luxon, Bruce A.; Sinha, Mala; Anastasiadis, Panos Z.; Copland, John A.			Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; TRANSCRIPTION FACTORS; OXIDATIVE-PHOSPHORYLATION; CANCER; KIDNEY; RECEPTOR-4; PROTEIN; CXCR4; DMRT2; TUMOR	Background: Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer. The purpose of this study is to define a biological pathway signature and a cellular differentiation program in ccRCC. Methodology: We performed gene expression profiling of early-stage ccRCC and patient-matched normal renal tissue using Affymetrix HG-U133a and HG-U133b GeneChips combined with a comprehensive bioinformatic analyses, including pathway analysis. The results were validated by real time PCR and IHC on two independent sample sets. Cellular differentiation experiments were performed on ccRCC cell lines and their matched normal renal epithelial cells, in differentiation media, to determine their mesenchymal differentiation potential. Principal Findings: We identified a unique pathway signature with three major biological alterations-loss of normal renal function, down-regulated metabolism, and immune activation-which revealed an adipogenic gene expression signature linked to the hallmark lipid-laden clear cell morphology of ccRCC. Culturing normal renal and ccRCC cells in differentiation media showed that only ccRCC cells were induced to undergo adipogenic and, surprisingly, osteogenic differentiation. A gene expression signature consistent with epithelial mesenchymal transition (EMT) was identified for ccRCC. We revealed significant down-regulation of four developmental transcription factors (GATA3, TFCP2L1, TFAP2B, DMRT2) that are important for normal renal development. Conclusions: ccRCC is characterized by a lack of epithelial differentiation, mesenchymal/adipogenic transdifferentiation, and pluripotent mesenchymal stem cell-like differentiation capacity in vitro. We suggest that down-regulation of developmental transcription factors may mediate the aberrant differentiation in ccRCC. We propose a model in which normal renal epithelial cells undergo dedifferentiation, EMT, and adipogenic transdifferentiation, resulting in ccRCC. Because ccRCC cells grown in adipogenic media regain the characteristic ccRCC phenotype, we have indentified a new in vitro ccRCC cell model more resembling ccRCC tumor morphology.	[Tun, Han W.] Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA; [Marlow, Laura A.; von Roemeling, Christina A.; Cooper, Simon J.; Kreinest, Pamela; Anastasiadis, Panos Z.; Copland, John A.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Wu, Kevin] Mayo Clin, Dept Pathol, Jacksonville, FL 32224 USA; [Luxon, Bruce A.; Sinha, Mala] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Luxon, Bruce A.; Sinha, Mala] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Tun, HW (corresponding author), Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA.	copland.john@mayo.edu	Luxon, Bruce A/C-9140-2012	Marlow, Laura/0000-0002-4726-9889; von Roemeling, Christina/0000-0002-3754-5544	Sarah and James Kennedy Career Development Award [CA104505, CA125807, CA104505-05S1]; Scheidel Foundation; David and Lois Stulberg Endowed Fund for Kidney Cancer; NATIONAL CANCER INSTITUTE [R44CA125807, R01CA104505, R43CA125807] Funding Source: NIH RePORTER	Sarah and James Kennedy Career Development Award; Scheidel Foundation; David and Lois Stulberg Endowed Fund for Kidney Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by a Sarah and James Kennedy Career Development Award (H. W. T.), CA104505 (J.A.C.), CA125807 (J.A.C.), CA104505-05S1 (J.A.C.), a generous gift from Susan A. Olde, OBE (J.A.C.), The Scheidel Foundation (J.A.C.) and the David and Lois Stulberg Endowed Fund for Kidney Cancer (J.A.C.). The parties who provided these funds had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2005, LIFE SCI, V76, P2559, DOI 10.1016/j.lfs.2004.10.054; Amato RJ, 2000, SEMIN ONCOL, V27, P177; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; BEHAM A, 1992, VIRCHOWS ARCH A, V421, P209, DOI 10.1007/BF01611177; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; COOPER SJ, 2010, ONCOGENE; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; DONHUIJSEN K, 1989, PATHOL RES PRACT, V184, P287, DOI 10.1016/S0344-0338(89)80088-3; EBLE J, 2004, TUMORS KIDNEY; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferraris S, 2009, AM J MED GENET A, V149A, P770, DOI 10.1002/ajmg.a.32689; Gmeiner WH, 2008, ONCOL REP, V19, P245; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; He Z, 2004, CANCER GENET CYTOGEN, V152, P89, DOI 10.1016/j.cancergencyto.2003.11.001; Hervouet E, 2008, CARCINOGENESIS, V29, P1528, DOI 10.1093/carcin/bgn125; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson GB, 2003, TRENDS IMMUNOL, V24, P19, DOI 10.1016/S1471-4906(02)00014-5; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Krambeck AE, 2007, CLIN CANCER RES, V13, P1749, DOI 10.1158/1078-0432.CCR-06-2129; LABASTIE MC, 1995, KIDNEY INT, V47, P1597, DOI 10.1038/ki.1995.223; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Le Lay S, 2009, BBA-MOL CELL BIOL L, V1791, P514, DOI 10.1016/j.bbalip.2008.10.008; Lipschutz JH, 1998, AM J KIDNEY DIS, V31, P383, DOI 10.1053/ajkd.1998.v31.pm9506676; LOHI J, 1995, INT J CANCER, V63, P442; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morikawa T, 2007, CLIN CANCER RES, V13, P5703, DOI 10.1158/1078-0432.CCR-07-0603; Moser M, 1997, GENE DEV, V11, P1938, DOI 10.1101/gad.11.15.1938; Motzer RJ, 2002, J CLIN ONCOL, V20, P2376, DOI 10.1200/JCO.2002.11.123; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Ottolenghi C, 2000, GENOMICS, V64, P179, DOI 10.1006/geno.2000.6120; Ounap K, 2004, AM J MED GENET A, V130A, P415, DOI 10.1002/ajmg.a.30269; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Perroud B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-64; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rezende RB, 1999, AM J SURG PATHOL, V23, P1532, DOI 10.1097/00000478-199912000-00011; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rosen ED, 2000, GENE DEV, V14, P1293; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Schuetz AN, 2005, J MOL DIAGN, V7, P206, DOI 10.1016/S1525-1578(10)60547-8; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Seo KW, 2007, COMPARATIVE MED, V57, P460; Taichman RS, 2002, CANCER RES, V62, P1832; Takahashi M, 2006, J MED INVESTIG, V53, P9, DOI 10.2152/jmi.53.9; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tun HW, 2008, BLOOD, V111, P3200, DOI 10.1182/blood-2007-10-119099; UNIPROT T, 2009, NUCLEIC ACIDS RES, V37, pD169; Upton MP, 2005, J IMMUNOTHER, V28, P488, DOI 10.1097/01.cji.0000170357.14962.9b; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoon Y, 2007, CANCER RES, V67, P7518, DOI 10.1158/0008-5472.CAN-06-2263; Zhao HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006039	69	132	139	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10696	10.1371/journal.pone.0010696	http://dx.doi.org/10.1371/journal.pone.0010696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502531	Green Published, gold			2022-12-25	WOS:000277776500013
J	Crowder, CD; Matthews, HE; Schutzer, S; Rounds, MA; Luft, BJ; Nolte, O; Campbell, SR; Phillipson, CA; Li, F; Sampath, R; Ecker, DJ; Eshoo, MW				Crowder, Chris D.; Matthews, Heather E.; Schutzer, Steven; Rounds, Megan A.; Luft, Benjamin J.; Nolte, Oliver; Campbell, Scott R.; Phillipson, Curtis A.; Li, Feng; Sampath, Ranga; Ecker, David J.; Eshoo, Mark W.			Genotypic Variation and Mixtures of Lyme Borrelia in Ixodes Ticks from North America and Europe	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; GENETIC DIVERSITY; MULTILOCUS PCR; BURGDORFERI; DISEASE; SCAPULARIS; INFECTION; OSPC; IDENTIFICATION; POPULATION	Background: Lyme disease, caused by various species of Borrelia, is transmitted by Ixodes ticks in North America and Europe. Studies have shown the genotype of Borrelia burgdorferi sensu stricto (s.s.) or the species of B. burgdorferi sensu lato (s.l.) affects the ability of the bacteria to cause local or disseminated infection in humans. Methodology/Principal Findings: We used a multilocus PCR electrospray mass spectrometry assay to determine the species and genotype Borrelia from ticks collected in New York, Connecticut, Indiana, Southern Germany, and California and characterized isolates from parts of the United States and Europe. These analyses identified 53 distinct genotypes of B. burgdorferi sensu stricto with higher resolution than ospC typing. Genotypes of other members of the B. burgdorferi sensu lato complex were also identified and genotyped including B. afzelii, B. garinii, B. lusitaniae, B. spielmanii, and B. valaisiana. While each site in North America had genotypes unique to that location, we found genotypes shared between individual regions and two genotypes found across the United States. Significant B. burgdorferi s.s. genotypic diversity was observed between North America and Europe: only 6.6% of US genotypes (3 of 45) were found in Europe and 27% of the European genotypes (3 of 11) were observed in the US. Interestingly, 39% of adult Ixodes scapularis ticks from North America were infected with more than one genotype of B. burgdorferi s.s. and 22.2% of Ixodes ricinus ticks from Germany were infected with more than one genotype of B. burgdorferi s.l. Conclusions/Significance: The presence of multiple Borrelia genotypes in ticks increases the probability that a person will be infected with more than one genotype of B. burgdorferi, potentially increasing the risks of disseminated Lyme disease. Our study indicates that the genotypic diversity of Borrelia in ticks in both North America and Europe is higher then previously reported and can have potential clinical consequences.	[Crowder, Chris D.; Matthews, Heather E.; Rounds, Megan A.; Phillipson, Curtis A.; Li, Feng; Sampath, Ranga; Ecker, David J.; Eshoo, Mark W.] Ibis Biosci, Carlsbad, CA USA; [Campbell, Scott R.] Suffolk Cty Dept Hlth Serv, Yaphank, NY USA; [Luft, Benjamin J.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Nolte, Oliver] Lab Dr Brunner, Constance, Germany; [Schutzer, Steven] Univ Med & Dent New Jersey, Dept Med, Newark, NJ 07103 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rutgers State University New Brunswick; Rutgers State University Medical Center	Crowder, CD (corresponding author), Ibis Biosci, Carlsbad, CA USA.	meshoo@ibisbio.com	Nolte, Oliver/AAW-9016-2020	Nolte, Oliver/0000-0002-1761-0812; Ecker, David/0000-0003-4350-9037; Luft, Benjamin/0000-0001-9008-7004	Lyme Disease Association; Tami Fund; National Institute of Allergy and Infectious Diseases [1R43AI077156-01, AI47553]; CDC [200-2008-M-27504]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI077156, R44AI047553] Funding Source: NIH RePORTER	Lyme Disease Association; Tami Fund; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge the Lyme Disease Association, the Tami Fund, National Institute of Allergy and Infectious Diseases (grant # 1R43AI077156-01 and AI47553) and the CDC (contract 200-2008-M-27504) for financial support for this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blyn LB, 2008, J CLIN MICROBIOL, V46, P644, DOI 10.1128/JCM.00801-07; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brownstein JS, 2003, ENVIRON HEALTH PERSP, V111, P1152, DOI 10.1289/ehp.6052; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Coyle P K, 1990, Infect Dis Clin North Am, V4, P731; Coyle PK, 2002, MED CLIN N AM, V86, P261, DOI 10.1016/S0025-7125(03)00086-5; COYLE PK, 1993, NEUROLOGY, V43, P1093, DOI 10.1212/WNL.43.6.1093; CROWDER CD, 2009, J MED ENTOM IN PRESS; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Ecker DJ, 2009, METHODS MOL BIOL, V551, P71, DOI 10.1007/978-1-60327-999-4_7; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Ecker JA, 2006, J CLIN MICROBIOL, V44, P2921, DOI 10.1128/JCM.00619-06; ESHOO MW, 2009, J CLIN MICROBIOL; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; Farlow J, 2002, J CLIN MICROBIOL, V40, P4612, DOI 10.1128/JCM.40.12.4612-4618.2002; Fikrig E, 2004, J CLIN MICROBIOL, V42, P1243, DOI 10.1128/JCM.42.3.1243-1246.2004; Guttman DS, 1996, J CLIN MICROBIOL, V34, P652, DOI 10.1128/JCM.34.3.652-656.1996; Hall TA, 2009, J CLIN MICROBIOL, V47, P1733, DOI 10.1128/JCM.02175-08; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P153, DOI 10.1128/AEM.01567-07; Hannis JC, 2008, J CLIN MICROBIOL, V46, P1220, DOI 10.1128/JCM.02158-07; HOEN AG, 2009, P NATL ACAD SCI US; Hulinska D, 2007, FOLIA MICROBIOL, V52, P315, DOI 10.1007/BF02932085; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Norris DE, 1997, J CLIN MICROBIOL, V35, P2359, DOI 10.1128/JCM.35.9.2359-2364.1997; Qiu WG, 2008, EMERG INFECT DIS, V14, P1097, DOI 10.3201/eid/1407.070880; Qiu WG, 2004, P NATL ACAD SCI USA, V101, P14150, DOI 10.1073/pnas.0402745101; Qiu WG, 2002, GENETICS, V160, P833; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Schutzer SE, 1997, J CLIN INVEST, V100, P763, DOI 10.1172/JCI119589; SCHUTZER SE, 1994, HOSP PRACT, V29, P8, DOI 10.1080/21548331.1994.11443039; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; TOKARZ R, 2009, VECTOR BORNE ZOONOTI; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Vitorino LR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004002; Wang IN, 1999, GENETICS, V151, P15; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	38	62	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10650	10.1371/journal.pone.0010650	http://dx.doi.org/10.1371/journal.pone.0010650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498837	Green Published, Green Submitted, gold			2022-12-25	WOS:000277771600014
J	Scantlebury, N; Zhao, XL; Moncalvo, VGR; Camiletti, A; Zahanova, S; Dineen, A; Xin, JH; Campos, AR				Scantlebury, Nadia; Zhao, Xiao Li; Moncalvo, Veronica G. Rodriguez; Camiletti, Alison; Zahanova, Stacy; Dineen, Aidan; Xin, Ji-Hou; Campos, Ana Regina			The Drosophila Gene RanBPM Functions in the Mushroom Body to Regulate Larval Behavior	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; SHORT NEUROPEPTIDE-F; K+ CHANNEL MUTANTS; BINDING-PROTEIN; NERVOUS-SYSTEM; FEEDING-BEHAVIOR; MORPHOMETRIC DESCRIPTION; WANDERING BEHAVIOR; SYNAPTIC STRUCTURE; AMINO-ACIDS	Background: In vertebrates, Ran-Binding Protein in the Microtubule Organizing Center (RanBPM) appears to function as a scaffolding protein in a variety of signal transduction pathways. In Drosophila, RanBPM is implicated in the regulation of germ line stem cell (GSC) niche organization in the ovary. Here, we addressed the role of RanBPM in nervous system function in the context of Drosophila larval behavior. Methodology/Principal Findings: We report that in Drosophila, RanBPM is required for larval feeding, light-induced changes in locomotion, and viability. RanBPM is highly expressed in the Kenyon cells of the larval mushroom body (MB), a structure well studied for its role in associative learning in Drosophila and other insects. RanBPM mutants do not display major disruption in nervous system morphology besides reduced proliferation. Expression of the RanBPM gene in the Kenyon cells is sufficient to rescue all behavioral phenotypes. Through genetic epistasis experiments, we demonstrate that RanBPM participates with the Drosophila orthologue of the Fragile X Mental Retardation Protein (FMRP) in the development of neuromuscular junction (NMJ). Conclusions/Significance: We demonstrate that the RanBPM gene functions in the MB neurons for larval behavior. Our results suggest a role for this gene in an FMRP-dependent process. Taken together our findings point to a novel role for the MB in larval behavior.	[Scantlebury, Nadia; Zhao, Xiao Li; Moncalvo, Veronica G. Rodriguez; Camiletti, Alison; Zahanova, Stacy; Dineen, Aidan; Xin, Ji-Hou; Campos, Ana Regina] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Scantlebury, N (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	camposa@mcmaster.ca			Canadian Institutes of Health Research (CIHR) [MOP 12700]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Work funded by a Canadian Institutes of Health Research (CIHR) grant (MOP 12700) to Ana Regina Campos. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Bader R, 2007, J COMP NEUROL, V502, P848, DOI 10.1002/cne.21342; Bai D, 2003, BIOCHEM BIOPH RES CO, V309, P552, DOI 10.1016/j.bbrc.2003.08.033; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; BRAND AH, 1993, DEVELOPMENT, V118, P401; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brunkhorst A, 2005, MOL CELL NEUROSCI, V29, P250, DOI 10.1016/j.mcn.2005.02.015; Busto M, 1999, J NEUROSCI, V19, P3337; Chang Y, 2010, DEV NEUROBIOL, V70, P1, DOI 10.1002/dneu.20750; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; DINEEN A, 2009, THESIS MCMASTER U HA; Gasque G, 2006, J CELL PHYSIOL, V209, P1046, DOI 10.1002/jcp.20764; Gatto CL, 2008, DEVELOPMENT, V135, P2637, DOI 10.1242/dev.022244; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HAASE A, 2008, J NEUROCHEM; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Johard HAD, 2008, J COMP NEUROL, V507, P1479, DOI 10.1002/cne.21636; Kaspar M, 2008, DEV BIOL, V324, P177, DOI 10.1016/j.ydbio.2008.08.031; Kim T, 2009, BIOCHEM BIOPH RES CO, V378, P15, DOI 10.1016/j.bbrc.2008.09.034; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Li YJ, 2008, BBA-GENE REGUL MECH, V1779, P702, DOI 10.1016/j.bbagrm.2008.07.003; LILLY M, 1990, GENETICS, V124, P293; Martin JR, 1998, LEARN MEMORY, V5, P179; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Migeon JC, 1999, MOL BIOL CELL, V10, P1733, DOI 10.1091/mbc.10.6.1733; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; MONCALVO VGR, 2009, SEROTONERGIC NEURONS; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; SCANTLEBURY N, 2007, DROSOPHILA LARVAL RE; Scantlebury N, 2007, BEHAV GENET, V37, P513, DOI 10.1007/s10519-007-9146-3; Schulz RA, 1996, ONCOGENE, V12, P1827; Seebahn A, 2008, FEBS LETT, V582, P2453, DOI 10.1016/j.febslet.2008.06.010; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; Siomi H, 2004, MENT RETARD DEV D R, V10, P68, DOI 10.1002/mrdd.20011; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Talbot JN, 2009, NEUROSCI LETT, V466, P154, DOI 10.1016/j.neulet.2009.09.048; Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wang JW, 2002, J NEUROGENET, V16, P45, DOI 10.1080/01677060213106; Wang JW, 1997, J NEUROGENET, V11, P231, DOI 10.3109/01677069709115098; WARREN ST, 2001, METABOLIC MOL BASES, P1257; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zinke I, 1999, DEVELOPMENT, V126, P5275	77	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10652	10.1371/journal.pone.0010652	http://dx.doi.org/10.1371/journal.pone.0010652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498842	Green Published, Green Submitted, gold			2022-12-25	WOS:000277771600016
J	Van der Burg, E; Cass, J; Olivers, CNL; Theeuwes, J; Alais, D				Van der Burg, Erik; Cass, John; Olivers, Christian N. L.; Theeuwes, Jan; Alais, David			Efficient Visual Search from Synchronized Auditory Signals Requires Transient Audiovisual Events	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; STIMULI; VISION; INPUTS; TIME; TOP	Background: A prevailing view is that audiovisual integration requires temporally coincident signals. However, a recent study failed to find any evidence for audiovisual integration in visual search even when using synchronized audiovisual events. An important question is what information is critical to observe audiovisual integration. Methodology/Principal Findings: Here we demonstrate that temporal coincidence (i.e., synchrony) of auditory and visual components can trigger audiovisual interaction in cluttered displays and consequently produce very fast and efficient target identification. In visual search experiments, subjects found a modulating visual target vastly more efficiently when it was paired with a synchronous auditory signal. By manipulating the kind of temporal modulation (sine wave vs. square wave vs. difference wave; harmonic sine-wave synthesis; gradient of onset/offset ramps) we show that abrupt visual events are required for this search efficiency to occur, and that sinusoidal audiovisual modulations do not support efficient search. Conclusions/Significance: Thus, audiovisual temporal alignment will only lead to benefits in visual search if the changes in the component signals are both synchronized and transient. We propose that transient signals are necessary in synchrony-driven binding to avoid spurious interactions with unrelated signals when these occur close together in time.	[Van der Burg, Erik; Olivers, Christian N. L.; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Cass, John] Univ Western Sydney, Sch Psychol, Sydney, NSW, Australia; [Cass, John] Univ Western Sydney, MARCS Auditory Res Labs, Sydney, NSW, Australia; [Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Vrije Universiteit Amsterdam; Western Sydney University; Western Sydney University; University of Sydney	Van der Burg, E (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	e.van.der.burg@psy.vu.nl	Theeuwes, Jan/B-6862-2008; Cass, John/AAC-7505-2021; Theeuwes, Jan/ABF-3771-2020; Van der Burg, Erik/E-3013-2010	Olivers, Christian/0000-0001-7470-5378; Theeuwes, Jan/0000-0002-5849-7721	Dutch Technology Foundation [07079]; NWO-VIDI [452-06-007]; Australian Research Council [JC: DP0774697, DA: DP0770299]	Dutch Technology Foundation(Technologiestichting STW); NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); Australian Research Council(Australian Research Council)	J. Theeuwes was supported by a Dutch Technology Foundation STW grant (07079), and C. Olivers by a NWO-VIDI grant 452-06-007. J. Cass and D. Alais were supported by Discovery Projects awarded by the Australian Research Council (JC: DP0774697; DA: DP0770299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1986, BRAIN RES, V365, P350; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Mottonen R, 2006, NEUROIMAGE, V30, P563, DOI 10.1016/j.neuroimage.2005.10.002; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Olivers CNL, 2008, BRAIN RES, V1242, P191, DOI 10.1016/j.brainres.2008.01.070; Roseboom W, 2009, J VISION, V9, DOI 10.1167/9.12.4; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Senkowski D, 2007, NEUROPSYCHOLOGIA, V45, P561, DOI 10.1016/j.neuropsychologia.2006.01.013; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE., 1993, MERGING SENSES; Terao M, 2008, NAT NEUROSCI, V11, P541, DOI 10.1038/nn.2111; Thomas GJ, 1941, J EXP PSYCHOL, V28, P163, DOI 10.1037/h0055183; van Atteveldt NM, 2007, NEUROIMAGE, V36, P1345, DOI 10.1016/j.neuroimage.2007.03.065; van Atteveldt NM, 2007, CEREB CORTEX, V17, P962, DOI 10.1093/cercor/bhl007; van der Burg E, 2008, J VISION, V8, DOI 10.1167/8.5.2; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; VANDERBURG E, 2008, HUMAN PERCEPTION PER, V34, P1053; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2001, PERCEPT PSYCHOPHYS, V63, P651, DOI 10.3758/BF03194427; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	40	74	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10664	10.1371/journal.pone.0010664	http://dx.doi.org/10.1371/journal.pone.0010664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	597PU	20498844	Green Published, gold			2022-12-25	WOS:000277771600023
J	Cabodi, S; Tinnirello, A; Bisaro, B; Tornillo, G; Camacho-Leal, MD; Forni, G; Cojoca, R; Iezzi, M; Amici, A; Montani, M; Eva, A; Di Stefano, P; Muthuswamy, SK; Tarone, G; Turco, E; Defilippi, P				Cabodi, Sara; Tinnirello, Agata; Bisaro, Brigitte; Tornillo, Giusy; Camacho-Leal, Maria del Pilar; Forni, Guido; Cojoca, Rodica; Iezzi, Manuela; Amici, Augusto; Montani, Maura; Eva, Alessandra; Di Stefano, Paola; Muthuswamy, Senthil K.; Tarone, Guido; Turco, Emilia; Defilippi, Paola			p130Cas is an essential transducer element in ErbB2 transformation	FASEB JOURNAL			English	Article						breast cancer; tumorigenesis; invasion; metastasis; signaling	CELL-PROLIFERATION; EPITHELIAL-CELLS; TRANSGENIC MICE; CANCER-CELLS; PROTEIN; SRC; KINASE; INVASION; INDUCTION; RECEPTOR	The ErbB2 oncogene is often overexpressed in breast tumors and associated with poor clinical outcome. p130Cas represents a nodal scaffold protein regulating cell survival, migration, and proliferation in normal and pathological cells. The functional role of p130Cas in ErbB2-dependent breast tumorigenesis was assessed by its silencing in breast cancer cells derived from mouse mammary tumors overexpressing ErbB2 (N202-1A cells), and by its reexpression in ErbB2-transformed p130Cas-null mouse embryonic fibroblasts. We demonstrate that p130Cas is necessary for ErbB2-dependent foci formation, anchorage-independent growth, and in vivo growth of orthotopic N202-1A tumors. Moreover, intranipple injection of p130Cas-stabilized siRNAs in the mammary gland of Balbc-NeuT mice decreases the growth of spontaneous tumors. In ErbB2-transformed cells, p130Cas is a crucial component of a functional molecular complex consisting of ErbB2, c-Src, and Fak. In human mammary cells, MCF10A. B2, the concomitant activation of ErbB2, and p130Cas overexpression sustain and strengthen signaling, leading to Rac1 activation and MMP9 secretion, thus providing invasive properties. Consistently, p130Cas drives N202-1A cell in vivo lung metastases colonization. These results demonstrate that p130Cas is an essential transducer in ErbB2 transformation and highlight its potential use as a novel therapeutic target in ErbB2 positive human breast cancers.-Cabodi, S., Tinnirello, A., Bisaro, B., Tornillo, G., Camacho-Leal, M. P., Forni, G., Cojoca, R., Iezzi, M., Amici, A., Montani, M., Eva, A., Di Stefano, P., Muthuswamy, S. K., Tarone, G., Turco, E., Defilippi, P. p130Cas is an essential transducer element in ErbB2 transformation. FASEB J. 24, 3796-3808 (2010). www.fasebj.org	[Cabodi, Sara; Tinnirello, Agata; Bisaro, Brigitte; Tornillo, Giusy; Camacho-Leal, Maria del Pilar; Forni, Guido; Cojoca, Rodica; Di Stefano, Paola; Tarone, Guido; Turco, Emilia; Defilippi, Paola] Univ Turin, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Eva, Alessandra] Ist Giannina Gaslini, Mol Biol Lab, Genoa, Italy; [Muthuswamy, Senthil K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Iezzi, Manuela] Univ G DAnnunzio, Ctr Aging Sci CESI, Aging Res Ctr, Chieti, Italy; [Amici, Augusto; Montani, Maura] Univ Camerino, Dept Mol Cellular & Anim Biol, I-62032 Camerino, Italy	University of Turin; University of Genoa; IRCCS Istituto Giannina Gaslini; Cold Spring Harbor Laboratory; G d'Annunzio University of Chieti-Pescara; University of Camerino	Defilippi, P (corresponding author), Univ Turin, Ctr Mol Biotechnol, Via Nizza 52, I-10126 Turin, Italy.	paola.defilippi@unito.it	Tornillo, Giusy/AAZ-8165-2020; DEFILIPPI, Paola/L-2232-2014; Iezzi, Manuela/AAB-7939-2019; Muthuswamy, Senthil K/AGY-2834-2022; Eva, Alessandra/J-8268-2016	Tornillo, Giusy/0000-0002-3934-3567; Iezzi, Manuela/0000-0002-6296-6498; Muthuswamy, Senthil K/0000-0001-6564-9634; Eva, Alessandra/0000-0003-2949-078X; Defilippi, Paola/0000-0001-6427-4906; Tarone, Guido/0000-0003-4805-086X; Amici, Augusto/0000-0002-4634-1500; Cabodi, Sara/0000-0003-1248-6549	Association for International Cancer Research (AICR); AIRC, Associazione Italiana Ricerca Cancro; EU; Ministero Universita e Ricerca; Programma di Ricerca di Rilevante Interesse Nazionale; Regione Piemonte-Progetti Sanita; Oncoprot; Piattaforma Staminali; Druidi; Comitato Interministeriale per la Programmazione Economica, Compagnia San Paolo, Progetto Alfieri-Fondazione Cassa Risparmio Torino, Turin, Italy; European Molecular Biology Organization	Association for International Cancer Research (AICR); AIRC, Associazione Italiana Ricerca Cancro(Fondazione AIRC per la ricerca sul cancro); EU(European Commission); Ministero Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Programma di Ricerca di Rilevante Interesse Nazionale; Regione Piemonte-Progetti Sanita; Oncoprot; Piattaforma Staminali; Druidi; Comitato Interministeriale per la Programmazione Economica, Compagnia San Paolo, Progetto Alfieri-Fondazione Cassa Risparmio Torino, Turin, Italy(Compagnia di San Paolo); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	The authors thank Dr. Pier Giorgio Lollini (University of Bologna, Bologna, Italy) for the N202-1A cells, Dr. Nancy Hynes (Friedrich Miescher Institute, Basel, Switzerland) for human mutated ErbB2, Roberto Piva (University of Torino, Turin, Italy) for shRNA vectors, and Elisa Penna (Molecular Biotechnology Center, University of Torino) for the transmigration assays. M.P.C.-L. is supported by the Association for International Cancer Research (AICR), and A.T. received a short-term European Molecular Biology Organization fellowship for her stay in S.K.M.'s lab. This work was supported by AIRC, Associazione Italiana Ricerca Cancro, EU FP7 Metafight, Ministero Universita e Ricerca, Programma di Ricerca di Rilevante Interesse Nazionale, Regione Piemonte-Progetti Sanita, Oncoprot, Piattaforma Staminali, Druidi, and Comitato Interministeriale per la Programmazione Economica, Compagnia San Paolo, Progetto Alfieri-Fondazione Cassa Risparmio Torino, Turin, Italy.	Ambrogio C, 2005, BLOOD, V106, P3907, DOI 10.1182/blood-2005-03-1204; AUVINEN M, 1995, MOL CELL BIOL, V15, P6513; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; CABODI S, 2006, INTEGRINS SIGNAL TRA; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cappello P, 2003, CANCER RES, V63, P2518; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Dolfi F, 1998, P NATL ACAD SCI USA, V95, P15394, DOI 10.1073/pnas.95.26.15394; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Kim IY, 2009, CANCER LETT, V275, P227, DOI 10.1016/j.canlet.2008.10.013; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakamoto T, 2000, MOL CELL BIOL, V20, P1649, DOI 10.1128/MCB.20.5.1649-1658.2000; Nanni P, 2000, INT J CANCER, V87, P186, DOI 10.1002/1097-0215(20000715)87:2<186::AID-IJC5>3.0.CO;2-1; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Stupack DG, 2000, IMMUNOL RES, V21, P83, DOI 10.1385/IR:21:2-3:83; Trono D, 2003, SCIENCE, V300, P1670, DOI 10.1126/science.1086238; Vanni C, 2005, CELL CYCLE, V4, P1675, DOI 10.4161/cc.4.11.2170; Yarden Y, 2004, SEMIN ONCOL, V31, P6, DOI 10.1053/j.seminoncol.2004.07.016; Zaidel-Bar R, 2005, J CELL SCI, V118, P3997, DOI 10.1242/jcs.02523	41	33	37	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3796	3808		10.1096/fj.10-157347	http://dx.doi.org/10.1096/fj.10-157347			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20505116	Green Accepted			2022-12-25	WOS:000285005900018
J	Bijland, S; Pieterman, EJ; Maas, ACE; van der Hoorn, JWA; van Erk, MJ; van Klinken, JB; Havekes, LM; van Dijk, KW; Princen, HMG; Rensen, PCN				Bijland, Silvia; Pieterman, Elsbet J.; Maas, Annemarie C. E.; van der Hoorn, Jose W. A.; van Erk, Marjan J.; van Klinken, Jan B.; Havekes, Louis M.; van Dijk, Ko Willems; Princen, Hans M. G.; Rensen, Patrick C. N.			Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE*3-Leiden.CETP Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTERYL ESTER TRANSFER; TRANSFER PROTEIN; TRANSGENIC MICE; PPAR-ALPHA; LDL RECEPTOR; SECRETION; EXPRESSION; KINETICS; B-100; VLDL	The peroxisome proliferator-activated receptor alpha (PPAR alpha) activator fenofibrate efficiently decreases plasma triglycerides (TG), which is generally attributed to enhanced very low density lipoprotein (VLDL)-TG clearance and decreased VLDL-TG production. However, because data on the effect of fenofibrate on VLDL production are controversial, we aimed to investigate in (more) detail the mechanism underlying the TG-lowering effect by studying VLDL-TG production and clearance using APOE*3-Leiden.CETP mice, a unique mouse model for human-like lipoprotein metabolism. Male mice were fed a Western-type diet for 4 weeks, followed by the same diet without or with fenofibrate (30 mg/kg bodyweight/day) for 4 weeks. Fenofibrate strongly lowered plasma cholesterol (-38%) and TG (-60%) caused by reduction of VLDL. Fenofibrate markedly accelerated VLDL-TG clearance, as judged from a reduced plasma half-life of glycerol tri[H-3]oleate-labeled VLDL-like emulsion particles (-68%). This was associated with an increased post-heparin lipoprotein lipase (LPL) activity (+110%) and an increased uptake of VLDL-derived fatty acids by skeletal muscle, white adipose tissue, and liver. Concomitantly, fenofibrate markedly increased the VLDL-TG production rate (+73%) but not the VLDL-apolipoprotein B (apoB) production rate. Kinetic studies using [H-3] palmitic acid showed that fenofibrate increased VLDL-TG production by equally increasing incorporation of re-esterified plasma fatty acids and liver TG into VLDL, which was supported by hepatic gene expression profiling data. We conclude that fenofibrate decreases plasma TG by enhancing LPL-mediated VLDL-TG clearance, which results in a compensatory increase in VLDL-TG production by the liver.	[Havekes, Louis M.; van Dijk, Ko Willems; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands; [Bijland, Silvia; van Klinken, Jan B.; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands; [Pieterman, Elsbet J.; Maas, Annemarie C. E.; van der Hoorn, Jose W. A.; Havekes, Louis M.; Princen, Hans M. G.] Netherlands Org Appl Sci Res Qual Life, Gaubius Lab, NL-2301 CE Leiden, Netherlands; [van Erk, Marjan J.] Netherlands Org Appl Sci Res Qual Life, NL-3700 AJ Zeist, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research	Rensen, PCN (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Dept Gen Internal Med, Room C4-R81,Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.	P.C.N.Rensen@lumc.nl	van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021; Princen, Hans MG/AID-9392-2022; Rensen, Patrick C.N./D-7176-2018	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; Princen, Hans MG/0000-0002-7206-1596; Rensen, Patrick C.N./0000-0002-8455-4988	Leiden Center for Cardiovascular Research LUMC-TNO; Nutrigenomics Consortium/Top Institute Food and Nutrition (TiFN); Center for Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative (NGI/NWO); Netherlands Organization for Health Care Research Medical Sciences (ZON-MW) [948 000 04]; Netherlands Organization for Scientific Research (NWO VIDI) [917.36.351]	Leiden Center for Cardiovascular Research LUMC-TNO; Nutrigenomics Consortium/Top Institute Food and Nutrition (TiFN); Center for Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Care Research Medical Sciences (ZON-MW)(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO VIDI)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Leiden Center for Cardiovascular Research LUMC-TNO and supported by grants from the Nutrigenomics Consortium/Top Institute Food and Nutrition (TiFN), the Center for Medical Systems Biology (CMSB), and the Netherlands Consortium for Systems Biology (NCSB), within the framework of the Netherlands Genomics Initiative (NGI/NWO), the Netherlands Organization for Health Care Research Medical Sciences (ZON-MW Project nr. 948 000 04), and the Netherlands Organization for Scientific Research (NWO VIDI Grant 917.36.351, to P. C. N. R.).	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Ameen C, 2005, J BIOL CHEM, V280, P1224, DOI 10.1074/jbc.M412107200; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BODEN WE, 2000, AM J CARDIOL, V86, P19, DOI DOI 10.1016/S0002-9149(00)01464-8; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Chapman MJ, 2003, ATHEROSCLEROSIS, V171, P1, DOI 10.1016/S0021-9150(03)00156-4; Duivenvoorden I, 2005, J LIPID RES, V46, P988, DOI 10.1194/jlr.M400505-JLR200; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; EGUSA G, 1983, J LIPID RES, V24, P1261; Fabbrini E, 2010, J CLIN ENDOCR METAB, V95, P2727, DOI 10.1210/jc.2009-2622; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Guerin M, 1996, ARTERIOSCL THROM VAS, V16, P763, DOI 10.1161/01.ATV.16.6.763; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; HAHN SE, 1992, BIOCHEM PHARMACOL, V43, P625, DOI 10.1016/0006-2952(92)90586-8; HELLER F, 1983, EUR J CLIN PHARMACOL, V25, P57, DOI 10.1007/BF00544015; Hogue JC, 2008, METABOLISM, V57, P246, DOI 10.1016/j.metabol.2007.09.008; JIANG XC, 1992, J CLIN INVEST, V90, P1290, DOI 10.1172/JCI115993; Kersten S, 2008, PPAR RES, V2008, DOI 10.1155/2008/132960; LAMB RG, 1993, BIOCHIM BIOPHYS ACTA, V1165, P299, DOI 10.1016/0005-2760(93)90140-5; Li XH, 1996, J LIPID RES, V37, P210; Linden D, 2002, J BIOL CHEM, V277, P23044, DOI 10.1074/jbc.M110416200; Linden D, 2001, J LIPID RES, V42, P1831; MALMENDIER CL, 1989, ATHEROSCLEROSIS, V77, P139, DOI 10.1016/0021-9150(89)90075-0; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; PIETZSCH J, 1995, BBA-LIPID LIPID MET, V1254, P77, DOI 10.1016/0005-2760(94)00171-T; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rensen PCN, 1997, J LIPID RES, V38, P1070; Schoderbock P, 1996, APPL SURF SCI, V93, P109, DOI 10.1016/0169-4332(95)00327-4; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; STAELS B, 1995, J CLIN INVEST, V95, P705, DOI 10.1172/JCI117717; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; Watts GF, 2006, CLIN SCI, V111, P193, DOI 10.1042/CS20060072; Watts GF, 2003, DIABETES, V52, P803, DOI 10.2337/diabetes.52.3.803; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; ZECHNER R, 1990, BIOCHIM BIOPHYS ACTA, V1044, P20, DOI 10.1016/0005-2760(90)90213-H	45	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25168	25175		10.1074/jbc.M110.123992	http://dx.doi.org/10.1074/jbc.M110.123992			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20501652	Green Published, hybrid			2022-12-25	WOS:000280682400009
J	Harada, K; Fukuda, E; Hirohashi, N; Chiba, K				Harada, Kaori; Fukuda, Eriko; Hirohashi, Noritaka; Chiba, Kazuyoshi			Regulation of Intracellular pH by p90Rsk-dependent Activation of an Na+/H+ Exchanger in Starfish Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-URCHIN EGGS; GERMINAL VESICLE BREAKDOWN; XENOPUS-LAEVIS OOCYTES; RAT NA/H EXCHANGER; METAPHASE-I ARREST; PROTEIN-KINASE; MEIOSIS REINITIATION; NHE3 ACTIVITY; BRUSH-BORDER; CELL-CYCLE	Starfish oocytes arrest at metaphase of the first meiotic division (MI arrest) in the ovary and resume meiosis after spawning into seawater. MI arrest is maintained by lower intracellular pH (pH(i)) and release from arrest by cellular alkalization. To elucidate pH(i) regulation in oocytes, we cloned the starfish (Asterina pectinifera) Na+/H+ exchanger 3 (ApNHE3) expressed in the plasma membrane of oocytes. The cytoplasmic domain of ApNHE3 contains p90 ribosomal S6 kinase (p90Rsk) phosphorylation sites, and injection of a constitutively active p90Rsk and the upstream regulator Mos to immature oocytes, stimulated an increase in pH(i). This increase was blocked by 5-(N-ethyl-N-isopropyl)-amiloride, a NHE inhibitor, and SL0101, a specific Rsk inhibitor. The MAPK kinase (MEK) inhibitor U0126 blocked the Mos-induced, but not the p90Rsk-induced, pH(i) increase, suggesting that the Mos-MEK-MAPK-p90Rsk pathway promotes ApNHE3 activation. In a cell-free extract, the Mos-MEK-MAPK-p90Rsk pathway phosphorylates ApNHE3 at Ser-590, -606, and -673. When p90Rsk-dependent ApNHE3 phosphorylation was blocked by a dominant-negative C-terminal fragment, or neutralizing antibody, the p90Rsk-induced pH(i) increase was suppressed in immature oocytes. However, ApNHE3 is up-regulated via the upstream phosphatidylinositol 3-kinase pathway before MAPK activation and the active state is maintained until spawning, suggesting that the p90Rsk-dependent ApNHE3 phosphorylation is unlikely to be the primary regulatory mechanism involved in MI arrest exit. After meiosis is completed, unfertilized eggs maintain their elevated pH(i) (similar to 7.4) until the onset of apoptosis. We suggest that the p90Rsk/ApNHE3-dependent elevation of pH(i) increases fertilization success by delaying apoptosis initiation.	Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan; [Fukuda, Eriko] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Hirohashi, Noritaka] Ochanomizu Univ, Grad Sch Humanities & Sci, Genet Counseling Program, Bunkyo Ku, Tokyo 1128610, Japan	Ochanomizu University; National Institute of Advanced Industrial Science & Technology (AIST); Ochanomizu University	Hirohashi, N (corresponding author), 2-1-1 Otsuka,Bunkyo Ku, Tokyo 1128610, Japan.	hirohashi.noritaka@ocha.ac.jp	Fukuda, Eriko/M-2854-2018	Fukuda, Eriko/0000-0003-3086-3707	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ocean Research Institute, University of Tokyo; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ocean Research Institute, University of Tokyo; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Human Frontier Science Program, the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. C.), the Cooperative Program provided by the Ocean Research Institute, University of Tokyo (to K. C. and N.H.), and Research Fellowships for Young Scientists from Japan Society for the Promotion of Science (to K. H.).	Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chalumeau C, 2001, AM J PHYSIOL-RENAL, V280, pF283, DOI 10.1152/ajprenal.2001.280.2.F283; Chiba K, 1999, DEV BIOL, V205, P217, DOI 10.1006/dbio.1998.9118; CHIBA K, 1993, MOL BIOL CELL, V4, P1027, DOI 10.1091/mbc.4.10.1027; DEGUCHI R, 1995, DEV BIOL, V171, P483, DOI 10.1006/dbio.1995.1298; DEGUCHI R, 1994, DEV BIOL, V163, P162, DOI 10.1006/dbio.1994.1132; EPEL D, 1974, DEV BIOL, V40, P245, DOI 10.1016/0012-1606(74)90127-4; FitzHarris G, 2007, DEVELOPMENT, V134, P4283, DOI 10.1242/dev.005272; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; HANOCQQUERTIER J, 1981, EUR J BIOCHEM, V120, P351, DOI 10.1111/j.1432-1033.1981.tb05711.x; Harada K, 2003, DEVELOPMENT, V130, P4581, DOI 10.1242/dev.00649; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; Kang MG, 1998, BIOL CELL, V90, P477, DOI 10.1016/S0248-4900(99)80006-9; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Kishimoto T, 1998, SEMIN CELL DEV BIOL, V9, P549, DOI 10.1006/scdb.1998.0249; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Kozikowski AP, 2003, J AM CHEM SOC, V125, P1144, DOI 10.1021/ja0285159; KRUPPA J, 1983, EUR J BIOCHEM, V129, P537; Kurashima K, 1999, J BIOL CHEM, V274, P29843, DOI 10.1074/jbc.274.42.29843; Liu D, 2000, J BIOL CHEM, V275, P9244, DOI 10.1074/jbc.275.13.9244; Luo J, 2007, CURR NEUROVASC RES, V4, P205; Marino M, 2000, MOL REPROD DEV, V56, P155, DOI 10.1002/(SICI)1098-2795(200006)56:2<155::AID-MRD6>3.0.CO;2-1; MAZIA D, 1974, EXP CELL RES, V85, P167, DOI 10.1016/0014-4827(74)90227-4; Moor AN, 2001, J BIOL CHEM, V276, P16113, DOI 10.1074/jbc.M100519200; Mori M, 2006, DEVELOPMENT, V133, P1823, DOI 10.1242/dev.02348; MORRILL GA, 1984, BIOCHIM BIOPHYS ACTA, V804, P107, DOI 10.1016/0167-4889(84)90104-6; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; NEANT I, 1988, DEVELOPMENT, V102, P505; Nofer JR, 2006, BIOCHEM BIOPH RES CO, V340, P751, DOI 10.1016/j.bbrc.2005.12.070; Oita E, 2004, J BIOL CHEM, V279, P18633, DOI 10.1074/jbc.M311122200; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Perdiguero E, 2003, EMBO J, V22, P5746, DOI 10.1093/emboj/cdg559; Rangel-Mata F, 2007, BIOCHEM BIOPH RES CO, V352, P264, DOI 10.1016/j.bbrc.2006.11.015; Sakaue M, 2006, BIOCHEM BIOPH RES CO, V350, P878, DOI 10.1016/j.bbrc.2006.09.119; Sasaki K, 2004, MOL BIOL CELL, V15, P1387, DOI 10.1091/mbc.E03-06-0367; Sasaki K, 2001, DEV BIOL, V237, P18, DOI 10.1006/dbio.2001.0337; Smith JA, 2005, CANCER RES, V65, P1027; STITH BJ, 1985, DEV BIOL, V107, P460, DOI 10.1016/0012-1606(85)90327-6; Tachibana K, 2000, P NATL ACAD SCI USA, V97, P14301, DOI 10.1073/pnas.97.26.14301; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Thangaraju M, 1999, CANCER RES, V59, P1649; Thangaraju M, 1999, J BIOL CHEM, V274, P29549, DOI 10.1074/jbc.274.41.29549; Usui K, 2008, DEV GROWTH DIFFER, V50, P357, DOI [10.1111/j.1440-169x.2008.01036.x, 10.1111/j.1440-169X.2008.01036.x]; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Wiederkehr MR, 1999, AM J PHYSIOL-CELL PH, V276, pC1205, DOI 10.1152/ajpcell.1999.276.5.C1205; Yamamoto DS, 2008, MECH DEVELOP, V125, P996, DOI 10.1016/j.mod.2008.08.004; Yamamoto K, 1997, DEV GROWTH DIFFER, V39, P763; YU FH, 1993, J BIOL CHEM, V268, P25536; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zhou CX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007417	56	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24044	24054		10.1074/jbc.M109.072553	http://dx.doi.org/10.1074/jbc.M109.072553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507995	Green Published, hybrid			2022-12-25	WOS:000280291400055
J	Kang, EL; Cameron, AN; Piazza, F; Walker, KR; Tesco, G				Kang, Eugene L.; Cameron, Andrew N.; Piazza, Fabrizio; Walker, Kendall R.; Tesco, Giuseppina			Ubiquitin Regulates GGA3-mediated Degradation of BACE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; SECRETASE CYTOSOLIC DOMAIN; DISEASE BETA-SECRETASE; GGA PROTEINS; SORTING-SIGNAL; BODY FORMATION; EGF RECEPTOR; VHS DOMAINS; ENDOSOMES	BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) is a membrane-tethered member of the aspartyl proteases, essential for the production of beta-amyloid, a toxic peptide that accumulates in the brain of subjects affected by Alzheimer disease. The BACE1 C-terminal fragment contains a DXXLL motif that has been shown to bind the VHS (VPS27, Hrs, and STAM) domain of GGA1-3 (Golgi-localized gamma-ear-containing ARF-binding proteins). GGAs are trafficking molecules involved in the transport of proteins containing the DXXLL signal from the Golgi complex to endosomes. Moreover, GGAs bind ubiquitin and traffic synthetic and endosomal ubiquitinated cargoes to lysosomes. We have previously shown that depletion of GGA3 results in increased BACE1 levels and activity because of impaired lysosomal degradation. Here, we report that the accumulation of BACE1 is rescued by the ectopic expression of GGA3 in H4 neuroglioma cells depleted of GGA3. Accordingly, the overexpression of GGA3 reduces the levels of BACE1 and alpha-amyloid. We then established that mutations in the GGA3 VPS27, Hrs, and STAM domain (N91A) or in BACE1 di-leucine motif (L499A/L500A), able to abrogate their binding, did not affect the ability of ectopically expressed GGA3 to rescue BACE1 accumulation in cells depleted of GGA3. Instead, we found that BACE1 is ubiquitinated at lysine 501 and is mainly monoubiquitinated and Lys-63-linked polyubiquitinated. Finally, a GGA3 mutant with reduced ability to bind ubiquitin (GGA3L276A) was unable to regulate BACE1 levels both in rescue and overexpression experiments. These findings indicate that levels of GGA3 tightly and inversely regulate BACE1 levels via interaction with ubiquitin sorting machinery.	[Kang, Eugene L.; Cameron, Andrew N.; Piazza, Fabrizio; Walker, Kendall R.; Tesco, Giuseppina] Tufts Univ, Sch Med, Alzheimers Dis Res Lab, Dept Neurosci, Boston, MA 02111 USA	Tufts University	Tesco, G (corresponding author), Tufts Univ, Sch Med, Alzheimers Dis Res Lab, Dept Neurosci, 136 Harrison Ave,Ste 328A, Boston, MA 02111 USA.	Giuseppina.Tesco@Tufts.edu	Piazza, Fabrizio/L-2094-2016	Piazza, Fabrizio/0000-0002-3385-3224	National Institutes of Health [1R01AG025952-04, 1R01AG033016-01A1]; NATIONAL INSTITUTE ON AGING [R01AG033016, R01AG025952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01AG025952-04 and 1R01AG033016-01A1 (to G. T.).	Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; De Strooper B, 2000, J CELL SCI, V113, P1857; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Kawasaki M, 2005, GENES CELLS, V10, P639, DOI 10.1111/j.1365-2443.2005.00865.x; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; Shiba T, 2004, TRAFFIC, V5, P437, DOI 10.1111/j.1600-0854.2004.00188.x; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang Y, 2010, J CEREBR BLOOD F MET, V30, P566, DOI 10.1038/jcbfm.2009.228	45	84	85	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24108	24119		10.1074/jbc.M109.092742	http://dx.doi.org/10.1074/jbc.M109.092742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20484053	Green Published, hybrid			2022-12-25	WOS:000280291400061
J	Tian, LJ; McClafferty, H; Jeffries, O; Shipston, MJ				Tian, Lijun; McClafferty, Heather; Jeffries, Owen; Shipston, Michael J.			Multiple Palmitoyltransferases Are Required for Palmitoylation-dependent Regulation of Large Conductance Calcium- and Voltage-activated Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN PALMITOYLATION; GABA(A) RECEPTORS; MEDIATED PALMITOYLATION; DYNAMIC PALMITOYLATION; MEMBRANE INTERACTIONS; NEURONAL DEVELOPMENT; TRAFFICKING; SUBUNIT; PHOSPHORYLATION	Palmitoylation is emerging as an important and dynamic regulator of ion channel function; however, the specificity with which the large family of acyl palmitoyltransferases ( zinc finger Asp-His-His-Cystype-containing acyl palmitoyltransferase (DHHCs)) control channel palmitoylation is poorly understood. We have previously demonstrated that the alternatively spliced stress-regulated exon (STREX) variant of the intracellular C-terminal domain of the large conductance calcium- and voltage- activated potassium (BK) channels is palmitoylated and targets the STREX domain to the plasma membrane. Using a combined imaging, biochemical, and functional approach coupled with loss-of-function ( small interfering RNA knockdown of endogenous DHHCs) and gain-of-function ( overexpression of recombinant DHHCs) assays, we demonstrate that multiple DHHCs control palmitoylation of the C terminus of STREX channels, the association of the STREX domain with the plasma membrane, and functional channel regulation. Cysteine residues 12 and 13 within the STREX insert were the only endogenously palmitoylated residues in the entire C terminus of the STREX channel. Palmitoylation of this dicysteine motif was controlled by DHHCs 3, 5, 7, 9, and 17, although DHHC17 showed the greatest specificity for this site upon overexpression of the cognate DHHC. DHHCs that palmitoylated the channel also co-assembled with the channel in co-immunoprecipitation experiments, and knockdown of any of these DHHCs blocked regulation of the channel by protein kinase A-dependent phosphorylation. Taken together our data reveal that a subset of DHHCs controls STREX palmitoylation and function and suggest that DHHC17 may preferentially target cysteine-rich domains. Finally, our approach may prove useful in elucidating the specificity of DHHC palmitoylation of intracellular domains of other ion channels and transmembrane proteins.	[Tian, Lijun; McClafferty, Heather; Jeffries, Owen; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; jeffries, owen/0000-0002-8169-1100	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Chan AW, 2007, CELL CALCIUM, V42, P419, DOI 10.1016/j.ceca.2007.04.009; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Hurley JF, 2000, P NATL ACAD SCI USA, V97, P9293, DOI 10.1073/pnas.160589697; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Suzuki H, 2008, BBA-BIOMEMBRANES, V1778, P1181, DOI 10.1016/j.bbamem.2007.12.007; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2003, J BIOL CHEM, V278, P8669, DOI 10.1074/jbc.M211661200; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	34	57	58	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23954	23962		10.1074/jbc.M110.137802	http://dx.doi.org/10.1074/jbc.M110.137802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507996	Green Published, hybrid			2022-12-25	WOS:000280291400046
J	Friedrich, MW; Aramuni, G; Mank, M; Mackinnon, JAG; Griesbeck, O				Friedrich, Michael W.; Aramuni, Gayane; Mank, Marco; Mackinnon, Jonathan A. G.; Griesbeck, Oliver			Imaging CREB Activation in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; NMDA RECEPTOR ACTIVATION; AKAP SIGNALING COMPLEXES; BINDING PROTEIN; FLUORESCENT PROTEINS; ANCHORING PROTEIN; SPATIOTEMPORAL DYNAMICS; INDUCED TRANSCRIPTION; SUBCELLULAR DYNAMICS; REGULATED KINASE	The Ca2+- and cAMP-responsive element-binding protein (CREB) and the related ATF-1 and CREM are stimulus-inducible transcription factors that link certain forms of cellular activity to changes in gene expression. They are attributed to complex integrative activation characteristics, but current biochemical technology does not allow dynamic imaging of CREB activation in single cells. Using fluorescence resonance energy transfer between mutants of green fluorescent protein we here develop a signal-optimized genetically encoded indicator that enables imaging activation of CREB due to phosphorylation of the critical serine 133. The indicator of CREB activation due to phosphorylation (ICAP) was used to investigate the role of the scaffold and anchoring protein AKAP79/150 in regulating signal pathways converging on CREB. We show that disruption of AKAP79/150-mediated protein kinase A anchoring or knock-down of AKAP150 dramatically reduces the ability of protein kinase A to activate CREB. In contrast, AKAP79/150 regulation of CREB via L-type channels may only have minor importance. ICAP allows dynamic and reversible imaging in living cells and may become useful in studying molecular components and cell-type specificity of activity-dependent gene expression.	[Friedrich, Michael W.; Aramuni, Gayane; Mank, Marco; Mackinnon, Jonathan A. G.; Griesbeck, Oliver] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Griesbeck, O (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	griesbeck@neuro.mpg.de		Griesbeck, Oliver/0000-0001-5883-5594	Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CARR DW, 1992, J BIOL CHEM, V267, P13376; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Conti AC, 2007, NEUROSCIENCE, V146, P713, DOI 10.1016/j.neuroscience.2007.01.045; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gervasi N, 2007, J NEUROSCI, V27, P2744, DOI 10.1523/JNEUROSCI.5352-06.2007; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Gomez LL, 2002, J NEUROSCI, V22, P7027; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; Green Harry M., 2005, BMC Chemical Biology, V5, P1, DOI 10.1186/1472-6769-5-1; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griesbeck O, 2004, CURR OPIN NEUROBIOL, V14, P636, DOI 10.1016/j.conb.2004.08.002; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu FC, 1998, P NATL ACAD SCI USA, V95, P4708, DOI 10.1073/pnas.95.8.4708; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Newman RH, 2008, MOL BIOSYST, V4, P496, DOI 10.1039/b720034j; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Sato M, 2007, ANAL CHEM, V79, P2570, DOI 10.1021/ac062171d; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Spotts JM, 2002, P NATL ACAD SCI USA, V99, P15142, DOI 10.1073/pnas.232565699; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VanEngelenburg SB, 2008, CURR OPIN CHEM BIOL, V12, P60, DOI 10.1016/j.cbpa.2008.01.020; Wang HB, 2002, J NEUROCHEM, V83, P946, DOI 10.1046/j.1471-4159.2002.01206.x; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	72	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23283	23293		10.1074/jbc.M110.124545	http://dx.doi.org/10.1074/jbc.M110.124545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484048	Green Published, hybrid			2022-12-25	WOS:000279999900062
J	Fujimura, T; Esteban, R				Fujimura, Tsutomu; Esteban, Rosa			Yeast Double-stranded RNA Virus L-A Deliberately Synthesizes RNA Transcripts with 5 '-Diphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC MESSENGER-RNA; POL FUSION PROTEIN; SACCHAROMYCES-CEREVISIAE; CAPPING ENZYME; CRITICAL RESIDUES; ANTIVIRAL SYSTEM; CAP STRUCTURE; COAT PROTEIN; MOSAIC-VIRUS; VIRAL-RNA	L-A is a persistent double-stranded RNA virus commonly found in the yeast Saccharomyces cerevisiae. Isolated L-A virus synthesizes positive strand transcripts in vitro. We found that the 5' termini of the transcripts are diphosphorylated. The 5'-terminal nucleotide is G, and GDP was the best substrate among those examined to prime the reaction. When GTP was used, the triphosphate of GTP incorporated into the 5'-end was converted to diphosphate. This activity was not dependent on host CTL1 RNA triphosphatase. The 5'-end of the GMP-primed transcript also was converted to diphosphate, the beta-phosphate of which was derived from the beta-phosphate of ATP present in the polymerization reaction. These results demonstrate that L-A virus commands elaborate enzymatic systems to ensure its transcript to be 5'-diphosphorylated. Transcripts of M1, a satellite RNA of L-A virus, also had diphosphate at the 5' termini. Because viral transcripts are released from the virion into the cytoplasm to be translated and encapsidated into a new viral particle, a stage most vulnerable to degradation in the virus replication cycle, our results suggest that the 5'-diphosphate status is important for transcript stability. Consistent with this, L-A transcripts made in vitro are resistant to the affinity-purified Ski1p 5'-exonuclease. We also discuss the implication of these findings on translation of viral RNA. Because the viral transcript has no conventional 5'-cap structure, this work may shed light on the metabolism of non-self-RNA in yeast.	[Fujimura, Tsutomu; Esteban, Rosa] Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Genet & Microbiol, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Fujimura, T (corresponding author), Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Genet & Microbiol, Avda Campo Charro S-N, Salamanca 37007, Spain.	tfujimura@usal.es	Fujimura, Tsutomu/K-5807-2014; Esteban, Rosa/K-4356-2014	Fujimura, Tsutomu/0000-0002-9457-6769; Esteban, Rosa/0000-0001-6804-7209	Spanish Ministry of Education and Science [BFU2007-60057]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported by Grant BFU2007-60057 from the Spanish Ministry of Education and Science.	Ahola T, 1997, J VIROL, V71, P392, DOI 10.1128/JVI.71.1.392-397.1997; Ahola T, 1999, J VIROL, V73, P10061, DOI 10.1128/JVI.73.12.10061-10069.1999; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; BARBONE FP, 1992, J VIROL, V187, P333; BLANC A, 1994, MOL CELL BIOL, V14, P2664, DOI 10.1128/MCB.14.4.2664; BLANC A, 1992, MOL CELL BIOL, V12, P3390, DOI 10.1128/MCB.12.8.3390; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUENN J, 1976, NUCLEIC ACIDS RES, V3, P2427, DOI 10.1093/nar/3.10.2427; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; Cheng CP, 2006, J VIROL, V80, P2631, DOI 10.1128/JVI.80.6.2631-2640.2006; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; DENTE L, 1985, DNA CLONING PRACTICA, V1, P101; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; ESTEBAN R, 1988, P NATL ACAD SCI USA, V85, P4411, DOI 10.1073/pnas.85.12.4411; Esteban R, 2008, J BIOL CHEM, V283, P25812, DOI 10.1074/jbc.M804400200; FUJIMURA T, 1992, J BIOL CHEM, V267, P2708; FUJIMURA T, 1992, NATURE, V359, P746, DOI 10.1038/359746a0; FUJIMURA T, 1988, CELL, V55, P663, DOI 10.1016/0092-8674(88)90225-5; FUJIMURA T, 1990, CELL, V62, P819, DOI 10.1016/0092-8674(90)90125-X; FUJIMURA T, 1986, P NATL ACAD SCI USA, V83, P4433, DOI 10.1073/pnas.83.12.4433; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; GEORGOPOULOS DE, 1987, YEAST, V3, P117, DOI 10.1002/yea.320030208; Huang YL, 2004, J VIROL, V78, P1271, DOI 10.1128/JVI.78.3.1271-1280.2004; ICHO T, 1989, J BIOL CHEM, V264, P6716; Koonin EV, 2010, P NATL ACAD SCI USA, V107, P3283, DOI 10.1073/pnas.0915061107; MASISON DC, 1995, MOL CELL BIOL, V15, P2763; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; NEMEROFF ME, 1987, J BIOL CHEM, V262, P6785; Ogino T, 2010, P NATL ACAD SCI USA, V107, P3463, DOI 10.1073/pnas.0913083107; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pellegrini O, 2008, METHOD ENZYMOL, V448, P167, DOI 10.1016/S0076-6879(08)02609-8; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; RIDLEY SP, 1984, MOL CELL BIOL, V4, P761, DOI 10.1128/MCB.4.4.761; Rodriguez CR, 1999, NUCLEIC ACIDS RES, V27, P2181, DOI 10.1093/nar/27.10.2181; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Searfoss AW, 2000, P NATL ACAD SCI USA, V97, P9133, DOI 10.1073/pnas.97.16.9133; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; TIPPER DJ, 1984, MICROBIOL REV, V48, P125, DOI 10.1128/MMBR.48.2.125-156.1984; TOHE A, 1978, J BACTERIOL, V136, P1002, DOI 10.1128/JB.136.3.1002-1007.1978; Wickner R.B., 2007, FIELDS VIROLOGY, P737; WICKNER RB, 1980, CELL, V21, P217, DOI 10.1016/0092-8674(80)90129-4; WIDNER WR, 1993, MOL CELL BIOL, V13, P4331, DOI 10.1128/MCB.13.7.4331; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	45	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22909	22916		10.1074/jbc.M110.138982	http://dx.doi.org/10.1074/jbc.M110.138982			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20511225	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000279999900024
J	Idevall-Hagren, O; Barg, S; Gylfe, E; Tengholm, A				Idevall-Hagren, Olof; Barg, Sebastian; Gylfe, Erik; Tengholm, Anders			cAMP Mediators of Pulsatile Insulin Secretion from Glucose-stimulated Single beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CYCLIC-AMP; PANCREATIC-ISLETS; CYTOPLASMIC CA2+; EXOCYTOSIS; OSCILLATIONS; ATP; PHOSPHORYLATION; ACTIVATION; PATHWAYS	Pulsatile insulin release from glucose-stimulated beta-cells is driven by oscillations of the Ca2+ and cAMP concentrations in the subplasma membrane space ([Ca2+](pm) and [cAMP](pm)). To clarify mechanisms by which cAMP regulates insulin secretion, we performed parallel evanescent wave fluorescence imaging of [cAMP](pm), [Ca2+](pm), and phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the plasma membrane. This lipid is formed by autocrine insulin receptor activation and was used to monitor insulin release kinetics from single MIN6 beta-cells. Elevation of the glucose concentration from 3 to 11 mM induced, after a 2.7-min delay, coordinated oscillations of [Ca2+](pm), [cAMP](pm), and PIP3. Inhibitors of protein kinase A (PKA) markedly diminished the PIP3 response when applied before glucose stimulation, but did not affect already manifested PIP3 oscillations. The reduced PIP3 response could be attributed to accelerated depolarization causing early rise of [Ca2+](pm) that preceded the elevation of [cAMP](pm). However, the amplitude of the PIP3 response after PKA inhibition was restored by a specific agonist to the cAMP-dependent guanine nucleotide exchange factor Epac. Suppression of cAMP formation with adenylyl cyclase inhibitors reduced already established PIP3 oscillations in glucose-stimulated cells, and this effect was almost completely counteracted by the Epac agonist. In cells treated with small interfering RNA targeting Epac2, the amplitudes of the glucose-induced PIP3 oscillations were reduced, and the Epac agonist was without effect. The data indicate that temporal coordination of the triggering [Ca2+](pm) and amplifying [cAMP](pm) signals is important for glucose-induced pulsatile insulin release. Although both PKA and Epac2 partake in initiating insulin secretion, the cAMP dependence of established pulsatility is mediated by Epac2.	[Idevall-Hagren, Olof; Barg, Sebastian; Gylfe, Erik; Tengholm, Anders] Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, SE-75123 Uppsala, Sweden	Uppsala University	Tengholm, A (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, Box 571, SE-75123 Uppsala, Sweden.	anders.tengholm@mcb.uu.se	Barg, Sebastian/F-9523-2010	Barg, Sebastian/0000-0003-4661-5724; Idevall Hagren, Olof/0000-0002-0241-6304; Gylfe, Erik/0000-0002-8414-2107	Ake Wiberg Foundation; European Foundation for the Study of Diabetes/MSD; Family Ernfors Foundation; Harald and Greta Jeanssons Foundations; Magnus Bergvall Foundation; Novo Nordisk Foundation; Swedish Diabetes Association; Swedish Research Council [32X-14643, 32BI-15333, 32P-15439, 12X-6240]	Ake Wiberg Foundation; European Foundation for the Study of Diabetes/MSD; Family Ernfors Foundation; Harald and Greta Jeanssons Foundations; Magnus Bergvall Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Ake Wiberg Foundation, the European Foundation for the Study of Diabetes/MSD, the Family Ernfors Foundation, Harald and Greta Jeanssons Foundations, the Magnus Bergvall Foundation, Novo Nordisk Foundation, the Swedish Diabetes Association, and the Swedish Research Council Grants 32X-14643, 32BI-15333, 32P-15439, and 12X-6240.	Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Eliasson L, 1997, J PHYSIOL-LONDON, V503, P399, DOI 10.1111/j.1469-7793.1997.399bh.x; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Furman B, 2004, J PHARM PHARMACOL, V56, P1477, DOI 10.1211/0022357044805; GILON P, 1993, J BIOL CHEM, V268, P22265; GRAPENGIESSER E, 1988, BIOCHEM BIOPH RES CO, V151, P1299, DOI 10.1016/S0006-291X(88)80503-5; GRILL V, 1973, FEBS LETT, V33, P311, DOI 10.1016/0014-5793(73)80218-2; Gromada J, 2004, BASIC CLIN PHARMACOL, V95, P252, DOI 10.1111/j.1742-7843.2004.t01-1-pto950502.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harris TE, 1997, BIOCHEM BIOPH RES CO, V232, P648, DOI 10.1006/bbrc.1997.6344; Hatakeyama H, 2006, J PHYSIOL-LONDON, V570, P271, DOI 10.1113/jphysiol.2005.096560; Hatakeyama H, 2007, J PHYSIOL-LONDON, V582, P1087, DOI 10.1113/jphysiol.2007.135228; HELLMAN B, 1974, P NATL ACAD SCI USA, V71, P3405, DOI 10.1073/pnas.71.9.3405; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HOSKER JP, 1989, METABOLISM, V38, P767, DOI 10.1016/0026-0495(89)90064-4; Idevall-Hagren O, 2006, J BIOL CHEM, V281, P39121; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kwan EP, 2007, PANCREAS, V35, pE45, DOI 10.1097/mpa.0b013e318073d1c9; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435; Leech CA, 2000, BIOCHEM BIOPH RES CO, V278, P44; Lester LB, 2001, ENDOCRINOLOGY, V142, P1218, DOI 10.1210/en.142.3.1218; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Michael DJ, 2007, DIABETES, V56, P1277, DOI 10.2337/db06-0367; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; PERSAUD SJ, 1990, BIOCHEM BIOPH RES CO, V173, P833, DOI 10.1016/S0006-291X(05)80862-9; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Qian WJ, 2004, BIOTECHNIQUES, V37, P922, DOI 10.2144/04376BI01; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; SCHUIT FC, 1985, ENDOCRINOLOGY, V117, P834, DOI 10.1210/endo-117-3-834; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Vikman J, 2009, AM J PHYSIOL-ENDOC M, V297, pE452, DOI 10.1152/ajpendo.90585.2008	47	58	60	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23005	23016		10.1074/jbc.M109.095992	http://dx.doi.org/10.1074/jbc.M109.095992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498366	Green Published, hybrid			2022-12-25	WOS:000279999900035
J	Kunkel, MT; Newton, AC				Kunkel, Maya T.; Newton, Alexandra C.			Calcium Transduces Plasma Membrane Receptor Signals to Produce Diacylglycerol at Golgi Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ENCODED FLUORESCENT REPORTER; TRANSPORT; RECRUITMENT; TGN	Protein kinase C and protein kinase D are potently activated by agonist-evoked increases in diacylglycerol. Using live cell-imaging probes for kinase activity, we have shown that both kinases are robustly activated at the Golgi following stimulation of Gq-coupled receptor signaling pathways, displaying activation signatures at the Golgi that are distinct from those at the plasma membrane. Here we report that Ca2+ is the mediator that allows signals received at the plasma membrane to activate these two protein kinases at the Golgi. Specifically, using fluorescence resonance energy transfer-based reporters to image diacylglycerol production, we show that Ca2+ is necessary and sufficient to elevate diacylglycerol levels at the Golgi. First, raising intracellular Ca2+ by treating cells with thapsigargin induces diacylglycerol production at the Golgi. Second, chelation of intracellular Ca2+ prevents UTP-stimulated increases in diacylglycerol at the Golgi. Thus, agonist-evoked increases in intracellular Ca2+ cause increases in Golgi diacylglycerol, allowing this intracellular membrane to serve as a platform for signaling by protein kinases C and D.	[Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [GM43154, P01 DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043154, R01GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM43154 and P01 DK54441 (to A.C.N.).	Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Ghanekar Y, 2005, TRENDS CELL BIOL, V15, P511, DOI 10.1016/j.tcb.2005.08.001; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Liu JW, 1997, J CELL BIOL, V137, P1525, DOI 10.1083/jcb.137.7.1525; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; PAGANO RE, 1988, TRENDS BIOCHEM SCI, V13, P202, DOI 10.1016/0968-0004(88)90082-5; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; van Meer G, 1998, TRENDS CELL BIOL, V8, P29, DOI 10.1016/S0962-8924(97)01196-3; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	18	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22746	22750		10.1074/jbc.C110.123133	http://dx.doi.org/10.1074/jbc.C110.123133			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20519514	Green Published, hybrid			2022-12-25	WOS:000279999900005
J	Tegtmeyer, N; Hartig, R; Delahay, RM; Rohde, M; Brandt, S; Conradi, J; Takahashi, S; Smolka, AJ; Sewald, N; Backert, S				Tegtmeyer, Nicole; Hartig, Roland; Delahay, Robin M.; Rohde, Manfred; Brandt, Sabine; Conradi, Jens; Takahashi, Seiichiro; Smolka, Adam J.; Sewald, Norbert; Backert, Steffen			A Small Fibronectin-mimicking Protein from Bacteria Induces Cell Spreading and Focal Adhesion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GASTRIC EPITHELIAL-CELLS; PSEUDOTUBERCULOSIS INVASIN PROTEIN; EXTRACELLULAR-MATRIX PROTEINS; IV SECRETION SYSTEMS; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; YERSINIA-PSEUDOTUBERCULOSIS; MAMMALIAN-CELLS; TYROSINE PHOSPHORYLATION	Fibronectin, a 250-kDa eukaryotic extracellular matrix protein containing an RGD motif plays crucial roles in cell-cell communication, development, tissue homeostasis, and disease development. The highly complex fibrillar fibronectin meshwork orchestrates the functions of other extracellular matrix proteins, promoting cell adhesion, migration, and intracellular signaling. Here, we demonstrate that CagL, a 26-kDa protein of the gastric pathogen and type I carcinogen Helicobacter pylori, mimics fibronectin in various cellular functions. Like fibronectin, CagL contains a RGD motif and is located on the surface of the bacterial type IV secretion pili as previously shown. CagL binds to the integrin receptor alpha(5)beta(1) and mediates the injection of virulence factors into host target cells. We show that purified CagL alone can directly trigger intracellular signaling pathways upon contact with mammalian cells and can complement the spreading defect of fibronectin(-/-) knock-out cells in vitro. During interaction with various human and mouse cell lines, CagL mimics fibronectin in triggering cell spreading, focal adhesion formation, and activation of several tyrosine kinases in an RGD-dependent manner. Among the activated factors are the nonreceptor tyrosine kinases focal adhesion kinase and Src but also the epidermal growth factor receptor and epidermal growth factor receptor family member Her3/ErbB3. Interestingly, fibronectin activates a similar range of tyrosine kinases but not Her3/ErbB3. These findings suggest that the bacterial protein CagL not only exhibits functional mimicry with fibronectin but is also capable of activating fibronectin-independent signaling events. We thus postulate that CagL may contribute directly to H. pylori pathogenesis by promoting aberrant signaling crosstalk within host cells.	[Backert, Steffen] Natl Univ Ireland Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Tegtmeyer, Nicole; Brandt, Sabine; Backert, Steffen] Otto Von Guericke Univ, Dept Microbiol, D-39120 Magdeburg, Germany; [Hartig, Roland] Otto Von Guericke Univ, Dept Immunol, D-39120 Magdeburg, Germany; [Delahay, Robin M.] Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; [Sewald, Norbert] Univ Bielefeld, Dept Chem Organ & Bioorgan Chem, D-33615 Bielefeld, Germany; [Takahashi, Seiichiro] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Smolka, Adam J.] Med Univ S Carolina, Charleston, SC 29425 USA	University College Dublin; Otto von Guericke University; Otto von Guericke University; University of Nottingham; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bielefeld; Max Planck Society; Medical University of South Carolina	Backert, S (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Biomol & Biomed Sci, Ardmore House,Belfield Campus, Dublin 4, Ireland.	Steffen.Backert@ucd.ie	Sewald, Norbert/A-2541-2012	Sewald, Norbert/0000-0002-0309-2655; Hartig, Roland/0000-0002-3706-7458; Delahay, Rob/0000-0002-7108-565X	Deutsche Forschungsgemeinschaft [Ba1671/8-1]; University College Dublin [R11408]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University College Dublin	This work was supported by Deutsche Forschungsgemeinschaft Grant Ba1671/8-1 and Research Grant R11408 from University College Dublin (to S. B.).	Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; AOTA S, 1994, J BIOL CHEM, V269, P24756; Arencibia I, 2002, EUR J IMMUNOL, V32, P1129, DOI 10.1002/1521-4141(200204)32:4<1129::AID-IMMU1129>3.0.CO;2-G; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Bax DV, 2004, J BIOL CHEM, V279, P22377, DOI 10.1074/jbc.M400180200; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; BOCKHOLT SM, 1993, J BIOL CHEM, V268, P14565; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Brandt S, 2009, CELL MOTIL CYTOSKEL, V66, P874, DOI 10.1002/cm.20373; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Copie V, 1998, J MOL BIOL, V277, P663; Dallas SL, 2006, CURR TOP DEV BIOL, V75, P1, DOI 10.1016/S0070-2153(06)75001-3; Delahay RM, 2008, J MOL BIOL, V377, P956, DOI 10.1016/j.jmb.2008.01.053; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; Du YQ, 2007, MICROBES INFECT, V9, P838, DOI 10.1016/j.micinf.2007.03.004; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; Eble J.A., 1997, INTEGRIN LIGAND INTE; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; ISBERG RR, 1988, P NATL ACAD SCI USA, V85, P6682, DOI 10.1073/pnas.85.18.6682; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Joh T, 2005, DIGEST DIS SCI, V50, P2081, DOI 10.1007/s10620-005-3011-0; Johansson S, 1997, FRONT BIOSCI, V2, P126; Keates S, 2005, GUT, V54, P1363, DOI 10.1136/gut.2005.066977; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kuwada SK, 2000, MOL BIOL CELL, V11, P2485, DOI 10.1091/mbc.11.7.2485; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; LEONG JM, 1990, EMBO J, V9, P1979, DOI 10.1002/j.1460-2075.1990.tb08326.x; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Matsuo M, 2006, CANCER SCI, V97, P155, DOI 10.1111/j.1349-7006.2006.00152.x; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; NHIEU GTV, 1991, J BIOL CHEM, V266, P24367; Nyberg P, 2004, EMBO J, V23, P2166, DOI 10.1038/sj.emboj.7600214; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SAHA A, 2010, GASTROENTER IN PRESS; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Schroder A, 2006, MOL BIOL CELL, V17, P5198, DOI 10.1091/mbc.E06-05-0463; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; VANNHIEU GT, 1993, EMBO J, V12, P1887, DOI 10.1002/j.1460-2075.1993.tb05837.x; Wallasch C, 2002, BIOCHEM BIOPH RES CO, V295, P695, DOI 10.1016/S0006-291X(02)00740-4; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	69	87	87	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23513	23524		10.1074/jbc.M109.096214	http://dx.doi.org/10.1074/jbc.M109.096214			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20507990	Green Published, hybrid			2022-12-25	WOS:000279999900083
J	Gullo, C; Koh, LK; Pang, WL; Ho, KT; Tan, SH; Schwarz, H				Gullo, Charles; Koh, Liang Kai; Pang, Wan Lu; Ho, Kian Tong; Tan, Shi Hao; Schwarz, Herbert			Inhibition of Proliferation and Induction of Apoptosis in Multiple Myeloma Cell Lines by CD137 Ligand Signaling	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; BONE-MARROW; B-CELLS; MONOCLONAL-ANTIBODY; MONOCYTE ACTIVATION; RECEPTOR FAMILY; GROWTH-FACTOR; 4-1BB; DIFFERENTIATION; INTERLEUKIN-6	Background: Multiple myeloma (MM) is a malignancy of terminally-differentiated plasma cells, and the second most prevalent blood cancer. At present there is no cure for MM, and the average prognosis is only three to five years. Current treatments such as chemotherapy are able to prolong a patient's life but rarely prevent relapse of the disease. Even hematopoietic stem cell transplants and novel drug combinations are often not curative, underscoring the need for a continued search for novel therapeutics. CD137 and its ligand are members of the Tumor Necrosis Factor (TNF) receptor and TNF superfamilies, respectively. Since CD137 ligand cross-linking enhances proliferation and survival of healthy B cells we hypothesized that it would also act as a growth stimulus for B cell cancers. Methodology/Principal Findings: Proliferation and survival of B cell lymphoma cell lines were not affected or slightly enhanced by CD137 ligand agonists in vitro. But surprisingly, they had the opposite effects on MM cells, where CD137 ligand signals inhibited proliferation and induced cell death by apoptosis. Furthermore, secretion of the pro-inflammatory cytokines, IL-6 and IL-8 were also enhanced in MM but not in non-MM cell lines in response to CD137 ligand agonists. The secretion of these cytokines in response to CD137 ligand signaling was consistent with the observed activation of the classical NF-kappa B pathway. We hypothesize that the induction of this pathway results in activation-induced cell death, and that this is the underlying mechanism of CD137-induced MM cell death and growth arrest. Conclusions/Significance: These data point to a hitherto unrecognized role of CD137 and CD137 ligand in MM cell biology. The selective inhibition of proliferation and induction of cell death in MM cells by CD137 ligand agonists may also warrant a closer evaluation of their therapeutic potential.	[Gullo, Charles; Ho, Kian Tong] Singapore Gen Hosp, Dept Clin Res, Canc Immunol Lab, Singapore 0316, Singapore; [Koh, Liang Kai; Pang, Wan Lu; Tan, Shi Hao; Schwarz, Herbert] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	Singapore General Hospital; National University of Singapore	Gullo, C (corresponding author), Singapore Gen Hosp, Dept Clin Res, Canc Immunol Lab, Singapore 0316, Singapore.	phssh@nus.edu.sg	Gullo, Charles A/X-9938-2019	Gullo, Charles A/0000-0002-4221-0087; Koh, Liang Kai/0000-0002-0687-3510	National Medical Research Council, Singapore [NMRC/1175/2008]; Singapore Cancer Syndicate	National Medical Research Council, Singapore(National Medical Research Council, Singapore); Singapore Cancer Syndicate	This work was supported by a grant (NMRC/1175/2008) from the National Medical Research Council, Singapore (https://www.nmrc.gov.sg/) to HS, and a grant (SCSBS0074) from the Singapore Cancer Syndicate (www.scs.a-star.edu.sg) to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bensinger William I, 2004, Clin Adv Hematol Oncol, V2, P46; Berard M, 1999, IMMUNOLOGY, V98, P47; Bringhen S, 2006, EXPERT OPIN INV DRUG, V15, P1565, DOI 10.1517/13543784.15.12.1565; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Daniel PT, 1997, EUR J IMMUNOL, V27, P1029, DOI 10.1002/eji.1830270433; Dankbar B, 2000, BLOOD, V95, P2630, DOI 10.1182/blood.V95.8.2630; Drenkard D, 2007, FASEB J, V21, P456, DOI 10.1096/fj.05-4739com; FUNAKOSHI S, 1994, BLOOD, V83, P2787, DOI 10.1182/blood.V83.10.2787.2787; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hwang WYK, 2006, LEUKEMIA, V20, P715, DOI 10.1038/sj.leu.2404099; Jiang D, 2008, STEM CELLS, V26, P2372, DOI 10.1634/stemcells.2008-0158; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Ju SW, 2003, HYBRIDOMA HYBRIDOM, V22, P333, DOI 10.1089/153685903322538872; Jung HW, 2004, EXP MOL MED, V36, P13, DOI 10.1038/emm.2004.2; KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KAWANO MM, 1995, BLOOD, V85, P487; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kline M, 2007, LEUKEMIA RES, V31, P591, DOI 10.1016/j.leukres.2006.06.012; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Laderach D, 2003, CELL IMMUNOL, V226, P37, DOI 10.1016/j.cellimm.2003.11.003; Langstein J, 2000, BIOCHEM BIOPH RES CO, V273, P117, DOI 10.1006/bbrc.2000.2889; Langstein J, 1999, BLOOD, V94, P3161, DOI 10.1182/blood.V94.9.3161.421k31_3161_3168; Langstein J, 1999, J LEUKOCYTE BIOL, V65, P829, DOI 10.1002/jlb.65.6.829; Langstein J, 1998, J IMMUNOL, V160, P2488; Lauta VM, 2003, CANCER, V97, P2440, DOI 10.1002/cncr.11072; Law CL, 2005, CANCER RES, V65, P8331, DOI 10.1158/0008-5472.CAN-05-0095; Lindstedt M, 2003, SCAND J IMMUNOL, V57, P305, DOI 10.1046/j.1365-3083.2003.01217.x; Lippert U, 2008, EUR J IMMUNOL, V38, P1024, DOI [10.1002/eji.200737800, 10.1002/eji.200890024]; Pauly S, 2002, J LEUKOCYTE BIOL, V72, P35; Podar K, 2004, BLOOD, V103, P3474, DOI 10.1182/blood-2003-10-3527; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; Rajkumar SV, 2005, MAYO CLIN PROC, V80, P1371, DOI 10.4065/80.10.1371; REIBNEGGER G, 1991, CANCER RES, V51, P6250; Schwarz H, 2005, J LEUKOCYTE BIOL, V77, P281, DOI 10.1189/jlb.0904558; Schwarz H, 1996, BLOOD, V87, P2839, DOI 10.1182/blood.V87.7.2839.bloodjournal8772839; SELINA SK, 2003, IMMUNOL REV, V194, P5; Sica G, 2000, ADV EXP MED BIOL, V465, P355; Szocinski JL, 2002, BLOOD, V100, P217, DOI 10.1182/blood.V100.1.217; Tai YT, 2004, CANCER RES, V64, P2846, DOI 10.1158/0008-5472.CAN-03-3630; Vallet S, 2008, LEUKEMIA LYMPHOMA, V49, P1238, DOI 10.1080/10428190802005191; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; ZHOU Z, 1995, IMMUNOL LETT, V45, P67, DOI 10.1016/0165-2478(94)00227-I	49	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10845	10.1371/journal.pone.0010845	http://dx.doi.org/10.1371/journal.pone.0010845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520765	Green Submitted, Green Published, gold			2022-12-25	WOS:000278221500030
J	Rizzi, M; Knoth, R; Hampe, CS; Lorenz, P; Gougeon, ML; Lemercier, B; Venhoff, N; Ferrera, F; Salzer, U; Thiesen, HJ; Peter, HH; Walker, UA; Eibel, H				Rizzi, Marta; Knoth, Rolf; Hampe, Christiane S.; Lorenz, Peter; Gougeon, Marie-Lise; Lemercier, Brigitte; Venhoff, Nils; Ferrera, Francesca; Salzer, Ulrich; Thiesen, Hans-Juergen; Peter, Hans-Hartmut; Walker, Ulrich A.; Eibel, Hermann			Long-Lived Plasma Cells and Memory B Cells Produce Pathogenic Anti-GAD65 Autoantibodies in Stiff Person Syndrome	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; HUMAN MONOCLONAL-ANTIBODIES; SYNDROME TYPE-I; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; AUTOIMMUNE-THYROIDITIS; CEREBROSPINAL-FLUID; DIABETES-MELLITUS; DEPLETION THERAPY; ENZYME-ACTIVITY	Stiff person syndrome (SPS) is a rare, neurological disorder characterized by sudden cramps and spasms. High titers of enzyme-inhibiting IgG autoantibodies against the 65 kD isoform of glutamic acid decarboxylase (GAD65) are a hallmark of SPS, implicating an autoimmune component in the pathology of the syndrome. Studying the B cell compartment and the anti-GAD65 B cell response in two monozygotic twins suffering from SPS, who were treated with the B cell-depleting monoclonal anti-CD20 antibody rituximab, we found that the humoral autoimmune response in SPS is composed of a rituximab-sensitive part that is rapidly cleared after treatment, and a rituximab-resistant component, which persists and acts as a reservoir for autoantibodies inhibiting GAD65 enzyme activity. Our data show that these potentially pathogenic anti-GAD65 autoantibodies are secreted by long-lived plasma cells, which may either be persistent or develop from rituximab-resistant memory B lymphocytes. Both subsets represent only a fraction of anti-GAD65 autoantibody secreting cells. Therefore, the identification and targeting of this compartment is a key factor for successful treatment planning of SPS and of similar autoimmune diseases.	[Rizzi, Marta; Venhoff, Nils; Salzer, Ulrich; Peter, Hans-Hartmut; Eibel, Hermann] Univ Med Ctr Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Rizzi, Marta; Venhoff, Nils; Salzer, Ulrich; Peter, Hans-Hartmut; Eibel, Hermann] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Rizzi, Marta; Eibel, Hermann] Univ Med Ctr Freiburg, Clin Res Unit Rheumatol, Freiburg, Germany; [Knoth, Rolf] Univ Med Ctr Freiburg, Inst Pathol, Dept Neuropathol, Freiburg, Germany; [Hampe, Christiane S.] Univ Washington, Dept Med, Seattle, WA USA; [Lorenz, Peter; Thiesen, Hans-Juergen] Univ Rostock, Inst Immunol, Rostock, Germany; [Gougeon, Marie-Lise; Lemercier, Brigitte] Inst Pasteur, Antiviral Immun Biotherapy & Vaccine Unit, Paris, France; [Ferrera, Francesca] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Walker, Ulrich A.] Univ Basel, Dept Rheumatol, Basel, Switzerland	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Washington; University of Washington Seattle; University of Rostock; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Genoa; University of Basel	Rizzi, M (corresponding author), Univ Med Ctr Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany.	hermann.eibel@uniklinik-freiburg.de	Hampe, Christiane Susanne/GSD-7679-2022; Rizzi, Marta/ABE-7264-2020	Rizzi, Marta/0000-0002-5153-6089; Lorenz, Peter A./0000-0001-7925-1002; Salzer, Ulrich/0000-0002-1769-1157; Hampe, Christiane/0000-0001-9111-6671	European Community [LSHM-CT-2004-G05264]; EUROPAD-net [HEALTH-F2-2008-201549]	European Community(European Commission); EUROPAD-net	This work was supported through the European Community funded project Autorome (LSHM-CT-2004-G05264) to HE, PL, MLG, and HJT, and EUROPAD-net (HEALTH-F2-2008-201549) to HE. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BJORK E, 1994, DIABETES, V43, P161, DOI 10.2337/diabetes.43.1.161; BRASHEAR HR, 1991, NEUROLOGY, V41, P1588, DOI 10.1212/WNL.41.10.1588; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P3612, DOI 10.1002/art.22211; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chattopadhyay S, 2002, HUM MOL GENET, V11, P1421, DOI 10.1093/hmg/11.12.1421; Dalakas MC, 2000, NEUROLOGY, V55, P1531, DOI 10.1212/WNL.55.10.1531; Dalakas MC, 2005, J NEUROL, V252, P19, DOI 10.1007/s00415-005-1105-4; Dalakas MC, 2001, NEW ENGL J MED, V345, P1870, DOI 10.1056/NEJMoa01167; Dalakas MC, 2001, NEUROLOGY, V57, P780, DOI 10.1212/WNL.57.5.780; Dinkel K, 1998, ANN NEUROL, V44, P194, DOI 10.1002/ana.410440209; El Fassi D, 2007, J CLIN ENDOCR METAB, V92, P1769, DOI 10.1210/jc.2006-2388; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Ferraro AJ, 2008, EUR J IMMUNOL, V38, P292, DOI 10.1002/eji.200737557; Ferrera F, 2007, CLIN IMMUNOL, V122, P13, DOI 10.1016/j.clim.2006.09.013; Foreman AL, 2008, AUTOIMMUNITY, V41, P80, DOI 10.1080/08916930701619656; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hampe CS, 2001, FEBS LETT, V488, P185, DOI 10.1016/S0014-5793(00)02429-7; Hampe CS, 2001, J NEUROIMMUNOL, V113, P63, DOI 10.1016/S0165-5728(00)00423-9; Hofer T, 2006, IMMUNOL REV, V211, P295, DOI 10.1111/j.0105-2896.2006.00380.x; Iwasaki H, 2001, ENDOCR J, V48, P261, DOI 10.1507/endocrj.48.261; Jaume JC, 2002, J IMMUNOL, V169, P665, DOI 10.4049/jimmunol.169.2.665; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Koelsch K, 2007, J CLIN INVEST, V117, P1558, DOI 10.1172/JCI27628; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Levy LM, 2005, ARCH NEUROL-CHICAGO, V62, P970, DOI 10.1001/archneur.62.6.970; Levy Lucien M., 1999, Annals of Internal Medicine, V131, P522; Lim A, 2008, INT IMMUNOL, V20, P105, DOI 10.1093/intimm/dxm125; Lorenz P, 2009, METHODS MOL BIOL, V524, P247, DOI 10.1007/978-1-59745-450-6_18; Madec AM, 1996, J IMMUNOL, V156, P3541; Moller B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2686; Monson NL, 2005, ARCH NEUROL-CHICAGO, V62, P258, DOI 10.1001/archneur.62.2.258; Mouquet H, 2008, J INVEST DERMATOL, V128, P2859, DOI 10.1038/jid.2008.178; Nakou M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2798; NOSSAL GJV, 1964, J EXP MED, V119, P485, DOI 10.1084/jem.119.3.485; Nyholt DR, 2006, TWIN RES HUM GENET, V9, P194, DOI 10.1375/twin.9.2.194; Padoa CJ, 2003, DIABETES, V52, P2689, DOI 10.2337/diabetes.52.11.2689; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Petereit HF, 2009, MULT SCLER J, V15, P189, DOI 10.1177/1352458508098268; Plesner A, 2001, AUTOIMMUNITY, V34, P221, DOI 10.3109/08916930109014691; Presciuttini S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-23; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Raju R, 2008, INT REV IMMUNOL, V27, P79, DOI 10.1080/08830180701883240; Rehnberg M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2789; RICHTER W, 1992, P NATL ACAD SCI USA, V89, P8467, DOI 10.1073/pnas.89.18.8467; RICHTER W, 1993, P NATL ACAD SCI USA, V90, P2832, DOI 10.1073/pnas.90.7.2832; Romijn HJ, 1999, J HISTOCHEM CYTOCHEM, V47, P229, DOI 10.1177/002215549904700211; Ruige JB, 1997, DIABETES CARE, V20, P1108, DOI 10.2337/diacare.20.7.1108; Schwartz HL, 1999, J MOL BIOL, V287, P983, DOI 10.1006/jmbi.1999.2655; Shaw PJ, 1999, LANCET, V353, P86, DOI 10.1016/S0140-6736(05)76151-1; Singec I, 2002, J COMP NEUROL, V452, P139, DOI 10.1002/cne.10371; Soderbergh A, 2004, J CLIN ENDOCR METAB, V89, P557, DOI 10.1210/jc.2003-030279; Taylor RP, 2008, CURR OPIN IMMUNOL, V20, P444, DOI 10.1016/j.coi.2008.05.011; Teng YKO, 2007, ARTHRITIS RHEUM-US, V56, P3909, DOI 10.1002/art.22967; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; Tremble J, 1997, J CLIN ENDOCR METAB, V82, P2664, DOI 10.1210/jc.82.8.2664; Tuomi T, 1996, J CLIN ENDOCR METAB, V81, P1488, DOI 10.1210/jc.81.4.1488; Venhoff N, 2009, ANN RHEUM DIS, V68, P1506, DOI 10.1136/ard.2008.103721; VICARI AM, 1989, NEW ENGL J MED, V320, P1498; Wasserman RL, 2009, EUR J PHARM SCI, V37, P272, DOI 10.1016/j.ejps.2009.02.014	64	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10838	10.1371/journal.pone.0010838	http://dx.doi.org/10.1371/journal.pone.0010838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520773	gold, Green Submitted, Green Published			2022-12-25	WOS:000278221500024
J	Tyagi, N; Anamika, K; Srinivasan, N				Tyagi, Nidhi; Anamika, Krishanpal; Srinivasan, Narayanaswamy			A Framework for Classification of Prokaryotic Protein Kinases	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SIGNAL-TRANSDUCTION PATHWAYS; SERINE THREONINE KINASE; MYCOBACTERIUM-TUBERCULOSIS; EUKARYOTIC-TYPE; MYXOCOCCUS-XANTHUS; TYROSINE KINASE; SER/THR KINASE; SERINE/THREONINE KINASE; CHLAMYDIA-TRACHOMATIS	Background: Overwhelming majority of the Serine/Threonine protein kinases identified by gleaning archaeal and eubacterial genomes could not be classified into any of the well known Hanks and Hunter subfamilies of protein kinases. This is owing to the development of Hanks and Hunter classification scheme based on eukaryotic protein kinases which are highly divergent from their prokaryotic homologues. A large dataset of prokaryotic Serine/Threonine protein kinases recognized from genomes of prokaryotes have been used to develop a classification framework for prokaryotic Ser/Thr protein kinases. Methodology/Principal Findings: We have used traditional sequence alignment and phylogenetic approaches and clustered the prokaryotic kinases which represent 72 subfamilies with at least 4 members in each. Such a clustering enables classification of prokaryotic Ser/Thr kinases and it can be used as a framework to classify newly identified prokaryotic Ser/Thr kinases. After series of searches in a comprehensive sequence database we recognized that 38 subfamilies of prokaryotic protein kinases are associated to a specific taxonomic level. For example 4, 6 and 3 subfamilies have been identified that are currently specific to phylum proteobacteria, cyanobacteria and actinobacteria respectively. Similarly subfamilies which are specific to an order, sub-order, class, family and genus have also been identified. In addition to these, we also identify organism-diverse subfamilies. Members of these clusters are from organisms of different taxonomic levels, such as archaea, bacteria, eukaryotes and viruses. Conclusion/Significance: Interestingly, occurrence of several taxonomic level specific subfamilies of prokaryotic kinases contrasts with classification of eukaryotic protein kinases in which most of the popular subfamilies of eukaryotic protein kinases occur diversely in several eukaryotes. Many prokaryotic Ser/Thr kinases exhibit a wide variety of modular organization which indicates a degree of complexity and protein-protein interactions in the signaling pathways in these microbes.	[Tyagi, Nidhi; Anamika, Krishanpal; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Tyagi, N (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in		Tyagi, Nidhi/0000-0002-2065-9051	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India; Microsoft Corporation	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Microsoft Corporation(Microsoft)	This research is supported by Department of Biotechnology, Government of India and also by the Mathematical Biology initiative supported by the Department of Science and Technology, Government of India. N.T. is supported by a grant from Microsoft Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adindla S, 2004, COMP FUNCT GENOM, V5, P2, DOI 10.1002/cfg.358; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Anamika K, 2008, PROTEINS, V71, P995, DOI 10.1002/prot.21790; Anamika K, 2007, PROTEIN PEPTIDE LETT, V14, P509; Anamika K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-625; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Bakal CJ, 2000, TRENDS CELL BIOL, V10, P32, DOI 10.1016/S0962-8924(99)01681-5; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 1998, PROTEIN SCI, V7, P1477, DOI 10.1002/pro.5560070625; BENTLEY SD, 2002, NATURE, V3, P417; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; BOURRET RB, 1989, J BIOL CHEM, V264, P7085; Brettar I, 2002, INT J SYST EVOL MICR, V52, P2211, DOI 10.1099/00207713-52-6-2211; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; D'Souza M, 2000, NUCLEIC ACIDS RES, V28, P335, DOI 10.1093/nar/28.1.335; D'Souza M, 2007, NUCLEIC ACIDS RES, V35, pD271, DOI 10.1093/nar/gkl949; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Frasch SC, 1996, J BACTERIOL, V178, P4084, DOI 10.1128/jb.178.14.4084-4088.1996; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Gowri VS, 2007, PROTEINS, V67, P789, DOI 10.1002/prot.21356; Gowri VS, 2006, NUCLEIC ACIDS RES, V34, pD243, DOI 10.1093/nar/gkj043; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Han GN, 2001, FEMS MICROBIOL LETT, V200, P79, DOI 10.1016/S0378-1097(01)00206-3; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; HUBER G, 1989, SYST APPL MICROBIOL, V12, P38; Iyer LM, 2004, PROTEINS, V55, P977, DOI 10.1002/prot.20076; Jadeau F, 2008, BIOINFORMATICS, V24, P2427, DOI 10.1093/bioinformatics/btn462; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kamei A, 2003, CURR MICROBIOL, V46, P296, DOI 10.1007/s00284-002-3887-2; Kamei A, 2002, DNA RES, V9, P71, DOI 10.1093/dnares/9.3.71; Kamei A, 2001, J BACTERIOL, V183, P1505, DOI 10.1128/JB.183.5.1505-1510.2001; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kari L, 2008, J INFECT DIS, V197, P449, DOI 10.1086/525285; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kennelly PJ, 1996, J BACTERIOL, V178, P4759, DOI 10.1128/jb.178.16.4759-4764.1996; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Krupa A, 2004, NUCLEIC ACIDS RES, V32, pD153, DOI 10.1093/nar/gkh019; Krupa A, 2002, PROTEIN SCI, V11, P1580, DOI 10.1110/ps.3560102; KUNZE B, 1985, J ANTIBIOT, V38, P1649, DOI 10.7164/antibiotics.38.1649; KUNZE B, 1984, J ANTIBIOT, V37, P454, DOI 10.7164/antibiotics.37.454; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lower BH, 2004, J BACTERIOL, V186, P463, DOI 10.1128/JB.186.2.463-472.2004; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Makemson JC, 1997, INT J SYST BACTERIOL, V47, P1034, DOI 10.1099/00207713-47-4-1034; Maltsev N, 2002, NUCLEIC ACIDS RES, V30, P349, DOI 10.1093/nar/30.1.349; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; MATSUMOTO A, 1994, GENE, V146, P47; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; MUNOZDORADO J, 1993, J CELL BIOCHEM, V51, P29, DOI 10.1002/jcb.240510107; Nariya H, 2003, MOL MICROBIOL, V49, P517, DOI 10.1046/j.1365-2958.2003.03572.x; Nariya H, 2002, MOL MICROBIOL, V46, P1353, DOI 10.1046/j.1365-2958.2002.03251.x; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neu JM, 2002, MOL MICROBIOL, V44, P417, DOI 10.1046/j.1365-2958.2002.02879.x; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; Oren A, 2004, INT J SYST EVOL MICR, V54, P1895, DOI 10.1099/ijs.0.03008-0; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Petrickova K, 2003, MICROBIOL-SGM, V149, P1609, DOI 10.1099/mic.0.26275-0; Poncet S, 2004, BBA-PROTEINS PROTEOM, V1697, P123, DOI 10.1016/j.bbapap.2003.11.018; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; REIZER J, 1988, CRC CR REV MICROBIOL, V15, P297, DOI 10.3109/10408418809104461; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sensen CW, 1998, EXTREMOPHILES, V2, P305, DOI 10.1007/s007920050073; SHAKIR SM, 2009, J BACTERIOL; SKORKO R, 1984, EUR J BIOCHEM, V145, P617, DOI 10.1111/j.1432-1033.1984.tb08601.x; SMITH RF, 1995, PROTEIN SCI, V4, P126; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SOUTH SL, 1994, MOL MICROBIOL, V12, P903, DOI 10.1111/j.1365-2958.1994.tb01078.x; STACKEBRANDT E, 1988, INT J SYST BACTERIOL, V38, P321, DOI 10.1099/00207713-38-3-321; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; Tauch A, 2008, J BIOTECHNOL, V136, P11, DOI 10.1016/j.jbiotec.2008.02.009; Thomasson B, 2002, MOL MICROBIOL, V46, P1399, DOI 10.1046/j.1365-2958.2002.03258.x; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; UDO H, 1995, GENE DEV, V9, P972, DOI 10.1101/gad.9.8.972; Ueda K, 1996, GENE, V169, P91, DOI 10.1016/0378-1119(95)00771-7; Umeyama T, 2002, APPL MICROBIOL BIOT, V59, P419, DOI 10.1007/s00253-002-1045-1; Venkateswaran K, 1998, INT J SYST BACTERIOL, V48, P965, DOI 10.1099/00207713-48-3-965; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Verma A, 2003, INFECT IMMUN, V71, P5772, DOI 10.1128/IAI.71.10.5772-5784.2003; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; WARNER KM, 1994, PLANT PHYSIOL, V105, P629, DOI 10.1104/pp.105.2.629; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; ZHANG CC, 1993, P NATL ACAD SCI USA, V90, P11840, DOI 10.1073/pnas.90.24.11840; Zhang CC, 1998, NUCLEIC ACIDS RES, V26, P3619, DOI 10.1093/nar/26.16.3619; Zhang WD, 1996, MOL MICROBIOL, V20, P435, DOI 10.1111/j.1365-2958.1996.tb02630.x; ZHANG WD, 1992, J BACTERIOL, V174, P5450, DOI 10.1128/JB.174.16.5450-5453.1992; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x; Zhulin IB, 2003, J BACTERIOL, V185, P285, DOI 10.1128/JB.185.1.285-294.2003	125	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10608	10.1371/journal.pone.0010608	http://dx.doi.org/10.1371/journal.pone.0010608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520783	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000278221500001
J	Beaume, M; Hernandez, D; Farinelli, L; Deluen, C; Linder, P; Gaspin, C; Romby, P; Schrenzel, J; Francois, P				Beaume, Marie; Hernandez, David; Farinelli, Laurent; Deluen, Cecile; Linder, Patrick; Gaspin, Christine; Romby, Pascale; Schrenzel, Jacques; Francois, Patrice			Cartography of Methicillin-Resistant S. aureus Transcripts: Detection, Orientation and Temporal Expression during Growth Phase and Stress Conditions	PLOS ONE			English	Article							SMALL NONCODING RNAS; ANTISENSE TRANSCRIPTION; REDUCED SUSCEPTIBILITY; LOCUS; REGULATOR; VANCOMYCIN; STRAINS; GENOME; AGR; IDENTIFICATION	Background: Staphylococcus aureus is a versatile bacterial opportunist responsible for a wide spectrum of infections. The severity of these infections is highly variable and depends on multiple parameters including the genome content of the bacterium as well as the condition of the infected host. Clinically and epidemiologically, S. aureus shows a particular capacity to survive and adapt to drastic environmental changes including the presence of numerous antimicrobial agents. Mechanisms triggering this adaptation remain largely unknown despite important research efforts. Most studies evaluating gene content have so far neglected to analyze the so-called intergenic regions as well as potential antisense RNA molecules. Principal Findings: Using high-throughput sequencing technology, we performed an inventory of the whole transcriptome of S. aureus strain N315. In addition to the annotated transcription units, we identified more than 195 small transcribed regions, in the chromosome and the plasmid of S. aureus strain N315. The coding strand of each transcript was identified and structural analysis enabled classification of all discovered transcripts. RNA purified at four time-points during the growth phase of the bacterium allowed us to define the temporal expression of such transcripts. A selection of 26 transcripts of interest dispersed along the intergenic regions was assessed for expression changes in the presence of various stress conditions including pH, temperature, oxidative shocks and growth in a stringent medium. Most of these transcripts showed expression patterns specific for the defined stress conditions that we tested. Conclusions: These RNA molecules potentially represent important effectors of S. aureus adaptation and more generally could support some of the epidemiological characteristics of the bacterium.	[Beaume, Marie; Hernandez, David; Schrenzel, Jacques; Francois, Patrice] Univ Hosp Geneva, Infect Dis Serv, Genom Res Lab, Geneva, Switzerland; [Farinelli, Laurent; Deluen, Cecile] Fasteris SA, Plan Les Ouates, Switzerland; [Linder, Patrick] Ctr Med Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Gaspin, Christine] UBIA & Plateforme GenoToul Bioinfo, INRA, UR 875, F-31326 Castanet Tolosan, France; [Romby, Pascale] Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, Strasbourg, France	University of Geneva; University of Geneva; INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Beaume, M (corresponding author), Univ Hosp Geneva, Infect Dis Serv, Genom Res Lab, Geneva, Switzerland.	marie.beaume@genomic.ch	francois, patrice/AAL-5583-2020; Gaspin, Christine/B-6756-2015; ROMBY, Pascale/AGP-3328-2022; Schrenzel, Jacques/P-8525-2017; Schrenzel, Jacques/AAC-5685-2021	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Gaspin, Christine/0000-0003-0304-5186; francois, patrice/0000-0002-0540-750X	Swiss National Science Foundation [3100A0 112370/1, 3100A0-116075, 31003A-118309]; Infectigen CGR [75298]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Infectigen CGR	This work was supported by grants from the Swiss National Science Foundation 3100A0 112370/1 (to JS), 3100A0-116075 (to PF), 31003A-118309 (to PL) and Infectigen CGR 75298 (to PF). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. However, the funders (LF, CD) appear as co-authors because they performed some experiments.	ABUQATOUSEH LF, 2010, J MOL MED; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01402.x; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Baba T, 2009, J BACTERIOL, V191, P1180, DOI 10.1128/JB.01058-08; Balbontin R, 2008, J BACTERIOL, V190, P4075, DOI 10.1128/JB.00220-08; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; BEAUME M, 2009, INT J MED MICROBIOL; Borg MA, 2005, CLIN MICROBIOL INFEC, V11, P405, DOI 10.1111/j.1469-0691.2005.01110.x; BOYCE JM, 1992, INFECT CONT HOSP EP, V13, P725; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Campbell KM, 2004, J CLIN MICROBIOL, V42, P4050, DOI 10.1128/JCM.42.9.4050-4053.2004; Chesneau O, 1999, FEMS MICROBIOL LETT, V177, P93, DOI 10.1016/S0378-1097(99)00296-7; CHEUNG AL, 1994, J BACTERIOL, V176, P580, DOI 10.1128/jb.176.3.580-585.1994; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; CHEVALIER C, 2010, PLOSPATHOGE IN PRESS; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cramton SE, 2000, INFECT IMMUN, V68, P2344, DOI 10.1128/IAI.68.4.2344-2348.2000; CROS MJ, 2007, NATURE PROTOCOLS; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Entenza JM, 2005, INFECT IMMUN, V73, P990, DOI 10.1128/IAI.73.2.990-998.2005; Ferraz V, 2000, S AFR MED J, V90, P1113; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FOZO EM, 2010, NUCL ACIDS RES; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Gordon JJ, 2006, BIOINFORMATICS, V22, P142, DOI 10.1093/bioinformatics/bti771; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Hiramatsu K, 2002, CURR OPIN INFECT DIS, V15, P407, DOI 10.1097/00001432-200208000-00009; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Jones ME, 2002, ANTIMICROB AGENTS CH, V46, P3104, DOI 10.1128/AAC.46.9.3104-3105.2002; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Lulitanond A, 2009, J CLIN MICROBIOL, V47, P2311, DOI 10.1128/JCM.01749-08; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Marchais A, 2009, GENOME RES, V19, P1084, DOI 10.1101/gr.089714.108; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; *NCBI, 2009, NCBI GEN PROJ; NI ED, 1998, MOL MICROBIOL, V30, P245; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Puskas LG, 2002, BIOTECHNIQUES, V32, P1330, DOI 10.2144/02326mt04; Reyes-Lopez M, 2003, NUCLEIC ACIDS RES, V31, P779, DOI 10.1093/nar/gkg132; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roberts C, 2006, J BACTERIOL, V188, P2593, DOI 10.1128/JB.188.7.2593-2603.2006; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Rosenblad MA, 2009, RNA BIOL, V6, P508, DOI 10.4161/rna.6.5.9753; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4; Sng LH, 2005, INT J ANTIMICROB AG, V25, P177, DOI 10.1016/j.ijantimicag.2004.11.001; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Sridhar Jayavel, 2007, In Silico Biology, V7, P601; Steckelberg JM, 2000, INFECT ASS INDWELLIN; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Vitreschak AG, 2008, RNA, V14, P717, DOI 10.1261/rna.819308; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wagner EGH, 2002, ADV GENET, V46, P361; WANG J, 2010, NUCL ACIDS RES; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; WURTZEL O, 2009, GENOME RES; Xiong YQ, 2004, INFECT IMMUN, V72, P1832, DOI 10.1128/IAI.72.3.1832-1836.2004; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106	91	105	107	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10725	10.1371/journal.pone.0010725	http://dx.doi.org/10.1371/journal.pone.0010725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505759	Green Published, gold			2022-12-25	WOS:000278017300005
J	Dahdul, WM; Balhoff, JP; Engeman, J; Grande, T; Hilton, EJ; Kothari, C; Lapp, H; Lundberg, JG; Midford, PE; Vision, TJ; Westerfield, M; Mabee, PM				Dahdul, Wasila M.; Balhoff, James P.; Engeman, Jeffrey; Grande, Terry; Hilton, Eric J.; Kothari, Cartik; Lapp, Hilmar; Lundberg, John G.; Midford, Peter E.; Vision, Todd J.; Westerfield, Monte; Mabee, Paula M.			Evolutionary Characters, Phenotypes and Ontologies: Curating Data from the Systematic Biology Literature	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; OSTARIOPHYSI; SILURIFORMES; TELEOSTEI; CHARACIFORMES; OSTEICHTHYES; LORICARIIDAE; GENOMICS; SUPPORT; PISCES	Background: The wealth of phenotypic descriptions documented in the published articles, monographs, and dissertations of phylogenetic systematics is traditionally reported in a free-text format, and it is therefore largely inaccessible for linkage to biological databases for genetics, development, and phenotypes, and difficult to manage for large-scale integrative work. The Phenoscape project aims to represent these complex and detailed descriptions with rich and formal semantics that are amenable to computation and integration with phenotype data from other fields of biology. This entails reconceptualizing the traditional free-text characters into the computable Entity-Quality (EQ) formalism using ontologies. Methodology/Principal Findings: We used ontologies and the EQ formalism to curate a collection of 47 phylogenetic studies on ostariophysan fishes (including catfishes, characins, minnows, knifefishes) and their relatives with the goal of integrating these complex phenotype descriptions with information from an existing model organism database (zebrafish, http://zfin.org). We developed a curation workflow for the collection of character, taxonomic and specimen data from these publications. A total of 4,617 phenotypic characters (10,512 states) for 3,449 taxa, primarily species, were curated into EQ formalism (for a total of 12,861 EQ statements) using anatomical and taxonomic terms from teleost-specific ontologies (Teleost Anatomy Ontology and Teleost Taxonomy Ontology) in combination with terms from a quality ontology (Phenotype and Trait Ontology). Standards and guidelines for consistently and accurately representing phenotypes were developed in response to the challenges that were evident from two annotation experiments and from feedback from curators. Conclusions/Significance: The challenges we encountered and many of the curation standards and methods for improving consistency that we developed are generally applicable to any effort to represent phenotypes using ontologies. This is because an ontological representation of the detailed variations in phenotype, whether between mutant or wildtype, among individual humans, or across the diversity of species, requires a process by which a precise combination of terms from domain ontologies are selected and organized according to logical relations. The efficiencies that we have developed in this process will be useful for any attempt to annotate complex phenotypic descriptions using ontologies. We also discuss some ramifications of EQ representation for the domain of systematics.	[Dahdul, Wasila M.; Engeman, Jeffrey; Mabee, Paula M.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Dahdul, Wasila M.; Balhoff, James P.; Kothari, Cartik; Lapp, Hilmar; Midford, Peter E.; Vision, Todd J.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Balhoff, James P.; Kothari, Cartik; Vision, Todd J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Grande, Terry] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Hilton, Eric J.] Virginia Inst Marine Sci, Coll William & Mary, Dept Fisheries Sci, Gloucester Point, VA 23062 USA; [Lundberg, John G.] Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; [Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of South Dakota; The National Evolutionary Synthesis Center; University of North Carolina; University of North Carolina Chapel Hill; Loyola University Chicago; William & Mary; Virginia Institute of Marine Science; Drexel University; University of Oregon	Dahdul, WM (corresponding author), Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA.	wasila.dahdul@usd.edu; pmabee@usd.edu	Lapp, Hilmar/A-8275-2009; Midford, Peter E./B-5946-2008; Vision, Todd/B-4867-2010	Midford, Peter E./0000-0001-6512-3296; Vision, Todd/0000-0002-6133-2581; Dahdul, Wasila/0000-0003-3162-7490; Balhoff, James/0000-0002-8688-6599; Lapp, Hilmar/0000-0001-9107-0714; Mabee, Paula/0000-0002-8455-3213	National Science Foundation [DBI 0641025]; National Institutes of Health [HG002659]; National Evolutionary Synthesis Center, NSF [EF-0423641]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG002659] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1062542] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center, NSF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank National Science Foundation (DBI 0641025), National Institutes of Health (HG002659), and the National Evolutionary Synthesis Center (NSF EF-0423641) for the support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JS, 2001, MISCELLANEOUS PUBLIC, V190; [Anonymous], 1991, ANATOMY RELATIONSHIP; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], MOUSE GENOME INFORM; Armbruster JW, 2004, ZOOL J LINN SOC-LOND, V141, P1, DOI 10.1111/j.1096-3642.2004.00109.x; Arratia Gloria, 1999, P265; BAGILS RZ, 2004, MESOZOIC FISHES, V3, P391; BALHOFF JP, 2010, PLOS ONE IN PRESS; BOCKMANN FA, 1998, ANALISE FILOGENETICA; BORNBUSCH AH, 1995, ZOOL J LINN SOC-LOND, V115, P1; Britto MR, 2003, P ACAD NAT SCI PHILA, V153, P119, DOI 10.1635/0097-3157(2003)153[0119:POTSCH]2.0.CO;2; Buckup Paulo Andreas, 1998, P123; Cavender T.M., 1993, P293; Chang MM, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)404<0001:ROEBAD>2.0.CO;2; CHEN XP, 1994, PHYLOGENETIC STUDIES; Clarke JA, 2009, ZOOL J LINN SOC-LOND, V157, P586, DOI 10.1111/j.1096-3642.2009.00550.x; COBURN MM, 1992, HIST ECOLOGY N AM FR; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; de Pinna M.C.C., 1993, HIGHER LEVEL PHYLOGE; De Pinna MCC, 2007, ZOOL J LINN SOC-LOND, V150, P755, DOI 10.1111/j.1096-3642.2007.00306.x; DEPINNA MCC, 1996, FIELDIANA ZOOLOGY, V84; DIDARIO F, 1999, FILOGENIA PRISTIGAST; Eschmeyer W. N., 2010, CATALOG FISHES ELECT; Fang F, 2003, COPEIA, P714; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; FRICKE R., 2010, GUIDE FISH COLLECTIO; Friel J.P., 1994, PHYLOGENETIC STUDY N; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Grande T, 2004, COPEIA, P743; Grande T, 1999, ZOOL J LINN SOC-LOND, V125, P197; GRANDE T, 2008, REEVALUATION GONORYN, P295; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; JOHNSON GD, 1993, B MAR SCI, V52, P554; Kailola Patricia J., 2004, Beagle, V20, P87; Lewis S.E., 2002, GENOME BIOL, V3, pRESEARCH0082, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Lucena Carlos A.S., 1998, P261; Lundberg J.G., 1993, P392; Mabee PM, 2007, J EXP ZOOL PART B, V308B, P655, DOI 10.1002/jez.b.21181; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Maddison, 2019, MESQUITE MODULAR SYS; Malabarba Luiz R., 1998, P193; Mayden R. L., 1989, MISC PUBL MUS NAT HI, V80, P1, DOI DOI 10.5962/BHL.TITLE.5480; Miko I, 2009, ZOOKEYS, P127, DOI 10.3897/zookeys.20.119; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; MUNGALL C, 2007, REPRESENTING PHENOTY; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; *PHEN, PHEN GUID CHAR ANN; *PHEN, PHEN CUR MAIL LIST; Poyato-Ariza F. J., 1996, PALEOICHTHYOLOGICA, V6, P1; ROYERO R, 1999, STUDIES SYSTEMATICS; Sanger TJ, 2002, ZOOL J LINN SOC-LOND, V135, P529, DOI 10.1046/j.1096-3642.2002.00014.x; SANTAGATA S, 2009, ZOOLOGICAL J LINNEAN, V157; SAWADA Y, 1982, Memoirs of the Faculty of Fisheries Hokkaido University, V28, P65; SCHAEFER S A, 1987, Contributions in Science (Los Angeles), P1; SCHAEFER SA, 1991, ZOOL J LINN SOC-LOND, V102, P1, DOI 10.1111/j.1096-3642.1991.tb01535.x; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; SHIBATTA OA, 1998, SISTEMATICA EVOLUCAO; Sidlauskas BL, 2008, ZOOL J LINN SOC-LOND, V154, P70, DOI 10.1111/j.1096-3642.2008.00407.x; SIEBERT DH, 1987, INTERRELATIONSHIPS F; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith G.R., 1993, P778; Soares-Porto Luisa Maria, 1998, P331; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Toledo-Piza M, 2007, ZOOL J LINN SOC-LOND, V151, P691, DOI 10.1111/j.1096-3642.2007.00355.x; Toledo-Piza Monica, 2000, American Museum Novitates, V3286, P1, DOI 10.1206/0003-0082(2000)286<0001:TNFSCT>2.0.CO;2; Vari R.P., 1995, SMITHSONIAN CONTRIBU, V564, P1, DOI [10.5479/si.00810282.564, DOI 10.5479/SI.00810282.564]; Vari RP, 2001, SMITHSONIAN CONTRIBU, V613; Vigliotta TR, 2008, P ACAD NAT SCI PHILA, V157, P73, DOI 10.1635/0097-3157(2008)157[73:APSOTA]2.0.CO;2; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Weitzman Stanley H., 1998, P171; Zanata AM, 2005, ZOOL J LINN SOC-LOND, V145, P1, DOI 10.1111/j.1096-3642.2005.00183.x; OBOPHENOTYPE MAILING; OBODISCUSS MAILING L; EVIDENCE CODES ONTOL; TELEOST ANATOMY ONTO; TELEOST TAXONOMY ONT; TELEOST DISCUSS MAIL	78	62	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10708	10.1371/journal.pone.0010708	http://dx.doi.org/10.1371/journal.pone.0010708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505755	Green Published, gold			2022-12-25	WOS:000278017300003
J	Crawford, BE; Garner, OB; Bishop, JR; Zhang, DY; Bush, KT; Nigam, SK; Esko, JD				Crawford, Brett E.; Garner, Omai B.; Bishop, Joseph R.; Zhang, David Y.; Bush, Kevin T.; Nigam, Sanjay K.; Esko, Jeffrey D.			Loss of the Heparan Sulfate Sulfotransferase, Ndst1, in Mammary Epithelial Cells Selectively Blocks Lobuloalveolar Development in Mice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GLAND DEVELOPMENT; BRANCHING MORPHOGENESIS; CONDITIONAL KNOCKOUT; TARGETED DISRUPTION; TEMPORAL EXPRESSION; BASAL LAMINA; GENE; DEFECTS; PROTEOGLYCANS	Background: Considerable evidence indicates that heparan sulfate is essential for the development of tissues consisting of branching ducts and tubules. However, there are few examples where specific sulfate residues regulate a specific stage in the formation of such tissues. Methodology/Principal Findings: We examined the role of heparan sulfation in mammary gland branching morphogenesis, lactation and lobuloalveolar development by inactivation of heparan sulfate GlcNAc N-deacetylase/N-sulfotransferase genes (Ndst) in mammary epithelial cells using the Cre-loxP system. Ndst1 deficiency resulted in an overall reduction in glucosamine N-sulfation and decreased binding of FGF to mammary epithelial cells in vitro and in vivo. Mammary epithelia lacking Ndst1 underwent branching morphogenesis, filling the gland with ductal tissue by sexual maturity to the same extent as wildtype epithelia. However, lobuloalveolar expansion did not occur in Ndst1-deficient animals, resulting in insufficient milk production to nurture newly born pups. Lactational differentiation of isolated mammary epithelial cells occurred appropriately via stat5 activation, further supporting the notion that the lack of milk production was due to lack of expansion of the lobuloalveoli. Conclusions/Significance: These findings demonstrate a selective, highly penetrant, cell autonomous effect of Ndst1-mediated sulfation on lobuloalveolar development.	[Crawford, Brett E.; Garner, Omai B.; Bishop, Joseph R.; Zhang, David Y.; Nigam, Sanjay K.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Crawford, Brett E.; Garner, Omai B.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Crawford, BE (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	snigam@ucsd.edu; jesko@ucsd.edu		Zhang, David/0000-0001-5809-0027	National Institutes of Health [CA67754, AI58916, AI52692, GM33063, HL57345]; NATIONAL CANCER INSTITUTE [T32CA067754] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI058916, F32AI052692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063, R01GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by training grant CA67754 (B. E. C), NRSA Minority Predoctoral Fellowship AI58916 (O.B.G.), NRSA Fellowship AI52692 (J.R.B) and GM33063 and HL57345 (J.D.E) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Brisken C, 2000, GENE DEV, V14, P650; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Delehedde M, 2001, J MAMMARY GLAND BIOL, V6, P253, DOI 10.1023/A:1011367423085; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Dunbar ME, 2001, J ENDOCRINOL, V171, P403, DOI 10.1677/joe.0.1710403; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Faraldo MM, 2001, EMBO REP, V2, P431, DOI 10.1093/embo-reports/kve086; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; GORDON JR, 1980, DEV BIOL, V74, P118, DOI 10.1016/0012-1606(80)90056-1; Green KA, 2004, CELL MOL LIFE SCI, V61, P1867, DOI 10.1007/s00018-004-3366-y; Grimm SL, 2002, MOL ENDOCRINOL, V16, P2675, DOI 10.1210/me.2002-0239; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Humphreys RC, 1997, MOL ENDOCRINOL, V11, P801, DOI 10.1210/me.11.6.801; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Ishiguro K, 2001, LAB INVEST, V81, P509, DOI 10.1038/labinvest.3780259; Jackson D, 1997, J CELL SCI, V110, P1261; Joseph H, 1999, MOL BIOL CELL, V10, P1221, DOI 10.1091/mbc.10.4.1221; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lewis MT, 1999, DEVELOPMENT, V126, P5181; Lewis MT, 2001, DEV BIOL, V238, P133, DOI 10.1006/dbio.2001.0410; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; LI M, 2000, METHODS MAMMARY GLAN, P233; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Liu BY, 2003, ONCOGENE, V22, P9243, DOI 10.1038/sj.onc.1207217; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Paguirigan A, 2006, EUR J CANCER, V42, P1225, DOI 10.1016/j.ejca.2006.01.048; Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pullan Shirley E., 1996, P97; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Robinson GW, 1997, DEVELOPMENT, V124, P2701; Ruan WF, 1999, ENDOCRINOLOGY, V140, P5075, DOI 10.1210/en.140.11.5075; Shah MM, 2010, DEV BIOL, V339, P354, DOI 10.1016/j.ydbio.2009.12.033; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SILBERSTEIN GB, 1982, DEV BIOL, V90, P215, DOI 10.1016/0012-1606(82)90228-7; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Steer DL, 2004, DEV BIOL, V272, P310, DOI 10.1016/j.ydbio.2004.04.029; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; STREULI CH, 1995, J BIOL CHEM, V270, P21639, DOI 10.1074/jbc.270.37.21639; Thomson AA, 2006, DIFFERENTIATION, V74, P382, DOI 10.1111/j.1432-0436.2006.00101.x; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wei G, 2000, J BIOL CHEM, V275, P27733; Wiesen JF, 1999, DEVELOPMENT, V126, P335; Xie W, 1997, MOL ENDOCRINOL, V11, P1766, DOI 10.1210/me.11.12.1766; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	76	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10691	10.1371/journal.pone.0010691	http://dx.doi.org/10.1371/journal.pone.0010691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502530	Green Published, Green Submitted, gold			2022-12-25	WOS:000277776500008
J	Liao, JY; Ma, LM; Guo, YH; Zhang, YC; Zhou, H; Shao, P; Chen, YQ; Qu, LH				Liao, Jian-You; Ma, Li-Ming; Guo, Yan-Hua; Zhang, Yu-Chan; Zhou, Hui; Shao, Peng; Chen, Yue-Qin; Qu, Liang-Hu			Deep Sequencing of Human Nuclear and Cytoplasmic Small RNAs Reveals an Unexpectedly Complex Subcellular Distribution of miRNAs and tRNA 3 ' Trailers	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; GENE; IDENTIFICATION; BIOGENESIS; DISCOVERY; TRANSCRIPTS; PROTEINS; SNORNA; SIRNAS	Background: MicroRNAs (miRNAs) are similar to 22-nt small non-coding regulatory RNAs that have generally been considered to regulate gene expression at the post-transcriptional level in the cytoplasm. However, recent studies have reported that some miRNAs localize to and function in the nucleus. Methodology/Principal Findings: To determine the number of miRNAs localized to the nucleus, we systematically investigated the subcellular distribution of small RNAs (sRNAs) by independent deep sequencing sequenced of the nuclear and cytoplasmic pools of 18- to 30-nucleotide sRNAs from human cells. We identified 339 nuclear and 324 cytoplasmic known miRNAs, 300 of which overlap, suggesting that the majority of miRNAs are imported into the nucleus. With the exception of a few miRNAs evidently enriched in the nuclear pool, such as the mir-29b, the ratio of miRNA abundances in the nuclear fraction versus in the cytoplasmic fraction vary to some extent. Moreover, our results revealed that a large number of tRNA 3'trailers are exported from the nucleus and accumulate in the cytoplasm. These tRNA 3' trailers accumulate in a variety of cell types, implying that the biogenesis of tRNA 3' trailers is conserved and that they have a potential functional role in vertebrate cells. Conclusion/Significance: Our results provide the first comprehensive view of the subcellular distribution of diverse sRNAs and new insights into the roles of miRNAs and tRNA 39 trailers in the cell.	[Liao, Jian-You; Ma, Li-Ming; Guo, Yan-Hua; Zhang, Yu-Chan; Zhou, Hui; Shao, Peng; Chen, Yue-Qin; Qu, Liang-Hu] Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Liao, JY (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	lssqlh@mail.sysu.edu.cn	Shao, Peng/AAN-4606-2020; Shao, Peng/M-5172-2019; Shao, Peng/A-6122-2019	Shao, Peng/0000-0002-8453-6480; Zhou, Hui/0000-0001-9157-3792; Ma, Liming/0000-0001-9319-5828; Qu, Liang-Hu/0000-0003-3657-2863	National Natural Science Foundation of China [30830066, 30771151, 30870530]; National High-Tech Program [2008AA02Z106]; Sun Yat-sen University [2009-33000-3161051]; Ministry of Science and Technology of China [2005CB724600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Program; Sun Yat-sen University; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by the National Natural Science Foundation of China (No. 30830066, 30771151 and 30870530), funds from National High-Tech Program (No. 2008AA02Z106), the Young Teacher Training Program of Sun Yat-sen University (2009-33000-3161051) and the National Basic Research Program (No. 2005CB724600) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayfield MA, 2007, MOL CELL BIOL, V27, P3303, DOI 10.1128/MCB.00026-07; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2009, P NATL ACAD SCI USA, V106, P11546, DOI 10.1073/pnas.0905222106; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Greenberg Michael E, 2007, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0410s78; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; HAGENBUCHLE O, 1979, CELL, V18, P1217, DOI 10.1016/0092-8674(79)90234-4; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hopper AK, 2008, TRENDS CELL BIOL, V18, P98, DOI 10.1016/j.tcb.2008.01.001; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; KOSKI RA, 1982, J BIOL CHEM, V257, P4514; Kruszka K, 2003, EMBO J, V22, P621, DOI 10.1093/emboj/cdg040; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li J, 2010, CANCER GENET CYTOGEN, V196, P23, DOI 10.1016/j.cancergencyto.2009.08.004; Li Y, 2008, NUCLEIC ACIDS RES, V36, P6048, DOI 10.1093/nar/gkn596; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Persson H, 2009, NAT CELL BIOL, V11, P1268, DOI 10.1038/ncb1972; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yang JH, 2010, NUCLEIC ACIDS RES, V38, pD123, DOI 10.1093/nar/gkp943; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	62	220	254	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10563	10.1371/journal.pone.0010563	http://dx.doi.org/10.1371/journal.pone.0010563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498841	Green Published, gold, Green Submitted			2022-12-25	WOS:000277771600001
J	Chia, R; Tattum, MH; Jones, S; Collinge, J; Fisher, EMC; Jackson, GS				Chia, Ruth; Tattum, M. Howard; Jones, Samantha; Collinge, John; Fisher, Elizabeth M. C.; Jackson, Graham S.			Superoxide Dismutase 1 and tgSOD1(G93A) Mouse Spinal Cord Seed Fibrils, Suggesting a Propagative Cell Death Mechanism in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; BODY-LIKE INCLUSIONS; TRANSGENIC MICE; FAMILIAL ALS; INTRANUCLEAR INCLUSIONS; DISEASE PROGRESSION; SOD1; MUTATIONS; AGGREGATION; MUTANTS	Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that specifically affects motor neurons and leads to a progressive and ultimately fatal loss of function, resulting in death typically within 3 to 5 years of diagnosis. The disease starts with a focal centre of weakness, such as one limb, and appears to spread to other parts of the body. Mutations in superoxide dismutase 1 (SOD1) are known to cause disease and it is generally accepted they lead to pathology not by loss of enzymatic activity but by gain of some unknown toxic function(s). Although different mutations lead to varying tendencies of SOD1 to aggregate, we suggest abnormal proteins share a common misfolding pathway that leads to the formation of amyloid fibrils. Methodology/Principal Findings: Here we demonstrate that misfolding of superoxide dismutase 1 leads to the formation of amyloid fibrils associated with seeding activity, which can accelerate the formation of new fibrils in an autocatalytic cascade. The time limiting event is nucleation to form a stable protein "seed" before a rapid linear polymerisation results in amyloid fibrils analogous to other protein misfolding disorders. This phenomenon was not confined to fibrils of recombinant protein as here we show, for the first time, that spinal cord homogenates obtained from a transgenic mouse model that overexpresses mutant human superoxide dismutase 1 (the TgSOD1(G93A) mouse) also contain amyloid seeds that accelerate the formation of new fibrils in both wildtype and mutant SOD1 protein in vitro. Conclusions/Significance: These findings provide new insights into ALS disease mechanism and in particular a mechanism that could account for the spread of pathology throughout the nervous system. This model of disease spread, which has analogies to other protein misfolding disorders such as prion disease, also suggests it may be possible to design assays for therapeutics that can inhibit fibril propagation and hence, possibly, disease progression.	[Chia, Ruth; Collinge, John; Fisher, Elizabeth M. C.] Univ Coll London Inst Neurol, Dept Neurodegenerat Dis, London, England; [Tattum, M. Howard; Jones, Samantha; Collinge, John; Jackson, Graham S.] Univ Coll London Inst Neurol, MRC Prion Unit, London, England	University of London; University College London; University of London; University College London	Chia, R (corresponding author), Univ Coll London Inst Neurol, Dept Neurodegenerat Dis, London, England.	e.fisher@prion.ucl.ac.uk	Chia, Ruth/AAF-4900-2021; Fisher, Elizabeth MC/C-2168-2008	Chia, Ruth/0000-0002-4709-7423; Fisher, Elizabeth MC/0000-0003-2850-9936; Jackson, Graham/0000-0002-3125-2011	Brain Research Trust; UK Medical Research Council; MRC [MC_U123170362, G0500288, MC_U123192748] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_U123170362, G0500288] Funding Source: researchfish	Brain Research Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Brain Research Trust and the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Andersen PM, 2004, ANN NEUROL, V55, P298, DOI 10.1002/ana.10850; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bowen S, 2007, EUR J NEUROSCI, V25, P2947, DOI 10.1111/j.1460-9568.2007.05554.x; Brown RH, 1998, NAT MED, V4, P1362, DOI 10.1038/3945; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2000, NAT MED, V6, P1320, DOI 10.1038/82122; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Ince PG, 1998, NEUROPATH APPL NEURO, V24, P104, DOI 10.1046/j.1365-2990.1998.00108.x; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; Mallucci G, 2005, NAT REV NEUROSCI, V6, P23, DOI 10.1038/nrn1584; Matsumoto S, 1996, CLIN NEUROPATHOL, V15, P41; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; NILSSON KM, 2007, AM SOC NEUR M; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Ravits J, 2007, NEUROLOGY, V68, P1576, DOI 10.1212/01.wnl.0000261045.57095.56; Ravits J, 2007, NEUROLOGY, V68, P1571, DOI 10.1212/01.wnl.0000260965.20021.47; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Santillo M, 2007, J NEUROCHEM, V102, P679, DOI 10.1111/j.1471-4159.2007.04538.x; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	60	101	104	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10627	10.1371/journal.pone.0010627	http://dx.doi.org/10.1371/journal.pone.0010627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498711	Green Submitted, Green Published, gold			2022-12-25	WOS:000277633500015
J	Kadekaro, AL; Leachman, S; Kavanagh, RJ; Swope, V; Cassidy, P; Supp, D; Sartor, M; Schwemberger, S; Babcock, G; Wakamatsu, K; Ito, S; Koshoffer, A; Boissy, RE; Manga, P; Sturm, RA; Abdel-Malek, ZA				Kadekaro, Ana Luisa; Leachman, Sancy; Kavanagh, Renny J.; Swope, Viki; Cassidy, Pamela; Supp, Dorothy; Sartor, Maureen; Schwemberger, Sandy; Babcock, George; Wakamatsu, Kazumasa; Ito, Shosuke; Koshoffer, Amy; Boissy, Raymond E.; Manga, Prashiela; Sturm, Richard A.; Abdel-Malek, Zalfa A.			Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation	FASEB JOURNAL			English	Article						DNA repair; melanoma susceptibility; MC1R variants; cAMP pathway	CUTANEOUS MALIGNANT-MELANOMA; DNA-DAMAGE; STIMULATING HORMONE; RECEPTOR VARIANTS; CDKN2A MUTATIONS; HUMAN EPIDERMIS; RISK; MC1R; PIGMENTATION; FAMILIES	The melanocortin 1 receptor gene is a main determinant of human pigmentation, and a melanoma susceptibility gene, because its variants that are strongly associated with red hair color increase melanoma risk. To test experimentally the association between melanocortin 1 receptor genotype and melanoma susceptibility, we compared the responses of primary human melanocyte cultures naturally expressing different melanocortin 1 receptor variants to alpha-melanocortin and ultraviolet radiation. We found that expression of 2 red hair variants abolished the response to alpha-melanocortin and its photoprotective effects, evidenced by lack of functional coupling of the receptor, and absence of reduction in ultraviolet radiation-induced hydrogen peroxide generation or enhancement of repair of DNA photoproducts, respectively. These variants had different heterozygous effects on receptor function. Microarray data confirmed the observed differences in responses of melanocytes with functional vs. nonfunctional receptor to alpha-melanocortin and ultraviolet radiation, and identified DNA repair and antioxidant genes that are modulated by alpha-melanocortin. Our findings highlight the molecular mechanisms by which the melanocortin 1 receptor genotype controls genomic stability of and the mutagenic effect of ultraviolet radiation on human melanocytes.-Kadekaro, A. L., Leachman, S., Kavanagh, R. J., Swope, V., Cassidy, P., Supp, D., Sartor, M., Schwemberger, S., Babcock, G., Wakamatsu, K., Ito, S., Koshoffer, A., Boissy, R. E., Manga, P., Sturm, R. A., Abdel-Malek, Z. A. Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation. FASEB J. 24, 3850-3860 (2010). www.fasebj.org	[Abdel-Malek, Zalfa A.] Univ Cincinnati, Dept Dermatol, Coll Med, Cincinnati, OH 45267 USA; [Supp, Dorothy; Schwemberger, Sandy; Babcock, George] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Sartor, Maureen] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Leachman, Sancy; Cassidy, Pamela] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Leachman, Sancy; Cassidy, Pamela] Univ Utah, Huntsman Canc Ctr, Salt Lake City, UT USA; [Supp, Dorothy; Babcock, George] Shriners Burns Hosp, Cincinnati, OH USA; [Wakamatsu, Kazumasa; Ito, Shosuke] Fujita Hlth Univ, Dept Chem, Sch Hlth Sci, Toyoake, Aichi, Japan; [Manga, Prashiela] NYU, Ronald O Perelman Dept Dermatol, New York, NY USA; [Sturm, Richard A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Fujita Health University; New York University; University of Queensland	Abdel-Malek, ZA (corresponding author), Univ Cincinnati, Dept Dermatol, Coll Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	abdelmza@ucmail.uc.edu	Wakamatsu, Kazumasa/AAZ-5877-2020; Koshoffer, Amy E/N-2278-2014; Sartor, Maureen/L-2902-2019; Supp, Dorothy/ABQ-7999-2022; Sturm, Richard A/C-9943-2009	Wakamatsu, Kazumasa/0000-0003-1748-9001; Koshoffer, Amy E/0000-0001-8130-103X; Supp, Dorothy/0000-0002-2429-6630; Sturm, Richard A/0000-0003-1301-0294; Ito, Shosuke/0000-0001-9182-5144	U.S. National Institutes of Health [R01ES009110, R011ES017561, P30 ES06096]; University of Cincinnati Cancer Center; Procter and Gamble Co. (Cincinnati, OH, USA); Japan Society for the Promotion of Sciences [20591357]; Dermatology Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009110, P30ES006096, R01ES017561] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Cancer Center; Procter and Gamble Co. (Cincinnati, OH, USA); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dermatology Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Silva Terzieva for technical assistance, Toshio Mori (Nara Medical University, Kashihara, Japan) for donating TDM-2 antibody, Jose Carlos Garcia Borron (University of Murcia, Murcia, Spain) for his gift of the pMC1R-WT plasmid, and David Fisher (Harvard University, Cambridge, MA, USA) for providing the Mitf antibody. This work was supported in part by U.S. National Institutes of Health grants R01ES009110 (Z.A.M.), R011ES017561 (Z.A.M. and S.L.), and P30 ES06096 (Z.A.M. and D.S.); the University of Cincinnati Cancer Center Pilot Project (Z.A.M.); Procter and Gamble Co. (Cincinnati, OH, USA) (Z.A.M.), a Dermatology Foundation research grant (S.L.); Ohio Cancer Research Associates (A.L.K.); and the Japan Society for the Promotion of Sciences, KAKENHI grant 20591357 (K.W. and S.I.).	ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; ABDELMALEK Z, 1993, J CELL SCI, V106, P1323; April CS, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030009; Bohm M, 2005, J BIOL CHEM, V280, P5795, DOI 10.1074/jbc.M406334200; Borchers MT, 2008, TOXICOL SCI, V105, P188, DOI 10.1093/toxsci/kfn106; Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; de Vries E, 2004, EUR J CANCER, V40, P2355, DOI 10.1016/j.ejca.2004.06.003; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Geller AC, 2002, JAMA-J AM MED ASSOC, V288, P1719, DOI 10.1001/jama.288.14.1719; Goldstein AM, 2005, CANCER EPIDEM BIOMAR, V14, P2208, DOI 10.1158/1055-9965.EPI-05-0321; Healy E, 2001, HUM MOL GENET, V10, P2397, DOI 10.1093/hmg/10.21.2397; Hennessy A, 2005, PIGM CELL RES, V18, P220, DOI 10.1111/j.1600-0749.2005.00233.x; HUNT G, 1995, PIGM CELL RES, V8, P202, DOI 10.1111/j.1600-0749.1995.tb00664.x; HUNT G, 1994, J CELL SCI, V107, P205; Im SB, 1998, CANCER RES, V58, P47; Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535; Kaldis P, 2005, CELL CYCLE, V4, P1491, DOI 10.4161/cc.4.11.2124; Kanetsky PA, 2006, CANCER RES, V66, P9330, DOI 10.1158/0008-5472.CAN-06-1634; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; KONDA Y, 1994, J BIOL CHEM, V269, P13162; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Linos E, 2009, J INVEST DERMATOL, V129, pS59; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Park HY, 1996, EXP CELL RES, V227, P70, DOI 10.1006/excr.1996.0251; Prosperi E, 2006, FASEB J, V20, P833, DOI 10.1096/fj.05-5469hyp; Purdue MP, 2008, J INVEST DERMATOL, V128, P2905, DOI 10.1038/jid.2008.159; Sarkar-Agrawal P, 2004, JNCI-J NATL CANCER I, V96, P1790, DOI 10.1093/jnci/djh307; Scott MC, 2002, J CELL SCI, V115, P2349; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; Smith R, 1998, J INVEST DERMATOL, V111, P119, DOI 10.1046/j.1523-1747.1998.00252.x; Song XZ, 2009, PIGM CELL MELANOMA R, V22, P809, DOI 10.1111/j.1755-148X.2009.00615.x; Stang A, 2006, INT J CANCER, V119, P380, DOI 10.1002/ijc.21836; Suzuki I, 1996, ENDOCRINOLOGY, V137, P1627, DOI 10.1210/en.137.5.1627; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; van der Velden PA, 2001, AM J HUM GENET, V69, P774, DOI 10.1086/323411; Wakamatsu K, 1997, PIGM CELL RES, V10, P288, DOI 10.1111/j.1600-0749.1997.tb00688.x; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Wei QY, 2003, J NATL CANCER I, V95, P308, DOI 10.1093/jnci/95.4.308; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamamura K, 1996, CANCER RES, V56, P3546	47	100	102	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2010	24	10					3850	3860		10.1096/fj.10-158485	http://dx.doi.org/10.1096/fj.10-158485			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20519635	Green Published			2022-12-25	WOS:000285005900023
J	Saam, J; Rosini, E; Molla, G; Schulten, K; Pollegioni, L; Ghisla, S				Saam, Jan; Rosini, Elena; Molla, Gianluca; Schulten, Klaus; Pollegioni, Loredano; Ghisla, Sandro			O-2 Reactivity of Flavoproteins DYNAMIC ACCESS OF DIOXYGEN TO THE ACTIVE SITE AND ROLE OF A H+ RELAY SYSTEM IN D-AMINO ACID OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; GLUCOSE-OXIDASE; TRIGONOPSIS-VARIABILIS; SOYBEAN LIPOXYGENASE-1; RHODOTORULA-GRACILIS; CHOLESTEROL OXIDASE; OXYGEN ACTIVATION; C-OXIDASE; PATHWAYS; MECHANISM	Molecular dynamics simulations and implicit ligand sampling methods have identified trajectories and sites of high affinity for O-2 in the protein framework of the flavoprotein D-amino-acid oxidase (DAAO). A specific dynamic channel for the diffusion of O-2 leads from solvent to the flavin Si-side ( amino acid substrate and product bind on the Re-side). Based on this, amino acids that flank the putative O-2 high affinity sites have been exchanged with bulky residues to introduce steric constraints. In G52V DAAO, the valine side chain occupies the site that in wild-type DAAO has the highest O-2 affinity. In this variant, the reactivity of the reduced enzyme with O-2 is decreased >= 100-fold and the turnover number approximate to 1000-fold thus verifying the concept. In addition, the simulations have identified a chain of three water molecules that might serve in relaying a H+ from the product imino acid +NH2+ group bound on the flavin Reside to the developing peroxide on the Si-side. This function would be comparable with that of a similarly located histidine in the flavoprotein glucose oxidase.	[Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano; Ghisla, Sandro] Univ Studi Insubria, Dipartimento Biotecnol & Sci Mol, I-21100 Varese, Italy; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano] Politecn Milan, Ctr Ric Interuniv Biotecnol Proteiche Prot Factor, I-21100 Varese, Italy	University of Insubria; University of Illinois System; University of Illinois Urbana-Champaign; Polytechnic University of Milan	Ghisla, S (corresponding author), Univ Studi Insubria, Dipartimento Biotecnol & Sci Mol, Via JH Dunant 3, I-21100 Varese, Italy.	sandro.ghisla@uni-konstanz.de	Rosini, Elena/H-3474-2012; Schulten, Klaus/D-5561-2009	Rosini, Elena/0000-0001-8384-7992; POLLEGIONI, LOREDANO/0000-0003-1733-7243; Molla, Gianluca/0000-0003-3688-3397	Fondo di Ateneo per la Ricerca; National Institutes of Health [NIH P41-RR005969]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER	Fondo di Ateneo per la Ricerca; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from Fondo di Ateneo per la Ricerca (to L. P. and G. M.). and by National Institutes of Health Grant NIH P41-RR005969 (to K. S.).	Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; FAVAUDON V, 1977, EUR J BIOCHEM, V78, P293, DOI 10.1111/j.1432-1033.1977.tb11740.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; HALL LH, 1987, INT J QUANTUM CHEM, V31, P217, DOI 10.1002/qua.560310204; Hofacker I, 1998, PROTEINS, V30, P100, DOI 10.1002/(SICI)1097-0134(199801)30:1<100::AID-PROT9>3.0.CO;2-S; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson BJ, 2007, J BIOL CHEM, V282, P17767, DOI 10.1074/jbc.M701308200; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kawazoe T, 2006, PROTEIN SCI, V15, P2708, DOI 10.1110/ps.062421606; KEMAL C, 1977, J AM CHEM SOC, V99, P7272, DOI 10.1021/ja00464a030; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Massey V, 2002, INT CONGR SER, V1233, P3, DOI 10.1016/S0531-5131(02)00519-8; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Pollegioni L, 2000, EUR J BIOCHEM, V267, P6624, DOI 10.1046/j.1432-1327.2000.01757.x; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; POLLEGIONI L, 1993, J BIOL CHEM, V268, P13850; PORTER DJT, 1977, J BIOL CHEM, V252, P4464; Rosini E, 2009, FEBS J, V276, P4921, DOI 10.1111/j.1742-4658.2009.07191.x; Roth JP, 2004, J AM CHEM SOC, V126, P15120, DOI 10.1021/ja047050e; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Tilocca A, 2002, BIOCHEMISTRY-US, V41, P14111, DOI 10.1021/bi020309q; Todone F, 1997, BIOCHEMISTRY-US, V36, P5853, DOI 10.1021/bi9630570; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; Vrielink A, 2009, FEBS J, V276, P6826, DOI 10.1111/j.1742-4658.2009.07377.x; Yorita K, 2000, P NATL ACAD SCI USA, V97, P2480, DOI 10.1073/pnas.040559797; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642	37	49	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24439	24446		10.1074/jbc.M110.131193	http://dx.doi.org/10.1074/jbc.M110.131193			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20498362	Green Published, hybrid			2022-12-25	WOS:000280542100016
J	Zhou, TF; Zhang, YX; Macchiarulo, A; Yang, ZH; Cellanetti, M; Coto, E; Xu, PY; Pellicciari, R; Wang, L				Zhou, Taofeng; Zhang, Yuxia; Macchiarulo, Antonio; Yang, Zhihong; Cellanetti, Marco; Coto, Eliecer; Xu, Pingyi; Pellicciari, Roberto; Wang, Li			Novel Polymorphisms of Nuclear Receptor SHP Associated with Functional and Structural Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL HETERODIMER PARTNER; ESTROGEN-RECEPTOR; ANDROGEN RECEPTOR; LIVER RECEPTOR; BIRTH-WEIGHT; GENE; EXPRESSION; REPRESSION; MIR-127; MIR-433	We identified three heterozygous nonsynonymous single nucleotide polymorphisms in the small heterodimer partner (SHP, NROB2) gene in normal subjects and CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)-like patients, including two novel missense mutations (p.R38H, p.K170N) and one of the previously reported polymorphism (p.G171A). Four novel heterozygous mutations were also identified in the intron ((Intron)1265T -> A), 3'-untranslated region ((3'-UTR)101C -> G, (3'-UTR)186T -> C), and promoter ((Pro)-423C -> T) of the SHP gene. The exonic R38H and K170N mutants exhibited impaired nuclear translocation. K170N made SHP more susceptible to ubiquitination mediated degradation and blocked SHP acetylation, which displayed lost repressive activity on its interacting partners ERR gamma and HNF4 alpha but not LRH-1. In contrast, G171A increased SHP mRNA and protein expression and maintained normal function. In general, the interaction of SHP mutants with LRH-1 and EID1 was enhanced. K170N also markedly impaired the recruitment of SHP, HNF4 alpha, HDAC1, and HDAC3 to the apoCIII promoter. Molecular dynamics simulations of SHP showed that G171A stabilized the nuclear receptor boxes, whereas K170N promoted the conformational destabilization of all the structural elements of the receptor. This study suggests that genetic variations in SHP are common among human subjects and the Lys-170 residue plays a key role in controllingSHPubiquitination and acetylation associated with SHP protein stability and repressive function.	[Wang, Li] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Wang, Li] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Zhou, Taofeng; Xu, Pingyi] Sun Yat Sen Univ Med Sci, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Macchiarulo, Antonio; Cellanetti, Marco; Pellicciari, Roberto] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06123 Perugia, Italy; [Coto, Eliecer] Univ Oviedo, Hosp Cent Asturias, Oviedo 33006, Spain	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Sun Yat Sen University; University of Perugia; Central University Hospital Asturias; University of Oviedo	Wang, L (corresponding author), 30 North,1900 East,SOM 3C310, Salt Lake City, UT 84132 USA.	l.wang@hsc.utah.edu	Macchiarulo, Antonio/L-2846-2017	Macchiarulo, Antonio/0000-0001-9535-4183	University of Utah School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	University of Utah School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the sequencing core facility at the University of Utah School of Medicine for support. We are very grateful to the generous plasmid gifts from Drs. Frances Sladek, Collin Clyne, John Chiang, Chiwai Wong, Eckardt Treuter, Akiyoshi Fukamizu, Uwe Borgmeyer, Timothy Osborne, and Jianyuan Luo. We thank the neurologists from Hospital University Central Asturias for contribution to this work. We thank Dr. Viswanath Gunda for help in reading the manuscript.	Bavner A, 2002, EMBO REP, V3, P478, DOI 10.1093/embo-reports/kvf087; Boulias K, 2004, NUCLEIC ACIDS RES, V32, P6096, DOI 10.1093/nar/gkh947; Cao HN, 2002, J HUM GENET, V47, P445, DOI 10.1007/s100380200062; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Dawson MI, 2008, J MED CHEM, V51, P5650, DOI 10.1021/jm800456k; Echwald SM, 2004, HUM MUTAT, V24, P381, DOI 10.1002/humu.20090; Enya M, 2008, HUM MUTAT, V29, pE271, DOI 10.1002/humu.20865; Fouillade C, 2008, HUM MUTAT, V29, P452, DOI 10.1002/humu.9527; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gobinet J, 2005, BIOCHEMISTRY-US, V44, P6312, DOI 10.1021/bi047308d; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Hung CCC, 2003, DIABETES, V52, P1288, DOI 10.2337/diabetes.52.5.1288; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Lee HK, 1998, J BIOL CHEM, V273, P14398, DOI 10.1074/jbc.273.23.14398; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102; Macchiarulo A, 2006, J MOL GRAPH MODEL, V24, P362, DOI 10.1016/j.jmgm.2005.09.016; Markward Nathan J, 2007, AMIA Annu Symp Proc, P1041; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; Miao J, 2009, MOL CELL BIOL, V29, P6170, DOI 10.1128/MCB.00825-09; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Mitchell SMS, 2003, DIABETES, V52, P1276, DOI 10.2337/diabetes.52.5.1276; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; SCHRODINGER LCC, 2009, MAESTRO; Seol W, 1997, MOL CELL BIOL, V17, P7126, DOI 10.1128/MCB.17.12.7126; Shaw D.E., 2009, DESMOND MOL DYNAMICS; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006880; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09	44	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24871	24881		10.1074/jbc.M110.133280	http://dx.doi.org/10.1074/jbc.M110.133280			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516075	hybrid, Green Published			2022-12-25	WOS:000280542100060
J	Bernal, P; Lemaire, S; Pinho, MG; Mobashery, S; Hinds, J; Taylor, PW				Bernal, Patricia; Lemaire, Sandrine; Pinho, Mariana G.; Mobashery, Shahriar; Hinds, Jason; Taylor, Peter W.			Insertion of Epicatechin Gallate into the Cytoplasmic Membrane of Methicillin-resistant Staphylococcus aureus Disrupts Penicillin-binding Protein (PBP) 2a-mediated beta-Lactam Resistance by Delocalizing PBP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL SYNTHESIS; TEA CATECHINS; EPIGALLOCATECHIN GALLATE; PHOSPHOLIPID-COMPOSITION; LIPID-BILAYERS; GREEN TEA; IN-VITRO; ANTIBIOTICS; DIVISION; SUSCEPTIBILITY	Epicatechin gallate (ECg) sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to oxacillin and other beta-lactam agents; it also reduces the secretion of virulence-associated proteins, prevents biofilm formation, and induces gross morphological changes in MRSA cells without compromising the growth rate. MRSA is resistant to oxacillin because of the presence of penicillin-binding protein 2a (PBP2a), which allows peptidoglycan synthesis to continue after oxacillin-mediated acylation of native PBPs. We show that ECg binds predominantly to the cytoplasmic membrane (CM), initially decreasing the fluidity of the bilayer, and induces changes in gene expression indicative of an attempt to preserve and repair a compromised cell wall. On further incubation, the CM is reorganized; the amount of lysylphosphatidylglycerol is markedly reduced, with a concomitant increase in phosphatidylglycerol, and the proportion of branched chain fatty acids increases, resulting in a more fluid structure. We found no evidence that ECg modulates the enzymatic activity of PBP2a through direct binding to the protein but determined that PBP2 is delocalized from the FtsZ-anchored cell wall biosynthetic machinery at the septal division site following intercalation into the CM. We argue that many features of the ECg-induced phenotype can be explained by changes in the fluid dynamics of the CM.	[Bernal, Patricia; Taylor, Peter W.] Univ London, Sch Pharm, London WC1N 1AX, England; [Lemaire, Sandrine] Catholic Univ Louvain, Unite Pharmacol Cellulaire & Mol, B-1200 Brussels, Belgium; [Pinho, Mariana G.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Bacterial Cell Biol Lab, P-2781901 Oeiras, Portugal; [Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Hinds, Jason] Univ London, Dept Cellular & Mol Med, London SW17 0RE, England	University of London; University College London; University of London School of Pharmacy; Universite Catholique Louvain; Universidade Nova de Lisboa; University of Notre Dame; University of London	Taylor, PW (corresponding author), Univ London, Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	peter.taylor@pharmacy.ac.uk	Pinho, Mariana/B-9192-2008; Bernal, Patricia/K-6399-2014	Pinho, Mariana/0000-0002-7132-8842; Bernal, Patricia/0000-0002-6228-0496; Hinds, Jason/0000-0002-2739-1908	Medical Research Council [G0600004]; Fundacao para a Ciencia e Tecnologia [PTDC/BIA-MIC/67845/2006]; Wellcome Trust; MRC [G0600004] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Research Grant G0600004 from the Medical Research Council.; Supported by Research Grant PTDC/BIA-MIC/67845/2006 from Fundacao para a Ciencia e Tecnologia.; We acknowledge the Bacterial Microarray Group at St. George's for supply of the microarray and the Wellcome Trust for funding the multicollaborative microbial pathogen microarray facility under its Functional Genomics Resources Initiative. We are grateful to Elena Lastochkin for purification of PBP2a and Yukihiko Hara for supply of [<SUP>3</SUP>H] ECg. We thank Anna Przyborowska (King's College London) for undertaking the fatty acid analyses and Kersti Karu (London School of Pharmacy) for MS identification of lysophosphatidylglycerol. We thank Jeff Errington (University of Newcastle) for the FtsZ antibody.	AMES GF, 1968, J BACTERIOL, V95, P833, DOI 10.1128/JB.95.3.833-843.1968; Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1135, DOI 10.1111/j.1462-2920.2006.01236.x; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Blanco AR, 2005, ANTIMICROB AGENTS CH, V49, P4339, DOI 10.1128/AAC.49.10.4339-4343.2005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Caturla N, 2003, FREE RADICAL BIO MED, V34, P648, DOI 10.1016/S0891-5849(02)01366-7; Chung M, 2008, ANTIMICROB AGENTS CH, V52, P2709, DOI 10.1128/AAC.00266-08; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Doyle M, 2009, J ANTIMICROB CHEMOTH, V64, P949, DOI 10.1093/jac/dkp325; Eliopoulos GM, 2009, J INFECTION, V59, pS17, DOI 10.1016/S0163-4453(09)60004-9; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; HAEST CWM, 1972, BIOCHIM BIOPHYS ACTA, V255, P720, DOI 10.1016/0005-2736(72)90385-9; Hamilton-Miller JMT, 1999, FEMS MICROBIOL LETT, V176, P463, DOI 10.1111/j.1574-6968.1999.tb13698.x; Hashimoto T, 1999, BIOSCI BIOTECH BIOCH, V63, P2252, DOI 10.1271/bbb.63.2252; Kajiya K, 2002, BIOSCI BIOTECH BIOCH, V66, P2330, DOI 10.1271/bbb.66.2330; Kajiya K, 2001, BIOSCI BIOTECH BIOCH, V65, P2638, DOI 10.1271/bbb.65.2638; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kumamoto M, 2001, BIOSCI BIOTECH BIOCH, V65, P126, DOI 10.1271/bbb.65.126; Kumazawa S, 2004, BIOSCI BIOTECH BIOCH, V68, P1743, DOI 10.1271/bbb.68.1743; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Lemaire S, 2008, J BIOL CHEM, V283, P12769, DOI 10.1074/jbc.M800079200; Lennarz W J, 1966, Adv Lipid Res, V4, P175; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Pereira PM, 2007, ANTIMICROB AGENTS CH, V51, P3627, DOI 10.1128/AAC.00431-07; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pinho MG, 1997, MICROB DRUG RESIST, V3, P409, DOI 10.1089/mdr.1997.3.409; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Shah S, 2008, LETT APPL MICROBIOL, V46, P181, DOI 10.1111/j.1472-765X.2007.02296.x; Shakil S, 2008, J CHEMOTHERAPY, V20, P411, DOI 10.1179/joc.2008.20.4.411; SHORT SA, 1971, J BACTERIOL, V108, P219, DOI 10.1128/JB.108.1.219-226.1971; Sorlozano A, 2010, EUR J CLIN MICROBIOL, V29, P73, DOI 10.1007/s10096-009-0823-4; Stapleton PD, 2007, MICROBIOL-SGM, V153, P2093, DOI 10.1099/mic.0.2007/007807-0; Stapleton PD, 2006, INT J FOOD MICROBIOL, V111, P276, DOI 10.1016/j.ijfoodmicro.2006.06.005; Stapleton PD, 2006, ANTIMICROB AGENTS CH, V50, P752, DOI 10.1128/AAC.50.2.752-755.2006; Stapleton PD, 2004, INT J ANTIMICROB AG, V23, P462, DOI 10.1016/j.ijantimicag.2003.09.027; SUTTON GC, 1990, BIOCHEM SOC T, V18, P950, DOI 10.1042/bst0180950; Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184; Taylor PW, 2009, PHARM RES SAF TEST, P43; Trevors JT, 2003, J BIOCHEM BIOPH METH, V57, P87, DOI 10.1016/S0165-022X(03)00076-9; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Velayutham P, 2008, CURR MED CHEM, V15, P1840; Wilkinson Brian J., 2005, Current Medicinal Chemistry - Anti-Infective Agents, V4, P259, DOI 10.2174/1568012054368119; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x	59	51	56	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24055	24065		10.1074/jbc.M110.114793	http://dx.doi.org/10.1074/jbc.M110.114793			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516078	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000280291400056
J	Pradipta, AR; Fujimoto, Y; Hasegawa, M; Inohara, N; Fukase, K				Pradipta, Ambara R.; Fujimoto, Yukari; Hasegawa, Mizuho; Inohara, Naohiro; Fukase, Koichi			Characterization of Natural Human Nucleotide-binding Oligomerization Domain Protein 1 (Nod1) Ligands from Bacterial Culture Supernatant for Elucidation of Immune Modulators in the Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PEPTIDOGLYCAN FRAGMENTS; HOST RECOGNITION; ASSOCIATION; WALL; POLYMORPHISMS; MOLECULES; SUSCEPTIBILITY; RECEPTORS	Nucleotide-binding oligomerization domain protein 1 (Nod1) is an intracellular protein involved in recognition of the bacterial component peptidoglycan. This recognition event induces a host defense response to eliminate invading pathogens. The genetic variation of Nod1 has been linked to several inflammatory diseases and allergies, which are strongly affected by environmental factors. We have found that many of the bacteria that contain DAP-type peptidoglycan release Nod1 ligands into the environment. However, the structures of natural Nod1 ligands in the environment are not well understood. Herein, we report the isolation and structural elucidation of natural human Nod1 (hNod1) ligands from the Escherichia coli K-12 culture supernatant. The supernatant was fractionated with reversed-phase high performance liquid chromatography (RP-HPLC), resulting in the isolation of several hNod1 stimulatory fractions. Structural characterization studies demonstrated that the molecular structure of the most active fraction was the native hNod1 ligand GlcNAc-(beta 1-4)-(anhydro)MurNAc-L-Ala-gamma-D-Glu-meso-DAP. We also found other peptidoglycan fragments using the 7-(diethylamino)coumarin-3-carbonyl labeling method to enhance sensitivity in mass spectroscopy studies. These results suggested that DAP-containing bacteria release certain hNod1 ligands to the environment, and these ligands would accumulate in the environment and regulate the immune system through Nod1.	[Pradipta, Ambara R.; Fujimoto, Yukari; Fukase, Koichi] Osaka Univ, Dept Chem, Grad Sch Sci, Osaka 5600043, Japan; [Hasegawa, Mizuho; Inohara, Naohiro] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA	Osaka University; University of Michigan System; University of Michigan	Fujimoto, Y (corresponding author), Machikaneyama 1-1, Osaka 5600043, Japan.	yukarif@chem.sci.osaka-u.ac.jp; koichi@chem.sci.osaka-u.ac.jp	Pradipta, Ambara Rachmat/E-8344-2016; Fujimoto, Yukari/M-7282-2014	Pradipta, Ambara Rachmat/0000-0002-9056-447X; Fujimoto, Yukari/0000-0001-5320-3192	Japan Society for the Promotion of Science [17510178, 19310144]; Institute for Fermentation, Osaka (IFO); Osaka University; Naito Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018503] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Fermentation, Osaka (IFO)(Institute for Fermentation (IFO)); Osaka University; Naito Foundation(Naito Memorial Foundation); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grants-in-aid for scientific research (17510178 and 19310144) from the Japan Society for the Promotion of Science, the Institute for Fermentation, Osaka (IFO), the Osaka University Global Center of Excellence program (Frontier Biomedical Science Underlying Organelle Network Biology), and the Naito Foundation.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; de Pedro MA, 2001, J BACTERIOL, V183, P4115, DOI 10.1128/JB.183.14.4115-4126.2001; Eder W, 2006, ALLERGY, V61, P1117, DOI 10.1111/j.1398-9995.2006.01128.x; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GOLDMAN WE, 1982, INFECT IMMUN, V36, P782, DOI 10.1128/IAI.36.2.782-794.1982; Hasegawa M, 2007, J BIOL CHEM, V282, P11757, DOI 10.1074/jbc.M700846200; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; Kawasaki A, 2008, CHEM-EUR J, V14, P10318, DOI 10.1002/chem.200801121; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meesters RJW, 2008, J CHROMATOGR B, V875, P444, DOI 10.1016/j.jchromb.2008.09.024; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Scheurwater EM, 2008, J BIOL CHEM, V283, P8363, DOI 10.1074/jbc.M710135200; Suvorov M, 2008, J AM CHEM SOC, V130, P11878, DOI 10.1021/ja805482b; TAYLOR A, 1975, EUR J BIOCHEM, V53, P47, DOI 10.1111/j.1432-1033.1975.tb04040.x; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Weidinger S, 2005, CLIN EXP ALLERGY, V35, P866, DOI 10.1111/j.1365-2222.2005.02269.x; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yoneyama M, 2008, ADV DRUG DELIVER REV, V60, P841, DOI 10.1016/j.addr.2007.12.001; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	40	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23607	23613		10.1074/jbc.M110.137893	http://dx.doi.org/10.1074/jbc.M110.137893			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519512	Green Published, hybrid			2022-12-25	WOS:000280291400010
J	Yang, JH; Shelat, NY; Bush, CA; Cisar, JO				Yang, Jinghua; Shelat, Nirav Y.; Bush, C. Allen; Cisar, John O.			Structure and Molecular Characterization of Streptococcus pneumoniae Capsular Polysaccharide 10F by Carbohydrate Engineering in Streptococcus oralis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGGREGATION RECEPTOR POLYSACCHARIDES; CELL-SURFACE POLYSACCHARIDE; ACTINOMYCES-NAESLUNDII; WALL POLYSACCHARIDES; BIOSYNTHETIC LOCI; C-POLYSACCHARIDE; NMR; IDENTIFICATION; RECOGNITION; ASSIGNMENT	Although closely related at the molecular level, the capsular polysaccharide (CPS) of serotype 10F Streptococcus pneumoniae and coaggregation receptor polysaccharide (RPS) of Streptococcus oralis C104 have distinct ecological roles. CPS prevents phagocytosis of pathogenic S. pneumoniae, whereas RPS of commensal S. oralis functions as a receptor for lectin-like adhesins on other members of the dental plaque biofilm community. Results from high resolution NMR identified the recognition region of S. oralis RPS (i.e. Galf beta 1-6GalNAc beta 1-3Gal alpha) in the hexasaccharide repeat of S. pneumoniae CPS10F. The failure of this polysaccharide to support fimbriae-mediated adhesion of Actinomyces naeslundii was explained by the position of Galf, which occurred as a branch in CPS10F rather than within the linear polysaccharide chain, as in RPS. Carbohydrate engineering of S. oralis RPS with wzy from S. pneumoniae attributed formation of the Galf branch in CPS10F to the linkage of adjacent repeating units through sub terminal GalNAc in Galf beta 1-6GalNAc beta 1-3Gal alpha rather than through terminal Galf, as in RPS. A gene (wcrD) from serotype 10A S. pneumoniae was then used to engineer a linear surface polysaccharide in S. oralis that was identical to RPS except for the presence of a beta 1-3 linkage between Galf and GalNAc beta 1-3Gal alpha. This polysaccharide also failed to support adhesion of A. naeslundii, thereby establishing the essential role of beta 1-6-linked Galf in recognition of adjacent GalNAc beta 1-3Gal alpha in wild-type RPS. These findings, which illustrate a molecular approach for relating bacterial polysaccharide structure to function, provide insight into the possible evolution of S. oralis RPS from S. pneumoniae CPS.	[Yang, Jinghua; Cisar, John O.] NIDCR, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Shelat, Nirav Y.; Bush, C. Allen] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland Baltimore	Cisar, JO (corresponding author), NIDCR, Oral Infect & Immun Branch, NIH, Bldg 30,Rm 3A-301,30 Convent Dr, Bethesda, MD 20892 USA.	john.cisar@nih.gov		Yang, Jinghua/0000-0001-7140-5548	NIDCR, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000672] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDCR, National Institutes of Health.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; ABEYGUNAWARDANA C, 1991, BIOCHEMISTRY-US, V30, P8568, DOI 10.1021/bi00099a012; ABEYGUNAWARDANA C, 1991, BIOCHEMISTRY-US, V30, P6528, DOI 10.1021/bi00240a025; Abeygunawardana C, 1993, ADV BIOPHYSICAL CHEM, V3, P199; BEIER RC, 1980, CAN J CHEM, V58, P2800, DOI 10.1139/v80-448; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; CISAR JO, 1984, INFECT IMMUN, V46, P453, DOI 10.1128/IAI.46.2.453-458.1984; Cisar JO, 1997, INFECT IMMUN, V65, P5035, DOI 10.1128/IAI.65.12.5035-5041.1997; CISAR JO, 1995, GLYCOBIOLOGY, V5, P655, DOI 10.1093/glycob/5.7.655; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Coffey TJ, 1999, MICROBIOL-SGM, V145, P2023, DOI 10.1099/13500872-145-8-2023; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; DUBOIS M, 1956, ANAL CHEM, V28, P356; JONES C, 1995, CARBOHYD RES, V269, P175, DOI 10.1016/0008-6215(94)00340-L; Kabat E., 1961, EXPT IMMUNOCHEMISTRY; Kamerling J. P., 2000, STREPTOCOCCUS PNEUMO; Karlsson C, 1999, EUR J BIOCHEM, V265, P1091, DOI 10.1046/j.1432-1327.1999.00835.x; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; MCINTIRE FC, 1988, J BACTERIOL, V170, P2229, DOI 10.1128/jb.170.5.2229-2235.1988; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Walz A, 2005, GLYCOBIOLOGY, V15, P700, DOI 10.1093/glycob/cwi049; Xu DQ, 2003, J BACTERIOL, V185, P5419, DOI 10.1128/JB.185.18.5419-5430.2003; Xu QW, 1996, BIOCHEMISTRY-US, V35, P14521, DOI 10.1021/bi961262+; Xu QW, 2005, ANAL BIOCHEM, V336, P262, DOI 10.1016/j.ab.2004.10.019; Yang JH, 2009, J BACTERIOL, V191, P1891, DOI 10.1128/JB.01532-08; Yoshida Y, 2005, MOL MICROBIOL, V58, P244, DOI 10.1111/j.1365-2958.2005.04820.x	31	12	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24217	24227		10.1074/jbc.M110.123562	http://dx.doi.org/10.1074/jbc.M110.123562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507989	Green Published, hybrid			2022-12-25	WOS:000280291400071
J	Zhai, BB; Yang, HQ; Mancini, A; He, QW; Antoniou, J; Di Battista, JA				Zhai, Beibei; Yang, Huiqing; Mancini, Arturo; He, QingWen; Antoniou, John; Di Battista, John A.			Leukotriene B-4 BLT Receptor Signaling Regulates the Level and Stability of Cyclooxygenase-2 (COX-2) mRNA through Restricted Activation of Ras/Raf/ERK/p42 AUF1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL GENE-REGULATION; HUMAN SYNOVIAL FIBROBLASTS; NECROSIS-FACTOR-ALPHA; BINDING-PROTEINS; 3'-UNTRANSLATED REGION; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGET; NUCLEAR EXPORT; KINASE PATHWAY; MAST-CELLS	Recent studies suggest that active resolution of the inflammatory response in animal models of arthritis may involve leukotriene B-4 (LTB4)-dependent stimulation of "intermediate" prostaglandin production, which in turn favors the synthesis of "downstream" anti-inflammatory and pro-resolving lipoxins, resolvins, and protectins. We explored a putative mechanism involving LTB4-dependent control of cyclooxygenase-2 (COX-2) expression, the rate-limiting step in inflammatory prostaglandin biosynthesis. Indeed, LTB4 potently up-regulated/stabilized interleukin-1 beta-induced COX-2 mRNA and protein expression under conditions of COX-2 inhibitor-dependent blockade of PGE(2) release in human synovial fibroblasts (EC50 = 16.5 +/- 1.7 nM for mRNA; 19 +/- 2.4 nM for protein, n = 4). The latter response was pertussis toxin-sensitive, and semi-quantitative reverse transcription-PCR confirmed the quantitative predominance of the BLT2 receptor. Transfection experiments, using human COX-2 promoter plasmids and chimeric luciferase-COX-2 mRNA 3'-untranslated region (3'-UTR) reporter constructs, revealed that LTB4 exerted its stabilizing effect at the post-transcriptional level through a 116-bp adenylate/uridylate-rich sequence in the proximal region of the COX-2 3'-UTR. Using luciferase-COX-2 mRNA 3'-UTR reporter constructs and Ras/c-Raf expression and mutant constructs, we showed that the Ras/c-Raf/MEK1/2/ERK1/2 signaling pathway mediated LTB4-dependent COX-2 mRNA stabilization. Knockdown experiments with specific short hairpin RNAs confirmed that LTB4 stabilization of COX-2 mRNA was apparently mediated through the RNA-binding protein, p42 AUF1. The nuclear export of p42 AUF1 was driven by c-Raf/MEK1/2/ERK1/2 signaling and sensitive to leptomycin B treatment, suggesting a CRM1-dependent mechanism. We conclude that LTB4 may support the resolution phase of the inflammatory response by stabilizing COX-2, ensuring a reservoir of ambient pro-resolution lipid mediators.	[Yang, Huiqing; He, QingWen; Di Battista, John A.] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Zhai, Beibei] McGill Univ, Dept Expt Med, Montreal, PQ H3A 1A1, Canada; [Mancini, Arturo] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A1, Canada; [Antoniou, John] Jewish Gen Hosp, Dept Orthopaed Surg, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University; McGill University	Di Battista, JA (corresponding author), McGill Univ, Ctr Hlth, Div Rheumatol & Clin Immunol, Royal Victoria Hosp, 687 Pine Ave,W,Rm M-11-22, Montreal, PQ H3A 1A1, Canada.	john.dibattista@mcgill.ca			Canadian Institutes for Health Research [M11557]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes for Health Research Grant M11557 (to J.A.D.B.).	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Burg ND, 2001, CLIN IMMUNOL, V99, P7, DOI 10.1006/clim.2001.5007; Campbell EL, 2007, FASEB J, V21, P3162, DOI 10.1096/fj.07-8473com; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CYA, 2004, RNA, V10, P669, DOI 10.1261/rna.5269304; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Faour WH, 2005, J BIOL CHEM, V280, P9536, DOI 10.1074/jbc.M414067200; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Faour WH, 2006, J BIOL CHEM, V281, P19849, DOI 10.1074/jbc.M601293200; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hashimoto A, 2003, J RHEUMATOL, V30, P1712; He W, 2002, J RHEUMATOL, V29, P546; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MANCINI A, 2008, OSTEOARTHRITIS CA S4, V16, pS16; Mancini A, 2007, INFLAMM RES, V56, pS374; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Meissner T, 2004, FEBS LETT, V576, P27, DOI 10.1016/j.febslet.2004.08.056; Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sarkar B, 2003, J BIOL CHEM, V278, P20700, DOI 10.1074/jbc.M301176200; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 1996, FASEB J, V10, P1147, DOI 10.1096/fasebj.10.10.8751717; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yuryev A, 2003, GENOMICS, V81, P112, DOI 10.1016/S0888-7543(02)00008-3; ZHAI B, 2008, OSTEOARTHRITIS CA S4, V16, pS189; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	50	23	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23568	23580		10.1074/jbc.M110.107623	http://dx.doi.org/10.1074/jbc.M110.107623			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20489206	hybrid, Green Published			2022-12-25	WOS:000280291400006
J	Ward, JR; West, PW; Ariaans, MP; Parker, LC; Francis, SE; Crossman, DC; Sabroe, I; Wilson, HL				Ward, Jon R.; West, Peter W.; Ariaans, Mark P.; Parker, Lisa C.; Francis, Sheila E.; Crossman, David C.; Sabroe, Ian; Wilson, Heather L.			Temporal Interleukin-1 beta Secretion from Primary Human Peripheral Blood Monocytes by P2X7-independent and P2X7-dependent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(7) RECEPTOR; IL-1-BETA RELEASE; MICROGLIAL CELLS; P2X7 RECEPTORS; MESSENGER-RNA; DYE UPTAKE; ATP; INFLAMMASOME; EXPRESSION; ACTIVATION	The processing and regulated secretion of IL-1 beta are critical points of control of the biological activity of this important pro-inflammatory cytokine. IL-1 beta is produced by both monocytes and macrophages, but the rate and mechanism of release differ according to the differentiation status and the origin of these cells. We aimed to study the control of processing and release in human blood monocytes and human monocyte-derived macrophages. Toll-like receptor (TLR)-induced IL-1 beta production and release were investigated for dependence upon caspase-1, P2X7 receptor activation, and loss of membrane asymmetry associated with microvesicle shedding. TLR agonists induced P2X7 receptor-dependent IL-1 beta release in both monocytes and macrophages; however, only monocytes also showed P2X7 receptor-independent release of mature IL-1 beta. Furthermore, in monocytes ATP-mediated PS exposure could be activated independently of IL-1 beta production. Release of IL-1 beta from monocytes showed selectivity for specific TLR agonists and was accelerated by P2X7 receptor activation. Human monocytes released more IL-1 beta/cell than macrophages. These data have important implications for inflammatory diseases that involve monocyte activation and IL-1 release.	[Ward, Jon R.; Ariaans, Mark P.; Francis, Sheila E.; Crossman, David C.; Wilson, Heather L.] Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Dept Cardiovasc Sci, Sheffield S10 2RX, S Yorkshire, England; [West, Peter W.; Parker, Lisa C.; Sabroe, Ian] Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Dept Infect & Immun, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield; University of Sheffield	Wilson, HL (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Dept Cardiovasc Sci, L Floor,Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	H.L.Wilson@sheffield.ac.uk	Sabroe, Ian/AAE-5858-2019; Sabroe, Ian/I-5981-2013; Wilson, Heather/O-5909-2019	Sabroe, Ian/0000-0001-9750-8975; Wilson, Heather/0000-0002-7892-3425; Ariaans, Markus/0000-0002-7392-8278; Francis, Sheila/0000-0001-6552-0339; West, Peter/0000-0002-0097-5006	British Heart Foundation [FS/06/004, FS/05/081/19423]; Medical Research Council [G116/170]; Research Councils UK; Novartis; National Institute of Health Research; MRC [G116/170] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Councils UK(UK Research & Innovation (UKRI)); Novartis(Novartis); National Institute of Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Grants FS/06/004 (to J. R. W.) and FS/05/081/19423 (to P. W. W.) and funds from the Medical Research Council (to L. C. P.) and Research Councils UK (to H. L. W.).; Supported by Novartis.; Supported by the National Institute of Health Research.; Supported by Medical Research Council Senior Clinical Fellowship G116/170.	Broom DC, 2008, J PHARMACOL EXP THER, V327, P620, DOI 10.1124/jpet.108.141853; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Chamberlain J, 2006, AM J PATHOL, V168, P1396, DOI 10.2353/ajpath.2006.051054; CHIN J, 1993, J IMMUNOL, V151, P5574; Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; HERZYK DJ, 1992, J IMMUNOL, V149, P3052; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hurst J, 2009, IMMUNOBIOLOGY, V214, P683, DOI 10.1016/j.imbio.2008.12.003; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kleinnijenhuis J, 2009, EUR J IMMUNOL, V39, P1914, DOI 10.1002/eji.200839115; Knofler R, 1997, AM J HEMATOL, V56, P259, DOI 10.1002/(SICI)1096-8652(199712)56:4<259::AID-AJH11>3.0.CO;2-4; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Laupeze B, 1999, HUM IMMUNOL, V60, P591, DOI 10.1016/S0198-8859(99)00025-7; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Moore SF, 2007, CELL SIGNAL, V19, P855, DOI 10.1016/j.cellsig.2006.10.010; Morris GE, 2005, AM J RESP CRIT CARE, V171, P814, DOI 10.1164/rccm.200403-406OC; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC766, DOI 10.1152/ajpcell.1999.277.4.C766; Simpson RJ, 2009, BRAIN BEHAV IMMUN, V23, P232, DOI 10.1016/j.bbi.2008.09.013; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Stockfleth E, 2003, BRIT J DERMATOL, V149, P53, DOI 10.1046/j.0366-077X.2003.05626.x; Tassi S, 2009, J IMMUNOL, V183, P1456, DOI 10.4049/jimmunol.0900578; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; West PW, 2008, IMMUNOLOGY, V125, P101, DOI 10.1111/j.1365-2567.2008.02825.x; Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202; ZOCCHI MR, 2001, FRONTIERS LIFE, P477	55	49	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23145	23156		10.1074/jbc.M109.072793	http://dx.doi.org/10.1074/jbc.M109.072793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20495003	Green Published, hybrid			2022-12-25	WOS:000279999900049
J	Al-Souhibani, N; Al-Ahmadi, W; Hesketh, JE; Blackshear, PJ; Khabar, KSA				Al-Souhibani, N.; Al-Ahmadi, W.; Hesketh, J. E.; Blackshear, P. J.; Khabar, K. S. A.			The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes	ONCOGENE			English	Article						posttranscriptional control; AU-rich elements; RNA-binding proteins; RNA stability; tristetraprolin	UROKINASE PLASMINOGEN-ACTIVATOR; ENDOTHELIAL GROWTH-FACTOR; POSTTRANSCRIPTIONAL REGULATION; PROGNOSTIC-FACTOR; GENE-EXPRESSION; HUR; RECEPTOR; ELEMENTS; CELL; CYCLOOXYGENASE-2	Tristetraprolin (TTP or ZFP36) is a tandem CCCH zinc-finger RNA-binding protein that regulates the stability of certain AU-rich element (ARE) mRNAs. Recent work suggests that TTP is deficient in cancer cells when compared with normal cell types. In this study we found that TTP expression was lower in invasive breast cancer cells (MDAMB231) compared with normal breast cell lines MCF12A and MCF-10. TTP targets were probed using a novel approach by expressing the C124R zinc-finger TTP mutant that functions as dominant negative and increases target mRNA expression. In contrast to wild-type TTP, C124R TTP was able to increase certain ARE-mRNA expressions in serum-stimulated breast cancer cells. Using an ARE-gene microarray, novel targets of TTP regulation were identified, namely, urokinase plasminogen activator (uPA), uPA receptor and matrix metalloproteinase-1, all known to have prominent roles in breast cancer invasion and metastasis. Expression of these targets was upregulated in tumorigenic types, particularly in highly invasive MDAMB231. The mRNA half-lives of these TTP-regulated genes were increased in TTP-knockout embryonic mouse fibroblasts, as assessed using real-time polymerase chain reaction, whereas forced restoration of TTP by transfection led to a reduction in their mRNA levels. RNA immunoprecipitation confirmed an association of TTP, but not C124R, with these target transcripts. Moreover, TTP reduced, whereas the mutant C124R TTP increased, the activity of reporter constructs fused to target ARE. As a result of TTP regulation, invasiveness of MDAMB231 cells was reduced. The data suggest that TTP, in a 30 untranslated region- and ARE-dependent manner, regulates an important subset of cancer-related genes that are involved in cellular growth, invasion and metastasis. Oncogene ( 2010) 29, 4205-4215; doi: 10.1038/onc.2010.168; published online 24 May 2010	[Al-Souhibani, N.; Al-Ahmadi, W.; Khabar, K. S. A.] King Faisal Specialist Hosp & Res Ctr, Program BioMol Res, Riyadh 11211, Saudi Arabia; [Hesketh, J. E.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Blackshear, P. J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC USA	King Faisal Specialist Hospital & Research Center; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Khabar, KSA (corresponding author), King Faisal Specialist Hosp & Res Ctr, Program BioMol Res, P3354, Riyadh 11211, Saudi Arabia.	khabar@kfshrc.edu.sa	Blackshear, Perry J./C-6206-2019; Khabar, Khalid/AAG-3487-2019	Blackshear, Perry J./0000-0002-9561-8529; Khabar, Khalid/0000-0003-1003-9788	King Khalid Foundation, Riyadh; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	King Khalid Foundation, Riyadh; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is a part of the Newcastle University doctoral thesis requirements of NA-S. NA-S was supported by a PhD scholarship from King Khalid Foundation, Riyadh. We acknowledge Dr Wi S Lai for TTP plasmids and for the knockout MEF line. We also acknowledge Mr Maher Al-Saif for his technical assistance.	Al-Ahmadi W, 2009, ONCOGENE, V28, P1782, DOI 10.1038/onc.2009.16; Al-Ahmadi W, 2009, NUCLEIC ACIDS RES, V37, P3612, DOI 10.1093/nar/gkp223; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Asyali MH, 2004, NUCLEIC ACIDS RES, V32, P2323, DOI 10.1093/nar/gkh544; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Christensen L, 1996, INT J CANCER, V66, P441; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; FINI ME, 1987, BIOCHEMISTRY-US, V26, P6156, DOI 10.1021/bi00393a032; Fisher JL, 2000, BREAST CANCER RES TR, V61, P1, DOI 10.1023/A:1006445129195; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Iwata H, 1996, JPN J CANCER RES, V87, P602, DOI 10.1111/j.1349-7006.1996.tb00266.x; Khabar KSA, 2004, J MOL BIOL, V342, P833, DOI 10.1016/j.jmb.2004.07.065; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, pS42, DOI 10.1007/s002800051097; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; LIOTTA LA, 1986, CANCER RES, V46, P1; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Mrena J, 2005, CLIN CANCER RES, V11, P7362, DOI 10.1158/1078-0432.CCR-05-0764; Nanbu R, 1997, EUR J BIOCHEM, V247, P169, DOI 10.1111/j.1432-1033.1997.00169.x; NANBU R, 1994, MOL CELL BIOL, V14, P4920, DOI 10.1128/MCB.14.7.4920; QUAX PHA, 1990, CANCER RES, V50, P1488; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Shetty S, 1997, MOL CELL BIOL, V17, P1075, DOI 10.1128/MCB.17.3.1075; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; VINCENTI MP, 1994, NUCLEIC ACIDS RES, V22, P4818, DOI 10.1093/nar/22.22.4818; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang GJ, 1998, P NATL ACAD SCI USA, V95, P6296, DOI 10.1073/pnas.95.11.6296; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010	45	85	87	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2010	29	29					4205	4215		10.1038/onc.2010.168	http://dx.doi.org/10.1038/onc.2010.168			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20498646	Green Accepted			2022-12-25	WOS:000280151500008
J	Nakahata, S; Yamazaki, S; Nakauchi, H; Morishita, K				Nakahata, S.; Yamazaki, S.; Nakauchi, H.; Morishita, K.			Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta 1-mediated growth suppression in adult T-cell leukemia/lymphoma	ONCOGENE			English	Article						ZEB1; Smad7; ATLL	FACTOR-BETA; POTENTIAL MECHANISM; LEUKEMIA-CELLS; LEUKEMOGENESIS; EXPRESSION; RECEPTOR; GENE; TAX; COREPRESSOR; DEGRADATION	Zinc-finger E-box binding homeobox 1 (ZEB1) is a candidate tumor-suppressor gene in adult T-cell leukemia/lymphoma ( ATLL). ZEB1 binds phosphorylated Smad2/3 to enhance transforming growth factor-beta 1 (TGF-beta 1) signaling. In addition to downregulation of ZEB1 mRNA, we found overexpression of inhibitory Smad, Smad7, in resistance of ATLL cells to growth suppression by TGF-beta 1. A protein complex of Smad7 and histone deacetylase constantly bound to the promoter region of TGF-beta 1 responsive genes with the Smad-responsive element (SRE) to inhibit TGF-beta 1 signaling; however, ectopic expression of ZEB1 reactivated TGF-beta 1 signaling by binding to Smad7 and recruiting the Smad3/p300 histone acetyltransferase complex to the promoter after TGF-beta 1 stimulation in ATLL. Conversely, because ZEB1 mRNA was detected in the late stages of T-cell development, we used CTLL2 cells with ZEB1 expression, a murine peripheral T-cell lymphoma, and found that a complex of Smad3, Smad7 and ZEB1 was bound to the SRE of the p21(CDKN1A) promoter after the induction of Smad7 by TGF-beta 1 treatment. Because the duration of TGF-beta 1-induced transcriptional activation of PAI-1 and p21 was shortened in shZEB1-expressing CTLL2 cells, ZEB1 may have a role in enhancing TGF-beta 1 signaling by binding not only to Smad3 but also to Smad7 in the nucleus. Altogether, these results suggest that both ZEB1 downregulation and Smad7 overexpression contribute to resistance to TGF-beta 1-mediated growth suppression in ATLL. Oncogene ( 2010) 29, 4157-4169; doi: 10.1038/onc.2010.172; published online 31 May 2010	[Nakahata, S.; Morishita, K.] Miyazaki Univ, Fac Med, Dept Med Sci, Div Tumor & Cellular Biochem, Miyazaki 8891692, Japan; [Yamazaki, S.; Nakauchi, H.] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab Stem Cell Therapy, Tokyo, Japan	University of Miyazaki; University of Tokyo	Morishita, K (corresponding author), Miyazaki Univ, Fac Med, Dept Med Sci, Div Tumor & Cellular Biochem, 5200 Kihara, Miyazaki 8891692, Japan.	kmorishi@med.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Leukemia Research fund; Miyazaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence, JST; Japan Society for the Promotion of Science [19790344]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leukemia Research fund; Miyazaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence, JST(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research of Priority Area from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Leukemia Research fund; Research fund from Miyazaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence, JST (KM) and Young Scientists (B) (19790344) of Japan Society for the Promotion of Science (SN).	Arnulf B, 2002, BLOOD, V100, P4129, DOI 10.1182/blood-2001-12-0372; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hidaka T, 2008, BLOOD, V112, P383, DOI 10.1182/blood-2008-01-131185; INGE TH, 1992, J IMMUNOL, V148, P3847; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; KIM SJ, 1990, J EXP MED, V172, P121, DOI 10.1084/jem.172.1.121; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Mori N, 2001, BLOOD, V97, P2137, DOI 10.1182/blood.V97.7.2137; OKADA M, 1985, J IMMUNOL, V135, P3995; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tsukasaki K, 2001, BLOOD, V97, P3875, DOI 10.1182/blood.V97.12.3875; van Grunsven LA, 2001, J BONE JOINT SURG AM, V83A, pS40; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Yamada Y, 1996, LEUKEMIA LYMPHOMA, V21, P443, DOI 10.3109/10428199609093442; Yasunaga JI, 2003, INT J HEMATOL, V78, P312, DOI 10.1007/BF02983555; Yoshida M, 2004, BLOOD, V103, P2753, DOI 10.1182/blood-2003-07-2482; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	31	57	59	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 22	2010	29	29					4157	4169		10.1038/onc.2010.172	http://dx.doi.org/10.1038/onc.2010.172			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20514018				2022-12-25	WOS:000280151500004
J	Wu, HH; Cheng, YW; Chang, JT; Wu, TC; Liu, WS; Chen, CY; Lee, H				Wu, H-H; Cheng, Y-W; Chang, J. T.; Wu, T-C; Liu, W-S; Chen, C-Y; Lee, H.			Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-kappa B activation	ONCOGENE			English	Article						cytoplasmic Ape1; NF-kappa B; Cox-2; lung tumor metastasis	FACTOR-I; HUMAN-MELANOMA; CANCER; EXPRESSION; APE1/REF-1; P53; APE/REF-1; ALPHA; RESVERATROL; PROGRESSION	Apurinic endonuclease 1 (Ape1) is not only involved in base excision repair, but also activates some transcriptional factors through its redox activity. However, which subcellular localization of Ape1 is involved in the activation of transcriptional factor remains unclear. We first observed that Cox-2 expression was associated with cytoplasmic Ape1 expression in lung tumors and cancer cell lines. We thus hypothesize that nuclear factor (NF)-kappa B is activated by cytoplasmic Ape1 to cause Cox-2 expression. Herein, we generated cytoplasmic and nuclear Ape1 in Ape1-knockdown lung cancer cells by exogenous expression of Ape1 containing various deletions and/or mutations of the nuclear localization sequence. It was observed that cytoplasmic Ape1, but not nuclear Ape1, induced Cox-2 expression through NF-kappa B activation. NF-kappa B activation by cytoplasmic Ape1 was diminished by the Ape1 redox activity inhibitor resveratrol. Cells expressing cytoplasmic Ape1 exhibited tumor progression and metastasis in vitro and in vivo as xenografts, but cells expressing nuclear Ape1 did not. Patients with tumors containing elevated cytoplasmic Ape1 had a poor prognosis and a 3.722-fold risk of tumor recurrence and/or metastasis. Cytoplasmic Ape1 could therefore enhance lung tumor malignancy through NF-kappa B activation, suggesting that combination of cisplatin and specific redox inhibitor could improve chemotherapeutic response in patients with tumors containing elevated cytoplasmic Ape1. Oncogene (2010) 29, 4330-4340; doi:10.1038/onc.2010.178; published online 24 May 2010	[Wu, H-H; Chang, J. T.; Lee, H.] Chung Shan Med Univ, Inst Med & Mol Toxicol, Taichung 402, Taiwan; [Cheng, Y-W; Lee, H.] Chung Shan Med Univ, Inst Med, Taichung 402, Taiwan; [Wu, T-C] Chung Shan Med Univ Hosp, Div Chest Med, Dept Internal Med, Taichung, Taiwan; [Liu, W-S] Chung Shan Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Chen, C-Y] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Lee, H.] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan	Lee, H (corresponding author), Chung Shan Med Univ, Inst Med & Mol Toxicol, 110,Sec 1,Jianguo N Rd, Taichung 402, Taiwan.	hlee@nhri.gov.tw	Lee, Huei/B-2664-2010		National Health Research Institute [NHRI96-TD-G-111-006, NHRI97-TD-G-111-006]; National Science Council of Taiwan, ROC [NSC-96-2628-B-040-002-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was jointly supported by grants from the National Health Research Institute (NHRI96-TD-G-111-006; NHRI97-TD-G-111-006) and the National Science Council (NSC-96-2628-B-040-002-MY3) of Taiwan, ROC.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; Angkeow P, 2002, CELL DEATH DIFFER, V9, P717, DOI 10.1038/sj.cdd.4401025; Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; Bapat A, 2009, ANTIOXID REDOX SIGN, V11, P651, DOI [10.1089/ars.2008.2218, 10.1089/ARS.2008.2218]; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Busso CS, 2009, ONCOGENE, V28, P1616, DOI 10.1038/onc.2009.5; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; CHENG YW, 2004, CANCER RES, V67, P10686; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Di Maso V, 2007, MOL MED, V13, P89, DOI 10.2119/2006-00084.DiMaso; Fantini D, 2008, FREE RADICAL RES, V42, P20, DOI 10.1080/10715760701765616; Freitas S, 2003, CLIN CANCER RES, V9, P4689; Gaiddon C, 1999, EMBO J, V18, P5609, DOI 10.1093/emboj/18.20.5609; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Jackson EB, 2005, NUCLEIC ACIDS RES, V33, P3303, DOI 10.1093/nar/gki641; Jiang YX, 2001, ONCOGENE, V20, P2254, DOI 10.1038/sj.onc.1204293; Kakolyris S, 1998, HISTOPATHOLOGY, V33, P561; Kakolyris S, 1999, J PATHOL, V189, P351, DOI 10.1002/(SICI)1096-9896(199911)189:3<351::AID-PATH435>3.0.CO;2-1; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kelly JW, 2000, NAT STRUCT BIOL, V7, P824, DOI 10.1038/82815; Liu J, 2006, MOL CANCER RES, V4, P803, DOI 10.1158/1541-7786.MCR-06-0201; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Moore DH, 2000, CLIN CANCER RES, V6, P602; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Pines A, 2005, NUCLEIC ACIDS RES, V33, P4379, DOI 10.1093/nar/gki751; Puglisi F, 2002, ONCOL REP, V9, P11; Puglisi F, 2001, ANTICANCER RES, V21, P4041; Qu J, 2007, NUCLEIC ACIDS RES, V35, P2522, DOI 10.1093/nar/gkl1163; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Stathopoulos GT, 2008, MOL CANCER RES, V6, P364, DOI 10.1158/1541-7786.MCR-07-0309; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu Y, 1997, ANTICANCER RES, V17, P3713; Yang S, 2005, MOL CANCER THER, V4, P1923, DOI 10.1158/1535-7163.MCT-05-0229; Yang Z, 2008, MOL CANCER THER, V7, P3751, DOI 10.1158/1535-7163.MCT-08-0562; Zaky A, 2008, NUCLEIC ACIDS RES, V36, P1555, DOI 10.1093/nar/gkm1173	45	38	39	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2010	29	30					4330	4340		10.1038/onc.2010.178	http://dx.doi.org/10.1038/onc.2010.178			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20498636	Bronze			2022-12-25	WOS:000280547900009
J	Androutsellis-Theotokis, A; Walbridge, S; Park, DM; Lonser, RR; Mckay, RDG				Androutsellis-Theotokis, Andreas; Walbridge, Stuart; Park, Deric M.; Lonser, Russell R.; McKay, Ronald D. G.			Cholera Toxin Regulates a Signaling Pathway Critical for the Expansion of Neural Stem Cell Cultures from the Fetal and Adult Rodent Brains	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; IN-VIVO; DENTATE GYRUS; PROGENITOR PROLIFERATION; MOUSE BRAIN; NEUROGENESIS; NEURONS; DIFFERENTIATION; RAT	Background: New mechanisms that regulate neural stem cell (NSC) expansion will contribute to improved assay systems and the emerging regenerative approach that targets endogenous stem cells. Expanding knowledge on the control of stem cell self renewal will also lead to new approaches for targeting the stem cell population of cancers. Methodology/Principal Findings: Here we show that Cholera toxin regulates two recently characterized NSC markers, the Tie2 receptor and the transcription factor Hes3, and promotes the expansion of NSCs in culture. Cholera toxin increases immunoreactivity for the Tie2 receptor and rapidly induces the nuclear localization of Hes3. This is followed by powerful cultured NSC expansion and induction of proliferation both in the presence and absence of mitogen. Conclusions/Significance: Our data suggest a new cell biological mechanism that regulates the self renewal and differentiation properties of stem cells, providing a new logic to manipulate NSCs in the context of regenerative disease and cancer.	[Androutsellis-Theotokis, Andreas; Park, Deric M.; McKay, Ronald D. G.] NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Walbridge, Stuart; Lonser, Russell R.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Androutsellis-Theotokis, A (corresponding author), Acad Athens, Biomed Res Fdn, Athens, Greece.	AndreasTheotokis@gmail.com	Park, Deric/C-5675-2013	Androutsellis-Theotokis, Andreas/0000-0002-1985-4589	National Institute of Neurological Disorders and Stroke; Michael J. Fox Foundation; National Parkinson's Foundation; Tuchman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981, ZIANS002881, ZIANS003051] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; National Parkinson's Foundation; Tuchman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, and by additional support from the Michael J. Fox Foundation, the National Parkinson's Foundation, and the Tuchman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; ANDROUTSELLISTH.A, PLOS ONE, V5, pE9414; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Craig CG, 1996, J NEUROSCI, V16, P2649; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; FISHMAN PH, 1993, ADV LIPID RES, V25, P165; Gniadecki R, 2003, J INVEST DERMATOL, V121, P522, DOI 10.1046/j.1523-1747.2003.12419.x; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Liu JL, 1998, J NEUROSCI, V18, P7768; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Maric Dragan, 2005, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0318s33; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Nakamura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007780; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Routsellis-Theotokis Andreas, 2008, V438, P31, DOI 10.1007/978-1-59745-133-8_4; Shindler KS, 1996, DEV BRAIN RES, V92, P199, DOI 10.1016/0165-3806(95)00215-4; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Yanagisawa M, 2006, GLYCOBIOLOGY, V16, p19G, DOI 10.1093/glycob/cwl003; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027	36	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10841	10.1371/journal.pone.0010841	http://dx.doi.org/10.1371/journal.pone.0010841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520777	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221500027
J	Perkol-Finkel, S; Airoldi, L				Perkol-Finkel, Shimrit; Airoldi, Laura			Loss and Recovery Potential of Marine Habitats: An Experimental Study of Factors Maintaining Resilience in Subtidal Algal Forests at the Adriatic Sea	PLOS ONE			English	Article							PHYSICAL DISTURBANCE; CLIMATE-CHANGE; KELP FORESTS; ECOLOGY; CONSEQUENCES; BIODIVERSITY; RESTORATION; DEGRADATION; VARIABILITY; LIMITATION	Background: Predicting and abating the loss of natural habitats present a huge challenge in science, conservation and management. Algal forests are globally threatened by loss and severe recruitment failure, but our understanding of resilience in these systems and its potential disruption by anthropogenic factors lags well behind other habitats. We tested hypotheses regarding triggers for decline and recovery potential in subtidal forests of canopy-forming algae of the genus Cystoseira. Methodology/Principal Findings: By using a combination of historical data, and quantitative in situ observations of natural recruitment patterns we suggest that recent declines of forests along the coasts of the north Adriatic Sea were triggered by increasing cumulative impacts of natural-and human-induced habitat instability along with several extreme storm events. Clearing and transplantation experiments subsequently demonstrated that at such advanced stages of ecosystem degradation, increased substratum stability would be essential but not sufficient to reverse the loss, and that for recovery to occur removal of the new dominant space occupiers (i.e., opportunistic species including turf algae and mussels) would be required. Lack of surrounding adult canopies did not seem to impair the potential for assisted recovery, suggesting that in these systems recovery could be actively enhanced even following severe depletions. Conclusions/Significance: We demonstrate that sudden habitat loss can be facilitated by long term changes in the biotic and abiotic conditions in the system, that erode the ability of natural ecosystems to absorb and recover from multiple stressors of natural and human origin. Moreover, we demonstrate that the mere restoration of environmental conditions preceding a loss, if possible, may be insufficient for ecosystem restoration, and is scarcely cost-effective. We conclude that the loss of complex marine habitats in human-dominated landscapes could be mitigated with appropriate consideration and management of incremental habitat changes and of attributes facilitating system recovery.	[Perkol-Finkel, Shimrit] Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Ravenna, Italy; Univ Bologna, Ctr Interdipartimentale Ric Sci Ambientali, Ravenna, Italy	University of Bologna; University of Bologna	Perkol-Finkel, S (corresponding author), Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Ravenna, Italy.	sperkol@gmail.com	Airoldi, Laura/I-3553-2019	Airoldi, Laura/0000-0001-5046-0871	EU [FP7-PEOPLE-2007-2-1-IEF-219818]; Italian Ministry of Education, University, and Research, Italy; University of Bologna, Italy	EU(European Commission); Italian Ministry of Education, University, and Research, Italy(Ministry of Education, Universities and Research (MIUR)); University of Bologna, Italy	Funding: MarUrbe - Sustainable management of urban marine structures: EU - FP7-PEOPLE-2007-2-1-IEF-219818 (Marie Curie Fellowship - SPF). BIORES -The resistance and resilience of coastal biodiversity to synergic effects of global and local environmental changes (PRIN 2007, Italian Ministry of Education, University, and Research, Italy). AdriaBio - Past, present and future of marine biodiversity in the Adriatic sea (University of Bologna Strategic Project, University of Bologna, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; AIROLDI L, 2009, HARD BOTTOM COMMUNIT, V206, P269; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; BenedettiCecchi L, 1996, MAR ECOL PROG SER, V138, P93, DOI 10.3354/meps138093; Ciavola P., 2007, J COAST RES SI, VS150, P1; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Cormaci M, 1999, HYDROBIOLOGIA, V399, P75; Corvalan C, 2005, ECOSYSTEMS HUMAN WEL; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DAVIS AN, 1987, MAR ECOL PROG SER, V37, P229, DOI 10.3354/meps037229; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; DEGRANDIS G, 2003, THESIS U BOLOGNA RAV; Edwards MS, 2006, MAR ECOL PROG SER, V320, P79, DOI 10.3354/meps320079; ESTES JA, 1989, CONSERV BIOL, V3, P252, DOI 10.1111/j.1523-1739.1989.tb00085.x; FABI G, 2003, AREA MARINA ANTISTAN; Falace A, 2006, HYDROBIOLOGIA, V555, P193, DOI 10.1007/s10750-005-1116-2; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fraschetti S, 2001, MAR ECOL PROG SER, V212, P1, DOI 10.3354/meps212001; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; HANNAH L, 1994, AMBIO, V23, P246; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Irving AD, 2006, MAR ECOL PROG SER, V324, P127, DOI 10.3354/meps324127; Irving AD, 2009, MAR BIOL, V156, P1223, DOI 10.1007/s00227-009-1164-7; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; Kiirikki M, 1996, EUR J PHYCOL, V31, P61, DOI 10.1080/09670269600651201; Knott NA, 2004, J MAR BIOL ASSOC UK, V84, P1117, DOI 10.1017/S0025315404010550h; LAM NWY, 2009, HONG KONG ZOOLOGICAL, V48, P184; LIEBERMAN M, 1979, ECOLOGY, V60, P1151, DOI 10.2307/1936963; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mangialajo L, 2008, MAR ECOL PROG SER, V358, P63, DOI 10.3354/meps07400; MUNDA IM, 1993, HYDROBIOLOGIA, V261, P239; Ormerod SJ, 2003, J APPL ECOL, V40, P44, DOI 10.1046/j.1365-2664.2003.00799.x; OTT JA, 1990, 25 EUR MAR BIOL S, P45; Reed DC, 2004, J PHYCOL, V40, P275, DOI 10.1046/j.1529-8817.2004.03119.x; Sales M, 2009, ESTUAR COAST SHELF S, V84, P476, DOI 10.1016/j.ecss.2009.07.013; Scheibling RE, 2009, J EXP MAR BIOL ECOL, V368, P94, DOI 10.1016/j.jembe.2008.10.017; Schiel DR, 2006, J EXP MAR BIOL ECOL, V338, P233, DOI 10.1016/j.jembe.2006.06.023; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schmidt AL, 2007, J EXP MAR BIOL ECOL, V341, P110, DOI 10.1016/j.jembe.2006.10.003; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661	55	106	110	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10791	10.1371/journal.pone.0010791	http://dx.doi.org/10.1371/journal.pone.0010791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520726	Green Published, gold, Green Submitted			2022-12-25	WOS:000278034600017
J	Moncaster, JA; Pineda, R; Moir, RD; Lu, SQ; Burton, MA; Ghosh, JG; Ericsson, M; Soscia, SJ; Mocofanescu, A; Folkerth, RD; Robb, RM; Kuszak, JR; Clark, JI; Tanzi, RE; Hunter, DG; Goldstein, LE				Moncaster, Juliet A.; Pineda, Roberto; Moir, Robert D.; Lu, Suqian; Burton, Mark A.; Ghosh, Joy G.; Ericsson, Maria; Soscia, Stephanie J.; Mocofanescu, Anca; Folkerth, Rebecca D.; Robb, Richard M.; Kuszak, Jer R.; Clark, John I.; Tanzi, Rudolph E.; Hunter, David G.; Goldstein, Lee E.			Alzheimer's Disease Amyloid-beta Links Lens and Brain Pathology in Down Syndrome	PLOS ONE			English	Article							PROTEIN-PRECURSOR; EXPRESSION; DEPOSITION; DEMENTIA; LOCUS; HYPOTHESIS; CRYSTALLIN; CATARACTS; PEOPLE; CDNA	Down syndrome (DS, trisomy 21) is the most common chromosomal disorder and the leading genetic cause of intellectual disability in humans. In DS, triplication of chromosome 21 invariably includes the APP gene (21q21) encoding the Alzheimer's disease (AD) amyloid precursor protein (APP). Triplication of the APP gene accelerates APP expression leading to cerebral accumulation of APP-derived amyloid-beta peptides (A beta), early-onset AD neuropathology, and age-dependent cognitive sequelae. The DS phenotype complex also includes distinctive early-onset cerulean cataracts of unknown etiology. Previously, we reported increased A beta accumulation, co-localizing amyloid pathology, and disease-linked supranuclear cataracts in the ocular lenses of subjects with AD. Here, we investigate the hypothesis that related AD-linked A beta pathology underlies the distinctive lens phenotype associated with DS. Ophthalmological examinations of DS subjects were correlated with phenotypic, histochemical, and biochemical analyses of lenses obtained from DS, AD, and normal control subjects. Evaluation of DS lenses revealed a characteristic pattern of supranuclear opacification accompanied by accelerated supranuclear A beta accumulation, co-localizing amyloid pathology, and fiber cell cytoplasmic A beta aggregates (similar to 5 to 50 nm) identical to the lens pathology identified in AD. Peptide sequencing, immunoblot analysis, and ELISA confirmed the identity and increased accumulation of A beta in DS lenses. Incubation of synthetic A beta with human lens protein promoted protein aggregation, amyloid formation, and light scattering that recapitulated the molecular pathology and clinical features observed in DS lenses. These results establish the genetic etiology of the distinctive lens phenotype in DS and identify the molecular origin and pathogenic mechanism by which lens pathology is expressed in this common chromosomal disorder. Moreover, these findings confirm increased A beta accumulation as a key pathogenic determinant linking lens and brain pathology in both DS and AD.	[Moncaster, Juliet A.; Lu, Suqian; Burton, Mark A.; Ghosh, Joy G.; Mocofanescu, Anca; Goldstein, Lee E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Mol Aging & Dev Lab,Dept Surg, Boston, MA 02115 USA; [Pineda, Roberto] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Moir, Robert D.; Soscia, Stephanie J.; Tanzi, Rudolph E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Genet & Aging Res Unit,Dept Neurol, Charlestown, MA USA; [Ericsson, Maria] Harvard Univ, Dept Cell Biol, Sch Med, Elect Microscopy Facil, Boston, MA USA; [Folkerth, Rebecca D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Robb, Richard M.; Hunter, David G.] Harvard Univ, Childrens Hosp, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Kuszak, Jer R.] Rush Univ, Med Ctr, Dept Ophthalmol, Chicago, IL 60612 USA; [Kuszak, Jer R.] Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA; [Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Clark, John I.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Rush University; Rush University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moncaster, JA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Mol Aging & Dev Lab,Dept Surg, Boston, MA 02115 USA.	LGOLD@BU.EDU	Tanzi, Rudolph/AAE-9622-2019; Moir, Robert D./M-7612-2017	Tanzi, Rudolph/0000-0002-7032-1454; Moir, Robert D./0000-0001-5431-3553; Hunter, David/0000-0002-4587-4794; Goldstein, Lee/0000-0001-8419-9800; Moncaster, Juliet/0000-0002-7849-4325	National Institutes of Health, Bethesda, MD [R01GM75986, K23AG024792]; American Federation for Aging Research, New York, NY; Alzheimer's Association, Chicago, IL; American Health Assistance Foundation, Clarksburg, MD; Cure Alzheimer's Fund, Wellesley Hills, MA; Boston University School of Medicine, Boston, MA; Boston University Alzheimer's Disease Center, Boston, MA (NIH ADCC) [P30AG13846]; NATIONAL EYE INSTITUTE [R01EY004542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846, K23AG024792] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research, New York, NY; Alzheimer's Association, Chicago, IL(Alzheimer's Association); American Health Assistance Foundation, Clarksburg, MD; Cure Alzheimer's Fund, Wellesley Hills, MA; Boston University School of Medicine, Boston, MA; Boston University Alzheimer's Disease Center, Boston, MA (NIH ADCC); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: National Institutes of Health, Bethesda, MD (R01GM75986 and K23AG024792, LEG); American Federation for Aging Research, New York, NY (LEG); Alzheimer's Association, Chicago, IL (LEG); American Health Assistance Foundation, Clarksburg, MD (LEG); Anonymous Foundation (LEG); Cure Alzheimer's Fund, Wellesley Hills, MA (RDM); Boston University School of Medicine, Boston, MA (LEG); and Boston University Alzheimer's Disease Center, Boston, MA (NIH ADCC grant P30AG13846). The funding sponsors had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The senior corresponding author (LEG) has full access to all study data and takes final responsibility for the decision to submit the results of the study for publication.	[Anonymous], ONLINE MENDELIAN INH; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; BEYREUTHER K, 1993, ANN NY ACAD SCI, V695, P91, DOI 10.1111/j.1749-6632.1993.tb23035.x; COGAN DAVID G., 1962, DOCUMENTA OPHTHALMOL, V16, P73, DOI 10.1007/BF00146720; Costello MJ, 2007, INVEST OPHTH VIS SCI, V48, P303, DOI 10.1167/iovs.06-0480; Creavin AL, 2009, J PEDIAT OPHTH STRAB, V46, P76, DOI 10.3928/01913913-20090301-06; daCunha RP, 1996, AM J OPHTHALMOL, V122, P236, DOI 10.1016/S0002-9394(14)72015-X; Down J.L., 1866, OBSERVATION ETHNIC C, DOI DOI 10.1038/HDY.1966.69; Epstein C. J., 1989, METABOLIC BASIS INHE, P291; EPSTEIN CJ, 2001, METABOLIC MOL BASES, P1223; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; Frederikse PH, 1998, CURR EYE RES, V17, P947, DOI 10.1076/ceyr.17.9.947.5135; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Haargaard B, 2006, BRIT J OPHTHALMOL, V90, P1024, DOI 10.1136/bjo.2006.090639; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hogan MJ, 1971, HISTOLOGY HUMAN EYE; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; IGERSHEIMER J, 1951, T AM OPHTHAL SOC, V49, P595; Kallen B, 1996, AM J MED GENET, V65, P160; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Leverenz JB, 1998, EXP NEUROL, V150, P296, DOI 10.1006/exnr.1997.6777; Li GH, 2003, MOL VIS, V9, P179; Lott IT, 2005, NEUROBIOL AGING, V26, P383, DOI 10.1016/j.neurobiolaging.2004.08.005; LOWE J, 1992, NEUROPATH APPL NEURO, V18, P341, DOI 10.1111/j.1365-2990.1992.tb00796.x; LOWE RF, 1949, BRIT J OPHTHALMOL, V33, P131, DOI 10.1136/bjo.33.3.131; LYLE R, 2008, EUR J HUM GENET, P1; MIKKELSEN M, 1977, HEREDITAS, V86, P45; Oliver C A, 1891, Trans Am Ophthalmol Soc, V6, P140; OYAMA F, 1994, J NEUROCHEM, V62, P1062; Pearce F H, 1910, Br Med J, V2, P186; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; PROPHET, 1992, LAB METHODS HISTOTEC; PUESCHEL SM, 1990, AM J MED GENET, P52; ROBAKIS NK, 1987, LANCET, V1, P384; ROBB RM, 1978, ARCH OPHTHALMOL-CHIC, V96, P1039; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schupf N, 2002, BRIT J PSYCHIAT, V180, P405, DOI 10.1192/bjp.180.5.405; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; The March of Dimes Birth Defects Foundation, 2006, MARCH DIM GLOB REP B; THULINE HC, 1982, ADV BIOMEDICINE BEHA; Wavrant-De Vrieze F, 1999, NEUROSCI LETT, V269, P67, DOI 10.1016/S0304-3940(99)00417-6; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163	50	101	104	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10659	10.1371/journal.pone.0010659	http://dx.doi.org/10.1371/journal.pone.0010659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20502642	Green Published, gold			2022-12-25	WOS:000278017300002
J	Rogalewski, A; Dittgen, T; Klugmann, M; Kirsch, F; Kruger, C; Pitzer, C; Minnerup, J; Schabitz, WR; Schneider, A				Rogalewski, Andreas; Dittgen, Tanjew; Klugmann, Matthias; Kirsch, Friederike; Krueger, Carola; Pitzer, Claudia; Minnerup, Jens; Schaebitz, Wolf-Ruediger; Schneider, Armin			Semaphorin 6A Improves Functional Recovery in Conjunction with Motor Training after Cerebral Ischemia	PLOS ONE			English	Article							MOVEMENT REPRESENTATIONS; GENE-EXPRESSION; BRAIN-INJURY; CORTEX; RAT; REORGANIZATION; NEURONS; STROKE	Background: We have previously identified Semaphorin 6a (Sema6A) as an upregulated gene product in a gene expression screen in cortical ischemia [1]. Semaphorin 6a was regulated during the recovery phase following ischemia in the cortex. Semaphorin 6a is a member of the superfamily of semaphorins involved in axon guidance and other functions. We hypothesized that the upregulation indicates a crucial role of this molecule in post-stroke rewiring of the brain. Here we have tested this hypothesis by overexpressing semaphorin 6a in the cortex by microinjection of a modified AAV2-virus. A circumscribed cortical infarct was induced, and the recovery of rats monitored for up to 4 weeks using a well-established test battery (accelerated rotarod training paradigm, cylinder test, adhesive tape removal). We observed a significant improvement in post-ischemic recovery of animals injected with the semaphorin 6a virus versus animals treated with a control virus. We conclude that semaphorin 6a overexpressed in the cortex enhances recovery after cerebral ischemia. Semaphorin 6a may represent a novel therapeutic candidate for the treatment of chronic stroke.	[Rogalewski, Andreas; Minnerup, Jens; Schaebitz, Wolf-Ruediger] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Dittgen, Tanjew; Kirsch, Friederike; Krueger, Carola; Pitzer, Claudia] Sygnis Biosci, Heidelberg, Germany; [Klugmann, Matthias; Schneider, Armin] Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-6500 Mainz, Germany	University of Munster; Johannes Gutenberg University of Mainz	Rogalewski, A (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	Wolf.Schaebitz@evkb.de; Schneider@Sygnis.de		Rogalewski, Andreas/0000-0002-6525-4832; Schneider, Armin/0000-0003-0296-0059	Sygnis Bioscience AG Heidelberg (Molecular Neurology); University of Muenster (Dept. of Neurology); University of Mainz (Inst. for Physiological Chemistry and Pathobiochemistry)	Sygnis Bioscience AG Heidelberg (Molecular Neurology); University of Muenster (Dept. of Neurology); University of Mainz (Inst. for Physiological Chemistry and Pathobiochemistry)	The authors' work is a collaboration of the Sygnis Bioscience AG Heidelberg (Molecular Neurology), University of Muenster (Dept. of Neurology), and University of Mainz (Inst. for Physiological Chemistry and Pathobiochemistry) without any further funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; DIETRICH WD, 1986, J CEREBR BLOOD F MET, V6, P184, DOI 10.1038/jcbfm.1986.31; Franich NR, 2008, MOL THER, V16, P947, DOI 10.1038/mt.2008.50; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Fujita H, 2001, BRAIN RES, V914, P1, DOI 10.1016/S0006-8993(01)02765-2; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kruger C, 2006, EXP NEUROL, V200, P135, DOI 10.1016/j.expneurol.2006.01.025; Kumar S, 2006, MENT RETARD DEV D R, V12, P157, DOI 10.1002/mrdd.20108; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Pasterkamp RJ, 2001, BRAIN RES REV, V35, P36, DOI 10.1016/S0165-0173(00)00050-3; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Schneider M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-105; Szumlinski KK, 2005, J NEUROSCI, V25, P7054, DOI 10.1523/JNEUROSCI.1529-05.2005; Xu XM, 2000, J NEUROSCI, V20, P2638; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Zhou L, 1997, MOL CELL NEUROSCI, V9, P26, DOI 10.1006/mcne.1997.0607	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10737	10.1371/journal.pone.0010737	http://dx.doi.org/10.1371/journal.pone.0010737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505770	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017300011
J	Chang, YS; Liu, WJ; Lee, CC; Chou, TL; Lee, YT; Wu, TS; Huang, JY; Huang, WT; Lee, TL; Kou, GH; Wang, AHJ; Lo, CF				Chang, Yun-Shiang; Liu, Wang-Jing; Lee, Cheng-Chung; Chou, Tsung-Lu; Lee, Yuan-Ting; Wu, Tz-Shian; Huang, Jiun-Yan; Huang, Wei-Tung; Lee, Tai-Lin; Kou, Guang-Hsiung; Wang, Andrew H. -J.; Lo, Chu-Fang			A 3D Model of the Membrane Protein Complex Formed by the White Spot Syndrome Virus Structural Proteins	PLOS ONE			English	Article							MAJOR ENVELOPE PROTEINS; HERPES-SIMPLEX-VIRUS; PENAEUS-MONODON; PROTEOMIC ANALYSIS; WSSV INFECTION; VIRAL-PROTEINS; SHRIMP CELLS; TIGER SHRIMP; IDENTIFICATION; VP26	Background: Outbreaks of white spot disease have had a large negative economic impact on cultured shrimp worldwide. However, the pathogenesis of the causative virus, WSSV (whit spot syndrome virus), is not yet well understood. WSSV is a large enveloped virus. The WSSV virion has three structural layers surrounding its core DNA: an outer envelope, a tegument and a nucleocapsid. In this study, we investigated the protein-protein interactions of the major WSSV structural proteins, including several envelope and tegument proteins that are known to be involved in the infection process. Principal Findings: In the present report, we used coimmunoprecipitation and yeast two-hybrid assays to elucidate and/or confirm all the interactions that occur among the WSSV structural (envelope and tegument) proteins VP51A, VP19, VP24, VP26 and VP28. We found that VP51A interacted directly not only with VP26 but also with VP19 and VP24. VP51A, VP19 and VP24 were also shown to have an affinity for self-interaction. Chemical cross-linking assays showed that these three self-interacting proteins could occur as dimers. Conclusions: From our present results in conjunction with other previously established interactions we construct a 3D model in which VP24 acts as a core protein that directly associates with VP26, VP28, VP38A, VP51A and WSV010 to form a membrane-associated protein complex. VP19 and VP37 are attached to this complex via association with VP51A and VP28, respectively. Through the VP26-VP51C interaction this envelope complex is anchored to the nucleocapsid, which is made of layers of rings formed by VP664. A 3D model of the nucleocapsid and the surrounding outer membrane is presented.	[Chang, Yun-Shiang; Chou, Tsung-Lu; Lee, Yuan-Ting; Wu, Tz-Shian; Huang, Wei-Tung; Lee, Tai-Lin] Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan; [Liu, Wang-Jing; Huang, Jiun-Yan; Kou, Guang-Hsiung; Lo, Chu-Fang] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lee, Cheng-Chung; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	Da Yeh University; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chang, YS (corresponding author), Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan.	yschang@mail.dyu.edu.tw; ahjwang@gate.sinica.edu.tw; gracelow@ntu.edu.tw	Lo, Chu-Fang/G-3088-2014	Lo, Chu-Fang/0000-0001-5136-8129	National Science Council [NSC95-2313-B-212-006-MY2, 97-2313-B-212-002-MY3, NSC 98-2311-B-002-013-MY2]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported financially by National Science Council (http://web1.nsc.gov.tw/mp.aspx) grants NSC95-2313-B-212-006-MY2, 97-2313-B-212-002-MY3 and NSC 98-2311-B-002-013-MY2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle KA, 1998, J VIROL, V72, P1826, DOI 10.1128/JVI.72.3.1826-1833.1998; Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; Chang YS, 2008, J VIROL, V82, P12555, DOI 10.1128/JVI.01238-08; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen J, 2007, VIROLOGY, V364, P208, DOI 10.1016/j.virol.2007.02.030; Durand S, 1997, DIS AQUAT ORGAN, V29, P205, DOI 10.3354/dao029205; ERICKSON HP, 2009, BIOL PROCED ONLINE; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huang CH, 2001, VIRUS RES, V76, P115, DOI 10.1016/S0168-1702(01)00247-7; Huang CH, 2002, J GEN VIROL, V83, P2385, DOI 10.1099/0022-1317-83-10-2385; Jie ZL, 2008, ARCH VIROL, V153, P2103, DOI 10.1007/s00705-008-0221-8; Kumar SR, 2008, FISH SHELLFISH IMMUN, V24, P467, DOI 10.1016/j.fsi.2008.01.004; Leu JH, 2005, J VIROL, V79, P140, DOI 10.1128/JVI.79.1.140-149.2005; Leu JH, 2008, DEV COMP IMMUNOL, V32, P121, DOI 10.1016/j.dci.2007.05.005; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Li LJ, 2006, ARCH VIROL, V151, P1309, DOI 10.1007/s00705-005-0719-2; Li ZJ, 2007, MOL CELL PROTEOMICS, V6, P1609, DOI 10.1074/mcp.M600327-MCP200; Liang Y, 2005, DIS AQUAT ORGAN, V66, P81, DOI 10.3354/dao066081; Liu QH, 2009, LETT APPL MICROBIOL, V48, P44, DOI 10.1111/j.1472-765X.2008.02482.x; Liu QH, 2009, DIS AQUAT ORGAN, V85, P23, DOI 10.3354/dao02050; Lo C.-F., 2005, DIS ASIAN AQUACULTUR, P421; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Lo CF, 1999, DIS AQUAT ORGAN, V35, P175, DOI 10.3354/dao035175; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajcani J., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P407, DOI 10.1556/AMicr.50.2003.4.8; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Rout N, 2007, VACCINE, V25, P2778, DOI 10.1016/j.vaccine.2006.12.056; SEARS AE, 1991, P NATL ACAD SCI USA, V88, P5087, DOI 10.1073/pnas.88.12.5087; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Tang XH, 2007, J VIROL, V81, P6709, DOI 10.1128/JVI.02505-06; Tsai JM, 2004, J VIROL, V78, P11360, DOI 10.1128/JVI.78.20.11360-11370.2004; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; van Hulten MCW, 2000, J GEN VIROL, V81, P2525, DOI 10.1099/0022-1317-81-10-2525; van Hulten MCW, 2001, VIROLOGY, V285, P228, DOI 10.1006/viro.2001.0928; van Hulten MCW, 2002, J GEN VIROL, V83, P257, DOI 10.1099/0022-1317-83-1-257; Vaseeharan B, 2006, LETT APPL MICROBIOL, V43, P137, DOI 10.1111/j.1472-765X.2006.01941.x; Vlak J.M., 2004, 8 INT COMM TAX VIR, P187; Wan Q, 2008, J VIROL, V82, P12598, DOI 10.1128/JVI.01732-08; Wang CH, 1995, DIS AQUAT ORGAN, V23, P239, DOI 10.3354/dao023239; Wang H-C, 2004, MAR BIOTECHNOL, V6, pS95; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wu WL, 2005, VIROLOGY, V332, P578, DOI 10.1016/j.virol.2004.12.011; Xie XX, 2006, J VIROL, V80, P10615, DOI 10.1128/JVI.01452-06; Xie XX, 2006, J GEN VIROL, V87, P1903, DOI 10.1099/vir.0.81570-0; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Yi GH, 2004, J BIOCHEM MOL BIOL, V37, P726; Zhang XB, 2004, PROTEINS, V55, P229, DOI 10.1002/prot.10640; Zhou Q, 2009, J VIROL, V83, P4709, DOI 10.1128/JVI.02360-08	55	64	67	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10718	10.1371/journal.pone.0010718	http://dx.doi.org/10.1371/journal.pone.0010718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502662	Green Published, gold, Green Submitted			2022-12-25	WOS:000277845400020
J	Edwards, LM; Murray, AJ; Tyler, DJ; Kemp, GJ; Holloway, CJ; Robbins, PA; Neubauer, S; Levett, D; Montgomery, HE; Grocott, MP; Clarke, K				Edwards, Lindsay M.; Murray, Andrew J.; Tyler, Damian J.; Kemp, Graham J.; Holloway, Cameron J.; Robbins, Peter A.; Neubauer, Stefan; Levett, Denny; Montgomery, Hugh E.; Grocott, Mike P.; Clarke, Kieran		Caudwell Xtreme Everest Res Grp	The Effect of High-Altitude on Human Skeletal Muscle Energetics: P-31-MRS Results from the Caudwell Xtreme Everest Expedition	PLOS ONE			English	Article							WEIGHT-LOSS; INTERLEUKIN-6 RESPONSE; IL-6-LIKE CYTOKINES; OPERATION EVEREST; BODY-COMPOSITION; CANCER CACHEXIA; OXYGEN-UPTAKE; EXERCISE; EXPOSURE; MRS	Many disease states are associated with regional or systemic hypoxia. The study of healthy individuals exposed to high-altitude hypoxia offers a way to explore hypoxic adaptation without the confounding effects of disease and therapeutic interventions. Using P-31 magnetic resonance spectroscopy and imaging, we investigated skeletal muscle energetics and morphology after exposure to hypobaric hypoxia in seven altitude-naive subjects (trekkers) and seven experienced climbers. The trekkers ascended to 5300 m while the climbers ascended above 7950 m. Before the study, climbers had better mitochondrial function (evidenced by shorter phosphocreatine recovery halftime) than trekkers: 16+/-1 vs. 22+/-2 s (mean +/- SE, p<0.01). Climbers had higher resting [Pi] than trekkers before the expedition and resting [Pi] was raised across both groups on their return (PRE: 2.6+/-0.2 vs. POST: 3.0+/-0.2 mM, p<0.05). There was significant muscle atrophy post-CXE (PRE: 4.7+/-0.2 vs. POST: 4.5+/-0.2 cm(2), p<0.05), yet exercising metabolites were unchanged. These results suggest that, in response to high altitude hypoxia, skeletal muscle function is maintained in humans, despite significant atrophy.	[Edwards, Lindsay M.; Murray, Andrew J.; Tyler, Damian J.; Robbins, Peter A.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Edwards, Lindsay M.; Tyler, Damian J.; Holloway, Cameron J.; Neubauer, Stefan] John Radcliffe Hosp, Oxford Ctr Clin Magnet Resonance Res, Oxford OX3 9DU, England; [Kemp, Graham J.] Univ Liverpool, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England; [Levett, Denny; Montgomery, Hugh E.; Grocott, Mike P.] UCL, Ctr Altitude Space & Extreme Environm Med, London, England; [Montgomery, Hugh E.] UCL, Inst Human Hlth & Performance, London, England	University of Oxford; University of Oxford; University of Liverpool; University of London; University College London; University of London; University College London	Edwards, LM (corresponding author), Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia.	L.M.Edwards@utas.edu.au	o'dwyer, michael/D-6561-2012; Levett, Denny/F-4474-2011; Levett, Denny/D-2239-2017; Tyler, Damian/E-6296-2011; Murray, Andrew/B-3130-2010; Mythen, Michael G/G-8682-2011; Kemp, Graham J/A-7540-2008; Grocott, Michael/C-4394-2008; Neubauer, Stefan/B-8448-2011; Levett, Denny Zelda Hope/AAY-4627-2021; Montgomery, Hugh/L-1229-2019; Robbins, Peter/C-7846-2016; Montgomery, Hugh/C-2592-2008	Levett, Denny/0000-0002-8418-1675; Levett, Denny/0000-0002-8418-1675; Tyler, Damian/0000-0002-0780-8905; Murray, Andrew/0000-0002-0929-9315; Kemp, Graham J/0000-0002-8324-9666; Grocott, Michael/0000-0002-9484-7581; Levett, Denny Zelda Hope/0000-0002-8418-1675; Robbins, Peter/0000-0002-4975-0609; Neubauer, Stefan/0000-0001-9017-5645; O'Dwyer, Michael J/0000-0003-4038-5745; Montgomery, Hugh/0000-0001-8797-5019	Defence Advanced Research Projects Agency (DARPA); Medical Research Council [G0601490]; Association of Anaesthetists of Great Britain and Ireland; Intensive Care Society; Sir Halley Stewart Trust; John Caudwell; BOC Medical (now Linde Gas Therapeutics); Lilly Critical Care; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; United Kingdom Department of Health's National Institute for Health Research; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish	Defence Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association of Anaesthetists of Great Britain and Ireland; Intensive Care Society; Sir Halley Stewart Trust; John Caudwell; BOC Medical (now Linde Gas Therapeutics); Lilly Critical Care; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; United Kingdom Department of Health's National Institute for Health Research; British Heart Foundation(British Heart Foundation)	Drs. Edwards and Holloway were supported by a grant from Defence Advanced Research Projects Agency (DARPA, code: ASRJMT1). Dr Tyler was funded by the Medical Research Council, grant number G0601490. Caudwell Xtreme Everest (CXE) is a research project coordinated by the UCL Centre for Altitude, Space and Extreme Environment Medicine, University College London, United Kingdom, and funded by grants from the Association of Anaesthetists of Great Britain and Ireland, Intensive Care Society, Sir Halley Stewart Trust, John Caudwell, BOC Medical (now Linde Gas Therapeutics), Lilly Critical Care, The London Clinic, Smiths Medical, Deltex Medical and The Rolex Foundation. All monies were given as unrestricted grants: the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some of this work was undertaken at University College London Hospital-University College London Comprehensive Biomedical Research Centre, which received a proportion of funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme.	Allen DG, 2001, J PHYSIOL-LONDON, V536, P657, DOI 10.1111/j.1469-7793.2001.t01-1-00657.x; Armellini F, 1997, HORM METAB RES, V29, P458, DOI 10.1055/s-2007-979077; Barton BE, 2001, CYTOKINE, V16, P251, DOI 10.1006/cyto.2001.0968; Barton BE, 2001, IMMUNOL RES, V23, P41, DOI 10.1385/IR:23:1:41; BOYER SJ, 1984, J APPL PHYSIOL, V57, P1580, DOI 10.1152/jappl.1984.57.5.1580; BRAUN M, 1941, DIFFERENTIAL EQUATIO; BUTTERFIELD GE, 1992, J APPL PHYSIOL, V72, P1741, DOI 10.1152/jappl.1992.72.5.1741; CONSOLAZIO CF, 1972, AM J CLIN NUTR, V25, P23; CONSOLAZIO CF, 1968, AM J CLIN NUTR, V21, P154, DOI 10.1093/ajcn/21.2.154; COYLE EF, 1984, J APPL PHYSIOL, V57, P1857, DOI 10.1152/jappl.1984.57.6.1857; CYMERMAN A, 1989, J APPL PHYSIOL, V66, P2446, DOI 10.1152/jappl.1989.66.5.2446; GILL MB, 1964, J APPL PHYSIOL, V19, P949, DOI 10.1152/jappl.1964.19.5.949; GOLDING EM, 1995, J EXP BIOL, V198, P1775; Green H, 2000, AM J PHYSIOL-REG I, V279, pR1872, DOI 10.1152/ajpregu.2000.279.5.R1872; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5921; GROVER RF, 1963, J APPL PHYSIOL, V18, P909, DOI 10.1152/jappl.1963.18.5.909; GUILLAND JC, 1985, EUR J APPL PHYSIOL O, V54, P517, DOI 10.1007/BF00422963; Hahn AG, 2001, SPORTS MED, V31, P533, DOI 10.2165/00007256-200131070-00008; HANNON JP, 1973, J APPL PHYSIOL, V34, P471, DOI 10.1152/jappl.1973.34.4.471; HANNON JP, 1976, AM J CLIN NUTR, V29, P604, DOI 10.1093/ajcn/29.6.604; HOCHACHKA PW, 1983, RESP PHYSIOL, V52, P303, DOI 10.1016/0034-5687(83)90087-7; HOCHACHKA PW, 2001, HIGH ALTITUDE EXPLOR, P131; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Jeneson JAL, 1997, MOL CELL BIOCHEM, V174, P17, DOI 10.1023/A:1006891420109; KELLOGG RH, 1957, J APPL PHYSIOL, V11, P65, DOI 10.1152/jappl.1957.11.1.65; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; Klausen B, 1997, AM J CLIN NUTR, V65, P895; Korzeniewski B, 2005, BIOPHYS CHEM, V116, P129, DOI 10.1016/j.bpc.2005.03.004; Korzeniewski B, 2003, BIOCHEM J, V375, P799, DOI 10.1042/BJ20030882; Lundby C, 2007, SCAND J MED SCI SPOR, V17, P281, DOI 10.1111/j.1600-0838.2006.00530.x; Lundby C, 2004, EUR J APPL PHYSIOL, V91, P88, DOI 10.1007/s00421-003-0935-y; Lynn EG, 2007, ANTIOXID REDOX SIGN, V9, P1353, DOI 10.1089/ars.2007.1700; MATHEW L, 1976, Indian Journal of Physiology and Pharmacology, V20, P197; Mawson JT, 2000, J APPL PHYSIOL, V88, P272, DOI 10.1152/jappl.2000.88.1.272; Mazzeo RS, 2001, J APPL PHYSIOL, V91, P2143; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Netzer NC, 2008, SLEEP BREATH, V12, P129, DOI 10.1007/s11325-007-0149-3; POLGREEN KE, 1994, BBA-MOL CELL RES, V1223, P279, DOI 10.1016/0167-4889(94)90238-0; REYNAFARJE B, 1962, J APPL PHYSIOL, V17, P301, DOI 10.1152/jappl.1962.17.2.301; ROSE MS, 1988, J APPL PHYSIOL, V65, P2545, DOI 10.1152/jappl.1988.65.6.2545; ROSSER BWC, 1993, EUR J APPL PHYSIOL O, V67, P513, DOI 10.1007/BF00241647; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Short K R, 2001, Exerc Sport Sci Rev, V29, P118, DOI 10.1097/00003677-200107000-00006; Shukla V, 2005, NUTR NEUROSCI, V8, P161, DOI 10.1080/10284150500132823; STOCK MJ, 1978, J APPL PHYSIOL, V45, P345, DOI 10.1152/jappl.1978.45.3.345; Tisdale MJ, 2001, FRONT BIOSCI, V6, pD164, DOI 10.2741/Tisdale; VANDENBORNE K, 1993, AM J PHYSIOL, V265, pC1332, DOI 10.1152/ajpcell.1993.265.5.C1332; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; WEST JB, 1983, J APPL PHYSIOL, V55, P688, DOI 10.1152/jappl.1983.55.3.688; Westerterp KR, 2006, EUR J GASTROEN HEPAT, V18, P1, DOI 10.1097/00042737-200601000-00001; Westerterp KR, 2001, J EXP BIOL, V204, P3183	51	41	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10681	10.1371/journal.pone.0010681	http://dx.doi.org/10.1371/journal.pone.0010681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502713	Green Published, Green Accepted, gold			2022-12-25	WOS:000277845400006
J	Lopez, MD; Guerra, JJM; Samuelsson, T				Davila Lopez, Marcela; Martinez Guerra, Juan Jose; Samuelsson, Tore			Analysis of Gene Order Conservation in Eukaryotes Identifies Transcriptionally and Functionally Linked Genes	PLOS ONE			English	Article							HEAD-TO-HEAD; BIDIRECTIONAL PROMOTER; EXPRESSION; EVOLUTION; PROTEIN; ORGANIZATION; METHYLATION; SENSITIVITY; PREDICTION; SEQUENCE	The order of genes in eukaryotes is not entirely random. Studies of gene order conservation are important to understand genome evolution and to reveal mechanisms why certain neighboring genes are more difficult to separate during evolution. Here, genome-wide gene order information was compiled for 64 species, representing a wide variety of eukaryotic phyla. This information is presented in a browser where gene order may be displayed and compared between species. Factors related to non-random gene order in eukaryotes were examined by considering pairs of neighboring genes. The evolutionary conservation of gene pairs was studied with respect to relative transcriptional direction, intergenic distance and functional relationship as inferred by gene ontology. The results show that among gene pairs that are conserved the divergently and co-directionally transcribed genes are much more common than those that are convergently transcribed. Furthermore, highly conserved pairs, in particular those of fungi, are characterized by a short intergenic distance. Finally, gene pairs of metazoa and fungi that are evolutionary conserved and that are divergently transcribed are much more likely to be related by function as compared to poorly conserved gene pairs. One example is the ribosomal protein gene pair L13/S16, which is unusual as it occurs both in fungi and alveolates. A specific functional relationship between these two proteins is also suggested by the fact that they are part of the same operon in both eubacteria and archaea. In conclusion, factors associated with non-random gene order in eukaryotes include relative gene orientation, intergenic distance and functional relationships. It seems likely that certain pairs of genes are conserved because the genes involved have a transcriptional and/or functional relationship. The results also indicate that studies of gene order conservation aid in identifying genes that are related in terms of transcriptional control.	[Davila Lopez, Marcela; Samuelsson, Tore] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Martinez Guerra, Juan Jose] Univ Autonoma Aguascalientes, Ctr Ciencias Basicas, Dept Quim, Aguascalientes, Mexico	University of Gothenburg; Universidad Autonoma de Aguascalientes	Lopez, MD (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.	Tore.Samuelsson@medkem.gu.se	Samuelsson, Tore/B-3548-2008; Samuelsson, Tore/X-7335-2019; Lopez, Marcela Davila/I-5433-2019	Lopez, Marcela Davila/0000-0002-1619-6795	Erik Philip-Srensen Foundation	Erik Philip-Srensen Foundation	This work was supported by the Erik Philip-Srensen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Agirre X, 2006, INT J CANCER, V118, P1945, DOI 10.1002/ijc.21584; Albig W, 1999, BIOL CHEM, V380, P7, DOI 10.1515/BC.1999.002; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Ame JC, 2001, J BIOL CHEM, V276, P11092, DOI 10.1074/jbc.M007870200; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; BRAYTON KA, 1994, J BIOL CHEM, V269, P5313; BURBELO PD, 1988, P NATL ACAD SCI USA, V85, P9679, DOI 10.1073/pnas.85.24.9679; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dresser DW, 2001, GENE, V277, P163, DOI 10.1016/S0378-1119(01)00690-4; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GAVALAS A, 1995, J BIOL CHEM, V270, P2403, DOI 10.1074/jbc.270.5.2403; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Hansen JJ, 2003, HUM GENET, V112, P71, DOI 10.1007/s00439-002-0837-9; Huang CC, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-67; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; JORGENEBERT LF, 2009, HUM MUTAT; Kaczanowska M, 2004, J BACTERIOL, V186, P3046, DOI 10.1128/JB.186.10.3046-3055.2004; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; KROMER WJ, 1991, J BIOL CHEM, V266, P24573; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lee SG, 2000, MOL CELLS, V10, P47, DOI 10.1007/s10059-000-0047-z; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Moreno-Hagelsieb Gabriel, 2008, V453, P181, DOI 10.1007/978-1-60327-429-6_8; Myler PJ, 2001, MED MICROBIOL IMMUN, V190, P9, DOI 10.1007/s004300100070; Piontkivska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-189; Poyatos JF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r233; Reed SH, 1998, J BIOL CHEM, V273, P29481, DOI 10.1074/jbc.273.45.29481; Requena JM, 1997, MEM I OSWALDO CRUZ, V92, P853, DOI 10.1590/S0074-02761997000600022; Ruths T, 2009, BIOINFORMATICS, V25, P1178, DOI 10.1093/bioinformatics/btp128; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; VandePeer Y, 1996, J MOL EVOL, V42, P201, DOI 10.1007/BF02198846; Vieira CP, 1997, MOL BIOL EVOL, V14, P985, DOI 10.1093/oxfordjournals.molbev.a025715; Voth H, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-28; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; Yang MQ, 2007, PLOS COMPUT BIOL, V3, P733, DOI 10.1371/journal.pcbi.0030072; Yang MQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S9; Yang Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240801905360; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193	56	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10654	10.1371/journal.pone.0010654	http://dx.doi.org/10.1371/journal.pone.0010654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498846	Green Published, gold, Green Submitted			2022-12-25	WOS:000277771600017
J	Washburn, ML; Kovalev, GI; Koroleva, E; Fu, YX; Su, LS				Washburn, Michael L.; Kovalev, Grigoriy I.; Koroleva, Ekaterina; Fu, Yang-Xin; Su, Lishan			LIGHT Induces Distinct Signals to Clear an AAV-Expressed Persistent Antigen in the Mouse Liver and to Induce Liver Inflammation	PLOS ONE			English	Article							LYMPHOTOXIN BETA-RECEPTOR; VERSUS-HOST-DISEASE; CELL RESPONSE; GENE-TRANSFER; T-CELLS; TUMOR; ALPHA; ERADICATION; PATHWAY; MICE	Background: Infection with adeno-associated virus (AAV) vector with liver tropism leads to persistent expression of foreign antigens in the mouse liver, with no significant liver inflammation or pathology. This provides a model to investigate antigen persistence in the liver and strategies to modulate host immunity to reduce or clear the foreign antigen expressed from AAV vector in the liver. Methods/Principal Findings: We showed that expressing LIGHT with an adenovirus vector ( Ad) in mice with established AAV in the liver led to clearance of the AAV. Ad-LIGHT enhanced CD8 effector T cells in the liver, correlated with liver inflammation. LT beta R-Ig proteins blocked Ad-LIGHT in clearing AAV. Interestingly, in LT beta R-null mice, Ad-LIGHT still cleared AAV but caused no significant liver inflammation. Conclusions/Significance: Our data suggest that LIGHT interaction with the LT beta R plays a critical role in liver inflammation but is not required for LIGHT-mediated AAV clearance. These findings will shed light on developing novel immunotherapeutics in treating people chronically infected with hepato-tropic viruses.	[Washburn, Michael L.; Su, Lishan] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA; [Washburn, Michael L.; Kovalev, Grigoriy I.; Su, Lishan] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kovalev, Grigoriy I.; Su, Lishan] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; [Kovalev, Grigoriy I.; Su, Lishan] Univ N Carolina, Dept Immunol, Chapel Hill, NC 27599 USA; [Koroleva, Ekaterina; Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Fu, Yang-Xin; Su, Lishan] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Chicago; Chinese Academy of Sciences; Institute of Biophysics, CAS	Washburn, ML (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	lsu@med.unc.edu	Kovalev, Grigoriy/V-8768-2018	fu, yang-xin/0000-0001-8441-6617; Kovalev, Grigoriy/0000-0003-4346-3585	National Institutes of Health (NIH) [AI076142, AA018009, CA115540, DK58891, T32 AI007273]; China MOST [0997141002]; NATIONAL CANCER INSTITUTE [R01CA115540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007273, R21AI076142, R01AI077454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018009] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China MOST(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from National Institutes of Health (NIH), AI076142, AA018009 (L. S.), CA115540 and DK58891 (Y.X.F.), and T32 AI007273 (M. L. W), and China MOST 0997141002 (L. S. and Y.X.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Bartlett JS, 1996, P NATL ACAD SCI USA, V93, P8852, DOI 10.1073/pnas.93.17.8852; Browning JL, 1997, J IMMUNOL, V159, P3288; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; Dobrzynski E, 2004, BLOOD, V104, P969, DOI 10.1182/blood-2004-03-0847; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Giannandrea M, 2009, HEPATOLOGY, V49, P2010, DOI 10.1002/hep.22869; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Lee CM, 2005, J GASTROEN HEPATOL, V20, P1762, DOI 10.1111/j.1440-1746.2005.04065.x; Li H, 2007, MOL THER, V15, P792, DOI 10.1038/sj.mt.6300090; Lin SW, 2007, J CLIN INVEST, V117, P3958, DOI 10.1172/JCI33138; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Tamada K, 2000, NAT MED, V6, P283; Wu Q, 1999, J EXP MED, V190, P629, DOI 10.1084/jem.190.5.629; Xu YH, 2007, BLOOD, V109, P4097, DOI 10.1182/blood-2006-09-047332; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Yu P, 2007, J IMMUNOL, V179, P1960, DOI 10.4049/jimmunol.179.3.1960; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	20	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10585	10.1371/journal.pone.0010585	http://dx.doi.org/10.1371/journal.pone.0010585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498840	Green Published, Green Submitted, gold			2022-12-25	WOS:000277771600002
J	Bollag, B; Hofstetter, CA; Reviriego-Mendoza, MM; Frisque, RJ				Bollag, Brigitte; Hofstetter, Catherine A.; Reviriego-Mendoza, Marta M.; Frisque, Richard J.			JC Virus Small t Antigen Binds Phosphatase PP2A and Rb Family Proteins and Is Required for Efficient Viral DNA Replication Activity	PLOS ONE			English	Article							SMALL TUMOR-ANTIGEN; SV40 SMALL-T; SIMIAN VIRUS-40; CELL-TRANSFORMATION; EPITHELIAL-CELLS; MONKEY CELLS; MIDDLE-T; IN-VITRO; SIMIAN-VIRUS-40; IDENTIFICATION	Background: The human polyomavirus, JC virus (JCV) produces five tumor proteins encoded by transcripts alternatively spliced from one precursor messenger RNA. Significant attention has been given to replication and transforming activities of JCV's large tumor antigen (TAg) and three T' proteins, but little is known about small tumor antigen (tAg) functions. Amino-terminal sequences of tAg overlap with those of the other tumor proteins, but the carboxy half of tAg is unique. These latter sequences are the least conserved among the early coding regions of primate polyomaviruses. Methodology and Findings: We investigated the ability of wild type and mutant forms of JCV tAg to interact with cellular proteins involved in regulating cell proliferation and survival. The JCV P99A tAg is mutated at a conserved proline, which in the SV40 tAg is required for efficient interaction with protein phosphatase 2A (PP2A), and the C157A mutant tAg is altered at one of two newly recognized LxCxE motifs. Relative to wild type and C157A tAgs, P99A tAg interacts inefficiently with PP2A in vivo. Unlike SV40 tAg, JCV tAg binds to the Rb family of tumor suppressor proteins. Viral DNAs expressing mutant t proteins replicated less efficiently than did the intact JCV genome. A JCV construct incapable of expressing tAg was replication-incompetent, a defect not complemented in trans using a tAg-expressing vector. Conclusions: JCV tAg possesses unique properties among the polyomavirus small t proteins. It contributes significantly to viral DNA replication in vivo; a tAg null mutant failed to display detectable DNA replication activity, and a tAg substitution mutant, reduced in PP2A binding, was replication-defective. Our observation that JCV tAg binds Rb proteins, indicates all five JCV tumor proteins have the potential to influence cell cycle progression in infected and transformed cells. It remains unclear how these proteins coordinate their unique and overlapping functions.	[Bollag, Brigitte; Hofstetter, Catherine A.; Reviriego-Mendoza, Marta M.; Frisque, Richard J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bollag, B (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	rjf6@psu.edu			National Cancer Institute [CA115771]; NATIONAL CANCER INSTITUTE [R01CA115771] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Public Health Service grant CA115771 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; BOLLAG B, 1989, J VIROL, V63, P863, DOI 10.1128/JVI.63.2.863-872.1989; Bollag B, 2000, VIROLOGY, V274, P165, DOI 10.1006/viro.2000.0451; Bollag B, 2006, J NEUROVIROL, V12, P428, DOI 10.1080/13550280601009553; Borger DR, 2006, J VIROL, V80, P4292, DOI 10.1128/JVI.80.9.4292-4303.2006; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; CARBONE M, 1992, J VIROL, V66, P1804, DOI 10.1128/JVI.66.3.1804-1808.1992; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; CHANG LS, 1985, VIROLOGY, V146, P246, DOI 10.1016/0042-6822(85)90008-X; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; CHUKE WF, 1986, J VIROL, V60, P960, DOI 10.1128/JVI.60.3.960-971.1986; CICALA C, 1994, J VIROL, V68, P3138, DOI 10.1128/JVI.68.5.3138-3144.1994; Fahrbach KM, 2008, VIROLOGY, V370, P255, DOI 10.1016/j.virol.2007.09.008; Frisque RJ, 2006, ADV EXP MED BIOL, V577, P288; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; HAGGERTY S, 1989, J VIROL, V63, P2180, DOI 10.1128/JVI.63.5.2180-2190.1989; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; JOG P, 1990, J VIROL, V64, P2895, DOI 10.1128/JVI.64.6.2895-2900.1990; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Lee C, 2002, REV MED VIROL, V12, P81, DOI 10.1002/rmv.340; LI JJ, 1985, MOL CELL BIOL, V5, P1238, DOI 10.1128/MCB.5.6.1238; LYNCH KJ, 1990, J VIROL, V64, P5812, DOI 10.1128/JVI.64.12.5812-5822.1990; LYNCH KJ, 1994, VIROLOGY, V204, P819, DOI 10.1006/viro.1994.1600; Mateer SC, 1998, J BIOL CHEM, V273, P35339, DOI 10.1074/jbc.273.52.35339; MUNGRE S, 1994, J VIROL, V68, P1675, DOI 10.1128/JVI.68.3.1675-1681.1994; Nesper J, 1997, J VIROL, V71, P7421, DOI 10.1128/JVI.71.10.7421-7428.1997; Nunbhakdi-Craig V, 2003, J VIROL, V77, P2807, DOI 10.1128/JVI.77.5.2807-2818.2003; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; PAN W, 2002, CANCER RES, V61, P2885; PEDEN KWC, 1989, VIROLOGY, V168, P13, DOI 10.1016/0042-6822(89)90398-X; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; Poulin DL, 2004, J VIROL, V78, P8245, DOI 10.1128/JVI.78.15.8245-8253.2004; Prins C, 2001, J NEUROVIROL, V7, P250; RAJ GV, 1995, VIROLOGY, V213, P283, DOI 10.1006/viro.1995.0001; Ravichandran V, 2006, PROTEOMICS, V6, P5628, DOI 10.1002/pmic.200600261; Ruediger R, 1997, VIROLOGY, V238, P432, DOI 10.1006/viro.1997.8873; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Saenz-Robles MT, 2001, ONCOGENE, V20, P7899, DOI 10.1038/sj.onc.1204936; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Shimazu T, 2006, ONCOGENE, V25, P7391, DOI 10.1038/sj.onc.1209731; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Suzuki S, 2001, VIROLOGY, V286, P100, DOI 10.1006/viro.2001.0972; SWENSON JJ, 1995, VIROLOGY, V212, P295, DOI 10.1006/viro.1995.1487; TAVIS JE, 1994, VIROLOGY, V199, P384, DOI 10.1006/viro.1994.1136; TEVETHIA SS, 1992, VIROLOGY, V190, P459, DOI 10.1016/0042-6822(92)91234-L; TOPP WC, 1980, J VIROL, V33, P1208, DOI 10.1128/JVI.33.3.1208-1210.1980; Tyagarajan SK, 2006, J VIROL, V80, P2083, DOI 10.1128/JVI.80.5.2083-2091.2006; VIRSHUP DM, 1989, EMBO J, V8, P3891, DOI 10.1002/j.1460-2075.1989.tb08568.x; WALTER G, 1989, P NATL ACAD SCI USA, V86, P8669, DOI 10.1073/pnas.86.22.8669; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Yu YJ, 2008, J VIROL, V82, P4521, DOI 10.1128/JVI.02365-07; Yuan H, 2002, J VIROL, V76, P10685, DOI 10.1128/JVI.76.21.10685-10691.2002; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256	65	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10606	10.1371/journal.pone.0010606	http://dx.doi.org/10.1371/journal.pone.0010606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485545	gold, Green Published, Green Submitted			2022-12-25	WOS:000277563400013
J	Boucrot, E; Saffarian, S; Zhang, RY; Kirchhausen, T				Boucrot, Emmanuel; Saffarian, Saveez; Zhang, Rongying; Kirchhausen, Tomas			Roles of AP-2 in Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COATED PITS; PLASMA-MEMBRANE; CELLS; TRAFFICKING; INTERNALIZATION; INVAGINATIONS; ENDOSOMES; FM1-43; ARH	Background: The notion that AP-2 clathrin adaptor is an essential component of an endocytic clathrin coat appears to conflict with recent observations that substantial AP-2 depletion, using RNA interference with synthesis of AP-2 subunits, fails to block uptake of certain ligands known to internalize through a clathrin-based pathway. Methodology/Principal Findings: We report here the use of in vivo imaging data obtained by spinning-disk confocal microscopy to study the formation of clathrin-coated structures at the plasma membranes of BSC1 and HeLa cells depleted by RNAi of the clathrin adaptor, AP-2. Very few clathrin coats continue to assemble after AP-2 knockdown. Moreover, there is a total absence of clathrin-containing structures completely lacking AP-2 while all the remaining coats still contain a small amount of AP-2. These observations suggest that AP-2 is essential for endocytic coated-pit and coated-vesicle formation. We also find that AP-2 knockdown strongly inhibits light-density lipoprotein (LDL) receptor-mediated endocytosis, as long as cells are maintained in complete serum and at 37 degrees C. If cells are first incubated with LDL at 4 degrees C, followed by warming, there is little or no decrease in LDL uptake with respect to control cells. LDL uptake at 37 degrees C is also not affected in AP-2 depleted cells first deprived of LDL by incubation with either serum-starved or LDL-starved cells for 24 hr. The LDL-deprived cells display a significant increase in endocytic structures enriched on deeply invaginated tubes that contain LDL and we suggest that under this condition of stress, LDL might enter through this alternative pathway. Conclusions/Significance: These results suggest that AP-2 is essential for endocytic clathrin coated-pit and coated-vesicle formation. They also indicate that under normal conditions, functional endocytic clathrin coated pits are required for LDL internalization. We also show that under certain conditions of stress, cells can upregulate alternative endocytic structures with the potential to provide compensatory trafficking pathways.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Boucrot, E (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	kirchhausen@crystal.harvard.edu		Boucrot, Emmanuel/0000-0001-7312-6462	National Institutes of Health (NIH) [GM 075252]; International Human Frontier Science Program Organization; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontier Science Program Organization(Human Frontier Science Program); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM 075252 (T.K.), the International Human Frontier Science Program Organization (E.B.) and the American Heart Association (S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLL W, 1995, CURR BIOL, V5, P1168, DOI 10.1016/S0960-9822(95)00233-8; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; KIRCHHAUSEN T, 2009, TRENDS CELL BIOL; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; Massol RH, 2005, EXP CELL RES, V306, P142, DOI 10.1016/j.yexcr.2005.01.021; Massol RH, 2004, MOL BIOL CELL, V15, P3631, DOI 10.1091/mbc.E04-04-0283; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001	31	101	101	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10597	10.1371/journal.pone.0010597	http://dx.doi.org/10.1371/journal.pone.0010597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485680	Green Published, Green Submitted, gold			2022-12-25	WOS:000277563400009
J	Wang, K; Sengupta, S; Magnani, L; Wilson, CA; Henry, RW; Knott, JG				Wang, Kai; Sengupta, Satyaki; Magnani, Luca; Wilson, Catherine A.; Henry, R. William; Knott, Jason G.			Brg1 Is Required for Cdx2-Mediated Repression of Oct4 Expression in Mouse Blastocysts	PLOS ONE			English	Article							EMBRYONIC STEM; TROPHECTODERM; CDX2; INNER; GENE; SPECIFICATION; COMPONENTS; CELLS; FATE	During blastocyst formation the segregation of the inner cell mass (ICM) and trophectoderm is governed by the mutually antagonistic effects of the transcription factors Oct4 and Cdx2. Evidence indicates that suppression of Oct4 expression in the trophectoderm is mediated by Cdx2. Nonetheless, the underlying epigenetic modifiers required for Cdx2-dependent repression of Oct4 are largely unknown. Here we show that the chromatin remodeling protein Brg1 is required for Cdx2-mediated repression of Oct4 expression in mouse blastocysts. By employing a combination of RNA interference (RNAi) and gene expression analysis we found that both Brg1 Knockdown (KD) and Cdx2 KD blastocysts exhibit widespread expression of Oct4 in the trophectoderm. Interestingly, in Brg1 KD blastocysts and Cdx2 KD blastocysts, the expression of Cdx2 and Brg1 is unchanged, respectively. To address whether Brg1 cooperates with Cdx2 to repress Oct4 transcription in the developing trophectoderm, we utilized preimplantation embryos, trophoblast stem (TS) cells and Cdx2-inducible embryonic stem (ES) cells as model systems. We found that: (1) combined knockdown (KD) of Brg1 and Cdx2 levels in blastocysts resulted in increased levels of Oct4 transcripts compared to KD of Brg1 or Cdx2 alone, (2) endogenous Brg1 co-immunoprecipitated with Cdx2 in TS cell extracts, (3) in blastocysts Brg1 and Cdx2 co-localize in trophectoderm nuclei and (4) in Cdx2-induced ES cells Brg1 and Cdx2 are recruited to the Oct4 promoter. Lastly, to determine how Brg1 may induce epigenetic silencing of the Oct4 gene, we evaluated CpG methylation at the Oct4 promoter in the trophectoderm of Brg1 KD blastocysts. This analysis revealed that Brg1-dependent repression of Oct4 expression is independent of DNA methylation at the blastocyst stage. In toto, these results demonstrate that Brg1 cooperates with Cdx2 to repress Oct4 expression in the developing trophectoderm to ensure normal development.	[Wang, Kai; Magnani, Luca; Wilson, Catherine A.; Knott, Jason G.] Michigan State Univ, Dept Anim Sci, Dev Epigenet Lab, E Lansing, MI 48824 USA; [Sengupta, Satyaki; Henry, R. William] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Wang, K (corresponding author), Michigan State Univ, Dept Anim Sci, Dev Epigenet Lab, E Lansing, MI 48824 USA.	knottj@msu.edu	wang, kai/G-4932-2011; Magnani, Luca/N-1094-2015; Sengupta, Satyaki/AAD-6065-2022	Magnani, Luca/0000-0002-7534-0785; 	Intramural Research Grants Program (IRGP) grant at Michigan State University; National Institute of General Medical Sciences [R01GM095347]; Gene Expression in Development & Disease Focus Group (GEDD) at Michigan State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095347] Funding Source: NIH RePORTER	Intramural Research Grants Program (IRGP) grant at Michigan State University; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Gene Expression in Development & Disease Focus Group (GEDD) at Michigan State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Intramural Research Grants Program (IRGP) grant at Michigan State University and R01GM095347 from the National Institute of General Medical Sciences to J.G.K. Mr. Sengupta was supported in part by the Gene Expression in Development & Disease Focus Group (GEDD) at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Datta J, 2005, CANCER RES, V65, P10891, DOI 10.1158/0008-5472.CAN-05-1455; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; HO L, 2009, PNAS, V13, P5187; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Knott JG, 2006, DEV BIOL, V296, P388, DOI 10.1016/j.ydbio.2006.06.004; Lal A, 2005, MOL CELL PROBE, V19, P385, DOI 10.1016/j.mcp.2005.06.007; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200	23	44	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10622	10.1371/journal.pone.0010622	http://dx.doi.org/10.1371/journal.pone.0010622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485553	Green Published, Green Submitted, gold			2022-12-25	WOS:000277563400024
J	Arnaud, N; Dabo, S; Maillard, P; Budkowska, A; Kalliampakou, KI; Mavromara, P; Garcin, D; Hugon, J; Gatignol, A; Akazawa, D; Wakita, T; Meurs, EF				Arnaud, Noella; Dabo, Stephanie; Maillard, Patrick; Budkowska, Agata; Kalliampakou, Katerina I.; Mavromara, Penelope; Garcin, Dominique; Hugon, Jacques; Gatignol, Anne; Akazawa, Daisuke; Wakita, Takaji; Meurs, Eliane F.			Hepatitis C Virus Controls Interferon Production through PKR Activation	PLOS ONE			English	Article							PROTEIN-KINASE PKR; RIG-I; RNA REPLICATION; INHIBITION; RECOGNITION; TRANSLATION; EXPRESSION; INFECTION; PATHWAY; MECHANISMS	Hepatitis C virus is a poor inducer of interferon (IFN), although its structured viral RNA can bind the RNA helicase RIG-I, and activate the IFN-induction pathway. Low IFN induction has been attributed to HCV NS3/4A protease-mediated cleavage of the mitochondria-adapter MAVS. Here, we have investigated the early events of IFN induction upon HCV infection, using the cell-cultured HCV JFH1 strain and the new HCV-permissive hepatoma-derived Huh7.25.CD81 cell subclone. These cells depend on ectopic expression of the RIG-I ubiquitinating enzyme TRIM25 to induce IFN through the RIG-I/MAVS pathway. We observed induction of IFN during the first 12 hrs of HCV infection, after which a decline occurred which was more abrupt at the protein than at the RNA level, revealing a novel HCV-mediated control of IFN induction at the level of translation. The cellular protein kinase PKR is an important regulator of translation, through the phosphorylation of its substrate the eIF2 alpha initiation factor. A comparison of the expression of luciferase placed under the control of an eIF2 alpha-dependent (IRESEMCV) or independent (IRESHCV) RNA showed a specific HCV-mediated inhibition of eIF2 alpha-dependent translation. We demonstrated that HCV infection triggers the phosphorylation of both PKR and eIF2 alpha at 12 and 15 hrs post-infection. PKR silencing, as well as treatment with PKR pharmacological inhibitors, restored IFN induction in JFH1-infected cells, at least until 18 hrs post-infection, at which time a decrease in IFN expression could be attributed to NS3/4A-mediated MAVS cleavage. Importantly, both PKR silencing and PKR inhibitors led to inhibition of HCV yields in cells that express functional RIG-I/MAVS. In conclusion, here we provide the first evidence that HCV uses PKR to restrain its ability to induce IFN through the RIG-I/MAVS pathway. This opens up new possibilities to assay PKR chemical inhibitors for their potential to boost innate immunity in HCV infection.	[Arnaud, Noella; Dabo, Stephanie; Maillard, Patrick; Budkowska, Agata; Meurs, Eliane F.] Inst Pasteur, Unite Hepacivirus & Immun Innee, Paris, France; [Kalliampakou, Katerina I.; Mavromara, Penelope] Hellenic Pasteur Inst, Mol Virol Lab, Athens, Greece; [Garcin, Dominique] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Hugon, Jacques] INSERM, UMRS 839, Inst Fer Moulin, Paris, France; [Gatignol, Anne] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Akazawa, Daisuke; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Lady Davis Institute; McGill University; National Institute of Infectious Diseases (NIID)	Arnaud, N (corresponding author), Inst Pasteur, Unite Hepacivirus & Immun Innee, Paris, France.	emeurs@pasteur.fr	Akazawa, Daisuke/S-5596-2019; Gatignol, Anne/AAA-6501-2020	Gatignol, Anne/0000-0002-4553-0836	Institut Pasteur (IP); CNRS [URA3015]; Ministere de l'Education et de la Recherche fellowship	Institut Pasteur (IP); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education et de la Recherche fellowship	Financial support was provided by grants from Institut Pasteur (IP) and CNRS (URA3015). Noella Arnaud is recipient of Ministere de l'Education et de la Recherche fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Brocard M, 2007, VIRUS GENES, V35, P5, DOI 10.1007/s11262-006-0038-z; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hugon J, 2009, EXPERT REV NEUROTHER, V9, P1455, DOI [10.1586/ern.09.92, 10.1586/ERN.09.92]; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Kalliampakou KI, 2005, J GEN VIROL, V86, P1015, DOI 10.1099/vir.0.80728-0; Kang JI, 2009, VIRUS RES, V142, P51, DOI 10.1016/j.virusres.2009.01.007; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; LAURENT AG, 1985, P NATL ACAD SCI USA, V82, P4341, DOI 10.1073/pnas.82.13.4341; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Nekhai S, 2000, PEPTIDES, V21, P1449, DOI 10.1016/S0196-9781(00)00297-7; Pavio N, 2002, J VIROL, V76, P1265, DOI 10.1128/JVI.76.3.1265-1272.2002; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Shimoike T, 2009, ANTIVIR RES, V83, P228, DOI 10.1016/j.antiviral.2009.05.004; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Yan XB, 2007, VIRUS RES, V125, P79, DOI 10.1016/j.virusres.2006.12.010; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	42	92	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10575	10.1371/journal.pone.0010575	http://dx.doi.org/10.1371/journal.pone.0010575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485506	Green Published, Green Submitted, gold			2022-12-25	WOS:000277563200010
J	Proskocil, BJ; Bruun, DA; Thompson, CM; Fryer, AD; Lein, PJ				Proskocil, Becky J.; Bruun, Donald A.; Thompson, Charles M.; Fryer, Allison D.; Lein, Pamela J.			Organophosphorus Pesticides Decrease M2 Muscarinic Receptor Function in Guinea Pig Airway Nerves via Indirect Mechanisms	PLOS ONE			English	Article							PULMONARY PARASYMPATHETIC NERVES; MAST-CELL DEGRANULATION; MAJOR BASIC-PROTEIN; ACETYLCHOLINE-RECEPTOR; AGRICULTURAL HEALTH; CHLORPYRIFOS-OXON; MACROPHAGE FUNCTION; SARIN VAPOR; IN-VITRO; EXPOSURE	Background: Epidemiological studies link organophosphorus pesticide (OP) exposures to asthma, and we have shown that the OPs chlorpyrifos, diazinon and parathion cause airway hyperreactivity in guinea pigs 24 hr after a single subcutaneous injection. OP-induced airway hyperreactivity involves M2 muscarinic receptor dysfunction on airway nerves independent of acetylcholinesterase (AChE) inhibition, but how OPs inhibit neuronal M2 receptors in airways is not known. In the central nervous system, OPs interact directly with neurons to alter muscarinic receptor function or expression; therefore, in this study we tested whether the OP parathion or its oxon metabolite, paraoxon, might decrease M2 receptor function on peripheral neurons via similar direct mechanisms. Methodology/Principal Findings: Intravenous administration of paraoxon, but not parathion, caused acute frequency-dependent potentiation of vagally-induced bronchoconstriction and increased electrical field stimulation (EFS)-induced contractions in isolated trachea independent of AChE inhibition. However, paraoxon had no effect on vagally-induced bradycardia in intact guinea pigs or EFS-induced contractions in isolated ileum, suggesting mechanisms other than pharmacologic antagonism of M2 receptors. Paraoxon did not alter M2 receptor expression in cultured cells at the mRNA or protein level as determined by quantitative RT-PCR and radio-ligand binding assays, respectively. Additionally, a biotinlabeled fluorophosphonate, which was used as a probe to identify molecular targets phosphorylated by OPs, did not phosphorylate proteins in guinea pig cardiac membranes that were recognized by M2 receptor antibodies. Conclusions/Significance: These data indicate that neither direct pharmacologic antagonism nor downregulated expression of M2 receptors contributes to OP inhibition of M2 function in airway nerves, adding to the growing evidence of non-cholinergic mechanisms of OP neurotoxicity.	[Proskocil, Becky J.; Fryer, Allison D.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Bruun, Donald A.; Lein, Pamela J.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Thompson, Charles M.] Univ Montana, Dept Biomed & Pharmaceut Sci, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	Oregon Health & Science University; University of California System; University of California Davis; University of Montana System; University of Montana	Proskocil, BJ (corresponding author), Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	pjlein@ucdavis.edu	Fryer, Allison/F-2420-2014	Fryer, Allison/0000-0003-1712-9831; Proskocil, Becky/0000-0002-7803-6447; Lein, Pamela/0000-0001-7665-7584	National Institutes of Health [ES014521, RO1-ES014601, UO1-ES016102]; OHSU Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014601, F32ES014521, R01ES017592, U01ES016102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support was provided by the National Institutes of Health (ES014521 to BJP; RO1-ES014601 to ADF and PJL; and UO1-ES016102 to CMT) and the OHSU Foundation (Medical Research Foundation seed grant to PJL). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Berkowitz GS, 2003, ENVIRON HEALTH PERSP, V111, P79, DOI 10.1289/ehp.5619; Bernard W, 2006, TRENDS NEUROSCI, V29, P140, DOI 10.1016/j.tins.2006.01.006; Billington CK, 2002, AM J RESP CELL MOL, V26, P269, DOI 10.1165/ajrcmb.26.3.f232; Bomser JA, 2001, TOXICOL LETT, V119, P21, DOI 10.1016/S0378-4274(00)00294-0; BRYANT DH, 1985, AUST NZ J MED, V15, P66, DOI 10.1111/j.1445-5994.1985.tb02740.x; Canning BJ, 2003, CURR OPIN PHARMACOL, V3, P244, DOI 10.1016/S1471-4892(03)00045-6; CASARETT LJ, 1975, TOXICOLOGY; *CDC, 2003, 030022 NCEH CDC; Costa LG, 2006, CLIN CHIM ACTA, V366, P1, DOI 10.1016/j.cca.2005.10.008; Costello RW, 1997, AM J PHYSIOL-LUNG C, V273, pL93, DOI 10.1152/ajplung.1997.273.1.L93; Coulson FR, 2003, PHARMACOL THERAPEUT, V98, P59, DOI 10.1016/S0163-7258(03)00004-4; Coulson FR, 2002, BRIT J PHARMACOL, V135, P1355, DOI 10.1038/sj.bjp.0704602; Dabisch PA, 2007, TOXICOL SCI, V99, P354, DOI 10.1093/toxsci/kfm167; DESCHAMPS D, 1994, LANCET, V344, P1712, DOI 10.1016/S0140-6736(94)90498-7; Dhein S, 2001, PHARMACOL RES, V44, P161, DOI 10.1006/phrs.2001.0835; Duramad P, 2006, J APPL TOXICOL, V26, P458, DOI 10.1002/jat.1162; Ecobichon D.J., 2001, CASARETT DOULLS TOXI, V6th, P763; Eggleston PA, 2001, J ALLERGY CLIN IMMUN, V107, pS422, DOI 10.1067/mai.2001.113671; EHRICH M, 1994, J TOXICOL ENV HEALTH, V43, P51, DOI 10.1080/15287399409531903; ELBON CL, 1995, AM J RESP CELL MOL, V12, P320, DOI 10.1165/ajrcmb.12.3.7873198; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ernst P, 2002, AM J RESP CRIT CARE, V165, P563, DOI 10.1164/ajrccm.165.5.2201001c; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Fenske RA, 2002, ENVIRON HEALTH PERSP, V110, P549, DOI 10.1289/ehp.02110549; Finkelman FD, 2010, J ALLERGY CLIN IMMUN, V125, P312, DOI 10.1016/j.jaci.2009.12.936; FLIPO D, 1992, INT J IMMUNOPHARMACO, V14, P747, DOI 10.1016/0192-0561(92)90071-R; FRYER AD, 1992, J CLIN INVEST, V90, P2292, DOI 10.1172/JCI116116; FRYER AD, 1984, BRIT J PHARMACOL, V83, P973, DOI 10.1111/j.1476-5381.1984.tb16539.x; FRYER AD, 1991, J APPL PHYSIOL, V71, P2255, DOI 10.1152/jappl.1991.71.6.2255; Fryer AD, 2004, AM J PHYSIOL-LUNG C, V286, pL963, DOI 10.1152/ajplung.00343.2003; FRYER AD, 1989, MEMBRANE BIOCHEM, V8, P127, DOI 10.3109/09687688909025826; Fryer AD, 1998, AM J RESP CRIT CARE, V158, pS154, DOI 10.1164/ajrccm.158.supplement_2.13tac120; GAMBONE LM, 1994, J APPL PHYSIOL, V77, P1492, DOI 10.1152/jappl.1994.77.3.1492; GUSTIN P, 1988, J APPL PHYSIOL, V64, P1786, DOI 10.1152/jappl.1988.64.5.1786; Hartert T V, 2000, Curr Opin Pulm Med, V6, P4, DOI 10.1097/00063198-200001000-00002; HERMANOWICZ A, 1984, CLIN IMMUNOL IMMUNOP, V33, P13, DOI 10.1016/0090-1229(84)90288-5; Higgins D., 1991, CULTURING NERVE CELL, P177; Hoppin JA, 2006, AM J EPIDEMIOL, V163, P1129, DOI 10.1093/aje/kwj138; Hoppin JA, 2002, AM J RESP CRIT CARE, V165, P683, DOI 10.1164/ajrccm.165.5.2106074; HOPPIN JA, 2007, AM J RESP CRIT CARE; Hoppin JA, 2007, AM J IND MED, V50, P969, DOI 10.1002/ajim.20523; Hoppin JA, 2006, ANN NY ACAD SCI, V1076, P343, DOI 10.1196/annals.1371.044; JACOBY DB, 1993, J CLIN INVEST, V91, P1314, DOI 10.1172/JCI116331; Jacoby DB, 1998, J CLIN INVEST, V102, P242, DOI 10.1172/JCI1114; JACOBY DB, 1991, AM REV RESPIR DIS, V144, P1422, DOI 10.1164/ajrccm/144.6.1422a; Jacoby DB, 2001, AM J RESP CELL MOL, V24, P485, DOI 10.1165/ajrcmb.24.4.4379; JETT DA, 1994, TOXICOL LETT, V73, P33, DOI 10.1016/0378-4274(94)90186-4; KILBINGER H, 1980, NEUROSCIENCE, V5, P1331, DOI 10.1016/0306-4522(80)90205-5; KILBINGER H, 1993, J PHYSIOLOGY-PARIS, V87, P77, DOI 10.1016/0928-4257(93)90001-A; Koch D, 2002, ENVIRON HEALTH PERSP, V110, P829, DOI 10.1289/ehp.02110829; Koenig JA, 1996, MOL PHARMACOL, V49, P351; Lee AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1255, DOI 10.1152/ajplung.00451.2003; Lein PJ, 2005, TOXICOL SCI, V83, P166, DOI 10.1093/toxsci/kfi001; LEIN PJ, 2009, ENCY NEUROSCIENCE, P625; Levy A, 2004, J APPL TOXICOL, V24, P501, DOI 10.1002/jat.1008; Lotti M., 2000, EXPT CLIN NEUROTOXIC, P898; Lu CS, 2001, ENVIRON HEALTH PERSP, V109, P299; MINETTE PA, 1988, J APPL PHYSIOL, V64, P2532, DOI 10.1152/jappl.1988.64.6.2532; MINETTE PAH, 1989, J APPL PHYSIOL, V67, P2461, DOI 10.1152/jappl.1989.67.6.2461; Moreno L, 2003, AM J PHYSIOL-LUNG C, V285, pL451, DOI 10.1152/ajplung.00046.2003; *NAT RES COUNC COA, 1993, ALT TECHN DESTR CHEM; Nelson CP, 2004, J PHARMACOL EXP THER, V310, P1255, DOI 10.1124/jpet.104.067140; Nie ZY, 2009, BRIT J PHARMACOL, V156, P201, DOI 10.1111/j.1476-5381.2008.00045.x; OMalley M, 1997, LANCET, V349, P1161, DOI 10.1016/S0140-6736(96)07222-4; Peeples ES, 2005, TOXICOL SCI, V83, P303, DOI 10.1093/toxsci/kfi023; Pena-Philippides JC, 2007, TOXICOL SCI, V97, P181, DOI 10.1093/toxsci/kfm017; Pope CN, 1999, J TOXICOL ENV HEAL B, V2, P161, DOI 10.1080/109374099281205; Proskocil BJ, 2008, ENVIRON HEALTH PERSP, V116, P381, DOI 10.1289/ehp.10694; Rodgers K, 1997, INT J IMMUNOPHARMACO, V19, P149, DOI 10.1016/S0192-0561(96)00073-2; RODGERS K, 1992, AGENTS ACTIONS, V35, P57, DOI 10.1007/BF01990952; Rodgers K, 1997, INT J IMMUNOPHARMACO, V19, P437, DOI 10.1016/S0192-0561(97)00098-2; Rodgers K, 1997, FUND APPL TOXICOL, V37, P95, DOI 10.1006/faat.1997.2302; RODGERS KE, 1990, AGENTS ACTIONS, V29, P277, DOI 10.1007/BF01966458; RODGERS KE, 1990, FUND APPL TOXICOL, V14, P309, DOI 10.1016/0272-0590(90)90210-B; ROFFEL A F, 1990, Pulmonary Pharmacology, V3, P47, DOI 10.1016/0952-0600(90)90009-8; ROFFEL AF, 1994, TRENDS PHARMACOL SCI, V15, P407, DOI 10.1016/0165-6147(94)90084-1; Salam MT, 2004, ENVIRON HEALTH PERSP, V112, P760, DOI 10.1289/ehp.6662; SAVOLAINEN KM, 1992, TOXICOL LETT, V64-5, P437, DOI 10.1016/0378-4274(92)90217-8; Schlador ML, 2000, J BIOL CHEM, V275, P23295, DOI 10.1074/jbc.M002380200; Schopfer LM, 2005, CHEM RES TOXICOL, V18, P747, DOI 10.1021/tx049672j; Segura P, 1999, N-S ARCH PHARMACOL, V360, P699, DOI 10.1007/s002109900101; SENTHILSELVAN A, 1992, AM REV RESPIR DIS, V146, P884, DOI 10.1164/ajrccm/146.4.884; SMOLEN A, 1985, PHARMACOL BIOCHEM BE, V22, P623, DOI 10.1016/0091-3057(85)90285-0; SMOLEN A, 1986, PHARMACOL BIOCHEM BE, V24, P1077, DOI 10.1016/0091-3057(86)90458-2; Sun Tingting, 2003, J Toxicol Sci, V28, P427, DOI 10.2131/jts.28.427; *USDA, 2003, AGR CHEM PROD TECHN; Verhein KC, 2008, AM J RESP CELL MOL, V39, P730, DOI 10.1165/rcmb.2008-0045OC; Ward TR, 1996, BRAIN RES BULL, V39, P49, DOI 10.1016/0361-9230(95)02044-6; WEISENBURGER DD, 1993, HUM PATHOL, V24, P571, DOI 10.1016/0046-8177(93)90234-8; WEITZMAN M, 1992, JAMA-J AM MED ASSOC, V268, P2673, DOI 10.1001/jama.268.19.2673; Whyatt RM, 2002, ENVIRON HEALTH PERSP, V110, P507, DOI 10.1289/ehp.02110507; WILHOIT L, 1999, PESTICIDE USE ANAL T; Xiong SQ, 1997, J TOXICOL ENV HEALTH, V51, P159, DOI 10.1080/009841097160140; Yagle K, 1996, NEUROTOXICOLOGY, V17, P523; Yang D, 2008, TOXICOL APPL PHARM, V228, P32, DOI 10.1016/j.taap.2007.11.005; Yoon HK, 2007, ENVIRON HEALTH PERSP, V115, P1557, DOI 10.1289/ehp.10289; Zamora EMU, 2008, J TOXICOL ENV HEAL A, V71, P1440, DOI 10.1080/15287390802328887	98	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10562	10.1371/journal.pone.0010562	http://dx.doi.org/10.1371/journal.pone.0010562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479945	Green Submitted, Green Published, gold			2022-12-25	WOS:000277467900017
J	Lee, CR; Imig, JD; Edin, ML; Foley, J; DeGraff, LM; Bradbury, JA; Graves, JP; Lih, FB; Clark, J; Myers, P; Perrow, AL; Lepp, AN; Kannon, MA; Ronnekleiv, OK; Alkayed, NJ; Falck, JR; Tomer, KB; Zeldin, DC				Lee, Craig R.; Imig, John D.; Edin, Matthew L.; Foley, Julie; DeGraff, Laura M.; Bradbury, J. Alyce; Graves, Joan P.; Lih, Fred B.; Clark, James; Myers, Page; Perrow, A. Ligon; Lepp, Adrienne N.; Kannon, M. Alison; Ronnekleiv, Oline K.; Alkayed, Nabil J.; Falck, John R.; Tomer, Kenneth B.; Zeldin, Darryl C.			Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice	FASEB JOURNAL			English	Article						CYP2J2; CYP2C8; epoxygenase; EETs; transgenic	SOLUBLE EPOXIDE HYDROLASE; SALT-SENSITIVE HYPERTENSION; ARACHIDONIC-ACID METABOLISM; ANGIOTENSIN-II; NITRIC-OXIDE; EPOXYEICOSATRIENOIC ACIDS; HYPERPOLARIZING FACTORS; CORONARY-ARTERIES; MOLECULAR-CLONING; GENE-EXPRESSION	Renal cytochrome P450 (CYP)-derived epoxyeicosatrienoic acids (EETs) regulate sodium transport and blood pressure. Although endothelial CYP-derived EETs are potent vasodilators, their contribution to the regulation of blood pressure remains unclear. Consequently, we developed transgenic mice with endothelial expression of the human CYP2J2 and CYP2C8 epoxygenases to increase endothelial EET biosynthesis. Compared to wild-type littermate controls, an attenuated afferent arteriole constrictor response to endothelin-1 and enhanced dilator response to acetylcholine was observed in CYP2J2 and CYP2C8 transgenic mice. CYP2J2 and CYP2C8 transgenic mice demonstrated modestly, but not significantly, lower mean arterial pressure under basal conditions compared to wild-type controls. However, mean arterial pressure was significantly lower in both CYP2J2 and CYP2C8 transgenic mice during coadministration of N-nitro-L-arginine methyl ester and indomethacin. In a separate experiment, a high-salt diet and subcutaneous angiotensin II was administered over 4 wk. The angiotensin/high-saltinduced increase in systolic blood pressure, proteinuria, and glomerular injury was significantly attenuated in CYP2J2 and CYP2C8 transgenic mice compared to wild-type controls. Collectively, these data demonstrate that increased endothelial CYP epoxygenase expression attenuates afferent arteriolar constrictor reactivity and hypertension-induced increases in blood pressure and renal injury in mice. We conclude that endothelial CYP epoxygenase function contributes to the regulation of blood pressure.-Lee, C. R., Imig, J. D., Edin, M. E., Foley, J., DeGraff, L. M., Bradbury, J. A., Graves, J. P., Lih, F. B., Clark, J., Myers, P., Perrow, A. L., Lepp, A. N., Kannon, M. A., Ronnekleiv, O. K., Alkayed, N. J., Falck, J. R., Tomer, K. B., Zeldin, D. C. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice. FASEB J. 24, 3770-3781 (2010). www.fasebj.org	[Lee, Craig R.; Edin, Matthew L.; Foley, Julie; DeGraff, Laura M.; Bradbury, J. Alyce; Graves, Joan P.; Lih, Fred B.; Clark, James; Myers, Page; Perrow, A. Ligon; Tomer, Kenneth B.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Lee, Craig R.; Kannon, M. Alison] Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC USA; [Imig, John D.; Lepp, Adrienne N.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Ronnekleiv, Oline K.; Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; Medical College of Wisconsin; Oregon Health & Science University; Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zeldin, DC (corresponding author), NIEHS, Div Intramural Res, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Tomer, Kenneth B/E-8018-2013; Zeldin, Darryl C/Y-7091-2018; Falck, John R/B-3030-2011; Edin, Matthew/AAI-1934-2019	Zeldin, Darryl C/0000-0002-2087-7307; Falck, John R/0000-0002-9219-7845; Edin, Matthew/0000-0002-7042-500X; Imig, John/0000-0002-9668-2899; Lee, Craig/0000-0003-3595-5301	American Heart Association; U.S. National Institutes of Health (NIH) [DK38826]; Advancing a Healthier Wisconsin; Robert A. Welch Foundation; NIH [P01 NS049210, GM31278]; NIH, National Institute of Environmental Health Sciences (NIEHS) [Z01 ES050167, Z01 ES025034]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226, R01DK038826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025034, ZIGES102505, Z01ES050167, ZIAES050167, ZIAES025034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088199, R01GM031278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070837, R01NS044313, P01NS049210] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advancing a Healthier Wisconsin; Robert A. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge the technical assistance of Dr. Taiping Jia in completion of the in situ hybridization studies, and Drs. Anton Jetten and Robert Langenbach for their helpful comments during the preparation of this manuscript. This publication was made possible by a Beginning Grant-in-Aid from the American Heart Association to C.R.L.; U.S. National Institutes of Health (NIH) grant DK38826 and an Advancing a Healthier Wisconsin grant to J.D.I.; NIH grant P01 NS049210 to O.K.R. and N.J.A.; NIH grant GM31278 and support from the Robert A. Welch Foundation to J.R.F., and funds from the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (NIEHS) to K.B.T. (Z01 ES050167) and D.C.Z. (Z01 ES025034). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS or NIH. D.C.Z. is a coinventor on U.S. Patent 6,531,506 B1 (issued March 11, 2003), Inhibition of Epoxide Hydrolases for the Treatment of Hypertension, and on U.S. Patent 6,916,843 B1 (issued July 12, 2005), Anti-inflammatory Actions of Cytochrome P450 Epoxygenase-Derived Eicosanoids. J.D.I. is a coinventor on U.S. Patent 7,550,617 (issued June 23, 2009), Compositions and Methods for the Treatment of Renal and Cardiovascular Disease. No other authors have conflicts of interest to disclose.	Athirakul K, 2008, FASEB J, V22, P4096, DOI 10.1096/fj.08-114413; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; Capdevila JH, 2007, KIDNEY INT, V72, P683, DOI 10.1038/sj.ki.5002394; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeLozier TC, 2007, DRUG METAB DISPOS, V35, P682, DOI 10.1124/dmd.106.012823; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Elmarakby AA, 2006, HYPERTENSION, V47, P557, DOI 10.1161/01.HYP.0000198545.01860.90; Fava C, 2008, HYPERTENSION, V52, P373, DOI 10.1161/HYPERTENSIONAHA.108.114199; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Gauthier KM, 2002, CIRC RES, V90, P1028, DOI 10.1161/01.RES.0000018162.87285.F8; Hartner A, 2003, NEPHROL DIAL TRANSPL, V18, P1999, DOI 10.1093/ndt/gfg299; Hercule HC, 2009, ARTERIOSCL THROM VAS, V29, P54, DOI 10.1161/ATVBAHA.108.171298; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2001, J VASC RES, V38, P247, DOI 10.1159/000051053; Imig JD, 2002, AM J PHYSIOL-RENAL, V283, pF415, DOI 10.1152/ajprenal.00351.2001; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 1996, J AM SOC NEPHROL, V7, pA1570; Imig JD, 1999, BRIT J PHARMACOL, V127, P1399, DOI 10.1038/sj.bjp.0702662; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Inoue K, 2009, AM J PHYSIOL-RENAL, V297, pF875, DOI 10.1152/ajprenal.00364.2009; Kaergel E, 2002, HYPERTENSION, V40, P273, DOI 10.1161/01.HYP.0000029240.44253.5E; King LM, 2002, MOL PHARMACOL, V61, P840, DOI 10.1124/mol.61.4.840; King Lorraine M, 2005, Pharmacogenet Genomics, V15, P7, DOI 10.1097/01213011-200501000-00002; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Larsen BT, 2006, AM J PHYSIOL-HEART C, V290, pH491, DOI 10.1152/ajpheart.00927.2005; Lee CR, 2007, PHARMACOGENET GENOM, V17, P145, DOI 10.1097/01.fpc.0000236340.87540.e3; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2004, MOL PHARMACOL, V65, P730, DOI 10.1124/mol.65.3.730; MAKITA K, 1994, J CLIN INVEST, V94, P2414, DOI 10.1172/JCI117608; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; Minuz P, 2008, HYPERTENSION, V51, P1379, DOI 10.1161/HYPERTENSIONAHA.107.105395; Muller DN, 2004, AM J PATHOL, V164, P521, DOI 10.1016/S0002-9440(10)63142-2; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; Ohashi Y, 1998, J CLIN INVEST, V102, P2061, DOI 10.1172/JCI4394; Peebles RS, 2000, AM J RESP CRIT CARE, V162, P676; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Singh H, 2007, HYPERTENSION, V50, P123, DOI 10.1161/HYPERTENSIONAHA.107.089599; Theken KN, 2007, PHARMACOGENOMICS, V8, P1369, DOI 10.2217/14622416.8.10.1369; Torok J, 2008, PHYSIOL RES, V57, P813, DOI 10.33549/physiolres.931581; Wang JS, 2006, CIRC RES, V98, P962, DOI 10.1161/01.RES.0000217283.98806.a6; Wu S, 1996, J BIOL CHEM, V271, P3460; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438; Zhao XY, 2004, J AM SOC NEPHROL, V15, P1244; Zhao XY, 2003, HYPERTENSION, V41, P709, DOI 10.1161/01.HYP.0000047877.36743.FA	53	117	120	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3770	3781		10.1096/fj.10-160119	http://dx.doi.org/10.1096/fj.10-160119			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20495177	Green Published			2022-12-25	WOS:000285005900016
J	Wang, BX; Mao, YK; Diorio, C; Pasyk, M; Wu, RY; Bienenstock, J; Kunze, WA				Wang, Bingxian; Mao, Yu-Kang; Diorio, Caroline; Pasyk, Michael; Wu, Richard You; Bienenstock, John; Kunze, Wolfgang A.			Luminal administration ex vivo of a live Lactobacillus species moderates mouse jejunal motility within minutes	FASEB JOURNAL			English	Article						enteric nervous system; small intestine; probiotics	GAMMA-AMINOBUTYRIC-ACID; SEGMENTED FILAMENTOUS BACTERIA; CA2+-ACTIVATED K+ CHANNEL; ENTERIC NERVOUS-SYSTEM; PIG MYENTERIC NEURONS; POTASSIUM-CHANNELS; INTESTINAL MUSCLE; PROBIOTIC THERAPY; AFFERENT-FIBERS; BLOOD-PRESSURE	Gut commensals modulate host immune, endocrine, and metabolic functions. They also affect peripheral and central neural reflexes and function. We have previously shown that daily ingestion of Lactobacillus reuteri (LR) for 9 d inhibits the pseudoaffective cardiac response and spinal single-fiber discharge evoked by visceral distension, and decreases intestinal motility and myenteric AH cell slow afterhyperpolarization (sAHP) by inhibiting a Ca-activated K (IKCa) channel. We tested whether luminal LR could acutely decrease motility in an ex vivo perfusion model of naive Balb/c jejunum. Live LR dose dependently decreased motor complex pressure wave amplitudes with 9- to 16-min onset latency and an IC50 of 5 x 10(7) cells/ml Krebs. Heat-killed LR or another live commensal, Lactobacillus salivarius, were without effect. The IKCa channel blocker TRAM-34, but neither the opener (DCEBIO) nor the hyperpolarization-activated cationic channel inhibitor ZD7288 (5 mu M) (or TTX 1 mu M), mimicked the LR effect on motility acutely ex vivo. We provide evidence for a rapid, strain-specific, dose-dependent action of a live Lactobacillus on small intestinal motility reflexes that recapitulates the long-term effects of LR ingestion. These observations may be useful as a first step to unraveling the pathways involved in bacteria to the nervous system communication.-Wang, B., Mao, Y.-K., Diorio, C., Pasyk, M., Wu, R.Y., Bienenstock, J., Kunze, W.A. Luminal administration ex vivo of a live Lactobacillus species moderates mouse jejunal motility within minutes. FASEB J. 24, 4078-4088 (2010). www.fasebj.org	[Wang, Bingxian; Mao, Yu-Kang; Diorio, Caroline; Pasyk, Michael; Wu, Richard You; Bienenstock, John; Kunze, Wolfgang A.] St Josephs Healthcare, McMaster Brain Body Inst, Hamilton, ON L8N 4A6, Canada; [Kunze, Wolfgang A.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Wang, Bingxian] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Bienenstock, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Kunze, WA (corresponding author), St Josephs Healthcare, McMaster Brain Body Inst, Juravinsky Innovat Tower,50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	kunzew@mcmaster.ca		Diorio, Caroline/0000-0002-8005-3836	Natural Sciences and Engineering Council of Canada; Guglietti Family Foundation; Abbott Nutrition	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Guglietti Family Foundation; Abbott Nutrition(Abbott Laboratories)	This study was supported by a grant from the Natural Sciences and Engineering Council of Canada, the Guglietti Family Foundation, and Abbott Nutrition.	Abdu F, 2002, AM J PHYSIOL-GASTR L, V282, pG624, DOI 10.1152/ajpgi.00354.2001; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bian XC, 2004, AM J PHYSIOL-GASTR L, V287, pG134, DOI 10.1152/ajpgi.00532.2003; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BIENENSTOCK J, 1989, ADV EXP MED BIOL, V257, P19; BULBRING E, 1958, J PHYSIOL-LONDON, V140, P381; Burley JR, 2000, NEUROPHARMACOLOGY, V39, P1740, DOI 10.1016/S0028-3908(99)00266-X; Bush TG, 2000, AUTON NEUROSCI-BASIC, V84, P162, DOI 10.1016/S1566-0702(00)00201-0; CERVERO F, 1988, J PHYSIOL-LONDON, V401, P381, DOI 10.1113/jphysiol.1988.sp017168; CHERUBINI E, 1984, BRIT J PHARMACOL, V82, P93, DOI 10.1111/j.1476-5381.1984.tb16445.x; Chiocchetti R, 2008, CELL TISSUE RES, V332, P185, DOI 10.1007/s00441-008-0583-y; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; D'Souza AL, 2002, BRIT MED J, V324, P1361, DOI 10.1136/bmj.324.7350.1361; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Davies PJ, 2006, AUTON NEUROSCI-BASIC, V124, P26, DOI 10.1016/j.autneu.2005.10.006; Ferens D, 2007, NEUROGASTROENT MOTIL, V19, P383, DOI 10.1111/j.1365-2982.2007.00898.x; Forsythe P, 2008, THERAPEUTIC MICROBIOLOGY: PROBIOTICS AND RELATED STRATEGIES, P285; Forsythe P, 2010, BRAIN BEHAV IMMUN, V24, P9, DOI 10.1016/j.bbi.2009.05.058; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 2004, CELL TISSUE RES, V317, P1, DOI 10.1007/s00441-004-0895-5; FURUKAWA K, 1986, J NEUROPHYSIOL, V55, P1395, DOI 10.1152/jn.1986.55.6.1395; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P1306, DOI 10.1111/j.1365-2982.2008.01201.x; Gionchetti P, 2006, WORLD J GASTROENTERO, V12, P3306, DOI 10.3748/wjg.v12.i21.3306; Guarner F, 2008, WORLD GASTROENTEROLO; Hanani M, 2000, AM J PHYSIOL-GASTR L, V278, pG644, DOI 10.1152/ajpgi.2000.278.4.G644; Hashiguchi-Ikeda M, 2003, ANESTHESIOLOGY, V99, P1340, DOI 10.1097/00000542-200312000-00015; Hayakawa K, 2004, BRIT J NUTR, V92, P411, DOI 10.1079/BJN20041221; HIRST GDS, 1974, J PHYSIOL-LONDON, V236, P303, DOI 10.1113/jphysiol.1974.sp010436; Huizinga JD, 1998, J PHYSIOL-LONDON, V506, P843, DOI 10.1111/j.1469-7793.1998.843bv.x; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iyer LM, 2004, TRENDS GENET, V20, P292, DOI 10.1016/j.tig.2004.05.007; JESSEN KR, 1981, MOL CELL BIOCHEM, V38, P69, DOI 10.1007/BF00235689; Kamiya T, 2006, GUT, V55, P191, DOI 10.1136/gut.2005.070987; Kamm K, 2004, NEUROGASTROENT MOTIL, V16, P53, DOI 10.1046/j.1365-2982.2003.00458.x; KEAST JR, 1984, GASTROENTEROLOGY, V86, P637; Kinross James M, 2008, Curr Gastroenterol Rep, V10, P396, DOI 10.1007/s11894-008-0075-y; KRANTIS A, 1987, EUR J PHARMACOL, V141, P291, DOI 10.1016/0014-2999(87)90274-3; Krantis A, 2000, NEWS PHYSIOL SCI, V15, P284; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; KUNZE WA, 2007, EE11 ANN M SOC NEUR; KUNZE WAA, 1994, PFLUG ARCH EUR J PHY, V428, P300, DOI 10.1007/BF00724511; KUNZE WAA, 1993, NEUROSCIENCE, V55, P685, DOI 10.1016/0306-4522(93)90434-H; Kunze WAA, 1999, J PHYSIOL-LONDON, V517, P547, DOI 10.1111/j.1469-7793.1999.0547t.x; Kunze WA, 2009, J CELL MOL MED, V13, P2261, DOI 10.1111/j.1582-4934.2009.00686.x; Ma XL, 2009, AM J PHYSIOL-GASTR L, V296, pG868, DOI 10.1152/ajpgi.90511.2008; Mao YK, 2006, J NEUROPHYSIOL, V96, P998, DOI 10.1152/jn.00204.2006; Mazzia C, 1997, NEUROSCIENCE, V80, P925, DOI 10.1016/S0306-4522(97)00058-4; Mazzuoli G, 2009, J PHYSIOL-LONDON, V587, P4681, DOI 10.1113/jphysiol.2009.177105; McCarthy E L, 1934, Science, V80, P100, DOI 10.1126/science.80.2065.100; Mignini F., 2003, Autonomic & Autacoid Pharmacology, V23, P1, DOI 10.1046/j.1474-8673.2003.00280.x; MINOCHA A, 1993, EUR J PHARMACOL, V230, P187, DOI 10.1016/0014-2999(93)90801-N; Morimura K, 2006, J PHARMACOL SCI, V100, p121P; Motulsky H., 1999, ANAL DATA GRAPHPAD P; Namba T, 2000, EUR J PHARMACOL, V395, P95, DOI 10.1016/S0014-2999(00)00254-5; Neal KB, 2009, J PHYSIOL-LONDON, V587, P567, DOI 10.1113/jphysiol.2008.160416; Nguyen TV, 2007, J NEUROPHYSIOL, V97, P2024, DOI 10.1152/jn.00935.2006; NORTH RA, 1987, J PHYSIOL-LONDON, V386, P333, DOI 10.1113/jphysiol.1987.sp016537; Nurgali K, 2004, J COMP NEUROL, V468, P112, DOI 10.1002/cne.10948; Nurgali K, 2007, J PHYSIOL-LONDON, V583, P593, DOI 10.1113/jphysiol.2007.135947; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; ODORISIO MS, 1988, INT J NEUROSCI, V38, P189, DOI 10.3109/00207458809000497; Park KB, 2007, BIORESOURCE TECHNOL, V98, P312, DOI 10.1016/j.biortech.2006.01.004; Pedarzani P, 2005, J BIOL CHEM, V280, P41404, DOI 10.1074/jbc.M509610200; Powley TL, 2008, NEUROGASTROENT MOTIL, V20, P69, DOI 10.1111/j.1365-2982.2007.00990.x; Ren JH, 2003, J PHYSIOL-LONDON, V552, P809, DOI 10.1113/jphysiol.2003.047944; Rong WF, 2004, J PHYSIOL-LONDON, V560, P867, DOI 10.1113/jphysiol.2004.071746; Rousseaux C, 2007, NAT MED, V13, P35, DOI 10.1038/nm1521; Rugiero F, 2002, J PHYSIOL-LONDON, V538, P447, DOI 10.1113/jphysiol.2001.013051; Salinas E, 2006, PLOS BIOL, V4, P2383, DOI 10.1371/journal.pbio.0040387; Sarna SK, 2007, AM J PHYSIOL-GASTR L, V292, pG572, DOI 10.1152/ajpgi.00332.2006; Schemann M, 2010, AUTON NEUROSCI-BASIC, V153, P21, DOI 10.1016/j.autneu.2009.08.003; Shanahan F, 2005, AM J PHYSIOL-GASTR L, V288, pG417, DOI 10.1152/ajpgi.00421.2004; Siragusa S, 2007, APPL ENVIRON MICROB, V73, P7283, DOI 10.1128/AEM.01064-07; Stanisz AM, 2000, ANN NY ACAD SCI, V917, P268; Studinger P, 2007, J PHYSIOL-LONDON, V583, P1041, DOI 10.1113/jphysiol.2007.139204; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tanida M, 2005, NEUROSCI LETT, V389, P109, DOI 10.1016/j.neulet.2005.07.036; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Verdu EF, 2006, GUT, V55, P182, DOI 10.1136/gut.2005.066100; Verdu EF, 2004, GASTROENTEROLOGY, V127, P826, DOI 10.1053/j.gastro.2004.06.007; WALKER R, 2006, PROBIOTIC MICROBES S; Wang B, 2010, NEUROGASTROENT MOTIL, V22, P98, DOI 10.1111/j.1365-2982.2009.01384.x; WANG B, 2009, NEUROGASTROENT MOTIL, V22, pE33; WATERMAN SA, 1994, J PHYSIOL-LONDON, V474, P539, DOI 10.1113/jphysiol.1994.sp020043; WOOD JD, 1972, AM J PHYSIOL, V222, P118, DOI 10.1152/ajplegacy.1972.222.1.118; Xiao J, 2004, NEUROSCIENCE, V129, P603, DOI 10.1016/j.neuroscience.2004.08.027; Yamano T, 2006, LIFE SCI, V79, P1963, DOI 10.1016/j.lfs.2006.06.038; Yanagida H, 2000, AM J PHYSIOL-CELL PH, V278, pC40, DOI 10.1152/ajpcell.2000.278.1.C40; Zholos AV, 2002, AUTON NEUROSCI-BASIC, V96, P93, DOI 10.1016/S1566-0702(01)00364-2; Zhou XP, 2000, J AUTONOM NERV SYST, V78, P122, DOI 10.1016/S0165-1838(99)00065-X	93	72	74	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					4078	4088		10.1096/fj.09-153841	http://dx.doi.org/10.1096/fj.09-153841			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20519636				2022-12-25	WOS:000285005900043
J	Gomez, MA; Alisaraie, L; Shio, MT; Berghuis, AM; Lebrun, C; Gautier-Luneau, I; Olivier, M				Gomez, Maria Adelaida; Alisaraie, Laleh; Shio, Marina Tiemi; Berghuis, Albert M.; Lebrun, Colette; Gautier-Luneau, Isabelle; Olivier, Martin			Protein Tyrosine Phosphatases Are Regulated by Mononuclear Iron Dicitrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON(III) CITRATE COMPLEXES; MEMBRANE TRANSPORTER FECA; STRUCTURAL BASIS; NATURAL-RESISTANCE; IMMUNE-RESPONSE; CITRIC-ACID; NRAMP1 GENE; MACROPHAGE; EXPRESSION; PHOSPHORYLATION	The involvement of macrophages (M phi s) as host, accessory, and effector cells in the development of infectious diseases, together with their central role in iron homeostasis, place these immune cells as key players in the interface between iron and infection. Having previously shown that the functional expression of NRAMP-1 results in increased protein phosphorylation mediated in part by an iron-dependent inhibition of M phi protein-tyrosine phosphatase (PTP) activity, we sought to study the mechanism(s) underlying this specific event. Herein we have identified the mononuclear dicitrate iron complex [Fe(cit)(2)H(4-x)]((1+x)-) as the species responsible for the specific inhibition of M phi PTP activity. By using biochemical and computational approaches, we show that [Fe(cit)(2)](5-) targets the catalytic pocket of the PTP SHP-1, competitively inhibiting its interaction with an incoming phosphosubstrate. In vitro and in vivo inhibition of PTP activity by iron-citrate results in protein hyperphosphorylation and enhanced MAPK signaling in response to LPS stimulation. We propose that iron-citrate-mediated PTP inhibition represents a novel and biologically relevant regulatory mechanism of signal transduction.	[Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Gomez, Maria Adelaida; Shio, Marina Tiemi; Olivier, Martin] McGill Univ, Ctr Study Host Resistance, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Gomez, Maria Adelaida; Shio, Marina Tiemi; Olivier, Martin] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Alisaraie, Laleh; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Lebrun, Colette] CEA Grenoble, INAC, Lab Reconnaissance Ion & Chim Coordinat, Serv Chim Inorgan & Biol UMR E CEA UJF 3, F-38054 Grenoble 09, France; [Gautier-Luneau, Isabelle] CNRS, Inst Neel, F-38042 Grenoble 9, France; [Gautier-Luneau, Isabelle] Univ Grenoble 1, F-38042 Grenoble 9, France	McGill University; McGill University; McGill University; McGill University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,Rm 610,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	martin.olivier@mcgill.ca	Shio, Marina Tiemi/E-6466-2019; Gautier-Luneau, Isabelle/ABF-7007-2020; Berghuis, Albert M/A-6495-2008; LEBRUN, Colette/I-1695-2014	Shio, Marina Tiemi/0000-0002-2494-6816; Gautier-Luneau, Isabelle/0000-0003-1800-0167; LEBRUN, Colette/0000-0001-7908-2202; Berghuis, Albert/0000-0002-2663-025X; Gomez, Maria Adelaida/0000-0001-8792-1563	Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institute of Health Research (CIHR) operating grant (to M. O.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BAKKEREN DL, 1985, INT J BIOCHEM, V17, P925, DOI 10.1016/0020-711X(85)90177-6; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Bino A, 1998, INORG CHEM, V37, P5168, DOI 10.1021/ic9715658; BLACKWELL JM, 1991, IMMUNOL LETT, V30, P241, DOI 10.1016/0165-2478(91)90032-6; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Canonne-Hergaux F, 2002, BLOOD, V100, P268, DOI 10.1182/blood.V100.1.268; Dadke S, 2001, MOL CELL BIOCHEM, V221, P147, DOI 10.1023/A:1010909031310; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Gautier-Luneau I, 2005, CHEM-EUR J, V11, P2207, DOI 10.1002/chem.200401087; Gautier-Luneau I, 2007, BIOMETALS, V20, P793, DOI 10.1007/s10534-006-9042-y; Gomez MA, 2007, J BIOL CHEM, V282, P36190, DOI 10.1074/jbc.M703140200; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; LORENZ U, 1994, MOL CELL BIOL, V14, P1824, DOI 10.1128/MCB.14.3.1824; Markova B, 2005, METHODS, V35, P22, DOI 10.1016/j.ymeth.2004.07.004; Matzapetakis M, 1998, J AM CHEM SOC, V120, P13266, DOI 10.1021/ja9807035; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Pierre JL, 2000, BIOMETALS, V13, P91, DOI 10.1023/A:1009225701332; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; ROACH TIA, 1991, INFECT IMMUN, V59, P3935, DOI 10.1128/IAI.59.11.3935-3944.1991; SCHAIBLE UE, 2004, NAT REV MICROBIOL, V2, P946, DOI DOI 10.1038/NRMICR01046; SHWEKY I, 1994, INORG CHEM, V33, P5161, DOI 10.1021/ic00101a001; Strack V, 2002, BIOCHEMISTRY-US, V41, P603, DOI 10.1021/bi011327v; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; Theurl I, 2005, BIOMETALS, V18, P359, DOI 10.1007/s10534-005-3710-1; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Wang LJ, 2008, J IMMUNOL, V181, P2723, DOI 10.4049/jimmunol.181.4.2723; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Yang J, 1998, J BIOL CHEM, V273, P28199, DOI 10.1074/jbc.273.43.28199; Yue WW, 2003, J MOL BIOL, V332, P353, DOI 10.1016/S0022-2836(03)00855-6	46	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24620	24628		10.1074/jbc.M110.107037	http://dx.doi.org/10.1074/jbc.M110.107037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519508	Green Published, hybrid			2022-12-25	WOS:000280542100034
J	Hartmann, AM; Wenz, M; Mercado, A; Storger, C; Mount, DB; Friauf, E; Nothwang, HG				Hartmann, Anna-Maria; Wenz, Meike; Mercado, Adriana; Stoerger, Christof; Mount, David B.; Friauf, Eckhard; Nothwang, Hans Gerd			Differences in the Large Extracellular Loop between the K+-Cl- Cotransporters KCC2 and KCC4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY NEUROTRANSMISSION; TRANSPORT; DOMAINS; BRAIN; IDENTIFICATION; DISRUPTION; MEMBRANE; TERMINUS; GRADIENT; ISOFORMS	K+Cl- cotransporters (KCCs) play fundamental physiological roles in processes such as inhibitory neurotransmission and cell volume regulation. Mammalian genomes encode four distinct KCC paralogs, which share basic transport characteristics but differ significantly in ion affinity, pharmacology, and relative sensitivity to cell volume. Studies to identify divergence in functional characteristics have thus far focused on the cytoplasmic termini. Here, we investigated sequence requirements of the large extracellular loop (LEL) for function in KCC2 and KCC4. Mutation of all four evolutionarily conserved cysteines abolished KCC2 transport activity. This behavior differs from that of its closest relative, KCC4, which is insensitive to this mutation. Chimeras supported the differences in the LEL of the two cotransporters, because swapping wild-type LEL resulted in functional KCC2 but rendered KCC4 inactive. Insertion of the quadruple cysteine substitution mutant of the KCC4 loop, which was functional in the parental isoform, abolished transport activity in KCC2. Dose-response curves of wild-type and chimeric KCCs revealed that the LEL contributes to the different sensitivity to loop diuretics; a KCC2 chimera containing the KCC4 LEL displayed an IC50 of 396.5 mu M for furosemide, which was closer to KCC4 (548.8 mu M) than to KCC2 (184.4 mu M). Cell surface labeling and immunocytochemistry indicated that mutations do not affect trafficking to the plasma membrane. Taken together, our results show a dramatic and unexpected difference in the sequence requirements of the LEL between the closely related KCC2 and KCC4. Furthermore, they demonstrate that evolutionarily highly conserved amino acids can have different functions within KCC members.	[Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, Inst Biol & Environm Sci, D-26111 Oldenburg, Germany; [Wenz, Meike; Stoerger, Christof; Friauf, Eckhard; Nothwang, Hans Gerd] Univ Kaiserslautern, Dept Biol, Anim Physiol Grp, D-67663 Kaiserslautern, Germany; [Mercado, Adriana; Mount, David B.] Harvard Univ, Sch Med, Div Renal, Brigham & Womens Hosp, Boston, MA 02115 USA; [Mount, David B.] Vet Affairs Boston Healthcare Syst, Div Renal, W Roxbury, MA 02132 USA	Carl von Ossietzky Universitat Oldenburg; University of Kaiserslautern; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, Inst Biol & Environm Sci, Carl von Ossietzky Str 9-11, D-26111 Oldenburg, Germany.	hans.g.nothwang@uni-oldenburg.de	Mercado, Adriana/AAR-6143-2021; Nothwang, Hans G/C-5847-2011; Friauf, Eckhard/D-7529-2012	Mercado, Adriana/0000-0002-6881-0160; Friauf, Eckhard/0000-0002-1833-1698; Nothwang, Hans Gerd/0000-0001-7695-6437	National Institutes of Health [DK57708]; Deutsche Forschungsgemeinschaft [428/2-3]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK57708 (to D.B.M.). This work was also supported by Deutsche Forschungsgemeinschaft Grant 428/2-3 (to H.G.N.).	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Casula S, 2009, BLOOD CELL MOL DIS, V42, P233, DOI 10.1016/j.bcmd.2009.01.021; CELL P, 1997, AM J PHYSIOL, V273, pC1516; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gerelsaikhan T, 2000, J BIOL CHEM, V275, P40471, DOI 10.1074/jbc.M007751200; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Hershfinkel M, 2009, NAT NEUROSCI, V12, P725, DOI 10.1038/nn.2316; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Isenring P, 1998, J GEN PHYSIOL, V112, P549, DOI 10.1085/jgp.112.5.549; Jacoby SC, 1999, AM J PHYSIOL-CELL PH, V277, pC684, DOI 10.1152/ajpcell.1999.277.4.C684; Karadsheh MF, 2004, NEUROSCIENCE, V123, P381, DOI 10.1016/j.neuroscience.2003.10.004; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Martinez GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002746; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Reynolds A, 2008, J NEUROSCI, V28, P1588, DOI 10.1523/JNEUROSCI.3791-07.2008; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Saeki T, 2002, BIOSCI BIOTECH BIOCH, V66, P467, DOI 10.1271/bbb.66.467; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Tanis JE, 2009, J NEUROSCI, V29, P9943, DOI 10.1523/JNEUROSCI.1989-09.2009; Uvarov P, 2009, J BIOL CHEM, V284, P13696, DOI 10.1074/jbc.M807366200; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014	40	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23994	24002		10.1074/jbc.M110.144063	http://dx.doi.org/10.1074/jbc.M110.144063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516068	Green Published, hybrid			2022-12-25	WOS:000280291400050
J	Pohl, S; Tiede, S; Marschner, K; Encarnacao, M; Castrichini, M; Kollmann, K; Muschol, N; Ullrich, K; Muller-Loennies, S; Braulke, T				Pohl, Sandra; Tiede, Stephan; Marschner, Katrin; Encarnacao, Marisa; Castrichini, Monica; Kollmann, Katrin; Muschol, Nicole; Ullrich, Kurt; Mueller-Loennies, Sven; Braulke, Thomas			Proteolytic Processing of the gamma-Subunit Is Associated with the Failure to Form GlcNAc-1-phosphotransferase Complexes and Mannose 6-Phosphate Residues on Lysosomal Enzymes in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-TRANSPLANTATION; UDP-N-ACETYLGLUCOSAMINE; CATHEPSIN-D; SANDHOFF-DISEASE; ACID-HYDROLASES; III GAMMA; RECEPTOR; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; CELLS; MICE	GlcNAc-1-phosphotransferase is a Golgi-resident 540-kDa complex of three subunits, alpha(2)beta(2)gamma(2), that catalyze the first step in the formation of the mannose 6-phosphate (M6P) recognition marker on lysosomal enzymes. Anti-M6P antibody analysis shows that human primary macrophages fail to generate M6P residues. Here we have explored the sorting and intracellular targeting of cathepsin D as a model, and the expression of the GlcNAc-1-phosphotransferase complex in macrophages. Newly synthesized cathepsin D is transported to lysosomes in an M6P-independent manner in association with membranes whereas the majority is secreted. Realtime PCR analysis revealed a 3-10-fold higher GlcNAc-1-phosphotransferase subunit mRNA levels in macrophages than in fibroblasts or HeLa cells. At the protein level, the gamma-subunit but not the beta-subunit was found to be proteolytically cleaved into three fragments which form irregular 97-kDa disulfide-linked oligomers in macrophages. Size exclusion chromatography showed that the gamma-subunit fragments lost the capability to assemble with other GlcNAc1-phosphotransferase subunits to higher molecular complexes. These findings demonstrate that proteolytic processing of the gamma-subunit represents a novel mechanism to regulate GlcNAc1-phosphotransferase activity and the subsequent sorting of lysosomal enzymes.	[Pohl, Sandra; Tiede, Stephan; Marschner, Katrin; Encarnacao, Marisa; Castrichini, Monica; Kollmann, Katrin; Muschol, Nicole; Ullrich, Kurt; Braulke, Thomas] Childrens Hosp, Dept Biochem, Univ Med Ctr Hamburg Eppendorf, D-20246 Hamburg, Germany; [Mueller-Loennies, Sven] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Med & Biochem Microbiol, D-23845 Borstel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Forschungszentrum Borstel	Braulke, T (corresponding author), Childrens Hosp, Dept Biochem, Univ Med Ctr Hamburg Eppendorf, Bldg N27,Martinistr 52, D-20246 Hamburg, Germany.	braulke@uke.uni-hamburg.de	Braulke, Thomas/AAV-9121-2020; Pohl, Sandra/AAF-1943-2020; Encarnação, Marisa/AAY-4609-2020; Encarnação, Marisa/P-4261-2016	Braulke, Thomas/0000-0002-2336-8532; Encarnação, Marisa/0000-0002-3726-2851; Tiede, Stephan/0000-0002-6045-3736; Pohl, Sandra/0000-0001-7409-7042	Deutsche Forschungsgemeinschaft [SFB470/C1, 470/C6, SFB877/B3, GRK1459]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB470/C1; 470/C6; SFB877/B3; GRK1459).	AERTS JMFG, 1988, BIOCHIM BIOPHYS ACTA, V964, P303, DOI 10.1016/0304-4165(88)90030-X; Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Braulke T, 2008, J INHERIT METAB DIS, V31, P253, DOI 10.1007/s10545-008-0862-5; BRAULKE T, 1987, J CELL BIOL, V104, P1735, DOI 10.1083/jcb.104.6.1735; BRAULKE T, 1987, EUR J CELL BIOL, V43, P316; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; CHAO HHJ, 1990, EMBO J, V9, P3507, DOI 10.1002/j.1460-2075.1990.tb07559.x; DIMENT S, 1989, J BIOL CHEM, V264, P13403; Dittmer F, 1999, J CELL SCI, V112, P1591; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; GABEL CA, 1987, J CELL BIOL, V105, P1561, DOI 10.1083/jcb.105.4.1561; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; GLICKMAN JN, 1993, J CELL BIOL, V123, P99, DOI 10.1083/jcb.123.1.99; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1980, J BIOL CHEM, V255, P4937; Hiesberger T, 1998, EMBO J, V17, P4617, DOI 10.1093/emboj/17.16.4617; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kornfeld R, 1998, J BIOL CHEM, V273, P23203, DOI 10.1074/jbc.273.36.23203; Kornfeld S., 2001, METABOLIC MOL BASES, P3421; Krivit W, 1999, Curr Opin Neurol, V12, P167, DOI 10.1097/00019052-199904000-00007; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; Muschol N, 2002, BIOCHEM J, V368, P845, DOI 10.1042/BJ20020249; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Oya Y, 2000, ACTA NEUROPATHOL, V99, P161, DOI 10.1007/PL00007420; Pohl S, 2010, AM J MED GENET A, V152A, P124, DOI 10.1002/ajmg.a.33170; Pohl S, 2009, BBA-MOL BASIS DIS, V1792, P221, DOI 10.1016/j.bbadis.2009.01.009; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P23586; Storch S, 2004, J BIOL CHEM, V279, P53625, DOI 10.1074/jbc.M410930200; Storch S, 2007, TRAFFIC, V8, P431, DOI 10.1111/j.1600-0854.2007.00537.x; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; Tiede S, 2005, AM J MED GENET A, V137A, P235, DOI 10.1002/ajmg.a.30868; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; Tiede Stephan, 2004, Hum Mutat, V24, P535, DOI 10.1002/humu.9293; VARKI A, 1980, J BIOL CHEM, V255, P847; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; WAHEED A, 1981, J BIOL CHEM, V256, P4150	46	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23936	23944		10.1074/jbc.M110.129684	http://dx.doi.org/10.1074/jbc.M110.129684			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20489197	Green Published, hybrid			2022-12-25	WOS:000280291400044
J	Graham, S; Ding, M; Ding, YF; Sours-Brothers, S; Luchowski, R; Gryczynski, Z; Yorio, T; Ma, HY; Ma, R				Graham, Sarabeth; Ding, Min; Ding, Yanfeng; Sours-Brothers, Sherry; Luchowski, Rafal; Gryczynski, Zygmunt; Yorio, Thomas; Ma, Haiying; Ma, Rong			Canonical Transient Receptor Potential 6 (TRPC6), a Redox-regulated Cation Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; HYDROGEN-PEROXIDE; ANGIOTENSIN-II; PLASMA-MEMBRANE; C-SRC; GENERATION; ACTIVATION; CELLS; PHOSPHORYLATION; MECHANISMS	This study examined the effect of H2O2 on the TRPC6 channel and its underlying mechanisms using a TRPC6 heterologous expression system. In TRPC6-expressing HEK293T cells, H2O2 significantly stimulated Ca2+ entry in a dose-dependent manner. Electrophysiological experiments showed that H2O2 significantly increased TRPC6 channel open probability and whole-cell currents. H2O2 also evoked a robust inward current in A7r5 vascular smooth muscle cells, which was nearly abolished by knockdown of TRPC6 using a small interfering RNA. Catalase substantially attenuated arginine vasopressin (AVP)-induced Ca2+ entry in cells co-transfected with TRPC6 and AVP V1 receptor. N-Ethylmaleimide and thimerosal were able to simulate the H2O2 response. Dithiothreitol or glutathione-reduced ethyl ester significantly antagonized the response. Furthermore, both N-ethylmaleimide- and H2O2-induced TRPC6 activations were only observed in the cell-attached patches but not in the inside-out patches. Moreover, 1-oleoyl-2-acetyl-sn-glycerol effect on TRPC6 was significantly greater in the presence of H2O2. Biotinylation assays revealed a significant increase in cell surface TRPC6 in response to H2O2. Similarly, in cells transfected with TRPC6-EGFP, confocal microscopy showed a significant increase in fluorescence intensity in the region of the cell membrane and adjacent to the membrane. AVP also increased the fluorescence intensity on the surface of the cells co-transfected with TRPC6-EGFP and V1 receptor, and this response was inhibited by catalase. These data indicate that H2O2 activates TRPC6 channels via modification of thiol groups of intracellular proteins. This cysteine oxidation-dependent pathway not only stimulates the TRPC6 channel by itself but also sensitizes the channels to diacylglycerol and promotes TRPC6 trafficking to the cell surface.	[Ma, Rong] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX 76107 USA; [Ma, Rong] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Ft Worth, TX 76107 USA; [Luchowski, Rafal; Gryczynski, Zygmunt] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA; [Yorio, Thomas; Ma, Haiying] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Ma, R (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, RES 302G,3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	sherry.sours-brothers@utsouthwestern.edu; rma@hsc.unt.edu	ma, rong/GVU-3096-2022	Luchowski, Rafal/0000-0003-1156-8059; Sours-Brothers, Sherry/0000-0002-1656-7154	NIDDK, National Institutes of Health [1 RO1 DK079968-01A2]; American Diabetes Association [7-07-RA-99]; American Heart Association [09GRNT2260926]; National Science Foundation, Graduate School of Biomedical Science, University of North Texas Health Science Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079968] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); National Science Foundation, Graduate School of Biomedical Science, University of North Texas Health Science Center(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 RO1 DK079968-01A2 from NIDDK (to R. M.). This work was also supported by American Diabetes Association Grant 7-07-RA-99 (to R. M.), American Heart Association Grant 09GRNT2260926 (to R. M.), and a National Science Foundation SCORE Fellowship from the Graduate School of Biomedical Science, University of North Texas Health Science Center (to S. G.).	Albert AP, 2008, J PHYSIOL-LONDON, V586, P3087, DOI 10.1113/jphysiol.2008.153676; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Dietrich A., 2007, V179, P125; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dietrich A, 2007, CELL CALCIUM, V42, P233, DOI 10.1016/j.ceca.2007.02.009; Du J, 2008, AM J PHYSIOL-RENAL, V294, pF909, DOI 10.1152/ajprenal.00606.2007; Du J, 2007, J AM SOC NEPHROL, V18, P1437, DOI 10.1681/ASN.2006091067; Edwards DH, 2008, ARTERIOSCL THROM VAS, V28, P1774, DOI 10.1161/ATVBAHA.108.172692; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138; Graham S, 2007, AM J PHYSIOL-RENAL, V293, pF1381, DOI 10.1152/ajprenal.00185.2007; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hool LC, 2007, ANTIOXID REDOX SIGN, V9, P409, DOI 10.1089/ars.2006.1446; Hsu MF, 2005, BIOCHEM PHARMACOL, V70, P1320, DOI 10.1016/j.bcp.2005.07.029; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lassegue B, 2004, AM J HYPERTENS, V17, P852, DOI 10.1016/j.amjhyper.2004.02.004; Lemonnier L, 2008, CELL CALCIUM, V43, P506, DOI 10.1016/j.ceca.2007.09.001; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Ma R, 2003, J BIOL CHEM, V278, P52763, DOI 10.1074/jbc.M309610200; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Schnackenberg CG, 2002, CURR OPIN PHARMACOL, V2, P121, DOI 10.1016/S1471-4892(02)00133-9; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soulsby M, 2009, PHYSIOLOGY, V24, P281, DOI 10.1152/physiol.00017.2009; Sours S, 2006, AM J PHYSIOL-RENAL, V290, pF1507, DOI 10.1152/ajprenal.00268.2005; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Tabet F, 2008, CIRC RES, V103, P149, DOI 10.1161/CIRCRESAHA.108.178608; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; WARD PA, 1991, AM J MED, V91, pS89, DOI 10.1016/0002-9343(91)90290-E; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Weibrecht I, 2007, FREE RADICAL BIO MED, V43, P100, DOI 10.1016/j.freeradbiomed.2007.03.021; Wilcox CS, 2002, CURR HYPERTENS REP, V4, P160, DOI 10.1007/s11906-002-0041-2; Winn MP, 2006, J AM SOC NEPHROL, V17, P378, DOI 10.1681/ASN.2005090962; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127	64	70	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23464	23474		10.1074/jbc.M109.093500	http://dx.doi.org/10.1074/jbc.M109.093500			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501650	hybrid, Green Published			2022-12-25	WOS:000279999900078
J	Schieder, M; Rotzer, K; Bruggemann, A; Biel, M; Wahl-Schott, CA				Schieder, Michael; Roetzer, Katrin; Brueggemann, Andrea; Biel, Martin; Wahl-Schott, Christian A.			Characterization of Two-pore Channel 2 (TPCN2)-mediated Ca2+ Currents in Isolated Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOCYTOSIS; LEADS	Two-pore channels (TPCNs) have been proposed to form lysosomal Ca2+ release channels that are activated by nicotinic acid adenine dinucleotide phosphate. Here, we employ a glass chip-based method to record for the first time nicotinic acid adenine dinucleotide phosphate-dependent currents through a two-pore channel (TPCN2) from intact lysosomes. We show that TPCN2 is a highly selective Ca2+ channel that is regulated by intralysosomal pH. Using site-directed mutagenesis, we identify an amino acid residue in the putative pore region that is crucial for conferring high Ca2+ selectivity. Our glass chip-based method will provide electrophysiological access not only to lysosomal TPCN channels but also to a broad range of other intracellular ion channels.	[Biel, Martin] Univ Munich, Dept Pharm, Ctr Integrated Prot Sci CIPS M, D-81377 Munich, Germany; [Schieder, Michael; Roetzer, Katrin; Biel, Martin; Wahl-Schott, Christian A.] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-81377 Munich, Germany; [Brueggemann, Andrea] Nan Technol GmbH, D-80335 Munich, Germany	University of Munich; University of Munich	Biel, M (corresponding author), Univ Munich, Dept Pharm, Ctr Integrated Prot Sci CIPS M, Butenandtstr 5-13, D-81377 Munich, Germany.	martin.biel@cup.uni-muenchen.de; christian.wahl@cup.uni-muenchen.de	Biel, Martin/G-1175-2014; Wahl-Schott, Christian A/J-2623-2015	Biel, Martin/0000-0002-9974-3052; Bruggemann, Andrea/0000-0002-7325-6715	Deutsche Forschungsgemeinschaft; Bayerische Forschungsstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerische Forschungsstiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Bayerische Forschungsstiftung.	Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Schenkman J B, 1978, Methods Enzymol, V52, P83; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	11	106	108	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21219	21222		10.1074/jbc.C110.143123	http://dx.doi.org/10.1074/jbc.C110.143123			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20495006	Green Published, hybrid			2022-12-25	WOS:000279516100006
J	Thacker, RW; Diaz, MC; de Voogd, NJ; van Soest, RWM; Freeman, CJ; Mobley, AS; LaPietra, J; Cope, K; McKenna, S				Thacker, Robert W.; Cristina Diaz, M.; de Voogd, Nicole J.; van Soest, Rob W. M.; Freeman, Christopher J.; Mobley, Andrew S.; LaPietra, Jessica; Cope, Kevin; McKenna, Sheila			Preliminary Assessment of Sponge Biodiversity on Saba Bank, Netherlands Antilles	PLOS ONE			English	Article							BOCAS DEL TORO; DISEASE; REEFS; SIZE	Background: Saba Bank Atoll, Netherlands Antilles, is one of the three largest atolls on Earth and provides habitat for an extensive coral reef community. To improve our knowledge of this vast marine resource, a survey of biodiversity at Saba Bank included a multi-disciplinary team that sampled fishes, mollusks, crustaceans, macroalgae, and sponges. Methodology/Principal Findings: A single member of the dive team conducted surveys of sponge biodiversity during eight dives at six locations, at depths ranging from 15 to 30 m. This preliminary assessment documented the presence of 45 species pooled across multiple locations. Rarefaction analysis estimated that only 48 to 84% of species diversity was sampled by this limited effort, clearly indicating a need for additional surveys. An analysis of historical collections from Saba and Saba Bank revealed an additional 36 species, yielding a total of 81 sponge species recorded from this area. Conclusions/Significance: This observed species composition is similar to that found on widespread Caribbean reefs, indicating that the sponge fauna of Saba Bank is broadly representative of the Caribbean as a whole. A robust population of the giant barrel sponge, Xestospongia muta, appeared healthy with none of the signs of disease or bleaching reported from other Caribbean reefs; however, more recent reports of anchor chain damage to these sponges suggests that human activities can have dramatic impacts on these communities. Opportunities to protect this extremely large habitat should be pursued, as Saba Bank may serve as a significant reservoir of sponge species diversity.	[Thacker, Robert W.; Freeman, Christopher J.; Mobley, Andrew S.; LaPietra, Jessica; Cope, Kevin] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Cristina Diaz, M.] Museo Marino Margarita, Nueva Esparta, Venezuela; [de Voogd, Nicole J.] Natl Museum Nat Hist, Leiden, Netherlands; [van Soest, Rob W. M.] Univ Amsterdam, Zool Museum, Amsterdam, Netherlands; [McKenna, Sheila] Deep Search Fdn, Alameda, CA USA; [McKenna, Sheila] Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia; [McKenna, Sheila] Univ Queensland, Commonwealth Facil Appl Environm Decis Anal, Brisbane, Qld, Australia	University of Alabama System; University of Alabama Birmingham; University of Amsterdam; University of Queensland; University of Queensland	Thacker, RW (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	thacker@uab.edu	de Voogd, Nicole/I-9280-2012	de Voogd, Nicole/0000-0002-7985-5604; Thacker, Robert/0000-0002-9654-0073	Conservation International; United States National Science Foundation [0829986]; Division Of Environmental Biology [0829986] Funding Source: National Science Foundation	Conservation International; United States National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by Conservation International (www.conservation.org) and the United States National Science Foundation (www.nsf.gov) under Grant No. 0829986 to RWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado Pedro M., 2002, Avicennia, V15, P53; ALCOLADO PM, 1994, SPONGES IN TIME AND SPACE, P251; Becerro MA, 2008, MAR ECOL-EVOL PERSP, V29, P167, DOI 10.1111/j.1439-0485.2008.00234.x; BRATTEGARD T, 1980, SARSIA, V65, P49, DOI 10.1080/00364827.1980.10431471; Bunkley-Williams L, 2004, CARIBB J SCI, V40, P88; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clarke KR, 1994, CHANGE MARINE COMMUN; Colwell RK, 2013, ESTIMATES STAT ESTIM; Diaz MC, 2001, B MAR SCI, V69, P535; Diaz MC, 2005, CARIBB J SCI, V41, P465; Dilrosun F, 2002, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P46; Dilrosun F, 2000, MONITORING SABA BANK; Freeman Christopher J., 2007, V28, P319; Gochfeld Deborah J., 2007, V28, P335; HOETJES P, 2010, PLOS ONE IN PRESS; Hooper J.N.A., 2002, SYSTEMA PORIFERA GUI; Kadison E, 2009, B MAR SCI, V85, P101; KNUDSEN J, 1982, P K NED AKAD C BIOL, V85, P121; Lehnert Helmut, 1996, Beaufortia, V46, P53; Lehnert Helmut, 1999, Beaufortia, V49, P141; Lehnert Helmut, 1998, Beaufortia, V48, P71; McMurray SE, 2009, RESTOR ECOL, V17, P192, DOI 10.1111/j.1526-100X.2008.00463.x; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; MURICY G, 1991, Vie et Milieu, V41, P205; MURICY G, 1989, Revista Brasileira de Biologia, V49, P347; Olson JB, 2006, DIS AQUAT ORGAN, V71, P163, DOI 10.3354/dao071163; Ruetzler K., 2004, BOLL MUS IST BIOL UN, V68, P85; Rutzler K., 1986, MARINE FAUNA FLORA B, P111; Rutzler Klaus, 2000, Atoll Research Bulletin, V476, P229; Toller W, 2008, ASSESSMENT COMMERCIA; van der Land J., 1977, FAO FISHERIES REPORT, V200, P469, DOI DOI 10.1371/JOURNAL.PONE.0009207; VANSOEST RWM, 1981, VERSLAGEN TECHNISCHE, V32, P1; Vilanova E., 2004, B MUS I BIOL U GEN, V68, P647; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WIEDENMAYER F, 1977, EXPERIENTIA S, V29; Wulff J, 2001, B MAR SCI, V69, P831; Wulff JL, 2006, CORAL REEFS, V25, P419, DOI 10.1007/s00338-006-0110-0	37	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e9622	10.1371/journal.pone.0009622	http://dx.doi.org/10.1371/journal.pone.0009622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20502643	Green Submitted, Green Published, gold			2022-12-25	WOS:000278017400002
J	Jackson, SA; Schiesser, J; Stanley, EG; Elefanty, AG				Jackson, Steven A.; Schiesser, Jacqueline; Stanley, Edouard G.; Elefanty, Andrew G.			Differentiating Embryonic Stem Cells Pass through 'Temporal Windows' That Mark Responsiveness to Exogenous and Paracrine Mesendoderm Inducing Signals	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; IN-VITRO DIFFERENTIATION; CANONICAL WNT/BETA-CATENIN; PRIMITIVE STREAK; GROWTH-FACTOR; MOUSE; MESODERM; EXPRESSION; TERATOCARCINOMAS; GASTRULATION	Background: Mesendoderm induction during embryonic stem cell (ESC) differentiation in vitro is stimulated by the Transforming Growth Factor and Wingless (Wnt) families of growth factors. Principal Findings: We identified the periods during which Bone Morphogenetic Protein (BMP) 4, Wnt3a or Activin A were able to induce expression of the mesendoderm marker, Mixl1, in differentiating mouse ESCs. BMP4 and Wnt3a were required between differentiation day (d) 1.5 and 3 to most effectively induce Mixl1, whilst Activin A induced Mixl1 expression in ESC when added between d2 and d4, indicating a subtle difference in the requirement for Activin receptor signalling in this process. Stimulation of ESCs with these factors at earlier or later times resulted in little Mixl1 induction, suggesting that the differentiating ESCs passed through 'temporal windows' in which they sequentially gained and lost competence to respond to each growth factor. Inhibition of either Activin or Wnt signalling blocked Mixl1 induction by any of the three mesendoderm-inducing factors. Mixing experiments in which chimeric EBs were formed between growth factor-treated and untreated ESCs revealed that BMP, Activin and Wnt signalling all contributed to the propagation of paracrine mesendoderm inducing signals between adjacent cells. Finally, we demonstrated that the differentiating cells passed through 'exit gates' after which point they were no longer dependent on signalling from inducing molecules for Mixl1 expression. Conclusions: These studies suggest that differentiating ESCs are directed by an interconnected network of growth factors similar to those present in early embryos and that the timing of growth factor activity is critical for mesendoderm induction.	[Jackson, Steven A.; Schiesser, Jacqueline; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia	Monash University	Jackson, SA (corresponding author), Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA.	andrew.elefanty@med.monash.edu.au	Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008	Stanley, Ed G/0000-0002-6389-3665; Schiesser, Jacqueline/0000-0002-5655-4382; Elefanty, Andrew/0000-0001-6448-8314	National Health and Medical Research Council (NHMRC) of Australia; Juvenile Diabetes Research Foundation (JDRF); Australian Stem Cell Centre (ASCC)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Australian Stem Cell Centre (ASCC)	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, the Juvenile Diabetes Research Foundation (JDRF) and the Australian Stem Cell Centre (ASCC). AGE and EGS are Senior Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Askanazy M., 1907, VERHANDL DEUTSH PATH, V11, P39; Barnett LD, 2000, METH MOL B, V158, P65; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Elefanty AG, 1999, BLOOD, V94, P3754, DOI 10.1182/blood.V94.11.3754.423k05_3754_3763; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gu ZY, 1998, GENE DEV, V12, P844, DOI 10.1101/gad.12.6.844; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Hamada S, 2007, BIOCHEM BIOPH RES CO, V355, P240, DOI 10.1016/j.bbrc.2007.01.143; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Hirota M, 2008, CELL SIGNAL, V20, P1632, DOI 10.1016/j.cellsig.2008.05.003; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; KAHAN BW, 1970, J NATL CANCER I, V44, P1015; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; MARTIN GR, 1975, CELL, V5, P229, DOI 10.1016/0092-8674(75)90098-7; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; MARTIN GR, 1975, CELL, V6, P467, DOI 10.1016/0092-8674(75)90035-5; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; SMITH J, 2007, CURRENT PROTOCOLS ST, V1; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; STEVENS LC, 1960, DEV BIOL, V2, P285, DOI 10.1016/0012-1606(60)90010-5; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; SZABO P, 1994, DEVELOPMENT, V120, P1651; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; TERESKY AK, 1974, J CELL PHYSIOL, V84, P319, DOI 10.1002/jcp.1040840218; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Willems E, 2008, DIFFERENTIATION, V76, P745, DOI 10.1111/j.1432-0436.2007.00257.x; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	63	46	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10706	10.1371/journal.pone.0010706	http://dx.doi.org/10.1371/journal.pone.0010706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502661	Green Published, Green Submitted, gold			2022-12-25	WOS:000277845400012
J	Frank, DN; Feazel, LM; Bessesen, MT; Price, CS; Janoff, EN; Pace, NR				Frank, Daniel N.; Feazel, Leah M.; Bessesen, Mary T.; Price, Connie S.; Janoff, Edward N.; Pace, Norman R.			The Human Nasal Microbiota and Staphylococcus aureus Carriage	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; MOLECULAR ANALYSIS; HUMAN SKIN; STREPTOCOCCUS-PNEUMONIAE; SOFTWARE ENVIRONMENT; UNITED-STATES; COLONIZATION; DIVERSITY; BACTERIAL; PREVALENCE	Background: Colonization of humans with Staphylococcus aureus is a critical prerequisite of subsequent clinical infection of the skin, blood, lung, heart and other deep tissues. S. aureus persistently or intermittently colonizes the nares of similar to 50% of healthy adults, whereas similar to 50% of the general population is rarely or never colonized by this pathogen. Because microbial consortia within the nasal cavity may be an important determinant of S. aureus colonization we determined the composition and dynamics of the nasal microbiota and correlated specific microorganisms with S. aureus colonization. Methodology/Principal Findings: Nasal specimens were collected longitudinally from five healthy adults and a cross-section of hospitalized patients (26 S. aureus carriers and 16 non-carriers). Culture-independent analysis of 16S rRNA sequences revealed that the nasal microbiota of healthy subjects consists primarily of members of the phylum Actinobacteria (e. g., Propionibacterium spp. and Corynebacterium spp.), with proportionally less representation of other phyla, including Firmicutes (e. g., Staphylococcus spp.) and Proteobacteria (e. g. Enterobacter spp). In contrast, inpatient nasal microbiotas were enriched in S. aureus or Staphylococcus epidermidis and diminished in several actinobacterial groups, most notably Propionibacterium acnes. Moreover, within the inpatient population S. aureus colonization was negatively correlated with the abundances of several microbial groups, including S. epidermidis (p = 0.004). Conclusions/Significance: The nares environment is colonized by a temporally stable microbiota that is distinct from other regions of the integument. Negative association between S. aureus, S. epidermidis, and other groups suggests microbial competition during colonization of the nares, a finding that could be exploited to limit S. aureus colonization.	[Frank, Daniel N.; Feazel, Leah M.; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Frank, Daniel N.; Bessesen, Mary T.; Janoff, Edward N.; Pace, Norman R.] Mucosal & Vaccine Res Program Colorado, Aurora, CO USA; [Bessesen, Mary T.; Janoff, Edward N.] Dept Vet Affairs Med Ctr, Denver, CO USA; [Frank, Daniel N.] Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO USA; [Price, Connie S.] Denver Hlth Med Ctr, Div Infect Dis, Denver, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Frank, DN (corresponding author), Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO USA.	norman.pace@colorado.edu		Bessesen, Mary/0000-0001-9305-1293	Butcher Foundation of Colorado; Mucosal and Vaccine Program Colorado (MAVRC); Veterans Affairs Research Service; University of Colorado Department of Medicine	Butcher Foundation of Colorado; Mucosal and Vaccine Program Colorado (MAVRC); Veterans Affairs Research Service(US Department of Veterans Affairs); University of Colorado Department of Medicine	This work was supported by the Butcher Foundation of Colorado, the Mucosal and Vaccine Program Colorado (MAVRC), the Veterans Affairs Research Service and the University of Colorado Department of Medicine Innovative grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000713; Beilman Greg J, 2005, Surg Infect (Larchmt), V6, P87, DOI 10.1089/sur.2005.6.87; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ellis MW, 2004, CLIN INFECT DIS, V39, P971, DOI 10.1086/423965; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Francois P, 2003, J CLIN MICROBIOL, V41, P254, DOI 10.1128/JCM.41.1.254-260.2003; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Frank DN, 2009, WOUND REPAIR REGEN, V17, P163, DOI 10.1111/j.1524-475X.2009.00472.x; Frank DN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-420; Frank DN, 2003, J CLIN MICROBIOL, V41, P295, DOI 10.1128/JCM.41.1.295-303.2003; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gilbert M, 2006, CAN MED ASSOC J, V175, P149, DOI 10.1503/cmaj.051565; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Huijsdens XW, 2006, EMERG INFECT DIS, V12, P1584, DOI 10.3201/eid1210.060387; Kaufman L., 2005, FINDING GROUPS DATA; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kreisel K, 2006, DIAGN MICR INFEC DIS, V55, P179, DOI 10.1016/j.diagmicrobio.2006.01.021; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LaMar JE, 2003, MIL MED, V168, P135, DOI 10.1093/milmed/168.2.135; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Main Cheryl L, 2005, Can J Infect Dis Med Microbiol, V16, P343; Nguyen DM, 2005, EMERG INFECT DIS, V11, P526, DOI 10.3201/eid1104.041094; Nickerson EK, 2009, LANCET INFECT DIS, V9, P130, DOI 10.1016/S1473-3099(09)70022-2; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Pan ES, 2003, CLIN INFECT DIS, V37, P1384, DOI 10.1086/379019; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Quinn GA, 2007, IMMUNOLOGY, V122, P80, DOI 10.1111/j.1365-2567.2007.02615.x; R Development Core Team, 2005, R LANG ENV STAT COMP; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Stacey AR, 1998, BRIT J SPORT MED, V32, P153, DOI 10.1136/bjsm.32.2.153; Tanner MA, 1999, J CLIN MICROBIOL, V37, P1863, DOI 10.1128/JCM.37.6.1863-1870.1999; Velazquez-Guadarrama N, 2009, CLIN INVEST MED, V32, pE57; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnes G., GPLOTS VARIOUS R PRO; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Zinderman CE, 2004, EMERG INFECT DIS, V10, P941, DOI 10.3201/eid1005.030604	66	271	281	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10598	10.1371/journal.pone.0010598	http://dx.doi.org/10.1371/journal.pone.0010598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498722	Green Submitted, Green Published, gold			2022-12-25	WOS:000277773700004
J	Traven, A; Lo, TL; Lithgow, T; Heierhorst, J				Traven, Ana; Lo, Tricia L.; Lithgow, Trevor; Heierhorst, Joerg			The Yeast PUF Protein Puf5 Has Pop2-Independent Roles in Response to DNA Replication Stress	PLOS ONE			English	Article							RNA-BINDING PROTEIN; POLY(A) TAIL LENGTH; CELL-WALL INTEGRITY; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; CCR4-NOT COMPLEX; POSTTRANSCRIPTIONAL REGULATION; MITOCHONDRIAL BIOGENESIS; DEADENYLASE COMPLEXES	PUFs are RNA binding proteins that promote mRNA deadenylation and decay and inhibit translation. Yeast Puf5 is the prototype for studying PUF-dependent gene repression. Puf5 binds to the Pop2 subunit of the Ccr4-Pop2-NOT mRNA deadenylase, recruiting the deadenylase and associated translational repressors to mRNAs. Here we used yeast genetics to show that Puf5 has additional roles in vivo that do not require Pop2. Deletion of PUF5 caused increased sensitivity to DNA replication stress in cells lacking Pop2, as well as in cells mutated for two activities recruited to mRNAs by the Puf5-Pop2 interaction, the deadenylase Ccr4 and the translational repressor Dhh1. A functional Puf5 RNA binding domain was required, and Puf5 cytoplasmic localisation was sufficient for resistance to replication stress, indicating posttranscriptional gene expression control is involved. In contrast to DNA replication stress, in response to the cell wall integrity pathway activator caffeine, PUF5 and POP2 acted in the same genetic pathway, indicating that functions of Puf5 in the caffeine response are mediated by Pop2-dependent gene repression. Our results support a model in which Puf5 uses multiple, Pop2-dependent and Pop2-independent mechanisms to control mRNA expression. The Pop2-independent roles for Puf5 could involve spatial control of gene expression, a proposition supported by our data indicating that the active form of Puf5 is localised to cytoplasmic foci.	[Traven, Ana; Lo, Tricia L.; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Lo, Tricia L.; Heierhorst, Joerg] St Vincents Inst Med Res, Mol Genet Unit, Melbourne, Vic, Australia	Monash University; St. Vincent's Institute of Medical Research	Traven, A (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	ana.traven@med.monash.edu.au	Lithgow, Trevor J/H-5925-2017; Traven, Ana/H-8174-2017	Lithgow, Trevor J/0000-0002-0102-7884; Traven, Ana/0000-0001-6252-3104	Australian National Health and Medical Research Council (NHMRC) [ID 345438, 448302, ID 502600]; Ramaciotti establishment grant [RAO75/06]; Australian Research Council Federation [FF0883204]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ramaciotti establishment grant; Australian Research Council Federation(Australian Research Council)	This work was supported by fellowships from the Australian National Health and Medical Research Council (NH&MRC) to AT and JH (ID 345438 and 448302), Ramaciotti establishment grant to AT (RAO75/06), NH&MRC project grant to JH (ID 502600) and Australian Research Council Federation Fellowship to TL (FF0883204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Denis CL, 2001, GENETICS, V158, P627; Falbo KB, 2009, MOL CELLS, V28, P149, DOI 10.1007/s10059-009-0127-7; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Hammet A, 2002, J BIOL CHEM, V277, P22469, DOI 10.1074/jbc.M202473200; Hata H, 1998, GENETICS, V148, P571; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Jiang YW, 2003, MOL BIOL CELL, V14, P5116, DOI 10.1091/mbc.E03-06-0375; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kaeberlein M, 2002, GENETICS, V160, P83; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Merker RJ, 2002, MOL CELL BIOL, V22, P421, DOI 10.1128/MCB.22.2.421-429.2002; Ohkuni K, 2006, MOL GENET GENOMICS, V275, P81, DOI 10.1007/s00438-005-0064-x; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Preiss T, 1998, RNA, V4, P1321, DOI 10.1017/S1355838298980669; Prinz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000249; Queralt E, 2005, GENETICS, V171, P1485, DOI 10.1534/genetics.105.045005; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Sinha M, 2009, CELL, V138, P1109, DOI 10.1016/j.cell.2009.07.013; Stewart MS, 2007, EUKARYOT CELL, V6, P262, DOI 10.1128/EC.00188-06; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; Traven A, 2005, GENETICS, V169, P65, DOI 10.1534/genetics.104.030940; Traven A, 2010, YEAST, V27, P41, DOI 10.1002/yea.1730; Traven A, 2009, GENETICS, V182, P955, DOI 10.1534/genetics.109.104414; Ulbricht RJ, 2008, RNA, V14, P246, DOI 10.1261/rna.847408; WHARTON RP, 2006, SCI STKE, V354, pPE37; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Woolstencroft RN, 2006, J CELL SCI, V119, P5178, DOI 10.1242/jcs.03221; Zipor G, 2009, P NATL ACAD SCI USA, V106, P19848, DOI 10.1073/pnas.0910754106	45	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10651	10.1371/journal.pone.0010651	http://dx.doi.org/10.1371/journal.pone.0010651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498834	Green Published, gold			2022-12-25	WOS:000277771600015
J	Arbones-Mainar, JM; Johnson, LA; Altenburg, MK; Kim, HS; Maeda, N				Arbones-Mainar, Jose M.; Johnson, Lance A.; Altenburg, Michael K.; Kim, Hyung-Suk; Maeda, Nobuyo			Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4	FASEB JOURNAL			English	Article						NAFLD; apoE; fatty liver; adipogenesis; Western-type diet; insulin resistance	E TYPE-4 ALLELE; FATTY LIVER; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; E POLYMORPHISM; TARGET GENES; RECEPTOR; APOE; GAMMA	Thiazolidinediones (TZDs) are insulin sensitizers used to treat patients with insulin resistance. To assess potential gene-drug interactions, mice expressing human apolipoprotein E3 or E4 (APOE3 or APOE4) were fed a Western-type high-fat diet for 12 wk, at which time they developed similarly impaired glucose tolerance. Supplementing the diet with rosiglitazone (1.5 mg/g body weight) for an additional 4 wk improved plasma lipid profiles in both APOE3 and APOE4 mice. However, glucose tolerance improved only in APOE3 mice. Induction of adipogenesis and lipogenesis was severely blunted in adipose tissues, but not in the livers, of APOE4 mice. Consequently, lipids were channeled to the liver, causing marked steatosis in these mice. Impaired glucose tolerance was not a prerequisite for this adverse effect, and long-term treatment with rosiglitazone altered liver enzymes and caused hepatic fibrosis in APOE4 mice. Finally, TZDs failed to stimulate PPAR gamma activation and adipocyte differentiation in preadipocytes and embryonic fibroblasts isolated from APOE4 mice compared to those from APOE3 mice. We conclude that the effects of TZDs are APOE isoform dependent, and that the metabolic damage observed in APOE4 mice is rooted in an impaired activation of the adipogenic program in the adipose tissues expressing APOE4.-Arbones-Mainar, J. M., Johnson, L. A., Altenburg, M. K., Kim, H.-S., Maeda, N. Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4. FASEB J. 24, 3809-3818 (2010). www.fasebj.org	[Arbones-Mainar, Jose M.; Johnson, Lance A.; Altenburg, Michael K.; Kim, Hyung-Suk; Maeda, Nobuyo] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Maeda, N (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, 701 Brinkhous Bullitt Bldg, Chapel Hill, NC 27599 USA.	nobuyo@med.unc.edu	Arbones-Mainar, Jose M/AGL-8624-2022	Arbones-Mainar, Jose M/0000-0002-8982-3737; Johnson, Lance/0000-0003-0134-7586	U.S. National Institute of Health [HL42630, HL87946]; Ministerio de Educacion y Ciencia (Spain); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630, U01HL087946, R37HL042630] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by U.S. National Institute of Health grants HL42630 and HL87946. J.M.A.-M. was partially supported by a postdoctoral fellowship from the Ministerio de Educacion y Ciencia (Spain). The authors thank Marcus McNair, Anna Garcia, and Jennifer Wilder for their assistance and Prof. Jesus Osada for his critical reading of this work.	Altenburg M, 2008, ARTERIOSCL THROM VAS, V28, P1104, DOI 10.1161/ATVBAHA.108.164863; Arbones-Mainar JM, 2008, INT J OBESITY, V32, P1595, DOI 10.1038/ijo.2008.143; Arbones-Mainar JM, 2006, J NUTR, V136, P353, DOI 10.1093/jn/136.2.353; Bazin R, 2000, METH MOL B, V155, P121; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bogacka I, 2004, DIABETES CARE, V27, P1660, DOI 10.2337/diacare.27.7.1660; Cardona F, 2006, CLIN CHEM, V52, P1920, DOI 10.1373/clinchem.2006.069690; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Conner DA, 2001, CURR PROTOC MOL BIOL; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Elosua R, 2003, OBES RES, V11, P1502, DOI 10.1038/oby.2003.201; Garcia-Ruiz I, 2007, HEPATOLOGY, V46, P414, DOI 10.1002/hep.21687; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; Im SS, 2005, DIABETES, V54, P1684, DOI 10.2337/diabetes.54.6.1684; Johnson L, 2008, ARTERIOSCL THROM VAS, V28, pE95; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; MAHLEY RW, 1979, J CLIN INVEST, V64, P743, DOI 10.1172/JCI109518; Malloy SI, 2004, ARTERIOSCL THROM VAS, V24, P91, DOI 10.1161/01.ATV.0000094963.07902.FB; Pagano C, 2005, EUR J ENDOCRINOL, V152, P113, DOI 10.1530/eje.1.01821; Pendse AA, 2009, J LIPID RES, V50, pS178, DOI 10.1194/jlr.R800070-JLR200; Peng DQ, 2003, INT J CARDIOL, V92, P257, DOI 10.1016/S0167-5273(03)00101-3; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Sima A, 2007, CLIN CHEM LAB MED, V45, P1149, DOI 10.1515/CCLM.2007.258; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; SMITH GS, 1992, ARCH NEUROL-CHICAGO, V49, P1142, DOI 10.1001/archneur.1992.00530350056020; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Ye JM, 2004, DIABETOLOGIA, V47, P1306, DOI 10.1007/s00125-004-1436-1; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yue L, 2009, J BIOL CHEM, V284, P10453, DOI 10.1074/jbc.M808482200; Yue LL, 2004, J BIOL CHEM, V279, P47626, DOI 10.1074/jbc.M408461200	37	23	23	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3809	3818		10.1096/fj.10-159517	http://dx.doi.org/10.1096/fj.10-159517			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20501792	Green Published			2022-12-25	WOS:000285005900019
J	Chastain, PD; Nakamura, J; Rao, SB; Chu, HT; Ibrahim, JG; Swenberg, JA; Kaufman, DG				Chastain, Paul D., II; Nakamura, Jun; Rao, Shangbang; Chu, Haitao; Ibrahim, Joseph G.; Swenberg, James A.; Kaufman, David G.			Abasic sites preferentially form at regions undergoing DNA replication	FASEB JOURNAL			English	Article						DNA damage; apurinic/apyrimidinic sites; oxidative stress; hydrogen peroxide; DNA fiber immunostaining	OXIDATIVE STRESS; HUMAN-CELLS; S-PHASE; MACULAR DEGENERATION; PARKINSONS-DISEASE; IONIZING-RADIATION; MITOCHONDRIAL-DNA; DAMAGE CLUSTERS; ANTIOXIDANTS; CATARACTS	We investigated whether apurinic/apyrimidinic (AP/abasic) sites were more frequent in regions of DNA replication in cells and whether their number increased during oxidative stress. DNA fiber spreading and fluorescent immunostaining were used to detect areas of DNA replication and sites of AP lesions in extended DNA fibers. The distribution of AP sites was determined in DNA fibers from vertebrate cells maintained under normal culture conditions or stressed with exogenous H(2)O(2). AP lesions per unit length were enumerated in bulk DNA or at replication sites. The background density of AP sites in DNA fibers was 5.4 AP sites/10(6) nt, while newly replicated DNA contained 12.9 AP sites/10(6) nt. In cells exposed to 20 mu M H(2)O(2), AP sites in newly replicated DNA increased to 20.8/10(6) nt. Determinations of AP site density in bulk DNA by fiber analysis or standard slot blot assays agreed to within 10%. Our findings show that the fiber assay not only accurately determines the frequency of AP sites but also shows their distribution. They also reveal that there is increased susceptibility to oxidative damage in DNA regions undergoing replication, which may explain the previously observed clustering of AP sites.-Chastain II, P. D., Nakamura, J., Rao, S., Chu, H., Ibrahim, J. G., Swenberg, J. A., Kaufman, D. G. Abasic sites preferentially form at regions undergoing DNA replication. FASEB J. 24, 3674-3680 (2010). www.fasebj.org	[Chastain, Paul D., II; Swenberg, James A.; Kaufman, David G.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Nakamura, Jun; Swenberg, James A.] Univ N Carolina, Dept Environm Sci & Engn, Sch Publ Hlth, Chapel Hill, NC 27599 USA; [Rao, Shangbang; Chu, Haitao; Ibrahim, Joseph G.; Swenberg, James A.; Kaufman, David G.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Rao, Shangbang; Chu, Haitao; Ibrahim, Joseph G.] Univ N Carolina, Dept Biostat, Sch Publ Hlth, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chastain, PD (corresponding author), Univ N Carolina, Sch Med, Dept Pathol & Lab Med, 620 Brinkhous Bullitt Bldg,CB 7525, Chapel Hill, NC 27599 USA.	pchastai@med.unc.edu	Chu, Haitao/J-7576-2012; Chastain, Paul/AAN-2692-2020	Chastain, Paul/0000-0001-6782-6788; Nakamura, Jun/0000-0002-1756-7199; Chu, Haitao/0000-0003-0932-598X	U.S. National Institutes of Health [R01-CA084493, R21-CA125337];  [P30-ES10126];  [P42-ES05948];  [T32-ES07017]; NATIONAL CANCER INSTITUTE [R21CA125337, R01CA084493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, T32ES007017, P42ES005948] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. National Institutes of Health grants R01-CA084493 and R21-CA125337 to D.G.K.; J.N. and J.A.S. were supported by grants P30-ES10126 and P42-ES05948; P.D.C. was also supported by grants T32-ES07017 and P42-ES05948. The authors have no conflicts of interest or financial disclosures to report.	Alexander R W, 1998, Trans Am Clin Climatol Assoc, V109, P129; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bennett P, 2008, FREE RADICAL BIO MED, V45, P1352, DOI 10.1016/j.freeradbiomed.2008.08.007; Bennett PV, 2005, FREE RADICAL BIO MED, V39, P832, DOI 10.1016/j.freeradbiomed.2005.05.008; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Bozner P, 1997, J NEUROPATH EXP NEUR, V56, P1356, DOI 10.1097/00005072-199712000-00010; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Chastain PD, 2006, FASEB J, V20, P2612, DOI 10.1096/fj.06-6145fje; Chastain PD, 2006, CELL CYCLE, V5, P2160, DOI 10.4161/cc.5.18.3236; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; De Rosa S, 2010, CURR VASC PHARMACOL, V8, P259; DeWeese TL, 1998, P NATL ACAD SCI USA, V95, P11915, DOI 10.1073/pnas.95.20.11915; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fiorillo C, 1998, CLIN CHEM LAB MED, V36, P149, DOI 10.1515/CCLM.1998.028; Frum RA, 2008, CELL CYCLE, V7, P1440, DOI 10.4161/cc.7.10.5879; Frum RA, 2009, CELL CYCLE, V8, P3133, DOI 10.4161/cc.8.19.9682; Georgakilas AG, 2002, NUCLEIC ACIDS RES, V30, P2800, DOI 10.1093/nar/gkf393; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(00)87170-9; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lebofsky Ronald, 2003, Briefings in Functional Genomics & Proteomics, V1, P385, DOI 10.1093/bfgp/1.4.385; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Matsuzaki Y, 2002, NUCLEIC ACIDS RES, V30, P3273, DOI 10.1093/nar/gkf440; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Miller RL, 2009, NEUROCHEM RES, V34, P55, DOI 10.1007/s11064-008-9656-2; Misra MK, 2009, MED SCI MONITOR, V15, pRA209; Mukherjee SK, 1997, MOL CHEM NEUROPATHOL, V32, P59, DOI 10.1007/BF02815167; Multhaup G, 1997, BIOCHEM PHARMACOL, V54, P533, DOI 10.1016/S0006-2952(97)00062-2; Nakamura J, 1999, CANCER RES, V59, P2522; Nicolas MG, 1996, EXP EYE RES, V62, P399, DOI 10.1006/exer.1996.0045; Nowsheen S, 2009, MUTAT RES-GEN TOX EN, V674, P131, DOI 10.1016/j.mrgentox.2008.09.010; Pastukh V, 2007, FREE RADICAL BIO MED, V43, P1616, DOI 10.1016/j.freeradbiomed.2007.08.027; PAULES RS, 1988, P NATL ACAD SCI USA, V85, P2176, DOI 10.1073/pnas.85.7.2176; Plafker SM, 2010, ADV EXP MED BIOL, V664, P447, DOI 10.1007/978-1-4419-1399-9_51; Radunovic A, 1997, NEUROSCI LETT, V239, P105, DOI 10.1016/S0304-3940(97)00905-1; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Scapagnini Giovanni, 2010, Front Biosci (Schol Ed), V2, P616; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; Sutherland BM, 2003, FREE RADICAL BIO MED, V35, P495, DOI 10.1016/S0891-5849(03)00327-7; Tian KG, 2002, DNA REPAIR, V1, P1039, DOI 10.1016/S1568-7864(02)00163-5; TISSIE G, 1988, OPHTHALMIC RES, V20, P27, DOI 10.1159/000266252; VARMA SD, 1995, CRIT REV FOOD SCI, V35, P111, DOI 10.1080/10408399509527691; VARMA SD, 1995, J OCUL PHARMACOL TH, V11, P543, DOI 10.1089/jop.1995.11.543; VUILLAUME M, 1987, MUTAT RES, V186, P43, DOI 10.1016/0165-1110(87)90014-5; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014	50	33	34	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2010	24	10					3674	3680		10.1096/fj.09-145276	http://dx.doi.org/10.1096/fj.09-145276			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20511393	Green Published			2022-12-25	WOS:000285005900008
J	Di Giovanni, J; Iborra, C; Maulet, Y; Leveque, C; El Far, O; Seagar, M				Di Giovanni, Jerome; Iborra, Cecile; Maulet, Yves; Leveque, Christian; El Far, Oussama; Seagar, Michael			Calcium-dependent Regulation of SNARE-mediated Membrane Fusion by Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; KISS-AND-RUN; NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN-I; RAPID ENDOCYTOSIS; LIPID-BINDING; PC12 CELLS; CA2+; EXOCYTOSIS; COMPLEX	Neuroexocytosis requires SNARE proteins, which assemble into trans complexes at the synaptic vesicle/plasma membrane interface and mediate bilayer fusion. Ca2+ sensitivity is thought to be conferred by synaptotagmin, although the ubiquitous Ca2+-effector calmodulin has also been implicated in SNARE-dependent membrane fusion. To examine the molecular mechanisms involved, we examined the direct action of calmodulin and synaptotagmin in vitro, using fluorescence resonance energy transfer to assay lipid mixing between target-and vesicle-SNARE liposomes. Ca2+/calmodulin inhibited SNARE assembly and membrane fusion by binding to two distinct motifs located in the membrane-proximal regions of VAMP2 (K-D = 500 nM) and syntaxin 1 (K-D = 2 mu M). In contrast, fusion was increased by full-length synaptotagmin 1 anchored in vesicle-SNARE liposomes. When synaptotagmin and calmodulin were combined, synaptotagmin overcame the inhibitory effects of calmodulin. Furthermore, synaptotagmin displaced calmodulin binding to target-SNAREs. These findings suggest that two distinct Ca2+ sensors act antagonistically in SNARE-mediated fusion.	[Seagar, Michael] Inst Jean Roche Neurosci, INSERM, UMR641, F-13344 Marseille, France; [Di Giovanni, Jerome; Iborra, Cecile; Maulet, Yves; Leveque, Christian; El Far, Oussama; Seagar, Michael] Univ Mediterrane, F-13344 Marseille, France; [Leveque, Christian] Inst Jean Roche Neurosci, Ctr Anal Prote Marseille, F-13344 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Seagar, M (corresponding author), Inst Jean Roche Neurosci, INSERM, UMR641, Bd P Dramard, F-13344 Marseille, France.	michael.seagar@univmed.fr	Far, Oussama El/D-4225-2017; EL FAR, Oussama/P-9915-2019; leveque, christian/GVU-3567-2022; Maulet, Yves/AAC-3207-2019	Far, Oussama El/0000-0002-7473-8345; EL FAR, Oussama/0000-0002-7473-8345; leveque, christian/0000-0003-2583-2148; Maulet, Yves/0000-0002-3162-0435	Association Francaise Contre les Myopathies; CNRS; INSERM; Ministere de l'Enseignement Superieur et de la Recherche-Action Concertee Incitative Biologie Cellulaire, Moleculaire et Structurale	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Enseignement Superieur et de la Recherche-Action Concertee Incitative Biologie Cellulaire, Moleculaire et Structurale	This work was supported by the Association Francaise Contre les Myopathies, CNRS, INSERM, and the Ministere de l'Enseignement Superieur et de la Recherche-Action Concertee Incitative Biologie Cellulaire, Moleculaire et Structurale.	Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; Chen YA, 1999, J BIOL CHEM, V274, P26469, DOI 10.1074/jbc.274.37.26469; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chen YA, 2001, J BIOL CHEM, V276, P26680, DOI 10.1074/jbc.M103522200; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Chicka MC, 2009, BIOCHEMISTRY-US, V48, P657, DOI 10.1021/bi801962d; de Haro L, 2004, P NATL ACAD SCI USA, V101, P1578, DOI 10.1073/pnas.0303274101; Elhamdani A, 2006, J NEUROSCI, V26, P3030, DOI 10.1523/JNEUROSCI.5275-05.2006; Fdez E, 2008, MOL BIOL CELL, V19, P3379, DOI 10.1091/mbc.E08-01-0010; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Hu K, 2004, BIOCHEM J, V377, P781, DOI 10.1042/bj20031164; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kim CS, 2002, BIOCHEMISTRY-US, V41, P10928, DOI 10.1021/bi026266v; Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; LLOBET A, 2008, J GEN PHYSIOL, V132, P3; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Perin MS, 1996, BIOCHEMISTRY-US, V35, P13808, DOI 10.1021/bi960853x; Quetglas S, 2002, EMBO J, V21, P3970, DOI 10.1093/emboj/cdf404; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Westerink RHS, 2002, BRAIN RES, V957, P25, DOI 10.1016/S0006-8993(02)03580-1; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	58	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23665	23675		10.1074/jbc.M109.096073	http://dx.doi.org/10.1074/jbc.M109.096073			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519509	Green Published, hybrid			2022-12-25	WOS:000280291400017
J	Murata, T; Hotta, N; Toyama, S; Nakayama, S; Chiba, S; Isomura, H; Ohshima, T; Kanda, T; Tsurumi, T				Murata, Takayuki; Hotta, Naoe; Toyama, Shigenori; Nakayama, Sanae; Chiba, Shigeki; Isomura, Hiroki; Ohshima, Takayuki; Kanda, Teru; Tsurumi, Tatsuya			Transcriptional Repression by Sumoylation of Epstein-Barr Virus BZLF1 Protein Correlates with Association of Histone Deacetylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY PROTEIN; CREB-BINDING-PROTEIN; CONJUGATING ENZYME UBC9; SUMO MODIFICATION; KINASE BGLF4; CELL-LINES; IN-VIVO; K-BZIP; REACTIVATION; LATENCY	The transition from latent to lytic phases of the Epstein-Barr virus life cycle is triggered by expression of a viral transactivator, BZLF1, that then induces expression of the viral immediate-early and early genes. The BZLF1 protein is post-translationally modified by a small ubiquitin-related modifier-1 (SUMO-1). Here we found that BZLF1 is conjugated at lysine 12 not only by SUMO-1 but also by SUMO-2 and 3. The K12R mutant of BZLF1, which no longer becomes sumoylated, exhibits stronger transactivation than the wild-type BZLF1 in a reporter assay system as well as in the context of virus genome with nucleosomal structures. Furthermore, exogenous supply of a SUMO-specific protease, SENP, caused de-sumoylation of BZLF1 and enhanced BZLF1-mediated transactivation. Immunoprecipitation experiments proved that histone deacetylase 3 preferentially associated with the sumoylated form of BZLF1. Levels of the sumoylated BZLF1 increased as lytic replication progressed. Based on these observations, we conclude that sumoylation of BZLF1 regulates its transcriptional activity through histone modification during Epstein-Barr virus productive replication.	[Murata, Takayuki; Hotta, Naoe; Toyama, Shigenori; Nakayama, Sanae; Chiba, Shigeki; Isomura, Hiroki; Kanda, Teru; Tsurumi, Tatsuya] Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Toyama, Shigenori; Tsurumi, Tatsuya] Nagoya City Univ, Dept Oncol, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Ohshima, Takayuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa 7692193, Japan	Aichi Cancer Center; Nagoya City University; Tokushima Bunri University	Tsurumi, T (corresponding author), Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Kanda, Teru/J-7313-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; Kanda, Teru/0000-0002-1391-3349; OHSHIMA, Takayuki/0000-0002-1501-6430	Ministry of Education, Science, Sports, Culture, and Technology of Japan [20390137, 21022055, 20790362, 22790448]; Uehara Memorial Research Fund; Japan Leukaemia Research Fund	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Research Fund(Uehara Memorial Foundation); Japan Leukaemia Research Fund	This work was supported by Grants-in-aid for Scientific Research 20390137 and 21022055 (to T.T.) and 20790362 and 22790448 (to T.M.) from the Ministry of Education, Science, Sports, Culture, and Technology of Japan and in part by the Uehara Memorial Research Fund (to T.T.) and the Japan Leukaemia Research Fund (to T.M.).	Adamson AL, 2005, BIOCHEM BIOPH RES CO, V336, P22, DOI 10.1016/j.bbrc.2005.08.036; Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Antoine K, 2005, MOL CELL BIOCHEM, V271, P215, DOI 10.1007/s11010-005-6417-2; Asai R, 2006, J VIROL, V80, P5125, DOI 10.1128/JVI.02674-05; Asai R, 2009, J GEN VIROL, V90, P1575, DOI 10.1099/vir.0.010462-0; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Chen CJ, 2001, MOL CELL BIOL, V21, P476, DOI 10.1128/MCB.21.2.476-487.2001; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Deng Z, 2003, MOL CELL BIOL, V23, P2633, DOI 10.1128/MCB.23.8.2633-2644.2003; Deng Z, 2001, J VIROL, V75, P10334, DOI 10.1128/JVI.75.21.10334-10347.2001; El-Guindy AS, 2006, J BIOL CHEM, V281, P3085, DOI 10.1074/jbc.M506076200; Eloranta JJ, 2002, J BIOL CHEM, V277, P30798, DOI 10.1074/jbc.M202780200; Feng WH, 2007, J VIROL, V81, P10113, DOI 10.1128/JVI.00692-07; Feng WH, 2004, JNCI-J NATL CANCER I, V96, P1691, DOI 10.1093/jnci/djh313; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gruffat H, 2002, EMBO REP, V3, P141, DOI 10.1093/embo-reports/kvf031; Hagemeier SR, 2010, J VIROL, V84, P4383, DOI 10.1128/JVI.02369-09; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Izumiya Y, 2005, J VIROL, V79, P9912, DOI 10.1128/JVI.79.15.9912-9925.2005; Izumiya Y, 2007, J VIROL, V81, P1072, DOI 10.1128/JVI.01473-06; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Jenkins PJ, 2000, J VIROL, V74, P710, DOI 10.1128/JVI.74.2.710-720.2000; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; JOAB I, 1991, INT J CANCER, V48, P647, DOI 10.1002/ijc.2910480503; Kanamori M, 2000, VIRUS GENES, V20, P117, DOI 10.1023/A:1008110312661; Katsumura KR, 2009, J GEN VIROL, V90, P2331, DOI 10.1099/vir.0.012831-0; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Liu B, 2008, CURR OPIN CELL BIOL, V20, P288, DOI 10.1016/j.ceb.2008.03.014; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Muraoka A, 2008, BIOCHEM BIOPH RES CO, V377, P1031, DOI 10.1016/j.bbrc.2008.09.149; Murata T, 2006, J BIOL CHEM, V281, P20788, DOI 10.1074/jbc.M600563200; Murata T, 2009, J BIOL CHEM, V284, P8033, DOI 10.1074/jbc.M808466200; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Nakayama S, 2009, J BIOL CHEM, V284, P21557, DOI 10.1074/jbc.M109.015685; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Nishida T, 2001, J BIOL CHEM, V276, P39060, DOI 10.1074/jbc.M103955200; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Oshima M, 2009, J BIOL CHEM, V284, P11017, DOI 10.1074/jbc.M808694200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Seeler JS, 2001, ONCOGENE, V20, P7243, DOI 10.1038/sj.onc.1204758; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Tempera I, 2010, BBA-GENE REGUL MECH, V1799, P236, DOI 10.1016/j.bbagrm.2009.10.004; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Wang WL, 2008, NUCLEIC ACIDS RES, V36, P6066, DOI 10.1093/nar/gkn607; Yang SH, 2006, E SCHERING RES FDN W, V57, P193; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Zerby D, 1999, MOL CELL BIOL, V19, P1617	57	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23925	23935		10.1074/jbc.M109.095356	http://dx.doi.org/10.1074/jbc.M109.095356			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516063	Green Published, hybrid			2022-12-25	WOS:000280291400043
J	Orellana, D; Liu, XY; Wang, GL; Jin, JL; Iakova, P; Timchenko, NA				Orellana, Daniel; Liu, Xiaoying; Wang, Gou-Li; Jin, Jingling; Iakova, Polina; Timchenko, Nikolai A.			Calmodulin Controls Liver Proliferation via Interactions with C/EBP beta-LAP and C/EBP beta-LIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; TRANSCRIPTIONAL INHIBITORY PROTEIN; CELL-CYCLE; INCREASES TRANSLATION; ALPHA; ISOFORM; RNA; PRB; PHOSPHORYLATION; MECHANISMS	A truncated isoform of C/EBP beta, C/EBP beta-LIP, is required for liver proliferation. This isoform is expressed at high levels in proliferating liver and in liver tumors. However, high levels of C/EBP beta-LIP are also observed in non-proliferating livers during acute phase response (APR). In this paper we present mechanisms by which liver regulates activities of C/EBP beta-LIP. We found that calmodulin (CaM) inhibits the ability of C/EBP beta-LIP to promote liver proliferation during APR through direct interactions. This activity of CaM is under negative control of Ca2+, which is reduced in nuclei of livers with APR, whereas it is increased in nuclei of proliferating livers. A mutant CaM, which does not interact with C/EBP beta-LIP, also fails to inhibit the growth promotion activity of C/EBP beta-LIP. Down-regulation of CaM in livers of LPS-treated mice causes liver proliferation via activation of C/EBP beta-LIP. Overexpression of C/EBP beta-LIP above levels of CaM also initiates liver proliferation in LPS-treated mice. In addition, CaM regulates transcriptional activity of another isoform of C/EBP beta, C/EBP beta-LAP, and might control liver biology through the regulation of both isoforms of C/EBP beta. In searching for molecular mechanisms by which C/EBP beta-LIP promotes cell proliferation, we found that C/EBP beta-LIP releases E2F.Rb-dependent repression of cell cycle genes by a disruption of E2F1.Rb complexes and by a direct interaction with E2F-dependent promoters. CaM inhibits these growth promotion activities of C/EBP beta-LIP and, therefore, supports liver quiescence. Thus, our findings discover a new pathway of the regulation of liver proliferation that involves calcium-CaM signaling.	[Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Jin, Jingling/0000-0002-4365-1837; Orellana, Daniel Ignacio/0000-0002-0431-7430	National Institutes of Health [GM55188, CA100070, AG20752]; NATIONAL CANCER INSTITUTE [R01CA100070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55188, CA100070, and AG20752 (to N.A.T.).	Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chang HT, 2008, TOXICOL LETT, V179, P53, DOI 10.1016/j.toxlet.2008.04.002; Charles A, 2001, J CELL BIOCHEM, V83, P414, DOI 10.1002/jcb.1239; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Choi J, 2006, CIRC RES, V98, P1273, DOI 10.1161/01.RES.0000223059.19250.91; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Diehl AM, 2005, AM J PHYSIOL-GASTR L, V288, pG1, DOI 10.1152/ajpgi.00376.2004; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Enomoto N, 1999, AM J PHYSIOL-GASTR L, V277, pG1251, DOI 10.1152/ajpgi.1999.277.6.G1251; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Finkler A, 2007, FEBS LETT, V581, P3893, DOI 10.1016/j.febslet.2007.07.051; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Harrison JR, 2005, J BIOL CHEM, V280, P8117, DOI 10.1074/jbc.M410076200; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Koledova VV, 2006, CIRC RES, V98, P1240, DOI 10.1161/01.RES.0000225860.41648.63; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Monaco S, 2009, CELL CYCLE, V8, P2024, DOI 10.4161/cc.8.13.8813; PORTOLES MT, 1994, EUR J CELL BIOL, V65, P200; Rodriguez-Vilarrupla A, 2005, MOL CELL BIOL, V25, P7364, DOI 10.1128/MCB.25.16.7364-7374.2005; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Taules M, 1999, J BIOL CHEM, V274, P24445, DOI 10.1074/jbc.274.35.24445; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang GL, 2005, MOL CELL BIOL, V25, P1325, DOI 10.1128/MCB.25.4.1325-1338.2005; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Welm AL, 2000, J BIOL CHEM, V275, P27406; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033	41	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23442	23454		10.1074/jbc.M110.129825	http://dx.doi.org/10.1074/jbc.M110.129825			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498378	Green Published, hybrid			2022-12-25	WOS:000279999900076
J	Xu, YB; Kershaw, NJ; Luo, CS; Soo, P; Pocock, MJ; Czabotar, PE; Hilton, DJ; Nicola, NA; Garrett, TPJ; Zhang, JG				Xu, Yibin; Kershaw, Nadia J.; Luo, Cindy S.; Soo, Priscilla; Pocock, Michael J.; Czabotar, Peter E.; Hilton, Douglas J.; Nicola, Nicos A.; Garrett, Thomas P. J.; Zhang, Jian-Guo			Crystal Structure of the Entire Ectodomain of gp130 INSIGHTS INTO THE MOLECULAR ASSEMBLY OF THE TALL CYTOKINE RECEPTOR COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL EXTRACELLULAR DOMAINS; SIGNAL TRANSDUCER GP130; DIFFRACTION DATA; LIGAND; OLIGOMERIZATION; DIMERIZATION; RECOGNITION; ACTIVATION; REGION	gp130 is the shared signal-transducing receptor subunit for the large and important family of interleukin 6-like cytokines. Previous x-ray structures of ligand-receptor complexes of this family lack the three membrane-proximal domains that are essential for signal transduction. Here we report the crystal structure of the entire extracellular portion of human gp130 (domains 1-6, D1-D6) at 3.6 angstrom resolution, in an unliganded form, as well as a higher resolution structure of the membrane-proximal fibronectin type III domains (D4-D6) at 1.9 angstrom. This represents the first atomic resolution structure of the complete ectodomain of any "tall" cytokine receptor. These structures show that other than a reorientation of the D1 domain, there is little structural change in gp130 upon ligand binding. They also reveal that the interface between the D4 and D5 domains forms an acute bend in the gp130 structure. Key residues at this interface are highly conserved across the entire tall receptor family, suggesting that this acute bend may be a common feature of these receptors. Importantly, this geometry positions the C termini of the membrane-proximal fibronectin type III domains of the tall cytokine receptors in close proximity within the transmembrane complex, favorable for receptor-associated Janus kinases to trans-phosphorylate and activate each other.	[Xu, Yibin; Kershaw, Nadia J.; Luo, Cindy S.; Soo, Priscilla; Pocock, Michael J.; Czabotar, Peter E.; Hilton, Douglas J.; Nicola, Nicos A.; Garrett, Thomas P. J.; Zhang, Jian-Guo] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute	Garrett, TPJ (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	tgarrett@wehi.edu.au; zhang@wehi.edu.au	Nicola, Nicos/D-2989-2011; Kershaw, Nadia/G-5770-2014; Hilton, Douglas J/C-7250-2013	Nicola, Nicos/0000-0003-1054-7889; Hilton, Douglas J/0000-0002-7698-2392; Czabotar, Peter/0000-0002-2594-496X; Kershaw, Nadia/0000-0002-3554-2622	Australian National Health and Medical Research Council [257500, 280912, 487922, 461219, 461221, 516730]; Australian Cancer Research Foundation; Victoria Government; Australian Government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Victoria Government; Australian Government(Australian GovernmentCGIAR)	This work was supported by the Australian National Health and Medical Research Council (Grants 257500, 280912, 487922, 461219, 461221, and 516730), the Australian Cancer Research Foundation, the Victoria Government Operational Infrastructure Scheme, and the Australian Government Independent Research Institutes Infrastructure Support Scheme.	Afonine P., 2005, CCP4 NEWSLETTER, V42; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; de Pereda JM, 1999, EMBO J, V18, P4087, DOI 10.1093/emboj/18.15.4087; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giese B, 2005, J CELL SCI, V118, P5129, DOI 10.1242/jcs.02628; Greiser JS, 2002, J BIOL CHEM, V277, P26959, DOI 10.1074/jbc.M204113200; Hammacher A, 2000, BIOCHEM J, V345, P25, DOI 10.1042/0264-6021:3450025; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moritz RL, 2001, J BIOL CHEM, V276, P8244, DOI 10.1074/jbc.M009979200; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflanz S, 2001, BIOCHEM J, V356, P605, DOI 10.1042/0264-6021:3560605; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tamada T, 2006, P NATL ACAD SCI USA, V103, P3135, DOI 10.1073/pnas.0511264103; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Timmermann A, 2002, EUR J BIOCHEM, V269, P2716, DOI 10.1046/j.1432-1033.2002.02941.x	40	59	61	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21214	21218		10.1074/jbc.C110.129502	http://dx.doi.org/10.1074/jbc.C110.129502			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20489211	Green Published, hybrid			2022-12-25	WOS:000279516100005
J	Su, L; Cheng, H; Sampaio, AV; Nielsen, TO; Underhill, TM				Su, L.; Cheng, H.; Sampaio, A. V.; Nielsen, T. O.; Underhill, T. M.			EGR1 reactivation by histone deacetylase inhibitors promotes synovial sarcoma cell death through the PTEN tumor suppressor	ONCOGENE			English	Article						HDAC inhibitors; synovial sarcoma; EGR1; PTEN; apoptosis	TRANSCRIPTION FACTOR; CANCER CELLS; INDUCED APOPTOSIS; IN-VITRO; GROWTH; EXPRESSION; PROTEIN; P53; TRANSFORMATION; TRICHOSTATIN	Synovial sarcoma is a high-grade soft tissue malignancy, for which current cytotoxic chemotherapies provide limited benefit. Although histone deacetylase (HDAC) inhibitors are known to suppress synovial sarcoma in vitro and in vivo, the exact mechanism is not clear. In this study, we report a central role of the transcription factor, early growth response-1 (EGR1), in the regulation of HDAC inhibitor-induced apoptotic cell death in synovial sarcoma. The SS18-SSX oncoprotein, characteristic of synovial sarcoma, maintains EGR1 expression at low levels, whereas it is significantly increased after HDAC inhibitor treatment. On the contrary, EGR1 knockdown leads to a decrease in HDAC inhibitor-induced apoptosis. Moreover, we find that under these conditions phosphatase and tensin homolog deleted in chromosome 10 (PTEN) is upregulated and this occurs through direct binding of EGR1 to an element upstream of the PTEN promoter. Using a combination of gain-and loss-of-function approaches, we show that EGR1 modulation of PTEN contributes to HDAC inhibitor-induced apoptosis in synovial sarcoma. Finally, restoration of EGR1 or PTEN expression is sufficient to induce synovial sarcoma cell death. Taken together, our findings indicate that SS18-SSX-mediated attenuation of an EGR1-PTEN network regulates synovial sarcoma cell survival, and that HDAC inhibitor-mediated apoptosis operates at least in part through reactivation of this pathway. Oncogene (2010) 29, 4352-4361; doi: 10.1038/onc.2010.204; published online 31 May 2010	[Underhill, T. M.] Univ British Columbia, Biomed Res Ctr, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Cheng, H.; Nielsen, T. O.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Nielsen, TO (corresponding author), Vancouver Coastal Hlth Res Inst, Room JP1502,855 W 12th Ave, Vancouver, BC V5Z 1M9, Canada.	torsten@interchange.ubc.ca; tunderhi@brc.ubc.ca			Canadian Cancer Society Research Institute [018355]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	We thank Dr Diederik RH de Bruijn (Radbound University Nijmegen Medical Centre, Nijmegen, the Netherlands) for the gift of rabbit polyclonal antibody against SS18-SSX. This work was supported by a grant from the Canadian Cancer Society Research Institute (Grant #018355). Dr TO Nielsen is a scholar of the Michael Smith Foundation for Health Research, and Dr TM Underhill is an Arthritis Society Investigator.	Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bozzi F, 2008, TRANSL ONCOL, V1, P95, DOI 10.1593/tlo.08121; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; Calogero A, 1996, ONCOGENE, V13, P2105; Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1; Condorelli F, 2008, BRIT J PHARMACOL, V153, P657, DOI 10.1038/sj.bjp.0707608; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; Downes CP, 2001, BIOCHEM SOC T, V29, P846, DOI 10.1042/BST0290846; Gan YH, 2009, ORAL ONCOL, V45, pE150, DOI 10.1016/j.oraloncology.2009.05.563; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Habold C, 2008, J CELL MOL MED, V12, P607, DOI 10.1111/j.1582-4934.2007.00136.x; HUANG RP, 1994, ONCOGENE, V9, P1367; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; HUANG RP, 1995, CANCER RES, V55, P5054; Italiano A, 2009, ANN ONCOL, V20, P425, DOI 10.1093/annonc/mdn678; Ito T, 2005, CANCER LETT, V224, P311, DOI 10.1016/j.canlet.2004.10.030; Khan O, 2008, NAT CLIN PRACT ONCOL, V5, P714, DOI 10.1038/ncponc1238; Kim J, 2006, CANCER RES, V66, P784, DOI 10.1158/0008-5472.CAN-05-1316; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; LEBEAU MM, 1993, P NATL ACAD SCI USA, V90, P5484, DOI 10.1073/pnas.90.12.5484; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; Liu CT, 1996, P NATL ACAD SCI USA, V93, P11831, DOI 10.1073/pnas.93.21.11831; Liu CT, 1999, J BIOL CHEM, V274, P4400, DOI 10.1074/jbc.274.7.4400; Liu J, 2001, INT J ONCOL, V18, P863; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Ma DZ, 2005, WORLD J GASTROENTERO, V11, P4472, DOI 10.3748/wjg.v11.i29.4472; Medina V, 1997, CANCER RES, V57, P3697; Moradei O, 2008, CURR TOP MED CHEM, V8, P841, DOI 10.2174/156802608784911581; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nair P, 1997, J BIOL CHEM, V272, P20131, DOI 10.1074/jbc.272.32.20131; Okcu MF, 2003, J CLIN ONCOL, V21, P1602, DOI 10.1200/JCO.2003.07.008; Pan LN, 2007, CANCER, V109, P1676, DOI 10.1002/cncr.22585; Roeb W, 2008, CELL CYCLE, V7, P837, DOI 10.4161/cc.7.7.5652; Roeb W, 2007, P NATL ACAD SCI USA, V104, P18085, DOI 10.1073/pnas.0708910104; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	48	42	44	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2010	29	30					4352	4361		10.1038/onc.2010.204	http://dx.doi.org/10.1038/onc.2010.204			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20514024				2022-12-25	WOS:000280547900011
J	Emadi, A; Ross, AE; Cowan, KM; Fortenberry, YM; Vuica-Ross, M				Emadi, Ashkan; Ross, Ashley E.; Cowan, Kathleen M.; Fortenberry, Yolanda M.; Vuica-Ross, Milena			A Chemical Genetic Screen for Modulators of Asymmetrical 2,2'-Dimeric Naphthoquinones Cytotoxicity in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; REGIOCONTROLLED SYNTHESIS; NATURAL-PRODUCTS; CELL-DEATH; CONOCURVONE; GENOME; STRESS; DEHYDROGENASE; MITOCHONDRIA; MECHANISMS	Background: Dimeric naphthoquinones (BiQ) were originally synthesized as a new class of HIV integrase inhibitors but have shown integrase-independent cytotoxicity in acute lymphoblastic leukemia cell lines suggesting their use as potential antineoplastic agents. The mechanism of this cytotoxicity is unknown. In order to gain insight into the mode of action of binaphthoquinones we performed a systematic high-throughput screen in a yeast isogenic deletion mutant array for enhanced or suppressed growth in the presence of binaphthoquinones. Methodology/Principal findings: Exposure of wild type yeast strains to various BiQs demonstrated inhibition of yeast growth with IC(50)s in the mu M range. Drug sensitivity and resistance screens were performed by exposing arrays of a haploid yeast deletion mutant library to BiQs at concentrations near their IC50. Sensitivity screens identified yeast with deletions affecting mitochondrial function and cellular respiration as having increased sensitivity to BiQs. Corresponding to this, wild type yeast grown in the absence of a fermentable carbon source were particularly sensitive to BiQs, and treatment with BiQs was shown to disrupt the mitochondrial membrane potential and lead to the generation of reactive oxygen species (ROS). Furthermore, baseline ROS production in BiQ sensitive mutant strains was increased compared to wild type and could be further augmented by the presence of BiQ. Screens for resistance to BiQ action identified the mitochondrial external NAD(P) H dehydrogenase, NDE1, as critical to BiQ toxicity and over-expression of this gene resulted in increased ROS production and increased sensitivity of wild type yeast to BiQ. Conclusions/Significance: In yeast, binaphthoquinone cytotoxicity is likely mediated through NAD(P)H:quonine oxidoreductases leading to ROS production and dysfunctional mitochondria. Further studies are required to validate this mechanism in mammalian cells.	[Emadi, Ashkan] Johns Hopkins Sch Med, Dept Internal Med & Oncol, Baltimore, MD 21218 USA; [Ross, Ashley E.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA; [Cowan, Kathleen M.; Vuica-Ross, Milena] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Fortenberry, Yolanda M.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Emadi, A (corresponding author), Johns Hopkins Sch Med, Dept Internal Med & Oncol, Baltimore, MD 21218 USA.	mvuica@jhmi.edu			Richard Starr Ross Clinician Scientist Award; JHH Department of Pathology funds	Richard Starr Ross Clinician Scientist Award; JHH Department of Pathology funds	This work was supported by Richard Starr Ross Clinician Scientist Award (to MVR) and the JHH Department of Pathology funds (to MVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; Bey EA, 2006, J CELL PHYSIOL, V209, P604, DOI 10.1002/jcp.20783; Bittner S, 2006, AMINO ACIDS, V30, P205, DOI 10.1007/s00726-005-0298-2; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; CLAYSON DB, 1994, MUTAT RES, V317, P25, DOI 10.1016/0165-1110(94)90010-8; Davermann D, 2002, FREE RADICAL BIO MED, V33, P1209, DOI 10.1016/S0891-5849(02)00984-X; Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001; DECOSTERD LA, 1993, J AM CHEM SOC, V115, P6673, DOI 10.1021/ja00068a026; Emadi A, 2002, ORG LETT, V4, P521, DOI 10.1021/ol010272m; FOX TD, 1991, METHODS ENZYMOL, V194, P149; Funk M, 2002, METHOD ENZYMOL, V350, P248, DOI 10.1016/S0076-6879(02)50967-8; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hallak M, 2009, BRIT J HAEMATOL, V147, P459, DOI 10.1111/j.1365-2141.2009.07867.x; Kanaan YM, 2009, ANTICANCER RES, V29, P191; Kuzyk MA, 2009, PROTEOMICS, V9, P3328, DOI 10.1002/pmic.200800412; LAATSCH H, 1994, ANGEW CHEM INT EDIT, V33, P422, DOI 10.1002/anie.199404221; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Lopez Andres, 2008, V66; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Luttik MAH, 1998, J BIOL CHEM, V273, P24529, DOI 10.1074/jbc.273.38.24529; MISKIMINS R, 1982, GENETICS, V101, P157; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; OHNISHI T, 1966, B SOC CHIM BIOL, V48, P1189; OLLINGER K, 1991, J BIOL CHEM, V266, P21496; Pardee AB, 2002, CURR CANCER DRUG TAR, V2, P227, DOI 10.2174/1568009023333854; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; ROCKWELL S, 1993, CANCER METAST REV, V12, P165, DOI 10.1007/BF00689808; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Small WC, 1998, J BACTERIOL, V180, P4051, DOI 10.1128/JB.180.16.4051-4055.1998; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Stagliano KW, 2006, BIOORGAN MED CHEM, V14, P5651, DOI 10.1016/j.bmc.2006.04.034; Stagliano KW, 2004, J ORG CHEM, V69, P5128, DOI 10.1021/jo049713g; STAGLIANO KW, 2004, Patent No. 6828347; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100	42	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10846	10.1371/journal.pone.0010846	http://dx.doi.org/10.1371/journal.pone.0010846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520766	gold, Green Published, Green Submitted			2022-12-25	WOS:000278221500031
J	Xie, WJ; Huang, YF; Xie, WL; Guo, AM; Wu, W				Xie, Wenjie; Huang, Yafang; Xie, Wenling; Guo, Aimin; Wu, Wei			Bacteria Peptidoglycan Promoted Breast Cancer Cell Invasiveness and Adhesiveness by Targeting Toll-Like Receptor 2 in the Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN PROSTATE-CANCER; GROWTH-FACTOR-BETA; TUMOR-GROWTH; INNATE IMMUNITY; INVASION; INFLAMMATION; METASTASIS; AGONISTS; STAT3	Chronic bacterial infection increased the risk of many solid malignancies and the underlying mechanism is usually ascribed to bacterial-caused inflammation. However, the direct interaction of infectious bacteria with cancer cells has been largely overlooked. We identified that highly metastatic breast cancer MDA-MB-231 cells expressed high level of Toll-like receptor 2 (TLR2) in contrast to poorly metastatic breast cancer cells and homogenous untransformed breast cells. TLR2 in MDA-MB-231 cells were actively triggered by peptidoglycan (PGN) from infectious bacterium Staphylococcus aureus (PGN-SA), resulting in the promoted invasiveness and adhesiveness of the cancer cells in vitro. PGN-SA induced phosphorylation of TAK1 and I kappa B in the TLR2-NF-kappa B pathway of the cancer cells and stimulated IL-6 and TGF-beta secretion in MDA-MB-231 cells. All these effects were abrogated by TLR2 blockade. Further investigation showed that the NF-kappa B, STAT3 and Smad3 activities were augmented sequentially in MDA-MB-231 cells after PGN-SA stimulation. Phosphorylation of NF-kappa Bp65 was initially increased and then followed by phosphorylation of STAT3 and Smad3 in the delayed 4 or 6 hours. NF-kappa B inhibition attenuated STAT3 and Smad3 activities whereas PGN-SA-stimulated cell culture supernatants reversed these inhibitory effects. Our study indicated that TLR2 activation by infectious bacterial PGN played an important role in breast cancer cell invasiveness and illustrated a new link between infectious bacteria and the cancer cells, suggesting the importance of antibiotic therapy to treat cancer with bacterial infection.	[Xie, Wenjie] United Labs Int Holdings Ltd, Biol Res Inst, Zhuhai, Peoples R China; [Huang, Yafang; Guo, Aimin; Wu, Wei] Capital Univ Med Sci, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Xie, Wenling] Xinjiang Modern Women Hosp, Urumqi, Peoples R China	Capital Medical University	Xie, WJ (corresponding author), United Labs Int Holdings Ltd, Biol Res Inst, Zhuhai, Peoples R China.	xiewj75@126.com; elite010@163.com			Post-doctor Foundation of Zhu Hai; major Science and Technology Project of Zhu Hai	Post-doctor Foundation of Zhu Hai; major Science and Technology Project of Zhu Hai	This work was mainly supported by the Post-doctor Foundation of Zhu Hai (to W. Xie) and the major Science and Technology Project of Zhu Hai (to W. Xie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andreani V, 2007, CANCER RES, V67, P10519, DOI 10.1158/0008-5472.CAN-07-0079; Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Becker C, 2005, CELL CYCLE, V4, P217; Bhutani M, 2007, CLIN CANCER RES, V13, P3024, DOI 10.1158/1078-0432.CCR-06-2575; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Connolly Lynette, 2002, Br J Biomed Sci, V59, P11; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; FERRARA AR, 2008, RADIOL TECHNOL, V80, P49; Hooper AT, 2005, J CLIN ONCOL, V23, p871S; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim SH, 2006, J SURG ONCOL, V93, P330, DOI 10.1002/jso.20461; Kokkinopoulos I, 2005, MOL IMMUNOL, V42, P957, DOI 10.1016/j.molimm.2004.09.037; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Labidi SI, 2008, ANN ONCOL, V19, P473, DOI 10.1093/annonc/mdm480; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lotfi R, 2007, J IMMUNOTHER, V30, P16, DOI 10.1097/01.cji.0000211324.53396.f6; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Lu S, 2007, CLIN CANCER RES, V13, P5692, DOI 10.1158/1078-0432.CCR-07-1078; Lutgens MWMD, 2008, GUT, V57, P1246, DOI 10.1136/gut.2007.143453; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Muss HB, 2006, NEW ENGL J MED, V355, P2783, DOI 10.1056/NEJMe068260; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Pinto-Santini D, 2005, CANCER EPIDEM BIOMAR, V14, P1853, DOI 10.1158/1055-9965.EPI-04-0784; QUAN S, 2004, AM J RESP CELL MOL B; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; STEIN RA, 2008, JAMA-J AM MED ASSOC, V299, P837; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takkouche B, 2008, JNCI-J NATL CANCER I, V100, P1439, DOI 10.1093/jnci/djn324; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yoshioka T, 2001, J INT MED RES, V29, P409, DOI 10.1177/147323000102900505; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	49	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10850	10.1371/journal.pone.0010850	http://dx.doi.org/10.1371/journal.pone.0010850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520770	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221500035
J	Hoetjes, PC; Carpenter, KE				Hoetjes, Paul C.; Carpenter, Kent E.			Saving Saba Bank: Policy Implications of Biodiversity Studies	PLOS ONE			English	Article								Saba Bank has always been an area of special importance to the neighboring island of Saba in the Netherlands Antilles. Sabans traditionally fished on the Bank as far back as 1907, but increasing foreign fishing pressures on the Bank in the 1970s and 1980s forced many Saban fishermen out. Concerns were compounded by the suspicion that shipping was also damaging the benthic habitat of the bank. Fishery legislation, enacted in 1996, brought an end to unlicensed fishing and established Coast Guard enforcement on the Bank, but also led to protests from neighboring countries that previously fished on the Bank. Research was necessary to support the need for protection. Review of available research of Saba Bank and rapid biological assessments and fisheries surveys since 1996 emphasized the richness of Saba Bank's biodiversity and the need for protection of fisheries stocks. The national nature policy plan recognized this and encouraged further research to base conservation measures on. Recent biological surveys of corals, fishes, and algae presented in this collection of articles emphasized habitat heterogeneity and the relative richness of the marine flora and fauna. These assessments formed the basis for a management plan to protect Saba Bank's biodiversity and a draft proposal to the International Maritime Organization (IMO) seeking Particularly Sensitive Sea Area (PSSA) status for the Bank. The intention of the PSSA proposal is to protect the benthic habitat on Saba Bank from anchor damage. This paper serves to provide the context for the results of the recent biodiversity surveys of Saba Bank. It is hoped that this collection will serve as a knowledge baseline and engender further research in the area.	[Hoetjes, Paul C.] Directorate Publ Hlth, Dept Environm & Nat, Willemstad, Curacao, Neth Antilles; [Carpenter, Kent E.] Old Dominion Univ, Int Union Conservat Nat Species Programme Species, Norfolk, VA USA	Old Dominion University	Hoetjes, PC (corresponding author), Directorate Publ Hlth, Dept Environm & Nat, Willemstad, Curacao, Neth Antilles.	paul@mina.vomil.an			Development Foundation of the Netherlands Antilles (SONA); Department of Environment and Nature of the Netherlands Antilles; Dutch Ministry of Transport and Water	Development Foundation of the Netherlands Antilles (SONA); Department of Environment and Nature of the Netherlands Antilles; Dutch Ministry of Transport and Water	This work was part of the implementation of the Nature and Environment Policy Plan (NEPP) of the Department of Environment and Nature of the Netherlands Antilles, funded by Dutch development support provided through the Development Foundation of the Netherlands Antilles (SONA) and carried out with the help of the Saba Conservation Foundation, Saba, Netherlands Antilles. Additional funding came from the Small Nature Projects Fund (KNAP fund) of the Department of Environment and Nature of the Netherlands Antilles, which made possible the first review of Saba Bank. The Dutch Ministry of Transport and Water provided funding for some of the preliminary work towards a Particularly Sensitive Sea Area (PSSA) status proposal to the International Maritime Organization (IMO) which also helped identify the needs for further research and data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeke J., 1907, RAPPORT BETREFFENDE; *CABS CONS INT, RAP ASS PROGR; DAVIS WM, 1926, AM GEOL SOC PUB, V2, P207; Dilrosun F, 2000, MONITORING SABA BANK; Etnoyer PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010668; *IMO, 2001, GUID DES SPEC AR MAR; Littler MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010677; LUNDVAL S, 2008, SABA BANK SPECIAL MA; MACINTYRE I G, 1975, Caribbean Journal of Science, V15, P11; McKenna SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010749; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; SPENCER JW, 1904, T CAN I, V7, P351; Thacker RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009622; Toller W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009207; *TRAFFIC IUCN, 2003, 19 M AN COMM DOC 8 3; VANDERLAND J, 1977, 200 FAO, P469; VAUGHAN TW, 1919, SMITHSONIAN I US NAT, V103; Williams JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010676	18	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10769	10.1371/journal.pone.0010769	http://dx.doi.org/10.1371/journal.pone.0010769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505823	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017400021
J	Nickerson, ML; Kostiha, BN; Brandt, W; Fredericks, W; Xu, KP; Yu, FS; Gold, B; Chodosh, J; Goldberg, M; Lu, DW; Yamada, M; Tervo, TM; Grutzmacher, R; Croasdale, C; Hoeltzenbein, M; Sutphin, J; Malkowicz, SB; Wessjohann, L; Kruth, HS; Dean, M; Weiss, JS				Nickerson, Michael L.; Kostiha, Brittany N.; Brandt, Wolfgang; Fredericks, William; Xu, Ke-Ping; Yu, Fu-Shin; Gold, Bert; Chodosh, James; Goldberg, Marc; Lu, Da Wen; Yamada, Masakazu; Tervo, Timo M.; Grutzmacher, Richard; Croasdale, Chris; Hoeltzenbein, Maria; Sutphin, John; Malkowicz, S. Bruce; Wessjohann, Ludger; Kruth, Howard S.; Dean, Michael; Weiss, Jayne S.			UBIAD1 Mutation Alters a Mitochondrial Prenyltransferase to Cause Schnyder Corneal Dystrophy	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTALLINE DYSTROPHY; TOPOLOGY PREDICTION; PROTEIN STRUCTURES; CHOLESTEROL; GENE; MEMBRANE; TRANSFERASE; METABOLISM; BLADDER	Background: Mutations in a novel gene, UBIAD1, were recently found to cause the autosomal dominant eye disease Schnyder corneal dystrophy (SCD). SCD is characterized by an abnormal deposition of cholesterol and phospholipids in the cornea resulting in progressive corneal opacification and visual loss. We characterized lesions in the UBIAD1 gene in new SCD families and examined protein homology, localization, and structure. Methodology/Principal Findings: We characterized five novel mutations in the UBIAD1 gene in ten SCD families, including a first SCD family of Native American ethnicity. Examination of protein homology revealed that SCD altered amino acids which were highly conserved across species. Cell lines were established from patients including keratocytes obtained after corneal transplant surgery and lymphoblastoid cell lines from Epstein-Barr virus immortalized peripheral blood mononuclear cells. These were used to determine the subcellular localization of mutant and wild type protein, and to examine cholesterol metabolite ratios. Immunohistochemistry using antibodies specific for UBIAD1 protein in keratocytes revealed that both wild type and N102S protein were localized sub-cellularly to mitochondria. Analysis of cholesterol metabolites in patient cell line extracts showed no significant alteration in the presence of mutant protein indicating a potentially novel function of the UBIAD1 protein in cholesterol biochemistry. Molecular modeling was used to develop a model of human UBIAD1 protein in a membrane and revealed potentially critical roles for amino acids mutated in SCD. Potential primary and secondary substrate binding sites were identified and docking simulations indicated likely substrates including prenyl and phenolic molecules. Conclusions/Significance: Accumulating evidence from the SCD familial mutation spectrum, protein homology across species, and molecular modeling suggest that protein function is likely down-regulated by SCD mutations. Mitochondrial UBIAD1 protein appears to have a highly conserved function that, at least in humans, is involved in cholesterol metabolism in a novel manner.	[Nickerson, Michael L.; Kostiha, Brittany N.; Gold, Bert; Dean, Michael] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA; [Nickerson, Michael L.] NIH, Grad Partnership Program, Bethesda, MD 20892 USA; [Nickerson, Michael L.] George Washington Univ, Inst Biomed Sci, Program Mol Med, Washington, DC USA; [Kostiha, Brittany N.] Hood Coll, Biomed Sci Grad Program, Frederick, MD 21701 USA; [Brandt, Wolfgang; Wessjohann, Ludger] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Saale, Germany; [Fredericks, William; Malkowicz, S. Bruce] Univ Penn, Dept Surg, Div Urol, Philadelphia, PA 19104 USA; [Fredericks, William; Malkowicz, S. Bruce] Vet Affairs Med Ctr, Philadelphia, PA USA; [Xu, Ke-Ping; Yu, Fu-Shin; Weiss, Jayne S.] Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA; [Xu, Ke-Ping; Yu, Fu-Shin; Weiss, Jayne S.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48201 USA; [Chodosh, James] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Howe Lab, Cambridge, MA 02138 USA; [Goldberg, Marc] Inst Eye, Tulsa, OK USA; [Lu, Da Wen] Triserv Gen Hosp, Taipei, Taiwan; [Yamada, Masakazu] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan; [Tervo, Timo M.] Univ Helsinki, Hosp Eye, Helsinki, Finland; [Grutzmacher, Richard] Grutzmacher Lewis & Sierra, Sacramento, CA USA; [Croasdale, Chris] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Hoeltzenbein, Maria] Max Planck Inst Mol Genet, Berlin, Germany; [Sutphin, John] Univ Kansas, Med Ctr, Dept Ophthalmol, Prairie Village, KS USA; [Kruth, Howard S.] NHLBI, Sect Expt Atherosclerosis, NIH, Bethesda, MD 20892 USA; [Weiss, Jayne S.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; George Washington University; Leibniz Institut fur Pflanzenbiochemie; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Wayne State University; Wayne State University; Harvard University; Massachusetts Eye & Ear Infirmary; Tri-Service General Hospital; University of Helsinki; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; University of Kansas; University of Kansas Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wayne State University	Nickerson, ML (corresponding author), NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA.	nickersonml@mail.nih.gov; jweiss@med.wayne.edu	Dean, Michael/R-7501-2019; Wessjohann, Ludger/AAZ-3838-2021; Hoeltzenbein, Maria/AAP-4145-2020; Hoeltzenbein, Maria/B-1134-2016; Dean, Michael C/G-8172-2012; weiss, jayne/AAL-9912-2020	Hoeltzenbein, Maria/0000-0002-2451-4247; Hoeltzenbein, Maria/0000-0002-2451-4247; Dean, Michael C/0000-0003-2234-0631; Wessjohann, Ludger A./0000-0003-2060-8235	National Eye Institute [EY12972]; Eye Bank Association of America (JSW); Midwest Eye Banks; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011300] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010869, R01EY012972] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002832] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Eye Bank Association of America (JSW); Midwest Eye Banks; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a grant from the National Eye Institute (grant EY12972 to J.S.W.) and by funding from the Eye Bank Association of America (JSW), and the Midwest Eye Banks (J.S.W. and K.-P.X.). This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; Brauer L, 2004, J MOL MODEL, V10, P317, DOI 10.1007/s00894-004-0197-6; Breitling R, 2007, BIOESSAYS, V29, P1085, DOI 10.1002/bies.20663; BRON AJ, 1989, CORNEA, V8, P75; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAMBLE W, 1978, J LIPID RES, V19, P1068; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kobayashi A, 2009, OPHTHALMOLOGY, V116, P1029, DOI 10.1016/j.ophtha.2008.12.042; KRUTH HS, 1995, J CELL BIOL, V129, P133, DOI 10.1083/jcb.129.1.133; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LISCH W, 1986, OPHTHALMIC PAED GEN, V7, P45, DOI 10.3109/13816818609058041; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McGarvey TW, 2005, J CELL BIOCHEM, V95, P419, DOI 10.1002/jcb.20432; McGarvey TW, 2001, ONCOGENE, V20, P1042, DOI 10.1038/sj.onc.1204143; MOMOSE K, 1972, J BIOL CHEM, V247, P3930; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Riebeling P, 2003, OPHTHALMOLOGE, V100, P979, DOI 10.1007/s00347-003-0883-2; RODRIGUES MM, 1987, AM J OPHTHALMOL, V104, P157, DOI 10.1016/0002-9394(87)90008-0; Schnyder WF., 1929, SCHWEIZ MED WSCHR, V10, P559; Shirakawa H, 2006, BBA-GEN SUBJECTS, V1760, P1482, DOI 10.1016/j.bbagen.2006.05.008; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Van Went JM., 1924, NIEDERL TIJDSCHR GEN, V68, P2996; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Weiss Jayne S, 2007, Trans Am Ophthalmol Soc, V105, P616; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; WEISS JS, 1992, CORNEA, V11, P93, DOI 10.1097/00003226-199203000-00001; Weiss JS, 1996, OPHTHALMOLOGY, V103, P465; Wessjohann L, 1996, ANGEW CHEM INT EDIT, V35, P1697, DOI 10.1002/anie.199616971; WESSJOHANN L, 2009, CHIMIA PHYT IN PRESS; Yellore VS, 2007, MOL VIS, V13, P1777	34	53	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10760	10.1371/journal.pone.0010760	http://dx.doi.org/10.1371/journal.pone.0010760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505825	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017400016
J	Arias, A; Perales, C; Escarmis, C; Domingo, E				Arias, Armando; Perales, Celia; Escarmis, Cristina; Domingo, Esteban			Deletion Mutants of VPg Reveal New Cytopathology Determinants in a Picornavirus	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; DEPENDENT RNA-POLYMERASE; PROTEIN LINKAGE MAP; NONSTRUCTURAL PROTEINS; POLIOVIRUS 2C; VIRULENCE DETERMINANTS; ERROR CATASTROPHE; BINDING ACTIVITY; MULLERS RATCHET; DNA-POLYMERASE	Background: Success of a viral infection requires that each infected cell delivers a sufficient number of infectious particles to allow new rounds of infection. In picornaviruses, viral replication is initiated by the viral polymerase and a viral-coded protein, termed VPg, that primes RNA synthesis. Foot-and-mouth disease virus (FMDV) is exceptional among picornaviruses in that its genome encodes 3 copies of VPg. Why FMDV encodes three VPgs is unknown. Methodology and Principal Findings: We have constructed four mutant FMDVs that encode only one VPg: either VPg(1), VPg(3), or two chimeric versions containing part of VPg(1) and VPg(3). All mutants, except that encoding only VPg(1), were replication-competent. Unexpectedly, despite being replication-competent, the mutants did not form plaques on BHK-21 cell monolayers. The one-VPg mutant FMDVs released lower amounts of encapsidated viral RNA to the extracellular environment than wild type FMDV, suggesting that deficient plaque formation was associated with insufficient release of infectious progeny. Mutant FMDVs subjected to serial passages in BHK-21 cells regained plaque-forming capacity without modification of the number of copies of VPg. Substitutions in non-structural proteins 2C, 3A and VPg were associated with restoration of plaque formation. Specifically, replacement R55W in 2C was repeatedly found in several mutant viruses that had regained competence in plaque development. The effect of R55W in 2C was to mediate an increase in the extracellular viral RNA release without a detectable increase of total viral RNA that correlated with an enhanced capacity to alter and detach BHK-21 cells from the monolayer, the first stage of cell killing. Conclusions: The results link the VPg copies in the FMDV genome with the cytopathology capacity of the virus, and have unveiled yet another function of 2C: modulation of picornavirus cell-to-cell transmission. Implications for picornaviruses pathogenesis are discussed.	[Arias, Armando; Perales, Celia; Escarmis, Cristina; Domingo, Esteban] CSIC, Ctr Biol Mol Severo Ochoa UAM, Dept Virol & Microbiol, Madrid, Spain; [Perales, Celia; Domingo, Esteban] CIBERehd, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Arias, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Virol, London, England.	edomingo@cbm.uam.es	Arias, Armando/E-1393-2016; Domingo, Esteban/K-3937-2014	Arias, Armando/0000-0002-4138-4608; Perales Viejo, Celia Belen/0000-0003-1618-1937; Domingo, Esteban/0000-0002-0573-1676	Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-02816/BMC]; Fundacion R. Areces; Instituto de Salud Carlos III; Centro Superior de Investigaciones Cientificas (CSIC); CIBERehd	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion R. Areces(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro Superior de Investigaciones Cientificas (CSIC); CIBERehd	Work supported by grants BFU2008-02816/BMC from Ministerio de Ciencia e Innovacion (MICINN), and Fundacion R. Areces. CIBERehd (Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas) is funded by Instituto de Salud Carlos III. AA was supported by an I3P contract from Centro Superior de Investigaciones Cientificas (CSIC) and CP is the recipient of a contract from CIBERehd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2005, J MOL BIOL, V353, P1021, DOI 10.1016/j.jmb.2005.09.022; Arias A, 2001, J GEN VIROL, V82, P1049, DOI 10.1099/0022-1317-82-5-1049; Arias A, 2004, J MOL BIOL, V339, P405, DOI 10.1016/j.jmb.2004.03.061; BALL LA, 2007, FIELDS VIROLOGY, P119; Banerjee R, 1997, J VIROL, V71, P9570, DOI 10.1128/JVI.71.12.9570-9578.1997; Baranowski E, 1998, J VIROL, V72, P6362, DOI 10.1128/JVI.72.8.6362-6372.1998; Belsham GJ, 2008, J GEN VIROL, V89, P485, DOI 10.1099/vir.0.83385-0; BIENZ K, 1987, VIROLOGY, V160, P220, DOI 10.1016/0042-6822(87)90063-8; CAO XM, 1993, J VIROL, V67, P5572, DOI 10.1128/JVI.67.9.5572-5578.1993; Cao XM, 1996, EMBO J, V15, P23, DOI 10.1002/j.1460-2075.1996.tb00330.x; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Domingo E, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P87, DOI 10.1016/B978-0-12-374153-0.00004-7; Escarmis C, 1996, J MOL BIOL, V264, P255, DOI 10.1006/jmbi.1996.0639; Escarmis C, 2009, J VIROL, V83, P6748, DOI 10.1128/JVI.00538-09; FALK MM, 1992, J VIROL, V66, P2251, DOI 10.1128/JVI.66.4.2251-2260.1992; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; FORSS S, 1982, NUCLEIC ACIDS RES, V10, P6441, DOI 10.1093/nar/10.20.6441; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Garcia-Briones M, 2006, VIROLOGY, V349, P409, DOI 10.1016/j.virol.2006.02.042; Grubman MJ, 2008, FEMS IMMUNOL MED MIC, V53, P8, DOI 10.1111/j.1574-695X.2008.00409.x; Harris JR, 2005, J VIROL, V79, P5363, DOI 10.1128/JVI.79.9.5363-5373.2005; Harris JR, 2003, J VIROL, V77, P4773, DOI 10.1128/JVI.77.8.4773-4780.2003; Herrera M, 2007, PLOS PATHOG, V3, P498, DOI 10.1371/journal.ppat.0030053; Kamtekar S, 2006, EMBO J, V25, P1335, DOI 10.1038/sj.emboj.7601027; KING AMQ, 1980, J VIROL, V34, P627, DOI 10.1128/JVI.34.3.627-634.1980; LEWIN B, 2007, GENES; LI JP, 1990, J VIROL, V64, P1102, DOI 10.1128/JVI.64.3.1102-1107.1990; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; Marcotte LL, 2007, J VIROL, V81, P3583, DOI 10.1128/JVI.02306-06; MARTINEZSALAS E, 1993, J VIROL, V67, P3748; MIRZAYAN C, 1994, VIROLOGY, V199, P176, DOI 10.1006/viro.1994.1110; Monaghan P, 2004, J GEN VIROL, V85, P933, DOI 10.1099/vir.0.19408-0; Nayak A, 2005, J VIROL, V79, P7698, DOI 10.1128/JVI.79.12.7698-7706.2005; Nayak A, 2006, J VIROL, V80, P9865, DOI 10.1128/JVI.00561-06; Nunez JI, 2001, J VIROL, V75, P3977, DOI 10.1128/JVI.75.8.3977-3983.2001; Pacheco JM, 2003, J VIROL, V77, P13017, DOI 10.1128/JVI.77.24.13017-13027.2003; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; Paul AV, 2003, J VIROL, V77, P891, DOI 10.1128/JVI.77.2.891-904.2003; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Pauluhn A, 2002, ESA SP PUBL, V508, P227; Perales C, 2007, J MOL BIOL, V369, P985, DOI 10.1016/j.jmb.2007.03.074; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Perales C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005554; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Ryan MD, 2004, FOOT AND MOUTH DISEASE: CURRENT PERSPECTIVES, P53; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; Steil BP, 2009, VIRUS RES, V139, P240, DOI 10.1016/j.virusres.2008.07.027; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Tellez AB, 2006, J MOL BIOL, V357, P665, DOI 10.1016/j.jmb.2005.12.044; Teterina NL, 2003, J VIROL, V77, P12679, DOI 10.1128/JVI.77.23.12679-12691.2003; Teterina NL, 1997, J VIROL, V71, P8962, DOI 10.1128/JVI.71.12.8962-8972.1997; Toja M, 1999, VIRUS RES, V64, P161, DOI 10.1016/S0168-1702(99)00089-1; Vance LM, 1997, J VIROL, V71, P8759, DOI 10.1128/JVI.71.11.8759-8765.1997; Verdaguer N, 1997, J VIROL, V71, P9813, DOI 10.1128/JVI.71.12.9813-9816.1997; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Xiang WK, 1998, J VIROL, V72, P6732, DOI 10.1128/JVI.72.8.6732-6741.1998; Yin J, 2003, J VIROL, V77, P5152, DOI 10.1128/JVI.77.9.5152-5166.2003; Yin J, 2007, J GEN VIROL, V88, P2259, DOI 10.1099/vir.0.82795-0	66	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10735	10.1371/journal.pone.0010735	http://dx.doi.org/10.1371/journal.pone.0010735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505767	gold, Green Submitted, Green Published			2022-12-25	WOS:000278017300019
J	Zhong, WM; Liu, F; Dong, LB; Lu, XH; Hancock, K; Reinherz, EL; Katz, JM; Sambhara, S				Zhong, Weimin; Liu, Feng; Dong, Libo; Lu, Xiuhua; Hancock, Kathy; Reinherz, Ellis L.; Katz, Jacqueline M.; Sambhara, Suryaprakash			Significant Impact of Sequence Variations in the Nucleoprotein on CD8 T Cell-Mediated Cross-Protection against Influenza A Virus Infections	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; HETEROSUBTYPIC IMMUNITY; V-BETA; H5N1; EPITOPE; VACCINE; MICE; RECOGNITION; LYMPHOCYTES; REPERTOIRE	Background: Memory CD8 T cells to influenza A viruses are widely detectable in healthy human subjects and broadly cross-reactive for serologically distinct influenza A virus subtypes. However, it is not clear to what extent such pre-existing cellular immunity can provide cross-subtype protection against novel emerging influenza A viruses. Methodology/Principal Findings: We show in the mouse model that naturally occurring sequence variations of the conserved nucleoprotein of the virus significantly impact cross-protection against lethal disease in vivo. When priming and challenge viruses shared identical sequences of the immunodominant, protective NP366/D-b epitope, strong cross-subtype protection was observed. However, when they did not share complete sequence identity in this epitope, cross-protection was considerably reduced. Contributions of virus-specific antibodies appeared to be minimal under these circumstances. Detailed analysis revealed that the magnitude of the memory CD8 T cell response triggered by the NP366/D-b variants was significantly lower than those triggered by the homologous NP366/D-b ligand. It appears that strict specificity of a dominant public TCR to the original NP366/D-b ligand may limit the expansion of cross-reactive memory CD8 T cells to the NP366/D-b variants. Conclusions/Significance: Pre-existing CD8 T cell immunity may provide substantial cross-protection against hetero-subtypic influenza A viruses, provided that the priming and the subsequent challenge viruses share the identical sequences of the immunodominant, protective CTL epitopes.	[Zhong, Weimin; Liu, Feng; Dong, Libo; Lu, Xiuhua; Hancock, Kathy; Katz, Jacqueline M.; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Reinherz, Ellis L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Zhong, WM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	wzhong@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021		National Institutes of Health [U19 AI50900]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by a pilot project grant to WZ from National Institutes of Health (U19 AI50900. Project Director: ELR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Boon ACM, 2002, J VIROL, V76, P2567, DOI 10.1128/JVI.76.5.2567-2572.2002; Crowe SR, 2006, VACCINE, V24, P457, DOI 10.1016/j.vaccine.2005.07.096; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Epstein Suzanne L, 2003, Expert Rev Anti Infect Ther, V1, P627, DOI 10.1586/14787210.1.4.627; GORMAN OT, 1990, J VIROL, V64, P1487, DOI 10.1128/JVI.64.4.1487-1497.1990; Hiromoto Y, 2000, J GEN VIROL, V81, P1293, DOI 10.1099/0022-1317-81-5-1293; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Jameson J, 1999, J IMMUNOL, V162, P7578; Katz JM, 1997, J INFECT DIS, V175, P352, DOI 10.1093/infdis/175.2.352; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; Kendal AP, 1982, CONCEPTS PROCEDURES; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; LIANG SH, 1994, J IMMUNOL, V152, P1653; LU LY, 1980, NATURE, V288, P164, DOI 10.1038/288164a0; McMichael A, 1994, Curr Top Microbiol Immunol, V189, P75; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Roose K, 2009, DRUG NEWS PERSPECT, V22, P80, DOI 10.1358/dnp.2009.22.2.1334451; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yoshikawa T, 2004, J GEN VIROL, V85, P2339, DOI 10.1099/vir.0.79892-0; Zhong WM, 2007, J MOL BIOL, V372, P535, DOI 10.1016/j.jmb.2007.06.057; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200; Zhong WM, 2004, INT IMMUNOL, V16, P1549, DOI 10.1093/intimm/dxh156	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10583	10.1371/journal.pone.0010583	http://dx.doi.org/10.1371/journal.pone.0010583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485501	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563200016
J	Stapleton, JA; Swartz, JR				Stapleton, James A.; Swartz, James R.			A Cell-Free Microtiter Plate Screen for Improved [FeFe] Hydrogenases	PLOS ONE			English	Article							SINGLE-MOLECULE-PCR; IN-VITRO EXPRESSION; FREE PROTEIN-SYNTHESIS; HIGH-THROUGHPUT CONSTRUCTION; POLYMERASE-CHAIN-REACTION; CHLAMYDOMONAS-REINHARDTII; DIRECTED EVOLUTION; DIGITAL PCR; DNA; LIBRARIES	Background: [FeFe] hydrogenase enzymes catalyze the production and dissociation of H(2), a potential renewable fuel. Attempts to exploit these catalysts in engineered systems have been hindered by the biotechnologically inconvenient properties of the natural enzymes, including their extreme oxygen sensitivity. Directed evolution has been used to improve the characteristics of a range of natural catalysts, but has been largely unsuccessful for [FeFe] hydrogenases because of a lack of convenient screening platforms. Methodology/Principal Findings: Here we describe an in vitro screening technology for oxygen-tolerant and highly active [FeFe] hydrogenases. Despite the complexity of the protocol, we demonstrate a level of reproducibility that allows moderately improved mutants to be isolated. We have used the platform to identify a mutant of the Chlamydomonas reinhardtii [FeFe] hydrogenase HydA1 with a specific activity similar to 4 times that of the wild-type enzyme. Conclusions/Significance: Our results demonstrate the feasibility of using the screen presented here for large-scale efforts to identify improved biocatalysts for energy applications. The system is based on our ability to activate these complex enzymes in E. coli cell extracts, which allows unhindered access to the protein maturation and assay environment.	[Stapleton, James A.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Stapleton, JA (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		Stapleton, James/0000-0003-1133-4180	Global Climate and Energy Project (GCEP) at Stanford University; National Defense Science and Engineering (NDSEG)	Global Climate and Energy Project (GCEP) at Stanford University; National Defense Science and Engineering (NDSEG)	This work was funded by the Global Climate and Energy Project (GCEP) at Stanford University (http://gcep.stanford.edu/) as well as a National Defense Science and Engineering (NDSEG) Fellowship (http://ndseg.asee.org/) to JAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1964, PLANT PHYSIOL, V39, P169, DOI 10.1104/pp.39.6.963; ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Arnold FH, 1998, ACCOUNTS CHEM RES, V31, P125, DOI 10.1021/ar960017f; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Chhibber A, 2008, ANAL BIOCHEM, V377, P46, DOI 10.1016/j.ab.2008.02.026; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; Cohen J, 2005, BIOCHEM SOC T, V33, P80, DOI 10.1042/BST0330080; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; ERBES DL, 1979, PLANT PHYSIOL, V63, P1138, DOI 10.1104/pp.63.6.1138; Florin L, 2001, J BIOL CHEM, V276, P6125, DOI 10.1074/jbc.M008470200; Flynn T, 2002, INT J HYDROGEN ENERG, V27, P1421, DOI 10.1016/S0360-3199(02)00117-9; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutchison CA, 2006, NAT BIOTECHNOL, V24, P657, DOI 10.1038/nbt0606-657; Jewett MC, 2004, BIOTECHNOL BIOENG, V86, P19, DOI 10.1002/bit.20026; Jewett MC, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.57; Kim DM, 2001, BIOTECHNOL BIOENG, V74, P309, DOI 10.1002/bit.1121; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Koga Yuichi, 2007, V375, P165; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; Levin DB, 2004, INT J HYDROGEN ENERG, V29, P173, DOI 10.1016/S0360-3199(03)00094-6; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Maeda T, 2008, APPL MICROBIOL BIOT, V79, P77, DOI 10.1007/s00253-008-1416-3; MCCAUGHAN F, 2009, J PATHOL, DOI DOI 10.1002/PATH.2647; MCTAVISH H, 1995, J BACTERIOL, V177, P3960, DOI 10.1128/jb.177.14.3960-3964.1995; Mertens R, 2004, CURR OPIN BIOTECH, V15, P343, DOI 10.1016/j.copbio.2004.06.010; Nagy LE, 2007, BIOTECHNOL LETT, V29, P421, DOI 10.1007/s10529-006-9254-9; Nakano H, 2000, J BIOSCI BIOENG, V90, P456, DOI 10.1016/S1389-1723(01)80019-0; Ohuchi S, 1998, NUCLEIC ACIDS RES, V26, P4339, DOI 10.1093/nar/26.19.4339; PECK HD, 1956, J BACTERIOL, V71, P70, DOI 10.1128/JB.71.1.70-80.1956; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961; ROESSLER PG, 1984, PLANT PHYSIOL, V75, P705, DOI 10.1104/pp.75.3.705; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Rungpragayphan S, 2004, J MOL CATAL B-ENZYM, V28, P223, DOI 10.1016/j.molcatb.2004.01.019; Rungpragayphan S, 2003, FEBS LETT, V540, P147, DOI 10.1016/S0014-5793(03)00251-5; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; Rungpragayphan Suang, 2007, V375, P79; Sitaraman K, 2004, J BIOTECHNOL, V110, P257, DOI 10.1016/j.jbiotec.2004.02.014; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Tye JW, 2005, P NATL ACAD SCI USA, V102, P16911, DOI 10.1073/pnas.0508740102; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Woodrow KA, 2006, J PROTEOME RES, V5, P3288, DOI 10.1021/pr050459y; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	52	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10554	10.1371/journal.pone.0010554	http://dx.doi.org/10.1371/journal.pone.0010554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479937	Green Submitted, Green Published, gold			2022-12-25	WOS:000277467900010
J	Book, AJ; Gladman, NP; Lee, SS; Scalf, M; Smith, LM; Vierstra, RD				Book, Adam J.; Gladman, Nicholas P.; Lee, Sang-Sook; Scalf, Mark; Smith, Lloyd M.; Vierstra, Richard D.			Affinity Purification of the Arabidopsis 26 S Proteasome Reveals a Diverse Array of Plant Proteolytic Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PARTICLE SUBUNITS; MASS-SPECTROMETRIC ANALYSIS; 20S PROTEASOME; UBIQUITYLATED PROTEINS; YEAST; IDENTIFICATION; BINDING; PROLIFERATION; DEGRADATION; ASSOCIATION	Selective proteolysis in plants is largely mediated by the ubiquitin (Ub)/proteasome system in which substrates, marked by the covalent attachment of Ub, are degraded by the 26 S proteasome. The 26 S proteasome is composed of two subparticles, the 20 S core protease (CP) that compartmentalizes the protease active sites and the 19 S regulatory particle that recognizes and translocates appropriate substrates into the CP lumen for breakdown. Here, we describe an affinity method to rapidly purify epitope-tagged 26 S proteasomes intact from Arabidopsis thaliana. In-depth mass spectrometric analyses of preparations generated from young seedlings confirmed that the 2.5-MDa CP-regulatory particle complex is actually a heterogeneous set of particles assembled with paralogous pairs for most subunits. A number of these subunits are modified post-translationally by proteolytic processing, acetylation, and/or ubiquitylation. Several proteasome-associated proteins were also identified that likely assist in complex assembly and regulation. In addition, we detected a particle consisting of the CP capped by the single subunit PA200 activator that may be involved in Ub-independent protein breakdown. Taken together, it appears that a diverse and highly dynamic population of proteasomes is assembled in plants, which may expand the target specificity and functions of intracellular proteolysis.	[Book, Adam J.; Gladman, Nicholas P.; Lee, Sang-Sook; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Scalf, Mark; Smith, Lloyd M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, 425-G Henry Mall, Madison, WI 53706 USA.	vierstra@wisc.edu	Gladman, Nicholas/AAF-7400-2020	Gladman, Nicholas/0000-0002-9000-8377	NHGRI [1P50HG004952]; NIGMS [P01GM081269]; United States Department of Energy [DE-FG02-88ER13968]; National Science Foundation Arabidopsis [MCB-0115870]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM081269] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation Arabidopsis(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The MS facility was supported in part by National Institutes of Health Grants 1P50HG004952 from NHGRI and P01GM081269 from NIGMS (to M.S. and L.M.S.). This work was supported by United States Department of Energy Basic Energy Sciences Program Grant DE-FG02-88ER13968 and National Science Foundation Arabidopsis 2010 Program Grant MCB-0115870 (to R.D.V.).	Boisson B, 2003, J BIOL CHEM, V278, P43418, DOI 10.1074/jbc.M307321200; Book AJ, 2009, PLANT CELL, V21, P460, DOI 10.1105/tpc.108.064444; Book AJ, 2005, PLANT PHYSIOL, V138, P1046, DOI 10.1104/pp.104.057406; Brukhin V, 2005, PLANT CELL, V17, P2723, DOI 10.1105/tpc.105.034975; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Denis NJ, 2007, PROTEOMICS, V7, P868, DOI 10.1002/pmic.200600410; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Ermolaeva MD, 2003, PLANT MOL BIOL, V51, P859, DOI 10.1023/A:1023001130337; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Fu HY, 1999, PLANT J, V18, P529, DOI 10.1046/j.1365-313X.1999.00479.x; Fu HY, 1998, GENETICS, V149, P677; FUJINAMI K, 1994, J BIOL CHEM, V269, P25905; FUJIWARA T, 1990, J BIOL CHEM, V265, P16604; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gallois JL, 2009, PLANT CELL, V21, P442, DOI 10.1105/tpc.108.062372; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Huelsenbeck JP, 2004, J MOL EVOL, V58, P661, DOI 10.1007/s00239-004-2588-9; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Kim HJ, 2008, NATURE, V455, P1134, DOI 10.1038/nature07289; Kim YK, 2007, GENE EXPR PATTERNS, V7, P143, DOI 10.1016/j.modgep.2006.06.006; Kimura Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P341, DOI 10.1016/S0003-9861(02)00639-2; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kurepa J, 2008, PLANT J, V53, P102, DOI 10.1111/j.1365-313X.2007.03322.x; Kurepa J, 2009, PLANT PHYSIOL, V150, P178, DOI 10.1104/pp.109.135970; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Paz-Aviram T, 2008, PLANT SIGNAL BEHAV, V3, P409, DOI 10.4161/psb.3.6.5434; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peng ZH, 2003, CURR BIOL, V13, pR504, DOI 10.1016/S0960-9822(03)00439-1; Perry RH, 2008, MASS SPECTROM REV, V27, P661, DOI 10.1002/mas.20186; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rivett AJ, 2001, BIOCHIMIE, V83, P363; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; ROHRBOUGH JG, J BIOMOL TECHNOL, V17, P327; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Saracco SA, 2009, PLANT J, V59, P344, DOI 10.1111/j.1365-313X.2009.03862.x; Satoh K, 2001, BIOCHEMISTRY-US, V40, P314, DOI 10.1021/bi001815n; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Shibahara T, 2002, EUR J BIOCHEM, V269, P1474, DOI 10.1046/j.1432-1033.2002.02792.x; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Smalle J, 2003, PLANT CELL, V15, P965, DOI 10.1105/tpc.009217; Smalle J, 2002, PLANT CELL, V14, P17, DOI 10.1105/tpc.010381; Sonoda Y, 2009, PLANT J, V60, P68, DOI 10.1111/j.1365-313X.2009.03932.x; Ueda M, 2004, DEVELOPMENT, V131, P2101, DOI 10.1242/dev.01096; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wenner BR, 2004, J AM SOC MASS SPECTR, V15, P150, DOI 10.1016/j.jasms.2003.10.006; Wiesner J, 2008, PROTEOMICS, V8, P4466, DOI 10.1002/pmic.200800329; Yang PZ, 2004, J BIOL CHEM, V279, P6401, DOI 10.1074/jbc.M311977200	68	90	147	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25554	25569		10.1074/jbc.M110.136622	http://dx.doi.org/10.1074/jbc.M110.136622			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20516081	hybrid, Green Published			2022-12-25	WOS:000280682400050
J	Greaves, J; Gorleku, OA; Salaun, C; Chamberlain, LH				Greaves, Jennifer; Gorleku, Oforiwa A.; Salaun, Christine; Chamberlain, Luke H.			Palmitoylation of the SNAP25 Protein Family SPECIFICITY AND REGULATION BY DHHC PALMITOYL TRANSFERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-STRING PROTEIN; MEMBRANE INTERACTIONS; CELL-SURFACE; PC12 CELLS; SNAP-25; TRAFFICKING; DOMAIN; EXOCYTOSIS; BINDING; IDENTIFICATION	SNAP25 plays an essential role in neuronal exocytosis pathways. SNAP25a and SNAP25b are alternatively spliced isoforms differing by only nine amino acids, three of which occur within the palmitoylated cysteine-rich domain. SNAP23 is 60% identical to SNAP25 and has a distinct cysteine-rich domain to both SNAP25a and SNAP25b. Despite the conspicuous differences within the palmitoylated domains of these secretory proteins, there is no information on their comparative interactions with palmitoyl transferases. We report that membrane association of all SNAP25/23 proteins is enhanced by Golgi-localized DHHC3, DHHC7, and DHHC17. In contrast, DHHC15 promoted a statistically significant increase in membrane association of only SNAP25b. To investigate the underlying cause of this differential specificity, we examined a SNAP23 point mutant (C79F) designed to mimic the cysteine-rich domain of SNAP25b. DHHC15 promoted a marked increase in membrane binding and palmitoylation of this SNAP23 mutant, demonstrating that the distinct cysteine-rich domains of SNAP25/23 contribute to differential interactions with DHHC15. The lack of activity of DHHC15 toward wild-type SNAP23 was not overcome by replacing its DHHC domain with that from DHHC3, suggesting that substrate specificity is not determined by the DHHC domain alone. Interestingly, DHHC2, which is closely related to DHHC15, associates with the plasma membrane in PC12 cells and can palmitoylate all SNAP25 isoforms. DHHC2 is, thus, a candidate enzyme to regulate SNAP25/23 palmitoylation dynamics at the plasma membrane. Finally, we demonstrate that overexpression of specific Golgi-localized DHHC proteins active against SNAP25/23 proteins perturbs the normal secretion of human growth hormone from PC12 cells.	[Greaves, Jennifer; Gorleku, Oforiwa A.; Chamberlain, Luke H.] Univ Edinburgh, Ctr Integrat Physiol, Sch Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland; [Salaun, Christine] Fac Med Paris Descartes, INSERM, U845, F-75730 Paris 15, France	University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chamberlain, LH (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Sch Biomed Sci, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	Luke.Chamberlain@ed.ac.uk		Greaves, Jennifer/0000-0001-8445-789X; Salaun, Christine/0000-0003-3002-6810	Medical Research Council; MRC [G0601597] Funding Source: UKRI; Medical Research Council [G0601597] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council Senior Research fellowship (to L. H. C.).	Aikawa Y, 2006, MOL BIOL CELL, V17, P711, DOI 10.1091/mbc.E05-05-0382; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gonelle-Gispert C, 2000, J CELL SCI, V113, P3197; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johansson JU, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000278; Kang RJ, 2004, J BIOL CHEM, V279, P50524, DOI 10.1074/jbc.M404981200; Lane SR, 1997, J NEUROCHEM, V69, P1864; LAWRENCE GW, 1994, EUR J BIOCHEM, V222, P325, DOI 10.1111/j.1432-1033.1994.tb18871.x; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Wang GY, 1997, J CELL SCI, V110, P505	29	79	81	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24629	24638		10.1074/jbc.M110.119289	http://dx.doi.org/10.1074/jbc.M110.119289			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519516	Green Published, hybrid			2022-12-25	WOS:000280542100035
J	Koskivirta, I; Kassiri, Z; Rahkonen, O; Kiviranta, R; Oudit, GY; Mckee, TD; Kyto, V; Saraste, A; Jokinen, E; Liu, PP; Vuorio, E; Khokha, R				Koskivirta, Ilpo; Kassiri, Zamaneh; Rahkonen, Otto; Kiviranta, Riku; Oudit, Gavin Y.; Mckee, Trevor D.; Kyto, Ville; Saraste, Antti; Jokinen, Eero; Liu, Peter P.; Vuorio, Eero; Khokha, Rama			Mice with Tissue Inhibitor of Metalloproteinases 4 (Timp4) Deletion Succumb to Induced Myocardial Infarction but Not to Cardiac Pressure Overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-FAILURE; MATRIX METALLOPROTEINASES; TIMP-1-DEFICIENT MICE; TARGETED DELETION; MMP-INHIBITION; ACTIVATION; ECHOCARDIOGRAPHY; DEFICIENCY; EXPRESSION; MOUSE	Tissue inhibitor of metalloproteinases 4 (TIMP4) is expressed highly in heart and found dysregulated in human cardiovascular diseases. It controls extracellular matrix remodeling by inhibiting matrix metalloproteinases (MMPs) and is implicated in processes including cell proliferation, apoptosis, and angiogenesis. Timp4-deficient mice (Timp4(-/-)) were generated to assess TIMP4 function in normal development and in models of heart disease. We deleted exons 1-3 of the Timp4 gene by homologous recombination. Timp4(-/-) mice are born healthy, develop normally, and produce litters of normal size and gender distribution. These mice show no compensation by overexpression of Timp1, Timp2, or Timp3 in the heart. Following cardiac pressure overload by aortic banding, Timp4(-/-) mice have comparable survival rate, cardiac histology, and cardiac function to controls. In this case, Timp4 deficiency is compensated by increased cardiac Timp2 expression. Strikingly, the induction of myocardial infarction (MI) leads to significantly increased mortality in Timp4(-/-) mice primarily due to left ventricular rupture. The post-MI mortality of Timp4(-/-) mice is reduced by administration of a synthetic MMP inhibitor. Furthermore, combining the genetic deletion of Mmp2 also rescues the higher post-MI mortality of Timp4(-/-) mice. Finally, Timp4(-/-) mice suffer reduced cardiac function at 20 months of age. Timp4 is not essential for murine development, although its loss moderately compromises cardiac function with aging. Timp4(-/-) mice are more susceptible to MI but not to pressure overload, and TIMP4 functions in its capacity as a metalloproteinase inhibitor after myocardial infarction.	[Koskivirta, Ilpo; Kassiri, Zamaneh; Mckee, Trevor D.; Khokha, Rama] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Koskivirta, Ilpo; Rahkonen, Otto; Kiviranta, Riku; Vuorio, Eero] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland; [Rahkonen, Otto; Jokinen, Eero] Univ Helsinki, Dept Pediat, FI-00029 Helsinki, Finland; [Oudit, Gavin Y.; Liu, Peter P.] Univ Toronto, Div Cardiol, Toronto, ON M5G 2N2, Canada; [Koskivirta, Ilpo; Kyto, Ville; Saraste, Antti] Turku Univ Hosp, Dept Med, FI-20521 Turku, Finland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Turku; University of Helsinki; University of Toronto; University of Turku	Khokha, R (corresponding author), Ontario Canc Inst, 610 Univ Ave,10-330, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca	Kytö, Ville/D-7971-2014; McKee, Trevor David/N-4308-2019	Kytö, Ville/0000-0002-4521-1093; McKee, Trevor David/0000-0002-2195-6146; Khokha, Rama/0000-0002-6028-1524; Vuorio, Eero/0000-0003-3404-2439	Academy of Finland; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada	Academy of Finland(Academy of Finland); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by research grants from the Academy of Finland, the Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Canada.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Broberg CS, 2003, J AM SOC ECHOCARDIOG, V16, P814, DOI 10.1067/S0894-7317(03)00399-7; Caterina JJ, 2000, J BIOL CHEM, V275, P26416, DOI 10.1074/jbc.M001271200; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Dollery CM, 1999, CIRC RES, V84, P498, DOI 10.1161/01.RES.84.5.498; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Fedak PWM, 2004, CIRCULATION, V110, P2401, DOI 10.1161/01.CIR.0000134959.83967.2D; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Hoit BD, 2002, MOL CELL BIOCHEM, V238, P145, DOI 10.1023/A:1019988024077; Ikonomidis JS, 2005, AM J PHYSIOL-HEART C, V288, pH149, DOI 10.1152/ajpheart.00370.2004; Jaworski DM, 2006, J NEUROBIOL, V66, P82, DOI 10.1002/neu.20205; Jaworski DM, 2005, BRAIN RES, V1051, P81, DOI 10.1016/j.brainres.2005.05.057; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Kassiri Z, 2005, THROMB HAEMOSTASIS, V93, P212, DOI 10.1160/TH04-08-0522; Koskivirta I, 2006, HISTOCHEM CELL BIOL, V126, P335, DOI 10.1007/s00418-006-0163-8; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Leco KJ, 1997, FEBS LETT, V401, P213, DOI 10.1016/S0014-5793(96)01474-3; Lee MM, 2005, INFECT IMMUN, V73, P661, DOI 10.1128/IAI.73.1.661-665.2005; Li H, 2000, CARDIOVASC RES, V46, P298, DOI 10.1016/S0008-6363(00)00028-6; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Melendez-Zajgla J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-85; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Mukherjee R, 2003, CIRCULATION, V107, P618, DOI 10.1161/01.CIR.0000046449.36178.00; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nothnick WB, 2001, REPRODUCTION, V122, P923, DOI 10.1530/reprod/122.6.923; Ohta K, 2004, AM J PHYSIOL-HEART C, V287, pH286, DOI 10.1152/ajpheart.00479.2002; Osiewicz K, 1999, ANN NY ACAD SCI, V878, P494, DOI 10.1111/j.1749-6632.1999.tb07706.x; Rahkonen OP, 2002, BBA-GENE STRUCT EXPR, V1577, P45, DOI 10.1016/S0167-4781(02)00404-9; Roten L, 2000, J MOL CELL CARDIOL, V32, P109, DOI 10.1006/jmcc.1999.1052; Saraste A, 2006, AM J PHYSIOL-HEART C, V291, pH871, DOI 10.1152/ajpheart.01375.2005; Schulze CJ, 2003, CIRCULATION, V107, P2487, DOI 10.1161/01.CIR.0000065603.09430.58; Seeland U, 2002, J MOL CELL CARDIOL, V34, P151, DOI 10.1006/jmcc.2001.1497; Soloway PD, 1996, ONCOGENE, V13, P2307; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; Stratmann B, 2001, BIOL CHEM, V382, P987, DOI 10.1515/BC.2001.124; Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109; Tian H, 2007, J MOL CELL CARDIOL, V43, P733, DOI 10.1016/j.yjmcc.2007.09.003; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Wilson EM, 2003, CIRCULATION, V107, P2857, DOI 10.1161/01.CIR.0000068375.40887.FA; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200	42	64	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24487	24493		10.1074/jbc.M110.136820	http://dx.doi.org/10.1074/jbc.M110.136820			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516072	hybrid, Green Published			2022-12-25	WOS:000280542100021
J	Mirza, S; Chen, JL; Murphy, JM; Young, IG				Mirza, Shamaruh; Chen, Jinglong; Murphy, James M.; Young, Ian G.			The Role of Interchain Heterodisulfide Formation in Activation of the Human Common beta and Mouse beta(IL-3) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; GM-CSF RECEPTORS; COMPLETE EXTRACELLULAR DOMAIN; HIGH-AFFINITY BINDING; IL-5 RECEPTORS; INTERLEUKIN-5 RECEPTOR; EXPRESSION CLONING; SIGNALING COMPLEX; CRYSTAL-STRUCTURE; LIGAND-BINDING	The cytokines, interleukin-3 (IL-3), interleukin-5 (IL-5), and granulocyte-macrophage colony-stimulating factor (GM-CSF), exhibit overlapping activities in the regulation of hematopoietic cells. In humans, the common beta (beta c) receptor is shared by the three cytokines and functions together with cytokine-specific alpha subunits in signaling. A widely accepted hypothesis is that receptor activation requires heterodisulfide formation between the domain 1 D-E loop disulfide in human beta c (h beta c) and unidentified cysteine residues in the N-terminal domains of the alpha receptors. Since the development of this hypothesis, new data have been obtained showing that domain 1 of h beta c is part of the cytokine binding epitope of this receptor and that an IL-3R alpha isoform lacking the N-terminal Ig-like domain (the "SP2" isoform) is competent for signaling. We therefore investigated whether distortion of the domain 1-domain 4 ligand-binding epitope in h beta c and the related mouse receptor, beta(IL-3), could account for the loss of receptor signaling when the domain 1 D-E loop disulfide is disrupted. Indeed, mutation of the disulfide in h beta c led to both a complete loss of high affinity binding with the humanIL-3R alpha SP2 isoform and of downstream signaling. Mutation of the orthologous residues in the mouse IL-3-specific receptor, beta(IL-3), not only precluded direct binding of mouse IL-3 but also resulted in complete loss of high affinity binding and signaling with the mouse IL-3R alpha SP2 isoform. Our data are most consistent with a role for the domain 1 D-E loop disulfide of h beta c and beta(IL-3) in maintaining the precise positions of ligand-binding residues necessary for normal high affinity binding and signaling.	[Murphy, James M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3050, Australia; [Mirza, Shamaruh; Chen, Jinglong; Young, Ian G.] Australian Natl Univ, Dept Biol Struct, John Curtin Sch Med Res, Canberra, ACT 0200, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Australian National University; John Curtin School of Medical Research	Murphy, JM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, 1G Royal Parade, Parkville, Vic 3050, Australia.	jamesm@wehi.edu.au; Ian.Young@anu.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949	National Health and Medical Research Council of Australia [471481]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grant number 471481 from the National Health and Medical Research Council of Australia.	BALDWIN GC, 1991, BLOOD, V78, P609, DOI 10.1182/blood.V78.3.609.bloodjournal783609; BERNDT RK, 1996, MOL CELL BIOL, V16, P3035; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; CORNELIS S, 1995, EMBO J, V14, P3395, DOI 10.1002/j.1460-2075.1995.tb07345.x; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; DEVOS R, 1994, EUR J BIOCHEM, V225, P635, DOI 10.1111/j.1432-1033.1994.00635.x; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; Gustin SE, 2001, EUR J BIOCHEM, V268, P2905, DOI 10.1046/j.1432-1327.2001.02178.x; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; Itoh T, 1996, J BIOL CHEM, V271, P7587, DOI 10.1074/jbc.271.13.7587; Itoh T, 1998, MOL CELL BIOL, V18, P742, DOI 10.1128/MCB.18.2.742; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Le F, 2000, J BIOL CHEM, V275, P5124, DOI 10.1074/jbc.275.7.5124; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; METCALF D, 1990, P NATL ACAD SCI USA, V87, P4670, DOI 10.1073/pnas.87.12.4670; MILLER J, 1985, J IMMUNOL, V134, P4212; MIRZA S, 2010, J BIOL CHEM IN PRESS; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murphy JM, 2008, CYTOKINE, V42, P234, DOI 10.1016/j.cyto.2008.02.010; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; Tamada T, 2006, P NATL ACAD SCI USA, V103, P3135, DOI 10.1073/pnas.0511264103; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	45	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24759	24768		10.1074/jbc.M109.097881	http://dx.doi.org/10.1074/jbc.M109.097881			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516062	Green Published, hybrid			2022-12-25	WOS:000280542100048
J	Malik, M; Shukla, A; Amin, P; Niedelman, W; Lee, J; Jividen, K; Phang, JM; Ding, JH; Suh, KS; Curmi, PMG; Yuspa, SH				Malik, Mariam; Shukla, Anjali; Amin, Palak; Niedelman, Wendy; Lee, Jessica; Jividen, Kasey; Phang, Juanita M.; Ding, Jinhui; Suh, Kwang S.; Curmi, Paul M. G.; Yuspa, Stuart H.			S-Nitrosylation Regulates Nuclear Translocation of Chloride Intracellular Channel Protein CLIC4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN BREAST-CANCER; ION CHANNEL; PROTEOMIC ANALYSIS; IN-VITRO; EXPRESSION; GLUTATHIONE; CARCINOMA; MECHANISM; CELLS	Nuclear translocation of chloride intracellular channel protein CLIC4 is essential for its role in Ca2+-induced differentiation, stress-induced apoptosis, and modulating TGF-beta signaling in mouse epidermal keratinocytes. However, post-translational modifications on CLIC4 that govern nuclear translocation and thus these activities remain to be elucidated. The structure of CLIC4 is dependent on the redox environment, in vitro, and translocation may depend on reactive oxygen and nitrogen species in the cell. Here we show that NO directly induces nuclear translocation of CLIC4 that is independent of the NO-cGMP pathway. Indeed, CLIC4 is directly modified by NO through S-nitrosylation of a cysteine residue, as measured by the biotin switch assay. NO enhances association of CLIC4 with the nuclear import proteins importin alpha and Ran. This is likely a result of the conformational change induced by S-nitrosylated CLIC4 that leads to unfolding of the protein, as exhibited by CD spectra analysis and trypsinolysis of the modified protein. Cysteine mutants of CLIC4 exhibit altered nitrosylation, nuclear residence, and stability, compared with the wild type protein likely as a consequence of altered tertiary structure. Moreover, tumor necrosis factor alpha-induced nuclear translocation of CLIC4 is dependent on nitric-oxide synthase activity. Inhibition of nitric-oxide synthase activity inhibits tumor necrosis factor alpha-induced nitrosylation and association with importin alpha and Ran and ablates CLIC4 nuclear translocation. These results suggest that S-nitrosylation governs CLIC4 structure, its association with protein partners, and thus its intracellular distribution.	[Suh, Kwang S.; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Phang, Juanita M.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Phang, Juanita M.; Curmi, Paul M. G.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Ding, Jinhui] NIA, Sect Bioinformat & Computat Biol, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Suh, Kwang S.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Tissue Bank, Hackensack, NJ 07601 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of New South Wales Sydney; St Vincents Hospital Sydney; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Hackensack University Medical Center	Yuspa, SH (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bldg 37,Rm 4068A1,37 Convent Dr, Bethesda, MD 20892 USA.	yuspas@mail.nih.gov	Shukla, Anjali/G-4046-2014; Curmi, Paul/G-7185-2011	Curmi, Paul/0000-0001-5762-7638; Amin, Palak/0000-0001-5617-8703; Jividen, Kasey/0000-0003-1022-5038	National Cancer Institute; Australian Research Council; The Australian Nuclear Science and Technology Organization; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Research Council(Australian Research Council); The Australian Nuclear Science and Technology Organization; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, by the National Institutes of Health Intramural Program of the National Cancer Institute and by grants from the Australian Research Council (to P.M.G.C.). J.M.P. was supported by a scholarship from The Australian Nuclear Science and Technology Organization.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Akool ES, 2005, J BIOL CHEM, V280, P39403, DOI 10.1074/jbc.M504140200; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Berryman M, 2004, J BIOL CHEM, V279, P34794, DOI 10.1074/jbc.M402835200; Bohman S, 2005, J BIOL CHEM, V280, P42397, DOI 10.1074/jbc.M506724200; Chiu C, 2001, INT J MOL MED, V8, P251; Edwards JC, 2006, J BIOL CHEM, V281, P28011, DOI 10.1074/jbc.M605865200; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Gatti G, 2004, BREAST, V13, P1, DOI 10.1016/j.breast.2003.09.001; Gius D, 2006, ANTIOXID REDOX SIGN, V8, P1249, DOI 10.1089/ars.2006.8.1249; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kitamura K, 2001, JPN J PHARMACOL, V85, P351, DOI 10.1254/jjp.85.351; Li CQ, 2005, CANCER LETT, V226, P1, DOI 10.1016/j.canlet.2004.10.021; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li SM, 2008, CARDIOVASC RES, V77, P107, DOI 10.1093/cvr/cvm022; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Qian ZJ, 1999, J BIOL CHEM, V274, P1621, DOI 10.1074/jbc.274.3.1621; Reveneau S, 1999, LAB INVEST, V79, P1215; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Sakai M, 2007, BIOCHEM BIOPH RES CO, V357, P575, DOI 10.1016/j.bbrc.2007.03.174; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; Saydam N, 1997, CANCER LETT, V119, P13, DOI 10.1016/S0304-3835(97)00245-0; Schreiter ER, 2007, J BIOL CHEM, V282, P19773, DOI 10.1074/jbc.M701363200; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Singh H, 2007, MOL MEMBR BIOL, V24, P41, DOI 10.1080/09687860600927907; Sirsjo A, 1996, BRIT J DERMATOL, V134, P643, DOI 10.1111/j.1365-2133.1996.tb06963.x; Sliskovic I, 2005, J BIOL CHEM, V280, P8733, DOI 10.1074/jbc.M408080200; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Suh KS, 2007, MOL CARCINOGEN, V46, P599, DOI 10.1002/mc.20324; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tannenbaum SR, 2006, ACS CHEM BIOL, V1, P615, DOI 10.1021/cb600439h; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tschugguel W, 1999, BREAST CANCER RES TR, V56, P145; Tung JJ, 2009, ANGIOGENESIS, V12, P209, DOI 10.1007/s10456-009-9139-3; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625	48	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23818	23828		10.1074/jbc.M109.091611	http://dx.doi.org/10.1074/jbc.M109.091611			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504765	Green Published, hybrid			2022-12-25	WOS:000280291400032
J	Abd Alla, J; Langer, A; Elzahwy, SS; Arman-Kalcek, G; Streichert, T; Quitterer, U				Abd Alla, Joshua; Langer, Andreas; Elzahwy, Sherif S.; Arman-Kalcek, Goekhan; Streichert, Thomas; Quitterer, Ursula			Angiotensin-converting Enzyme Inhibition Down-regulates the Pro-atherogenic Chemokine Receptor 9 (CCR9)-Chemokine Ligand 25 (CCL25) Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; DIET-INDUCED ATHEROSCLEROSIS; ACUTE-MYOCARDIAL-INFARCTION; E-KNOCKOUT MICE; T-CELL; DYSFUNCTION; CAPTOPRIL; TECK; HYPERTENSION; STIMULATION	Many experimental and clinical studies suggest a relationship between enhanced angiotensin II release by the angiotensin-converting enzyme (ACE) and the pathophysiology of atherosclerosis. The atherosclerosis-enhancing effects of angiotensin II are complex and incompletely understood. To identify anti-atherogenic target genes, we performed microarray gene expression profiling of the aorta during atherosclerosis prevention with the ACE inhibitor, captopril. Atherosclerosis-prone apolipoprotein E (apoE)-deficient mice were used as a model to decipher susceptible genes regulated during atherosclerosis prevention with captopril. Microarray gene expression profiling and immunohistology revealed that captopril treatment for 7 months strongly decreased the recruitment of pro-atherogenic immune cells into the aorta. Captopril-mediated inhibition of plaque-infiltrating immune cells involved down-regulation of the C-C chemokine receptor 9 (CCR9). Reduced cell migration correlated with decreased numbers of aorta-resident cells expressing the CCR9-specific chemoattractant factor, chemokine ligand 25 (CCL25). The CCL25-CCR9 axis was pro-atherogenic, because inhibition of CCR9 by RNA interference in hematopoietic progenitors of apoE-deficient mice significantly retarded the development of atherosclerosis. Analysis of coronary artery biopsy specimens of patients with coronary artery atherosclerosis undergoing bypass surgery also showed strong infiltrates of CCR9-positive cells in atherosclerotic lesions. Thus, the C-C chemokine receptor, CCR9, exerts a significant role in atherosclerosis.	[Abd Alla, Joshua; Langer, Andreas; Quitterer, Ursula] Swiss Fed Inst Technol, Mol Pharmacol Unit, CH-8057 Zurich, Switzerland; [Abd Alla, Joshua; Langer, Andreas; Quitterer, Ursula] Univ Zurich, CH-8057 Zurich, Switzerland; [Elzahwy, Sherif S.] Ain Shams Univ Hosp, Cardiol Clin, Cairo, Egypt; [Arman-Kalcek, Goekhan] Univ Hamburg, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Cent Labs, D-20246 Hamburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Egyptian Knowledge Bank (EKB); Ain Shams University; Heinrich Pette Institute; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Quitterer, U (corresponding author), Y17M70,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch		elzahwy, sherif/0000-0001-8451-4583	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by the Swiss National Science Foundation.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Alla JA, 2009, BIOCHEM BIOPH RES CO, V387, P186, DOI 10.1016/j.bbrc.2009.07.011; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Bursill CA, 2004, CIRCULATION, V110, P2460, DOI 10.1161/01.CIR.0000145122.58420.CO; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; CHOBANIAN AV, 1990, HYPERTENSION, V15, P327, DOI 10.1161/01.HYP.15.3.327; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Eto H, 2008, HYPERTENS RES, V31, P1631, DOI 10.1291/hypres.31.1631; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Fukuda D, 2008, PHARMACOL THERAPEUT, V118, P268, DOI 10.1016/j.pharmthera.2008.02.007; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; Gewaltig J, 2008, HUM PATHOL, V39, P1756, DOI 10.1016/j.humpath.2008.04.018; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hayek T, 1998, J CARDIOVASC PHARM, V31, P540, DOI 10.1097/00005344-199804000-00011; Hosoe N, 2004, AM J PHYSIOL-GASTR L, V286, pG458, DOI 10.1152/ajpgi.00167.2003; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Jung YJ, 2008, INT ARCH ALLERGY IMM, V146, P227, DOI 10.1159/000115891; Keidar S, 1997, BIOCHEM BIOPH RES CO, V236, P622, DOI 10.1006/bbrc.1997.6844; KIM SK, 1995, CIRCULATION, V92, P88, DOI 10.1161/01.CIR.92.1.88; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Lean JM, 2002, J CELL BIOCHEM, V87, P386, DOI 10.1002/jcb.10319; Lonn EM, 2001, CIRCULATION, V103, P919; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Major TC, 2009, CARDIOVASC DRUG THER, V23, P113, DOI 10.1007/s10557-008-6157-0; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; McMurray J, 2006, J AM COLL CARDIOL, V47, P726, DOI 10.1016/j.jacc.2005.09.055; Olsen MH, 2005, BLOOD PRESSURE, V14, P177, DOI 10.1080/08037050510034185; Parissis JT, 2002, J INTERF CYTOK RES, V22, P223, DOI 10.1089/107999002753536194; SCHINDLER R, 1995, CYTOKINE, V7, P526, DOI 10.1006/cyto.1995.0071; Stumpe Klaus O, 2007, Ther Adv Cardiovasc Dis, V1, P97, DOI 10.1177/1753944707085982; Valdivia-Silva JE, 2009, CANCER LETT, V283, P176, DOI 10.1016/j.canlet.2009.03.040; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zaballos A, 1999, J IMMUNOL, V162, P5671; Zhou XH, 2000, CIRCULATION, V102, P2919	41	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23494	23503		10.1074/jbc.M110.117481	http://dx.doi.org/10.1074/jbc.M110.117481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504763	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000279999900081
J	Dutta, T; Deutscher, MP				Dutta, Tanmay; Deutscher, Murray P.			Mode of Action of RNase BN/RNase Z on tRNA Precursors RNase BN DOES NOT REMOVE THE CCA SEQUENCE FROM tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRNASE-Z; EXORIBONUCLEASES; GROWTH; PROTEINS; PLAYS; END	RNase BN, the Escherichia coli homolog of RNase Z, was previously shown to act as both a distributive exoribonuclease and an endoribonuclease on model RNA substrates and to be inhibited by the presence of a 3'-terminal CCA sequence. Here, we examined the mode of action of RNase BN on bacteriophage and bacterial tRNA precursors, particularly in light of a recent report suggesting that RNase BN removes CCA sequences (Takaku, H., and Nashimoto, M. (2008) Genes Cells 13, 1087-1097). We show that purified RNase BN can process both CCA-less and CCA-containing tRNA precursors. On CCA-less precursors, RNase BN cleaved endonucleolytically after the discriminator nucleotide to allow subsequent CCA addition. On CCA-containing precursors, RNase BN acted as either an exoribonuclease or endoribonuclease depending on the nature of the added divalent cation. Addition of Co2+ resulted in higher activity and predominantly exoribonucleolytic activity, whereas in the presence of Mg2+, RNase BN was primarily an endoribonuclease. In no case was any evidence obtained for removal of the CCA sequence. Certain tRNA precursors were extremely poor substrates under any conditions tested. These findings provide important information on the ability of RNase BN to process tRNA precursors and help explain the known physiological properties of this enzyme. In addition, they call into question the removal of CCA sequences by RNase BN.	[Dutta, Tanmay; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Dutta, Tanmay/ABH-2431-2021		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317.	ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; DEUTSCHER MP, 1985, P NATL ACAD SCI USA, V82, P6427, DOI 10.1073/pnas.82.19.6427; Deutscher MP, 2001, PROG NUCLEIC ACID RE, V66, P67; DEUTSCHER MP, 1993, J BACTERIOL, V175, P4577, DOI 10.1128/JB.175.15.4577-4583.1993; DEUTSCHER MP, 1974, J BIOL CHEM, V249, P6696; Deutscher Murray P., 1995, P51; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Dutta T, 2009, J BIOL CHEM, V284, P15425, DOI 10.1074/jbc.M109.005462; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; LI ZW, 1994, J BIOL CHEM, V269, P6064; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Perwez T, 2006, MOL MICROBIOL, V60, P723, DOI 10.1111/j.1365-2958.2006.05124.x; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; REUVEN NB, 1993, FASEB J, V7, P143, DOI 10.1096/fasebj.7.1.8422961; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2004, BIOCHEM BIOPH RES CO, V320, P1365, DOI 10.1016/j.bbrc.2004.05.227; SEIDMAN JG, 1975, P NATL ACAD SCI USA, V72, P1491, DOI 10.1073/pnas.72.4.1491; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Takaku H, 2008, GENES CELLS, V13, P1087, DOI 10.1111/j.1365-2443.2008.01230.x; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Weiner AM, 2004, CURR BIOL, V14, pR883, DOI 10.1016/j.cub.2004.09.069	27	15	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22872	22879		10.1074/jbc.M110.141101	http://dx.doi.org/10.1074/jbc.M110.141101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489203	Green Published, hybrid			2022-12-25	WOS:000279999900020
J	Tipps, ME; Lawshe, JE; Ellington, AD; Mihic, SJ				Tipps, Megan E.; Lawshe, Jessica E.; Ellington, Andrew D.; Mihic, S. John			Identification of Novel Specific Allosteric Modulators of the Glycine Receptor Using Phage Display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; MOLECULAR-MECHANISMS; CHANNEL SUPERFAMILY; CHLORIDE CHANNEL; A RECEPTOR; PEPTIDES; ALCOHOL; ETHANOL; BRAIN; NEUROPROTECTION	The glycine receptor (GlyR) is a member of the Cys-loop superfamily of ligand-gated ion channels and the major mediator of inhibitory neurotransmission in the spinal cord and brainstem. Many allosteric modulators affect the functioning of members of this superfamily, with some such as benzodiazepines showing great specificity and others such as zinc, alcohols, and volatile anesthetics acting on multiple members. To date, no potent and efficacious allosteric modulator acting specifically at the GlyR has been identified, hindering both experimental characterization of the receptor and development of GlyR-related therapeutics. We used phage display to identify novel peptides that specifically modulate GlyR function. Peptide D12-116 markedly enhanced GlyR currents at low micromolar concentrations but had no effects on the closely related gamma-aminobutyric acid type A receptors. This approach can readily be adapted for use with other channels that currently lack specific allosteric modulators.	[Mihic, S. John] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas Austin, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Tipps, Megan E.; Mihic, S. John] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Ellington, Andrew D.; Mihic, S. John] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Mihic, SJ (corresponding author), Univ Texas Austin, Neurobiol Sect, A4800,2500 Speedway,MBB 1-148, Austin, TX 78712 USA.	mihic@mail.utexas.edu			National Institutes of Health [1R03AA018197, 1P20AA017838]; National Institute on Alcohol Abuse and Alcoholism [5T32AA007471, F31AA018887]; Welch Foundation [F-1654]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017838, F31AA018887, R03AA018197, T32AA007471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03AA018197 and 1P20AA017838 (to S.J.M.) and 5T32AA007471 and F31AA018887 (to M.E.T.) from the National Institute on Alcohol Abuse and Alcoholism. This work was also supported by Welch Foundation Grant F-1654 (to A.D.E.).	Adamian L, 2009, PROTEIN SCI, V18, P2371, DOI 10.1002/pro.247; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; Berg T, 2003, ANGEW CHEM INT EDIT, V42, P2462, DOI 10.1002/anie.200200558; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Colman A., 1984, TRANSCRIPTION TRANSL, P49; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; DOORBAR J, 1994, J MOL BIOL, V244, P361, DOI 10.1006/jmbi.1994.1736; Freshney RI, 2002, CYTOTECHNOLOGY, V39, P55, DOI 10.1023/A:1022949730029; GILBERT DF, 2009, FRONT MOL NEUROSCI, V2, P1; GOODSON RJ, 1994, P NATL ACAD SCI USA, V91, P7129, DOI 10.1073/pnas.91.15.7129; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; Guzman L, 2009, J PHARMACOL EXP THER, V331, P933, DOI 10.1124/jpet.109.160440; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; Hou ST, 2004, J NEUROSCI METH, V138, P39, DOI 10.1016/j.jneumeth.2004.03.013; Jensen AA, 2007, CURR NEUROPHARMACOL, V5, P180, DOI 10.2174/157015907781695982; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; Krasowski MD, 2000, BRIT J PHARMACOL, V129, P731, DOI 10.1038/sj.bjp.0703087; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Li M, 1996, NAT BIOTECHNOL, V14, P986, DOI 10.1038/nbt0896-986; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; May LT, 2004, CURR PHARM DESIGN, V10, P2003, DOI 10.2174/1381612043384303; MIHIC SJ, 1994, J BIOL CHEM, V269, P32768; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Molander A, 2005, ALCOHOL CLIN EXP RES, V29, P27, DOI 10.1097/01.ALC.0000150012.09608.81; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Rajendra Sundran, 1995, Trends in Neurosciences, V18, P80, DOI 10.1016/0166-2236(95)93880-7; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; Ye JH, 2009, ALCOHOL CLIN EXP RES, V33, P1069, DOI 10.1111/j.1530-0277.2009.00928.x	35	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22838	22843		10.1074/jbc.M110.130815	http://dx.doi.org/10.1074/jbc.M110.130815			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501662	hybrid, Green Published			2022-12-25	WOS:000279999900016
J	Falk, S; Sinning, I				Falk, Sebastian; Sinning, Irmgard			cpSRP43 Is a Novel Chaperone Specific for Light-harvesting Chlorophyll a,b-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; MITOCHONDRIAL INNER MEMBRANE; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONES; THYLAKOID MEMBRANE; SECRETORY PATHWAY; ESCHERICHIA-COLI; A/B COMPLEX; IN-VITRO; CHLOROPLAST	The biosynthesis of most membrane proteins is directly coupled to membrane insertion, and therefore, molecular chaperones are not required. The light-harvesting chlorophyll a, b-binding proteins (LHCPs) present a prominent exception as they are synthesized in the cytoplasm, and after import into the chloroplast, they are targeted and inserted into the thylakoid membrane. Upon arrival in the stroma, LHCPs form a soluble transit complex with the chloroplast signal recognition particle (cpSRP) consisting of an SRP54 homolog and the unique cpSRP43 composed of three chromodomains and four ankyrin repeats. Here we describe that cpSRP43 alone prevents aggregation of LHCP by formation of a complex with nanomolar affinity, whereas cpSRP54 is not required for this chaperone activity. Other stromal chaperones like trigger factor cannot replace cpSRP43, which implies that LHCPs require a specific chaperone. Although cpSRP43 does not have an ATPase activity, it can dissolve aggregates of LHCPs similar to chaperones of the Hsp104/ClpB family. We show that the LHCP-cpSRP43 interaction is predominantly hydrophobic but strictly depends on an intact DPLG motif between the second and third transmembrane region. The cpSRP43 ankyrin repeats that provide the binding site for the DPLG motif are sufficient for the chaperone function, whereas the chromodomains are dispensable. Taken together, we define cpSRP43 as a highly specific chaperone for LHCPs in addition to its established function as a targeting factor for this family of membrane proteins.	[Falk, Sebastian; Sinning, Irmgard] Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sinning, I (corresponding author), Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Falk, Sebastian/T-4796-2017; Falk, Sebastian/AAG-9706-2019	Falk, Sebastian/0000-0001-7848-4621; Falk, Sebastian/0000-0001-7848-4621	Deutsche Forschungsgemeinschaft [FOR697, SFB638]; Graduiertenkolleg [1188]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg(German Research Foundation (DFG))	The work was supported by collaborative research grants from the Deutsche Forschungsgemeinschaft (Grants FOR697 and SFB638) and the Graduiertenkolleg 1188.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Booth PJ, 1996, BIOCHEMISTRY-US, V35, P5103, DOI 10.1021/bi953053f; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Fersht A, 1998, STRUCTURE MECH PROTE, P103; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; High S, 1997, J BIOL CHEM, V272, P11622; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Huang GC, 2000, PROTEIN SCI, V9, P1254, DOI 10.1110/ps.9.6.1254; Ito K, 2005, MOL MICROBIOL, V57, P313, DOI 10.1111/j.1365-2958.2005.04696.x; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang M, 2001, J BIOL CHEM, V276, P7985, DOI 10.1074/jbc.M006417200; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Nanjo Y, 2006, PLANT CELL, V18, P2582, DOI 10.1105/tpc.105.039891; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539; PLUMLEY FG, 1995, PLANT CELL, V7, P689, DOI 10.2307/3870172; Radhamony RN, 2006, TRENDS CELL BIOL, V16, P385, DOI 10.1016/j.tcb.2006.06.003; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Villarejo A, 2005, NAT CELL BIOL, V7, P1224, DOI 10.1038/ncb1330; YALOVSKY S, 1992, P NATL ACAD SCI USA, V89, P5616, DOI 10.1073/pnas.89.12.5616; YUAN JG, 1993, P NATL ACAD SCI USA, V90, P8552, DOI 10.1073/pnas.90.18.8552	55	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21655	21661		10.1074/jbc.C110.132746	http://dx.doi.org/10.1074/jbc.C110.132746			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20498370	hybrid, Green Published			2022-12-25	WOS:000279516100052
J	Santhanam, AN; Baker, AR; Hegamyer, G; Kirschmann, DA; Colburn, NH				Santhanam, A. N.; Baker, A. R.; Hegamyer, G.; Kirschmann, D. A.; Colburn, N. H.			Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion	ONCOGENE			English	Article						PDCD4; lysyl oxidase; breast cancer; hypoxia	TRANSFORMATION SUPPRESSOR PDCD4; TUMOR-SUPPRESSOR; PROTEIN PDCD4; INDUCIBLE FACTOR-1-ALPHA; EUKARYOTIC TRANSLATION; GENE-EXPRESSION; CARCINOMA; AKT; METASTASIS; ACTIVATION	Metastasis to bone, liver and lungs is the primary cause of death in breast cancer patients. Our studies have revealed that the novel tumor suppressor Pdcd4 inhibits breast cancer cell migration and invasion in vitro. Loss of Pdcd4 in human nonmetastatic breast cancer cells increased the expression of lysyl oxidase (LOX) mRNA. LOX is a hypoxia-inducible amine oxidase, the activity of which enhances breast cancer cell invasion in vitro and in vivo. Specific inhibition of LOX activity by beta-aminopropionitrile or small interfering RNA decreased the invasiveness of T47D and MCF7 breast cancer cells attenuated for Pdcd4 function. Most significantly, loss of Pdcd4 augments hypoxia induction of LOX as well. Conversely, overexpression of Pdcd4 significantly reversed the hypoxia induction of LOX expression in T47D cells attenuated for Pdcd4. However, Pdcd4 did not affect hypoxia-inducible factor-1 (HIF-1) protein expression or HIF-1-responsive element-luciferase activity in response to hypoxia, suggesting that Pdcd4 regulation of LOX occurs through an HIF-independent mechanism. Nevertheless, the loss of Pdcd4 early in cancer progression may have an important role in the increased sensitivity of cancer cells to hypoxia through increased LOX activity and concomitant enhanced invasiveness. Oncogene (2010) 29, 3921-3932; doi:10.1038/onc.2010.158; published online 24 May 2010	[Santhanam, A. N.; Baker, A. R.; Hegamyer, G.; Colburn, N. H.] NCI, Gene Regulat Sect, Lab Canc Prevent, Ctr Canc Res, Frederick, MD 21702 USA; [Kirschmann, D. A.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Childrens Mem Res Ctr,Canc Biol & Epigen Program, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Santhanam, AN (corresponding author), NCI, Gene Regulat Sect, Lab Canc Prevent, Ctr Canc Res, Boyles St, Frederick, MD 21702 USA.	santhanama@ncifcrf.gov			NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010026] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Giovanni Melillo and Annamaria Rapisarda (Tumor Hypoxia Laboratory, NCI-Frederick) for helpful suggestions and for the use of reagents and hypoxia chambers. We also thank members of the Gene Regulation Section, Laboratory of Cancer Prevention, for helpful discussions. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Arsham AM, 2004, CANCER RES, V64, P3500, DOI 10.1158/0008-5472.CAN-03-2239; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Chen HHW, 2007, BREAST CANCER RES TR, V103, P167, DOI 10.1007/s10549-006-9360-3; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Csiszar K, 1996, MOL BIOL REP, V23, P97, DOI 10.1007/BF00424435; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Erler JT, 2006, CANCER RES, V66, P10238, DOI 10.1158/0008-5472.CAN-06-3197; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Goke R, 2004, ANN NY ACAD SCI, V1014, P220, DOI 10.1196/annals.1294.024; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kang YB, 2005, EXPERT REV MOL DIAGN, V5, P385, DOI 10.1586/14737159.5.3.385; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kronblad A, 2006, INT J CANCER, V118, P2609, DOI 10.1002/ijc.21676; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Lundgren K, 2007, CELL MOL LIFE SCI, V64, P3233, DOI 10.1007/s00018-007-7390-6; Melillo G, 1999, CANCER RES, V59, P5433; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Nieves-Alicea R, 2009, BREAST CANCER RES TR, V114, P203, DOI 10.1007/s10549-008-9993-5; PASTOREK J, 1994, ONCOGENE, V9, P2877; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Postovit LM, 2008, J CELL BIOCHEM, V103, P1369, DOI 10.1002/jcb.21517; Rucker RB, 1998, AM J CLIN NUTR, V67, p996S, DOI 10.1093/ajcn/67.5.996S; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schmitz KJ, 2004, MODERN PATHOL, V17, P15, DOI 10.1038/modpathol.3800002; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Tan RSP, 1996, CANCER RES, V56, P2417; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Wen YH, 2007, ONCOL REP, V18, P1387; Yagata H, 2003, PATHOL INT, V53, P501, DOI 10.1046/j.1440-1827.2003.01514.x; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Zakowicz H, 2005, RNA, V11, P261, DOI 10.1261/rna.7191905; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	62	53	59	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2010	29	27					3921	3932		10.1038/onc.2010.158	http://dx.doi.org/10.1038/onc.2010.158			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20498644	Green Accepted			2022-12-25	WOS:000279603200005
J	Brandl, C; Ortler, S; Herrmann, T; Cardell, S; Lutz, MB; Wiendl, H				Brandl, Carolin; Ortler, Sonja; Herrmann, Thomas; Cardell, Susanna; Lutz, Manfred B.; Wiendl, Heinz			B7-H1-Deficiency Enhances the Potential of Tolerogenic Dendritic Cells by Activating CD1d-Restricted Type II NKT Cells	PLOS ONE			English	Article							KILLER T-CELLS; B7 FAMILY; IMMUNE-RESPONSES; ANERGY INDUCTION; CROSS-REGULATION; CUTTING EDGE; EXPRESSION; LIGANDS; PD-1; AUTOIMMUNITY	Background: Dendritic cells (DC) can act tolerogenic at a semi-mature stage by induction of protective CD4(+) T cell and NKT cell responses. Methodology/Principal Findings: Here we studied the role of the co-inhibitory molecule B7-H1 (PD-L1, CD274) on semimature DC that were generated from bone marrow (BM) cells of B7-H1(-/-) mice and applied to the model of Experimental Autoimmune Encephalomyelitis (EAE). Injections of B7-H1-deficient DC showed increased EAE protection as compared to wild type (WT)-DC. Injections of B7-H1(-/-) TNF-DC induced higher release of peptide-specific IL-10 and IL-13 after restimulation in vitro together with elevated serum cytokines IL-4 and IL-13 produced by NKT cells, and reduced IL-17 and IFN-gamma production in the CNS. Experiments in CD1d(-/-) and J alpha 281(-/-) mice as well as with type I and II NKT cell lines indicated that only type II NKT cells but not type I NKT cells (invariant NKT cells) could be stimulated by an endogenous CD1d-ligand on DC and were responsible for the increased serum cytokine production in the absence of B7-H1. Conclusions/Significance: Together, our data indicate that BM-DC express an endogenous CD1d ligand and B7-H1 to ihibit type II but not type I NKT cells. In the absence of B7-H1 on these DC their tolerogenic potential to stimulate tolerogenic CD4(+) and NKT cell responses is enhanced.	[Brandl, Carolin; Herrmann, Thomas; Lutz, Manfred B.] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Ortler, Sonja; Wiendl, Heinz] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Cardell, Susanna] Gothenburg Univ, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Wurzburg; University of Wurzburg; University of Gothenburg	Brandl, C (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany.	m.lutz@vim.uni-wuerzburg.de	Wiendl, Heinz/AAX-6041-2021; Herrmann, Thomas/J-4943-2012; Cardell, Susanna/ABC-4944-2021	Herrmann, Thomas/0000-0002-1093-0194; Wiendl, Heinz/0000-0003-4310-3432; Lutz, Manfred B./0000-0001-9193-1772	German Research Council (DFG); Collaborative Research Centre [SFB581]	German Research Council (DFG)(German Research Foundation (DFG)); Collaborative Research Centre	This study was supported by the German Research Council (DFG, www.dfg.de) by the projects A8 (S.O., H.W.) and A9 (C.G., M.B.L.) of the Collaborative Research Centre (SFB581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; Arrenberg P, 2009, J CELL PHYSIOL, V218, P246, DOI 10.1002/jcp.21597; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Behar SM, 1999, J IMMUNOL, V162, P161; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Carreno BM, 2005, CURR OPIN PHARMACOL, V5, P424, DOI 10.1016/j.coph.2005.02.003; Carter LL, 2007, J NEUROIMMUNOL, V182, P124, DOI 10.1016/j.jneuroim.2006.10.006; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chang WS, 2008, J IMMUNOL, V181, P6707, DOI 10.4049/jimmunol.181.10.6707; Dong HD, 1999, NAT MED, V5, P1365; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Hayakawa Y, 2004, NAT IMMUNOL, V5, P590, DOI 10.1038/ni1069; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Magnus T, 2005, J NEUROSCI, V25, P2537, DOI 10.1523/JNEUROSCI.4794-04.2005; Makowska A, 2000, SCAND J IMMUNOL, V52, P71; Martin-Orozco N, 2006, J IMMUNOL, V177, P8291, DOI 10.4049/jimmunol.177.12.8291; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Ortler S, 2008, EUR J IMMUNOL, V38, P1734, DOI 10.1002/eji.200738071; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Parekh VV, 2009, J IMMUNOL, V182, P2816, DOI 10.4049/jimmunol.0803648; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Schreiner B, 2008, EUR J IMMUNOL, V38, P2706, DOI 10.1002/eji.200838137; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Skold M, 2000, J IMMUNOL, V165, P168, DOI 10.4049/jimmunol.165.1.168; Sonoda KH, 2002, EUR J IMMUNOL, V32, P848, DOI 10.1002/1521-4141(200203)32:3<848::AID-IMMU848>3.0.CO;2-I; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Wiethe C, 2007, J IMMUNOL, V178, P4908, DOI 10.4049/jimmunol.178.8.4908; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhu B, 2006, J IMMUNOL, V176, P3480, DOI 10.4049/jimmunol.176.6.3480; Zozulya AL, 2009, J NEUROSCI, V29, P140, DOI 10.1523/JNEUROSCI.2199-08.2009	45	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10800	10.1371/journal.pone.0010800	http://dx.doi.org/10.1371/journal.pone.0010800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520738	Green Published, Green Submitted, gold			2022-12-25	WOS:000278034600027
J	Toller, W; Debrot, AO; Vermeij, MJA; Hoetjes, PC				Toller, Wes; Debrot, Adolphe O.; Vermeij, Mark J. A.; Hoetjes, Paul C.			Reef Fishes of Saba Bank, Netherlands Antilles: Assemblage Structure across a Gradient of Habitat Types	PLOS ONE			English	Article							CORAL-REEF; SEAGRASS BEDS; COMMUNITY STRUCTURE; SPECIES RICHNESS; MANGROVES; NURSERY; BIODIVERSITY; HYPOTHESIS; COMPLEXITY; RANGE	Saba Bank is a 2,200 km(2) submerged carbonate platform in the northeastern Caribbean Sea off Saba Island, Netherlands Antilles. The presence of reef-like geomorphic features and significant shelf edge coral development on Saba Bank have led to the conclusion that it is an actively growing, though wholly submerged, coral reef atoll. However, little information exists on the composition of benthic communities or associated reef fish assemblages of Saba Bank. We selected a 40 km(2) area of the bank for an exploratory study. Habitat and reef fish assemblages were investigated in five shallow-water benthic habitat types that form a gradient from Saba Bank shelf edge to lagoon. Significant coral cover was restricted to fore reef habitat (average cover 11.5%) and outer reef flat habitat (2.4%) and declined to near zero in habitats of the central lagoon zone. Macroalgae dominated benthic cover in all habitats (average cover: 32.5-48.1%) but dominant algal genera differed among habitats. A total of 97 fish species were recorded. The composition of Saba Bank fish assemblages differed among habitat types. Highest fish density and diversity occurred in the outer reef flat, fore reef and inner reef flat habitats. Biomass estimates for commercially valued species in the reef zone (fore reef and reef flat habitats) ranged between 52 and 83 g/m(2). The composition of Saba Bank fish assemblages reflects the absence of important nursery habitats, as well as the effects of past fishing. The relatively high abundance of large predatory fish (i.e. groupers and sharks), which is generally considered an indicator of good ecosystem health for tropical reef systems, shows that an intact trophic network is still present on Saba Bank.	[Toller, Wes] Saba Conservat Fdn, Saba, Neth Antilles; [Debrot, Adolphe O.; Vermeij, Mark J. A.] Caribbean Res & Management Biodivers Fdn, Willemstad, Curacao, Neth Antilles; [Hoetjes, Paul C.] Minist Publ Hlth & Social Dev, Dept Environm & Nat, Willemstad, Curacao, Neth Antilles		Toller, W (corresponding author), Accreditat Serv Int GmbH, Bonn, Germany.	westoller@yahoo.com	Vermeij, Mark/B-2752-2013; Vermeij, Mark/AAR-6757-2020	Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527	Development Foundation of the Netherlands Antilles (SONA)	Development Foundation of the Netherlands Antilles (SONA)	This work was part of the implementation of the Nature and Environment Policy Plan (NEPP) of the Department of Environment and Nature of the Netherlands Antilles, funded by Dutch development support provided through the Development Foundation of the Netherlands Antilles (SONA) and carried out with the help of the Saba Conservation Foundation, Saba, Netherlands Antilles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAK R P M, 1975, Bijdragen tot de Dierkunde, V45, P181; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bohnsack J.A., 1986, STATIONARY VISUAL CE; BORTONE S A, 1989, Northeast Gulf Science, V10, P85; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; Diaz Juan M., 1996, Atoll Research Bulletin, V435, P1; Dilrosun F, 2000, MONITORING SABA BANK; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; GLADFELTER WB, 1978, REV BIOL TROP, V26, P65; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hilborn Ray, 1997, V28; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Kendall MS, 2004, AQUAT CONSERV, V14, P113, DOI 10.1002/aqc.601; Kendall MS, 2001, METHODS USED MAP BEN; Klomp Kristi D., 2003, Atoll Research Bulletin, V496, P404; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MACINTYRE I G, 1975, Caribbean Journal of Science, V15, P11; MCKENNA S, 2006, PRELIMINARY REPORT M; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; MILLIMAN JD, 1973, BIOL GEOLOGY CORAL R, V1, P1; Monaco ME, 2007, FISHERIES MANAG ECOL, V14, P33, DOI 10.1111/j.1365-2400.2006.00521.x; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nagelkerken I., 2003, Gulf and Caribbean Research, V14, P43; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; Rothenberger Paige, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P29; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Toller W, 2008, ASSESSMENT COMMERCIA; Toller W., 2008, SOME OBSERVATIONS MA; VANDERLAND J, 1977, 200 FAO, P469; Vermeij MJA, 2007, MAR ECOL PROG SER, V351, P91, DOI 10.3354/meps07085; WANDERS J B W, 1976, Aquatic Botany, V2, P327, DOI 10.1016/0304-3770(76)90030-9	42	17	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e9207	10.1371/journal.pone.0009207	http://dx.doi.org/10.1371/journal.pone.0009207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20502637	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017400001
J	Ragnarsdottir, B; Jonsson, K; Urbano, A; Gronberg-Hernandez, J; Lutay, N; Tammi, M; Gustafsson, M; Lundstedt, AC; Leijonhufvud, I; Karpman, D; Wullt, B; Truedsson, L; Jodal, U; Andersson, B; Svanborg, C				Ragnarsdottir, Bryndis; Jonsson, Klas; Urbano, Alexander; Gronberg-Hernandez, Jenny; Lutay, Nataliya; Tammi, Martti; Gustafsson, Mattias; Lundstedt, Ann-Charlotte; Leijonhufvud, Irene; Karpman, Diana; Wullt, Bjorn; Truedsson, Lennart; Jodal, Ulf; Andersson, Bjorn; Svanborg, Catharina			Toll-Like Receptor 4 Promoter Polymorphisms: Common TLR4 Variants May Protect against Severe Urinary Tract Infection	PLOS ONE			English	Article							DEFICIENCY CONFERS SUSCEPTIBILITY; UROPATHOGENIC ESCHERICHIA-COLI; HOST RESPONSE INDUCTION; ASYMPTOMATIC BACTERIURIA; ACUTE PYELONEPHRITIS; P-FIMBRIAE; CYTOKINE RESPONSES; SIGNALING PATHWAY; EPITHELIAL-CELLS; INNATE IMMUNITY	Background: Polymorphisms affecting Toll-like receptor (TLR) structure appear to be rare, as would be expected due to their essential coordinator role in innate immunity. Here, we assess variation in TLR4 expression, rather than structure, as a mechanism to diversify innate immune responses. Methodology/Principal Findings: We sequenced the TLR4 promoter (4,3 kb) in Swedish blood donors. Since TLR4 plays a vital role in susceptibility to urinary tract infection (UTI), promoter sequences were obtained from children with mild or severe disease. We performed a case-control study of pediatric patients with asymptomatic bacteriuria (ABU) or those prone to recurrent acute pyelonephritis (APN). Promoter activity of the single SNPs or multiple allelic changes corresponding to the genotype patterns (GPs) was tested. We then conducted a replication study in an independent cohort of adult patients with a history of childhood APN. Last, in vivo effects of the different GPs were examined after therapeutic intravesical inoculation of 19 patients with Escherichia coli 83972. We identified in total eight TLR4 promoter sequence variants in the Swedish control population, forming 19 haplotypes and 29 genotype patterns, some with effects on promoter activity. Compared to symptomatic patients and healthy controls, ABU patients had fewer genotype patterns, and their promoter sequence variants reduced TLR4 expression in response to infection. The ABU associated GPs also reduced innate immune responses in patients who were subjected to therapeutic urinary E. coli tract inoculation. Conclusions: The results suggest that genetic variation in the TLR4 promoter may be an essential, largely overlooked mechanism to influence TLR4 expression and UTI susceptibility.	[Ragnarsdottir, Bryndis; Lutay, Nataliya; Gustafsson, Mattias; Lundstedt, Ann-Charlotte; Leijonhufvud, Irene; Truedsson, Lennart; Svanborg, Catharina] Lund Univ, Inst Lab Med Lund, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Jonsson, Klas; Urbano, Alexander; Svanborg, Catharina] ASTAR, Inst Biomed Sci, Singapore Immunol Network, Singapore, Singapore; [Gronberg-Hernandez, Jenny; Wullt, Bjorn] Lund Univ, Univ Lund Hosp, Inst Clin Sci Lund, Dept Urol, Lund, Sweden; [Tammi, Martti] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Karpman, Diana] Lund Univ, Dept Pediat, Inst Clin Sci Lund, Lund, Sweden; [Jodal, Ulf] Gothenburg Univ, Dept Pediat, Queen Silvia Childrens Hosp, S-41124 Gothenburg, Sweden; [Andersson, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Lund University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Lund University; Skane University Hospital; National University of Singapore; Lund University; Queen Silvia Children's Hospital; University of Gothenburg; Karolinska Institutet	Ragnarsdottir, B (corresponding author), Lund Univ, Inst Lab Med Lund, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	catharina.svanborg@med.lu.se	Lutay, Nataliya/K-1733-2014; Andersson, Bjorn/G-9832-2013; Gustafsson, Mattias C. U./A-7451-2010	Lutay, Nataliya/0000-0003-1852-1288; Andersson, Bjorn/0000-0002-4624-0259; Gustafsson, Mattias C. U./0000-0003-3260-0724; Aradottir, Sigridur Sunna/0000-0002-6898-3256; Karpman, Diana/0000-0001-7220-7658	Swedish Medical Research Council; Network of Excellence: EuroPathoGenomics; Crafoord, Wallenberg, Lundberg and Osterlund Foundations; Blood and Defense Network (Faculty of Medicine, Lund University); Royal Physiografic Society	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Network of Excellence: EuroPathoGenomics; Crafoord, Wallenberg, Lundberg and Osterlund Foundations; Blood and Defense Network (Faculty of Medicine, Lund University); Royal Physiografic Society(Royal Society of London)	This study was supported by grants from the Swedish Medical Research Council, the Network of Excellence: EuroPathoGenomics, the Crafoord, Wallenberg, Lundberg and Osterlund Foundations, the Blood and Defense Network (Faculty of Medicine, Lund University) and the Royal Physiografic Society. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bergsten G, 2005, INT J MED MICROBIOL, V295, P487, DOI 10.1016/j.ijmm.2005.07.008; Bergsten G, 2004, J INFECT DIS, V189, P1734, DOI 10.1086/383278; Bergsten G, 2007, CELL MICROBIOL, V9, P1766, DOI 10.1111/j.1462-5822.2007.00912.x; De Staercke C, 2007, THROMB RES, V119, P105, DOI 10.1016/j.thromres.2005.12.010; EDEN CS, 1984, INFECTION, V12, P118, DOI 10.1007/BF01641692; FISCHER H, 2007, CELL MICROBIOL; Fischer JE, 2006, SURG-J R COLL SURG E, V4, P267, DOI 10.1016/S1479-666X(06)80003-X; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; FOXMAN B, 1985, AM J PUBLIC HEALTH, V75, P1314, DOI 10.2105/AJPH.75.11.1314; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Frendeus B, 2001, MOL MICROBIOL, V40, P37, DOI 10.1046/j.1365-2958.2001.02361.x; Frendeus B, 2001, J INFECT DIS, V183, pS56, DOI 10.1086/318848; Gollapudi R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-414; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008300; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hedlund M, 1996, J EXP MED, V183, P1037, DOI 10.1084/jem.183.3.1037; Ingberg CM, 1998, DIABETES METAB, V24, P351; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; KININGHAM RB, 1993, AM FAM PHYSICIAN, V47, P1232; Kunin CM, 1997, URINARY TRACT INFECT; LEFFLER H, 1980, FEMS MICROBIOL LETT, V8, P127, DOI 10.1111/j.1574-6968.1980.tb05064.x; Li XX, 2005, J MOL MED, V83, P258, DOI 10.1007/s00109-004-0622-4; Lichtinger M, 2007, J BIOL CHEM, V282, P26874, DOI 10.1074/jbc.M703856200; LINDBERG U, 1978, J PEDIATR-US, V92, P194, DOI 10.1016/S0022-3476(78)80003-1; LOMBERG H, 1983, NEW ENGL J MED, V308, P1189, DOI 10.1056/NEJM198305193082003; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Mably JD, 1996, CIRC RES, V79, P4, DOI 10.1161/01.RES.79.1.4; MARTINELL J, 1995, PEDIATR NEPHROL, V9, P131, DOI 10.1007/BF00860724; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; NICOLLE LE, 1994, J ANTIMICROB CHEMOTH, V33, P99, DOI 10.1093/jac/33.suppl_A.99; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; RANSLEY PG, 1978, BRIT J RADIOL      S, V14, P1; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Samuelsson P, 2004, INFECT IMMUN, V72, P3179, DOI 10.1128/IAI.72.6.3179-3186.2004; Smirnova I, 2001, GENETICS, V158, P1657; STAPLETON A, 1992, J CLIN INVEST, V90, P965, DOI 10.1172/JCI115973; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Svensson M, 2008, KIDNEY INT, V74, P81, DOI 10.1038/ki.2008.105; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; WEGNER M, 1993, P NATL ACAD SCI USA, V90, P4743, DOI 10.1073/pnas.90.10.4743; Wullt B, 2000, MOL MICROBIOL, V38, P456, DOI 10.1046/j.1365-2958.2000.02165.x; Wullt B, 1998, J UROLOGY, V159, P2057, DOI 10.1016/S0022-5347(01)63246-4; Wullt B, 2001, J INFECT DIS, V183, pS43, DOI 10.1086/318849; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	57	76	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10734	10.1371/journal.pone.0010734	http://dx.doi.org/10.1371/journal.pone.0010734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505764	Green Published, gold, Green Submitted			2022-12-25	WOS:000278017300010
J	Li, MC; Liang, JF; Li, YC; Feng, B; Yang, ZL; James, TY; Xu, JP				Li, Mochan; Liang, Junfeng; Li, Yanchun; Feng, Bang; Yang, Zhu-Liang; James, Timothy Y.; Xu, Jianping			Genetic Diversity of Dahongjun, the Commercially Important "Big Red Mushroom'' from Southern China	PLOS ONE			English	Article							TRICHOLOMA-MATSUTAKE; ECTOMYCORRHIZAL FUNGI; SPECIES RECOGNITION; RUSSULA; GENEALOGIES; RECOMBINATION; BASIDIOMYCETE; POPULATIONS; ECOLOGY; COMMON	Background: In southern China, a wild ectomycorrhizal mushroom commonly called "Dahongjun'' or "Big Red Mushroom'' by the local residents, has been harvested, consumed, and/or exported as an exotic food for many years. Although ecologically and economically important, very little is known about this mushroom, including its diversity and population structure. Methodology and Principal Findings: In this study, we analyzed 122 samples from five local populations representing the known distribution ranges of this mushroom in southern China. We investigated the genetic diversity and geographic structure of this mushroom using sequences from four DNA fragments. Our analyses identified that this mushroom contained at least three divergent lineages: one corresponds to a recently described species Russula griseocarnosa from southern China and the remaining two likely represent two novel species. While these lineages were prominently structured geographically based on ITS sequences, evidence for ancient and/or recent gene flow was also identified within individual lineages. In addition, a local population from Ailaoshan in central Yunnan Province where 85 of our 122 specimens came from showed clear evidence of recombination. Conclusion and Significance: The ectomycorrhizal mushroom "Dahongjun'' from southern China is a species complex with at least three divergent lineages. These lineages are largely geographically structured and there is evidence for recombination in nature. Our results indicate mature Dahongjun mushrooms with abundant basidiospores are important for the reproduction of this mushroom in nature and that individual populations of this species should be managed separately.	[Li, Mochan; James, Timothy Y.; Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Liang, Junfeng] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China; [Li, Yanchun; Feng, Bang; Yang, Zhu-Liang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China	McMaster University; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, MC (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jpxu@mcmaster.ca		Li, Yanchun/0000-0002-7109-9269	Natural Science and Engineering Research Council of Canada; National Natural Science Foundation of China; Yunnan Provincial Government [U0836604]; National Basic Research Program of China [2009CB522300]; Key Laboratory of Biodiversity and Biogeography of the Chinese Academy of Sciences [0806371111]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Government; National Basic Research Program of China(National Basic Research Program of China); Key Laboratory of Biodiversity and Biogeography of the Chinese Academy of Sciences	This study was supported by Natural Science and Engineering Research Council of Canada, Premiers Research Excellence Award, the Joint Funds of the National Natural Science Foundation of China and Yunnan Provincial Government (No. U0836604), the National Basic Research Program of China (No. 2009CB522300), and the Key Laboratory of Biodiversity and Biogeography of the Chinese Academy of Sciences (No. 0806371111). The authors confirm that the funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Allen MF, 1984, MYCOLOGICAL SOC AM N, V35, P17; Bergemann SE, 2006, NEW PHYTOL, V170, P177, DOI 10.1111/j.1469-8137.2006.01654.x; Bergemann SE, 2005, MOL ECOL NOTES, V5, P472, DOI 10.1111/j.1471-8286.2005.00949.x; Bergemann SE, 2002, NEW PHYTOL, V156, P313, DOI 10.1046/j.1469-8137.2002.00507.x; Bertolino S, 2004, FOREST ECOL MANAG, V202, P227, DOI 10.1016/j.foreco.2004.07.024; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Brundrett M, 2004, BIOL REV, V79, P473, DOI 10.1017/S1464793103006316; Buyck B, 2006, MYCOLOGIA, V98, P612, DOI 10.3852/mycologia.98.4.612; Douhan GW, 2005, NEW PHYTOL, V166, P263, DOI 10.1111/j.1469-8137.2004.01305.x; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Hedh J, 2008, MYCOL RES, V112, P965, DOI 10.1016/j.mycres.2008.01.026; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Kasuga T, 2003, MOL ECOL, V12, P3383, DOI 10.1046/j.1365-294X.2003.01995.x; Kauserud H, 2006, MOL ECOL, V15, P421, DOI 10.1111/j.1365-294X.2005.02768.x; Kirk PM, 2008, DICT FUNGI; LAMB RJ, 1979, AUST FOREST RES, V9, P25; LEGON NW, 2005, CHECKLIST BRIT IRISH, P517; Li Mo-Chan, 2009, Acta Botanica Yunnanica, V31, P193, DOI 10.3724/SP.J.1143.2009.09086; LIAN B, 2008, J BIOTECHNOL, V11, P1; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Liang Y, 2004, MYCORRHIZA, V14, P235, DOI 10.1007/s00572-003-0260-7; Miller SL, 2002, MYCOL RES, V106, P259, DOI 10.1017/S0953756202005610; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pujol C, 2005, EVOL GENET, P149; Redecker D, 2001, MOL ECOL, V10, P1025, DOI 10.1046/j.1365-294X.2001.01230.x; RICHARDSON MJ, 1970, T BRIT MYCOL SOC, V55, P217, DOI 10.1016/S0007-1536(70)80006-7; Romagnesi H, 1967, RUSSULES EUROPE AFRI; Sha T, 2008, MICROBIOL-SGM, V154, P3460, DOI 10.1099/mic.0.2008/020495-0; Sha T, 2007, CHINESE SCI BULL, V52, P1212, DOI 10.1007/s11434-007-0194-0; Singer R, 1986, AGARICALES MODERN TA, P1; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Tedersoo L, 2003, NEW PHYTOL, V159, P153, DOI 10.1046/j.1469-8137.2003.00792.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang XH, 2009, NOVA HEDWIGIA, V88, P269, DOI 10.1127/0029-5035/2009/0088-0269; Xu J., 2005, EVOL GENET, P87; Xu J, 2005, EVOL GENET, P189; Xu JP, 2008, MOL ECOL, V17, P1238, DOI 10.1111/j.1365-294X.2007.03665.x; Xu JP, 2007, MICROBIOL-SGM, V153, P2002, DOI 10.1099/mic.0.2006/005686-0; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; XU JP, 1994, TRENDS GENET, V10, P226, DOI 10.1016/0168-9525(94)90158-9; Xu JP, 1996, MYCOL RES, V100, P188, DOI 10.1016/S0953-7562(96)80119-5; Yang Z. L., 2004, Frontiers in Basidiomycote mycology, P419; [杨祝良 Yang Zhuliang], 2002, [自然资源学报, Journal of Natural Resources], V17, P463	46	15	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10684	10.1371/journal.pone.0010684	http://dx.doi.org/10.1371/journal.pone.0010684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502696	Green Published, gold, Green Submitted			2022-12-25	WOS:000277776500003
J	Quinzii, CM; Lopez, LC; Gilkerson, RW; Dorado, B; Coku, J; Naini, AB; Lagier-Tourenne, C; Schuelke, M; Salviati, L; Carrozzo, R; Santorelli, F; Rahman, S; Tazir, M; Koenig, M; DiMauro, S; Hirano, M				Quinzii, Catarina M.; Lopez, Luis C.; Gilkerson, Robert W.; Dorado, Beatriz; Coku, Jorida; Naini, Ali B.; Lagier-Tourenne, Clotilde; Schuelke, Markus; Salviati, Leonardo; Carrozzo, Rosalba; Santorelli, Filippo; Rahman, Shamima; Tazir, Meriem; Koenig, Michel; DiMauro, Salvatore; Hirano, Michio			Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ(10) deficiency	FASEB JOURNAL			English	Article						mitochondria; respiratory chain; ATP; ubiquinone; mitochondrial disease	COENZYME Q(10); BIOSYNTHESIS; MITOCHONDRIA; NEPHROPATHY; DEGRADATION; METABOLISM; RESISTANCE; MUTATIONS; DEFECTS; ND5	Coenzyme Q(10) (CoQ(10)) is essential for electron transport in the mitochondrial respiratory chain and antioxidant defense. The relative importance of respiratory chain defects, ROS production, and apoptosis in the pathogenesis of CoQ(10) deficiency is unknown. We determined previously that severe CoQ(10) deficiency in cultured skin fibroblasts harboring COQ2 and PDSS2 mutations produces divergent alterations of bioenergetics and oxidative stress. Here, to better understand the pathogenesis of CoQ(10) deficiency, we have characterized the effects of varying severities of CoQ(10) deficiency on ROS production and mitochondrial bioenergetics in cells harboring genetic defects of CoQ(10) biosynthesis. Levels of CoQ(10) seem to correlate with ROS production; 10-15% and >60% residual CoQ(10) are not associated with significant ROS production, whereas 30-50% residual CoQ(10) is accompanied by increased ROS production and cell death. Our results confirm that varying degrees of CoQ(10) deficiency cause variable defects of ATP synthesis and oxidative stress. These findings may lead to more rational therapeutic strategies for CoQ(10) deficiency.-Quinzii, C. M., Lopez, L. C., Gilkerson, R. W., Dorado, B., Coku, J., Naini, A. B., Lagier-Tourenne, C., Schuelke, M., Salviati, L., Carrozzo, R., Santorelli, F., Rahman, S., Tazir, M., Koenig, M., DiMauro, S., Hirano, M. Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ(10) deficiency. FASEB J. 24, 3733-3743 (2010). www.fasebj.org	[Quinzii, Catarina M.; Lopez, Luis C.; Gilkerson, Robert W.; Dorado, Beatriz; Coku, Jorida; Naini, Ali B.; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Lagier-Tourenne, Clotilde; Koenig, Michel] Univ Strasbourg, Inst Genet & Mol & Cellular Biol, CNRS, INSERM, Illrirch, France; [Schuelke, Markus] Charite Virchow Univ Hosp, Dept Neuropediat, Berlin, Germany; [Salviati, Leonardo] Univ Padua, Dept Pediat, Serv Genet Clin & Epidemiol, Padua, Italy; [Carrozzo, Rosalba; Santorelli, Filippo] Bambi Gesu Childrens Hosp, Ist Ricovero & Cura Carattere Sci, Rome, Italy; [Rahman, Shamima] UCL, Mitochondrial Res Grp, Clin & Mol Genet Unit, Inst Child Hlth, London, England; [Tazir, Meriem] Ctr Hosp Univ Mustapha, Serv Neurol, Algiers, Algeria	Columbia University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Padua; IRCCS Bambino Gesu; University of London; University College London	Hirano, M (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 630 W 168th St,P&S 4-423, New York, NY 10032 USA.	mh29@columbia.edu	Santorelli, Filippo M/ABE-5124-2020; Rahman, Shamima/C-5232-2008; Salviati, Leonardo/L-1007-2016; lagier-Tourenne, Clotilde/ABE-6303-2020; Lopez, Luis Carlos/L-5129-2014; Rahman, Shamima/M-7904-2019; Carrozzo, Rosalba/A-2808-2014; Lopez, Luis Carlos/AAP-9411-2020	Santorelli, Filippo M/0000-0002-1359-9062; Rahman, Shamima/0000-0003-2088-730X; Salviati, Leonardo/0000-0001-5642-9963; lagier-Tourenne, Clotilde/0000-0002-3058-8322; Lopez, Luis Carlos/0000-0003-3355-0298; Carrozzo, Rosalba/0000-0002-3327-4054; Lopez, Luis Carlos/0000-0003-3355-0298; Dorado, Beatriz/0000-0002-1958-4558; Schuelke, Markus/0000-0003-2824-3891	U.S. National Institutes of Health (NIH) [HD32062]; NIH [NS11786]; Muscular Dystrophy Association; Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF); Ministerio de Educacion y Ciencia, Spain; Telethon [GGP09207]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057543, P01HD032062] Funding Source: NIH RePORTER; Medical Research Council [G0200335] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1220] Funding Source: researchfish; MRC [G0200335] Funding Source: UKRI	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF); Ministerio de Educacion y Ciencia, Spain(Spanish Government); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by U.S. National Institutes of Health (NIH) grant HD32062. M.H. is also supported by grants from the NIH (NS11786), the Muscular Dystrophy Association, and the Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF). C.M.Q. was supported by the Muscular Dystrophy Association. L.C.L. was supported by a postdoctoral fellowship from the Ministerio de Educacion y Ciencia, Spain. L.S. is supported by Telethon grant GGP09207.	Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015; Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Blanchard-Fillion B, 2006, J NEUROSCI, V26, P6124, DOI 10.1523/JNEUROSCI.1038-06.2006; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Geromel V, 2001, FREE RADICAL RES, V35, P11, DOI 10.1080/10715760100300551; Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Krysko DV, 2008, METHOD ENZYMOL, V442, P307, DOI [10.1016/S0070-6879(08)01416-X, 10.1016/S0076-6879(08)01416-X]; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lee MS, 2004, ANN NY ACAD SCI, V1011, P146, DOI 10.1196/annals.1293.015; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Peng M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000061; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Saiki R, 2008, AM J PHYSIOL-RENAL, V295, pF1535, DOI 10.1152/ajprenal.90445.2008; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012	33	112	116	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3733	3743		10.1096/fj.09-152728	http://dx.doi.org/10.1096/fj.09-152728			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20495179	Green Submitted, Green Published			2022-12-25	WOS:000285005900013
J	Cuong, CT; Vohradsky, J				Cuong Chieu To; Vohradsky, Jiri			Measurement variation determines the gene network topology reconstructed from experimental data: a case study of the yeast cyclin network	FASEB JOURNAL			English	Article						numerical modeling; genetic programming	CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; REGULATORY NETWORKS; TRANSCRIPTIONAL RESPONSE; EXPRESSION DATA; MICROARRAY; MODEL; INFERENCE; TARGETS; GENOME	Inference of the topology of gene regulatory networks from experimental data is one of the primary challenges of systems biology. In an example of a genetic network of cyclins in the yeast cell cycle, we analyzed static genome-wide location data together with microarray kinetic measurements using a recurrent neural network-based model of gene expression and a newly developed, unbiased algorithm based on evolutionary programming principles. The modeling and simulation of gene expression dynamics identified cyclin genetic networks that were active during the cell cycle. We document that because there is inherent experimental variation, it is not possible to identify a single genetic network, only a set of equivalent networks with the same probability of occurrence. Analysis of these networks showed that each target gene was controlled by only a few regulators and that the control was robust. These results led to the reformulation of the cyclin genetic network in the yeast cell cycle as previously published. The analysis shows that with the methodologies that are currently available, it is not possible to predict only one genetic network; rather, we must work with the hypothesis of multiple, equivalent networks. Chromatin immunoprecipitation (ChIP)-on-chip experiments are not sufficient to predict the functional networks that are active during an investigated process. Such predictions must be considered as only potential, and their actual realization during particular cellular processes must be identified by incorporating both kinetic and other types of data.-To, C. C., Vohradsky, J. Measurement variation determines the gene network topology reconstructed from experimental data: a case study of the yeast cyclin network. FASEB J. 24, 3468-3478 (2010). www.fasebj.org	[Vohradsky, Jiri] Acad Sci Czech Republ, Inst Microbiol, Lab Bioinformat, CR-14220 Prague, Czech Republic; [Cuong Chieu To] Saigon Inst Technol, Saigon, Vietnam	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Vohradsky, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Bioinformat, Videnska 1083, CR-14220 Prague, Czech Republic.	vohr@biomed.cas.cz			Czech Science Foundation [310/07/1009]; Institutional Research Concept [AV0Z50200510]; EC [LSHM-CT-2004-005224]	Czech Science Foundation(Grant Agency of the Czech Republic); Institutional Research Concept; EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Czech Science Foundation (310/07/1009), the Institutional Research Concept (AV0Z50200510), and the EC Integrated Project Actino-GEN (LSHM-CT-2004-005224).	Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Barenco M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r25; Barenco M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.84; Cantu-Paz E., 2001, EFFICIENT ACCURATE P, P33, DOI [10.1007/978-1-4615-4369-5, DOI 10.1007/978-1-4615-4369-5]; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hart CE, 2006, PLOS COMPUT BIOL, V2, P1592, DOI 10.1371/journal.pcbi.0020169; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hollenhorst PC, 2001, GENE DEV, V15, P2445, DOI 10.1101/gad.906201; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Khanin R, 2006, P NATL ACAD SCI USA, V103, P18592, DOI 10.1073/pnas.0603390103; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Li H, 2008, BIOINFORMATICS, V24, P1874, DOI 10.1093/bioinformatics/btn332; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Sabatti C, 2006, BIOINFORMATICS, V22, P739, DOI 10.1093/bioinformatics/btk017; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; van Someren E P, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P355; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Vohradsky J, 2001, FASEB J, V15, P846, DOI 10.1096/fj.00-0361com; Vohradsky J, 2001, J BIOL CHEM, V276, P36168, DOI 10.1074/jbc.M104391200; Vu TT, 2007, NUCLEIC ACIDS RES, V35, P279, DOI 10.1093/nar/gkl1001; Vu TT, 2009, GENOMICS, V93, P426, DOI 10.1016/j.ygeno.2009.01.006; Wang RS, 2007, MOL CELLS, V24, P307; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396	31	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3468	3478		10.1096/fj.10-160515	http://dx.doi.org/10.1096/fj.10-160515			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20511392				2022-12-25	WOS:000281446400034
J	Ouertatani-Sakouhi, H; El-Turk, F; Fauvet, B; Cho, MK; Karpinar, DP; Le Roy, D; Dewor, M; Roger, T; Bernhagen, J; Calandra, T; Zweckstetter, M; Lashuel, HA				Ouertatani-Sakouhi, Hajer; El-Turk, Farah; Fauvet, Bruno; Cho, Min-Kyu; Karpinar, Damla Pinar; Le Roy, Didier; Dewor, Manfred; Roger, Thierry; Bernhagen, Juergen; Calandra, Thierry; Zweckstetter, Markus; Lashuel, Hilal A.			Identification and Characterization of Novel Classes of Macrophage Migration Inhibitory Factor (MIF) Inhibitors with Distinct Mechanisms of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAUTOMERASE INHIBITORS; RHEUMATOID-ARTHRITIS; ENZYMATIC-ACTIVITY; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; POTENTIAL ROLE; IN-VITRO; EBSELEN; GLUTATHIONE; SITE	Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine, is considered an attractive therapeutic target in multiple inflammatory and autoimmune disorders. In addition to its known biologic activities, MIF can also function as a tautomerase. Several small molecules have been reported to be effective inhibitors of MIF tautomerase activity in vitro. Herein we employed a robust activity-based assay to identify different classes of novel inhibitors of the catalytic and biological activities of MIF. Several novel chemical classes of inhibitors of the catalytic activity of MIF with IC50 values in the range of 0.2-15.5 mu M were identified and validated. The interaction site and mechanism of action of these inhibitors were defined using structure-activity studies and a battery of biochemical and biophysical methods. MIF inhibitors emerging from these studies could be divided into three categories based on their mechanism of action: 1) molecules that covalently modify the catalytic site at the N-terminal proline residue, Pro(1); 2) a novel class of catalytic site inhibitors; and finally 3) molecules that disrupt the trimeric structure of MIF. Importantly, all inhibitors demonstrated total inhibition of MIF-mediated glucocorticoid overriding and AKT phosphorylation, whereas ebselen, a trimer-disrupting inhibitor, additionally acted as a potent hyperagonist in MIF-mediated chemotactic migration. The identification of biologically active compounds with known toxicity, pharmacokinetic properties, and biological activities in vivo should accelerate the development of clinically relevant MIF inhibitors. Furthermore, the diversity of chemical structures and mechanisms of action of our inhibitors makes them ideal mechanistic probes for elucidating the structure-function relationships of MIF and to further determine the role of the oligomerization state and catalytic activity of MIF in regulating the function(s) of MIF in health and disease.	[Ouertatani-Sakouhi, Hajer; El-Turk, Farah; Fauvet, Bruno; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Funct Neuroprote, CH-1015 Lausanne, Switzerland; [Cho, Min-Kyu; Karpinar, Damla Pinar; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Le Roy, Didier; Roger, Thierry; Calandra, Thierry] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Le Roy, Didier; Roger, Thierry; Calandra, Thierry] CHU Vaudois, Dept Med, Infect Dis Serv, CH-1011 Lausanne, Switzerland; [Dewor, Manfred; Bernhagen, Juergen] Tech Hsch RWTH Univ Aachen, Dept Biochem & Mol Cell Biol, Inst Biochem & Mol Biol, D-52074 Aachen, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); RWTH Aachen University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Funct Neuroprote, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Roger, Thierry/G-2007-2012; Cho, Min-Kyu/H-1303-2011; Calandra, Thierry/D-9017-2015	Roger, Thierry/0000-0002-9358-0109; Cho, Min-Kyu/0000-0003-0537-2340; Calandra, Thierry/0000-0003-3051-1285; Zweckstetter, Markus/0000-0002-2536-6581; LE ROY, Didier/0000-0001-8954-5442	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation [310000-110027, 3100-118266]; German Research Council (DFG) [Be1977/4-1, SFB542-A7]	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Swiss Federal Institute of Technology Lausanne (to H. A. L., F. E., and H. O.-S.), Swiss National Science Foundation Grants 310000-110027(to H. A. L.) and 3100-118266 (to T. C.), and German Research Council (DFG) Grants Be1977/4-1 and SFB542-A7 (to J.B.).	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Balachandran S, 2009, BIOORG MED CHEM LETT, V19, P4773, DOI 10.1016/j.bmcl.2009.06.052; Beishuizen A, 2001, J CLIN ENDOCR METAB, V86, P2811, DOI 10.1210/jc.86.6.2811; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Brown SDM, 2002, MAMM GENOME, V13, P1, DOI 10.1007/s00335-001-0015-8; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; CHOOK YM, 1994, J MOL BIOL, V240, P476, DOI 10.1006/jmbi.1994.1462; COTGREAVE IA, 1989, BIOCHEM PHARMACOL, V38, P649, DOI 10.1016/0006-2952(89)90211-6; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; Crichlow GV, 2009, BIOCHEMISTRY-US, V48, P132, DOI 10.1021/bi8014423; Dabideen DR, 2007, J MED CHEM, V50, P1993, DOI 10.1021/jm061477+; Dagia NM, 2009, EUR J PHARMACOL, V607, P201, DOI 10.1016/j.ejphar.2009.02.031; Daiber A, 2000, BIOCHEM PHARMACOL, V59, P153, DOI 10.1016/S0006-2952(99)00309-3; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhanasekaran M, 2006, BRAIN RES, V1118, P251, DOI 10.1016/j.brainres.2006.08.020; DIMMELER S, 1991, BIOCHEM PHARMACOL, V42, P1151, DOI 10.1016/0006-2952(91)90303-M; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; El-Turk F, 2008, BIOCHEMISTRY-US, V47, P10740, DOI 10.1021/bi800603x; ELTURK F, 2010, BIOCHEMISTR IN PRESS; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Garai J, 2009, CURR MED CHEM, V16, P1091, DOI 10.2174/092986709787581842; HURT S, 2010, OPTIMIZATION ALPHASC; Jacob C, 1998, BIOCHEM BIOPH RES CO, V248, P569, DOI 10.1006/bbrc.1998.9026; Kleemann R, 1998, FEBS LETT, V430, P191, DOI 10.1016/S0014-5793(98)00654-1; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; Liu M, 2010, BIOCHEMISTRY-US, V49, P2008, DOI 10.1021/bi901851y; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Moussaoui S, 2000, EXP NEUROL, V166, P235, DOI 10.1006/exnr.2000.7516; NIKAWA T, 1994, BIOCHEM PHARMACOL, V47, P1007, DOI 10.1016/0006-2952(94)90411-1; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; Orita M, 2002, CURR PHARM DESIGN, V8, P1297, DOI 10.2174/1381612023394674; Orita M, 2001, J MED CHEM, V44, P540, DOI 10.1021/jm000386o; Ouertatani-Sakouhi H, 2009, BIOCHEMISTRY-US, V48, P9858, DOI 10.1021/bi900957e; Philo JS, 2004, BIOPHYS CHEM, V108, P77, DOI 10.1016/j.bpc.2003.10.010; Porciuncula LO, 2001, NEUROSCI LETT, V299, P217, DOI 10.1016/S0304-3940(01)01519-1; Rendon BE, 2009, EXP MOL PATHOL, V86, P180, DOI 10.1016/j.yexmp.2009.01.001; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Saito I, 1998, NEUROSURGERY, V42, P269, DOI 10.1097/00006123-199802000-00038; Sakurai T, 2006, CHEM RES TOXICOL, V19, P1196, DOI 10.1021/tx0601105; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; SIMONS D, 2010, J CELL MOL IN PRESS; Solano F, 1999, NEUROTOX RES, V1, P153, DOI 10.1007/BF03033287; Stivers JT, 1996, BIOCHEMISTRY-US, V35, P814, DOI 10.1021/bi9510789; Subramanya HS, 1996, BIOCHEMISTRY-US, V35, P792, DOI 10.1021/bi951732k; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Swope MD, 1998, J BIOL CHEM, V273, P14877, DOI 10.1074/jbc.273.24.14877; Terentis AC, 2010, BIOCHEMISTRY-US, V49, P591, DOI 10.1021/bi901546e; WANG JF, 1992, HEPATOLOGY, V15, P1112, DOI 10.1002/hep.1840150623; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; WENDEL A, 1984, BIOCHEM PHARMACOL, V33, P3241, DOI 10.1016/0006-2952(84)90084-4; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Ying J, 2007, ARTERIOSCL THROM VAS, V27, P783, DOI 10.1161/01.ATV.0000258413.72747.23; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZHANG M, 1995, FEBS LETT, V373, P203, DOI 10.1016/0014-5793(95)01041-C; Zhang XN, 1999, BIOORG MED CHEM LETT, V9, P3193	83	69	71	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26581	26598		10.1074/jbc.M110.113951	http://dx.doi.org/10.1074/jbc.M110.113951			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20516071	Green Published, hybrid			2022-12-25	WOS:000280921000074
J	Asari, A; Kanemitsu, T; Kurihara, H				Asari, Akira; Kanemitsu, Tomoyuki; Kurihara, Hitoshi			Oral Administration of High Molecular Weight Hyaluronan (900 kDa) Controls Immune System via Toll-like Receptor 4 in the Intestinal Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; CELL-DEATH; EXPRESSION; INFLAMMATION; MICE; LIPOPOLYSACCHARIDE; ARTHRITIS; OLIGOSACCHARIDES; INTERLEUKIN-10; RESPONSIVENESS	Low molecular weight hyaluronan enhances or induces inflammation through toll-like receptor 4 (TLR-4). However, the effects of high molecular weight hyaluronan (HA900) on TLR-4 are unknown. In this study, HA900 (900 kDa) was administered orally to MRL-lpr/lpr mice, a Th-1-type autoimmune disease model. Lymphoaccumulation of double-negative T cells, which is enhanced by proinflammatory cytokines, was suppressed by HA900 treatment. Cytokine array analysis showed that HA900 treatment enhanced production of interleukin-10, an anti-inflammatory cytokine, and down-regulated chemokine production. HA900 colocalized with TLR-4 on the luminal surface of epithelial cells in the large intestine. These cells are parts of the immune system and express cytokines. DNA array analysis of the tissue from the large intestine showed that HA900 treatment up-regulated suppressor of cytokine signaling 3 (SOCS3) expression and down-regulated pleiotrophin expression. Treatment of cultured double-negative T cells from MRL-lpr/lpr mice with pleiotrophin rescued these cells. SOCS3, which is known to suppress inflammation, was enhanced by HA900 treatment. In TLR-4 knockdown HT29 cells (a cell line derived from large intestinal cells), HA900 did not bind to HT29 cells and did not up-regulate SOCS3 expression. Our results suggest that oral administration of HA900 modulates Th-1-type autoimmune disease and inflammation by up-regulating SOCS3 expression and down-regulating pleiotrophin expression via TLR-4 in intestinal epithelial cells.	[Asari, Akira] Hyaluronan Res Inst Inc, Musashino, Tokyo 1800003, Japan; [Asari, Akira] Tokyo Med & Dent Univ, Dept Hard Tissue Engn, Div Biochem, Bunkyo Ku, Tokyo 1138459, Japan; [Kanemitsu, Tomoyuki; Kurihara, Hitoshi] QP Corp, Fuchu, Tokyo 1830034, Japan	Tokyo Medical & Dental University (TMDU)	Asari, A (corresponding author), Hyaluronan Res Inst Inc, 4-5-9 Kichijojiminami Cho, Musashino, Tokyo 1800003, Japan.	a.asari@hyaluronan.co.jp	Asari, Akira/AAU-9212-2021					Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Bocker U, 2003, INT J COLORECTAL DIS, V18, P25, DOI 10.1007/s00384-002-0415-6; Bonder CS, 2005, AM J PATHOL, V167, P1647, DOI 10.1016/S0002-9440(10)61248-5; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Ceponis A, 1998, J RHEUMATOL, V25, P2304; Clavel G, 2007, CLIN IMMUNOL, V124, P158, DOI 10.1016/j.clim.2007.04.014; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Kikawada E, 2003, J IMMUNOL, V170, P3915, DOI 10.4049/jimmunol.170.7.3915; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Liu X, 1998, GLIA, V24, P390, DOI 10.1002/(SICI)1098-1136(199812)24:4<390::AID-GLIA4>3.0.CO;2-1; Maldonado MA, 1999, J IMMUNOL, V162, P6322; Mihaescu A, 2007, DIS COLON RECTUM, V50, P2194, DOI 10.1007/s10350-007-9065-7; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; Petit-Bertron AF, 2003, J LEUKOCYTE BIOL, V73, P145, DOI 10.1189/jlb.0802388; Pufe T, 2003, ARTHRITIS RHEUM, V48, P660, DOI 10.1002/art.10839; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; SCHUERERMALY CC, 1994, IMMUNOLOGY, V81, P85; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Szczepanik AM, 2003, J ALZHEIMERS DIS, V5, P105, DOI 10.3233/JAD-2003-5205; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; VANHOUTEN N, 1992, J IMMUNOL, V149, P2513; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Xu HP, 2005, J BIOL CHEM, V280, P20879, DOI 10.1074/jbc.M411954200; Xu HP, 2001, J AUTOIMMUN, V16, P87, DOI 10.1006/jaut.2000.0468; Xu HP, 2002, J BIOL CHEM, V277, P17308, DOI 10.1074/jbc.M112371200	30	60	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24751	24758		10.1074/jbc.M110.104950	http://dx.doi.org/10.1074/jbc.M110.104950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20504769	hybrid, Green Published			2022-12-25	WOS:000280542100047
J	Huskens, D; Ferir, G; Vermeire, K; Kehr, JC; Balzarini, J; Dittmann, E; Schols, D				Huskens, Dana; Ferir, Geoffrey; Vermeire, Kurt; Kehr, Jan-Christoph; Balzarini, Jan; Dittmann, Elke; Schols, Dominique			Microvirin, a Novel alpha(1,2)-Mannose-specific Lectin Isolated from Microcystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN GP120; CD4 BINDING-SITE; INACTIVATING PROTEIN; GLYCOSYLATION SITES; PRADIMICIN-S; HIV; POTENT; MICROBICIDE; RESISTANCE	Microvirin (MVN), a recently isolated lectin from the cyanobacterium Microcystis aeruginosa PCC7806, shares 33% identity with the potent anti-human immunodeficiency virus (HIV) protein cyanovirin-N (CV-N) isolated from Nostoc ellipsosporum, and both lectins bind to similar carbohydrate structures. MVN is able to inhibit infection by a wide variety of HIV-1 laboratory-adapted strains and clinical isolates of different tropisms and subtypes in peripheral blood mononuclear cells. MVN also inhibits syncytium formation between persistently HIV-1-infected T cells and uninfected CD4(+) T cells and inhibits DC-SIGN-mediated HIV-1 binding and transmission to CD4(+) T cells. Long term passaging of HIV-1 exposed to dose-escalating concentrations of MVN resulted in the selection of a mutant virus with four deleted high mannose-type glycans in the envelope gp120. The MVN-resistant virus was still highly sensitive to various other carbohydrate binding lectins (e.g. CV-N, HHA, GNA, and UDA) but not anymore to the carbohydrate-specific 2G12 monoclonal antibody. Importantly, MVN is more than 50-fold less cytotoxic than CV-N. Also in sharp contrast to CV-N, MVN did not increase the level of the activation markers CD25, CD69, and HLA-DR in CD4(+) T lymphocytes, and subsequently, MVN did not enhance viral replication in pretreated peripheral blood mononuclear cells. Therefore, MVN may qualify as a useful lectin for potential microbicidal use based on its broad and potent antiviral activity and virtual lack of any stimulatory properties and cellular toxicity.	[Huskens, Dana; Ferir, Geoffrey; Vermeire, Kurt; Balzarini, Jan; Schols, Dominique] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Kehr, Jan-Christoph; Dittmann, Elke] Humboldt Univ, Dept Mol Ecol, Inst Biol, D-10115 Berlin, Germany	KU Leuven; Humboldt University of Berlin	Schols, D (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	Dominique.Schols@rega.kuleuven.be	Dittmann, Elke/B-4742-2018; Vermeire, Kurt/P-9992-2017; Schols, Dominique/AAC-1309-2021; Schols, Dominique/S-9057-2017	Dittmann, Elke/0000-0002-7549-7918; Vermeire, Kurt/0000-0003-1123-1907; Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850	K.U. Leuven [GOA 10/014]; Center of Excellence [EF/05/15]; Foundation of Scientific Research [FWO G-485-08]; European Commission	K.U. Leuven(KU Leuven); Center of Excellence; Foundation of Scientific Research; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Foundation Dormeur, Concerted Actions of the K.U. Leuven Grant GOA 10/014, Center of Excellence Grant EF/05/15, Foundation of Scientific Research Grant FWO G-485-08, and the CHAARM project of the European Commission.	Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; Balzarini J, 2006, J VIROL, V80, P8411, DOI 10.1128/JVI.00369-06; Balzarini J, 2010, ANTIMICROB AGENTS CH, V54, P1425, DOI 10.1128/AAC.01347-09; Bewley CA, 2002, J MOL BIOL, V322, P881, DOI 10.1016/S0022-2836(02)00842-2; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Bolmstedt AJ, 2001, MOL PHARMACOL, V59, P949, DOI 10.1124/mol.59.5.949; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; Gavrovic-Jankulovic M, 2008, INT J BIOCHEM CELL B, V40, P929, DOI 10.1016/j.biocel.2007.10.033; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Huskens D, 2007, VIROLOGY, V360, P294, DOI 10.1016/j.virol.2006.10.027; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; Jenabian MA, 2009, J ANTIMICROB CHEMOTH, V64, P1192, DOI 10.1093/jac/dkp380; *JOINT UN PROGR HI, 2008, REP GLOB AIDS EP; Kehr JC, 2006, MOL MICROBIOL, V59, P893, DOI 10.1111/j.1365-2958.2005.05001.x; KOSHTE VL, 1990, BIOCHEM J, V272, P721, DOI 10.1042/bj2720721; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matei E, 2010, J BIOL CHEM, V285, P13057, DOI 10.1074/jbc.M109.094938; Mori T, 1997, BIOCHEM BIOPH RES CO, V238, P218, DOI 10.1006/bbrc.1997.7202; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; SAITOH K, 1993, J ANTIBIOT, V46, P580, DOI 10.7164/antibiotics.46.580; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Shenoy SR, 2001, J PHARMACOL EXP THER, V297, P704; Swanson MD, 2010, J BIOL CHEM, V285, P8646, DOI 10.1074/jbc.M109.034926; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003; Vermeire K, 2004, AIDS, V18, P2115, DOI 10.1097/00002030-200411050-00003; West AP, 2009, J VIROL, V83, P98, DOI 10.1128/JVI.01564-08; Witvrouw M, 2005, J VIROL, V79, P7777, DOI 10.1128/JVI.79.12.7777-7784.2005; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	44	91	95	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24845	24854		10.1074/jbc.M110.128546	http://dx.doi.org/10.1074/jbc.M110.128546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507987	Green Published, hybrid			2022-12-25	WOS:000280542100057
J	Fujii, S; Sawa, T; Ihara, H; Tong, KI; Ida, T; Okamoto, T; Ahtesham, AK; Ishima, Y; Motohashi, H; Yamamoto, M; Akaike, T				Fujii, Shigemoto; Sawa, Tomohiro; Ihara, Hideshi; Tong, Kit I.; Ida, Tomoaki; Okamoto, Tatsuya; Ahtesham, Ahmed Khandaker; Ishima, Yu; Motohashi, Hozumi; Yamamoto, Masayuki; Akaike, Takaaki			The Critical Role of Nitric Oxide Signaling, via Protein S-Guanylation and Nitrated Cyclic GMP, in the Antioxidant Adaptive Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-RESPONSE; KEAP1 PROTEIN; DLG MOTIFS; INDUCTION; 8-NITROGUANOSINE; OXIDANTS; GROWTH; NRF2; LOCALIZATION; ACCUMULATION	A nitrated guanine nucleotide, 8-nitroguanosine 3',5'-cyclic monophosphate (8-nitro-cGMP), is formed via nitric oxide (NO) and causes protein S-guanylation. However, intracellular 8-nitro-cGMP levels and mechanisms of formation of 8-nitroc-GMP and S-guanylation are yet to be identified. In this study, we precisely quantified NO-dependent formation of 8-nitroc-GMP in C6 glioma cells via liquid chromatography-tandem mass spectrometry. Treatment of cells with S-nitroso-N-acetylpenicillamine led to a rapid, transient increase in cGMP, after which 8-nitro-cGMP increased linearly up to a peak value comparable with that of cGMP at 24 h and declined thereafter. Markedly high levels (>40 mu M) of 8-nitro-cGMP were also evident in C6 cells that had been stimulated to express inducible NO synthase with excessive NO production. The amount of 8-nitro-cGMP generated was comparable with or much higher than that of cGMP, whose production profile slightly preceded 8-nitro-cGMP formation in the activated inducible NO synthase-expressing cells. These unexpectedly large amounts of 8-nitro-cGMP suggest that GTP ( a substrate of cGMP biosynthesis), rather than cGMP per se, may undergo guanine nitration. Also, 8-nitro-cGMP caused S-guanylation of KEAP1 in cells, which led to Nrf2 activation and subsequent induction of antioxidant enzymes, including heme oxygenase-1; thus, 8-nitro-cGMP protected cells against cytotoxic effects of hydrogen peroxide. Proteomic analysis for endogenously modified KEAP1 with matrix-assisted laser desorption/ionization time-of-flight-tandem mass spectrometry revealed that 8-nitro-cGMP S-guanylated the Cys434 of KEAP1. The present report is therefore the first substantial corroboration of the biological significance of cellular 8-nitro-cGMP formation and potential roles of 8-nitro-cGMP in the Nrf2-dependent antioxidant response.	[Fujii, Shigemoto; Sawa, Tomohiro; Okamoto, Tatsuya; Ahtesham, Ahmed Khandaker; Ishima, Yu; Akaike, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Ihara, Hideshi; Ida, Tomoaki] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan; [Tong, Kit I.; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan; [Motohashi, Hozumi] Tohoku Univ, Grad Sch Med, Ctr Radioisotope Sci, Sendai, Miyagi 9808575, Japan	Kumamoto University; Osaka Metropolitan University; Tohoku University; Tohoku University	Akaike, T (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	takakaik@gpo.kumamoto-u.ac.jp	Motohashi, Hozumi/AAZ-2628-2020; Yamamoto, Masayuki/A-4873-2010; Ahmed, Khandaker Ahtesham/A-5326-2015	Yamamoto, Masayuki/0000-0002-9073-9436; Ahmed, Khandaker Ahtesham/0000-0003-3999-907X	Ministry of Education, Sciences, Sports and Technology (MEXT); Ministry of Health, Labor and Welfare of Japan; Tohoku University Global Centers of Excellence	Ministry of Education, Sciences, Sports and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Tohoku University Global Centers of Excellence	This work was supported in part by grants-in-aid for scientific research and grants-in-aid for scientific research on Innovative Areas (research in a proposed area) from the Ministry of Education, Sciences, Sports and Technology (MEXT) and the Targeted Protein Research Program promoted by MEXT. This work was also supported by grants from the Ministry of Health, Labor and Welfare of Japan and Tohoku University Global Centers of Excellence program for the Conquest of Diseases with Network Medicine.	Akaike T, 2003, P NATL ACAD SCI USA, V100, P685, DOI 10.1073/pnas.0235623100; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Buckley BJ, 2008, FREE RADICAL BIO MED, V44, P692, DOI 10.1016/j.freeradbiomed.2007.10.055; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Doi K, 1999, BRIT J CANCER, V80, P1945, DOI 10.1038/sj.bjc.6690624; Eggler AL, 2007, CHEM RES TOXICOL, V20, P1878, DOI 10.1021/tx700217c; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Holland R, 2008, CHEM RES TOXICOL, V21, P2051, DOI 10.1021/tx800226m; Hur J, 2010, BIOCHEM BIOPH RES CO, V391, P1526, DOI 10.1016/j.bbrc.2009.12.114; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kirkland RA, 2007, J NEUROSCI, V27, P11315, DOI 10.1523/JNEUROSCI.3590-07.2007; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Koppenol WH, 1996, METHOD ENZYMOL, V269, P296; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Saito Y, 2008, CHEM COMMUN, P5984, DOI 10.1039/b810771h; Sawa T, 2003, BIOCHEM BIOPH RES CO, V311, P300, DOI 10.1016/j.bbrc.2003.10.003; SAWA T, 2010, BIOCONJUG C IN PRESS; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Tanaka S, 2003, BRIT J CANCER, V88, P902, DOI 10.1038/sj.bjc.6600830; Terasaki Y, 2006, AM J RESP CRIT CARE, V174, P665, DOI 10.1164/rccm.200510-1580OC; Tomita T, 1997, J BIOCHEM-TOKYO, V122, P531; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Xu ZL, 2004, AM J PHYSIOL-HEART C, V286, pH1433, DOI 10.1152/ajpheart.00882.2003; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yoshitake J, 2004, J VIROL, V78, P8709, DOI 10.1128/JVI.78.16.8709-8719.2004; Zaki MH, 2009, J IMMUNOL, V182, P3746, DOI 10.4049/jimmunol.0803363	41	116	121	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23970	23984		10.1074/jbc.M110.145441	http://dx.doi.org/10.1074/jbc.M110.145441			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498371	Green Published, hybrid			2022-12-25	WOS:000280291400048
J	Mojzita, D; Penttila, M; Richard, P				Mojzita, Dominik; Penttila, Merja; Richard, Peter			Identification of an L-Arabinose Reductase Gene in Aspergillus niger and Its Role in L-Arabinose Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-XYLOSE REDUCTASE; HYPOCREA-JECORINA; EXPRESSION; METABOLISM; PATHWAY; PENTOSE; XYLAN; XLNR	The first enzyme in the pathway for L-arabinose catabolism in eukaryotic microorganisms is a reductase, reducing L-arabinose to L-arabitol. The enzymes catalyzing this reduction are in general nonspecific and would also reduce D-xylose to xylitol, the first step in eukaryotic D-xylose catabolism. It is not clear whether microorganisms use different enzymes depending on the carbon source. Here we show that Aspergillus niger makes use of two different enzymes. We identified, cloned, and characterized an L-arabinose reductase, larA, that is different from the D-xylose reductase, xyrA. The larA is up-regulated on L-arabinose, while the xyrA is up-regulated on D-xylose. There is however an initial up-regulation of larA also on D-xylose but that fades away after about 4 h. The deletion of the larA gene in A. niger results in a slow growth phenotype on Larabinose, whereas the growth on D-xylose is unaffected. The L-arabinose reductase can convert L-arabinose and D-xylose to their corresponding sugar alcohols but has a higher affinity for L-arabinose. The K-m for L-arabinose is 54 +/- 6 mM and for D-xylose 155 +/- 15 mM.	[Mojzita, Dominik; Penttila, Merja; Richard, Peter] VTT Tech Res Ctr Finland, Espoo 02044, VTT, Finland	VTT Technical Research Center Finland	Richard, P (corresponding author), VTT Tech Res Ctr Finland, Tietotie 2,POB 1500, Espoo 02044, VTT, Finland.	Peter.Richard@vtt.fi	Richard, Peter/A-4229-2009; Penttilä, Merja E/A-4710-2013	Richard, Peter/0000-0003-0922-6092; Penttila, Merja/0000-0002-6929-1032; Mojzita, Dominik/0000-0001-6078-4503	Academy of Finland through the Finnish Centre of Excellence in White Biotechnology, Green Chemistry; Academy Research Fellowship	Academy of Finland through the Finnish Centre of Excellence in White Biotechnology, Green Chemistry(Academy of Finland); Academy Research Fellowship(Academy of Finland)	This work was supported by the Academy of Finland through the Finnish Centre of Excellence in White Biotechnology, Green Chemistry, and an Academy Research Fellowship (to P. R.).	Akel E, 2009, EUKARYOT CELL, V8, P1837, DOI 10.1128/EC.00162-09; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; de Groot MJL, 2007, FOOD TECHNOL BIOTECH, V45, P134; de Groot MJL, 2005, BIOTECHNOL PROGR, V21, P1610, DOI 10.1021/bp050189o; de Groot MJL, 2003, MICROBIOL-SGM, V149, P1183, DOI 10.1099/mic.0.25993-0; DEVRIES RP, 1994, FEMS MICROBIOL LETT, V123, P83, DOI 10.1016/0378-1097(94)90278-X; Hasper AA, 2000, MOL MICROBIOL, V36, P193, DOI 10.1046/j.1365-2958.2000.01843.x; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; Mojzita D, 2010, APPL ENVIRON MICROB, V76, P169, DOI 10.1128/AEM.02273-09; Noguchi Y, 2009, APPL MICROBIOL BIOT, V85, P141, DOI 10.1007/s00253-009-2236-9; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; Seiboth B, 2003, EUKARYOT CELL, V2, P867, DOI 10.1128/EC.2.5.867-875.2003; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; Sherman F., 1983, METHODS YEAST GENETI; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; vanKuyk PA, 2001, EUR J BIOCHEM, V268, P5414, DOI 10.1046/j.0014-2956.2001.02482.x; WITTEVEEN CFB, 1989, J GEN MICROBIOL, V135, P2163; WITTEVEEN CFB, 1994, MICROBIOL-SGM, V140, P1679, DOI 10.1099/13500872-140-7-1679	19	34	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23622	23628		10.1074/jbc.M110.113399	http://dx.doi.org/10.1074/jbc.M110.113399			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511228	Green Published, hybrid			2022-12-25	WOS:000280291400012
J	Sakr, S; Cirinesi, AM; Ullers, RS; Schwager, F; Georgopoulos, C; Genevaux, P				Sakr, Samer; Cirinesi, Anne-Marie; Ullers, Ronald S.; Schwager, Francoise; Georgopoulos, Costa; Genevaux, Pierre			Lon Protease Quality Control of Presecretory Proteins in Escherichia coli and Its Dependence on the SecB and DnaJ (Hsp40) Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; NEWLY SYNTHESIZED PROTEINS; TRIGGER FACTOR; MOLECULAR CHAPERONES; ATPASE ACTIVITY; SUBSTRATE-SPECIFICITY; PLASMA-MEMBRANE; NASCENT CHAINS; J-DOMAIN; EXPORT	Various environmental insults result in irreversible damage to proteins and protein complexes. To cope, cells have evolved dedicated protein quality control mechanisms involving molecular chaperones and proteases. Here, we provide both genetic and biochemical evidence that the Lon protease and the SecB and DnaJ/Hsp40 chaperones are involved in the quality control of presecretory proteins in Escherichia coli. We showed that mutations in the lon gene alleviate the cold-sensitive phenotype of a secB mutant. Such suppression was not observed with either clpP or clpQ protease mutants. In comparison to the respective single mutants, the double secB lon mutant strongly accumulates aggregates of SecB substrates at physiological temperatures, suggesting that the chaperone and the protease share substrates. These observations were extended in vitro by showing that the main substrates identified in secB lon aggregates, namely proOmpF and proOmpC, are highly sensitive to specific degradation by Lon. In contrast, both substrates are significantly protected from Lon degradation by SecB. Interestingly, the chaperone DnaJ by itself protects substrates better from Lon degradation than SecB or the complete DnaK/DnaJ/GrpE chaperone machinery. In agreement with this finding, a DnaJ mutant protein that does not functionally interact in vivo with DnaK efficiently suppresses the SecB cold-sensitive phenotype, highlighting the role of DnaJ in assisting presecretory proteins. Taken together, our data suggest that when the Sec secretion pathway is compromised, a pool of presecretory proteins is transiently maintained in a translocation-competent state and, thus, protected from Lon degradation by either the SecB or DnaJ chaperones.	[Sakr, Samer; Cirinesi, Anne-Marie; Genevaux, Pierre] CNRS, LMGM, F-31062 Toulouse 9, France; [Sakr, Samer; Cirinesi, Anne-Marie; Genevaux, Pierre] Univ Toulouse 3, F-31062 Toulouse 9, France; [Ullers, Ronald S.; Schwager, Francoise; Georgopoulos, Costa] Ctr Med Univ Geneva, Dept Microbiol & Med Mol, CH-1211 Geneva, Switzerland; [Georgopoulos, Costa] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Geneva; Utah System of Higher Education; University of Utah	Genevaux, P (corresponding author), CNRS, LMGM, 118 Route Narbonne, F-31062 Toulouse 9, France.	genevaux@ibcg.biotoul.fr	Genevaux, Pierre/A-4851-2015	GENEVAUX, Pierre/0000-0001-7539-3126	CNRS; Fond National Swiss [FN-3100A0-114063]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fond National Swiss	This work was supported by a CNRS ATIP grant (to P. G.) and by Fond National Swiss Grant FN-3100A0-114063 (to C. G. and P. G.).	ALTMAN E, 1991, EMBO J, V10, P239, DOI 10.1002/j.1460-2075.1991.tb07943.x; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Bernstein KD, 2001, J BACTERIOL, V183, P2187, DOI 10.1128/JB.183.7.2187-2197.2001; Bochkareva E, 1996, J BIOL CHEM, V271, P22256, DOI 10.1074/jbc.271.36.22256; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; CHUNG CH, 1981, P NATL ACAD SCI-BIOL, V78, P4931, DOI 10.1073/pnas.78.8.4931; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Diamond DL, 1997, J BIOL CHEM, V272, P28994, DOI 10.1074/jbc.272.46.28994; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Gouridis G, 2009, NATURE, V462, P363, DOI 10.1038/nature08559; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HOWARDFLANDERS P, 1964, GENETICS, V49, P237; Jong WSP, 2004, EUR J BIOCHEM, V271, P4779, DOI 10.1111/j.1432-1033.2004.04442.x; Jubete Y, 1996, J BIOL CHEM, V271, P30798, DOI 10.1074/jbc.271.48.30798; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; KUMAMOTO CA, 1983, J BACTERIOL, V154, P253, DOI 10.1128/JB.154.1.253-260.1983; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Lilly AA, 2009, PROTEIN SCI, V18, P1860, DOI 10.1002/pro.197; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Miller J.H., 1992, SHORT COURSE BACTERI, P150; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; PAINBENI E, 1993, J MOL BIOL, V234, P1021, DOI 10.1006/jmbi.1993.1656; Qi HY, 2002, J BIOL CHEM, V277, P51077, DOI 10.1074/jbc.M209238200; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; RIGGS PD, 1988, GENETICS, V118, P571; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rotanova TV, 2006, PROTEIN SCI, V15, P1815, DOI 10.1110/ps.052069306; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Siegenthaler RK, 2006, J BIOL CHEM, V281, P34448, DOI 10.1074/jbc.M606382200; SNYDER WB, 1992, J BACTERIOL, V174, P5661, DOI 10.1128/JB.174.17.5661-5668.1992; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; van der Sluis EO, 2006, TRENDS MICROBIOL, V14, P105, DOI 10.1016/j.tim.2006.01.009; van Melderen L, 1999, P NATL ACAD SCI USA, V96, P6064, DOI 10.1073/pnas.96.11.6064; WALL D, 1994, J BIOL CHEM, V269, P5446; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; WEI SQ, 1994, J BIOL CHEM, V269, P1648; WILD J, 1992, GENE DEV, V6, P1165, DOI 10.1101/gad.6.7.1165; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437	78	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23504	23512		10.1074/jbc.M110.133058	http://dx.doi.org/10.1074/jbc.M110.133058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504766	Green Published, hybrid			2022-12-25	WOS:000279999900082
J	Castellino, RC; Barwick, BG; Schniederjan, M; Buss, MC; Becher, O; Hambardzumyan, D; MacDonald, TJ; Brat, DJ; Durden, DL				Castellino, Robert C.; Barwick, Benjamin G.; Schniederjan, Matthew; Buss, Meghan C.; Becher, Oren; Hambardzumyan, Dolores; MacDonald, Tobey J.; Brat, Daniel J.; Durden, Donald L.			Heterozygosity for Pten Promotes Tumorigenesis in a Mouse Model of Medulloblastoma	PLOS ONE			English	Article							BRAIN-TUMORS; SONIC HEDGEHOG; GROWTH-FACTOR; MICROVESSEL DENSITY; EXPRESSION; MICE; ANGIOGENESIS; CHILDHOOD; PATHWAY; CELLS	Background: Recent publications have described an important role for cross talk between PI-3 kinase and sonic hedgehog signaling pathways in the pathogenesis of medulloblastoma. Methodology/Principal Findings: We crossed mice with constitutive activation of Smoothened, SmoA1, with Pten deficient mice. Both constitutive and conditional Pten deficiency doubled the incidence of mice with symptoms of medulloblastoma and resulted in decreased survival. Analysis revealed a clear separation of gene signatures, with up-regulation of genes in the PI-3 kinase signaling pathway, including downstream activation of angiogenesis in SmoA1+/-; Pten +/- medulloblastomas. Western blotting and immunohistochemistry confirmed reduced or absent Pten, Akt activation, and increased angiogenesis in Pten deficient tumors. Down-regulated genes included genes in the sonic hedgehog pathway and tumor suppressor genes. SmoA1+/-; Pten +/+ medulloblastomas appeared classic in histology with increased proliferation and diffuse staining for apoptosis. In contrast, Pten deficient tumors exhibited extensive nodularity with neuronal differentiation separated by focal areas of intense staining for proliferation and virtually absent apoptosis. Examination of human medulloblastomas revealed low to absent PTEN expression in over half of the tumors. Kaplan-Meier analysis confirmed worse overall survival in patients whose tumor exhibited low to absent PTEN expression. Conclusions/Significance: This suggests that PTEN expression is a marker of favorable prognosis and mouse models with activation of PI-3 kinase pathways may be important tools for preclinical evaluation of promising agents for the treatment of medulloblastoma.	[Castellino, Robert C.; Buss, Meghan C.; MacDonald, Tobey J.] Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Castellino, Robert C.; Buss, Meghan C.; MacDonald, Tobey J.] Emory Univ, Sch Med, Blood Disorders Serv, Childrens Healthcare Atlanta, Atlanta, GA USA; [Barwick, Benjamin G.; Brat, Daniel J.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Schniederjan, Matthew; Brat, Daniel J.] Emory Univ, Sch Med, Lab Med, Atlanta, GA USA; [Becher, Oren] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Hambardzumyan, Dolores] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Durden, Donald L.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Emory University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego	Castellino, RC (corresponding author), Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA.	rccaste@emory.edu	Castellino, Robert/GRF-7847-2022; MacDonald, Tobey/D-4554-2013; Becher, Oren/AAI-7495-2020; Barwick, Benjamin/O-5185-2019	Barwick, Benjamin/0000-0001-9810-3566; Becher, Oren/0000-0003-4016-8492	St. Baldrick's Foundation Scholar Award; Bear Necessities Pediatric Cancer Foundation; AACR-Aflac, Inc. Career Development Award; CURE Childhood Cancer Foundation; Winship Cancer Institute MPB Program Seed Grant; Emory Egleston Children's Research Center Seed Grant; NIH [R01CA94233]; Goldhirsh Foundation; Alex's Lemonade Stand; NATIONAL CANCER INSTITUTE [R01CA094233] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	St. Baldrick's Foundation Scholar Award; Bear Necessities Pediatric Cancer Foundation; AACR-Aflac, Inc. Career Development Award; CURE Childhood Cancer Foundation; Winship Cancer Institute MPB Program Seed Grant; Emory Egleston Children's Research Center Seed Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldhirsh Foundation; Alex's Lemonade Stand; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	RCC: St. Baldrick's Foundation Scholar Award, Bear Necessities Pediatric Cancer Foundation, AACR-Aflac, Inc. Career Development Award in Pediatric Cancer Research, CURE Childhood Cancer Foundation, Winship Cancer Institute MPB Program Seed Grant, Emory Egleston Children's Research Center Seed Grant; DLD: NIH R01CA94233, Goldhirsh Foundation, Alex's Lemonade Stand, CURE Childhood Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backlund LM, 2003, CLIN CANCER RES, V9, P4151; Binning MJ, 2008, CANCER RES, V68, P7838, DOI 10.1158/0008-5472.CAN-08-1899; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Castellino RC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-127; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Delgado-Esteban M, 2007, J NEUROCHEM, V102, P194, DOI 10.1111/j.1471-4159.2007.04450.x; Ellison D, 2002, NEUROPATH APPL NEURO, V28, P257, DOI 10.1046/j.1365-2990.2002.00419.x; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Garre ML, 2009, CLIN CANCER RES, V15, P2463, DOI 10.1158/1078-0432.CCR-08-2023; GRIFFIN CA, 1988, CANCER RES, V48, P175; Grotzer MA, 2001, NEUROPEDIATRICS, V32, P75, DOI 10.1055/s-2001-13872; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hartmann W, 2006, CLIN CANCER RES, V12, P3019, DOI 10.1158/1078-0432.CCR-05-2187; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Huber H, 2001, EUR J CANCER, V37, P2064, DOI 10.1016/S0959-8049(01)00225-8; Iijima M, 1997, PATHOL INT, V47, P25, DOI 10.1111/j.1440-1827.1997.tb04431.x; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kim JYH, 2003, DEV BIOL, V263, P50, DOI 10.1016/S0012-1606(03)00434-2; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; LI VW, 1994, LANCET, V344, P82, DOI 10.1016/S0140-6736(94)91280-7; Lin CH, 2004, DEV BIOL, V265, P234, DOI 10.1016/j.ydbio.2003.08.027; Longo R, 2008, EXPERT REV MOL DIAGN, V8, P301, DOI 10.1586/14737159.8.3.301; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; McCall TD, 2007, CANCER RES, V67, P5179, DOI 10.1158/0008-5472.CAN-06-4177; Nagase T, 2008, ANGIOGENESIS, V11, P71, DOI 10.1007/s10456-008-9105-5; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Packer RJ, 2003, PEDIATR NEUROSURG, V39, P60, DOI 10.1159/000071316; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Rood BR, 2004, SEMIN ONCOL, V31, P666, DOI 10.1053/j.seminoncol.2004.07.009; Rutkowski S, 2005, NEW ENGL J MED, V352, P978, DOI 10.1056/NEJMoa042176; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; [No title captured]	41	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10849	10.1371/journal.pone.0010849	http://dx.doi.org/10.1371/journal.pone.0010849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520772	gold, Green Submitted, Green Published			2022-12-25	WOS:000278221500034
J	Puterman, E; Lin, J; Blackburn, E; O'Donovan, A; Adler, N; Epel, E				Puterman, Eli; Lin, Jue; Blackburn, Elizabeth; O'Donovan, Aoife; Adler, Nancy; Epel, Elissa			The Power of Exercise: Buffering the Effect of Chronic Stress on Telomere Length	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; CORTISOL RESPONSES; HUMAN T; ASSOCIATION; MORTALITY; HEALTH; MEN	Background: Chronic psychological stress is associated with detrimental effects on physical health, and may operate in part through accelerated cell aging, as indexed by shorter telomeres at the ends of chromosomes. However, not all people under stress have distinctly short telomeres, and we examined whether exercise can serve a stress-buffering function. We predicted that chronic stress would be related to short telomere length (TL) in sedentary individuals, whereas in those who exercise, stress would not have measurable effects on telomere shortening. Methodology and Principal Findings: 63 healthy post-menopausal women underwent a fasting morning blood draw for whole blood TL analysis by a quantitative polymerase chain reaction method. Participants completed the Perceived Stress Scale (Cohen et al., 1983), and for three successive days reported daily minutes of vigorous activity. Participants were categorized into two groups-sedentary and active (those getting Centers for Disease Control-recommended daily amount of activity). The likelihood of having short versus long telomeres was calculated as a function of stress and exercise group, covarying age, BMI and education. Logistic regression analyses revealed a significant moderating effect of exercise. As predicted, among non-exercisers a one unit increase in the Perceived Stress Scale was related to a 15-fold increase in the odds of having short telomeres (p<.05), whereas in exercisers, perceived stress appears to be unrelated to TL ( B = -.59, SE = .78, p = .45). Discussion: Vigorous physical activity appears to protect those experiencing high stress by buffering its relationship with TL. We propose pathways through which physical activity acts to buffer stress effects.	[Puterman, Eli; O'Donovan, Aoife; Adler, Nancy; Epel, Elissa] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Lin, Jue; Blackburn, Elizabeth] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [O'Donovan, Aoife] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puterman, E (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	eli.puterman@ucsf.edu	Puterman, Eli/AAA-5237-2022	Puterman, Eli/0000-0002-5898-2348	Division of Behavioral and Social Research at the National Institute of Aging/National Institutes of Health [R56]; Bernard and Barbro Foundation; UCSF-GIVI Center for AIDS Research [P30AI027763]; NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	Division of Behavioral and Social Research at the National Institute of Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bernard and Barbro Foundation; UCSF-GIVI Center for AIDS Research; NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research study was supported by the Division of Behavioral and Social Research at the National Institute of Aging/National Institutes of Health R56 grant (Epel) and Bernard and Barbro Foundation (Blackburn). The Gladstone flow core and the Core Immunology Lab were supported by the UCSF-GIVI Center for AIDS Research P30AI027763. The CTSI CCRC and the Core Immunology Lab were supported by NIH/NCRR UCSF-CTSI grant number UL1 RR024131. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2003, CURR DIR PSYCHOL SCI, V12, P119, DOI 10.1111/1467-8721.01245; ALESSIO HM, 1993, MED SCI SPORT EXER, V25, P218, DOI 10.1249/00005768-199302000-00010; Bayne S, 2008, CELL RES, V18, P1141, DOI 10.1038/cr.2008.291; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Castillo-Garzon MJ, 2006, CLIN INTERV AGING, V1, P213, DOI 10.2147/ciia.2006.1.3.213; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Craft LL, 2005, PSYCHOL SPORT EXERC, V6, P151, DOI 10.1016/j.psychsport.2003.11.003; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; *DNPAO CDC, PHYS ACT EV GUID AD; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Earnest CP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002288; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Elosua R, 2003, ATHEROSCLEROSIS, V167, P327, DOI 10.1016/S0021-9150(03)00018-2; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; FORD ES, 1991, AM J EPIDEMIOL, V133, P1246, DOI 10.1093/oxfordjournals.aje.a115836; Fransson E, 2008, J CLIN EPIDEMIOL, V61, P840, DOI 10.1016/j.jclinepi.2007.09.004; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Gidron Y, 2006, BIOL PSYCHOL, V72, P291, DOI 10.1016/j.biopsycho.2005.11.011; Gillmore MR, 2001, J SEX RES, V38, P35, DOI 10.1080/00224490109552068; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Janicki-Deverts D, 2008, ANN BEHAV MED, V36, P176, DOI 10.1007/s12160-008-9056-5; Jurca R, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.024; Kiecolt-Glaser JK, 1999, JAMA-J AM MED ASSOC, V282, P2259, DOI 10.1001/jama.282.23.2259; KIECOLTGLASER JK, 1987, PSYCHOSOM MED, V49, P523, DOI 10.1097/00006842-198709000-00008; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Li GL, 2009, MED HYPOTHESES, V72, P527, DOI 10.1016/j.mehy.2008.12.037; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mooy JM, 2000, DIABETES CARE, V23, P197, DOI 10.2337/diacare.23.2.197; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Mueller PJ, 2007, CLIN EXP PHARMACOL P, V34, P377, DOI 10.1111/j.1440-1681.2007.04590.x; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; SHEPHARD RJ, 1994, BRIT J SPORT MED, V28, P247, DOI 10.1136/bjsm.28.4.247; Steptoe A, 2005, PSYCHOSOM MED, V67, P281, DOI 10.1097/01.psy.0000156932.96261.d2; Traustadottir T, 2005, PSYCHONEUROENDOCRINO, V30, P392, DOI 10.1016/j.psyneuen.2004.11.002; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; VERBRUGGE LM, 1980, MED CARE, V18, P73, DOI 10.1097/00005650-198001000-00006; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Werner C, 2008, J AM COLL CARDIOL, V52, P470, DOI 10.1016/j.jacc.2008.04.034; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Zoccola PM, 2008, PSYCHOSOM MED, V70, P661, DOI 10.1097/PSY.0b013e31817bbc77	61	220	224	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10837	10.1371/journal.pone.0010837	http://dx.doi.org/10.1371/journal.pone.0010837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	603PW	20520771	gold, Green Published, Green Submitted			2022-12-25	WOS:000278221500023
J	Petruney, T; Harlan, SV; Lanham, M; Robinson, ET				Petruney, Tricia; Harlan, Sarah V.; Lanham, Michele; Robinson, Elizabeth T.			Increasing Support for Contraception as HIV Prevention: Stakeholder Mapping to Identify Influential Individuals and Their Perceptions	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; WOMEN; PROGRAMS; DESIRES	Background: Voluntary contraceptive use by HIV-positive women currently prevents more HIV-positive births, at a lower cost, than anti-retroviral drug (ARV) regimens. Despite this evidence, most prevention of mother-to-child transmission (PMTCT) programs focus solely on providing ARV prophylaxis to pregnant women and rarely include the prevention of unintended pregnancies among HIV-positive women. Methodology/Principal Findings: To strengthen support for family planning as HIV prevention, we systematically identified key individuals in the field of international HIV/AIDS-those who could potentially influence the issue-and sought to determine their perceptions of barriers to and facilitators for implementing this PMTCT strategy. We used a criteria-based approach to determine which HIV/AIDS stakeholders have the most significant impact on HIV/AIDS research, programs, funding and policy and stratified purposive sampling to conduct interviews with a subset of these individuals. The interview findings pointed to obstacles to strengthening linkages between family planning and HIV/AIDS, including the need for: resources to integrate family planning and HIV services, infrastructure or capacity to provide integrated services at the facility level, national leadership and coordination, and targeted advocacy to key decision-makers. Conclusions/Significance: The individuals we identified as having regional or international influence in the field of HIV/AIDS have the ability to leverage an increasingly conducive funding environment and a growing evidence base to address the policy, programmatic and operational challenges to integrating family planning with HIV/AIDS. Fostering greater support for implementing contraception for HIV prevention will require the dedication, collaboration and coordination of many such actors. Our findings can inform a targeted advocacy campaign.	[Petruney, Tricia] Family Hlth Int, Res Utilizat, Res Triangle Pk, NC 27709 USA; [Harlan, Sarah V.; Robinson, Elizabeth T.] Family Hlth Int, Informat Programs, Res Triangle Pk, NC 27709 USA; [Lanham, Michele] Family Hlth Int, Behav & Biomed Res, Res Triangle Pk, NC 27709 USA		Petruney, T (corresponding author), Family Hlth Int, Res Utilizat, POB 13950, Res Triangle Pk, NC 27709 USA.	tpetruney@fhi.org		Lanham, Michele/0000-0003-3012-5683	Family Health International (FHI), United States Agency for International Development (USAID) [GPO-A-00-05-00022-00]	Family Health International (FHI), United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding: Support for this study was provided by Family Health International (FHI) with funds from the United States Agency for International Development (USAID), Cooperative Agreement Number GPO-A-00-05-00022-00, although the views expressed in this publication do not necessarily reflect those of FHI or USAID (www.usaid.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Dearing JW, 2004, J HEALTH COMMUN, V9, P21, DOI 10.1080/10810730490271502; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; Elul B, 2009, AIDS, V23, pS19, DOI 10.1097/01.aids.0000363774.91376.dc; Gladwell M., 2006, TIPPING POINT LITTLE; Guest G, 2008, HDB TEAM BASED QUALI; Halperin DT, 2009, AIDS, V23, pS123, DOI 10.1097/01.aids.0000363785.73450.5a; Heys J, 2009, AIDS, V23, pS37, DOI 10.1097/01.aids.0000363776.76129.fd; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Johnson KB, 2009, AIDS, V23, pS7, DOI 10.1097/01.aids.0000363773.83753.27; Kates J., 2009, FINANCING RESPONSE A; Nutt P.C., 1992, STRATEG MANAG; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; *PEPFAR, 2009, PEPFAR OV US COMM GL; Reynolds HW, 2008, SEX TRANSM INFECT, V84, pII49, DOI 10.1136/sti.2008.030049; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Reynolds HW, 2005, SEX TRANSM INFECT, V81, P184, DOI 10.1136/sti.2004.012013; Rochat TJ, 2006, JAMA-J AM MED ASSOC, V295, P1376, DOI 10.1001/jama.295.12.1376; Rogers E.M., 2010, DIFFUSION INNOVATION, V4th ed; Rutenberg N, 2005, STUD FAMILY PLANN, V36, P235, DOI 10.1111/j.1728-4465.2005.00064.x; Schmeer K., 1999, GUIDELINES CONDUCTIN; Singh S, 2009, ADDING IT COSTS BENE; Spaulding AB, 2009, AIDS, V23, pS79, DOI 10.1097/01.aids.0000363780.42956.ff; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Ulin PR, 2005, QUALITATIVE METHODS; Valente TW, 1999, ANN AM ACAD POLIT SS, V566, P55, DOI 10.1177/0002716299566001005; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; *WHO, 2002, WHO M PRES MORG SWIT; Wilcher R, 2008, SEX TRANSM INFECT, V84, pII54, DOI 10.1136/sti.2008.030098; World Health Organization, 2002, STRAT APPR PREV HIV; World Health Organization (WHO), 2009, STRAT CONS STRENGTH	32	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10781	10.1371/journal.pone.0010781	http://dx.doi.org/10.1371/journal.pone.0010781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520728	Green Submitted, gold, Green Published			2022-12-25	WOS:000278034600004
J	Pinzan, CF; Ruas, LP; Casabona-Fortunato, AS; Carvalho, FC; Roque-Barreira, MC				Pinzan, Camila Figueiredo; Ruas, Luciana Pereira; Casabona-Fortunato, Analia Sulamita; Carvalho, Fernanda Caroline; Roque-Barreira, Maria-Cristina			Immunological Basis for the Gender Differences in Murine Paracoccidioides brasiliensis Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; STEROID SEX-HORMONES; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; TNF-ALPHA; MACROPHAGE FUNCTION; INTERFERON-GAMMA; BINDING LECTIN; YEAST-CELLS; IMMUNITY	This study aimed to investigate the immunological mechanisms involved in the gender distinct incidence of paracoccidioidomycosis (pcm), an endemic systemic mycosis in Latin America, which is at least 10 times more frequent in men than in women. Then, we compared the immune response of male and female mice to Paracoccidioides brasiliensis infection, as well as the influence in the gender differences exerted by paracoccin, a P. brasiliensis component with carbohydrate recognition property. High production of Th1 cytokines and T-bet expression have been detected in the paracoccin stimulated cultures of spleen cells from infected female mice. In contrast, in similar experimental conditions, cells from infected males produced higher levels of the Th2 cytokines and expressed GATA-3. Macrophages from male and female mice when stimulated with paracoccin displayed similar phagocytic capability, while fungicidal activity was two times more efficiently performed by macrophages from female mice, a fact that was associated with 50% higher levels of nitric oxide production. In order to evaluate the role of sexual hormones in the observed gender distinction, we have utilized mice that have been submitted to gonadectomy followed by inverse hormonal reconstitution. Spleen cells derived from castrated males reconstituted with estradiol have produced higher levels of IFN-gamma (1291+/-15 pg/mL) and lower levels of IL-10 (494+/-38 pg/mL), than normal male in response to paracoccin stimulus. In contrast, spleen cells from castrated female mice that had been treated with testosterone produced more IL-10 (1284+/-36 pg/mL) and less IFN-gamma (587614 pg/mL) than cells from normal female. In conclusion, our results reveal that the sexual hormones had a profound effect on the biology of immune cells, and estradiol favours protective responses to P. brasiliensis infection. In addition, fungal components, such as paracoccin, may provide additional support to the gender dimorphic immunity that marks P. brasiliensis infection.	[Pinzan, Camila Figueiredo; Ruas, Luciana Pereira; Casabona-Fortunato, Analia Sulamita; Carvalho, Fernanda Caroline; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil	Universidade de Sao Paulo	Pinzan, CF (corresponding author), Univ Sao Paulo, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil.	mcrbarre@fmrp.usp.br	Pinzan, Camila Figueiredo/C-2470-2015; Ruas, Luciana/A-4259-2013; Roque-Barreira, Maria-Cristina/A-4552-2008	Ruas, Luciana/0000-0002-1028-7872; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq). C.F.P. is a PhD student with a scholarship from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANGO M, 1982, MYCOPATHOLOGIA, V79, P115, DOI 10.1007/BF00468089; Aristizabal BH, 2002, MED MYCOL, V40, P169, DOI 10.1080/mmy.40.2.169.178; Aristizabal BH, 1998, INFECT IMMUN, V66, P5587, DOI 10.1128/IAI.66.11.5587-5591.1998; Azenabor AA, 2004, BIOCHEM CELL BIOL, V82, P381, DOI 10.1139/O04-032; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Benten WPM, 1997, J ENDOCRINOL, V153, P275, DOI 10.1677/joe.0.1530275; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; CALICH VLG, 1979, MYCOPATHOLOGIA, V66, P175, DOI 10.1007/BF00683967; Calich VLG, 1998, RES IMMUNOL, V149, P407, DOI 10.1016/S0923-2494(98)80764-5; Cernetich A, 2006, INFECT IMMUN, V74, P3190, DOI 10.1128/IAI.00008-06; Chao T C, 1996, Changgeng Yi Xue Za Zhi, V19, P95; Chao TC, 1996, AM J REPROD IMMUNOL, V35, P106; CHAO TC, 1995, CELL IMMUNOL, V160, P43, DOI 10.1016/0008-8749(95)80007-6; CHAO TC, 1994, AM J REPROD IMMUNOL, V32, P43, DOI 10.1111/j.1600-0897.1994.tb00877.x; Coltri KC, 2008, AM J PATHOL, V173, P423, DOI 10.2353/ajpath.2008.080126; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; D'Agostino P, 1999, ANN NY ACAD SCI, V876, P426, DOI 10.1111/j.1749-6632.1999.tb07667.x; DUTT A, 1986, ENDOCRINOLOGY, V118, P661, DOI 10.1210/endo-118-2-661; FOX HS, 1991, J IMMUNOL, V146, P4362; Friedl R, 2000, LIFE SCI, V68, P417, DOI 10.1016/S0024-3205(00)00953-X; Ganiko L, 2007, MICROBES INFECT, V9, P695, DOI 10.1016/j.micinf.2007.02.012; GIRALDO R, 1976, MYCOPATHOLOGIA, V58, P63, DOI 10.1007/BF00707174; Gonzalez A, 2000, INFECT IMMUN, V68, P2546, DOI 10.1128/IAI.68.5.2546-2552.2000; Grosso DD, 2003, INFECT IMMUN, V71, P6534, DOI 10.1128/IAI.71.11.6534-6542.2003; Hannah MF, 2008, BRAIN BEHAV IMMUN, V22, P503, DOI 10.1016/j.bbi.2007.10.005; HAYES GR, 1983, J BIOL CHEM, V258, P5095; Hong M, 2004, EXP TOXICOL PATHOL, V55, P385, DOI 10.1078/0940-2993-00335; Karhawi ASK, 2000, MED MYCOL, V38, P225, DOI 10.1080/714030939; Karpuzoglu E, 2007, MOL IMMUNOL, V44, P1808, DOI 10.1016/j.molimm.2006.08.005; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; Karpuzoglu E, 2009, ENDOCRINOLOGY, V150, P1310, DOI 10.1210/en.2008-0832; Karpuzoglu-Sahin E, 2001, J REPROD IMMUNOL, V52, P113, DOI 10.1016/S0165-0378(01)00117-6; Karpuzoglu-Sahin E, 2001, CYTOKINE, V14, P208, DOI 10.1006/cyto.2001.0876; KASHINO SS, 1995, MYCOPATHOLOGIA, V130, P131, DOI 10.1007/BF01103095; Kashino SS, 2000, J INTERF CYTOK RES, V20, P89, DOI 10.1089/107999000312766; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Livonesi MC, 2008, MED MYCOL, V46, P637, DOI 10.1080/13693780801982762; LOOSE DS, 1983, P NATL ACAD SCI-BIOL, V80, P7659, DOI 10.1073/pnas.80.24.7659; Marques Silvio Alencar, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P261, DOI 10.1590/S0036-46651995000300014; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; Moreira AP, 2008, MYCOPATHOLOGIA, V166, P17, DOI 10.1007/s11046-007-9046-3; MOTA NGS, 1985, T ROY SOC TROP MED H, V79, P765, DOI 10.1016/0035-9203(85)90112-9; Muchmore H G, 1974, Bol Oficina Sanit Panam, V77, P55; Netto C F, 1969, Rev Inst Med Trop Sao Paulo, V11, P177; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; Pereira A.J.C.S., 1988, REV PAT TROP, V17, P157; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; RAMOS ESM, 2008, DERMATOL CLIN, V26, pR7; Ramos-E-Silva M, 2008, DERMATOL CLIN, V26, P257, DOI 10.1016/j.det.2007.11.005; RESTREPO A, 1984, INFECT IMMUN, V46, P346, DOI 10.1128/IAI.46.2.346-353.1984; Restrepo A, 2008, SEMIN RESP CRIT CARE, V29, P182, DOI 10.1055/s-2008-1063857; Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001; Roberts CW, 1996, PARASITOL TODAY, V12, P382, DOI 10.1016/0169-4758(96)10060-0; Rodrigues DR, 2007, MED MYCOL, V45, P27, DOI 10.1080/13693780600981676; Romano CC, 2002, CYTOKINE, V18, P149, DOI 10.1006/cyto.2002.0884; SALAZAR ME, 1988, INFECT IMMUN, V56, P711, DOI 10.1128/IAI.56.3.711-713.1988; San-Blas G, 2005, J CLIN MICROBIOL, V43, P4255, DOI 10.1128/JCM.43.8.4255-4257.2005; Sano T, 1999, PLANT CELL PHYSIOL, V40, P1, DOI 10.1093/oxfordjournals.pcp.a029464; SINGERVERMES LM, 1993, CLIN EXP IMMUNOL, V94, P75, DOI 10.1111/j.1365-2249.1993.tb05980.x; Snider H, 2009, NEUROIMMUNOMODULAT, V16, P106, DOI 10.1159/000180265; Sommer P, 2001, CELL BIOL INT, V25, P103, DOI 10.1006/cbir.2000.0682; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; STARR CM, 1985, ARCH BIOCHEM BIOPHYS, V237, P261, DOI 10.1016/0003-9861(85)90277-2; STEVENS DA, 1989, J MED VET MYCOL, V27, P133; Tobon AM, 2003, CLIN INFECT DIS, V37, P898, DOI 10.1086/377538; Vijay IK, 1998, J MAMMARY GLAND BIOL, V3, P325, DOI 10.1023/A:1018771628925; Wilcoxen SC, 2000, J IMMUNOL, V164, P6237, DOI 10.4049/jimmunol.164.12.6237; YAMAMOTO Y, 1991, INFECT IMMUN, V59, P4089, DOI 10.1128/IAI.59.11.4089-4096.1991; You HJ, 2003, BIOCHEM BIOPH RES CO, V303, P1129, DOI 10.1016/S0006-291X(03)00477-7	73	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10757	10.1371/journal.pone.0010757	http://dx.doi.org/10.1371/journal.pone.0010757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505765	Green Published, gold, Green Submitted			2022-12-25	WOS:000278017400013
J	Al-Swailem, AM; Shehata, MM; Abu-Duhier, FM; Al-Yamani, EJ; Al-Busadah, KA; Al-Arawi, MS; Al-Khider, AY; Al-Muhaimeed, AN; Al-Qahtani, FH; Manee, MM; Al-Shomrani, BM; Al-Qhtani, SM; Al-Harthi, AS; Akdemir, KC; Inan, MS; Otu, HH				Al-Swailem, Abdulaziz M.; Shehata, Maher M.; Abu-Duhier, Faisel M.; Al-Yamani, Essam J.; Al-Busadah, Khalid A.; Al-Arawi, Mohammed S.; Al-Khider, Ali Y.; Al-Muhaimeed, Abdullah N.; Al-Qahtani, Fahad H.; Manee, Manee M.; Al-Shomrani, Badr M.; Al-Qhtani, Saad M.; Al-Harthi, Amer S.; Akdemir, Kadir C.; Inan, Mehmet S.; Otu, Hasan H.			Sequencing, Analysis, and Annotation of Expressed Sequence Tags for Camelus dromedarius	PLOS ONE			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; FATTY-ACID COMPOSITION; CONSTANT-REGION GENES; ALPHA-GENES; STRESS; ORGANIZATION; P27(KIP1); ALIGNMENT; GLUCOSE; BLOOD	Despite its economical, cultural, and biological importance, there has not been a large scale sequencing project to date for Camelus dromedarius. With the goal of sequencing complete DNA of the organism, we first established and sequenced camel EST libraries, generating 70,272 reads. Following trimming, chimera check, repeat masking, cluster and assembly, we obtained 23,602 putative gene sequences, out of which over 4,500 potentially novel or fast evolving gene sequences do not carry any homology to other available genomes. Functional annotation of sequences with similarities in nucleotide and protein databases has been obtained using Gene Ontology classification. Comparison to available full length cDNA sequences and Open Reading Frame (ORF) analysis of camel sequences that exhibit homology to known genes show more than 80% of the contigs with an ORF>300 bp and similar to 40% hits extending to the start codons of full length cDNAs suggesting successful characterization of camel genes. Similarity analyses are done separately for different organisms including human, mouse, bovine, and rat. Accompanying web portal, CAGBASE (http://camel.kacst.edu.sa/), hosts a relational database containing annotated EST sequences and analysis tools with possibility to add sequences from public domain. We anticipate our results to provide a home base for genomic studies of camel and other comparative studies enabling a starting point for whole genome sequencing of the organism.	[Al-Swailem, Abdulaziz M.; Shehata, Maher M.; Abu-Duhier, Faisel M.; Al-Yamani, Essam J.; Al-Arawi, Mohammed S.; Al-Khider, Ali Y.; Al-Muhaimeed, Abdullah N.; Al-Qahtani, Fahad H.; Manee, Manee M.; Al-Shomrani, Badr M.; Al-Qhtani, Saad M.; Al-Harthi, Amer S.; Inan, Mehmet S.; Otu, Hasan H.] King Abdulaziz City Sci & Technol, Biotechnol Res Ctr, Nat Resources & Environm Res Inst, Riyadh, Saudi Arabia; [Al-Busadah, Khalid A.] King Faisal Univ, Fac Vet Med & Anim Resources, Al Hasa, Saudi Arabia; [Akdemir, Kadir C.; Otu, Hasan H.] Harvard Univ, Sch Med, Dept Med, BIDMC Genom Ctr, Boston, MA USA	King Abdulaziz City for Science & Technology; King Faisal University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Al-Swailem, AM (corresponding author), King Abdulaziz City Sci & Technol, Biotechnol Res Ctr, Nat Resources & Environm Res Inst, Riyadh, Saudi Arabia.	hotu@bidmc.harvard.edu	Manee, Manee/CAA-8005-2022; Almuhaimeed, Abdullah/GPG-4180-2022	Manee, Manee/0000-0001-9493-619X; Almuhaimeed, Abdullah/0000-0002-1155-9382; Alqahtani, Fahad/0000-0002-2498-4871; Otu, Hasan/0000-0002-9253-8152; Al-Shomrani, Badr M/0000-0002-7015-6110; Al-Swailem, Abdulaziz/0000-0002-9484-5973	King Abdulaziz City for Science and Technology (KACST); Natural Resources and Environment Research Institute (NRERI), Riyadh, Saudi Arabia; Dubai-Harvard Foundation for Medical Research	King Abdulaziz City for Science and Technology (KACST); Natural Resources and Environment Research Institute (NRERI), Riyadh, Saudi Arabia; Dubai-Harvard Foundation for Medical Research	This project was supported by a grant from King Abdulaziz City for Science and Technology (KACST), Natural Resources and Environment Research Institute (NRERI), Riyadh, Saudi Arabia (http://www.kacst.edu.sa). HHO is partially supported by Dubai-Harvard Foundation for Medical Research (http://www.dhfmr.hms.harvard.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fattah M, 1999, J VET MED A, V46, P473, DOI 10.1046/j.1439-0442.1999.00237.x; Al Ani F.K., 2004, CAMEL MANAGEMENT DIS; Al-Hashem F. H., 2009, American Journal of Applied Sciences, V6, P1868, DOI 10.3844/ajassp.2009.1868.1875; Al-Swailem AM, 2007, J FOOD AGRIC ENVIRON, V5, P143; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anonymous, 2003, Archives of Physiology and Biochemistry, V111, P407, DOI 10.3109/13813450312331342265; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; BRUGGEMANN M, 1986, P NATL ACAD SCI USA, V83, P6075, DOI 10.1073/pnas.83.16.6075; BUTLER JE, 1994, VET IMMUNOL IMMUNOP, V43, P5, DOI 10.1016/0165-2427(94)90114-7; DUNCAN WRH, 1967, J SCI FOOD AGR, V18, P99, DOI 10.1002/jsfa.2740180304; Dusek JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002576; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; Elmahdi B, 1997, COMP BIOCHEM PHYS A, V118, P147, DOI 10.1016/S0300-9629(96)00449-5; EMMANUEL B, 1980, COMP BIOCHEM PHYS B, V67, P701, DOI 10.1016/0305-0491(80)90435-6; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; HOLLER H, 1989, COMP BIOCHEM PHYS B, V93, P413, DOI 10.1016/0305-0491(89)90101-6; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Kaske M, 2001, J COMP PHYSIOL B, V171, P549, DOI 10.1007/s003600100205; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; KNIGHT KL, 1985, J IMMUNOL, V134, P1245; KNIGHT KL, 1988, J IMMUNOL, V140, P3654; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Li S, 2004, BIOINFORMATICS, V20, P2865, DOI 10.1093/bioinformatics/bth302; Malde K, 2006, BIOINFORMATICS, V22, P2232, DOI 10.1093/bioinformatics/btl368; Mao CH, 2003, BIOINFORMATICS, V19, P1720, DOI 10.1093/bioinformatics/btg205; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Morita K, 2005, NEUROSCI LETT, V381, P57, DOI 10.1016/j.neulet.2005.01.081; Muyldermans S, 2001, J Biotechnol, V74, P277; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; ROSATI M, 1991, NUCLEIC ACIDS RES, V19, P5661, DOI 10.1093/nar/19.20.5661; Saleh MA, 2009, VET PARASITOL, V162, P192, DOI 10.1016/j.vetpar.2009.03.035; Schmidt-Nielsen K, 1979, DESERT ANIMALS PHYSL; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; SHIRAZIBEECHY SP, 1994, RUM PHYS DIG MET GRO; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Terada Y, 1999, KIDNEY INT, V56, P494, DOI 10.1046/j.1523-1755.1999.00568.x; Tibary A, 2007, Soc Reprod Fertil Suppl, V64, P297; Wagner B, 2002, IMMUNOGENETICS, V54, P353, DOI 10.1007/s00251-002-0458-4; Wagner B, 1998, IMMUNOBIOLOGY, V199, P105, DOI 10.1016/S0171-2985(98)80067-3; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wolf G, 2001, AM J PATHOL, V158, P1091, DOI 10.1016/S0002-9440(10)64056-4; YAGIL R, 1985, DESERT CAMEL COMP PH; Zierath JR, 1998, MOL CELL BIOCHEM, V182, P153, DOI 10.1023/A:1006861628496	50	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10720	10.1371/journal.pone.0010720	http://dx.doi.org/10.1371/journal.pone.0010720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502665	Green Published, gold			2022-12-25	WOS:000277845400022
J	Senar, JC; Moller, AP; Ruiz, I; Negro, JJ; Broggi, J; Hohtola, E				Carlos Senar, Juan; Moller, Anders Pape; Ruiz, Iker; Jose Negro, Juan; Broggi, Juli; Hohtola, Esa			Specific Appetite for Carotenoids in a Colorful Bird	PLOS ONE			English	Article							PARUS; DIET; QUANTIFICATION; PIGMENTS; BLUE	Background: Since carotenoids have physiological functions necessary for maintaining health, individuals should be selected to actively seek and develop a specific appetite for these compounds. Methodology/Principal Findings: Great tits Parus major in a diet choice experiment, both in captivity and the field, preferred carotenoid-enriched diets to control diets. The food items did not differ in any other aspects measured besides carotenoid content. Conclusions/Significance: Specific appetite for carotenoids is here demonstrated for the first time, placing these compounds on a par with essential nutrients as sodium or calcium.	[Carlos Senar, Juan; Ruiz, Iker; Broggi, Juli] Museu Ciencies Nat Barcelona, CSIC, Evolutionary & Behav Ecol Associate Res Unit, Barcelona, Spain; [Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Moller, Anders Pape] Ctr Adv Study, Oslo, Norway; [Jose Negro, Juan; Broggi, Juli] CSIC, Estac Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain; [Hohtola, Esa] Univ Oulu, Dept Biol, Oulu, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); Museu de Ciencies Naturals de Barcelona; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Oulu	Senar, JC (corresponding author), Museu Ciencies Nat Barcelona, CSIC, Evolutionary & Behav Ecol Associate Res Unit, Barcelona, Spain.	jcsenar@bcn.cat	Senar, Joan Carles/V-2371-2018; Moller, Anders/O-6665-2016; Negro, Juan Jose/I-2653-2015; Broggi, Juli/AAB-1796-2020	Senar, Joan Carles/0000-0001-9955-3892; Moller, Anders/0000-0003-3739-4675; Negro, Juan Jose/0000-0002-8697-5647; Broggi, Juli/0000-0002-1706-4014	Spanish Research Council; Ministerio de Educacion y Ciencia; CIRIT [FPI2000-0014]; Generalitat de Catalunya;  [CGL2006-07481]	Spanish Research Council; Ministerio de Educacion y Ciencia(Spanish Government); CIRIT; Generalitat de Catalunya(Generalitat de Catalunya); 	This work was funded by CGL2006-07481 research project to JCS and JJN, from the Spanish Research Council, Ministerio de Educacion y Ciencia and FPI2000-0014 to IR from CIRIT, Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ESM, 2007, J AGR FOOD CHEM, V55, P787, DOI 10.1021/jf062764p; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; BLEM CR, 1976, AM ZOOL, V16, P671; Clarke T, 2001, NATURE, V412, P263; CZECZUGA B, 1990, FOLIA BIOL-KRAKOW, V38, P5; de Oliveira GPR, 2007, J FOOD SCI, V72, pS79, DOI 10.1111/j.1750-3841.2006.00235.x; Goodwin TW., 1976, CHEM BIOCH PLANT PIG, V1; Gosler A, 1993, GREAT TIT; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hill G. E., 2006, BIRD COLORATION, V2; Hill G. E., 2006, BIRD COLORATION, V1; Hurst W.J., 2002, METHODS ANAL FUNCTIO; Isaksson C, 2007, J AVIAN BIOL, V38, P564, DOI 10.1111/j.2007.0908-8857.04030.x; ISLER O, 1971, CAROTENOIDS; MCPHERSON JM, 1988, ANIM BEHAV, V36, P961, DOI 10.1016/S0003-3472(88)80054-X; *MIN CORP LTD, 1994, PREC COL COMM COL CO; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; MURPHY ME, 1987, PHYSIOL ZOOL, V60, P279, DOI 10.1086/physzool.60.2.30158652; NEAVE HR, 1992, DISTRIBUTION FREE TE; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; PARTALI V, 1987, COMP BIOCHEM PHYS B, V87, P885, DOI 10.1016/0305-0491(87)90408-1; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Schaefer HM, 2008, FUNCT ECOL, V22, P303, DOI 10.1111/j.1365-2435.2007.01363.x; Senar JC, 2008, BEHAVIOUR, V145, P1195, DOI 10.1163/156853908785387638; Senar J.C., 1997, Butlleti del Grup Catala d'Anellament, V14, P17; SHULKIN J, 1992, SODIUM HUNGER, P204; Tordoff MG, 2001, PHYSIOL REV, V81, P1567, DOI 10.1152/physrev.2001.81.4.1567	28	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10716	10.1371/journal.pone.0010716	http://dx.doi.org/10.1371/journal.pone.0010716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502717	Green Published, gold			2022-12-25	WOS:000277845400018
J	Liang, CW; Zhang, XW; Zou, J; Xu, D; Su, F; Ye, NH				Liang, Chengwei; Zhang, Xiaowen; Zou, Jian; Xu, Dong; Su, Feng; Ye, Naihao			Identification of miRNA from Porphyra yezoensis by High-Throughput Sequencing and Bioinformatics Analysis	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; SMALL RNAS; REGULATORY ROLES; PLANT MICRORNAS; PREDICTION; TARGETS; BIOGENESIS; DIVERSE; CLONING; SYSTEM	Background: miRNAs are a class of non-coding, small RNAs that are approximately 22 nucleotides long and play important roles in the translational level regulation of gene expression by either directly binding or cleaving target mRNAs. The red alga, Porphyra yezoensis is one of the most important marine economic crops worldwide. To date, only a few miRNAs have been identified in green unicellar alga and there is no report about Porphyra miRNAs. Methodology/Principal Findings: To identify miRNAs in Porphyra yezoensis, a small RNA library was constructed. Solexa technology was used to perform high throughput sequencing of the library and subsequent bioinformatics analysis to identify novel miRNAs. Specifically, 180,557,942 reads produced 13,324 unique miRNAs representing 224 conserved miRNA families that have been identified in other plants species. In addition, seven novel putative miRNAs were predicted from a limited number of ESTs. The potential targets of these putative miRNAs were also predicted based on sequence homology search. Conclusions/Significance: This study provides a first large scale cloning and characterization of Porphyra miRNAs and their potential targets. These miRNAs belong to 224 conserved miRNA families and 7 miRNAs are novel in Porphyra. These miRNAs add to the growing database of new miRNA and lay the foundation for further understanding of miRNA function in the regulation of Porphyra yezoensis development.	[Liang, Chengwei; Su, Feng] Qingdao Univ Technol & Sci, Qingdao, Peoples R China; [Zhang, Xiaowen; Zou, Jian; Xu, Dong; Ye, Naihao] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China	Qingdao University of Science & Technology; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Liang, CW (corresponding author), Qingdao Univ Technol & Sci, Qingdao, Peoples R China.	yenh@ysfri.ac.cn			National Natural Science Foundation of China [40706050, 40706048, 30700619]; National Science Technology [2006BAD01A13, 2008BAC49B04]; National Special Fund [2009ZX08009-019B]; Natural Science Foundation of Shandong Province [2009ZRA02075, 2008D03]; Qingdao Municipal Science and Technology [09-2-5-8-hy]; Open Foundation of Chemical Engineering Subject; Qingdao University of Science & Technology, China; Hi-TechResearch and Development Program (863) of China [2009AA10Z106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Technology; National Special Fund; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Qingdao Municipal Science and Technology; Open Foundation of Chemical Engineering Subject; Qingdao University of Science & Technology, China; Hi-TechResearch and Development Program (863) of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (40706050, 40706048 and 30700619), the National Science & Technology Pillar Program (2006BAD01A13 and 2008BAC49B04), National Special Fund for Transgenic Project (2009ZX08009-019B), Natural Science Foundation of Shandong Province (2009ZRA02075 and 2008D03), Qingdao Municipal Science and Technology Plan Project (09-2-5-8-hy), Open Foundation of Chemical Engineering Subject, Qingdao University of Science & Technology, China and the Hi-TechResearch and Development Program (863) of China (2009AA10Z106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Dezulian T., 2005, GENOME BIOL, V6, pP13, DOI DOI 10.1186/GB-2005-6-11-P13; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Floyd SK, 2006, GENETICS, V173, P373, DOI 10.1534/genetics.105.054239; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Mette MF, 2002, PLANT PHYSIOL, V130, P6, DOI 10.1104/pp.007047; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Provasoli L., 1968, CULTURES COLLECTIONS, P63; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Saga N, 2002, FISH SCI S, V68, P1075, DOI DOI 10.2331/fishsci.68.sup2_1075; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sunkar R, 2005, NUCLEIC ACIDS RES, V33, P4443, DOI 10.1093/nar/gki758; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	74	79	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10698	10.1371/journal.pone.0010698	http://dx.doi.org/10.1371/journal.pone.0010698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502668	Green Published, gold, Green Submitted			2022-12-25	WOS:000277845400008
J	Lee, AY; Perreault, R; Harel, S; Boulier, EL; Suderman, M; Hallett, M; Jenna, S				Lee, Anna Y.; Perreault, Richard; Harel, Sharon; Boulier, Elodie L.; Suderman, Matthew; Hallett, Michael; Jenna, Sarah			Searching for Signaling Balance through the Identification of Genetic Interactors of the Rab Guanine-Nucleotide Dissociation Inhibitor gdi-1	PLOS ONE			English	Article							OOCYTE MEIOTIC MATURATION; CAENORHABDITIS-ELEGANS; SYNAPTIC PLASTICITY; KINASE ACTIVATION; GONAD DEVELOPMENT; SOMATIC GONAD; RHO GTPASES; PROTEIN; RECEPTOR; MUSCLE	Background: The symptoms of numerous diseases result from genetic mutations that disrupt the homeostasis maintained by the appropriate integration of signaling gene activities. The relationships between signaling genes suggest avenues through which homeostasis can be restored and disease symptoms subsequently reduced. Specifically, disease symptoms caused by loss-of-function mutations in a particular gene may be reduced by concomitant perturbations in genes with antagonistic activities. Methodology/Principal Findings: Here we use network-neighborhood analyses to predict genetic interactions in Caenorhabditis elegans towards mapping antagonisms and synergisms between genes in an animal model. Most of the predicted interactions are novel, and the experimental validation establishes that our approach provides a gain in accuracy compared to previous efforts. In particular, we identified genetic interactors of gdi-1, the orthologue of GDI1, a gene associated with mental retardation in human. Interestingly, some gdi-1 interactors have human orthologues with known neurological functions, and upon validation of the interactions in mammalian systems, these orthologues would be potential therapeutic targets for GDI1-associated neurological disorders. We also observed the conservation of a gdi-1 interaction between different cellular systems in C. elegans, suggesting the involvement of GDI1 in human muscle degeneration. Conclusions/Significance: We developed a novel predictor of genetic interactions that may have the ability to significantly streamline the identification of therapeutic targets for monogenic disorders involving genes conserved between human and C. elegans.	[Lee, Anna Y.; Suderman, Matthew; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Lee, Anna Y.; Hallett, Michael] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Hallett, Michael] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada; [Perreault, Richard; Harel, Sharon; Boulier, Elodie L.; Jenna, Sarah] Univ Quebec, Dept Chem, Montreal, PQ H3C 3P8, Canada	McGill University; McGill University; McGill University; University of Quebec; University of Quebec Montreal	Lee, AY (corresponding author), McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada.	jenna.sarah@uqam.ca		Hallett, Michael/0000-0001-6738-6786; Suderman, Matthew/0000-0002-2715-9930	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Foundation for Innovation; Canada Research Chair program; Fonds de la recherche en santedu Quebec	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair program(Canada Research Chairs); Fonds de la recherche en santedu Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Natural Sciences and Engineering Research Council (NSERC, http://www.nserc-crsng.gc.ca) of Canada and the Canada Foundation for Innovation (http://www.innovation.ca). S.J. is funded by the Canada Research Chair program (http://www.chairs-chaires.gc.ca). A.Y.L. and S. H. are funded by the NSERC, and R.P. by the Fonds de la recherche en santedu Quebec (http://www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Barbara JG, 2002, BBA-PROTEINS PROTEOM, V1600, P12, DOI 10.1016/S1570-9639(02)00439-9; Bender AM, 2007, DEV BIOL, V302, P448, DOI 10.1016/j.ydbio.2006.09.051; Bender AM, 2004, DEV BIOL, V273, P335, DOI 10.1016/j.ydbio.2004.06.009; Benian GM, 1996, J CELL BIOL, V132, P835, DOI 10.1083/jcb.132.5.835; Bianchi V, 2009, HUM MOL GENET, V18, P105, DOI 10.1093/hmg/ddn321; Blake DJ, 1998, P NATL ACAD SCI USA, V95, P241, DOI 10.1073/pnas.95.1.241; Blake DJ, 2002, NEUROMUSCULAR DISORD, V12, pS110, DOI 10.1016/S0960-8966(02)00091-3; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; BOTTCHER SG, 2003, J STAT SOFTW, V8, P1; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Caruso ME, 2008, MOL CELL BIOL, V28, P4261, DOI 10.1128/MCB.02252-07; Chipman KC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-17; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'Adamo P, 2004, EUR J NEUROSCI, V19, P1895, DOI 10.1111/j.1460-9568.2004.03270.x; D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; de Voer G, 2008, BBA-MOL BASIS DIS, V1782, P433, DOI 10.1016/j.bbadis.2008.04.003; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Gieseler K, 1999, NEUROGENETICS, V2, P87, DOI 10.1007/s100480050057; Gieseler K, 2000, CURR BIOL, V10, P1092, DOI 10.1016/S0960-9822(00)00691-6; Gieseler K, 2002, NEUROMUSCULAR DISORD, V12, P371, DOI 10.1016/S0960-8966(01)00330-3; Gilbert SF, 2001, J EXP ZOOL, V291, P1, DOI 10.1002/jez.1; Grisoni K, 2002, GENE, V294, P77, DOI 10.1016/S0378-1119(02)00762-X; Grote P, 2006, DEV CELL, V11, P561, DOI 10.1016/j.devcel.2006.07.015; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Jenna S, 2005, MOL BIOL CELL, V16, P1629, DOI 10.1091/mbc.E04-08-0760; Johnson RP, 2006, DEVELOPMENT, V133, P1911, DOI 10.1242/dev.02363; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kemmer D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001440; Kim H, 2004, NATURE, V430, P891, DOI 10.1038/nature02798; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lamprecht R, 2006, NEUROSCIENCE, V139, P821, DOI 10.1016/j.neuroscience.2005.12.055; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Mercer KB, 2006, MOL BIOL CELL, V17, P3832, DOI 10.1091/mbc.E06-02-0144; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Miller MA, 2003, GENE DEV, V17, P187, DOI 10.1101/gad.1028303; Miskowski J, 2001, DEV BIOL, V230, P61, DOI 10.1006/dbio.2000.9998; MOORE D, 2009, INTRO PRACTISE STAT, P16; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; R Development Core Team, 2007, R LANG ENV STAT COMP; Riddle DL, 1997, C ELEGANS; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tokuoka SM, 2008, MOL BIOL CELL, V19, P2241, DOI 10.1091/mbc.E07-09-0982; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wissmann A, 1999, DEV BIOL, V209, P111, DOI 10.1006/dbio.1999.9242; Xu XJ, 2005, FEBS LETT, V579, P549, DOI 10.1016/j.febslet.2004.12.026; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	72	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10624	10.1371/journal.pone.0010624	http://dx.doi.org/10.1371/journal.pone.0010624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498707	Green Submitted, Green Published, gold			2022-12-25	WOS:000277633500013
J	Strotmann, R; Semtner, M; Kepura, F; Plant, TD; Schoneberg, T				Strotmann, Rainer; Semtner, Marcus; Kepura, Frauke; Plant, Tim D.; Schoeneberg, Torsten			Interdomain Interactions Control Ca2+-Dependent Potentiation in the Cation Channel TRPV4	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CALMODULIN-BINDING DOMAIN; NUCLEOTIDE-GATED CHANNELS; HEAT-EVOKED ACTIVATION; PROTEIN-KINASE-C; EPITHELIAL-CELLS; CA2+ DEPENDENCE; ION-CHANNEL; VR-OAC; CALCIUM	Several Ca2+-permeable channels, including the non-selective cation channel TRPV4, are subject to Ca2+-dependent facilitation. Although it has been clearly demonstrated in functional experiments that calmodulin (CaM) binding to intracellular domains of TRP channels is involved in this process, the molecular mechanism remains elusive. In this study, we provide experimental evidence for a comprehensive molecular model that explains Ca2+-dependent facilitation of TRPV4. In the resting state, an intracellular domain from the channel N terminus forms an autoinhibitory complex with a C-terminal domain that includes a high-affinity CaM binding site. CaM binding, secondary to rises in intracellular Ca2+, displaces the N-terminal domain which may then form a homologous interaction with an identical domain from a second subunit. This represents a novel potentiation mechanism that may also be relevant in other Ca2+-permeable channels.	[Strotmann, Rainer; Schoeneberg, Torsten] Univ Leipzig, Fak Med, Inst Biochem, Leipzig, Germany; [Semtner, Marcus; Kepura, Frauke; Plant, Tim D.] Univ Marburg, Inst Pharmakol & Toxikol, Fachbereich Med, D-3550 Marburg, Germany	Leipzig University; Philipps University Marburg	Strotmann, R (corresponding author), Univ Leipzig, Fak Med, Inst Biochem, Leipzig, Germany.	rainer.strotmann@medizin.uni-leipzig.de			IZKF Leipzig; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung	IZKF Leipzig; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the IZKF Leipzig, the Deutsche Forschungsgemeinschaft and Bundesministerium fur Bildung und Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; ARNIGES M, 2005, J BIOL CHEM; Bodding M, 2004, J BIOL CHEM, V279, P36546, DOI 10.1074/jbc.M404679200; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Guler AD, 2002, J NEUROSCI, V22, P6408; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hirnet D, 2003, CELL CALCIUM, V33, P509, DOI 10.1016/S0143-4160(03)00066-6; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Paszty K, 2002, J BIOL CHEM, V277, P36146, DOI 10.1074/jbc.M205457200; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Shi J, 2004, J PHYSIOL-LONDON, V561, P415, DOI 10.1113/jphysiol.2004.075051; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zheng J, 2003, J NEUROSCI, V23, P8167; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10580	10.1371/journal.pone.0010580	http://dx.doi.org/10.1371/journal.pone.0010580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485495	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563200014
J	Duarte, J; Agua-Doce, A; Oliveira, VG; Fonseca, JE; Graca, L				Duarte, Joana; Agua-Doce, Ana; Oliveira, Vanessa G.; Fonseca, Joao Eurico; Graca, Luis			Modulation of IL-17 and Foxp3 Expression in the Prevention of Autoimmune Arthritis in Mice	PLOS ONE			English	Article							ANTI-CD4 MONOCLONAL-ANTIBODY; REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; TRANSPLANTATION TOLERANCE; CYTOKINE MILIEU; INDUCTION; INTERLEUKIN-17; CD4(+)CD25(+); RECRUITMENT	Background: Rheumatoid Arthritis (RA) is a chronic immune mediated disease associated with deregulation of many cell types. It has been reported that different T cell subsets have opposite effects in disease pathogenesis, in particular Th17 and Treg cells. Methodology and Findings: We investigated whether non-depleting anti-CD4 monoclonal antibodies, which have been reported as pro-tolerogenic, can lead to protection from chronic autoimmune arthritis in SKG mice - a recently described animal model of RA - by influencing the Th17/Treg balance. We found that non-depleting anti-CD4 prevented the onset of chronic autoimmune arthritis in SKG mice. Moreover, treated mice were protected from the induction of arthritis up to 60 days following anti-CD4 treatment, while remaining able to mount CD4-dependent immune responses to unrelated antigens. The antibody treatment also prevented disease progression in arthritic mice, although without leading to remission. Protection from arthritis was associated with an increased ratio of Foxp3, and decreased IL-17 producing T cells in the synovia. In vitro assays under Th17-polarizing conditions showed CD4-blockade prevents Th17 polarization, while favoring Foxp3 induction. Conclusions: Non-depleting anti-CD4 can therefore induce long-term protection from chronic autoimmune arthritis in SKG mice through reciprocal changes in the frequency of Treg and Th17 cells in peripheral tissues, thus shifting the balance towards immune tolerance.	[Duarte, Joana; Agua-Doce, Ana; Oliveira, Vanessa G.; Fonseca, Joao Eurico; Graca, Luis] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Duarte, Joana; Agua-Doce, Ana; Oliveira, Vanessa G.; Graca, Luis] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Fonseca, Joao Eurico] Hosp Santa Maria, Dept Rheumatol, Lisbon, Portugal	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Hospital Santa Maria	Duarte, J (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	lgraca@fm.ul.pt	iMed.ULisboa, EEPHIV/B-4222-2014; Duarte, Joana/A-6184-2014; Graca, Luis/B-8887-2008; Agua-Doce, Ana/L-2997-2014	Duarte, Joana/0000-0002-5736-9138; Graca, Luis/0000-0001-6935-8500; Goncalves de Oliveira, Vanessa Alexandra/0000-0001-6884-2675; Fonseca, Joao/0000-0003-1432-3671; Agua-Doce, Ana/0000-0002-0466-7297	SUDOE [IMMUNONET-SOE1/1P1/E014]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [FCT/POCI/SAU-MMO/55974/2004]; FCT [SFRH/BD/23631/2005, SFRH/BD/49093/2008, SFRH/BPD/22575/2005]	SUDOE; Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by SUDOE, grant number IMMUNONET-SOE1/1P1/E014, and supported by a research grant from Fundacao para a Ciencia e Tecnologia (FCT), Portugal (FCT/POCI/SAU-MMO/55974/2004). JD, AA-D, and VGO are funded with scholarships from FCT (SFRH/BD/23631/2005, SFRH/BD/49093/2008, and SFRH/BPD/22575/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE S, 1992, CELL IMMUNOL, V144, P347, DOI 10.1016/0008-8749(92)90250-S; BREEDVELD FC, 1989, CELL IMMUNOL, V121, P1, DOI 10.1016/0008-8749(89)90001-4; Caetano-Lopes J, 2009, CLIN EXP RHEUMATOL, V27, P475; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chehata JC, 2001, RHEUMATOLOGY, V40, P447, DOI 10.1093/rheumatology/40.4.447; Choy EHS, 2000, RHEUMATOLOGY, V39, P1139, DOI 10.1093/rheumatology/39.10.1139; Chu CQ, 1996, J IMMUNOL, V157, P2685; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Coppieters K, 2007, RHEUMATOLOGY, V46, P565, DOI 10.1093/rheumatology/kel437; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gabriel SE, 2003, ARTHRITIS RHEUM-US, V48, P54, DOI 10.1002/art.10705; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Graca L, 2004, P NATL ACAD SCI USA, V101, P10122, DOI 10.1073/pnas.0400084101; Graca L, 2003, IMMUNOL RES, V28, P181, DOI 10.1385/IR:28:3:181; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; Graca L, 2000, J IMMUNOL, V165, P4783, DOI 10.4049/jimmunol.165.9.4783; Graca L, 2006, METH MOL B, V333, P247; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; HERZOG C, 1987, LANCET, V2, P1461; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HORNEFF G, 1991, ARTHRITIS RHEUM, V34, P129, DOI 10.1002/art.1780340202; HORNEFF G, 1991, CLIN IMMUNOL IMMUNOP, V59, P89, DOI 10.1016/0090-1229(91)90084-N; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Isaacs JD, 2008, RHEUMATOLOGY, V47, P1461, DOI 10.1093/rheumatology/ken163; Isaacs JD, 2007, CURR OPIN PHARMACOL, V7, P418, DOI 10.1016/j.coph.2007.05.001; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; Karim M, 2002, CURR OPIN IMMUNOL, V14, P584, DOI 10.1016/S0952-7915(02)00379-5; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Mason U, 2002, J RHEUMATOL, V29, P220; Mauri C, 1997, J IMMUNOL, V159, P5032; QIN SX, 1989, J EXP MED, V169, P779, DOI 10.1084/jem.169.3.779; Ranges G E, 1988, Int Rev Immunol, V4, P83, DOI 10.3109/08830188809044772; RANGES GE, 1985, J EXP MED, V162, P1105, DOI 10.1084/jem.162.3.1105; REITER C, 1991, ARTHRITIS RHEUM-US, V34, P525, DOI 10.1002/art.1780340504; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schulze-Koops H, 1999, DRUG TODAY, V35, P327, DOI 10.1358/dot.1999.35.4-5.552208; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; VANBOXEL JA, 1975, NEW ENGL J MED, V293, P517, DOI 10.1056/NEJM197509112931101; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	46	37	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10558	10.1371/journal.pone.0010558	http://dx.doi.org/10.1371/journal.pone.0010558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479941	Green Published, gold			2022-12-25	WOS:000277467900014
J	Kim, H; Lee, BS; Tomita, M; Kanai, A				Kim, Hyunchul; Lee, Baek-Seok; Tomita, Masaru; Kanai, Akio			Transcription-Associated Mutagenesis Increases Protein Sequence Diversity More Effectively than Does Random Mutagenesis in Escherichia coli	PLOS ONE			English	Article							BASE-SUBSTITUTION MUTATIONS; NONTRANSCRIBED STRAND; THYMINE MUTATIONS; DNA-SEQUENCES; EVOLUTION; RATES; GENE; FRAMESHIFT; MODEL; PAIRS	Background: During transcription, the nontranscribed DNA strand becomes single-stranded DNA (ssDNA), which can form secondary structures. Unpaired bases in the ssDNA are less protected from mutagens and hence experience more mutations than do paired bases. These mutations are called transcription-associated mutations. Transcription-associated mutagenesis is increased under stress and depends on the DNA sequence. Therefore, selection might significantly influence protein-coding sequences in terms of the transcription-associated mutability per transcription event under stress to improve the survival of Escherichia coli. Methodology/Principal Findings: The mutability index (MI) was developed by Wright et al. to estimate the relative transcription-associated mutability of bases per transcription event. Using the most stable fold of each ssDNA that have an average length n, MI was defined as (the number of folds in which the base is unpaired)/nx(highest-Delta G of all n folds in which the base is unpaired), where Delta G is the free energy. The MI values show a significant correlation with mutation data under stress but not with spontaneous mutations in E. coli. Protein sequence diversity is preferred under stress but not under favorable conditions. Therefore, we evaluated the selection pressure on MI in terms of the protein sequence diversity for all the protein-coding sequences in E. coli. The distributions of the MI values were lower at bases that could be substituted with each of the other three bases without affecting the amino acid sequence than at bases that could not be so substituted. Start codons had lower distributions of MI values than did nonstart codons. Conclusions/Significance: Our results suggest that the majority of protein-coding sequences have evolved to promote protein sequence diversity and to reduce gene knockout under stress. Consequently, transcription-associated mutagenesis increases protein sequence diversity more effectively than does random mutagenesis under stress. Nonrandom transcription-associated mutagenesis under stress should improve the survival of E. coli.	[Kim, Hyunchul; Lee, Baek-Seok; Tomita, Masaru; Kanai, Akio] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Kim, Hyunchul; Tomita, Masaru; Kanai, Akio] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan	Keio University; Keio University	Kim, H (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	akio@sfc.keio.ac.jp	Kanai, Akio/C-4921-2014	Kanai, Akio/0000-0002-6362-2419	Keio University Global Center; Yamagata prefectural government; Tsuruoka City, Japan	Keio University Global Center; Yamagata prefectural government; Tsuruoka City, Japan	This research was supported in part by a Grant-in-Aid from Keio University Global Center of Excellence Program and Mori memorial grant and by research funds from the Yamagata prefectural government and Tsuruoka City, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; Beletskii A, 2001, J BACTERIOL, V183, P6491, DOI 10.1128/JB.183.21.6491-6493.2001; Beletskii A, 2000, J MOL BIOL, V300, P1057, DOI 10.1006/jmbi.2000.3944; Burkala E, 2007, MICROBIOL-SGM, V153, P2180, DOI 10.1099/mic.0.2007/005470-0; Da Sylva TR, 2009, MUTAT RES-FUND MOL M, V670, P68, DOI 10.1016/j.mrfmmm.2009.07.008; DATTA A, 1995, SCIENCE, V268, P1616, DOI 10.1126/science.7777859; Day MJ, 2004, MICROBIAL EVOLUTION: GENE ESTABLISHMENT, SURVIVAL, AND EXCHANGE, P290; DEBOER JG, 1984, P NATL ACAD SCI-BIOL, V81, P5528; Drake JW, 1998, GENETICS, V148, P1667; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Fix D, 2008, DNA REPAIR, V7, P1289, DOI 10.1016/j.dnarep.2008.04.008; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hoede C, 2006, PLOS GENET, V2, P1697, DOI 10.1371/journal.pgen.0020176; Hudson RE, 2003, NUCLEIC ACIDS RES, V31, P4517, DOI 10.1093/nar/gkg651; Klapacz J, 2005, DNA REPAIR, V4, P806, DOI 10.1016/j.dnarep.2005.04.017; Klapacz J, 2002, J BACTERIOL, V184, P6866, DOI 10.1128/JB.184.24.6866-6872.2002; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; MacLean RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000406; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Mugal CF, 2009, MOL BIOL EVOL, V26, P131, DOI 10.1093/molbev/msn245; R Core Team, 2022, R LANG ENV STAT COMP; Reimers JM, 2004, MICROBIOL-SGM, V150, P1457, DOI 10.1099/mic.0.26954-0; RIPLEY LS, 1982, P NATL ACAD SCI-BIOL, V79, P4128, DOI 10.1073/pnas.79.13.4128; SINGER B, 1982, ANNU REV BIOCHEM, V51, P655, DOI 10.1146/annurev.bi.51.070182.003255; SKANDALIS A, 1994, MUTAT RES, V314, P21, DOI 10.1016/0921-8777(94)90057-4; SOWERS LC, 1987, MUTAT RES, V177, P201, DOI 10.1016/0027-5107(87)90003-0; WILLIAMS LD, 1987, P NATL ACAD SCI USA, V84, P1779, DOI 10.1073/pnas.84.7.1779; Wright BE, 2008, MOL IMMUNOL, V45, P3600, DOI 10.1016/j.molimm.2008.05.012; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x; Wright BE, 2003, MOL MICROBIOL, V48, P429, DOI 10.1046/j.1365-2958.2003.t01-1-03436.x	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10567	10.1371/journal.pone.0010567	http://dx.doi.org/10.1371/journal.pone.0010567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479947	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467900019
J	Courapied, S; Sellier, H; Trecesson, SD; Vigneron, A; Bernard, AC; Gamelin, E; Barre, B; Coqueret, O				Courapied, Sandy; Sellier, Helene; Trecesson, Sophie de Carne; Vigneron, Arnaud; Bernard, Anne-Charlotte; Gamelin, Erick; Barre, Benjamin; Coqueret, Olivier			The cdk5 Kinase Regulates the STAT3 Transcription Factor to Prevent DNA Damage upon Topoisomerase I Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNAL TRANSDUCER; UNPHOSPHORYLATED STAT3; CONFERS RESISTANCE; INDUCED APOPTOSIS; DRUG-RESISTANCE; GENE-EXPRESSION; C-MYC; ACTIVATION; PATHWAY	The STAT3 transcription factors are cytoplasmic proteins that induce gene activation in response to growth factor stimulation. Following tyrosine phosphorylation, STAT3 proteins dimerize, translocate to the nucleus, and activate specific target genes involved in cell-cycle progression. Despite its importance in cancer cells, the molecular mechanisms by which this protein is regulated in response to DNA damage remain to be characterized. In this study, we show that STAT3 is activated in response to topoisomerase I inhibition. Following treatment, STAT3 is phosphorylated on its C-terminal serine 727 residue but not on its tyrosine 705 site. We also show that topoisomerase I inhibition induced the up-regulation of the cdk5 kinase, a protein initially described in neuronal stress responses. In co-immunoprecipitations, cdk5 was found to associate with STAT3, and pulldown experiments indicated that it associates with the C-terminal activation domain of STAT3 upon DNA damage. Importantly, the cdk5-STAT3 pathway reduced DNA damage in response to topoisomerase I inhibition through the up-regulation of Eme1, an endonuclease involved in DNA repair. ChIP experiments indicated that STAT3 can be found associated with the Eme1 promoter when phosphorylated only on its serine 727 residue and not on tyrosine 705. We therefore propose that the cdk5-STAT3 oncogenic pathway plays an important role in the expression of DNA repair genes and that these proteins could be used as predictive markers of tumors that will fail to respond to chemotherapy.	[Courapied, Sandy; Sellier, Helene; Trecesson, Sophie de Carne; Vigneron, Arnaud; Bernard, Anne-Charlotte; Gamelin, Erick; Barre, Benjamin; Coqueret, Olivier] Paul Papin Canc Ctr, INSERM, U892, F-49933 Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de cancerologie de Lorraine (ICL); Institut de Cancerologie de l'Ouest (ICO); Universite d'Angers	Coqueret, O (corresponding author), Ctr Reg Lutte Contre Canc Paul Papin, INSERM, U892, 2 Rue Moll, F-49033 Angers, France.	olivier.coqueret@univ-angers.fr	Vigneron, Arnaud/ABC-7306-2021; Coqueret, Olivier/K-9660-2015	Vigneron, Arnaud/0000-0003-4161-0676; Coqueret, Olivier/0000-0002-2843-7867	Ligue Contre le Cancer and Institut du Cancer; Inserm-Pays de Loire; Ministere de la Recherche	Ligue Contre le Cancer and Institut du Cancer; Inserm-Pays de Loire; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by fellowships (to S. C. and A. V.), by a grant (Equipe Labelisee) from the Ligue Contre le Cancer and Institut du Cancer, and a fellowship from Inserm-Pays de Loire (to S. C. T.), and by the Ministere de la Recherche (to H. S.).	Alexander K, 2004, MOL CELL BIOL, V24, P2808, DOI 10.1128/MCB.24.7.2808-2819.2004; Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Barre B, 2003, J BIOL CHEM, V278, P2990, DOI 10.1074/jbc.M210422200; Barre B, 2007, TRENDS MOL MED, V13, P4, DOI 10.1016/j.molmed.2006.11.001; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bienvenu F, 2005, MOL BIOL CELL, V16, P1850, DOI 10.1091/mbc.e04-08-0654; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; Florenes VA, 1999, ONCOGENE, V18, P1023, DOI 10.1038/sj.onc.1202382; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Henderson BW, 2007, CLIN CANCER RES, V13, P3156, DOI 10.1158/1078-0432.CCR-06-2950; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee JH, 2008, J BIOL CHEM, V283, P19826, DOI 10.1074/jbc.M706201200; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lin H, 2007, J BIOL CHEM, V282, P2776, DOI 10.1074/jbc.M607234200; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Thomas M, 2004, CANCER RES, V64, P8357, DOI 10.1158/0008-5472.CAN-04-1864; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Townsend PA, 2005, J CELL SCI, V118, P1629, DOI 10.1242/jcs.01728; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Le H, 2005, J BIOL CHEM, V280, P32018, DOI 10.1074/jbc.M504689200; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Vigneron A, 2008, CANCER RES, V68, P815, DOI 10.1158/0008-5472.CAN-07-5115; Vigneron A, 2006, J BIOL CHEM, V281, P34742, DOI 10.1074/jbc.M602492200; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	57	55	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26765	26778		10.1074/jbc.M109.092304	http://dx.doi.org/10.1074/jbc.M109.092304			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20516069	Green Published, hybrid			2022-12-25	WOS:000281172700007
J	Bergstroem, B; Johnsen, IB; Nguyen, TT; Hagen, L; Slupphaug, G; Thommesen, L; Anthonsen, MW				Bergstroem, Bjarte; Johnsen, Ingvild B.; Nguyen, Thuy Thanh; Hagen, Lars; Slupphaug, Geir; Thommesen, Liv; Anthonsen, Marit W.			Identification of a Novel in Vivo Virus-targeted Phosphorylation Site in Interferon Regulatory Factor-3 (IRF3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; KAPPA-B; ACTIVATION; INFECTION; TRANSACTIVATION; RECOGNITION; ASSOCIATION; EPSILON; COMPLEX	The transcription factor interferon regulatory factor-3 (IRF3) regulates expression of type I interferon-beta and plays an important role in antiviral immunity. Despite the biological importance of IRF3, its in vivo phosphorylation pattern has not been reported. In this study, we have identified residues in IRF3 that are phosphorylated in vivo after infection with Sendai virus. We found that Sendai virus induced phosphorylation of the C-terminal residues Thr(390) and Ser(396), in addition to either Ser(385) or Ser(386). Moreover, Ser(173) and Ser(175) were constitutively phosphorylated. Ser(396) has previously been suggested to be the major target of the IRF3-activating kinase TBK1 (TANK-binding kinase-1), whereas Thr(390) has not previously been implicated in IRF3 regulation. Mutagenesis studies indicated that phosphorylation of Thr(390) promotes Ser(396) phosphorylation and binding to the coactivator cAMP-response element-binding protein. Taken together, our results show that IRF3 is subject to multiple interdependent phosphorylations, and we identify Thr(390) as a novel in vivo phosphorylation site that modulates the phosphorylation status of TBK1-targeted Ser(396).	[Anthonsen, Marit W.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, N-7006 Trondheim, Norway; [Hagen, Lars; Slupphaug, Geir; Thommesen, Liv] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7006 Trondheim, Norway; [Bergstroem, Bjarte; Thommesen, Liv] Sor Trondelag Univ Coll HiST, Fac Technol, N-7004 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Anthonsen, MW (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, N-7006 Trondheim, Norway.	Marit.W.Anthonsen@ntnu.no	Bergstrøm, Bjarte/H-8159-2016; Slupphaug, Geir/AAN-3794-2020	Bergstrøm, Bjarte/0000-0002-5042-6697; Bjellmo Johnsen, Ingvild/0000-0002-3520-6776; Slupphaug, Geir/0000-0002-7498-3500	National Programme for Research in Functional Genomics (FUGE) in Norway; Research Council of Norway; Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; Norwegian Cancer Society	National Programme for Research in Functional Genomics (FUGE) in Norway; Research Council of Norway(Research Council of Norway); Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the National Programme for Research in Functional Genomics (FUGE) in Norway (to M.W.A.), FUGE Mid-Norway (to M.W.A.), the Research Council of Norway (to M.W.A.), the Faculty of Medicine, Norwegian University of Science and Technology (to I.B.J. and M.W.A.), the Cancer Fund at St. Olavs Hospital (to M.W.A.), and the Norwegian Cancer Society.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Chen WJ, 2008, J MOL BIOL, V379, P251, DOI 10.1016/j.jmb.2008.03.050; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Johnsen IB, 2009, J BIOL CHEM, V284, P19122, DOI 10.1074/jbc.M808233200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Noyce RS, 2009, J VIROL, V83, P4013, DOI 10.1128/JVI.02069-08; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8	30	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24904	24914		10.1074/jbc.M109.084822	http://dx.doi.org/10.1074/jbc.M109.084822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20511230	hybrid, Green Published			2022-12-25	WOS:000280542100063
J	Hosomi, A; Tanabe, K; Hirayama, H; Kim, I; Rao, H; Suzuki, T				Hosomi, Akira; Tanabe, Kaori; Hirayama, Hiroto; Kim, Ikjin; Rao, Hai; Suzuki, Tadashi			Identification of an Htm1 (EDEM)-dependent, Mns1-independent Endoplasmic Reticulum-associated Degradation (ERAD) Pathway in Saccharomyces cerevisiae APPLICATION OF A NOVEL ASSAY FOR GLYCOPROTEIN ERAD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSIDASE-LIKE PROTEIN; PEPTIDE-N-GLYCANASE; QUALITY-CONTROL; MEMBRANE-PROTEIN; MISFOLDED GLYCOPROTEINS; CYTOPLASMIC PEPTIDE; UBIQUITIN-LIGASE; RETRO-TRANSLOCATION; ANCHORED PROTEINS; LUMINAL PROTEIN	Endoplasmic reticulum (ER)-associated degradation (ERAD) is a quality control system for newly synthesized proteins in the ER; nonfunctional proteins, which fail to form their correct folding state, are then degraded. The cytoplasmic peptide: N-glycanase is a deglycosylating enzyme that is involved in the ERAD and releases N-glycans from misfolded glycoproteins/glycopeptides. We have previously identified a mutant plant toxin protein, RTA (ricin A-chain nontoxic mutant), as the first in vivo Png1 (the cytoplasmic peptide: N-glycanase in Saccharomyces cerevisiae)-dependent ERAD substrate. Here, we report a new genetic device to assay the Png1-dependent ERAD pathway using the new model protein designated RTL (RTA-transmembrane-Leu2). Our extensive studies using different yeast mutants identified various factors involved in RTL degradation. The degradation of RTA/RTL was independent of functional Sec61 but was dependent on Der1. Interestingly, ER-mannosidase Mns1 was not involved in RTA degradation, but it was dependent on Htm1 (ERAD-related alpha-mannosidase in yeast) and Yos9 (a putative degradation lectin), indicating that mannose trimming by Mns1 is not essential for efficient ERAD of RTA/RTL. The newly established RTL assay will allow us to gain further insight into the mechanisms involved in the Png1-dependent ERAD-L pathway.	[Hosomi, Akira; Hirayama, Hiroto; Suzuki, Tadashi] RIKEN, Glycometabolome Team, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Tanabe, Kaori] Osaka Univ, Dept Biochem, 21st Century Ctr Excellence Program, Grad Sch Med, Suita, Osaka 5650871, Japan; [Kim, Ikjin; Rao, Hai] Univ Texas San Antonio, Dept Mol Med, Inst Biotechnol, Ctr Hlth, San Antonio, TX 78245 USA; [Suzuki, Tadashi] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Kawaguchi, Saitama 3320012, Japan	RIKEN; Osaka University; University of Texas System; University of Texas at San Antonio (UTSA); Japan Science & Technology Agency (JST)	Suzuki, T (corresponding author), RIKEN, Glycometabolome Team, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Suzuki, Tadashi/I-4536-2014; Suzuki, Tadashi/AAX-5707-2021; Hosomi, Akira/O-1538-2015; hirayama, hiroto/HCH-9202-2022	Suzuki, Tadashi/0000-0003-1030-7631; RAO, HAI/0000-0002-4235-2210; Hirayama, Hiroto/0000-0003-1909-9488	Global Center of Excellence Program; Ministry of Education, Culture, Sports, Science and Technology of Japan; RIKEN President's Discretionary Fund	Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN President's Discretionary Fund	This work was supported in part by the Global Center of Excellence Program (to A. H. and T. S.), grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and RIKEN President's Discretionary Fund (Strategic Programs for R&D) (to T. S.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Baker BM, 2007, J BIOL CHEM, V282, P26845, DOI 10.1074/jbc.M704315200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Heiligenstein S, 2006, EMBO J, V25, P4717, DOI 10.1038/sj.emboj.7601350; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Huttunen HJ, 2007, J BIOL CHEM, V282, P28285, DOI 10.1074/jbc.M702951200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Jolliffe NA, 2006, J BIOL CHEM, V281, P23377, DOI 10.1074/jbc.M602678200; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kim I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007604; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Knop M, 1996, YEAST, V12, P1229, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1229::AID-YEA15>3.0.CO;2-H; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, J CELL SCI, V112, P4123; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schwieger I, 2008, MOL PHARMACOL, V73, P697, DOI 10.1124/mol.107.040931; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Steel GJ, 1999, BIOCHEMISTRY-US, V38, P7764, DOI 10.1021/bi990315v; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2002, GLYCOBIOLOGY, V12, P803, DOI 10.1093/glycob/cwf095; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; [No title captured]	83	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24324	24334		10.1074/jbc.M109.095919	http://dx.doi.org/10.1074/jbc.M109.095919			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20511219	hybrid, Green Published			2022-12-25	WOS:000280542100004
J	Geeraert, C; Ratier, A; Pfisterer, SG; Perdiz, D; Cantaloube, I; Rouault, A; Pattingre, S; Proikas-Cezanne, T; Codogno, P; Pous, C				Geeraert, Camille; Ratier, Ameetha; Pfisterer, Simon G.; Perdiz, Daniel; Cantaloube, Isabelle; Rouault, Audrey; Pattingre, Sophie; Proikas-Cezanne, Tassula; Codogno, Patrice; Poues, Christian			Starvation-induced Hyperacetylation of Tubulin Is Required for the Stimulation of Autophagy by Nutrient Deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; IN-VIVO; DYNAMIC MICROTUBULES; MAMMALIAN AUTOPHAGY; DEPENDENT MOVEMENT; PUNCTA-FORMATION; KINESIN; FUSION; CELLS; LYSOSOMES	The molecular mechanisms underlying microtubule participation in autophagy are not known. In this study, we show that starvation-induced autophagosome formation requires the most dynamic microtubule subset. Upon nutrient deprivation, labile microtubules specifically recruit markers of autophagosome formation like class III-phosphatidylinositol kinase, WIPI-1, the Atg12-Atg5 conjugate, and LC3-I, whereas mature autophagosomes may bind to stable microtubules. We further found that upon nutrient deprivation, tubulin acetylation increases both in labile and stable microtubules and is required to allow autophagy stimulation. Tubulin hyperacetylation on lysine 40 enhances kinesin-1 and JIP-1 recruitment on microtubules and allows JNK phosphorylation and activation. JNK, in turn, triggers the release of Beclin 1 from Bcl-2-Beclin 1 complexes and its recruitment on microtubules where it may initiate autophagosome formation. Finally, although kinesin-1 functions to carry autophagosomes in basal conditions, it is not involved in motoring autophagosomes after nutrient deprivation. Our results show that the dynamics of microtubules and tubulin post-translational modifications play a major role in the regulation of starvation-induced autophagy.	[Poues, Christian] Univ Paris 11, Fac Pharm, JE 2493, IFR141, F-92296 Chatenay Malabry, France; [Pattingre, Sophie; Codogno, Patrice] Univ Paris 11, Fac Pharm, INSERM, IFR141,U 756, F-92290 Chatenay Malabry, France; [Poues, Christian] Hop Antoine Beclere, AP HP, F-92141 Clamart, France; [Proikas-Cezanne, Tassula] Univ Tubingen, Autophagy Lab, Inst Cell Biol, D-72076 Tubingen, Germany	UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Eberhard Karls University of Tubingen	Pous, C (corresponding author), Univ Paris 11, Fac Pharm, JE 2493, IFR141, 5 Rue JB Clement, F-92296 Chatenay Malabry, France.	christian.pous@u-psud.fr	Perdiz, Daniel/R-4471-2018; POÜS, Christian/R-5089-2018; Codogno, Patrice/G-1384-2013	Codogno, Patrice/0000-0002-5492-3180; POUS, Christian/0000-0002-2502-7854; Perdiz, Daniel/0000-0002-6804-5980; Pattingre, Sophie/0000-0001-6284-6050; Proikas-Cezanne, Prof. Dr. Tassula/0000-0001-6934-132X; Pfisterer, Simon Georg/0000-0001-5606-2102	INSERM; Association pour la Recherche sur le Cancer; Ministere de l'Enseignement Superieur et de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported in part by institutional funding from INSERM (to P. C.) and a grant from the Association pour la Recherche sur le Cancer (to S. G. P.).; Supported by a grant from the "Ministere de l'Enseignement Superieur et de la Recherche."	APLIN A, 1992, J CELL PHYSIOL, V152, P458, DOI 10.1002/jcp.1041520304; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Chaumorcel M, 2008, AUTOPHAGY, V4, P46, DOI 10.4161/auto.5184; Cieehomska IA, 2007, AUTOPHAGY, V3, P586, DOI 10.4161/auto.4843; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Daire V, 2009, J BIOL CHEM, V284, P31992, DOI 10.1074/jbc.M109.007906; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Giustiniani J, 2009, EXP CELL RES, V315, P3509, DOI 10.1016/j.yexcr.2009.07.018; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Gupta V, 2008, TRAFFIC, V9, P1850, DOI 10.1111/j.1600-0854.2008.00811.x; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; KUZNETSOV SA, 1987, FEBS LETT, V212, P145, DOI 10.1016/0014-5793(87)81574-0; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; MANN SS, 1994, J BIOL CHEM, V269, P11492; MARKS DL, 1994, J CELL SCI, V107, P2417; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Phung-Koskas T, 2005, J BIOL CHEM, V280, P1123, DOI 10.1074/jbc.M409918200; Pous C, 1998, J CELL BIOL, V142, P153, DOI 10.1083/jcb.142.1.153; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2009, METHOD ENZYMOL, V452, P247, DOI 10.1016/S0076-6879(08)03616-1; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Rubinsztein DC, 2005, AUTOPHAGY, V1, P177, DOI 10.4161/auto.1.3.2050; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; VOM DS, 2001, BIOCHEM J, V354, P31; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	59	127	134	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24184	24194		10.1074/jbc.M109.091553	http://dx.doi.org/10.1074/jbc.M109.091553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20484055	hybrid, Green Published			2022-12-25	WOS:000280291400068
J	Shiina, N; Tokunaga, M				Shiina, Nobuyuki; Tokunaga, Makio			RNA Granule Protein 140 (RNG140), a Paralog of RNG105 Localized to Distinct RNA Granules in Neuronal Dendrites in the Adult Vertebrate Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BINDING PROTEINS; TRANSLATION; DOMAIN; PHOSPHORYLATION; RECRUITMENT; STRESS; SITES	RNA granules mediate the transport and local translation of their mRNA cargoes, which regulate cellular processes such as stress response and neuronal synaptic plasticity. RNA granules contain specific RNA-binding proteins, including RNA granule protein 105 (RNG105), which is likely to participate in the transport and translation of mRNAs. In the present report, an RNG105 paralog, RNG140 is described. A homolog of RNG105/RNG140 is found in insects, echinoderms, and urochordates, whereas vertebrates have both of the two genes. RNG140 and RNG105 are similar in that both bind to mRNAs and inhibit translation in vitro, induce the formation of RNA granules, are most highly expressed in the brain, and are localized to dendritic RNA granules, part of which are accumulated at postsynapses. However, they differ in several characteristics; RNG105 is highly expressed in embryonic brains, whereas RNG140 is highly expressed in adult brains. Furthermore, the granules where RNG105 or RNG140 is localized are distinct RNA granules in both cultured cells and neuronal dendrites. Thus, RNG140 is an RNA-binding protein that shows different expression and localization patterns from RNG105. Knockdown experiments in cultured neurons also are performed, which demonstrate that suppression of RNG140 or RNG105 reduces dendrite length and spine density. Knockdown effects of RNG140 were not rescued by RNG105, and vise versa, suggesting distinct roles of RNG105 and RNG140. These results suggest that RNG140 has roles in the maintenance of the dendritic structure in the adult vertebrate brain through localizing to a kind of RNA granules that are distinct from RNG105-containing granules.	[Shiina, Nobuyuki] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Lab Neuronal Cell Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki; Tokunaga, Makio] Res Org Informat & Syst, Struct Biol Ctr, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Shiina, Nobuyuki; Tokunaga, Makio] SOKENDAI, Dept Genet, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki; Tokunaga, Makio] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Kanagawa 2268501, Japan; [Shiina, Nobuyuki] SOKENDAI, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Tokunaga, Makio] RIKEN, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Tokyo Institute of Technology; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); RIKEN	Shiina, N (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Lab Neuronal Cell Biol, Nishigonaka 38, Okazaki, Aichi 4448585, Japan.	nshiina@nibb.ac.jp; mtoku@bio.titech.ac.jp		Tokunaga, Makio/0000-0003-4586-8922; Shiina, Nobuyuki/0000-0002-1854-4239	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [20114004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. S. and M. T.).	Aerbajinai W, 2004, J BIOL CHEM, V279, P1916, DOI 10.1074/jbc.M305634200; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; Innamorati G, 2006, CELL SIGNAL, V18, P761, DOI 10.1016/j.cellsig.2005.11.004; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Knowles RB, 1996, J NEUROSCI, V16, P7812; NELSON HCM, 1995, CURR OPIN GENET DEV, V5, P180, DOI 10.1016/0959-437X(95)80006-9; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rupert PB, 2000, STRUCTURE, V8, pR99, DOI 10.1016/S0969-2126(00)00138-6; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 1999, MOL BIOL CELL, V10, P597, DOI 10.1091/mbc.10.3.597; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Strom AC, 1996, NUCLEIC ACIDS RES, V24, P1981, DOI 10.1093/nar/24.11.1981; Tacnet P, 2008, BBA-PROTEINS PROTEOM, V1784, P518, DOI 10.1016/j.bbapap.2007.12.005; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013	23	25	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24260	24269		10.1074/jbc.M110.108944	http://dx.doi.org/10.1074/jbc.M110.108944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516077	Green Published, hybrid			2022-12-25	WOS:000280291400075
J	Yamazaki, T; Takata, N; Uemura, M; Kawamura, Y				Yamazaki, Tomokazu; Takata, Naoki; Uemura, Matsuo; Kawamura, Yukio			Arabidopsis Synaptotagmin SYT1, a Type I Signal-anchor Protein, Requires Tandem C2 Domains for Delivery to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SYNAPTIC VESICLE; H+-ATPASE; LENGTH; LOCALIZATION; COMPARTMENT; EXOCYTOSIS; MOTIF; VII; TOPOGENESIS	The correct localization of integral membrane proteins to subcellular compartments is important for their functions. Synaptotagmin contains a single transmembrane domain that functions as a type I signal-anchor sequence in its N terminus and two calcium-binding domains (C(2)A and C2B) in its C terminus. Here, we demonstrate that the localization of an Arabidopsis synaptotagmin homolog, SYT1, to the plasma membrane ( PM) is modulated by tandem C2 domains. An analysis of the roots of a transformant-expressing green fluorescent protein-tagged SYT1 driven by native SYT1 promoter suggested that SYT1 is synthesized in the endoplasmic reticulum, and then delivered to the PM via the exocytotic pathway. We transiently expressed a series of truncated proteins in protoplasts, and determined that tandem C(2)A-C2B domains were necessary for the localization of SYT1 to the PM. The PM localization of SYT1 was greatly reduced following mutation of the calcium-binding motifs of the C2B domain, based on sequence comparisons with other homologs, such as endomembrane-localized SYT5. The localization of SYT1 to the PM may have been required for the functional divergence that occurred in the molecular evolution of plant synaptotagmins.	[Uemura, Matsuo; Kawamura, Yukio] Iwate Univ, Fac Agr, Cryobiofrontier Res Ctr, Morioka, Iwate 0208550, Japan; [Yamazaki, Tomokazu; Uemura, Matsuo; Kawamura, Yukio] Iwate Univ, 21st Century Ctr Excellence Program, Morioka, Iwate 0208550, Japan; [Takata, Naoki; Uemura, Matsuo; Kawamura, Yukio] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan	Iwate University; Iwate University; Iwate University	Kawamura, Y (corresponding author), Iwate Univ, Fac Agr, Cryobiofrontier Res Ctr, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	ykawa@iwate-u.ac.jp	Takata, Naoki/AAD-9822-2020; Uemura, Matsuo/B-1364-2012	Takata, Naoki/0000-0002-8479-8165; Uemura, Matsuo/0000-0003-0436-2976; Kawamura, Yukio/0000-0002-1498-5352	21st Century COE Program [K-03]; Ministry of Education, Culture, Sports, Science and Technology of Japan [18780242, 22780288, 20780229, 17380062]; Japan Society for the Promotion of Science [19.9498]; Iwate University	21st Century COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Iwate University	This work was supported by a grant from the 21st Century COE Program to Iwate University (K-03) and the Tohoku University Ecosystem Adaptive Global COE Program (J03) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grants-in-Aid for Scientific Research (18780242 and 22780288 to Y. K., 20780229 to T. Y., and 17380062 to M. U.), a grant from the Japan Society for the Promotion of Science (19.9498 to N. T.), and the President Fund of Iwate University.	Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Baluska F, 2000, DEV BIOL, V227, P618, DOI 10.1006/dbio.2000.9908; Benghezal M, 2000, PLANT CELL, V12, P1179, DOI 10.1105/tpc.12.7.1179; Berton F, 2000, EUR J NEUROSCI, V12, P1294, DOI 10.1046/j.1460-9568.2000.00013.x; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Brandizzi F, 2002, PLANT CELL, V14, P1077, DOI 10.1105/tpc.000620; Chae YK, 1998, J BIOL CHEM, V273, P25659, DOI 10.1074/jbc.273.40.25659; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Creutz CE, 2004, CELL MOL LIFE SCI, V61, P1208, DOI 10.1007/s00018-004-4029-8; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; daSilva LLP, 2005, PLANT CELL, V17, P132, DOI 10.1105/tpc.104.026351; Dasilva LLP, 2006, PLANT CELL, V18, P1477, DOI 10.1105/tpc.105.040394; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2004, J BIOL CHEM, V279, P52677, DOI 10.1074/jbc.M409241200; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; Grimberg E, 2003, J CELL SCI, V116, P145, DOI 10.1242/jcs.00186; Grise F, 2007, BIOCHEM J, V403, P483, DOI 10.1042/BJ20061182; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hanton SL, 2005, PLANT CELL, V17, P3081, DOI 10.1105/tpc.105.034900; HIGH S, 1991, J CELL BIOL, V113, P25, DOI 10.1083/jcb.113.1.25; Hutt DM, 2002, BIOL REPROD, V66, P50, DOI 10.1095/biolreprod66.1.50; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jimenez JL, 2007, PROTEINS, V68, P770, DOI 10.1002/prot.21449; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; Lam SK, 2009, PLANT J, V60, P865, DOI 10.1111/j.1365-313X.2009.04007.x; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; Lefebvre B, 2004, PLANT CELL, V16, P1772, DOI 10.1105/tpc.022277; Levius O, 1997, EUR J CELL BIOL, V73, P81; Lewis JD, 2010, P NATL ACAD SCI USA, V107, P2491, DOI 10.1073/pnas.0909080107; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Minami A, 2009, PLANT CELL PHYSIOL, V50, P341, DOI 10.1093/pcp/pcn202; Monterrat C, 2007, HISTOCHEM CELL BIOL, V127, P625, DOI 10.1007/s00418-007-0271-0; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Ohshima Y, 2001, PLANT CELL PHYSIOL, V42, P1119, DOI 10.1093/pcp/pce141; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; PALMGREN MG, 1990, PLANT PHYSIOL, V92, P871, DOI 10.1104/pp.92.4.871; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Ridge RW, 1999, PLANT CELL PHYSIOL, V40, P1253, DOI 10.1093/oxfordjournals.pcp.a029513; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Rojo E, 2008, PLANT PHYSIOL, V147, P1493, DOI 10.1104/pp.108.124552; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Ting JT, 2006, J NEUROSCI, V26, P372, DOI 10.1523/JNEUROSCI.3997-05.2006; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Watson RT, 2001, AM J PHYSIOL-CELL PH, V281, pC215, DOI 10.1152/ajpcell.2001.281.1.C215; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022	73	35	36	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23163	23174		10.1074/jbc.M109.084046	http://dx.doi.org/10.1074/jbc.M109.084046			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498364	Green Published, hybrid			2022-12-25	WOS:000279999900051
J	Suraneni, MV; Schneider-Broussard, R; Moore, JR; Davis, TC; Maldonado, CJ; Li, H; Newman, RA; Kusewitt, D; Hu, J; Yang, P; Tang, DG				Suraneni, M. V.; Schneider-Broussard, R.; Moore, J. R.; Davis, T. C.; Maldonado, C. J.; Li, H.; Newman, R. A.; Kusewitt, D.; Hu, J.; Yang, P.; Tang, D. G.			Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence	ONCOGENE			English	Article						15-lipoxygenase 2; prostate; hyperplasia; senescence; tumor suppression; stem cells	FUNCTIONAL TUMOR-SUPPRESSOR; ACTIVATED RECEPTOR-GAMMA; HUMAN BREAST-CANCER; INTRAEPITHELIAL NEOPLASIA; STEM-CELL; ELEVATED EXPRESSION; EPITHELIAL-CELLS; PROGENITOR CELLS; GENE-EXPRESSION; IN-VITRO	15-Lipoxygenase 2 (15-LOX2), a lipid-peroxidizing enzyme, is mainly expressed in the luminal compartment of the normal human prostate, and is often decreased or lost in prostate cancer. Previous studies from our lab implicate 15-LOX2 as a functional tumor suppressor. To better understand the biological role of 15-LOX2 in vivo, we generated prostate-specific 15-LOX2 transgenic mice using the ARR2PB promoter. Unexpectedly, transgenic expression of 15-LOX2 or 15-LOX2sv-b, a splice variant that lacks arachidonic acid-metabolizing activity, resulted in age-dependent prostatic hyperplasia and enlargement of the prostate. Prostatic hyperplasia induced by both 15-LOX2 and 15-LOX2sv-b was associated with an increase in luminal and Ki-67(+) cells; however, 15-LOX2-transgenic prostates also showed a prominent increase in basal cells. Microarray analysis revealed distinct gene expression profiles that could help explain the prostate phenotypes. Strikingly, 15-LOX2, but not 15-LOX2sv-b, transgenic prostate showed upregulation of several well-known stem or progenitor cell molecules including Sca-1, Trop2, p63, Nkx3.1 and Psca. Prostatic hyperplasia caused by both 15-LOX2 and 15-LOX2sv-b did not progress to prostatic intraprostate neoplasia or carcinoma and, mechanistically, prostate lobes (especially those of 15-LOX2 mice) showed a dramatic increase in senescent cells as revealed by increased SA-beta gal, p27(Kip1) and heterochromatin protein 1 gamma staining. Collectively, our results suggest that 15-LOX2 expression in mouse prostate leads to hyperplasia and also induces cell senescence, which may, in turn, function as a barrier to tumor development. Oncogene (2010) 29, 4261-4275; doi: 10.1038/onc.2010.197; published online 31 May 2010	[Suraneni, M. V.; Schneider-Broussard, R.; Moore, J. R.; Davis, T. C.; Maldonado, C. J.; Li, H.; Kusewitt, D.; Tang, D. G.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, Smithville, TX 78957 USA; [Newman, R. A.; Yang, P.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Hu, J.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Tang, D. G.] Univ Texas Grad Sch Biomed Sci, Program Mol Carcinogenesis, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Tang, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, 1808 Pk Rd,1C, Smithville, TX 78957 USA.	dtang@mdanderson.org	Kusewitt, Donna F/E-8107-2011; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174	NIH [R01-AG023374, R01-ES015888, R21-ES015893-01A1]; American Cancer Society [RSG MGO-105961]; Department of Defense [W81XWH-07-1-0616, W81XWH-08-1-0472]; Elsa Pardee Foundation; Center Grants [CCSG-5 P30 CA016672, ES07784]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015893, P30ES007784, R01ES015888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023374] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); Elsa Pardee Foundation; Center Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr R Matusik (Vanderbilt University) for providing the ARR2PB promoter, D Holowell for transgenic studies, Dr H Thames and K Lin for assistance in statistics, the Histology Core for help in IHC, Animal Facility Core for animal-related experiments, Molecular Biology Core, especially J Repass, for assistance in qPCR analysis, C Perez for assistance in LCM, S Gaddis, L Shen and S Tsavachidis for assistance in microarray analysis, Drs S Fischer and C Jeter for critically reading the paper and other members of the Tang lab for support and helpful discussions. This work was supported in part by grants from NIH (R01-AG023374, R01-ES015888 and R21-ES015893-01A1), American Cancer Society (RSG MGO-105961), Department of Defense (W81XWH-07-1-0616 and W81XWH-08-1-0472) and Elsa Pardee Foundation (DGT) and by two Center Grants (CCSG-5 P30 CA016672 and ES07784).	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Allred DC, 1998, MODERN PATHOL, V11, P155; Bhatia B, 2005, ONCOGENE, V24, P3583, DOI 10.1038/sj.onc.1208406; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Bhatia B, 2008, J BIOL CHEM, V283, P27957, DOI 10.1074/jbc.M803467200; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chen GG, 2003, INT J CANCER, V107, P837, DOI 10.1002/ijc.11447; Chen X, 2009, DIFFERENTIATION, V77, P324, DOI 10.1016/j.diff.2008.10.011; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Dillner K, 2003, ENDOCRINOLOGY, V144, P4955, DOI 10.1210/en.2003-0415; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Gonzalez AL, 2004, HUM PATHOL, V35, P840, DOI 10.1016/j.humpath.2004.04.001; Ibaragi S, 2009, MOL CANCER RES, V7, P415, DOI 10.1158/1541-7786.MCR-08-0137; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Jack GS, 2000, HUM PATHOL, V31, P1146, DOI 10.1053/hupa.2000.16670; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P235, DOI 10.1016/j.plefa.2006.01.009; Jisaka M, 1997, J BIOL CHEM, V272, P24410, DOI 10.1074/jbc.272.39.24410; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kasper S, 1998, LAB INVEST, V78, pI; Katona TM, 2005, CLIN CANCER RES, V11, P8358, DOI 10.1158/1078-0432.CCR-05-0962; Kelavkar UP, 2006, NEOPLASIA, V8, P510, DOI 10.1593/neo.06202; Kilty I, 1999, EUR J BIOCHEM, V266, P83, DOI 10.1046/j.1432-1327.1999.00818.x; Kim E, 2005, ONCOGENE, V24, P1174, DOI 10.1038/sj.onc.1208269; Kindblom J, 2003, ENDOCRINOLOGY, V144, P2269, DOI 10.1210/en.2002-0187; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Mahipal SVK, 2007, BIOCHEM PHARMACOL, V74, P202, DOI 10.1016/j.bcp.2007.04.005; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Masumori N, 2001, CANCER RES, V61, P2239; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Schweiger D, 2007, J LIPID RES, V48, P553, DOI 10.1194/jlr.M600311-JLR200; Shappell SB, 1999, AM J PATHOL, V155, P235, DOI 10.1016/S0002-9440(10)65117-6; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shappell SB, 2003, CANCER RES, V63, P2256; Shappell SB, 2001, J INVEST DERMATOL, V117, P36, DOI 10.1046/j.1523-1747.2001.01378.x; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Spindler SA, 1997, BIOCHEM BIOPH RES CO, V239, P775, DOI 10.1006/bbrc.1997.7471; Subbarayan V, 2006, ONCOGENE, V25, P6015, DOI 10.1038/sj.onc.1209617; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Tang DG, 2007, PROSTAG OTH LIPID M, V82, P135, DOI 10.1016/j.prostaglandins.2006.05.022; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; Tang Y, 2009, INT J CANCER, V124, P1545, DOI 10.1002/ijc.24118; Tran CP, 2002, MOL CANCER RES, V1, P113; Wang D, 2006, TUMOR BIOL, V27, P261, DOI 10.1159/000094761; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Xu XC, 2003, NEOPLASIA, V5, P121, DOI 10.1016/S1476-5586(03)80003-9; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	54	29	30	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2010	29	30					4261	4275		10.1038/onc.2010.197	http://dx.doi.org/10.1038/onc.2010.197			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20514017	Green Accepted			2022-12-25	WOS:000280547900003
J	Richardson, CR; Luo, QJ; Gontcharova, V; Jiang, YW; Samanta, M; Youn, E; Rock, CD				Richardson, Casey R.; Luo, Qing-Jun; Gontcharova, Viktoria; Jiang, Ying-Wen; Samanta, Manoj; Youn, Eunseog; Rock, Christopher D.			Analysis of Antisense Expression by Whole Genome Tiling Microarrays and siRNAs Suggests Mis-Annotation of Arabidopsis Orphan Protein-Coding Genes	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; CAP-BINDING COMPLEX; MESSENGER-RNA; NONCODING RNAS; WIDE ANALYSIS; COMPUTATIONAL PREDICTION; THALIANA MICRORNAS; REGULATORY ROLES; DNA METHYLATION; PLANT MICRORNAS	Background: MicroRNAs (miRNAs) and trans-acting small-interfering RNAs (tasi-RNAs) are small (20-22 nt long) RNAs (smRNAs) generated from hairpin secondary structures or antisense transcripts, respectively, that regulate gene expression by Watson-Crick pairing to a target mRNA and altering expression by mechanisms related to RNA interference. The high sequence homology of plant miRNAs to their targets has been the mainstay of miRNA prediction algorithms, which are limited in their predictive power for other kingdoms because miRNA complementarity is less conserved yet transitive processes (production of antisense smRNAs) are active in eukaryotes. We hypothesize that antisense transcription and associated smRNAs are biomarkers which can be computationally modeled for gene discovery. Principal Findings: We explored rice (Oryza sativa) sense and antisense gene expression in publicly available whole genome tiling array transcriptome data and sequenced smRNA libraries (as well as C. elegans) and found evidence of transitivity of MIRNA genes similar to that found in Arabidopsis. Statistical analysis of antisense transcript abundances, presence of antisense ESTs, and association with smRNAs suggests several hundred Arabidopsis 'orphan' hypothetical genes are non-coding RNAs. Consistent with this hypothesis, we found novel Arabidopsis homologues of some MIRNA genes on the antisense strand of previously annotated protein-coding genes. A Support Vector Machine (SVM) was applied using thermodynamic energy of binding plus novel expression features of sense/antisense transcription topology and siRNA abundances to build a prediction model of miRNA targets. The SVM when trained on targets could predict the "ancient'' (deeply conserved) class of validated Arabidopsis MIRNA genes with an accuracy of 84%, and 76% for "new'' rapidly-evolving MIRNA genes. Conclusions: Antisense and smRNA expression features and computational methods may identify novel MIRNA genes and other non-coding RNAs in plants and potentially other kingdoms, which can provide insight into antisense transcription, miRNA evolution, and post-transcriptional gene regulation.	[Richardson, Casey R.; Luo, Qing-Jun; Jiang, Ying-Wen; Rock, Christopher D.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Gontcharova, Viktoria; Youn, Eunseog] Texas Tech Univ, Dept Comp Sci, Lubbock, TX 79409 USA; [Samanta, Manoj] Systemix Inst, Redmond, WA USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Richardson, CR (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	chris.rock@ttu.edu		, Christopher/0000-0002-2090-0650	National Institutes of Health (NIH) [R21GM077245]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM077245] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R21GM077245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Ansari AZ, 2009, CRIT REV BIOCHEM MOL, V44, P50, DOI [10.1080/10409230902734044, 10.1080/10409230902734044 ]; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Backman TWH, 2008, NUCLEIC ACIDS RES, V36, pD982, DOI 10.1093/nar/gkm997; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Biemar F, 2006, P NATL ACAD SCI USA, V103, P12763, DOI 10.1073/pnas.0604484103; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Bulow L, 2009, NUCLEIC ACIDS RES, V37, pD983, DOI 10.1093/nar/gkn709; Burleigh SH, 1999, PLANT PHYSIOL, V119, P241, DOI 10.1104/pp.119.1.241; Carninci P, 2008, CURR OPIN CELL BIOL, V20, P274, DOI 10.1016/j.ceb.2008.03.008; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; CAWLEY GC, MATLAB SUPPORT VECTO; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chen J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-414; Chen XM, 2010, PLANT J, V61, P941, DOI 10.1111/j.1365-313X.2009.04089.x; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Dai XB, 2008, NUCLEIC ACIDS RES, V36, pW114, DOI 10.1093/nar/gkn297; Dallosso AR, 2007, RNA, V13, P2287, DOI 10.1261/rna.562907; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finocchiaro G, 2007, NUCLEIC ACIDS RES, V35, P1488, DOI 10.1093/nar/gkm027; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grinchuk OV, 2010, NUCLEIC ACIDS RES, V38, P534, DOI 10.1093/nar/gkp954; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; He HS, 2007, GENOME RES, V17, P1471, DOI 10.1101/gr.6611807; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Henz SR, 2007, PLANT PHYSIOL, V144, P1247, DOI 10.1104/pp.107.100396; Hilbricht T, 2008, NEW PHYTOL, V179, P877, DOI 10.1111/j.1469-8137.2008.02480.x; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Jiang SY, 2009, PLANT PHYSIOL, V150, P1997, DOI 10.1104/pp.109.139402; Jiao YL, 2008, PLANT CELL, V20, P2571, DOI 10.1105/tpc.108.062786; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Joung JG, 2009, BIOINFORMATICS, V25, P387, DOI 10.1093/bioinformatics/btn626; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Kato A, 1999, GENE, V239, P309, DOI 10.1016/S0378-1119(99)00403-5; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kurihara Y, 2008, BIOCHEM BIOPH RES CO, V376, P553, DOI 10.1016/j.bbrc.2008.09.046; Kurihara Y, 2009, PLANT CELL PHYSIOL, V50, P1715, DOI 10.1093/pcp/pcp109; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Lacombe S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-123; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lindow M, 2007, PLOS COMPUT BIOL, V3, P2379, DOI 10.1371/journal.pcbi.0030238; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Luo QJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000457; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; MacIntosh GC, 2001, PLANT PHYSIOL, V127, P765, DOI 10.1104/pp.010501; Mallory AC, 2008, TRENDS PLANT SCI, V13, P359, DOI 10.1016/j.tplants.2008.03.007; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marker C, 2002, CURR BIOL, V12, P2002, DOI 10.1016/S0960-9822(02)01304-0; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mhuantong W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-366; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Morris KV, 2009, EPIGENETICS-US, V4, P296, DOI 10.4161/epi.4.5.9282; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Nelson DC, 2007, FEBS LETT, V581, P3363, DOI 10.1016/j.febslet.2007.06.033; Ner-Gaon H, 2006, DNA RES, V13, P111, DOI 10.1093/dnares/dsl003; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Riano-Pachon DM, 2005, PLANT J, V43, P205, DOI 10.1111/j.1365-313X.2005.02438.x; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Song DD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S36; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Stolc V, 2005, P NATL ACAD SCI USA, V102, P4453, DOI 10.1073/pnas.0408203102; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, P13; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Taft RJ, 2009, CELL CYCLE, V8, P2332, DOI 10.4161/cc.8.15.9154; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Teramoto H, 1996, PLANT MOL BIOL, V32, P797, DOI 10.1007/BF00020478; Terryn N, 1998, GENE, V215, P11, DOI 10.1016/S0378-1119(98)00286-8; TISDALL JD, 2003, MASTERING PERL BIOIN, P377; Trask HW, 2009, RNA, V15, P1917, DOI 10.1261/rna.1677409; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2008, CURR OPIN PLANT BIOL, V11, P464, DOI 10.1016/j.pbi.2008.04.006; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; WU L, 2010, MOL CELL, DOI DOI 10.1016/J.MOLCEL.2010.1003.1008; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi H, 2007, PLANT CELL, V19, P2929, DOI 10.1105/tpc.107.051821; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	159	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10710	10.1371/journal.pone.0010710	http://dx.doi.org/10.1371/journal.pone.0010710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520764	Green Submitted, Green Published, gold			2022-12-25	WOS:000278221500004
J	Arora, G; Sajid, A; Gupta, M; Bhaduri, A; Kumar, P; Basu-Modak, S; Singh, Y				Arora, Gunjan; Sajid, Andaleeb; Gupta, Meetu; Bhaduri, Asani; Kumar, Pawan; Basu-Modak, Sharmila; Singh, Yogendra			Understanding the Role of PknJ in Mycobacterium tuberculosis: Biochemical Characterization and Identification of Novel Substrate Pyruvate Kinase A	PLOS ONE			English	Article							SERINE/THREONINE PROTEIN-KINASE; CELL-DIVISION; SER/THR KINASE; ESCHERICHIA-COLI; STRESS-RESPONSE; IN-VIVO; PHOSPHORYLATION; ACTIVATION; INFECTION; SEQUENCE	Reversible protein phosphorylation is a prevalent signaling mechanism which modulates cellular metabolism in response to changing environmental conditions. In this study, we focus on previously uncharacterized Mycobacterium tuberculosis Ser/Thr protein kinase (STPK) PknJ, a putative transmembrane protein. PknJ is shown to possess autophosphorylation activity and is also found to be capable of carrying out phosphorylation on the artificial substrate myelin basic protein (MyBP). Previous studies have shown that the autophosphorylation activity of M. tuberculosis STPKs is dependent on the conserved residues in the activation loop. However, our results show that apart from the conventional conserved residues, additional residues in the activation loop may also play a crucial role in kinase activation. Further characterization of PknJ reveals that the kinase utilizes unusual ions (Ni2+, Co2+) as cofactors, thus hinting at a novel mechanism for PknJ activation. Additionally, as shown for other STPKs, we observe that PknJ possesses the capability to dimerize. In order to elucidate the signal transduction cascade emanating from PknJ, the M. tuberculosis membrane-associated protein fraction is treated with the active kinase and glycolytic enzyme Pyruvate kinase A (mtPykA) is identified as one of the potential substrates of PknJ. The phospholabel is found to be localized on serine and threonine residue(s), with Ser(37) identified as one of the sites of phosphorylation. Since Pyk is known to catalyze the last step of glycolysis, our study shows that the fundamental pathways such as glycolysis can also be governed by STPK-mediated signaling.	[Arora, Gunjan; Sajid, Andaleeb; Gupta, Meetu; Bhaduri, Asani; Kumar, Pawan; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi, India; [Arora, Gunjan; Basu-Modak, Sharmila] Univ Delhi, Dept Zool, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi	Arora, G (corresponding author), CSIR, Inst Genom & Integrat Biol, Delhi, India.	ysingh@igib.res.in	Sajid, Andaleeb/AAI-2960-2020; Kumar, Pawan/GXF-7072-2022; Arora, Gunjan/AAL-3448-2020	Sajid, Andaleeb/0000-0001-6248-4985; Arora, Gunjan/0000-0003-0575-6205	Council of Industrial Research, Government of India [NWP 0038]	Council of Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Funding: This work was supported by a grant (NWP 0038) from the Council of Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Campbell DR, 2007, J BIOL CHEM, V282, P32298, DOI 10.1074/jbc.M703451200; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chavadi S, 2009, J BACTERIOL, V191, P7545, DOI 10.1128/JB.00619-09; Chopra P, 2003, BIOCHEM BIOPH RES CO, V311, P112, DOI 10.1016/j.bbrc.2003.09.173; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Gay LM, 2006, J MOL BIOL, V360, P409, DOI 10.1016/j.jmb.2006.05.015; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Gopalaswamy R, 2009, FEMS MICROBIOL LETT, V295, P23, DOI 10.1111/j.1574-6968.2009.01570.x; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; ISHIBASHI H, 1978, J BIOL CHEM, V253, P8767; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Lu TJ, 2005, J INORG BIOCHEM, V99, P1306, DOI 10.1016/j.jinorgbio.2005.03.003; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Peirs P, 1997, EUR J BIOCHEM, V244, P604, DOI 10.1111/j.1432-1033.1997.00604.x; Portela P, 2006, BIOCHEM J, V396, P117, DOI 10.1042/BJ20051642; SAEKI T, 1974, J BIOCHEM-TOKYO, V76, P631, DOI 10.1093/oxfordjournals.jbchem.a130607; SCHWORER CM, 1985, J BIOL CHEM, V260, P3018; Shankar S, 1997, MOL MICROBIOL, V24, P477, DOI 10.1046/j.1365-2958.1997.3491724.x; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Singh A, 2006, TUBERCULOSIS, V86, P28, DOI 10.1016/j.tube.2005.04.002; Sinha S, 2005, MICROBIOL-SGM, V151, P2411, DOI 10.1099/mic.0.27799-0; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Voet D, 2006, FUNDAMENTALS BIOCH; Vohra Reena, 2006, Recent Pat Antiinfect Drug Discov, V1, P95, DOI 10.2174/157489106775244127; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Xiong Y, 2005, J PROTEOME RES, V4, P855, DOI 10.1021/pr0500049	57	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10772	10.1371/journal.pone.0010772	http://dx.doi.org/10.1371/journal.pone.0010772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520732	Green Submitted, Green Published, gold			2022-12-25	WOS:000278034600006
J	Bandera, A; Ferrario, G; Saresella, M; Marventano, I; Soria, A; Zanini, F; Sabbatini, F; Airoldi, M; Marchetti, G; Franzetti, F; Trabattoni, D; Clerici, M; Gori, A				Bandera, Alessandra; Ferrario, Giulio; Saresella, Marina; Marventano, Ivana; Soria, Alessandro; Zanini, Fabio; Sabbatini, Francesca; Airoldi, Monica; Marchetti, Giulia; Franzetti, Fabio; Trabattoni, Daria; Clerici, Mario; Gori, Andrea			CD4+T Cell Depletion, Immune Activation and Increased Production of Regulatory T Cells in the Thymus of HIV-Infected Individuals	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; LYMPHOID-TISSUES; GASTROINTESTINAL-TRACT; PERIPHERAL-BLOOD; SIV INFECTION; IN-VITRO; CD4(+); RECONSTITUTION; THYMOPOIESIS	Mechanisms by which HIV affects the thymus are multiple and only partially known, and the role of thymic dysfunction in HIV/AIDS immunopathogenesis remains poorly understood. To evaluate the effects of HIV infection on intra-thymic precursors of T cells in HIV-infected adults, we conducted a detailed immunophenotypic study of thymic tissue isolated from 7 HIV-infected and 10 HIV-negative adults who were to undergo heart surgery. We found that thymuses of HIV-infected individuals were characterized by a relative depletion of CD4+ single positive T cells and a corresponding enrichment of CD8+ single positive T cells. In addition, thymocytes derived from HIV-infected subjects showed increased levels of activated and proliferating cells. Our analysis also revealed a decreased expression of interleukin-7 receptor in early thymocytes from HIV-infected individuals, along with an increase in this same expression in mature double-and single-positive cells. Frequency of regulatory T cells (CD25+FoxP3+) was significantly increased in HIV-infected thymuses, particularly in priorly-committed CD4 single positive cells. Our data suggest that HIV infection is associated with a complex set of changes in the immunophenotype of thymocytes, including a reduction of intrathymic CD4+ T cell precursors, increased expression of activation markers, changes in the expression pattern of IL-7R and enrichment of T regulatory cells generation.	[Bandera, Alessandra; Soria, Alessandro; Sabbatini, Francesca; Airoldi, Monica; Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy; [Ferrario, Giulio; Zanini, Fabio; Franzetti, Fabio] Univ Milan, Luigi Sacco Hosp, Dept Clin Sci, Infect Dis Sect, Milan, Italy; [Saresella, Marina; Marventano, Ivana; Clerici, Mario] Don C Gnocchi Fdn IRCCS, Milan, Italy; [Marchetti, Giulia] Univ Milan, San Paolo Hosp, Clin Infect Dis, Milan, Italy; [Trabattoni, Daria] Univ Milan, Dept Preclin Sci, LITA VIALBA, Chair Immunol, Milan, Italy; [Clerici, Mario] Univ Milan, Dept Biomed Sci & Technol, Chair Immunol, I-20133 Milan, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of Milan; Luigi Sacco Hospital; IRCCS Fondazione Don Carlo Gnocchi Onlus; San Paolo-Polo Universitaria Hospital; University of Milan; University of Milan; University of Milan	Bandera, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy.	a.bandera@hsgerardo.org	Bandera, Alessandra/AAC-6081-2022; Bandera, Alessandra/D-6255-2015; franzetti, fabio/AAK-9158-2020; Saresella, Marina/G-7810-2012; Trabattoni, Daria/G-7424-2012; Marchetti, Giulia/GPX-7655-2022; Gori, Andrea/AAC-6078-2022; MARCHETTI, GIULIA CARLA/K-4384-2018	franzetti, fabio/0000-0001-9253-4453; Saresella, Marina/0000-0002-2295-3043; Trabattoni, Daria/0000-0001-9535-3359; BANDERA, ALESSANDRA/0000-0001-9440-4601; Bandera, Alessandra/0000-0003-1626-0328; SORIA, Alessandro/0000-0002-4447-2574; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; Clerici, Mario/0000-0001-5920-6191; Marventano, Ivana/0000-0001-8111-3522	Cariplo Foundation [2006.0687/10.4877]; "Ermenegildo Zegna" Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	Cariplo Foundation(Fondazione Cariplo); "Ermenegildo Zegna" Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	Funding: The present study was funded by a grant from Cariplo Foundation (2006.0687/10.4877), "Ermenegildo Zegna" Foundation, Italy, and Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; BASKIN GB, 1991, LAB INVEST, V65, P400; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, J VIROL, V80, P6801, DOI 10.1128/JVI.00070-06; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fernandez S, 2006, AIDS RES HUM RETROV, V22, P163, DOI 10.1089/aid.2006.22.163; Franco JM, 2002, BLOOD, V99, P3702, DOI 10.1182/blood.V99.10.3702; GRODY WW, 1985, AM J CLIN PATHOL, V84, P85, DOI 10.1093/ajcp/84.1.85; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI200522492; Hardy G, 2004, HIV MED, V5, P67, DOI 10.1111/j.1468-1293.2004.00187.x; Haynes BF, 1999, J CLIN INVEST, V103, P453, DOI 10.1172/JCI5201; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; HELLER DE, 1999, REV AFRICAN AM ED, V1, P5; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; JOSHI VV, 1986, ARCH PATHOL LAB MED, V110, P837; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Lee JC, 2006, AIDS, V20, P667, DOI 10.1097/01.aids.0000216366.46195.81; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Markert ML, 2001, AIDS RES HUM RETROV, V17, P1635, DOI 10.1089/088922201753342040; Napolitano LA, 2003, J IMMUNOL, V171, P645, DOI 10.4049/jimmunol.171.2.645; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Nolte MA, 2005, NAT IMMUNOL, V6, P412, DOI 10.1038/ni1174; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; PAPIERNIK M, 1992, PEDIATRICS, V89, P297; Plum J, 1996, BLOOD, V88, P4239; Ruiz-Mateos E, 2004, CLIN EXP IMMUNOL, V136, P501, DOI 10.1111/j.1365-2249.2004.02474.x; Scoggins RM, 2000, J VIROL, V74, P3205, DOI 10.1128/JVI.74.7.3205-3216.2000; Siliciano JD, 2000, J CLIN INVEST, V106, P823, DOI 10.1172/JCI11246; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sodora DL, 2000, EUR J IMMUNOL, V30, P1145, DOI 10.1002/(SICI)1521-4141(200004)30:4<1145::AID-IMMU1145>3.0.CO;2-7; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Zaitseva MB, 1998, J IMMUNOL, V161, P3103	43	37	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10788	10.1371/journal.pone.0010788	http://dx.doi.org/10.1371/journal.pone.0010788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520721	Green Published, Green Submitted, gold			2022-12-25	WOS:000278034600014
J	Yang, JC; Gao, C; Chai, L; Ma, YP				Yang, Jianchang; Gao, Chong; Chai, Li; Ma, Yupo			A Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells	PLOS ONE			English	Article							TOWNES-BROCKS-SYNDROME; RENAL-OCULAR SYNDROME; RADIAL RAY SYNDROME; OKIHIRO-SYNDROME; KIDNEY DEVELOPMENT; MURINE HOMOLOG; GENE; SALL1; MUTATIONS; NANOG	Background: SALL4 is a member of the SALL gene family that encodes a group of putative developmental transcription factors. Murine Sall4 plays a critical role in maintaining embryonic stem cell (ES cell) pluripotency and self-renewal. We have shown that Sall4 activates Oct4 and is a master regulator in murine ES cells. Other SALL gene members, especially Sall1 and Sall3 are expressed in both murine and human ES cells, and deletions of these two genes in mice lead to perinatal death due to developmental defects. To date, little is known about the molecular mechanisms controlling the regulation of expressions of SALL4 or other SALL gene family members. Methodology/Principal Findings: This report describes a novel SALL4/OCT4 regulator feedback loop in ES cells in balancing the proper expression dosage of SALL4 and OCT4 for the maintenance of ESC stem cell properties. While we have observed that a positive feedback relationship is present between SALL4 and OCT4, the strong self-repression of SALL4 seems to be the "break'' for this loop. In addition, we have shown that SALL4 can repress the promoters of other SALL family members, such as SALL1 and SALL3, which competes with the activation of these two genes by OCT4. Conclusions/Significance: Our findings, when taken together, indicate that SALL4 is a master regulator that controls its own expression and the expression of OCT4. SALL4 and OCT4 work antagonistically to balance the expressions of other SALL gene family members. This novel SALL4/OCT4 transcription regulation feedback loop should provide more insight into the mechanism of governing the "stemness'' of ES cells.	[Yang, Jianchang; Ma, Yupo] Nevada Canc Inst, Div Lab Med, Las Vegas, NV USA; [Gao, Chong; Chai, Li] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Yang, JC (corresponding author), Nevada Canc Inst, Div Lab Med, Las Vegas, NV USA.	lchai@partners.org; yma@nvcancer.org		Chai, Li/0000-0003-1937-4750	Leukemia & Lymphoma Society [3366-09]; NIH [R01HL087948, R21CA131522, RO1HL092437]; NATIONAL CANCER INSTITUTE [R21CA131522] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087948, R01HL092437] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Leukemia & Lymphoma Society special fellow award (3366-09) (to J.Y.), the NIH under grants R01HL087948, NIH R21CA131522 (to Y.M.) and RO1HL092437 (to L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Chai L, 2006, J BIOL CHEM, V281, P18918, DOI 10.1074/jbc.M600180200; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Haus AH, 2008, OPHTHALMOLOGE, V105, P588, DOI 10.1007/s00347-007-1633-7; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Kohlhase J, 2003, J MED GENET, V40, P473, DOI 10.1136/jmg.40.7.473; Kohlhase J, 1999, GENOMICS, V62, P216, DOI 10.1006/geno.1999.6005; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Li SSL, 2006, STEM CELLS DEV, V15, P532, DOI 10.1089/scd.2006.15.532; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Paradisi I, 2007, AM J MED GENET A, V143A, P326, DOI 10.1002/ajmg.a.31603; Parrish M, 2004, MOL CELL BIOL, V24, P7102, DOI 10.1128/MCB.24.16.7102-7112.2004; Powell CM, 1999, J MED GENET, V36, P89; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	28	99	117	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10766	10.1371/journal.pone.0010766	http://dx.doi.org/10.1371/journal.pone.0010766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505821	Green Submitted, Green Published, gold			2022-12-25	WOS:000278017400024
J	Sabatelli, L				Sabatelli, Lorenzo			Effect of Heterogeneous Mixing and Vaccination on the Dynamics of Anthelmintic Resistance: A Nested Model	PLOS ONE			English	Article							HOOKWORM INFECTION; DRUG-RESISTANCE; PARASITE TRANSMISSION; DENSITY-DEPENDENCE; EFFICACY; POPULATION; VACCINES; MALARIA; PREDISPOSITION; EPIDEMIOLOGY	Anthelmintic resistance is a major threat to current measures for helminth control in humans and animals. The introduction of anthelmintic vaccines, as a complement to or replacement for drug treatments, has been advocated as a preventive measure. Here, a computer-based simulation, tracking the dynamics of hosts, parasites and parasite-genes, shows that, depending on the degree of host-population mixing, the frequency of totally recessive autosomes associated with anthelmintic resistance can follow either a fast dynamical regime with a low equilibrium point or a slow dynamical regime with a high equilibrium point. For fully dominant autosomes, only one regime is predicted. The effectiveness of anthelminthic vaccines against resistance is shown to be strongly influenced by the underlying dynamics of resistant autosomes. Vaccines targeting adult parasites, by decreasing helminth fecundity or lifespan, are predicted to be more effective than vaccines targeting parasite larvae, by decreasing host susceptibility to infection, in reducing the spread of resistance. These results may inform new strategies to prevent, monitor and control the spread of anthelmintic resistance, including the development of viable anthelmintic vaccines.	[Sabatelli, Lorenzo] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Sabatelli, L (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Dept Global Hlth, Seattle, WA 98195 USA.	lsabatel@fhcrc.org						Albonico M, 2005, INT J PARASITOL, V35, P803, DOI 10.1016/j.ijpara.2005.02.016; Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Albonico M, 2003, ACTA TROP, V86, P233, DOI 10.1016/S0001-706X(03)00043-3; ALBONICO M, 1995, T ROY SOC TROP MED H, V89, P538, DOI 10.1016/0035-9203(95)90101-9; ANDERSON R M, 1991; Anderson R.M., 1982, P67; ANDERSON RM, 1985, T ROY SOC TROP MED H, V79, P812, DOI 10.1016/0035-9203(85)90128-2; ANDERSON RM, 1985, ADV PARASITOLOGY, V24; [Anonymous], 2006, PREV CHEM HUM HELM C; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Bethony J, 2005, FASEB J, V19, P1743, DOI 10.1096/fj.05-3936fje; Bethony J, 2002, CLIN INFECT DIS, V35, P1336, DOI 10.1086/344268; BRADLEY M, 1992, T ROY SOC TROP MED H, V86, P73, DOI 10.1016/0035-9203(92)90448-L; BUNDY DAP, 1995, PARASITOLOGY, V110, pS51, DOI 10.1017/S0031182000001499; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Churcher TS, 2008, EVOLUTION, V62, P528, DOI 10.1111/j.1558-5646.2007.00290.x; Cornell SJ, 2003, P NATL ACAD SCI USA, V100, P7401, DOI 10.1073/pnas.0832206100; DIETZ K, 1988, PARASITOL TODAY, V4, P91, DOI 10.1016/0169-4758(88)90034-8; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; Goud GN, 2005, VACCINE, V23, P4754, DOI 10.1016/j.vaccine.2005.04.040; HADELER KP, 1983, COMPUT MATH APPL, V9, P415, DOI 10.1016/0898-1221(83)90056-1; Halloran ME, 1999, EPIDEMIOL REV, V21, P73, DOI 10.1093/oxfordjournals.epirev.a017990; Hartwell L., 2018, GENETICS GENES GENOM; Hotez PJ, 2006, TRENDS PARASITOL, V22, P327, DOI 10.1016/j.pt.2006.05.004; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; MEDLEY GF, 1993, PARASITOLOGY, V106, P211, DOI 10.1017/S0031182000075016; Montresor A., 1998, WORLD HLTH ORG; Mzilahowa T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000613; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Quinnell RJ, 2004, J INFECT DIS, V190, P430, DOI 10.1086/422256; Quinnell RJ, 2001, T ROY SOC TROP MED H, V95, P139, DOI 10.1016/S0035-9203(01)90138-5; QUINNELL RJ, 1993, PARASITOLOGY, V106, P379, DOI 10.1017/S0031182000067123; Sabatelli L, 2008, J R SOC INTERFACE, V5, P1329, DOI 10.1098/rsif.2007.1255; Schad G. A., 1984, Tropical and geographical medicine., P359; SCHAD GA, 1985, SCIENCE, V228, P1537, DOI 10.1126/science.4012307; Schwab AE, 2007, PARASITOLOGY, V134, P1025, DOI 10.1017/S0031182007002363; SHIELD JM, 1981, PAPUA NEW GUINEA MED, V24, P19; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; SMITH PG, 1984, INT J EPIDEMIOL, V13, P87, DOI 10.1093/ije/13.1.87; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith WD, 2006, VET PARASITOL, V139, P347, DOI 10.1016/j.vetpar.2006.04.024; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WIJFFELS GL, 1994, EXP PARASITOL, V78, P132, DOI 10.1006/expr.1994.1014; Zhang WY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-206	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10686	10.1371/journal.pone.0010686	http://dx.doi.org/10.1371/journal.pone.0010686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502690	Green Published, gold, Green Submitted			2022-12-25	WOS:000277776500004
J	Baldridge, D; Lennington, J; Weis, M; Homan, EP; Jiang, MM; Munivez, E; Keene, DR; Hogue, WR; Pyott, S; Byers, PH; Krakow, D; Cohn, DH; Eyre, DR; Lee, B; Morello, R				Baldridge, Dustin; Lennington, Jennifer; Weis, MaryAnn; Homan, Erica P.; Jiang, Ming-Ming; Munivez, Elda; Keene, Douglas R.; Hogue, William R.; Pyott, Shawna; Byers, Peter H.; Krakow, Deborah; Cohn, Daniel H.; Eyre, David R.; Lee, Brendan; Morello, Roy			Generalized Connective Tissue Disease in Crtap-/- Mouse	PLOS ONE			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; CARTILAGE-ASSOCIATED PROTEIN; PULMONARY HYPOPLASIA; COLLAGEN; MUTATION; SKIN; DEFICIENCY; DISORDERS; FIBRILS; COL5A1	Mutations in CRTAP (coding for cartilage-associated protein), LEPRE1 (coding for prolyl 3-hydroxylase 1 [P3H1]) or PPIB (coding for Cyclophilin B [CYPB]) cause recessive forms of osteogenesis imperfecta and loss or decrease of type I collagen prolyl 3-hydroxylation. A comprehensive analysis of the phenotype of the Crtap-/- mice revealed multiple abnormalities of connective tissue, including in the lungs, kidneys, and skin, consistent with systemic dysregulation of collagen homeostasis within the extracellular matrix. Both Crtap-/- lung and kidney glomeruli showed increased cellular proliferation. Histologically, the lungs showed increased alveolar spacing, while the kidneys showed evidence of segmental glomerulosclerosis, with abnormal collagen deposition. The Crtap-/- skin had decreased mechanical integrity. In addition to the expected loss of proline 986 3-hydroxylation in alpha 1(I) and alpha 1(II) chains, there was also loss of 3Hyp at proline 986 in alpha 2(V) chains. In contrast, at two of the known 3Hyp sites in alpha 1(IV) chains from Crtap-/- kidneys there were normal levels of 3-hydroxylation. On a cellular level, loss of CRTAP in human OI fibroblasts led to a secondary loss of P3H1, and vice versa. These data suggest that both CRTAP and P3H1 are required to maintain a stable complex that 3-hydroxylates canonical proline sites within clade A (types I, II, and V) collagen chains. Loss of this activity leads to a multi-systemic connective tissue disease that affects bone, cartilage, lung, kidney, and skin.	[Baldridge, Dustin; Lennington, Jennifer; Homan, Erica P.; Jiang, Ming-Ming; Munivez, Elda; Lee, Brendan; Morello, Roy] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Weis, MaryAnn; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Keene, Douglas R.] Shriners Hosp Children, Portland, OR 97201 USA; [Hogue, William R.] Univ Arkansas Med Sci, Ctr Orthopaed Res, Little Rock, AR 72205 USA; [Pyott, Shawna; Byers, Peter H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Byers, Peter H.] Univ Washington, Dept Med, Seattle, WA USA; [Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90095 USA; [Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; University of Washington; University of Washington Seattle; University of Arkansas System; University of Arkansas Medical Sciences; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute	Baldridge, D (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.edu	Krakow, Deborah/B-5778-2009	Krakow, Deborah/0000-0001-9906-4968; Byers, Peter H./0000-0001-7786-7030	NIH [AR051459, HD022657, DE1771, AR36794]; Baylor College of Medicine IDDRC [HD024064]; Osteogenesis Imperfecta Foundation; Rolanette and Berdon Lawrence Bone Disease Program of Texas; Freudmann Fund at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036794, R37AR037318, R01AR036794, R03AR051459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine IDDRC; Osteogenesis Imperfecta Foundation; Rolanette and Berdon Lawrence Bone Disease Program of Texas; Freudmann Fund at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grants AR051459 (RM), HD022657 (BL, DHC, DK, DRE), DE1771 (BL), AR36794 (DRE), the Baylor College of Medicine IDDRC HD024064 (BL), the Osteogenesis Imperfecta Foundation (RM, SP, PHB), the Rolanette and Berdon Lawrence Bone Disease Program of Texas (BL, RM), and the Freudmann Fund at the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; BIRK DE, 1990, J CELL SCI, V95, P649; Bodian DL, 2009, HUM MOL GENET, V18, P463, DOI 10.1093/hmg/ddn374; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; Burnei G, 2008, J AM ACAD ORTHOP SUR, V16, P356, DOI 10.5435/00124635-200806000-00008; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; CHANG W, 2009, HUM MOL GENET; Cheung MS, 2008, REV ENDOCR METAB DIS, V9, P153, DOI 10.1007/s11154-008-9074-4; CHINES A, 1995, BONE, V16, P333, DOI 10.1016/8756-3282(94)00046-8; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; FALVO KA, 1973, J BONE JOINT SURG AM, VA 55, P275, DOI 10.2106/00004623-197355020-00003; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Hakim AJ, 2006, CLIN DERMATOL, V24, P521, DOI 10.1016/j.clindermatol.2006.07.013; Hansen B, 2002, ARCH DERMATOL, V138, P909, DOI 10.1001/archderm.138.7.909; HOLBROOK KA, 1982, J INVEST DERMATOL, V79, pS7, DOI 10.1111/1523-1747.ep12544609; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Kypreos KE, 2000, J CELL BIOCHEM, V80, P146; McAllion SJ, 1996, J CLIN PATHOL, V49, P627, DOI 10.1136/jcp.49.8.627; McComb JG, 2008, AM J PATHOL, V173, P949, DOI 10.2353/ajpath.2008.071034; Morello R, 1999, MATRIX BIOL, V18, P319, DOI 10.1016/S0945-053X(99)00002-5; Morello R, 2008, J CELL PHYSIOL, V217, P127, DOI 10.1002/jcp.21483; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; PENTTINEN RP, 1975, P NATL ACAD SCI USA, V72, P586, DOI 10.1073/pnas.72.2.586; Phillips CL, 2002, KIDNEY INT, V62, P383, DOI 10.1046/j.1523-1755.2002.00451.x; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; SHAPIRO JR, 1989, BONE, V10, P165, DOI 10.1016/8756-3282(89)90049-5; Thibeault DW, 1995, PEDIATR PULM, V20, P301, DOI 10.1002/ppul.1950200508; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; VANDIJK FS, 2009, EUR J HUM GENET; VETTER U, 1989, EUR J PEDIATR, V149, P184, DOI 10.1007/BF01958277; VRANKA JA, 2004, J BIOL CHEM; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Widmann RF, 1999, SPINE, V24, P1673, DOI 10.1097/00007632-199908150-00008; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729	39	50	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10560	10.1371/journal.pone.0010560	http://dx.doi.org/10.1371/journal.pone.0010560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485499	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563200003
J	Kriehuber, T; Rattei, T; Weinmaier, T; Bepperling, A; Haslbeck, M; Buchner, J				Kriehuber, Thomas; Rattei, Thomas; Weinmaier, Thomas; Bepperling, Alexander; Haslbeck, Martin; Buchner, Johannes			Independent evolution of the core domain and its flanking sequences in small heat shock proteins	FASEB JOURNAL			English	Article						alpha-crystallin; protein folding; Hsp20; protein evolution	ALPHA-CRYSTALLIN; MOLECULAR CHAPERONES; MULTIDOMAIN PROTEINS; UNFOLDING PROTEINS; SUBUNIT EXCHANGE; STRESS-PROTEINS; FAMILY; HSP25; DIVERSITY; GENOMES	Small heat shock proteins (sHsps) are molecular chaperones involved in maintaining protein homeostasis; they have also been implicated in protein folding diseases and in cancer. In this protein family, a conserved core domain, the so-called alpha-crystallin or Hsp20 domain, is flanked by highly variable, nonconserved sequences that are essential for chaperone function. Analysis of 8714 sHsps revealed a broad variation of primary sequences within the superfamily as well as phyla-dependent differences. Significant variations were found in the number of sHsps per genome, their amino acid composition, and the length distribution of the different sequence parts. Reconstruction of the evolutionary tree for the sHsp superfamily shows that the flanking regions fall into several subgroups, indicating that they were remodeled several times in parallel but independent of the evolution of the alpha-crystallin domain. The evolutionary history of sHsps is thus set apart from that of other protein families in that two exon boundary-independent strategies are combined: the evolution of the conserved alpha-crystallin domain and the independent evolution of the N- and C-terminal sequences. This scenario allows for increased variability in specific small parts of the protein and thus promotes functional and structural differentiation of sHsps, which is not reflected in the general evolutionary tree of species.-Kriehuber, T., Rattei, T., Weinmaier, T., Bepperling, A., Haslbeck, M., Buchner, J. Independent evolution of the core domain and its flanking sequences in small heat shock proteins. FASEB J. 24, 3633-3642 (2010). www.fasebj.org	[Kriehuber, Thomas; Bepperling, Alexander; Haslbeck, Martin; Buchner, Johannes] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany; [Kriehuber, Thomas; Bepperling, Alexander; Haslbeck, Martin; Buchner, Johannes] Tech Univ Munich, Munich Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Rattei, Thomas; Weinmaier, Thomas] Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephan, D-8050 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany.	t.rattei@wzw.tum.de; johannes.buchner@ch.tum.de	Buchner, Johannes/A-2651-2010; Rattei, Thomas/F-1366-2011; Weinmaier, Thomas/K-5780-2013; Haslbeck, Martin/A-4413-2013	Rattei, Thomas/0000-0002-0592-7791; Weinmaier, Thomas/0000-0002-9552-3220; Buchner, Johannes/0000-0003-1282-7737	Deutsche Forschungsgemeinschaft [SFB594]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB594 to J.B. and M.H.). T.K. was supported by a fellowship from the Fonds der Chemischen Industrie.	ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; Bellyei S, 2007, EUR J CELL BIOL, V86, P161, DOI 10.1016/j.ejcb.2006.12.004; Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; BOWRING SA, 1993, SCIENCE, V261, P1293, DOI 10.1126/science.11539488; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Candido E Peter M, 2002, Prog Mol Subcell Biol, V28, P61; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Chang Hung-Chun, 2007, Cell, V128, P212; Chen J, 2010, J MOL BIOL, V398, P122, DOI 10.1016/j.jmb.2010.02.022; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrnsperger M, 1999, J BIOL CHEM, V274, P14867, DOI 10.1074/jbc.274.21.14867; Ehrnsperger M, 1998, ANAL BIOCHEM, V259, P218, DOI 10.1006/abio.1998.2630; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; FELSENSTEIN J, 2005, PHYLIP PHYLOGENS INF; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; Franck E, 2004, J MOL EVOL, V59, P792, DOI 10.1007/s00239-004-0013-z; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Haslbeck M, 2004, J MOL BIOL, V343, P445, DOI 10.1016/j.jmb.2004.08.048; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kappe G, 2010, CELL STRESS CHAPERON, V15, P457, DOI 10.1007/s12192-009-0155-4; Kappe Guido, 2002, Prog Mol Subcell Biol, V28, P1; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kokke BPA, 1998, FEBS LETT, V433, P228, DOI 10.1016/S0014-5793(98)00917-X; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lindner RA, 2000, EUR J BIOCHEM, V267, P1923, DOI 10.1046/j.1432-1327.2000.01188.x; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; PLESOFSKYVIG N, 1992, J MOL EVOL, V35, P537, DOI 10.1007/BF00160214; R Development Core Team, 2005, R LANG ENV STAT COMP; Ramelot TA, 2009, PROTEINS, V75, P147, DOI 10.1002/prot.22229; Rattei T, 2008, NUCLEIC ACIDS RES, V36, pD289, DOI 10.1093/nar/gkm963; Sakano D, 2006, BIOSCI BIOTECH BIOCH, V70, P2443, DOI 10.1271/bbb.60176; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Scharf KD, 2001, CELL STRESS CHAPERON, V6, P225, DOI 10.1379/1466-1268(2001)006<0225:TEFOAT>2.0.CO;2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Tang Yun-Chi, 2007, Cell, V128, P412; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Ventura M, 2007, APPL ENVIRON MICROB, V73, P4695, DOI 10.1128/AEM.02496-06; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Walter MC, 2009, NUCLEIC ACIDS RES, V37, pD408, DOI 10.1093/nar/gkn749; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Waters ER, 2008, CELL STRESS CHAPERON, V13, P127, DOI 10.1007/s12192-008-0023-7; Waters ER, 2007, J MOL EVOL, V65, P162, DOI 10.1007/s00239-006-0223-7; WATERS ER, 1995, GENETICS, V141, P785; Waters ER, 1999, MOL BIOL EVOL, V16, P127, DOI 10.1093/oxfordjournals.molbev.a026033; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325	70	175	185	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3633	3642		10.1096/fj.10-156992	http://dx.doi.org/10.1096/fj.10-156992			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20501794				2022-12-25	WOS:000285005900004
J	Norstrom, MF; Smithback, PA; Rock, RS				Norstrom, Melanie F.; Smithback, Philip A.; Rock, Ronald S.			Unconventional Processive Mechanics of Non-muscle Myosin IIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; NEURITE OUTGROWTH; LIGHT-CHAIN; STEP-SIZE; IN-VITRO; MOTOR; ACTIN; FORCE; LOAD; ISOFORMS	Proper tension maintenance in the cytoskeleton is essential for regulated cell polarity, cell motility, and division. Non-muscle myosin IIB (NMIIB) generates tension along actin filaments in many cell types, including neuronal, cardiac, and smooth muscle cells. Using a three-bead optical trapping assay, we recorded NMIIB interactions with actin filaments to determine if a NMIIB dimer cycles along an actin filament in a processive manner. Our results show that NMIIB is the first myosin II to exhibit evidence of processive stepping behavior. Analysis of these data reveals a forward displacement of 5.4 nm and, surprisingly, frequent backward steps of -5.9 nm. Processive stepping along the long pitch helix of actin may provide a mechanism for disassembly of fascin-actin bundles. Forward steps and detachment are weakly force-dependent at all forces, consistent with rate-limiting and force-dependent ADP release. However, backward steps are nearly force-independent. Our data support a model in which NMIIB can readily move in both directions at stall, which may be important for a general regulator of cytoskeleton tension.	[Norstrom, Melanie F.; Smithback, Philip A.; Rock, Ronald S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Rock, RS (corresponding author), GCIS W240R,929 E 57th St, Chicago, IL 60637 USA.	rrock@uchicago.edu			National Institutes of Health [GM078450]; Molecular and Cellular Biology Training [GM008720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078450, T32GM008720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular and Cellular Biology Training; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078450 (to R.S.R.) and Molecular and Cellular Biology Training Grant GM008720 (to M.F.N.).	ADELSTEIN RS, 1982, METHOD ENZYMOL, V85, P298; Ali MY, 2004, BIOPHYS J, V86, P3804, DOI 10.1529/biophysj.103.037416; Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; FACEMYER KC, 1992, BIOCONJUGATE CHEM, V3, P408, DOI 10.1021/bc00017a009; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; GOPALAKRISHNA R, 1985, Journal of Applied Biochemistry, V7, P311; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Iwamoto H, 2007, J MOL BIOL, V369, P249, DOI 10.1016/j.jmb.2007.03.031; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Kolega J, 1998, J CELL SCI, V111, P2085; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kolomeisky AB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031902; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Lofgren M, 2003, J GEN PHYSIOL, V121, P301, DOI 10.1085/jgp.200208720; MAUPIN P, 1994, J CELL SCI, V107, P3077; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mehta AD, 1997, P NATL ACAD SCI USA, V94, P7927, DOI 10.1073/pnas.94.15.7927; Murphy CT, 2001, NAT CELL BIOL, V3, P311, DOI 10.1038/35060110; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Palmiter KA, 2000, J MUSCLE RES CELL M, V21, P609, DOI 10.1023/A:1005678905119; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; Tsygankov D, 2007, P NATL ACAD SCI USA, V104, P19321, DOI 10.1073/pnas.0709911104; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vignjevic D, 2006, METHOD ENZYMOL, V406, P727, DOI 10.1016/S0076-6879(06)06057-5; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613	60	60	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26326	26334		10.1074/jbc.M110.123851	http://dx.doi.org/10.1074/jbc.M110.123851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20511646	Green Published, hybrid			2022-12-25	WOS:000280921000050
J	Shibata, N; Tamagaki, H; Hieda, N; Akita, K; Komori, H; Shomura, Y; Terawaki, S; Mori, K; Yasuoka, N; Higuchi, Y; Toraya, T				Shibata, Naoki; Tamagaki, Hiroko; Hieda, Naoki; Akita, Keita; Komori, Hirofumi; Shomura, Yasuhito; Terawaki, Shin-ichi; Mori, Koichi; Yasuoka, Noritake; Higuchi, Yoshiki; Toraya, Tetsuo			Crystal Structures of Ethanolamine Ammonia-lyase Complexed with Coenzyme B-12 Analogs and Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; ADENOSYLCOBALAMIN-DEPENDENT ENZYME; RADICAL PAIR STATE; DIOL-DEHYDRATASE; ACTIVE-SITE; B-12-DEPENDENT ENZYME; CLOSTRIDIAL FERMENTATIONS; POTASSIUM-ION; PROTEIN; INTERMEDIATE	N-terminal truncation of the Escherichia coli ethanolamine ammonia-lyase beta-subunit does not affect the catalytic properties of the enzyme (Akita, K., Hieda, N., Baba, N., Kawaguchi, S., Sakamoto, H., Nakanishi, Y., Yamanishi, M., Mori, K., and Toraya, T. (2010) J. Biochem. 147, 83-93). The binary complex of the truncated enzyme with cyanocobalamin and the ternary complex with cyanocobalamin or adeninylpentylcobalamin and substrates were crystallized, and their x-ray structures were analyzed. The enzyme exists as a trimer of the (alpha beta)(2) dimer. The active site is in the (alpha/beta)(8) barrel of the alpha-subunit; the beta-subunit covers the lower part of the cobalamin that is bound in the interface of the alpha- and beta-subunits. The structure complexed with adeninylpentylcobalamin revealed the presence of an adenine ring-binding pocket in the enzyme that accommodates the adenine moiety through a hydrogen bond network. The substrate is bound by six hydrogen bonds with active-site residues. Arg alpha(160) contributes to substrate binding most likely by hydrogen bonding with the O1 atom. The modeling study implies that marked angular strains and tensile forces induced by tight enzyme-coenzyme interactions are responsible for breaking the coenzyme Co-C bond. The coenzyme adenosyl radical in the productive conformation was modeled by superimposing its adenine ring on the adenine ring-binding site followed by ribosyl rotation around the N-glycosidic bond. A major structural change upon substrate binding was not observed with this particular enzyme. Glu alpha(287), one of the substrate-binding residues, has a direct con-tact with the ribose group of the modeled adenosylcobalamin, which may contribute to the substrate-induced additional labilization of the Co-C bond.	[Shibata, Naoki; Terawaki, Shin-ichi; Yasuoka, Noritake; Higuchi, Yoshiki] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Shibata, Naoki; Higuchi, Yoshiki] RIKEN Harima Inst, SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Hieda, Naoki; Akita, Keita; Mori, Koichi; Toraya, Tetsuo] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Okayama 7008530, Japan	University of Hyogo; RIKEN; Okayama University	Shibata, N (corresponding author), Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	shibach@sci.u-hyogo.ac.jp; toraya@cc.okayama-u.ac.jp	Terawaki, Shin-ichi/V-7082-2019; Shibata, Naoki/AFK-9971-2022; Mori, Koichi/ABC-7268-2021; MORI, Koichi/B-2567-2011	Terawaki, Shin-ichi/0000-0002-2859-0589; Shibata, Naoki/0000-0002-5096-1104; Mori, Koichi/0000-0001-8865-2107; Higuchi, Yoshiki/0000-0001-8284-5709	Global Centers of Excellence (COE); Japan Society for the Promotion of Science [18GS0207, 22370061, 13480195, 17370038, 513]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency; Asahi Glass Foundation, Tokyo, Japan; Grants-in-Aid for Scientific Research [22570143] Funding Source: KAKEN	Global Centers of Excellence (COE); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Asahi Glass Foundation, Tokyo, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Global Centers of Excellence (COE) Program (to N. S. and Y. H.) and Grants-in-aid for Scientific Research 18GS0207 and (B) 22370061 (to Y. H.) and (B) 13480195, 17370038, and Priority Areas 513 (to T. T.) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was also supported by a grant from the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (to Y. H.) and a grant for natural sciences research assistance from the Asahi Glass Foundation, Tokyo, Japan (to T. T.).	ABELES RH, 1976, ACCOUNTS CHEM RES, V9, P114, DOI 10.1021/ar50099a006; Abend A, 1999, ARCH BIOCHEM BIOPHYS, V370, P138, DOI 10.1006/abbi.1999.1382; Akita K, 2010, J BIOCHEM, V147, P83, DOI 10.1093/jb/mvp145; BABIOR B M, 1988, Biofactors, V1, P21; BABIOR BM, 1975, ACCOUNTS CHEM RES, V8, P376, DOI 10.1021/ar50095a003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandarian V, 2000, BIOCHEMISTRY-US, V39, P12069, DOI 10.1021/bi001014k; Bandarian V, 2002, BIOCHEMISTRY-US, V41, P8580, DOI 10.1021/bi0201217; BANERJEE R, 1999, CHEMISTRY BIOCH B12; Bender G, 2008, BIOCHEMISTRY-US, V47, P11360, DOI 10.1021/bi801316v; Berkovitch F, 2004, P NATL ACAD SCI USA, V101, P15870, DOI 10.1073/pnas.0407074101; BRADBEER C, 1965, J BIOL CHEM, V240, P4675; BRADBEER C, 1965, J BIOL CHEM, V240, P4669; Canfield JM, 2005, J PHYS CHEM B, V109, P3053, DOI 10.1021/jp046167m; Canfield JM, 2002, J PHYS CHEM B, V106, P8831, DOI 10.1021/jp0207634; CHANG GW, 1975, NATURE, V254, P150, DOI 10.1038/254150a0; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DIZIOL P, 1980, EUR J BIOCHEM, V106, P211; Dolphin D., 1982, B12; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAUST LP, 1992, ARCH BIOCHEM BIOPHYS, V294, P50, DOI 10.1016/0003-9861(92)90135-J; FAUST LRP, 1990, J BIOL CHEM, V265, P12462; GRAVES SW, 1980, BIOCHEMISTRY-US, V19, P3630, DOI 10.1021/bi00556a032; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Kamachi T, 2004, J AM CHEM SOC, V126, P16207, DOI 10.1021/ja045572o; Ke SC, 1999, BIOCHEMISTRY-US, V38, P12681, DOI 10.1021/bi983067w; Ke SC, 2003, BBA-GEN SUBJECTS, V1620, P267, DOI 10.1016/S0304-4165(03)00006-0; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005326; LoBrutto R, 2001, BIOCHEMISTRY-US, V40, P9, DOI 10.1021/bi001865s; Magnusson OT, 2002, BIOCHEMISTRY-US, V41, P1695, DOI 10.1021/bi011947w; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Masuda J, 2001, J SYNCHROTRON RADIAT, V8, P1182, DOI 10.1107/S0909049501015606; Masuda J, 2000, STRUCTURE, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OBRIEN RJ, 1985, J BIOL CHEM, V260, P6131; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Schwartz PA, 2007, BIOCHEMISTRY-US, V46, P7293, DOI 10.1021/bi700078z; Shibata N, 2005, STRUCTURE, V13, P1745, DOI 10.1016/j.str.2005.08.011; Shibata N, 1999, STRUCTURE, V7, P997, DOI 10.1016/S0969-2126(99)80126-9; Shibata N, 2002, BIOCHEMISTRY-US, V41, P12607, DOI 10.1021/bi026104z; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sun L, 2008, BIOCHEMISTRY-US, V47, P5523, DOI 10.1021/bi702366e; Sun L, 2006, PROTEINS, V64, P308, DOI 10.1002/prot.20997; Toraya T, 2003, CHEM REV, V103, P2095, DOI 10.1021/cr020428b; TORAYA T, 2010, BIOCHEMISTR IN PRESS; WAGNER OW, 1966, J BIOL CHEM, V241, P1751; WALLIS OC, 1979, FEBS LETT, V97, P196, DOI 10.1016/0014-5793(79)80083-6; Warncke K, 2001, J AM CHEM SOC, V123, P8564, DOI 10.1021/ja003658l; Yamanishi M, 2002, EUR J BIOCHEM, V269, P4484, DOI 10.1046/j.1432-1033.2002.03151.x	59	65	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26484	26493		10.1074/jbc.M110.125112	http://dx.doi.org/10.1074/jbc.M110.125112			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20519496	hybrid, Green Published			2022-12-25	WOS:000280921000066
J	Guo, L; Zhou, DQ; Pryse, KM; Okunade, AL; Su, XO				Guo, Lin; Zhou, Dequan; Pryse, Kenneth M.; Okunade, Adewole L.; Su, Xiong			Fatty Acid 2-Hydroxylase Mediates Diffusional Mobility of Raft-associated Lipids, GLUT4 Level, and Lipogenesis in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTANOYL-COA HYDROXYLASE; ALPHA-OXIDATION; ADIPOSE-TISSUE; LATERAL MOBILITY; GENE-EXPRESSION; CHAIN-LENGTH; INSULIN; DIFFERENTIATION; TRAFFICKING; ORGANIZATION	Straight chain fatty acid alpha-oxidation increases during differentiation of 3T3-L1 adipocytes, leading to a marked accumulation of odd chain length fatty acyl moieties. Potential roles of this pathway in adipocyte differentiation and lipogenesis are unknown. Mammalian fatty acid 2-hydroxylase (FA2H) was recently identified and suggested to catalyze the initial step of straight chain fatty acid alpha-oxidation. Accordingly, we examined whether FA2H modulates adipocyte differentiation and lipogenesis in mature adipocytes. FA2H level markedly increases during differentiation of 3T3-L1 adipocytes, and small interfering RNAs against FA2H inhibit the differentiation process. In mature adipocytes, depletion of FA2H inhibits basal and insulin-stimulated glucose uptake and lipogenesis, which are partially rescued by the enzymatic product of FA2H, 2-hydroxy palmitic acid. Expression of fatty-acid synthase and SCD1 was decreased in FA2H-depleted cells, and levels of GLUT4 and insulin receptor proteins were reduced. 2-Hydroxy fatty acids are enriched in cellular sphingolipids, which are components of membrane rafts. Accelerated diffusional mobility of raft-associated lipids was shown to enhance degradation of GLUT4 and insulin receptor in adipocytes. Consistent with this, depletion of FA2H appeared to increase raft lipid mobility as it significantly accelerated the rates of fluorescence recovery after photo-bleaching measurements of lipid rafts labeled with Alexa 488-conjugated cholera toxin subunit B. Moreover, the enhanced recovery rates were partially reversed by treatment with 2-hydroxy palmitic acid. In conclusion, our findings document the novel role of FA2H in adipocyte lipogenesis possibly by modulation of raft fluidity and level of GLUT4.	[Guo, Lin; Zhou, Dequan; Okunade, Adewole L.; Su, Xiong] Washington Univ, Sch Med, Dept Internal Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Pryse, Kenneth M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Su, Xiong] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Su, XO (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Human Nutr, Campus Box 8031,660 S Euclid, St Louis, MO 63110 USA.	xsu@wustl.edu	zhou, dequan/J-9937-2012	zhou, dequan/0000-0002-2662-2882	National Institutes of Health [R21DK082951]; American Heart Association [835140N]; core services of the Nutrition Obesity Research Center at Washington University School of Medicine [P30DK56341]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R21DK082951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); core services of the Nutrition Obesity Research Center at Washington University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21DK082951 (to X. S.). This work was also supported by Scientist Development Grant 835140N from the American Heart Association (to X. S.) and by the core services of the Nutrition Obesity Research Center Grant P30DK56341 at Washington University School of Medicine.	Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Croes K, 2000, J LIPID RES, V41, P629; Eckhardt M, 2005, BIOCHEM J, V388, P245, DOI 10.1042/BJ20041451; FOUFELLE F, 1992, J BIOL CHEM, V267, P20543; Foulon V, 2005, J BIOL CHEM, V280, P9802, DOI 10.1074/jbc.M413362200; Foulon V, 2003, J LIPID RES, V44, P2349, DOI 10.1194/jlr.M300230-JLR200; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Hama H, 2000, FEBS LETT, V478, P26, DOI 10.1016/S0014-5793(00)01821-4; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hao MM, 2004, J BIOL CHEM, V279, P14171, DOI 10.1074/jbc.M309793200; Herrero AB, 2008, CANCER RES, V68, P9779, DOI 10.1158/0008-5472.CAN-08-1981; Jenske R, 2008, J AGR FOOD CHEM, V56, P11578, DOI 10.1021/jf802772a; Jenske R, 2008, CHEM PHYS LIPIDS, V154, P26, DOI 10.1016/j.chemphyslip.2008.03.010; Koivusalo M, 2007, MOL BIOL CELL, V18, P5113, DOI 10.1091/mbc.E07-04-0330; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Laude AJ, 2004, MOL MEMBR BIOL, V21, P193, DOI 10.1080/09687680410001700517; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Letexier D, 2003, J LIPID RES, V44, P2127, DOI 10.1194/jlr.M300235-JLR200; LEVIS GM, 1964, J BIOL CHEM, V239, P77; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Liu YQ, 2010, AM J PHYSIOL-CELL PH, V298, pC921, DOI 10.1152/ajpcell.00541.2009; LOFGREN H, 1977, CHEM PHYS LIPIDS, V20, P273, DOI 10.1016/0009-3084(77)90068-8; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Maldonado EN, 2008, J LIPID RES, V49, P153, DOI 10.1194/jlr.M700400-JLR200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Mukherji M, 2002, CHEM BIOL, V9, P597, DOI 10.1016/S1074-5521(02)00139-4; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Palacios S, 2001, J BIOL CHEM, V276, P3371, DOI 10.1074/jbc.M006739200; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Roettger BF, 1999, AM J PHYSIOL-CELL PH, V276, pC539, DOI 10.1152/ajpcell.1999.276.3.C539; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SHAH J, 1995, J LIPID RES, V36, P1945; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Su X, 2004, J BIOL CHEM, V279, P21740, DOI 10.1074/jbc.M314166200; Su X, 2004, BIOCHEMISTRY-US, V43, P5033, DOI 10.1021/bi035867z; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Uchida Y, 2007, J BIOL CHEM, V282, P13211, DOI 10.1074/jbc.M611562200; Villena JA, 2002, HORM METAB RES, V34, P664, DOI 10.1055/s-2002-38244; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wanders RJA, 2003, BBA-MOL CELL BIOL L, V1631, P119, DOI 10.1016/S1388-1981(03)00003-9; Yang CZ, 1999, J BIOL CHEM, V274, P25297, DOI 10.1074/jbc.274.36.25297; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008	52	42	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25438	25447		10.1074/jbc.M110.119933	http://dx.doi.org/10.1074/jbc.M110.119933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20519515	Green Published, hybrid			2022-12-25	WOS:000280682400037
J	Perry, JJP; Asaithamby, A; Barnebey, A; Kiamanesch, F; Chen, DJ; Han, S; Tainer, JA; Yannone, SM				Perry, J. Jefferson P.; Asaithamby, Aroumougame; Barnebey, Adam; Kiamanesch, Foad; Chen, David J.; Han, Seungil; Tainer, John A.; Yannone, Steven M.			Identification of a Coiled Coil in Werner Syndrome Protein That Facilitates Multimerization and Promotes Exonuclease Processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-NITROQUINOLINE 1-OXIDE SENSITIVITY; RECQ HELICASE; DNA HELICASE; HRDC DOMAIN; SUBSTRATE SPECIFICITIES; EXCISION-REPAIR; CELL-LINES; KINASE; WRN; DAMAGE	Werner syndrome (WS) is a rare progeroid disorder characterized by genomic instability, increased cancer incidence, and early onset of a variety of aging pathologies. WS is unique among early aging syndromes in that affected individuals are developmentally normal, and phenotypic onset is in early adulthood. The protein defective in WS (WRN) is a member of the large RecQ family of helicases but is unique among this family in having an exonuclease. RecQ helicases form multimers, but the mechanism and consequence of multimerization remain incompletely defined. Here, we identify a novel heptad repeat coiled coil region between the WRN nuclease and helicase domains that facilitates multimerization of WRN. We mapped a novel and unique DNA-dependent protein kinase phosphorylation site proximal to the WRN multimerization region. However, phosphorylation at this site affected neither exonuclease activity nor multimeric state. We found that WRN nuclease is stimulated by DNA-dependent protein kinase independently of kinase activity or WRN nuclease multimeric status. In addition, WRN nuclease multimerization significantly increased nuclease processivity. We found that the novel WRN coiled coil domain is necessary for multimerization of the nuclease domain and sufficient to multimerize with full-length WRN in human cells. Importantly, correct homomultimerization is required for WRN function in vivo as overexpression of this multimerization domain caused increased sensitivity to camptothecin and 4-nitroquinoline 1-oxide similar to that in cells lacking functional WRN protein.	[Barnebey, Adam; Tainer, John A.; Yannone, Steven M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Yannone, Steven M.] Buck Inst Age Res, Novato, CA 94945 USA; [Perry, J. Jefferson P.; Tainer, John A.] Scripps Res Inst, Div Mol Radiat Biol, La Jolla, CA 92037 USA; [Asaithamby, Aroumougame; Kiamanesch, Foad; Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Han, Seungil] Pfizer Global Res & Dev, Groton, CT 06340 USA; [Perry, J. Jefferson P.] Amrita Univ, Sch Biotechnol, Kollam 690525, Kerala, India	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging; Scripps Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pfizer; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri	Yannone, SM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Mail Stop 84-171,1 Cyclotron Rd, Berkeley, CA 94720 USA.	SMYannone@lbl.gov	Yannone, Steven/ABA-3524-2021; Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022; Yannone, Steven/G-1927-2011	Tainer, John/0000-0003-1659-2429; 	National Institutes of Health [CA104660, CA92584, CA134991]; United States Department of Energy Office of Science [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA134991, R01CA104660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104660 (to J.J.P. P., J.A.T., and S.M.Y.), CA92584 (to J.A.T. and D.J.C.), and CA134991 (to D.J.C.). This work was also supported by United States Department of Energy Office of Science Contract DE-AC02-05CH11231.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; Beresten SF, 1999, PROTEIN EXPRES PURIF, V17, P239, DOI 10.1006/prep.1999.1135; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Cooper MP, 2000, GENE DEV, V14, P907; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dietschy T, 2007, CELL MOL LIFE SCI, V64, P796, DOI 10.1007/s00018-007-6468-5; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Grigorova M, 2000, MUTAGENESIS, V15, P303, DOI 10.1093/mutage/15.4.303; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Hisama FM, 2000, CANCER RES, V60, P2372; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kaneko H, 2004, EXPERT REV MOL DIAGN, V4, P393, DOI 10.1586/14737159.4.3.393; Karmakar P, 2002, J BIOL CHEM, V277, P18291, DOI 10.1074/jbc.M111523200; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kawasaki K, 2002, NUCLEIC ACIDS RES, V30, P3682, DOI 10.1093/nar/gkf487; Killoran MP, 2008, NUCLEIC ACIDS RES, V36, P3139, DOI 10.1093/nar/gkn143; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kitano K, 2007, J BIOL CHEM, V282, P2717, DOI 10.1074/jbc.M610142200; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MARTIN GM, 1970, LAB INVEST, V23, P86; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matsumoto Y, 2000, FEBS LETT, V478, P67, DOI 10.1016/S0014-5793(00)01800-7; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Oksenych V, 2009, EMBO J, V28, P2971, DOI 10.1038/emboj.2009.230; Oshima J, 2002, CANCER RES, V62, P547; Ozgenc A, 2006, GENOME DYN, V1, P206, DOI 10.1159/000092509; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Pichierri P, 2000, MUTAT RES-FUND MOL M, V456, P45, DOI 10.1016/S0027-5107(00)00109-3; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Poot M, 2002, FASEB J, V16, P757, DOI 10.1096/fj.01-0906fje; Poot M, 1999, HUM GENET, V104, P10, DOI 10.1007/s004390050903; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Prince PR, 1999, HUM GENET, V105, P132, DOI 10.1007/s004390051075; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Sun JZ, 2005, J BIOMOL NMR, V32, P261, DOI 10.1007/s10858-005-7960-6; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Xue Y, 2002, BIOCHEMISTRY-US, V41, P2901, DOI 10.1021/bi0157161; Yannone SM, 2001, J BIOL CHEM, V276, P38242; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	65	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25699	25707		10.1074/jbc.M110.124941	http://dx.doi.org/10.1074/jbc.M110.124941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20516064	hybrid, Green Published			2022-12-25	WOS:000280682400063
J	Armstrong, SP; Caunt, CJ; Fowkes, RC; Tsaneva-Atanasova, K; McArdle, CA				Armstrong, Stephen P.; Caunt, Christopher J.; Fowkes, Robert C.; Tsaneva-Atanasova, Krasimira; McArdle, Craig A.			Pulsatile and Sustained Gonadotropin-releasing Hormone (GnRH) Receptor Signaling DOES THE ERK SIGNALING PATHWAY DECODE GnRH PULSE FREQUENCY?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DUAL-SPECIFICITY PHOSPHATASES; PERIFUSED L-BETA-T2 CELLS; SUBUNIT GENE-EXPRESSION; C-TERMINAL TAIL; DIFFERENTIAL REGULATION; SPATIOTEMPORAL REGULATION; IN-VIVO; RECOMBINANT ADENOVIRUS; DEPENDENT ACTIVATION	Gonadotropin-releasing hormone (GnRH) acts via G-protein-coupled receptors on gonadotrophs to stimulate synthesis and secretion of luteinizing hormone and follicle-stimulating hormone. It is secreted in pulses, and its effects depend on pulse frequency, but decoding mechanisms are unknown. Here we have used an extracellular signal regulated kinase-green fluorescent protein (ERK2-GFP) reporter to monitor GnRH signaling. GnRH caused dose-dependent ERK2-GFP translocation to the nucleus, providing a live-cell readout for activation. Pulsatile GnRH caused dose- and frequency-dependent ERK2-GFP translocation. These responses were rapid and transient, showed only digital tracking, and did not desensitize under any condition tested (dose, frequency, and receptor number varied). We also tested for the effects of cycloheximide (to prevent induction of nuclear-inducible MAPK phosphatases) and used GFP fusions containing ERK mutations (D319N, which prevents docking domain-dependent binding to MAPK phosphatases, and K52R, which prevents catalytic activity). These manipulations had little or no effect on the translocation responses, arguing against a role for MAPK phosphatases or ERK-mediated feedback in shaping ERK activation during pulsatile stimulation. GnRH also caused dose- and frequency-dependent activation of the alpha-gonadotropin subunit-, luteinizing hormone beta-, and follicle-stimulating hormone beta-luciferase reporters, and the latter response was inhibited by ERK1/2 knockdown. Moreover, GnRH caused frequency-dependent activation of an Egr1-luciferase reporter, but the response was proportional to cumulative pulse duration. Our data suggest that frequency decoding is not due to negative feedback shaping ERK signaling in this model.	[Armstrong, Stephen P.; McArdle, Craig A.] S Bristol Univ, Labs Integrat Neurosci & Endocrinol, Dept Clin Sci, Bristol BS1 3NY, Avon, England; [Caunt, Christopher J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Fowkes, Robert C.] Royal Vet Coll, Endocrine Signaling Grp, London NW1 0TU, England; [Tsaneva-Atanasova, Krasimira] Univ Bristol, Bristol Ctr Appl Nonlinear Math, Dept Engn Math, Bristol BS8 1TR, Avon, England	University of Bristol; University of Bath; University of London; University of London Royal Veterinary College; University of Bristol	McArdle, CA (corresponding author), S Bristol Univ, Labs Integrat Neurosci & Endocrinol, Dept Clin Sci, Whitson St, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	Fowkes, Robert/HHT-0664-2022; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; Fowkes, Robert/AAI-4756-2020; McArdle, Craig/AAQ-5660-2021	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Fowkes, Robert/0000-0002-2222-2056; McArdle, Craig/0000-0003-4836-5351	Wellcome Trust [084588, 078407]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grants 084588 and 078407 (to C. A. M.) and a Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom Doctoral Training Grant Award to the University of Bristol Laboratories for Integrative Neuroscience and Endocrinology.	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Berridge MJ, 2008, CELL SIGNALLING BIOL; Burger LL, 2008, BIOL REPROD, V79, P947, DOI 10.1095/biolreprod.108.070987; Burger LL, 2009, BIOL REPROD, V81, P1206, DOI 10.1095/biolreprod.109.079426; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Durham PL, 2000, MOL ENDOCRINOL, V14, P1570, DOI 10.1210/me.14.10.1570; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Finch AR, 2004, J CLIN ENDOCR METAB, V89, P1823, DOI 10.1210/jc.2003-030787; Haisenleder DJ, 1998, ENDOCRINOLOGY, V139, P3104, DOI 10.1210/en.139.7.3104; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Heding A, 2000, ENDOCRINOLOGY, V141, P299, DOI 10.1210/en.141.1.299; Hislop JN, 2005, J MOL ENDOCRINOL, V35, P177, DOI 10.1677/jme.1.01809; Hislop JN, 2000, ENDOCRINOLOGY, V141, P4564, DOI 10.1210/en.141.12.4564; Holdstock JG, 1996, MOL ENDOCRINOL, V10, P1308, DOI 10.1210/me.10.11.1308; KAISER UB, 1993, ENDOCRINOLOGY, V133, P931, DOI 10.1210/en.133.2.931; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Kupzig S, 2005, P NATL ACAD SCI USA, V102, P7577, DOI 10.1073/pnas.0409611102; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Maru BS, 2009, BONE, V44, P102, DOI 10.1016/j.bone.2008.09.016; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; MITCHELL R, 1994, J ENDOCRINOL, V140, pR15, DOI 10.1677/joe.0.140R015; Morgan K, 2008, CANCER RES, V68, P6331, DOI 10.1158/0008-5472.CAN-08-0197; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; ROBERSON MS, 1995, MOL CELL BIOL, V15, P3531; Ruf F, 2006, J BIOL CHEM, V281, P30967, DOI 10.1074/jbc.M606486200; Schally AV, 1999, PEPTIDES, V20, P1247, DOI 10.1016/S0196-9781(99)00130-8; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; Sim Pauline, 1993, Biochemical Society Transactions, V21, p357S; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tsutsumi R, 2009, ENDOCR J, V56, P729, DOI 10.1507/endocrj.K09E-185; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; WEISS J, 1990, MOL ENDOCRINOL, V4, P557, DOI 10.1210/mend-4-4-557; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; YASIN M, 1995, ENDOCRINOLOGY, V136, P1559, DOI 10.1210/en.136.4.1559; Zhang T, 2006, J MOL ENDOCRINOL, V36, P41, DOI 10.1677/jme.1.01881; Zhang T, 2001, MOL CELL ENDOCRINOL, V172, P79, DOI 10.1016/S0303-7207(00)00378-6	59	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24360	24371		10.1074/jbc.M110.115964	http://dx.doi.org/10.1074/jbc.M110.115964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507982	Green Published, hybrid			2022-12-25	WOS:000280542100007
J	Tan, L; Varnai, P; Lamport, DTA; Yuan, CH; Xu, JF; Qiu, F; Kieliszewski, MJ				Tan, Li; Varnai, Peter; Lamport, Derek T. A.; Yuan, Chunhua; Xu, Jianfeng; Qiu, Feng; Kieliszewski, Marcia J.			Plant O-Hydroxyproline Arabinogalactans Are Composed of Repeating Trigalactosyl Subunits with Short Bifurcated Side Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; GLYCOSYLATION CODES; MOLECULAR-STRUCTURE; NICOTIANA-TABACUM; ACACIA-SENEGAL; PROTEINS; GLYCOPROTEIN; TOBACCO; GUM; POLYSACCHARIDE	Classical arabinogalactan proteins partially defined by type II O-Hyp-linked arabinogalactans (Hyp-AGs) are structural components of the plant extracellular matrix. Recently we described the structure of a small Hyp-AG putatively based on repetitive trigalactosyl subunits and suggested that AGs are less complex and varied than generally supposed. Here we describe three additional AGs with similar subunits. The Hyp-AGs were isolated from two different arabinogalactan protein fusion glycoproteins expressed in tobacco cells; that is, a 22-residue Hyp-AG and a 20-residue Hyp-AG, both isolated from interferon alpha 2b-(Ser-Hyp)(20), and a 14-residue Hyp-AG isolated from (Ala-Hyp)(51)-green fluorescent protein. We used NMR spectroscopy to establish the molecular structure of these Hyp-AGs, which share common features: (i) a galactan main chain composed of two 1 -> 3 beta-linked trigalactosyl blocks linked by a beta-1 -> 6 bond; (ii) bifurcated side chains with Ara, Rha, GlcUA, and a Gal 6-linked to Gal-1 and Gal-2 of the main-chain trigalactosyl repeats; (iii) a common side chain structure composed of up to six residues, the largest consisting of an alpha-L-Rhap-(1 -> 5)-alpha-L-Araf-(1 -> 3)-alpha-L-Araf-(1 -> 3- unit and an alpha-L-Rhap-(1 -> 4)-beta-D-GlcUAp-(1 -> 6)-unit, both linked to Gal. The conformational ensemble obtained by using nuclear Overhauser effect data in structure calculations revealed a galactan main chain with a reverse turn involving the beta-1 -> 6 link between the trigalactosyl blocks, yielding a moderately compact structure stabilized by H-bonds.	[Tan, Li; Xu, Jianfeng; Kieliszewski, Marcia J.] Ohio Univ, Biochem Res Facil, Dept Chem & Biochem, Athens, OH 45701 USA; [Varnai, Peter] Univ Sussex, Dept Chem & Biochem, Brighton BN1 9QG, E Sussex, England; [Lamport, Derek T. A.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Yuan, Chunhua] Ohio State Univ, Campus Chem Instrument Ctr, Columbus, OH 43210 USA; [Qiu, Feng] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA	University System of Ohio; Ohio University; University of Sussex; University of Sussex; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kieliszewski, MJ (corresponding author), Ohio Univ, Biochem Res Facil, Dept Chem & Biochem, 350 W State St, Athens, OH 45701 USA.	kielisze@helios.phy.ohiou.edu	Varnai, Peter/A-6870-2012	Varnai, Peter/0000-0003-4267-4671	National Institutes of Health [2-P41-RR05351-06]; United States Department of Agriculture [2004-34490-14579]; Herman Frasch Foundation [526-HF02]; Ohio University [GC0013845]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); Herman Frasch Foundation; Ohio University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 2-P41-RR05351-06 (to the Complex Carbohydrate Research Center). This work was also funded by United States Department of Agriculture Grants 2004-34490-14579), Herman Frasch Foundation Grant 526-HF02, The Ohio University Biomimetic, Nanoscience, and Nanotechnology Program Grant GC0013845), and by the Ohio University Molecular and Cellular Biology Program.	[Anonymous], 2008, AMBER 10; BACIC A, 1987, CARBOHYD RES, V162, P85, DOI 10.1016/0008-6215(87)80203-3; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chaves I, 2002, PHYSIOL PLANTARUM, V116, P548, DOI 10.1034/j.1399-3054.2002.1160414.x; CHURMS SC, 1983, CARBOHYD RES, V123, P267, DOI 10.1016/0008-6215(83)88483-3; CHURMS SC, 1981, CARBOHYD RES, V94, P119, DOI 10.1016/S0008-6215(00)85603-7; CHURMS SC, 1984, CARBOHYD RES, V133, P105, DOI 10.1016/0008-6215(84)85187-3; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DEFAYE J, 1986, CARBOHYD RES, V150, P221, DOI 10.1016/0008-6215(86)80018-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FINCHER GB, 1983, ANNU REV PLANT PHYS, V34, P47, DOI 10.1146/annurev.pp.34.060183.000403; GANE AM, 1995, CARBOHYD RES, V277, P67, DOI 10.1016/0008-6215(95)00197-2; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; Gens JS, 2000, PROTOPLASMA, V212, P115, DOI 10.1007/BF01279353; Guan Y, 2004, PLANT PHYSIOL, V135, P1346, DOI 10.1104/pp.104.039370; Hill JM, 2000, EUR J BIOCHEM, V267, P4649, DOI 10.1046/j.1432-1327.2000.01507.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KIELISZEWSKI M, 1992, PLANT PHYSIOL, V98, P919, DOI 10.1104/pp.98.3.919; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lamport DTA, 2006, NEW PHYTOL, V169, P479, DOI 10.1111/j.1469-8137.2005.01591.x; LAMPORT DTA, 1967, NATURE, V216, P1322, DOI 10.1038/2161322a0; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; LAMPORT DTA, 1970, ANN REV PLANT PHYSIO, V21, P235, DOI 10.1146/annurev.pp.21.060170.001315; Lamport DTA, 1977, RECENT ADV PHYTOCHEM, V11, P79; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; POPE DG, 1977, PLANT PHYSIOL, V59, P894, DOI 10.1104/pp.59.5.894; Rees DA, 1977, POLYSACCHARIDE SHAPE, P1; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; SERPE MD, 1995, PLANT PHYSIOL, V109, P1007, DOI 10.1104/pp.109.3.1007; Serpe MD, 1999, ADV BOT RES, V30, P207; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Takahata K, 2004, PLANT CELL PHYSIOL, V45, P1658, DOI 10.1093/pcp/pch188; Tan L, 2003, PLANT PHYSIOL, V132, P1362, DOI 10.1104/pp.103.021766; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; TAN L, 2003, THESIS OHIO U; Xia JC, 2007, J CHEM THEORY COMPUT, V3, P1629, DOI 10.1021/ct700034q; Xu JF, 2005, BIOTECHNOL BIOENG, V90, P578, DOI 10.1002/bit.20441; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Xu JF, 2007, BIOTECHNOL BIOENG, V97, P997, DOI 10.1002/bit.21407; Zhao ZD, 2002, PLANT J, V31, P431, DOI 10.1046/j.1365-313X.2002.01365.x	42	79	80	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24575	24583		10.1074/jbc.M109.100149	http://dx.doi.org/10.1074/jbc.M109.100149			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20489210	Green Published, hybrid			2022-12-25	WOS:000280542100029
J	Kovermann, P; Machtens, JP; Ewers, D; Fahlke, C				Kovermann, Peter; Machtens, Jan-Philipp; Ewers, David; Fahlke, Christoph			A Conserved Aspartate Determines Pore Properties of Anion Channels Associated with Excitatory Amino Acid Transporter 4 (EAAT4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUTAMATE TRANSPORTER; PYROCOCCUS-HORIKOSHII; CHLORIDE CHANNELS; CONDUCTANCE; SUBSTRATE; BINDING; EAAC1; MECHANISM; CURRENTS; HOMOLOG	Excitatory amino acid transporter (EAAT) glutamate transporters function not only as secondary active glutamate transporters but also as anion channels. Recently, a conserved aspartic acid (Asp(112)) within the intracellular loop near to the end of transmembrane domain 2 was proposed as a major determinant of substrate-dependent gating of the anion channel associated with the glial glutamate transporter EAAT1. We studied the corresponding mutation (D117A) in another EAAT isoform, EAAT4, using heterologous expression in mammalian cells, whole cell patch clamp, and noise analysis. In EAAT4, D117A modifies unitary conductances, relative anion permeabilities, as well as gating of associated anion channels. EAAT4 anion channel gating is characterized by two voltage-dependent gating processes with inverse voltage dependence. In wild type EAAT4, external L-glutamate modifies the voltage dependence as well as the minimum open probabilities of both gates, resulting in concentration-dependent changes of the number of open channels. Not only transport substrates but also anions affect wild type EAAT4 channel gating. External anions increase the open probability and slow down relaxation constants of one gating process that is activated by depolarization. D117A abolishes the anion and glutamate dependence of EAAT4 anion currents and shifts the voltage dependence of EAAT4 anion channel activation by more than 200 mV to more positive potentials. D117A is the first reported mutation that changes the unitary conductance of an EAAT anion channel. The finding that mutating a pore-forming residue modifies gating illustrates the close linkage between pore conformation and voltage-and substrate-dependent gating in EAAT4 anion channels.	[Kovermann, Peter; Machtens, Jan-Philipp; Ewers, David; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Kovermann, Peter; Machtens, Jan-Philipp; Ewers, David; Fahlke, Christoph] Zentrum Syst Neurowissensch, D-30559 Hannover, Germany	Hannover Medical School	Kovermann, P (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	kovermann.peter@mh-hannover.de	Ewers, David/AAG-8478-2021; Fahlke, Christoph/G-3635-2013; Kovermann, Peter/AAF-4411-2020; Machtens, Jan-Philipp/M-8659-2013	Ewers, David/0000-0003-1037-1027; Fahlke, Christoph/0000-0001-8602-9952; Machtens, Jan-Philipp/0000-0003-1673-8571; Kovermann, Peter/0000-0001-5296-4918	Deutsche Forschungsgemeinschaft [Fa301/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Fa301/9-1 (to C.F.).	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; DeFelice L. J., 1981, INTRO MEMBRANE NOISE; Fahlke C, 1997, P NATL ACAD SCI USA, V94, P2729, DOI 10.1073/pnas.94.6.2729; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fairman WA, 1999, AM J PHYSIOL-RENAL, V277, pF481, DOI 10.1152/ajprenal.1999.277.4.F481; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Huang SW, 2007, BIOCHEMISTRY-US, V46, P9685, DOI 10.1021/bi700647f; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Shachnai L, 2005, NEUROPHARMACOLOGY, V49, P862, DOI 10.1016/j.neuropharm.2005.07.005; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	32	35	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23676	23686		10.1074/jbc.M110.126557	http://dx.doi.org/10.1074/jbc.M110.126557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519505	Green Published, hybrid			2022-12-25	WOS:000280291400018
J	Thomas, M; Felcht, M; Kruse, K; Kretschmer, S; Deppermann, C; Biesdorf, A; Rohr, K; Benest, AV; Fiedler, U; Augustin, HG				Thomas, Markus; Felcht, Moritz; Kruse, Karoline; Kretschmer, Stella; Deppermann, Carleen; Biesdorf, Andreas; Rohr, Karl; Benest, Andrew V.; Fiedler, Ulrike; Augustin, Hellmut G.			Angiopoietin-2 Stimulation of Endothelial Cells Induces alpha v beta 3 Integrin Internalization and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE KINASE; RECEPTOR; TIE2; PHOSPHORYLATION; ANGIOGENESIS; ANTAGONIST; ACTIVATION; FAK; REQUIREMENT	The angiopoietins (Ang-1 and Ang-2) have been identified as agonistic and antagonistic ligands of the endothelial receptor tyrosine kinase Tie2, respectively. Both ligands have been demonstrated to induce translocation of Tie2 to cell-cell junctions. However, only Ang-1 induces Tie2-dependent Akt activation and subsequent survival signaling and endothelial quiescence. Ang-2 interferes negatively with Ang-1/Tie2 signaling, thereby antagonizing the Ang-1/Tie2 axis. Here, we show that both Ang-1 and Ang-2 recruit beta 3 integrins to Tie2. This co-localization is most prominent in cell-cell junctions. However, only Ang-2 stimulation resulted in complex formation among Tie2, alpha v beta 3 integrin, and focal adhesion kinase as evidenced by co-immunoprecipitation experiments. Focal adhesion kinase was phosphorylated in the FAT domain at Ser(910) upon Ang-2 stimulation and the adaptor proteins p130Cas and talin dissociated from alpha v beta 3 integrin. The alpha v beta 3 integrin was internalized, ubiquitinylated, and gated toward lysosomes. Taken together, the experiments define Tie2/alpha v beta 3 integrin association-induced integrin internalization and degradation as mechanistic consequences of endothelial Ang-2 stimulation.	[Benest, Andrew V.; Augustin, Hellmut G.] Heidelberg Univ, Res Div Vasc Biol, Med Fac Mannheim CBTM, D-69120 Heidelberg, Germany; [Benest, Andrew V.; Augustin, Hellmut G.] German Canc Res Ctr Heidelberg, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Biesdorf, Andreas; Rohr, Karl] Heidelberg Univ, Dept Bioinformat & Funct Genom, BIOQUANT, IPMB, D-69120 Heidelberg, Germany; [Fiedler, Ulrike] ProQinase GmbH, D-79106 Freiburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; ProQinase	Augustin, HG (corresponding author), Heidelberg Univ, Res Div Vasc Biol, Med Fac Mannheim CBTM, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	augustin@angiogenese.de	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242; Benest, Andrew/0000-0002-8225-5159	German Research Council (DFG) [SFB-TR23]	German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Council (DFG, SFB-TR23, Vascular Differentiation and Remodeling, Project A3).	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Avraham HK, 2003, J BIOL CHEM, V278, P36661, DOI 10.1074/jbc.M301253200; Bezuidenhout L, 2009, INFLAMMATION, V32, P393, DOI 10.1007/s10753-009-9148-9; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; DRAKE CJ, 1995, J CELL SCI, V108, P2655; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gao BC, 2000, J CELL SCI, V113, P247; Garmy-Susini Barbara, 2008, Lymphatic Research and Biology, V6, P155, DOI 10.1089/lrb.2008.1011; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Masson-Gadais B, 2003, CELL STRESS CHAPERON, V8, P37, DOI 10.1379/1466-1268(2003)8<37:IVRFVA>2.0.CO;2; Nasarre P, 2009, CANCER RES, V69, P1324, DOI 10.1158/0008-5472.CAN-08-3030; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Reiss Y, 2007, CIRC RES, V101, P88, DOI 10.1161/CIRCRESAHA.106.143594; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Serini G, 2008, CARDIOVASC RES, V78, P213, DOI 10.1093/cvr/cvn045; Sheu JR, 1997, BBA-GEN SUBJECTS, V1336, P445, DOI 10.1016/S0304-4165(97)00057-3; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Storgard CM, 1999, J CLIN INVEST, V103, P47, DOI 10.1172/JCI3756; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537	43	71	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23842	23849		10.1074/jbc.M109.097543	http://dx.doi.org/10.1074/jbc.M109.097543			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519501	hybrid, Green Published			2022-12-25	WOS:000280291400034
J	Thompson, JE; Pourhossein, M; Waterhouse, A; Hudson, T; Goldrick, M; Derrick, JP; Roberts, IS				Thompson, James E.; Pourhossein, Meraj; Waterhouse, Amy; Hudson, Thomas; Goldrick, Marie; Derrick, Jeremy P.; Roberts, Ian S.			The K5 Lyase KflA Combines a Viral Tail Spike Structure with a Bacterial Polysaccharide Lyase Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN AC LYASE; PARALLEL BETA-HELIX; GLYCOSAMINOGLYCAN-DEGRADING ENZYMES; PNEUMONIAE HYALURONATE LYASE; P22 TAILSPIKE PROTEIN; ESCHERICHIA-COLI K5; CRYSTAL-STRUCTURE; ACTIVE-SITE; FLAVOBACTERIUM-HEPARINUM; ENZYMATIC DEGRADATION	K5 lyase A (KflA) is a tail spike protein (TSP) encoded by a K5A coliphage, which cleaves K5 capsular polysaccharide, a glycosaminoglycan with the repeat unit [-4)-beta GlcA-(1,4)-alpha GlcNAc(1-], displayed on the surface of Escherichia coli K5 strains. The crystal structure of KflA reveals a trimeric arrangement, with each monomer containing a right-handed, single-stranded parallel beta-helix domain. Stable trimer formation by the intertwining of strands in the C-terminal domain, followed by proteolytic maturation, is likely to be catalyzed by an autochaperone as described for K1F endosialidase. The structure of KflA represents the first bacteriophage tail spike protein combining polysaccharide lyase activity with a single-stranded parallel beta-helix fold. We propose a catalytic site and mechanism representing convergence with the syn-beta-elimination site of heparinase II from Pedobacter heparinus.	[Derrick, Jeremy P.; Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Pourhossein, Meraj] Isfahan Univ Med Sci, Dept Genet & Mol Biol, Sch Med, Motahhari 8174673441, Yasuj, Iran	University of Manchester; Isfahan University Medical Science	Roberts, IS (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	i.s.roberts@manchester.ac.uk	Pourhossein, Meraj/W-3666-2017	pourhossein, meraj/0000-0002-9627-8589; Derrick, Jeremy/0000-0002-4350-5354	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; Biotechnology and Biological Sciences Research Council [BBS/B/09627] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anandakrishnan R, 2008, J COMPUT BIOL, V15, P165, DOI 10.1089/cmb.2007.0144; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Blundell CD, 2009, J MOL MICROB BIOTECH, V17, P71, DOI 10.1159/000215933; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARDIN AD, 1991, METHOD ENZYMOL, V203, P556; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Clarke BR, 2000, J BACTERIOL, V182, P3761, DOI 10.1128/JB.182.13.3761-3766.2000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GUPTA DS, 1983, FEMS MICROBIOL LETT, V16, P13; Han YH, 2009, J BIOL CHEM, V284, P34019, DOI 10.1074/jbc.M109.025338; Hanfling P, 1996, J BACTERIOL, V178, P4747; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kreisberg JF, 2002, PROTEIN SCI, V11, P820, DOI 10.1110/ps.3440102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legoux R, 1996, J BACTERIOL, V178, P7260, DOI 10.1128/jb.178.24.7260-7264.1996; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; Muhlenhoff M, 2003, J BIOL CHEM, V278, P12634, DOI 10.1074/jbc.M212048200; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIMMICH W, 1994, J CLIN MICROBIOL, V32, P2843, DOI 10.1128/JCM.32.11.2843-2845.1994; NIMMICH W, 1991, FEMS MICROBIOL LETT, V82, P137, DOI 10.1016/0378-1097(91)90322-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pojasek K, 2000, BIOCHEMISTRY-US, V39, P4012, DOI 10.1021/bi992514k; Pritchard DG, 2000, PROTEINS, V40, P126; Rek A, 2007, BBA-PROTEINS PROTEOM, V1774, P72, DOI 10.1016/j.bbapap.2006.10.017; Rigden DJ, 2003, J BIOL CHEM, V278, P50596, DOI 10.1074/jbc.M307596200; Rossmann MG, 2004, CURR OPIN STRUC BIOL, V14, P171, DOI 10.1016/j.sbi.2004.02.001; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Schulz EC, 2010, NAT STRUCT MOL BIOL, V17, P210, DOI 10.1038/nsmb.1746; Schwarzer D, 2007, J BIOL CHEM, V282, P2821, DOI 10.1074/jbc.M609543200; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Su HS, 1996, APPL ENVIRON MICROB, V62, P2723, DOI 10.1128/AEM.62.8.2723-2734.1996; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Vitali J, 1998, PLANT PHYSIOL, V116, P69, DOI 10.1104/pp.116.1.69; Warwicker J, 2004, PROTEIN SCI, V13, P2793, DOI 10.1110/ps.04785604; YODER MD, 1995, FASEB J, V9, P335, DOI 10.1096/fasebj.9.5.7896002; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	66	38	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23963	23969		10.1074/jbc.M110.127571	http://dx.doi.org/10.1074/jbc.M110.127571			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519506	hybrid, Green Published			2022-12-25	WOS:000280291400047
J	Belouzard, S; Madu, I; Whittaker, GR				Belouzard, Sandrine; Madu, Ikenna; Whittaker, Gary R.			Elastase-mediated Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein at Discrete Sites within the S2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS CORONAVIRUS; CATHEPSIN-L; FUSION PEPTIDE; VIRUS ENTRY; CLEAVAGE; PROTEASES; HEMAGGLUTININ; GLYCOPROTEIN; CELLS	Proteolytic priming is a common method of controlling the activation of membrane fusion mediated by viral glycoproteins. The severe acute respiratory syndrome coronavirus spike protein (SARS-CoV S) can be primed by a variety of host cell proteases, with proteolytic cleavage occurring both as the S1/S2 boundary and adjacent to a fusion peptide in the S2 domain. Here, we studied the priming of SARS-CoV S by elastase and show an important role for residue Thr(795) in the S2 domain. A series of alanine mutants were generated in the vicinity of the S2 cleavage site, with the goal of examining elastase-mediated cleavage within S2. Both proteolytic cleavage and fusion activation were modulated by altering the cleavage site position. We propose a novel mechanism whereby SARS-CoV fusion protein function can be controlled by spatial regulation of the proteolytic priming site, with important implications for viral pathogenesis.	[Belouzard, Sandrine; Madu, Ikenna; Whittaker, Gary R.] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Cornell University	Whittaker, GR (corresponding author), Cornell Univ, Dept Microbiol & Immunol, C4127 VMC, Ithaca, NY 14853 USA.	grw7@cornell.edu	Belouzard, Sandrine/O-8527-2016; Belouzard, Sandrine/AAX-1584-2021	Belouzard, Sandrine/0000-0002-9972-4054; Belouzard, Sandrine/0000-0002-9972-4054	NIAID [R21 AI1076258]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082084] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 AI1076258 from NIAID.	Ami Y, 2008, MICROBIOL IMMUNOL, V52, P118, DOI 10.1111/j.1348-0421.2008.00011.x; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Bosch BJ, 2008, NIDOVIRUSES, P157; Callan RJ, 1997, J VIROL, V71, P7579, DOI 10.1128/JVI.71.10.7579-7585.1997; Du LY, 2007, BIOCHEM BIOPH RES CO, V359, P174, DOI 10.1016/j.bbrc.2007.05.092; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870; KLENK HD, 1994, COLD SPRING HARBOR M, P241; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Madu IG, 2009, VIROLOGY, V393, P265, DOI 10.1016/j.virol.2009.07.038; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Woessner JF, 2004, HDB PROTEOLYTIC ENZY	19	59	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22756	22761		10.1074/jbc.M110.103275	http://dx.doi.org/10.1074/jbc.M110.103275			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20507992	Green Published, hybrid			2022-12-25	WOS:000279999900007
J	Long, JY; Wang, Y; Wang, WJ; Chang, BHJ; Danesh, FR				Long, Jianyin; Wang, Yin; Wang, Wenjian; Chang, Benny H. J.; Danesh, Farhad R.			Identification of MicroRNA-93 as a Novel Regulator of Vascular Endothelial Growth Factor in Hyperglycemic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HIGH GLUCOSE; DIABETIC-NEPHROPATHY; KIDNEY GLOMERULI; MOUSE PODOCYTES; CELL-LINES; VEGF; MICE; REPRESSION; INHIBITION	Vascular endothelial growth factor (VEGF) is a dimeric glycoprotein that plays a crucial role in microvascular complications of diabetes, including diabetic nephropathy. However, the precise regulatory mechanisms governing VEGF expression in the diabetic milieu are still poorly understood. Here, we provide evidence that microRNA-93 (miR-93) regulates VEGF expression in experimental models of diabetes both in vitro and in vivo. Comparative microRNA expression profile arrays identified miR-93 as a signature microRNA in hyperglycemic conditions. We identified VEGF-A as a putative target of miR-93 in the kidney with a perfect complementarity between miR-93 and the 3'-untranslated region of vegfa in several species. When cotransfected with a luciferase reporter construct containing the mouse vegfa 3'-untranslated region, expression of miR-93 markedly decreased the luciferase activity. We showed that forced expression of miR-93 in cells abrogated VEGF protein secretion. Conversely, anti-miR-93 inhibitors increased VEGF release. Transfection of miR-93 also prevented the effect of high glucose on VEGF downstream targets. Using transgenic mice containing VEGF-LacZ bicistronic transcripts, we found that inhibition of glomerular miR-93 by peptide-conjugated morpholino oligomers elicited increased expression of VEGF. Our findings also indicate that high glucose decreases miR-93 expression by down-regulating the promoter of the host MCM7 gene. Taken together, our findings provide new insights into the role of miR-93 in VEGF signaling pathway and offer a potentially novel target in preventing the progression of diabetic nephropathy.	[Long, Jianyin; Wang, Yin; Wang, Wenjian; Danesh, Farhad R.] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Chang, Benny H. J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Danesh, Farhad R.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Danesh, FR (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, 1 Baylor Plaza, Houston, TX 77030 USA.	danesh@bcm.edu	Long, Jianyin/H-8261-2013	Danesh, Farhad/0000-0001-6849-5239	National Institutes of Health through the NIDDK [R01DK067604, R01DK078900]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078900, R01DK091310, R01DK067604] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK067604 and R01DK078900 through the NIDDK.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asaumi S, 2003, J DIABETES COMPLICAT, V17, P34, DOI 10.1016/S1056-8727(02)00189-7; Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carson JP, 2005, J MICROSC-OXFORD, V217, P275, DOI 10.1111/j.1365-2818.2005.01450.x; Chen S, 2004, DIABETES, V53, P2939, DOI 10.2337/diabetes.53.11.2939; Chen S, 2008, CURR DIABETES REP, V8, P470, DOI 10.1007/s11892-008-0081-3; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du M, 2006, FEBS J, V273, P732, DOI 10.1111/j.1742-4658.2006.05106.x; Enciso JM, 2003, J CELL BIOL, V160, P605, DOI 10.1083/jcb.200209014; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; Forsburg SL, 2008, BIOCHEM SOC T, V36, P114, DOI 10.1042/BST0360114; Giuliani S, 2008, J UROLOGY, V179, P365, DOI 10.1016/j.juro.2007.08.092; Hoshi S, 2002, BIOCHEM BIOPH RES CO, V290, P177, DOI 10.1006/bbrc.2001.6138; Iglesias-de la Cruz MC, 2002, KIDNEY INT, V62, P901, DOI 10.1046/j.1523-1755.2002.00528.x; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Langley RR, 2003, CANCER RES, V63, P2971; Li FX, 2003, P NATL ACAD SCI USA, V100, P12935, DOI 10.1073/pnas.2231861100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Natarajan R, 1997, AM J PHYSIOL-HEART C, V273, pH2224, DOI 10.1152/ajpheart.1997.273.5.H2224; Nikopoulos GN, 2008, BIOTECHNIQUES, V44, P547, DOI 10.2144/000112725; Olena AF, 2010, J CELL PHYSIOL, V222, P540, DOI 10.1002/jcp.21993; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; WANG J, 2010, GENESIS IN PRESS; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje	49	219	239	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23455	23463		10.1074/jbc.M110.136168	http://dx.doi.org/10.1074/jbc.M110.136168			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501654	Green Published, hybrid			2022-12-25	WOS:000279999900077
J	Wang, XB; Hu, GQ; Zhou, JL				Wang, Xiaobo; Hu, Guoqing; Zhou, Jiliang			Repression of Versican Expression by MicroRNA-143	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; SERUM RESPONSE FACTOR; GENE-EXPRESSION; BALLOON ANGIOPLASTY; VASCULAR-DISEASE; GROWTH; MYOCARDIN; MIGRATION; DIFFERENTIATION; PROLIFERATION	Smooth muscle cells (SMCs) retain remarkable plasticity to undergo phenotypic modulation in which the expression of smooth muscle markers is markedly attenuated while conversely expression of extracellular matrix (ECM) is dramatically up-regulated. Myocardin is perhaps the most potent transcription factor for stimulating expression of smooth muscle-specific genes; little is known, however, about whether myocardin can orchestrate ECM expression to act in concert with smooth muscle differentiation program. In this study, we demonstrated myocardin coordinate smooth muscle differentiation by inducing transcription of microRNA-143 (miR-143), which attenuates ECM versican protein expression. Previous studies have shown that versican is a chondroitin sulfate proteoglycan of the ECM that is produced by synthetic SMCs and promotes SMC migration and proliferation. Our data demonstrated that myocardin significantly represses versican expression in multiple cell lines, and this occurs through the induction of miR-143 by myocardin. By a modified reverse transcribed PCR, we found that miR-143 specifically binds to the 3'-untranslated region of versican mRNA. Reporter assays validated that miR-143 targets versican 3'-untranslated region through an evolutionarily conserved miR-143 binding site. Furthermore, overexpression of miR-143 significantly represses versican expression, whereas conversely, depletion of endogenous miR-143 results in up-regulation of versican expression. In addition, we demonstrated that myocardin represses versican through induction of miR-143. Finally, we found that the regulation of versican by miR-143 is involved in platelet-derived growth factor BB-induced SMC migration. This study provides the first evidence that myocardin, in addition to activating smooth muscle-specific genes, regulates ECM expression through induction of microRNAs during smooth muscle differentiation.	[Wang, Xiaobo; Hu, Guoqing; Zhou, Jiliang] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Zhou, JL (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	zhouj1@mail.amc.edu	Wang, Xiaobo/S-2476-2019; Wang, Xiaobo/J-4312-2014	Wang, Xiaobo/0000-0001-6044-914X; 	Albany Medical College; American Heart Association	Albany Medical College; American Heart Association(American Heart Association)	This work was supported by a grant from the Albany Medical College start-up fund and an American Heart Association Scientist Development Grant (to J.Z.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Domenzain-Reyna C, 2009, J BIOL CHEM, V284, P12306, DOI 10.1074/jbc.M807108200; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Huang R, 2006, CIRC RES, V98, P370, DOI 10.1161/01.RES.0000202051.28319.c8; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Kaplan-Albuquerque N, 2003, J BIOL CHEM, V278, P39830, DOI 10.1074/jbc.M305991200; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang XK, 1996, ARTERIOSCL THROM VAS, V16, P1365, DOI 10.1161/01.ATV.16.11.1365; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; YAO LY, 1994, MATRIX BIOL, V14, P213, DOI 10.1016/0945-053X(94)90185-6; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	35	67	70	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23239	23248		10.1074/jbc.M109.084673	http://dx.doi.org/10.1074/jbc.M109.084673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489207	hybrid, Green Published			2022-12-25	WOS:000279999900058
J	Aslam, A; Logie, C				Aslam, Aamir; Logie, Colin			Histone H3 Serine 57 and Lysine 56 Interplay in Transcription Elongation and Recovery from S-Phase Stress	PLOS ONE			English	Article							NUCLEOSOME CORE PARTICLE; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; H3K56 ACETYLATION; DNA-DAMAGE; CELL-CYCLE; ANGSTROM RESOLUTION; GENOMIC STABILITY; STRUCTURAL BASIS; REPLICATION	Background: Acetylation of lysine 56 of histone H3 plays an important role in the DNA damage response and it has been postulated to play an as yet undefined role in transcription, both in yeast and in higher eukaryotes. Because phosphorylated human histone H3 serine 57 peptides have been detected by mass spectrometry we examined whether H3-S57 phosphorylation interplays with H3-K56 acetylation in vivo. Methodology/Principal Findings: To explore the physiological role of H3-S57, H3-K56 was mutated to mimic constitutively (un)acetylated forms of H3-K56 and these were combined with constitutively (un) phosphorylated mimics of H3-S57, in yeast. A phosphorylated serine mimic at position 57 lessened sensitivities to a DNA replication fork inhibitor and to a transcription elongation inhibitor that were caused by an acetylated lysine mimic at position 56, while the same substitution exacerbated sensitivities due to mimicking a constitutive non-acetylated lysine at position 56. Strikingly, opposite results were obtained in the context of a serine to alanine substitution at position 57 of histone H3. Conclusions/Significance: The phenotypes elicited and the context-dependent interplay of the H3-K56 and -S57 point mutations that mimic their respective modification states suggest that serine 57 phosphorylation promotes a nucleosomal transaction when lysine 56 is acetylated. We speculate that histone H3-S57 couples H3-K56 acetylation to histone quaternary structures involving arginine 40 on histone H4 helix 1.	[Aslam, Aamir; Logie, Colin] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands	Radboud University Nijmegen	Aslam, A (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands.	c.logie@ncmls.ru.nl	Logie, Colin/A-1528-2010; Logie, Colin/L-9833-2019	Logie, Colin/0000-0002-8534-6582; Logie, Colin/0000-0002-8534-6582	Dutch Cancer Foundation Koningin Wilhelmina Fonds (KWF); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Higher Education Commission of Pakistan	Dutch Cancer Foundation Koningin Wilhelmina Fonds (KWF); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by grants from the Dutch Cancer Foundation Koningin Wilhelmina Fonds (KWF) and the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) to C. Logie, and from the Higher Education Commission of Pakistan to A. Aslam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Davidson MB, 2009, DNA REPAIR, V8, P1110, DOI 10.1016/j.dnarep.2009.03.010; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Erkmann JA, 2009, DNA REPAIR, V8, P1371, DOI 10.1016/j.dnarep.2009.09.004; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Knapp AR, 2007, METHODS, V41, P312, DOI 10.1016/j.ymeth.2006.08.017; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Miller A, 2008, GENETICS, V179, P793, DOI 10.1534/genetics.107.084525; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schleker T, 2009, DNA REPAIR, V8, P1089, DOI 10.1016/j.dnarep.2009.04.010; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998d; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Varv S, 2010, MOL CELL BIOL, V30, P1467, DOI 10.1128/MCB.01151-09; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Yang JH, 2010, DNA REPAIR, V9, P414, DOI 10.1016/j.dnarep.2009.12.022; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zielinska DF, 2009, J PROTEOME RES, V8, P4039, DOI 10.1021/pr900384k	54	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10851	10.1371/journal.pone.0010851	http://dx.doi.org/10.1371/journal.pone.0010851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520775	gold, Green Submitted, Green Published			2022-12-25	WOS:000278221500036
J	Filippi, M; Riccitelli, G; Falini, A; Di Salle, F; Vuilleumier, P; Comi, G; Rocca, MA				Filippi, Massimo; Riccitelli, Gianna; Falini, Andrea; Di Salle, Francesco; Vuilleumier, Patrik; Comi, Giancarlo; Rocca, Maria A.			The Brain Functional Networks Associated to Human and Animal Suffering Differ among Omnivores, Vegetarians and Vegans	PLOS ONE			English	Article							AMYGDALA RESPONSE; EMPATHY QUOTIENT; EMOTION; FMRI; STIMULI; CORTEX; METAANALYSIS; NEUROSCIENCE; MODULATION; SYSTEMS	Empathy and affective appraisals for conspecifics are among the hallmarks of social interaction. Using functional MRI, we hypothesized that vegetarians and vegans, who made their feeding choice for ethical reasons, might show brain responses to conditions of suffering involving humans or animals different from omnivores. We recruited 20 omnivore subjects, 19 vegetarians, and 21 vegans. The groups were matched for sex and age. Brain activation was investigated using fMRI and an event-related design during observation of negative affective pictures of human beings and animals (showing mutilations, murdered people, human/animal threat, tortures, wounds, etc.). Participants saw negative-valence scenes related to humans and animals, alternating with natural landscapes. During human negative valence scenes, compared with omnivores, vegetarians and vegans had an increased recruitment of the anterior cingulate cortex (ACC) and inferior frontal gyrus (IFG). More critically, during animal negative valence scenes, they had decreased amygdala activation and increased activation of the lingual gyri, the left cuneus, the posterior cingulate cortex and several areas mainly located in the frontal lobes, including the ACC, the IFG and the middle frontal gyrus. Nonetheless, also substantial differences between vegetarians and vegans have been found responding to negative scenes. Vegetarians showed a selective recruitment of the right inferior parietal lobule during human negative scenes, and a prevailing activation of the ACC during animal negative scenes. Conversely, during animal negative scenes an increased activation of the inferior prefrontal cortex was observed in vegans. These results suggest that empathy toward non conspecifics has different neural representation among individuals with different feeding habits, perhaps reflecting different motivational factors and beliefs.	[Filippi, Massimo; Riccitelli, Gianna; Rocca, Maria A.] Inst Sci, Neuroimaging Res Unit, Inst Expt Neurol, Div Neurosci, Milan, Italy; [Filippi, Massimo; Riccitelli, Gianna; Falini, Andrea; Rocca, Maria A.] Univ Hosp San Raffaele, Milan, Italy; [Filippi, Massimo; Rocca, Maria A.] Inst Sci, Dept Neurol, Milan, Italy; [Falini, Andrea] Inst Sci, Dept Neuroradiol, Milan, Italy; [Di Salle, Francesco] Univ Maastricht, Dept Cognit Neurosci, Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Vuilleumier, Patrik] Univ Geneva, Ctr Med Univ Geneva, Geneva, Switzerland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Maastricht University; University of Geneva	Filippi, M (corresponding author), Inst Sci, Neuroimaging Res Unit, Inst Expt Neurol, Div Neurosci, Milan, Italy.	filippi.massimo@hsr.it	Filippi, Massimo/K-1755-2018; Vuilleumier, Patrik/AAJ-1839-2021; Rocca, Maria Assunta/K-1619-2018; Riccitelli, Gianna Carla/AAD-9415-2020	Filippi, Massimo/0000-0002-5485-0479; Vuilleumier, Patrik/0000-0002-8198-9214; Rocca, Maria Assunta/0000-0003-2358-4320; Riccitelli, Gianna Carla/0000-0002-1202-5534; falini, andrea/0000-0002-1461-8755				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; DARGEMBEAU A, 2009, J COGN NEUROSCI; Decety J, 2003, CONSCIOUS COGN, V12, P577, DOI 10.1016/S1053-8100(03)00076-X; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Lang P.J., 2008, A8 U FLOR; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Mottaghy FM, 2006, NEUROIMAGE, V29, P225, DOI 10.1016/j.neuroimage.2005.07.034; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Regan T., 1985, CASE ANIMAL RIGHTS; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Schienle A, 2006, NEUROSCI LETT, V393, P174, DOI 10.1016/j.neulet.2005.09.072; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Teasdale JD, 1999, AM J PSYCHIAT, V156, P209; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Westbury HR, 2008, BIOL PSYCHOL, V78, P66, DOI 10.1016/j.biopsycho.2007.12.009	39	50	52	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10847	10.1371/journal.pone.0010847	http://dx.doi.org/10.1371/journal.pone.0010847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520767	gold, Green Published, Green Submitted			2022-12-25	WOS:000278221500032
J	Li, ZY; Qi, CF; Shin, DM; Zingone, A; Newbery, HJ; Kovalchuk, AL; Abbott, CM; Morse, HC				Li, Zhaoyang; Qi, Chen-Feng; Shin, Dong-Mi; Zingone, Adriana; Newbery, Helen J.; Kovalchuk, Alexander L.; Abbott, Catherine M.; Morse, Herbert C., III			Eef1a2 Promotes Cell Growth, Inhibits Apoptosis and Activates JAK/STAT and AKT Signaling in Mouse Plasmacytomas	PLOS ONE			English	Article							ELONGATION-FACTOR EEF1A2; MULTIPLE-MYELOMA; THERAPEUTIC TARGET; OVARIAN CARCINOMAS; MAMMALIAN-CELLS; GENE-EXPRESSION; FACTOR 1-ALPHA; FACTOR 1A; JAK-STAT; B-CELLS	Background: The canonical function of EEF1A2, normally expressed only in muscle, brain, and heart, is in translational elongation, but recent studies suggest a non-canonical function as a proto-oncogene that is overexpressed in a variety of solid tumors including breast and ovary. Transcriptional profiling of a spectrum of primary mouse B cell lineage neoplasms showed that transcripts encoding EEF1A2 were uniquely overexpressed in plasmacytomas (PCT), tumors of mature plasma cells. Cases of human multiple myeloma expressed significantly higher levels of EEF1A2 transcripts than normal bone marrow plasma cells. High-level expression was also a feature of a subset of cell lines developed from mouse PCT and from the human MM. Methodology/Principal Findings: Heightened expression of EEF1A2 was not associated with increased copy number or coding sequence mutations. shRNA-mediated knockdown of Eef1a2 transcripts and protein was associated with growth inhibition due to delayed G1-S progression, and effects on apoptosis that were seen only under serum-starved conditions. Transcriptional profiles and western blot analyses of knockdown cells revealed impaired JAK/STAT and PI3K/AKT signaling suggesting their contributions to EEF1A2-mediated effects on PCT induction or progression. Conclusions/Significance: EEF1A2 may play contribute to the induction or progression of some PCT and a small percentage of MM. Eef1a2 could also prove to be a useful new marker for a subset of MM and, ultimately, a possible target for therapy.	[Li, Zhaoyang; Qi, Chen-Feng; Shin, Dong-Mi; Kovalchuk, Alexander L.; Morse, Herbert C., III] NIAID, Immunopathol Lab, NIH, Rockville, MD USA; [Zingone, Adriana] USN Hosp, NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20814 USA; [Newbery, Helen J.; Abbott, Catherine M.] Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Mol Med Ctr, Edinburgh, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Navy; University of Edinburgh	Li, ZY (corresponding author), NIAID, Immunopathol Lab, NIH, Rockville, MD USA.	hmorse@niaid.nih.gov	Abbott, Catherine M/C-7306-2013	Abbott, Catherine/0000-0001-8794-7173; Morse, Herbert/0000-0002-9331-3705; Kovalchuk, Alexander/0000-0003-2761-0442	National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Cancer Institute; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001024, ZIAAI000858] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Cancer Institute. Work in the lab of CMA is supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Akilesh S, 2003, GENOME RES, V13, P1719, DOI 10.1101/gr.533003; Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Cao HX, 2009, BIOCHEM BIOPH RES CO, V380, P11, DOI 10.1016/j.bbrc.2008.12.171; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Ferrajoli A, 2006, CURR CANCER DRUG TAR, V6, P671, DOI 10.2174/156800906779010227; Fredrickson TN, 1999, AM J PATHOL, V154, P805, DOI 10.1016/S0002-9440(10)65327-8; Grassi G, 2007, BIOCHIMIE, V89, P1544, DOI 10.1016/j.biochi.2007.07.007; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Jeganathan S, 2008, MOL CELL BIOL, V28, P4549, DOI 10.1128/MCB.00150-08; Jeganathan S, 2007, J BIOL CHEM, V282, P372, DOI 10.1074/jbc.M602955200; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kido T, 2008, INT J CANCER, V123, P1573, DOI 10.1002/ijc.23697; Kim MJ, 1999, MOL CELLS, V9, P631; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kulkarni G, 2007, BREAST CANCER RES TR, V102, P31, DOI 10.1007/s10549-006-9315-8; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; LEE S, 1995, EXP CELL RES, V219, P589, DOI 10.1006/excr.1995.1268; LEE S, 1992, J BIOL CHEM, V267, P24064; Li R, 2006, ONCOGENE, V25, P2628, DOI 10.1038/sj.onc.1209289; Morse HC, 2001, LEUKEMIA RES, V25, P719, DOI 10.1016/S0145-2126(01)00022-4; Morse HC, 2003, ADV IMMUNOL, V81, P97, DOI 10.1016/S0065-2776(03)81003-9; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; Park ES, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-302; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Qi CF, 2006, LEUKEMIA RES, V30, P153, DOI 10.1016/j.leukres.2005.06.025; Qi CF, 2007, CANCER RES, V67, P2439, DOI 10.1158/0008-5472.CAN-06-1561; Qi CF, 2010, J PATHOL, V221, P106, DOI 10.1002/path.2692; Quintanilla-Martinez L, 2003, AM J PATHOL, V162, P1449, DOI 10.1016/S0002-9440(10)64278-2; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shin DM, 2008, CANCER RES, V68, P9202, DOI 10.1158/0008-5472.CAN-07-6555; Sun Y, 2008, INT J CANCER, V123, P1761, DOI 10.1002/ijc.23708; Tomlinson VAL, 2007, BRIT J CANCER, V96, P1613, DOI 10.1038/sj.bjc.6603748; Tomlinson VAL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-113; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Zhang JQ, 2004, J EXP MED, V200, P1467, DOI 10.1084/jem.20041575	49	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10755	10.1371/journal.pone.0010755	http://dx.doi.org/10.1371/journal.pone.0010755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505761	Green Submitted, Green Published, gold			2022-12-25	WOS:000278017400012
J	McKenna, SA; Etnoyer, P				McKenna, Sheila A.; Etnoyer, Peter			Rapid Assessment of Stony Coral Richness and Condition on Saba Bank, Netherlands Antilles	PLOS ONE			English	Article							CLIMATE-CHANGE; REEFS; COMMUNITY; IMPACTS; FLORIDA	The benthic habitats of Saba Bank (17 degrees 25'N, 63 degrees 30'W) are at risk from maritime traffic, especially oil tankers (e.g., anchoring). To mitigate this risk, information is needed on the biodiversity and location of habitats to develop a zone use plan. A rapid survey to document the biodiversity of macro-algae, sponges, corals and fishes was conducted. Here we report on the richness and condition of stony coral species at 18 select sites, and we test for the effects of bottom type, depth, and distance from platform edge. Species richness was visually assessed by roving scuba diver with voucher specimens of each species collected. Coral tissue was examined for bleaching and diseases. Thirty-three coral species were documented. There were no significant differences in coral composition among bottom types or depth classes (ANOSIM, P>0.05). There was a significant difference between sites (ANOSIM, P<0.05) near and far from the platform edge. The number of coral species observed ranged from zero and one in algal dominated habitats to 23 at a reef habitat on the southern edge of the Bank. Five reef sites had stands of Acropora cervicornis, a critically endangered species on the IUCN redlist. Bleaching was evident at 82% of the sites assessed with 43 colonies bleached. Only three coral colonies were observed to have disease. Combining our findings with that of other studies, a total of 43 species have been documented from Saba Bank. The coral assemblage on the bank is representative and typical of those found elsewhere in the Caribbean. Although our findings will help develop effective protection, more information is needed on Saba Bank to create a comprehensive zone use plan. Nevertheless, immediate action is warranted to protect the diverse coral reef habitats documented here, especially those containing A. cervicornis.	[McKenna, Sheila A.] Ctr Appl Biodivers Sci Conservat Int, Arlington, VA USA; [McKenna, Sheila A.] Mission Blue, Alameda, CA USA; [McKenna, Sheila A.] Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia; [McKenna, Sheila A.] Univ Queensland, Commonwealth Facil Appl Environm Decis Anal AEDA, Brisbane, Qld, Australia; [Etnoyer, Peter] NOAA, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA	University of Queensland; University of Queensland; National Oceanic Atmospheric Admin (NOAA) - USA	McKenna, SA (corresponding author), Ctr Appl Biodivers Sci Conservat Int, Arlington, VA USA.	sheilamckenna@yahoo.com		Etnoyer, Peter/0000-0002-9932-3066	Center for Applied Biodiversity Science at Conservation International; Netherlands Antilles Department of Environment and Nature (MINA); Saba Bank Conservation Foundation; Saba National Marine Park; Nature Foundation St. Maarten; Conservation International	Center for Applied Biodiversity Science at Conservation International; Netherlands Antilles Department of Environment and Nature (MINA); Saba Bank Conservation Foundation; Saba National Marine Park; Nature Foundation St. Maarten; Conservation International	The Saba Bank rapid assessment was funded by the Center for Applied Biodiversity Science at Conservation International, Netherlands Antilles Department of Environment and Nature (MINA) and Saba Bank Conservation Foundation. In kind support was provided by Saba National Marine Park and Nature Foundation St. Maarten. The publication fees for this contribution on the stony corals of Saba Bank are funded by Conservation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON R, 2008, IUCN 2009 IUCN RED L; Bouchon C., 2008, STATUS CORAL REEFS L, P85; CAIRNS SD, 2000, STUDIES NATURAL HIST, V75, P1; Cairns Stephen D., 1999, Atoll Research Bulletin, V459, P13; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chiappone M., 1996, Caribbean Journal of Science, V32, P1; Clarke K.R., 2006, PRIMER V6 1 USER MAN; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collier C, 2007, RAPID RESPONSE RESTO; Colwell RK, 2013, ESTIMATES STAT ESTIM; DAVIS G E, 1977, Biological Conservation, V11, P29, DOI 10.1016/0006-3207(77)90024-6; Diaz JM, 2000, SCI MAR, V64, P327, DOI 10.3989/scimar.2000.64n3327; DUSTAN P, 1987, CORAL REEFS, V6, P91, DOI 10.1007/BF00301378; Fenner D, 2001, B MAR SCI, V69, P1175; Fenner Douglas, 1998, Caribbean Marine Studies, V6, P19; Global Invasive Species Database, 2005, GLOBAL INVASIVE SPEC; HOETJES P, 2002, STATUS CORAL REEFS W, P325; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Klomp Kristi D., 2003, Atoll Research Bulletin, V496, P404; Kramer P., 2005, ATLANTIC GULF RAPID; MACINTYRE I G, 1975, Caribbean Journal of Science, V15, P11; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; *NOAA COR REEF HLT, NOAAS COR REEF HLTH; *SOC MAN EL BIOD D, 2009, WORLD REG MAR SPEC; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; van der Land J., 1977, FAO FISHERIES REPORT, V200, P469, DOI DOI 10.1371/JOURNAL.PONE.0009207; Veron J.E.N., 2000, CORALS WORLD, V1-3; VERON JEN, 1995, CORALS SPACE TIME BI; Weil E, 2004, CORAL HEALTH AND DISEASE, P35	33	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10749	10.1371/journal.pone.0010749	http://dx.doi.org/10.1371/journal.pone.0010749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505771	Green Published, Green Accepted, gold			2022-12-25	WOS:000278017400010
J	Lauren, HB; Lopez-Picon, FR; Brandt, AM; Rios-Rojas, CJ; Holopainen, IE				Lauren, Hanna B.; Lopez-Picon, Francisco R.; Brandt, Annika M.; Rios-Rojas, Clarissa J.; Holopainen, Irma E.			Transcriptome Analysis of the Hippocampal CA1 Pyramidal Cell Region after Kainic Acid-Induced Status Epilepticus in Juvenile Rats	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CALCIUM-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION; SUBUNIT MESSENGER-RNA; GENE-EXPRESSION; GABA(A) RECEPTOR; INDUCED SEIZURES; DENTATE GYRUS; ADULT-RAT	Molecular mechanisms involved in epileptogenesis in the developing brain remain poorly understood. The gene array approach could reveal some of the factors involved by allowing the identification of a broad scale of genes altered by seizures. In this study we used microarray analysis to reveal the gene expression profile of the laser microdissected hippocampal CA1 subregion one week after kainic acid (KA)-induced status epilepticus (SE) in 21-day-old rats, which are developmentally roughly comparable to juvenile children. The gene expression analysis with the Chipster software generated a total of 1592 differently expressed genes in the CA1 subregion of KA-treated rats compared to control rats. The KEGG database revealed that the identified genes were involved in pathways such as oxidative phosporylation (26 genes changed), and long-term potentiation (LTP; 18 genes changed). Also genes involved in Ca2+ homeostasis, gliosis, inflammation, and GABAergic transmission were altered. To validate the microarray results we further examined the protein expression for a subset of selected genes, glial fibrillary protein (GFAP), apolipoprotein E (apo E), cannabinoid type 1 receptor (CB1), Purkinje cell protein 4 (PEP-19), and interleukin 8 receptor (CXCR1), with immunohistochemistry, which confirmed the transcriptome results. Our results showed that SE resulted in no obvious CA1 neuronal loss, and alterations in the expression pattern of several genes during the early epileptogenic phase were comparable to previous gene expression studies of the adult hippocampus of both experimental epileptic animals and patients with temporal lobe epilepsy (TLE). However, some changes seem to occur after SE specifically in the juvenile rat hippocampus. Insight of the SE-induced alterations in gene expression and their related pathways could give us hints for the development of new target-specific antiepileptic drugs that interfere with the progression of the disease in the juvenile age group.	[Lauren, Hanna B.; Lopez-Picon, Francisco R.; Holopainen, Irma E.] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Lauren, Hanna B.; Holopainen, Irma E.] MediCity Res Lab, Turku, Finland; [Brandt, Annika M.; Rios-Rojas, Clarissa J.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Brandt, Annika M.; Rios-Rojas, Clarissa J.] Abo Akad Univ, Turku, Finland	University of Turku; University of Turku; University of Turku; Abo Akademi University	Lauren, HB (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	irma.holopainen@utu.fi		Rios Rojas, Clarissa Jazmin/0000-0001-6544-4663; Lopez Picon, Francisco R./0000-0002-3871-1735	Academy of Finland [8117438, 8127008]; Arvo and Lea Ylppo Foundation; Finnish Cultural Foundation; Drug Discovery Graduate School; Finnish Graduate School of Neuroscience	Academy of Finland(Academy of Finland); Arvo and Lea Ylppo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Drug Discovery Graduate School; Finnish Graduate School of Neuroscience	The financial support of the Academy of Finland, projects # 8117438 (IEH) and # 8127008 (HBL), the Arvo and Lea Ylppo Foundation (IEH), the Finnish Cultural Foundation (HBL), the Drug Discovery Graduate School (HBL), and the Finnish Graduate School of Neuroscience (FRL) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 1996, J BIOL CHEM, V271, P225, DOI 10.1074/jbc.271.1.225; Akahoshi N, 2007, NEUROSCI LETT, V429, P136, DOI 10.1016/j.neulet.2007.10.007; Aronica E, 2001, EUR J NEUROSCI, V14, P1485, DOI 10.1046/j.0953-816x.2001.01779.x; BARGER SW, 1992, J BIOL CHEM, V267, P9689; Becker AJ, 2003, EUR J NEUROSCI, V18, P2792, DOI 10.1111/j.1460-9568.2003.02993.x; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bendotti C, 2000, EXP NEUROL, V161, P317, DOI 10.1006/exnr.1999.7262; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; Blair RE, 2008, EUR J PHARMACOL, V588, P64, DOI 10.1016/j.ejphar.2008.04.021; Bo T, 2004, DEV BRAIN RES, V152, P137, DOI 10.1016/j.devbrainres.2004.06.011; Bouilleret V, 2000, HIPPOCAMPUS, V10, P305; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; BRZIN J, 1984, BIOCHEM BIOPH RES CO, V118, P103, DOI 10.1016/0006-291X(84)91073-8; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Carter DS, 2008, EPILEPSY RES, V79, P213, DOI 10.1016/j.eplepsyres.2008.02.006; Champagne D, 2005, EXP NEUROL, V194, P31, DOI 10.1016/j.expneurol.2005.01.016; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Danik M, 2003, J NEUROSCI RES, V74, P286, DOI 10.1002/jnr.10744; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Ding M, 2000, NEUROCHEM INT, V36, P313, DOI 10.1016/S0197-0186(99)00139-4; Elliott RC, 2003, J NEUROSCI, V23, P2218; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; French PJ, 2001, EUR J NEUROSCI, V14, P2037, DOI 10.1046/j.0953-816x.2001.01818.x; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Fritschy JM, 1999, NEUROCHEM INT, V34, P435, DOI 10.1016/S0197-0186(99)00040-6; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; GILLARDON F, 1995, NEUROSCI LETT, V192, P85, DOI 10.1016/0304-3940(95)11619-8; Gorter JA, 2003, EPILEPSIA, V44, P647, DOI 10.1046/j.1528-1157.2003.53902.x; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Haas KZ, 2001, HIPPOCAMPUS, V11, P615, DOI 10.1002/hipo.1076; Hashiguchi A, 2003, NEUROSCIENCE, V121, P379, DOI 10.1016/S0306-4522(03)00490-1; Haut SR, 2004, LANCET NEUROL, V3, P608, DOI 10.1016/S1474-4422(04)00881-6; Hellsten J, 2005, BIOL PSYCHIAT, V58, P871, DOI 10.1016/j.biopsych.2005.05.023; Hendriksen H, 2001, EUR J NEUROSCI, V14, P1475, DOI 10.1046/j.0953-816x.2001.01778.x; Henshall DC, 2000, J NEUROCHEM, V74, P1215; Hoffman AF, 2000, J NEUROSCI, V20, P2470; Houser CR, 2003, HIPPOCAMPUS, V13, P633, DOI 10.1002/hipo.10108; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Jarvela JT, 2008, EPILEPSIA, V49, P832, DOI 10.1111/j.1528-1167.2007.01454.x; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kingham PJ, 2001, J NEUROCHEM, V76, P1475, DOI 10.1046/j.1471-4159.2001.00146.x; Lauren HB, 2005, J NEUROCHEM, V94, P1384, DOI 10.1111/j.1471-4159.2005.03274.x; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; LERANTH C, 1991, EXP BRAIN RES, V85, P129; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lopez-Picon F, 2004, NEUROBIOL DIS, V17, P415, DOI 10.1016/j.nbd.2004.08.004; Lopez-Picon FR, 2003, HIPPOCAMPUS, V13, P767, DOI 10.1002/hipo.10122; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; MARKS N, 1988, ARCH BIOCHEM BIOPHYS, V267, P448, DOI 10.1016/0003-9861(88)90050-1; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matsumoto T, 1997, LAB INVEST, V77, P119; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mennicken F, 2002, GLIA, V37, P124, DOI 10.1002/glia.10021; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Montpied P, 1999, EPILEPSY RES, V35, P135, DOI 10.1016/S0920-1211(99)00003-0; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Ozbas-Gerceker F, 2006, NEUROSCIENCE, V138, P457, DOI 10.1016/j.neuroscience.2005.11.043; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Puma C, 2001, J NEUROCHEM, V78, P960, DOI 10.1046/j.1471-4159.2001.00469.x; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Ravizza T, 2005, EPILEPSIA, V46, P113, DOI 10.1111/j.1528-1167.2005.01006.x; Rice A, 1996, P NATL ACAD SCI USA, V93, P9665, DOI 10.1073/pnas.93.18.9665; Ritter LM, 2002, DEV BRAIN RES, V139, P227, DOI 10.1016/S0165-3806(02)00572-2; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Sanden E, 2003, AM J DENT, V16, P170; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; SPERBER EF, 1991, DEV BRAIN RES, V60, P88, DOI 10.1016/0165-3806(91)90158-F; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Takano H, 2004, BIOL PHARM BULL, V27, P1788, DOI 10.1248/bpb.27.1788; Tang FR, 2006, NEUROSCIENCE, V140, P1467, DOI 10.1016/j.neuroscience.2006.03.022; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; TORRE ER, 1993, BRAIN RES, V631, P256, DOI 10.1016/0006-8993(93)91543-2; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Twitchell W, 1997, J NEUROPHYSIOL, V78, P43, DOI 10.1152/jn.1997.78.1.43; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Wasterlain CG, 2002, PROG BRAIN RES, V135, P335; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007; Zhao XY, 2001, J COMP NEUROL, V441, P187, DOI 10.1002/cne.1406	101	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10733	10.1371/journal.pone.0010733	http://dx.doi.org/10.1371/journal.pone.0010733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505763	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017300009
J	Gupta, N; Fisker, N; Asselin, MC; Lindholm, M; Rosenbohm, C; Orum, H; Elmen, J; Seidah, NG; Straarup, EM				Gupta, Nidhi; Fisker, Niels; Asselin, Marie-Claude; Lindholm, Marie; Rosenbohm, Christoph; Orum, Henrik; Elmen, Joacim; Seidah, Nabil G.; Straarup, Ellen Marie			A Locked Nucleic Acid Antisense Oligonucleotide (LNA) Silences PCSK9 and Enhances LDLR Expression In Vitro and In Vivo	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PROPROTEIN CONVERTASE PCSK9; NONHUMAN-PRIMATES; LIVER-REGENERATION; PLASMA-CHOLESTEROL; MOUSE-LIVER; MICE; DEGRADATION; MUTATIONS	Background: The proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important factor in the etiology of familial hypercholesterolemia (FH) and is also an attractive therapeutic target to reduce low density lipoprotein (LDL) cholesterol. PCSK9 accelerates the degradation of hepatic low density lipoprotein receptor (LDLR) and low levels of hepatic PCSK9 activity are associated with reduced levels of circulating LDL-cholesterol. Methodology/Principal Findings: The present study presents the first evidence for the efficacy of a locked nucleic acid (LNA) antisense oligonucleotide (LNA ASO) that targets both human and mouse PCSK9. We employed human hepatocytes derived cell lines HepG2 and HuH7 and a pancreatic mouse beta-TC3 cell line known to express high endogenous levels of PCSK9. LNA ASO efficiently reduced the mRNA and protein levels of PCSK9 with a concomitant increase in LDLR protein levels after transfection in these cells. In vivo efficacy of LNA ASO was further investigated in mice by tail vein intravenous administration of LNA ASO in saline solution. The level of PCSK9 mRNA was reduced by similar to 60%, an effect lasting more than 16 days. Hepatic LDLR protein levels were significantly up-regulated by 2.5-3 folds for at least 8 days and similar to 2 fold for 16 days. Finally, measurement of liver alanine aminotransferase (ALT) levels revealed that long term LNA ASO treatment (7 weeks) does not cause hepatotoxicity. Conclusion/Significance: LNA-mediated PCSK9 mRNA inhibition displayed potent reduction of PCSK9 in cell lines and mouse liver. Our data clearly revealed the efficacy and safety of LNA ASO in reducing PCSK9 levels, an approach that is now ready for testing in primates. The major significance and take home message of this work is the development of a novel and promising approach for human therapeutic intervention of the PCSK9 pathway and hence for reducing some of the cardiovascular risk factors associated with the metabolic syndrome.	[Gupta, Nidhi; Asselin, Marie-Claude; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Fisker, Niels; Lindholm, Marie; Rosenbohm, Christoph; Orum, Henrik; Elmen, Joacim; Straarup, Ellen Marie] Santaris Pharma AS, Horsholm, Denmark	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Gupta, N (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Lindholm, Marie W/B-8736-2015; Seidah, Nabil/I-3596-2013; Gupta, Nidhi/ADR-1996-2022	Lindholm, Marie W/0000-0003-4309-3203; Seidah, Nabil/0000-0001-6503-9342; Gupta, Nidhi/0000-0002-1086-1336; Wikstrom Lindholm, Marie/0000-0002-0975-2394	Canadian Institutes of Health [MOP 36496, CTP 82946]; Santaris Pharma A/S	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Santaris Pharma A/S	This work was supported by a Canadian Institutes of Health Research grant MOP 36496 and a team grant CTP 82946. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, this project was partially funded by Santaris Pharma A/S, allowing a collaborative effort in which Santaris Pharma was co-author in this study. The design of the LNA and its synthesis and mouse work was done at Santaris, and the extensive cell biology work was done at the IRCM. The decision to publish and prepration of the manuscript was by common agreement and effort between the IRCM and Santaris.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cariou B, 2009, ARTERIOSCL THROM VAS, V29, P2191, DOI 10.1161/ATVBAHA.109.194191; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	37	148	157	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10682	10.1371/journal.pone.0010682	http://dx.doi.org/10.1371/journal.pone.0010682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498851	gold, Green Published, Green Submitted			2022-12-25	WOS:000277773700018
J	Qi, QB; Li, HX; Loos, RJF; Liu, C; Hu, FB; Wu, HY; Yu, ZJ; Lin, X				Qi, Qibin; Li, Huaixing; Loos, Ruth J. F.; Liu, Chen; Hu, Frank B.; Wu, Hongyu; Yu, Zhijie; Lin, Xu			Association of PCSK1 rs6234 with Obesity and Related Traits in a Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; GENE; ADULTS; RISK	Methodology/Principal Findings: Two PCSK1 variants rs6234 and rs6235 (in strong LD with each other, r(2) = 0.98) were genotyped in a population-based cohort of 3,210 Chinese Hans. The rs6234 was used for further association analyses with obesity and related traits. We found no significant association of rs6234 with obesity, overweight, BMI, waist circumference, or body fat percentage (P > 0.05) in all participants. However, the rs6234 G-allele showed a significant association with increased risk of combined phenotype of obesity and overweight (OR 1.21[1.03-1.43], P = 0.0193) and a trend toward association with obesity (OR 1.25[0.98-1.61], P = 0.08) in men, but not in women (P >= 0.29). Consistently, the rs6234 G-allele showed significant association with increased BMI (P = 0.0043), waist circumference (P = 0.008) and body fat percentage (P = 0.0131) only in men, not in women (P >= 0.24). Interestingly, the rs6234 G-allele was significantly associated with increased HOMA-B (P = 0.0059) and decreased HOMA-S (P = 0.0349) in all participants. Conclusion/Significance: In this study, we found modest evidence for association of the PCSK1 rs6234 with BMI and overweight in men only but not in women, which suggested that PCSK1 rs6234 might not be an important contributor to obesity in Chinese Hans. However, further studies with larger sample sizes are needed to draw a firm conclusion.	[Qi, Qibin; Li, Huaixing; Liu, Chen; Wu, Hongyu; Yu, Zhijie; Lin, Xu] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Qi, Qibin; Li, Huaixing; Liu, Chen; Wu, Hongyu; Yu, Zhijie; Lin, Xu] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Loos, Ruth J. F.] Addenbrookes Hosp, Inst Metab Sci, Epidemiol Unit, MRC, Cambridge, England; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health	Qi, QB (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	lihx@sibs.ac.cn; xlin@sibs.ac.cn	Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022; Qi, Qibin/H-9055-2012	Loos, Ruth J F/0000-0002-8532-5087; 	Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [SIBS2008006, KSCX1-YW-02]; National Natural Science Foundation of China [30930081]; Ministry of Science and Technology of China [2006CB503900, 2007AA02Z332, 2008DFA31960]; MRC [MC_U106188470] Funding Source: UKRI; Medical Research Council [MC_U106188470] Funding Source: researchfish	Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by the Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006), the National Natural Science Foundation of China (30930081), the Ministry of Science and Technology of China (973 Program, Grant No. 2006CB503900; 863 Program, Grant No. 2007AA02Z332; and International Collaboration Program, Grant No. 2008DFA31960), and the Chinese Academy of Sciences (The Knowledge Innovation Program, Grant No. KSCX1-YW-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; CHANG YC, 2009, OBESITY         1029, DOI DOI 10.1038/OBY.2009.390; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	12	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10590	10.1371/journal.pone.0010590	http://dx.doi.org/10.1371/journal.pone.0010590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498726	Green Published, gold, Green Submitted			2022-12-25	WOS:000277773700003
J	Bernhard, S; Noe, F				Bernhard, Stefan; Noe, Frank			Optimal Identification of Semi-Rigid Domains in Macromolecules from Molecular Dynamics Simulation	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; STRUCTURAL DOMAINS; TRANSTHYRETIN; FLEXIBILITY; MICROHETEROGENEITY; CONFORMATION; PREALBUMIN; STABILITY; PROTEINS	Biological function relies on the fact that biomolecules can switch between different conformations and aggregation states. Such transitions involve a rearrangement of parts of the biomolecules involved that act as dynamic domains. The reliable identification of such domains is thus a key problem in biophysics. In this work we present a method to identify semi-rigid domains based on dynamical data that can be obtained from molecular dynamics simulations or experiments. To this end the average inter-atomic distance-deviations are computed. The resulting matrix is then clustered by a constrained quadratic optimization problem. The reliability and performance of the method are demonstrated for two artificial peptides. Furthermore we correlate the mechanical properties with biological malfunction in three variants of amyloidogenic transthyretin protein, where the method reveals that a pathological mutation destabilizes the natural dimer structure of the protein. Finally the method is used to identify functional domains of the GroEL-GroES chaperone, thus illustrating the efficiency of the method for large biomolecular machines.	[Bernhard, Stefan; Noe, Frank] Free Univ Berlin, DFG Res Ctr MATHEON, D-1000 Berlin, Germany	Free University of Berlin; German Research Foundation (DFG)	Bernhard, S (corresponding author), Free Univ Berlin, DFG Res Ctr MATHEON, D-1000 Berlin, Germany.	bernhard@math.fu-berlin.de	Noe, Frank/Y-2766-2019		DFG Research Center	DFG Research Center(German Research Foundation (DFG))	This work was funded by the DFG Research Center MATHEON (http://www.matheon.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2006, PROTEINS, V63, P1038, DOI 10.1002/prot.20907; Altland K, 1999, ELECTROPHORESIS, V20, P1349, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1349::AID-ELPS1349>3.0.CO;2-5; Altland K, 2007, ELECTROPHORESIS, V28, P2053, DOI 10.1002/elps.200600840; Anselmi C, 2001, BIOPOLYMERS, V58, P218, DOI 10.1002/1097-0282(200102)58:2<218::AID-BIP100>3.0.CO;2-M; Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Ayton GS, 2007, CURR OPIN STRUC BIOL, V17, P192, DOI 10.1016/j.sbi.2007.03.004; Bagci Z, 2002, J CHEM PHYS, V116, P2269, DOI 10.1063/1.1432502; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Balsera MA, 1996, J PHYS CHEM-US, V100, P2567, DOI 10.1021/jp9536920; Bao G, 2002, J MECH PHYS SOLIDS, V50, P2237, DOI 10.1016/S0022-5096(02)00035-2; BLAKE CCF, 1974, J MOL BIOL, V88, P1, DOI 10.1016/0022-2836(74)90291-5; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Carlson HA, 2000, MOL PHARMACOL, V57, P213; Cendron L, 2009, J BIOL CHEM, V284, P25832, DOI 10.1074/jbc.M109.017657; CHENNUBHOTLA C, 2006, MOL SYST BIOL, V36, P1; Damas AM, 2000, J STRUCT BIOL, V130, P290, DOI 10.1006/jsbi.2000.4273; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gill P., 1995, USERS GUIDE QPOPT 1; Hayward S, 2004, J MOL BIOL, V339, P1001, DOI 10.1016/j.jmb.2004.04.004; Hery S, 1998, J MOL BIOL, V279, P303, DOI 10.1006/jmbi.1998.1754; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999; Jenne DE, 1996, P NATL ACAD SCI USA, V93, P6302, DOI 10.1073/pnas.93.13.6302; JUNGER M, 2004, OPTIMIZATION OPERATI, P321; Keskin O, 2002, BIOCHEMISTRY-US, V41, P491, DOI 10.1021/bi011393x; Kim MK, 2005, BIOPHYS J, V89, P43, DOI 10.1529/biophysj.104.044347; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Lavery R, 2002, J PHYS-CONDENS MAT, V14, pR383, DOI 10.1088/0953-8984/14/14/202; LESK AM, 1981, P NATL ACAD SCI-BIOL, V78, P4304, DOI 10.1073/pnas.78.7.4304; Liljas A., 1974, ANNU REV BIOCHEM, V43, P475; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Menor SA, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036017; Micheletti C, 2002, J MOL BIOL, V321, P909, DOI 10.1016/S0022-2836(02)00710-6; Motozaki Y, 2007, J NEUROL SCI, V260, P236, DOI 10.1016/j.jns.2007.03.021; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Navizet I, 2004, PROTEINS, V54, P384, DOI 10.1002/prot.10476; NICOLAS WL, 1995, PROTEIN-STRUCT FUNCT, V23, P38; Noe F, 2008, J PHYS CHEM B, V112, P11155, DOI 10.1021/jp801391t; Potestio R, 2009, BIOPHYS J, V96, P4993, DOI 10.1016/j.bpj.2009.03.051; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; SHIBUYA T, 2008, IEEE ACM T COMPUT BI, P1; Sorensen J, 2007, BIOPOLYMERS, V86, P73, DOI 10.1002/bip.20705; SPLETTSTOESSER T, 2008, PROTEINS STRUCTURE F; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; TAKEUCHI M, 2006, PROTEIN-STRUCT FUNCT, V66, P716; TAN SY, 1994, HISTOPATHOLOGY, V25, P403, DOI 10.1111/j.1365-2559.1994.tb00001.x; Taylor WR, 1999, PROTEIN ENG, V12, P203, DOI 10.1093/protein/12.3.203; Walter S, 2002, CELL MOL LIFE SCI, V59, P1589, DOI 10.1007/PL00012485; WODAK SJ, 1981, BIOCHEMISTRY-US, V20, P6544, DOI 10.1021/bi00526a005; Wriggers W, 1997, PROTEINS, V29, P1; Xuan ZY, 2000, EUR BIOPHYS J BIOPHY, V29, P7, DOI 10.1007/s002490050246; Yesylevskyy SO, 2009, PROTEINS, V74, P980, DOI 10.1002/prot.22208; Yesylevskyy SO, 2006, BIOPHYS CHEM, V119, P84, DOI 10.1016/j.bpc.2005.07.004; ZEHFUS MH, 1987, PROTEIN-STRUCT FUNCT, V16, P90; Zhang ZY, 2008, BIOPHYS J, V95, P5073, DOI 10.1529/biophysj.108.139626	66	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10491	10.1371/journal.pone.0010491	http://dx.doi.org/10.1371/journal.pone.0010491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498702	Green Submitted, Green Published, gold			2022-12-25	WOS:000277633500004
J	Naylor, MG; Lin, XH; Weiss, ST; Raby, BA; Lange, C				Naylor, Melissa G.; Lin, Xihong; Weiss, Scott T.; Raby, Benjamin A.; Lange, Christoph			Using Canonical Correlation Analysis to Discover Genetic Regulatory Variants	PLOS ONE			English	Article								Background: Discovering genetic associations between genetic markers and gene expression levels can provide insight into gene regulation and, potentially, mechanisms of disease. Such analyses typically involve a linkage or association analysis in which expression data are used as phenotypes. This approach leads to a large number of multiple comparisons and may therefore lack power. We assess the potential of applying canonical correlation analysis to partitioned genomewide data as a method for discovering regulatory variants. Methodology/Principal Findings: Simulations suggest that canonical correlation analysis has higher power than standard pairwise univariate regression to detect single nucleotide polymorphisms when the expression trait has low heritability. The increase in power is even greater under the recessive model. We demonstrate this approach using the Childhood Asthma Management Program data. Conclusions/Significance: Our approach reduces multiple comparisons and may provide insight into the complex relationships between genotype and gene expression.	[Naylor, Melissa G.; Lin, Xihong; Lange, Christoph] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Weiss, Scott T.; Raby, Benjamin A.; Lange, Christoph] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Naylor, MG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	mnaylor@hsph.harvard.edu	Raby, Benjamin/AAK-3866-2021		National Institutes of Health (NIH) [T32 MH17119, T32 HL07427-26, R01 HL086601, 1 UL1 RR025780]; NIH/National Heart, Lung and Blood Institute [U01 HL075419, U01 HL65899, P01 HL083069, T32 HL07427]; National Center for Research Resources (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007427, R01HL086601, U01HL075419, P01HL083069, U01HL065899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH017119] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work has been supported by the National Institutes of Health (NIH) through grants T32 MH17119, T32 HL07427-26, and R01 HL086601. The CAMP Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069 and T32 HL07427 from the NIH/National Heart, Lung and Blood Institute, and through the Colorado Clinical and Translational Science Award (CTSA) grant 1 UL1 RR025780 from the NIH and National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartlett MS, 1941, BIOMETRIKA, V32, P29; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; JOHNSON RA, 2001, APPL MULTIVARIATE ST; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Parkhomenko E, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1406; R Development Core Team, 2009, R FDN STAT COMP; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Waaijenborg S, 2008, STAT APPL GENET MOL, V7	11	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10395	10.1371/journal.pone.0010395	http://dx.doi.org/10.1371/journal.pone.0010395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485529	Green Published, Green Submitted, gold			2022-12-25	WOS:000277633500002
J	Tommasi, S; Kim, SI; Zhong, XY; Wu, XW; Pfeifer, GP; Besaratinia, A				Tommasi, Stella; Kim, Sang-in; Zhong, Xueyan; Wu, Xiwei; Pfeifer, Gerd P.; Besaratinia, Ahmad			Investigating the Epigenetic Effects of a Prototype Smoke-Derived Carcinogen in Human Cells	PLOS ONE			English	Article							GENE PROMOTER HYPERMETHYLATION; ISLAND RECOVERY ASSAY; LUNG-CANCER; DNA METHYLATION; 5-METHYLCYTOSINE CONTENT; CPG-ISLANDS; HYPOMETHYLATION; METHYLTRANSFERASE; EPIGENOMICS; RESOLUTION	Global loss of DNA methylation and locus/gene-specific gain of DNA methylation are two distinct hallmarks of carcinogenesis. Aberrant DNA methylation is implicated in smoking-related lung cancer. In this study, we have comprehensively investigated the modulation of DNA methylation consequent to chronic exposure to a prototype smoke-derived carcinogen, benzo[a] pyrene diol epoxide (B[a]PDE), in genomic regions of significance in lung cancer, in normal human cells. We have used a pulldown assay for enrichment of the CpG methylated fraction of cellular DNA combined with microarray platforms, followed by extensive validation through conventional bisulfite-based analysis. Here, we demonstrate strikingly similar patterns of DNA methylation in non-transformed B[a]PDE-treated cells vs control using high-throughput microarray-based DNA methylation profiling confirmed by conventional bisulfite-based DNA methylation analysis. The absence of aberrant DNA methylation in our model system within a timeframe that precedes cellular transformation suggests that following carcinogen exposure, other as yet unknown factors (secondary to carcinogen treatment) may help initiate global loss of DNA methylation and region-specific gain of DNA methylation, which can, in turn, contribute to lung cancer development. Unveiling the initiating events that cause aberrant DNA methylation in lung cancer has tremendous public health relevance, as it can help define future strategies for early detection and prevention of this highly lethal disease.	[Tommasi, Stella; Kim, Sang-in; Zhong, Xueyan; Pfeifer, Gerd P.; Besaratinia, Ahmad] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Wu, Xiwei] City Hope Natl Med Ctr, Beckman Res Inst, Div Informat Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Tommasi, S (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ania@coh.org		Tommasi, Stella/0000-0001-6897-4985; Besaratinia, Ahmad/0000-0001-7231-228X	University of California [18KT-0040]; National Cancer Institute [2R01CA084469]; NATIONAL CANCER INSTITUTE [R01CA084469] Funding Source: NIH RePORTER	University of California(University of California System); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the University of California Tobacco Related Disease Research Program (18KT-0040 to A. B.), and National Cancer Institute (2R01CA084469 to G.P.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskunov VB, 2005, BIOCHEMISTRY-US, V44, P1054, DOI 10.1021/bi048130y; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Besaratinia A, 2008, LANCET ONCOL, V9, P657, DOI 10.1016/S1470-2045(08)70172-4; Besaratinia A, 2006, CARCINOGENESIS, V27, P1526, DOI 10.1093/carcin/bgi311; Besaratinia A, 2005, CARCINOGENIC EFFECTS OF POLYCYCLIC AROMATIC HYDROCARBONS, P171; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1988, CANCER RES, V48, P1159; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Girard L, 2000, CANCER RES, V60, P4894; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Hsu GW, 2005, J BIOL CHEM, V280, P3764, DOI 10.1074/jbc.M411276200; Hutt JA, 2005, CARCINOGENESIS, V26, P1999, DOI 10.1093/carcin/bgi150; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim DH, 2001, ONCOGENE, V20, P1765, DOI 10.1038/sj.onc.1204302; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Kuerbitz SJ, 1996, CELL GROWTH DIFFER, V7, P847; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Nia AB, 2000, CARCINOGENESIS, V21, P1335, DOI 10.1093/carcin/21.7.1335; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; PFEIFER GP, 1984, CARCINOGENESIS, V5, P931, DOI 10.1093/carcin/5.7.931; Rauch T, 2005, LAB INVEST, V85, P1172, DOI 10.1038/labinvest.3700311; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Sadikovic B, 2007, TOXICOL APPL PHARM, V225, P300, DOI 10.1016/j.taap.2007.08.013; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Subach OM, 2006, BIOCHEMISTRY-US, V45, P6142, DOI 10.1021/bi0511639; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tommasi S, 2000, NUCLEIC ACIDS RES, V28, P3991, DOI 10.1093/nar/28.20.3991; TOMMASI S, 1995, MOL CELL BIOL, V15, P6901; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Vaissiere T, 2009, CANCER RES, V69, P243, DOI 10.1158/0008-5472.CAN-08-2489; VENKATACHALAM S, 1994, CARCINOGENESIS, V15, P565, DOI 10.1093/carcin/15.4.565; Vuillemenot BR, 2006, MOL CANCER RES, V4, P267, DOI 10.1158/1541-7786.MCR-05-0218; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7; WILSON VL, 1984, CARCINOGENESIS, V5, P1027, DOI 10.1093/carcin/5.8.1027; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	52	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10594	10.1371/journal.pone.0010594	http://dx.doi.org/10.1371/journal.pone.0010594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485678	Green Submitted, Green Published, gold			2022-12-25	WOS:000277563400007
J	Ford, N; Darder, M; Spelman, T; Maclean, E; Mills, E; Boulle, A				Ford, Nathan; Darder, Marta; Spelman, Tim; Maclean, Emi; Mills, Edward; Boulle, Andrew			Early Adherence to Antiretroviral Medication as a Predictor of Long-Term HIV Virological Auppression: Five-Year Follow Up of an Observational Cohort	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CLINICAL-TRIALS; SOUTH-AFRICA; VIRAL LOAD; THERAPY; METAANALYSIS; KHAYELITSHA; SURVIVAL; OUTCOMES; FAILURE	Background: The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretroviral treatment using a fixed dose first-line antiretroviral regimen containing stavudine, lamivudine, and nevirapine. One of the primary concerns with the use of this regimen is nevirapine-associated hepatotoxicity. Methodology: Study participants were 1809 HIV-infected, antiretroviral naive adults initiating nevirapine-based antiretroviral therapy between November 2002 and December 2006. The primary outcome was early hepatotoxicity. Secondary outcomes were associations with hepatotoxicity and mortality at six months. The cumulative proportion of early hepatotoxicity ranged from 1.0-2.0% giving an incidence-rate at 102 days of 3.6-7.6 per 100 person-years. Median time to hepatotoxicity was 32 (IQR 28-58) days. At 12 weeks, only 8% of patients had alanine aminotransferase monitoring at all the time-points recommended by national guidelines. No association was found between age, gender, baseline CD4 count, concurrent tuberculosis infection, prior participation in a prevention of mother-to-child-transmission program, or baseline weight and early hepatotoxicity. There was no association between early hepatotoxicity and mortality. Conclusions: The cumulative proportion of early hepatotoxicity in nevirapine based antiretroviral therapy was low in this resource-constrained setting. Hepatotoxicity was not associated with mortality. Frequent routine monitoring of alanine aminotransferase proved difficult to implement in this public sector primary care programme. Focused monitoring in the first month may be a more cost-effective and pragmatic option in settings with limited resources. Correlation with clinical signs and symptoms may allow future alanine aminotransferase testing to be dictated by clinical criteria.	[Ford, Nathan; Darder, Marta; Maclean, Emi] Med Sans Frontieres, Cape Town, South Africa; [Spelman, Tim] Burnet Inst, Melbourne, Vic, Australia; [Mills, Edward] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Boulle, Andrew] Univ Cape Town, Ctr Infect Dis & Epidemiol Res, ZA-7925 Cape Town, South Africa	Burnet Institute; University of Ottawa; University of Cape Town	Ford, N (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	nathan.ford@joburg.msf.org	Boulle, Andrew/C-1413-2008	Boulle, Andrew/0000-0002-7713-8062	M�decins Sans Fronti�res [09_NAT_ERB_014] Funding Source: researchfish	M�decins Sans Fronti�res		Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Boulle A, 2009, 5 IAS C HIV PATH TRE; Boulle A, 2007, ANTIVIR THER, V12, P753; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Colosimo EA, 2002, J STAT COMPUT SIM, V72, P299, DOI 10.1080/00949650212847; Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Friedland GH, 2006, JAIDS-J ACQ IMM DEF, V43, pS3, DOI 10.1097/01.qai.0000248333.44449.ea; Garcia R, 2006, AIDS RES HUM RETROV, V22, P1248, DOI 10.1089/aid.2006.22.1248; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Orrell C, 2009, ANTIVIR THER, V14, P523; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	23	59	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10460	10.1371/journal.pone.0010460	http://dx.doi.org/10.1371/journal.pone.0010460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20485480	Green Published, gold			2022-12-25	WOS:000277379400012
J	Gardner, AM; Cook, MR; Gardner, PR				Gardner, Anne M.; Cook, Matthew R.; Gardner, Paul R.			Nitric-oxide Dioxygenase Function of Human Cytoglobin with Cellular Reductants and in Rat Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE GLOBIN FAMILY; ASCORBATE PEROXIDASE; DEPENDENT METABOLISM; MYOGLOBIN FUNCTION; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OXIDATIVE STRESS; MAMMALIAN-CELLS; CYTOCHROME-C	Cytoglobin (Cygb) was investigated for its capacity to function as a NO dioxygenase (NOD) in vitro and in hepatocytes. Ascorbate and cytochrome b(5) were found to support a high NOD activity. Cygb-NOD activity shows respective K-m values for ascorbate, cytochrome b(5), NO, and O-2 of 0.25 mM, 0.3 mu M, 40 nM, and similar to 20 mu M and achieves a k(cat) of 0.5 s(-1). Ascorbate and cytochrome b(5) reduce the oxidized Cygb-NOD intermediate with apparent second order rate constants of 1000 M-1 s(-1) and 3 x 10(6) M-1 s(-1), respectively. In rat hepatocytes engineered to express human Cygb, Cygb-NOD activity shows a similar kcat of 1.2 s(-1), a K-m(NO) of 40 nM, and a k(cat)/K-m(NO) (k'(NOD)) value of 3 x 10(7) M-1 s(-1), demonstrating the efficiency of catalysis. NO inhibits the activity at [NO]/[O-2] ratios > 1:500 and limits catalytic turnover. The activity is competitively inhibited by CO, is slowly inactivated by cyanide, and is distinct from the microsomal NOD activity. Cygb-NOD provides protection to the NO-sensitive aconitase. The results define the NOD function of Cygb and demonstrate roles for ascorbate and cytochrome b(5) as reductants.	[Gardner, Paul R.] Miami Valley Biotech, Dayton, OH 45402 USA; Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Cook, Matthew R.; Gardner, Paul R.] Univ Dayton, Dept Chem, Dayton, OH 45469 USA	Cincinnati Children's Hospital Medical Center; University of Dayton	Gardner, PR (corresponding author), Miami Valley Biotech, 1000 E 2nd St,Suite 2445, Dayton, OH 45402 USA.	paul.gardner@mvbiotech.com	Cook, matthew/F-4151-2019	Cook, matthew/0000-0002-3331-9363; Gardner, Anne/0000-0001-7095-772X; Gardner, Paul/0000-0001-8189-0903	National Institutes of Health [GM65090]; American Heart Association Scientist Development [9730193N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM65090. This work was also supported by American Heart Association Scientist Development Grant 9730193N. Part of this work was presented at the 12th Annual Meeting of the Society for Free Radical Biology and Medicine (Gardner, P. R. and Gardner, A. M., Free Radic. Biol. Med. 39, (Suppl. 1) 100 (abstr.)).	BECANA M, 1990, P NATL ACAD SCI USA, V87, P7295, DOI 10.1073/pnas.87.18.7295; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bentmann A, 2005, J BIOL CHEM, V280, P20660, DOI 10.1074/jbc.M501338200; BRENNER MC, 1989, BIOCHEMISTRY-US, V28, P4656, DOI 10.1021/bi00437a022; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Bursey EH, 2000, BIOCHEMISTRY-US, V39, P7374, DOI 10.1021/bi000446s; Chan TS, 2005, FREE RADICAL BIO MED, V38, P867, DOI 10.1016/j.freeradbiomed.2004.12.006; Coffey MJ, 2001, P NATL ACAD SCI USA, V98, P8006, DOI 10.1073/pnas.141136098; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dordas C, 2003, PLANT J, V35, P763, DOI 10.1046/j.1365-313X.2003.01846.x; Dou Y, 2002, BIOPHYS CHEM, V98, P127, DOI 10.1016/S0301-4622(02)00090-X; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Fordel E, 2004, IUBMB LIFE, V56, P681, DOI 10.1080/15216540500037406; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; GALARIS D, 1989, ARCH BIOCHEM BIOPHYS, V273, P497, DOI 10.1016/0003-9861(89)90509-2; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner PR, 2008, METHOD ENZYMOL, V436, P217, DOI 10.1016/S0076-6879(08)36012-1; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner Paul R., 2004, V279, P133; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; Gardner PR, 2001, FREE RADICAL BIO MED, V31, P191, DOI 10.1016/S0891-5849(01)00569-X; Giuffre A, 2008, IUBMB LIFE, V60, P410, DOI 10.1002/iub.88; Godecke A, 2006, CARDIOVASC RES, V69, P309, DOI 10.1016/j.cardiores.2005.10.010; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hall CN, 2009, BIOCHEM J, V419, P411, DOI 10.1042/BJ20082419; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hallstrom CK, 2004, FREE RADICAL BIO MED, V37, P216, DOI 10.1016/j.freeradbiomed.2004.04.031; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Igamberdiev AU, 2006, PLANTA, V223, P1033, DOI 10.1007/s00425-005-0146-3; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kim HS, 2008, AM J PHYSIOL-GASTR L, V295, pG146, DOI 10.1152/ajpgi.00105.2007; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macdonald IK, 2006, BIOCHEMISTRY-US, V45, P7808, DOI 10.1021/bi0606849; MOREAU S, 1995, PHYTOCHEMISTRY, V39, P1281, DOI 10.1016/0031-9422(95)00161-Y; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Palacios-Callender M, 2007, P NATL ACAD SCI USA, V104, P18508, DOI 10.1073/pnas.0709440104; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Trandafir F, 2007, GENE, V398, P103, DOI 10.1016/j.gene.2007.02.038; TSCHANK G, 1994, BIOCHEM J, V300, P75, DOI 10.1042/bj3000075; VONBODMAN SB, 1986, P NATL ACAD SCI USA, V83, P9443; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	64	74	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23850	23857		10.1074/jbc.M110.132340	http://dx.doi.org/10.1074/jbc.M110.132340			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511233	Green Published, hybrid			2022-12-25	WOS:000280291400035
J	Li, ZL; Zhang, HQ; Lundin, L; Thullberg, M; Liu, YJ; Wang, YL; Claesson-Welsh, L; Stromblad, S				Li, Zhilun; Zhang, Hongquan; Lundin, Lars; Thullberg, Minna; Liu, Yajuan; Wang, Yunling; Claesson-Welsh, Lena; Stromblad, Staffan			p21-activated Kinase 4 Phosphorylation of Integrin beta 5 Ser-759 and Ser-762 Regulates Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; FOCAL ADHESION KINASE; CYTOPLASMIC DOMAIN; ALPHA-V; TYROSINE PHOSPHORYLATION; IN-VITRO; THREONINE PHOSPHORYLATION; CYTOSKELETAL ASSOCIATION; MELANOMA-CELL; BINDING	Modulation of integrin alpha v beta 5 regulates vascular permeability, angiogenesis, and tumor dissemination. In addition, we previously found a role for p21-activated kinase 4 (PAK4) in selective regulation of integrin alpha v beta 5-mediated cell motility (Zhang, H., Li, Z., Viklund, E. K., and Stromblad, S. (2002) J. Cell Biol. 158, 1287-1297). This report focuses on the molecular mechanisms of this regulation. We here identified a unique PAK4-binding membrane-proximal integrin beta 5-SERS-motif involved in controlling cell attachment and migration. We also mapped the integrin beta 5-binding site within PAK4. We found that PAK4 binding to integrin beta 5 was not sufficient to promote cell migration, but that PAK4 kinase activity was required for PAK4 promotion of cell motility. Importantly, PAK4 specifically phosphorylated the integrin beta 5 subunit at Ser-759 and Ser-762 within the beta 5-SERS-motif. Point mutation of these two serine residues abolished the PAK4-induced cell migration, indicating a functional role for these phosphorylations in migration. Our results may give important leads to the functional regulation of integrin alpha v beta 5, with implications for vascular permeability, angiogenesis, and cancer dissemination.	[Stromblad, Staffan] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Stromblad, Staffan] Karolinska Inst, Breast Canc Theme Ctr, S-14183 Huddinge, Sweden; [Liu, Yajuan] Karolinska Inst, Dept Lab Med, S-14183 Huddinge, Sweden; [Lundin, Lars; Claesson-Welsh, Lena] Uppsala Univ, Dept Genet & Pathol, S-75185 Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Uppsala University	Zhang, HQ (corresponding author), Peking Univ, Hlth Sci Ctr, Lab Mol Cell Biol & Tumor Biol,Minist Educ, Dept Histol,Key Lab Carcinogenesis & Translat Res, Beijing 100191, Peoples R China.	Hongquan.zhang@bjmu.edu.cn; staffan.stromblad@ki.se		Stromblad, Staffan/0000-0002-1236-6339	Swedish Cancer Society; Swedish Research Council; Center for Biosciences at the Karolinska Institutet; Swedish Strategic Research Foundation; Swedish Society of Medicine; NSFC [30830048]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Biosciences at the Karolinska Institutet(Karolinska Institutet); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Swedish Society of Medicine; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Center for Biosciences at the Karolinska Institutet, and the Swedish Strategic Research Foundation (to S. S.), the Swedish Society of Medicine and Grant NSFC # 30830048 to (H.Z.), and the Swedish Research Council (to L.C.-W.).	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Barreuther MF, 1996, EXP CELL RES, V222, P10, DOI 10.1006/excr.1996.0002; Bodeau AL, 2001, J CELL SCI, V114, P2795; Boettiger D, 2001, J BIOL CHEM, V276, P31684, DOI 10.1074/jbc.M103997200; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brooks PC, 1997, J CLIN INVEST, V99, P1390, DOI 10.1172/JCI119298; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; DAHL SC, 1989, J CELL BIOL, V108, P183, DOI 10.1083/jcb.108.1.183; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Fagerholm SC, 2004, TRENDS BIOCHEM SCI, V29, P504, DOI 10.1016/j.tibs.2004.07.005; FREED E, 1989, EMBO J, V8, P2955, DOI 10.1002/j.1460-2075.1989.tb08445.x; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GIMOND C, 1995, EXP CELL RES, V216, P232, DOI 10.1006/excr.1995.1029; Han JW, 2001, J BIOL CHEM, V276, P40903, DOI 10.1074/jbc.M102665200; Hilden TJ, 2003, J IMMUNOL, V170, P4170, DOI 10.4049/jimmunol.170.8.4170; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito N, 1998, J BIOL CHEM, V273, P23410, DOI 10.1074/jbc.273.36.23410; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu SC, 2000, J CELL SCI, V113, P3563; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Phillips DR, 2001, CURR OPIN CELL BIOL, V13, P546, DOI 10.1016/S0955-0674(00)00250-7; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 2001, P NATL ACAD SCI USA, V98, P3808, DOI 10.1073/pnas.240456398; Sheppard D, 2004, CURR OPIN CELL BIOL, V16, P552, DOI 10.1016/j.ceb.2004.06.017; Stromblad S, 1996, CHEM BIOL, V3, P881, DOI 10.1016/S1074-5521(96)90176-3; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tang SQ, 1999, J CELL BIOL, V147, P1073, DOI 10.1083/jcb.147.5.1073; THOMAS L, 1993, J CELL SCI, V105, P191; Valmu L, 1999, BIOCHEM J, V339, P119, DOI 10.1042/0264-6021:3390119; Valmu L, 1999, EUR J IMMUNOL, V29, P2107, DOI 10.1002/(SICI)1521-4141(199907)29:07<2107::AID-IMMU2107>3.0.CO;2-T; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; Zage PE, 1998, CELL ADHES COMMUN, V5, P335, DOI 10.3109/15419069809010780; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008	64	45	46	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23699	23710		10.1074/jbc.M110.123497	http://dx.doi.org/10.1074/jbc.M110.123497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507994	Green Published, hybrid			2022-12-25	WOS:000280291400020
J	Ponferrada-Marin, MI; Martinez-Macias, MI; Morales-Ruiz, T; Roldan-Arjona, T; Ariza, RR				Isabel Ponferrada-Marin, Maria; Isabel Martinez-Macias, Maria; Morales-Ruiz, Teresa; Roldan-Arjona, Teresa; Ariza, Rafael R.			Methylation-independent DNA Binding Modulates Specificity of Repressor of Silencing 1 (ROS1) and Facilitates Demethylation in Long Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLASE/LYASE ROS1; ARABIDOPSIS ENDOSPERM; MUTATIONAL ANALYSIS; PROTEIN; GENE; DEMETER; RECOGNITION; PATTERNS; GENOME; MARK	DNA cytosine methylation is an epigenetic mark that promotes gene silencing and performs critical roles during reproduction and development in both plants and animals. The genomic distribution of DNA methylation is the dynamic outcome of opposing methylation and demethylation processes. In plants, active demethylation occurs through a base excision repair pathway initiated by 5-methycytosine (5-meC) DNA glycosylases of the REPRESSOR OF SILENCING 1 (ROS1)/DEMETER (DME) family. To gain insight into the mechanism by which Arabidopsis ROS1 recognizes and excises 5-meC, we have identified those protein regions that are required for efficient DNA binding and catalysis. We have found that a short N-terminal lysine-rich domain conserved in members of the ROS1/DME family mediates strong methylation-independent binding of ROS1 to DNA and is required for efficient activity on 5-meC center dot G, but not for T center dot G processing. Removal of this domain does not significantly affect 5-meC excision from short molecules, but strongly decreases ROS1 activity on long DNA substrates. This region is not required for product binding and is not involved in the distributive behavior of the enzyme on substrates containing multiple 5-meC residues. Altogether, our results suggest that methylation-independent DNA binding allows ROS1 to perform a highly redundant search for efficient excision of a nondamaged, correctly paired base such as 5-meC in long stretches of DNA. These findings may have implications for understanding the evolution of structure and target specificity in DNA glycosylases.	[Isabel Ponferrada-Marin, Maria; Isabel Martinez-Macias, Maria; Morales-Ruiz, Teresa; Roldan-Arjona, Teresa; Ariza, Rafael R.] Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain	Universidad de Cordoba	Ariza, RR (corresponding author), Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain.	ge1roarr@uco.es	Macias, Maria Isabel Martinez/B-4571-2019; Martinez Macias, Maria Isabel/ACH-3606-2022; Morales-Ruiz, Teresa/L-4842-2014; Roldan-Arjona, Teresa/H-5976-2015	Macias, Maria Isabel Martinez/0000-0001-8611-476X; Martinez Macias, Maria Isabel/0000-0001-8611-476X; Morales-Ruiz, Teresa/0000-0002-6357-6977; Roldan-Arjona, Teresa/0000-0003-2842-3956; Rodriguez Ariza, Rafael/0000-0002-0338-7306	Spanish Ministry of Science and Innovation [BFU2007-60956/BMC]; European Regional Development Fund; Junta de Andalucia, Spain [P07-CVI-02770]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This work was supported by Grant BFU2007-60956/BMC from the Spanish Ministry of Science and Innovation and the European Regional Development Fund, and Grant P07-CVI-02770 from Junta de Andalucia, Spain.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2003, NUCLEIC ACIDS RES, V31, P2261, DOI 10.1093/nar/gkg344; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Ponferrada-Marin MI, 2009, NUCLEIC ACIDS RES, V37, P4264, DOI 10.1093/nar/gkp390; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Liu X, 2002, J MOL BIOL, V321, P265, DOI 10.1016/S0022-2836(02)00623-X; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Roldan-Arjona T., 2009, DNA RNA MODIFICATION, P149; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Zaika EI, 2004, J BIOL CHEM, V279, P4849, DOI 10.1074/jbc.M310262200; Zharkov DO, 2005, MUTAT RES-FUND MOL M, V577, P24, DOI 10.1016/j.mrfmmm.2005.03.011; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	35	29	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23030	23037		10.1074/jbc.M110.124578	http://dx.doi.org/10.1074/jbc.M110.124578			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489198	hybrid, Green Published			2022-12-25	WOS:000279999900037
J	Sameshima, T; Iizuka, R; Ueno, T; Wada, J; Aoki, M; Shimamoto, N; Ohdomari, I; Tanii, T; Funatsu, T				Sameshima, Tomoya; Iizuka, Ryo; Ueno, Taro; Wada, Junichi; Aoki, Mutsuko; Shimamoto, Naonobu; Ohdomari, Iwao; Tanii, Takashi; Funatsu, Takashi			Single-molecule Study on the Decay Process of the Football-shaped GroEL-GroES Complex Using Zero-mode Waveguides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE MOLECULES; CHAPERONIN GROEL; FUNCTIONAL CYCLE; FOLDED PROTEIN; ATP; POLYPEPTIDE; CONFORMATION; FLUORESCENCE; CATALYSIS; HEPTAMER	It has been widely believed that an asymmetric GroEL-GroES complex (termed the bullet-shaped complex) is formed solely throughout the chaperonin reaction cycle, whereas we have recently revealed that a symmetric GroEL-(GroES)(2) complex (the football-shaped complex) can form in the presence of denatured proteins. However, the dynamics of the GroEL-GroES interaction, including the football-shaped complex, is unclear. We investigated the decay process of the football-shaped complex at a single-molecule level. Because submicromolar concentrations of fluorescent GroES are required in solution to form saturated amounts of the football-shaped complex, single-molecule fluorescence imaging was carried out using zero-mode waveguides. The single-molecule study revealed two insights into the GroEL-GroES reaction. First, the first GroES to interact with GroEL does not always dissociate from the football-shaped complex prior to the dissociation of a second GroES. Second, there are two cycles, the "football cycle " and the "bullet cycle," in the chaperonin reaction, and the lifetimes of the football-shaped and the bullet-shaped complexes were determined to be 3-5 s and about 6 s, respectively. These findings shed new light on the molecular mechanism of protein folding mediated by the GroEL-GroES chaperonin system.	[Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Wada, Junichi; Aoki, Mutsuko; Shimamoto, Naonobu; Ohdomari, Iwao; Tanii, Takashi] Waseda Univ, Grad Sch Sci & Engn, Shinjuku Ku, Tokyo 1658555, Japan; [Funatsu, Takashi] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan; [Funatsu, Takashi] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	University of Tokyo; Waseda University; University of Tokyo; Japan Science & Technology Agency (JST)	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Shimamoto, Naonobu/AGP-3424-2022; Shimamoto, Naonobu/D-6708-2012; Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308; Iizuka, Ryo/0000-0002-9328-5628	Ministry of Education, Science, Sports, and Culture of Japan [21121004, 20059009, 22020006, 21370065]; Japan Society for the Promotion of Science for Young Scientists [20-11078]; Grants-in-Aid for Scientific Research [20310069] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid 21121004 for Scientific Research on Innovative Areas, Grants-in-aid 20059009 (to T. F.) and 22020006 (to R. I.) for Scientific Research on Priority Areas, and Grant-in-aid 21370065 for Scientific Research (B) (to T. F.) from the Ministry of Education, Science, Sports, and Culture of Japan. This work was also supported by Research Fellowship 20-11078 from the Japan Society for the Promotion of Science for Young Scientists (to T.S.).	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Beissinger M, 1999, J MOL BIOL, V289, P1075, DOI 10.1006/jmbi.1999.2780; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Miyake T, 2008, ANAL CHEM, V80, P6018, DOI 10.1021/ac800726g; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Nojima T, 2009, J BIOL CHEM, V284, P22834, DOI 10.1074/jbc.M109.020057; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sakane I, 2007, J MOL BIOL, V367, P1171, DOI 10.1016/j.jmb.2007.01.037; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Yifrach O, 1996, J MOL BIOL, V255, P356, DOI 10.1006/jmbi.1996.0028	28	30	30	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23157	23162		10.1074/jbc.M110.122101	http://dx.doi.org/10.1074/jbc.M110.122101			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20511221	hybrid, Green Published			2022-12-25	WOS:000279999900050
J	Ariyama, H; Kono, N; Matsuda, S; Inoue, T; Arai, H				Ariyama, Hiroyuki; Kono, Nozomu; Matsuda, Shinji; Inoue, Takao; Arai, Hiroyuki			Decrease in Membrane Phospholipid Unsaturation Induces Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; STEAROYL-COA DESATURASE; LIPOTOXIC CELL-DEATH; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; GENE-EXPRESSION; FATTY-ACIDS; LYSOPHOSPHOLIPID ACYLTRANSFERASE; PALMITIC ACID; MBOAT FAMILY; LIVER-CELLS	Various kinds of fatty acids are distributed in membrane phospholipids in mammalian cells and tissues. The degree of fatty acid unsaturation in membrane phospholipids affects many membrane-associated functions and can be influenced by diet and by altered activities of lipid-metabolizing enzymes such as fatty acid desaturases. However, little is known about how mammalian cells respond to changes in phospholipid fatty acid composition. In this study we showed that stearoyl-CoA desaturase 1 (SCD1) knockdown increased the amount of saturated fatty acids and decreased that of monounsaturated fatty acids in phospholipids without affecting the amount or the composition of free fatty acid and induced unfolded protein response (UPR), evidenced by increased expression of C/EBP homologous protein (CHOP) and glucose-regulated protein 78 (GRP78) mRNAs and splicing of Xbox-binding protein 1 (XBP1) mRNA. SCD1 knockdown-induced UPR was rescued by various unsaturated fatty acids and was enhanced by saturated fatty acid. Lysophosphatidylcholine acyltransferase 3 (LPCAT3), which incorporates preferentially polyunsaturated fatty acids into phosphatidylcholine, was up-regulated in SCD1 knockdown cells. Knockdown of LPCAT3 synergistically enhanced UPR with SCD1 knockdown. Finally we showed that palmitic acid-induced UPR was significantly enhanced by LPCAT3 knockdown as well as SCD1 knockdown. These results suggest that a decrease in membrane phospholipid unsaturation induces UPR.	[Ariyama, Hiroyuki; Kono, Nozomu; Matsuda, Shinji; Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Arai, H (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	harai@mol.f.u-tokyo.ac.jp	KONO, nozomu/AAM-3178-2020		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Core Research for Evolutional Science and Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Core Research for Evolutional Science and Technology.	Almaguel FG, 2009, J NEUROSCI RES, V87, P1207, DOI 10.1002/jnr.21918; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Collins JM, 2010, J BIOL CHEM, V285, P6044, DOI 10.1074/jbc.M109.053280; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Holub B J, 1978, Adv Lipid Res, V16, P1; Inaba M, 2003, J BIOL CHEM, V278, P12191, DOI 10.1074/jbc.M212204200; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Lands W., 1976, ENZYMES BIOL MEMBRAN, V2, P3; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Matsuda S, 2008, GENES CELLS, V13, P879, DOI 10.1111/j.1365-2443.2008.01212.x; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NTAMBI JM, 1995, PROG LIPID RES, V34, P139, DOI 10.1016/0163-7827(94)00010-J; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VIGH L, 1993, P NATL ACAD SCI USA, V90, P9090, DOI 10.1073/pnas.90.19.9090; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wei Y, 2007, MOL CELL BIOCHEM, V303, P105, DOI 10.1007/s11010-007-9461-2; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	50	173	181	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22027	22035		10.1074/jbc.M110.126870	http://dx.doi.org/10.1074/jbc.M110.126870			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20489212	Green Published, hybrid			2022-12-25	WOS:000279702200015
J	Uhlmann, S; Zhang, JD; Schwager, A; Mannsperger, H; Riazalhosseini, Y; Burmester, S; Ward, A; Korf, U; Wiemann, S; Sahin, O				Uhlmann, S.; Zhang, J. D.; Schwaeger, A.; Mannsperger, H.; Riazalhosseini, Y.; Burmester, S.; Ward, A.; Korf, U.; Wiemann, S.; Sahin, Oe			miR-200bc/429 cluster targets PLC gamma 1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer	ONCOGENE			English	Article						miR-200 family; PLC gamma 1; invasion; cell proliferation; tumor suppressor; breast cancer	MESENCHYMAL TRANSITION; GROWTH; MICRORNAS; CONTRIBUTES; SENSITIVITY; ACTIVATION; RESISTANCE; ARREST; FAMILY	The genes encoding microRNAs of the human miR-200 family map to fragile chromosomal regions and are frequently downregulated upon tumor progression. Although having been reported to regulate epithelial-to-mesenchymal transition and transforming growth factor-beta- driven cell invasion, the role of the miR-200 family in EGF-driven breast cancer cell invasion, viability, apoptosis and cell cycle progression is still unknown. In particular, there is no study comparing the roles of the two clusters of this miRNA family. In this study, we show for the first time that miR-200 family members differentially regulate EGF-driven invasion, viability, apoptosis and cell cycle progression of breast cancer cells. We showed that, all miR-200 family members regulate EGF-driven invasion, with the miR-200bc/429 cluster showing stronger effects than the miR-200a/141 cluster. Furthermore, expression of the miR-200a/141 cluster results in G1 arrest supported by increased p27/Kip1 and decreased cyclin dependent kinase 6 expression. In contrast, expression of the 200bc/429 cluster decreases G1 population and increases G2/M phase, in line with the observed reduction of p27/Kip1 and upregulation of the inhibitory phosphorylation of Cdc25C, respectively. To test the hypothesis that phenotypical differences observed between the two clusters are caused by differential targeting spectrums, we performed genome-wide microarray profiling in combination with gain-of-function studies. This identified phospholipase C gamma 1 (PLCG1), which was downregulated only by the miR-200bc/429 cluster, as a potential candidate contributing to these phenotypical differences. Luciferase reporter assays validated PLCG1 as a direct functional target of miR-200bc/429 cluster, but not of miR-200a/141 cluster. Finally, loss of PLCG1 in part mimicked the effect of miR-200bc/429 overexpression in viability, apoptosis and EGF-driven cell invasion of breast cancer cells. Our results suggest that the miR-200 family has a tumor-suppressor function by negatively regulating EGF-driven cell invasion, viability and cell cycle progression in breast cancer. Oncogene (2010) 29, 4297-4306; doi: 10.1038/onc.2010.201; published online 31 May 2010	[Uhlmann, S.; Zhang, J. D.; Schwaeger, A.; Mannsperger, H.; Burmester, S.; Ward, A.; Korf, U.; Wiemann, S.; Sahin, Oe] German Canc Res Ctr, Div Mol Genome Anal, D-6900 Heidelberg, Germany; [Riazalhosseini, Y.] German Canc Res Ctr, Div Funct Genome Anal, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Sahin, O (corresponding author), German Canc Res Ctr, Div Mol Genome Anal, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	oe.sahin@dkfz-heidelberg.de	Sahin, Özgür/F-4403-2014; Korf, Ulrike/G-2795-2013; Wiemann, Stefan/E-4424-2013	Sahin, Özgür/0000-0002-8033-7089; Wiemann, Stefan/0000-0003-4683-3174; Ward Gahlawat, Aoife/0000-0001-7854-7207; Fullgrabe, Anja/0000-0002-8674-0039	National Genome Research Network of the Federal Ministry of Education and Research (BMBF) [01GS0864]; Wilhelm-Sander Stiftung [2009.051.1]; DKFZ International PhD Program	National Genome Research Network of the Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Wilhelm-Sander Stiftung; DKFZ International PhD Program	This work was supported in part by the National Genome Research Network (Contract No. 01GS0864) of the Federal Ministry of Education and Research (BMBF) and by Wilhelm-Sander Stiftung (Contract No. 2009.051.1). JDZ is supported by the DKFZ International PhD Program. We thank Moritz Kublbeck, Christian Schmidt and Ute Ernst for their excellent technical assistance.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Browaeys-Poly E, 2009, ANTICANCER RES, V29, P4965; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li SW, 2009, MOL ENDOCRINOL, V23, P901, DOI 10.1210/me.2008-0368; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Markova B, 2010, ONCOGENE, V29, P739, DOI 10.1038/onc.2009.374; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sahin O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-1; Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Sato Y, 2001, LEUKEMIA, V15, P1193, DOI 10.1038/sj.leu.2402188; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	33	171	188	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2010	29	30					4297	4306		10.1038/onc.2010.201	http://dx.doi.org/10.1038/onc.2010.201			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20514023				2022-12-25	WOS:000280547900006
J	Stevens, KN; Hakonarson, H; Kim, CE; Doevendans, PA; Koeleman, BPC; Mital, S; Raue, J; Glessner, JT; Coles, JG; Moreno, V; Granger, A; Gruber, SB; Gruber, PJ				Stevens, Kristen N.; Hakonarson, Hakon; Kim, Cecilia E.; Doevendans, Pieter A.; Koeleman, Bobby P. C.; Mital, Seema; Raue, Jennifer; Glessner, Joseph T.; Coles, John G.; Moreno, Victor; Granger, Anne; Gruber, Stephen B.; Gruber, Peter J.			Common Variation in ISL1 Confers Genetic Susceptibility for Human Congenital Heart Disease	PLOS ONE			English	Article							CELLS; MUTATIONS; LINEAGES; DEFECTS; POPULATION; GATA4	Congenital heart disease (CHD) is the most common birth abnormality and the etiology is unknown in the overwhelming majority of cases. ISLET1 (ISL1) is a transcription factor that marks cardiac progenitor cells and generates diverse multipotent cardiovascular cell lineages. The fundamental role of ISL1 in cardiac morphogenesis makes this an exceptional candidate gene to consider as a cause of complex congenital heart disease. We evaluated whether genetic variation in ISL1 fits the common variant-common disease hypothesis. A 2-stage case-control study examined 27 polymorphisms mapping to the ISL1 locus in 300 patients with complex congenital heart disease and 2,201 healthy pediatric controls. Eight genic and flanking ISL1 SNPs were significantly associated with complex congenital heart disease. A replication study analyzed these candidate SNPs in 1,044 new cases and 3,934 independent controls and confirmed that genetic variation in ISL1 is associated with risk of non-syndromic congenital heart disease. Our results demonstrate that two different ISL1 haplotypes contribute to risk of CHD in white and black/African American populations.	[Stevens, Kristen N.; Gruber, Stephen B.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Hakonarson, Hakon; Kim, Cecilia E.; Raue, Jennifer; Glessner, Joseph T.; Granger, Anne; Gruber, Peter J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Doevendans, Pieter A.] UMC Utrecht, Dept Cardiol, Utrecht, Netherlands; [Koeleman, Bobby P. C.] UMC Utrecht, Dept Med Genet, Utrecht, Netherlands; [Mital, Seema; Coles, John G.] Hosp Sick Children, Ctr Heart, Toronto, ON M5G 1X8, Canada; [Moreno, Victor] IDIBELL Catalan Inst Oncol, Biostat & Bioinformat Unit, Barcelona, Spain; [Moreno, Victor] Univ Barcelona, Hosp Llobregat, Barcelona, Spain; [Gruber, Stephen B.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gruber, Stephen B.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Gruber, Peter J.] Univ Penn, Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Gruber, Peter J.] Univ Penn, Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania	Stevens, KN (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	pgruber@mail.med.upenn.edu; sgruber@umich.edu	Purrington, Kristen/AAN-6494-2021; Mital, Seema/G-7456-2011; Moreno, Victor/A-1697-2010	Purrington, Kristen/0000-0002-5710-1692; Moreno, Victor/0000-0002-2818-5487; Glessner, Joseph/0000-0001-5131-2811	Fondacion Leducq (PJG)	Fondacion Leducq (PJG)	Fondacion Leducq (PJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Black BL, 2007, SEMIN CELL DEV BIOL, V18, P67, DOI 10.1016/j.semcdb.2007.01.001; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gruber PJ, 2004, CIRC RES, V94, P273, DOI 10.1161/01.RES.0000116144.43797.3B; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048	19	60	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10855	10.1371/journal.pone.0010855	http://dx.doi.org/10.1371/journal.pone.0010855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520780	Green Published, gold, Green Submitted			2022-12-25	WOS:000278221500039
J	Zuluaga, AF; Agudelo, M; Cardeno, JJ; Rodriguez, CA; Vesga, O				Zuluaga, Andres F.; Agudelo, Maria; Cardeno, John J.; Rodriguez, Carlos A.; Vesga, Omar			Determination of Therapeutic Equivalence of Generic Products of Gentamicin in the Neutropenic Mouse Thigh Infection Model	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; DRUG SUBSTITUTION; BIOEQUIVALENCE; ISSUES; MICE; CEFUROXIME; EXCIPIENTS; MEDICINES; CALCIUM; HEPARIN	Background: Drug regulatory agencies (DRA) support prescription of generic products of intravenous antibiotics assuming therapeutic equivalence from pharmaceutical equivalence. Recent reports of deaths associated with generic heparin and metoprolol have raised concerns about the efficacy and safety of DRA-approved drugs. Methodology/Principal Findings: To challenge the assumption that pharmaceutical equivalence predicts therapeutic equivalence, we determined in vitro and in vivo the efficacy of the innovator product and 20 pharmaceutically equivalent generics of gentamicin. The data showed that, while only 1 generic product failed in vitro (MIC = 45.3 vs. 0.7 mg/L, P < 0.05), 10 products (including gentamicin reference powder) failed in vivo against E. coli due to significantly inferior efficacy (E-max = 4.81 to 5.32 vs. 5.99 log(10) CFU/g, P <= 0.043). Although the design lacked power to detect differences in survival after thigh infection with P. aeruginosa, dissemination to vital organs was significantly higher in animals treated with generic gentamicin despite 4 days of maximally effective treatment. Conclusion: Pharmaceutical equivalence does not predict therapeutic equivalence of generic gentamicin. Stricter criteria based on solid experimental evidence should be required before approval for human use.	[Zuluaga, Andres F.; Rodriguez, Carlos A.; Vesga, Omar] Univ Antioquia, Sch Med, Dept Pharmacol & Toxicol, Medellin, Colombia; [Zuluaga, Andres F.; Agudelo, Maria; Cardeno, John J.; Rodriguez, Carlos A.; Vesga, Omar] Univ Antioquia, Sch Med, Grp Investigador Problemas Enfermedades Infeccios, Medellin, Colombia; [Vesga, Omar] Hosp Univ San Vicente de Paul, Dept Med, Infect Dis Sect, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Zuluaga, AF (corresponding author), Univ Antioquia, Sch Med, Dept Pharmacol & Toxicol, Medellin, Colombia.	omar.vesga@siu.udea.edu.co	Rodriguez, Carlos A./P-8324-2019; Zuluaga, Andres F./K-7366-2016	Rodriguez, Carlos A./0000-0002-4042-4313; Zuluaga, Andres F./0000-0001-5656-4153; Cardeno, John/0000-0003-3145-3945	University of Antioquia, and Colciencias [1115-04-731-98]	University of Antioquia, and Colciencias	This work was financed by the University of Antioquia, and Colciencias (grant number 1115-04-731-98). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers MJ, 2002, J PHARM SCI-US, V91, P2283, DOI 10.1002/jps.10154; Allen LV, 2008, CLIN THER, V30, P2102, DOI 10.1016/j.clinthera.2008.11.015; Ammerlaan H, 2009, CLIN INFECT DIS, V49, P997, DOI 10.1086/605555; APTE SP, 2003, PHARM TECHNOL EUROPE, V15, P45; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Brashier MK, 1998, AM J VET RES, V59, P1055; *CLIN LAB STAND I, 2003, M7A6 CLSI; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Crowley PJ, 1999, PHARM SCI TECHNOL TO, V2, P237, DOI 10.1016/S1461-5347(99)00158-3; DETTELBACH HR, 1986, J CLIN PHARMACOL, V26, P307, DOI 10.1002/j.1552-4604.1986.tb03530.x; Dodd S, 2009, CURR DRUG SAF, V4, P1, DOI 10.2174/157488609787354431; Duenas-Laita A, 2009, NEW ENGL J MED, V361, P1317, DOI 10.1056/NEJMc0904562; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Feldschreiber P, 2009, CLIN MED, V9, P63, DOI 10.7861/clinmedicine.9-1-63; *FOOD DRUG ADM, 2001, GUID IND BIOAN METH, V22; *GEN DRUGS, 2002, MED LETT DRUGS THER, V44, P89; GERBER AU, 1983, J INFECT DIS, V147, P910, DOI 10.1093/infdis/147.5.910; Glantz SA, 2006, PRIMER BIOSTATISTICS; Gonzalez LS, 1998, AM FAM PHYSICIAN, V58, P1811; Henderson JD, 2001, SOUTHERN MED J, V94, P16; Henry D, 2002, LANCET, V360, P1590, DOI 10.1016/S0140-6736(02)11527-3; Jia H, 2008, NAT BIOTECHNOL, V26, P477, DOI 10.1038/nbt0508-477; Jones RN, 2008, DIAGN MICR INFEC DIS, V61, P76, DOI 10.1016/j.diagmicrobio.2007.12.010; Katzung BG, 2007, BASIC CLIN PHARM; Kirking D M, 2001, J Am Pharm Assoc (Wash), V41, P578; Lees P, 2004, J VET PHARMACOL THER, V27, P397, DOI 10.1111/j.1365-2885.2004.00620.x; Mastoraki E, 2008, J INFECTION, V56, P35, DOI 10.1016/j.jinf.2007.09.011; Mattew A, 2006, M2A9 CLSI; Meredith P, 2003, CLIN THER, V25, P2875, DOI 10.1016/S0149-2918(03)80340-5; Moellering RC, 2009, CLIN INFECT DIS, V49, P1006, DOI 10.1086/605556; NAPKE E, 1984, CAN MED ASSOC J, V131, P1449; NATION RL, 1994, PHARMACOL THERAPEUT, V62, P41, DOI 10.1016/0163-7258(94)90004-3; POLLACK M, 1984, REV INFECT DIS, V6, pS617; Recht MI, 1999, EMBO J, V18, P3133, DOI 10.1093/emboj/18.11.3133; RHEINSTEIN PH, 1990, DRUG SAFETY, V5, P114, DOI 10.2165/00002018-199000051-00018; Rodriguez CA, 2009, J INFECTION, V59, P277, DOI 10.1016/j.jinf.2009.08.005; Roy Jiben, 2002, AAPS PharmSciTech, V3, pE6; SINGH YN, 1978, ANESTHESIOLOGY, V48, P418, DOI 10.1097/00000542-197806000-00008; STROM BL, 1987, NEW ENGL J MED, V316, P1456, DOI 10.1056/NEJM198706043162306; Toutain PL, 2004, J VET PHARMACOL THER, V27, P467, DOI 10.1111/j.1365-2885.2004.00613.x; Tracy M, 2001, ANTIMICROB AGENTS CH, V45, P1511, DOI 10.1128/AAC.45.5.1511-1514.2001; *US FDA, 2001, GUID IND STAT APPR; *US PHARM CONV, 2002, PHARM US AM; WANG D, 1994, J PHARM SCI, V83, P577, DOI 10.1002/jps.2600830427; WEINSTEIN MJ, 1963, J MED CHEM, V6, P463, DOI 10.1021/jm00340a034; Welage L S, 2001, J Am Pharm Assoc (Wash), V41, P856; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55; Zuluaga Andres F, 2009, BMC Clin Pharmacol, V9, P1, DOI 10.1186/1472-6904-9-1	48	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10744	10.1371/journal.pone.0010744	http://dx.doi.org/10.1371/journal.pone.0010744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505762	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017300016
J	Telleria, EL; de Araujo, APO; Secundino, NF; d'Avila-Levy, CM; Traub-Cseko, YM				Telleria, Erich Loza; Oliveira de Araujo, Adriana Pereira; Secundino, Nagila Francinete; d'Avila-Levy, Claudia Masini; Traub-Csekoe, Yara Maria			Trypsin-Like Serine Proteases in Lutzomyia longipalpis - Expression, Activity and Possible Modulation by Leishmania infantum chagasi	PLOS ONE			English	Article							CHYMOTRYPSIN-LIKE ENZYMES; AEGYPTI L DIPTERA; PHLEBOTOMUS-PAPATASI; AEDES-AEGYPTI; SAND FLIES; BLOOD-MEAL; VISCERAL LEISHMANIASIS; MIDGUT TRANSCRIPTOME; ANTHOPHORA DIPTERA; DIGESTIVE ENZYMES	Background: Midgut enzymatic activity is one of the obstacles that Leishmania must surpass to succeed in establishing infection. Trypsins are abundant digestive enzymes in most insects. We have previously described two trypsin cDNAs of L. longipalpis: one (Lltryp1) with a bloodmeal induced transcription pattern, the other (Lltryp2) with a constitutive transcription pattern. We have now characterized the expression and activity of trypsin-like proteases of Lutzomyia longipalpis, the main vector of visceral leishmaniasis in Brazil. Methodology and Principal Findings: In order to study trypsin expression profiles we produced antibodies against peptides specific for Lltryp1 and Lltryp2. The anti-Lltryp1-peptide antibody revealed a band of 28 kDa between 6 and 48 hours. The anti-Lltryp2 peptide antibody did not evidence any band. When proteinaceous substrates (gelatin, hemoglobin, casein or albumin) were co-polymerized in polyacrylamide gels, insect midguts obtained at 12 hours after feeding showed a unique proteolytic pattern for each substrate. All activity bands were strongly inhibited by TLCK, benzamidine and 4-amino-benzamidine, indicating that they are trypsin-like proteases. The trypsin-like activity was also measured in vitro at different time points after ingestion of blood or blood containing Leishmania infantum chagasi, using the chromogenic substrate BA rho NA. L. longipalpis females fed on blood infected with L. i. chagasi had lower levels of trypsin activity after 12 and 48 hours than non-infected insects, suggesting that the parasite may have a role in this modulation. Conclusions and Significance: Trypsins are important and abundant digestive enzymes in L. longipalpis. Protein production and enzymatic activity followed previously identified gene expression of a blood modulated trypsin gene. A decrease of enzymatic activity upon the parasite infection, previously detected mostly in Old World vectors, was detected for the first time in the natural vector-parasite pair L. longipalpis-L. i. chagasi.	[Telleria, Erich Loza; Oliveira de Araujo, Adriana Pereira; Traub-Csekoe, Yara Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil; [Secundino, Nagila Francinete] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Entomol Med, Belo Horizonte, MG, Brazil; [d'Avila-Levy, Claudia Masini] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Telleria, EL (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil.	ytraub@ioc.fiocruz.br	Telleria, Erich L/F-1580-2015; Traub-Cseko, Yara M/F-2723-2015; Secundino, Nagila/AAM-4553-2020; d'Avila-Levy, Claudia M/O-7192-2014	Telleria, Erich L/0000-0003-0006-0057; d'Avila-Levy, Claudia M/0000-0001-8042-4695	CNPq; FAPERJ; FIOCRUZ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ	This study was supported by the Brazilian funding agencies: CNPq, FAPERJ and FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; BILLINGSLEY PF, 1991, J MED ENTOMOL, V28, P865, DOI 10.1093/jmedent/28.6.865; BOROVSKY D, 1987, MED VET ENTOMOL, V1, P235, DOI 10.1111/j.1365-2915.1987.tb00349.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Brazil RP, 2003, FLEBOTOMINEOS BRASIL, P257; DILLON RJ, 1993, PARASITOL RES, V79, P492, DOI 10.1007/BF00931590; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; do Vale VF, 2007, J INSECT PHYSIOL, V53, P1151, DOI 10.1016/j.jinsphys.2007.06.005; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Eschenlauer SCP, 2009, CELL MICROBIOL, V11, P106, DOI 10.1111/j.1462-5822.2008.01243.x; FELIX CR, 1991, INSECT BIOCHEM, V21, P197, DOI 10.1016/0020-1790(91)90050-O; Gontijo NF, 1998, EXP PARASITOL, V90, P212, DOI 10.1006/expr.1998.4336; GOODING R H, 1975, Acta Tropica, V32, P96; GRAF R, 1982, REV SUISSE ZOOL, V89, P845, DOI 10.5962/bhl.part.82479; GRAF R, 1991, EXPERIENTIA, V47, P603, DOI 10.1007/BF01949885; GRAF R, 1989, INSECT BIOCHEM, V19, P129, DOI 10.1016/0020-1790(89)90083-8; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; HOPP TP, 1981, P NATL ACAD SCI USA, V86, P152; HORLER E, 1995, ARCH INSECT BIOCHEM, V28, P189, DOI 10.1002/arch.940280208; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; LEHANE MJ, 1994, INT J PARASITOL, V24, P27, DOI 10.1016/0020-7519(94)90056-6; MAHMOOD F, 1992, J MED ENTOMOL, V29, P489, DOI 10.1093/jmedent/29.3.489; MAHMOOD F, 1993, J MED ENTOMOL, V30, P683, DOI 10.1093/jmedent/30.4.683; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Muhlia-Almazan A, 2008, J COMP PHYSIOL B, V178, P655, DOI 10.1007/s00360-008-0263-y; Muller HM, 1995, EXP PARASITOL, V81, P371, DOI 10.1006/expr.1995.1128; MULLER HM, 1993, EMBO J, V12, P2891, DOI 10.1002/j.1460-2075.1993.tb05951.x; Oliveira F, 2009, PARASITOL INT, V58, P1, DOI 10.1016/j.parint.2008.07.004; Pimenta PFP, 1997, PARASITOLOGY, V115, P359, DOI 10.1017/S0031182097001510; Pitaluga AN, 2009, MOL GENET GENOMICS, V282, P307, DOI 10.1007/s00438-009-0466-2; Ramalho-Ortigao JM, 2003, INSECT BIOCHEM MOLEC, V33, P163, DOI 10.1016/S0965-1748(02)00187-X; Ramalho-Ortigao JM, 2001, MEM I OSWALDO CRUZ, V96, P105, DOI 10.1590/S0074-02762001000100012; Ramalho-Ortigao M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-300; Rosenfeld A, 1998, J PARASITOL, V84, P361, DOI 10.2307/3284496; Sant'Anna MRV, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-62; Schlein Y, 1998, PARASITOLOGY, V117, P467, DOI 10.1017/S0031182098003321; Shahabuddin M, 1996, INFECT IMMUN, V64, P739, DOI 10.1128/IAI.64.3.739-743.1996; Telleria EL, 2007, ARCH INSECT BIOCHEM, V66, P53, DOI 10.1002/arch.20198; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; WARD CW, 1973, ANAL BIOCHEM, V56, P596, DOI 10.1016/0003-2697(73)90228-5	43	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10697	10.1371/journal.pone.0010697	http://dx.doi.org/10.1371/journal.pone.0010697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502532	Green Published, Green Submitted, gold			2022-12-25	WOS:000277776500014
J	Manoj, KM; Baburaj, A; Ephraim, B; Pappachan, F; Maviliparambathu, PP; Vijayan, UK; Narayanan, SV; Periasamy, K; George, EA; Mathew, LT				Manoj, Kelath Murali; Baburaj, Arun; Ephraim, Binoy; Pappachan, Febin; Maviliparambathu, Pravitha Parapurathu; Vijayan, Umesh K.; Narayanan, Sivaprasad Valiyaveettil; Periasamy, Kalaiselvi; George, Ebi Ashley; Mathew, Lazar T.			Explaining the Atypical Reaction Profiles of Heme Enzymes with a Novel Mechanistic Hypothesis and Kinetic Treatment	PLOS ONE			English	Article							SUBSTRATE-INHIBITION; COMPOUND-I; CYTOCHROME-P450; CHLOROPEROXIDASE; PEROXIDASE; OXIDATION; ROLES	Many heme enzymes show remarkable versatility and atypical kinetics. The fungal extracellular enzyme chloroperoxidase (CPO) characterizes a variety of one and two electron redox reactions in the presence of hydroperoxides. A structural counterpart, found in mammalian microsomal cytochrome P450 (CYP), uses molecular oxygen plus NADPH for the oxidative metabolism (predominantly hydroxylation) of substrate in conjunction with a redox partner enzyme, cytochrome P450 reductase. In this study, we employ the two above-mentioned heme-thiolate proteins to probe the reaction kinetics and mechanism of heme enzymes. Hitherto, a substrate inhibition model based upon non-productive binding of substrate (two-site model) was used to account for the inhibition of reaction at higher substrate concentrations for the CYP reaction systems. Herein, the observation of substrate inhibition is shown for both peroxide and final substrate in CPO catalyzed peroxidations. Further, analogy is drawn in the "steady state kinetics" of CPO and CYP reaction systems. New experimental observations and analyses indicate that a scheme of competing reactions (involving primary product with enzyme or other reaction components/intermediates) is relevant in such complex reaction mixtures. The presence of non-selective reactive intermediate(s) affords alternate reaction routes at various substrate/product concentrations, thereby leading to a lowered detectable concentration of "the product of interest" in the reaction milieu. Occam's razor favors the new hypothesis. With the new hypothesis as foundation, a new biphasic treatment to analyze the kinetics is put forth. We also introduce a key concept of "substrate concentration at maximum observed rate". The new treatment affords a more acceptable fit for observable experimental kinetic data of heme redox enzymes.	[Manoj, Kelath Murali; Periasamy, Kalaiselvi; George, Ebi Ashley; Mathew, Lazar T.] Vellore Inst Technol Univ, Ctr Biomed Res, Vellore, Tamil Nadu, India; [Baburaj, Arun; Ephraim, Binoy; Pappachan, Febin; Maviliparambathu, Pravitha Parapurathu; Vijayan, Umesh K.; Narayanan, Sivaprasad Valiyaveettil] Mala Educ Trust METs Sch Engn, Mala, Thrissur, India	Vellore Institute of Technology	Manoj, KM (corresponding author), Vellore Inst Technol Univ, Ctr Biomed Res, Vellore, Tamil Nadu, India.	muralimanoj@vit.ac.in			Science Foundation and departmental research funds of Vellore Institute of Technology (VIT); University and Mala Education Trust (MET's) School of Engineering, India	Science Foundation and departmental research funds of Vellore Institute of Technology (VIT); University and Mala Education Trust (MET's) School of Engineering, India	This research was powered by Satyamjayatu: The Science Foundation and departmental research funds of Vellore Institute of Technology (VIT) University and Mala Education Trust (MET's) School of Engineering, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004; Bhakta MN, 2005, EUR J ORG CHEM, V2005, P4801, DOI 10.1002/ejoc.200500333; CASELLA L, 1994, BIOCHEMISTRY-US, V33, P6377, DOI 10.1021/bi00187a001; Collom SL, 2008, J BIOL CHEM, V283, P3487, DOI 10.1074/jbc.M707630200; COPELAND RA, 2000, ENZYMES PRACTICAL IN, P136; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; DEMONTELLANO PRO, 1987, J BIOL CHEM, V262, P11641; Guengerich FP, 1996, J BIOL CHEM, V271, P27321, DOI 10.1074/jbc.271.44.27321; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HOLLENBERG PF, 1992, FASEB J, V6, P686, DOI 10.1096/fasebj.6.2.1537457; Koley AP, 1996, BIOCHIMIE, V78, P706, DOI 10.1016/S0300-9084(97)82528-X; Kumar S, 2005, DRUG METAB DISPOS, V33, P1131, DOI 10.1124/dmd.105.004606; LIBBY RD, 1982, J BIOL CHEM, V257, P5030; Lin Y, 2001, DRUG METAB DISPOS, V29, P368; Manoj KM, 2007, PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON CYTOCHROMES P450 - BIOCHEMISTRY, BIOPHYSICS AND FUNCTIONAL GENOMICS, P97; Manoj KM, 2008, BIOCHEMISTRY-US, V47, P2997, DOI 10.1021/bi7022656; Manoj KM, 2006, BBA-PROTEINS PROTEOM, V1764, P1325, DOI 10.1016/j.bbapap.2006.05.012; MANOJ KM, 2002, RECENT RES DEV ORG C, V6, P393; MCCARTHY MB, 1983, J BIOL CHEM, V258, P9153; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; PORTER TD, 1991, J BIOL CHEM, V266, P13469; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shou M, 2001, CURR DRUG METAB, V2, P17, DOI 10.2174/1389200013338784; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yun CH, 2006, CURR DRUG METAB, V7, P411, DOI 10.2174/138920006776873472; Zhang R, 2006, ORG LETT, V8, P2731, DOI 10.1021/ol060762k	28	27	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10601	10.1371/journal.pone.0010601	http://dx.doi.org/10.1371/journal.pone.0010601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498847	Green Published, gold, Green Submitted			2022-12-25	WOS:000277773700005
J	Read, TD; Turingan, RS; Cook, C; Giese, H; Thomann, UH; Hogan, CC; Tan, E; Selden, RF				Read, Timothy D.; Turingan, Rosemary S.; Cook, Christopher; Giese, Heidi; Thomann, Ulrich Hans; Hogan, Catherine C.; Tan, Eugene; Selden, Richard F.			Rapid Multi-Locus Sequence Typing Using Microfluidic Biochips	PLOS ONE			English	Article							BACILLUS-CEREUS; POPULATION-STRUCTURE; DIVERSITY; ANTHRACIS; THURINGIENSIS; EVOLUTION	Background: Multiple locus sequence typing (MLST) has become a central genotyping strategy for analysis of bacterial populations. The scheme involves de novo sequencing of 6-8 housekeeping loci to assign unique sequence types. In this work we adapted MLST to a rapid microfluidics platform in order to enhance speed and reduce laboratory labor time. Methodology/Principal Findings: Using two integrated microfluidic devices, DNA was purified from 100 Bacillus cereus soil isolates, used as a template for multiplex amplification of 7 loci and sequenced on forward and reverse strands. The time on instrument from loading genomic DNA to generation of electropherograms was only 1.5 hours. We obtained full-length sequence of all seven MLST alleles from 84 representing 46 different Sequence Types. At least one allele could be sequenced from a further 15 strains. The nucleotide diversity of B. cereus isolated in this study from one location in Rockville, Maryland (0.04 substitutions per site) was found to be as great as the global collection of isolates. Conclusions/Significance: Biogeographical investigation of pathogens is only one of a panoply of possible applications of microfluidics based MLST; others include microbiologic forensics, biothreat identification, and rapid characterization of human clinical samples.	[Read, Timothy D.; Cook, Christopher] USN, Med Res Ctr, Biol Def Res Directorate, Rockville, MD USA; [Read, Timothy D.] Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA; [Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Turingan, Rosemary S.; Giese, Heidi; Thomann, Ulrich Hans; Hogan, Catherine C.; Tan, Eugene; Selden, Richard F.] Network Biosyst Inc, Woburn, MA USA	United States Department of Defense; United States Navy; Emory University; Emory University	Read, TD (corresponding author), USN, Med Res Ctr, Biol Def Res Directorate, Rockville, MD USA.	tread@emory.edu	Read, Timothy/E-6240-2011	Read, Timothy/0000-0001-8966-9680	Emory University School of Medicine; Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) [TMTI0068_07_NM_T]; Defense Threat Reduction Agency Initiative; Network Biosystems Inc. Development; Wellcome Trust	Emory University School of Medicine; Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)(United States Department of DefenseDefense Threat Reduction Agency); Defense Threat Reduction Agency Initiative(United States Department of DefenseDefense Threat Reduction Agency); Network Biosystems Inc. Development; Wellcome Trust(Wellcome Trust)	This work was supported by a developmental grant from Emory University School of Medicine to TDR, grant TMTI0068_07_NM_T from the Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD), Defense Threat Reduction Agency Initiative to TDR and internal funding from Network Biosystems Inc. Development and maintenance of the PubMLST site used in this study has been funded by the Wellcome Trust. Network Biosystems employees were involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	ASH C, 1991, INT J SYST BACTERIOL, V41, P343, DOI 10.1099/00207713-41-3-343; Barker M, 2005, FEMS MICROBIOL LETT, V245, P179, DOI 10.1016/j.femsle.2005.03.003; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Collier FA, 2005, FEMS MICROBIOL ECOL, V54, P417, DOI 10.1016/j.femsec.2005.05.005; Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; GIESE H, 2009, J FORENSIC IN PRESS; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourasse NJ, 2008, NUCLEIC ACIDS RES, V36, pD461, DOI 10.1093/nar/gkm877; Vilas-Boas G, 2002, APPL ENVIRON MICROB, V68, P1414, DOI 10.1128/AEM.68.3.1414-1424.2002; Vos M, 2008, CURR BIOL, V18, P386, DOI 10.1016/j.cub.2008.02.050; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x	29	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10595	10.1371/journal.pone.0010595	http://dx.doi.org/10.1371/journal.pone.0010595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485679	gold, Green Published, Green Submitted			2022-12-25	WOS:000277563400008
J	Li, N; Zhao, CT; Wang, Y; Yuan, XB				Li, Ning; Zhao, Chun-Tao; Wang, Ying; Yuan, Xiao-Bing			The Transcription Factor Cux1 Regulates Dendritic Morphology of Cortical Pyramidal Neurons	PLOS ONE			English	Article							CCAAT DISPLACEMENT PROTEIN; CELL-CYCLE EXIT; HOMEODOMAIN PROTEIN; HOMEOBOX GENE; CEREBRAL-CORTEX; RHO-GTPASES; P27(KIP1) EXPRESSION; SUBVENTRICULAR ZONE; TRANSGENIC MICE; DROSOPHILA CUT	In the murine cerebral cortex, mammalian homologues of the Cux family transcription factors, Cux1 and Cux2, have been identified as restricted molecular markers for the upper layer (II-IV) pyramidal neurons. However, their functions in cortical development are largely unknown. Here we report that increasing the intracellular level of Cux1, but not Cux2, reduced the dendritic complexity of cultured cortical pyramidal neurons. Consistently, reducing the expression of Cux1 promoted the dendritic arborization in these pyramidal neurons. This effect required the existence of the DNA-binding domains, hence the transcriptional passive repression activity of Cux1. Analysis of downstream signals suggested that Cux1 regulates dendrite development primarily through suppressing the expression of the cyclin-dependent kinase inhibitor p27(Kip1), and RhoA may mediate the regulation of dendritic complexity by Cux1 and p27. Thus, Cux1 functions as a negative regulator of dendritic complexity for cortical pyramidal neurons.	[Li, Ning; Zhao, Chun-Tao; Yuan, Xiao-Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Li, Ning; Zhao, Chun-Tao; Yuan, Xiao-Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurobiol, Shanghai, Peoples R China; [Li, Ning; Zhao, Chun-Tao] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Wang, Ying] Wenzhou Med Coll, Sch Lab Med & Life Sci, Wenzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Wenzhou Medical University	Li, N (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.	yuanxb@ion.ac.cn		Yuan, Xiaobing/0000-0002-1632-8460	National Basic Research Program of China [2006CB943903]; National Natural Science Foundation of China [30625023]; Chinese Academy of Sciences [KSCX2-YW-R-103]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (2006CB943903, 2006CB943903) and grants from the National Natural Science Foundation of China (30625023) and the Chinese Academy of Sciences (KSCX2-YW-R-103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Akashiba H, 2006, CELL MOL LIFE SCI, V63, P2397, DOI 10.1007/s00018-006-6194-4; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Cadieux C, 2008, J BIOL CHEM, V283, P13817, DOI 10.1074/jbc.M709332200; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cubelos B, 2008, CEREB CORTEX, V18, P1758, DOI 10.1093/cercor/bhm199; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Dergham P, 2002, J NEUROSCI, V22, P6570; Ferrere A, 2006, ANAT REC PART A, V288A, P158, DOI 10.1002/ar.a.20284; Gingras N, 2005, GENE, V344, P273, DOI 10.1016/j.gene.2004.11.008; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Iulianella A, 2008, DEVELOPMENT, V135, P729, DOI 10.1242/dev.013276; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; KRIEGSTEIN AR, 1983, J NEUROSCI, V3, P1634; Ledford AW, 2002, DEV BIOL, V245, P157, DOI 10.1006/dbio.2002.0636; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Paris M, 2006, MOL CELL BIOL, V26, P8826, DOI 10.1128/MCB.00575-06; Ponimaskin E, 2008, J NEUROSCI, V28, P8897, DOI 10.1523/JNEUROSCI.2171-08.2008; Quaggin SE, 1997, J CLIN INVEST, V99, P718, DOI 10.1172/JCI119216; Quaggin SE, 1996, J BIOL CHEM, V271, P22624, DOI 10.1074/jbc.271.37.22624; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Redmond L, 2008, NEUROSIGNALS, V16, P194, DOI 10.1159/000111563; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Sharma M, 2009, GENE, V439, P87, DOI 10.1016/j.gene.2009.03.014; SKALNIK DG, 1991, J BIOL CHEM, V266, P16736; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VALARCHE I, 1993, DEVELOPMENT, V119, P881; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; VandenHeuvel GB, 1996, BIOL REPROD, V55, P731, DOI 10.1095/biolreprod55.4.731; VANWIJNEN AJ, 1991, P NATL ACAD SCI USA, V88, P2573, DOI 10.1073/pnas.88.6.2573; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	48	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10596	10.1371/journal.pone.0010596	http://dx.doi.org/10.1371/journal.pone.0010596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485671	gold, Green Published, Green Submitted			2022-12-25	WOS:000277563200023
J	Yang, L; Zhao, LY; Gan, ZJ; He, ZX; Xu, JY; Gao, XA; Wang, XR; Han, WP; Chen, LY; Xu, T; Li, WJ; Liu, Y				Yang, Liu; Zhao, Liyun; Gan, Zhenji; He, Zixuan; Xu, Jingyue; Gao, Xiang; Wang, Xiaorui; Han, Weiping; Chen, Liangyi; Xu, Tao; Li, Wenjun; Liu, Yong			Deficiency in RNA editing enzyme ADAR2 impairs regulated exocytosis	FASEB JOURNAL			English	Article						GSIS; adenosine deaminase; pancreatic beta cells; PC12 cells	PANCREATIC BETA-CELLS; SENSITIVE K+ CHANNEL; NEURONAL SNARE COMPLEX; INSULIN-SECRETION; ADENOSINE-DEAMINASE; GRANULE EXOCYTOSIS; RECEPTOR CHANNELS; RAT-BRAIN; GLUTAMATE; EXPRESSION	Mammalian RNA editing catalyzed by adenosine deaminases acting on RNA (ADARs) ADAR1 and ADAR2 plays pivotal roles in the brain through functional modifications of neurotransmitter receptors and ion channels. We have demonstrated previously that RNA editing by ADAR2 is regulated metabolically in pancreatic beta cells. To investigate the cellular functions of ADAR2 in professional secretory cells, we studied the effects of ADAR2 knockdown on regulated exocytosis. Selective knockdown of ADAR2 expression markedly impaired glucose-stimulated insulin secretion in the rat insulinoma INS-1 cells and primary pancreatic islets and significantly diminished KC1-stimulated secretion of exogenous human growth hormone or endogenous chromogranin B protein in the rat adrenal pheochromocytoma PC12 cells. Notably, restored overexpression of catalytically active but not editing-deficient mutant ADAR2 could rescue the impairment in stimulated secretion from ADAR2 knockdown cells. Moreover, ADAR2 suppression significantly attenuated Ca2(+) -evoked membrane capacitance increases and appreciably reduced the number of membrane-docked insulin granules in INS-1 cells. Interestingly, the secretory defects resulting from ADAR2 deficiency were coupled to decreased expression of Munc18-1 and synaptotagmin-7, two key molecules in the regulation of vesicle exocytosis. Thus, these findings reveal an important aspect of ADAR2 actions in regulated exocytosis, implicating RNA editing in the control of cellular secretory machinery.-Yang, L., Zhao, L., Gan, Z., He, Z., Xu, J., Gao, X., Wang, X., Han, W., Chen, L., Xu, T., Li, W., Liu, Y. Deficiency in RNA editing enzyme ADAR2 impairs regulated exocytosis. FASEB J. 24, 3720-3732 (2010). www.fasebj.org	[Yang, Liu; Zhao, Liyun; Gan, Zhenji; Li, Wenjun; Liu, Yong] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [He, Zixuan; Chen, Liangyi; Xu, Tao] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Xu, Jingyue; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Peoples R China; [Wang, Xiaorui; Han, Weiping] ASTAR, Singapore Bioimaging Consortium, Singapore, Singapore	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Nanjing University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Li, WJ (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China.	wjli@sibs.ac.cn; liuy@sibs.ac.cn	Chen, Liangyi/F-1352-2010; he, zixuan/ADY-7938-2022	Chen, Liangyi/0000-0003-1270-7321; LIU, YONG/0000-0001-7771-4181; Gan, Zhenji/0000-0001-5940-207X	China National Natural Science Foundation [30830033, 90713027, 30988002]; Ministry of Science and Technology [2006CB503900, 2007CB947100, 2006BAI23B00]; Chinese Academy of Sciences [KSCX1-YW-02, KSCX2-YW-R-115, SIBS2008006]; Science and Technology Commission of Shanghai Municipality [10XD1406400]; A*STAR Biomedical Research Council	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	The authors thank Dr. Philippe A. Halban (University of Geneva, Geneva, Switzerland) and Dr. Romano Regazzi (University of Lausanne, Lausanne, Switzerland) for kindly providing the hGH expression plasmid; and Dr. Charles E. Samuel (University of California, Santa Barbara, CA, USA), Dr. Liangyou Rui (University of Michigan, Ann Arbor, MI, USA) and Dr. Zheng-gang Liu (National Cancer Institute, U.S. National Institutes of Health) for critical reading of the manuscript. This work was supported by grants from the China National Natural Science Foundation (30830033, 90713027, and 30988002), the Ministry of Science and Technology (973 Programs 2006CB503900, 2007CB947100 and 2006BAI23B00), the Chinese Academy of Sciences (Knowledge Innovation programs KSCX1-YW-02 and KSCX2-YW-R-115, and CS program SIBS2008006), the Science and Technology Commission of Shanghai Municipality (10XD1406400), and the A*STAR Biomedical Research Council to Y.L., W.J.L., X.G., and W.H. The authors declare no conflicts of interest.	Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cai HJ, 2008, P NATL ACAD SCI USA, V105, P19538, DOI 10.1073/pnas.0810232105; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; FEHMANN HC, 1990, FEBS LETT, V262, P279, DOI 10.1016/0014-5793(90)80210-A; Gan ZJ, 2006, J BIOL CHEM, V281, P33386, DOI 10.1074/jbc.M604484200; Gauthier BR, 2008, FASEB J, V22, P194, DOI 10.1096/fj.07-8333com; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Gut A, 2001, J CELL SCI, V114, P1709; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; Kanno T, 2004, METHODS, V33, P302, DOI 10.1016/j.ymeth.2004.01.003; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Komatsu M, 2001, ENDOCR J, V48, P275, DOI 10.1507/endocrj.48.275; Koster JC, 2005, DIABETES, V54, P3065, DOI 10.2337/diabetes.54.11.3065; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Ma GQ, 2008, TRAFFIC, V9, P2165, DOI 10.1111/j.1600-0854.2008.00836.x; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Singh M, 2007, J BIOL CHEM, V282, P22448, DOI 10.1074/jbc.M700265200; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Tomas A, 2008, TRAFFIC, V9, P813, DOI 10.1111/j.1600-0854.2008.00709.x; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	62	18	20	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3720	3732		10.1096/fj.09-152363	http://dx.doi.org/10.1096/fj.09-152363			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20501795				2022-12-25	WOS:000285005900012
J	Santangelo, TJ; Reeve, JN				Santangelo, Thomas J.; Reeve, John N.			Deletion of Switch 3 Results in an Archaeal RNA Polymerase That Is Defective in Transcript Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOCOCCUS-KODAKARAENSIS KOD1; DNA HYBRID; HYPERTHERMOPHILIC ARCHAEON; STRUCTURAL BASIS; ANGSTROM RESOLUTION; IN-VITRO; COMPLEX; TERMINATION; HOLOENZYME; INITIATION	Switch 3 is a polypeptide loop conserved in all multisubunit DNA-dependent RNA polymerases (RNAPs) that extends into the main cleft of the RNAP and contacts each base in a nascent transcript as that base is released from the internal DNA-RNA hybrid. Plasmids have been constructed and transformed into Thermococcus kodakaraensis, which direct the constitutive synthesis of the archaeal RNAP subunit RpoB with an N-terminal His(6) tag and the Switch 3 loop either intact (wild-type) or deleted (Delta S3). RNAPs containing these plasmid-encoded RpoB subunits were purified, and, in vitro, the absence of Switch 3 had no negative effects on transcription initiation or elongation complex stability but reduced the rate of transcript elongation. The defect in elongation occurred at every template position and increased the sensitivity of the archaeal RNAP to intrinsic termination. Comparing these properties and those reported for a bacterial RNAP lacking Switch 3 argues that this loop functions differently in the RNAPs from the two prokaryotic domains. The close structural homology of archaeal and eukaryotic RNAPs would predict that eukaryotic Switch 3 loops likely conform to the archaeal rather than bacterial functional paradigm.	[Santangelo, Thomas J.; Reeve, John N.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Santangelo, TJ (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	santangelo.11@osu.edu	Santangelo, Tom/L-8206-2019	Santangelo, Tom/0000-0003-4559-3244	National Institutes of Health [R01GM53185, 1F32-GM073336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053185, F32GM073336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM53185 (to J.N.R.) and 1F32-GM073336 (to T.J.S.).	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bell SD, 2001, BIOCHEM SOC T, V29, P392, DOI 10.1042/BST0290392; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Brueckner F, 2009, ACTA CRYSTALLOGR D, V65, P112, DOI 10.1107/S0907444908039875; Cramer P, 2004, ADV PROTEIN CHEM, V67, P1; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hirata A, 2009, CURR OPIN STRUC BIOL, V19, P724, DOI 10.1016/j.sbi.2009.10.006; Hirata A, 2008, MOL MICROBIOL, V70, P623, DOI 10.1111/j.1365-2958.2008.06430.x; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; Kent T, 2009, J BIOL CHEM, V284, P13497, DOI 10.1074/jbc.M901898200; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; Liu XQ, 2009, J BIOL CHEM, V284, P36262, DOI 10.1074/jbc.M109.056820; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Murakami KS, 2003, METHOD ENZYMOL, V370, P42; Naji S, 2008, NUCLEIC ACIDS RES, V36, P676, DOI 10.1093/nar/gkm1086; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Reeve JN, 1997, CELL, V89, P999, DOI 10.1016/S0092-8674(00)80286-X; Santangelo TJ, 2008, APPL ENVIRON MICROB, V74, P3099, DOI 10.1128/AEM.00305-08; Santangelo TJ, 2007, J MOL BIOL, V367, P344, DOI 10.1016/j.jmb.2006.12.069; Santangelo TJ, 2010, APPL ENVIRON MICROB, V76, P1044, DOI 10.1128/AEM.02497-09; Santangelo TJ, 2009, J BACTERIOL, V191, P7102, DOI 10.1128/JB.00982-09; Santangelo TJ, 2006, J MOL BIOL, V355, P196, DOI 10.1016/j.jmb.2005.10.062; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Soler N, 2007, MOL MICROBIOL, V66, P357, DOI 10.1111/j.1365-2958.2007.05912.x; Spitalny P, 2008, MOL MICROBIOL, V67, P958, DOI 10.1111/j.1365-2958.2007.06084.x; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Werner F, 2008, TRENDS MICROBIOL, V16, P247, DOI 10.1016/j.tim.2008.03.008; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732	40	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23908	23915		10.1074/jbc.M109.094565	http://dx.doi.org/10.1074/jbc.M109.094565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511223	Green Published, hybrid			2022-12-25	WOS:000280291400041
J	Le Clainche, C; Dwivedi, SP; Didry, D; Carlier, MF				Le Clainche, Christophe; Dwivedi, Satya Prakash; Didry, Dominique; Carlier, Marie-France			Vinculin Is a Dually Regulated Actin Filament Barbed End-capping and Side-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION FORMATION; ALPHA-ACTININ; TALIN ROD; INTRAMOLECULAR ASSOCIATION; ACTIVATE VINCULIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TAIL DOMAINS; CELLS; SITES	The focal adhesion protein vinculin is an actin-binding protein involved in the mechanical coupling between the actin cytoskeleton and the extracellular matrix. An autoinhibitory interaction between the N-terminal head (Vh) and the C-terminal tail (Vt) of vinculin masks an actin filament side-binding domain in Vt. The binding of several proteins to Vh disrupts this intramolecular interaction and exposes the actin filament side-binding domain. Here, by combining kinetic assays and microscopy observations, we show that Vt inhibits actin polymerization by blocking the barbed ends of actin filaments. In low salt conditions, Vt nucleates actin filaments capped at their barbed ends. We determined that the interaction between vinculin and the barbed end is characterized by slow association and dissociation rate constants. This barbed end capping activity requires C-terminal amino acids of Vt that are dispensable for actin filament side binding. Like the side-binding domain, the capping domain of vinculin is masked by an autoinhibitory interaction between Vh and Vt. In contrast to the side-binding domain, the capping domain is not unmasked by the binding of a talin domain to Vh and requires the dissociation of an additional autoinhibitory interaction. Finally, we show that vinculin and the formin mDia1, which is involved in the processive elongation of actin filaments in focal adhesions, compete for actin filament barbed ends.	[Le Clainche, Christophe; Dwivedi, Satya Prakash; Didry, Dominique; Carlier, Marie-France] CNRS, UPR3082, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Le Clainche, C (corresponding author), CNRS, UPR3082, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France.	Christophe.Leclainche@lebs.cnrs-gif.fr	Le Clainche, Christophe/A-4782-2015	Le Clainche, Christophe/0000-0001-5659-677X	Agence Nationale pour la Recherche [ANR-09-JCJC-0111-01]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	Supported by Agence Nationale pour la Recherche Grant ANR-09-JCJC-0111-01 ADERACTIN. To whom correspondence should be addressed.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Bourdet-Sicard R, 2000, MICROBES INFECT, V2, P813, DOI 10.1016/S1286-4579(00)90366-6; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; CHUANG JZ, 1995, J CELL BIOL, V128, P1095, DOI 10.1083/jcb.128.6.1095; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; GIMONA M, 1988, EMBO J, V7, P2329, DOI 10.1002/j.1460-2075.1988.tb03076.x; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; MENKEL AR, 1994, J CELL BIOL, V126, P1231, DOI 10.1083/jcb.126.5.1231; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Ramarao N, 2007, FEBS LETT, V581, P853, DOI 10.1016/j.febslet.2007.01.057; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Van Nhieu GT, 2007, EMBO J, V26, P4588; VOLBERG T, 1995, J CELL SCI, V108, P2253; WACHSSTOCK DH, 1987, BIOCHEM BIOPH RES CO, V146, P554, DOI 10.1016/0006-291X(87)90564-X; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295; Xu WM, 1998, J CELL SCI, V111, P1535; Zamir E, 2001, J CELL SCI, V114, P3583; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	55	43	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23418	23430		10.1074/jbc.M110.102830	http://dx.doi.org/10.1074/jbc.M110.102830			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484056	Green Published, hybrid			2022-12-25	WOS:000279999900074
J	Austin, P; Heller, M; Williams, DE; McIntosh, LP; Vogl, AW; Foster, LJ; Andersen, RJ; Roberge, M; Roskelley, CD				Austin, Pamela; Heller, Markus; Williams, David E.; McIntosh, Lawrence P.; Vogl, A. Wayne; Foster, Leonard J.; Andersen, Raymond J.; Roberge, Michel; Roskelley, Calvin D.			Release of Membrane-Bound Vesicles and Inhibition of Tumor Cell Adhesion by the Peptide Neopetrosiamide A	PLOS ONE			English	Article							FOCAL ADHESIONS; CANCER-THERAPY; STRESS FIBERS; INVASION; INTEGRINS; PROTEIN; ACTIN; STRONGYLOPHORINE-26; ANGIOGENESIS; ASSOCIATION	Background: Neopetrosiamide A (NeoA) is a 28-amino acid tricyclic peptide originally isolated from a marine sponge as a tumor cell invasion inhibitor whose mechanism of action is unknown. Methodology/Principal Findings: We show that NeoA reversibly inhibits tumor cell adhesion, disassembles focal adhesions in pre-attached cells, and decreases the level of beta 1 integrin subunits on the cell surface. NeoA also induces the formation of dynamic, membrane-bound protrusions on the surface of treated cells and the release of membrane-bound vesicles into the culture medium. Proteomic analysis indicates that the vesicles contain EGF and transferrin receptors as well as a number of proteins involved in adhesion and migration including: beta 1 integrin and numerous alpha integrin subunits; actin and actin-binding proteins such as cofilin, moesin and myosin 1C; and membrane modulating eps15 homology domain (EHD) proteins. Surface labeling, trafficking inhibition, and real-time imaging experiments all suggest that beta 1 integrin-containing vesicles are released directly from NeoA-induced cell surface protrusions rather than from vesicles generated intracellularly. The biological activity of NeoA is dependent on its disulfide bond pattern and NMR spectroscopy indicates that the peptide is globular with a continuous ridge of hydrophobic groups flanked by charged amino acid residues that could facilitate a simultaneous interaction with lipids and proteins in the membrane. Conclusions/Significance: NeoA is an anti-adhesive peptide that decreases cell surface integrin levels through a novel, yet to be elucidated, mechanism that involves the release of adhesion molecule-containing vesicles from the cell surface.	[Austin, Pamela; Vogl, A. Wayne; Roskelley, Calvin D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Austin, Pamela; Heller, Markus; McIntosh, Lawrence P.; Foster, Leonard J.; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Williams, David E.; McIntosh, Lawrence P.; Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC V5Z 1M9, Canada; [Williams, David E.; Andersen, Raymond J.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Roskelley, Calvin D.] Univ British Columbia, Program Breast Canc Metastasis, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Austin, P (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	roskelly@interchange.ubc.ca	Roskelley, Calvin D/F-4630-2011		Canadian Cancer Society through the National Cancer Institute of Canada; Canadian Breast Cancer Research Alliance; Michael Smith Foundation for Health Research; Canadian Institutes for Health Research; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; UBC Blusson Fund; Alexander-von-Humboldt Foundation	Canadian Cancer Society through the National Cancer Institute of Canada; Canadian Breast Cancer Research Alliance; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; UBC Blusson Fund; Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by grants from the Canadian Cancer Society through the National Cancer Institute of Canada (to MR and CDR, RJA, LPM), the Canadian Breast Cancer Research Alliance Metastasis Program (CDR), and by funding from the Michael Smith Foundation for Health Research to the Solid Tumor Progression Research Unit (CDR, MR, RJA). LJF is Canada Research Chair in Organelle Proteomics and a Michael Smith Foundation Scholar. Instrument support was provided by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the UBC Blusson Fund, and the Michael Smith Foundation for Health Research. MH gratefully acknowledges the Alexander-von-Humboldt Foundation for a Feodor-Lynen Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerner JL, 2005, MOL ENDOCRINOL, V19, P2660, DOI 10.1210/me.2004-0439; Bonilha VL, 2004, MOL CELL PROTEOMICS, V3, P1119, DOI 10.1074/mcp.M400106-MCP200; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Cai Weibo, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P407, DOI 10.2174/187152006778226530; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diaz-Marrero AR, 2006, ORG LETT, V8, P3749, DOI 10.1021/ol061333p; DOLO V, 1994, J SUBMICR CYTOL PATH, V26, P173; Dunehoo AL, 2006, J PHARM SCI-US, V95, P1856, DOI 10.1002/jps.20676; Eble JA, 2006, CURR CANCER DRUG TAR, V6, P89, DOI 10.2174/156800906776056518; Elvin P, 2005, CURR OPIN PHARMACOL, V5, P374, DOI 10.1016/j.coph.2005.02.008; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Han KH, 1997, BIOCHEMISTRY-US, V36, P1669, DOI 10.1021/bi962301k; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Keezer SM, 2003, CANCER RES, V63, P6405; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Kuo HJ, 2001, J BIOL CHEM, V276, P43103, DOI 10.1074/jbc.M106128200; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Lirazan MB, 2000, BIOCHEMISTRY-US, V39, P1583, DOI 10.1021/bi9923712; LIU H, J AM CHEM SOC, V132, P1486; Maciver SK, 2002, GENOME BIOL, V3; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; McHardy LM, 2005, MOL CANCER THER, V4, P772, DOI 10.1158/1535-7163.MCT-04-0310; McHardy LM, 2004, CANCER RES, V64, P1468, DOI 10.1158/0008-5472.CAN-03-2733; Paradela A, 2005, J PROTEOME RES, V4, P2435, DOI 10.1021/pr050308v; Park SK, 1996, J BIOCHEM, V119, P235; Pluskota E, 2008, BLOOD, V112, P2327, DOI 10.1182/blood-2007-12-127183; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Roskelley CD, 2001, CANCER RES, V61, P6788; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; SIMPSON KJ, 2008, NAT CELL BIOL; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Wang L, 2008, J CANCER RES CLIN, V134, P365, DOI 10.1007/s00432-007-0292-z; Warabi K, 2004, J NAT PROD, V67, P1387, DOI 10.1021/np0340246; Westhoff MA, 2009, DRUG RESIST UPDATE, V12, P127, DOI 10.1016/j.drup.2009.08.001; Williams DE, 2005, ORG LETT, V7, P4173, DOI 10.1021/ol051524c; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Zent R, 2000, J BIOL CHEM, V275, P5059, DOI 10.1074/jbc.275.7.5059	52	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10836	10.1371/journal.pone.0010836	http://dx.doi.org/10.1371/journal.pone.0010836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520768	Green Published, gold, Green Submitted			2022-12-25	WOS:000278221500022
J	Lundgren, JG; Lehman, M				Lundgren, Jonathan G.; Lehman, Michael			Bacterial Gut Symbionts Contribute to Seed Digestion in an Omnivorous Beetle	PLOS ONE			English	Article							CHRYSOPERLA-RUFILABRIS NEUROPTERA; GENOME SEQUENCE; BLOCHMANNIA-FLORIDANUS; VERTICAL TRANSMISSION; ABUTILON-THEOPHRASTI; CHRYSOPIDAE ADULTS; POECILUS-CHALCITES; OBLIGATE SYMBIONT; GROUND BEETLE; LIFE-CYCLE	Background: Obligate bacterial symbionts alter the diets of host animals in numerous ways, but the ecological roles of facultative bacterial residents that colonize insect guts remain unclear. Carabid beetles are a common group of beneficial insects appreciated for their ability to consume insect prey and seeds, but the contributions of microbes to diet diversification in this and similar groups of facultative granivores are largely unknown. Methodology and Principal Findings: Using 16S rRNA gene clone libraries and terminal restriction fragment (tRF) length polymorphism analyses of these genes, we examined the bacterial communities within the guts of facultatively granivorous, adult Harpalus pensylvanicus (Carabidae), fed one of five dietary treatments: 1) an untreated Field population, 2) Seeds with antibiotics (seeds were from Chenopodium album), 3) Seeds without antibiotics, 4) Prey with antibiotics (prey were Acheta domesticus eggs), and 5) Prey without antibiotics. The number of seeds and prey consumed by each beetle were recorded following treatment. Harpalus pensylvanicus possessed a fairly simple gut community of approximately 3-4 bacterial operational taxonomic units (OTU) per beetle that were affiliated with the Gammaproteobacteria, Bacilli, Alphaproteo-bacteria, and Mollicutes. Bacterial communities of the host varied among the diet and antibiotic treatments. The field population and beetles fed seeds without antibiotics had the closest matching bacterial communities, and the communities in the beetles fed antibiotics were more closely related to each other than to those of the beetles that did not receive antibiotics. Antibiotics reduced and altered the bacterial communities found in the beetle guts. Moreover, beetles fed antibiotics ate fewer seeds, and those beetles that harbored the bacterium Enterococcus faecalis consumed more seeds on average than those lacking this symbiont. Conclusions/Significance: We conclude that the relationships between the bacterium E. faecalis and this factultative granivore's ability to consume seeds merit further investigation, and that facultative associations with symbiotic bacteria have important implications for the nutritional ecology of their hosts.	[Lundgren, Jonathan G.; Lehman, Michael] ARS, N Cent Agr Res Lab, USDA, Brookings, SD USA	United States Department of Agriculture (USDA)	Lundgren, JG (corresponding author), ARS, N Cent Agr Res Lab, USDA, Brookings, SD USA.	Jonathan.Lundgren@ars.usda.gov		Lehman, Michael/0000-0002-3391-3178	United States Department of Agriculture Agricultural Research Service	United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the United States Department of Agriculture Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Allen HK, 2009, DNA CELL BIOL, V28, P109, DOI 10.1089/dna.2008.0812; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1990, ROLE GROUND BEETLES; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; AZAMBUJA P, 2005, TRENDS PARISITOLOGY, V21, DOI DOI 10.1016/J.PT.2005.1009.1011; Ba AS, 1996, MYCOL RES, V100, P740, DOI 10.1016/S0953-7562(96)80208-5; Ball GE, 2000, AM BEETLES, V1, P32; BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; Blackburn MB, 2008, BIOL CONTROL, V46, P434, DOI 10.1016/j.biocontrol.2008.05.005; Brauman A, 2001, FEMS MICROBIOL ECOL, V35, P27, DOI 10.1111/j.1574-6941.2001.tb00785.x; Brinkmann N, 2008, APPL ENVIRON MICROB, V74, P7189, DOI 10.1128/AEM.01464-08; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Brust G. E., 1988, American Journal of Alternative Agriculture, V3, P19, DOI 10.1017/S0889189300002083; BRUST GE, 1986, ENVIRON ENTOMOL, V15, P1017, DOI 10.1093/ee/15.5.1017; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Campbell B.C., 1989, P1; Chandler SM, 2008, P ROY SOC B-BIOL SCI, V275, P565, DOI 10.1098/rspb.2007.1478; COCHRAN DG, 1985, ANNU REV ENTOMOL, V30, P29, DOI 10.1146/annurev.en.30.010185.000333; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Czarnetzki AB, 2004, FEMS MICROBIOL ECOL, V49, P217, DOI 10.1016/j.femsec.2004.03.007; Dillon RJ, 2008, J INVERTEBR PATHOL, V97, P265, DOI 10.1016/j.jip.2007.09.010; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Doring TF, 2003, AGR ECOSYST ENVIRON, V98, P133, DOI 10.1016/S0167-8809(03)00075-6; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Ennahar S, 2003, APPL ENVIRON MICROB, V69, P444, DOI 10.1128/AEM.69.1.444-451.2003; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; FORSYTHE TG, 1983, ZOOL J LINN SOC-LOND, V79, P319, DOI 10.1111/j.1096-3642.1983.tb01170.x; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Heggenstaller AH, 2006, J APPL ECOL, V43, P999, DOI 10.1111/j.1365-2664.2006.01198.x; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Honek A, 2005, J ECOL, V93, P345, DOI 10.1111/j.1365-2745.2005.00987.x; Honek A, 2003, EUR J ENTOMOL, V100, P531, DOI 10.14411/eje.2003.081; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hunter MD, 2009, AGR FOREST ENTOMOL, V11, P125, DOI 10.1111/j.1461-9563.2008.00427.x; Inglis GD, 2000, J ECON ENTOMOL, V93, P1619, DOI 10.1603/0022-0493-93.6.1619; Janson EM, 2008, EVOLUTION, V62, P997, DOI 10.1111/j.1558-5646.2008.00348.x; Jones C.G., 1984, P53; Jorgensen HB, 1997, ECOL ENTOMOL, V22, P7, DOI 10.1046/j.1365-2311.1997.00045.x; KAUFMAN MG, 1989, J INSECT PHYSIOL, V35, P957, DOI 10.1016/0022-1910(89)90019-X; KAUFMAN MG, 1991, COMP BIOCHEM PHYS A, V98, P117, DOI 10.1016/0300-9629(91)90588-4; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; KIRK VM, 1972, ANN ENTOMOL SOC AM, V65, P1426, DOI 10.1093/aesa/65.6.1426; KIRK VM, 1973, ANN ENTOMOL SOC AM, V66, P513, DOI 10.1093/aesa/66.3.513; KLIMES P, 2010, J APPL ENTO IN PRESS; Kounatidis I, 2009, APPL ENVIRON MICROB, V75, P3281, DOI 10.1128/AEM.02933-08; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Li HW, 2005, J INVERTEBR PATHOL, V89, P203, DOI 10.1016/j.jip.2005.05.008; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lundgren JG, 2005, J ENTOMOL SCI, V40, P126, DOI 10.18474/0749-8004-40.2.126; LUNDGREN JG, 2009, RELATIONSHI IN PRESS; Lundgren JG, 2007, ARTHROPOD-PLANT INTE, V1, P93, DOI 10.1007/s11829-007-9008-1; Lundgren JG, 2007, ANN ENTOMOL SOC AM, V100, P275, DOI 10.1603/0013-8746(2007)100[275:BCWDTO]2.0.CO;2; Lundgren JG, 2006, RENEW AGR FOOD SYST, V21, P227, DOI 10.1079/RAF2006152; Macovei L, 2006, APPL ENVIRON MICROB, V72, P4028, DOI 10.1128/AEM.00034-06; MARTIN JD, 1972, APPL MICROBIOL, V24, P575, DOI 10.1128/AEM.24.4.575-580.1972; MARTIN MM, 1992, AM ZOOL, V32, P593; MARTIN MM, 1980, OECOLOGIA, V46, P360, DOI 10.1007/BF00346265; Mauchline AL, 2005, WEED RES, V45, P157, DOI 10.1111/j.1365-3180.2004.00443.x; Menalled FD, 1999, BIOCONTROL, V43, P441, DOI 10.1023/A:1009946004251; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Morales-Ramos JA, 2000, ANN ENTOMOL SOC AM, V93, P541, DOI 10.1603/0013-8746(2000)093[0541:SRBHHC]2.0.CO;2; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Nguyen NH, 2006, MYCOL RES, V110, P346, DOI 10.1016/j.mycres.2005.11.010; Park SY, 2007, INFECT IMMUN, V75, P1861, DOI 10.1128/IAI.01473-06; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Prado SS, 2009, CURR MICROBIOL, V58, P64, DOI 10.1007/s00284-008-9267-9; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; *SYST SOFTW INC, 2004, SYSTAT SOFTW 1 SYSTA; Tholen A, 1997, FEMS MICROBIOL ECOL, V24, P137, DOI 10.1016/S0168-6496(97)00053-6; Thomas GH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-24; van der Hoeven R, 2008, FEMS MICROBIOL LETT, V286, P249, DOI 10.1111/j.1574-6968.2008.01277.x; Vasanthakumar A, 2006, ENVIRON ENTOMOL, V35, P1710, DOI 10.1603/0046-225X(2006)35[1710:COGBIL]2.0.CO;2; Westerman P, 2005, WEED SCI, V53, P382, DOI 10.1614/WS-04-130R; Westerman PR, 2003, AGR ECOSYST ENVIRON, V95, P417, DOI 10.1016/S0167-8809(02)00224-4; Woolfolk SW, 2004, ANN ENTOMOL SOC AM, V97, P796, DOI 10.1603/0013-8746(2004)097[0796:MOTACO]2.0.CO;2; Woolfolk SW, 2004, BIOL CONTROL, V29, P155, DOI 10.1016/S1049-9644(03)00139-7; YAMANOUCHI T, 1992, INT J REMOTE SENS, V13, P111, DOI 10.1080/01431169208904029; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; ZHaVOROnKOVa T.n., 1969, ENTOMOL REV, V48, P462; Zientz E, 2006, APPL ENVIRON MICROB, V72, P6027, DOI 10.1128/AEM.00933-06	91	55	62	7	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10831	10.1371/journal.pone.0010831	http://dx.doi.org/10.1371/journal.pone.0010831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520762	Green Submitted, Green Published, gold			2022-12-25	WOS:000278221500017
J	Berry, RP; Ibbotson, MR				Berry, Richard P.; Ibbotson, Michael R.			A Three-Dimensional Atlas of the Honeybee Neck	PLOS ONE			English	Article							APIS-MELLIFERA; MOTOR-NEURONS; BRAIN; RECONSTRUCTION; ANATOMY; FLOW	Three-dimensional digital atlases are rapidly becoming indispensible in modern biology. We used serial sectioning combined with manual registration and segmentation of images to develop a comprehensive and detailed three-dimensional atlas of the honeybee head-neck system. This interactive atlas includes skeletal structures of the head and prothorax, the neck musculature, and the nervous system. The scope and resolution of the model exceeds atlases previously developed on similar sized animals, and the interactive nature of the model provides a far more accessible means of interpreting and comprehending insect anatomy and neuroanatomy.	[Berry, Richard P.; Ibbotson, Michael R.] Australian Natl Univ, Sch Biol, Div Biomed Sci & Biochem, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia	Australian National University	Berry, RP (corresponding author), Australian Natl Univ, Sch Biol, Div Biomed Sci & Biochem, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia.	Michael.Ibbotson@anu.edu.au	Ibbotson, Michael R/C-9305-2009	Ibbotson, Michael R/0000-0002-3803-6653; Berry, Richard/0000-0002-7594-1433	ARC Centre of Excellence in Vision Science, Air Force Office of Scientific Research [CE0561903, FA 4869]	ARC Centre of Excellence in Vision Science, Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)Australian Research Council)	Funding: This work was funded by the ARC Centre of Excellence in Vision Science (CE0561903) together with the Air Force Office of Scientific Research (FA 4869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Frantsevich L, 2009, ARTHROPOD STRUCT DEV, V38, P16, DOI 10.1016/j.asd.2008.06.002; HOYLE G, 1966, PFLUG ARCH GES PHYS, V291, P12, DOI 10.1007/BF00362649; IBBOTSON MR, 1991, J EXP BIOL, V157, P573; Kelber C, 2006, J COMP NEUROL, V496, P395, DOI 10.1002/cne.20930; Kikinis R, 1996, IEEE T VIS COMPUT GR, V2, P232, DOI 10.1109/2945.537306; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Markl H., 1966, Zoologische Jahrbuecher (Anatomie), V83, P107; ODGAARD A, 1990, J MICROSC-OXFORD, V159, P335, DOI 10.1111/j.1365-2818.1990.tb03038.x; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Ribi W, 2008, J NEUROSCI METH, V171, P93, DOI 10.1016/j.jneumeth.2008.02.010; Schroter U, 2007, J COMP PHYSIOL A, V193, P289, DOI 10.1007/s00359-006-0182-x; SHEPHEARD P, 1973, J MORPHOL, V139, P439, DOI 10.1002/jmor.1051390406; Snodgrass R. E., 1942, SMITHSONIAN MISC COLL, V103, P1; STRAUSFELD NJ, 1987, J COMP PHYSIOL A, V160, P205, DOI 10.1007/BF00609727; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; TOGA AW, 1995, BRAIN RES BULL, V38, P77, DOI 10.1016/0361-9230(95)00074-O; Weninger WJ, 1998, ANAT EMBRYOL, V197, P341, DOI 10.1007/s004290050144	19	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10771	10.1371/journal.pone.0010771	http://dx.doi.org/10.1371/journal.pone.0010771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520729	Green Submitted, Green Published, gold			2022-12-25	WOS:000278034600005
J	Kvell, K; Varecza, Z; Bartis, D; Hesse, S; Parnell, S; Anderson, G; Jenkinson, EJ; Pongracz, JE				Kvell, Krisztian; Varecza, Zoltan; Bartis, Domokos; Hesse, Sebastian; Parnell, Sonia; Anderson, Graham; Jenkinson, Eric J.; Pongracz, Judit E.			Wnt4 and LAP2alpha as Pacemakers of Thymic Epithelial Senescence	PLOS ONE			English	Article							CELLS; GENE; ADIPOGENESIS; REGENERATION; THYMOCYTES; INVOLUTION; RECEPTORS; DISEASE; CANCER; MICE	Age-associated thymic involution has considerable physiological impact by inhibiting de novo T-cell selection. This impaired T-cell production leads to weakened immune responses. Yet the molecular mechanisms of thymic stromal adipose involution are not clear. Age-related alterations also occur in the murine thymus providing an excellent model system. In the present work structural and molecular changes of the murine thymic stroma were investigated during aging. We show that thymic epithelial senescence correlates with significant destruction of epithelial network followed by adipose involution. We also show in purified thymic epithelial cells the age-related down-regulation of Wnt4 (and subsequently FoxN1), and the prominent increase in LAP2 alpha expression. These senescence-related changes of gene expression are strikingly similar to those observed during mesenchymal to pre-adipocyte differentiation of fibroblast cells suggesting similar molecular background in epithelial cells. For molecular level proof-of-principle stable LAP2 alpha and Wnt4-over-expressing thymic epithelial cell lines were established. LAP2 alpha over-expression provoked a surge of PPAR gamma expression, a transcription factor expressed in pre-adipocytes. In contrast, additional Wnt4 decreased the mRNA level of ADRP, a target gene of PPAR gamma. Murine embryonic thymic lobes have also been transfected with LAP2 alpha- or Wnt4-encoding lentiviral vectors. As expected LAP2 alpha over-expression increased, while additional Wnt4 secretion suppressed PPAR gamma expression. Based on these pioneer experiments we propose that decreased Wnt activity and increased LAP2 alpha expression provide the molecular basis during thymic senescence. We suggest that these molecular changes trigger thymic epithelial senescence accompanied by adipose involution. This process may either occur directly where epithelium can trans-differentiate into pre-adipocytes; or indirectly where first epithelial to mesenchymal transition (EMT) occurs followed by subsequent pre-adipocyte differentiation. The latter version fits better with literature data and is supported by the observed histological and molecular level changes.	[Kvell, Krisztian; Varecza, Zoltan; Bartis, Domokos; Hesse, Sebastian; Pongracz, Judit E.] Univ Pecs, Dept Med Biotechnol, Inst Immunol & Biotechnol, Pecs, Hungary; [Parnell, Sonia; Anderson, Graham; Jenkinson, Eric J.; Pongracz, Judit E.] Univ Birmingham, Dept Anat, Inst Biomed Res, Div Immun & Infect, Birmingham, W Midlands, England	University of Pecs; University of Birmingham	Kvell, K (corresponding author), Univ Pecs, Dept Med Biotechnol, Inst Immunol & Biotechnol, Pecs, Hungary.	judit.e.pongracz@aok.pte.hu	Bartis, Domokos/C-7763-2016; Pongracz, Judit E/N-7927-2018; Pongracz, Judit E/J-7517-2019	Bartis, Domokos/0000-0003-2301-3704; Pongracz, Judit E/0000-0002-0278-5556; Pongracz, Judit E/0000-0002-0278-5556; anderson, graham/0000-0002-2917-4085; Kvell MD PhD dr. habil., Krisztian/0000-0001-8609-6274	Wellcome Trust [079415]; 'Science Please' Research Team on Innovation [SROP-4.2.2/08/1/2008-0011]; OTKA [78310]; MRC [G0401620] Funding Source: UKRI; Medical Research Council [G0401620] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); 'Science Please' Research Team on Innovation; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Research was supported by the following grants: The Wellcome Trust grant No.: 079415 (grant-holders: J.E.P., G. A. and E.J.J.), 'Science Please' Research Team on Innovation grant No.: SROP-4.2.2/08/1/2008-0011 (grant holder: J.E.P.) and OTKA (Hungarian Scientific Research Fund) type: PD (post-doctoral) grant No.: 78310 (grant-holder: K. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2001, EUR J IMMUNOL, V31, P3349, DOI 10.1002/1521-4141(200111)31:11<3349::AID-IMMU3349>3.0.CO;2-S; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; BEARDSLEY TR, 1983, P NATL ACAD SCI-BIOL, V80, P6005, DOI 10.1073/pnas.80.19.6005; Berger R, 1996, GENOME RES, V6, P361, DOI 10.1101/gr.6.5.361; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Chidgey A, 2007, SEMIN IMMUNOL, V19, P331, DOI 10.1016/j.smim.2007.10.006; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Dreger M, 1999, BIOCHEMISTRY-US, V38, P9426, DOI 10.1021/bi990645f; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grubeck-Loebenstein B, 2009, J COMP PATHOL; Gui JG, 2007, INT IMMUNOL, V19, P1201, DOI 10.1093/intimm/dxm095; HIRIPI L, TRANSGENIC RES; Hsu HC, 2003, IMMUNOL ALLERGY CLIN, V23, P65, DOI 10.1016/S0889-8561(02)00074-7; Hutchison CJ, 2001, J CELL SCI, V114, P9; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Kvell K, 2005, MOL THER, V12, P892, DOI 10.1016/j.ymthe.2005.05.010; KVELL K, TRANSGENIC RES, V19, P105; Marinova TT, 2005, GERONTOLOGY, V51, P14, DOI 10.1159/000081429; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; OKSANEN A, 1971, J PATHOL, V105, P223, DOI 10.1002/path.1711050310; Osada M, 2006, CLIN DEV IMMUNOL, V13, P299, DOI 10.1080/17402520600935097; Pongracz J, 2003, EUR J IMMUNOL, V33, P1949, DOI 10.1002/eji.200323564; Pongracz JE, 2006, EUR J IMMUNOL, V36, P2376, DOI 10.1002/eji.200535721; Ribeiro RM, 2007, IMMUNOL REV, V216, P21; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Seike Masahiro, 2009, J Nippon Med Sch, V76, P181; Torday JS, 2006, PEDIATR RES, V60, P382, DOI 10.1203/01.pdr.0000238326.42590.03	30	49	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10701	10.1371/journal.pone.0010701	http://dx.doi.org/10.1371/journal.pone.0010701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502698	gold, Green Published, Green Submitted			2022-12-25	WOS:000277776500016
J	Biagi, E; Nylund, L; Candela, M; Ostan, R; Bucci, L; Pini, E; Nikkila, J; Monti, D; Satokari, R; Franceschi, C; Brigidi, P; De Vos, W				Biagi, Elena; Nylund, Lotta; Candela, Marco; Ostan, Rita; Bucci, Laura; Pini, Elisa; Nikkila, Janne; Monti, Daniela; Satokari, Reetta; Franceschi, Claudio; Brigidi, Patrizia; De Vos, Willem			Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; REAL-TIME PCR; BUTYRATE-PRODUCING BACTERIA; FECAL MICROBIOTA; EUBACTERIUM-LIMOSUM; HUMAN FECES; HUMAN LONGEVITY; HUMAN COLON; T-CELLS; AGE	Background: Age-related physiological changes in the gastrointestinal tract, as well as modifications in lifestyle, nutritional behaviour, and functionality of the host immune system, inevitably affect the gut microbiota, resulting in a greater susceptibility to infections. Methodology/Principal Findings: By using the Human Intestinal Tract Chip (HITChip) and quantitative PCR of 16S rRNA genes of Bacteria and Archaea, we explored the age-related differences in the gut microbiota composition among young adults, elderly, and centenarians, i.e subjects who reached the extreme limits of the human lifespan, living for over 100 years. We observed that the microbial composition and diversity of the gut ecosystem of young adults and seventy-years old people is highly similar but differs significantly from that of the centenarians. After 100 years of symbiotic association with the human host, the microbiota is characterized by a rearrangement in the Firmicutes population and an enrichment in facultative anaerobes, notably pathobionts. The presence of such a compromised microbiota in the centenarians is associated with an increased inflammatory status, also known as inflammageing, as determined by a range of peripheral blood inflammatory markers. This may be explained by a remodelling of the centenarians' microbiota, with a marked decrease in Faecalibacterium prauznitzii and relatives, symbiotic species with reported anti-inflammatory properties. As signature bacteria of the long life we identified specifically Eubacterium limosum and relatives that were more than ten-fold increased in the centenarians. Conclusions/Significance: We provide evidence for the fact that the ageing process deeply affects the structure of the human gut microbiota, as well as its homeostasis with the host's immune system. Because of its crucial role in the host physiology and health status, age-related differences in the gut microbiota composition may be related to the progression of diseases and frailty in the elderly population.	[Biagi, Elena; Candela, Marco; Brigidi, Patrizia] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Nylund, Lotta; Satokari, Reetta] Univ Turku, Turku, Finland; [Nylund, Lotta; Nikkila, Janne] Univ Helsinki, Div Microbiol & Epidemiol, Dept Basic Vet Med, Helsinki, Finland; [Ostan, Rita; Bucci, Laura; Pini, Elisa; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Ostan, Rita; Bucci, Laura; Pini, Elisa; Franceschi, Claudio] Univ Bologna, CIG Interdepartmental Ctr L Galvani, Bologna, Italy; [Monti, Daniela] Univ Florence, Dept Expt Pathol, Florence, Italy; [De Vos, Willem] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands	University of Bologna; University of Turku; University of Helsinki; University of Bologna; University of Bologna; University of Florence; Wageningen University & Research	Biagi, E (corresponding author), Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy.	elena.biagi@unibo.it; elena.biagi@unibo.it	Monti, Daniela/G-9556-2012; Candela, Marco/G-5411-2012; Satokari, Reetta/C-4782-2011; Ostan, Rita/K-3074-2018; Franceschi, Claudio/L-4484-2017	Monti, Daniela/0000-0001-8651-8123; Ostan, Rita/0000-0002-0299-2811; Franceschi, Claudio/0000-0001-9841-6386; Brigidi, Patrizia/0000-0001-8375-6150; Satokari, Reetta/0000-0002-4258-3414; Nylund, Lotta/0000-0002-4765-9537				Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Alberti S, 2006, MECH AGEING DEV, V127, P560, DOI 10.1016/j.mad.2006.01.014; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Baggio G, 1998, FASEB J, V12, P433, DOI 10.1096/fasebj.12.6.433; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; BROKLEHU.JC, 1972, P ROY SOC MED, V65, P66, DOI 10.1177/003591577206500126; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2000, AGING-CLIN EXP RES, V12, P77, DOI 10.1007/BF03339894; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Guigoz Y, 2008, CURR OPIN CLIN NUTR, V11, P13, DOI 10.1097/MCO.0b013e3282f2bfdf; Hayashi H, 2003, MICROBIOL IMMUNOL, V47, P557, DOI 10.1111/j.1348-0421.2003.tb03418.x; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Hur HG, 2000, FEMS MICROBIOL LETT, V192, P21, DOI 10.1111/j.1574-6968.2000.tb09353.x; IMAHORI K, 1992, NUTR REV, V50, P351; Kanauchi O, 2006, WORLD J GASTROENTERO, V12, P1071, DOI 10.3748/wjg.v12.i7.1071; Kaufmann P, 1997, APPL ENVIRON MICROB, V63, P1268, DOI 10.1128/AEM.63.4.1268-1273.1997; Kleessen B, 1997, AM J CLIN NUTR, V65, P1397, DOI 10.1093/ajcn/65.5.1397; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Kullen MJ, 2000, J APPL MICROBIOL, V89, P511, DOI 10.1046/j.1365-2672.2000.01146.x; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007; Leps J, 2003, MULTIVARIATE ANAL EC; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; LEY R, 2006, NATURE, V444, P1023; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; MACFARLANE GT, 1989, J APPL BACTERIOL, V67, P521, DOI 10.1111/j.1365-2672.1989.tb02524.x; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nasi M, 2006, AGING CELL, V5, P167, DOI 10.1111/j.1474-9726.2006.00204.x; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Ostan R, 2008, NEUROIMMUNOMODULAT, V15, P224, DOI 10.1159/000156466; Passeri G, 2003, J CLIN ENDOCR METAB, V88, P5109, DOI 10.1210/jc.2003-030515; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Possemiers S, 2008, J NUTR, V138, P1310, DOI 10.1093/jn/138.7.1310; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; RAJILICSTOJANOV.M, 2009, ENV MICROBIOL; Recasens N, 2005, J CLIN ENDOCR METAB, V90, P112, DOI 10.1210/jc.2004-0708; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SALONEN A, 2010, J MICROBIOL METHODS; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Sansonetti PJ, 2009, CELL, V138, P416, DOI 10.1016/j.cell.2009.07.024; Satokari R., 2010, HDB PREBIOTICS PROBI, P341; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; SWIDSINSKI A, 2009, GUT; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603; Zwielehner J, 2009, EXP GERONTOL, V44, P440, DOI 10.1016/j.exger.2009.04.002	67	896	939	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10667	10.1371/journal.pone.0010667	http://dx.doi.org/10.1371/journal.pone.0010667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498852	Green Published, gold			2022-12-25	WOS:000277773700011
J	Cavalheiro, RA; Marin, RM; Rocco, SA; Cerqueira, FM; da Silva, CCC; Rittner, R; Kowaltowski, AJ; Vercesi, AE; Franchini, KG; Castilho, RF				Cavalheiro, Renata A.; Marin, Rodrigo M.; Rocco, Silvana A.; Cerqueira, Fernanda M.; Caldeira da Silva, Camille C.; Rittner, Roberto; Kowaltowski, Alicia J.; Vercesi, Anibal E.; Franchini, Kleber G.; Castilho, Roger F.			Potent Cardioprotective Effect of the 4-Anilinoquinazoline Derivative PD153035: Involvement of Mitochondrial K-ATP Channel Activation	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PERMEABILITY TRANSITION; REPERFUSION INJURY; PROTEIN-KINASE; POTASSIUM-TRANSPORT; CANCER-CHEMOTHERAPY; CARDIAC-HYPERTROPHY; POSSIBLE MECHANISM; OXIDATIVE STRESS; EGF RECEPTOR	Background: The aim of the present study was to evaluate the protective effects of the 4-anilinoquinazoline derivative PD153035 on cardiac ischemia/reperfusion and mitochondrial function. Methodology/Principal Findings: Perfused rat hearts and cardiac HL-1 cells were used to determine cardioprotective effects of PD153035. Isolated rat heart mitochondria were studied to uncover mechanisms of cardioprotection. Nanomolar doses of PD153035 strongly protect against heart and cardiomyocyte damage induced by ischemia/reperfusion and cyanide/aglycemia. PD153035 did not alter oxidative phosphorylation, nor directly prevent Ca2+ induced mitochondrial membrane permeability transition. The protective effect of PD153035 on HL-1 cells was also independent of AKT phosphorylation state. Interestingly, PD153035 activated K+ transport in isolated mitochondria, in a manner prevented by ATP and 5-hydroxydecanoate, inhibitors of mitochondrial ATP-sensitive K+ channels (mitoK(ATP)). 5-Hydroxydecanoate also inhibited the cardioprotective effect of PD153035 in cardiac HL-1 cells, demonstrating that this protection is dependent on mitoK(ATP) activation. Conclusions/Significance: We conclude that PD153035 is a potent cardioprotective compound and acts in a mechanism involving mitoK(ATP) activation.	[Cavalheiro, Renata A.; Vercesi, Anibal E.; Castilho, Roger F.] Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil; [Marin, Rodrigo M.; Rocco, Silvana A.; Franchini, Kleber G.] Univ Estadual Campinas, Fac Ciencias Med, Dept Clin Med, Campinas, SP, Brazil; [Cerqueira, Fernanda M.; Caldeira da Silva, Camille C.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Rittner, Roberto] Univ Estadual Campinas, Inst Quim, Dept Quim Organ, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Cavalheiro, RA (corresponding author), Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil.	franchin@unicamp.br; roger@fcm.unicamp.br	Vercesi, Aníbal E/C-8767-2012; Rocco, Silvana Aparecida/Q-3828-2019; Marin, Rodrigo Miguel/M-5687-2013; Castilho, Roger F/G-3906-2012; Kowaltowski, Alicia J/H-8698-2012; cerqueira, fernanda/C-8326-2014; Rocco, Silvana Aparecida/H-6300-2014	Rocco, Silvana Aparecida/0000-0003-4551-3443; Rocco, Silvana Aparecida/0000-0003-4551-3443; Vercesi, Anibal Eugenio/0000-0001-6671-7125; Rittner, Roberto/0000-0002-4715-6139; Franchini, Kleber/0000-0002-0190-6635; Castilho, Roger/0000-0003-2338-8717	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Supported by Brazilian funding agencies Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisa e Desenvolvimento (CNPq). RAC was supported by a CNPq fellowship and RMM and FMC were supported by FAPESP fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2003, CLIN CANCER RES, V9, P1579; AUCHAMPACH JA, 1992, CARDIOVASC RES, V26, P1054, DOI 10.1093/cvr/26.11.1054; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Belisle E, 2002, J BIOENERG BIOMEMBR, V34, P285, DOI 10.1023/A:1020256502583; Ciardiello F, 2000, DRUGS, V60, P25, DOI 10.2165/00003495-200060001-00003; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cohen MV, 2000, ANNU REV PHYSIOL, V62, P79, DOI 10.1146/annurev.physiol.62.1.79; Costa ADT, 2005, CIRC RES, V97, P329, DOI 10.1161/01.RES.0000178451.08719.5b; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Domingos PP, 2002, AM J PHYSIOL-HEART C, V282, pH556, DOI 10.1152/ajpheart.00534.2001; Dos Santos P, 2002, AM J PHYSIOL-HEART C, V283, pH284, DOI 10.1152/ajpheart.00034.2002; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790; Facundo HTF, 2007, FREE RADICAL BIO MED, V42, P1039, DOI 10.1016/j.freeradbiomed.2007.01.001; Facundo HTF, 2006, FREE RADICAL BIO MED, V40, P469, DOI 10.1016/j.freeradbiomed.2005.08.041; Facundo HTF, 2006, BBA-MOL BASIS DIS, V1762, P202, DOI 10.1016/j.bbadis.2005.06.003; Facundo HTF, 2005, J BIOENERG BIOMEMBR, V37, P75, DOI 10.1007/s10863-005-4130-1; Fry DW, 1999, PHARMACOL THERAPEUT, V82, P207, DOI 10.1016/S0163-7258(98)00050-3; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Garlid KD, 1997, CIRC RES, V81, P1072; Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, pH921, DOI 10.1152/ajpheart.00421.2003; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Ishida H, 2001, CIRC RES, V89, P856, DOI 10.1161/hh2201.100341; Jaburek M, 1998, J BIOL CHEM, V273, P13578; Kagiyama S, 2002, CIRCULATION, V106, P909, DOI 10.1161/01.CIR.0000030181.63741.56; KARSTEN U, 1980, EXPERIENTIA, V36, P263, DOI 10.1007/BF01953772; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Liu N, 2009, J NUCL MED, V50, P303, DOI 10.2967/jnumed.108.056556; Marczin N, 2003, ARCH BIOCHEM BIOPHYS, V420, P222, DOI 10.1016/j.abb.2003.08.037; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Minarini A, 1998, BIOORG MED CHEM LETT, V8, P1353, DOI 10.1016/S0960-894X(98)00217-0; Mironova GD, 2004, J BIOL CHEM, V279, P32562, DOI 10.1074/jbc.M401115200; Mubagwa K, 2001, CARDIOVASC RES, V52, P25, DOI 10.1016/S0008-6363(01)00358-3; Murata M, 2001, CIRC RES, V89, P891, DOI 10.1161/hh2201.100205; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nuntharatanapong N, 2005, AM J PHYSIOL-HEART C, V289, pH99, DOI 10.1152/ajpheart.00901.2004; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Prada PO, 2009, DIABETES, V58, P2910, DOI 10.2337/db08-0506; Rewcastle GW, 2000, CURR ORG CHEM, V4, P679, DOI 10.2174/1385272003376094; Rocco SA, 2004, SYNTHESIS-STUTTGART, P429, DOI 10.1055/s-2004-815949; Scarpa A, 1979, Methods Enzymol, V56, P301; Seymour EM, 2003, J SURG RES, V114, P187, DOI 10.1016/S0022-4804(03)00248-8; Spector NL, 2007, P NATL ACAD SCI USA, V104, P10607, DOI 10.1073/pnas.0701286104; Suc I, 1998, FASEB J, V12, P665, DOI 10.1096/fasebj.12.9.665; Szewczyk A, 2006, BBA-BIOENERGETICS, V1757, P715, DOI 10.1016/j.bbabio.2006.05.002; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y; Yamazaki T, 1998, CELL SIGNAL, V10, P693, DOI 10.1016/S0898-6568(98)00036-9	53	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10666	10.1371/journal.pone.0010666	http://dx.doi.org/10.1371/journal.pone.0010666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498724	Green Published, Green Submitted, gold			2022-12-25	WOS:000277773700010
J	Jeyabalan, J; Nesbit, MA; Galvanovskis, J; Callaghan, R; Rorsman, P; Thakker, RV				Jeyabalan, Jeshmi; Nesbit, M. Andrew; Galvanovskis, Juris; Callaghan, Richard; Rorsman, Patrik; Thakker, Rajesh V.			SEDLIN Forms Homodimers: Characterisation of SEDLIN Mutations and Their Interactions with Transcription Factors MBP1, PITX1 and SF1	PLOS ONE			English	Article							LINKED SPONDYLOEPIPHYSEAL DYSPLASIA; PROTEIN; GENE; LOCALIZATION; PHOSPHORYLATION; EXPRESSION; COMPLEX; TARDA; TRAPP	Background: SEDLIN, a 140 amino acid subunit of the Transport Protein Particle (TRAPP) complex, is ubiquitously expressed and interacts with the transcription factors c-myc promoter-binding protein 1 (MBP1), pituitary homeobox 1 (PITX1) and steroidogenic factor 1 (SF1). SEDLIN mutations cause X-linked spondyloepiphyseal dysplasia tarda (SEDT). Methodology/Principal Findings: We investigated the effects of 4 missense (Asp47Tyr, Ser73Leu, Phe83Ser and Val130Asp) and the most C-terminal nonsense (Gln131Stop) SEDT-associated mutations on interactions with MBP1, PITX1 and SF1 by expression in COS7 cells. Wild-type SEDLIN was present in the cytoplasm and nucleus and interacted with MBP1, PITX1 and SF1; the SEDLIN mutations did not alter these subcellular localizations or the interactions. However, SEDLIN was found to homodimerize, and the formation of dimers between wild-type and mutant SEDLIN would mask a loss in these interactions. A mammalian SEDLIN null cell-line is not available, and the interactions between SEDLIN and the transcription factors were therefore investigated in yeast, which does not endogenously express SEDLIN. This revealed that all the SEDT mutations, except Asp47Tyr, lead to a loss of interaction with MBP1, PITX1 and SF1. Three-dimensional modelling studies of SEDLIN revealed that Asp47 resides on the surface whereas all the other mutant residues lie within the hydrophobic core of the protein, and hence are likely to affect the correct folding of SEDLIN and thereby disrupt protein-protein interactions. Conclusions/Significance: Our studies demonstrate that SEDLIN is present in the nucleus, forms homodimers and that SEDT-associated mutations cause a loss of interaction with the transcription factors MBP1, PITX1 and SF1.	[Jeyabalan, Jeshmi; Nesbit, M. Andrew; Thakker, Rajesh V.] Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp,Acad Endocrine Unit, Oxford, England; [Galvanovskis, Juris; Rorsman, Patrik] Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs,Churchill Hosp, Oxford, England; [Callaghan, Richard] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford	Jeyabalan, J (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp,Acad Endocrine Unit, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Callaghan, Richard/B-7032-2012; Callaghan, Richard/ABG-1638-2020; Rorsman, Patrik/A-4331-2016	Callaghan, Richard/0000-0001-6136-3532; Callaghan, Richard/0000-0001-6136-3532; Rorsman, Patrik/0000-0001-7578-0767; Thakker, Rajesh/0000-0002-1438-3220	Oliver Bird Fund [RHE/00029/G]; Nuffield Foundation; Arthritis Research Campaign [16438]; European Community [HEALTH-F2-2008-00]; Medical Research Council; Medical Research Council [G9825289] Funding Source: researchfish; MRC [G9825289] Funding Source: UKRI	Oliver Bird Fund; Nuffield Foundation; Arthritis Research Campaign(Versus Arthritis); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Oliver Bird Fund (Studentship No. RHE/00029/G), The Nuffield Foundation (J.J.), Arthritis Research Campaign (Grant ID 16438) (M.A.N. and R. V. T.), European Community Framework 7 programme grant TREAT-OA (HEALTH-F2-2008-00) (M.A.N. and R. V. T.) and the Medical Research Council (J.J., M.A.N. and R. V. T.). J.J. was an Oliver Bird funded PhD student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa T, 1999, J BONE JOINT SURG BR, V81B, P921, DOI 10.1302/0301-620X.81B5.9492; Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Borsello T, 2007, J NEUROSCI RES, V85, P3632, DOI 10.1002/jnr.21435; Bradley KJ, 2007, ONCOGENE, V26, P1213, DOI 10.1038/sj.onc.1209893; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; CRAVCHIK A, 1993, GENE, V137, P139, DOI 10.1016/0378-1119(93)90262-2; Fan LB, 2003, FEBS LETT, V540, P77, DOI 10.1016/S0014-5793(03)00228-X; Gecz J, 2000, GENOMICS, V69, P242, DOI 10.1006/geno.2000.6326; Gecz J, 2003, GENE, V320, P137, DOI 10.1016/S0378-1119(03)00819-9; Gedeon AK, 2001, AM J HUM GENET, V68, P1386, DOI 10.1086/320592; Ghosh AK, 2003, J BIOL CHEM, V278, P24033, DOI 10.1074/jbc.M211982200; Ghosh AK, 2001, MOL CELL BIOL, V21, P655, DOI 10.1128/MCB.21.2.655-662.2001; Grunebaum E, 2001, J MED GENET, V38, P409, DOI 10.1136/jmg.38.6.409; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; IWABUCHI K, 1993, ONCOGENE, V8, P1693; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Mumm S, 2001, GENE, V273, P285, DOI 10.1016/S0378-1119(01)00571-6; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; PATI UK, 1992, GENE, V114, P285, DOI 10.1016/0378-1119(92)90589-H; Picard C, 2007, CLIN ORTHOP RELAT R, P59, DOI 10.1097/BLO0b013e3180d09d9c; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Shaw MA, 2003, CLIN GENET, V64, P235, DOI 10.1034/j.1399-0004.2003.00132.x; Takahashi T, 2002, CLIN GENET, V61, P319; Whyte MP, 1999, MEDICINE, V78, P9, DOI 10.1097/00005792-199901000-00002; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235	27	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10646	10.1371/journal.pone.0010646	http://dx.doi.org/10.1371/journal.pone.0010646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498720	Green Published, gold, Green Submitted			2022-12-25	WOS:000277771600010
J	Boominathan, L				Boominathan, Lakshmanane			The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex	PLOS ONE			English	Article							NEGATIVE REGULATOR; DICER EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; DIFFERENTIAL REGULATION; REDUCED EXPRESSION; GENE-EXPRESSION; UP-REGULATION; SELF-RENEWAL; STEM-CELLS; C-MYC	The tumor suppressors p53, p73, and p63 are known to function as transcription factors. They promote either growth arrest or apoptosis, depending upon the DNA damage. A number of microRNAs (miRNAs) have been shown to function as transcriptional targets of p53 and they appear to aid p53 in promoting growth arrest and apoptosis. However, the question of p53/p63/p73 regulating the miRNA processing complex has not been addressed in depth so far. Comparative/computational genomic analysis was performed using Target scan, Mami, and Diana software to identify miRNAs that regulate the miRNA processing complex. Here, I present evidence for the first time that the tumor suppressors p53, p63, and p73 function as both positive and negative regulators of the miRNA processing components. Curated p53-dependent miRNA expression data was used to identify p53-miRs that target the components of the miRNA-processing complex. This analysis suggests that most of the components (mRNAs' 3'UTR) of the miRNA processing complex are targeted by p53-miRs. Remarkably, this data revealed the conserved nature of p53-miRs in targeting a number of components of the miRNA processing complex. p53/p73/p63 appears to regulate the major components of the miRNA processing, such as Drosha-DGCR8, Dicer-TRBP2, and Argonaute proteins. In particular, p53/p73/p63 appears to regulate the processing of miRNAs, such as let-7, miR-200c, miR-143, miR-107, miR-16, miR-145, miR-134, miR-449a, miR-503, and miR-21. Interestingly, there seems to be a phenotypic similarity between p63(-/-) and dicer(-/-) mice, suggesting that p63 and dicer could regulate each other. In addition, p63, p73, and the DGCR8 proteins contain a conserved interaction domain. Further, promoters of a number of components of the miRNA processing machinery, including dicer and P2P-R, contain p53-REs, suggesting that they could be direct transcriptional targets of p63/p73/p53. Together, this study provides mechanistic insights into how p53, p63, and p73 regulate the components of the miRNA processing; and how p53, TA-p63, and TA-p73 regulated miRNAs inhibit tumorigenesis, EMT, metastasis, and cancer stem cell proliferation.	Genome Discovery, Murungapakkam, India		Boominathan, L (corresponding author), Genome Discovery, Murungapakkam, India.	lakshmanan.boominathan@gmail.com	Lakshamanane, Boominathan/AAW-5331-2020; Xie, Huangming/B-2260-2012					Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; BOOMINATHAN L, 2010, NATURE PRECEDINGS; BOOMINATHAN L, 2009, NATURE PRECEDINGS; Boominathan L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-27; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cui XS, 2007, BIOCHEM BIOPH RES CO, V352, P231, DOI 10.1016/j.bbrc.2006.11.009; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Fontemaggi G, 2005, ONCOGENE, V24, P7273, DOI 10.1038/sj.onc.1208891; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Muller S, 2007, IMMUNITY, V27, P1, DOI 10.1016/j.immuni.2007.07.003; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Salzman DW, 2007, J BIOL CHEM, V282, P32773, DOI 10.1074/jbc.M705054200; Scheel AHJ, 2009, CELL CYCLE, V8, P1426, DOI 10.4161/cc.8.9.8324; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sinha AU, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-88; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tang KF, 2008, J CELL BIOL, V182, P233, DOI 10.1083/jcb.200801169; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Ting AH, 2008, CANCER RES, V68, P2570, DOI 10.1158/0008-5472.CAN-07-6405; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Waltermann A, 2003, ONCOGENE, V22, P5686, DOI 10.1038/sj.onc.1206859; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Xiong SB, 2007, CIRCULATION, V115, P2925, DOI 10.1161/CIRCULATIONAHA.107.689901; YAMAGATA K, 2009, CELL, V36, P340; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zucchi I, 2008, P NATL ACAD SCI USA, V105, P16940, DOI 10.1073/pnas.0808978105	82	149	164	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10615	10.1371/journal.pone.0010615	http://dx.doi.org/10.1371/journal.pone.0010615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485546	Green Published, gold			2022-12-25	WOS:000277563400018
J	Tennie, C; Call, J; Tomasello, M				Tennie, Claudio; Call, Josep; Tomasello, Michael			Evidence for Emulation in Chimpanzees in Social Settings Using the Floating Peanut Task	PLOS ONE			English	Article							NUT-CRACKING BEHAVIOR; PAN-TROGLODYTES; TOOL USE; IMITATION; EVOLUTION; APES	Background: It is still unclear which observational learning mechanisms underlie the transmission of difficult problem-solving skills in chimpanzees. In particular, two different mechanisms have been proposed: imitation and emulation. Previous studies have largely failed to control for social factors when these mechanisms were targeted. Methods: In an attempt to resolve the existing discrepancies, we adopted the 'floating peanut task', in which subjects need to spit water into a tube until it is sufficiently full for floating peanuts to be grasped. In a previous study only a few chimpanzees were able to invent the necessary solution (and they either did so in their first trials or never). Here we compared success levels in baseline tests with two experimental conditions that followed: 1) A full model condition to test whether social demonstrations would be effective, and 2) A social emulation control condition, in which a human experimenter poured water from a bottle into the tube, to test whether results information alone (present in both experimental conditions) would also induce successes. Crucially, we controlled for social factors in both experimental conditions. Both types of demonstrations significantly increased successful spitting, with no differences between demonstration types. We also found that younger subjects were more likely to succeed than older ones. Our analysis showed that mere order effects could not explain our results. Conclusion: The full demonstration condition (which potentially offers additional information to observers, in the form of actions), induced no more successes than the emulation condition. Hence, emulation learning could explain the success in both conditions. This finding has broad implications for the interpretation of chimpanzee traditions, for which emulation learning may perhaps suffice.	[Tennie, Claudio; Call, Josep; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Max Planck Society	Tennie, C (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	tennie@eva.mpg.de		Tennie, Claudio/0000-0002-5302-4925; Call Balaguer, Josep/0000-0002-8597-8336				Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; Boyd R., 2005, ORIGIN EVOLUTION CUL; Caldwell CA, 2008, PHILOS T R SOC B, V363, P3529, DOI 10.1098/rstb.2008.0133; Call J, 2005, ANIM COGN, V8, P151, DOI 10.1007/s10071-004-0237-8; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Call J, 2002, FROM ANIM ANIMAT, P211; CALL J, 2005, INTERACTION STUDIES, V6, P413; Carpenter M, 2002, DEVELOPMENTAL SCI, V5, P22, DOI 10.1111/1467-7687.00199; Csibra G., 2006, ROOTS HUMAN SOCIALIT, P229; Custance D, 1999, J COMP PSYCHOL, V113, P13, DOI 10.1037/0735-7036.113.1.13; Dai B., 2008, IME4 LINEAR MIXED EF; De Waal Frans, 2009, QUESTION ANIMAL CULT, P19; DEWAAL FBM, APE SUSHI MASTER CUL, P448; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Dindo M, 2009, AM J PRIMATOL, V71, P419, DOI 10.1002/ajp.20669; FARAWAY JJ, EXTENDING LINEAR MOD; Galef BG, 2009, QUESTION ANIMAL CULT, P222; HANUS D, COMPARING PERF UNPUB; Hopper LM, 2008, P ROY SOC B-BIOL SCI, V275, P835, DOI 10.1098/rspb.2007.1542; Hopper LM, 2007, ANIM BEHAV, V73, P1021, DOI 10.1016/j.anbehav.2006.07.016; Horne PJ, 2009, BRIT J DEV PSYCHOL, V27, P269, DOI 10.1348/026151008X297126; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Huang CT, 2005, J EXP CHILD PSYCHOL, V92, P276, DOI 10.1016/j.jecp.2005.06.003; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; Huffman MA, 2004, PRIMATES, V45, P113, DOI 10.1007/s10329-003-0065-5; Lonsdorf EV, 2009, ANIM BEHAV, V77, P1119, DOI 10.1016/j.anbehav.2009.01.020; Marshall-Pescini S, 2008, J COMP PSYCHOL, V122, P186, DOI 10.1037/0735-7036.122.2.186; Mendes N, 2007, BIOL LETTERS, V3, P453, DOI 10.1098/rsbl.2007.0198; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; R Core Team, 2022, R LANG ENV STAT COMP; Spence KW, 1937, PSYCHOL BULL, V34, P806, DOI 10.1037/h0061498; Stoinski TS, 2001, J COMP PSYCHOL, V115, P272, DOI 10.1037//0735-7036.115.3.272; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tennie C, 2006, ETHOLOGY, V112, P1159, DOI 10.1111/j.1439-0310.2006.01269.x; Tennie C, 2009, ANIM SCI ISSUES PROF, P95; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Tennie C, 2009, ANIM BEHAV, V77, P1491, DOI 10.1016/j.anbehav.2009.03.008; Thorpe, 1963, LEARNING INSTINCT AN; Tomasello M., 1987, HUM EVOL, V2, P175, DOI DOI 10.1007/BF02436405; Tomasello M., 1997, EVOLUTION COMMUNICAT, V1, P223, DOI [DOI 10.1075/EOC.1.2.04TOM, 10.1075/eoc.1.2.04tom]; Tomasello M., 2009, CULTURAL ORIGINS HUM; TOMASELLO M, 1990, ANGUAGE INTELLIGENCE, P274; Tomasello Michael, 1996, P319, DOI 10.1016/B978-012273965-1/50016-9; VISALBERGHI E, 1987, FOLIA PRIMATOL, V49, P168, DOI 10.1159/000156320; Voelkl B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000611; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 1998, J COMP PSYCHOL, V112, P270, DOI 10.1037/0735-7036.112.3.270; Whiten A, 1996, J COMP PSYCHOL, V110, P3, DOI 10.1037/0735-7036.110.1.3; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Zentall TR, 2004, LEARN BEHAV, V32, P15, DOI 10.3758/BF03196003	53	64	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10544	10.1371/journal.pone.0010544	http://dx.doi.org/10.1371/journal.pone.0010544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485684	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563400002
J	Xia, A; Sharakhova, MV; Leman, SC; Tu, ZJ; Bailey, JA; Smith, CD; Sharakhov, IV				Xia, Ai; Sharakhova, Maria V.; Leman, Scotland C.; Tu, Zhijian; Bailey, Jeffrey A.; Smith, Christopher D.; Sharakhov, Igor V.			Genome Landscape and Evolutionary Plasticity of Chromosomes in Malaria Mosquitoes	PLOS ONE			English	Article							VECTOR ANOPHELES-FUNESTUS; TRANSPOSABLE ELEMENT; DROSOPHILA-MELANOGASTER; SEGMENTAL DUPLICATIONS; GAMBIAE COMPLEX; SPECIES COMPLEX; NUCLEAR LAMINS; GENE ONTOLOGY; INVERSION 2LA; SPECIATION	Background: Nonrandom distribution of rearrangements is a common feature of eukaryotic chromosomes that is not well understood in terms of genome organization and evolution. In the major African malaria vector Anopheles gambiae, polymorphic inversions are highly nonuniformly distributed among five chromosomal arms and are associated with epidemiologically important adaptations. However, it is not clear whether the genomic content of the chromosomal arms is associated with inversion polymorphism and fixation rates. Methodology/Principal Findings: To better understand the evolutionary dynamics of chromosomal inversions, we created a physical map for an Asian malaria mosquito, Anopheles stephensi, and compared it with the genome of An. gambiae. We also developed and deployed novel Bayesian statistical models to analyze genome landscapes in individual chromosomal arms An. gambiae. Here, we demonstrate that, despite the paucity of inversion polymorphisms on the X chromosome, this chromosome has the fastest rate of inversion fixation and the highest density of transposable elements, simple DNA repeats, and GC content. The highly polymorphic and rapidly evolving autosomal 2R arm had overrepresentation of genes involved in cellular response to stress supporting the role of natural selection in maintaining adaptive polymorphic inversions. In addition, the 2R arm had the highest density of regions involved in segmental duplications that clustered in the breakpoint-rich zone of the arm. In contrast, the slower evolving 2L, 3R, and 3L, arms were enriched with matrix-attachment regions that potentially contribute to chromosome stability in the cell nucleus. Conclusions/Significance: These results highlight fundamental differences in evolutionary dynamics of the sex chromosome and autosomes and revealed the strong association between characteristics of the genome landscape and rates of chromosomal evolution. We conclude that a unique combination of various classes of genes and repetitive DNA in each arm, rather than a single type of repetitive element, is likely responsible for arm-specific rates of rearrangements.	[Xia, Ai; Sharakhova, Maria V.; Sharakhov, Igor V.] Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA; [Leman, Scotland C.] Virginia Tech, Dept Stat, Blacksburg, VA USA; [Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Div Transfus Med, Dept Med, Worcester, MA 01605 USA; [Smith, Christopher D.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Smith, Christopher D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; California State University System; San Francisco State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Xia, A (corresponding author), Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA.	igor@vt.edu	Sharakhov, Igor/B-1972-2008	Sharakhov, Igor/0000-0003-0752-3747	National Institutes of Health [1R21AI081023-01, 5R01HG000747-14]; Virginia Tech; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tech; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 1R21AI081023-01 and startup funds from Virginia Tech ( to I.V.S) and NIH 5R01HG000747-14 (to C.D.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulard S, 2004, HEREDITY, V92, P151, DOI 10.1038/sj.hdy.6800375; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Baricheva EA, 1996, GENE, V171, P171, DOI 10.1016/0378-1119(96)00002-9; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Caceres M, 1997, EVOLUTION, V51, P1149, DOI 10.1111/j.1558-5646.1997.tb03962.x; Cassone BJ, 2008, MOL ECOL, V17, P2491, DOI 10.1111/j.1365-294X.2008.03774.x; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1973, Parassitologia (Rome), V15, P129; Cornel AJ, 2000, J HERED, V91, P364, DOI 10.1093/jhered/91.5.364; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Costantini C., 1999, Parassitologia (Rome), V41, P595; Coulibaly MB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000849; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; DELGADO CLR, 2009, CHROMOSOME RES; DEVI KG, 1992, J CYTOL GENET, V27, P153; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Fisher AM, 2005, GENE CHROMOSOME CANC, V43, P383, DOI 10.1002/gcc.20196; Folle GA, 2008, MUTAT RES-REV MUTAT, V658, P172, DOI 10.1016/j.mrrev.2007.08.005; Fontanillas P, 2007, PLOS GENET, V3, P2256, DOI 10.1371/journal.pgen.0030210; Frisch M, 2002, GENOME RES, V12, P349, DOI 10.1101/gr.206602.ArticlepublishedonlinebeforeprintinJanuary2002; Goidts V, 2004, HUM GENET, V115, P116, DOI 10.1007/s00439-004-1120-z; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Gonzalez J, 2002, GENETICS, V161, P1137; Gordon L, 2007, GENOME RES, V17, P1603, DOI 10.1101/gr.6775107; Gray EM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-215; GREEN CA, 1980, GENETICA, V51, P187, DOI 10.1007/BF00121610; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; KITZMILLER J B, 1977, Mosquito Systematics, V9, P112; Krimbas Costas B., 1992, P1; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lobachev KS, 2007, FRONT BIOSCI-LANDMRK, V12, P4208, DOI 10.2741/2381; LYTTLE TW, 1992, GENETICA, V86, P113, DOI 10.1007/BF00133715; Machado CA, 2007, GENETICS, V175, P1289, DOI 10.1534/genetics.106.064758; MAHMOOD F, 1984, CAN J GENET CYTOL, V26, P538, DOI 10.1139/g84-086; Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Mathiopoulos KD, 1998, P NATL ACAD SCI USA, V95, P12444, DOI 10.1073/pnas.95.21.12444; Mathiopoulos KD, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P119; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Pombi M, 2008, BMC EVOL BIOL, V8, P309, DOI DOI 10.1186/1471-2148-8-309; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Sharakhov I, 2004, J HERED, V95, P29, DOI 10.1093/jhered/esh011; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Sharakhova MV, 2006, J MED ENTOMOL, V43, P861, DOI 10.1603/0022-2585(2006)43[861:ASCPFT]2.0.CO;2; Slotman M, 2005, EVOLUTION, V59, P1016, DOI 10.1111/j.0014-3820.2005.tb01040.x; Slotman M, 2004, GENETICS, V167, P275, DOI 10.1534/genetics.167.1.275; Subbarao Sarala K., 1996, Proceedings of the National Academy of Sciences India Section B (Biological Sciences), V66, P51; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	69	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10592	10.1371/journal.pone.0010592	http://dx.doi.org/10.1371/journal.pone.0010592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485676	gold, Green Submitted, Green Published			2022-12-25	WOS:000277563400006
J	Ji, JB; Braam, J				Ji, Jiabing; Braam, Janet			Restriction Site Extension PCR: A Novel Method for High-Throughput Characterization of Tagged DNA Fragments and Genome Walking	PLOS ONE			English	Article							LIGATION-MEDIATED PCR; POLYMERASE CHAIN-REACTION; FLANKING DNA; T-DNA; ARABIDOPSIS; AMPLIFICATION; SEQUENCES; INSERTION; CLONING	Background: Insertion mutant isolation and characterization are extremely valuable for linking genes to physiological function. Once an insertion mutant phenotype is identified, the challenge is to isolate the responsible gene. Multiple strategies have been employed to isolate unknown genomic DNA that flanks mutagenic insertions, however, all these methods suffer from limitations due to inefficient ligation steps, inclusion of restriction sites within the target DNA, and nonspecific product generation. These limitations become close to insurmountable when the goal is to identify insertion sites in a high throughput manner. Methodology/Principal Findings: We designed a novel strategy called Restriction Site Extension PCR (RSE-PCR) to efficiently conduct large-scale isolation of unknown genomic DNA fragments linked to DNA insertions. The strategy is a modified adaptor-mediated PCR without ligation. An adapter, with complementarity to the 3' overhang of the endonuclease (KpnI, NsiI, PstI, or SacI) restricted DNA fragments, extends the 3' end of the DNA fragments in the first cycle of the primary RSE-PCR. During subsequent PCR cycles and a second semi-nested PCR (secondary RSE-PCR), touchdown and two-step PCR are combined to increase the amplification specificity of target fragments. The efficiency and specificity was demonstrated in our characterization of 37 tex mutants of Arabidopsis. All the steps of RSE-PCR can be executed in a 96 well PCR plate. Finally, RSE-PCR serves as a successful alternative to Genome Walker as demonstrated by gene isolation from maize, a plant with a more complex genome than Arabidopsis. Conclusions/Significance: RSE-PCR has high potential application in identifying tagged (T-DNA or transposon) sequence or walking from known DNA toward unknown regions in large-genome plants, with likely application in other organisms as well.	[Ji, Jiabing; Braam, Janet] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University	Ji, JB (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	ji6@purdue.edu; braam@rice.edu	Braam, Janet/B-3549-2009		National Science Foundation [0313432, MCB 0817976]; Div Of Molecular and Cellular Bioscience [0817976] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by National Science Foundation grants # 0313432 and MCB 0817976 to Janet Braam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 1991, PCR Methods Appl, V1, P39; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P6812, DOI 10.1073/pnas.81.21.6812; Dai SM, 2000, NAT BIOTECHNOL, V18, P1108, DOI 10.1038/80323; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; Hui EKW, 1998, CELL MOL LIFE SCI, V54, P1403, DOI 10.1007/s000180050262; JONES DH, 1992, NUCLEIC ACIDS RES, V20, P595, DOI 10.1093/nar/20.3.595; Koiwa H, 2006, J EXP BOT, V57, P1119, DOI 10.1093/jxb/erj093; Krysan Patrick J., 2002, OMICS A Journal of Integrative Biology, V6, P163, DOI 10.1089/153623102760092760; Levano-Garcia J, 2005, BIOTECHNIQUES, V38, P225, DOI 10.2144/05382ST03; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Nardmann J, 2004, DEVELOPMENT, V131, P2827, DOI 10.1242/dev.01164; OCHMAN H, 1988, GENETICS, V120, P621; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; RICH JJ, 1990, NUCLEIC ACIDS RES, V18, P6673, DOI 10.1093/nar/18.22.6673; RILEY J, 1990, NUCLEIC ACIDS RES, V19, P5395; ROSENTHAL A, 1990, NUCLEIC ACIDS RES, V18, P3095, DOI 10.1093/nar/18.10.3095; SILVER J, 1989, J VIROL, V63, P1924, DOI 10.1128/JVI.63.5.1924-1928.1989; Spertini D, 1999, BIOTECHNIQUES, V27, P308, DOI 10.2144/99272st01; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; UPCROFT P, 1993, NUCLEIC ACIDS RES, V21, P4854, DOI 10.1093/nar/21.20.4854; WARSHAWSKY D, 1994, BIOTECHNIQUES, V16, P792; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; ZAMBRYSKI P, 1988, ANNU REV GENET, V22, P1, DOI 10.1146/annurev.ge.22.120188.000245	26	32	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10577	10.1371/journal.pone.0010577	http://dx.doi.org/10.1371/journal.pone.0010577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485508	Green Published, gold			2022-12-25	WOS:000277563200012
J	Lee, J; Jeong, Y; Jeong, S; Rhee, K				Lee, Jungmin; Jeong, Yeontae; Jeong, Saimi; Rhee, Kunsoo			Centrobin/NIP2 Is a Microtubule Stabilizer Whose Activity Is Enhanced by PLK1 Phosphorylation during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; POLO-LIKE KINASE-1; PROTEIN-KINASES; SUBSTRATE; NEK2; DYNAMICS; MAP4; POLYMERIZATION; ROLES; NIP2/CENTROBIN	Centrobin/NIP2 is a centrosomal protein that is required for centrosome duplication. It is also critical for microtubule organization in both interphase and mitotic cells. In the present study, we observed that centrobin is phosphorylated in a cell cycle stage-specific manner, reaching its maximum at M phase. PLK1 is a kinase that is responsible for M phase-specific phosphorylation of centrobin. The microtubule forming activity of centrobin was enhanced by PLK1 phosphorylation. Furthermore, mitotic spindles were not assembled properly with the phospho-resistant mutant of centrobin. Based on these results, we propose that centrobin functions as a microtubule stabilizing factor and PLK1 enhances centrobin activity for proper spindle formation during mitosis.	[Lee, Jungmin; Jeong, Yeontae; Jeong, Saimi; Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul 151747, South Korea	Seoul National University (SNU)	Rhee, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 151747, South Korea.	rheek@snu.ac.kr			BioImaging Research Center at Gwangju Institute of Science and Technology [R01-2007-000-20116-0]; Science Research Center Program [R11-2005-009-03005-0]; Brain Korea 21 Project	BioImaging Research Center at Gwangju Institute of Science and Technology; Science Research Center Program; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported in part by grants from the BioImaging Research Center at Gwangju Institute of Science and Technology, Basic Research Program Grant R01-2007-000-20116-0, and Science Research Center Program Grant R11-2005-009-03005-0.; Supported by the second stage of the Brain Korea 21 Project in 2007.	Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bondallaz P, 2006, CELL MOTIL CYTOSKEL, V63, P681, DOI 10.1002/cm.20154; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Cassey P, 1999, ENVIRONMETRICS, V10, P261, DOI 10.1002/(SICI)1099-095X(199905/06)10:3<261::AID-ENV351>3.0.CO;2-O; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kitazawa H, 2000, CELL STRUCT FUNCT, V25, P33, DOI 10.1247/csf.25.33; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee J, 2009, MOL CELLS, V28, P31, DOI 10.1007/s10059-009-0097-9; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Mayor T, 2002, J CELL SCI, V115, P3275; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Nadano D, 2002, BIOCHEM J, V364, P669, DOI 10.1042/BJ20011836; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Sonn S, 2009, MOL REPROD DEV, V76, P587, DOI 10.1002/mrd.20990; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yoo JC, 2004, EXP CELL RES, V292, P393, DOI 10.1016/j.yexcr.2003.09.025; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	37	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25476	25484		10.1074/jbc.M109.099127	http://dx.doi.org/10.1074/jbc.M109.099127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20511645	Green Published, hybrid			2022-12-25	WOS:000280682400041
J	Ochiai, A; Yamasaki, M; Mikami, B; Hashimoto, W; Murata, K				Ochiai, Akihito; Yamasaki, Masayuki; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Crystal Structure of Exotype Alginate Lyase Atu3025 from Agrobacterium tumefaciens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMONIAE HYALURONATE LYASE; PECTATE LYASE; SUBSTRATE RECOGNITION; MOLECULAR-IDENTIFICATION; ERWINIA-CHRYSANTHEMI; OLIGOALGINATE LYASE; STRAIN C58; COMPLEX; MECHANISM; DISACCHARIDE	Alginate, a major component of the cell wall matrix in brown seaweeds, is degraded by alginate lyases through a beta-elimination reaction. Almost all alginate lyases act endolytically on substrate, thereby yielding unsaturated oligouronic acids having 4-deoxy-L-erythro-hex-4-enepyranosyluronic acid at the nonreducing end. In contrast, Agrobacterium tumefaciens alginate lyase Atu3025, a member of polysaccharide lyase family 15, acts on alginate polysaccharides and oligosaccharides exolytically and releases unsaturated monosaccharides from the substrate terminal. The crystal structures of Atu3025 and its inactive mutant in complex with alginate trisaccharide (H531A/Delta GGG) were determined at 2.10- and 2.99-angstrom resolutions with final R-factors of 18.3 and 19.9%, respectively, by x-ray crystallography. The enzyme is comprised of an alpha/alpha-barrel + anti-parallel beta-sheet as a basic scaffold, and its structural fold has not been seen in alginate lyases analyzed thus far. The structural analysis of H531A/Delta GGG and subsequent site-directed mutagenesis studies proposed the enzyme reaction mechanism, with His(311) and Tyr(365) as the catalytic base and acid, respectively. Two structural determinants, i.e. a short alpha-helix in the central alpha/alpha-barrel domain and a conformational change at the interface between the central and C-terminal domains, are essential for the exolytic mode of action. This is, to our knowledge, the first report on the structure of the family 15 enzyme.	[Murata, Kousaku] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Yamasaki, Masayuki; Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan	This work was supported in part by Grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.), the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (to A. O.) and the program (to K. M.) for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan.	Abbott DW, 2007, J BIOL CHEM, V282, P35328, DOI 10.1074/jbc.M705511200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS AD, 1990, J BACTERIOL, V172, P6950, DOI 10.1128/jb.172.12.6950-6958.1990; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Creze C, 2008, J BIOL CHEM, V283, P18260, DOI 10.1074/jbc.M709931200; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Doublie S, 1992, CRYSTALLIZATION NUCL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09; Han YH, 2009, J BIOL CHEM, V284, P34019, DOI 10.1074/jbc.M109.025338; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kluskens LD, 2003, BIOCHEM J, V370, P651, DOI 10.1042/BJ20021595; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINKER A, 1956, J BIOL CHEM, V219, P13; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Maruyama Y, 2007, BIOCHEMISTRY-US, V46, P781, DOI 10.1021/bi0619775; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; McDonough MA, 2004, FEBS LETT, V565, P188, DOI 10.1016/j.febslet.2004.03.094; Mishra P, 2009, FEBS J, V276, P3392, DOI 10.1111/j.1742-4658.2009.07065.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ochiai A, 2006, ACTA CRYSTALLOGR F, V62, P486, DOI 10.1107/S1744309106014333; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; Ochiai A, 2006, RES MICROBIOL, V157, P642, DOI 10.1016/j.resmic.2006.02.006; Ochiai A, 2009, J BIOL CHEM, V284, P10181, DOI 10.1074/jbc.M807799200; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Rigden DJ, 2003, J BIOL CHEM, V278, P50596, DOI 10.1074/jbc.M307596200; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Suda K, 1999, FEMS MICROBIOL LETT, V180, P45, DOI 10.1016/S0378-1097(99)00459-0; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; YOON HJ, 2010, PROTEIN EXPRES PURIF, V19, P84	50	72	76	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24519	24528		10.1074/jbc.M110.125450	http://dx.doi.org/10.1074/jbc.M110.125450			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507980	hybrid, Green Published			2022-12-25	WOS:000280542100024
J	Okada, S; Muto, A; Ogawa, E; Nakanome, A; Katoh, Y; Ikawa, S; Aiba, S; Igarashi, K; Okuyama, R				Okada, Shuko; Muto, Akihiko; Ogawa, Eisaku; Nakanome, Ayako; Katoh, Yasutake; Ikawa, Shuntaro; Aiba, Setsuya; Igarashi, Kazuhiko; Okuyama, Ryuhei			Bach1-dependent and -independent Regulation of Heme Oxygenase-1 in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION REPRESSOR BACH1; OXIDATIVE STRESS; GENETIC ABLATION; NUCLEAR EXPORT; FACTOR BLIMP-1; SKIN DISEASES; STEM-CELLS; DIFFERENTIATION; EXPRESSION; PSORIASIS	Bach1 is a member of the basic leucine zipper transcription factor family, and the Bach1/small Maf heterodimer specifically represses transcriptional activity directed by the Maf recognition element (MARE). Because Bach1 is a repressor of the oxidative stress response, we examined the function(s) of Bach1 in keratinocytes subjected to oxidative stress. Oxidative stress induced by H2O2 led to an increase in MARE activity and expression of heme oxygenase-1 (HO-1), an inducible antioxidant defense enzyme. Bach1 depletion by small interfering RNAs or by deletion of Bach1 enhanced HO-1 expression in the absence of H2O2, indicating that Bach1 is a critical repressor of HO-1 in keratinocytes. Although Bach1-deficient or -reduced keratinocytes expressed higher levels of HO-1 than control cells in response to H2O2, Bach1 down-regulation did not attenuate the production of reactive oxygen species by H2O2. In contrast, Bach1 overexpression abolished HO-1 induction by H2O2, which led to increased reactive oxygen species accumulation. HO-1 was induced during keratinocyte differentiation, but MARE activity did not change during differentiation. Furthermore, Bach1 overexpression did not inhibit differentiation-associated induction of HO-1 expression, suggesting that HO-1 induction in differentiation is independent of Bach1. Thus, in response to oxidative stress, Bach1 regulates the oxidation state through the negative control of HO-1 expression prior to terminal keratinocyte differentiation. However, Bach1-mediated repression is negated during keratinocyte differentiation.	[Aiba, Setsuya; Okuyama, Ryuhei] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi 9808574, Japan; [Muto, Akihiko; Nakanome, Ayako; Katoh, Yasutake; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808574, Japan; [Ikawa, Shuntaro] Tohoku Univ, Ikawa Grp, Interdisciplinary Res Ctr, Sendai, Miyagi 9808578, Japan; [Okuyama, Ryuhei] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 3908621, Japan	Tohoku University; Tohoku University; Tohoku University; Shinshu University	Okuyama, R (corresponding author), 3-1-1 Asahi, Nagano 3908621, Japan.	rokuyama@shinshu-u.ac.jp	井川, 俊太郎/L-5911-2015	Igarashi, Kazuhiko/0000-0002-2470-2475	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government.	Alam J, 2000, J BIOL CHEM, V275, P27694; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Briganti S, 2003, J EUR ACAD DERMATOL, V17, P663, DOI 10.1046/j.1468-3083.2003.00751.x; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kawachi Y, 2008, J INVEST DERMATOL, V128, P1773, DOI 10.1038/sj.jid.5701245; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Ma LJ, 2009, ARCH DERMATOL RES, V301, P459, DOI 10.1007/s00403-009-0956-4; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Motohashi H, 2007, CANCER SCI, V98, P135, DOI 10.1111/j.1349-7006.2006.00358.x; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Numata I, 2009, J INVEST DERMATOL, V129, P2594, DOI 10.1038/jid.2009.119; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Odaka Y, 2000, BIOCHEM PHARMACOL, V59, P871, DOI 10.1016/S0006-2952(99)00386-X; Ogawa E, 2008, J BIOL CHEM, V283, P34241, DOI 10.1074/jbc.M804101200; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Omura S, 2005, GENES CELLS, V10, P277, DOI 10.1111/j.1365-2443.2005.00832.x; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Shibahara S, 2003, TOHOKU J EXP MED, V200, P167, DOI 10.1620/tjem.200.167; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Takahashi T, 2007, MINI-REV MED CHEM, V7, P745; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; Wagener FADTG, 2003, BLOOD, V102, P521, DOI 10.1182/blood-2002-07-2248; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wojas-Pelc A, 2007, INT J EXP PATHOL, V88, P95, DOI 10.1111/j.1365-2613.2006.00505.x; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zhong JL, 2010, FREE RADICAL BIO MED, V48, P196, DOI 10.1016/j.freeradbiomed.2009.10.037	50	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23581	23589		10.1074/jbc.M109.068197	http://dx.doi.org/10.1074/jbc.M109.068197			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501657	hybrid, Green Published			2022-12-25	WOS:000280291400007
J	Ranguelova, K; Chatterjee, S; Ehrenshaft, M; Ramirez, DC; Summers, FA; Kadiiska, MB; Mason, RP				Ranguelova, Kalina; Chatterjee, Saurabh; Ehrenshaft, Marilyn; Ramirez, Dario C.; Summers, Fiona A.; Kadiiska, Maria B.; Mason, Ronald P.			Protein Radical Formation Resulting from Eosinophil Peroxidase-catalyzed Oxidation of Sulfite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOPEROXIDASE COMPOUND-I; HYDROGEN-PEROXIDE; HORSERADISH-PEROXIDASE; SULFUR-DIOXIDE; MOLYBDENUM COFACTOR; THYROID PEROXIDASE; SO5-RADICALS; OXIDASE; THIOCYANATE; ANION	Eosinophil peroxidase (EPO) is an abundant heme protein in eosinophils that catalyzes the formation of cytotoxic oxidants implicated in asthma, allergic inflammatory disorders, and cancer. It is known that some proteins with peroxidase activity (horseradish peroxidase and prostaglandin hydroperoxidase) can catalyze oxidation of bisulfite (hydrated sulfur dioxide), leading to the formation of sulfur trioxide anion radical ((SO3-)-S-center dot). This free radical further reacts with oxygen to form peroxymonosulfate anion radical ((O3SOO center dot)-O-center dot) and the very reactive sulfate anion radical (SO4(sic)), which is nearly as strong an oxidant as the hydroxyl radical. However, the ability of EPO to generate reactive sulfur radicals has not yet been reported. Here we demonstrate that eosinophil peroxidase/H2O2 is able to oxidize bisulfite, ultimately forming the sulfate anion radical (SO4(sic)), and that these reactive intermediates can oxidize target proteins to protein radicals, thereby initiating protein oxidation. We used immuno-spin trapping and confocal microscopy to study protein oxidation by EPO/H2O2 in the presence of bisulfite in a pure enzymatic system and in human promyelocytic leukemia HL-60 clone 15 cells, maturated to eosinophils. Polyclonal antiserum raised against the spin trap 5,5dimethyl- 1-pyrroline N-oxide (DMPO) detected the presence of DMPO covalently attached to the proteins resulting from the DMPO trapping of protein free radicals. We found that sulfite oxidation mediated by EPO/H2O2 induced the formation of radical-derived DMPO spin-trapped human serum albumin and, to a lesser extent, of DMPO-EPO. These studies suggest that EPO-dependent oxidative damage may play a role in tissue injury in bisulfite-exacerbated eosinophilic inflammatory disorders.	[Ranguelova, Kalina; Kadiiska, Maria B.; Mason, Ronald P.] NIEHS, Pharmacol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Ramirez, Dario C.] Oklahoma Med Res Fdn, Free Radical Biol & Aging Res Program, Oklahoma City, OK 73104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Oklahoma Medical Research Foundation	Ranguelova, K (corresponding author), NIEHS, Pharmacol Lab, NIH, MD F0-02,POB 12233, Res Triangle Pk, NC 27709 USA.	RanguelovaK@niehs.nih.gov	Mason, Ronald P/G-5967-2019; Kadiiska, Maria B./AAC-9981-2019; RAMIREZ, DARIO C/K-3312-2013	Mason, Ronald P/0000-0002-1859-9109; RAMIREZ, DARIO C/0000-0001-6725-3326	National Institutes of Health, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050117, ZIAES050139] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIEHS.	ACOSTA R, 1989, ANN ALLERGY, V62, P402; AGOSTI JM, 1987, J ALLERGY CLIN IMMUN, V79, P496, DOI 10.1016/0091-6749(87)90368-X; ARAISO T, 1976, BIOCHEMISTRY-US, V15, P3059, DOI 10.1021/bi00659a019; Arlandson M, 2001, J BIOL CHEM, V276, P215, DOI 10.1074/jbc.M004881200; Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P177, DOI 10.1016/0167-4838(84)90125-0; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; COHEN HJ, 1973, P NATL ACAD SCI USA, V70, P3655, DOI 10.1073/pnas.70.12.3655; COHEN HJ, 1971, J BIOL CHEM, V246, P359; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Detweiler CD, 2002, FREE RADICAL BIO MED, V33, P364, DOI 10.1016/S0891-5849(02)00895-X; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; Ehrenshaft M, 2006, FREE RADICAL BIO MED, V41, P422, DOI 10.1016/j.freeradbiomed.2006.02.023; FISCHKOFF SA, 1988, LEUKEMIA RES, V12, P679, DOI 10.1016/0145-2126(88)90103-8; FRIDOVICH I, 1961, J BIOL CHEM, V236, P1836; Furtmuller PG, 2001, BBA-PROTEIN STRUCT M, V1548, P121, DOI 10.1016/S0167-4838(01)00230-8; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; GUNNISON AF, 1974, AM IND HYG ASSOC J, V35, P288, DOI 10.1080/0002889748507036; GUNNISON AF, 1981, FOOD COSMET TOXICOL, V19, P667, DOI 10.1016/0015-6264(81)90519-8; HAYON E, 1972, J AM CHEM SOC, V94, P47, DOI 10.1021/ja00756a009; HOLTZMAN JL, 1976, ANAL CHEM, V48, P229, DOI 10.1021/ac60365a048; HORWITZ RJ, 1995, CLIN CHEST MED, V16, P583; HUIE RE, 1984, J PHYS CHEM-US, V88, P5665, DOI 10.1021/j150667a042; JI AJ, 1995, CLIN CHEM, V41, P897; JOHNSON JL, 1980, P NATL ACAD SCI-BIOL, V77, P3715, DOI 10.1073/pnas.77.6.3715; KOHLER H, 1988, ARCH BIOCHEM BIOPHYS, V264, P438, DOI 10.1016/0003-9861(88)90309-8; LESTER MR, 1995, J AM COLL NUTR, V14, P229; Lu T, 2008, BRIT J PHARMACOL, V154, P1308, DOI 10.1038/bjp.2008.173; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; Mitsuhashi H, 2001, CLIN CHEM, V47, P1872; MOTTLEY C, 1988, ARCH BIOCHEM BIOPHYS, V267, P681, DOI 10.1016/0003-9861(88)90077-X; MOTTLEY C, 1982, MOL PHARMACOL, V22, P732; MOTTLEY C, 1982, J BIOL CHEM, V257, P5050; Nagy P, 2006, CHEM RES TOXICOL, V19, P587, DOI 10.1021/tx050338c; NETA P, 1988, J PHYS CHEM REF DATA, V17, P1027, DOI 10.1063/1.555808; NETA P, 1985, ENVIRON HEALTH PERSP, V64, P209, DOI 10.2307/3430011; Niknahad H, 2008, CHEM-BIOL INTERACT, V174, P147, DOI 10.1016/j.cbi.2008.05.032; OSHINO N, 1975, ARCH BIOCHEM BIOPHYS, V170, P514, DOI 10.1016/0003-9861(75)90147-2; RALL D P, 1974, Environmental Health Perspectives, V8, P97, DOI 10.2307/3428194; Ramirez DC, 2005, FREE RADICAL BIO MED, V38, P201, DOI 10.1016/j.freeradbiomed.2004.10.008; Ramirez DC, 2003, FREE RADICAL BIO MED, V34, P830, DOI 10.1016/S0891-5849(02)01437-5; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P11377, DOI 10.1021/bi800952b; Ranguelova K, 2009, FREE RADICAL BIO MED, V47, P128, DOI 10.1016/j.freeradbiomed.2009.04.006; REED GA, 1986, P NATL ACAD SCI USA, V83, P7499, DOI 10.1073/pnas.83.19.7499; ROMAN R, 1973, CAN J CHEM, V51, P588, DOI 10.1139/v73-089; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; SHIH VE, 1977, NEW ENGL J MED, V297, P1022, DOI 10.1056/NEJM197711102971902; SLUNGAARD A, 1991, J EXP MED, V173, P117, DOI 10.1084/jem.173.1.117; SLUNGAARD A, 1991, J BIOL CHEM, V266, P4903; STEELE WV, 1982, J CHEM THERMODYN, V14, P337, DOI 10.1016/0021-9614(82)90052-0; WARDLAW AJ, 1994, POSTGRAD MED J, V70, P536, DOI 10.1136/pgmj.70.826.536; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; WILKINS JW, 1968, CLIN PHARMACOL THER, V9, P328; YOKOYAMA E, 1971, ARCH ENVIRON HEALTH, V22, P389, DOI 10.1080/00039896.1971.10665861	57	47	47	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24195	24205		10.1074/jbc.M109.069054	http://dx.doi.org/10.1074/jbc.M109.069054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501663	Green Published, hybrid			2022-12-25	WOS:000280291400069
J	Venceslau, SS; Lino, RR; Pereira, IAC				Venceslau, Sofia S.; Lino, Rita R.; Pereira, Ines A. C.			The Qrc Membrane Complex, Related to the Alternative Complex III, Is a Menaquinone Reductase Involved in Sulfate Respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; SITE-DIRECTED MUTAGENESIS; GENE-EXPRESSION ANALYSIS; COLI FUMARATE REDUCTASE; ESCHERICHIA-COLI; ELECTRON-TRANSFER; DESULFURICANS ATCC-27774; FORMATE DEHYDROGENASE; BACTERIAL RESPIRATION; RHODOTHERMUS-MARINUS	Biological sulfate reduction is a process with high environmental significance due to its major contribution to the carbon and sulfur cycles in anaerobic environments. However, the respiratory chain of sulfate-reducing bacteria is still poorly understood. Here we describe a new respiratory complex that was isolated as a major protein present in the membranes of Desulfovibrio vulgaris Hildenborough. The complex, which was named Qrc, is the first representative of a new family of redox complexes. It has three subunits related to the complex iron-sulfur molybdoenzyme family and a multiheme cytochrome c and binds six hemes c, one [3Fe-4S](+1/0) cluster, and several interacting [4Fe-4S](2+/1+) clusters but no molybdenum. Qrc is related to the alternative complex III, and we show that it has the reverse catalytic activity, acting as a Type I cytochrome c(3):menaquinone oxidoreductase. The qrc genes are found in the genomes of deltaproteobacterial sulfate reducers, which have periplasmic hydrogenases and formate dehydrogenases that lack a membrane subunit for reduction of the quinone pool. In these organisms, Qrc acts as a menaquinone reductase with electrons from periplasmic hydrogen or formate oxidation. Binding of a menaquinone analogue affects the EPR spectrum of the [3Fe-4S](+1/0) cluster, indicating the presence of a quinone-binding site close to the periplasmic subunits. Qrc is the first respiratory complex from sulfate reducers to have its physiological function clearly elucidated.	[Pereira, Ines A. C.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, EAN, P-2780157 Oeiras, Portugal	Universidade Nova de Lisboa	Pereira, IAC (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, EAN, Av Republ, P-2780157 Oeiras, Portugal.	ipereira@itqb.unl.pt	Venceslau, Sofia/M-2882-2016; Pereira, Inês/C-2748-2009	Venceslau, Sofia/0000-0001-8774-1351; Pereira, Inês/0000-0003-3283-4520	Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal) [PTDC/QUI/68368/2006]; FEDER	Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal)(Portuguese Foundation for Science and Technology); FEDER(European Commission)	This work was supported by Research Grant PTDC/QUI/68368/2006 funded by Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal) and FEDER program.	Baymann F, 2003, PHILOS T ROY SOC B, V358, P267, DOI 10.1098/rstb.2002.1184; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Pereira IAC, 2008, MICROBIAL SULFUR METABOLISM, P24, DOI 10.1007/978-3-540-72682-1_3; Cheng VWT, 2005, BIOCHEMISTRY-US, V44, P8068, DOI 10.1021/bi050362p; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Gao XL, 2009, FEBS LETT, V583, P3275, DOI 10.1016/j.febslet.2009.09.022; GUIGLIARELLI B, 1992, EUR J BIOCHEM, V207, P61, DOI 10.1111/j.1432-1033.1992.tb17020.x; Haveman SA, 2003, J BACTERIOL, V185, P4345, DOI 10.1128/JB.185.15.4345-4353.2003; Haveman SA, 2004, J BACTERIOL, V186, P7944, DOI 10.1128/JB.186.23.7944-7950.2004; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Jormakka M, 2003, FEBS LETT, V545, P25, DOI 10.1016/S0014-5793(03)00389-2; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Li XZ, 2009, J BACTERIOL, V191, P2675, DOI 10.1128/JB.01814-08; MANODORI A, 1992, BIOCHEMISTRY-US, V31, P2703, DOI 10.1021/bi00125a010; Matias PM, 2005, PROG BIOPHYS MOL BIO, V89, P292, DOI 10.1016/j.pbiomolbio.2004.11.003; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Oliveira TF, 2008, J BIOL CHEM, V283, P34141, DOI 10.1074/jbc.M805643200; Pereira IAC, 1998, J BIOL INORG CHEM, V3, P494, DOI 10.1007/s007750050259; Pereira IAC, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P215, DOI 10.1017/CBO9780511541490.008; Pereira MM, 2007, FEBS LETT, V581, P4831, DOI 10.1016/j.febslet.2007.09.008; Pereira MM, 1999, BIOCHEMISTRY-US, V38, P1268, DOI 10.1021/bi9818063; Pereira PM, 2008, ANTON LEEUW INT J G, V93, P347, DOI 10.1007/s10482-007-9212-0; Pereira PM, 2006, BIOCHEMISTRY-US, V45, P10359, DOI 10.1021/bi0610294; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Pires RH, 2003, BBA-BIOENERGETICS, V1605, P67, DOI 10.1016/S0005-2728(03)00065-3; Rabus R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P659, DOI 10.1007/0-387-30742-7_22; REFOJO PN, 2010, BIOCH BIOPH IN PRESS; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; ROSSI M, 1993, J BACTERIOL, V175, P4699, DOI 10.1128/JB.175.15.4699-4711.1993; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; Rothery RA, 2005, FEBS J, V272, P313, DOI 10.1111/j.1742-4658.2004.04469.x; Rothery RA, 1998, J BIOL CHEM, V273, P7462, DOI 10.1074/jbc.273.13.7462; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SEBBAN C, 1995, FEMS MICROBIOL LETT, V133, P143, DOI 10.1111/j.1574-6968.1995.tb07875.x; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Simon J, 2008, BIOCHEM SOC T, V36, P1011, DOI 10.1042/BST0361011; Simon J, 2008, BBA-BIOENERGETICS, V1777, P1480, DOI 10.1016/j.bbabio.2008.09.008; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; Valente FMA, 2001, CHEMBIOCHEM, V2, P895, DOI 10.1002/1439-7633(20011203)2:12<895::AID-CBIC895>3.0.CO;2-V; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l; Zhang WW, 2006, PROTEOMICS, V6, P4286, DOI 10.1002/pmic.200500930	44	70	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22772	22781		10.1074/jbc.M110.124305	http://dx.doi.org/10.1074/jbc.M110.124305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498375	Green Published, hybrid			2022-12-25	WOS:000279999900009
J	Beenken, KE; Mrak, LN; Griffin, LM; Zielinska, AK; Shaw, LN; Rice, KC; Horswill, AR; Bayles, KW; Smeltzer, MS				Beenken, Karen E.; Mrak, Lara N.; Griffin, Linda M.; Zielinska, Agnieszka K.; Shaw, Lindsey N.; Rice, Kelly C.; Horswill, Alexander R.; Bayles, Kenneth W.; Smeltzer, Mark S.			Epistatic Relationships between sarA and agr in Staphylococcus aureus Biofilm Formation	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; METHICILLIN-RESISTANT; VIRULENCE DETERMINANTS; IN-VITRO; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; REGULATOR; SIGMA(B); USA300	Background: The accessory gene regulator (agr) and staphylococcal accessory regulator (sarA) play opposing roles in Staphylococcus aureus biofilm formation. There is mounting evidence to suggest that these opposing roles are therapeutically relevant in that mutation of agr results in increased biofilm formation and decreased antibiotic susceptibility while mutation of sarA has the opposite effect. To the extent that induction of agr or inhibition of sarA could potentially be used to limit biofilm formation, this makes it important to understand the epistatic relationships between these two loci. Methodology/Principal Findings: We generated isogenic sarA and agr mutants in clinical isolates of S. aureus and assessed the relative impact on biofilm formation. Mutation of agr resulted in an increased capacity to forma biofilmin the 8325-4 laboratory strain RN6390 but had little impact in clinical isolates S. aureus. In contrast, mutation of sarA resulted in a reduced capacity to form a biofilm in all clinical isolates irrespective of the functional status of agr. This suggests that the regulatory role of sarA in biofilm formation is independent of the interaction between sarA and agr and that sarA is epistatic to agr in this context. This was confirmed by demonstrating that restoration of sarA function restored the ability to form a biofilm even in the corresponding agr mutants. Mutation of sarA in clinical isolates also resulted in increased production of extracellular proteases and extracellular nucleases, both of which contributed to the biofilm-deficient phenotype of sarA mutants. However, studies comparing different strains with and without proteases inhibitors and/or mutation of the nuclease genes demonstrated that the agr-independent, sarA-mediated repression of extracellular proteases plays a primary role in this regard. Conclusions and Significance: The results we report suggest that inhibitors of sarA-mediated regulation could be used to limit biofilm formation in S. aureus and that the efficacy of such inhibitors would not be limited by spontaneous mutation of agr in the human host.	[Beenken, Karen E.; Mrak, Lara N.; Griffin, Linda M.; Zielinska, Agnieszka K.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Shaw, Lindsey N.] Univ S Florida, Dept Biol, Tampa, FL 33620 USA; [Rice, Kelly C.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Bayles, Kenneth W.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Arkansas System; University of Arkansas Medical Sciences; State University System of Florida; University of South Florida; State University System of Florida; University of Florida; University of Iowa; University of Nebraska System; University of Nebraska Medical Center	Beenken, KE (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	smeltzermarks@uams.edu	Shaw, Lindsey/AAI-1741-2020; Smeltzer, Mark/M-2009-2018	Shaw, Lindsey/0000-0002-0629-8990; Smeltzer, Mark/0000-0002-0878-0692	National Institute of Allergy and Infectious Disease [AI43356, AI083211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211, R01AI074935, R01AI043356] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by grants AI43356 (MSS) and AI083211 (KWB, ARH) from the National Institute of Allergy and Infectious Disease. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Calhoun JH, 2005, INFECT DIS CLIN N AM, V19, P765, DOI 10.1016/j.idc.2005.07.009; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chien YT, 1998, MOL MICROBIOL, V30, P991, DOI 10.1046/j.1365-2958.1998.01126.x; Coelho LR, 2008, MICROBIOL-SGM, V154, P3480, DOI 10.1099/mic.0.2007/016014-0; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Eggimann P, 2004, MICROBES INFECT, V6, P1033, DOI 10.1016/j.micinf.2004.05.018; Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7; Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Gustafsson E, 2009, INT J MED MICROBIOL, V299, P65, DOI 10.1016/j.ijmm.2008.05.011; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Miller LG, 2009, INFECT DIS CLIN N AM, V23, P35, DOI 10.1016/j.idc.2008.10.002; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Sakoulas G, 2006, CLIN INFECT DIS, V42, pS40, DOI 10.1086/491713; Sau S, 1997, J BACTERIOL, V179, P1614, DOI 10.1128/jb.179.5.1614-1621.1997; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Sifri CD, 2007, CLIN INFECT DIS, V45, pE113, DOI 10.1086/522171; Tang JN, 2008, FEMS MICROBIOL LETT, V284, P176, DOI 10.1111/j.1574-6968.2008.01194.x; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Viale P, 2006, J CHEMOTHERAPY, V18, P235, DOI 10.1179/joc.2006.18.3.235; Vinh Donald C, 2005, J Long Term Eff Med Implants, V15, P467, DOI 10.1615/JLongTermEffMedImplants.v15.i5.20; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P2475, DOI 10.1128/AAC.01432-08; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Zhu Y, 2007, INFECT IMMUN, V75, P4219, DOI 10.1128/IAI.00509-07	57	112	117	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10790	10.1371/journal.pone.0010790	http://dx.doi.org/10.1371/journal.pone.0010790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520723	gold, Green Submitted, Green Published			2022-12-25	WOS:000278034600016
J	Irie, T; Nagata, N; Igarashi, T; Okamoto, I; Sakaguchi, T				Irie, Takashi; Nagata, Natsuko; Igarashi, Tomoki; Okamoto, Isao; Sakaguchi, Takemasa			Conserved Charged Amino Acids within Sendai Virus C Protein Play Multiple Roles in the Evasion of Innate Immune Responses	PLOS ONE			English	Article							VIRAL-RNA SYNTHESIS; RIG-I; ANTIVIRAL RESPONSE; STRANDED-RNA; V-PROTEINS; WILD-TYPE; EXPRESSION; ACTIVATION; INDUCTION; PROMOTER	One of the accessory proteins of Sendai virus (SeV), C, translated from an alternate reading frame of P/V mRNA has been shown to function at multiple stages of infection in cell cultures as well as in mice. C protein has been reported to counteract signal transduction by interferon (IFN), inhibit apoptosis induced by the infection, enhance the efficiency of budding of viral particles, and regulate the polarity of viral genome-length RNA synthesis to maximize production of infectious particles. In this study, we have generated a series of SeV recombinants containing substitutions of highly conserved, charged residues within the C protein, and characterized them together with previously-reported C'/C(-), 4C(-), and F170S recombinant viruses in infected cell cultures in terms of viral replication, cytopathogenicity, and antagonizing effects on host innate immunity. Unexpectedly, the amino acid substitutions had no or minimal effect on viral growth and viral RNA synthesis. However, all the substitutions of charged amino acids resulted in the loss of a counteracting effect against the establishment of an IFN-alpha-mediated anti-viral state. Infection by the virus (Cm2') containing mutations at K77 and D80 induced significant IFN-beta production, severe cytopathic effects, and detectable amounts of viral dsRNA production. In addition to the Cm2' virus, the virus containing mutations at E114 and E115 did not inhibit the poly(I:C)triggered translocation of cellular IRF-3 to the nucleus. These results suggest that the C protein play important roles in viral escape from induction of IFN-beta and cell death triggered by infection by means of counteracting the pathway leading to activation of IRF-3 as well as of minimizing viral dsRNA production.	[Irie, Takashi; Nagata, Natsuko; Igarashi, Tomoki; Okamoto, Isao; Sakaguchi, Takemasa] Hiroshima Univ, Grad Sch Biomed Sci, Dept Virol, Hiroshima, Japan	Hiroshima University	Irie, T (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Virol, Hiroshima, Japan.	tirie@hiroshima-u.ac.jp	Sakaguchi, Takemasa/H-1488-2019	Sakaguchi, Takemasa/0000-0002-3754-1252	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Cadd T, 1996, J VIROL, V70, P5067, DOI 10.1128/JVI.70.8.5067-5074.1996; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; CURRAN J, 1991, EMBO J, V10, P3079, DOI 10.1002/j.1460-2075.1991.tb07860.x; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Garcin D, 2002, VIROLOGY, V295, P256, DOI 10.1006/viro.2001.1342; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 2001, J VIROL, V75, P6800, DOI 10.1128/JVI.75.15.6800-6807.2001; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Grandvaux N, 2005, FEBS J, V272, P3120, DOI 10.1111/j.1742-4658.2005.04726.x; Grogan CC, 2001, VIROLOGY, V288, P96, DOI 10.1006/viro.2001.1068; Hasan MK, 2000, J VIROL, V74, P5619, DOI 10.1128/JVI.74.12.5619-5628.2000; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Irie T, 2008, VIROLOGY, V374, P495, DOI 10.1016/j.virol.2008.01.004; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Itoh M, 1998, J VIROL, V72, P2927, DOI 10.1128/JVI.72.4.2927-2934.1998; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Kato A, 2002, J VIROL, V76, P7114, DOI 10.1128/JVI.76.14.7114-7124.2002; Kato A, 2001, J VIROL, V75, P3802, DOI 10.1128/JVI.75.8.3802-3810.2001; Kato A, 2007, J VIROL, V81, P3264, DOI 10.1128/JVI.02590-06; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KIYOTANI K, 1990, VIROLOGY, V177, P65, DOI 10.1016/0042-6822(90)90460-9; Komatsu T, 2002, FEBS LETT, V511, P139, DOI 10.1016/S0014-5793(01)03301-4; Koyama AH, 2003, MICROBES INFECT, V5, P373, DOI 10.1016/S1286-4579(03)00043-1; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; Lamb R.A., 2006, FIELDS VIROLOGY, P1449; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Nishimura K, 2007, J BIOL CHEM, V282, P27383, DOI 10.1074/jbc.M702028200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Sakaguchi T, 2005, J VIROL, V79, P8933, DOI 10.1128/JVI.79.14.8933-8941.2005; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Tapparel C, 1997, J VIROL, V71, P9588, DOI 10.1128/JVI.71.12.9588-9599.1997	39	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10719	10.1371/journal.pone.0010719	http://dx.doi.org/10.1371/journal.pone.0010719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502666	Green Published, gold, Green Submitted			2022-12-25	WOS:000277845400021
J	Geisbert, TW; Daddario-DiCaprio, KM; Hickey, AC; Smith, MA; Chan, YP; Wang, LF; Mattapallil, JJ; Geisbert, JB; Bossart, KN; Broder, CC				Geisbert, Thomas W.; Daddario-DiCaprio, Kathleen M.; Hickey, Andrew C.; Smith, Mark A.; Chan, Yee-Peng; Wang, Lin-Fa; Mattapallil, Joseph J.; Geisbert, Joan B.; Bossart, Katharine N.; Broder, Christopher C.			Development of an Acute and Highly Pathogenic Nonhuman Primate Model of Nipah Virus Infection	PLOS ONE			English	Article							EMERGENT DEADLY PARAMYXOVIRUS; HENDRA-VIRUS; EQUINE MORBILLIVIRUS; RECEPTOR-BINDING; SUBUNIT VACCINE; G-GLYCOPROTEIN; HAMSTER MODEL; FLYING-FOXES; PIG-FARMERS; ENCEPHALITIS	Nipah virus (NiV) is an enigmatic emerging pathogen that causes severe and often fatal neurologic and/or respiratory disease in both animals and humans. Amongst people, case fatality rates range between 40 and 75 percent and there are no vaccines or treatments approved for human use. Guinea pigs, hamsters, cats, ferrets, pigs and most recently squirrel monkeys (New World monkey) have been evaluated as animal models of human NiV infection, and with the exception of the ferret, no model recapitulates all aspects of NiV-mediated disease seen in humans. To identify a more viable nonhuman primate (NHP) model, we examined the pathogenesis of NiV in African green monkeys (AGM). Exposure of eight monkeys to NiV produced a severe systemic infection in all eight animals with seven of the animals succumbing to infection. Viral RNA was detected in the plasma of challenged animals and occurred in two of three subjects as a peak between days 7 and 21, providing the first clear demonstration of plasma-associated viremia in NiV experimentally infected animals and suggested a progressive infection that seeded multiple organs simultaneously from the initial site of virus replication. Unlike the cat, hamster and squirrel monkey models of NiV infection, severe respiratory pathology, neurological disease and generalized vasculitis all manifested in NiV-infected AGMs, providing an accurate reflection of what is observed in NiV-infected humans. Our findings demonstrate the first consistent and highly pathogenic NHP model of NiV infection, providing a new and critical platform in the evaluation and licensure of either passive and active immunization or therapeutic strategies for human use.	[Geisbert, Thomas W.; Daddario-DiCaprio, Kathleen M.; Geisbert, Joan B.; Bossart, Katharine N.] Boston Univ, Sch Med, Natl Emerging Infect Dis Labs Inst, Boston, MA 02118 USA; [Geisbert, Thomas W.; Bossart, Katharine N.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Geisbert, Thomas W.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Hickey, Andrew C.; Smith, Mark A.; Chan, Yee-Peng; Mattapallil, Joseph J.; Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD USA; [Smith, Mark A.] USA, Div Pathol, Med Res Inst Infect Dis, Frederick, MD USA; [Wang, Lin-Fa] Australian Commonwealth Sci & Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia	Boston University; Boston University; Boston University; Uniformed Services University of the Health Sciences - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Geisbert, TW (corresponding author), Boston Univ, Sch Med, Natl Emerging Infect Dis Labs Inst, Boston, MA 02118 USA.	cbroder@usuhs.mil	wang, lin/GSE-3040-2022; Broder, Christopher/E-1169-2013	Bossart, Katharine/0000-0001-6886-6896; Mattapallil, Joseph/0000-0002-7412-9507	Department of Health and Human Services, National Institutes of Health [AI082121, AI057159, DE018339, DE019397, AI071812, AI054715, AI077995]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077995, U54AI057159, R01AI054715, K22AI071812, U01AI082121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018339, R01DE019397] Funding Source: NIH RePORTER	Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported in part by the Department of Health and Human Services, National Institutes of Health, grants AI082121 and AI057159 to TWG; DE018339, DE019397 and AI071812 to JJM, and AI054715 and AI077995 to CCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop KA, 2007, J VIROL, V81, P5893, DOI 10.1128/JVI.02022-06; Bishop Kimberly A., 2008, V8, P155; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bossart Katharine N, 2007, Open Virol J, V1, P14, DOI 10.2174/1874357900701010014; Bossart KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000642; Bossart KN, 2005, J VIROL, V79, P6690, DOI 10.1128/JVI.79.11.6690-6702.2005; Bossart KN, 2009, VIRAL ENTRY HOST CEL; BRODER CC, 2008, NEW GENERATION VACCI; Carbone KM, 2007, FIELDS VIROLOGY, P1527; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eaton BT, 2007, FIELDS VIROLOGY, P1587; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Griffin DE., 2007, FIELDS VIROLOGY, P1551; Guillaume V, 2006, J VIROL, V80, P1972, DOI 10.1128/JVI.80.4.1972-1978.2006; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; Guillaume V, 2009, VIROLOGY, V387, P459, DOI 10.1016/j.virol.2009.03.001; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Harit AK, 2006, INDIAN J MED RES, V123, P553; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hooper PT, 1997, VET PATHOL, V34, P323, DOI 10.1177/030098589703400408; JAHRLING PB, 1999, MANUAL CLIN MICROBIO, P1125; Karron RA., 2007, FIELDS VIROLOGY, V5, P1497; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Marianneau P, 2010, EMERG INFECT DIS, V16, P507, DOI 10.3201/eid1603.091346; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Mungall BA, 2007, J INFECT DIS, V196, P812, DOI 10.1086/520818; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Tan Chong-Tin, 2008, Curr Infect Dis Rep, V10, P315, DOI 10.1007/s11908-008-0051-6; Westbury HA, 1996, AUST VET J, V74, P132, DOI 10.1111/j.1751-0813.1996.tb14813.x; Williamson MM, 2001, J COMP PATHOL, V124, P273, DOI 10.1053/jcpa.2001.0464; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Zhu Z, 2008, J INFECT DIS, V197, P846, DOI 10.1086/528801	48	104	106	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10690	10.1371/journal.pone.0010690	http://dx.doi.org/10.1371/journal.pone.0010690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502528	Green Published, Green Submitted, gold			2022-12-25	WOS:000277776500007
J	Petersen, L; Andersen, PK; Sorensen, TIA				Petersen, Liselotte; Andersen, Per Kragh; Sorensen, Thorkild I. A.			Genetic Influences on Incidence and Case-Fatality of Infectious Disease	PLOS ONE			English	Article							ADULT ADOPTEES; PREMATURE DEATH; ENVIRONMENTAL-INFLUENCES; MENINGOCOCCAL DISEASE; OTITIS-MEDIA; SUSCEPTIBILITY; HERITABILITY; ASSOCIATION; GENOMICS; TWIN	Background: Family, twin and adoption studies suggest that genetic susceptibility contributes to familial aggregation of infectious diseases or to death from infections. We estimated genetic and shared environmental influences separately on the risk of acquiring an infection (incidence) and on dying from it (case fatality). Methods: Genetic influences were estimated by the association between rates of hospitalization for infections and between case-fatality rates of adoptees and their biological full- and half-siblings. Familial environmental influences were investigated in adoptees and their adoptive siblings. Among 14,425 non-familial adoptions, granted in Denmark during the period 1924-47, we selected 1,603 adoptees, who had been hospitalized for infections and/or died with infection between 1977 and 1993. Their siblings were considered predisposed to infection, and compared with non-predisposed siblings of randomly selected 1,348 adoptees alive in 1993 and not hospitalized for infections in the observation period. The risk ratios presented were based on a Cox regression model. Results: Among 9971 identified siblings, 2829 had been hospitalised for infections. The risk of infectious disease was increased among predisposed compared with non-predisposed in both biological (1.18; 95% confidence limits 1.03-1.36) and adoptive siblings (1.23; 0.98-1.53). The risk of a fatal outcome of the infections was strongly increased (9.36; 2.94-29.8) in biological full siblings, but such associations were not observed for the biological half siblings or for the adoptive siblings. Conclusion: Risk of getting infections appears to be weakly influenced by both genetically determined susceptibility to infection and by family environment, whereas there appears to be a strong non-additive genetic influence on risk of fatal outcome.	[Petersen, Liselotte] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Petersen, Liselotte; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Andersen, Per Kragh] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Aarhus University; University of Copenhagen; University of Copenhagen	Petersen, L (corresponding author), Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark.	llp@ncrr.dk		Petersen, Liselotte Vogdrup/0000-0002-0479-5379	Danish National Research Foundation; Lundbeck Foundation; Velux Fonden	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Velux Fonden(Velux Fonden)	The Danish National Research Foundation supported the adoption study. This work was also supported by grants from The Lundbeck Foundation and from Velux Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2007, J INTERN MED, V261, P112, DOI 10.1111/j.1365-2796.2006.01742.x; Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; BORCHJOHNSEN K, 1993, ACTA PSYCHIAT SCAND, V87, P73, DOI 10.1111/j.1600-0447.1993.tb05364.x; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; ELDRED CA, 1976, AM J ORTHOPSYCHIAT, V46, P279, DOI 10.1111/j.1939-0025.1976.tb00928.x; Folstein Marshal F., J PSYCHIATR RES, V12, P189, DOI [10.1016/0022-3956(75)90026-6, DOI 10.1016/0022-3956(75)90026-6, DOI 10.1016/0022-3956(68)90026-5]; Haralambous E, 2003, EPIDEMIOL INFECT, V130, P413, DOI 10.1017/S0950268803008513; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Hjuler T, 2008, AM J EPIDEMIOL, V167, P814, DOI 10.1093/aje/kwm376; LIN TM, 1989, ANTICANCER RES, V9, P737; LYKKEN DT, 1990, BEHAV GENET, V20, P547, DOI 10.1007/BF01065871; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Motsinger AA, 2007, J INFECT DIS, V195, P1737, DOI 10.1086/518247; Obel N, 2010, AM J EPIDEMIOL, V171, P1007, DOI 10.1093/aje/kwq037; Petersen L, 2005, GENET EPIDEMIOL, V28, P376, DOI 10.1002/gepi.20071; Petersen L, 2002, GENET EPIDEMIOL, V23, P123, DOI 10.1002/gepi.1122; Petersen L, 2008, EPIDEMIOLOGY, V19, P472, DOI 10.1097/EDE.0b013e3181692769; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Tuite A, 2006, MICROBES INFECT, V8, P1647, DOI 10.1016/j.micinf.2005.11.016; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361	28	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10603	10.1371/journal.pone.0010603	http://dx.doi.org/10.1371/journal.pone.0010603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498716	Green Published, gold, Green Submitted			2022-12-25	WOS:000277771600003
J	Vermeij, MJA; Marhaver, KL; Huijbers, CM; Nagelkerken, I; Simpson, SD				Vermeij, Mark J. A.; Marhaver, Kristen L.; Huijbers, Chantal M.; Nagelkerken, Ivan; Simpson, Stephen D.			Coral Larvae Move toward Reef Sounds	PLOS ONE			English	Article							FISHES; RECRUITMENT; ATTRACTION	Free-swimming larvae of tropical corals go through a critical life-phase when they return from the open ocean to select a suitable settlement substrate. During the planktonic phase of their life cycle, the behaviours of small coral larvae (, 1 mm) that influence settlement success are difficult to observe in situ and are therefore largely unknown. Here, we show that coral larvae respond to acoustic cues that may facilitate detection of habitat from large distances and from upcurrent of preferred settlement locations. Using in situ choice chambers, we found that settling coral larvae were attracted to reef sounds, produced mainly by fish and crustaceans, which we broadcast underwater using loudspeakers. Our discovery that coral larvae can detect and respond to sound is the first description of an auditory response in the invertebrate phylum Cnidaria, which includes jellyfish, anemones, and hydroids as well as corals. If, like settlement-stage reef fish and crustaceans, coral larvae use reef noise as a cue for orientation, the alleviation of noise pollution in the marine environment may gain further urgency.	[Vermeij, Mark J. A.] Carmabi Fdn, Willemstad, Curacao, Neth Antilles; [Vermeij, Mark J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Marhaver, Kristen L.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Huijbers, Chantal M.; Nagelkerken, Ivan] Radboud Univ Nijmegen, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands; [Simpson, Stephen D.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Amsterdam; University of California System; University of California San Diego; Scripps Institution of Oceanography; Radboud University Nijmegen; University of Bristol	Vermeij, MJA (corresponding author), Carmabi Fdn, Willemstad, Curacao, Neth Antilles.	m.vermeij@carmabi.org	Nagelkerken, Ivan/E-1093-2011; Vermeij, Mark/AAR-6757-2020; Huijbers, Chantal/J-5176-2014; Langhamer, Olivia/J-3425-2012; Marhaver, Kristen L/B-4948-2011; Vermeij, Mark/B-2752-2013	Nagelkerken, Ivan/0000-0003-4499-3940; Vermeij, Mark/0000-0001-9612-9527; Huijbers, Chantal/0000-0001-5206-3415; Marhaver, Kristen L/0000-0002-8953-1902; Vermeij, Mark/0000-0001-9612-9527; Simpson, Stephen/0000-0002-4856-6164	Scripps Graduate Department; National Science Foundation; Natural Environment Research Council; Netherlands Organization for Scientific Research (NWO)	Scripps Graduate Department; National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	KLM was supported by the Scripps Graduate Department and a National Science Foundation Graduate Research Fellowship. SDS was supported by the Natural Environment Research Council. CMH and IN were supported by a Vidi grant from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2000, MAR ECOL PROG SER, V195, P231, DOI 10.3354/meps195231; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Cato D, 1992, ACOUST AUST, V20, P76; Gleason DF, 2009, CORAL REEFS, V28, P549, DOI 10.1007/s00338-009-0480-1; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kingsford MJ, 2002, B MAR SCI, V70, P309; Mann DA, 2007, J FISH BIOL, V70, P109, DOI 10.1111/j.1095-8649.2006.01279.x; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; MCCAULEY RD, 1997, ASPECTS MARINE BIOL, V4; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Robert D, 2009, CURR BIOL, V19, pR446, DOI 10.1016/j.cub.2009.04.021; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Slabbekoorn H, 2008, ANIM BEHAV, V76, pE5, DOI 10.1016/j.anbehav.2008.06.010; Swearer SE, 2002, B MAR SCI, V70, P251; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119	17	124	125	7	203	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10660	10.1371/journal.pone.0010660	http://dx.doi.org/10.1371/journal.pone.0010660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498831	Green Submitted, Green Published, gold			2022-12-25	WOS:000277771600020
J	Chaturvedi, P; Parnaik, VK				Chaturvedi, Pankaj; Parnaik, Veena K.			Lamin A Rod Domain Mutants Target Heterochromatin Protein 1 alpha and beta for Proteasomal Degradation by Activation of F-Box Protein, FBXW10	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; A-TYPE LAMINS; DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; INHIBITING FARNESYLATION; RETINOBLASTOMA PROTEIN; DILATED CARDIOMYOPATHY; PARTIAL LIPODYSTROPHY; HP1 PROTEINS; ORGANIZATION	Background: Lamins are major structural proteins of the nucleus and contribute to the organization of various nuclear functions. Mutations in the human lamin A gene cause a number of highly degenerative diseases, collectively termed as laminopathies. Cells expressing lamin mutations exhibit abnormal nuclear morphology and altered heterochromatin organization; however, the mechanisms responsible for these defects are not well understood. Methodology and Principal Findings: The lamin A rod domain mutants G232E, Q294P and R386K are either diffusely distributed or form large aggregates in the nucleoplasm, resulting in aberrant nuclear morphology in various cell types. We examined the effects of these lamin mutants on the distribution of heterochromatin protein 1 (HP1) isoforms. HeLa cells expressing these mutants showed a heterogeneous pattern of HP1 alpha and beta depletion but without altering HP1 gamma levels. Changes in HP1 alpha and beta were not observed in cells expressing wild-type lamin A or mutant R482L, which assembled normally at the nuclear rim. Treatment with proteasomal inhibitors led to restoration of levels of HP1 isoforms and also resulted in stable association of lamin mutants with the nuclear periphery, rim localization of the inner nuclear membrane lamin-binding protein emerin and partial improvement of nuclear morphology. A comparison of the stability of HP1 isoforms indicated that HP1 alpha and beta displayed increased turnover and higher basal levels of ubiquitination than HP1 gamma. Transcript analysis of components of the ubiquitination pathway showed that a specific F-box protein, FBXW10 was induced several-fold in cells expressing lamin mutants. Importantly, ectopic expression of FBXW10 in HeLa cells led to depletion of HP1 alpha and beta without alteration of HP1 gamma levels. Conclusions: Mislocalized lamins can induce ubiquitin-mediated proteasomal degradation of certain HP1 isoforms by activation of FBXW10, a member of the F-box family of proteins that is involved in E3 ubiquitin ligase activity.	[Chaturvedi, Pankaj; Parnaik, Veena K.] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chaturvedi, P (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India.	veenap@ccmb.res.in	Chaturvedi, Pankaj/ABC-4658-2020	Chaturvedi, Pankaj/0000-0001-7596-2165	Department of Biotechnology, India; Council of Scientific and Industrial Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by the Department of Biotechnology, India. PC was supported by a pre-doctoral fellowship from the Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Broers JLV, 1999, J CELL SCI, V112, P3463; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; De Conto F, 2000, J CELL SCI, V113, P2399; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2000, J CELL SCI, V113, P3473; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Favreau C, 2003, EXP CELL RES, V282, P14, DOI 10.1006/excr.2002.5669; Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005; Gilchrist S, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-46; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kudlow BA, 2005, AIDS, V19, P1565, DOI 10.1097/01.aids.0000186827.91408.90; Lattanzi G, 2007, J CELL BIOCHEM, V102, P1149, DOI 10.1002/jcb.21467; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Mateos-Langerak J, 2007, MOL BIOL CELL, V18, P1464, DOI 10.1091/mbc.E06-01-0025; Matitioli E, 2008, EXP CELL RES, V314, P453, DOI 10.1016/j.yexcr.2O07.11.012; Meaburn KJ, 2007, AGING CELL, V6, P139, DOI 10.1111/j.1474-9726.2007.00270.x; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Muchir A, 2006, BIOCHEM BIOPH RES CO, V351, P1011, DOI 10.1016/j.bbrc.2006.10.147; NICKERSON JA, 1992, J CELL BIOL, V116, P977, DOI 10.1083/jcb.116.4.977; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Ostlund C, 2001, J CELL SCI, V114, P4435; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Parnaik VK, 2006, J BIOSCIENCES, V31, P405, DOI 10.1007/BF02704113; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Raharjo WH, 2001, J CELL SCI, V114, P4447; Ritou E, 2007, J CELL SCI, V120, P3425, DOI 10.1242/jcs.012955; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Taimen P, 2009, P NATL ACAD SCI USA, V106, P20788, DOI 10.1073/pnas.0911895106; Tripathi K, 2009, INT J INTEGRATIVE BI, V5, P1; Vaughan OA, 2001, J CELL SCI, V114, P2577; Vigouroux C, 2001, J CELL SCI, V114, P4459; Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170; Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102	62	33	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10620	10.1371/journal.pone.0010620	http://dx.doi.org/10.1371/journal.pone.0010620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498703	gold, Green Published			2022-12-25	WOS:000277633500011
J	Halfon, P; Giorgetti, C; Khiri, H; Penaranda, G; Terriou, P; Porcu-Buisson, G; Chabert-Orsini, V				Halfon, Philippe; Giorgetti, Claude; Khiri, Hacene; Penaranda, Guillaume; Terriou, Philippe; Porcu-Buisson, Geraldine; Chabert-Orsini, Veronique			Semen May Harbor HIV Despite Effective HAART: Another Piece in the Puzzle	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS; HIV-1-DISCORDANT COUPLES; SEXUAL TRANSMISSION; RNA; SPERM; BLOOD; COMPARTMENTALIZATION; INFECTION; EFFICIENT	Background: The risk of male-to-female intravaginal HIV-1 transmission is estimated at about 1 event per 200-2000 coital acts. The aim of this study was to assess the residual risk of HIV presence in semen in patients under HAART therapy. Methods and Findings: The study took place in France from October 2001 to March 2009. 394 paired blood and semen samples were provided from 332 HIV-1 infected men. The Roche Cobas AMPLICOR Monitor HIV assay was used to quantify HIV-1 RNA in blood and in seminal plasma. Three percent of 394 HIV-1 infected men enrolled in an assisted reproductive technology program harbored detectable HIV-1 RNA in semen, although they had no other sexually transmitted disease and their blood viral load was undetectable for at least 6 months under antiretroviral treatment. Conclusion: These data suggest that undetectable plasma HIV RNA means a lower risk of viral transmission through seminal fluid on a population level, but not necessarily at the level of the individual.	[Halfon, Philippe] Lab Alphabio, Dept Virol, Marseille, France; [Giorgetti, Claude; Terriou, Philippe; Porcu-Buisson, Geraldine; Chabert-Orsini, Veronique] Inst Reprod Med, Marseille, France; [Khiri, Hacene] Lab Alphabio, Dept Mol Biol, Marseille, France; [Penaranda, Guillaume] Lab Alphabio, Dept Biostat, Marseille, France		Halfon, P (corresponding author), Lab Alphabio, Dept Virol, Marseille, France.	philippe.halfon@alphabio.fr; g.penaranda@alphabio.fr		PENARANDA, Guillaume/0000-0002-7461-4254				BEATEN J, 2009, GENITAL HIV 1 RNA CO; Bujan L, 2004, AIDS, V18, P757, DOI 10.1097/00002030-200403260-00006; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Halfon P, 2006, AIDS, V20, P241, DOI 10.1097/01.aids.0000200532.56490.fe; Kashima K, 2009, JPN J INFECT DIS, V62, P173; Leruez-Ville M, 2002, AIDS, V16, P486, DOI 10.1097/00002030-200202150-00023; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Munch J, 2005, J VIROL, V79, P10547, DOI 10.1128/JVI.79.16.10547-10560.2005; Pasquier C, 2009, J CLIN MICROBIOL, V47, P2883, DOI 10.1128/JCM.02131-08; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Taylor S, 2001, J ANTIMICROB CHEMOTH, V48, P351, DOI 10.1093/jac/48.3.351; TAYLOR S, 2010, DARUNAVIR DRV CONCEN; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006	20	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10569	10.1371/journal.pone.0010569	http://dx.doi.org/10.1371/journal.pone.0010569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485526	gold, Green Published			2022-12-25	WOS:000277633500005
J	Meijerink, M; van Hemert, S; Taverne, N; Wels, M; de Vos, P; Bron, PA; Savelkoul, HF; van Bilsen, J; Kleerebezem, M; Wells, JM				Meijerink, Marjolein; van Hemert, Saskia; Taverne, Nico; Wels, Michiel; de Vos, Paul; Bron, Peter A.; Savelkoul, Huub F.; van Bilsen, Jolanda; Kleerebezem, Michiel; Wells, Jerry M.			Identification of Genetic Loci in Lactobacillus plantarum That Modulate the Immune Response of Dendritic Cells Using Comparative Genome Hybridization	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LACTIC-ACID BACTERIA; REGULATORY T-CELLS; FUNCTIONAL-ANALYSIS; LIPOTEICHOIC ACID; IMMUNOMODULATORY PROPERTIES; INTESTINAL INFLAMMATION; MANGANESE TRANSPORT; PROBIOTIC BACTERIA; ALLERGIC DISEASES	Background: Probiotics can be used to stimulate or regulate epithelial and immune cells of the intestinal mucosa and generate beneficial mucosal immunomodulatory effects. Beneficial effects of specific strains of probiotics have been established in the treatment and prevention of various intestinal disorders, including allergic diseases and diarrhea. However, the precise molecular mechanisms and the strain-dependent factors involved are poorly understood. Methodology/Principal Findings: In this study, we aimed to identify gene loci in the model probiotic organism Lactobacillus plantarum WCFS1 that modulate the immune response of host dendritic cells. The amounts of IL-10 and IL-12 secreted by dendritic cells (DCs) after stimulation with 42 individual L. plantarum strains were measured and correlated with the strain-specific genomic composition using comparative genome hybridisation and the Random Forest algorithm. This in silico "gene-trait matching" approach led to the identification of eight candidate genes in the L. plantarum genome that might modulate the DC cytokine response to L. plantarum. Six of these genes were involved in bacteriocin production or secretion, one encoded a bile salt hydrolase and one encoded a transcription regulator of which the exact function is unknown. Subsequently, gene deletions mutants were constructed in L. plantarum WCFS1 and compared to the wild-type strain in DC stimulation assays. All three bacteriocin mutants as well as the transcription regulator (lp_2991) had the predicted effect on cytokine production confirming their immunomodulatory effect on the DC response to L. plantarum. Transcriptome analysis and qPCR data showed that transcript level of gtcA3, which is predicted to be involved in glycosylation of cell wall teichoic acids, was substantially increased in the lp_2991 deletion mutant (44 and 29 fold respectively). Conclusion: Comparative genome hybridization led to the identification of gene loci in L. plantarum WCFS1 that modulate the immune response of DCs.	[Meijerink, Marjolein; van Hemert, Saskia; Taverne, Nico; Wels, Michiel; de Vos, Paul; Bron, Peter A.; Savelkoul, Huub F.; van Bilsen, Jolanda; Kleerebezem, Michiel; Wells, Jerry M.] Top Inst Food & Nutr, Wageningen, Netherlands; [Savelkoul, Huub F.] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands; [van Hemert, Saskia; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [van Bilsen, Jolanda] TNO Qual Life, Zeist, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; NIZO Food Research; University of Groningen; Netherlands Organization Applied Science Research; Wageningen University & Research	Meijerink, M (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	jerry.wells@wur.nl	Meijerink, Marjolein/B-9258-2014; de Vos, Paul/A-3170-2013; Kleerebezem, Michiel/AAT-2078-2021; Savelkoul, Huub FJ/F-6026-2012; van Hemert, Saskia/H-9308-2013; van Hemert, Saskia/P-8135-2019	Meijerink, Marjolein/0000-0003-3994-9785; van Hemert, Saskia/0000-0002-1098-1477; van Hemert, Saskia/0000-0002-1098-1477; Kleerebezem, Michiel/0000-0001-8552-2235; de vos, paul/0000-0001-9618-2408; van Bilsen, Jolanda/0000-0003-3439-5445	Top Institute Food and Nutrition, Wageningen, The Netherlands	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Braat H, 2004, AM J CLIN NUTR, V80, P1618, DOI 10.1093/ajcn/80.6.1618; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Diep DB, 1996, J BACTERIOL, V178, P4472, DOI 10.1128/jb.178.15.4472-4483.1996; Diep DB, 2009, PEPTIDES, V30, P1562, DOI 10.1016/j.peptides.2009.05.014; Drakes M, 2004, INFECT IMMUN, V72, P3299, DOI 10.1128/IAI.72.6.3299-3309.2004; FABIA R, 1993, SCAND J GASTROENTERO, V28, P155, DOI 10.3109/00365529309096063; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Groot MNN, 2005, MICROBIOL-SGM, V151, P1229, DOI 10.1099/mic.0.27375-0; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Holo H, 2001, MICROBIOL-SGM, V147, P643, DOI 10.1099/00221287-147-3-643; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Jim K, 2004, GENOME RES, V14, P109; Kalliomaki M, 2010, J NUTR, V140, p713S, DOI 10.3945/jn.109.113761; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kim HG, 2007, FEMS IMMUNOL MED MIC, V49, P205, DOI 10.1111/j.1574-695X.2006.00175.x; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lambert JM, 2008, APPL ENVIRON MICROB, V74, P4719, DOI 10.1128/AEM.00137-08; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Maldonado A, 2002, INT J FOOD MICROBIOL, V77, P117, DOI 10.1016/S0168-1605(02)00049-1; Mao YL, 1996, GASTROENTEROLOGY, V111, P334, DOI 10.1053/gast.1996.v111.pm8690198; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Miettinen M, 1996, INFECT IMMUN, V64, P5403, DOI 10.1128/IAI.64.12.5403-5405.1996; Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Niers LEM, 2007, CLIN EXP IMMUNOL, V149, P344, DOI 10.1111/j.1365-2249.2007.03421.x; Niers LEM, 2005, CLIN EXP ALLERGY, V35, P1481, DOI 10.1111/j.1365-2222.2005.02375.x; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Remiger A, 1999, J APPL MICROBIOL, V86, P1053, DOI 10.1046/j.1365-2672.1999.00792.x; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Resta-Lenert SC, 2009, ANN NY ACAD SCI, V1165, P175, DOI 10.1111/j.1749-6632.2009.04042.x; Rijkers GT, 2010, J NUTR, V140, p671S, DOI 10.3945/jn.109.113779; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Rojo-Bezares B, 2008, ARCH MICROBIOL, V189, P491, DOI 10.1007/s00203-007-0342-6; Ross RP, 1999, ANTON LEEUW INT J G, V76, P337, DOI 10.1023/A:1002069416067; Ryu YH, 2009, INT IMMUNOPHARMACOL, V9, P127, DOI 10.1016/j.intimp.2008.10.014; SIEZEN RJ, 2009, ENV MICROBI IN PRESS; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Troost FJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-374; Twomey D, 2002, ANTON LEEUW INT J G, V82, P165, DOI 10.1023/A:1020660321724; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Montfrans C, 2002, GASTROENTEROLOGY, V123, P1877, DOI 10.1053/gast.2002.37066; Velez MP, 2007, APPL ENVIRON MICROB, V73, P3595, DOI 10.1128/AEM.02083-06; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vesa T, 2000, ALIMENT PHARM THER, V14, P823; Wells JM, 2010, INT J MED MICROBIOL, V300, P41, DOI 10.1016/j.ijmm.2009.08.008; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yasuda E, 2008, APPL ENVIRON MICROB, V74, P4746, DOI 10.1128/AEM.00412-08; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	81	141	148	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10632	10.1371/journal.pone.0010632	http://dx.doi.org/10.1371/journal.pone.0010632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498715	Green Published, gold, Green Submitted			2022-12-25	WOS:000277633500018
J	Vasiev, B; Balter, A; Chaplain, M; Glazier, JA; Weijer, CJ				Vasiev, Bakhtier; Balter, Ariel; Chaplain, Mark; Glazier, James A.; Weijer, Cornelis J.			Modeling Gastrulation in the Chick Embryo: Formation of the Primitive Streak	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM; EXPRESSION PATTERNS; AXIAL STRUCTURES; CELL-MOVEMENT; CHEMOTAXIS; DIFFERENTIATION; INDUCTION; AMNIOTE; GENE	The body plan of all higher organisms develops during gastrulation. Gastrulation results from the integration of cell proliferation, differentiation and migration of thousands of cells. In the chick embryo gastrulation starts with the formation of the primitive streak, the site of invagination of mesoderm and endoderm cells, from cells overlaying Koller's Sickle. Streak formation is associated with large-scale cell flows that carry the mesoderm cells overlying Koller's sickle into the central midline region of the embryo. We use multi-cell computer simulations to investigate possible mechanisms underlying the formation of the primitive streak in the chick embryo. Our simulations suggest that the formation of the primitive streak employs chemotactic movement of a subpopulation of streak cells, as well as differential adhesion between the mesoderm cells and the other cells in the epiblast. Both chemo-attraction and chemo-repulsion between various combinations of cell types can create a streak. However, only one combination successfully reproduces experimental observations of the manner in which two streaks in the same embryo interact. This finding supports a mechanism in which streak tip cells produce a diffusible morphogen which repels cells in the surrounding epiblast. On the other hand, chemotactic interaction alone does not reproduce the experimental observation that the large-scale vortical cell flows develop simultaneously with streak initiation. In our model the formation of large scale cell flows requires an additional mechanism that coordinates and aligns the motion of neighboring cells.	[Vasiev, Bakhtier; Chaplain, Mark] Univ Dundee, Div Math, Dundee, Scotland; [Balter, Ariel; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN USA; [Balter, Ariel; Glazier, James A.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Weijer, Cornelis J.] Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee, Scotland	University of Dundee; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Dundee	Vasiev, B (corresponding author), Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England.	bnvasiev@liverpool.ac.uk	Vasiev, Bakhtier/D-8006-2011; Chaplain, Mark AJ/A-5355-2010; weijer, cornelis j/I-4538-2012	Vasiev, Bakhtier/0000-0002-3452-7885; Chaplain, Mark AJ/0000-0001-5727-2160; Glazier, James Alexander/0000-0003-3634-190X; Weijer, Cornelis/0000-0003-2192-8150	Biotechnology and Biological Sciences Research Council (BBSRC) [94/E18787]; Biocomplexity Institute; Indiana University Faculty Research Support Program [NIGMS R01 GM76692, NIGMS R01 GM077138]; Biotechnology and Biological Sciences Research Council [G18071, E18787] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biocomplexity Institute; Indiana University Faculty Research Support Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by Biotechnology and Biological Sciences Research Council (BBSRC) Grant 94/E18787, "An individual based mathematical model of chick embryo gastrulation: developing a virtual embryo computational tool''; the Biocomplexity Institute and the Indiana University Faculty Research Support Program, NIGMS R01 GM76692 and NIGMS R01 GM077138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; Bertocchini F, 2004, DEVELOPMENT, V131, P3381, DOI 10.1242/dev.01178; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Bodenstein L, 2005, J THEOR BIOL, V233, P253, DOI 10.1016/j.jtbi.2004.10.008; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Chuai M, 2008, CURR TOP DEV BIOL, V81, P135, DOI 10.1016/S0070-2153(07)81004-0; Chuai ML, 2006, DEV BIOL, V296, P137, DOI 10.1016/j.ydbio.2006.04.451; Chuai M, 2009, CURR OPIN GENET DEV, V19, P343, DOI 10.1016/j.gde.2009.06.007; Cui C, 2005, DEV BIOL, V284, P37, DOI 10.1016/j.ydbio.2005.04.021; DeLuca SM, 1999, EXP CELL RES, V251, P3, DOI 10.1006/excr.1999.4577; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Eichmann A, 1998, DEVELOPMENT, V125, P743; Graeper L, 1929, WILHELM ROUX ARCH EN, V116, P382; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hogeweg P, 2002, BIOSYSTEMS, V64, P97, DOI 10.1016/S0303-2647(01)00178-2; Karabagli H, 2002, ANAT EMBRYOL, V205, P365, DOI 10.1007/s00429-002-0264-7; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; Lawson A, 2001, GENESIS, V29, P188, DOI 10.1002/gene.1023; Lunn JS, 2007, DEV BIOL, V302, P536, DOI 10.1016/j.ydbio.2006.10.014; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; Mikawa T, 2004, DEV DYNAM, V229, P422, DOI 10.1002/dvdy.10458; MITRANI E, 1990, SCIENCE, V247, P1092, DOI 10.1126/science.11032544; Painter KJ, 2000, B MATH BIOL, V62, P501, DOI 10.1006/bulm.1999.0166; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Seleiro EAP, 1996, CURR BIOL, V6, P1476, DOI 10.1016/S0960-9822(96)00752-X; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Skromne I, 2001, DEVELOPMENT, V128, P2915; STERN CD, 1990, DEVELOPMENT, V110, P1271; STERN CD, 2004, GASTRULATION CELLS E, P219; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Walshe J, 2000, MECH DEVELOP, V90, P103, DOI 10.1016/S0925-4773(99)00225-7; WEINBERGER C, 1982, ROUX ARCH DEV BIOL, V191, P127, DOI 10.1007/BF00848450; Wolpert L., 2002, PRINCIPLES DEV; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; ZIV T, 1992, DEVELOPMENT, V115, P689	39	49	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10571	10.1371/journal.pone.0010571	http://dx.doi.org/10.1371/journal.pone.0010571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485500	Green Submitted, Green Published, gold			2022-12-25	WOS:000277563200007
J	Zhu, FX; Sathish, N; Yuan, Y				Zhu, Fan Xiu; Sathish, Narayanan; Yuan, Yan			Antagonism of Host Antiviral Responses by Kaposi's Sarcoma-Associated Herpesvirus Tegument Protein ORF45	PLOS ONE			English	Article							INTERFERON REGULATORY FACTOR; IMMUNODEFICIENCY-VIRUS REPLICATION; BACTERIAL ARTIFICIAL CHROMOSOME; PRIMARY EFFUSION LYMPHOMA; I INTERFERON; GENE INDUCTION; DNA-SEQUENCES; SIMPLEX-VIRUS; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION	Virus infection of a cell generally evokes an immune response by the host to defeat the intruder in its effort. Many viruses have developed an array of strategies to evade or antagonize host antiviral responses. Kaposi's sarcoma-associated herpesvirus (KSHV) is demonstrated in this report to be able to prevent activation of host antiviral defense mechanisms upon infection. Cells infected with wild-type KSHV were permissive for superinfection with vesicular stomatitis virus (VSV), suggesting that KSHV virions fail to induce host antiviral responses. We previously showed that ORF45, a KSHV immediate-early protein as well as a tegument protein of virions, interacts with IRF-7 and inhibits virus-mediated type I interferon induction by blocking IRF-7 phosphorylation and nuclear translocation (Zhu et al., Proc. Natl. Acad. Sci. USA. 99:5573-5578, 2002). Here, using an ORF45-null recombinant virus, we demonstrate a profound role of ORF45 in inhibiting host antiviral responses. Infection of cells with an ORF45-null mutant recombinant KSHV (BAC-stop45) triggered an immune response that resisted VSV super-infection, concomitantly associated with appreciable increases in transcription of type I IFN and downstream anti-viral effector genes. Gain-of-function analysis showed that ectopic expression of ORF45 in human fibroblast cells by a lentivirus vector decreased the antiviral responses of the cells. shRNA-mediated silencing of IRF-7, that predominantly regulates both the early and late phase induction of type I IFNs, clearly indicated its critical contribution to the innate antiviral responses generated against incoming KSHV particles. Thus ORF45 through its targeting of the crucial IRF-7 regulated type I IFN antiviral responses significantly contributes to the KSHV survival immediately following a primary infection allowing for progression onto subsequent stages in its life-cycle.	[Zhu, Fan Xiu] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Sathish, Narayanan; Yuan, Yan] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA	State University System of Florida; Florida State University; University of Pennsylvania	Zhu, FX (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	yuan2@pobox.upenn.edu			National Institutes of Health [R01CA86839, R01DE016680]; NATIONAL CANCER INSTITUTE [R01CA086839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants R01CA86839 to Y.Y. and R01DE016680 to F.Z. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Al-Khatib K, 2003, VIROLOGY, V313, P126, DOI 10.1016/S0042-6822(03)00298-8; Ankel H, 1998, VIROLOGY, V251, P317, DOI 10.1006/viro.1998.9432; ASANO M, 1990, VIROLOGY, V176, P30, DOI 10.1016/0042-6822(90)90227-I; BACA LM, 1994, J LEUKOCYTE BIOL, V55, P299, DOI 10.1002/jlb.55.3.299; Berking C, 2001, CANCER RES, V61, P8306; Bisson SA, 2009, J VIROL, V83, P5056, DOI 10.1128/JVI.02516-08; Boehme KW, 2004, J VIROL, V78, P1202, DOI 10.1128/JVI.78.3.1202-1211.2004; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Browne EP, 2003, P NATL ACAD SCI USA, V100, P11439, DOI 10.1073/pnas.1534570100; Caselli E, 2005, BLOOD, V106, P2790, DOI 10.1182/blood-2005-04-1390; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; DeFilippis V, 2005, J VIROL, V79, P6419, DOI 10.1128/JVI.79.10.6419-6431.2005; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Duguay D, 2002, CANCER RES, V62, P5148; Fuld S, 2006, J VIROL, V80, P3092, DOI 10.1128/JVI.80.6.3092-3097.2006; Gaidano G, 2001, ADV CANCER RES, V80, P115, DOI 10.1016/S0065-230X(01)80014-2; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang LM, 2001, J BIOL CHEM, V276, P13427, DOI 10.1074/jbc.M011314200; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kenworthy R, 2009, NUCLEIC ACIDS RES, V37, P6587, DOI 10.1093/nar/gkp714; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Larcher C, 2005, EXP DERMATOL, V14, P41, DOI 10.1111/j.0906-6705.2005.00234.x; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Li MT, 1998, J VIROL, V72, P5433, DOI 10.1128/JVI.72.7.5433-5440.1998; Liang CY, 2008, SEMIN CANCER BIOL, V18, P423, DOI 10.1016/j.semcancer.2008.09.003; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Lubyova B, 2000, J VIROL, V74, P8194, DOI 10.1128/JVI.74.17.8194-8201.2000; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767; Perry ST, 2006, J VIROL, V80, P11105, DOI 10.1128/JVI.00846-06; RAMEZANI A, 2002, CURRENT PROTOCOL MOL; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sangfelt O, 2001, MED ONCOL, V18, P3, DOI 10.1385/MO:18:1:3; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Varthakavi V, 1999, J VIROL, V73, P10329, DOI 10.1128/JVI.73.12.10329-10338.1999; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wang FZ, 2001, J VIROL, V75, P7517, DOI 10.1128/JVI.75.16.7517-7527.2001; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 2006, J VIROL, V80, P12187, DOI 10.1128/JVI.01275-06; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599; Zhu LJ, 1999, VIROLOGY, V262, P237, DOI 10.1006/viro.1999.9900; Zimring JC, 1998, J VIROL, V72, P701, DOI 10.1128/JVI.72.1.701-707.1998	67	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10573	10.1371/journal.pone.0010573	http://dx.doi.org/10.1371/journal.pone.0010573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485504	gold, Green Published, Green Submitted			2022-12-25	WOS:000277563200009
J	Couvreur, TLP; Gort, G; Richardson, JE; Sosef, MSM; Chatrou, LW				Couvreur, Thomas L. P.; Gort, Gerrit; Richardson, James E.; Sosef, Marc S. M.; Chatrou, Lars W.			Insights into the Influence of Priors in Posterior Mapping of Discrete Morphological Characters: A Case Study in Annonaceae	PLOS ONE			English	Article							PHYLOGENY RECONSTRUCTION; PRIOR DISTRIBUTIONS; BAYESIAN-INFERENCE; EVOLUTION; STATES; LIKELIHOOD; MODEL; RATES; SYNCARPY; HISTORY	Background: Posterior mapping is an increasingly popular hierarchical Bayesian based method used to infer character histories and reconstruct ancestral states at nodes of molecular phylogenies, notably of morphological characters. As for all Bayesian analyses specification of prior values is an integrative and important part of the analysis. He we provide an example of how alternative prior choices can seriously influence results and mislead interpretations. Methods/Principal Findings: For two contrasting discrete morphological characters, namely a slow and a fast evolving character found in the plant family Annonaceae, we specified a total of eight different prior distributions per character. We investigated how these prior settings affected important summary statistics. Our analyses showed that the different prior distributions had marked effects on the results in terms of average number of character state changes. These differences arise because priors play a crucial role in determining which areas of parameter space the values of the simulation will be drawn from, independent of the data at hand. However, priors seemed to fit the data better if they would result in a more even sampling of parameter space (normal posterior distribution), in which case alternative standard deviation values had little effect on the results. The most probable character history for each character was affected differently by the prior. For the slower evolving character, the same character history always had the highest posterior probability independent of the priors used. In contrast, the faster evolving character showed different most probable character histories depending on the prior. These differences could be related to the level of homoplasy exhibited by each character. Conclusions: Although our analyses were restricted to two morphological characters within a single family, our results underline the importance of carefully choosing prior values for posterior mapping. Prior specification will be of crucial importance when interpreting the results in a meaningful way. It is hard to suggest a statistically sound method for prior specification without more detailed studies. Meanwhile, we propose that the data could be used to estimate the prior value of the gamma distribution placed on the transformation rate in posterior mapping.	[Couvreur, Thomas L. P.] New York Bot Garden, New York, NY USA; [Couvreur, Thomas L. P.; Sosef, Marc S. M.] Wageningen Univ, Biosystemat Grp, Netherlands Ctr Biodivers Nat, Sect Natl Herbarium Nerderland, Wageningen, Netherlands; [Richardson, James E.] Royal Bot Gardens, Edinburgh, Midlothian, Scotland	New York Botanical Garden; Wageningen University & Research; Royal Botanic Gardens, Kew	Couvreur, TLP (corresponding author), New York Bot Garden, New York, NY USA.	tcouvreur@nybg.org	Sosef, Marc SM/N-3655-2017; Couvreur, Thomas LP/D-8172-2011; Richardson, James-Edward/L-2768-2016	Sosef, Marc SM/0000-0002-6997-5813; Couvreur, Thomas LP/0000-0002-8509-6587; Richardson, James-Edward/0000-0001-9014-4865; Chatrou, Lars/0000-0003-0131-0302				Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; Archie James W., 1996, P153, DOI 10.1016/B978-012618030-5/50008-3; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bollback JP, 2005, STAT BIOL HEALTH, P439, DOI 10.1007/0-387-27733-1_16; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Buschbom J, 2006, SYST BIOL, V55, P471, DOI 10.1080/10635150600697465; CARLIN BP, 2000, C&H TEXT STAT SCI, P1; Carr SGM, 1961, PHYTOMORPHOLOGY, V11, P249, DOI DOI 10.1046/J.1460-9592.2001.0666H.X; Chaverri P, 2005, MYCOLOGIA, V97, P1225, DOI 10.3852/mycologia.97.6.1225; Couvreur TLP, 2008, MOL PHYLOGENET EVOL, V47, P302, DOI 10.1016/j.ympev.2008.01.018; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Donoghue MJ, 2000, AM ZOOL, V40, P759, DOI 10.1668/0003-1569(2000)040[0759:HADCAM]2.0.CO;2; Doyle J. A., 1996, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V18, P279; Eilers PHC, 2007, STAT MODEL, V7, P239, DOI 10.1177/1471082X0700700302; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; ENDRESS P K, 1990, Memoirs of the New York Botanical Garden, V55, P5; ENDRESS PK, 1982, TAXON, V31, P48, DOI 10.2307/1220588; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Hart MW, 1997, EVOLUTION, V51, P1848, DOI 10.1111/j.1558-5646.1997.tb05108.x; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Kass RE, 1996, J AM STAT ASSOC, V91, P1343, DOI 10.2307/2291752; Leschen RAB, 2007, SYST BIOL, V56, P97, DOI 10.1080/10635150701211844; Lewis LA, 2005, SYST BIOL, V54, P936, DOI 10.1080/10635150500354852; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; MADDISON WP, 2006, MESQUITE MODULAR SYS; McLeish MJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-3; Mols JB, 2004, AM J BOT, V91, P590, DOI 10.3732/ajb.91.4.590; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Nylander J, 2004, MR MODELTEST V2 PROG; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pirie MD, 2006, J BIOGEOGR, V33, P31, DOI 10.1111/j.1365-2699.2005.01388.x; PIRIE MD, 2005, CREMASTOSPERMA OTHER, P1; RAMBAUT A, 2003, TRACER VERSION 1 4; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Sanderson Michael J., 1996, P67, DOI 10.1016/B978-012618030-5/50005-8; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schultz TR, 1999, SYST BIOL, V48, P651, DOI 10.1080/106351599260229; Smedmark JEE, 2006, MOL PHYLOGENET EVOL, V39, P706, DOI 10.1016/j.ympev.2006.01.018; Stern DL, 1998, EVOLUTION, V52, P155, DOI 10.2307/2410930; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Van Dongen S, 2006, J THEOR BIOL, V242, P90, DOI 10.1016/j.jtbi.2006.02.002; Yang Z, 2005, SYST BIOL, V54, P455, DOI 10.1080/10635150590945313; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zwickl DJ, 2004, SYST BIOL, V53, P877, DOI 10.1080/10635150490522584	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10473	10.1371/journal.pone.0010473	http://dx.doi.org/10.1371/journal.pone.0010473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479935	gold, Green Published			2022-12-25	WOS:000277467900002
J	Gruez, A; Libiad, M; Boschi-Muller, S; Branlant, G				Gruez, Arnaud; Libiad, Marouane; Boschi-Muller, Sandrine; Branlant, Guy			Structural and Biochemical Characterization of Free Methionine-R-sulfoxide Reductase from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC MECHANISM; GAF DOMAIN; CHEMICAL CATALYSIS; ESCHERICHIA-COLI; AMINO-ACIDS; DIMERIZATION; SPECIFICITY; OXIDATION; BINDING; STEP	A new family of methionine-sulfoxide reductase (Msr) was recently described. The enzyme, named fRMsr, selectively reduces the R isomer at the sulfoxide function of free methionine sulfoxide (Met-R-O). The fRMsrs belong to the GAF fold family. They represent the first GAF domain to show enzymatic activity. Two other Msr families, MsrA and MsrB, were already known. MsrA and MsrB reduce free Met-S-O and Met-R-O, respectively, but exhibit higher catalytic efficiency toward Met-O within a peptide or a protein context. The fold of the three families differs. In the present work, the crystal structure of the fRMsr from Neisseria meningitidis has been determined in complex with S-Met-R-O. Based on biochemical and kinetic data as well as genomic analyses, Cys(118) is demonstrated to be the catalytic Cys on which a sulfenic acid is formed. All of the structural factors involved in the stereoselectivity of the L-Met-R-O binding were identified and account for why Met-S-O, DMSO, and a Met-O within a peptide are not substrates. Taking into account the structural, enzymatic, and biochemical information, a scenario of the catalysis for the reductase step is proposed. Based on the thiol content before and after Met-O reduction and the stoichiometry of Met formed per subunit of wild type and Cys-to-Ala mutants, a scenario of the recycling process of the N. meningitidis fRMsr is proposed. All of the biochemical, enzymatic, and structural properties of the N. meningitidis fRMsr are compared with those of MsrA and MsrB and are discussed in terms of the evolution of function of the GAF domain.	[Gruez, Arnaud; Libiad, Marouane; Boschi-Muller, Sandrine; Branlant, Guy] Nancy Univ, AREMS, CNRS, UMR UHP 7214,Fac Sci & Technol, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Branlant, G (corresponding author), Nancy Univ, AREMS, CNRS, UMR UHP 7214,Fac Sci & Technol, Bld Aiguillettes,BP 70239, F-54506 Vandoeuvre Les Nancy, France.	Guy.Branlant@maem.uhp-nancy.fr		Boschi, Sandrine/0000-0001-8962-4749; Libiad, Marouane/0000-0003-1717-9206	CNRS; University of Nancy I; IFR 111 Bioingenierie; French Ministry of Research	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nancy I; IFR 111 Bioingenierie; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the CNRS, the University of Nancy I, and the IFR 111 Bioingenierie.; Supported by the French Ministry of Research.	Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; Antoine M, 2006, J BIOL CHEM, V281, P39062, DOI 10.1074/jbc.M608844200; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Neiers F, 2007, J BIOL CHEM, V282, P32397, DOI 10.1074/jbc.M704730200; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021; Ranaivoson FM, 2009, J MOL BIOL, V394, P83, DOI 10.1016/j.jmb.2009.08.073; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	24	28	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25033	25043		10.1074/jbc.M110.134528	http://dx.doi.org/10.1074/jbc.M110.134528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20489204	Green Published, hybrid			2022-12-25	WOS:000280542100076
J	Wang, JH; Chen, YA				Wang, Jianghai; Chen, Yuan			Role of the Zn2+ Motif of E1 in SUMO Adenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ACTIVATING ENZYME; E1-E2 INTERACTION; MODIFIER SUMO-1; PROTEIN; MECHANISM; NUCLEAR; E2; RECRUITMENT; CONJUGATION; INSIGHTS	Post-translational modifications by ubiquitin-like proteins are among the most important mechanisms for regulating a wide variety of cellular functions. In these modifications an E1 enzyme activates each ubiquitin-like protein (Ubl) by adenylation of the Ubl C-terminal COOH group and then forms a thioester bond with the adenylated C-terminal COOH group of the Ubl. Previous x-ray crystallography studies revealed a conserved zinc motif in the SUMO and NEDD8 E1; however, the function of this Zn2+ motif is unclear. In this study, using quantitative ATP:PPi isotope exchange assays in combination with site-directed mutagenesis, we show that the conserved Zn2+ motif in the SUMO E1 is important for SUMO adenylation and is critical for the E1 pseudo-ordered substrate binding mechanism. Furthermore, Zn2+ motif mutants showed significantly reduced k(cat) values for ATP: PPi isotope exchange assays, suggesting that the Zn2+ motif is important in binding and preventing SUMO adenylate from dissociating from E1 before formation of the thioester conjugate. Because the Zn2+ motif is located in a crossover loop that is known to have conformational flexibility, the results described here suggest that this cross-over loop interacts with Ubl in the multistep, dynamic process of Ubl activation by E1s.	[Wang, Jianghai; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Med, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Chen, YA (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Med, Duarte, CA 91010 USA.	ychen@coh.org			National Institutes of Health [R01GM074748, R01GM086171]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074748, R01GM086171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074748 and R01GM086171.	Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Guo B, 2007, BIOCHEM SOC T, V35, P1414, DOI 10.1042/BST0351414; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700	24	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23732	23738		10.1074/jbc.M110.114660	http://dx.doi.org/10.1074/jbc.M110.114660			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501649	Green Published, hybrid			2022-12-25	WOS:000280291400023
J	Boyko, RH; Marshall, AJ				Boyko, Ryan H.; Marshall, Andrew J.			Using Simulation Models to Evaluate Ape Nest Survey Techniques	PLOS ONE			English	Article							ORANGUTAN PONGO-PYGMAEUS; WEST KALIMANTAN; POPULATION; FOREST	Background: Conservationists frequently use nest count surveys to estimate great ape population densities, yet the accuracy and precision of the resulting estimates are difficult to assess. Methodology/Principal Findings: We used mathematical simulations to model nest building behavior in an orangutan population to compare the quality of the population size estimates produced by two of the commonly used nest count methods, the 'marked recount method' and the 'matrix method.' We found that when observers missed even small proportions of nests in the first survey, the marked recount method produced large overestimates of the population size. Regardless of observer reliability, the matrix method produced substantial overestimates of the population size when surveying effort was low. With high observer reliability, both methods required surveying approximately 0.26% of the study area (0.26 km(2) out of 100 km(2) in this simulation) to achieve an accurate estimate of population size; at or above this sampling effort both methods produced estimates within 33% of the true population size 50% of the time. Both methods showed diminishing returns at survey efforts above 0.26% of the study area. The use of published nest decay estimates derived from other sites resulted in widely varying population size estimates that spanned nearly an entire order of magnitude. The marked recount method proved much better at detecting population declines, detecting 5% declines nearly 80% of the time even in the first year of decline. Conclusions/Significance: These results highlight the fact that neither nest surveying method produces highly reliable population size estimates with any reasonable surveying effort, though either method could be used to obtain a gross population size estimate in an area. Conservation managers should determine if the quality of these estimates are worth the money and effort required to produce them, and should generally limit surveying effort to 0.26% of the study area, unless specific management goals require more intensive sampling. Using site-and time-specific nest decay rates (or the marked recount method) are essential for accurate population size estimation. Marked recount survey methods with sufficient sampling effort hold promise for detecting population declines.	[Boyko, Ryan H.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Boyko, RH (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	rboyko@ucdavis.edu						Buij R, 2002, BIOL CONSERV, V107, P83, DOI 10.1016/S0006-3207(02)00048-4; Buij R, 2003, BIOL CONSERV, V114, P103, DOI 10.1016/S0006-3207(03)00015-6; HASHIMOTO C, 1995, PRIMATES, V36, P477, DOI 10.1007/BF02382870; Husson Simon J., 2009, P77; Johnson AE, 2005, BIOL CONSERV, V121, P495, DOI 10.1016/j.biocon.2004.06.002; K?hl H., 2008, BEST PRACTICE GUIDEL; KEMENY JG, 1956, INTRO FINITE MATH; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall AJ, 2009, ORYX, V43, P416, DOI 10.1017/S0030605309001513; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; MOLYNEAUX A, 2007, THESIS OXFORD BROOKS; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Prasetyo Didik, 2009, P269; Russon AE, 2001, BIOL CONSERV, V97, P21, DOI 10.1016/S0006-3207(00)00087-2; Singleton I, 2000, THESIS U KENT CANTER THESIS U KENT CANTER; van Schaik Carel P., 2009, P351; vanSchaik CP, 1995, NEGLECTED APE, P109; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X	18	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10754	10.1371/journal.pone.0010754	http://dx.doi.org/10.1371/journal.pone.0010754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505781	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017400011
J	Jung, M; Peterson, H; Chavez, L; Kahlem, P; Lehrach, H; Vilo, J; Adjaye, J				Jung, Marc; Peterson, Hedi; Chavez, Lukas; Kahlem, Pascal; Lehrach, Hans; Vilo, Jaak; Adjaye, James			A Data Integration Approach to Mapping OCT4 Gene Regulatory Networks Operative in Embryonic Stem Cells and Embryonal Carcinoma Cells	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; TARGET GENES; CHIP-CHIP; EC CELLS; EXPRESSION; NANOG; DIFFERENTIATION; IDENTIFICATION; BINDING	It is essential to understand the network of transcription factors controlling self-renewal of human embryonic stem cells (ESCs) and human embryonal carcinoma cells (ECs) if we are to exploit these cells in regenerative medicine regimes. Correlating gene expression levels after RNAi-based ablation of OCT4 function with its downstream targets enables a better prediction of motif-specific driven expression modules pertinent for self-renewal and differentiation of embryonic stem cells and induced pluripotent stem cells. We initially identified putative direct downstream targets of OCT4 by employing CHIP-on-chip analysis. A comparison of three peak analysis programs revealed a refined list of OCT4 targets in the human EC cell line NCCIT, this list was then compared to previously published OCT4 CHIP-on-chip datasets derived from both ES and EC cells. We have verified an enriched POU-motif, discovered by a de novo approach, thus enabling us to define six distinct modules of OCT4 binding and regulation of its target genes. A selection of these targets has been validated, like NANOG, which harbours the evolutionarily conserved OCT4-SOX2 binding motif within its proximal promoter. Other validated targets, which do not harbour the classical HMG motif are USP44 and GADD45G, a key regulator of the cell cycle. Overexpression of GADD45G in NCCIT cells resulted in an enrichment and up-regulation of genes associated with the cell cycle (CDKN1B, CDKN1C, CDK6 and MAPK4) and developmental processes (BMP4, HAND1, EOMES, ID2, GATA4, GATA5, ISL1 and MSX1). A comparison of positively regulated OCT4 targets common to EC and ES cells identified genes such as NANOG, PHC1, USP44, SOX2, PHF17 and OCT4, thus further confirming their universal role in maintaining self-renewal in both cell types. Finally we have created a user-friendly database (http://biit.cs.ut.ee/escd/), integrating all OCT4 and stem cell related datasets in both human and mouse ES and EC cells. In the current era of systems biology driven research, we envisage that our integrated embryonic stem cell database will prove beneficial to the booming field of ES, iPS and cancer research.	[Jung, Marc; Chavez, Lukas; Lehrach, Hans; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany; [Peterson, Hedi] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Peterson, Hedi; Vilo, Jaak] Quretec Ltd, Tartu, Estonia; [Kahlem, Pascal] EMBL European Bioinformat Inst, Cambridge, England; [Vilo, Jaak] Univ Tartu, Inst Comp Sci, EE-50090 Tartu, Estonia	Max Planck Society; University of Tartu; European Molecular Biology Laboratory (EMBL); University of Tartu	Jung, M (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany.	jung@molgen.mpg.de; adjaye@molgen.mpg.de	Peterson, Hedi/F-4920-2017; Vilo, Jaak/AAK-2228-2020; Peterson, Hedi/ABA-3355-2020; Vilo, Jaak/A-7183-2008; Peterson, Hedi/C-7514-2012	Peterson, Hedi/0000-0001-9951-5116; Vilo, Jaak/0000-0001-5604-4107; Peterson, Hedi/0000-0001-9951-5116; Vilo, Jaak/0000-0001-5604-4107; Kahlem, Pascal/0000-0002-8810-444X; Chavez, Lukas/0000-0002-8718-8848	ENFIN; European Commission [LSHG-CT-2005-518254]; Max Planck Society	ENFIN(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area "Life sciences, genomics and biotechnology for health'', contract number LSHG-CT-2005-518254, and also the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Adjaye J, 1999, GENE, V237, P373, DOI 10.1016/S0378-1119(99)00329-7; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen YH, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-75; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cotta CV, 2003, BLOOD, V101, P4342, DOI 10.1182/blood-2002-10-3139; DAMJANOV I, 1993, LAB INVEST, V68, P220; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deshpande AM, 2009, J BIOL CHEM, V284, P6043, DOI 10.1074/jbc.C800158200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Garcia-Dominguez M, 2003, DEVELOPMENT, V130, P6013, DOI 10.1242/dev.00840; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GORDAN R, 2009, GENOME RES; Gordon DB, 2005, BIOINFORMATICS, V21, P3164, DOI 10.1093/bioinformatics/bti481; Goto T, 1999, MOL HUM REPROD, V5, P851, DOI 10.1093/molehr/5.9.851; GREBER B, 2008, STEM CELLS DEV; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jin VX, 2007, GENOME RES, V17, P807, DOI 10.1101/gr.6006107; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Li HY, 2008, OBESITY, V16, P356, DOI 10.1038/oby.2007.76; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; LISTER R, 2009, NATURE; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; RAMJI DP, 1991, NUCLEIC ACIDS RES, V19, P1139, DOI 10.1093/nar/19.5.1139; Regenbrecht CRA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-49; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; TANTIN D, 2008, GENOME RES; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Xiong C, 2005, STEM CELLS DEV, V14, P367, DOI 10.1089/scd.2005.14.367	76	72	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10709	10.1371/journal.pone.0010709	http://dx.doi.org/10.1371/journal.pone.0010709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505756	Green Submitted, gold, Green Published			2022-12-25	WOS:000278017400009
J	Imanian, B; Pombert, JF; Keeling, PJ				Imanian, Behzad; Pombert, Jean-Francois; Keeling, Patrick J.			The Complete Plastid Genomes of the Two 'Dinotoms' Durinskia baltica and Kryptoperidinium foliaceum	PLOS ONE			English	Article							DINOFLAGELLATE PERIDINIUM-BALTICUM; SP-NOV DINOPHYCEAE; GLENODINIUM-FOLIACEUM; MARINE DINOFLAGELLATE; DIATOM ENDOSYMBIONT; SERIAL REPLACEMENT; QUINQUECORNE ABE; GENE-TRANSFER; CHLOROPLAST; RECOMBINATION	Background: In one small group of dinoflagellates, photosynthesis is carried out by a tertiary endosymbiont derived from a diatom, giving rise to a complex cell that we collectively refer to as a 'dinotom'. The endosymbiont is separated from its host by a single membrane and retains plastids, mitochondria, a large nucleus, and many other eukaryotic organelles and structures, a level of complexity suggesting an early stage of integration. Although the evolution of these endosymbionts has attracted considerable interest, the plastid genome has not been examined in detail, and indeed no tertiary plastid genome has yet been sequenced. Methodology/Principal Findings: Here we describe the complete plastid genomes of two closely related dinotoms, Durinskia baltica and Kryptoperidinium foliaceum. The D. baltica (116470 bp) and K. foliaceum (140426 bp) plastid genomes map as circular molecules featuring two large inverted repeats that separate distinct single copy regions. The organization and gene content of the D. baltica plastid closely resemble those of the pennate diatom Phaeodactylum tricornutum. The K. foliaceum plastid genome is much larger, has undergone more reorganization, and encodes a putative tyrosine recombinase (tyrC) also found in the plastid genome of the heterokont Heterosigma akashiwo, and two putative serine recombinases (serC1 and serC2) homologous to recombinases encoded by plasmids pCf1 and pCf2 in another pennate diatom, Cylindrotheca fusiformis. The K. foliaceum plastid genome also contains an additional copy of serC1, two degenerate copies of another plasmid-encoded ORF, and two non-coding regions whose sequences closely resemble portions of the pCf1 and pCf2 plasmids. Conclusions/Significance: These results suggest that while the plastid genomes of two dinotoms share very similar gene content and genome organization with that of the free-living pennate diatom P. tricornutum, the K. folicaeum plastid genome has absorbed two exogenous plasmids. Whether this took place before or after the tertiary endosymbiosis is not clear.	[Imanian, Behzad; Pombert, Jean-Francois; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Imanian, B (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	pkeeling@interchange.ubc.ca		Keeling, Patrick/0000-0002-7644-0745; Pombert, Jean-Francois/0000-0002-3449-8375; Imanian, Behzad/0000-0002-8768-0453	Natural Sciences and Engineering Research Council of Canada [227301]; Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec Louis-Berlinguet	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec Louis-Berlinguet(FQRNT)	This work was supported by a Natural Sciences and Engineering Research Council operating grant (227301) to PJK. BI is the recipient of a Doctoral Scholarship from the Natural Sciences and Engineering Research Council of Canada. JFP is the recipient of the Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec Louis-Berlinguet Postdoctoral Fellowship. PJK is a Fellow of the Canadian Institute for Advanced Research and a Senior Scholar of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; BLAKELY GW, 1994, NUCLEIC ACIDS RES, V22, P5613; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; CARTY S, 1986, PHYCOLOGIA, V25, P197, DOI 10.2216/i0031-8884-25-2-197.1; Cattolico RA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-211; Chesnick JM, 1997, J EUKARYOT MICROBIOL, V44, P314, DOI 10.1111/j.1550-7408.1997.tb05672.x; CHESNICK JM, 1987, BIOSYSTEMS, V21, P69, DOI 10.1016/0303-2647(87)90007-4; CHESNICK JM, 1989, AM J BOT, V76, P1060, DOI 10.2307/2444528; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Deane JA, 2000, PROTIST, V151, P239, DOI 10.1078/1434-4610-00022; DEMADARIAGA I, 1989, BOT MAR, V32, P159, DOI 10.1515/botm.1989.32.2.159; DODGE JD, 1971, PROTOPLASMA, V73, P145, DOI 10.1007/BF01275591; ESCHBACH S, 1990, J PHYCOL, V26, P324, DOI 10.1111/j.0022-3646.1990.00324.x; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; Figueroa RI, 2009, PROTIST, V160, P285, DOI 10.1016/j.protis.2008.12.003; FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9; Garate-Lizarraga I, 2008, ACTA BOT MEX, V83, P33, DOI 10.21829/abm83.2008.1059; GORDON D, 2004, CURRENT PROTOCOLS BI; Hackett JD, 2003, J PHYCOL, V39, P440, DOI 10.1046/j.1529-8817.2003.02100.x; HAN YPW, 1993, EMBO J, V12, P4577, DOI 10.1002/j.1460-2075.1993.tb06146.x; Hewes CD, 1998, J PHYCOL, V34, P945, DOI 10.1046/j.1529-8817.1998.340945.x; HILDEBRAND M, 1991, J BACTERIOL, V173, P5924, DOI 10.1128/jb.173.18.5924-5927.1991; HILDEBRAND M, 1992, PLANT MOL BIOL, V19, P759, DOI 10.1007/BF00027072; HORIGUCHI T, 1991, BOT MAR, V34, P123, DOI 10.1515/botm.1991.34.2.123; HORIGUCHI T, 1994, EUR J PHYCOL, V29, P237, DOI 10.1080/09670269400650691; Horiguchi T, 2006, PHYCOL RES, V54, P193, DOI 10.1111/j.1440-1835.2006.00426.x; Imanian B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-172; Imanian B, 2007, J EUKARYOT MICROBIOL, V54, P146, DOI 10.1111/j.1550-7408.2007.00245.x; JACOBS JD, 1992, MOL GEN GENET, V233, P302, DOI 10.1007/BF00587592; Jarvis P, 2002, BBA-MOL CELL RES, V1590, P177, DOI 10.1016/S0167-4889(02)00176-3; JEFFREY SW, 1976, J PHYCOL, V12, P450, DOI 10.1111/j.1529-8817.1976.tb02872.x; JEFFREY SW, 1975, J PHYCOL, V11, P374, DOI 10.1111/j.1529-8817.1975.tb02799.x; Kempton Jason W., 2002, Harmful Algae, V1, P383, DOI 10.1016/S1568-9883(02)00051-3; KITE GC, 1988, BIOSYSTEMS, V21, P151, DOI 10.1016/0303-2647(88)90008-1; KITE GC, 1985, J PHYCOL, V21, P50; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lesterlin C, 2004, MOL MICROBIOL, V54, P1151, DOI 10.1111/j.1365-2958.2004.04356.x; MANDELLI EF, 1968, J PHYCOL, V4, P347, DOI 10.1111/j.1529-8817.1968.tb04706.x; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McEwan ML, 2004, J EUKARYOT MICROBIOL, V51, P651, DOI 10.1111/j.1550-7408.2004.tb00604.x; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; Pienaar RN, 2007, J PLANT RES, V120, P247, DOI 10.1007/s10265-006-0047-y; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schnepf E, 1999, GRANA, V38, P81, DOI 10.1080/00173139908559217; SCHNEPF E, 1988, BOT ACTA, V101, P196, DOI 10.1111/j.1438-8677.1988.tb00033.x; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Takano Y, 2008, PHYCOLOGIA, V47, P41, DOI 10.2216/07-36.1; Tamura M, 2005, J PHYCOL, V41, P658, DOI 10.1111/j.1529-8817.2005.00085.x; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; TIPPIT DH, 1976, J CELL SCI, V21, P273; TOMAS RN, 1973, J PHYCOL, V9, P304; WITHERS NW, 1977, J PHYCOL, V13, P354, DOI 10.1111/j.0022-3646.1977.00354.x; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352	64	69	72	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10711	10.1371/journal.pone.0010711	http://dx.doi.org/10.1371/journal.pone.0010711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502706	Green Published, gold, Green Submitted			2022-12-25	WOS:000277845400014
J	Zeller, T; Wild, P; Szymczak, S; Rotival, M; Schillert, A; Castagne, R; Maouche, S; Germain, M; Lackner, K; Rossmann, H; Eleftheriadis, M; Sinning, CR; Schnabel, RB; Lubos, E; Mennerich, D; Rust, W; Perret, C; Proust, C; Nicaud, V; Loscalzo, J; Hubner, N; Tregouet, D; Munzel, T; Ziegler, A; Tiret, L; Blankenberg, S; Cambien, F				Zeller, Tanja; Wild, Philipp; Szymczak, Silke; Rotival, Maxime; Schillert, Arne; Castagne, Raphaele; Maouche, Seraya; Germain, Marine; Lackner, Karl; Rossmann, Heidi; Eleftheriadis, Medea; Sinning, Christoph R.; Schnabel, Renate B.; Lubos, Edith; Mennerich, Detlev; Rust, Werner; Perret, Claire; Proust, Carole; Nicaud, Viviane; Loscalzo, Joseph; Huebner, Norbert; Tregouet, David; Muenzel, Thomas; Ziegler, Andreas; Tiret, Laurence; Blankenberg, Stefan; Cambien, Francois			Genetics and Beyond - The Transcriptome of Human Monocytes and Disease Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; EXPRESSION PROFILES; GENES; LOCI; VARIANTS; RISK; MACROPHAGES; HAPLOTYPE; SMOKING	Background: Variability of gene expression in human may link gene sequence variability and phenotypes; however, non-genetic variations, alone or in combination with genetics, may also influence expression traits and have a critical role in physiological and disease processes. Methodology/Principal Findings: To get better insight into the overall variability of gene expression, we assessed the transcriptome of circulating monocytes, a key cell involved in immunity-related diseases and atherosclerosis, in 1,490 unrelated individuals and investigated its association with >675,000 SNPs and 10 common cardiovascular risk factors. Out of 12,808 expressed genes, 2,745 expression quantitative trait loci were detected (P<5.78x10(-12)), most of them (90%) being cis-modulated. Extensive analyses showed that associations identified by genome-wide association studies of lipids, body mass index or blood pressure were rarely compatible with a mediation by monocyte expression level at the locus. At a study-wide level (P<3.9x10(-7)), 1,662 expression traits (13.0%) were significantly associated with at least one risk factor. Genome-wide interaction analyses suggested that genetic variability and risk factors mostly acted additively on gene expression. Because of the structure of correlation among expression traits, the variability of risk factors could be characterized by a limited set of independent gene expressions which may have biological and clinical relevance. For example expression traits associated with cigarette smoking were more strongly associated with carotid atherosclerosis than smoking itself. Conclusions/Significance: This study demonstrates that the monocyte transcriptome is a potent integrator of genetic and non-genetic influences of relevance for disease pathophysiology and risk assessment.	[Zeller, Tanja; Wild, Philipp; Eleftheriadis, Medea; Sinning, Christoph R.; Schnabel, Renate B.; Lubos, Edith; Muenzel, Thomas; Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin, Mainz, Germany; [Szymczak, Silke; Schillert, Arne; Ziegler, Andreas] Med Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Rotival, Maxime; Castagne, Raphaele; Maouche, Seraya; Germain, Marine; Perret, Claire; Proust, Carole; Nicaud, Viviane; Tregouet, David; Tiret, Laurence; Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, Paris, France; [Rotival, Maxime; Castagne, Raphaele; Maouche, Seraya; Germain, Marine; Perret, Claire; Proust, Carole; Nicaud, Viviane; Tregouet, David; Tiret, Laurence; Cambien, Francois] Sch Med, Paris, France; [Lackner, Karl; Rossmann, Heidi] Johannes Gutenberg Univ Mainz, Inst Klin Chem & Labs Med, Mainz, Germany; [Mennerich, Detlev; Rust, Werner] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Huebner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany	Johannes Gutenberg University of Mainz; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Johannes Gutenberg University of Mainz; Boehringer Ingelheim; Harvard University; Brigham & Women's Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Zeller, T (corresponding author), Johannes Gutenberg Univ Mainz, Med Klin & Poliklin, Mainz, Germany.	blankenberg@2-med.klinik.uni-mainz.de; francois.cambien@upmc.fr	Szymczak, Silke/C-6625-2013; Wild, Philipp S./M-2106-2019; Loscalzo, Joseph/ABD-8980-2021; Trégouët, David-Alexandre/P-9210-2019; Schnabel, Renate B/ABE-6668-2021; Schnabel, Renate B/F-6527-2014; Munzel, Thomas/A-2912-2014; Rossmann, Heidi/ABE-5694-2020; Tregouet, David-Alexandre/E-3961-2016; Szymczak, Silke/HGT-8202-2022; Cambien, Francois/AAP-9751-2020; Ziegler, Andreas/G-4246-2012	Trégouët, David-Alexandre/0000-0001-9084-7800; Schnabel, Renate B/0000-0001-7170-9509; Munzel, Thomas/0000-0001-5503-4150; Rossmann, Heidi/0000-0002-7532-8540; Rotival, Maxime/0000-0003-2519-8044; Castagne, Raphaele/0000-0003-0067-6775; Maouche, Seraya/0000-0001-8186-1635; Wild, Philipp/0000-0003-4413-9752; Ziegler, Andreas/0000-0002-8386-5397; Germain, Marine/0000-0002-8489-8916; Zeller, Tanja/0000-0003-3379-2641; Szymczak, Silke/0000-0002-8897-9035	government of Rheinland-Pfalz (Stiftung Rheinland Pfalz fur Innovation) [AZ 961-386261/733]; Wissen schafft Zukunft and Schwerpunkt Vaskulare Pravention of the Johannes Gutenberg-University of Mainz; Federal Ministry of Education and Research, Germany [A3 01GS0833]	government of Rheinland-Pfalz (Stiftung Rheinland Pfalz fur Innovation); Wissen schafft Zukunft and Schwerpunkt Vaskulare Pravention of the Johannes Gutenberg-University of Mainz; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF))	The Gutenberg Heart Study is funded through the government of Rheinland-Pfalz (Stiftung Rheinland Pfalz fur Innovation, contract number AZ 961-386261/733), the research programs Wissen schafft Zukunft and Schwerpunkt Vaskulare Pravention of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Heart Study. Specifically, the research reported in this article was supported by the National Genome Network NGFNplus (contract number project A3 01GS0833) by the Federal Ministry of Education and Research, Germany. For this particular research paper, Boehringer Ingelheim provided payment of two employees for expression microarray analyses and array purchase. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; [Anonymous], 1932, STAT METHODS RES WOR; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Buttner P, 2007, IMMUNOGENETICS, V59, P37, DOI 10.1007/s00251-006-0177-3; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Charles PC, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-38; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cox MA, 2005, BIOCHEM BIOPH RES CO, V330, P467, DOI 10.1016/j.bbrc.2005.03.004; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Handunnetthi L, 2010, GENES IMMUN, V11, P99, DOI 10.1038/gene.2009.83; He JQ, 2008, MOL IMMUNOL, V45, P4041, DOI 10.1016/j.molimm.2008.07.011; Huber W, 2002, BIOINFORMATICS, V18, pS96; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lindholm D, 2009, CELL MOL LIFE SCI, V66, P3399, DOI 10.1007/s00018-009-0127-y; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nica AC, 2008, HUM MOL GENET, V17, pR129, DOI 10.1093/hmg/ddn285; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; R Core Team, 2022, R LANG ENV STAT COMP; Rimkus C, 2006, BRIT J CANCER, V95, P1419, DOI 10.1038/sj.bjc.6603452; Samani NJ, 2008, J MOL MED, V86, P1233, DOI 10.1007/s00109-008-0387-2; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schmitz G, 2001, J LIPID RES, V42, P1513; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tan QH, 2008, GENOMICS, V92, P94, DOI 10.1016/j.ygeno.2008.04.001; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Watanabe M, 2002, CIRC RES, V91, P382, DOI 10.1161/01.RES.0000033593.05545.7B; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhou T, 2006, CELL MOL IMMUNOL, V3, P279; Zudaire E, 2006, J LEUKOCYTE BIOL, V80, P237, DOI 10.1189/jlb.0206123	57	479	489	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10693	10.1371/journal.pone.0010693	http://dx.doi.org/10.1371/journal.pone.0010693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502693	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000277776500010
J	Prakash, H; Luth, A; Grinkina, N; Holzer, D; Wadgaonkar, R; Gonzalez, AP; Anes, E; Kleuser, B				Prakash, Hridayesh; Lueth, Anja; Grinkina, Natalia; Holzer, Daniela; Wadgaonkar, Raj; Gonzalez, Alexis Perez; Anes, Elsa; Kleuser, Burkhard			Sphingosine Kinase-1 (SphK-1) Regulates Mycobacterium smegmatis Infection in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-2; BACILLUS-CALMETTE-GUERIN; NITRIC-OXIDE PRODUCTION; PHAGOSOME MATURATION; IN-VITRO; DIFFERENTIAL REGULATION; GRANULOMA-FORMATION; GROWTH-FACTOR	Sphingosine kinase-1 is known to mediate Mycobacterium smegmatis induced inflammatory responses in macrophages, but its role in controlling infection has not been reported to date. We aimed to unravel the significance of SphK-1 in controlling M. smegmatis infection in RAW 264.7 macrophages. Our results demonstrated for the first time that selective inhibition of SphK-1 by either D, L threo dihydrosphingosine (DHS; a competitive inhibitor of Sphk-1) or Sphk-1 siRNA rendered RAW macrophages sensitive to M. smegmatis infection. This was due to the reduction in the expression of iNOs, p38, pp-38, late phagosomal marker, LAMP-2 and stabilization of the RelA (pp-65) subunit of NF-kappa B. This led to a reduction in the generation of NO and secretion of TNF-alpha in infected macrophages. Congruently, overexpression of SphK-1 conferred resistance in macrophages to infection which was due to enhancement in the generation of NO and expression of iNOs, pp38 and LAMP-2. In addition, our results also unraveled a novel regulation of p38MAPK by SphK-1 during M. smegmatis infection and generation of NO in macrophages. Enhanced NO generation and expression of iNOs in SphK-1++ infected macrophages demonstrated their M-1(bright) phenotype of these macrophages. These findings thus suggested a novel antimycobacterial role of SphK-1 in macrophages.	[Prakash, Hridayesh; Holzer, Daniela] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Gonzalez, Alexis Perez] European Mol Biol Lab, Flow Cytometry Core Facil, Heidelberg, Germany; [Lueth, Anja; Kleuser, Burkhard] Univ Potsdam, Fac Math & Nat Sci, Berlin, Germany; [Anes, Elsa] Univ Lisbon, Fac Farm, Ctr Patogenese Mol URIA, Inst Mol Med, Lisbon, Portugal; [Grinkina, Natalia; Wadgaonkar, Raj] SUNY, Dept Med, Brooklyn, NY USA	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Potsdam; Universidade de Lisboa; State University of New York (SUNY) System; SUNY Maritime College	Prakash, H (corresponding author), German Canc Res Ctr, Div Tumor Immunol, D-6900 Heidelberg, Germany.	h.prakash@dkfz-heidelberg.de	Hridayesh, Prakash/W-9478-2019; iMed.ULisboa, HPI/B-4239-2014; Anes, Elsa/K-3124-2013	Hridayesh, Prakash/0000-0001-5269-2481; iMed.ULisboa, HPI/0000-0001-5934-0198; Anes, Elsa/0000-0001-5934-0198; Kleuser, Burkhard/0000-0002-1888-9595	Deutsche Forschungsgemeinschaft (German Research Foundation); Portuguese National Foundation for Science [PIC/IC/82859/2007, PTDC/SAU-MII/098024/2008]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Portuguese National Foundation for Science	This work was supported by the SFB grant from Deutsche Forschungsgemeinschaft (German Research Foundation) and Portuguese National Foundation for Science (PIC/IC/82859/2007; PTDC/SAU-MII/098024/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Baumruker T, 2005, IMMUNOL LETT, V96, P175, DOI 10.1016/j.imlet.2004.09.001; Becker S, 2002, AM J RESP CELL MOL, V27, P611, DOI 10.1165/rcmb.4868; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bermudez LE, 1999, CLIN EXP IMMUNOL, V116, P94; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; BUEHRER BM, 1992, J BIOL CHEM, V267, P3154; Castillo SS, 2001, J NUTR, V131, P2826, DOI 10.1093/jn/131.11.2826; CHAMPSI JH, 1994, BIOTHERAPY, V7, P187, DOI 10.1007/BF01878485; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; Chernenko SM, 2006, J HEART LUNG TRANSPL, V25, P1447, DOI 10.1016/j.healun.2006.09.003; Darieva Z, 2004, J LEUKOCYTE BIOL, V75, P689, DOI 10.1189/jlb.0603280; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Doherty TM, 1997, J IMMUNOL, V158, P4822; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ehlers S, 1999, IMMUNOLOGY, V98, P313; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Galkina E, 2007, ADV EXP MED BIOL, V601, P75; Garg SK, 2004, J INFECT DIS, V189, P2129, DOI 10.1086/386286; Gauthier DT, 2008, ECOL APPL, V18, P1718, DOI 10.1890/07-2083.1; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Hamai H, 2009, J LIPID RES, V50, P1101, DOI 10.1194/jlr.M800427-JLR200; Hammad SM, 2008, PROSTAG OTH LIPID M, V85, P107, DOI 10.1016/j.prostaglandins.2007.11.002; Hollingsworth JW, 2007, J IMMUNOL, V179, P4367, DOI 10.4049/jimmunol.179.7.4367; Iyer Shankar S., 2009, V531, P347, DOI 10.1007/978-1-59745-396-7_21; Jolly PS, 2002, MOL IMMUNOL, V38, P1239, DOI 10.1016/S0161-5890(02)00070-6; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; KAWAMORI T, 2008, FASEB J; Kusner DJ, 2007, J BIOL CHEM, V282, P23147, DOI 10.1074/jbc.M700193200; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; Lahiri A, 2008, MICROBES INFECT, V10, P1166, DOI 10.1016/j.micinf.2008.06.008; Lahti Aleksi, 2006, BMC Pharmacology, V6, P5, DOI 10.1186/1471-2210-6-5; Lai WQ, 2008, J IMMUNOL, V180, P4323, DOI 10.4049/jimmunol.180.6.4323; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; Li QF, 2008, BIOCHEM BIOPH RES CO, V371, P159, DOI 10.1016/j.bbrc.2008.04.037; Limaye V, 2008, ENDOTHELIUM-J ENDOTH, V15, P101, DOI 10.1080/10623320802125342; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maher P, 2001, J NEUROSCI, V21, P2929, DOI 10.1523/JNEUROSCI.21-09-02929.2001; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Marshall BG, 1997, INFECT IMMUN, V65, P1931, DOI 10.1128/IAI.65.5.1931-1935.1997; Melendez AJ, 2008, BBA-PROTEINS PROTEOM, V1784, P66, DOI 10.1016/j.bbapap.2007.07.013; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Orman KL, 2000, J INFECT DIS, V182, P1561, DOI 10.1086/315861; Tumitan ARP, 2007, MICROBIOL IMMUNOL, V51, P1021, DOI 10.1111/j.1348-0421.2007.tb03986.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; Plum J, 1999, PERITON DIALYSIS INT, V19, pS378; Pyne NJ, 2008, BBA-MOL CELL BIOL L, V1781, P467, DOI 10.1016/j.bbalip.2008.05.004; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Skeritzian CA, 2007, PHARMACOL THERAPEUT, V115, P390, DOI 10.1016/j.pharmthera.2007.05.011; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Thompson CR, 2005, J IMMUNOL, V174, P3551, DOI 10.4049/jimmunol.174.6.3551; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Uhlig S, 2008, AM J RESP CRIT CARE, V178, P1100, DOI 10.1164/rccm.200804-595SO; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wang F, 1996, GLYCOCONJUGATE J, V13, P937, DOI 10.1007/BF01053189; Wang SL, 2002, J EUKARYOT MICROBIOL, V49, P305, DOI 10.1111/j.1550-7408.2002.tb00374.x; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; Wong RCB, 2007, STEM CELLS DEV, V16, P989, DOI 10.1089/scd.2007.0057; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Yan BS, 2007, J IMMUNOL, V179, P6919, DOI 10.4049/jimmunol.179.10.6919; Yan GJ, 2008, CARDIOVASC RES, V78, P308, DOI 10.1093/cvr/cvn006; Yang JF, 2005, J IMMUNOL, V175, P6580, DOI 10.4049/jimmunol.175.10.6580; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; YATOMI Y, 1995, ANAL BIOCHEM, V230, P315, DOI 10.1006/abio.1995.1480; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	79	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10657	10.1371/journal.pone.0010657	http://dx.doi.org/10.1371/journal.pone.0010657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498849	Green Published, gold			2022-12-25	WOS:000277773700008
J	He, WC; Tan, RY; Dai, CS; Li, YJ; Wang, D; Hao, S; Kahn, M; Liu, YH				He, Weichun; Tan, Ruoyun; Dai, Chunsun; Li, Yingjian; Wang, Dan; Hao, Sha; Kahn, Michael; Liu, Youhua			Plasminogen Activator Inhibitor-1 Is a Transcriptional Target of the Canonical Pathway of Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; PODOCYTE DYSFUNCTION; RENAL INJURY; CELL-DEATH; PAI-1; EXPRESSION; TYPE-1; KIDNEY; NEPHROPATHY; SPECIFICITY	Plasminogen activator inhibitor-1 (PAI-1) is a multifunctional glycoprotein that plays a critical role in the pathogenesis of chronic kidney and cardiovascular diseases. Although transforming growth factor (TGF)-beta 1 is a known inducer of PAI-1, how it controls PAI-1 expression remains enigmatic. Here we investigated the mechanism underlying TGF-beta 1 regulation of PAI-1 in kidney tubular epithelial cells (HKC-8). Surprisingly, overexpression of Smad2 or Smad3 in HKC-8 cells blocked PAI-1 induction by TGF-beta 1, whereas knockdown of them sensitized the cells to TGF-beta 1 stimulation, suggesting that Smad signaling is not responsible for PAI-1 induction. Blockade of several TGF-beta 1 downstream pathways such as p38 MAPK or JNK, but not phosphatidylinositol 3-kinase/Akt and ERK1/2, only partially inhibited PAI-1 expression. TGF-beta 1 stimulated beta-catenin activation in tubular epithelial cells, and ectopic expression of beta-catenin induced PAI-1 expression, whereas inhibition of beta-catenin abolished its induction. A functional T cell factor/lymphoid enhancer-binding factor-binding site was identified in the promoter region of the PAI-1 gene, which interacted with T cell factor upon beta-catenin activation. Deletion or site-directed mutation of this site abolished PAI-1 response to beta-catenin or TGF-beta 1 stimulation. Similarly, ectopic expression of Wnt1 also activated PAI-1 expression and promoter activity. In vivo, PAI-1 was induced in kidney tubular epithelia in obstructive nephropathy. Delivery of Wnt1 gene activated beta-catenin and promoted PAI-1 expression after obstructive injury, whereas blockade of Wnt/beta-catenin signaling by Dick-kopf-1 gene inhibited PAI-1 induction. Collectively, these studies identify PAI-1 as a direct downstream target of Wnt/beta-catenin signaling and demonstrate that PAI-1 induction could play a role in mediating the fibrogenic action of this signaling.	[He, Weichun; Tan, Ruoyun; Dai, Chunsun; Li, Yingjian; Wang, Dan; Hao, Sha; Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; Nanjing Med Univ, Dept Med, Affiliated Hosp 1, Nanjing 210029, Peoples R China; [Kahn, Michael] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing Medical University; University of Southern California	Liu, YH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, S-405 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	liuy@upmc.edu		Liu, Youhua/0000-0002-4740-805X	National Institutes of Health [DK061408, DK064005, DK071040]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071040, R01DK061408, R01DK064005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061408, DK064005, and DK071040.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; Dai CS, 2003, J BIOL CHEM, V278, P12537, DOI 10.1074/jbc.M300777200; Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411; Eddy AA, 2002, AM J PHYSIOL-RENAL, V283, pF209, DOI 10.1152/ajprenal.00032.2002; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Eguchi M, 2005, MED CHEM, V1, P467, DOI 10.2174/1573406054864098; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fukukawa C, 2009, ONCOGENE, V28, P1110, DOI 10.1038/onc.2008.467; Hamano K, 2002, AM J KIDNEY DIS, V39, P695, DOI 10.1053/ajkd.2002.31986; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huang YF, 2009, AM J PHYSIOL-RENAL, V297, pF1045, DOI 10.1152/ajprenal.00024.2009; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kitching AR, 2003, J AM SOC NEPHROL, V14, P1487, DOI 10.1097/01.ASN.0000065550.13931.00; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Li YJ, 2009, J AM SOC NEPHROL, V20, P1907, DOI 10.1681/ASN.2008090930; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Ma LJ, 2009, FRONT BIOSCI-LANDMRK, V14, P2028, DOI 10.2741/3361; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Mukai Y, 2007, AM J PHYSIOL-HEART C, V292, pH1937, DOI 10.1152/ajpheart.00868.2006; Nagamine Y, 2008, THROMB HAEMOSTASIS, V100, P1007, DOI 10.1160/TH08-05-0294; Nakamura S, 2000, KIDNEY INT, V58, P251, DOI 10.1046/j.1523-1755.2000.00160.x; Nicholas SB, 2005, KIDNEY INT, V67, P1297, DOI 10.1111/j.1523-1755.2005.00207.x; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Paueksakon P, 2002, KIDNEY INT, V61, P2142, DOI 10.1046/j.1523-1755.2002.00384.x; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Segarra A, 2001, J AM SOC NEPHROL, V12, P1255, DOI 10.1681/ASN.V1261255; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Tan RY, 2008, AM J PHYSIOL-RENAL, V294, pF1076, DOI 10.1152/ajprenal.00323.2007; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Venugopal J, 2007, J CELL BIOCHEM, V101, P369, DOI 10.1002/jcb.21173; von Toerne C, 2009, AM J TRANSPLANT, V9, P2223, DOI 10.1111/j.1600-6143.2009.02762.x; White BD, 2007, CURR BIOL, V17, pR923, DOI 10.1016/j.cub.2007.08.062; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003	50	84	88	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24665	24675		10.1074/jbc.M109.091256	http://dx.doi.org/10.1074/jbc.M109.091256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519507	hybrid, Green Published			2022-12-25	WOS:000280542100039
J	Rzymski, T; Milani, M; Pike, L; Buffa, F; Mellor, HR; Winchester, L; Pires, I; Hammond, E; Ragoussis, I; Harris, AL				Rzymski, T.; Milani, M.; Pike, L.; Buffa, F.; Mellor, H. R.; Winchester, L.; Pires, I.; Hammond, E.; Ragoussis, I.; Harris, A. L.			Regulation of autophagy by ATF4 in response to severe hypoxia	ONCOGENE			English	Article						autophagy; UPR; cancer; hypoxia; anoxia; tumour	CELL-SURVIVAL; TRANSLATIONAL REGULATION; MOLECULAR-CLONING; PHOSPHORYLATION; RESISTANCE; DEATH; PERK; STABILIZATION; LYSOSOMES; INDUCTION	Activating transcription factor 4 (ATF4) is a transcription factor induced under severe hypoxia and a component of the PERK pathway involved in the unfolded protein response (UPR), a process that protects cells from the negative consequences of endoplasmic reticulum (ER) stress. In this study, we have used small interfering RNA (siRNA) and microarray analysis to provide the first whole-genome analysis of genes regulated by ATF4 in cancer cells in response to severe and prolonged hypoxic stress. We show that ATF4 is required for ER stress and hypoxia-induced expansion of autophagy. MAP1LC3B (LC3B) is a key component of the autophagosomal membrane, and in this study we demonstrate that ATF4 facilitates autophagy through direct binding to a cyclic AMP response element binding site in the LC3B promoter, resulting in LC3B upregulation. Previously, we have shown that Bortezomib-induced ATF4 stabilization, which then upregulated LC3B expression and had a critical role in activating autophagy, protecting cells from Bortezomib-induced cell death. We also showed that severe hypoxia stabilizes ATF4. In this study, we demonstrate that severe hypoxia leads to ER stress and induces ATF4-dependent autophagy through LC3 as a survival mechanism. In summary, we show that ATF4 has a key role in the regulation of autophagy in response to ER stress and provide a direct mechanistic link between the UPR and the autophagic machinery. Oncogene (2010) 29, 4424-4435; doi: 10.1038/onc.2010.191; published online 31 May 2010	[Rzymski, T.; Milani, M.; Pike, L.; Buffa, F.; Mellor, H. R.; Harris, A. L.] Univ Oxford, John Radcliffe Hosp, Growth Factor Grp,Mol Oncol Labs, Canc Res UK,Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Winchester, L.; Ragoussis, I.] Wellcome Trust Ctr Human Genet, Genom Lab, Oxford, England; [Pires, I.; Hammond, E.] Univ Oxford, Canc Res UK, MRC Gray Inst Radiat Oncol & Biol, Churchill Hosp, Oxford OX3 9DU, England	Cancer Research UK; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Cancer Research UK; University of Oxford	Harris, AL (corresponding author), Univ Oxford, John Radcliffe Hosp, Growth Factor Grp,Mol Oncol Labs, Canc Res UK,Weatherall Inst Mol Med, Oxford OX3 9DU, England.	aharris.lab@imm.ox.ac.uk	Buffa, Francesca/D-2574-2013; Ragoussis, Ioannis/AAD-9790-2022; Harris, Adrian L/ABA-3343-2020	Buffa, Francesca/0000-0003-0409-406X; Harris, Adrian L/0000-0003-1376-8409; Ragoussis, Ioannis/0000-0002-8515-0934; Hammond, Ester/0000-0002-2335-3146; Pires, Isabel/0000-0002-0417-2710				Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mujcic H, 2009, RADIOTHER ONCOL, V92, P450, DOI 10.1016/j.radonc.2009.08.017; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Olive PL, 2002, RADIAT RES, V158, P159, DOI 10.1667/0033-7587(2002)158[0159:TROOIS]2.0.CO;2; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rzymski T, 2008, ONCOGENE, V27, P4532, DOI 10.1038/onc.2008.100; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2008, AUTOPHAGY, V4, P534, DOI 10.4161/auto.5956; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wenger RH, 1996, NATURE, V380, P100, DOI 10.1038/380100d0; Wouters BG, 1997, RADIAT RES, V147, P541, DOI 10.2307/3579620; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	41	261	265	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2010	29	31					4424	4435		10.1038/onc.2010.191	http://dx.doi.org/10.1038/onc.2010.191			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	634DG	20514020				2022-12-25	WOS:000280559100006
J	Iyer, S; Darley, PI; Acharya, KR				Iyer, Shalini; Darley, Paula I.; Acharya, K. Ravi			Structural Insights into the Binding of Vascular Endothelial Growth Factor-B by VEGFR-1(D2) RECOGNITION AND SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; VEGF-B; ANGSTROM RESOLUTION; NEUTRALIZING ANTIBODY; RECEPTOR-BINDING; FAB FRAGMENT; ANGIOGENESIS; COMPLEX; EXPRESSION; MOUSE	The formation of blood vessels ( angiogenesis) is a highly orchestrated sequence of events involving crucial receptor-ligand interactions. Angiogenesis is critical for physiological processes such as development, wound healing, reproduction, tissue regeneration, and remodeling. It also plays a major role in sustaining tumor progression and chronic inflammation. Vascular endothelial growth factor (VEGF)-B, a member of the VEGF family of angiogenic growth factors, effects blood vessel formation by binding to a tyrosine kinase receptor, VEGFR-1. There is growing evidence of the important role played by VEGF-B in physiological and pathological vasculogenesis. Development of VEGF-B antagonists, which inhibit the interaction of this molecule with its cognate receptor, would be important for the treatment of pathologies associated specifically with this growth factor. In this study, we present the crystal structure of the complex of VEGF-B with domain 2 of VEGFR-1 at 2.7 angstrom resolution. Our analysis reveals that each molecule of the ligand engages two receptor molecules using two symmetrical binding sites. Based on these interactions, we identify the receptor-binding determinants on VEGF-B and shed light on the differences in specificity towards VEGFR-1 among the different VEGF homologs.	[Iyer, Shalini; Darley, Paula I.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk		Acharya, K. Ravi/0000-0002-3009-4058	Wellcome Trust (United Kingdom) [083191]; Royal Society (United Kingdom) Industry Fellowship	Wellcome Trust (United Kingdom)(Wellcome Trust); Royal Society (United Kingdom) Industry Fellowship(Royal Society of London)	This work was supported by the Wellcome Trust (United Kingdom) Programme Grant 083191 and a Royal Society (United Kingdom) Industry Fellowship (to K.R.A.).	Aase K, 1999, DEV DYNAM, V215, P12, DOI 10.1002/(SICI)1097-0177(199905)215:1<12::AID-DVDY3>3.0.CO;2-N; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Davis-Smyth T, 1998, J BIOL CHEM, V273, P3216, DOI 10.1074/jbc.273.6.3216; Detoraki A, 2009, J ALLERGY CLIN IMMUN, V123, P1142, DOI 10.1016/j.jaci.2009.01.044; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Gunningham SP, 2001, J PATHOL, V193, P325, DOI 10.1002/path.814; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Iyer S, 2001, J BIOL CHEM, V276, P12153, DOI 10.1074/jbc.M008055200; Iyer S, 2006, J MOL BIOL, V359, P76, DOI 10.1016/j.jmb.2006.03.002; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Lagercrantz J, 1998, BBA-GENE STRUCT EXPR, V1398, P157, DOI 10.1016/S0167-4781(98)00040-2; Leonard P, 2008, J MOL BIOL, V384, P1203, DOI 10.1016/j.jmb.2008.09.076; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Li XR, 2001, GROWTH FACTORS, V19, P49, DOI 10.3109/08977190109001075; Louzier V, 2003, AM J PHYSIOL-LUNG C, V284, pL926, DOI 10.1152/ajplung.00247.2002; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Mousa SA, 2007, SEMIN THROMB HEMOST, V33, P524, DOI 10.1055/s-2007-982084; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Neufeld G, 2007, ADV EXP MED BIOL, V600, P118; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; OTWINOWSKI Z, 1994, ACTA CRYSTALLOGR D, V50, P760; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Scotney PD, 2002, CLIN EXP PHARMACOL P, V29, P1024, DOI 10.1046/j.1440-1681.2002.03769.x; Scrofani SDB, 2000, PROTEIN SCI, V9, P2018, DOI 10.1110/ps.9.10.2018; Stuttfeld E, 2009, IUBMB LIFE, V61, P915, DOI 10.1002/iub.234; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106	42	45	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23779	23789		10.1074/jbc.M110.130658	http://dx.doi.org/10.1074/jbc.M110.130658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501651	hybrid, Green Published			2022-12-25	WOS:000280291400028
J	Leone, V; Mansueto, G; Pierantoni, GM; Tornincasa, M; Merolla, F; Cerrato, A; Santoro, M; Grieco, M; Scaloni, A; Celetti, A; Fusco, A				Leone, V.; Mansueto, G.; Pierantoni, G. M.; Tornincasa, M.; Merolla, F.; Cerrato, A.; Santoro, M.; Grieco, M.; Scaloni, A.; Celetti, A.; Fusco, A.			CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1	ONCOGENE			English	Article						CREB1; CCDC6; HDAC1; RET/PTC1; papillary thyroid carcinomas	PAPILLARY THYROID-CARCINOMA; FACTOR RECEPTOR-BETA; GROWTH-FACTOR; GENE-TRANSCRIPTION; TRANSGENIC MICE; CELL-LINE; EXPRESSION; RET; REARRANGEMENTS; H4(D10S170)	RET/papillary thyroid carcinoma 1 (PTC1) oncogene is frequently activated in human PTCs. It is characterized by the fusion of the intracellular kinase-encoding domain of RET to the first 101 amino acids of CCDC6. The aim of our work is to characterize the function of the CCDC6 protein to better understand the function of its truncation, that results in the loss of the expression of one allele, in the process of thyroid carcinogenesis. Here, we report that CCDC6 interacts with CREB1 and represses its transcriptional activity by recruiting histone deacetylase 1 and protein phosphatase 1 proteins at the CRE site of the CREB1 target genes. Finally, we show an increased CREB1 phosphorylation and activity in PTCs carrying the RET/PTC1 oncogene. Consistently, an increased expression of two known CREB1 target genes, AREG and cyclin A, was observed in this subgroup of thyroid papillary carcinomas. Therefore, the repression of CREB1 activity by CCDC6 has a critical function in the development of human thyroid papillary carcinomas carrying RET/PTC1 activation. Oncogene (2010) 29, 4341-4351; doi:10.1038/onc.2010.179; published online 24 May 2010	[Fusco, A.] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, Ist Endocrinol & Oncol Sperimentale, Fac Med & Chirurg Napoli,CNR, I-80131 Naples, Italy; [Leone, V.; Mansueto, G.; Fusco, A.] Biotechnol Avanzate Napoli, NOGEC, CEINGE, Naples, Italy; [Leone, V.; Mansueto, G.; Fusco, A.] European Sch Mol Med, SEMM, Naples, Italy; [Scaloni, A.] CNR, Prote & Mass Spectrometry Lab, ISPAAM, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Fusco, A (corresponding author), Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, Ist Endocrinol & Oncol Sperimentale, Fac Med & Chirurg Napoli,CNR, Via Pansini 5, I-80131 Naples, Italy.	afusco@napoli.com	Celetti, Angela/AAY-7172-2020; Mansueto, Gelsomina/AAD-6317-2021; Pierantoni, Giovanna Maria/O-7527-2015; Cerrato, Aniello/AAY-1484-2020	Mansueto, Gelsomina/0000-0002-0544-5100; Pierantoni, Giovanna Maria/0000-0003-4078-8528; Grieco, Michele/0000-0002-4212-7814; Fusco, Alfredo/0000-0003-3332-5197; Scaloni, Andrea/0000-0001-9362-8515	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [CCPKRP_002]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC) and from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (MERIT and PRIN 2008 CCPKRP_002). We are grateful to Konstantina Vergadou (Scientific Communication) for editing the text and Mario Berardone for artwork.	Bennett D, 2005, BIOCHEM SOC T, V33, P1444, DOI 10.1042/BST0331444; Berasain C, 2007, CANCER LETT, V254, P30, DOI 10.1016/j.canlet.2007.01.015; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; De Martino I, 2009, CANCER RES, V69, P1844, DOI 10.1158/0008-5472.CAN-08-4133; Dettori T, 2004, CANCER GENET CYTOGEN, V151, P171, DOI 10.1016/j.cancergencyto.2003.09.023; Drechsler M, 2007, ANN HEMATOL, V86, P353, DOI 10.1007/s00277-006-0247-5; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Gao JX, 2009, BIOCHEM BIOPH RES CO, V379, P1, DOI 10.1016/j.bbrc.2008.11.135; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; GRIECO M, 1994, ONCOGENE, V9, P2531; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Han YB, 2007, ARCH ANDROLOGY, V53, P169, DOI 10.1080/01485010701314032; Hu XD, 2006, J NEUROCHEM, V98, P1841, DOI 10.1111/j.1471-4159.2006.04070.x; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kulkarni S, 2000, CANCER RES, V60, P3592; Luciani P, 2003, EUR J ENDOCRINOL, V148, P579, DOI 10.1530/eje.0.1480579; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Merolla F, 2007, ONCOGENE, V26, P6167, DOI 10.1038/sj.onc.1210446; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Pierantoni GM, 2006, CELL DEATH DIFFER, V13, P1554, DOI 10.1038/sj.cdd.4401839; Pierantoni GM, 2007, PROTEOMICS, V7, P3735, DOI 10.1002/pmic.200700148; PIEROTTI MA, 1992, P NATL ACAD SCI USA, V89, P1616, DOI 10.1073/pnas.89.5.1616; Puxeddu E, 2005, MUTAT RES-FUND MOL M, V570, P17, DOI 10.1016/j.mrfmmm.2004.09.010; SANTISTEBAN DA, 1994, J CHILD ADOLES SUBST, V3, P9, DOI 10.1300/J029v03n02_02; Santoro M, 1996, ONCOGENE, V12, P1821; Santoro M, 2006, EUR J ENDOCRINOL, V155, P645, DOI 10.1530/eje.1.02289; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; Sheils OM, 2000, J PATHOL, V192, P32; Talamo F, 2003, PROTEOMICS, V3, P440, DOI 10.1002/pmic.200390059; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; VIGLIETTO G, 1995, ONCOGENE, V11, P1207; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang BJ, 2008, SCI CHINA SER C, V51, P487, DOI 10.1007/s11427-008-0068-y	40	29	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2010	29	30					4341	4351		10.1038/onc.2010.179	http://dx.doi.org/10.1038/onc.2010.179			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20498639				2022-12-25	WOS:000280547900010
J	Thorogood, NP; Brown, CJ				Thorogood, Nancy P.; Brown, Carolyn J.			Active Chromatin Marks Are Retained on X Chromosomes Lacking Gene or Repeat Silencing Despite XIST/Xist Expression in Somatic Cell Hybrids	PLOS ONE			English	Article							XIST RNA; DNA METHYLATION; INACTIVATION; LOCALIZATION; STABILIZATION; INITIATION	Background: X-chromosome inactivation occurs early in mammalian development and results in the inactive X chromosome acquiring numerous hallmarks of heterochromatin. While XIST is a key player in the inactivation process, the method of action of this ncRNA is yet to be determined. Methodology/Principal Findings: To assess which features of heterochromatin may be directly recruited by the expression and localization of the XIST RNA we have analyzed a mouse/human somatic cell hybrid in which expression of human and mouse XIST/Xist has been induced from the active X by demethylation. Such hybrids had previously been demonstrated to disconnect XIST/Xist expression from gene silencing and we confirm maintenance of X-linked gene expression, even close to the Xist locus, despite the localized expression of mouse Xist. Conclusions/Significance: Loss of the active chromatin marks H3 acetylation and H3 lysine 4 methylation was not observed upon XIST/Xist expression, nor was there a gain of DNA methylation; thus these marks of facultative heterochromatin are not solely dependent upon Xist expression. Cot-1 holes, regions of depleted RNA hybridization with a Cot-1 probe, were observed upon Xist expression; however, these were at reduced frequency and intensity in these somatic cells. Domains of human Cot-1 transcription were observed corresponding to the human chromosomes in the somatic cell hybrids. The Cot-1 domain of the X was not reduced with the expression of XIST, which fails to localize to the human X chromosome in a mouse somatic cell background. The human inactive X in a mouse/human hybrid cell also shows delocalized XIST expression and an ongoing Cot-1 domain, despite X-linked gene silencing. These results are consistent with recent reports separating Cot-1 silencing from genic silencing, but also demonstrate repetitive element expression from an otherwise silent X chromosome in these hybrid cells.	[Thorogood, Nancy P.; Brown, Carolyn J.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	University of British Columbia	Thorogood, NP (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	cbrown@interchange.ubc.ca	Brown, Carolyn J/A-5159-2014	Brown, Carolyn J/0000-0002-8959-0101; Thorogood, Nancy/0000-0002-1135-8476	Canadian Institute for Health Research [MOP-13690]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Funding: The work was supported by the Canadian Institute for Health Research (MOP-13690) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2002, HUM GENET, V110, P271, DOI 10.1007/s00439-002-0676-8; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; CHEN TR, 1987, CANCER GENET CYTOGEN, V24, P95, DOI 10.1016/0165-4608(87)90086-0; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Clemson CM, 1998, J CELL BIOL, V142, P13, DOI 10.1083/jcb.142.1.13; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hansen RS, 1998, P NATL ACAD SCI USA, V95, P5133, DOI 10.1073/pnas.95.9.5133; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Heller G, 2008, CANCER RES, V68, P44, DOI 10.1158/0008-5472.CAN-07-2531; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Komura J, 1997, J BIOL CHEM, V272, P10975; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; OHNO S, 1967, MONOGRAPHS ENDROCRIN, P192; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Plath K, 2004, J CELL BIOL, V167, P1025, DOI 10.1083/jcb.200409026; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pullirsch D, 2010, DEVELOPMENT, V137, P935, DOI 10.1242/dev.035956; RACK KA, 1994, HUM MOL GENET, V3, P1053, DOI 10.1093/hmg/3.7.1053; Sado T, 2004, DEVELOPMENT, V131, P975, DOI 10.1242/dev.00995; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Tinker AV, 1998, NUCLEIC ACIDS RES, V26, P2935, DOI 10.1093/nar/26.12.2935; Veerla S, 2008, GENE CHROMOSOME CANC, V47, P368, DOI 10.1002/gcc.20542; WILLARD HF, 1993, COLD SPRING HARB SYM, V58, P315, DOI 10.1101/SQB.1993.058.01.037; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10787	10.1371/journal.pone.0010787	http://dx.doi.org/10.1371/journal.pone.0010787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520737	Green Published, gold, Green Submitted			2022-12-25	WOS:000278034600013
J	Nikolaev, Y; Deillon, C; Hoffmann, SRK; Bigler, L; Friess, S; Zenobi, R; Pervushin, K; Hunziker, P; Gutte, B				Nikolaev, Yaroslav; Deillon, Christine; Hoffmann, Stefan R. K.; Bigler, Laurent; Friess, Sebastian; Zenobi, Renato; Pervushin, Konstantin; Hunziker, Peter; Gutte, Bernd			The Leucine Zipper Domains of the Transcription Factors GCN4 and c-Jun Have Ribonuclease Activity	PLOS ONE			English	Article							COILED-COIL; ARTIFICIAL RIBONUCLEASES; QUALITY-CONTROL; MESSENGER-RNA; PEPTIDE; HYDROLYSIS; REPRESSOR; PROTEINS; CLEAVAGE; OLIGONUCLEOTIDES	Basic-region leucine zipper (bZIP) proteins are one of the largest transcription factor families that regulate a wide range of cellular functions. Owing to the stability of their coiled coil structure leucine zipper (LZ) domains of bZIP factors are widely employed as dimerization motifs in protein engineering studies. In the course of one such study, the X-ray structure of the retro-version of the LZ moiety of yeast transcriptional activator GCN4 suggested that this retro-LZ may have ribonuclease activity. Here we show that not only the retro-LZ but also the authentic LZ of GCN4 has weak but distinct ribonuclease activity. The observed cleavage of RNA is unspecific, it is not suppressed by the ribonuclease A inhibitor RNasin and involves the breakage of 39,59-phosphodiester bonds with formation of 29,39-cyclic phosphates as the final products as demonstrated by HPLC/electrospray ionization mass spectrometry. Several mutants of the GCN4 leucine zipper are catalytically inactive, providing important negative controls and unequivocally associating the enzymatic activity with the peptide under study. The leucine zipper moiety of the human factor c-Jun as well as the entire c-Jun protein are also shown to catalyze degradation of RNA. The presented data, which was obtained in the test-tube experiments, adds GCN4 and c-Jun to the pool of proteins with multiple functions (also known as moonlighting proteins). If expressed in vivo, the endoribonuclease activity of these bZIP-containing factors may represent a direct coupling between transcription activation and controlled RNA turnover. As an additional result of this work, the retro-leucine zipper of GCN4 can be added to the list of functional retro-peptides.	[Nikolaev, Yaroslav; Deillon, Christine; Hoffmann, Stefan R. K.; Gutte, Bernd] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Nikolaev, Yaroslav; Pervushin, Konstantin] Univ Basel, Biozentrum, Basel, Switzerland; [Bigler, Laurent] Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland; [Friess, Sebastian; Zenobi, Renato] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Hunziker, Peter] Funct Genom Ctr Zurich, Zurich, Switzerland	University of Zurich; University of Basel; University of Zurich; ETH Zurich	Nikolaev, Y (corresponding author), Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland.	gutte@bioc.unizh.ch	Zenobi, Renato/F-1113-2010; Bigler, Laurent/AAP-3799-2020; Pervushin, Konstantin/AAJ-6580-2020; Nikolaev, Yaroslav/I-1976-2013	Bigler, Laurent/0000-0003-3548-3594; Pervushin, Konstantin/0000-0002-6393-4340; Nikolaev, Yaroslav/0000-0002-1479-7474	Kanton of Zurich; Mesta Foundation; Swiss National Science Foundation [3100A0-118381]; Stiftung fur wissenschaftliche Forschung an der Universitat Zurich	Kanton of Zurich; Mesta Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung fur wissenschaftliche Forschung an der Universitat Zurich	This work was supported by the Kanton of Zurich, the Mesta Foundation, Swiss National Science Foundation (grant 3100A0-118381 to K. Pervushin) and the Stiftung fur wissenschaftliche Forschung an der Universitat Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; BARBIER B, 1992, J AM CHEM SOC, V114, P3511, DOI 10.1021/ja00035a053; BASHKIN JK, 1994, J AM CHEM SOC, V116, P5981, DOI 10.1021/ja00092a064; Bibillo A, 1999, NUCLEIC ACIDS RES, V27, P3931, DOI 10.1093/nar/27.19.3931; BRESLOW R, 1978, J AM CHEM SOC, V100, P3227, DOI 10.1021/ja00478a052; Brittain IJ, 1998, BIOCHEMISTRY-US, V37, P12113, DOI 10.1021/bi9806605; Caderas G, 1999, EUR J BIOCHEM, V266, P599, DOI 10.1046/j.1432-1327.1999.00899.x; CARPINO LA, 1970, J AM CHEM SOC, V92, P5748, DOI 10.1021/ja00722a043; d'Avignon DA, 2006, BIOPOLYMERS, V83, P255, DOI 10.1002/bip.20555; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fouace S, 2004, NUCLEIC ACIDS RES, V32, P151, DOI 10.1093/nar/gkh157; Gnaccarini C, 2006, J AM CHEM SOC, V128, P8063, DOI 10.1021/ja061036f; HEHLGANS T, 1993, FEBS LETT, V315, P51, DOI 10.1016/0014-5793(93)81131-I; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Koroleva LS, 2007, PROTEIN PEPTIDE LETT, V14, P151, DOI 10.2174/092986607779816177; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Landt O, 1997, BIOL CHEM, V378, P553, DOI 10.1515/bchm.1997.378.6.553; Lei G, 1998, ARCH BIOCHEM BIOPHYS, V355, P160, DOI 10.1006/abbi.1998.0735; Lima WF, 1999, P NATL ACAD SCI USA, V96, P10010, DOI 10.1073/pnas.96.18.10010; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Liu N, 2001, CURR PROTEIN PEPT SC, V2, P107, DOI 10.2174/1389203013381161; Liu NK, 1997, EUR BIOPHYS J BIOPHY, V25, P399, DOI 10.1007/s002490050052; Liu NK, 1998, PROTEIN SCI, V7, P1214, DOI 10.1002/pro.5560070517; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MERRIFIELD RB, 1995, PEPTIDES SYNTHESIS S, P93; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; Mittl PRE, 2000, P NATL ACAD SCI USA, V97, P2562, DOI 10.1073/pnas.97.6.2562; Moore MJ, 2002, CELL, V108, P431, DOI 10.1016/S0092-8674(02)00645-1; Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017; Niittymaki T, 2006, ORG BIOMOL CHEM, V4, P15, DOI 10.1039/b509022a; Nikolaev Y, 2007, J AM CHEM SOC, V129, P6461, DOI 10.1021/ja0685295; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Perreault DM, 1997, BIOORGAN MED CHEM, V5, P1209, DOI 10.1016/S0968-0896(97)00051-5; Pitsch S, 2003, HELV CHIM ACTA, V86, P3740, DOI 10.1002/hlca.200390316; RICHARDS FM, 1971, ENZYMES, V4, P647; Rieker JD, 2000, METHOD ENZYMOL, V328, P282, DOI 10.1016/S0076-6879(00)28403-6; Scheffer U, 2005, J AM CHEM SOC, V127, P2211, DOI 10.1021/ja0443934; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; STADLER K, 1995, INT J PEPT PROT RES, V46, P333; STEYAERT J, 1990, BIOCHEMISTRY-US, V29, P9064, DOI 10.1021/bi00490a025; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10765	10.1371/journal.pone.0010765	http://dx.doi.org/10.1371/journal.pone.0010765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505831	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017400019
J	Aluru, N; Leatherland, JF; Vijayan, MM				Aluru, Neelakanteswar; Leatherland, John F.; Vijayan, Mathilakath M.			Bisphenol A in Oocytes Leads to Growth Suppression and Altered Stress Performance in Juvenile Rainbow Trout	PLOS ONE			English	Article							MEDAKA ORYZIAS-LATIPES; ONCORHYNCHUS-MYKISS; MESSENGER-RNA; EMBRYONIC-DEVELOPMENT; HORMONE RECEPTORS; MATERNAL EXPOSURE; GENE-EXPRESSION; THYROID-HORMONE; AXIS; ESTROGEN	Background: Bisphenol A (BPA), used in the manufacture of plastics, is ubiquitously distributed in the aquatic environment. However, the effect of maternal transfer of these xenobiotics on embryonic development and growth is poorly understood in fish. We tested the hypothesis that BPA in eggs, mimicking maternal transfer, impact development, growth and stress performance in juveniles of rainbow trout (Oncorhynchus mykiss). Methodology/Principal Findings: Trout oocytes were exposed to 0, 30 and 100 mu g.mL(-1) BPA for 3 h in ovarian fluid, followed by fertilization. The embryos were maintained in clean water and sampled temporally over 156-days post-fertilization (dpf), and juveniles were sampled at 400-dpf. The egg BPA levels declined steadily after exposure and were undetectable after 21-dpf. Oocyte exposure to BPA led to a delay in hatching and yolk absorption and a consistently lower body mass over 152-dpf. The growth impairment, especially in the high BPA group, correlated with higher growth hormone (GH) content and lower GH receptors gene expression. Also, mRNA abundances of insulin-like growth factors (IGF-1 and IGF-2) and their receptors were suppressed in the BPA treated groups. The juvenile fish grown from the BPA-enriched eggs had lower body mass and showed perturbations in plasma cortisol and glucose response to an acute stressor. Conclusion: BPA accumulation in eggs, prior to fertilization, leads to hatching delays, growth suppression and altered stress response in juvenile trout. The somatotropic axis appears to be a key target for BPA impact during early embryogenesis, leading to long term growth and stress performance defects in fish.	[Aluru, Neelakanteswar; Vijayan, Mathilakath M.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Leatherland, John F.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Waterloo; University of Guelph	Aluru, N (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mvijayan@uwaterloo.ca	Vijayan, Mathilakath/AAC-2190-2020; Vijayan, Mathilakath/F-6756-2012		Natural Science and Engineering Research Council (NSERC) of Canada; Ontario Ministry of Agriculture and Food	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture and Food	This work was supported by funds from the Natural Science and Engineering Research Council (NSERC) of Canada Discovery grant and the Ontario Ministry of Agriculture and Food. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru N, 2006, ENDOCRINOLOGY, V147, P1895, DOI 10.1210/en.2005-1143; Aluru N, 2004, AM J PHYSIOL-REG I, V287, pR787, DOI 10.1152/ajpregu.00091.2004; Ashfield LA, 1998, ENVIRON TOXICOL CHEM, V17, P679; Bjerregaard P, 2007, ENVIRON TOXICOL CHEM, V26, P1910, DOI 10.1897/06-645R.1; Carlson DB, 2000, ENVIRON HEALTH PERSP, V108, P249, DOI 10.2307/3454442; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Crain DA, 2007, REPROD TOXICOL, V24, P225, DOI 10.1016/j.reprotox.2007.05.008; Davis LK, 2007, BIOL REPROD, V77, P614, DOI 10.1095/biolreprod.107.060947; FARBRIDGE KJ, 1992, FISH PHYSIOL BIOCHEM, V10, P245, DOI 10.1007/BF00004518; Filby AL, 2006, J MOL ENDOCRINOL, V37, P121, DOI 10.1677/jme.1.01997; Finn RN, 2007, AQUAT TOXICOL, V81, P337, DOI 10.1016/j.aquatox.2006.12.021; Gabillard JC, 2003, J EXP ZOOL PART A, V298A, P134, DOI 10.1002/jez.a.10280; Gabillard JC, 2003, MOL REPROD DEV, V64, P32, DOI 10.1002/mrd.10222; Gomez JM, 1999, J REPROD FERTIL, V115, P275, DOI 10.1530/jrf.0.1150275; Holt RIG, 2002, TRENDS ENDOCRIN MET, V13, P392, DOI 10.1016/S1043-2760(02)00697-5; Honkanen JO, 2004, CHEMOSPHERE, V55, P187, DOI 10.1016/j.chemosphere.2003.10.028; HONTELA A, 2008, ADRENAL TOX IN PRESS; Iwama George K., 2006, P319; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahnsteiner F, 2005, AQUAT TOXICOL, V75, P213, DOI 10.1016/j.aquatox.2005.08.004; LeGac F, 1996, MOL REPROD DEV, V44, P23, DOI 10.1002/(SICI)1098-2795(199605)44:1&lt;23::AID-MRD3&gt;3.0.CO;2-V; Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035; Li M, 2006, COMP BIOCHEM PHYS A, V143, P514, DOI 10.1016/j.cbpa.2006.01.024; Li M, 2007, GEN COMP ENDOCR, V153, P302, DOI 10.1016/j.ygcen.2007.02.012; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Norbeck LA, 2007, GEN COMP ENDOCR, V151, P332, DOI 10.1016/j.ygcen.2007.01.039; Nye JA, 2007, AQUAT TOXICOL, V82, P242, DOI 10.1016/j.aquatox.2007.02.011; Ostrach DJ, 2008, P NATL ACAD SCI USA, V105, P19354, DOI 10.1073/pnas.0802616105; Pedersen SN, 1999, J CHROMATOGR A, V864, P17, DOI 10.1016/S0021-9673(99)01011-0; Pierce AL, 2005, GEN COMP ENDOCR, V140, P192, DOI 10.1016/j.ygcen.2004.10.017; Raine JC, 2004, J FISH BIOL, V65, P206, DOI 10.1111/j.0022-1112.2004.00445.x; Raine JC, 2003, COMP BIOCHEM PHYS B, V136, P267, DOI 10.1016/S1096-4959(03)00203-3; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Schlueter PJ, 2007, DEV BIOL, V305, P377, DOI 10.1016/j.ydbio.2007.02.015; SHAMBLOTT MJ, 1995, P NATL ACAD SCI USA, V92, P6943, DOI 10.1073/pnas.92.15.6943; Shioda T, 2000, CHEMOSPHERE, V40, P239, DOI 10.1016/S0045-6535(99)00235-0; Vijayan MM, 2005, BIOCH MOLEC, V6, P365; Westerlund L, 2000, ENVIRON TOXICOL CHEM, V19, P1582, DOI 10.1002/etc.5620190615; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Yamamoto T, 2001, CHEMOSPHERE, V42, P415, DOI 10.1016/S0045-6535(00)00079-5; Yang BY, 1999, MOL REPROD DEV, V53, P127, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;127::AID-MRD1&gt;3.0.CO;2-H; Yeoh CG, 1996, GEN COMP ENDOCR, V102, P197, DOI 10.1006/gcen.1996.0061; Zha JM, 2006, SCI TOTAL ENVIRON, V357, P112, DOI 10.1016/j.scitotenv.2005.04.038; Zhu Y, 2007, GEN COMP ENDOCR, V150, P395, DOI 10.1016/j.ygcen.2006.10.009	46	75	79	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10741	10.1371/journal.pone.0010741	http://dx.doi.org/10.1371/journal.pone.0010741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505776	Green Published, gold			2022-12-25	WOS:000278017300014
J	Koehler, RN; Walsh, AM; Sanders-Buell, EE; Eller, LA; Eller, M; Currier, JR; Bautista, CT; Wabwire-Mangen, F; Hoelscher, M; Maboko, L; Kim, J; Michael, NL; Robb, ML; McCutchan, FE; Kijak, GH				Koehler, Rebecca N.; Walsh, Anne M.; Sanders-Buell, Eric E.; Eller, Leigh Anne; Eller, Michael; Currier, Jeffrey R.; Bautista, Christian T.; Wabwire-Mangen, Fred; Hoelscher, Michael; Maboko, Leonard; Kim, Jerome; Michael, Nelson L.; Robb, Merlin L.; McCutchan, Francine E.; Kijak, Gustavo H.			High-Throughput High- Resolution Class I HLA Genotyping in East Africa	PLOS ONE			English	Article							RAKAI DISTRICT; MBEYA REGION; GENOMIC DNA; B ALLELES; HIV-1; POPULATIONS; DIVERSITY; SELECTION; POLYMORPHISM; DISEASE	HLA, the most genetically diverse loci in the human genome, play a crucial role in host-pathogen interaction by mediating innate and adaptive cellular immune responses. A vast number of infectious diseases affect East Africa, including HIV/AIDS, malaria, and tuberculosis, but the HLA genetic diversity in this region remains incompletely described. This is a major obstacle for the design and evaluation of preventive vaccines. Available HLA typing techniques, that provide the 4-digit level resolution needed to interpret immune responses, lack sufficient throughput for large immunoepidemiological studies. Here we present a novel HLA typing assay bridging the gap between high resolution and high throughput. The assay is based on real-time PCR using sequence-specific primers (SSP) and can genotype carriers of the 49 most common East African class I HLA-A, -B, and -C alleles, at the 4-digit level. Using a validation panel of 175 samples from Kampala, Uganda, previously defined by sequence-based typing, the new assay performed with 100% sensitivity and specificity. The assay was also implemented to define the HLA genetic complexity of a previously uncharacterized Tanzanian population, demonstrating its inclusion in the major East African genetic cluster. The availability of genotyping tools with this capacity will be extremely useful in the identification of correlates of immune protection and the evaluation of candidate vaccine efficacy.	[Koehler, Rebecca N.; Walsh, Anne M.; Sanders-Buell, Eric E.; Currier, Jeffrey R.; Bautista, Christian T.; Robb, Merlin L.; McCutchan, Francine E.; Kijak, Gustavo H.] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA; [Eller, Leigh Anne; Eller, Michael] Makerere Univ, Walter Reed Res Project, Henry M Jackson Fdn, Kampala, Uganda; [Hoelscher, Michael] Univ Munich, Dept Trop Med & Infect Dis, Munich, Germany; [Hoelscher, Michael; Maboko, Leonard] Mbeya Med Res Program, Mbeya, Tanzania; [Kim, Jerome; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Makerere University; University of Munich; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Koehler, RN (corresponding author), Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA.	gkijak@hivresearch.org	Bautista, Christian/B-2812-2011; Hoelscher, Michael/D-3436-2012; Walsh, Anne/GXI-0454-2022; Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877; Bautista, Christian/0000-0002-1228-0754; Lenzi, Rebecca/0000-0002-7975-9268	Henry M. Jackson Foundation; United States Department of Defense; National Institute for Allergy and Infectious Diseases, National Institutes of Health [Y1-AI-2642-11]	Henry M. Jackson Foundation; United States Department of Defense(United States Department of Defense); National Institute for Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through a cooperative agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the United States Department of Defense, by the National Institute for Allergy and Infectious Diseases, National Institutes of Health ("HIV Vaccine Research and Development - Project 2'' Y1-AI-2642-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*A NOL RES I, 2009, FULL LIST HLA CLASS; ABDELSALAM E, 1986, TISSUE ANTIGENS, V27, P142, DOI 10.1111/j.1399-0039.1986.tb01513.x; Adams Sharon D, 2004, J Transl Med, V2, P30, DOI 10.1186/1479-5876-2-30; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2007, RIFT VALL FEV KEN SO; Arroyo MA, 2005, AIDS, V19, P1517, DOI 10.1097/01.aids.0000183515.14642.76; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Basu R, 2007, J INFECT DIS, V195, P1373, DOI 10.1086/513439; Brander C, 2006, CURR OPIN IMMUNOL, V18, P430, DOI 10.1016/j.coi.2006.05.012; BROWNING MJ, 1993, P NATL ACAD SCI USA, V90, P2842, DOI 10.1073/pnas.90.7.2842; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Ellis JM, 2000, TISSUE ANTIGENS, V56, P291, DOI 10.1034/j.1399-0039.2000.560401.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; HILL AVS, 1994, PHILOS T R SOC B, V346, P379, DOI 10.1098/rstb.1994.0155; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hoelscher M, 2001, AIDS, V15, P1461, DOI 10.1097/00002030-200108170-00002; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; *JOINT UN PROGR HI, 2008, REP GLOB AIDS EP 200; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kettaneh A, 2006, INT J TUBERC LUNG D, V10, P717; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kijak GH, 2009, TISSUE ANTIGENS, V73, P262, DOI 10.1111/j.1399-0039.2008.01192.x; KITTS A, 2003, NCBI HDB; Koehler RN, 2009, TISSUE ANTIGENS, V74, P73, DOI 10.1111/j.1399-0039.2009.01265.x; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Lienert K, 1996, IMMUNOL CELL BIOL, V74, P349, DOI 10.1038/icb.1996.62; Louie LG, 2004, J INFECT DIS, V189, P1084, DOI 10.1086/382030; Luedeck H, 1997, TISSUE ANTIGENS, V50, P627, DOI 10.1111/j.1399-0039.1997.tb02921.x; Luo M, 2002, TISSUE ANTIGENS, V59, P370, DOI 10.1034/j.1399-0039.2002.590503.x; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mouritzen P, 2003, EXPERT REV MOL DIAGN, V3, P27, DOI 10.1586/14737159.3.1.27; Olsson KS, 2008, EUR J HAEMATOL, V81, P36, DOI 10.1111/j.1600-0609.2008.01078.x; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Probst CM, 2000, HUM BIOL, V72, P597; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Raja A, 2004, INDIAN J MED RES, V120, P213; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Robinson James, 2007, V409, P61, DOI 10.1007/978-1-60327-118-9_4; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez A, 2007, J INFECT DIS, V196, pS329, DOI 10.1086/520588; Sanchez-Mazas A, 2000, TISSUE ANTIGENS, V56, P303, DOI 10.1034/j.1399-0039.2000.560402.x; Slateva K, 1998, TISSUE ANTIGENS, V52, P462, DOI 10.1111/j.1399-0039.1998.tb03073.x; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Stenger S, 2001, SCAND J INFECT DIS, V33, P483, DOI 10.1080/00365540110026584; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; TAKAHATA N, 1990, GENETICS, V124, P967; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JM, 2000, EXP CLIN IMMUNOGENET, V17, P185, DOI 10.1159/000019138; *TEL AV MED CTR, GLOB INF DIS EP NETW; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Walczak R, 2008, MIXDES 2008: PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON MIXED DESIGN OF INTEGRATED CIRCUITS AND SYSTEMS, P633; *WHO, 2007, EB HAEM FEV UG; *WHO, 2006, WEEKLY EPIDEMIOLOGIC, V82, P381; *WHO, 2009, WHO REP 2009 GLOB TU; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P145; Williams F, 2001, HUM IMMUNOL, V62, P645, DOI 10.1016/S0198-8859(01)00247-6; World Health Organisation, 2008, WORLD MAL REP 2008; Xiang Q, 2005, BIOMED MICRODEVICES, V7, P273, DOI 10.1007/s10544-005-6069-8	79	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10751	10.1371/journal.pone.0010751	http://dx.doi.org/10.1371/journal.pone.0010751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505773	gold, Green Published, Green Submitted			2022-12-25	WOS:000278017300022
J	Rangarajan, ES; Lee, JH; Yogesha, SD; Izard, T				Rangarajan, Erumbi S.; Lee, Jun Hyuck; Yogesha, S. D.; Izard, Tina			A Helix Replacement Mechanism Directs Metavinculin Functions	PLOS ONE			English	Article							F-ACTIN-BINDING; DILATED CARDIOMYOPATHY; VINCULIN BINDING; CRYSTAL-STRUCTURE; PROTEIN; ADHESION; TALIN; MODEL; ASSOCIATION; RAVER1	Cells require distinct adhesion complexes to form contacts with their neighbors or the extracellular matrix, and vinculin links these complexes to the actin cytoskeleton. Metavinculin, an isoform of vinculin that harbors a unique 68-residue insert in its tail domain, has distinct actin bundling and oligomerization properties and plays essential roles in muscle development and homeostasis. Moreover, patients with sporadic or familial mutations in the metavinculin-specific insert invariably develop fatal cardiomyopathies. Here we report the high resolution crystal structure of the metavinculin tail domain, as well as the crystal structures of full-length human native metavinculin (1,134 residues) and of the full-length cardiomyopathy-associated Delta Leu954 metavinculin deletion mutant. These structures reveal that an alpha-helix (H1') and extended coil of the metavinculin insert replace alpha-helix H1 and its preceding extended coil found in the N-terminal region of the vinculin tail domain to form a new five-helix bundle tail domain. Further, biochemical analyses demonstrate that this helix replacement directs the distinct actin bundling and oligomerization properties of metavinculin. Finally, the cardiomyopathy associated Delta Leu954 and Arg975Trp metavinculin mutants reside on the replaced extended coil and the H1' alpha-helix, respectively. Thus, a helix replacement mechanism directs metavinculin's unique functions.	[Rangarajan, Erumbi S.; Lee, Jun Hyuck; Yogesha, S. D.; Izard, Tina] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL USA	Scripps Research Institute; State University System of Florida; University of Florida	Rangarajan, ES (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL USA.	mkernick@scripps.edu			National Institutes of Health (NIH); American Heart Association (AHA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071596] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Institutes of Health (NIH) and American Heart Association (AHA) funded part of the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly M, 2003, TRENDS CELL BIOL, V13, P163, DOI 10.1016/S0962-8924(03)00030-8; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Bricogne G, 1997, METHOD ENZYMOL, V276, P361, DOI 10.1016/S0076-6879(97)76069-5; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; HUANG FL, 1991, J BIOL CHEM, V266, P8727; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Huttelmaier S, 2001, J CELL BIOL, V155, P775, DOI 10.1083/jcb.200105044; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Korneeva NL, 1996, EUR J CELL BIOL, V71, P351; Lee JH, 2009, STRUCTURE, V17, P833, DOI 10.1016/j.str.2009.04.010; Madl T, 2009, STRUCTURE, V17, P781, DOI 10.1016/j.str.2009.05.004; Maeda M, 1997, CIRCULATION, V95, P17, DOI 10.1161/01.CIR.95.1.17; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Miller GJ, 2001, J BIOL CHEM, V276, P11729, DOI 10.1074/jbc.M008646200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MOLONY L, 1985, J CELL BIOCHEM, V29, P31, DOI 10.1002/jcb.240290104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer SM, 2009, J BIOL CHEM, V284, P7223, DOI 10.1074/jbc.M807842200; Rudiger M, 1998, FEBS LETT, V431, P49, DOI 10.1016/S0014-5793(98)00723-6; SMART OS, 2008, ANN M AM CRYST ASS K; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Van Nhieu GT, 2007, EMBO J, V26, P4588; Vasile VC, 2006, MOL GENET METAB, V87, P169, DOI 10.1016/j.ymgme.2005.08.006; Weis WI, 2004, NATURE, V430, P513, DOI 10.1038/430513a; Witt S, 2004, J BIOL CHEM, V279, P31533, DOI 10.1074/jbc.M314245200; Xu WM, 1998, DEVELOPMENT, V125, P327; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zieseniss A, 2007, CELL TISSUE RES, V327, P583, DOI 10.1007/s00441-006-0322-1	42	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10679	10.1371/journal.pone.0010679	http://dx.doi.org/10.1371/journal.pone.0010679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502710	Green Published, gold, Green Submitted			2022-12-25	WOS:000277845400004
J	Ma, J; Naumann, RT; Kanwal, JS				Ma, Jie; Naumann, Robert T.; Kanwal, Jagmeet S.			Fear Conditioned Discrimination of Frequency Modulated Sweeps within Species-Specific Calls of Mustached Bats	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; LATERAL AMYGDALA; BASOLATERAL AMYGDALA; COMPLEX SOUNDS; HEART-RATE; MEMORY CONSOLIDATION; COMMUNICATION CALLS; NUCLEUS BASALIS; TARGET RANGE; NEURONS	Social and echolocation vocalizations of bats contain different patterns of frequency modulations. An adult bat's ability to discriminate between various FM parameters, however, is not well established. Using changes in heart rate (HR) as a quantitative measure of associative learning, we demonstrate that mustached bats (Pteronotus parnellii) can be fear conditioned to linear frequency modulated (FM) sweeps typically centered at their acoustic fovea (similar to 60 kHz). We also show that HR is sensitive to a change in the direction of the conditional frequency modulation keeping all other parameters constant. In addition, a change in either depth or duration co-varied with FM rate is reflected in the change in HR. Finally, HR increases linearly with FM rate incremented by 0.1 kHz/ms from a pure tone to a target rate of 1.0 kHz/ms of the conditional stimulus. Learning is relatively rapid, occurring after a single training session. We also observed that fear conditioning enhances local field potential activity within the basolateral amygdala. Neural response enhancement coinciding with rapid learning and a fine scale cortical representation of FM sweeps shown earlier make FMs prime candidates for discriminating between different call types and possibly communicating socially relevant information within species-specific sounds.	[Ma, Jie; Naumann, Robert T.; Kanwal, Jagmeet S.] Georgetown Univ, Dept Physiol & Biophys, Washington, DC USA	Georgetown University	Ma, J (corresponding author), Georgetown Univ, Dept Physiol & Biophys, Washington, DC USA.	kanwalj@georgetown.edu	Kanwal, Jagmeet/D-2145-2009	Kanwal, Jagmeet/0000-0002-4529-3631	National Institute for Deafness and other Communication Disorders (NIDCD), NIH [DC008822, DC01009]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008822] Funding Source: NIH RePORTER	National Institute for Deafness and other Communication Disorders (NIDCD), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported in part by a NIH research grants DC008822 to J.S.K. and DC01009 to R.T.N. from the National Institute for Deafness and other Communication Disorders (NIDCD). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; APPLEGATE CD, 1982, BRAIN RES, V238, P457, DOI 10.1016/0006-8993(82)90123-8; AUBIN T, 1987, BEHAVIOUR, V100, P123, DOI 10.1163/156853987X00107; Becker P.H., 1982, P213; Blair HT, 2003, ANN NY ACAD SCI, V985, P485; Blair HT, 2005, NEUROSCIENCE, V133, P561, DOI 10.1016/j.neuroscience.2005.02.043; BURNS LH, 1994, BEHAV NEURAL BIOL, V61, P242, DOI 10.1016/S0163-1047(05)80007-X; Charrier I, 2005, BEHAV PROCESS, V70, P271, DOI 10.1016/j.beproc.2005.07.007; Clement Matthew J., 2006, P57; Cuddy LL, 2005, MED HYPOTHESES, V64, P229, DOI 10.1016/j.mehy.2004.09.005; DELIEGE I, 1996, MUSICAL BEGINNINGS O; Erulkar S D, 1968, Contrib Sens Physiol, V3, P149; Esser KH, 1997, J COMP PHYSIOL A, V180, P513, DOI 10.1007/s003590050068; Esser KH, 1996, J COMP PHYSIOL A, V178, P787; Fenton MB, 2004, J ZOOL, V262, P11, DOI 10.1017/S095283690300431X; Fenzl T, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-17; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; FLOODY OR, 1977, J COMP PHYSIOL PSYCH, V91, P443, DOI 10.1037/h0077341; Gaese BH, 2006, JARO-J ASSOC RES OTO, V7, P48, DOI 10.1007/s10162-005-0022-7; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; Ghazanfar AA, 2002, ANIM BEHAV, V64, P427, DOI 10.1006/anbe.2002.3074; Gordon M, 1998, HEARING RES, V122, P97, DOI 10.1016/S0378-5955(98)00087-2; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; HAUSER MD, 1991, ETHOLOGY, V89, P29; HEIL P, 1992, J COMP NEUROL, V322, P548, DOI 10.1002/cne.903220409; HEIL P, 1992, J COMP PHYSIOL A, V171, P583; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; HORNBY PJ, 1988, BRAIN BEHAV EVOLUT, V31, P181, DOI 10.1159/000116585; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Jouventin P, 1999, ANIM BEHAV, V57, P1175, DOI 10.1006/anbe.1999.1086; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; KANWAL JS, 2006, BEHAV NEURODYNAMICS, P163; KELLEY AE, 1982, NEUROSCIENCE, V7, P615, DOI 10.1016/0306-4522(82)90067-7; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Kraus M, 2002, LEARN MEMORY, V9, P293, DOI 10.1101/lm.47502; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LEDOUX JE, 1986, NEUROSCIENCE, V17, P615, DOI 10.1016/0306-4522(86)90034-5; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Ma XF, 2003, J NEUROPHYSIOL, V89, P90, DOI 10.1152/jn.00968.2001; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082; Medvedev AV, 2004, J NEUROPHYSIOL, V92, P52, DOI 10.1152/jn.01253.2003; MENDELSON JR, 1985, BRAIN RES, V327, P331, DOI 10.1016/0006-8993(85)91530-6; MENDELSON JR, 1993, EXP BRAIN RES, V94, P65; Mercado E, 2005, J COMP PSYCHOL, V119, P90, DOI 10.1037/0735-7036.119.1.90; METZNER W, 1987, J COMP PHYSIOL A, V160, P395, DOI 10.1007/BF00613029; Miasnikov AA, 2006, NEUROBIOL LEARN MEM, V86, P47, DOI 10.1016/j.nlm.2005.12.010; Miller CT, 2004, ANIM BEHAV, V68, P713, DOI 10.1016/j.anbehav.2003.10.028; Morton E.S., 1982, P183; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Nelken I, 2000, EUR J NEUROSCI, V12, P549, DOI 10.1046/j.1460-9568.2000.00935.x; ONEILL WE, 1982, J NEUROSCI, V2, P17; ONEILL WE, 1979, SCIENCE, V203, P69, DOI 10.1126/science.758681; Orduna I, 2005, BEHAV NEUROSCI, V119, P256, DOI 10.1037/0735-7044.119.1.256; Pare D, 2000, J NEUROSCI, V20, P2701; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; PHILLIPS DP, 1985, EXP BRAIN RES, V58, P443; POLA YV, 1975, ANIM BEHAV, V23, P826, DOI 10.1016/0003-3472(75)90108-6; POON PWF, 1991, EXP BRAIN RES, V83, P598; Razak KA, 2006, J NEUROPHYSIOL, V96, P1303, DOI 10.1152/jn.00020.2006; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; ROVERUD RC, 1993, J NEUROSCI, V13, P2306, DOI 10.1523/JNEUROSCI.13-06-02306.1993; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; SCHULLER G, 1986, J NEUROSCI METH, V18, P339, DOI 10.1016/0165-0270(86)90022-1; Searby A, 2003, P ROY SOC B-BIOL SCI, V270, P1765, DOI 10.1098/rspb.2003.2442; SHAMMA SA, 1993, J NEUROPHYSIOL, V69, P367, DOI 10.1152/jn.1993.69.2.367; Soha JA, 2000, ANIM BEHAV, V60, P297, DOI 10.1006/anbe.2000.1499; SUGA N, 1972, AUDIOLOGY, V11, P58; SUGA N, 1968, J PHYSIOL-LONDON, V198, P51, DOI 10.1113/jphysiol.1968.sp008593; Suga N, 1983, ADV VERTEBRATE NEURO, P829; Suga N, 2008, LEARN MEMORY, V15, P198, DOI 10.1101/lm.791408; Sugase-Miyamoto Y, 2005, J NEUROSCI, V25, P11071, DOI 10.1523/JNEUROSCI.1796-05.2005; Sugiura H, 1998, ANIM BEHAV, V55, P673, DOI 10.1006/anbe.1997.0602; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Washington SD, 2008, J NEUROPHYSIOL, V100, P3285, DOI 10.1152/jn.90442.2008; Weinberger NM, 2008, LEARN MEMORY, V15, P202, DOI 10.1101/lm.914208; Wellman LL, 2005, J NEUROSCI, V25, P4577, DOI 10.1523/JNEUROSCI.2257-04.2005; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Wetzel W, 1998, BEHAV BRAIN RES, V91, P29, DOI 10.1016/S0166-4328(97)00099-5; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	87	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10579	10.1371/journal.pone.0010579	http://dx.doi.org/10.1371/journal.pone.0010579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485675	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563400004
J	Wang, P; Zhu, F; Lee, NH; Konstantopoulos, K				Wang, Pu; Zhu, Fei; Lee, Norman H.; Konstantopoulos, Konstantinos			Shear-induced Interleukin-6 Synthesis in Chondrocytes ROLES OF E PROSTANOID (EP) 2 AND EP3 IN cAMP/PROTEIN KINASE A-AND PI3-K/Akt-DEPENDENT NF-kappa B ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN E-2; EXPRESSION; OSTEOARTHRITIS; RECEPTORS; CYCLOOXYGENASE-2; CARTILAGE; STRESS; COX-2; GENE; RAT	Mechanical overloading of cartilage producing hydrostatic stress, tensile strain, and fluid flow can adversely affect chondrocyte function and precipitate osteoarthritis (OA). Application of high fluid shear stress to chondrocytes recapitulates the earmarks of OA, as evidenced by the release of pro-inflammatory mediators, matrix degradation, and chondrocyte apoptosis. Elevated levels of cyclooxygenase-2 (COX-2), prostaglandin (PG) E-2, and interleukin (IL)-6 have been reported in OA cartilage in vivo, and in shear-activated chondrocytes in vitro. Although PGE(2) positively regulates IL-6 synthesis in chondrocytes, the underlying signaling pathway of shear-induced IL-6 expression remains unknown. Using the human T/C-28a2 chondrocyte cell line as a model system, we demonstrate that COX-2-derived PGE(2) signals via up-regulation of E prostanoid (EP) 2 and down-regulation of EP3 receptors to raise intracellular cAMP, and activate protein kinase A (PKA) and phosphatidylinositol 3-kinase (PI3-K)/Akt pathways. PKA and PI3-K/Akt transactivate the NF-kappa B p65 subunit via phosphorylation at Ser-276 and Ser-536, respectively. Binding of p65 to the IL-6 promoter elicits IL-6 synthesis in sheared chondrocytes. Selective knockdown of EP2 or ectopic expression of EP3 blocks PKA- and PI3-K/Akt-dependent p65 activation and markedly diminishes shear-induced IL-6 expression. Similar inhibitory effects on IL-6 synthesis were observed by inhibiting PKA, PI3-K, or NF-kappa B using pharmacological and/or genetic interventions. Reconstructing the signaling network regulating shear-induced IL-6 expression in chondrocytes may provide insights for developing therapeutic strategies for arthritic disorders and for culturing artificial cartilage in bioreactors.	[Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Lee, Norman H.] George Washington Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20037 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; George Washington University; Johns Hopkins University	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kkonsta1@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		National Institutes of Health NIAMS [R01 AR053358]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053358] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by the National Institutes of Health NIAMS Grant R01 AR053358.	Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Anderson GD, 1996, J CLIN INVEST, V97, P2672, DOI 10.1172/JCI118717; Aoyama T, 2005, J BONE MINER RES, V20, P377, DOI 10.1359/JBMR.041122; Attur M, 2008, J IMMUNOL, V181, P5082, DOI 10.4049/jimmunol.181.7.5082; Brenn D, 2007, ARTHRITIS RHEUM, V56, P351, DOI 10.1002/art.22282; Buckwalter JA, 2006, BIORHEOLOGY, V43, P603; Carter DR, 2004, CLIN ORTHOP RELAT R, pS69, DOI 10.1097/01.blo.0000144970.05107.7e; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Chen LX, 2008, OSTEOARTHR CARTILAGE, V16, P174, DOI 10.1016/j.joca.2007.06.006; Ciullo I, 2001, ONCOGENE, V20, P1186, DOI 10.1038/sj.onc.1204219; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Gerlag DM, 2000, J IMMUNOL, V165, P1652, DOI 10.4049/jimmunol.165.3.1652; Goldring MB, 2004, METH MOLEC MED, V100, P37; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102; Hinson RM, 1996, P NATL ACAD SCI USA, V93, P4885, DOI 10.1073/pnas.93.10.4885; Inoue H, 2002, BRIT J PHARMACOL, V136, P287, DOI 10.1038/sj.bjp.0704705; Kunisch E, 2009, J IMMUNOL, V183, P1328, DOI 10.4049/jimmunol.0900801; Kurihara Y, 2001, CLIN EXP IMMUNOL, V123, P323, DOI 10.1046/j.1365-2249.2001.01442.x; Li X, 2009, ARTHRITIS RHEUM-US, V60, P513, DOI 10.1002/art.24258; Martel-Pelletier Johanne, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS31; Martin JA, 2006, BIORHEOLOGY, V43, P517; Mohtai M, 1996, J ORTHOP RES, V14, P67, DOI 10.1002/jor.1100140112; Noguchi K, 2002, J PERIODONTAL RES, V37, P29, DOI 10.1034/j.1600-0765.2002.00641.x; Notoya K, 2000, J IMMUNOL, V165, P3402, DOI 10.4049/jimmunol.165.6.3402; Papadaki M, 1997, BIOTECHNOL PROGR, V13, P209, DOI 10.1021/bp970029f; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takaoka Y, 1999, J BIOCHEM-TOKYO, V126, P553, DOI 10.1093/oxfordjournals.jbchem.a022485; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; ZHU F, 2010, CELL DEATH IN PRESS	36	72	74	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24793	24804		10.1074/jbc.M110.110320	http://dx.doi.org/10.1074/jbc.M110.110320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516073	Green Published, hybrid			2022-12-25	WOS:000280542100052
J	Groskreutz, DJ; Babor, EC; Monick, MM; Varga, SM; Hunninghake, GW				Groskreutz, Dayna J.; Babor, Ellen C.; Monick, Martha M.; Varga, Steven M.; Hunninghake, Gary W.			Respiratory Syncytial Virus Limits alpha Subunit of Eukaryotic Translation Initiation Factor 2 (eIF alpha) Phosphorylation to Maintain Translation and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PKR; AIRWAY EPITHELIAL-CELLS; PHOSPHATASE 2A; HEPATITIS-C; CATALYTIC SUBUNIT; GLYCOPROTEIN-G; KAPPA-B; ACTIVATION; RNA; EXPRESSION	The impact of respiratory syncytial virus (RSV) on morbidity and mortality is significant in that it causes bronchiolitis in infants, exacerbations in patients with obstructive lung disease, and pneumonia in immunocompromised hosts. RSV activates protein kinase R (PKR), a cellular kinase relevant to limiting viral replication (Groskreutz, D. J., Monick, M. M., Powers, L. S., Yarovinsky, T. O., Look, D. C., and Hunninghake, G. W. (2006) J. Immunol. 176, 1733-1740). It is activated by autophosphorylation, likely triggered by a double-stranded RNA intermediate during replication of the virus. In most instances, ph-PKR targets the alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) protein via phosphorylation, leading to an inhibition of translation of cellular and viral protein. However, we found that although ph-PKR increases in RSV infection, significant eIF2 alpha phosphorylation is not observed, and inhibition of protein translation does not occur. RSV infection attenuates eIF2 alpha phosphorylation by favoring phosphatase rather than kinase activity. Although PKR is activated, RSV sequesters PKR away from eIF2 alpha by binding of the kinase to the RSV N protein. This occurs in conjunction with an increase in the association of the phosphatase, PP2A, with eIF2 alpha following PKR activation. The result is limited phosphorylation of eIF2 alpha and continued translation of cellular and viral proteins.	[Groskreutz, Dayna J.; Babor, Ellen C.; Monick, Martha M.; Hunninghake, Gary W.] Univ Iowa, Div Pulm Crit Care & Occupat Med, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Groskreutz, Dayna J.; Hunninghake, Gary W.] Univ Iowa, Inst Clin & Translat Sci, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Varga, Steven M.] Univ Iowa, Dept Microbiol, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Varga, Steven M.] Univ Iowa, Interdisciplinary Grad Program Immunol, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Groskreutz, DJ (corresponding author), Univ Iowa, Div Pulm Crit Care & Occupat Med, Roy J & Lucille Carver Coll Med, 100 EMRB, Iowa City, IA 52242 USA.	dayna-groskreutz@uiowa.edu	Varga, Steven/C-2009-2009	Varga, Steven/0000-0001-7332-4290	National Institutes of Health [HL089392-02, HL073967-01, HL077431-01, HL075559-04, R01 HL079901-01A1, AI 063520]; General Clinical Research Centers [RR00059]; NCRR [UL1RR024979]; Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000059, UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073967, K08HL089392, R01HL079901, R01HL075559, R01HL096625, R01HL077431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089392-02, HL073967-01, HL077431-01, HL075559-04, R01 HL079901-01A1, AI 063520, and RR00059 from the General Clinical Research Centers Program and Grant UL1RR024979 from the NCRR. This work was also supported by a Veterans Affairs Merit Review grant.	Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Azevedo A M N, 2003, Allergol Immunopathol (Madr), V31, P311, DOI 10.1157/13055209; BALL LA, 1986, P NATL ACAD SCI USA, V83, P246, DOI 10.1073/pnas.83.2.246; Bernsmeier C, 2008, J HEPATOL, V49, P429, DOI 10.1016/j.jhep.2008.04.007; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Budt M, 2009, J VIROL, V83, P1260, DOI 10.1128/JVI.01558-08; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cheng GF, 2003, J VIROL, V77, P10154, DOI 10.1128/JVI.77.18.10154-10161.2003; CHERRIE AH, 1992, J VIROL, V66, P2102, DOI 10.1128/JVI.66.4.2102-2110.1992; Christen V, 2007, HEPATOLOGY, V46, P558, DOI 10.1002/hep.21611; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Duong FHT, 2005, J VIROL, V79, P15342, DOI 10.1128/JVI.79.24.15342-15350.2005; Eigen H, 1999, J PEDIATR-US, V135, pS1; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Eriksson M, 2000, PEDIAT ALLERG IMM-UK, V11, P193, DOI 10.1034/j.1399-3038.2000.00076.x; Garcia-Bonilla L, 2007, J NEUROCHEM, V103, P1368, DOI 10.1111/j.1471-4159.2007.04844.x; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Garofalo R, 1996, J IMMUNOL, V157, P2506; Georgopoulou U, 2006, BIOCHIMIE, V88, P651, DOI 10.1016/j.biochi.2005.12.003; Groskreutz DJ, 2007, J IMMUNOL, V179, P2741, DOI 10.4049/jimmunol.179.5.2741; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Hakki M, 2008, VIROLOGY, V380, P255, DOI 10.1016/j.virol.2008.07.028; Harris J, 2003, CELL MICROBIOL, V5, P671, DOI 10.1046/j.1462-5822.2003.00313.x; Jammi NV, 2001, NUCLEIC ACIDS RES, V29, P3020; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kang JI, 2009, VIRUS RES, V142, P51, DOI 10.1016/j.virusres.2009.01.007; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Lemen Richard J., 1995, Acta Paediatrica Sinica, V36, P78; Mastronarde JG, 1996, J INFECT DIS, V174, P262, DOI 10.1093/infdis/174.2.262; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; PETRYSHYN R, 1982, P NATL ACAD SCI-BIOL, V79, P6512, DOI 10.1073/pnas.79.21.6512; Poppers J, 2000, J VIROL, V74, P11215, DOI 10.1128/JVI.74.23.11215-11221.2000; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Rivera J, 2007, J VIROL, V81, P2923, DOI 10.1128/JVI.02077-06; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Sawicki DL, 2003, J VIROL, V77, P1801, DOI 10.1128/JVI.77.3.1801-1811.2003; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; SIGURS N, 1995, PEDIATRICS, V95, P500; Smyth RL, 1999, LANCET, V354, P1997, DOI 10.1016/S0140-6736(05)76769-6; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; SZYSZKA R, 1989, J BIOL CHEM, V264, P3827; Tan SL, 2002, J BIOL CHEM, V277, P36109, DOI 10.1074/jbc.M205109200; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Tung HYL, 1997, FEBS LETT, V401, P197, DOI 10.1016/S0014-5793(96)01470-6; WERTZ GW, 1987, J VIROL, V61, P293, DOI 10.1128/JVI.61.2.293-301.1987; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07	58	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24023	24031		10.1074/jbc.M109.077321	http://dx.doi.org/10.1074/jbc.M109.077321			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519500	hybrid, Green Published			2022-12-25	WOS:000280291400053
J	Suzuki, Y; Ogawa, K; Koyanagi, Y; Suzuki, Y				Suzuki, Yasutsugu; Ogawa, Kanako; Koyanagi, Yoshio; Suzuki, Youichi			Functional Disruption of the Moloney Murine Leukemia Virus Preintegration Complex by Vaccinia-related Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-AUTOINTEGRATION FACTOR; HUMAN VACCINIA-RELATED-KINASE-1 VRK1; CELL-CYCLE PROGRESSION; HIV TYPE-1 INTEGRATION; NUCLEAR-ENVELOPE; RETROVIRAL DNA; IN-VITRO; BINDING-SITE; PROTEIN; BARRIER	Retroviral integration is executed by the preintegration complex (PIC), which contains viral DNA together with a number of proteins. Barrier-to-autointegration factor (BAF), a cellular component of Moloney murine leukemia virus (MMLV) PICs, has been demonstrated to protect viral DNA from autointegration and stimulate the intermolecular integration activity of the PIC by its DNA binding activity. Recent studies reveal that the functions of BAF are regulated by phosphorylation via a family of cellular serine/threonine kinases called vaccinia-related kinases (VRK), and VRK-mediated phosphorylation causes a loss of the DNA binding activity of BAF. These results raise the possibility that BAF phosphorylation may influence the integration activities of the PIC through removal of BAF from viral DNA. In the present study, we report that VRK1 was able to abolish the intermolecular integration activity of MMLV PICs in vitro. This was accompanied by an enhancement of autointegration activity and dissociation of BAF from the PICs. In addition, in vitro phosphorylation of BAF by VRK1 abrogated the activity of BAF in PIC function. Among the VRK family members, VRK1 as well as VRK2, which catalyze hyperphosphorylation of BAF, could abolish PIC function. We also found that treatment of PICs with certain nucleotides such as ATP resulted in the inhibition of the intermolecular integration activity of PICs through the dissociation of BAF. More importantly, the ATP-induced disruption was not observed with the PICs from VRK1 knockdown cells. Our in vitro results therefore suggest the presence of cellular kinases including VRKs that can inactivate the retroviral integration complex via BAF phosphorylation.	[Suzuki, Youichi] Kyoto Univ, Inst Virus Res, Ctr AIDS Res, Lab Viral Pathogenesis,Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Ctr Emerging Virus Res, Lab Host Factors, Kyoto 6068507, Japan; [Suzuki, Yasutsugu] Kyoto Univ, Grad Sch Biostudies, Dept Mammalian Regulatory Network, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University	Suzuki, Y (corresponding author), Kyoto Univ, Inst Virus Res, Ctr AIDS Res, Lab Viral Pathogenesis,Sakyo Ku, 53 Shogoin Kawara Cho, Kyoto 6068507, Japan.	ysuzuki@virus.kyoto-u.ac.jp	Suzuki, Yasutsugu/Z-2378-2019	Suzuki, Yasutsugu/0000-0002-8202-3032; Suzuki, Youichi/0000-0003-3554-0755	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health, Labor, and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Chen HM, 2001, MOL CELL BIOL, V21, P6758, DOI 10.1128/MCB.21.20.6758-6767.2001; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; FARNET CM, 1991, J VIROL, V65, P6942, DOI 10.1128/JVI.65.12.6942-6952.1991; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; Furukawa K, 1999, J CELL SCI, V112, P2485; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Harris D, 2000, J BIOL CHEM, V275, P39671, DOI 10.1074/jbc.M002626200; Jacque JM, 2006, NATURE, V441, P641, DOI 10.1038/nature04682; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kang TH, 2006, NAT CELL BIOL, V8, P863, DOI 10.1038/ncb1447; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; LEADER DP, 1988, J GEN VIROL, V69, P1441, DOI 10.1099/0022-1317-69-7-1441; LEE MS, 1994, P NATL ACAD SCI USA, V91, P9823, DOI 10.1073/pnas.91.21.9823; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Nili E, 2001, J CELL SCI, V114, P3297; Sanz-Garcia M, 2008, MOL CELL PROTEOMICS, V7, P2199, DOI 10.1074/mcp.M700586-MCP200; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Suzuki Y, 2004, EMBO J, V23, P4670, DOI 10.1038/sj.emboj.7600452; Suzuki Y, 2002, J VIROL, V76, P12376, DOI 10.1128/JVI.76.23.12376-12380.2002; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Vlcek S, 2001, CELL MOL LIFE SCI, V58, P1758, DOI 10.1007/PL00000815; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Zelko I, 1998, ARCH BIOCHEM BIOPHYS, V352, P31, DOI 10.1006/abbi.1998.0582; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197	50	12	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24032	24043		10.1074/jbc.M110.116640	http://dx.doi.org/10.1074/jbc.M110.116640			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511217	Green Published, hybrid			2022-12-25	WOS:000280291400054
J	Shen, H; Maki, CG				Shen, Hong; Maki, Carl G.			Persistent p21 Expression after Nutlin-3a Removal Is Associated with Senescence-like Arrest in 4N Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; CELLULAR SENESCENCE; CDC2 KINASE; IN-VIVO; MDM2; P53; CYCLE; PHOSPHORYLATION; ANTAGONISTS; APOPTOSIS	Nutlin-3a is a preclinical drug that stabilizes p53 by blocking the interaction between p53 and MDM2. In our previous study, Nutlin-3a promoted a tetraploid G(1) arrest in two p53 wild-type cell lines (HCT116 and U2OS), and both cell lines underwent endoreduplication after Nutlin-3a removal. Endoreduplication gave rise to stable tetraploid clones resistant to therapy-induced apoptosis. Prior knowledge of whether cells are susceptible to Nutlin-induced endoreduplication and therapy resistance could help direct Nutlin-3a-based therapies. In the present study, Nutlin-3a promoted a tetraploid G(1) arrest in multiple p53 wildtype cell lines. However, some cell lines underwent endoreduplication to relatively high extents after Nutlin-3a removal whereas other cell lines did not. The resistance to endoreduplication observed in some cell lines was associated with a prolonged 4N arrest after Nutlin-3a removal. Knockdown of either p53 or p21 immediately after Nutlin-3a removal could drive endoreduplication in otherwise resistant 4N cells. Finally, 4N-arrested cells retained persistent p21 expression; expressed senescence-associated beta-galactosidase; displayed an enlarged, flattened phenotype; and underwent a proliferation block that lasted at least 2 weeks after Nutlin-3a removal. These findings demonstrate that transient Nutlin-3a treatment can promote an apparently permanent proliferative block in 4N cells of certain cell lines associated with persistent p21 expression and resistance to endoreduplication.	[Shen, Hong; Maki, Carl G.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Rush University	Maki, CG (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, 1750 W Harrison Ave,Jelke Bldg,Rm 1306, Chicago, IL 60612 USA.	Carl_Maki@rush.edu						Badie C, 2000, MOL CELL BIOL, V20, P2358, DOI 10.1128/MCB.20.7.2358-2366.2000; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chen JJ, 1996, NUCLEIC ACIDS RES, V24, P1727, DOI 10.1093/nar/24.9.1727; Drakos E, 2009, LEUKEMIA, V23, P2290, DOI 10.1038/leu.2009.180; Efeyan A, 2007, CANCER RES, V67, P7350, DOI 10.1158/0008-5472.CAN-07-0200; Fujita M, 1999, J BIOL CHEM, V274, P25927, DOI 10.1074/jbc.274.36.25927; Fujita M, 1998, J BIOL CHEM, V273, P17095, DOI 10.1074/jbc.273.27.17095; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Hasegawa H, 2009, LEUKEMIA, V23, P2090, DOI 10.1038/leu.2009.171; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hendrickson M, 1996, P NATL ACAD SCI USA, V93, P12223, DOI 10.1073/pnas.93.22.12223; Huang BY, 2009, MOL CANCER RES, V7, P1497, DOI 10.1158/1541-7786.MCR-09-0144; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kitagawa M, 2008, ONCOGENE, V27, P5303, DOI 10.1038/onc.2008.164; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Korotchkina LG, 2009, CELL CYCLE, V8, P3777, DOI 10.4161/cc.8.22.10121; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Secchiero P, 2006, BLOOD, V107, P4122, DOI 10.1182/blood-2005-11-4465; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Steelman LS, 2009, CELL CYCLE, V8, P3634, DOI 10.4161/cc.8.22.10165; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	33	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23103	23112		10.1074/jbc.M110.124990	http://dx.doi.org/10.1074/jbc.M110.124990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489208	Green Published, hybrid			2022-12-25	WOS:000279999900045
J	Weiner, EM; Robson, S; Marohn, M; Clubb, RT				Weiner, Ethan M.; Robson, Scott; Marohn, Melanie; Clubb, Robert T.			The Sortase A Enzyme That Attaches Proteins to the Cell Wall of Bacillus anthracis Contains an Unusual Active Site Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; NMR STRUCTURE DETERMINATION; SORTING SIGNAL BINDING; IMIDAZOLIUM ION-PAIR; STAPHYLOCOCCUS-AUREUS; SURFACE-PROTEINS; TRANSPEPTIDASE SRTA; CRYSTAL-STRUCTURES; SUBSTRATE COMPLEX; KINETIC MECHANISM	The pathogen Bacillus anthracis uses the Sortase A (SrtA) enzyme to anchor proteins to its cell wall envelope during vegetative growth. To gain insight into the mechanism of protein attachment to the cell wall in B. anthracis we investigated the structure, backbone dynamics, and function of SrtA. The NMR structure of SrtA has been determined with a backbone coordinate precision of 0.40 +/- 0.07A. SrtA possesses several novel features not previously observed in sortase enzymes including the presence of a structurally ordered amino terminus positioned within the active site and in contact with catalytically essential histidine residue (His126). We propose that this appendage, in combination with a unique flexible active site loop, mediates the recognition of lipid II, the second substrate to which proteins are attached during the anchoring reaction. pKa measurements indicate that His126 is uncharged at physiological pH compatible with the enzyme operating through a "reverse protonation" mechanism. Interestingly, NMR relaxation measurements and the results of a model building study suggest that SrtA recognizes the LPXTG sorting signal through a lock-in-key mechanism in contrast to the prototypical	[Weiner, Ethan M.; Robson, Scott; Marohn, Melanie; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clubb, Robert T.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Clubb, Robert T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu		/0000-0002-5800-3672; Robson, Scott/0000-0002-0529-0399	National Institutes of Health [AI52217]; Department of Energy [DE-FC-03-87ER60615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI52217 and Department of Energy Grant DE-FC-03-87ER60615 (to R. T. C.).	Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Connolly KM, 2003, J BIOL CHEM, V278, P34061, DOI 10.1074/jbc.M305245200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Goddard T. D., 2006, SPARKY 3; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jung ME, 2005, BIOORG MED CHEM LETT, V15, P5076, DOI 10.1016/j.bmcl.2005.07.073; Keller R., 2004, COMPUTER AIDED RESON, V1; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2007, J BIOL CHEM, V282, P23129, DOI 10.1074/jbc.M701857200; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Palmer III A. G., 1995, PROTEIN NMR SPECTROS; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Suree N, 2009, BIOORGAN MED CHEM, V17, P7174, DOI 10.1016/j.bmc.2009.08.067; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Teng Q., 2005, STRUCTURAL BIOL PRAC; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zink SD, 2005, INFECT IMMUN, V73, P5222, DOI 10.1128/IAI.73.8.5222-5228.2005; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	55	48	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23431	23441		10.1074/jbc.M110.135434	http://dx.doi.org/10.1074/jbc.M110.135434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489200	hybrid, Green Published			2022-12-25	WOS:000279999900075
J	Bhadra, R; Guan, HB; Khan, IA				Bhadra, Rajarshi; Guan, Hongbing; Khan, Imtiaz A.			Absence of Both IL-7 and IL-15 Severely Impairs the Development of CD8(+) T Cell Response against Toxoplasma gondii	PLOS ONE			English	Article							IFN-GAMMA; RECEPTOR-ALPHA; CUTTING EDGE; HOMEOSTATIC PROLIFERATION; MURINE TOXOPLASMOSIS; MEDIATED-IMMUNITY; MEMORY; EXPRESSION; INFECTION; MICE	CD8(+) T cells play an essential role in the protection against both acute as well as chronic Toxoplasma gondii infection. Although the role of IL-15 has been reported to be important for the development of long-term CD8(+) T cell immunity against the pathogen, the simultaneous roles played by both IL-15 and related gamma-chain family cytokine IL-7 in the generation of this response during acute phase of infection has not been described. We demonstrate that while lack of IL-7 or IL-15 alone has minimal impact on splenic CD8(+) T cell maturation or effector function development during acute Toxoplasmosis, absence of both IL-7 and IL-15 only in the context of infection severely down-regulates the development of a potent CD8(+) T cell response. This impairment is characterized by reduction in CD44 expression, IFN-gamma production, proliferation and cytotoxicity. However, attenuated maturation and decreased effector functions in these mice are essentially downstream consequences of reduced number of antigen-specific CD8(+) T cells. Interestingly, the absence of both cytokines did not impair initial CD8(+) T cell generation but affected their survival and differentiation into memory phenotype IL-7R alpha(hi) cells. Significantly lack of both cytokines severely affected expression of Bcl-2, an anti-apoptotic protein, but minimally affected proliferation. The overarching role played by these cytokines in eliciting a potent CD8(+) T cell immunity against T. gondii infection is further evidenced by poor survival and high parasite burden in anti IL-7 treated IL-15(-/-) mice. These studies demonstrate that the two cytokines, IL-7 and IL-15, are exclusively important for the development of protective CD8(+) T cell immune response against T. gondii. To the best of our knowledge this synergism between IL-7 and IL-15 in generating an optimal CD8(+) T cell immunity against intracellular parasite or any other infectious disease model has not been previously reported.	[Bhadra, Rajarshi; Khan, Imtiaz A.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Guan, Hongbing] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA	George Washington University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bhadra, R (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.	mtmixk@gwumc.edu			National Institutes of Health [AI33325]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI033325, R21AI033325, R01AI033325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI33325 awarded to IAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard EL, 2007, EUR J IMMUNOL, V37, P3069, DOI 10.1002/eji.200637017; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Bianchi T, 2006, BLOOD, V107, P3992, DOI 10.1182/blood-2005-09-3851; Blass SL, 2001, J IMMUNOL, V166, P5726, DOI 10.4049/jimmunol.166.9.5726; Borger P, 1996, J IMMUNOL, V156, P1333; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; CANDOLFI E, 1994, INFECT IMMUN, V62, P1995, DOI 10.1128/IAI.62.5.1995-2001.1994; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; Casciotti L, 2002, INFECT IMMUN, V70, P434, DOI 10.1128/IAI.70.2.434-443.2002; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cheung KP, 2009, J IMMUNOL, V182; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Combe CL, 2006, P NATL ACAD SCI USA, V103, P6635, DOI 10.1073/pnas.0506180103; Denkers EY, 1997, J IMMUNOL, V159, P1903; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Guan HB, 2007, J IMMUNOL, V179, P590, DOI 10.4049/jimmunol.179.1.590; HAKIM FT, 1991, J IMMUNOL, V147, P2310; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; HAQUE S, 1994, INFECT IMMUN, V62, P2908, DOI 10.1128/IAI.62.7.2908-2916.1994; HUGHES HPA, 1988, CLIN EXP IMMUNOL, V72, P394; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Karawajew L, 2000, BLOOD, V96, P297, DOI 10.1182/blood.V96.1.297.013k24_297_306; KASPER LH, 1995, J IMMUNOL, V155, P4798; KHAN IA, 1995, PARASITE IMMUNOL, V17, P185, DOI 10.1111/j.1365-3024.1995.tb00888.x; Khan IA, 1999, J IMMUNOL, V163, P4503; Khan IA, 2002, J EXP MED, V195, P1463, DOI 10.1084/jem.20011915; Khan IA, 1996, J IMMUNOL, V157, P2103; Khan IA, 1999, INFECT IMMUN, V67, P5869, DOI 10.1128/IAI.67.11.5869-5876.1999; KHAN IA, 1994, J IMMUNOL, V152, P1856; Klonowski KD, 2006, J IMMUNOL, V177, P4247, DOI 10.4049/jimmunol.177.7.4247; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Morrot A, 2005, J EXP MED, V202, P551, DOI 10.1084/jem.20042463; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nakazato K, 2007, J IMMUNOL, V178, P757, DOI 10.4049/jimmunol.178.2.757; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Purner MB, 1996, INFECT IMMUN, V64, P4330, DOI 10.1128/IAI.64.10.4330-4338.1996; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Starborg M, 1996, J CELL SCI, V109, P143; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; Wilson DC, 2008, J IMMUNOL, V180, P5935, DOI 10.4049/jimmunol.180.9.5935; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	61	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10842	10.1371/journal.pone.0010842	http://dx.doi.org/10.1371/journal.pone.0010842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520779	gold, Green Published, Green Submitted			2022-12-25	WOS:000278221500028
J	Mao, CH; Wang, MA; Luo, BQ; Wey, SA; Dong, DZ; Wesselschmidt, R; Rawlings, S; Lee, AS				Mao, Changhui; Wang, Miao; Luo, Biquan; Wey, Shiuan; Dong, Dezheng; Wesselschmidt, Robin; Rawlings, Stephen; Lee, Amy S.			Targeted Mutation of the Mouse Grp94 Gene Disrupts Development and Perturbs Endoplasmic Reticulum Stress Signaling	PLOS ONE			English	Article							SHOCK-PROTEIN GP96; GLUCOSE-REGULATED PROTEINS; PEPTIDE-BINDING-SITE; ER CHAPERONE; IN-VIVO; GRP78/BIP; INDUCTION; CELLS; APOPTOSIS; PROMOTER	Glucose-regulated protein 94 (GRP94) is one of the most abundant endoplasmic reticulum (ER) resident proteins and is the ER counterpart of the cytoplasmic heat shock protein 90 (HSP90). GRP94, a component of the GRP78 chaperone system in protein processing, has pro-survival properties with implicated function in cancer progression and autoimmune disease. Previous studies on the loss of GRP94 function showed that it is required for embryonic development, regulation of toll-like receptors and innate immunity of macrophages. Here we report the creation of mouse models targeting exon 2 of the Grp94 allele that allows both traditional and conditional knockout (KO) of Grp94. In this study, we utilized the viable Grp94+/+ and +/- mice, as well as primary mouse embryonic fibroblasts generated from them as experimental tools to study its role in ER chaperone balance and ER stress signaling. Our studies reveal that while Grp94 heterozygosity reduces GRP94 level it does not alter ER chaperone levels or the ER stress response. To study the effect of complete loss of GRP94 function, since homozygous GRP94 KO leads to embryonic lethality, we generated Grp94-/- embryonic stem cells. In contrast to Grp94 heterozygosity, complete knockout of GRP94 leads to compensatory upregulation of the ER chaperones GRP78, calnexin and calreticulin but not protein disulphide isomerase. Unexpectedly, loss of GRP94 leads to significant decrease in the level of ER-stress induced spliced form of XBP-1 protein, a downstream target of the IRE1 signaling pathway. Furthermore, from analysis of microarray database and immunohistochemical staining, we present predictions where GRP94 may play an important role in specific adult organ homeostasis and function.	[Mao, Changhui; Wang, Miao; Luo, Biquan; Wey, Shiuan; Dong, Dezheng; Rawlings, Stephen; Lee, Amy S.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Wesselschmidt, Robin] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Mao, CH (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	amylee@ccnt.usc.edu		Lee, Amy/0000-0002-0378-5443	NIH/NCI [CA027607]; NATIONAL CANCER INSTITUTE [R37CA027607, R01CA027607] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/NCI, CA027607, http://www.nih.gov/; Freeman Cosmetic Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Baker-LePain JC, 2004, J IMMUNOL, V172, P4195, DOI 10.4049/jimmunol.172.7.4195; Barnes JA, 1997, ANAT EMBRYOL, V196, P335, DOI 10.1007/s004290050102; Barnes JA, 2000, ANAT EMBRYOL, V202, P67, DOI 10.1007/s004290000090; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Facciponte JG, 2006, CANCER IMMUNOL IMMUN, V55, P339, DOI 10.1007/s00262-005-0020-y; Fu H, 2007, GENESIS, V45, P477, DOI 10.1002/dvg.20316; Gidalevitz T, 2004, J BIOL CHEM, V279, P16543, DOI 10.1074/jbc.M313060200; Hilf N, 2002, INT J HYPERTHER, V18, P521, DOI 10.1080/02656730210166177; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; KIM KS, 1990, DIFFERENTIATION, V42, P153, DOI 10.1111/j.1432-0436.1990.tb00756.x; Le YZ, 2000, METH MOL B, V136, P477; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Linderoth NA, 2001, J BIOL CHEM, V276, P11049, DOI 10.1074/jbc.M010059200; Linderoth NA, 2001, BIOCHEMISTRY-US, V40, P1483, DOI 10.1021/bi0016218; LITTLE E, 1995, J BIOL CHEM, V270, P9526, DOI 10.1074/jbc.270.16.9526; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Mao CH, 2004, NAT MED, V10, P1013, DOI 10.1038/nm1004-1013; MARTINON F, 2010, NAT IMMUNOL; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Menoret A, 2001, J BIOL CHEM, V276, P33313, DOI 10.1074/jbc.M103383200; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Nardai G, 2006, TRENDS IMMUNOL, V27, P74, DOI 10.1016/j.it.2005.11.009; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; RAMAKRISHNAN M, 1995, DNA CELL BIOL, V14, P373, DOI 10.1089/dna.1995.14.373; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Wagner E, 2002, J CELL SCI, V115, P3033; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Xu XL, 2001, GENESIS, V30, P1, DOI 10.1002/gene.1025; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755	52	57	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10852	10.1371/journal.pone.0010852	http://dx.doi.org/10.1371/journal.pone.0010852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520781	Green Published, gold, Green Submitted			2022-12-25	WOS:000278221500037
J	Musch, T; Oz, Y; Lyko, F; Breiling, A				Musch, Tanja; Oez, Yuva; Lyko, Frank; Breiling, Achim			Nucleoside Drugs Induce Cellular Differentiation by Caspase-Dependent Degradation of Stem Cell Factors	PLOS ONE			English	Article							HUMAN EMBRYONAL CARCINOMA; POLYCOMB; METHYLATION; CANCER; EXPRESSION; COMPLEX; EZH2; PLURIPOTENCY; DISRUPTION; ACTIVATION	Background: Stem cell characteristics are an important feature of human cancer cells and play a major role in the therapy resistance of tumours. Strategies to target cancer stem cells are thus of major importance for cancer therapy. Differentiation therapy by nucleoside drugs represents an attractive approach for the elimination of cancer stem cells. However, even if it is generally assumed that the activity of these drugs is mediated by their ability to modulate epigenetic pathways, their precise mode of action remains to be established. We therefore analysed the potential of three nucleoside analogues to induce differentiation of the embryonic cancer stem cell line NTERA 2 D1 and compared their effect to the natural ligand retinoic acid. Methodology/Principal Findings: All nucleoside analogues analyzed, but not retinoic acid, triggered proteolytic degradation of the Polycomb group protein EZH2. Two of them, 3-Deazaneplanocin A (DZNep) and 29-deoxy-5-azacytidine (decitabine), also induced a decrease in global DNA methylation. Nevertheless, only decitabine and 1b-arabinofuranosylcytosine (cytarabine) effectively triggered neuronal differentiation of NT2 cells. We show that drug-induced differentiation, in contrast to retinoic acid induction, is caused by caspase activation, which mediates depletion of the stem cell factors NANOG and OCT4. Consistent with this observation, protein degradation and differentiation could be counteracted by co-treatment with caspase inhibitors or by depletion of CASPASE-3 and CASPASE-7 through dsRNA interference. In agreement with this, OCT4 was found to be a direct in-vitro-target of CASPASE-7. Conclusions/Significance: We show that drug-induced differentiation is not a consequence of pharmacologic epigenetic modulation, but is induced by the degradation of stem-cell-specific proteins by caspases. Our results thus uncover a novel pathway that induces differentiation of embryonic cancer stem cells and is triggered by the established anticancer drugs cytarabine and decitabine. These findings suggest new approaches for directly targeting the stem cell fraction of human tumours.	[Musch, Tanja; Oez, Yuva; Lyko, Frank; Breiling, Achim] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Epigenet, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Musch, T (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Epigenet, D-6900 Heidelberg, Germany.	a.breiling@dkfz.de		Breiling, Achim/0000-0002-7928-299X	DKFZ; Deutsche Forschungsgemeinschaft [1356]	DKFZ(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the DKFZ Intramural Research Programme and the Deutsche Forschungsgemeinschaft (Priority Programme 1356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1984, LAB INVEST, V50, P147; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Breiling A, 2007, INT REV CYTOL, V258, P83, DOI 10.1016/S0074-7696(07)58002-2; Capp JP, 2005, BIOESSAYS, V27, P1277, DOI 10.1002/bies.20326; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Curtin JC, 2001, ONCOGENE, V20, P2559, DOI 10.1038/sj.onc.1204370; D'Sa-Eipper C, 2000, DEV NEUROSCI-BASEL, V22, P116, DOI 10.1159/000017433; DEGOS L, 1990, LEUKEMIA RES, V14, P717, DOI 10.1016/0145-2126(90)90101-E; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Hatse S, 1999, BIOCHEM PHARMACOL, V58, P539, DOI 10.1016/S0006-2952(99)00035-0; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiemjit A, 2008, ONCOGENE, V27, P3615, DOI 10.1038/sj.onc.1211018; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; LEE VMY, 1986, J NEUROSCI, V6, P514; LUISIDELUCA C, 1984, J CLIN INVEST, V74, P821, DOI 10.1172/JCI111498; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Pal R, 2006, CELL PROLIFERAT, V39, P585, DOI 10.1111/j.1365-2184.2006.00400.x; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Plimack ER, 2007, LEUKEMIA LYMPHOMA, V48, P1472, DOI 10.1080/10428190701471981; Przyborski SA, 2004, STEM CELLS DEV, V13, P400, DOI 10.1089/1547328041797507; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Rao R, 2008, BLOOD, V112, P327; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sheridan KM, 1998, J MOL NEUROSCI, V10, P121, DOI 10.1007/BF02737123; Stach D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng002; Tamm I, 2005, ANN HEMATOL, V84, P47, DOI 10.1007/s00277-005-0013-0; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; von Wangenheim KH, 2008, J CANCER RES CLIN, V134, P725, DOI 10.1007/s00432-008-0381-7; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; WU C, 1989, METHOD ENZYMOL, V170, P269; Xi SC, 2007, P NATL ACAD SCI USA, V104, P14366, DOI 10.1073/pnas.0703669104; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yoshida K, 2002, J BIOL CHEM, V277, P48372, DOI 10.1074/jbc.M205485200	55	37	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10726	10.1371/journal.pone.0010726	http://dx.doi.org/10.1371/journal.pone.0010726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502711	gold, Green Published, Green Submitted			2022-12-25	WOS:000277845400026
J	Chaput-Bardy, A; Gregoire, A; Baguette, M; Pagano, A; Secondi, J				Chaput-Bardy, Audrey; Gregoire, Arnaud; Baguette, Michel; Pagano, Alain; Secondi, Jean			Condition and Phenotype-Dependent Dispersal in a Damselfly, Calopteryx splendens	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; BODY-SIZE; TRADE-OFF; SURVIVAL ESTIMATION; NATURAL-POPULATION; GOLDENROD BEETLE; MATING TACTICS; FLIGHT; DENSITY; BEHAVIOR	Individual dispersal decisions may be affected by the internal state of the individual and the external information of its current environment. Here we estimated the influence of dispersal on survival and investigated if individual phenotype (sex and wing length) and environmental condition (conspecific density and sex-ratio) affected dispersal decisions in the banded damselfly, Calopteryx splendens. As suspected from the literature, we showed that the proportion of dispersing individuals was higher in females than in males. We also found negative-density dependent dispersal in both sexes and influence of sex-ratio on dispersal. Individuals moved less when sex-ratio was male biased. These results are consistent with a lek mating system where males aggregate in a place and hold mating territories. Contrary to our expectations, neither dispersal nor survival was affected by wing length. Nevertheless, mean adult survival was about 8% lower in dispersing individuals than in residents. This might reflect a mortality cost due to dispersal.	[Chaput-Bardy, Audrey; Pagano, Alain; Secondi, Jean] Univ Angers, Lab Etud Environm Syst Anthropises, Angers, France; [Gregoire, Arnaud] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Chaput-Bardy, Audrey; Baguette, Michel] MNHN, CNRS, UMR 7179, Equipe EvolTrait, Brunoy, France; [Baguette, Michel] CNRS, Stn Expt, USR 2936, Moulis, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Chaput-Bardy, A (corresponding author), Univ Angers, Lab Etud Environm Syst Anthropises, Angers, France.	chaput_bardy_audrey@hotmail.com	Gregoire, Arnaud/B-6321-2008; Pagano, Alain/A-2478-2009; Baguette, Michel/HHZ-3609-2022; Baguette, Michel/E-4754-2011	Gregoire, Arnaud/0000-0001-6103-355X; Pagano, Alain/0000-0001-8487-8352; Secondi, Jean/0000-0001-8130-1195	Region Pays-de-la-Loire	Region Pays-de-la-Loire(Region Pays de la Loire)	This study was funded by Region Pays-de-la-Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew R. R., 2004, DRAGONFLIES EUROPE; Baguette M, 1998, ACTA OECOL, V19, P17, DOI 10.1016/S1146-609X(98)80004-0; Baguette M, 1996, ACTA OECOL, V17, P225; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Beck ML, 2002, ETHOLOGY, V108, P779, DOI 10.1046/j.1439-0310.2002.00814.x; Beirinckx K, 2006, OIKOS, V113, P539, DOI 10.1111/j.2006.0030-1299.14391.x; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Beukema JJ, 2002, ODONATOLOGICA, V31, P9; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chaput-Bardy A, 2007, FRESHWATER BIOL, V52, P1677, DOI 10.1111/j.1365-2427.2007.01794.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Clobert Jean, 2004, P307, DOI 10.1016/B978-012323448-3/50015-5; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cordoba-Aguilar A, 2009, BEHAVIOUR, V146, P189, DOI 10.1163/156853909X410739; den Boer P. J., 1970, Oecologia, V4, P1, DOI 10.1007/BF00390612; DENNO RF, 1991, AM NAT, V138, P1513, DOI 10.1086/285298; Denno Robert F., 1995, P113, DOI 10.1016/B978-012159270-7/50007-5; Dobzhansky T., 1977, EVOLUTION; Fernando CH, 1958, CEYLON J SCI BIOL SC, V1, P117; Gimenez O, 2008, AM NAT, V172, P441, DOI 10.1086/589520; Gu HN, 2006, ECOL ENTOMOL, V31, P68, DOI 10.1111/j.0307-6946.2006.00761.x; Gundersen G, 2002, ECOL LETT, V5, P294, DOI 10.1046/j.1461-0248.2002.00320.x; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; HASSON E, 1993, GENETICA, V92, P61, DOI 10.1007/BF00057508; Hedenstrom A, 2001, FUNCT ECOL, V15, P417, DOI 10.1046/j.0269-8463.2001.00531.x; HERZIG AL, 1995, ECOLOGY, V76, P2044, DOI 10.2307/1941679; Herzig AL, 1996, ECOL ENTOMOL, V21, P344, DOI 10.1046/j.1365-2311.1996.00023.x; Horton GE, 2008, OIKOS, V117, P1131, DOI 10.1111/j.0030-1299.2008.16686.x; ICHIKAWA T, 1982, APPL ENTOMOL ZOOL, V17, P439, DOI 10.1303/aez.17.439; IMS RAI, 2001, DISPERSAL, P110; Ims Rolf A., 1997, P247, DOI 10.1016/B978-012323445-2/50015-8; Ishikawa A, 2009, EVOL DEV, V11, P680, DOI 10.1111/j.1525-142X.2009.00375.x; Johansen NS, 1997, ENTOMOL EXP APPL, V83, P347, DOI 10.1046/j.1570-7458.1997.00190.x; Kingsolver JG, 1999, EVOLUTION, V53, P1479, DOI [10.2307/2640894, 10.1111/j.1558-5646.1999.tb05412.x]; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Koskimaki J, 2009, ODONATOLOGICA, V38, P159; Kuussaari M, 1996, J ANIM ECOL, V65, P791, DOI 10.2307/5677; Lambin Xavier, 2001, P110; Langellotto GA, 2000, ECOLOGY, V81, P865, DOI 10.1890/0012-9658(2000)081[0865:ATOBFC]2.0.CO;2; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Letcher BH, 2005, EVOL ECOL RES, V7, P643; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Malmqvist B, 2000, BIOL CONSERV, V93, P271, DOI 10.1016/S0006-3207(99)00139-1; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; Menendez R, 2002, ECOL ENTOMOL, V27, P317, DOI 10.1046/j.1365-2311.2002.00404.x; Morrissey MB, 2009, AM NAT, V174, P875, DOI 10.1086/648311; Nespolo RF, 2008, FUNCT ECOL, V22, P624, DOI 10.1111/j.1365-2435.2008.01394.x; Nichols J., 2001, DISPERSAL; Raihani G, 2008, ANIM BEHAV, V75, P1851, DOI 10.1016/j.anbehav.2007.11.002; RAY C, 1991, BIOL J LINN SOC, V42, P123, DOI 10.1111/j.1095-8312.1991.tb00555.x; REHFELDT G, 1992, OECOLOGIA, V89, P550, DOI 10.1007/BF00317162; Rodriguez C, 1999, EVOLUTION, V53, P612, DOI 10.2307/2640797; ROFF DA, 1994, RES POPUL ECOL, V36, P145, DOI 10.1007/BF02514929; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Rouquette JR, 2007, J APPL ECOL, V44, P692, DOI 10.1111/j.1365-2664.2007.01284.x; Rouquette JR, 2005, BIOL CONSERV, V123, P225, DOI 10.1016/j.biocon.2004.11.011; SHAPIRO AM, 1970, AM NAT, V104, P367, DOI 10.1086/282670; Sokolovska N, 2000, ECOL ENTOMOL, V25, P239, DOI 10.1046/j.1365-2311.2000.00251.x; SPEDDING GR, 1992, MECH ANIMAL LOCOMOTI, P51; Srygley RB, 1999, P ROY SOC B-BIOL SCI, V266, P2239, DOI 10.1098/rspb.1999.0914; Stenseth N.C., 1992, ANIMAL DISPERSAL SMA; Stettmer C, 1996, EUR J ENTOMOL, V93, P579; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; THOMPSON DJ, 1991, OECOLOGIA, V87, P600, DOI 10.1007/BF00320427; Toivanen T, 2009, CAN J ZOOL, V87, P684, DOI 10.1139/Z09-055; Ward L, 2005, EUR J ENTOMOL, V102, P47, DOI 10.14411/eje.2005.007; Ward L, 2007, EUR J ENTOMOL, V104, P195, DOI 10.14411/eje.2007.030; Weisser Wolfgang W., 2001, Symposia of the Royal Entomological Society of London, V20, P261, DOI 10.1079/9780851994567.0261; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	76	44	44	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10694	10.1371/journal.pone.0010694	http://dx.doi.org/10.1371/journal.pone.0010694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502694	Green Published, gold			2022-12-25	WOS:000277776500011
J	Wang, S; Zhang, LL; Meyer, E; Matz, MV				Wang, Shi; Zhang, Lingling; Meyer, Eli; Matz, Mikhail V.			Characterization of a Group of MITEs with Unusual Features from Two Coral Genomes	PLOS ONE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; INVERTED-REPEAT; WIDE ANALYSIS; ARABIDOPSIS-THALIANA; RECENT AMPLIFICATION; REPETITIVE ELEMENTS; TRANSPOSITION; EVOLUTION; PIGGYBAC; FAMILY	Background: Miniature inverted-repeat transposable elements (MITEs), which are common in eukaryotic genomes, are small non-coding elements that transpose by utilizing transposases encoded by autonomous transposons. Recent genome-wide analyses and cross-mobilization assays have greatly improved our knowledge on MITE proliferation, however, specific mechanisms for the origin and evolution of MITEs are still unclear. Principal Findings: A group of coral MITEs called CMITE were identified from two corals, Acropora millepora and Acropora palmata. CMITEs conform to many common characteristics of MITEs, but also present several unusual features. The most unusual feature of CMITEs is conservation of the internal region, which is more conserved between MITE families than the TIRs. The origin of this internal region remains unknown, although we found one CMITE family that seems to be derived from a piggyBac-like transposon in A. millepora. CMITEs can form tandem arrays, suggesting an unconventional way for MITEs to increase copy numbers. We also describe a case in which a novel transposable element was created by a CMITE insertion event. Conclusions: To our knowledge, this is the first report of identification of MITEs from coral genomes. Proliferation of CMITEs seems to be related to the transposition machinery of piggyBac-like autonomous transposons. The highly conserved internal region of CMITEs suggests a potential role for this region in their successful transposition. However, the origin of these unusual features in CMITEs remains unclear, and thus represents an intriguing topic for future investigations.	[Wang, Shi; Meyer, Eli; Matz, Mikhail V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Wang, Shi; Zhang, Lingling] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Wang, S (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	swang@mail.utexas.edu	zhang, lingling/HDM-2189-2022; Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819				Adelman ZN, 2004, TRANSGENIC RES, V13, P411, DOI 10.1007/s11248-004-6067-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benjak A, 2009, GENOME BIOL EVOL, V1, P75, DOI 10.1093/gbe/evp009; Bergemann M, 2008, J MOL EVOL, V67, P631, DOI 10.1007/s00239-008-9164-7; Dufresne M, 2007, GENETICS, V175, P441, DOI 10.1534/genetics.106.064360; Elick TA, 1997, MOL GEN GENET, V255, P605, DOI 10.1007/s004380050534; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; Feschotte C, 2003, GENETICS, V163, P747; Feschotte C, 2000, GENE, V250, P109, DOI 10.1016/S0378-1119(00)00187-6; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Hikosaka A, 2004, J MOL EVOL, V59, P738, DOI 10.1007/s00239-004-2664-1; Hikosaka A, 2000, J MOL EVOL, V51, P554, DOI 10.1007/s002390010119; Hikosaka A, 2007, MOL BIOL EVOL, V24, P2648, DOI 10.1093/molbev/msm191; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Izsvak Z, 1999, J MOL EVOL, V48, P13, DOI 10.1007/PL00006440; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Matz Mikhail V, 2003, Methods Mol Biol, V221, P103; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Santiago N, 2002, MOL BIOL EVOL, V19, P2285, DOI 10.1093/oxfordjournals.molbev.a004052; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Song WY, 1998, MOL GEN GENET, V258, P449, DOI 10.1007/s004380050755; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tu ZJ, 2001, MOL BIOL EVOL, V18, P893, DOI 10.1093/oxfordjournals.molbev.a003871; Tu ZJ, 2001, P NATL ACAD SCI USA, V98, P1699, DOI 10.1073/pnas.041593198; UNSAL K, 1995, J MOL BIOL, V248, P812, DOI 10.1006/jmbi.1995.0262; Wessler SR, 2006, IMPLICIT GENOME, P138; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688; Zhang XY, 2004, GENETICS, V166, P971, DOI 10.1534/genetics.166.2.971	38	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10700	10.1371/journal.pone.0010700	http://dx.doi.org/10.1371/journal.pone.0010700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502527	Green Submitted, Green Published, gold			2022-12-25	WOS:000277776500015
J	Dickerson, BR; Ream, RR; Vignieri, SN; Bentzen, P				Dickerson, Bobette R.; Ream, Rolf R.; Vignieri, Sacha N.; Bentzen, Paul			Population Structure as Revealed by mtDNA and Microsatellites in Northern Fur Seals, Callorhinus ursinus, throughout Their Range	PLOS ONE			English	Article							ARCTOCEPHALUS-GAZELLA; CONTROL-REGION; SITE FIDELITY; DIFFERENTIATION; MITOCHONDRIAL; ISLAND; SEQUENCES; GENETICS; GROWTH; DIET	Background: The northern fur seal (Callorhinus ursinus; NFS) is a widely distributed pinniped that has been shown to exhibit a high degree of philopatry to islands, breeding areas on an island, and even to specific segments of breeding areas. This level of philopatry could conceivably lead to highly genetically divergent populations. However, northern fur seals have the potential for dispersal across large distances and have experienced repeated rapid population expansions following glacial retreat and the more recent cessation of intensive harvest pressure. Methodology/Principal Findings: Using microsatellite and mitochondrial loci, we examined population structure in NFS throughout their range. We found only weak population genetic structure among breeding islands including significant F-ST and Phi(ST) values between eastern and western Pacific islands. Conclusions: We conclude that insufficient time since rapid population expansion events (both post glacial and following the cessation of intense harvest pressure) mixed with low levels of contemporary migration have resulted in an absence of genetic structure across the entire northern fur seal range.	[Dickerson, Bobette R.; Ream, Rolf R.] NOAA, Natl Marine Fisheries Serv, Mol Ecol Res Lab, Natl Marine Mammal Lab,Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Vignieri, Sacha N.] Harvard Univ, Dept Organism & Evolutionary Biol, Museum Comparat Zool, Cambridge, MA 02138 USA; [Bentzen, Paul] Dalhousie Univ, Halifax, NS, Canada	National Oceanic Atmospheric Admin (NOAA) - USA; Harvard University; Dalhousie University	Dickerson, BR (corresponding author), NOAA, Natl Marine Fisheries Serv, Mol Ecol Res Lab, Natl Marine Mammal Lab,Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA.	Bobette.Dickerson@noaa.gov		Bentzen, Paul/0000-0003-4288-7730	Alaska Fisheries Science Center	Alaska Fisheries Science Center	Funding came from the Alaska Fisheries Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1995, MOL ECOL, V4, P653, DOI 10.1111/j.1365-294X.1995.tb00266.x; Antonelis GA, 1997, J ZOOL, V242, P435, DOI 10.1111/j.1469-7998.1997.tb03847.x; BAKER JD, 1995, ANIM BEHAV, V50, P237, DOI 10.1006/anbe.1995.0236; Bickham JW, 1996, J MAMMAL, V77, P95, DOI 10.2307/1382712; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; Call KA, 2008, DEEP-SEA RES PT II, V55, P1883, DOI 10.1016/j.dsr2.2008.04.022; CHELNOKOV FG, 1982, STUDY PRESERVATION R, P401; Coltman DW, 2007, MOL ECOL, V16, P1639, DOI 10.1111/j.1365-294X.2007.03229.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FitzSimmons NN, 1997, GENETICS, V147, P1843; Gemmell NJ, 2001, MOL ECOL, V10, P451, DOI 10.1046/j.1365-294x.2001.01186.x; Gemmell NJ, 1997, MOL ECOL, V6, P661, DOI 10.1046/j.1365-294X.1997.00235.x; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; Goldsworthy S, 2000, J HERED, V91, P371, DOI 10.1093/jhered/91.5.371; Goodman SJ, 1997, ANIM GENET, V28, P310; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1996, GENETICS, V144, P1933; GRIBEN MR, 1979, THESIS U WASHINGTON; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haberl M, 1999, MOL ECOL, V8, P1347, DOI 10.1046/j.1365-294X.1999.00692.x; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; Hoelzel AR, 2001, P ROY SOC B-BIOL SCI, V268, P325; Hoelzel AR, 1999, BEHAV ECOL SOCIOBIOL, V46, P298; Hoffman JI, 2006, MOL ECOL, V15, P2821, DOI 10.1111/j.1365-294X.2006.02991.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Kenyon K. W., 1960, Mammalia Paris, V24, P431; KENYON KW, 1953, J MAMMAL, V34, P86, DOI 10.2307/1375947; LANDER RH, 1982, FAO FISH SER 5, V4, P319; Lea MA, 2009, BIOL LETTERS, V5, P252, DOI 10.1098/rsbl.2008.0643; LOUGHLIN TR, 1989, ARCTIC, V42, P368; MANTEL N, 1967, CANCER RES, V27, P209; Matthee CA, 2006, MAR BIOL, V148, P899, DOI 10.1007/s00227-005-0121-3; *NAT MAR FISH SERV, 1993, FIN CONS PLAN NO FUR; PETERSON RS, 1968, NATURE, V219, P899, DOI 10.1038/219899a0; Pielou E.C., 1991, ICE AGE RETURN LIFE; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ream RR, 2005, DEEP-SEA RES PT II, V52, P823, DOI 10.1016/j.dsr2.2004.12.021; Ream RR, 1999, FUR SEAL INVESTIGATI, P81; ROBERTSON BC, 2005, DOC SCI INTERNAL SER, V196; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Slade RW, 1998, GENETICS, V149, P1945; SLATKIN M, 1991, GENETICS, V129, P555; Sterling JT, 2004, CAN J ZOOL, V82, P1621, DOI 10.1139/Z04-136; Towell RG, 2006, MAR MAMMAL SCI, V22, P486, DOI 10.1111/j.1748-7692.2006.00026.x; Trujillo RG, 2004, J MAMMAL, V85, P338, DOI 10.1644/1545-1542(2004)085<0338:VIMAMA>2.0.CO;2; Waples RS, 1995, AM FISH S S, V17, P8; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wynen LP, 2000, MOL ECOL, V9, P299, DOI 10.1046/j.1365-294x.2000.00856.x; YORK AE, 1981, CAN J FISH AQUAT SCI, V38, P84, DOI 10.1139/f81-011; Zeppelin TK, 2006, J ZOOL, V270, P565, DOI 10.1111/j.1469-7998.2006.00122.x	58	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10671	10.1371/journal.pone.0010671	http://dx.doi.org/10.1371/journal.pone.0010671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498854	gold, Green Published, Green Submitted			2022-12-25	WOS:000277773700014
J	Vallely, A; Hambleton, IR; Kasindi, S; Knight, L; Francis, SC; Chirwa, T; Everett, D; Shagi, C; Cook, C; Barberousse, C; Watson-Jones, D; Changalucha, J; Ross, D; Hayes, RJ				Vallely, Andrew; Hambleton, Ian R.; Kasindi, Stella; Knight, Louise; Francis, Suzanna C.; Chirwa, Tobias; Everett, Dean; Shagi, Charles; Cook, Claire; Barberousse, Celia; Watson-Jones, Deborah; Changalucha, John; Ross, David; Hayes, Richard J.		Microbicides Dev Programme	Are Women Who Work in Bars, Guesthouses and Similar Facilities a Suitable Study Population for Vaginal Microbicide Trials in Africa?	PLOS ONE			English	Article							VACCINE EFFICACY TRIALS; FEMALE SEX WORKERS; SEXUALLY-TRANSMITTED INFECTIONS; INJECTION-DRUG USERS; HIV PREVENTION; INFORMED-CONSENT; NORTHERN TANZANIA; HOTEL WORKERS; MBEYA REGION; GAY MEN	Background: A feasibility study was conducted to investigate whether an occupational at-risk cohort of women in Mwanza, Tanzania are a suitable study population for future phase III vaginal microbicide trials. Methodology/Principal Findings: 1573 women aged 16-54 y working in traditional and modern bars, restaurants, hotels, guesthouses or as local food-handlers were enrolled at community-based reproductive health clinics, provided specimens for HIV/STI and pregnancy testing, and asked to attend three-monthly clinical follow-up visits for 12-months. HIV positive and negative women were eligible to enter the feasibility study and to receive free reproductive health services at any time. HIV prevalence at baseline was 26.5% (417/1573). HIV incidence among 1156 sero-negative women attending at baseline was 2.9/100PYs. Among 1020 HIV sero-negative, non-pregnant women, HIV incidence was 2.0/100PYs, HSV-2 incidence 12.7/100PYs and pregnancy rate 17.8/100PYs. Retention at three-months was 76.3% (778/1020). Among 771 HIV seronegative, non-pregnant women attending at three-months, subsequent follow-up at 6, 9 and 12-months was 83.7%, 79.6%, and 72.1% respectively. Older women, those who had not moved home or changed their place of work in the last year, and women working in traditional bars or as local food handlers had the highest re-attendance. Conclusions/Significance: Women working in food outlets and recreational facilities in Tanzania and other parts of Africa may be a suitable study population for microbicide and other HIV prevention trials. Effective locally-appropriate strategies to address high pregnancy rates and early losses to follow-up are essential to minimise risk to clinical trials in these settings.	[Vallely, Andrew; Hambleton, Ian R.; Knight, Louise; Francis, Suzanna C.; Chirwa, Tobias; Everett, Dean; Cook, Claire; Barberousse, Celia; Watson-Jones, Deborah; Ross, David; Hayes, Richard J.] London Sch Hyg & Trop Med, London WC1, England; [Vallely, Andrew; Kasindi, Stella; Shagi, Charles; Watson-Jones, Deborah] African Med & Res Fdn, Mwanza, Tanzania; [Hambleton, Ian R.; Knight, Louise; Chirwa, Tobias; Everett, Dean; Cook, Claire; Barberousse, Celia; Changalucha, John] Natl Inst Med Res, Mwanza, Tanzania; [Hambleton, Ian R.] Univ W Indies, Res Inst Trop Med, Bridgetown, Barbados	University of London; London School of Hygiene & Tropical Medicine; African Medical & Research Foundation (AMREF); National Institute of Medical Research; University West Indies Mona Jamaica; University of the West Indies Open Campus	Vallely, A (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	a.vallely@uq.edu.au	Chirwa, Tobias/AAI-9087-2021; Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794; Everett, Dean/0000-0002-8458-6779; Francis, Suzanna Carter/0000-0002-3724-4813; Vallely, Andrew/0000-0003-1558-4822; Hayes, Richard/0000-0002-1729-9892	Department for International Development; Medical Research Council, United Kingdom; MRC [G0701039, G0901756, G0700837, G0100137] Funding Source: UKRI; Medical Research Council [G0100137, G0701039, G0901756, G0700837] Funding Source: researchfish	Department for International Development; Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Department for International Development and the Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2000, J ACQ IMMUN DEF SYND, V24, P458, DOI 10.1097/00126334-200008150-00011; Bakobaki JM, 2005, AIDS, V19, P2149, DOI 10.1097/01.aids.0000194129.05264.55; Behets F, 2005, SEX TRANSM INFECT, V81, P472, DOI 10.1136/sti.2005.015107; Boerma JT, 1999, AIDS, V13, P1233, DOI 10.1097/00002030-199907090-00013; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307; Desmond N, 2005, SOC SCI MED, V60, P1739, DOI 10.1016/j.socscimed.2004.08.027; Esparza J, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200100005-00008; Fitzgerald DW, 2002, LANCET, V360, P1301, DOI 10.1016/S0140-6736(02)11338-9; Fonck K, 2001, SEX TRANSM INFECT, V77, P271, DOI 10.1136/sti.77.4.271; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Guenter D, 2000, J MED ETHICS, V26, P37, DOI 10.1136/jme.26.1.37; Halpern SD, 2001, J ACQ IMMUN DEF SYND, V27, P281, DOI 10.1097/00126334-200107010-00011; JACKSON DJ, 1995, AIDS, V9, P1279, DOI 10.1097/00002030-199511000-00010; Joseph P, 2006, JAIDS-J ACQ IMM DEF, V42, P588, DOI 10.1097/01.qai.0000229998.59869.05; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kelly JA, 2006, BMJ-BRIT MED J, V333, P1098, DOI 10.1136/bmj.38992.478299.55; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; Lazzarini Z, 2000, AIDS PUBLIC POLICY J, V15, P105; Mantell JE, 2006, AM J PUBLIC HEALTH, V96, P1073, DOI 10.2105/AJPH.2004.047514; Markowitz LE, 1999, J ACQ IMMUN DEF SYND, V20, P488, DOI 10.1097/00042560-199904150-00012; McCormack S, 2001, BRIT MED J, V322, P410, DOI 10.1136/bmj.322.7283.410; MEYERS K, 1995, J ACQ IMMUN DEF SYND, V10, P577, DOI 10.1097/00042560-199510050-00012; Mgalla Z, 1997, AIDS CARE, V9, P407, DOI 10.1080/713613167; Mills E, 2006, PLOS MED, V3, P308, DOI 10.1371/journal.pmed.0030094; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Moser DJ, 2004, COMPR PSYCHIAT, V45, P1, DOI 10.1016/j.comppsych.2003.09.009; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; NKYA WMMM, 1991, INT J STD AIDS, V2, P432, DOI 10.1177/095646249100200608; Nuttall J, 2007, INFECT DIS CLIN N AM, V21, P219, DOI 10.1016/j.idc.2007.01.009; Nyamathi Adeline, 2004, J Interprof Care, V18, P369, DOI 10.1080/13561820400011735; NYAMATHI AM, 2006, AIDS BEHAV, V3, P3; Olin J, 2006, CULT HEALTH SEX, V8, P529, DOI 10.1080/13691050600888434; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; Ramjee Gita, 2006, AIDS Res Ther, V3, P25, DOI 10.1186/1742-6405-3-25; Reproductive & Child Health Section MoH Tanzania, 2003, SEX TRANSM INF MAN S; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Riedner G, 2003, SEX TRANSM INFECT, V79, P382, DOI 10.1136/sti.79.5.382; Salvi V, 2006, J POSTGRAD MED, V52, P161; Scheer S, 1999, J ACQ IMMUN DEF SYND, V20, P172, DOI 10.1097/00042560-199902010-00010; Shapiro K, 2005, J MED ETHICS, V31, P39, DOI 10.1136/jme.2004.008102; Sherr L, 2004, AIDS CARE, V16, P565, DOI 10.1080/0954010001716351; Suligoi B, 2005, VACCINE, V23, P1437, DOI 10.1016/j.vaccine.2004.10.002; Tassiopoulos KK, 2007, J INFECT DIS, V195, P493, DOI 10.1086/510537; Tolley EE, 2006, CULT HEALTH SEX, V8, P351, DOI 10.1080/13691050600793071; VALLELY A, 2007, MICROBICIDES DEV PRO; Vallely A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-133; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Vanichseni S, 2004, AIDS, V18, P311, DOI 10.1097/00002030-200401230-00022; Veldhuijzen N, 2006, CULT HEALTH SEX, V8, P395, DOI 10.1080/13691050600859302; Verastegui EL, 2006, BMC MED ETHICS, V7, P13, DOI [10.1186/1472-6939-7-13, DOI 10.1186/1472-6939-7-13]; Whitehead SJ, 2006, AIDS, V20, P2141, DOI 10.1097/QAD.0b013e32801086c9	52	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10661	10.1371/journal.pone.0010661	http://dx.doi.org/10.1371/journal.pone.0010661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	597PU	20498833	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000277771600021
J	Sellier, P; Mannioui, A; Bourry, O; Dereuddre-Bosquet, N; Delache, B; Brochard, P; Calvo, J; Prevot, S; Roques, P				Sellier, Pierre; Mannioui, Abdelkrim; Bourry, Olivier; Dereuddre-Bosquet, Nathalie; Delache, Benoit; Brochard, Patricia; Calvo, Julien; Prevot, Sophie; Roques, Pierre			Antiretroviral Treatment Start-Time during Primary SIVmac Infection in Macaques Exerts a Different Impact on Early Viral Replication and Dissemination	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL DEPLETION; POSTEXPOSURE PROPHYLAXIS; HIV-INFECTION; GASTROINTESTINAL-TRACT; ANTIVIRAL THERAPY; TYPE-1 INFECTION; RHESUS MACAQUES; LYMPHOID-TISSUE; RESTORATION	Background: The time therapy (ART) on the peripheral viral load and the establishment of viral reservoirs are poorly understood. Methodology/Principal Findings: Six groups of macaques, infected intravenously with SIVmac251, were given placebo or antiretroviral therapy to explore reservoir establishment; macaques were treated for 2 weeks, with treatment starting 4 hours, 7 or 14 days after infection. Viral replication and dissemination were measured in the gut (rectum), in the lung and in blood and lymphoid tissues (peripheral lymph nodes), by quantifying viral RNA, DNA and 2LTR circles. We used immunohistochemistry (CD4 and CD68) to assess the impact of these treatments on the relative amount of virus target cells in tissue. Treatment that was started 4 hours post-infection (pi) decreased viral replication and dissemination in blood and tissue samples, which were assessed on day 14 (RNA/DNA/2LTR circles). The virus remained detectable and lymphoid tissues were activated in LN and the gut in both placebo- and ART-treated animals. Viral RNA in plasma continued to be lower in macaques treated seven days after infection; however, this was not the case for viral DNA in peripheral blood mononuclear cells. There was a small but significant difference in RNA and DNA levels in tissues between placebo- and ART-treated animals on day 21. When started 14 days after infection, treatment resulted in a limited decrease in the plasma viral load. Conclusions: Treatment that was started 4 hours after infection significantly reduced viral replication and dissemination. When started 7 days after infection, it was of slight virological benefit in peripheral blood and in tissues, and treatment was even less effective if started 14 days pi. These data favor starting ART no longer than one week after intravenous SIVmac251 exposure.	[Sellier, Pierre; Mannioui, Abdelkrim; Bourry, Olivier; Dereuddre-Bosquet, Nathalie; Delache, Benoit; Brochard, Patricia; Calvo, Julien; Roques, Pierre] CEA, Inst Emerging Dis & Innovat Therapies IMETI, Div ImmunoVirol SIV, Fontenay Aux Roses, France; [Sellier, Pierre; Mannioui, Abdelkrim; Bourry, Olivier; Dereuddre-Bosquet, Nathalie; Delache, Benoit; Brochard, Patricia; Calvo, Julien; Roques, Pierre] Univ Paris 11, UMR E1, Orsay, France; [Sellier, Pierre] Hop Lariboisiere, AP HP, F-75475 Paris, France; [Prevot, Sophie] Hop Antoine Beclere, AP HP, Serv Anat & Cytol Pathol, Clamart, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Sellier, P (corresponding author), CEA, Inst Emerging Dis & Innovat Therapies IMETI, Div ImmunoVirol SIV, Fontenay Aux Roses, France.	pierre.roques@cea.fr	Roques, Pierre/M-2212-2013; Calvo, Julien/HCI-0693-2022	Roques, Pierre/0000-0003-1825-1054; 	APHP-CEA PhD; EMPRO [LSH-2002-2.3.0-2]; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS, Paris France); Commissariat a l'Energie Atomique (CEA, France)	APHP-CEA PhD; EMPRO; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS, Paris France)(ANRSFrench National Research Agency (ANR)); Commissariat a l'Energie Atomique (CEA, France)(French Atomic Energy Commission)	PS was awarded an APHP-CEA PhD fellowship. AM is financed by the "European Microbicide project'' EMPRO (LSH-2002-2.3.0-2). This work was supported by Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS, Paris France), and the Commissariat a l'Energie Atomique (CEA, France). AZT and 3TC were provided by GSK GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Bourry O, 2009, AIDS, V23, P447, DOI 10.1097/QAD.0b013e328321302d; Cara A, 2004, VIROLOGY, V324, P531, DOI 10.1016/j.virol.2004.04.006; Clayton F, 1997, CLIN EXP IMMUNOL, V107, P288, DOI 10.1111/j.1365-2249.1997.236-ce1111.x; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hodge S, 1999, J VIROL, V73, P8630, DOI 10.1128/JVI.73.10.8630-8639.1999; Hu LH, 2004, WORLD J GASTROENTERO, V10, P3514; Hu YL, 2004, PRENATAL DIAG, V24, P704, DOI 10.1002/pd.968; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Le Grand R, 2000, AIDS, V14, P1864; LEGRAND R, 1994, AIDS RES HUM RETROV, V10, P1279, DOI 10.1089/aid.1994.10.1279; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x; Mallik RC, 2008, MET MATER INT, V14, P223, DOI 10.3365/met.mat.2008.04.223; Mannioui A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-106; Mattapallil JJ, 1999, J VIROL, V73, P6661, DOI 10.1128/JVI.73.8.6661-6669.1999; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mehandru S, 2007, J VIROL, V81, P599, DOI 10.1128/JVI.01739-06; Merchant RC, 2004, EMERG MED J, V21, P449, DOI 10.1136/emj.2002.002824; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000; Peruchon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005966; Puaux AL, 2004, VACCINE, V22, P3535, DOI 10.1016/j.vaccine.2004.03.044; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SCHNEIDER T, 1995, GUT, V37, P524, DOI 10.1136/gut.37.4.524; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Smith MS, 2000, VIROLOGY, V277, P306, DOI 10.1006/viro.2000.0609; Tincati C, 2009, ANTIVIR THER, V14, P321; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Verhoeven D, 2007, J MED PRIMATOL, V36, P219, DOI 10.1111/j.1600-0684.2007.00239.x; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; YENI P, 2008, PRISE CHARGE MED PER, P412	37	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10570	10.1371/journal.pone.0010570	http://dx.doi.org/10.1371/journal.pone.0010570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485497	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563200006
J	Funakoshi, Y; Negishi, Y; Gergen, JP; Seino, J; Ishii, K; Lennarz, WJ; Matsuo, I; Ito, Y; Taniguchi, N; Suzuki, T				Funakoshi, Yoko; Negishi, Yuki; Gergen, J. Peter; Seino, Junichi; Ishii, Kumiko; Lennarz, William J.; Matsuo, Ichiro; Ito, Yukishige; Taniguchi, Naoyuki; Suzuki, Tadashi			Evidence for an Essential Deglycosylation-Independent Activity of PNGase in Drosophila melanogaster	PLOS ONE			English	Article							PEPTIDE-N-GLYCANASE; RETICULUM-ASSOCIATED DEGRADATION; CYTOPLASMIC PEPTIDE; FREE OLIGOSACCHARIDES; ENZYMATIC-PROPERTIES; YEAST PEPTIDE; PUB DOMAIN; PROTEIN; IDENTIFICATION; COMPLEX	Background: Peptide: N-glycanase (PNGase) is an enzyme which releases N-linked glycans from glycopeptides/glycoproteins. This enzyme plays a role in the ER-associated degradation (ERAD) pathway in yeast and mice, but the biological importance of this activity remains unknown. Principal Findings: In this study, we characterized the ortholog of cytoplasmic PNGases, PNGase-like (Pngl), in Drosophila melanogaster. Pngl was found to have a molecular weight of similar to 74K and was mainly localized in the cytosol. Pngl lacks a CXXC motif that is critical for enzymatic activity in other species and accordingly did not appear to possess PNGase activity, though it still retains carbohydrate-binding activity. We generated microdeletions in the Pngl locus in order to investigate the functional importance of this protein in vivo. Elimination of Pngl led to a serious developmental delay or arrest during the larval and pupal stages, and surviving mutant adult males and females were frequently sterile. Most importantly, these phenotypes were rescued by ubiquitous expression of Pngl, clearly indicating that those phenotypic consequences were indeed due to the lack of functional Pngl. Interestingly, a putative "catalytic-inactive" mutant could not rescue the growth-delay phenotype, indicating that a biochemical activity of this protein is important for its biological function. Conclusion: Pngl was shown to be inevitable for the proper developmental transition and the biochemical properties other than deglycosylation activity is important for its biological function.	[Funakoshi, Yoko; Negishi, Yuki; Seino, Junichi; Ishii, Kumiko; Suzuki, Tadashi] RIKEN, Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, Wako, Saitama, Japan; [Gergen, J. Peter] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Gergen, J. Peter; Lennarz, William J.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Lennarz, William J.] SUNY Stony Brook, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA; [Matsuo, Ichiro] Gunma Univ, Dept Chem & Chem Biol, Gunma, Japan; [Ito, Yukishige] RIKEN, Adv Sci Inst, Synthet Cellular Chem Lab, Wako, Saitama, Japan; [Ito, Yukishige] Japan Sci & Technol Agcy, Glycotril Project, Kawaguchi, Saitama, Japan; [Taniguchi, Naoyuki] Osaka Univ, Dept Dis Glyc, Inst Sci & Ind Res, Osaka, Japan; [Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Dis Glyc Team, Wako, Saitama, Japan	RIKEN; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Gunma University; RIKEN; Japan Science & Technology Agency (JST); Osaka University; RIKEN	Funakoshi, Y (corresponding author), RIKEN, Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, 2-1 Hirosawa, Wako, Saitama, Japan.	yokofuna@riken.jp; tsuzuki_gm@riken.jp	Ito, Yukishige/ACL-6203-2022; Suzuki, Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014; Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016; Ito, Yukishige/M-5119-2014	Ito, Yukishige/0000-0001-6251-7249; Suzuki, Tadashi/0000-0003-1030-7631; Taniguchi, Naoyuki/0000-0001-5889-5968; Ito, Yukishige/0000-0001-6251-7249	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by the Global COE (Center of Excellence) Program and Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Biswas S, 2004, BIOCHEM BIOPH RES CO, V323, P149, DOI 10.1016/j.bbrc.2004.08.061; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Della Mea M, 2004, PLANT PHYSIOL, V135, P2046, DOI 10.1104/pp.104.042549; Diepold A, 2007, PLANT J, V52, P94, DOI 10.1111/j.1365-313X.2007.03215.x; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Habibi-Babadi N, 2010, J NEUROSCI, V30, P1766, DOI 10.1523/JNEUROSCI.4962-08.2010; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Katiyar S, 2002, J BIOL CHEM, V277, P12953, DOI 10.1074/jbc.M111383200; Kato T, 2007, J BIOCHEM, V142, P175, DOI 10.1093/jb/mvm117; Kim HS, 2006, DYNAM CONT DIS SER B, V13, P1; KITAJIMA K, 1995, ARCH BIOCHEM BIOPHYS, V319, P393, DOI 10.1006/abbi.1995.1309; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Li GT, 2005, P NATL ACAD SCI USA, V102, P15809, DOI 10.1073/pnas.0507155102; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; Miyazaki A, 2009, GLYCOCONJUGATE J, V26, P133, DOI 10.1007/s10719-008-9171-3; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Nishihara S, 2004, GLYCOCONJUGATE J, V21, P63, DOI 10.1023/B:GLYC.0000043750.80389.14; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; PLUMMER TH, 1987, EUR J BIOCHEM, V163, P167, DOI 10.1111/j.1432-1033.1987.tb10751.x; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; ROSEMAN RR, 1995, GENETICS, V141, P1061; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; SEKO A, 1991, BIOCHEM BIOPH RES CO, V180, P1165, DOI 10.1016/S0006-291X(05)81318-X; Seko A, 1999, GLYCOBIOLOGY, V9, P887, DOI 10.1093/glycob/9.9.887; STAPLETON M, 2002, GENOME BIOL, V0003; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2005, METHODS, V35, P360, DOI 10.1016/j.ymeth.2004.10.008; Suzuki T, 2001, BIOCHEM BIOPH RES CO, V287, P1083, DOI 10.1006/bbrc.2001.5688; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V358, P837, DOI 10.1016/j.bbrc.2007.04.199; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; Suzuki T, 2006, J BIOL CHEM, V281, P22152, DOI 10.1074/jbc.M603236200; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104; Zhao G, 2009, GLYCOBIOLOGY, V19, P118, DOI 10.1093/glycob/cwn108; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	55	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10545	10.1371/journal.pone.0010545	http://dx.doi.org/10.1371/journal.pone.0010545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479940	Green Submitted, Green Published, gold			2022-12-25	WOS:000277467900004
J	Jiao, J; Herl, LD; Farese, RV; Gao, FB				Jiao, Jian; Herl, Lauren D.; Farese, Robert V., Jr.; Gao, Fen-Biao			MicroRNA-29b Regulates the Expression Level of Human Progranulin, a Secreted Glycoprotein Implicated in Frontotemporal Dementia	PLOS ONE			English	Article							LOBAR DEGENERATION; EPITHELIN PRECURSOR; MUTATIONS; TDP-43; TAU; DISEASE; BONE; FUS	Progranulin deficiency is thought to cause some forms of frontotemporal dementia (FTD), a major early-onset age-dependent neurodegenerative disease. How progranulin (PGRN) expression is regulated is largely unknown. We identified an evolutionarily conserved binding site for microRNA-29b (miR-29b) in the 3' untranslated region (3'UTR) of the human PGRN (hPGRN) mRNA. miR-29b downregulates the expression of luciferase through hPGRN or mouse PGRN (mPGRN) 3'UTRs, and the regulation was abolished by mutations in the miR-29b binding site. To examine the direct effect of manipulating endogenous miR-29b on hPGRN expression, we established a stable NIH3T3 cell line that expresses hPGRN under the control of the cytomegalovirus promoter. Ectopic expression of miR-29b decreased hPGRN expression at the both mRNA and protein levels. Conversely, knockdown of endogenous miR-29b with locked nucleic acid increased the production and secretion of hPGRN in NIH3T3 cells. Endogenous hPGRN in HEK 293 cells was also regulated by miR-29b. These findings identify miR-29b as a novel posttranscriptional regulator of PGRN expression, raising the possibility that miR-29b or other miRNAs might be targeted therapeutically to increase hPGRN levels in some FTD patients.	[Jiao, Jian; Gao, Fen-Biao] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; [Jiao, Jian; Gao, Fen-Biao] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Herl, Lauren D.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Herl, Lauren D.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Herl, Lauren D.; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Herl, Lauren D.; Farese, Robert V., Jr.; Gao, Fen-Biao] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jiao, J (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA.	fen-biao.gao@umassmed.edu			Consortium for FTD Research; National Institutes of Health [NS066586, NS057553]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS057553, R01NS057553, R01NS066586] Funding Source: NIH RePORTER	Consortium for FTD Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Consortium for FTD Research and the National Institutes of Health (NS066586 and NS057553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; Boxer AL, 2005, ALZ DIS ASSOC DIS, V19, pS3, DOI 10.1097/01.wad.0000183086.99691.91; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Gitcho MA, 2009, J BIOL CHEM, V284, P12384, DOI 10.1074/jbc.M900992200; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lee JA, 2008, BMB REP, V41, P827, DOI 10.5483/BMBRep.2008.41.12.827; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; ROLLINSON S, 2009, NEUROBIOL AGING 0513; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; THURN T, 2008, NATURE, V456, P980; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Vossel KA, 2008, CURR OPIN NEUROL, V21, P708, DOI 10.1097/WCO.0b013e328318444d; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517	40	69	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10551	10.1371/journal.pone.0010551	http://dx.doi.org/10.1371/journal.pone.0010551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479936	Green Submitted, Green Published, gold			2022-12-25	WOS:000277467900007
J	Lee, YS; Johnson, KA; Molineux, IJ; Yin, YW				Lee, Young-Sam; Johnson, Kenneth A.; Molineux, Ian J.; Yin, Y. Whitney			A Single Mutation in Human Mitochondrial DNA Polymerase Pol gamma A Affects Both Polymerization and Proofreading Activities of Only the Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY SUBUNIT; KLENOW FRAGMENT; EXPRESSION; REPLISOME; EXPLORER	Common causes of human mitochondrial diseases are mutations affecting DNA polymerase (Pol) gamma, the sole polymerase responsible for DNA synthesis in mitochondria. Although the polymerase and exonuclease active sites are located on the catalytic subunit Pol gamma A, in holoenzyme both activities are regulated by the accessory subunit Pol gamma B. Several patients with severe neurological and muscular disorders were reported to carry the Pol gamma A substitutions R232G or R232H, which lie outside of either active site. We report that Arg(232) substitutions have no effect on independent Pol gamma A activities but show major defects in the Pol gamma A-Pol gamma B holoenzyme, including decreased polymerase and increased exonuclease activities, the latter with decreased selectivity for mismatches. We show that Pol gamma B facilitates distinguishing mismatched from base-paired primer termini and that Pol gamma A Arg(232) is essential for mediating this regulatory function of the accessory subunit. This study provides a molecular basis for the disease symptoms exhibited by patients carrying those substitutions.	[Lee, Young-Sam; Johnson, Kenneth A.; Molineux, Ian J.; Yin, Y. Whitney] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Molineux, Ian J.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Johnson, Kenneth A.; Yin, Y. Whitney] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Yin, YW (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	whitney.yin@mail.utexas.edu			National Institutes of Health [GM044613, GM032095, GM083703]; Welch Foundation [F-1592]; KinTek Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044613, R01GM032095, R01GM083703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); KinTek Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM044613 (to K. A. J.), GM032095 (to I. J. M.), and GM083703 (to Y. W. Y.). This work was also supported by Welch Foundation Grant F-1592 (to Y. W. Y.). Financial conflict of interest: K. A. J. is President of KinTek Corporation, which provided the RQF-3 rapid quench flow instrument and the KinTek Explorer data fitting software used in this study.	Bailey MF, 2004, J MOL BIOL, V336, P673, DOI 10.1016/j.jmb.2003.11.023; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; Chinnery Patrick F, 2008, Neuromuscul Disord, V18, P259, DOI 10.1016/j.nmd.2007.11.005; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; GUPTA AP, 1984, NUCLEIC ACIDS RES, V12, P5897, DOI 10.1093/nar/12.14.5897; Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Taanman JW, 2009, NEUROMUSCULAR DISORD, V19, P151, DOI 10.1016/j.nmd.2008.11.002; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	26	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28105	28116		10.1074/jbc.M110.122283	http://dx.doi.org/10.1074/jbc.M110.122283			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20513922	Green Published, hybrid			2022-12-25	WOS:000288742300009
J	Brown, HJ; Peng, L; Harada, JN; Walker, JR; Cole, S; Lin, SF; Zack, JA; Chanda, SK; Sun, R				Brown, Helen J.; Peng, Li; Harada, Josephine N.; Walker, John R.; Cole, Steven; Lin, Su-Fang; Zack, Jerome A.; Chanda, Sumit K.; Sun, Ren			Gene Expression and Transcription Factor Profiling Reveal Inhibition of Transcription Factor cAMP-response Element-binding Protein by gamma-Herpesvirus Replication and Transcription Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; EPSTEIN-BARR-VIRUS; READING FRAME 50; RTA PROMOTES DEGRADATION; LYTIC SWITCH PROTEIN; DNA-BINDING; ENDOTHELIAL-CELLS; CYCLIC-AMP; CREB; REACTIVATION	Herpesvirus replication involves the expression of over 80 viral genes in a well ordered sequence, leading to the production of new virions. Viral genes expressed during the earliest phases of replication often regulate both viral and cellular genes. Therefore, they have the potential to bring about dramatic functional changes within the cell. Replication and transcription activator (RTA) is a potent immediate early transcription activator of the gamma-herpesvirus family. This family includes Epstein-Barr virus and Kaposi sarcoma-associated herpesvirus, human pathogens associated with malignancy. Here we combine gene array technology with transcription factor profiling to identify the earliest DNA promoter and cellular transcription factor targets of RTA in the cellular genome. We find that expression of RTA leads to both activation and inhibition of distinct groups of cellular genes. The identity of the target genes suggests that RTA rapidly changes the cellular environment to counteract cell death pathways, support growth factor signaling, and also promote immune evasion of the infected cell. Transcription factor profiling of the target gene promoters highlighted distinct pathways involved in gene activation at specific time points. Most notable throughout was the high level of cAMP-response element-binding protein (CREB)-response elements in RTA target genes. We find that RTA can function as either an activator or an inhibitor of CREB-response genes, depending on the promoter context. The association with CREB also highlights a novel connection and coordination between viral and cellular "immediate early" responses.	[Brown, Helen J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Peng, Li; Sun, Ren] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Cole, Steven; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Harada, Josephine N.; Walker, John R.; Chanda, Sumit K.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Lin, Su-Fang] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town 350, Miaoli County, Taiwan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Novartis; National Health Research Institutes - Taiwan	Brown, HJ (corresponding author), BSRB 173,615 Charles Young Dr S, Los Angeles, CA 90095 USA.	hjbrown@mednet.ucla.edu	Lin, Su-Fang/B-2666-2010	Lin, Su-Fang/0000-0001-8706-2439	National Institutes of Health [CA091791, CA127042, DE019085, AI070010]; NATIONAL CANCER INSTITUTE [R01CA091791, R21CA127042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA091791, CA127042, DE019085, and AI070010.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ALBRECHT JC, 1992, J VIROL, V66, P3937, DOI 10.1128/JVI.66.6.3937-3940.1992; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; BURKE AP, 1990, MODERN PATHOL, V3, P377; Carroll KD, 2007, J VIROL, V81, P8451, DOI 10.1128/JVI.00265-07; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chang H, 2005, J VIROL, V79, P4651, DOI 10.1128/JVI.79.8.4651-4663.2005; Chang M, 2005, J VIROL, V79, P13538, DOI 10.1128/JVI.79.21.13538-13547.2005; Chang PJ, 2008, J VIROL, V82, P9700, DOI 10.1128/JVI.00862-08; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Cole SW, 2003, BIOINFORMATICS, V19, P1808, DOI 10.1093/bioinformatics/btg242; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deng HY, 2002, J VIROL, V76, P8252, DOI 10.1128/JVI.76.16.8252-8264.2002; Deutsch E, 2004, J VIROL, V78, P10187, DOI 10.1128/JVI.78.18.10187-10192.2004; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Foreman KE, 1997, NEW ENGL J MED, V336, P163, DOI 10.1056/NEJM199701163360302; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Gwack Y, 2003, MOL CELL BIOL, V23, P2055, DOI 10.1128/MCB.23.6.2055-2067.2003; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Hottiger MO, 2000, TRENDS MICROBIOL, V8, P560, DOI 10.1016/S0966-842X(00)01874-6; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; JANSEN E, 1995, J BIOL CHEM, V270, P15391, DOI 10.1074/jbc.270.25.15391; Jansen E, 1997, J BIOL CHEM, V272, P2500; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 2001, J VIROL, V75, P6786, DOI 10.1128/JVI.75.15.6786-6799.2001; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558; MERI S, 1990, IMMUNOLOGY, V71, P1; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Peng L, 2010, J GEN VIROL, V91, P463, DOI 10.1099/vir.0.015073-0; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; Qian LW, 2007, J VIROL, V81, P7001, DOI 10.1128/JVI.00016-07; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Renne R, 1998, J VIROL, V72, P5182, DOI 10.1128/JVI.72.6.5182-5188.1998; RICKINSON AB, 2001, FIELDS VIROLOGY, P2817; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROTHER RP, 1994, J VIROL, V68, P730, DOI 10.1128/JVI.68.2.730-737.1994; Sakakibara S, 2001, J VIROL, V75, P6894, DOI 10.1128/JVI.75.15.6894-6900.2001; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; SHIBATA D, 1992, AM J PATHOL, V140, P769; SHIBATA D, 1991, AM J PATHOL, V139, P469; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; Spiller OB, 2003, J BIOL CHEM, V278, P9283, DOI 10.1074/jbc.M211579200; Spiller OB, 1997, J INFECT DIS, V176, P339, DOI 10.1086/514050; Staudt MR, 2007, CURR TOP MICROBIOL, V312, P71; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Wang SS, 2010, VIROLOGY, V397, P311, DOI 10.1016/j.virol.2009.11.031; Wang SZE, 2003, J VIROL, V77, P9590, DOI 10.1128/JVI.77.17.9590-9612.2003; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Ye JJ, 2005, J VIROL, V79, P1397, DOI 10.1128/JVI.79.3.1397-1408.2005; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang L, 1998, DNA CELL BIOL, V17, P735; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	75	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25139	25153		10.1074/jbc.M110.137737	http://dx.doi.org/10.1074/jbc.M110.137737			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20516076	Green Published, hybrid			2022-12-25	WOS:000280682400006
J	Ambrosi, C; Gassmann, O; Pranskevich, JN; Boassa, D; Smock, A; Wang, JJ; Dahl, G; Steinem, C; Sosinsky, GE				Ambrosi, Cinzia; Gassmann, Oliver; Pranskevich, Jennifer N.; Boassa, Daniela; Smock, Amy; Wang, Junjie; Dahl, Gerhard; Steinem, Claudia; Sosinsky, Gina E.			Pannexin1 and Pannexin2 Channels Show Quaternary Similarities to Connexons and Different Oligomerization Numbers from Each Other	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; GAP-JUNCTION PROTEINS; FAMILY; MEMBRANE; INFLAMMASOME; HEXAMER; REVEALS; RELEASE; NEURONS	Pannexins are homologous to innexins, the invertebrate gap junction family. However, mammalian pannexin1 does not form canonical gap junctions, instead forming hexameric oligomers in single plasma membranes and intracellularly. Pannexin1 acts as an ATP release channel, whereas less is known about the function of Pannexin2. We purified cellular membranes isolated from MDCK cells stably expressing rat Pannexin1 or Pannexin2 and identified pannexin channels (pannexons) in single membranes by negative stain and immunogold labeling. Protein gel and Western blot analysis confirmed Pannexin1 (Panx1) or Pannexin2 (Panx2) as the channel-forming proteins. We expressed and purified Panx1 and Panx2 using a baculovirus Sf9 expression system and obtained doughnut-like structures similar to those seen previously in purified connexin hemichannels (connexons) and mammalian membranes. Purified pannexons were comparable in size and overall appearance to Connexin46 and Connexin50 connexons. Pannexons and connexons were further analyzed by single-particle averaging for oligomer and pore diameters. The oligomer diameter increased with increasing monomer molecular mass, and we found that the measured oligomeric pore diameter for Panxs was larger than for Connexin26. Panx1 and Panx2 formed active homomeric channels in Xenopus oocytes and in vitro vesicle assays. Crosslinking and native gels of purified homomeric full-length and a C-terminal Panx2 truncation mutant showed a banding pattern more consistent with an octamer. We purified Panx1/Panx2 heteromeric channels and found that they were unstable over time, possibly because Panx1 and Panx2 homomeric pannexons have different monomer sizes and oligomeric symmetry from each other.	[Sosinsky, Gina E.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Sch Med, La Jolla, CA 92093 USA; [Sosinsky, Gina E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Gassmann, Oliver; Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Wang, Junjie; Dahl, Gerhard] Univ Miami, Dept Physiol & Biophys, Sch Med, Miami, FL 33136 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Gottingen; University of Miami	Sosinsky, GE (corresponding author), Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Sch Med, BSB 1070,9500 Gilman Dr,MC 0608, La Jolla, CA 92093 USA.	gsosinsky@ucsd.edu	Steinem, Claudia/K-7534-2018; Steinem, Claudia/O-4801-2019	Steinem, Claudia/0000-0001-8778-9283	National Institutes of Health [GM072881, GM065937, GM048610, RR04050]; National Science Foundation [MCB0543934]; European Union; Bundesministerium fur Bildung und Forschung [13N9110]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065937, R01GM072881, R01GM048610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072881 and GM065937 (to G. E. S.) and GM048610 (to G. D.). This work was also supported by National Science Foundation Grant MCB0543934 (to G. E. S.) and the European Union within the framework of the Marie Curie Training Network 019335 Translocation (to C. S.) and by Bundesministerium fur Bildung und Forschung Grant 13N9110 (to C. S.). Most of this work was conducted at the National Center for Microscopy and Imaging Research at San Diego, which is supported by National Institutes of Health Grant RR04050.	Ambrosi C, 2010, BIOPHYS J, V98, P1809, DOI 10.1016/j.bpj.2010.01.019; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Bunse S, 2009, FEBS J, V276, P6258, DOI 10.1111/j.1742-4658.2009.07334.x; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; DAHL G, 1992, BIOPHYS J, V62, P172, DOI 10.1016/S0006-3495(92)81803-9; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; DIEZ JA, 1996, HDB NONMEDICAL APPL, P261; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GOODEN M, 1985, BIOCHEM BIOPH RES CO, V128, P993, DOI 10.1016/0006-291X(85)90145-7; Hand GM, 2002, J MOL BIOL, V315, P587, DOI 10.1006/jmbi.2001.5262; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jiang H, 2007, BRIT J PHARMACOL, V151, P1033, DOI 10.1038/sj.bjp.0707311; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Li XL, 2008, J BIOL CHEM, V283, P5748, DOI 10.1074/jbc.M709288200; Locke D, 2004, J BIOL CHEM, V279, P22883, DOI 10.1074/jbc.M401980200; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Panchin YV, 2005, J EXP BIOL, V208, P1415, DOI 10.1242/jeb.01547; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Ramundo-Orlando A, 2005, BBA-BIOMEMBRANES, V1668, P33, DOI 10.1016/j.bbamem.2004.11.003; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Stebbings LA, 2000, MOL BIOL CELL, V11, P2459, DOI 10.1091/mbc.11.7.2459; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Verselis VK, 2002, CURR DRUG TARGETS, V3, P483, DOI 10.2174/1389450023347272; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Zappala A, 2007, NEUROSCIENCE, V148, P653, DOI 10.1016/j.neuroscience.2007.06.028	45	124	124	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24420	24431		10.1074/jbc.M110.115444	http://dx.doi.org/10.1074/jbc.M110.115444			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516070	Green Published, hybrid			2022-12-25	WOS:000280542100014
J	Michelow, IC; Dong, MD; Mungall, BA; Yantosca, LM; Lear, C; Ji, X; Karpel, M; Rootes, CL; Brudner, M; Houen, G; Eisen, DP; Kinane, TB; Takahashi, K; Stahl, GL; Olinger, GG; Spear, GT; Ezekowitz, RAB; Schmidt, EV				Michelow, Ian C.; Dong, Mingdong; Mungall, Bruce A.; Yantosca, L. Michael; Lear, Calli; Ji, Xin; Karpel, Marshall; Rootes, Christina L.; Brudner, Matthew; Houen, Gunnar; Eisen, Damon P.; Kinane, T. Bernard; Takahashi, Kazue; Stahl, Gregory L.; Olinger, Gene G.; Spear, Gregory T.; Ezekowitz, R. Alan B.; Schmidt, Emmett V.			A Novel L-ficolin/Mannose-binding Lectin Chimeric Molecule with Enhanced Activity against Ebola Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION MOLECULE; CELL-SURFACE CALRETICULIN; SERINE PROTEASES; OPSONIC ACTIVITY; DEFICIENT MICE; HUMAN PLASMA; L-FICOLIN; PROTEIN; COMPLEMENT; SITE	Ebola viruses constitute a newly emerging public threat because they cause rapidly fatal hemorrhagic fevers for which no treatment exists, and they can be manipulated as bioweapons. We targeted conserved N-glycosylated carbohydrate ligands on viral envelope surfaces using novel immune therapies. Mannose-binding lectin (MBL) and L-ficolin (L-FCN) were selected because they function as opsonins and activate complement. Given that MBL has a complex quaternary structure unsuitable for large scale cost-effective production, we sought to develop a less complex chimeric fusion protein with similar ligand recognition and enhanced effector functions. We tested recombinant human MBL and three L-FCN/MBL variants that contained the MBL carbohydrate recognition domain and varying lengths of the L-FCN collagenous domain. Non-reduced chimeric proteins formed predominantly nona-and dodecameric oligomers, whereas recombinant human MBL formed octadecameric and larger oligomers. Surface plasmon resonance revealed that L-FCN/MBL76 had the highest binding affinities for N-acetylglucosamine-bovine serum albumin and mannan. The same chimeric protein displayed superior complement C4 cleavage and binding to calreticulin (cC1qR), a putative receptor for MBL. L-FCN/MBL76 reduced infection by wild type Ebola virus Zaire significantly greater than the other molecules. Tapping mode atomic force microscopy revealed that L-FCN/MBL76 was significantly less tall than the other molecules despite similar polypeptide lengths. We propose that alterations in the quaternary structure of L-FCN/MBL76 resulted in greater flexibility in the collagenous or neck region. Similarly, a more pliable molecule might enhance cooperativity between the carbohydrate recognition domains and their cognate ligands, complement activation, and calreticulin binding dynamics. L-FCN/MBL chimeric proteins should be considered as potential novel therapeutics.	[Michelow, Ian C.; Brudner, Matthew; Kinane, T. Bernard; Takahashi, Kazue] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp,Program Dev Immunol, Boston, MA 02114 USA; [Dong, Mingdong] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Mungall, Bruce A.; Rootes, Christina L.] Commonwealth Sci & Ind Res Org Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Lear, Calli; Olinger, Gene G.] USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21702 USA; [Ji, Xin; Spear, Gregory T.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Eisen, Damon P.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia; [Stahl, Gregory L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Aarhus University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Rush University; Statens Serum Institut; Royal Melbourne Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michelow, IC (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp,Program Dev Immunol, 55 Fruit St,GRJ 1402, Boston, MA 02114 USA.	imichelow@partners.org	Dong, Mingdong/AAC-3023-2020; Michelow, Ian C./AAH-2373-2020; eisen, damon/AAC-7433-2019; dong, mingdong/AAK-9315-2020; Rootes, Christina/AAS-6972-2021; Rootes, Christina L/H-4905-2013; Dong, Mingdong/B-3341-2010	Dong, Mingdong/0000-0002-2025-2171; Michelow, Ian C./0000-0002-8399-480X; Rootes, Christina/0000-0002-7448-8307; Rootes, Christina L/0000-0002-7448-8307; Dong, Mingdong/0000-0002-2025-2171; Olinger, Gene/0000-0001-7338-0292; Mungall, Bruce/0000-0002-6772-1633; Houen, Gunnar/0000-0002-5948-4156; Eisen, Damon/0000-0002-8987-4358; Stahl, Gregory/0000-0002-4805-8119	National Institutes of Health [U01 AI070330, R01 HL52886, R01 HL56086, R21 HL092469, P50 DE016191]; United States Department of Defense, Defense Threat Reduction Agency [4.10006, 4.10007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052886, R21HL092469, R01HL056086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077081, U01AI070330, U01AI074503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 AI070330 (to E. V. S.) and R01 HL52886, R01 HL56086, R21 HL092469, and P50 DE016191 (to G. L. S.). This work was also supported by United States Department of Defense, Defense Threat Reduction Agency Biological Therapeutics Program Grants 4.10006 and 4.10007 (to G. G. O.).	Aljofan M, 2008, J VIROL METHODS, V149, P12, DOI 10.1016/j.jviromet.2008.01.016; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Cseh S, 2002, J IMMUNOL, V169, P5735, DOI 10.4049/jimmunol.169.10.5735; Dolnik O, 2008, CELL MOL LIFE SCI, V65, P756, DOI 10.1007/s00018-007-7406-2; Dong MD, 2007, J IMMUNOL, V178, P3016, DOI 10.4049/jimmunol.178.5.3016; EDGAR PF, 1995, FEBS LETT, V375, P159, DOI 10.1016/0014-5793(95)01205-S; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Hartshorn KL, 2000, AM J PHYSIOL-LUNG C, V278, pL90, DOI 10.1152/ajplung.2000.278.1.L90; HARUMIYA S, 1995, J BIOCHEM-TOKYO, V117, P1029, DOI 10.1093/oxfordjournals.jbchem.a124802; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Hyatt AD, 1996, VIRUS RES, V43, P1, DOI 10.1016/0168-1702(96)01307-X; Jensen PH, 2005, J BIOL CHEM, V280, P11043, DOI 10.1074/jbc.M412472200; Jensenius JC, 2003, BIOCHEM SOC T, V31, P763, DOI 10.1042/BST0310763; Ji X, 2005, J GEN VIROL, V86, P2535, DOI 10.1099/vir.0.81199-0; Juozapaitis M, 2007, VIRUS RES, V124, P95, DOI 10.1016/j.virusres.2006.10.008; Kase T, 1999, IMMUNOLOGY, V97, P385; Kilpatrick DC, 1999, IMMUNOL LETT, V67, P109, DOI 10.1016/S0165-2478(98)00147-3; KONGERSLEV L, 2006, Patent No. 20060188963; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Meschi J, 2005, J GEN VIROL, V86, P3097, DOI 10.1099/vir.0.80764-0; MESCHI J, LETHON; Moller-Kristensen M, 2007, J INVEST DERMATOL, V127, P1524, DOI 10.1038/sj.jid.5700748; Montalto MC, 2001, J IMMUNOL, V166, P4148, DOI 10.4049/jimmunol.166.6.4148; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ohashi T, 2004, J BIOL CHEM, V279, P6534, DOI 10.1074/jbc.M310555200; Pagh R, 2008, FEBS J, V275, P515, DOI 10.1111/j.1742-4658.2007.06218.x; Petersen KA, 2006, J CLIN IMMUNOL, V26, P465, DOI 10.1007/s10875-006-9037-z; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Shiell BJ, 2003, VIRUS RES, V92, P55, DOI 10.1016/S0168-1702(02)00313-1; Stuart GR, 1997, IMMUNOPHARMACOLOGY, V38, P73, DOI 10.1016/S0162-3109(97)00076-3; Tacken PJ, 2004, J IMMUNOL, V172, P4934, DOI 10.4049/jimmunol.172.8.4934; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Vorup-Jensen T, 2001, INT IMMUNOPHARMACOL, V1, P677, DOI 10.1016/S1567-5769(00)00052-7; Wainberg MA, 2009, ANTIVIR RES, V81, P1, DOI 10.1016/j.antiviral.2008.09.003; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; White MR, 2000, J IMMUNOL, V165, P2108, DOI 10.4049/jimmunol.165.4.2108; White MR, 2001, BIOCHEM BIOPH RES CO, V286, P206, DOI 10.1006/bbrc.2001.5373	47	45	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24729	24739		10.1074/jbc.M110.106260	http://dx.doi.org/10.1074/jbc.M110.106260			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516066	Green Published, hybrid			2022-12-25	WOS:000280542100045
J	Sweeney, TR; Cisnetto, V; Bose, D; Bailey, M; Wilson, JR; Zhang, XD; Belsham, GJ; Curry, S				Sweeney, Trevor R.; Cisnetto, Valentina; Bose, Daniel; Bailey, Matthew; Wilson, Jon R.; Zhang, Xiaodong; Belsham, Graham J.; Curry, Stephen			Foot-and-Mouth Disease Virus 2C Is a Hexameric AAA plus Protein with a Coordinated ATP Hydrolysis Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLIOVIRUS RNA REPLICATION; NEGATIVE-STRAND RNA; LARGE TUMOR-ANTIGEN; NUCLEOSIDE TRIPHOSPHATASE; NONSTRUCTURAL PROTEIN-2C; SECRETORY PATHWAY; DNA-REPLICATION; FUSION PROTEINS; POLYPEPTIDE 2C; BINDING	Foot-and-mouth disease virus (FMDV), a positive sense, single-stranded RNA virus, causes a highly contagious disease in cloven-hoofed livestock. Like other picornaviruses, FMDV has a conserved 2C protein assigned to the superfamily 3 helicases, a group of AAA+ ATPases that has a predicted N-terminal membrane-binding amphipathic helix attached to the main ATPase domain. In infected cells, 2C is involved in the formation of membrane vesicles, where it co-localizes with viral RNA replication complexes, but its precise role in virus replication has not been elucidated. We show here that deletion of the predicted N-terminal amphipathic helix enables overexpression in Escherichia coli of a highly soluble truncated protein, 2C(34-318), that has ATPase and RNA binding activity. ATPase activity was abrogated by point mutations in the Walker A (K116A) and B (D160A) motifs and Motif C (N207A) in the active site. Unliganded 2C(34-318) exhibits concentration-dependent self-association to yield oligomeric forms, the largest of which is tetrameric. Strikingly, in the presence of ATP and RNA, FMDV 2C(34-318) containing the N207A mutation, which binds but does not hydrolyze ATP, was found to oligomerize specifically into hexamers. Visualization of FMDV 2C-ATP-RNA complexes by negative stain electron microscopy revealed hexameric ring structures with 6-fold symmetry that are characteristic of AAA+ ATPases. ATPase assays performed by mixing purified active and inactive 2C(34-318) subunits revealed a coordinated mechanism of ATP hydrolysis. Our results provide new insights into the structure and mechanism of picornavirus 2C proteins that will facilitate new investigations of their roles in infection.	[Sweeney, Trevor R.; Cisnetto, Valentina; Curry, Stephen] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Div Cell & Mol Biol, London SW7 2AZ, England; [Bose, Daniel; Zhang, Xiaodong] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Bailey, Matthew; Wilson, Jon R.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [Belsham, Graham J.] Tech Univ Denmark, Natl Vet Inst, DK-4771 Lindholm, Denmark	Imperial College London; Imperial College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Technical University of Denmark	Curry, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Div Cell & Mol Biol, Prince Consort Rd, London SW7 2AZ, England.	s.curry@imperial.ac.uk	Bose, Daniel/AAI-2775-2020; Belsham, Graham/J-3132-2019; Belsham, Graham J./H-8589-2019; Bailey, Matthew A./AAH-3395-2020; Wilson, Jon R/B-7362-2019	Bose, Daniel/0000-0002-0276-6486; Belsham, Graham/0000-0003-1187-4873; Belsham, Graham J./0000-0003-1187-4873; Bailey, Matthew A./0000-0003-4244-5668; Wilson, Jon R/0000-0002-5157-5432; Zhang, Xiaodong/0000-0001-9786-7038; Cisnetto, Valentina/0000-0002-2642-9345; Curry, Stephen/0000-0002-0552-8870; Sweeney, Trevor/0000-0003-4016-7326	Imperial College; Wellcome Trust [076909]; Cancer Research UK	Imperial College; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	Supported by a faculty studentship from Imperial College.; Supported by the Wellcome Trust (Ref. 076909).; Supported by a grant from Cancer Research UK.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Adams P, 2009, J BIOL CHEM, V284, P22012, DOI 10.1074/jbc.M109.031807; Banerjee R, 1997, J VIROL, V71, P9570, DOI 10.1128/JVI.71.12.9570-9578.1997; Banerjee R, 2001, VIROLOGY, V280, P41, DOI 10.1006/viro.2000.0770; Banerjee R, 2001, J GEN VIROL, V82, P2621, DOI 10.1099/0022-1317-82-11-2621; Belsham GJ, 2008, J GEN VIROL, V89, P485, DOI 10.1099/vir.0.83385-0; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; Birtley JR, 2005, ACTA CRYSTALLOGR D, V61, P646, DOI 10.1107/S0907444905007924; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; De Palma AM, 2008, J VIROL, V82, P4720, DOI 10.1128/JVI.01338-07; Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Echeverri A, 1998, VIRUS RES, V54, P217, DOI 10.1016/S0168-1702(98)00016-1; Edwards AM, 2000, NAT STRUCT BIOL, V7, P970, DOI 10.1038/80751; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; HOHENWALLNER W, 1973, CLIN CHIM ACTA, V45, P169, DOI 10.1016/0009-8981(73)90406-3; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Klein M, 2000, J GEN VIROL, V81, P2481, DOI 10.1099/0022-1317-81-10-2481; Klein M, 2000, J GEN VIROL, V81, P895, DOI 10.1099/0022-1317-81-4-895; Klein M, 1999, VIRUS RES, V65, P155, DOI 10.1016/S0168-1702(99)00110-0; Kusov YY, 1998, ARCH VIROL, V143, P931, DOI 10.1007/s007050050343; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; MIRZAYAN C, 1994, VIROLOGY, V199, P176, DOI 10.1006/viro.1994.1110; MIRZAYAN C, 1992, VIROLOGY, V189, P547, DOI 10.1016/0042-6822(92)90578-D; Moffat K, 2005, J VIROL, V79, P4382, DOI 10.1128/JVI.79.7.4382-4395.2005; Moffat K, 2007, J VIROL, V81, P1129, DOI 10.1128/JVI.00393-06; Monaghan P, 2004, J GEN VIROL, V85, P933, DOI 10.1099/vir.0.19408-0; Murray L, 2009, VIRUS RES, V144, P74, DOI 10.1016/j.virusres.2009.04.001; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; Pfister T, 2000, J VIROL, V74, P334, DOI 10.1128/JVI.74.1.334-343.2000; Pfister T, 1999, J BIOL CHEM, V274, P6992, DOI 10.1074/jbc.274.11.6992; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; PINCUS SE, 1986, J VIROL, V57, P638, DOI 10.1128/JVI.57.2.638-646.1986; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Samuilova O, 2006, J VIROL, V80, P1053, DOI 10.1128/JVI.80.2.1053-1058.2006; Sanz-Parra A, 1998, J GEN VIROL, V79, P433, DOI 10.1099/0022-1317-79-3-433; SAUNDERS K, 1982, J VIROL, V42, P389, DOI 10.1128/JVI.42.2.389-394.1982; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Schuck S, 2005, MOL CELL, V20, P377, DOI 10.1016/j.molcel.2005.09.020; Schumacher J, 2004, J MOL BIOL, V338, P863, DOI 10.1016/j.jmb.2004.02.071; SEO YS, 1993, P NATL ACAD SCI USA, V90, P702, DOI 10.1073/pnas.90.2.702; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Teterina NL, 2006, J VIROL, V80, P5327, DOI 10.1128/JVI.02684-05; Teterina NL, 2006, VIROLOGY, V344, P453, DOI 10.1016/j.virol.2005.08.044; TETERINA NL, 1992, J GEN VIROL, V73, P1977, DOI 10.1099/0022-1317-73-8-1977; TOLSKAYA EA, 1994, J MOL BIOL, V236, P1310, DOI 10.1016/0022-2836(94)90060-4; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	71	48	49	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24347	24359		10.1074/jbc.M110.129940	http://dx.doi.org/10.1074/jbc.M110.129940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507978	Green Published, hybrid			2022-12-25	WOS:000280542100006
J	Hypponen, E; Berry, D; Cortina-Borja, M; Power, C				Hyppoenen, Elina; Berry, Diane; Cortina-Borja, Mario; Power, Chris			25-Hydroxyvitamin D and Pre-Clinical Alterations in Inflammatory and Hemostatic Markers: A Cross Sectional Analysis in the 1958 British Birth Cohort	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; AGE 45 YEARS; SERUM 25-HYDROXYVITAMIN-D; CARDIOVASCULAR-DISEASE; 1,25-DIHYDROXYVITAMIN D-3; MYOCARDIAL-INFARCTION; PARATHYROID-HORMONE; D ANALOGS; RISK; HEMODIALYSIS	Background: Vitamin D deficiency has been suggested as a cardiovascular risk factor, but little is known about underlying mechanisms or associations with inflammatory or hemostatic markers. Our aim was to investigate the association between 25-hydroxyvitamin D [25(OH) D, a measure for vitamin D status] concentrations with pre-clinical variations in markers of inflammation and hemostasis. Methodology/Principal Findings: Serum concentrations of 25(OH) D, C-reactive protein (CRP), fibrinogen, D-dimer, tissue plasminogen activator (tPA) antigen, and von Willebrand factor (vWF) were measured in a large population based study of British whites (aged 45y). Participants for the current investigation were restricted to individuals free of drug treated cardiovascular disease (n=6538). Adjusted for sex and month, 25(OH) D was inversely associated with all outcomes (p<0.015 for all), but associations with CRP, fibrinogen, and vWF were explained by adiposity. Association with tPA persisted after full adjustment (body mass index, waist circumference, physical activity, TV watching, smoking, alcohol consumption, social class, sex, and month), and average concentrations were 18.44% (95% CI 8.13, 28.75) lower for 25(OH) D >= 75 nmol/l compared to,25 nmol/l. D-dimer concentrations were lower for participants with 25(OH) D 50-90nmol/l compared to others (quadratic term p=0.01). We also examined seasonal variation in hemostatic and inflammatory markers, and evaluated 25(OH) D contribution to the observed patterns using mediation models. TPA concentrations varied by season (p=0.02), and much of this pattern was related to fluctuations in 25(OH) D concentrations (p<0.001). Some evidence of a seasonal variation was observed also for fibrinogen, D-dimer and vWF (p<0.05 for all), with 25(OH)D mediating some of the pattern for fibrinogen and D-dimer, but not vWF. Conclusions: Current vitamin D status was associated with tPA concentrations, and to a lesser degree with fibrinogen and D-dimer, suggesting that vitamin D status/intake may be important for maintaining antithrombotic homeostasis.	[Hyppoenen, Elina] UCL, Inst Child Hlth, MRC, Ctr Epidemiol Child Hlth, London, England; UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of London; University College London; University of London; University College London	Hypponen, E (corresponding author), UCL, Inst Child Hlth, MRC, Ctr Epidemiol Child Hlth, London, England.	e.hypponen@ich.ucl.ac.uk	Hypponen, Elina/B-2596-2014; Borja, Mario Cortina/A-3847-2009	Hypponen, Elina/0000-0003-3670-9399; Borja, Mario Cortina/0000-0003-0627-2624	British Heart Foundation [PG/09/023]; UK Medical Research Council (MRC) [G0601653, G0000934]; BUPA Foundation; NHS; MRC [G0601653, G0400546, G0000934] Funding Source: UKRI; Medical Research Council [G0601653, G0000934, G0400546B, G0400546] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BUPA Foundation; NHS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This study was supported by the British Heart Foundation (PG/09/023). Data collection at age 44-46 years and statistical analyses were funded by the UK Medical Research Council (MRC grants G0601653, G0000934), and 25(OH) D assays by the BUPA Foundation. E. H. is a Department of Health (UK) Public Health Career Scientist. This work was undertaken at the Centre for Paediatric Epidemiology and Biostatistics which benefits from funding support from the MRC in its capacity as the MRC Centre of Epidemiology for Child Health. Research at the University College London Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust benefits from R&D funding received from the NHS Executive. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Atherton K, 2007, EUR J PUBLIC HEALTH, V17, P486, DOI 10.1093/eurpub/ckl269; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; [Food and Nutrition Board Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes], 1997, DIET REF INT CALC PH, DOI 10.17226/5776; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Heaney RP, 2005, J ENDOCRINOL INVEST, V28, P180, DOI 10.1007/BF03345364; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Hypponen E, 2007, J CLIN ENDOCR METAB, V92, P4615, DOI 10.1210/jc.2007-1279; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Jefferis BJMH, 2004, J PUBLIC HEALTH-UK, V26, P13, DOI 10.1093/pubmed/fdh110; Jorde R, 2007, ACTA HAEMATOL-BASEL, V117, P91, DOI 10.1159/000097383; Kelly GS, 2005, ALTERN MED REV, V10, P307; Koyama T, 1998, BLOOD, V92, P160, DOI 10.1182/blood.V92.1.160.413k16_160_167; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Manfredini R, 2004, AM J CARDIOL, V94, P276, DOI 10.1016/j.amjcard.2004.02.076; Manfredini R, 2009, AM J EMERG MED, V27, P1097, DOI 10.1016/j.ajem.2008.08.009; Norman PE, 2005, ARTERIOSCL THROM VAS, V25, P39, DOI 10.1161/01.ATV.0000148450.56697.4a; Parsons TJ, 2006, MED SCI SPORT EXER, V38, P547, DOI 10.1249/01.mss.0000188446.65651.67; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Pradhan AD, 2004, CIRCULATION, V110, P292, DOI 10.1161/01.CIR.0000134965.73212.A6; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559; Shea MK, 2008, AM J EPIDEMIOL, V167, P313, DOI 10.1093/aje/kwm306; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; Sobel ME., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, 10.2307/270723]; Targher G, 2006, CLIN ENDOCRINOL, V65, P593, DOI 10.1111/j.1365-2265.2006.02633.x; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Timms PM, 2002, QJM-INT J MED, V95, P787, DOI 10.1093/qjmed/95.12.787; Towler DA, 2007, J AM SOC NEPHROL, V18, P369, DOI 10.1681/ASN.2006121367; Towler DA, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P899; Vieth R, 2005, J ENDOCRINOL INVEST, V28, P183, DOI 10.1007/BF03345365; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755; Wu-Wong JR, 2007, J CELL BIOCHEM, V100, P1395, DOI 10.1002/jcb.21133; Wu-Wong JR, 2006, THROMB RES, V118, P709, DOI 10.1016/j.thromres.2005.10.017; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621; Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544; Zittermann A, 2007, CURR OPIN LIPIDOL, V18, P41, DOI 10.1097/MOL.0b013e328011c6fc; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	50	81	82	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10801	10.1371/journal.pone.0010801	http://dx.doi.org/10.1371/journal.pone.0010801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520739	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000278034600028
J	Satoh, R; Oizumi, M; Kazama, H; Okada, M				Satoh, Ryota; Oizumi, Masafumi; Kazama, Hokto; Okada, Masato			Mechanisms of Maximum Information Preservation in the Drosophila Antennal Lobe	PLOS ONE			English	Article							OLFACTORY LOCAL INTERNEURONS; GAIN-CONTROL; MAP; NEURONS; REPRESENTATION; POPULATIONS; INHIBITION	We examined the presence of maximum information preservation, which may be a fundamental principle of information transmission in all sensory modalities, in the Drosophila antennal lobe using an experimentally grounded network model and physiological data. Recent studies have shown a nonlinear firing rate transformation between olfactory receptor neurons (ORNs) and second-order projection neurons (PNs). As a result, PNs can use their dynamic range more uniformly than ORNs in response to a diverse set of odors. Although this firing rate transformation is thought to assist the decoder in discriminating between odors, there are no comprehensive, quantitatively supported studies examining this notion. Therefore, we quantitatively investigated the efficiency of this firing rate transformation from the viewpoint of information preservation by computing the mutual information between odor stimuli and PN responses in our network model. In the Drosophila olfactory system, all ORNs and PNs are divided into unique functional processing units called glomeruli. The nonlinear transformation between ORNs and PNs is formed by intraglomerular transformation and interglomerular interaction through local neurons (LNs). By exploring possible nonlinear transformations produced by these two factors in our network model, we found that mutual information is maximized when a weak ORN input is preferentially amplified within a glomerulus and the net LN input to each glomerulus is inhibitory. It is noteworthy that this is the very combination observed experimentally. Furthermore, the shape of the resultant nonlinear transformation is similar to that observed experimentally. These results imply that information related to odor stimuli is almost maximally preserved in the Drosophila olfactory circuit. We also discuss how intraglomerular transformation and interglomerular inhibition combine to maximize mutual information.	[Satoh, Ryota; Oizumi, Masafumi; Okada, Masato] Univ Tokyo, Kashiwa, Chiba, Japan; [Kazama, Hokto] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Okada, Masato] RIKEN Brain Sci Inst, Wako, Saitama, Japan	University of Tokyo; Harvard University; Harvard Medical School; RIKEN	Satoh, R (corresponding author), Univ Tokyo, Kashiwa, Chiba, Japan.	okada@k.u-tokyo.ac.jp	Kazama, Hokto/N-7505-2015	Kazama, Hokto/0000-0002-3239-1873; Oizumi, Masafumi/0000-0001-8802-2607; Sato, Ryota/0000-0002-3418-2987	Ministry of Education, Culture, Sports, Science and Technology, Japan [18079003, 20240020, 20650019]; JSPS [08J08950]; National Institutes of Health (NIH) [F32DC009538]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC009538] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Grants-in-Aid for Scientific Research (18079003, 20240020, 20650019) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to M. Okada). M. Oizumi was supported by a Grant-in-Aid for JSPS Fellows (08J08950). H. K. was supported by a postdoctoral fellowship from the National Institutes of Health (NIH) (F32DC009538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Cover T. M, 2006, ELEMENTS INFORM THEO, V2nd, DOI 10.1002/0471200611; Dan Y, 1996, J NEUROSCI, V16, P3351; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Laissue PP, 1999, J COMP NEUROL, V405, P543; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; LINSKER R, 1988, COMPUTER, V21, P105, DOI 10.1109/2.36; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Robertson RG, 1999, HIPPOCAMPUS, V9, P206, DOI 10.1002/(SICI)1098-1063(1999)9:3<206::AID-HIPO2>3.0.CO;2-H; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10644	10.1371/journal.pone.0010644	http://dx.doi.org/10.1371/journal.pone.0010644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20502639	gold, Green Published, Green Submitted			2022-12-25	WOS:000278017400005
J	Varanasi, SS; Olstad, OK; Swan, DC; Sanderson, P; Gautvik, VT; Reppe, S; Francis, RM; Gautvik, KM; Datta, HK				Varanasi, Satya S.; Olstad, Ole K.; Swan, Daniel C.; Sanderson, Paul; Gautvik, Vigdis T.; Reppe, Sjur; Francis, Roger M.; Gautvik, Kaare M.; Datta, Harish K.			Skeletal Site-Related Variation in Human Trabecular Bone Transcriptome and Signaling	PLOS ONE			English	Article							MINERAL DENSITY; GENOME SCREEN; LOCI; OSTEOCYTES; STRAIN; GENE; OSTEOPOROSIS; POLYMORPHISM; FORCES; BMD	Background: The skeletal site-specific influence of multiple genes on bone morphology is recognised, but the question as to how these influences may be exerted at the molecular and cellular level has not been explored. Methodology: To address this question, we have compared global gene expression profiles of human trabecular bone from two different skeletal sites that experience vastly different degrees of mechanical loading, namely biopsies from iliac crest and lumbar spinal lamina. Principal Findings: In the lumbar spine, compared to the iliac crest, the majority of the differentially expressed genes showed significantly increased levels of expression; 3406 transcripts were up-whilst 838 were down-regulated. Interestingly, all gene transcripts that have been recently demonstrated to be markers of osteocyte, as well as osteoblast and osteoclast-related genes, were markedly up-regulated in the spine. The transcriptome data is consistent with osteocyte numbers being almost identical at the two anatomical sites, but suggesting a relatively low osteocyte functional activity in the iliac crest. Similarly, osteoblast and osteoclast expression data suggested similar numbers of the cells, but presented with higher activity in the spine than iliac crest. This analysis has also led to the identification of expression of a number of transcripts, previously known and novel, which to our knowledge have never earlier been associated with bone growth and remodelling. Conclusions and Significance: This study provides molecular evidence explaining anatomical and micro-architectural site-related changes in bone cell function, which is predominantly attributable to alteration in cell transcriptional activity. A number of novel signaling molecules in critical pathways, which have been hitherto not known to be expressed in bone cells of mature vertebrates, were identified.	[Varanasi, Satya S.; Datta, Harish K.] Univ Newcastle, Sch Med, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Olstad, Ole K.; Gautvik, Vigdis T.; Reppe, Sjur; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Clin Biochem, Ulleval, Norway; [Swan, Daniel C.] Univ Newcastle, Sch Med, Bioinformat Support Unit, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Sanderson, Paul] Newcastle Gen Hosp, Dept Orthopaed Surg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Francis, Roger M.] Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Gautvik, Vigdis T.; Reppe, Sjur; Gautvik, Kaare M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Gautvik, Kaare M.] Lovisenberg Deacon Hosp, Dept Clin Chem, Oslo, Norway	Newcastle University - UK; University of Oslo; Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK; University of Oslo	Varanasi, SS (corresponding author), Univ Newcastle, Sch Med, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.	h.k.datta@ncl.ac.uk	Datta, Harish/AAN-5621-2020	Swan, Daniel/0000-0001-8978-8129	EU [FP6-502491]; Newcastle University; Newcastle University Hospital Trust	EU(European Commission); Newcastle University; Newcastle University Hospital Trust	The support of the EU project OSTEOGENE (No. FP6-502491) was under FP6 programme and partially funded by Newcastle University and Newcastle University Hospital Trust is thankfully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerssens J, 1997, J ENDOCRINOL, V155, P411, DOI 10.1677/joe.0.1550411; Al-oanzi ZH, 2006, CLIN CHEM, V52, P248, DOI 10.1373/clinchem.2005.059568; Bonewald L., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P331; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; DATTA HK, 2009, ASBMR 31 ANN M; DATTA HK, 2008, EUROPEAN MUSCULOSKEL, V3, P48; Enjuanes A, 2006, BONE, V38, P738, DOI 10.1016/j.bone.2005.10.010; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; KALOGEROPOULOS M, 2010, FASEB J IN PRESS; Karasik D, 2002, J BONE MINER RES, V17, P1718, DOI 10.1359/jbmr.2002.17.9.1718; Koller DL, 2000, J CLIN ENDOCR METAB, V85, P3116, DOI 10.1210/jc.85.9.3116; LANYON LE, 1984, CALCIFIED TISSUE INT, V36, pS56, DOI 10.1007/BF02406134; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorentzon M, 2004, J BONE MINER RES, V19, P2005, DOI 10.1359/JBMR.040909; Mannion AF, 2000, SPINE, V25, P842, DOI 10.1097/00007632-200004010-00013; NAGANATHAN V, 2003, J BONE MINER RES, V18, P1531; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Peacock M, 2004, OSTEOPOROSIS INT, V15, P489, DOI 10.1007/s00198-003-1560-7; Peacock M, 2005, BONE, V37, P467, DOI 10.1016/j.bone.2005.05.005; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Reppe S, 2006, BONE, V39, P189, DOI 10.1016/j.bone.2005.12.020; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; SEMB H, 1969, ACTA ORTHOP SCAND, V40, P552, DOI 10.3109/17453676908989520; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Xiong DH, 2006, J BONE MINER RES, V21, P1678, DOI 10.1359/JBMR.060808; Zerath E, 1998, ADV SPACE RES, V21, P1049, DOI 10.1016/S0273-1177(98)00026-X; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	33	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10692	10.1371/journal.pone.0010692	http://dx.doi.org/10.1371/journal.pone.0010692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502692	gold, Green Published, Green Submitted			2022-12-25	WOS:000277776500009
J	Aho, T; Almusa, H; Matilainen, J; Larjo, A; Ruusuvuori, P; Aho, KL; Wilhelm, T; Lahdesmaki, H; Beyer, A; Harju, M; Chowdhury, S; Leinonen, K; Roos, C; Yli-Harja, O				Aho, Tommi; Almusa, Henrikki; Matilainen, Jukka; Larjo, Antti; Ruusuvuori, Pekka; Aho, Kaisa-Leena; Wilhelm, Thomas; Lahdesmaki, Harri; Beyer, Andreas; Harju, Manu; Chowdhury, Sharif; Leinonen, Kalle; Roos, Christophe; Yli-Harja, Olli			Reconstruction and Validation of RefRec: A Global Model for the Yeast Molecular Interaction Network	PLOS ONE			English	Article							BIOLOGY MARKUP LANGUAGE; SACCHAROMYCES-CEREVISIAE; GENOME ANNOTATION; DATABASE; ONTOLOGY; DELETION; ENZYMES; SYSTEM; GENES	Molecular interaction networks establish all cell biological processes. The networks are under intensive research that is facilitated by new high-throughput measurement techniques for the detection, quantification, and characterization of molecules and their physical interactions. For the common model organism yeast Saccharomyces cerevisiae, public databases store a significant part of the accumulated information and, on the way to better understanding of the cellular processes, there is a need to integrate this information into a consistent reconstruction of the molecular interaction network. This work presents and validates RefRec, the most comprehensive molecular interaction network reconstruction currently available for yeast. The reconstruction integrates protein synthesis pathways, a metabolic network, and a protein-protein interaction network from major biological databases. The core of the reconstruction is based on a reference object approach in which genes, transcripts, and proteins are identified using their primary sequences. This enables their unambiguous identification and non-redundant integration. The obtained total number of different molecular species and their connecting interactions is similar to 67,000. In order to demonstrate the capacity of RefRec for functional predictions, it was used for simulating the gene knockout damage propagation in the molecular interaction network in similar to 590,000 experimentally validated mutant strains. Based on the simulation results, a statistical classifier was subsequently able to correctly predict the viability of most of the strains. The results also showed that the usage of different types of molecular species in the reconstruction is important for accurate phenotype prediction. In general, the findings demonstrate the benefits of global reconstructions of molecular interaction networks. With all the molecular species and their physical interactions explicitly modeled, our reconstruction is able to serve as a valuable resource in additional analyses involving objects from multiple molecular -omes. For that purpose, RefRec is freely available in the Systems Biology Markup Language format.	[Aho, Tommi; Larjo, Antti; Ruusuvuori, Pekka; Aho, Kaisa-Leena; Lahdesmaki, Harri; Harju, Manu; Chowdhury, Sharif; Leinonen, Kalle; Yli-Harja, Olli] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Almusa, Henrikki; Matilainen, Jukka; Roos, Christophe] Medicel Ltd, Espoo, Finland; [Wilhelm, Thomas] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, FIN-02150 Espoo, Finland; [Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany	Tampere University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Aalto University; Technische Universitat Dresden	Aho, T (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	tommi.aho@tut.fi	Ruusuvuori, Pekka/AAC-2617-2022; Ruusuvuori, Pekka/C-9229-2016; Beyer, Andreas/AAQ-5519-2020; Beyer, Andreas/A-3352-2009	Ruusuvuori, Pekka/0000-0001-9086-9591; Beyer, Andreas/0000-0002-3891-2123; Beyer, Andreas/0000-0002-3891-2123; Roos, Christophe/0000-0003-0982-7664; Yli-Harja, Olli/0000-0001-8581-4414	Academy of Finland; EU [APO-SYS/200767]; BBSRC [BBS/E/F/00044461] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044461] Funding Source: researchfish	Academy of Finland(Academy of Finland); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	At Tampere University of Technology, this work was supported by the Academy of Finland, (http://www.aka.fi, application number 213462, Finnish Programme for Centres of Excellence in Research 2006-2011). Some of the work done at Medicel on data integration is supported by EU/FP7/HEALTH grant (http://cordis.europa.eu/fp7/health/, APO-SYS/200767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO T, 2006, P 4 TICSP WORKSH COM, P23; Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Coles SJ, 2005, ORG BIOMOL CHEM, V3, P1832, DOI 10.1039/b502828k; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Finney A, 2003, BIOCHEM SOC T, V31, P1472; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Goto S, 1998, BIOINFORMATICS, V14, P591, DOI 10.1093/bioinformatics/14.7.591; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Hashimoto K, 2006, GLYCOBIOLOGY, V16, p63R, DOI 10.1093/glycob/cwj010; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kharchenko P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-177; Kharchenko P, 2004, BIOINFORMATICS, V20, P178, DOI 10.1093/bioinformatics/bth930; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Le Novere N, 2005, NAT BIOTECHNOL, V23, P1509, DOI 10.1038/nbt1156; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lemke N, 2004, BIOINFORMATICS, V20, P115, DOI 10.1093/bioinformatics/btg386; Maltsev N, 2006, NUCLEIC ACIDS RES, V34, pD369, DOI 10.1093/nar/gkj095; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Nookaew I, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-71; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Philippi S, 2006, NAT REV GENET, V7, P482, DOI 10.1038/nrg1872; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Scholkopf B, 2001, LEARNING KERNELS SUP; Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065; Stein SE, 2003, PROCEEDINGS OF THE 2003 INTERNATIONAL CHEMICAL INFORMATION CONFERENCE, P131; Sulakhe Dinanath, 2005, J Clin Monit Comput, V19, P361, DOI 10.1007/s10877-005-3463-y; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; TONG AH, 2004, SCIENCE, V303, P774; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	51	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10662	10.1371/journal.pone.0010662	http://dx.doi.org/10.1371/journal.pone.0010662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498836	Green Published, Green Submitted, gold			2022-12-25	WOS:000277771600022
J	Miller, J; Parker, M; Bourret, RB; Giddings, MC				Miller, Jameson; Parker, Miles; Bourret, Robert B.; Giddings, Morgan C.			An Agent-Based Model of Signal Transduction in Bacterial Chemotaxis	PLOS ONE			English	Article							PHOSPHORYLATED CHEY; SIMULATED DIFFUSION; ASPARTATE RECEPTOR; LIGAND-BINDING; DOMAIN; ORGANIZATION; SENSITIVITY; CYTOPLASM; PROTEINS; COMPLEX	We report the application of agent-based modeling to examine the signal transduction network and receptor arrays for chemotaxis in Escherichia coli, which are responsible for regulating swimming behavior in response to environmental stimuli. Agent-based modeling is a stochastic and bottom-up approach, where individual components of the modeled system are explicitly represented, and bulk properties emerge from their movement and interactions. We present the Chemoscape model: a collection of agents representing both fixed membrane-embedded and mobile cytoplasmic proteins, each governed by a set of rules representing knowledge or hypotheses about their function. When the agents were placed in a simulated cellular space and then allowed to move and interact stochastically, the model exhibited many properties similar to the biological system including adaptation, high signal gain, and wide dynamic range. We found the agent based modeling approach to be both powerful and intuitive for testing hypotheses about biological properties such as self-assembly, the non-linear dynamics that occur through cooperative protein interactions, and non-uniform distributions of proteins in the cell. We applied the model to explore the role of receptor type, geometry and cooperativity in the signal gain and dynamic range of the chemotactic response to environmental stimuli. The model provided substantial qualitative evidence that the dynamic range of chemotactic response can be traced to both the heterogeneity of receptor types present, and the modulation of their cooperativity by their methylation state.	[Miller, Jameson; Giddings, Morgan C.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA; [Miller, Jameson; Giddings, Morgan C.] Univ N Carolina, Bioinformat & Computat Biol Training Program, Chapel Hill, NC USA; [Parker, Miles] Metascape LLC, Nelson, BC, Canada; [Bourret, Robert B.; Giddings, Morgan C.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Giddings, Morgan C.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Miller, J (corresponding author), Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA.	giddings@unc.edu	Bourret, Robert/X-3606-2019	Bourret, Robert/0000-0002-6666-9220	NIH [RR020823, HG003700, GM050860]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020823] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050860] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH awards RR020823 and HG003700 to MCG, and GM050860 to RBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2004, BIOPHYS J, V86, P2650, DOI 10.1016/S0006-3495(04)74321-0; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; Bornhorst JA, 2001, J GEN PHYSIOL, V118, P693, DOI 10.1085/jgp.118.6.693; Bray D, 2002, P NATL ACAD SCI USA, V99, P7, DOI 10.1073/pnas.022641699; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; BRAY D, 1993, MOL BIOL CELL, V4, P469, DOI 10.1091/mbc.4.5.469; BRAY D, 1995, MOL BIOL CELL, V6, P1367, DOI 10.1091/mbc.6.10.1367; Bray D, 2007, CURR BIOL, V17, P12, DOI 10.1016/j.cub.2006.11.027; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Corning P. A., 2002, Complexity, V7, P18, DOI 10.1002/cplx.10043; DANIELSON MA, 1994, BIOCHEMISTRY-US, V33, P6100, DOI 10.1021/bi00186a009; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elliott Euel, 2004, Nonlinear Dynamics Psychol Life Sci, V8, P121; Emonet T, 2005, BIOINFORMATICS, V21, P2714, DOI 10.1093/bioinformatics/bti391; FOWLER DJ, 2010, BIOCHEMISTRY; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Goldman JP, 2009, MOL BIOSYST, V5, P1853, DOI [10.1039/B903397a, 10.1039/b903397a]; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2005, J BACTERIOL, V187, P23, DOI 10.1128/JB.187.1.23-25.2005; Inchiosa ME, 2002, P NATL ACAD SCI USA, V99, P7304, DOI 10.1073/pnas.082081199; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kim SH, 2002, P NATL ACAD SCI USA, V99, P11611, DOI 10.1073/pnas.132376499; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; LEVIN MD, 2008, RATE TABLES; Levit MN, 2002, J BIOL CHEM, V277, P36748, DOI 10.1074/jbc.M204317200; LI M, 2005, MOL MICROBIOL, V61, P407; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; LOVDOK L, 2007, J BIOTECHNOL; LUPAS A, 1989, J BIOL CHEM, V264, P17337; MADDOCK JR, 1993, SCIENCE, V259, P1717; Mao HB, 2003, P NATL ACAD SCI USA, V100, P5449, DOI 10.1073/pnas.0931258100; Mello BA, 2004, BIOPHYS J, V87, P1578, DOI 10.1529/biophysj.104.042739; Mello BA, 2003, P NATL ACAD SCI USA, V100, P8223, DOI 10.1073/pnas.1330839100; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; PARKER MT, 2001, JASSS-J ARTIF SOC S, V4, pU101; Parkinson JS, 2005, CURR OPIN MICROBIOL, V8, P116, DOI 10.1016/j.mib.2005.02.008; Rao CV, 2004, J MOL BIOL, V343, P291, DOI 10.1016/j.jmb.2004.08.046; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Shimizu TS, 2000, NAT CELL BIOL, V2, P792, DOI 10.1038/35041030; Shimizu TS, 2003, J MOL BIOL, V329, P291, DOI 10.1016/S0022-2836(03)00437-6; Silversmith RE, 2008, J BIOL CHEM, V283, P756, DOI 10.1074/jbc.M704400200; Skoge ML, 2006, BIOPHYS J, V90, P4317, DOI 10.1529/biophysj.105.079905; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Studdert CA, 2005, P NATL ACAD SCI USA, V102, P15623, DOI 10.1073/pnas.0506040102; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Weis RM, 2003, J BACTERIOL, V185, P3636, DOI 10.1128/JB.185.12.3636-3643.2003; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	62	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e9454	10.1371/journal.pone.0009454	http://dx.doi.org/10.1371/journal.pone.0009454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485527	Green Published, Green Submitted, gold			2022-12-25	WOS:000277633500001
J	Coulombe, Y; Lemieux, M; Moreau, J; Aubin, J; Joksimovic, M; Berube-Simard, FA; Tabaries, S; Boucherat, O; Guillou, F; Larochelle, C; Tuggle, CK; Jeannotte, L				Coulombe, Yan; Lemieux, Margot; Moreau, Julie; Aubin, Josee; Joksimovic, Milan; Berube-Simard, Felix-Antoine; Tabaries, Sebastien; Boucherat, Olivier; Guillou, Francois; Larochelle, Christian; Tuggle, Christopher K.; Jeannotte, Lucie			Multiple Promoters and Alternative Splicing: Hoxa5 Transcriptional Complexity in the Mouse Embryo	PLOS ONE			English	Article							MESSENGER-RNA; CHROMATIN DECONDENSATION; ANTISENSE TRANSCRIPTION; NUCLEAR REORGANIZATION; GENE-EXPRESSION; NERVOUS-SYSTEM; PROTEIN; SPECIFICATION; LOCUS; MECHANISMS	Background: The genomic organization of Hox clusters is fundamental for the precise spatio-temporal regulation and the function of each Hox gene, and hence for correct embryo patterning. Multiple overlapping transcriptional units exist at the Hoxa5 locus reflecting the complexity of Hox clustering: a major form of 1.8 kb corresponding to the two characterized exons of the gene and polyadenylated RNA species of 5.0, 9.5 and 11.0 kb. This transcriptional intricacy raises the question of the involvement of the larger transcripts in Hox function and regulation. Methodology/Principal Findings: We have undertaken the molecular characterization of the Hoxa5 larger transcripts. They initiate from two highly conserved distal promoters, one corresponding to the putative Hoxa6 promoter, and a second located nearby Hoxa7. Alternative splicing is also involved in the generation of the different transcripts. No functional polyadenylation sequence was found at the Hoxa6 locus and all larger transcripts use the polyadenylation site of the Hoxa5 gene. Some larger transcripts are potential Hoxa6/Hoxa5 bicistronic units. However, even though all transcripts could produce the genuine 270 a. a. HOXA5 protein, only the 1.8 kb form is translated into the protein, indicative of its essential role in Hoxa5 gene function. The Hoxa6 mutation disrupts the larger transcripts without major phenotypic impact on axial specification in their expression domain. However, Hoxa5-like skeletal anomalies are observed in Hoxa6 mutants and these defects can be explained by the loss of expression of the 1.8 kb transcript. Our data raise the possibility that the larger transcripts may be involved in Hoxa5 gene regulation. Significance: Our observation that the Hoxa5 larger transcripts possess a developmentally-regulated expression combined to the increasing sum of data on the role of long noncoding RNAs in transcriptional regulation suggest that the Hoxa5 larger transcripts may participate in the control of Hox gene expression.	[Coulombe, Yan; Lemieux, Margot; Moreau, Julie; Aubin, Josee; Berube-Simard, Felix-Antoine; Tabaries, Sebastien; Boucherat, Olivier; Guillou, Francois; Larochelle, Christian; Jeannotte, Lucie] Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech & Cancerol, Quebec City, PQ, Canada; [Joksimovic, Milan; Tuggle, Christopher K.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	Laval University; Iowa State University	Coulombe, Y (corresponding author), Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech & Cancerol, Quebec City, PQ, Canada.	lucie.jeannotte@crhdq.ulaval.ca		Joksimovic, Milan/0000-0002-3936-4632; Jeannotte, Lucie/0000-0001-5578-420X	Canadian Institutes of Health Research (CIHR) [MOP-68999]; Fonds de la Recherche en Sante du Quebec-Institut National de la Sante et de la Recherche Medicale (FRSQ-INSERM)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec-Institut National de la Sante et de la Recherche Medicale (FRSQ-INSERM)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a Canadian Institutes of Health Research (CIHR) grant (MOP-68999 to L.J.) and a postdoctoral fellowship from the Fonds de la Recherche en Sante du Quebec-Institut National de la Sante et de la Recherche Medicale (FRSQ-INSERM; to O.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin J, 1997, DEV BIOL, V192, P432, DOI 10.1006/dbio.1997.8746; Aubin J, 1998, DEV DYNAM, V212, P141, DOI 10.1002/(SICI)1097-0177(199805)212:1<141::AID-AJA13>3.0.CO;2-A; Aubin J, 2002, DEVELOPMENT, V129, P4075; Aubin J, 1999, AM J PHYSIOL-CELL PH, V277, pC965, DOI 10.1152/ajpcell.1999.277.5.C965; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; Bijl J, 2005, GENE DEV, V19, P224, DOI 10.1101/gad.1268505; Bradshaw MS, 1996, P NATL ACAD SCI USA, V93, P2426, DOI 10.1073/pnas.93.6.2426; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Brock HW, 2009, BIOCHEM CELL BIOL, V87, P27, DOI 10.1139/O08-108; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen WSV, 2003, METHOD ENZYMOL, V365, P367; Dintilhac A, 2004, GENE EXPR PATTERNS, V4, P215, DOI 10.1016/j.modgep.2003.08.006; DONY C, 1987, EMBO J, V6, P2965, DOI 10.1002/j.1460-2075.1987.tb02602.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Folberg A, 1997, J BIOL CHEM, V272, P29151, DOI 10.1074/jbc.272.46.29151; Garin E, 2006, DEV DYNAM, V235, P1858, DOI 10.1002/dvdy.20822; GAUNT SJ, 1990, DEVELOPMENT, V109, P329; Gendronneau G, 2010, AM J PATHOL, V176, P995, DOI 10.2353/ajpath.2010.090499; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Hogan B, 1994, MANIPULATING MOUSE E; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; JAFFE L, 1990, J IMMUNOL, V145, P3474; JEANNOTTE L, 1991, MOL CELL BIOL, V11, P5578, DOI 10.1128/MCB.11.11.5578; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Joksimovic M, 2005, GENE EXPR PATTERNS, V5, P792, DOI 10.1016/j.modgep.2005.03.008; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; KOSTIC D, 1994, MECH DEVELOP, V46, P231, DOI 10.1016/0925-4773(94)90073-6; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Larochelle C, 1999, DEV DYNAM, V214, P127, DOI 10.1002/(SICI)1097-0177(199902)214:2<127::AID-AJA3>3.0.CO;2-F; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Meunier D, 2003, DEV DYNAM, V227, P367, DOI 10.1002/dvdy.10325; Moreau J, 2002, DNA SEQUENCE, V13, P203, DOI 10.1080/10425170290034507; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nowling T, 1999, DEV BIOL, V208, P134, DOI 10.1006/dbio.1998.9189; ODENWALD WF, 1987, GENE DEV, V1, P482, DOI 10.1101/gad.1.5.482; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Packer AI, 1998, DEVELOPMENT, V125, P1991; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Popovic R, 2008, BLOOD CELL MOL DIS, V40, P156, DOI 10.1016/j.bcmd.2007.07.016; PUSCHEL AW, 1990, DEVELOPMENT, V108, P435; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P724, DOI 10.1016/j.bbrc.2007.03.200; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; SHAM MH, 1992, EMBO J, V11, P1825, DOI 10.1002/j.1460-2075.1992.tb05234.x; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; SIMEONE A, 1988, NUCLEIC ACIDS RES, V16, P5379, DOI 10.1093/nar/16.12.5379; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Tabaries S, 2005, MOL CELL BIOL, V25, P1389, DOI 10.1128/MCB.25.4.1389-1401.2005; Tabaries S, 2007, GENESIS, V45, P218, DOI 10.1002/dvg.20292; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; ZAKANY J, 1988, NEURON, V1, P679, DOI 10.1016/0896-6273(88)90167-5	64	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10600	10.1371/journal.pone.0010600	http://dx.doi.org/10.1371/journal.pone.0010600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485555	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563400011
J	Sebinger, DDR; Unbekandt, M; Ganeva, VV; Ofenbauer, A; Werner, C; Davies, JA				Sebinger, David D. R.; Unbekandt, Mathieu; Ganeva, Veronika V.; Ofenbauer, Andreas; Werner, Carsten; Davies, Jamie A.			A Novel, Low-Volume Method for Organ Culture of Embryonic Kidneys That Allows Development of Cortico-Medullary Anatomical Organization	PLOS ONE			English	Article							DEVELOPING MOUSE KIDNEY; BRANCHING MORPHOGENESIS; IN-VITRO; GROWTH-FACTOR; TUBULE DIFFERENTIATION; NEUROTROPHIC FACTOR; INTERFERON-GAMMA; SKELETAL-MUSCLE; CELL-ADHESION; EXPRESSION	Here, we present a novel method for culturing kidneys in low volumes of medium that offers more organotypic development compared to conventional methods. Organ culture is a powerful technique for studying renal development. It recapitulates many aspects of early development very well, but the established techniques have some disadvantages: in particular, they require relatively large volumes (1-3 mls) of culture medium, which can make high-throughput screens expensive, they require porous (filter) substrates which are difficult to modify chemically, and the organs produced do not achieve good cortico-medullary zonation. Here, we present a technique of growing kidney rudiments in very low volumes of medium-around 85 microliters-using silicone chambers. In this system, kidneys grow directly on glass, grow larger than in conventional culture and develop a clear anatomical cortico-medullary zonation with extended loops of Henle.	[Sebinger, David D. R.; Ofenbauer, Andreas; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, Dresden, Germany; [Unbekandt, Mathieu; Ganeva, Veronika V.; Davies, Jamie A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	Leibniz Institut fur Polymerforschung Dresden; Technische Universitat Dresden; University of Edinburgh	Sebinger, DDR (corresponding author), Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, Dresden, Germany.	jamie.davies@ed.ac.uk	Werner, Carsten/F-8127-2010; Davies, Jamie/AAE-7111-2019; Werner, Carsten/AAF-1510-2019	Werner, Carsten/0000-0003-0189-3448; Davies, Jamie/0000-0001-6660-4032; Ofenbauer, Andreas/0000-0003-0379-9105	European Union [LSHG-CT-2004-005085, MRTN-CT-2006-036097, HEALTH-F5-2008-223007]; National Centre for 3Rs [G0700480]; National Centre for the Replacement [G0700480/1] Funding Source: researchfish	European Union(European Commission); National Centre for 3Rs; National Centre for the Replacement	This work was supported by the European Union - EU Framework 6 (EuReGene: LSHG-CT-2004-005085), EU and Framework 7 (MRTN-CT-2006-036097 KidStem and HEALTH-F5-2008-223007 STAR-T REK) and National Centre for 3Rs (G0700480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto Tetsu, 2005, Organogenesis, V2, P17; AUERBACH R, 1958, EXP CELL RES, V15, P384, DOI 10.1016/0014-4827(58)90039-9; AVNER ED, 1982, IN VITRO CELL DEV B, V18, P675; BARD JBL, 1991, DEVELOPMENT, V113, P193; BUCKLER AJ, 1991, MOL CELL BIOL, V11, P1707, DOI 10.1128/MCB.11.3.1707; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; DAVIES J, 1994, DEV DYNAM, V199, P45, DOI 10.1002/aja.1001990105; Davies JA, 2003, GROWTH FACTORS, V21, P109, DOI 10.1080/08977190310001621005; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; DAVIES JA, 1995, DEV BIOL, V167, P50, DOI 10.1006/dbio.1995.1006; ENGELMYER E, 1995, J AM SOC NEPHROL, V5, P1675; Fisher CE, 2001, DEVELOPMENT, V128, P4329; GLEUCKSOHNWAELS.S, 1963, DEV BIOL, V7, P432; GROBSTEIN C, 1953, NATURE, V172, P869, DOI 10.1038/172869a0; GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52; GROBSTEIN C, 1953, J EXP ZOOL, V124, P383, DOI 10.1002/jez.1401240211; HANSEN FK, 1991, J COLLOID INTERF SCI, V141, P1, DOI 10.1016/0021-9797(91)90296-K; HIGHTOWER LE, 1981, J CELL PHYSIOL, V108, P261, DOI 10.1002/jcp.1041080216; Kossakowska AE, 1998, AM J PATHOL, V153, P1895, DOI 10.1016/S0002-9440(10)65703-3; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; Lee Wen-Chin, 2008, Organogenesis, V4, P176; LIU LT, 1993, KIDNEY INT, V44, P322, DOI 10.1038/ki.1993.247; Loughna S, 1998, BIOCHEM BIOPH RES CO, V247, P361, DOI 10.1006/bbrc.1998.8768; MATSUSHIMA K, 1989, CYTOKINE, V1, P1; McEarchern JA, 1999, CANCER IMMUNOL IMMUN, V48, P63, DOI 10.1007/s002620050549; Michael L, 2004, J ANAT, V204, P241, DOI 10.1111/j.0021-8782.2004.00285.x; Michael L, 2007, J ANAT, V210, P89, DOI 10.1111/j.1469-7580.2006.00670.x; MICHOS O, 2007, DEVELOPMENT; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Peterson JM, 2009, J APPL PHYSIOL, V106, P130, DOI 10.1152/japplphysiol.90584.2008; Pillai RG, 2008, BRIT J OPHTHALMOL, V92, P259, DOI 10.1136/bjo.2007.115923; RIENHOFF WF, 1922, J HOPKINS HOSP B, V33, P392; Rogers Sharon A, 2004, Organogenesis, V1, P52; Rosines E, 2007, BIOMATERIALS, V28, P4806, DOI 10.1016/j.biomaterials.2007.07.034; Sainio K, 1997, DEVELOPMENT, V124, P4077; SAINIO K, 1994, CELL MOL NEUROBIOL, V14, P439, DOI 10.1007/BF02088830; Sakurai H, 1997, AM J PHYSIOL-RENAL, V272, pF139, DOI 10.1152/ajprenal.1997.272.1.F139; Saxen L., 1968, P251; SAXEN L, 1962, J NATL CANCER I, V29, P597; SAXEN L, 1966, INT J CANCER, V1, P271, DOI 10.1002/ijc.2910010307; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Shibata F, 1996, CYTOKINE, V8, P222, DOI 10.1006/cyto.1996.0031; TAJIMA K, 1985, BIOPHYS J, V47, P203, DOI 10.1016/S0006-3495(85)83892-3; Tan HK, 2008, BIOTECHNOL APPL BIOC, V49, P247, DOI 10.1042/BA20070032; THESLEFF I, 1984, J EMBRYOL EXP MORPH, V82, P147; Towers PR, 1998, EXP NEPHROL, V6, P337; VESTWEBER D, 1985, DEV BIOL, V112, P213, DOI 10.1016/0012-1606(85)90135-6; Voronov DA, 2002, DEV DYNAM, V224, P413, DOI 10.1002/dvdy.10121; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; WOOLF AS, 1995, J CELL BIOL, V128, P171, DOI 10.1083/jcb.128.1.171; Yamagata M, 2001, ENDOCRINOLOGY, V142, P3223, DOI 10.1210/en.142.7.3223	52	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10550	10.1371/journal.pone.0010550	http://dx.doi.org/10.1371/journal.pone.0010550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479933	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467900006
J	Leissring, MA; Malito, E; Hedouin, S; Reinstatler, L; Sahara, T; Abdul-Hay, SO; Choudhry, S; Maharvi, GM; Fauq, AH; Huzarska, M; May, PS; Choi, S; Logan, TP; Turk, BE; Cantley, LC; Manolopoulou, M; Tang, WJ; Stein, RL; Cuny, GD; Selkoe, DJ				Leissring, Malcolm A.; Malito, Enrico; Hedouin, Sabrine; Reinstatler, Lael; Sahara, Tomoko; Abdul-Hay, Samer O.; Choudhry, Shakeel; Maharvi, Ghulam M.; Fauq, Abdul H.; Huzarska, Malwina; May, Philip S.; Choi, Sungwoon; Logan, Todd P.; Turk, Benjamin E.; Cantley, Lewis C.; Manolopoulou, Marika; Tang, Wei-Jen; Stein, Ross L.; Cuny, Gregory D.; Selkoe, Dennis J.			Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; MOLECULAR-BASIS; DEGRADATION; SOFTWARE; RECOGNITION; PEPTIDASE; INSULYSIN; CLEAVAGE; TARGET; IDE	Background: Insulin is a vital peptide hormone that is a central regulator of glucose homeostasis, and impairments in insulin signaling cause diabetes mellitus. In principle, it should be possible to enhance the activity of insulin by inhibiting its catabolism, which is mediated primarily by insulin-degrading enzyme (IDE), a structurally and evolutionarily distinctive zinc-metalloprotease. Despite interest in pharmacological inhibition of IDE as an attractive anti-diabetic approach dating to the 1950s, potent and selective inhibitors of IDE have not yet emerged. Methodology/Principal Findings: We used a rational design approach based on analysis of combinatorial peptide mixtures and focused compound libraries to develop novel peptide hydroxamic acid inhibitors of IDE. The resulting compounds are similar to 10(6) times more potent than existing inhibitors, non-toxic, and surprisingly selective for IDE vis-a-vis conventional zincmetalloproteases. Crystallographic analysis of an IDE-inhibitor complex reveals a novel mode of inhibition based on stabilization of IDE's "closed,'' inactive conformation. We show further that pharmacological inhibition of IDE potentiates insulin signaling by a mechanism involving reduced catabolism of internalized insulin. Conclusions/Significance: The inhibitors we describe are the first to potently and selectively inhibit IDE or indeed any member of this atypical zinc-metalloprotease superfamily. The distinctive structure of IDE's active site, and the mode of action of our inhibitors, suggests that it may be possible to develop inhibitors that cross-react minimally with conventional zinc-metalloproteases. Significantly, our results reveal that insulin signaling is normally regulated by IDE activity not only extracellularly but also within cells, supporting the longstanding view that IDE inhibitors could hold therapeutic value for the treatment of diabetes.	[Leissring, Malcolm A.; Hedouin, Sabrine; Reinstatler, Lael; Sahara, Tomoko; Abdul-Hay, Samer O.; Choudhry, Shakeel; Maharvi, Ghulam M.; Fauq, Abdul H.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Leissring, Malcolm A.; Huzarska, Malwina; May, Philip S.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Leissring, Malcolm A.; Logan, Todd P.; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Leissring, Malcolm A.; Logan, Todd P.; Cantley, Lewis C.; Selkoe, Dennis J.] Harvard Univ, Sch Med, Boston, MA USA; [Malito, Enrico; Manolopoulou, Marika; Tang, Wei-Jen] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; [Choi, Sungwoon; Stein, Ross L.; Cuny, Gregory D.] Brigham & Womens Hosp, Lab Drug Discovery Neurodegenerat, Cambridge, MA USA; [Choi, Sungwoon; Stein, Ross L.; Cuny, Gregory D.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Mayo Clinic; Scripps Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard University; Yale University; Harvard University; Beth Israel Deaconess Medical Center	Leissring, MA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	Leissring@mayo.edu	LEISSRING, MALCOLM/AAW-5361-2021; Cantley, Lewis C/D-1800-2014	LEISSRING, MALCOLM/0000-0001-7185-4255; Cantley, Lewis C/0000-0002-1298-7653; Hedouin, Sabrine/0000-0002-3977-1852; Cuny, Gregory/0000-0002-3188-4748; Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [AG025070, DA024888, AG12749, GM81539]; Ellison Medical Foundation; American Health Assistance Foundation; Unforgettable Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, R01GM081539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012749, R21AG025070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Health Assistance Foundation(BrightFocus Foundation); Unforgettable Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health (AG025070 and DA024888 to MAL; AG12749 to MAL and DJS; GM81539 to W-JT), the Ellison Medical Foundation (to MAL), the American Health Assistance Foundation (to EM), and by a generous donation from The Unforgettable Fund (to SH and MAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Authier F, 2002, J BIOL CHEM, V277, P9437, DOI 10.1074/jbc.M110188200; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; BECKER AB, 1995, METHOD ENZYMOL, V248, P693; Brange J, 1993, Pharm Biotechnol, V5, P315; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1981, ENDOCR REV, V2, P210, DOI 10.1210/edrv-2-2-210; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; GARCIA JV, 1988, BIOCHEMISTRY-US, V27, P4237, DOI 10.1021/bi00412a006; Giugliano D, 2009, ACTA DIABETOL, V46, P173, DOI 10.1007/s00592-009-0134-3; HAMEL FG, 1991, DIABETES, V40, P436, DOI 10.2337/diabetes.40.4.436; Hentz NG, 1997, ANAL CHEM, V69, P4994, DOI 10.1021/ac970726m; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leissring MA, 2006, NATURE, V443, P761, DOI 10.1038/nature05210; Makarova KS, 1999, J MOL BIOL, V292, P11, DOI 10.1006/jmbi.1999.3059; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; MIRSKY IA, 1955, SCIENCE, V122, P559, DOI 10.1126/science.122.3169.559; MIRSKY IA, 1956, METABOLISM, V5, P138; MIRSKY IA, 1957, RECENT PROG HORM RES, V13, P429; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; NISHINO N, 1978, BIOCHEMISTRY-US, V17, P2846, DOI 10.1021/bi00607a023; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powers J C, 1993, Agents Actions Suppl, V42, P3; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; TERRIS S, 1975, J BIOL CHEM, V250, P8389; Tong M, 2006, BIOCHEM PHARMACOL, V72, P701, DOI 10.1016/j.bcp.2006.06.004; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; WATANABE T, 2009, CANC SCI; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	50	86	91	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10504	10.1371/journal.pone.0010504	http://dx.doi.org/10.1371/journal.pone.0010504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20498699	gold, Green Published, Green Submitted			2022-12-25	WOS:000277467800004
J	Huang, CY; Ogawa, R				Huang, Chenyu; Ogawa, Rei			Mechanotransduction in bone repair and regeneration	FASEB JOURNAL			English	Review						mechanical stimulation; mechanosensation; mechanotransductive pathways; skeletal adaptation; bone reparation and reconstruction	FOCAL ADHESION KINASE; MANDIBULAR DISTRACTION OSTEOGENESIS; IN-VIVO EVIDENCE; MECHANICAL STRAIN; NITRIC-OXIDE; TISSUE DIFFERENTIATION; RECEPTOR ACTIVATOR; STRUCTURAL BASIS; PROSTAGLANDIN SYNTHESIS; BIOPHYSICAL STIMULI	Mechanotransduction is the process by which physical forces are converted into biochemical signals that are then integrated into cellular responses. It plays a crucial role in bone repair and regeneration and thus has attracted a great deal of interest from researchers in various fields. This report reviews the current clinical evidence that shows the role mechanotransduction plays in bone processes such as physical adaptation, pathological fracture healing, and therapeutic distraction osteogenesis. We also outline the progress that has been made in understanding bone mechanotransduction from both the macro-and microperspectives. Specifically, we describe the theories that postulate how mechanical force exhibits effects on bone repair and regeneration (i.e., the tensegrity and mechanosome theories). We also summarize the recent advances in our understanding of the molecular signaling pathways of mechanotransduction, which include calcium ion channels, integrins, Wnt/beta-catenin, prostaglandin, and nitric oxide. A better understanding of skeletal mechanotransduction will facilitate research into this promising field and could lead to the development of applications that improve bone structures and functions.-Huang, C., Ogawa, R. Mechanotransduction in bone repair and regeneration. FASEB J. 24, 3625-3632 (2010). www.fasebj.org	[Huang, Chenyu] Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, Tokyo 1138603, Japan; [Huang, Chenyu] Meitan Gen Hosp, Dept Plast Surg, Beijing, Peoples R China	Nippon Medical School	Huang, CY (corresponding author), Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	huangchenyu2000@gmail.com	Huang, Chenyu/I-4410-2018; HUANG, CHENYU/GVT-7299-2022	Huang, Chenyu/0000-0001-9521-5650; 				Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Alam I, 2005, J BONE MINER RES, V20, P438, DOI 10.1359/JBMR.041124; Baker AB, 2000, MICROVASC RES, V60, P177, DOI 10.1006/mvre.2000.2252; Bhatt KA, 2007, J SURG RES, V143, P329, DOI 10.1016/j.jss.2007.01.023; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Cheng BX, 2001, ENDOCRINOLOGY, V142, P3464, DOI 10.1210/en.142.8.3464; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Cowin SC, 2007, J BIOMECH, V40, pS105, DOI 10.1016/j.jbiomech.2007.02.012; David V, 2006, AM J PHYSIOL-ENDOC M, V290, pE440, DOI 10.1152/ajpendo.00293.2004; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; El Haj AJ, 1999, MED BIOL ENG COMPUT, V37, P403, DOI 10.1007/BF02513320; Flick LM, 2003, J ORTHOP RES, V21, P676, DOI 10.1016/S0736-0266(03)00011-1; Forwood MR, 1996, J BONE MINER RES, V11, pP210; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Hung CT, 1996, J BIOMECH, V29, P1411, DOI 10.1016/0021-9290(96)84536-2; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249, DOI 10.1097/00003086-198901000-00038; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P263; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Inoue M, 2000, BONE, V26, P281, DOI 10.1016/S8756-3282(99)00282-3; Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037; Jansen JHW, 2010, J ORTHOP RES, V28, P390, DOI 10.1002/jor.20991; Kanno T, 2005, J ORAL MAXIL SURG, V63, P499, DOI 10.1016/j.joms.2004.07.023; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Leucht P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000390; Lewinson D, 2003, J HISTOCHEM CYTOCHEM, V51, P1161, DOI 10.1177/002215540305100906; Li J, 2002, J BONE MINER RES, V17, pS191; Li J, 2002, CALCIFIED TISSUE INT, V70, P320, DOI 10.1007/s00223-001-1025-y; Mi LY, 2005, BIOMECH MODEL MECHAN, V4, P132, DOI 10.1007/s10237-004-0066-3; Morgan EF, 2008, J BONE JOINT SURG AM, V90A, P25, DOI 10.2106/JBJS.G.01164; Mullender MG, 1997, BONE, V20, P527, DOI 10.1016/S8756-3282(97)00036-7; Myers KA, 2007, BIOCHEM CELL BIOL, V85, P543, DOI 10.1139/O07-108; Nichols DL, 2007, SPORTS MED, V37, P1001, DOI 10.2165/00007256-200737110-00006; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Ponik SM, 2004, J APPL PHYSIOL, V97, P135, DOI 10.1152/japplphysiol.01260.2003; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Reich A, 2005, J APPL PHYSIOL, V98, P2381, DOI 10.1152/japplphysiol.01073.2004; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Rhee ST, 2006, PLAST RECONSTR SURG, V117, P2243, DOI 10.1097/01.prs.0000224298.93486.1b; Rhee ST, 2005, ANN PLAS SURG, V55, P207, DOI 10.1097/01.sap.0000164576.10754.aa; Riddle RC, 2007, J BONE MINER RES, V22, P589, DOI 10.1359/JBMR.070113; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; Robling AG, 2002, MED SCI SPORT EXER, V34, P196, DOI 10.1097/00005768-200202000-00003; Robling AG, 2007, J BONE MINER RES, V22, P984, DOI 10.1359/JBMR.070327; Rubin J, 2003, J BIOL CHEM, V278, P34018, DOI 10.1074/jbc.M302822200; Salter DM, 1997, J BONE MINER RES, V12, P1133, DOI 10.1359/jbmr.1997.12.7.1133; Santos A, 2009, OSTEOPOROSIS INT, V20, P1027, DOI 10.1007/s00198-009-0858-5; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2006, BONE, V39, P1261, DOI 10.1016/j.bone.2006.06.030; Saxon LK, 2005, BONE, V36, P454, DOI 10.1016/j.bone.2004.12.001; Seeman E, 2008, RHEUMATOLOGY, V47, P2, DOI 10.1093/rheumatology/ken177; Seeman E, 2008, J BONE MINER METAB, V26, P1, DOI 10.1007/s00774-007-0793-5; Seeman Ego, 2004, Curr Osteoporos Rep, V2, P90, DOI 10.1007/s11914-004-0016-0; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Singh SP, 2007, J AM COLL SURGEONS, V204, P426, DOI 10.1016/j.jamcollsurg.2006.11.019; Smalt R, 1997, ADV EXP MED BIOL, V433, P311; Smith SM, 2005, J BONE MINER RES, V20, P208, DOI 10.1359/JBMR.041105; Spurney RF, 2002, J CLIN INVEST, V109, P1361, DOI 10.1172/JCI200214663; Tan SD, 2007, BONE, V41, P745, DOI 10.1016/j.bone.2007.07.019; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tong L, 2003, PLAST RECONSTR SURG, V111, P211, DOI 10.1097/01.PRS.0000033180.01581.9A; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; TURNER CH, 1995, J BONE MINER RES, V10, pS235; Turner CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE634, DOI 10.1152/ajpendo.1996.270.4.E634; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Vezeridis PS, 2006, BIOCHEM BIOPH RES CO, V348, P1082, DOI 10.1016/j.bbrc.2006.07.146; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Westbroek I, 2000, BIOCHEM BIOPH RES CO, V268, P414, DOI 10.1006/bbrc.2000.2154; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102; Zhang YL, 2009, AM J PHYSIOL-CELL PH, V296, pC1391, DOI 10.1152/ajpcell.00549.2008	84	118	126	2	74	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3625	3632		10.1096/fj.10-157370	http://dx.doi.org/10.1096/fj.10-157370			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20505115				2022-12-25	WOS:000285005900003
J	Yang, H; Liu, S; Cai, HW; Wan, L; Li, SF; Li, YP; Cheng, JQ; Lu, XF				Yang, Hao; Liu, Shan; Cai, Huawei; Wan, Lin; Li, Shengfu; Li, Youping; Cheng, Jingqiu; Lu, Xiaofeng			Chondroitin Sulfate as a Molecular Portal That Preferentially Mediates the Apoptotic Killing of Tumor Cells by Penetratin-directed Mitochondria-disrupting Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL PEPTIDE; TARGETED CANCER-THERAPY; IN-VIVO; SURFACE GLYCOSAMINOGLYCANS; BIOLOGICAL ROLE; DRUG-DELIVERY; P53; BINDING; INDUCTION; GROWTH	The use of cell-penetrating peptides (CPPs) as drug carriers for targeted therapy is limited by the unrestricted cellular translocation of CPPs. The preferential induction of tumor cell death by penetratin (Antp)-directed peptides (PNC27 and PNC28), however, suggests that the CPP Antp may contribute to the preferential cytotoxicity of these peptides. Using PNC27 as a molecular model, we constructed three novel peptides (PT, PR9, and PD3) by replacing the leader peptide Antp with one of three distinct CPPs (TAT, R9, or DPV3), respectively. The IC50 values of PNC27 in tumor cells were 2-3 times lower than in normal cells. However, all three engineered peptides demonstrated similar cytotoxic effects in tumor and normal cells. Another three chimeric peptides containing the leader peptide Antp with different mitochondria-disrupting peptides (KLA-Antp (KGA), B27-Antp (BA27), and B28-Antp (BA28)), preferentially induced apoptosis in tumor cells. The IC50 values of these peptides (3-10 mu M) were 3-6 times lower in tumor cells than in normal cells. In contrast, TAT-directed peptides (TAT-KLA (TK), TAT-B27 (TB27), and TAT-B28 (TB28)), were cytotoxic to both tumor and normal cells. These data demonstrate that the leader peptide Antp contributes to the preferential cytotoxicity of Antp-directed peptides. Furthermore, Antp-directed peptides bind chondroitin sulfate (CS), and the removal of endogenous CS reduces the cytotoxic effects of Antp-directed peptides in tumor cells. The overexpression of CS in tumor cells is positively correlated to the cell entry and cytotoxicity of Antp-directed peptides. These results suggest that CS overexpression in tumor cells is an important molecular portal that mediates the preferential cytotoxicity of Antp-directed peptides.	[Yang, Hao; Liu, Shan; Cai, Huawei; Wan, Lin; Li, Shengfu; Li, Youping; Cheng, Jingqiu; Lu, Xiaofeng] Sichuan Univ, W China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610041, Peoples R China	Sichuan University	Lu, XF (corresponding author), 1 Keyuan 4th Rd, Chengdu 610041, Peoples R China.	xiaofenglu@scu.edu.cn	Yang, Hao/ABV-4834-2022; Lu, Xiaofeng/ABD-9075-2021	Yang, Hao/0000-0003-2214-9474; Cai, Huawei/0000-0003-1341-8417	National Basic Research Program of China [2009CB522401]; Natural Science Fund of China [30873184]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 2009CB522401 (to Y. L.) and Natural Science Fund of China 30873184 (to X. L.).	Asimakopoulou AP, 2008, IN VIVO, V22, P385; Bowne Wilbur B, 2007, Cancer Ther, V5B, P331; Bowne WB, 2008, ANN SURG ONCOL, V15, P3588, DOI 10.1245/s10434-008-0147-0; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; De Coupade C, 2005, BIOCHEM J, V390, P407, DOI 10.1042/BJ20050401; Do TN, 2003, ONCOGENE, V22, P1431, DOI 10.1038/sj.onc.1206258; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Foerg C, 2008, J PHARM SCI-US, V97, P144, DOI 10.1002/jps.21117; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Jain M, 2005, CANCER RES, V65, P7840, DOI 10.1158/0008-5472.CAN-05-0662; Kanovsky M, 2001, P NATL ACAD SCI USA, V98, P12438, DOI 10.1073/pnas.211280698; Kim AL, 1999, J BIOL CHEM, V274, P34924, DOI 10.1074/jbc.274.49.34924; Kodama J, 2007, EUR J CANCER, V43, P1460, DOI 10.1016/j.ejca.2007.02.007; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Law B, 2006, MOL CANCER THER, V5, P1944, DOI 10.1158/1535-7163.MCT-05-0509; Lee CM, 2002, CANCER RES, V62, P4282; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li Y, 2005, INT J CANCER, V115, P55, DOI 10.1002/ijc.20838; Li Y, 2002, BIOCHEM BIOPH RES CO, V298, P439, DOI 10.1016/S0006-291X(02)02470-1; Marty C, 2004, CELL MOL LIFE SCI, V61, P1785, DOI 10.1007/s00018-004-4166-0; Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P2104, DOI 10.1021/bi961870p; Michl J, 2006, INT J CANCER, V119, P1577, DOI 10.1002/ijc.22029; Mueller J, 2008, BIOCONJUGATE CHEM, V19, P2363, DOI 10.1021/bc800194e; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; Myrberg H, 2008, BIOCONJUGATE CHEM, V19, P70, DOI 10.1021/bc0701139; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Rege K, 2007, CANCER RES, V67, P6368, DOI 10.1158/0008-5472.CAN-06-3658; Rezler EM, 2007, J AM CHEM SOC, V129, P4961, DOI 10.1021/ja066929m; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; Senatus PB, 2006, MOL CANCER THER, V5, P20, DOI 10.1158/1535-7163.MCT-05-0181; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Snyder EL, 2005, CANCER RES, V65, P10646, DOI 10.1158/0008-5472.CAN-05-0118; Stewart KM, 2008, ORG BIOMOL CHEM, V6, P2242, DOI 10.1039/b719950c; Tan M, 2006, CANCER RES, V66, P3764, DOI 10.1158/0008-5472.CAN-05-2747; Vives E, 2008, BBA-REV CANCER, V1786, P126, DOI 10.1016/j.bbcan.2008.03.001; Wang ZY, 2003, BLOOD, V102, P1307, DOI 10.1182/blood-2002-09-2753; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	42	33	35	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25666	25676		10.1074/jbc.M109.089417	http://dx.doi.org/10.1074/jbc.M109.089417			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20484051	Green Published, hybrid			2022-12-25	WOS:000280682400060
J	Gilio, K; van Kruchten, R; Braun, A; Berna-Erro, A; Feijge, MAH; Stegner, D; van der Meijden, PEJ; Kuijpers, MJE; Varga-Szabo, D; Heemskerk, JWM; Nieswandt, B				Gilio, Karen; van Kruchten, Roger; Braun, Attila; Berna-Erro, Alejandro; Feijge, Marion A. H.; Stegner, David; van der Meijden, Paola E. J.; Kuijpers, Marijke J. E.; Varga-Szabo, David; Heemskerk, Johan W. M.; Nieswandt, Bernhard			Roles of Platelet STIM1 and Orai1 in Glycoprotein VI- and Thrombin-dependent Procoagulant Activity and Thrombus Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORE-INDEPENDENT MODES; CRAC CHANNEL ACTIVATION; MEDIATED CALCIUM-ENTRY; OPERATED CA2+ ENTRY; IN-VIVO; PHOSPHATIDYLSERINE EXPOSURE; P2Y(12) RECEPTORS; CELL-ACTIVATION; SENSOR STIM1; BLOOD-CELLS	In platelets, STIM1 has been recognized as the key regulatory protein in store-operated Ca2+ entry (SOCE) with Orai1 as principal Ca2+ entry channel. Both proteins contribute to collagen-dependent arterial thrombosis in mice in vivo. It is unclear whether STIM2 is involved. A key platelet response relying on Ca2+ entry is the surface exposure of phosphatidylserine (PS), which accomplishes platelet procoagulant activity. We studied this response in mouse platelets deficient in STIM1, STIM2, or Orai1. Upon high shear flow of blood over collagen, Stim1(-/-) and Orai1(-/-) platelets had greatly impaired glycoprotein (GP) VI-dependent Ca2+ signals, and they were deficient in PS exposure and thrombus formation. In contrast, Stim2(-/-) platelets reacted normally. Upon blood flow in the presence of thrombin generation and coagulation, Ca2+ signals of Stim1(-/-) and Orai1(-/-) platelets were partly reduced, whereas the PS exposure and formation of fibrin-rich thrombi were normalized. Washed Stim1(-/-) and Orai1(-/-) platelets were deficient in GPVI-induced PS exposure and prothrombinase activity, but not when thrombin was present as co-agonist. Markedly, SKF96365, a blocker of (receptor-operated) Ca2+ entry, inhibited Ca2+ and procoagulant responses even in Stim1(-/-) and Orai1(-/-) platelets. These data show for the first time that: (i) STIM1 and Orai1 jointly contribute to GPVI-induced SOCE, procoagulant activity, and thrombus formation; (ii) a compensating Ca2+ entry pathway is effective in the additional presence of thrombin; (iii) platelets contain two mechanisms of Ca2+ entry and PS exposure, only one relying on STIM1-Orai1 interaction.	[Gilio, Karen; van Kruchten, Roger; Feijge, Marion A. H.; van der Meijden, Paola E. J.; Kuijpers, Marijke J. E.; Heemskerk, Johan W. M.] Maastricht Univ, Dept Biochem, CARIM, NL-6200 MD Maastricht, Netherlands; [Braun, Attila; Berna-Erro, Alejandro; Stegner, David; Varga-Szabo, David; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr Expt Med, D-97080 Wurzburg, Germany	Maastricht University; Maastricht University Medical Centre (MUMC); University of Wurzburg	Heemskerk, JWM (corresponding author), Maastricht Univ, Dept Biochem, CARIM, POB 616, NL-6200 MD Maastricht, Netherlands.	jwm.heemskerk@bioch.unimaas.nl; bernhard.nieswandt@virchow.uni-wuerzburg.de	Kuijpers, Marijke/AAN-9876-2021; Heemskerk, Johan/AAM-8323-2021; Stegner, David/AAA-4948-2019; Erro, Alejandro Berna/S-5909-2019	Heemskerk, Johan/0000-0002-2848-5121; Stegner, David/0000-0003-1059-9865; Erro, Alejandro Berna/0000-0003-1459-6418; van der Meijden, Paola/0000-0002-6532-2583	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [11.400.0076]; Netherlands Heart Foundation [2005-B079]; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 688, Sonderforschungsbereich 487]; German Excellence Initiative	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Excellence Initiative	This work was supported in part by Nederlandse Organisatie voor Wetenschappelijk Onderzoek Grant 11.400.0076, The Netherlands Heart Foundation Grant 2005-B079, and Deutsche Forschungsgemeinschaft Grants Sonderforschungsbereich 688 and 487.; Recipient of a grant from the German Excellence Initiative to the University of Wurzburg.	Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; BEVERS EM, 1982, EUR J BIOCHEM, V122, P429, DOI 10.1111/j.1432-1033.1982.tb05898.x; BEVERS EM, 1996, PRACT APPROACH SER, P319; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; DACHARYPRIGENT J, 1995, BIOCHEMISTRY-US, V34, P11625, DOI 10.1021/bi00036a039; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Heemskerk JWM, 2005, TRENDS CARDIOVAS MED, V15, P86, DOI 10.1016/j.tcm.2005.03.003; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Heemskerk JWM, 2001, J PHYSIOL-LONDON, V535, P625, DOI 10.1111/j.1469-7793.2001.00625.x; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Kuijpers MJE, 2008, MICROCIRCULATION, V15, P269, DOI 10.1080/10739680701653517; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Lecut C, 2004, ARTERIOSCL THROM VAS, V24, P1727, DOI 10.1161/01.ATV.0000137974.85068.93; Leon C, 2003, ARTERIOSCL THROM VAS, V23, P1941, DOI 10.1161/01.ATV.0000092127.16125.E6; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Martin S, 2000, BIOCHEM BIOPH RES CO, V279, P639, DOI 10.1006/bbrc.2000.3980; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Munnix ICA, 2003, THROMB HAEMOSTASIS, V89, P687, DOI 10.1055/s-0037-1613576; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Sage SO, 1997, EXP PHYSIOL, V82, P807, DOI 10.1113/expphysiol.1997.sp004066; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; THIAGARAJAN P, 1991, J BIOL CHEM, V266, P24302; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; van der Meijden PEJ, 2005, THROMB HAEMOSTASIS, V93, P1128, DOI 10.1160/TH04-09-0597; Vanschoonbeek K, 2008, ARTERIOSCL THROM VAS, V28, P2023, DOI 10.1161/ATVBAHA.107.156992; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Varga-Szabo D, 2008, PFLUG ARCH EUR J PHY, V457, P377, DOI 10.1007/s00424-008-0531-4; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	44	87	95	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23629	23638		10.1074/jbc.M110.108696	http://dx.doi.org/10.1074/jbc.M110.108696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519511	Green Published, hybrid			2022-12-25	WOS:000280291400013
J	Masalkar, P; Wallace, IS; Hwang, JH; Roberts, DM				Masalkar, Pintu; Wallace, Ian S.; Hwang, Jin Ha; Roberts, Daniel M.			Interaction of Cytosolic Glutamine Synthetase of Soybean Root Nodules with the C-terminal Domain of the Symbiosome Membrane Nodulin 26 Aquaglyceroporin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC PROTEIN AQUAPORIN-0; WATER CHANNEL AQUAPORIN-2; PERIBACTEROID MEMBRANE; POSTTRANSLATIONAL REGULATION; DIFFERENTIAL EXPRESSION; NITROGEN ASSIMILATION; MEDICAGO-TRUNCATULA; SYMBIOTIC MEMBRANES; PHASEOLUS-VULGARIS; LEGUME NODULES	Nodulin 26 (nod26) is a major intrinsic protein that constitutes the major protein component on the symbiosome membrane (SM) of N-2-fixing soybean nodules. Functionally, nod26 forms a low energy transport pathway for water, osmolytes, and NH3 across the SM. Besides their transport functions, emerging evidence suggests that high concentrations of major intrinsic proteins on membranes provide interaction and docking targets for various cytosolic proteins. Here it is shown that the C-terminal domain peptide of nod26 interacts with a 40-kDa protein from soybean nodule extracts, which was identified as soybean cytosolic glutamine synthetase GS(1)beta 1 by mass spectrometry. Fluorescence spectroscopy assays show that recombinant soybean GS(1)beta 1 binds the nod26 C-terminal domain with a 1:1 stoichiometry (K-d = 266 nM). GS(1)beta 1 also binds to isolated SMs, and this binding can be blocked by preincubation with the C-terminal peptide of nod26. In vivo experiments using either a split ubiquitin yeast two-hybrid system or bimolecular fluorescence complementation show that the four cytosolic GS isoforms expressed in soybean nodules interact with full-length nod26. The binding of GS, the principal ammonia assimilatory enzyme, to the conserved C-terminal domain of nod26, a transporter of NH3, is proposed to promote efficient assimilation of fixed nitrogen, as well as prevent potential ammonia toxicity, by localizing the enzyme to the cytosolic side of the symbiosome membrane.	[Masalkar, Pintu; Wallace, Ian S.; Hwang, Jin Ha; Roberts, Daniel M.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Hwang, Jin Ha; Roberts, Daniel M.] Univ Tennessee, Program Genome Sci & Technol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Roberts, DM (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	drobert2@utk.edu		Roberts, Daniel/0000-0002-0780-7056	National Science Foundation [MCB-0618075]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0618075 (to D.M.R.) and by a National Science Foundation Graduate Fellowship (to I.S.W.).	Bernard SM, 2009, NEW PHYTOL, V182, P608, DOI 10.1111/j.1469-8137.2009.02823.x; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Brown D, 2008, CURR OPIN NEPHROL HY, V17, P491, DOI 10.1097/MNH.0b013e3283094eb1; Day DA, 2001, CELL MOL LIFE SCI, V58, P61, DOI 10.1007/PL00000778; Dean RM, 1999, BIOCHEMISTRY-US, V38, P347, DOI 10.1021/bi982110c; Fan JG, 2005, MOL VIS, V11, P76; Finnemann J, 2000, PLANT J, V24, P171, DOI 10.1046/j.1365-313x.2000.00863.x; FORDE BG, 1989, PLANT CELL, V1, P391, DOI 10.1105/tpc.1.4.391; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; FORTIN MG, 1985, EMBO J, V4, P3041, DOI 10.1002/j.1460-2075.1985.tb04043.x; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gawronski JD, 2004, ANAL BIOCHEM, V327, P114, DOI 10.1016/j.ab.2003.12.024; GEBHARDT C, 1986, EMBO J, V5, P1429, DOI 10.1002/j.1460-2075.1986.tb04379.x; GIRSCH SJ, 1991, CURR EYE RES, V10, P839, DOI 10.3109/02713689109013880; GREFEN C, 2007, CURR PROTOC NEUROSCI, V41; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Jensen ON, 1999, METH MOL B, V112, P513; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JF, 2007, J BIOL CHEM, V282, P20593, DOI 10.1074/jbc.M700645200; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Lima L, 2006, J EXP BOT, V57, P2751, DOI 10.1093/jxb/erl036; Liu BF, 2008, J CELL BIOCHEM, V104, P51, DOI 10.1002/jcb.21598; MCPARLAND RH, 1976, BIOCHEM J, V153, P597, DOI 10.1042/bj1530597; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Minet R, 1997, CLIN CHIM ACTA, V268, P121, DOI 10.1016/S0009-8981(97)00173-3; Morey KJ, 2002, PLANT PHYSIOL, V128, P182, DOI 10.1104/pp.010380; Niemietz CM, 2000, FEBS LETT, V465, P110, DOI 10.1016/S0014-5793(99)01729-9; Noda Y, 2005, BIOL CELL, V97, P885; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Obermeyer G, 2005, PLANT PHYSIOL, V139, P1015, DOI 10.1104/pp.105.066670; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Rivers RL, 1997, J BIOL CHEM, V272, P16256, DOI 10.1074/jbc.272.26.16256; Roberts DM, 2002, PLANT PHYSIOL, V128, P370, DOI 10.1104/pp.010568; Rose KML, 2008, BIOCHEMISTRY-US, V47, P339, DOI 10.1021/bi701980t; Rose KML, 2006, INVEST OPHTH VIS SCI, V47, P1562, DOI 10.1167/iovs.05-1313; Sambrook J, 2001, MOL CLONING LAB MANU; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; STANFORD AC, 1993, PLANT PHYSIOL, V103, P73, DOI 10.1104/pp.103.1.73; STREETER JG, 1989, PLANT PHYSIOL, V90, P779, DOI 10.1104/pp.90.3.779; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Takata K, 2006, CELL MOL BIOL, V52, P34, DOI 10.1170/T747; TEMPLE SJ, 1995, MOL PLANT MICROBE IN, V8, P218, DOI 10.1094/MPMI-8-0218; Temple SJ, 1996, PLANT PHYSIOL, V112, P1723, DOI 10.1104/pp.112.4.1723; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; TYERMAN SD, 1995, NATURE, V378, P629, DOI 10.1038/378629a0; UDVARDI MK, 1990, PLANT PHYSIOL, V94, P71, DOI 10.1104/pp.94.1.71; Udvardi MK, 1997, ANNU REV PLANT PHYS, V48, P493, DOI 10.1146/annurev.arplant.48.1.493; Unno H, 2006, J BIOL CHEM, V281, P29287, DOI 10.1074/jbc.M601497200; Wallace IS, 2006, BBA-BIOMEMBRANES, V1758, P1165, DOI 10.1016/j.bbamem.2006.03.024; WEAVER CD, 1991, PLANT PHYSIOL, V95, P222, DOI 10.1104/pp.95.1.222; WEAVER CD, 1992, BIOCHEMISTRY-US, V31, P8954, DOI 10.1021/bi00152a035; Yu XS, 2005, J BIOL CHEM, V280, P22081, DOI 10.1074/jbc.M414377200; Yu XS, 2004, J CELL SCI, V117, P871, DOI 10.1242/jcs.00945	55	51	55	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23880	23888		10.1074/jbc.M110.135657	http://dx.doi.org/10.1074/jbc.M110.135657			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504761	Green Published, hybrid			2022-12-25	WOS:000280291400038
J	Zhou, JL; Hu, GQ; Wang, XB				Zhou, Jiliang; Hu, Guoqing; Wang, Xiaobo			Repression of Smooth Muscle Differentiation by a Novel High Mobility Group Box-containing Protein, HMG2L1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM-RESPONSE FACTOR; GENE-EXPRESSION; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; CELL DIFFERENTIATION; MYOCARDIN; HMG1; ASSOCIATION; INTERACTS; GROWTH	The molecular mechanisms regulating smooth muscle-specific gene expression during smooth muscle development are poorly understood. Myocardin is an extraordinarily powerful cofactor of serum response factor (SRF) that stimulates expression of smooth muscle-specific genes. In an effort to search for proteins that regulate myocardin function, we identified a novel HMG box-containing protein HMG2L1 (high mobility group 2 like 1). We found that HMG2L1 expression is correlated with the smooth muscle cell (SMC) synthetic phenotype. Overexpression of HMG2L1 in SMCs down-regulated smooth muscle marker expression. Conversely, depletion of endogenous HMG2L1 in SMCs increases smooth muscle-specific gene expression. Furthermore, we found HMG2L1 specifically abrogates myocardin-induced activation of smooth muscle-specific genes. By GST pulldown assays, the interaction domains between HMG2L1 and myocardin were mapped to the N termini of each of the proteins. Finally, we demonstrated that HMG2L1 abrogates myocardin function through disrupting its binding to SRF and abolishing SRF-myocardin complex binding to the promoters of smooth muscle-specific genes. This study provides the first evidence of this novel HMG2L1 molecule playing an important role in attenuating smooth muscle differentiation.	[Zhou, Jiliang; Hu, Guoqing; Wang, Xiaobo] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Zhou, JL (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	zhouj1@mail.amc.edu	Wang, Xiaobo/J-4312-2014; Wang, Xiaobo/S-2476-2019	Wang, Xiaobo/0000-0001-6044-914X	Albany Medical College; American Heart Association	Albany Medical College; American Heart Association(American Heart Association)	This work was supported by funding of Albany Medical College start-up and a Scientist Development Grant from American Heart Association (to J. Z.).	Aidinis V, 1999, MOL CELL BIOL, V19, P6532; Banerjee S, 2003, NUCLEIC ACIDS RES, V31, P3236, DOI 10.1093/nar/gkg412; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chin MT, 1999, J MOL CELL CARDIOL, V31, P2199, DOI 10.1006/jmcc.1999.1054; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Garcia-Ramirez M, 2005, ARTERIOSCL THROM VAS, V25, P2398, DOI 10.1161/01.ATV.0000187464.81959.23; Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005; Koopman P, 2005, TRENDS GENET, V21, P367, DOI 10.1016/j.tig.2005.05.006; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Nery FC, 2006, BIOCHEM BIOPH RES CO, V341, P847, DOI 10.1016/j.bbrc.2006.01.036; Oren M, 1997, CELL, V90, P829, DOI 10.1016/S0092-8674(00)80347-5; Pelletier G, 2000, MOL CELL, V6, P1059, DOI 10.1016/S1097-2765(00)00104-0; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Potash JB, 2008, AM J MED GENET B, V147B, P59, DOI 10.1002/ajmg.b.30574; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Yamada M, 2003, GENES CELLS, V8, P677, DOI 10.1046/j.1365-2443.2003.00666.x; Yin F, 2005, J BIOL CHEM, V280, P4745, DOI 10.1074/jbc.M411585200; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2008, J BIOL CHEM, V283, P35383, DOI 10.1074/jbc.M805489200; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	30	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23175	23183		10.1074/jbc.M110.109868	http://dx.doi.org/10.1074/jbc.M110.109868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20511232	hybrid, Green Published			2022-12-25	WOS:000279999900052
J	Polo, ML; Arnoni, MV; Riggio, M; Wargon, V; Lanari, C; Novaro, V				Laura Polo, Maria; Victoria Arnoni, Maria; Riggio, Marina; Wargon, Victoria; Lanari, Claudia; Novaro, Virginia			Responsiveness to PI3K and MEK Inhibitors in Breast Cancer. Use of a 3D Culture System to Study Pathways Related to Hormone Independence in Mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MOUSE MAMMARY-TUMOR; IN-VITRO; MEDROXYPROGESTERONE ACETATE; ENDOCRINE THERAPY; EPITHELIAL INTERACTIONS; PROGESTERONE-RECEPTORS; 3-DIMENSIONAL CULTURE; MODEL; RESISTANCE	Background: A significant proportion of breast cancer patients face failure of endocrine therapy due to the acquisition of endocrine resistance. We have explored mechanisms involved in such disease progression by using a mouse breast cancer model that is induced by medroxyprogesterone acetate (MPA). These tumors transit through different stages of hormone sensitivity. However, when cells from tumor variants were seeded on plastic, all were stimulated by progestins and inhibited by antiprogestins such as RU486. Furthermore, cells from a RU486-resistant tumor variant recovered antiprogestin sensitivity. Hypothesis: A three-dimensional (3D) culture system, by maintaining differential cellular organization that is typical of each tumor variant, may allow for the maintenance of particular hormone responses and thus be appropriate for the study of the effects of specific inhibitors of signaling pathways associated with disease progression. Method: We compared the behavior of tumors growing in vivo and cancer cells ex vivo ( in 3D Matrigel). In this system, we evaluated the effects of kinase inhibitors and hormone antagonists on tumor growth. Principal Findings: LY294002, a PI3K/AKT pathway inhibitor, decreased both tumor growth in vivo and cell survival in Matrigel in MPA-independent tumors with higher AKT activity. Induction of cell death by anti-hormones such as ICI182780 and ZK230211 was more effective in MPA-dependent tumors with lower AKT activity. Inhibition of MEK with PD98059 did not affect tumor growth in any tested variant. Finally, while Matrigel reproduced differential responsiveness of MPA-dependent and -independent breast cancer cells, it was not sufficient to preserve antiprogestin resistance of RU486-resistant tumors. Conclusion: We demonstrated that the PI3K/AKT pathway is relevant for MPA-independent tumor growth. Three-dimensional cultures were useful to test the effects of kinase inhibitors on breast cancer growth and highlight the need for in vivo models to validate experimental tools used for selective therapeutic targeting.	[Laura Polo, Maria; Victoria Arnoni, Maria; Riggio, Marina; Wargon, Victoria; Lanari, Claudia; Novaro, Virginia] Natl Council Sci & Tech Res CONICET, Inst Expt Biol & Med IBYME, Lab Hormonal Carcinogenesis, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Polo, ML (corresponding author), Natl Council Sci & Tech Res CONICET, Inst Expt Biol & Med IBYME, Lab Hormonal Carcinogenesis, Buenos Aires, DF, Argentina.	vnovaro@gmail.com		Novaro, Virginia/0000-0002-9917-4953; Lanari, Claudia/0000-0003-0555-2309	Sales Foundation, by Sciences and Technology Secretary (SECyT) [PICT 03 01-15038, PICT 07 00939]; National Council for Scientific and Technical Research (CONICET), Argentina	Sales Foundation, by Sciences and Technology Secretary (SECyT)(Secretaria de Ciencia y Tecnologia (SECYT)); National Council for Scientific and Technical Research (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Sales Foundation, by Sciences and Technology Secretary (SECyT, Grant numbers: PICT 03 01-15038 and PICT 07 00939), and by National Council for Scientific and Technical Research (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 2008, J MAMMARY GLAND BIOL, V13, P279, DOI 10.1007/s10911-008-9093-5; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Barcellos-Hoff MH, 2005, BREAST CANCER RES, V7, P33, DOI 10.1186/bcr972; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Beeram M, 2007, ANN ONCOL, V18, P1323, DOI 10.1093/annonc/mdm170; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; Fuhrmann U, 2000, J MED CHEM, V43, P5010, DOI 10.1021/jm001000c; Furuya F, 2007, CARCINOGENESIS, V28, P2451, DOI 10.1093/carcin/bgm174; Giulianelli S, 2008, INT J CANCER, V123, P2518, DOI 10.1002/ijc.23802; Helguero LA, 2003, BREAST CANCER RES TR, V79, P379, DOI 10.1023/A:1024029826248; Hu LM, 2002, CANCER RES, V62, P1087; *I LAB AN RES COMM, 1996, GUID CAR US LAB AN; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; KLIJN JGM, 1989, CANCER RES, V49, P2851; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Lamb C, 1999, J STEROID BIOCHEM, V70, P133, DOI 10.1016/S0960-0760(99)00108-9; LANARI C, 1986, CANCER LETT, V33, P215, DOI 10.1016/0304-3835(86)90027-3; Lanari C, 2001, CANCER RES, V61, P293; Lanari C, 2009, ENDOCR-RELAT CANCER, V16, P333, DOI 10.1677/ERC-08-0244; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li LF, 2008, CRIT CARE, V12, DOI 10.1186/cc6983; Liang Y, 2007, CANCER RES, V67, P9929, DOI 10.1158/0008-5472.CAN-07-1103; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu W, 2007, FRONT BIOSCI-LANDMRK, V12, P4011, DOI 10.2741/2367; Macedo LF, 2008, CANCER RES, V68, P3516, DOI 10.1158/0008-5472.CAN-07-6807; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; MOLINOLO AA, 1987, J NATL CANCER I, V79, P1341; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Novaro V, 2004, CLIN CANCER RES, V10, p402S, DOI 10.1158/1078-0432.CCR-031209; Novaro V, 2003, J CELL SCI, V116, P2975, DOI 10.1242/jcs.00523; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Pontiggia O, 2009, BREAST CANCER RES TR, V116, P247, DOI 10.1007/s10549-008-0113-3; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Robertson JFR, 2007, ONCOLOGIST, V12, P774, DOI 10.1634/theoncologist.12-7-774; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Simian M, 2006, AM J PATHOL, V168, P270, DOI 10.2353/ajpath.2006.050012; Simian M, 2009, BREAST CANCER RES TR, V113, P1, DOI 10.1007/s10549-007-9888-x; SOLDATI R, 2009, BREAST CANC RES 1211; Vanzulli S, 2002, CARCINOGENESIS, V23, P749, DOI 10.1093/carcin/23.5.749; Vanzulli SI, 2005, CARCINOGENESIS, V26, P1055, DOI 10.1093/carcin/bgi060; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wargon V, 2009, BREAST CANCER RES TR, V116, P449, DOI 10.1007/s10549-008-0150-y; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; WEIGELT B, 2009, BREAST CANC RES 0822; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wells V, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2217; Zhang M, 2006, CURR OPIN GENET DEV, V16, P60, DOI 10.1016/j.gde.2005.12.008; Zhang YY, 2009, MOL CANCER RES, V7, P498, DOI 10.1158/1541-7786.MCR-08-0415	63	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10786	10.1371/journal.pone.0010786	http://dx.doi.org/10.1371/journal.pone.0010786			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520761	Green Published, gold, Green Submitted			2022-12-25	WOS:000278221500008
J	Andreu, N; Zelmer, A; Fletcher, T; Elkington, PT; Ward, TH; Ripoll, J; Parish, T; Bancroft, GJ; Schaible, U; Robertson, BD; Wiles, S				Andreu, Nuria; Zelmer, Andrea; Fletcher, Taryn; Elkington, Paul T.; Ward, Theresa H.; Ripoll, Jorge; Parish, Tanya; Bancroft, Gregory J.; Schaible, Ulrich; Robertson, Brian D.; Wiles, Siouxsie			Optimisation of Bioluminescent Reporters for Use with Mycobacteria	PLOS ONE			English	Article							EXPRESSING FIREFLY LUCIFERASE; IN-VIVO; BOVIS BCG; ESCHERICHIA-COLI; GENE-EXPRESSION; STAPHYLOCOCCUS-AUREUS; BACTERIAL LUCIFERASE; RAPID DETECTION; ANTIMYCOBACTERIAL ACTIVITY; ANTIMICROBIAL AGENTS	Background: Mycobacterium tuberculosis, the causative agent of tuberculosis, still represents a major public health threat in many countries. Bioluminescence, the production of light by luciferase-catalyzed reactions, is a versatile reporter technology with multiple applications both in vitro and in vivo. In vivo bioluminescence imaging (BLI) represents one of its most outstanding uses by allowing the non-invasive localization of luciferase-expressing cells within a live animal. Despite the extensive use of luminescent reporters in mycobacteria, the resultant luminescent strains have not been fully applied to BLI. Methodology/Principal Findings: One of the main obstacles to the use of bioluminescence for in vivo imaging is the achievement of reporter protein expression levels high enough to obtain a signal that can be detected externally. Therefore, as a first step in the application of this technology to the study of mycobacterial infection in vivo, we have optimised the use of firefly, Gaussia and bacterial luciferases in mycobacteria using a combination of vectors, promoters, and codon-optimised genes. We report for the first time the functional expression of the whole bacterial lux operon in Mycobacterium tuberculosis and M. smegmatis thus allowing the development of auto-luminescent mycobacteria. We demonstrate that the Gaussia luciferase is secreted from bacterial cells and that this secretion does not require a signal sequence. Finally we prove that the signal produced by recombinant mycobacteria expressing either the firefly or bacterial luciferases can be non-invasively detected in the lungs of infected mice by bioluminescence imaging. Conclusions/Significance: While much work remains to be done, the finding that both firefly and bacterial luciferases can be detected non-invasively in live mice is an important first step to using these reporters to study the pathogenesis of M. tuberculosis and other mycobacterial species in vivo. Furthermore, the development of auto-luminescent mycobacteria has enormous ramifications for high throughput mycobacterial drug screening assays which are currently carried out either in a destructive manner using LuxAB or the firefly luciferase.	[Andreu, Nuria; Fletcher, Taryn; Elkington, Paul T.; Robertson, Brian D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Zelmer, Andrea; Ward, Theresa H.; Bancroft, Gregory J.; Schaible, Ulrich; Wiles, Siouxsie] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Ripoll, Jorge] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion, Crete, Greece; [Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA; [Schaible, Ulrich] Res Ctr Borstel, Dept Mol Infect Res, Borstel, Germany; [Wiles, Siouxsie] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Foundation for Research & Technology - Hellas (FORTH); University of London; Queen Mary University London; Forschungszentrum Borstel; University of Auckland	Andreu, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.	s.wiles@auckland.ac.nz	Ripoll, Jorge/AAW-2245-2020; Wiles, Siouxsie/E-1690-2011; Schaible, Ulrich/C-7837-2011; Ripoll, Jorge/J-8134-2012; Ward, Theresa H./E-9650-2013	Ripoll, Jorge/0000-0001-8856-7738; Wiles, Siouxsie/0000-0002-0467-0015; Schaible, Ulrich/0000-0002-6638-7282; Ripoll, Jorge/0000-0001-8856-7738; Ward, Theresa H./0000-0002-9881-8649; Robertson, Brian D./0000-0001-5785-5307; Andreu, Nuria/0000-0001-5768-6566; Elkington, Paul/0000-0003-0390-0613	Bill and Melinda Gates Foundation [42786]; BBSRC [BB/E52708X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: researchfish; National Institute for Health Research [DHCS/06/05/012] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This work is funded by an award (42786) to the Imaging TB Consortium from the Bill and Melinda Gates Foundation (www.gatesfoundation.org) TB Drug Accelerator program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah R, 2006, CLIN EXP IMMUNOL, V145, P520, DOI 10.1111/j.1365-2249.2006.03133.x; ANDREW PW, 1993, J CLIN MICROBIOL, V31, P2251, DOI 10.1128/JCM.31.9.2251-2254.1993; Arain TM, 1996, ANTIMICROB AGENTS CH, V40, P1536, DOI 10.1128/AAC.40.6.1536; Arain TM, 1996, ANTIMICROB AGENTS CH, V40, P1542, DOI 10.1128/AAC.40.6.1542; Banaiee N, 2001, J CLIN MICROBIOL, V39, P3883, DOI 10.1128/JCM.39.11.3883-3888.2001; Banaiee N, 2008, TUBERCULOSIS, V88, P64, DOI 10.1016/j.tube.2007.08.006; Bardarov S, 2003, DIAGN MICR INFEC DIS, V45, P53, DOI 10.1016/S0732-8893(02)00478-9; Barker LP, 1998, MOL MICROBIOL, V29, P1167, DOI 10.1046/j.1365-2958.1998.00996.x; Barker LP, 1999, FEMS MICROBIOL LETT, V175, P79, DOI 10.1111/j.1574-6968.1999.tb13604.x; Bastos RG, 2002, VACCINE, V21, P21, DOI 10.1016/S0264-410X(02)00443-7; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Bonay M, 1999, AM J RESP CRIT CARE, V159, P1629, DOI 10.1164/ajrccm.159.5.9807021; Bouchonnet F, 2002, INFECT IMMUN, V70, P3020, DOI 10.1128/IAI.70.6.3020-3025.2002; Bourn WR, 2007, TUBERCULOSIS, V87, P481, DOI 10.1016/j.tube.2007.08.003; Buckley SMK, 2008, HUM GENE THER, V19, P1050, DOI 10.1089/hum.2008.023; Carriere C, 1997, J CLIN MICROBIOL, V35, P3232; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; COOKSEY RC, 1995, ANTIMICROB AGENTS CH, V39, P754, DOI 10.1128/AAC.39.3.754; COOKSEY RC, 1993, ANTIMICROB AGENTS CH, V37, P1348, DOI 10.1128/AAC.37.6.1348; Craney A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm086; da Cruz FW, 2001, VACCINE, V20, P731, DOI 10.1016/S0264-410X(01)00414-5; Davis SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006297; Deb DK, 2000, BIOCHEM BIOPH RES CO, V279, P457, DOI 10.1006/bbrc.2000.3957; DELLAGOSTIN OA, 1995, MICROBIOL-UK, V141, P1785, DOI 10.1099/13500872-141-8-1785; Dennehy M, 2005, VACCINE, V23, P1209, DOI 10.1016/j.vaccine.2004.08.039; Dennehy M, 2007, VACCINE, V25, P3646, DOI 10.1016/j.vaccine.2007.01.087; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Galluzzi L, 2007, J BIOTECHNOL, V127, P188, DOI 10.1016/j.jbiotec.2006.06.019; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Gheysens O, 2009, METHODS, V48, P139, DOI 10.1016/j.ymeth.2009.03.013; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Gordon S, 1998, METH MOL B, V101, P235, DOI 10.1385/0-89603-471-2:235; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; Heuts F, 2009, MICROBES INFECT, V11, P1114, DOI 10.1016/j.micinf.2009.08.005; Hickey MJ, 1996, ANTIMICROB AGENTS CH, V40, P400, DOI 10.1128/AAC.40.2.400; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; JANASZEK W, 1987, J BIOL STAND, V15, P11, DOI 10.1016/0092-1157(87)90012-6; Kadurugamuwa Jagath L, 2005, Mol Imaging, V4, P137; Kadurugamuwa JL, 2005, INFECT IMMUN, V73, P7836, DOI 10.1128/IAI.73.12.7836-7843.2005; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Koga K, 2005, MOL GENET GENOMICS, V274, P180, DOI 10.1007/s00438-005-0008-5; KONG DQ, 1995, INFECT IMMUN, V63, P799, DOI 10.1128/IAI.63.3.799-803.1995; Kumar D, 1998, VACCINE, V16, P1212, DOI 10.1016/S0264-410X(98)80121-7; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Le Dantec C, 2001, J BACTERIOL, V183, P2157, DOI 10.1128/JB.183.7.2157-2164.2001; Loimaranta V, 1998, ANTIMICROB AGENTS CH, V42, P1906, DOI 10.1128/AAC.42.8.1906; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Morin CE, 2009, FEMS IMMUNOL MED MIC, V57, P69, DOI 10.1111/j.1574-695X.2009.00580.x; Pai M, 2005, J INFECTION, V51, P175, DOI 10.1016/j.jinf.2005.05.017; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; PRIOLI RP, 1985, TUBERCLE, V66, P99, DOI 10.1016/0041-3879(85)90074-1; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; RANES MG, 1990, J BACTERIOL, V172, P2793, DOI 10.1128/jb.172.5.2793-2797.1990; Riska PF, 1997, J CLIN MICROBIOL, V35, P3225, DOI 10.1128/JCM.35.12.3225-3231.1997; Riska PF, 1998, METH MOL B, V101, P431, DOI 10.1385/0-89603-471-2:431; Shawar RM, 1997, ANTIMICROB AGENTS CH, V41, P570, DOI 10.1128/AAC.41.3.570; Sjolinder H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000241; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Steinhuber A, 2008, INT J MED MICROBIOL, V298, P599, DOI 10.1016/j.ijmm.2007.09.008; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Szittner R, 2003, BIOCHEM BIOPH RES CO, V309, P66, DOI 10.1016/S0006-291X(03)01530-4; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Turner DJ, 2002, MICROBIOL-SGM, V148, P2929, DOI 10.1099/00221287-148-10-2929; Wang HF, 2007, PARASITOL INT, V56, P263, DOI 10.1016/j.parint.2007.04.003; WHO, 2009, GLOB TUB CONTR 2009; Wiles S, 2005, APPL ENVIRON MICROB, V71, P3427, DOI 10.1128/AEM.71.7.3427-3432.2005; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005; Zhao Hui, 2004, Mol Imaging, V3, P43, DOI 10.1162/153535004773861714	75	183	184	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10777	10.1371/journal.pone.0010777	http://dx.doi.org/10.1371/journal.pone.0010777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520722	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000278034600008
J	Sei, Y; Li, Z; Song, J; Ren-Patterson, R; Tunbridge, EM; Iizuka, Y; Inoue, M; Alfonso, BT; Beltaifa, S; Nakai, Y; Kolachana, BS; Chen, JS; Weinberger, DR				Sei, Yoshitatsu; Li, Zhen; Song, Jian; Ren-Patterson, Renee; Tunbridge, Elizabeth M.; Iizuka, Yukihiko; Inoue, Masahiro; Alfonso, Berenice T.; Beltaifa, Senda; Nakai, Yoko; Kolachana, Bhaskar S.; Chen, Jingshan; Weinberger, Daniel R.			Epistatic and Functional Interactions of Catechol-O-Methyltransferase (COMT) and AKT1 on Neuregulin1-ErbB Signaling in Cell Models	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PROTEIN-KINASE B/AKT; WORKING-MEMORY; BREAST-CANCER; GENETIC-VARIATION; MESSENGER-RNA; HUMAN BRAIN; SCHIZOPHRENIA; ASSOCIATION; RISK	Background: Neuregulin1 (NRG1)-ErbB signaling has been implicated in the pathogenesis of cancer and schizophrenia. We have previously reported that NRG1-stimulated migration of B lymphoblasts is PI3K-AKT1dependent and impaired in patients with schizophrenia and significantly linked to the catechol-o-methyltransferase (COMT) Val108/158Met functional polymorphism. Methodology/Principal Findings: We have now examined AKT1 activation in NRG1-stimulated B lymphoblasts and other cell models and explored a functional relationship between COMT and AKT1. NRG1-induced AKT1 phosphorylation was significantly diminished in Val carriers compared to Met carriers in both normal subjects and in patients. Further, there was a significant epistatic interaction between a putatively functional coding SNP in AKT1 (rs1130233) and COMT Val108/158Met genotype on AKT1 phosphorylation. NRG1 induced translocation of AKT1 to the plasma membrane also was impaired in Val carriers, while PIP3 levels were not decreased. Interestingly, the level of COMT enzyme activity was inversely correlated with the cells' ability to synthesize phosphatidylserine (PS), a factor that attracts the pleckstrin homology domain (PHD) of AKT1 to the cell membrane. Transfection of SH-SY5Y cells with a COMT Val construct increased COMT activity and significantly decreased PS levels as well as NRG1-induced AKT1 phosphorylation and migration. Administration of S-adenosylmethionine (SAM) rescued all of these deficits. These data suggest that AKT1 function is influenced by COMT enzyme activity through competition with PS synthesis for SAM, which in turn dictates AKT1-dependent cellular responses to NRG1-mediated signaling. Conclusion/Significance: Our findings implicate genetic and functional interactions between COMT and AKT1 and may provide novel insights into pathogenesis of schizophrenia and other ErbB-associated human diseases such as cancer.	[Sei, Yoshitatsu; Li, Zhen; Song, Jian; Ren-Patterson, Renee; Iizuka, Yukihiko; Alfonso, Berenice T.; Beltaifa, Senda; Nakai, Yoko; Kolachana, Bhaskar S.; Chen, Jingshan; Weinberger, Daniel R.] NIMH, Clin Brain Disorder Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Tunbridge, Elizabeth M.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Inoue, Masahiro] Kurume Univ Med, Dept Infect Dis, Fukuoka, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Oxford; Kurume University	Sei, Y (corresponding author), NIMH, Clin Brain Disorder Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA.	seiy@mail.nih.gov; daniel.weinberger@mail.nih.gov		Tunbridge, Elizabeth/0000-0002-2966-2281	National Institute of Mental Health, NIH; UK Medical Research Council; University College, Oxford; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002907] Funding Source: NIH RePORTER	National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College, Oxford; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This research was supported by the Intramural Research Program of the National Institute of Mental Health, NIH. EMT is supported by a project grant from the UK Medical Research Council and the Weir Junior Research Fellowship, University College, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Al-Fulaij MA, 2008, J MOL NEUROSCI, V34, P211, DOI 10.1007/s12031-007-9030-x; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bajestan SN, 2006, AM J MED GENET B, V141B, P383, DOI 10.1002/ajmg.b.30291; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Catts VS, 2008, ACTA PSYCHIAT SCAND, V117, P323, DOI 10.1111/j.1600-0447.2008.01163.x; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Egan MF, 2000, AM J PSYCHIAT, V157, P1309, DOI 10.1176/appi.ajp.157.8.1309; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Harris SL, 2005, P NATL ACAD SCI USA, V102, P16297, DOI 10.1073/pnas.0508390102; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HUANG BX, 2007, FASEB J, V21, P781; Huang CS, 1999, CANCER RES, V59, P4870; Inoue H, 2005, ONCOL REP, V14, P707; Kanakry CG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001369; Lavigne JA, 1997, CANCER RES, V57, P5493; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Matsui A, 2000, CANCER LETT, V150, P23, DOI 10.1016/S0304-3835(99)00368-7; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Norton N, 2007, SCHIZOPHR RES, V93, P58, DOI 10.1016/j.schres.2007.02.006; PRESSMAN S, 1991, AM J HUM GENET, V49, P467; Sazci A, 2004, TOXICOLOGY, V204, P197, DOI 10.1016/j.tox.2004.06.026; Schwab SG, 2005, BIOL PSYCHIAT, V58, P446, DOI 10.1016/j.biopsych.2005.05.005; Sei Y, 2007, MOL PSYCHIATR, V12, P946, DOI 10.1038/sj.mp.4001994; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Suzuki M, 2005, EUR UROL, V48, P752, DOI 10.1016/j.eururo.2005.07.007; Tan Changqiang, 2003, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V17, P25; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Thiselton DL, 2008, BIOL PSYCHIAT, V63, P449, DOI 10.1016/j.biopsych.2007.06.005; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; TUNBRIDGE EM, 2008, AM J MED GENET B; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Weickert TW, 2004, BIOL PSYCHIAT, V56, P677, DOI 10.1016/j.biopsych.2004.08.012; Xu MQ, 2007, J CLIN PSYCHIAT, V68, P1358, DOI 10.4088/JCP.v68n0906; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10789	10.1371/journal.pone.0010789	http://dx.doi.org/10.1371/journal.pone.0010789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520724	Green Submitted, Green Published, gold			2022-12-25	WOS:000278034600015
J	Hu, QY; Fink, E; Hong, Y; Wang, C; Grant, CK; Elder, JH				Hu, Qiong-Ying; Fink, Elizabeth; Hong, Yang; Wang, Cathy; Grant, Chris K.; Elder, John H.			Fine Definition of the CXCR4-Binding Region on the V3 Loop of Feline Immunodeficiency Virus Surface Glycoprotein	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; 2ND EXTRACELLULAR LOOP; MONOCLONAL-ANTIBODY; FIV INFECTION; UP-REGULATION; CELL TROPISM; BINDING-SITE; TYPE-1 GP120; SHARED USAGE; ENVELOPE	The chemokine receptor CXCR4 is shared by primary and laboratory-adapted strains of feline immunodeficiency virus (FIV) for viral entry. Our previous studies implicated a contiguous nine-amino-acid region of the V3 loop of the FIV envelope surface as important in CXCR4 binding and virus entry. The binding is specific for CXCR4 since it can be inhibited by AMD3100, a selective CXCR4 inhibitor. Additional site-directed mutagenesis was used to further reveal the key residues. Binding studies indicated that basic residues R395, K397, R399 as well as N398 are critical for CXCR4 binding. The effect of other amino acid residues on receptor binding depends on the type of amino acid residue substituted. The binding study results were confirmed on human CXCR4-expressing SupT1 cells and correlated with entry efficiency using a virus entry assay. Amino acid residues critical for CXCR4 are not critical for interactions with the primary binding receptor CD134, which has an equivalent role as CD4 for HIV-1 binding. The ELISA results show that W394 and W400 are crucial for the recognition by neutralizing anti-V3 antibodies. Since certain strains of HIV-1 also use CXCR4 as the entry receptor, the findings make the feline model attractive for development of broad-based entry antagonists and for study of the molecular mechanism of receptor/virus interactions.	[Hu, Qiong-Ying; Fink, Elizabeth; Hong, Yang; Wang, Cathy; Elder, John H.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Grant, Chris K.] Custom Monoclonals Int, W Sacramento, CA USA	Scripps Research Institute	Hu, QY (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	jelder@scripps.edu			National Institute of Allergy and Infection Diseases [R01 AI25825]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025825] Funding Source: NIH RePORTER	National Institute of Allergy and Infection Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by grant (R01 AI25825) from the National Institute of Allergy and Infection Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Basmaciogullari S, 2002, J VIROL, V76, P10791, DOI 10.1128/JVI.76.21.10791-10800.2002; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chabot DJ, 1999, J VIROL, V73, P6598, DOI 10.1128/JVI.73.8.6598-6609.1999; de Parseval A, 2006, J VIROL, V80, P3088, DOI 10.1128/JVI.80.6.3088-3091.2006; de Parseval A, 2005, NAT STRUCT MOL BIOL, V12, P60, DOI 10.1038/nsmb872; de Parseval A, 2004, J VIROL, V78, P9132, DOI 10.1128/JVI.78.17.9132-9143.2004; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; de Parseval A, 2001, J VIROL, V75, P4528, DOI 10.1128/JVI.75.10.4528-4539.2001; deParseval A, 1997, J VIROL, V71, P5742, DOI 10.1128/JVI.71.8.5742-5749.1997; Dittmar MT, 1997, NATURE, V385, P495, DOI 10.1038/385495a0; Elder JH, 2008, VET IMMUNOL IMMUNOP, V123, P3, DOI 10.1016/j.vetimm.2008.01.007; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Hatse S, 2003, FEBS LETT, V546, P300, DOI 10.1016/S0014-5793(03)00609-4; Huang QG, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/03/001; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Johnston JC, 1999, J VIROL, V73, P4991, DOI 10.1128/JVI.73.6.4991-5000.1999; LAROSA GJ, 1990, SCIENCE, V249, P932, DOI 10.1126/science.2392685; Lerner DL, 1998, VET IMMUNOL IMMUNOP, V65, P277, DOI 10.1016/S0165-2427(98)00162-7; Ling H, 2004, AIDS RES HUM RETROV, V20, P213, DOI 10.1089/088922204773004932; McKnight A, 1997, J VIROL, V71, P1692, DOI 10.1128/JVI.71.2.1692-1696.1997; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; MORIKAWA S, 1991, VIRUS RES, V21, P53, DOI 10.1016/0168-1702(91)90071-3; Pancino G, 1994, Curr Top Microbiol Immunol, V188, P77; PANCINO G, 1993, VIROLOGY, V192, P659, DOI 10.1006/viro.1993.1083; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; PHILLIPS TR, 1990, J VIROL, V64, P4605, DOI 10.1128/JVI.64.10.4605-4613.1990; Picard L, 1997, VIROLOGY, V231, P105, DOI 10.1006/viro.1997.8506; PODELL M, 2002, CURR PROTOC NEUROSCI, V9; Richardson J, 1999, J VIROL, V73, P3661, DOI 10.1128/JVI.73.5.3661-3671.1999; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; Sanders T, 2007, BRIT J SOCIOL, V58, P1, DOI 10.1111/j.1468-4446.2007.00136.x; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; SIEBELINK KHJ, 1992, J VIROL, V66, P1091, DOI 10.1128/JVI.66.2.1091-1097.1992; Sundaravaradan V, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-126; Sundstrom M, 2008, J VIROL, V82, P9134, DOI 10.1128/JVI.00394-08; Sundstrom M, 2008, VIROLOGY, V371, P394, DOI 10.1016/j.virol.2007.09.039; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Uhl EW, 2008, VET IMMUNOL IMMUNOP, V123, P65, DOI 10.1016/j.vetimm.2008.01.030; Willett BJ, 1997, NATURE, V385, P587, DOI 10.1038/385587a0; Willett BJ, 1998, J VIROL, V72, P6475, DOI 10.1128/JVI.72.8.6475-6481.1998; Willett BJ, 1997, J VIROL, V71, P6407, DOI 10.1128/JVI.71.9.6407-6415.1997; Willett BJ, 2002, J VIROL, V76, P9242, DOI 10.1128/JVI.76.18.9242-9252.2002; Willett BJ, 2008, VET IMMUNOL IMMUNOP, V123, P56, DOI 10.1016/j.vetimm.2008.01.012; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0	49	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10689	10.1371/journal.pone.0010689	http://dx.doi.org/10.1371/journal.pone.0010689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502526	gold, Green Submitted, Green Published			2022-12-25	WOS:000277776500006
J	Baron, RM; Lopez-Guzman, S; Riascos, DF; Macias, AA; Layne, MD; Cheng, GY; Harris, C; Chung, SW; Reeves, R; von Andrian, UH; Perrella, MA				Baron, Rebecca M.; Lopez-Guzman, Silvia; Riascos, Dario F.; Macias, Alvaro A.; Layne, Matthew D.; Cheng, Guiying; Harris, Cailin; Chung, Su Wol; Reeves, Raymond; von Andrian, Ulrich H.; Perrella, Mark A.			Distamycin A Inhibits HMGA1-Binding to the P-Selectin Promoter and Attenuates Lung and Liver Inflammation during Murine Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; MOBILITY GROUP-I(Y) PROTEIN; MINOR-GROOVE BINDERS; TRANSCRIPTIONAL REGULATION; INDUCED EXPRESSION; ADHESION MOLECULE; ENDOTHELIAL-CELLS; IMPROVES SURVIVAL; VIRUS INDUCTION; DOWN-REGULATION	Background: The architectural transcription factor High Mobility Group-A1 (HMGA1) binds to the minor groove of AT-rich DNA and forms transcription factor complexes ("enhanceosomes'') that upregulate expression of select genes within the inflammatory cascade during critical illness syndromes such as acute lung injury (ALI). AT-rich regions of DNA surround transcription factor binding sites in genes critical for the inflammatory response. Minor groove binding drugs (MGBs), such as Distamycin A (Dist A), interfere with AT-rich region DNA binding in a sequence and conformation-specific manner, and HMGA1 is one of the few transcription factors whose binding is inhibited by MGBs. Objectives: To determine whether MGBs exert beneficial effects during endotoxemia through attenuating tissue inflammation via interfering with HMGA1-DNA binding and modulating expression of adhesion molecules. Methodology/Principal Findings: Administration of Dist A significantly decreased lung and liver inflammation during murine endotoxemia. In intravital microscopy studies, Dist A attenuated neutrophil-endothelial interactions in vivo following an inflammatory stimulus. Endotoxin induction of P-selectin expression in lung and liver tissue and promoter activity in endothelial cells was significantly reduced by Dist A, while E-selectin induction was not significantly affected. Moreover, Dist A disrupted formation of an inducible complex containing NF-kappa B that binds an AT-rich region of the P-selectin promoter. Transfection studies demonstrated a critical role for HMGA1 in facilitating cytokine and NF-kappa B induction of P-selectin promoter activity, and Dist A inhibited binding of HMGA1 to this AT-rich region of the P-selectin promoter in vivo. Conclusions/Significance: We describe a novel targeted approach in modulating lung and liver inflammation in vivo during murine endotoxemia through decreasing binding of HMGA1 to a distinct AT-rich region of the P-selectin promoter. These studies highlight the ability of MGBs to function as molecular tools for dissecting transcriptional mechanisms in vivo and suggest alternative treatment approaches for critical illness.	[Baron, Rebecca M.; Lopez-Guzman, Silvia; Riascos, Dario F.; Macias, Alvaro A.; Harris, Cailin; Chung, Su Wol; Perrella, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Baron, Rebecca M.; Perrella, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Perrella, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Newborn Med, Boston, MA 02115 USA; [Riascos, Dario F.] Pontificia Univ Javeriana, Dept Physiol Sci, Bogota, Colombia; [Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Cheng, Guiying; von Andrian, Ulrich H.] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; [Cheng, Guiying; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chung, Su Wol] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Reeves, Raymond] Washington State Univ, Dept Biochem & Biophys, Pullman, WA 99164 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pontificia Universidad Javeriana; Boston University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Ulsan; Washington State University	Baron, RM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	rbaron@partners.org	von Andrian, Ulrich H/A-5775-2008; Lopez-Guzman, Silvia/G-7595-2012	Layne, Matthew/0000-0003-0007-4870; Riascos Bernal, Dario/0000-0002-8790-4699; Lopez-Guzman, Silvia/0000-0003-0271-3576	National Institutes of Health [AI054465, HL091957, AI061246, GM53249, HL60788]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091957, R01HL060788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061246, K08AI054465, R01AI072252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants AI054465 (to R. M. B.), HL091957 (to R. M. B.), AI061246 (to M. A. P.), GM53249 (to M. A. P.), and HL60788 (to M. A. P.), all from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; ASADUZZAMAN M, 2009, BRIT J PHARMACOL, DOI DOI 10.1111/J.1476-5381.2008.00021; Baraldi PG, 2004, MED RES REV, V24, P475, DOI 10.1002/med.20000; Baraldi PG, 2007, BIOORGAN MED CHEM, V15, P17, DOI 10.1016/j.bmc.2006.07.004; Baron RM, 2004, FASEB J, V18, P1276, DOI 10.1096/fj.04-1518fje; Baron RM, 2004, J IMMUNOL, V173, P4147, DOI 10.4049/jimmunol.173.6.4147; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Bell A, 1997, J MOL RECOGNIT, V10, P245, DOI 10.1002/(SICI)1099-1352(199711/12)10:6<245::AID-JMR367>3.0.CO;2-3; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Carvajal IM, 2002, CRIT CARE MED, V30, pS36, DOI 10.1097/00003246-200201001-00005; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; COUGHLAN AF, 1994, J EXP MED, V179, P329, DOI 10.1084/jem.179.1.329; Cozzi P, 2000, FARMACO, V55, P168, DOI 10.1016/S0014-827X(00)00013-6; Dolenc J, 2005, NUCLEIC ACIDS RES, V33, P725, DOI 10.1093/nar/gki195; Dolenc J, 2006, BIOPHYS J, V91, P1460, DOI 10.1529/biophysj.105.074617; Doss RM, 2006, J AM CHEM SOC, V128, P9074, DOI 10.1021/ja0621795; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; Ghersa P, 1997, NUCLEIC ACIDS RES, V25, P339, DOI 10.1093/nar/25.2.339; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Grant MA, 2009, BIOCHEM J, V418, P103, DOI 10.1042/BJ20081427; Henikoff S, 2000, CELL, V103, P695, DOI 10.1016/S0092-8674(00)00172-0; Hickey MJ, 2001, ACTA PHYSIOL SCAND, V173, P119, DOI 10.1046/j.1365-201X.2001.00892.x; Himes SR, 2000, J IMMUNOL, V164, P3157, DOI 10.4049/jimmunol.164.6.3157; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Janssen S, 2000, MOL CELL, V6, P1013, DOI 10.1016/S1097-2765(00)00100-3; Janssen S, 2000, MOL CELL, V6, P999, DOI 10.1016/S1097-2765(00)00099-X; Kamochi M, 1999, AM J PHYSIOL-LUNG C, V277, pL310, DOI 10.1152/ajplung.1999.277.2.L310; Klintman D, 2004, CLIN DIAGN LAB IMMUN, V11, P56, DOI 10.1128/CDLI.11.1.56-62.2004; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; Lewis JF, 2003, CRIT CARE MED, V31, pS324, DOI 10.1097/01.CCM.0000057911.19145.9F; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Marshall JC, 1999, SEPSIS, V3, P5; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Pan JL, 1998, J BIOL CHEM, V273, P10068, DOI 10.1074/jbc.273.16.10068; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; Pellacani A, 2001, J BIOL CHEM, V276, P1653, DOI 10.1074/jbc.M008170200; Pellacani A, 1999, J BIOL CHEM, V274, P1525, DOI 10.1074/jbc.274.3.1525; Perrella MA, 1999, J BIOL CHEM, V274, P9045, DOI 10.1074/jbc.274.13.9045; RADIC MZ, 1992, CHROMOSOMA, V101, P602, DOI 10.1007/BF00360537; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Reeves R, 1999, METHOD ENZYMOL, V304, P155; REEVES R, 1990, J BIOL CHEM, V265, P8573; SANDERS WE, 1992, BLOOD, V80, P795; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Steeber DA, 1998, P NATL ACAD SCI USA, V95, P7562, DOI 10.1073/pnas.95.13.7562; Steeber DA, 1999, J IMMUNOL, V163, P2176; Susbielle Guillaume, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P409, DOI 10.2174/1568011054222355; Takamiya R, 2008, FEBS LETT, V582, P810, DOI 10.1016/j.febslet.2008.02.008; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; THOMAS R, 2004, NUCLEIC ACIDS RES, V32, P1; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang X, 2004, J BIOL CHEM, V279, P5237, DOI 10.1074/jbc.M309271200; Wang Y, 2006, J IMMUNOL, V176, P275, DOI 10.4049/jimmunol.176.1.275; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEGNER M, 1990, BIOCHEM BIOPH RES CO, V166, P1110, DOI 10.1016/0006-291X(90)90981-R; WELLER A, 1992, J BIOL CHEM, V267, P15176; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	75	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10656	10.1371/journal.pone.0010656	http://dx.doi.org/10.1371/journal.pone.0010656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498830	Green Published, gold, Green Submitted			2022-12-25	WOS:000277771600018
J	Cornelissen, LAHM; de Vries, RP; de Boer-Luijtze, EA; Rigter, A; Rottier, PJM; de Haan, CAM				Cornelissen, Lisette A. H. M.; de Vries, Robert P.; de Boer-Luijtze, Els A.; Rigter, Alan; Rottier, Peter J. M.; de Haan, Cornelis A. M.			A Single Immunization with Soluble Recombinant Trimeric Hemagglutinin Protects Chickens against Highly Pathogenic Avian Influenza Virus H5N1	PLOS ONE			English	Article							PANDEMIC INFLUENZA; VACCINE; MICE; INFECTIONS; CHALLENGE; ADJUVANTS; PROTEINS; EFFICACY; IMMUNITY; BINDING	Background: The highly pathogenic avian influenza (HPAI) virus H5N1 causes multi-organ disease and death in poultry, resulting in significant economic losses in the poultry industry. In addition, it poses a major public health threat as it can be transmitted directly from infected poultry to humans with very high (60%) mortality rate. Effective vaccination against HPAI H5N1 would protect commercial poultry and would thus provide an important control measure by reducing the likelihood of bird-to-bird and bird-to-human transmission. Methodology/Principal Findings: In the present study we evaluated the vaccine potential of recombinant soluble trimeric subtype 5 hemagglutinin (sH5(3)) produced in mammalian cells. The secreted, purified sH5(3) was biologically active as demonstrated by its binding to ligands in a sialic acid-dependent manner. It was shown to protect chickens, in a dose-dependent manner, against a lethal challenge with H5N1 after a single vaccination. Protected animals did not shed challenge virus as determined by a quantitative RT-PCR on RNA isolated from trachea and cloaca swabs. Also in mice, vaccination with sH5(3) provided complete protection against challenge with HPAI H5N1. Conclusions/Significance: Our results demonstrate that sH5(3) constitutes an attractive vaccine antigen for protection of chickens and mammals against HPAI H5N1. As these recombinant soluble hemagglutinin preparations can be produced with high yields and with relatively short lead time, they enable a rapid response to circulating and potentially pandemic influenza viruses.	[Cornelissen, Lisette A. H. M.; de Boer-Luijtze, Els A.] Wageningen Univ, Cent Vet Inst, Lelystad, Netherlands; [de Vries, Robert P.; Rigter, Alan; Rottier, Peter J. M.; de Haan, Cornelis A. M.] Univ Utrecht, Fac Vet Med, Div Virol, Dept Infect Dis & Immunol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Cornelissen, LAHM (corresponding author), Wageningen Univ, Cent Vet Inst, Lelystad, Netherlands.	c.a.m.dehaan@uu.nl	de Vries, Robert/K-7212-2013	de Haan, Cornelis/0000-0002-4459-9874; Tripp, Ralph/0000-0002-2924-9956; de Vries, Robert/0000-0002-1586-4464	Economic Structure Enhancing Fund	Economic Structure Enhancing Fund	This work has been financially supported by the Economic Structure Enhancing Fund: "Impulse Veterinary Avian Influenza Research in the Netherlands''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck I, 2003, VACCINE, V21, P1006, DOI 10.1016/S0264-410X(02)00552-2; Bhattacharya P, 2010, J VIROL, V84, P361, DOI 10.1128/JVI.01355-09; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; DiNapoli JM, 2010, J VIROL, V84, P1489, DOI 10.1128/JVI.01946-09; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Ellebedy AH, 2009, VACCINE, V27, pD65, DOI 10.1016/j.vaccine.2009.08.038; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Herfst S, 2007, J GEN VIROL, V88, P2702, DOI 10.1099/vir.0.83084-0; Keitel WA, 2009, CURR TOP MICROBIOL, V333, P431, DOI 10.1007/978-3-540-92165-3_21; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; LEENAARS PPAM, 1994, VET IMMUNOL IMMUNOP, V40, P225, DOI 10.1016/0165-2427(94)90022-1; Mueller SN, 2010, J VIROL, V84, P1847, DOI 10.1128/JVI.01317-09; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; Reeves PJ, 1999, P NATL ACAD SCI USA, V96, P1927, DOI 10.1073/pnas.96.5.1927; Safdar A, 2007, EXPERT OPIN INV DRUG, V16, P927, DOI 10.1517/13543784.16.7.927; Tchoudakova A, 2009, MABS, V1, P163, DOI 10.4161/mabs.1.2.7945; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Uyeki TM, 2008, RESPIROLOGY, V13, pS2, DOI 10.1111/j.1440-1843.2008.01246.x; van Oirschot JT, 2001, VET QUART, V23, P100, DOI 10.1080/01652176.2001.9695094; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wu QF, 2009, MOL IMMUNOL, V46, P2210, DOI 10.1016/j.molimm.2009.04.017; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105; Zwicker N, 1999, BIOTECHNIQUES, V27, P368, DOI 10.2144/99272rr05	30	64	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10645	10.1371/journal.pone.0010645	http://dx.doi.org/10.1371/journal.pone.0010645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498717	Green Published, gold, Green Submitted			2022-12-25	WOS:000277771600009
J	Yu, YD; Choi, Y; Teo, YY; Dalby, AR				Yu, Yoon-Dong; Choi, Yoonjoo; Teo, Yik-Ying; Dalby, Andrew R.			Developing Stochastic Models for Spatial Inference: Bacterial Chemotaxis	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOCHEMICAL PATHWAYS; PARAMETER-ESTIMATION; GENE-EXPRESSION; SINGLE-CELL; LOCALIZATION; COMPLEX; CYTOPLASM; CHEA; OPTIMIZATION	Background: Biological systems are inherently inhomogeneous and spatial effects play a significant role in processes such as pattern formation. At the cellular level proteins are often localised either through static attachment or via a dynamic equilibrium. As well as spatial heterogeneity many cellular processes exhibit stochastic fluctuations and so to make inferences about the location of molecules there is a need for spatial stochastic models. A test case for spatial models has been bacterial chemotaxis which has been studied extensively as a model of signal transduction. Results: By creating specific models of a cellular system that incorporate the spatial distributions of molecules we have shown how the fit between simulated and experimental data can be used to make inferences about localisation, in the case of bacterial chemotaxis. This method allows the robust comparison of different spatial models through alternative model parameterisations. Conclusions: By using detailed statistical analysis we can reliably infer the parameters for the spatial models, and also to evaluate alternative models. The statistical methods employed in this case are particularly powerful as they reduce the need for a large number of simulation replicates. The technique is also particularly useful when only limited molecular level data is available or where molecular data is not quantitative.	[Yu, Yoon-Dong; Choi, Yoonjoo; Dalby, Andrew R.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Teo, Yik-Ying] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 3TG, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Yu, YD (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	dalby@stats.ox.ac.uk	Choi, Yoonjoo/AAH-6163-2020	Choi, Yoonjoo/0000-0001-9687-8093; Dalby, Andrew/0000-0002-3598-8595	Sulsong Foundation of South Korea	Sulsong Foundation of South Korea	During his DPhil studies, Y-DY is supported by the Sulsong Foundation of South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Cantwell BJ, 2003, J BACTERIOL, V185, P2354, DOI 10.1128/JB.185.7.2354-2361.2003; Cleveland W.S., 1992, LOCAL REGRESSION MOD, P309; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; DELOURA M, 2001, GAMES PROGRAMMING GE, V2; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Emonet T, 2005, BIOINFORMATICS, V21, P2714, DOI 10.1093/bioinformatics/bti391; Francis NR, 2002, J BIOL CHEM, V277, P36755, DOI 10.1074/jbc.M204324200; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; KOSHLAND DE, 1981, ANNU REV BIOCHEM, V50, P765, DOI 10.1146/annurev.bi.50.070181.004001; Lewontin R, 2000, TRIPLE HELIX; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Liberman L, 2004, J BACTERIOL, V186, P6643, DOI 10.1128/JB.186.19.6643-6646.2004; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; LUBYPHELPS K, 2000, CYTOARCHITECTURE PHY, V192; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Paton R, 2004, IEEE T NANOBIOSCI, V3, P208, DOI 10.1109/TNB.2004.833701; R Development Core Team, 2009, R FDN STAT COMP; Rao CV, 2005, PHYS BIOL, V2, P148, DOI 10.1088/1478-3975/2/3/002; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Sagi Y, 2003, J BIOL CHEM, V278, P25867, DOI 10.1074/jbc.M303201200; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Stewart RC, 2000, BIOCHEMISTRY-US, V39, P13157, DOI 10.1021/bi001100k; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Yaffee R.A., 2000, INTRO TIME SERIES AN; Yi TM, 2007, METHOD ENZYMOL, V422, P123, DOI 10.1016/S0076-6879(06)22006-8	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10464	10.1371/journal.pone.0010464	http://dx.doi.org/10.1371/journal.pone.0010464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498704	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000277633500003
J	Engkilde, K; Buschard, K; Hansen, AK; Menne, T; Johansen, JD				Engkilde, Kaare; Buschard, Karsten; Hansen, Axel Kornerup; Menne, Torkil; Johansen, Jeanne Duus			Prevention of Diabetes in NOD Mice by Repeated Exposures to a Contact Allergen Inducing a Sub-Clinical Dermatitis	PLOS ONE			English	Article							CD8+ T-CELLS; CYTOKINE PRODUCTION; NKT CELLS; HYPERSENSITIVITY; SENSITIVITY; SKIN; PARAPHENYLENEDIAMINE; MOUSE; ASSAY; SENSITIZATION	Background: Type 1 diabetes is an autoimmune disease, while allergic contact dermatitis although immune mediated, is considered an exposure driven disease that develops due to epicutanous contact with reactive low-molecular chemicals. The objective of the present study was to experimentally study the effect of contact allergens on the development of diabetes in NOD mice. As the link between contact allergy and diabetes is yet unexplained we also examined the effect of provocation with allergens on Natural Killer T (NKT) cells, since involvement of NKT cells could suggest an innate connection between the two diseases. Method: NOD mice 4 weeks of age were exposed, on the ears, to two allergens, p-phenylenediamine and 2,4-dinitrochlorobenzene respectively, to investigate the diabetes development. The mice were followed for a maximum of 32 weeks, and they were either repeatedly exposed to the allergens or only sensitized a week after arrival. The stimulation of NKT cells by the two allergens were additionally studied in C57BL/6 mice. The mice were sensitized and two weeks later provocated with the allergens. The mice were subsequently euthanized at different time points after the provocation. Results: It was found that repeated application of p-phenylenediamine reduced the incidence of diabetes compared to application with water (47% vs. 93%, P = 0.004). Moreover it was shown that in C57BL/6 mice both allergens resulted in a slight increment in the quantity of NKT cells in the liver. Application of the allergens at the same time resulted in an increased number of NKT cells in the draining auricular lymph node, and the increase appeared to be somewhat allergen specific as the accumulation was stronger for p-phenylenediamine. Conclusion: The study showed that repeated topical application on the ears with a contact allergen could prevent the development of diabetes in NOD mice. The contact allergens gave a non-visible, sub-clinical dermatitis on the application site. The preventive effect on diabetes may be due to stimulation of peripheral NKT cells, as shown for provocation with p-phenylenediamine in the C57BL/6 mouse. This epicutanous procedure may lead to new strategies in prevention of type 1 diabetes in humans.	[Engkilde, Kaare; Menne, Torkil; Johansen, Jeanne Duus] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Natl Allergy Res Ctr, Gentofte, Denmark; [Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Hansen, Axel Kornerup] Univ Copenhagen, Fac Life Sci, Dept Dis Biol, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen	Engkilde, K (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Natl Allergy Res Ctr, Gentofte, Denmark.	kaaeng02@geh.regionh.dk	Johansen, Jeanne/AAM-6382-2021	Johansen, Jeanne/0000-0002-3537-8463; Buschard, Karsten/0000-0002-0126-7423	National Board of Health; Research Foundation of the Region of Copenhagen	National Board of Health; Research Foundation of the Region of Copenhagen	This work was supported by the National Board of Health and the Research Foundation of the Region of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Basketter DA, 2008, BRIT J DERMATOL, V159, P267, DOI 10.1111/j.1365-2133.2008.08625.x; Basketter DA, 2007, CONTACT DERMATITIS, V57, P70, DOI 10.1111/j.1600-0536.2007.01141.x; BONEFELD CM, 2009, BR J DERMATOL; Campos RA, 2006, J IMMUNOL, V177, P3686, DOI 10.4049/jimmunol.177.6.3686; Cardell SL, 2006, CLIN EXP IMMUNOL, V143, P194, DOI 10.1111/j.1365-2249.2005.02942.x; Cardwell CR, 2003, DIABETES CARE, V26, P2568, DOI 10.2337/diacare.26.9.2568; Cavani A, 2007, CURR OPIN ALLERGY CL, V7, P404, DOI 10.1097/ACI.0b013e3282ef6923; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Dean JH, 2001, REGUL TOXICOL PHARM, V34, P258, DOI 10.1006/rtph.2001.1497; EDWARDS EK, 1984, CUTIS, V34, P87; Engkilde K, 2006, DIABETOLOGIA, V49, P644, DOI 10.1007/s00125-006-0162-2; FURUE M, 1985, J INVEST DERMATOL, V85, P139, DOI 10.1111/1523-1747.ep12276557; Gazda LS, 1996, IMMUNOL CELL BIOL, V74, P401, DOI 10.1038/icb.1996.69; Gober MD, 2008, J INVEST DERMATOL, V128, P1460, DOI 10.1038/sj.jid.5701199; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Green A, 2000, LANCET, V355, P873; Harada D, 2005, J DERMATOL SCI, V37, P159, DOI 10.1016/j.jdermsci.2004.11.007; KAUFMAN A, 2009, DIABETES METAB RES R; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Martin SF, 2008, CURR OPIN ALLERGY CL, V8, P289, DOI 10.1097/ACI.0b013e3283088cf9; Mitjans M, 2007, TOXICOL LETT, V172, pS86, DOI 10.1016/j.toxlet.2007.05.242; NAKANO Y, 1981, IMMUNOLOGY, V42, P111; Nieuwenhuis EES, 2005, EXP DERMATOL, V14, P250, DOI 10.1111/j.0906-6705.2005.00289.x; Olesen AB, 2001, LANCET, V357, P1749, DOI 10.1016/S0140-6736(00)04896-0; Poulton LD, 2001, DIABETES-METAB RES, V17, P429, DOI 10.1002/dmrr.238; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P131; Seidel-Guyenot W, 2006, J ALLERGY CLIN IMMUN, V117, P1170, DOI 10.1016/j.jaci.2006.01.014; Tirosh A, 2006, ANN INTERN MED, V144, P877, DOI 10.7326/0003-4819-144-12-200606200-00004; Vocanson M, 2006, J INVEST DERMATOL, V126, P815, DOI 10.1038/sj.jid.5700174; Warbrick EV, 1999, J APPL TOXICOL, V19, P255, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<255::AID-JAT573>3.0.CO;2-S; White JML, 2007, CONTACT DERMATITIS, V56, P262, DOI 10.1111/j.1600-0536.2007.01072.x; Wu L, 2007, AM J PHYSIOL-GASTR L, V293, pG919, DOI 10.1152/ajpgi.00242.2007; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10591	10.1371/journal.pone.0010591	http://dx.doi.org/10.1371/journal.pone.0010591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485668	Green Published, Green Submitted, gold			2022-12-25	WOS:000277563200021
J	Lorquet, S; Berndt, S; Blacher, S; Gengoux, E; Peulen, O; Maquoi, E; Noel, A; Foidart, JM; Munaut, C; Pequeux, C				Lorquet, Sophie; Berndt, Sarah; Blacher, Silvia; Gengoux, Emily; Peulen, Olivier; Maquoi, Erik; Noel, Agnes; Foidart, Jean-Michel; Munaut, Carine; Pequeux, Christel			Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment	FASEB JOURNAL			English	Article						mural cell migration; vessel normalization; eNOS; NO; S1P1	ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; SPHINGOSINE-1-PHOSPHATE RECEPTORS; TUMOR VASCULATURE; VESSEL MATURATION; ANGIOGENESIS; NORMALIZATION; METASTASIS; INHIBITION; MEMBRANE	Two soluble forms of vascular endothelial growth factor (VEGF) receptors, sVEGFR-1 and sVEGFR-2, are physiologically released and overproduced in some pathologies. They are known to act as anti-VEGF agents. Here we report that these soluble receptors contribute to vessel maturation by mediating a dialogue between endothelial cells (ECs) and mural cells that leads to blood vessel stabilization. Through a multidisciplinary approach, we provide evidence that these soluble VEGF receptors promote mural cell migration through a paracrine mechanism involving interplay in ECs between VEGF/VEGFR-2 and sphingosine1-phosphate type-1 (S1P)/S1P1 pathways that leads to endothelial nitric oxyde synthase (eNOS) activation. This new paradigm is supported by the finding that sVEGFR-1 and -2 perform the following actions: 1) induce an eNOS-dependent outgrowth of a mural cell network in an ex vivo model of angiogenesis, 2) increase the mural cell coverage of neovessels in vitro and in vivo, 3) promote mural cell migration toward ECs, and 4) stimulate endothelial S1P1 overproduction and eNOS activation that promote the migration and the recruitment of neighboring mural cells. These findings provide new insights into mechanisms regulating physiological and pathological angiogenesis and vessel stabilization.-Lorquet, S., Berndt, S., Blacher, S., Gengoux, E., Peulen, O., Maquoi, E., Noel, A., Foidart, J.-M., Munaut, C., Pequeux, C. Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB J. 24, 3782-3795 (2010). www.fasebj.org	[Lorquet, Sophie; Berndt, Sarah; Blacher, Silvia; Gengoux, Emily; Peulen, Olivier; Maquoi, Erik; Noel, Agnes; Foidart, Jean-Michel; Munaut, Carine; Pequeux, Christel] Univ Liege, Lab Tumor & Dev Biol, Inst Pathol, GIGA Canc, B-4000 Liege, Belgium; [Lorquet, Sophie; Foidart, Jean-Michel] Univ Liege, Dept Gynecol & Obstet, CHR Citadelle, B-4000 Liege, Belgium	University of Liege; University of Liege	Foidart, JM (corresponding author), Univ Liege, Lab Tumor & Dev Biol, Inst Pathol, GIGA Canc, CHU B23, B-4000 Liege, Belgium.	jmfoidart@ulg.ac.be	Peulen, Olivier/C-1250-2018; Munaut, Carine/K-8138-2019	Peulen, Olivier/0000-0002-6933-0134; Noel, Agnes/0000-0002-7670-6179; Pequeux, Christel/0000-0001-8275-1489	European 7th Research Framework Programme [HEALTH-2007-2.4.1-6]; EMBIC [6-NOE LSHM-CT-2004-512040]; Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique (FNRS; Belgium); Fondation contre le Cancer; Fonds speciaux Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Region Wallonne (NEOANGIO); Fonds Social Europeen; Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium)	European 7th Research Framework Programme; EMBIC; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (FNRS; Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer; Fonds speciaux Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Region Wallonne (NEOANGIO); Fonds Social Europeen(European Social Fund (ESF)); Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office)	The authors thank B. Brouwers, I. Dasoul, D. Gabriel-Delapierre, N. Lefin, M.-R. Pignon, E. Konradowski, F. Olivier, P. Gavitelli, and G. Rolland for their excellent technical assistance. Confocal microscopy was performed at CIL- and GIGA-Imaging and Flow Cytometry Facility. This work was supported by grants from the European 7th Research Framework Programme: HEALTH-2007-2.4.1-6 "MICROENVIMET," Framework Programme 6-NOE LSHM-CT-2004-512040, EMBIC, the Fonds de la Recherche Scientifique Medicale, the Fonds National de la Recherche Scientifique (FNRS; Belgium), the Fondation contre le Cancer, the Fonds speciaux Recherche (University of Liege), the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the DGTRE from the Region Wallonne (NEOANGIO), the Fonds Social Europeen, and the Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium). S.L. and C.P. performed all cellular experiments; S. Berndt performed the aortic ring assays; S. Blacher did all quantification based on image analysis; E.G. contributed to the mouse Matrigel plug assay; O.P., E.M., and A.N. contributed to the work with scientific advice; J.-M.F. supervised the study, provided scientific suggestions, and contributed to manuscript preparation and review; C.M. participated to data analysis; and C.P. designed the study, analyzed the data, and wrote the manuscript.	Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Allende ML, 2002, BBA-MOL CELL BIOL L, V1582, P222, DOI 10.1016/S1388-1981(02)00175-0; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Berndt S, 2006, FASEB J, V20, P2630, DOI 10.1096/fj.06-5885fje; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chabottaux V, 2009, J CELL MOL MED, V13, P4002, DOI 10.1111/j.1582-4934.2009.00764.x; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Dings RPM, 2007, CLIN CANCER RES, V13, P3395, DOI 10.1158/1078-0432.CCR-06-2441; Ebos JML, 2004, MOL CANCER RES, V2, P315; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Igarashi J, 2008, BBA-MOL CELL BIOL L, V1781, P489, DOI 10.1016/j.bbalip.2008.06.008; Jacobi J, 2004, CIRCULATION, V110, P2424, DOI 10.1161/01.CIR.0000145142.85645.EA; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kashiwagi S, 2005, J CLIN INVEST, V115, P1816, DOI 10.1172/JCI24015; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kou BJ, 2004, EXP MOL PATHOL, V76, P129, DOI 10.1016/j.yexmp.2003.10.010; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Munaut C, 2008, HUM REPROD, V23, P1407, DOI 10.1093/humrep/den114; PASSANITI A, 1992, LAB INVEST, V67, P519; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Robak E, 2003, MEDIAT INFLAMM, V12, P293, DOI 10.1080/09629350310001619726; Roeckl W, 1998, EXP CELL RES, V241, P161, DOI 10.1006/excr.1998.4039; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Szentirmai O, 2008, J NEUROSURG, V108, P979, DOI 10.3171/JNS/2008/108/5/0979; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tsatsaris V, 2004, NEW ENGL J MED, V350, P2003; Wierzbowska A, 2003, EUR CYTOKINE NETW, V14, P149; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102	50	40	41	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2010	24	10					3782	3795		10.1096/fj.09-149070	http://dx.doi.org/10.1096/fj.09-149070			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20484670	Green Submitted			2022-12-25	WOS:000285005900017
J	Qiang, L; Banks, AS; Accili, D				Qiang, Li; Banks, Alexander S.; Accili, Domenico			Uncoupling of Acetylation from Phosphorylation Regulates FoxO1 Function Independent of Its Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; BETA-CELL FUNCTION; FACTOR FKHR; SIGNALING PATHWAY; GENE-EXPRESSION; 14-3-3 BINDING; PROTEIN FOXO1; LIFE-SPAN; INSULIN; DIFFERENTIATION	The activity of transcription factor FoxO1 is regulated by phosphorylation-dependent nuclear exclusion and deacetylation-dependent nuclear retention. It is unclear whether and how these two post-translational modifications affect each other. To answer this question, we expressed FoxO1 cDNAs with combined mutations of phosphorylation and acetylation sites in HEK-293 cells and analyzed their subcellular localization patterns. We show that mutations mimicking the acetylated state (KQ series) render FoxO1 more sensitive to Akt-mediated phosphorylation and nuclear exclusion and can reverse the constitutively nuclear localization of phosphorylation-defective FoxO1. Conversely, mutations mimicking the deacetylated state (KR series) promote FoxO1 nuclear retention. Oxidative stress and the Sirt1 activator resveratrol are thought to promote FoxO1 deacetylation and nuclear retention, thus increasing its activity. Accordingly, FoxO1 deacetylation was required for the effect of oxidative stress (induced by H2O2) to retain FoxO1 in the nucleus. H2O2 also inhibited FoxO1 phosphorylation on Ser-253 and Thr-24, the key insulin-regulated sites, irrespective of its acetylation. In contrast, the effect of resveratrol was independent of FoxO1 acetylation and its phosphorylation on Ser-253 and Thr-24, suggesting that resveratrol acts on FoxO1 in a Sirt1- and Akt-independent manner. The dissociation of deacetylation from dephosphorylation in H2O2-treated cells indicates that the two modifications can occur independently of each other. It can be envisaged that FoxO1 exists in multiple nuclear forms with distinct activities depending on the balance of acetylation and phosphorylation.	[Qiang, Li; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA; [Banks, Alexander S.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA	Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu	Banks, Alexander/B-4832-2012; Qiang, Li/C-9560-2012	Banks, Alexander/0000-0003-1787-6925; Qiang, Li/0000-0001-8322-1797	National Institutes of Health, Columbia University Diabetes and Endocrinology Research Center [DK57539, DK63608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, P30DK063608] Funding Source: NIH RePORTER	National Institutes of Health, Columbia University Diabetes and Endocrinology Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK57539 and DK63608 from the Columbia University Diabetes and Endocrinology Research Center.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fukuoka M, 2003, INT J MOL MED, V12, P503; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Nakae J, 2001, BIOCHEMISTRY-US, V40, P11768, DOI 10.1021/bi015532m; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200	39	125	128	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27396	27401		10.1074/jbc.M110.140228	http://dx.doi.org/10.1074/jbc.M110.140228			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20519497	hybrid, Green Published			2022-12-25	WOS:000281172700068
J	Kim, BJ; Li, YH; Zhang, JL; Xi, YX; Li, YM; Yang, T; Jung, SY; Pan, XW; Chen, R; Li, W; Wang, Y; Qin, J				Kim, Beom-Jun; Li, Yehua; Zhang, Jinglan; Xi, Yuanxin; Li, Yumei; Yang, Tao; Jung, Sung Yun; Pan, Xuewen; Chen, Rui; Li, Wei; Wang, Yi; Qin, Jun			Genome-wide Reinforcement of Cohesin Binding at Pre-existing Cohesin Sites in Response to Ionizing Radiation in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; S-PHASE; ATM; PROTEIN; ACETYLATION; COMPLEX; ROLES; ECO1	The cohesin complex plays a central role in genome maintenance by regulation of chromosome segregation in mitosis and DNA damage response (DDR) in other phases of the cell cycle. The ATM/ATR phosphorylates SMC1 and SMC3, two core components of the cohesin complex to regulate checkpoint signaling and DNA repair. In this report, we show that the genome-wide binding of SMC1 and SMC3 after ionizing radiation (IR) is enhanced by reinforcing pre-existing cohesin binding sites in human cancer cells. We demonstrate that ATM and SMC3 phosphorylation at Ser(1083) regulate this process. We also demonstrate that acetylation of SMC3 at Lys(105) and Lys(106) is induced by IR and this induction depends on the acetyltransferase ESCO1 as well as the ATM/ATR kinases. Consistently, both ESCO1 and SMC3 acetylation are required for intra-S phase checkpoint and cellular survival after IR. Although both IR-induced acetylation and phosphorylation of SMC3 are under the control of ATM/ATR, the two forms of modification are independent of each other and both are required to promote reinforcement of SMC3 binding to cohesin sites. Thus, SMC3 modifications is a mechanism for genome-wide reinforcement of cohesin binding in response to DNA damage response in human cells and enhanced cohesion is a downstream event of DDR.	[Kim, Beom-Jun; Li, Yehua; Zhang, Jinglan; Yang, Tao; Jung, Sung Yun; Pan, Xuewen; Wang, Yi; Qin, Jun] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Ctr Mol Discovery, Houston, TX 77030 USA; [Jung, Sung Yun; Wang, Yi; Qin, Jun] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Li, Yumei; Chen, Rui] Baylor Coll Med, Genome Ctr, Houston, TX 77030 USA; [Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Qin, J (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	jqin@bcm.tmc.edu	Li, Wei/A-8544-2009; Zhang, Jinglan/D-4752-2011; Zhang, Jinglan/AAI-1793-2020	Zhang, Jinglan/0000-0002-4600-7123; Jung, Sung Yun/0000-0003-1521-7977; Li, Wei/0000-0001-9931-5990	National Institutes of Health [CA84199, CA98500]; Welch Foundation; NATIONAL CANCER INSTITUTE [R01CA098500, R01CA084199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA84199 and CA98500 and the Welch Foundation (to J.Q.).	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bernard P, 2008, EMBO J, V27, P111, DOI 10.1038/sj.emboj.7601955; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Luo H, 2008, J BIOL CHEM, V283, P19176, DOI 10.1074/jbc.M802299200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	45	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22782	22790		10.1074/jbc.M110.134577	http://dx.doi.org/10.1074/jbc.M110.134577			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501661	Green Published, hybrid			2022-12-25	WOS:000279999900010
J	Liu, J; Majumdar, A; Liu, JL; Thompson, LH; Seidman, MM				Liu, Jia; Majumdar, Alokes; Liu, Jilan; Thompson, Lawrence H.; Seidman, Michael M.			Sequence Conversion by Single Strand Oligonucleotide Donors via Non-homologous End Joining in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX-FORMING OLIGONUCLEOTIDES; FANCONI-ANEMIA FIBROBLASTS; ZINC-FINGER NUCLEASES; BREAK REPAIR PATHWAY; HOMOLOGOUS RECOMBINATION; DNA-REPAIR; 2'-O-(2-AMINOETHYL) RESIDUES; MRE11-RAD50-NBS1 COMPLEX; SACCHAROMYCES-CEREVISIAE; RAD51 RECOMBINATION	Double strand breaks (DSBs) can be repaired by homology independent nonhomologous end joining (NHEJ) pathways involving proteins such as Ku70/80, DNAPKcs, Xrcc4/Ligase 4, and the Mre11/Rad50/Nbs1 (MRN) complex. DSBs can also be repaired by homology-dependent pathways (HDR), in which the MRN and CtIP nucleases produce single strand ends that engage homologous sequences either by strand invasion or strand annealing. The entry of ends into HDR pathways underlies protocols for genomic manipulation that combine site-specific DSBs with appropriate informational donors. Most strategies utilize long duplex donors that participate by strand invasion. Work in yeast indicates that single strand oligonucleotide (SSO) donors are also active, over considerable distance, via a single strand annealing pathway. We examined the activity of SSO donors in mammalian cells at DSBs induced either by a restriction nuclease or by a targeted interstrand cross-link. SSO donors were effective immediately adjacent to the break, but activity declined sharply beyond similar to 100 nucleotides. Overexpression of the resection nuclease CtIP increased the frequency of SSO-mediated sequence modulation distal to the break site, but had no effect on the activity of an SSO donor adjacent to the break. Genetic and in vivo competition experiments showed that sequence conversion by SSOs in the immediate vicinity of the break was not by strand invasion or strand annealing pathways. Instead these donors competed for ends that would have otherwise entered NHEJ pathways.	[Liu, Jia; Majumdar, Alokes; Seidman, Michael M.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Liu, Jilan] Mission Res Inc, Baltimore, MD 21224 USA; [Thompson, Lawrence H.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94551 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Seidman, MM (corresponding author), 251 Bayview Blvd,BRC 5B133, Baltimore, MD 21224 USA.	seidmanm@grc.nia.nih.gov			National Institutes of Health; NIA; Fanconi Anemia Research Foundation; NATIONAL INSTITUTE ON AGING [ZIAAG000747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIA, and by the Fanconi Anemia Research Foundation, through a R&D contract with MedStar Research Institute.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Al-Minawi AZ, 2008, NUCLEIC ACIDS RES, V36, P1, DOI 10.1093/nar/gkm888; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bell NM, 2009, CHEMBIOCHEM, V10, P2691, DOI 10.1002/cbic.200900341; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Capp JP, 2007, NUCLEIC ACIDS RES, V35, P3551, DOI 10.1093/nar/gkm243; Capp JP, 2006, NUCLEIC ACIDS RES, V34, P2998, DOI 10.1093/nar/gkl380; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen MF, 2006, INT J RADIAT ONCOL, V66, P244, DOI 10.1016/j.ijrobp.2006.03.062; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Delacote F, 2008, CELL CYCLE, V7, P33, DOI 10.4161/cc.7.1.5149; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Donahue SL, 2003, J BIOL CHEM, V278, P29487, DOI 10.1074/jbc.M213251200; Donahue SL, 2002, J BIOL CHEM, V277, P46243, DOI 10.1074/jbc.M207937200; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Eklund JL, 2007, NUCLEIC ACIDS RES, V35, P5839, DOI 10.1093/nar/gkm624; Garner KM, 2009, NAT CHEM BIOL, V5, P129, DOI 10.1038/nchembio0309-129; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Lambert S, 2000, EMBO J, V19, P3090, DOI 10.1093/emboj/19.12.3090; Lambert S, 2002, ONCOGENE, V21, P4065, DOI 10.1038/sj.onc.1205535; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lieber MR, 2008, CELL RES, V18, P125, DOI 10.1038/cr.2007.108; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; LIN FL, 1984, COLD SPRING HARB SYM, V49, P139, DOI 10.1101/SQB.1984.049.01.017; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Majumdar A, 1998, NAT GENET, V20, P212, DOI 10.1038/2530; Majumdar A, 2008, J BIOL CHEM, V283, P11244, DOI 10.1074/jbc.M800607200; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Meulle A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003345; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mirchandani KD, 2006, EXP CELL RES, V312, P2647, DOI 10.1016/j.yexcr.2006.06.014; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Nijnik A, 2009, J CLIN INVEST, V119, P1696, DOI 10.1172/JCI32743; Porteus Matthew, 2008, V435, P47, DOI 10.1007/978-1-59745-232-8_4; Puri N, 2004, BIOCHEMISTRY-US, V43, P1343, DOI 10.1021/bi035808l; Puri N, 2002, BIOCHEMISTRY-US, V41, P7716, DOI 10.1021/bi025734y; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Richards S, 2005, NUCLEIC ACIDS RES, V33, P5382, DOI 10.1093/nar/gki851; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SAWAI M, 1990, EXP CELL RES, V187, P4, DOI 10.1016/0014-4827(90)90108-M; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Van Dyck E, 2001, EMBO REP, V2, P905, DOI 10.1093/embo-reports/kve201; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang XL, 2008, CHINESE PHYS C, V32, P18, DOI 10.1088/1674-1137/32/1/004; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wiegant WW, 2006, MUTAT RES-FUND MOL M, V600, P79, DOI 10.1016/j.mrfmmm.2006.03.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Wilson JH, 2008, P NATL ACAD SCI USA, V105, P5653, DOI 10.1073/pnas.0802298105; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yuan JS, 2010, J BIOL CHEM, V285, P1097, DOI 10.1074/jbc.M109.078436; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zha S, 2009, NAT STRUCT MOL BIOL, V16, P798, DOI 10.1038/nsmb0809-798; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	94	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23196	23205		10.1074/jbc.M110.123844	http://dx.doi.org/10.1074/jbc.M110.123844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489199	hybrid, Green Published			2022-12-25	WOS:000279999900054
J	Pan, R; Zhang, XJ; Zhang, ZJ; Zhou, Y; Tian, WX; He, RQ				Pan, Rong; Zhang, Xue-Jing; Zhang, Zi-Jian; Zhou, Yuan; Tian, Wei-Xi; He, Rong-Qiao			Substrate-induced Changes in Protease Active Site Conformation Impact on Subsequent Reactions with Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED-FIT; SPECIFICITY; FLEXIBILITY; DYNAMICS; ENZYMES; DOCKING; KINASE	Enzymatic catalysis of biochemical reactions is essential to all living systems. The "lock and key" and "induced fit" models were early contributions to our understanding of the mechanisms involved in the reaction between an enzyme and its substrate. However, whether a given substrate-induced conformation is rigid or remains flexible has not yet been determined. By measuring the enzyme activity and intrinsic fluorescence of a nonspecific Eisenia fetida protease-I with different chromogenic substrates, we show that in subsequent reactions of protease with substrates, both the "lock and key" and "induced fit" mechanisms are used depending on the degree of conformational change required. Chromozym-Th-or chromosym-Ch-induced protease conformations were unable to bind chromozym-U. The chromosym-U-induced protease conformation remained flexible and could be further induced by chromozym-Th and chromozym-Ch. When low concentrations of guanidine HCl were used to disturb the conformation of the enzyme, only small changes in intrinsic fluorescence of the chromozym-Th-induced protease were detected, in contrast to the native enzyme whose intrinsic fluorescence markedly increased. This indicates that the substrate-induced enzyme was relatively rigid compared with the native protease. Utilizing a lock and key mechanism for secondary substrate reactions may have adaptive value in that it facilitates high efficiency in enzymatic reactions.	[Pan, Rong; Zhang, Xue-Jing; Zhang, Zi-Jian; Zhou, Yuan; He, Rong-Qiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Zhang, Xue-Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Zhang, Zi-Jian; Zhou, Yuan; Tian, Wei-Xi; He, Rong-Qiao] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, RQ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, 15 Da Tun Rd, Beijing 100101, Peoples R China.	herq@sun5.ibp.ac.cn	Pan, Rong/J-4113-2014; Pan, Rong/B-3161-2013; Zhang, Zijian/H-6190-2016		National Natural Science Foundation of China [30870544]; 973 projects of China [2006CB500703, 2010CB912303]; Chinese Academy of Sciences [KSCX2-YW-R-119, KSCX2-YW-R-256]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 projects of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grant 30870544, 973 projects of China Grants 2006CB500703 and 2010CB912303, and the Knowledge Innovation Program of the Chinese Academy of Sciences Grants KSCX2-YW-R-119 and KSCX2-YW-R-256.	ANDERSON CM, 1979, SCIENCE, V204, P375, DOI 10.1126/science.220706; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Hritz J, 2008, J MED CHEM, V51, P7469, DOI 10.1021/jm801005m; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Li YC, 2008, J BIOL CHEM, V283, P2917, DOI 10.1074/jbc.M707470200; Matsushima N, 2008, CURR PROTEIN PEPT SC, V9, P591, DOI 10.2174/138920308786733886; Nelson DL, 2000, LEHNINGER PRINCIPLES; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Somorjai GA, 2004, NATURE, V430, P730, DOI 10.1038/430730a; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Sundberg EJ, 2000, STRUCTURE, V8, pR137, DOI 10.1016/S0969-2126(00)00167-2; Swift RV, 2009, J AM CHEM SOC, V131, P5126, DOI 10.1021/ja808064g; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wu JX, 2007, INT J BIOL MACROMOL, V40, P399, DOI 10.1016/j.ijbiomac.2006.10.001; YAO QZ, 1984, BIOCHEMISTRY-US, V23, P2740, DOI 10.1021/bi00307a032; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zhao J, 2007, INT J BIOL MACROMOL, V40, P67, DOI 10.1016/j.ijbiomac.2006.05.007; Zhao J, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/97654	24	17	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22948	22954		10.1074/jbc.M110.103549	http://dx.doi.org/10.1074/jbc.M110.103549			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484054	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000279999900029
J	Wang, S; Huang, X; Lee, CK; Liu, B				Wang, S.; Huang, X.; Lee, C-K; Liu, B.			Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin	ONCOGENE			English	Article						erbB3; erbB2; Survivin; paclitaxel resistance; breast cancer	GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; MONOCLONAL-ANTIBODY; ESTROGEN-RECEPTOR; SIGNALING PATHWAY; ACTIVATION LEADS; TAXOL; OVEREXPRESSION; TRASTUZUMAB; MECHANISMS	The coexpression of erbB3 and erbB2 is frequently observed in breast cancer; and erbB3 has a critical role in erbB2 promotion of breast cancer progression and anti-estrogen resistance. In this study, we determine the role of erbB3 in erbB2-mediated paclitaxel resistance in breast cancer cells. The overexpression of exogenous erbB3 via either stable or transient transfection in erbB2-overexpressing, but not epidermal growth factor receptor (EGFR)-expressing, breast cancer cells significantly decreases paclitaxel-induced growth inhibition and apoptosis. Consistently, knockdown of erbB3 expression with a specific short hairpin RNA (shRNA) in breast cancer cells with coexpression of both erbB2 and erbB3 enhances paclitaxel-induced apoptosis evidenced by increased DNA fragmentation, poly (ADP-ribose) polymerase ( PARP) cleavage and activation of caspase- 3 and -8. Furthermore, while forced overexpression of erbB3 increases, specific knockdown of erbB3 decreases the expression levels of Survivin only in the erbB2-overexpressing breast cancer cells. Targeting Survivin with specific shRNA overcomes paclitaxel resistance without effect on the expression levels of either erbB2 or erbB3. Mechanistic studies indicate that the specific phosphoinositide 3-kinase (PI-3K), Akt and mammalian target of rapamycin (mTOR) inhibitors, but not the mitogen-activated protein kinase kinase (MEK) inhibitor, not only abrogate erbB3-mediated upregulation of Survivin, but also reinforce the erbB2/erbB3-coexpressing breast cancer cells to paclitaxel-induced growth inhibition. These data demonstrate that heterodimerization of erbB2/erbB3 is a prerequisite for erbB2 tyrosine kinase activation; and elevated expression of erbB3 is required for erbB2-mediated paclitaxel resistance in breast cancer cells via PI-3K/Akt/mTOR signaling pathway-dependent upregulation of Survivin. Our studies suggest that new strategies targeting erbB3 or Survivin may enhance the efficacy of chemotherapeutic agents against erbB2-overexpressing breast cancer. Oncogene (2010) 29, 4225-4236; doi: 10.1038/onc.2010.180; published online 24 May 2010	[Wang, S.; Huang, X.; Liu, B.] Univ Colorado Denver, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Lee, C-K] Univ Colorado Denver, Sch Med, Dept Med, Myeloma & Amyloidosis Program, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Liu, B (corresponding author), Univ Colorado Denver, Sch Med, Dept Pathol, MS-8104,POB 6511,12801 E 17th Ave, Aurora, CO 80045 USA.	bolin.liu@ucdenver.edu	Wang, Shuiliang/R-4080-2019	Wang, Shuiliang/0000-0002-5054-9064; Liu, Bolin/0000-0003-0150-8650	Susan G Komen for the Cure	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation)	We thank Dr Haihua Gu for providing the pLKO.1-ErbB3shRNA expression vector and lentivirus packaging plasmids pCMV-VSVG and pCMV-DA. 9. We also thank Ms Lisa Litzenberger for her excellent art preparation. This work was supported in part by a research Grant from Susan G Komen for the Cure (to BL).	ALIMANDI M, 1995, ONCOGENE, V10, P1813; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Asanuma H, 2005, CANCER RES, V65, P11018, DOI 10.1158/0008-5472.CAN-05-0491; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; deFazio A, 2000, INT J CANCER, V87, P487, DOI 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.0.CO;2-J; Ferlini C, 2007, CURR CANCER DRUG TAR, V7, P704, DOI 10.2174/156800907783220453; Grupka NL, 2004, ARCH PATHOL LAB MED, V128, P974; Hawthorne VS, 2009, MOL CANCER RES, V7, P592, DOI 10.1158/1541-7786.MCR-08-0316; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; Huang XP, 2009, CANCER RES, V69, P8403, DOI 10.1158/0008-5472.CAN-09-2146; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Jensen EV, 2003, CLIN CANCER RES, V9, P1980; Kim A, 2005, BREAST CANCER RES, V7, pR708, DOI 10.1186/bcr1281; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Liu BL, 2009, MOL CANCER RES, V7, P1882, DOI 10.1158/1541-7786.MCR-08-0509; Liu Q, 2008, CANCER BIOL THER, V7, P1053, DOI 10.4161/cbt.7.7.6100; Lu J, 2009, CLIN CANCER RES, V15, P1326, DOI 10.1158/1078-0432.CCR-08-0954; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Morris PG, 2009, EXPERT REV ANTICANC, V9, P175, DOI 10.1586/14737140.9.2.175; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Oh SH, 2008, CLIN CANCER RES, V14, P1581, DOI 10.1158/1078-0432.CCR-07-0952; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Pack SD, 2004, CANCER RES, V64, P789, DOI 10.1158/0008-5472.CAN-03-1982; Saloustros E, 2008, EXPERT OPIN PHARMACO, V9, P2603, DOI [10.1517/14656566.9.15.2603, 10.1517/14656566.9.15.2603 ]; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; THOR AD, 1989, CANCER RES, V49, P7147; Vaira V, 2007, ONCOGENE, V26, P2678, DOI 10.1038/sj.onc.1210094; van Amerongen R, 2006, GENE DEV, V20, P1975, DOI 10.1101/gad.1460806; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Xia WL, 2006, CANCER RES, V66, P1640, DOI 10.1158/0008-5472.CAN-05-2000; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Yu DH, 1998, MOL CELL, V2, P581, DOI 10.1016/S1097-2765(00)80157-4; Yu DH, 1996, ONCOGENE, V13, P1359	49	94	97	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2010	29	29					4225	4236		10.1038/onc.2010.180	http://dx.doi.org/10.1038/onc.2010.180			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20498641				2022-12-25	WOS:000280151500010
J	Chen, Z; Li, Y; Zhang, H; Huang, P; Luthra, R				Chen, Z.; Li, Y.; Zhang, H.; Huang, P.; Luthra, R.			Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression	ONCOGENE			English	Article						miR-210; mitochondria; hypoxia; COX10; ISCU; ROS	CANCER-CELLS; DNA-REPAIR; INHIBITION; STRATEGY	The mechanisms of compromised mitochondrial function under various pathological conditions, including hypoxia, remain largely unknown. Recent studies have shown that microRNA-210 (miR-210) is induced by hypoxia under the regulation of hypoxia-inducible factor-1 alpha and has an important role in cell survival under hypoxic microenvironment. Hence, we hypothesized that miR-210 has a role in regulating mitochondrial metabolism and investigated miR-210 effects on mitochondrial function in cancer cell lines under normal and hypoxic conditions. Our results demonstrate that miR-210 decreases mitochondrial function and upregulates the glycolysis, thus make cancer cells more sensitive to glycolysis inhibitor. miR-210 can also activate the generation of reactive oxygen species (ROS). ISCU (iron-sulfur cluster scaffold homolog) and COX10 (cytochrome c oxidase assembly protein), two important factors of the mitochondria electron transport chain and the tricarboxylic acid cycle have been identified as potential targets of miR-210. The unique means by which miR-210 regulates mitochondrial function reveals an miRNA-mediated link between microenvironmental stress, oxidative phosphorylation, ROS and iron homeostasis. Oncogene (2010) 29, 4362-4368; doi:10.1038/onc.2010.193; published online 24 May 2010	[Chen, Z.; Li, Y.; Luthra, R.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77054 USA; [Zhang, H.; Huang, P.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77054 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Luthra, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, 8515 Fannin St,NAO1-061A, Houston, TX 77054 USA.	rluthra@mdanderson.org						Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Xu RH, 2005, CANCER RES, V65, P613	20	282	304	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2010	29	30					4362	4368		10.1038/onc.2010.193	http://dx.doi.org/10.1038/onc.2010.193			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20498629				2022-12-25	WOS:000280547900012
J	Yan, Y; Cao, PT; Greer, PM; Nagengast, ES; Kolb, RH; Mumby, MC; Cowan, KH				Yan, Y.; Cao, P. T.; Greer, P. M.; Nagengast, E. S.; Kolb, R. H.; Mumby, M. C.; Cowan, K. H.			Protein phosphatase 2A has an essential role in the activation of gamma-irradiation-induced G2/M checkpoint response	ONCOGENE			English	Article						PP2A; ATM/ATR; Chk1/2; irradiation and G2/M arrest	CELL-CYCLE CHECKPOINTS; DNA-DAMAGE CHECKPOINT; IONIZING-RADIATION; SERINE/THREONINE PHOSPHATASES; OKADAIC ACID; CALYCULIN-A; PHOSPHORYLATION; KINASE; ATR; CHK1	G2/M checkpoint activation after DNA damage results in G2/M cell cycle arrest that allows time for DNA repair before the entry of cells into mitosis. Activation of G2/M checkpoint involves a series of signaling events, which include activation of ataxia telangiectecia-mutated and Rad3-related (ATR) and Chk1 kinases and inhibition of Cdc2/Cyclin B activity. Studies presented in this report show that serine (Ser)/threonine (Thr) protein phosphatase 2A (PP2A) has an important role in G2/M checkpoint activation in response to gamma-irradiation (IR) exposure. Using PP2A inhibitors, as well as siRNA targeting various forms of Ser/Thr protein phosphatases, results presented in this report show that specific PP2A inhibition abrogates IR-induced activation of ATR and Chk1 kinases, as well as phosphorylation of Cdc2-Tyr15, and attenuates IR-induced G2/M arrest. These results suggest an important regulation of PP2A on IR-induced G2/M checkpoint signaling response. Oncogene (2010) 29, 4317-4329; doi:10.1038/onc.2010.187; published online 24 May 2010	[Yan, Y.; Cao, P. T.; Greer, P. M.; Nagengast, E. S.; Kolb, R. H.; Cowan, K. H.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Mumby, M. C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Nebraska System; University of Nebraska Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cowan, KH (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	kcowan@unmc.edu		Kolb, Ryan/0000-0001-6305-2885	Nebraska [DHHS-LB506, 2007-45]; NCI [NCI T32 CA009476]; NCI Cancer Center Support Grant [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727, T32CA009476] Funding Source: NIH RePORTER	Nebraska; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Michel Ouellette for providing HPNE cells, Dr Helen Piwnica Worms for GST-Cdc25C construct, Dr Charles Kuzynski, Victoria Smith and Megan Michalak for assistance on the flow cytometry analysis, and Dr Janina Baranowska-Kortylewicz for assistance on the operation of Mark I 68A Cesium-137 Irradiator. This work was supported by Nebraska DHHS-LB506 grant 2007-45 to YY, NCI Training Grant (NCI T32 CA009476) to RK and NCI Cancer Center Support Grant (P30CA036727) to KC.	Ahn JY, 2000, CANCER RES, V60, P5934; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; ATHERTONFESSLER S, 1993, MOL CELL BIOL, V13, P1675, DOI 10.1128/MCB.13.3.1675; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; COHEN P, 1991, METHOD ENZYMOL, V201, P389; Cohen PTW, 2002, J CELL SCI, V115, P241; Essmann F, 2004, CANCER RES, V64, P7065, DOI 10.1158/0008-5472.CAN-04-1082; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jang YJ, 2007, J BIOL CHEM, V282, P2473, DOI 10.1074/jbc.M605480200; Janssens IA, 2005, BIOGEOSCIENCES, V2, P15, DOI 10.5194/bg-2-15-2005; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Li G, 2007, J BIOL CHEM, V282, P7287, DOI 10.1074/jbc.M607951200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Liu QH, 2000, GENE DEV, V14, P1448; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Nagasawa H, 1998, CANCER RES, V58, P2036; O'Connell MJ, 2005, J CELL SCI, V118, P1, DOI 10.1242/jcs.01626; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Swingle Mark, 2007, V365, P23; TAKAI A, 1995, BIOCHEM J, V306, P657, DOI 10.1042/bj3060657; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu Bo, 2004, Methods Mol Biol, V281, P283; Yan Y, 2007, ONCOGENE, V26, P4689, DOI 10.1038/sj.onc.1210268; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	49	48	54	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2010	29	30					4317	4329		10.1038/onc.2010.187	http://dx.doi.org/10.1038/onc.2010.187			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20498628	Green Accepted			2022-12-25	WOS:000280547900008
J	Banyai, L; Sonderegger, P; Patthy, L				Banyai, Laszlo; Sonderegger, Peter; Patthy, Laszlo			Agrin Binds BMP2, BMP4 and TGF beta 1	PLOS ONE			English	Article							FOLLISTATIN-RELATED PROTEIN; NEUROMUSCULAR-JUNCTION; DENDRITIC FILOPODIA; GROWTH; MYOSTATIN; CELLS; SYNAPTOGENESIS; IDENTIFICATION; NEUROTRYPSIN; INHIBITION	The C-terminal 95 kDa fragment of some isoforms of vertebrate agrins is sufficient to induce clustering of acetylcholine receptors but despite two decades of intense agrin research very little is known about the function of the other isoforms and the function of the larger, N-terminal part of agrins that is common to all isoforms. Since the N-terminal part of agrins contains several follistatin-domains, a domain type that is frequently implicated in binding TGF beta s, we have explored the interaction of the N-terminal part of rat agrin (Agrin-Nterm) with members of the TGF beta family using surface plasmon resonance spectroscopy and reporter assays. Here we show that agrin binds BMP2, BMP4 and TGF beta 1 with relatively high affinity, the K-D values of the interactions calculated from SPR experiments fall in the 10(-8) M-10(-7) M range. In reporter assays Agrin-Nterm inhibited the activities of BMP2 and BMP4, half maximal inhibition being achieved at similar to 5x10(-7) M. Paradoxically, in the case of TGF beta 1 Agrin N-term caused a slight increase in activity in reporter assays. Our finding that agrin binds members of the TGF beta family may have important implications for the role of these growth factors in the regulation of synaptogenesis as well as for the role of agrin isoforms that are unable to induce clustering of acetylcholine receptors. We suggest that binding of these TGF beta family members to agrin may have a dual function: agrin may serve as a reservoir for these growth factors and may also inhibit their growth promoting activity. Based on analysis of the evolutionary history of agrin we suggest that agrin's growth factor binding function is more ancient than its involvement in acetylcholine receptor clustering.	[Banyai, Laszlo; Patthy, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, Budapest, Hungary; [Sonderegger, Peter] Univ Zurich, Dept Biochem, Zurich, Switzerland	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; University of Zurich	Banyai, L (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, Budapest, Hungary.	patthy@enzim.hu	Patthy, Laszlo/Q-6058-2019; Patthy, Laszlo/A-2353-2013		National Scientific Research Fund of Hungary [72125, 75836]	National Scientific Research Fund of Hungary	This work was supported by grants 72125 and 75836 from the National Scientific Research Fund of Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Annies M, 2006, MOL CELL NEUROSCI, V31, P515, DOI 10.1016/j.mcn.2005.11.005; Baerwald-De La Torre K, 2004, J NEUROCHEM, V90, P50, DOI 10.1111/j.1471-4159.2004.02454.x; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bixby JL, 2002, J NEUROBIOL, V50, P164, DOI 10.1002/neu.10025; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Harrow J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-201; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Hrus A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000731; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Matsumoto-Miyai K, 2009, CELL, V136, P1161, DOI 10.1016/j.cell.2009.02.034; McCroskery S, 2009, NEUROSCIENCE, V163, P168, DOI 10.1016/j.neuroscience.2009.06.012; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; Moon JI, 2008, DEV BIOL, V315, P404, DOI 10.1016/j.ydbio.2007.12.041; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; PATTHY L, 1987, J MOL BIOL, V198, P567, DOI 10.1016/0022-2836(87)90200-2; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; Porten E, 2010, J BIOL CHEM, V285, P3114, DOI 10.1074/jbc.M109.039420; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200; Sidis Y, 2002, ENDOCRINOLOGY, V143, P1613, DOI 10.1210/en.143.5.1613; Sonderegger P, 2007, SCIENCE, V316, DOI 10.1126/science.1138410; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41	37	22	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10758	10.1371/journal.pone.0010758	http://dx.doi.org/10.1371/journal.pone.0010758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505824	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017400014
J	Egles, C; Huet, HA; Dogan, F; Cho, S; Dong, SM; Smith, A; Knight, EB; McLachlan, KR; Garlick, JA				Egles, Christophe; Huet, Heather A.; Dogan, Furkan; Cho, Sam; Dong, Shumin; Smith, Avi; Knight, Elana B.; McLachlan, Karen R.; Garlick, Jonathan A.			Integrin-Blocking Antibodies Delay Keratinocyte Re-Epithelialization in a Human Three-Dimensional Wound Healing Model	PLOS ONE			English	Article							ALPHA(6)BETA(4) INTEGRIN; TUMOR PROGRESSION; CARCINOMA; ACTIVATION; GROWTH; DIFFERENTIATION; ALPHA-6-BETA-4; EXPRESSION; SURVIVAL; ADHESION	The alpha 6 beta 4 integrin plays a significant role in tumor growth, angiogenesis and metastasis through modulation of growth factor signaling, and is a potentially important therapeutic target. However, alpha 6 beta 4-mediated cell-matrix adhesion is critical in normal keratinocyte attachment, signaling and anchorage to the basement membrane through its interaction with laminin-5, raising potential risks for targeted therapy. Bioengineered Human Skin Equivalent (HSE), which have been shown to mimic their normal and wounded counterparts, have been used here to investigate the consequences of targeting beta 4 to establish toxic effects on normal tissue homeostasis and epithelial wound repair. We tested two antibodies directed to different beta 4 epitopes, one adhesion-blocking (ASC-8) and one non-adhesion blocking (ASC-3), and determined that these antibodies were appropriately localized to the basal surface of keratinocytes at the basement membrane interface where beta 4 is expressed. While normal tissue architecture was not altered, ASC-8 induced a sub-basal split at the basement membrane in non-wounded tissue. In addition, wound closure was significantly inhibited by ASC-8, but not by ASC-3, as the epithelial tongue only covered 40 percent of the wound area at 120 hours post-wounding. These results demonstrate beta 4 adhesion-blocking antibodies may have adverse effects on normal tissue, whereas antibodies directed to other epitopes may provide safer alternatives for therapy. Taken together, we conclude that these three-dimensional tissue models provide a biologically relevant platform to identify toxic effects induced by candidate therapeutics, which will allow generation of findings that are more predictive of in vivo responses early in the drug development process.	[Egles, Christophe; Dogan, Furkan; Dong, Shumin; Smith, Avi; Knight, Elana B.; Garlick, Jonathan A.] Tufts Univ, Sch Dent Med, Dept Oral & Maxillofacial Pathol, Div Canc Biol & Tissue Engn, Boston, MA 02111 USA; [Huet, Heather A.] Biogen Idec Inc, Discovery Oncobiol, Cambridge, MA USA; [Cho, Sam; McLachlan, Karen R.] Biogen Idec Inc, Translat Oncobiol, San Diego, CA USA	Tufts University; Biogen; Biogen	Egles, C (corresponding author), Tufts Univ, Sch Dent Med, Dept Oral & Maxillofacial Pathol, Div Canc Biol & Tissue Engn, Boston, MA 02111 USA.	Christophe.egles@tufts.edu		Smith, Avi/0000-0002-8904-7539; EGLES, Christophe/0000-0003-0982-7752	Biogen-Idec; Center for Integrated Tissue Engineering at Tufts University, School of Dental Medicine	Biogen-Idec(Biogen); Center for Integrated Tissue Engineering at Tufts University, School of Dental Medicine	This work was funded by Biogen-Idec and by the Center for Integrated Tissue Engineering at Tufts University, School of Dental Medicine. Other than the input of three authors in the wording of the manuscript, and in providing materials and approving permission to publish freely, Biogen-Idec as a funder had no direct role in the conception of the method, the study design, data collection, or analysis. The Center for Integrated Tissue Engineering, as a funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra M, 2003, J INVEST DERMATOL, V121, P1336, DOI 10.1111/j.1523-1747.2003.12625.x; Andriani F, 2003, J INVEST DERMATOL, V120, P923, DOI 10.1046/j.1523-1747.2003.12235.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; CARLSON MW, 2008, CURR PROTOC CELL BIO, V19; Chen LL, 2008, CELL COMMUN ADHES, V15, P317, DOI 10.1080/15419060802428356; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Folgiero V, 2007, CANCER RES, V67, P1645, DOI 10.1158/0008-5472.CAN-06-2980; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Garlick JA, 1996, J DENT RES, V75, P912, DOI 10.1177/00220345960750030801; GARLICK JA, 1994, LAB INVEST, V70, P916; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guo C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-23; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Herold-Mende C, 2001, CELL TISSUE RES, V306, P399, DOI 10.1007/s004410100462; Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Pylayeva Y, 2007, METHOD ENZYMOL, V426, P439, DOI 10.1016/S0076-6879(07)26019-7; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Segal N, 2008, MATRIX BIOL, V27, P163, DOI 10.1016/j.matbio.2007.09.002; Vaccariello M, 1999, J INVEST DERMATOL, V113, P384, DOI 10.1046/j.1523-1747.1999.00701.x; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Westmoreland C, 2009, ORGANOGENESIS, V5, P67, DOI 10.4161/org.5.2.9128; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941	29	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10528	10.1371/journal.pone.0010528	http://dx.doi.org/10.1371/journal.pone.0010528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20502640	Green Published, gold, Green Submitted			2022-12-25	WOS:000278017400004
J	Nahid, P; Bliven, EE; Kim, EY; Mac Kenzie, WR; Stout, JE; Diem, L; Johnson, JL; Gagneux, S; Hopewell, PC; Kato-Maeda, M				Nahid, Payam; Bliven, Erin E.; Kim, Elizabeth Y.; Mac Kenzie, William R.; Stout, Jason E.; Diem, Lois; Johnson, John L.; Gagneux, Sebastien; Hopewell, Philip C.; Kato-Maeda, Midori		TB Trials Consortium	Influence of M. tuberculosis Lineage Variability within a Clinical Trial for Pulmonary Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENOTYPE; DIVERSITY; STRAINS	Recent studies suggest that M. tuberculosis lineage and host genetics interact to impact how active tuberculosis presents clinically. We determined the phylogenetic lineages of M. tuberculosis isolates from participants enrolled in the Tuberculosis Trials Consortium Study 28, conducted in Brazil, Canada, South Africa, Spain, Uganda and the United States, and secondarily explored the relationship between lineage, clinical presentation and response to treatment. Large sequence polymorphisms and single nucleotide polymorphisms were analyzed to determine lineage and sublineage of isolates. Of 306 isolates genotyped, 246 (80.4%) belonged to the Euro-American lineage, with sublineage 724 predominating at African sites (99/192, 51.5%), and the Euro-American strains other than 724 predominating at non-African sites (89/114, 78.1%). Uneven distribution of lineages across regions limited our ability to discern significant associations, nonetheless, in univariate analyses, Euro-American sublineage 724 was associated with more severe disease at baseline, and along with the East Asian lineage was associated with lower bacteriologic conversion after 8 weeks of treatment. Disease presentation and response to drug treatment varied by lineage, but these associations were no longer statistically significant after adjustment for other variables associated with week-8 culture status.	[Nahid, Payam; Kim, Elizabeth Y.; Hopewell, Philip C.; Kato-Maeda, Midori] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Natl TB Ctr, San Francisco, CA 94143 USA; [Bliven, Erin E.; Mac Kenzie, William R.; Diem, Lois] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Stout, Jason E.] Duke Univ, Med Ctr, Durham, NC USA; [Johnson, John L.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Gagneux, Sebastien] Natl Inst Med Res, MRC, London NW7 1AA, England; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Duke University; Case Western Reserve University; MRC National Institute for Medical Research; University of Basel; Swiss Tropical & Public Health Institute	Nahid, P (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Natl TB Ctr, San Francisco, CA 94143 USA.	pnahid@ucsf.edu	Kenzie, William R Mac/F-1528-2013; Gagneux, Sebastien/ABE-7909-2020; Mayanja-Kizza, Harriet/AAM-5372-2020	Kenzie, William R Mac/0000-0001-7723-0339; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Narita, Masahiro/0000-0001-5825-5450; Nahid, Payam/0000-0003-2811-1311; Gagneux, Sebastien/0000-0001-7783-9048; Joloba, Moses/0000-0002-0334-9983; de Souza Galvao, Maria Luiza/0000-0001-9703-989X; Stout, Jason/0000-0002-6698-8176	Centers for Disease Control and Prevention; National Institutes of Health through the National Heart, Lung, and Blood Institute [K23HL092629]; National Institute of Allergy and Infectious Diseases [AI034238]; CDC; MRC [MC_U117588500] Funding Source: UKRI; Medical Research Council [MC_U117588500] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health through the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centers for Disease Control and Prevention-funded Tuberculosis Trials Consortium and the National Institutes of Health through the National Heart, Lung, and Blood Institute (K23HL092629) and National Institute of Allergy and Infectious Diseases (AI034238). Several of the authors listed (EEB, LD and WRM) are employed by the the CDC-funded TBTC and are listed as they participated in the analysis of data and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiimwe BB, 2008, INT J TUBERC LUNG D, V12, P386; Burman WJ, 2009, EMERG INFECT DIS, V15, P1061, DOI 10.3201/eid1507.081253; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Cubillos-Ruiz Andres, 2008, BMC Res Notes, V1, P110, DOI 10.1186/1756-0500-1-110; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Manca C, 1999, J IMMUNOL, V162, P6740; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	22	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10753	10.1371/journal.pone.0010753	http://dx.doi.org/10.1371/journal.pone.0010753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505778	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017300023
J	Dudas, S; Yang, JM; Graham, C; Czub, M; McAllister, TA; Coulthart, MB; Czub, S				Dudas, Sandor; Yang, Jianmin; Graham, Catherine; Czub, Markus; McAllister, Tim A.; Coulthart, Michael B.; Czub, Stefanie			Molecular, Biochemical and Genetic Characteristics of BSE in Canada	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRION PROTEIN; STRAIN VARIATION; ATYPICAL BSE; SCRAPIE; IDENTIFICATION; VARIANT; SHEEP; DISCRIMINATION; TRANSMISSION	The epidemiology and possibly the etiology of bovine spongiform encephalopathy (BSE) have recently been recognized to be heterogeneous. In particular, three types [classical (C) and two atypical (H, L)] have been identified, largely on the basis of characteristics of the proteinase K (PK)-resistant core of the misfolded prion protein associated with the disease (PrPres). The present study was conducted to characterize the 17 Canadian BSE cases which occurred prior to November 2009 based on the molecular and biochemical properties of their PrPres, including immunoreactivity, molecular weight, glycoform profile and relative PK sensitivity. Two cases exhibited molecular weight and glycoform profiles similar to those of previously reported atypical cases, one corresponding to H-type BSE (case 6) and the other to L-type BSE (case 11). All other cases were classified as C-type. PK digestion under mild and stringent conditions revealed a reduced protease resistance in both of these cases compared to the C-type cases. With Western immunoblotting, N-terminal-specific antibodies bound to PrPres from case 6 but not to that from case 11 or C-type cases. C-terminal-specific antibodies revealed a shift in the glycoform profile and detected a fourth protein fragment in case 6, indicative of two PrPres subpopulations in H-type BSE. No mutations suggesting a genetic etiology were found in any of the 17 animals by sequencing the full PrP-coding sequence in exon 3 of the PRNP gene. Thus, each of the three known BSE types have been confirmed in Canadian cattle and show molecular characteristics highly similar to those of classical and atypical BSE cases described from Europe, Japan and the USA. The occurrence of atypical cases of BSE in countries such as Canada with low BSE prevalence and transmission risk argues for the occurrence of sporadic forms of BSE worldwide.	[Dudas, Sandor; Yang, Jianmin; Graham, Catherine; Czub, Stefanie] Canadian Food Inspect Agcy Lethbridge Lab, Canadian & OIE Reference Labs BSE, Lethbridge, AB, Canada; [Yang, Jianmin; McAllister, Tim A.] Agr & Agri Food Canada, Res Ctr, Lethbridge, AB, Canada; [Yang, Jianmin] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Czub, Markus] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Coulthart, Michael B.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada	Canadian Food Inspection Agency; Agriculture & Agri Food Canada; China Agricultural University; University of Calgary; Public Health Agency of Canada	Dudas, S (corresponding author), Canadian Food Inspect Agcy Lethbridge Lab, Canadian & OIE Reference Labs BSE, Lethbridge, AB, Canada.	stefanie.czub@inspection.gc.ca	yang, jian/HIK-0188-2022; McAllister, Tim A./R-9201-2017	McAllister, Tim A./0000-0002-8266-6513	Canadian Food Inspection Agency	Canadian Food Inspection Agency	Funding for this project was provided by the Canadian Food Inspection Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Clawson ML, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-51; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1996, LANCET, V347, P916, DOI 10.1016/S0140-6736(96)91407-5; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; DEBOSSCHERE RS, 2004, J APPL RES VET MED, V2, P52; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gavier-Widen D, 2005, J VET DIAGN INVEST, V17, P509, DOI 10.1177/104063870501700601; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; Hagiwara K, 2007, JPN J INFECT DIS, V60, P305; Heaton MP, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-25; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lee HS, 1999, AM J HUM GENET, V64, P1063, DOI 10.1086/302340; Nicholson EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002912; Orge L, 2000, VET REC, V147, P486, DOI 10.1136/vr.147.17.486; Polak MP, 2008, ARCH VIROL, V153, P69, DOI 10.1007/s00705-007-1062-6; Prusiner Stanley B., 2004, VVolume 41, P1; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Richt JA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000156; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Terry LA, 2007, VET REC, V160, P873, DOI 10.1136/vr.160.25.873; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221	37	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10638	10.1371/journal.pone.0010638	http://dx.doi.org/10.1371/journal.pone.0010638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498835	Green Published, gold, Green Submitted			2022-12-25	WOS:000277771600006
J	Bueno, R; De Rienzo, A; Dong, LS; Gordon, GJ; Hercus, CF; Richards, WG; Jensen, RV; Anwar, A; Maulik, G; Chirieac, LR; Ho, KF; Taillon, BE; Turcotte, CL; Hercus, RG; Gullans, SR; Sugarbaker, DJ				Bueno, Raphael; De Rienzo, Assunta; Dong, Lingsheng; Gordon, Gavin J.; Hercus, Colin F.; Richards, William G.; Jensen, Roderick V.; Anwar, Arif; Maulik, Gautam; Chirieac, Lucian R.; Ho, Kim-Fong; Taillon, Bruce E.; Turcotte, Cynthia L.; Hercus, Robert G.; Gullans, Steven R.; Sugarbaker, David J.			Second Generation Sequencing of the Mesothelioma Tumor Genome	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; COPY-NUMBER; LYMPHOBLASTIC-LEUKEMIA; STRUCTURAL VARIATION; GENE-EXPRESSION; CANCER GENOMES; ARRAY-CGH; FUSION; MUTATION; CLONING	The current paradigm for elucidating the molecular etiology of cancers relies on the interrogation of small numbers of genes, which limits the scope of investigation. Emerging second-generation massively parallel DNA sequencing technologies have enabled more precise definition of the cancer genome on a global scale. We examined the genome of a human primary malignant pleural mesothelioma (MPM) tumor and matched normal tissue by using a combination of sequencing-by-synthesis and pyrosequencing methodologies to a 9.6X depth of coverage. Read density analysis uncovered significant aneuploidy and numerous rearrangements. Method-dependent informatics rules, which combined the results of different sequencing platforms, were developed to identify and validate candidate mutations of multiple types. Many more tumor-specific rearrangements than point mutations were uncovered at this depth of sequencing, resulting in novel, large-scale, inter-and intra-chromosomal deletions, inversions, and translocations. Nearly all candidate point mutations appeared to be previously unknown SNPs. Thirty tumor-specific fusions/translocations were independently validated with PCR and Sanger sequencing. Of these, 15 represented disrupted gene-encoding regions, including kinases, transcription factors, and growth factors. One large deletion in DPP10 resulted in altered transcription and expression of DPP10 transcripts in a set of 53 additional MPM tumors correlated with survival. Additionally, three point mutations were observed in the coding regions of NKX6-2, a transcription regulator, and NFRKB, a DNA-binding protein involved in modulating NFKB1. Several regions containing genes such as PCBD2 and DHFR, which are involved in growth factor signaling and nucleotide synthesis, respectively, were selectively amplified in the tumor. Second-generation sequencing uncovered all types of mutations in this MPM tumor, with DNA rearrangements representing the dominant type.	[Bueno, Raphael; De Rienzo, Assunta; Dong, Lingsheng; Gordon, Gavin J.; Richards, William G.; Maulik, Gautam; Chirieac, Lucian R.; Sugarbaker, David J.] Brigham & Womens Hosp, Int Mesothelioma Program, Boston, MA 02115 USA; [Bueno, Raphael; De Rienzo, Assunta; Dong, Lingsheng; Gordon, Gavin J.; Richards, William G.; Maulik, Gautam; Sugarbaker, David J.] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA; [Chirieac, Lucian R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Taillon, Bruce E.; Turcotte, Cynthia L.] 454 Life Sci Inc, Branford, CT USA; [Hercus, Colin F.; Anwar, Arif; Ho, Kim-Fong; Hercus, Robert G.] Synamatix, Kuala Lumpur, Malaysia; [Jensen, Roderick V.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Gullans, Steven R.] Excel Med Ventures, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Virginia Polytechnic Institute & State University	Bueno, R (corresponding author), Brigham & Womens Hosp, Int Mesothelioma Program, 75 Francis St, Boston, MA 02115 USA.	dsugarbaker@partners.org	Chirieac, Lucian R./AAD-2030-2019		International Mesothelioma Program (IMP) at Brigham and Women's Hospital; NCI [P20CA9057801-A1, U01 CA65170-07, U24CA114725-01, RO1 CA 120528, R21/R33 CA 100315]; NATIONAL CANCER INSTITUTE [U01CA065170, R33CA100315, U24CA114725, R21CA100315, R01CA120528, P20CA090578] Funding Source: NIH RePORTER	International Mesothelioma Program (IMP) at Brigham and Women's Hospital; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from the International Mesothelioma Program (IMP) at Brigham and Women's Hospital (www.impmeso.org). DJS is also supported by P20CA9057801-A1, U01 CA65170-07 and U24CA114725-01 from the NCI, WGR is also supported by P20CA9057801-A1 and U24CA114725-01 from the NCI, RB is also supported by RO1 CA 120528 and R21/R33 CA 100315 from the NCI.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Bashir A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000051; Blaschke S, 2002, INT J CANCER, V101, P327, DOI 10.1002/ijc.10623; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; De Rienzo A, 2000, GENE CHROMOSOME CANC, V28, P337, DOI 10.1002/1098-2264(200007)28:3<337::AID-GCC12>3.0.CO;2-B; Gordon GJ, 2009, JNCI-J NATL CANCER I, V101, P678, DOI 10.1093/jnci/djp061; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; HUNCHAREK M, 1995, EUR J CANCER, V31A, P1741, DOI 10.1016/0959-8049(95)00365-P; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joshi N, 2006, CANCER RES, V66, P6851, DOI 10.1158/0008-5472.CAN-06-0662; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim N, 2006, NUCLEIC ACIDS RES, V34, pD21, DOI 10.1093/nar/gkj019; Kindler H L, 2000, Curr Treat Options Oncol, V1, P313, DOI 10.1007/s11864-000-0047-4; Kindler HL, 2008, CURR TREAT OPTION ON, V9, P171, DOI 10.1007/s11864-008-0071-3; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kotackova L, 2009, FOLIA BIOL-PRAGUE, V55, P77; Krug LM, 2005, HEMATOL ONCOL CLIN N, V19, P1117, DOI 10.1016/j.hoc.2005.09.010; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lee SH, 2001, MAMM GENOME, V12, P157, DOI 10.1007/s003350010247; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li HL, 2006, AM J PHYSIOL-CELL PH, V291, pC966, DOI 10.1152/ajpcell.00571.2005; Lindholm PM, 2007, CYTOGENET GENOME RES, V119, P46, DOI 10.1159/000109618; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morales C, 2005, ONCOGENE, V24, P6842, DOI 10.1038/sj.onc.1208834; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Musti M, 2006, CANCER GENET CYTOGEN, V170, P9, DOI 10.1016/j.cancergencyto.2006.04.011; Nelson SB, 2007, DEVELOPMENT, V134, P2491, DOI 10.1242/dev.002691; Ong ST, 1996, J CLIN ONCOL, V14, P1007, DOI 10.1200/JCO.1996.14.3.1007; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pylkkanen L, 2002, ONCOL REP, V9, P955; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Qiao Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-167; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rebouissou S, 2004, ONCOGENE, V23, P7588, DOI 10.1038/sj.onc.1207989; RICHARDS WG, 2007, BIOTECH HISTOCHEM, P1; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Schmid M, 2000, ONCOGENE, V19, P5747, DOI 10.1038/sj.onc.1203942; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Sugarbaker DJ, 2008, P NATL ACAD SCI USA, V105, P3521, DOI 10.1073/pnas.0712399105; Sugarbaker DJ, 2006, J THORAC ONCOL, V1, P175, DOI 10.1097/01243894-200602000-00014; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tyybakinoja A, 2006, GENE CHROMOSOME CANC, V45, P257, DOI 10.1002/gcc.20288; Vauhkonen H, 2007, CYTOGENET GENOME RES, V118, P277, DOI 10.1159/000108311; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whitson BA, 2006, CANCER LETT, V239, P183, DOI 10.1016/j.canlet.2005.08.010; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; XIAO S, 1995, ONCOGENE, V11, P511; Yamamoto F, 2007, ELECTROPHORESIS, V28, P1882, DOI 10.1002/elps.200700093; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	62	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10612	10.1371/journal.pone.0010612	http://dx.doi.org/10.1371/journal.pone.0010612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485525	Green Published, gold, Green Submitted			2022-12-25	WOS:000277633500010
J	van den Boorn, JG; Konijnenberg, D; Tjin, EPM; Picavet, DI; Meeuwenoord, NJ; Filippov, DV; van der Veen, JPW; Bos, JD; Melief, CJM; Luiten, RM				van den Boorn, Jasper G.; Konijnenberg, Debby; Tjin, Esther P. M.; Picavet, Daisy I.; Meeuwenoord, Nico J.; Filippov, Dmitri V.; van der Veen, J. P. Wietze; Bos, Jan D.; Melief, Cornelis J. M.; Luiten, Rosalie M.			Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG	PLOS ONE			English	Article							MURINE MALIGNANT-MELANOMA; DENDRITIC CELLS; IN-VIVO; RECOMBINANT INTERLEUKIN-2; CANCER-IMMUNOTHERAPY; TUMOR-GROWTH; VITILIGO; REGRESSION; INHIBITION; INTERFERON	Background: Presently melanoma still lacks adequate treatment options for metastatic disease. While melanoma is exceptionally challenging to standard regimens, it is suited for treatment with immunotherapy based on its immunogenicity. Since treatment-related skin depigmentation is considered a favourable prognostic sign during melanoma intervention, we here aimed at the reverse approach of directly inducing vitiligo as a shortcut to effective anti-melanoma immunity. Methodology and Principal Findings: We developed an effective and simple to use form of immunotherapy by combining the topical skin-bleaching agent monobenzone with immune-stimulatory imiquimod cream and cytosine-guanine oligodeoxynucleotides (CpG) injections (MIC therapy). This powerful new approach promptly induced a melanoma antigen-specific immune response, which abolished subcutaneous B16. F10 melanoma growth in up to 85% of C57BL/6 mice. Importantly, this regimen induced over 100 days of tumor-free survival in up to 60% of the mice, and forcefully suppressed tumor growth upon re-challenge either 65- or 165 days after MIC treatment cessation. Conclusions: MIC therapy is effective in eradicating melanoma, by vigilantly incorporating NK-, B-and T cells in its therapeutic effect. Based on these results, the MIC regimen presents a high-yield, low-cost and simple therapy, readily applicable in the clinic.	[van den Boorn, Jasper G.; Konijnenberg, Debby; Tjin, Esther P. M.; Picavet, Daisy I.; van der Veen, J. P. Wietze; Bos, Jan D.; Luiten, Rosalie M.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [van den Boorn, Jasper G.; Konijnenberg, Debby; Tjin, Esther P. M.; Picavet, Daisy I.; van der Veen, J. P. Wietze; Bos, Jan D.; Luiten, Rosalie M.] Univ Amsterdam, Acad Med Ctr, Netherlands Inst Pigment Disorders, NL-1105 AZ Amsterdam, Netherlands; [Meeuwenoord, Nico J.; Filippov, Dmitri V.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RA Leiden, Netherlands; [van der Veen, J. P. Wietze] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Dermatol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	van den Boorn, JG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands.	r.m.luiten@amc.uva.nl	Luiten, Rosalie M/I-7633-2019; Filippov, Dmitri/J-7612-2017	Luiten, Rosalie M/0000-0002-0800-0721; Filippov, Dmitri/0000-0002-6978-7425; Tjin, Esther/0000-0001-8642-168X	Dutch Organization for Scientific Research [NWO VIDI 016.056.337]; Dutch Cancer Societ [UvA 2006-3606]	Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Societ	J.G.v.d.B. was supported by a grant from the Dutch Organization for Scientific Research (grant NWO VIDI 016.056.337; www.nwo.nl). E. P. M. T. was supported by a grant from the Dutch Cancer Society (grant UvA 2006-3606; www.kwfkankerbestrijding.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2008, J IMMUNOL, V181, P776, DOI 10.4049/jimmunol.181.1.776; Anbar TS, 2009, J EUR ACAD DERMATOL, V23, P934, DOI 10.1111/j.1468-3083.2009.03233.x; BART RS, 1980, CANCER RES, V40, P614; BECKER SW, 1962, JAMA-J AM MED ASSOC, V180, P279, DOI 10.1001/jama.1962.03050170011003; Berghofer B, 2007, J IMMUNOL, V178, P4072, DOI 10.4049/jimmunol.178.7.4072; Boissy RE, 2004, PIGM CELL RES, V17, P208, DOI 10.1111/j.1600-0749.2004.00130.x; Chen KG, 2009, JNCI-J NATL CANCER I, V101, P1259, DOI 10.1093/jnci/djp259; Cormier JN, 1998, J IMMUNOTHER, V21, P27, DOI 10.1097/00002371-199801000-00003; Fang L, 2008, J INVEST DERMATOL, V128, P2596, DOI 10.1038/jid.2008.101; FORMAN L, 1953, BRIT J DERMATOL, V65, P406, DOI 10.1111/j.1365-2133.1953.tb13174.x; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; GROJEAN MF, 1982, ANN DERMATOL VENER, V109, P641; Hariharan V, 2010, J INVEST DERMATOL, V130, P211, DOI 10.1038/jid.2009.214; KAHN G, 1970, ARCH DERMATOL, V102, P177; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Lonsdorf AS, 2003, J IMMUNOL, V171, P3941, DOI 10.4049/jimmunol.171.8.3941; Luiten RM, 2005, J CLIN ONCOL, V23, P8978, DOI 10.1200/JCO.2005.01.6816; Lyon CC, 1998, CONTACT DERMATITIS, V39, P132, DOI 10.1111/j.1600-0536.1998.tb05863.x; MANINI P, 2009, CHEM RES TOXICOL; MCGUIRE J, 1971, J INVEST DERMATOL, V57, P256, DOI 10.1111/1523-1747.ep12261579; MENTER JM, 1993, MELANOMA RES, V3, P443, DOI 10.1097/00008390-199311000-00007; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; MOSHER DB, 1977, BRIT J DERMATOL, V97, P669, DOI 10.1111/j.1365-2133.1977.tb14275.x; Najar HM, 2008, J INVEST DERMATOL, V128, P2204, DOI 10.1038/jid.2008.59; NAZIH A, 1993, CHEM RES TOXICOL, V6, P215, DOI 10.1021/tx00032a011; OLIVER E. A., 1939, Journal of the American Medical Association, V113, P927; Overwijk WW, 2005, CURR OPIN IMMUNOL, V17, P187, DOI 10.1016/j.coi.2005.01.011; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Quaglino P, 2010, ANN ONCOL, V21, P409, DOI 10.1093/annonc/mdp325; Ray CM, 2005, INT J DERMATOL, V44, P428, DOI 10.1111/j.1365-4632.2005.02582.x; Redondo P, 2007, J INVEST DERMATOL, V127, P1673, DOI 10.1038/sj.jid.5700777; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; ROSENBERG SA, 1985, J EXP MED, V161, P1169, DOI 10.1084/jem.161.5.1169; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Ruckert R, 1998, J INVEST DERMATOL, V111, P25, DOI 10.1046/j.1523-1747.1998.00228.x; Schuurhuis DH, 2006, J IMMUNOL, V176, P4573, DOI 10.4049/jimmunol.176.8.4573; Sharma S, 2003, BIOTECHNOL LETT, V25, P149, DOI 10.1023/A:1021927621813; SIDKY YA, 1992, CANCER RES, V52, P3528; SMITH JL, 1965, CANCER-AM CANCER SOC, V18, P1399, DOI 10.1002/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Switaj T, 2004, CLIN CANCER RES, V10, P4165, DOI 10.1158/1078-0432.CCR-04-0022; Tayama K, 2002, PIGM CELL RES, V15, P447, DOI 10.1034/j.1600-0749.2002.02057.x; van den Boorn JG, 2006, INT REV IMMUNOL, V25, P235, DOI 10.1080/08830180600743081; van den Boorn JG, 2009, J INVEST DERMATOL; Wooldridge JE, 1997, BLOOD, V89, P2994, DOI 10.1182/blood.V89.8.2994	48	26	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10626	10.1371/journal.pone.0010626	http://dx.doi.org/10.1371/journal.pone.0010626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498710	gold, Green Submitted, Green Published			2022-12-25	WOS:000277633500014
J	Engel, A; Aguilar, PS; Walter, P				Engel, Alex; Aguilar, Pablo S.; Walter, Peter			The Yeast Cell Fusion Protein Prm1p Requires Covalent Dimerization to Promote Membrane Fusion	PLOS ONE			English	Article							INFLUENZA HEMAGGLUTININ; LYSIS; MECHANISMS; SNARES	Prm1p is a multipass membrane protein that promotes plasma membrane fusion during yeast mating. The mechanism by which Prm1p and other putative regulators of developmentally controlled cell-cell fusion events facilitate membrane fusion has remained largely elusive. Here, we report that Prm1p forms covalently linked homodimers. Covalent Prm1p dimer formation occurs via intermolecular disulfide bonds of two cysteines, Cys-120 and Cys-545. PRM1 mutants in which these cysteines have been substituted are fusion defective. These PRM1 mutants are normally expressed, retain homotypic interaction and can traffic to the fusion zone. Because prm1-C120S and prm1-C545S mutants can form covalent dimers when coexpressed with wild-type PRM1, an intermolecular C120-C545 disulfide linkage is inferred. Cys-120 is adjacent to a highly conserved hydrophobic domain. Mutation of a charged residue within this hydrophobic domain abrogates formation of covalent dimers, trafficking to the fusion zone, and fusion-promoting activity. The importance of intermolecular disulfide bonding informs models regarding the mechanism of Prm1-mediated cell-cell fusion.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Engel, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	alex.engel@berkeley.edu	Aguilar, Pablo/E-4576-2010; Aguilar, Pablo/AAV-7336-2020	Aguilar, Pablo/0000-0002-9312-2474	National Institutes of Health [5R01GM032384-27]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, grant 5R01GM032384-27 (http://grants.nih.gov/grants/guide/index.html), and Peter Walter is an investigator of the Howard Hughes Medical Institute (http://www.hhmi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2007, MOL BIOL CELL, V18, P547, DOI 10.1091/mbc.E06-09-0776; Clemente-Ramos JA, 2009, MOL MICROBIOL, V73, P695, DOI 10.1111/j.1365-2958.2009.06800.x; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; Blumenthal R, 1999, MOL MEMBR BIOL, V16, P43, DOI 10.1080/096876899294742; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Cho SJ, 2002, ANN NY ACAD SCI, V971, P254, DOI 10.1111/j.1749-6632.2002.tb04471.x; Engel A, 2008, J CELL BIOL, V183, P181, DOI 10.1083/jcb.200805182; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fleissner A, 2009, GENETICS, V181, P497, DOI 10.1534/genetics.108.096149; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jin H, 2004, EUKARYOT CELL, V3, P1664, DOI 10.1128/EC.3.6.1664-1673.2004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Muller M, 2003, BIOPHYS J, V85, P1611, DOI 10.1016/S0006-3495(03)74592-5; Olmo VN, 2010, J BIOL CHEM, V285, P2284, DOI 10.1074/jbc.M109.068874; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Tong SG, 1996, BIOCHEMISTRY-US, V35, P4956, DOI 10.1021/bi9526903; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177	26	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10593	10.1371/journal.pone.0010593	http://dx.doi.org/10.1371/journal.pone.0010593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485669	gold, Green Published, Green Submitted			2022-12-25	WOS:000277563200022
J	Xu, JZ; Seo, AY; Vorobyeva, DA; Carter, CS; Anton, SD; Lezza, AMS; Leeuwenburgh, C				Xu, Jinze; Seo, Arnold Y.; Vorobyeva, Darya A.; Carter, Christy S.; Anton, Stephen D.; Lezza, Angela M. S.; Leeuwenburgh, Christiaan			Beneficial Effects of a Q-ter (R) Based Nutritional Mixture on Functional Performance, Mitochondrial Function, and Oxidative Stress in Rats	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; SKELETAL-MUSCLE APOPTOSIS; COENZYME Q(10); CREATINE SUPPLEMENTATION; MECHANICAL VENTILATION; ANTIOXIDANT CAPACITY; PANAX-GINSENG; INTERFIBRILLAR MITOCHONDRIA; NEURODEGENERATIVE DISEASES; PROTEIN CARBONYLATION	Background: Mitochondrial dysfunction and oxidative stress are central mechanisms underlying the aging process and the pathogenesis of many age-related diseases. Selected antioxidants and specific combinations of nutritional compounds could target many biochemical pathways that affect both oxidative stress and mitochondrial function and, thereby, preserve or enhance physical performance. Methodology/Principal Findings: In this study, we evaluated the potential anti-aging benefits of a Q-ter (R) based nutritional mixture (commercially known as Eufortyn (R)) mainly containing the following compounds: terclatrated coenzyme Q(10) (Q-ter (R)), creatine and a standardized ginseng extract. We found that Eufortyn (R) supplementation significantly ameliorated the age-associated decreases in grip strength and gastrocnemius subsarcolemmal mitochondria Ca(2+) retention capacity when initiated in male Fischer344 x Brown Norway rats at 21 months, but not 29 months, of age. Moreover, the increases in muscle RNA oxidation and subsarcolemmal mitochondrial protein carbonyl levels, as well as the decline of total urine antioxidant power, which develop late in life, were mitigated by Eufortyn (R) supplementation in rats at 29 months of age. Conclusions/Significance: These data imply that Eufortyn (R) is efficacious in reducing oxidative damage, improving the age-related mitochondrial functional decline, and preserving physical performance when initiated in animals at early midlife (21 months). The efficacy varied, however, according to the age at which the supplementation was provided, as initiation in late middle age (29 months) was incapable of restoring grip strength and mitochondrial function. Therefore, the Eufortyn (R) supplementation may be particularly beneficial when initiated prior to major biological and functional declines that appear to occur with advancing age.	[Xu, Jinze; Seo, Arnold Y.; Vorobyeva, Darya A.; Carter, Christy S.; Anton, Stephen D.; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr Res, Inst Aging, Div Biol Aging Genom & Biomarkers Core, Gainesville, FL 32610 USA; [Lezza, Angela M. S.] Univ Bari, Dept Biochem & Mol Biol E Quagliariello, Bari, Italy	State University System of Florida; University of Florida; Universita degli Studi di Bari Aldo Moro	Xu, JZ (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Inst Aging, Div Biol Aging Genom & Biomarkers Core, Gainesville, FL 32610 USA.	jxu@aging.ufl.edu; cleeuwen@aging.ufl.edu	Xu, Jinze/G-7868-2011; Carter, Christy/E-6630-2011	Leeuwenburgh, Christiaan/0000-0003-0826-4257	National Institute on Aging [AG17994]; University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center National Institutes of Health [1 P30 AG028740]; American Heart Association [09POST2060112, 09CRP2390173, 1K23AT004251]; University of Florida Honors Program; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K23AT004251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017994, P30AG028740] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center National Institutes of Health; American Heart Association(American Heart Association); University of Florida Honors Program; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Pharmaland SA, grants to CL from the National Institute on Aging (AG17994), the University of Florida Institute on Aging and the Claude D. Pepper Older Americans Independence Center National Institutes of Health Grant (1 P30 AG028740), fellowship awards from the American Heart Association to JX (09POST2060112) and SDA (09CRP2390173 and 1K23AT004251), and a University Scholars Program award from the University of Florida Honors Program to DAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2008, NEUROMOL MED, V10, P275, DOI 10.1007/s12017-008-8053-y; Adhihetty PJ, 2005, AM J PHYSIOL-CELL PH, V289, pC994, DOI 10.1152/ajpcell.00031.2005; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Barreiro E, 2010, ANTIOXID REDOX SIGN, V12, P417, DOI 10.1089/ars.2009.2808; Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Beal F, 2004, METHOD ENZYMOL, V382, P473; Beal MF, 2003, ANN NEUROL, V53, pS39, DOI 10.1002/ana.10479; Beal MF, 1998, BRAIN RES, V783, P109, DOI 10.1016/S0006-8993(97)01192-X; Bentler SE, 2005, J CLIN PSYCHIAT, V66, P625, DOI 10.4088/JCP.v66n0513; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; Boctor SY, 2010, NEUROTOXICOLOGY, V31, P42, DOI 10.1016/j.neuro.2009.10.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buford TW, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-6; Campos C, 2010, CLIN BIOCHEM, V43, P228, DOI 10.1016/j.clinbiochem.2009.09.017; Carli F., 2003, Patent Number, Patent No. [03097012, 03/097012 A1]; Carter CS, 2009, J GERONTOL A-BIOL, V64, P850, DOI 10.1093/gerona/glp060; Carter CS, 2004, J GERONTOL A-BIOL, V59, P416; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Cleren C, 2008, J NEUROCHEM, V104, P1613, DOI 10.1111/j.1471-4159.2007.05097.x; Cordero MD, 2009, TOXICOL APPL PHARM, V235, P329, DOI 10.1016/j.taap.2008.12.026; Czarkowska-Paczek Bozena, 2006, Przegl Lek, V63, P658; de Oliveira ACC, 2005, J ETHNOPHARMACOL, V97, P211, DOI 10.1016/j.jep.2004.10.029; Dolder M, 2003, J BIOL CHEM, V278, P17760, DOI 10.1074/jbc.M208705200; Engelhardt M, 1998, MED SCI SPORT EXER, V30, P1123, DOI 10.1097/00005768-199807000-00016; Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508; Feng J, 2008, ELECTROPHORESIS, V29, P475, DOI 10.1002/elps.200700262; Fetoni AR, 2009, BRAIN RES, V1257, P108, DOI 10.1016/j.brainres.2008.12.027; Fu Y, 2003, J NUTR, V133, P3603, DOI 10.1093/jn/133.11.3603; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Goffaux J, 2005, SOUTH MED J, V98, P985, DOI 10.1097/01.smj.0000182178.22607.47; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Hofer T, 2009, MECH AGEING DEV, V130, P297, DOI 10.1016/j.mad.2009.01.004; Hyun DH, 2006, AGEING RES REV, V5, P209, DOI 10.1016/j.arr.2006.03.005; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Kehl LJ, 2000, PAIN, V85, P333, DOI 10.1016/S0304-3959(99)00282-1; Kennedy DO, 2003, PHARMACOL BIOCHEM BE, V75, P687, DOI 10.1016/S0091-3057(03)00126-6; Kim YH, 1996, J BIOL CHEM, V271, P24539, DOI 10.1074/jbc.271.40.24539; Kirkland JL, 2009, J GERONTOL A-BIOL, V64, P209, DOI 10.1093/gerona/gln063; Kirschbaum B, 2001, CLIN CHIM ACTA, V305, P167, DOI 10.1016/S0009-8981(01)00381-3; Kooncumchoo P, 2006, J MOL NEUROSCI, V28, P125, DOI 10.1385/JMN:28:2:125; Koren E, 2009, J INHERIT METAB DIS, V32, P651, DOI 10.1007/s10545-009-1242-5; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Leeuwenburgh C, 1999, AM J PHYSIOL-REG I, V276, pR128, DOI 10.1152/ajpregu.1999.276.1.R128; Leeuwenburgh C, 2006, ANTIOXID REDOX SIGN, V8, P503, DOI 10.1089/ars.2006.8.503; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Li G, 2005, BIOFACTORS, V25, P97, DOI 10.1002/biof.5520250111; Li XT, 2009, AM J CHINESE MED, V37, P1139, DOI 10.1142/S0192415X09007454; Littarru GP, 2007, MOL BIOTECHNOL, V37, P31, DOI 10.1007/s12033-007-0052-y; Mahoney DJ, 2002, CURR OPIN CLIN NUTR, V5, P619, DOI 10.1097/00075197-200211000-00004; Mannello F, 2009, CELL ONCOL, V31, P383, DOI 10.3233/CLO-2009-0483; Margetis PI, 2009, EXP MOL PATHOL, V87, P76, DOI 10.1016/j.yexmp.2009.04.001; Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0; Marzetti E, 2008, AM J PHYSIOL-REG I, V294, pR558, DOI 10.1152/ajpregu.00620.2007; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; McCarthy S, 2004, TOXICOL APPL PHARM, V201, P21, DOI 10.1016/j.taap.2004.04.019; McClung JM, 2008, AM J PHYSIOL-REG I, V294, pR1608, DOI 10.1152/ajpregu.00044.2008; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Papucci L, 2003, J BIOL CHEM, V278, P28220, DOI 10.1074/jbc.M302297200; Passaquin AC, 2002, NEUROMUSCULAR DISORD, V12, P174, DOI 10.1016/S0960-8966(01)00273-5; Qian ZM, 2009, J CHROMATOGR A, V1216, P3825, DOI 10.1016/j.chroma.2009.02.065; Raj IS, 2010, EXP GERONTOL, V45, P81, DOI 10.1016/j.exger.2009.10.013; Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688; Sahach V F, 2007, Fiziol Zh, V53, P35; Schmelzer C, 2009, J CLIN BIOCHEM NUTR, V44, P62, DOI 10.3164/jcbn.08-182; Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x; Shanely RA, 2002, AM J RESP CRIT CARE, V166, P1369, DOI 10.1164/rccm.200202-088OC; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4; TAKAHASHI T, 1993, LIPIDS, V28, P803, DOI 10.1007/BF02536234; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001; Tatar M, 2009, J GERONTOL A-BIOL, V64, P161, DOI 10.1093/gerona/gln067; Voces J, 2004, BRAZ J MED BIOL RES, V37, P1863, DOI 10.1590/S0100-879X2004001200012; Volek JS, 1999, MED SCI SPORT EXER, V31, P1147, DOI 10.1097/00005768-199908000-00011; Werbach M R, 2000, Altern Med Rev, V5, P93; Williams MH, 1998, J AM COLL NUTR, V17, P216, DOI 10.1080/07315724.1998.10718751; Willoughby DS, 2003, MED SCI SPORT EXER, V35, P923, DOI 10.1249/01.MSS.0000069746.05241.F0; Willoughby DS, 2001, MED SCI SPORT EXER, V33, P1674, DOI 10.1097/00005768-200110000-00010; Xie XS, 2009, J ETHNOPHARMACOL, V122, P35, DOI 10.1016/j.jep.2008.11.020; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Zergeroglu MA, 2003, J APPL PHYSIOL, V95, P1116, DOI 10.1152/japplphysiol.00824.2002; ZHANG YY, 1995, J NUTR, V125, P446; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023; Zmitek J, 2008, ANN NUTR METAB, V52, P281, DOI 10.1159/000129661	91	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10572	10.1371/journal.pone.0010572	http://dx.doi.org/10.1371/journal.pone.0010572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485503	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563200008
J	Slagter, HA; Johnstone, T; Beets, IAM; Davidson, RJ				Slagter, Heleen A.; Johnstone, Tom; Beets, Iseult A. M.; Davidson, Richard J.			Neural Competition for Conscious Representation across Time: An fMRI Study	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; ATTENTIONAL BLINK; TEMPORAL ATTENTION; TASK; CORTEX; PERCEPTION; MASKING; SUPPRESSION; PERFORMANCE; SELECTION	Background: The information processing capacity of the human mind is limited, as is evidenced by the attentional blink (AB) - a deficit in identifying the second of two temporally-close targets (T1 and T2) embedded in a rapid stream of distracters. Theories of the AB generally agree that it results from competition between stimuli for conscious representation. However, they disagree in the specific mechanisms, in particular about how attentional processing of T1 determines the AB to T2. Methodology/Principal Findings: The present study used the high spatial resolution of functional magnetic resonance imaging ( fMRI) to examine the neural mechanisms underlying the AB. Our research approach was to design T1 and T2 stimuli that activate distinguishable brain areas involved in visual categorization and representation. ROI and functional connectivity analyses were then used to examine how attentional processing of T1, as indexed by activity in the T1 representation area, affected T2 processing. Our main finding was that attentional processing of T1 at the level of the visual cortex predicted T2 detection rates Those individuals who activated the T1 encoding area more strongly in blink versus no-blink trials generally detected T2 on a lower percentage of trials. The coupling of activity between T1 and T2 representation areas did not vary as a function of conscious T2 perception. Conclusions/Significance: These data are consistent with the notion that the AB is related to attentional demands of T1 for selection, and indicate that these demands are reflected at the level of visual cortex. They also highlight the importance of individual differences in attentional settings in explaining AB task performance.	[Slagter, Heleen A.] Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands; [Slagter, Heleen A.; Johnstone, Tom; Beets, Iseult A. M.; Davidson, Richard J.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Johnstone, Tom] Univ Reading, Sch Psychol, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England; [Johnstone, Tom] Univ Reading, CLS, Reading, Berks, England; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Amsterdam; University of Wisconsin System; University of Wisconsin Madison; University of Reading; University of Reading; University of Wisconsin System; University of Wisconsin Madison	Slagter, HA (corresponding author), Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands.	h.a.slagter@uva.nl	Slagter, Heleen/ABF-1338-2020; Johnstone, Tom/C-5909-2011	Slagter, Heleen/0000-0002-4180-1483; Johnstone, Tom/0000-0001-8635-8158; Davidson, Richard/0000-0002-8506-4964	National Institute of Mental Health [R01-MH43454]; University of Leiden, The Netherlands; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043454] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Leiden, The Netherlands(Netherlands Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institute of Mental Health (R01-MH43454 to RJD) and an outbound study grant from the University of Leiden, The Netherlands (to IAMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CRASTON P, J COGNITIVE IN PRESS; DESIMONE R, 2005, ANN REV NEUROSCIL, V8, P193; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ., 2004, HUMAN BRAIN FUNCTION, P971, DOI DOI 10.1016/B978-012264841-0/50050-0; Giesbrecht B, 1998, J EXP PSYCHOL HUMAN, V24, P1454, DOI 10.1037/0096-1523.24.5.1454; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Hein G, 2009, J COGNITIVE NEUROSCI, V21, P197, DOI 10.1162/jocn.2008.21026; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Johnston SJ, 2007, NEUROREPORT, V18, P1475, DOI 10.1097/WNR.0b013e3282cdeefd; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Jolicoeur P, 1999, J EXP PSYCHOL HUMAN, V25, P1097, DOI 10.1037/0096-1523.25.4.1097; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kranczioch C, 2005, NEUROIMAGE, V24, P704, DOI 10.1016/j.neuroimage.2004.09.024; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Kranczioch C, 2007, NEUROIMAGE, V37, P947, DOI 10.1016/j.neuroimage.2007.05.044; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Marcantoni WS, 2003, BRAIN COGNITION, V53, P318, DOI 10.1016/S0278-2626(03)00134-9; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mumford JA, 2008, NEUROIMAGE, V39, P261, DOI 10.1016/j.neuroimage.2007.07.061; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Seiffert AE, 1997, J EXP PSYCHOL HUMAN, V23, P1061, DOI 10.1037/0096-1523.23.4.1061; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; Shapiro KL, 2007, NEUROREPORT, V18, P341, DOI 10.1097/WNR.0b013e32801299e2; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Slagter HA, 2009, J COGNITIVE NEUROSCI, V21, P1536, DOI 10.1162/jocn.2009.21125; Stein T, 2008, NEUROREPORT, V19, P1277, DOI 10.1097/WNR.0b013e32830bab02; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Visser TAW, 2007, J EXP PSYCHOL HUMAN, V33, P285, DOI 10.1037/0096-1523.33.2.285; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Ward R, 1996, COGNITIVE PSYCHOL, V30, P79, DOI 10.1006/cogp.1996.0003; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Williams MA, 2008, J NEUROSCI, V28, P9890, DOI 10.1523/JNEUROSCI.3057-08.2008; WYBLE B, J EXP PSYCH IN PRESS	58	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10556	10.1371/journal.pone.0010556	http://dx.doi.org/10.1371/journal.pone.0010556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479939	Green Published, gold, Green Submitted			2022-12-25	WOS:000277467900012
J	Seng, S; Avraham, HK; Birrane, G; Jiang, SX; Avraham, S				Seng, Seyha; Avraham, Hava Karsenty; Birrane, Gabriel; Jiang, Shuxian; Avraham, Shalom			Nuclear Matrix Protein (NRP/B) Modulates the Nuclear Factor (Erythroid-derived 2)-related 2 (NRF2)-dependent Oxidative Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; DT-DIAPHORASE; ALZHEIMERS-DISEASE; PROCESS ELONGATION; NEURITE OUTGROWTH; HEME OXYGENASE-1; BRAIN-TUMORS; NRF2; GENE; CANCER	Reactive molecules have diverse effects on cells and contribute to several pathological conditions. Cells have evolved complex protective systems to neutralize these molecules and restore redox homeostasis. Previously, we showed that association of nuclear factor (NF)-erythroid-derived 2 (E2)-related factor 2 (NRF2) with the nuclear matrix protein NRP/B was essential for the transcriptional activity of NRF2 target genes in tumor cells. The present study demonstrates the molecular mechanism by which NRP/B, via NRF2, modulates the transcriptional activity of antioxidant response element (ARE)-driven genes. NRP/B is localized in the nucleus of primary brain tissue and human neuroblastoma (SH-SY5Y) cells. Treatment with hydrogen peroxide (H2O2) enhances the nuclear colocalization of NRF2 and NRP/B and induces heme oxygenase 1 (HO1). Treatment of NRP/B or NRF2 knockdowns with H2O2 induced apoptosis. Co-expression of NRF2 with members of the Kelch protein family, NRP/B, MAYVEN, or MAYVEN-related protein 2 (MRP2), revealed that the NRF2-NRP/B complex is important for the transcriptional activity of ARE-driven genes HO1 and NAD(P) H: quinine oxidoreductase 1 (NQO1). NRP/B interaction with Nrf2 was mapped to NRF2 ECH homology 4 (Neh4)/Neh5 regions of NRF2. NRP/B mutations that resulted in low binding affinity to NRF2 were unable to activate NRF2-modulated transcriptional activity of the ARE-driven genes, HO1 and NQO1. Thus, the interaction of NRP/B with the Neh4/Neh5 domains of NRF2 is indispensable for activation of NRF2-mediated ARE-driven antioxidant and detoxifying genes that confer cellular defense against oxidative stress-induced damage.	Beth Israel Deaconess Med Ctr, Div Expt Med, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Avraham, S (corresponding author), 99 Brookline Ave, Boston, MA 02215 USA.	savraham@bidmc.harvard.edu		Avraham, Hava/0000-0002-7545-3640; Birrane, Gabriel/0000-0002-1759-5499	National Institutes of Health [HL80699, CA096805, CA135226]; Department of Defense Cancer Concept; Flight Attendant Medical Research Institute Young Clinical Scientist Faculty; NATIONAL CANCER INSTITUTE [R21CA135226, R01CA096805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Cancer Concept(United States Department of Defense); Flight Attendant Medical Research Institute Young Clinical Scientist Faculty; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL80699 (to S.A.), CA096805 (to H.K.A.), CA135226 (to H.K.A.), a Department of Defense Cancer Concept Award (to S.A.), and Flight Attendant Medical Research Institute Young Clinical Scientist Faculty Award (to S.S.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Begleiter A, 1997, ONCOL RES, V9, P371; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; Chung SW, 2005, J BIOL CHEM, V280, P4578, DOI 10.1074/jbc.M409125200; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Ghanbari HA, 2004, AGING CELL, V3, P41, DOI 10.1111/j.1474-9728.2004.00083.x; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Jiang S, 2005, J NEUROCHEM, V92, P1191, DOI 10.1111/j.1471-4159.2004.02946.x; Jiang SX, 2007, J BIOL CHEM, V282, P12319, DOI 10.1074/jbc.M701019200; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim TA, 2005, J CELL SCI, V118, P5537, DOI 10.1242/jcs.02643; Kim TA, 1998, J CELL BIOL, V141, P553, DOI 10.1083/jcb.141.3.553; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Liang XQ, 2004, ONCOGENE, V23, P5890, DOI 10.1038/sj.onc.1207776; Mhatre M, 2004, J ALZHEIMERS DIS, V6, P147; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; RILEY RJ, 1992, BIOCHEM PHARMACOL, V43, P1657, DOI 10.1016/0006-2952(92)90694-E; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; ROSS D, 1993, CANCER METAST REV, V12, P83, DOI 10.1007/BF00689803; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seng S, 2009, ONCOGENE, V28, P378, DOI 10.1038/onc.2008.396; Seng S, 2007, CANCER RES, V67, P8596, DOI 10.1158/0008-5472.CAN-06-3785; Seng S, 2006, MOL CELL BIOL, V26, P8371, DOI 10.1128/MCB.02167-05; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Taille C, 2003, J BIOL CHEM, V278, P27160, DOI 10.1074/jbc.M300364200; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Zhang M, 2002, CELL RES, V12, P123, DOI 10.1038/sj.cr.7290118; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	41	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26190	26198		10.1074/jbc.M109.095786	http://dx.doi.org/10.1074/jbc.M109.095786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20511222	hybrid, Green Published			2022-12-25	WOS:000280921000036
J	Cryle, MJ; Meinhart, A; Schlichting, I				Cryle, Max J.; Meinhart, Anton; Schlichting, Ilme			Structural Characterization of OxyD, a Cytochrome P450 Involved in beta-Hydroxytyrosine Formation in Vancomycin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO-TRANSCRIBED GENES; GLYCOPEPTIDE ANTIBIOTICS; PROTEIN-STRUCTURE; MOLECULAR CHARACTERIZATION; PEPTIDYL MOIETY; AMINO-ACID; CLUSTER; IDENTIFICATION; INSIGHTS; MODEL	The cytochrome P450 OxyD from the balhimycin glycopeptide antibiotic biosynthetic operon of Amycolatopsis mediterranei is involved in the biosynthesis of the modified amino acid beta-R-hydroxytyrosine,an essential precursor for biosynthesis of the vancomycin-type aglycone. OxyD binds the substrate tyrosine not free in solution, but rather covalently linked to the carrier protein (CP) domain of the non-ribosomal peptide synthase BpsD, exhibiting micromolar binding affinity to a tyrosine-loaded carrier protein construct. The crystal structure of OxyD was determined to 2.1-angstrom resolution, revealing a potential binding site for the carrier protein-bound substrate in a different orientation to that seen with the acyl carrier protein-bound P450(BioI) (Cryle, M. J., and Schlichting, I. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 15696-15701). A series of residues were identified across known aminoacyl-CP-oxidizing P450s that are highly conserved and cluster in the active site or potential CP binding site of OxyD. These residues appear to be characteristic for aminoacyl-CP-oxidizing P450s, allowing sequence based identification of P450 function for this subgroup of P450s that play vital roles in the biosyntheses of many important natural products in addition to the vancomycin-type antibiotics. The ability to analyze such P450 function based upon sequence data alone should prove an important tool in the analysis and identification of new medicinally relevant biomolecules.	[Cryle, Max J.; Meinhart, Anton; Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Cryle, MJ (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	Max.Cryle@mpimf-heidelberg.mpg.de	Cryle, Max/H-7656-2017; Schlichting, Ilme/I-1339-2013; Meinhart, Anton/M-9647-2014	Cryle, Max/0000-0002-9739-6157; 	Human Frontier Science Program (Cross Disciplinary Fellowship)	Human Frontier Science Program (Cross Disciplinary Fellowship)(Human Frontier Science Program)	Supported by the Human Frontier Science Program (Cross Disciplinary Fellowship). To whom correspondence should be addressed: Max-Planck Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P4688, DOI 10.1002/1521-3773(20011217)40:24<4688::AID-ANIE4688>3.0.CO;2-M; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P1693, DOI 10.1002/1521-3773(20010504)40:9<1693::AID-ANIE16930>3.0.CO;2-8; Bischoff D, 2005, CHEMBIOCHEM, V6, P267, DOI 10.1002/cbic.200400328; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruntner C, 1999, MOL GEN GENET, V262, P102; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Cryle MJ, 2003, AUST J CHEM, V56, P749, DOI 10.1071/CH03040; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEMONTELLANO PRO, 2008, CYTOCHROME P450 STRU, P183; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Ehmann DE, 2000, CHEM BIOL, V7, P765, DOI 10.1016/S1074-5521(00)00022-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galm U, 2009, MOL BIOSYST, V5, P77, DOI 10.1039/b814075h; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GOTOH O, 1992, J BIOL CHEM, V267, P83; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; Jungmann V, 2005, APPL ENVIRON MICROB, V71, P6968, DOI 10.1128/AEM.71.11.6968-6976.2005; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauer B, 2001, MOL GEN GENET, V264, P662, DOI 10.1007/s004380000352; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; Mulyani S, 2010, CHEMBIOCHEM, V11, P266, DOI 10.1002/cbic.200900600; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolaou KC, 1999, ANGEW CHEM INT EDIT, V38, P2096, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2096::AID-ANIE2096>3.0.CO;2-F; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pelzer S, 1999, ANTIMICROB AGENTS CH, V43, P1565, DOI 10.1128/AAC.43.7.1565; PETERSON JA, 1992, J BIOL CHEM, V267, P14193; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Puk O, 2004, J BACTERIOL, V186, P6093, DOI 10.1128/jb.186.18.6093-6100.2004; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Recktenwald J, 2002, MICROBIOL-SGM, V148, P1105, DOI 10.1099/00221287-148-4-1105; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Solenberg PJ, 1997, CHEM BIOL, V4, P195, DOI 10.1016/S1074-5521(97)90288-X; Steffensky M, 2000, ANTIMICROB AGENTS CH, V44, P1214, DOI 10.1128/AAC.44.5.1214-1222.2000; Stegmann E, 2006, J BIOTECHNOL, V124, P640, DOI 10.1016/j.jbiotec.2006.04.009; Strieker M, 2009, J AM CHEM SOC, V131, P13523, DOI 10.1021/ja9054417; Sussmuth RD, 1999, ANGEW CHEM INT EDIT, V38, P1976, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1976::AID-ANIE1976>3.0.CO;2-3; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6; Wang ZX, 2000, ANTIMICROB AGENTS CH, V44, P3040, DOI 10.1128/AAC.44.11.3040-3048.2000; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Williams DH, 1999, ANGEW CHEM INT EDIT, V38, P1173, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Woithe K, 2007, J AM CHEM SOC, V129, P6887, DOI 10.1021/ja071038f; YU CA, 1974, J BIOL CHEM, V249, P94; Zerbe K, 2002, J BIOL CHEM, V277, P47476, DOI 10.1074/jbc.M206342200	62	50	50	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24562	24574		10.1074/jbc.M110.131904	http://dx.doi.org/10.1074/jbc.M110.131904			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519494	Green Published, hybrid			2022-12-25	WOS:000280542100028
J	Kavran, JM; Ward, MD; Oladosu, OO; Mulepati, S; Leahy, DJ				Kavran, Jennifer M.; Ward, Matthew D.; Oladosu, Oyindamola O.; Mulepati, Sabin; Leahy, Daniel J.			All Mammalian Hedgehog Proteins Interact with Cell Adhesion Molecule, Down-regulated by Oncogenes (CDO) and Brother of CDO (BOC) in a Conserved Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRACHYDACTYLY TYPE A1; CRYSTAL-STRUCTURE; PATHWAY; MUTATIONS; DOMAIN; ACTIVATION; COMPLEX; LIGAND; CANCER; ACTS	Hedgehog (Hh) signaling proteins stimulate cell proliferation, differentiation, and tissue patterning at multiple points in animal development. A single Hh homolog is present in Drosophila, but three Hh homologs, Sonic Hh, Indian Hh, and Desert Hh, are present in mammals. Distribution, movement, and reception of Hh signals are tightly regulated, and abnormal Hh signaling is associated with developmental defects and cancer. In addition to the integral membrane proteins Patched and Smoothened, members of the Drosophila Ihog family of adhesion-like molecules have recently been shown to bind Hh proteins with micromolar affinity and positively regulate Hh signaling. Cell adhesion molecule-related, down-regulated by oncogenes (CDO) and Brother of CDO (BOC) are the closest mammalian relatives of Drosophila Ihog, and CDO binds Sonic Hh with micromolar affinity and positively regulates Hh signaling. Despite these similarities, structural and biochemical studies have shown that Ihog and CDO utilize nonorthologous domains and completely different binding modes to interact with cognate Hh proteins. We report here biochemical and x-ray structural studies of Sonic, Indian, and Desert Hh proteins both alone and complexed with active domains of CDO and BOC. These results show that all mammalian Hh proteins bind CDO and BOC in the same manner. We also show that interactions between Hh proteins and CDO are weakened at low pH. Formation of Hh-mediated Hh oligomers is thought to be an important feature of normal Hh signaling, but no conserved self-interaction between Hh proteins is apparent from inspection of 14 independent Hh-containing crystal lattices.	[Kavran, Jennifer M.; Ward, Matthew D.; Oladosu, Oyindamola O.; Mulepati, Sabin; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Leahy, DJ (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	dleahy@jhmi.edu			National Institutes of Health [R01HD055545]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055545] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD055545.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Byrnes AM, 2009, EUR J HUM GENET, V17, P1112, DOI 10.1038/ejhg.2009.18; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Guo SZ, 2010, CELL MOL BIOL LETT, V15, P153, DOI 10.2478/s11658-009-0040-2; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liu MG, 2006, J HUM GENET, V51, P727, DOI 10.1007/s10038-006-0012-6; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Valdar WSJ, 2001, J MOL BIOL, V313, P399, DOI 10.1006/jmbi.2001.5034; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	40	48	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24584	24590		10.1074/jbc.M110.131680	http://dx.doi.org/10.1074/jbc.M110.131680			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519495	Green Published, hybrid			2022-12-25	WOS:000280542100030
J	Chuang, TD; Chen, SJ; Lin, FF; Veeramani, S; Kumar, S; Batra, SK; Tu, YP; Lin, MF				Chuang, Tsai-Der; Chen, Siu-Ju; Lin, Fen-Fen; Veeramani, Suresh; Kumar, Satyendra; Batra, Surinder K.; Tu, Yaping; Lin, Ming-Fong			Human Prostatic Acid Phosphatase, an Authentic Tyrosine Phosphatase, Dephosphorylates ErbB-2 and Regulates Prostate Cancer Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN-INDEPENDENT PROLIFERATION; SIGNAL TRANSDUCER; IN-VITRO; RECEPTOR; EXPRESSION; PROTEIN; PHOSPHORYLATION; ACTIVATION; KINASE; SITE	Cellular prostatic acid phosphatase (cPAcP), an authentic tyrosine phosphatase, is proposed to function as a negative growth regulator of prostate cancer (PCa) cells in part through its dephosphorylation of ErbB-2. Nevertheless, the direct interaction between cPAcP and ErbB-2 has not been shown nor the specific dephosphorylation site of ErbB-2 by cPAcP. In this report, our data show that the phosphorylation level of ErbB-2 primarily at Tyr(1221/2) correlates with the growth rate of both LNCaP and MDA PCa2b human PCa cells. Further, cPAcP reciprocally co-immunoprecipitated with ErbB-2 in a non-permissive growth condition. Expression of wild type cPAcP, but not inactive mutant, by cDNA in cPAcP-null LNCaP C-81 cells results in decreased tyrosine phosphorylation of ErbB-2 including Tyr(1221/2). Concurrently, Tyr(317) phosphorylation of p52(Shc), proliferating cell nuclear antigen expression, and cell growth are decreased in these cells. Conversely, decreased cPAcP expression by short hairpin RNA in LNCaP C-33 cells was associated with elevated phosphorylation of ErbB-2 initially at Tyr(1221/2). Its downstream p52(Shc), ERK1/2, Akt, Src, STAT-3, and STAT-5 were activated, and cell proliferation, proliferating cell nuclear antigen, and cyclin D1 expression were increased. Stable subclones of C-33 cells by small interfering PAcP had elevated Tyr(1221/2) phosphorylation of ErbB-2 and exhibited androgen-independent growth and increased tumorigenicity in xenograft female animals. In summary, our data together indicate that in prostate epithelia, cPAcP interacts with and dephosphorylates ErbB-2 primarily at Tyr(1221/2) and hence blocks downstream signaling, leading to reduced cell growth. In PCa cells, decreased cPAcP expression is associated with androgen-independent cell proliferation and tumorigenicity as seen in advanced hormone-refractory prostate carcinomas.	[Chuang, Tsai-Der; Chen, Siu-Ju; Lin, Fen-Fen; Veeramani, Suresh; Kumar, Satyendra; Batra, Surinder K.; Lin, Ming-Fong] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Batra, Surinder K.; Lin, Ming-Fong] Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Tu, Yaping] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Creighton University	Lin, MF (corresponding author), 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	mlin@unmc.edu	Veeramani, Suresh/P-7838-2019	Veeramani, Suresh/0000-0001-9217-0872	National Institutes of Health [2R01CA88184, P20RR018759]; United States Department of Defense [PC074289, PC050769]; Nebraska Research Initiative; NATIONAL CANCER INSTITUTE [R01CA088184] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Nebraska Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01CA88184 (to M.-F.L.) and P20RR018759 (to S.-J.C.). This study was also supported by United States Department of Defense Grants PC074289 and PC050769 and the Nebraska Research Initiative.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; BENLEVY R, 1994, EMBO J, V13, P3302, DOI 10.1002/j.1460-2075.1994.tb06632.x; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Calvo BF, 2003, CLIN CANCER RES, V9, P1087; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; CULIG Z, 1995, EUR UROL, V27, P45; Dagvadorj A, 2008, CLIN CANCER RES, V14, P1317, DOI 10.1158/1078-0432.CCR-07-2024; FOTI AG, 1977, CLIN CHEM, V23, P95; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Gioeli D, 1999, CANCER RES, V59, P279; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Igawa T, 2003, PROSTATE, V55, P247, DOI 10.1002/pros.10240; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Lee MS, 2004, ONCOGENE, V23, P3048, DOI 10.1038/sj.onc.1207451; Lee MS, 2003, ONCOGENE, V22, P781, DOI 10.1038/sj.onc.1206066; LI HC, 1984, EUR J BIOCHEM, V138, P45, DOI 10.1111/j.1432-1033.1984.tb07879.x; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; Lin MF, 1996, BIOCHEM BIOPH RES CO, V226, P206, DOI 10.1006/bbrc.1996.1334; LIN MF, 1986, MOL CELL BIOL, V6, P4753, DOI 10.1128/MCB.6.12.4753; LIN MF, 1986, BIOCHEM J, V235, P351, DOI 10.1042/bj2350351; Lin MF, 1998, J BIOL CHEM, V273, P5939, DOI 10.1074/jbc.273.10.5939; LIN MF, 1993, CELL MOL BIOL RES, V39, P739; LIN MF, 1992, CANCER RES, V52, P4600; LIN MF, 1994, DIFFERENTIATION, V57, P143, DOI 10.1046/j.1432-0436.1994.5720143.x; Lin MF, 2001, J UROLOGY, V166, P1943, DOI 10.1016/S0022-5347(05)65725-4; LIN MF, 1983, BIOCHEMISTRY-US, V22, P1055, DOI 10.1021/bi00274a009; Luchter-Wasylewska E, 2003, J PROTEIN CHEM, V22, P243, DOI 10.1023/A:1025016402860; Luchter-Wasylewska E, 2001, BBA-PROTEIN STRUCT M, V1548, P257, DOI 10.1016/S0167-4838(01)00239-4; Malinowska K, 2009, ENDOCR-RELAT CANCER, V16, P155, DOI 10.1677/ERC-08-0174; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Meng TC, 2000, ONCOGENE, V19, P2664, DOI 10.1038/sj.onc.1203576; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; MIKAMI Y, 1992, P NATL ACAD SCI USA, V89, P7335, DOI 10.1073/pnas.89.16.7335; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Osman I, 2001, CLIN CANCER RES, V7, P2643; Rahman M, 2004, CLIN CANCER RES, V10, P2208, DOI 10.1158/1078-0432.CCR-0746-3; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Sharma S, 2005, PROTEINS, V58, P295, DOI 10.1002/prot.20335; Shi Y, 2006, BJU INT, V97, P170, DOI 10.1111/j.1464-410X.2006.05857.x; Signoretti S, 2000, JNCI-J NATL CANCER I, V92, P1918, DOI 10.1093/jnci/92.23.1918; Stevenson LE, 1998, BREAST CANCER RES TR, V49, P119, DOI 10.1023/A:1006007227747; Sweeney C, 2000, ONCOGENE, V19, P5568, DOI 10.1038/sj.onc.1203913; Tan SH, 2008, CANCER RES, V68, P236, DOI 10.1158/0008-5472.CAN-07-2972; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Toualbi-Abed K, 2008, CARCINOGENESIS, V29, P536, DOI 10.1093/carcin/bgm293; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; Veeramani S, 2009, TRENDS BIOCHEM SCI, V34, P273, DOI 10.1016/j.tibs.2009.03.002; VIHKO P, 1988, FEBS LETT, V236, P275, DOI 10.1016/0014-5793(88)80037-1; Wen Y, 2000, CANCER RES, V60, P6841; Zhang HT, 1998, ONCOGENE, V16, P2835, DOI 10.1038/sj.onc.1201820; Zhang L, 2009, CANCER LETT, V285, P58, DOI 10.1016/j.canlet.2009.04.041; Zhang XQ, 2001, J BIOL CHEM, V276, P2544, DOI 10.1074/jbc.M006661200; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	64	39	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23598	23606		10.1074/jbc.M109.098301	http://dx.doi.org/10.1074/jbc.M109.098301			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498373	Green Published, hybrid			2022-12-25	WOS:000280291400009
J	Nijeholt, JALA; Bulacu, M; Marrink, SJ; Driessen, AJM				Nijeholt, Jelger A. Lycklama A.; Bulacu, Monica; Marrink, Siewert Jan; Driessen, Arnold J. M.			Immobilization of the Plug Domain Inside the SecY Channel Allows Unrestricted Protein Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CROSS-LINKING; CONDUCTING CHANNEL; PRECURSOR PROTEINS; FORCE-FIELD; MEMBRANE; PHENOTYPES; EFFICIENT; COMPLEX; PRLA	The SecYEG complex forms a protein-conducting channel in the inner membrane of Escherichia coli to support the translocation of secretory proteins in their unfolded state. The SecY channel is closed at the periplasmic face of the membrane by a small re-entrance loop that connects transmembrane segment 1 with 2b. This helical domain 2a is termed the plug domain. By the introduction of pairs of cysteines and crosslinkers, the plug domain was immobilized inside the channel and connected to transmembrane segment 10. Translocation was inhibited to various degrees depending on the position and crosslinker spacer length. With one of the crosslinked mutants translocation occurred unrestricted. Biochemical characterization of this mutant as well as molecular dynamics simulations suggest that only a limited movement of the plug domain suffices for translocation.	Univ Groningen, Mol Microbiol Groningen Biomol Sci & Biotechnol I, NL-9751 NN Haren, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9751 NN Haren, Netherlands; [Bulacu, Monica; Marrink, Siewert Jan] Univ Groningen, Mol Dynam Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Bulacu, Monica; Marrink, Siewert Jan] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Kerklaan 30, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012; Bulacu, Monica/B-4888-2009; Marrink, Siewert J/G-3706-2014; Institute, Zernike/W-7033-2019	Marrink, Siewert J/0000-0001-8423-5277; Driessen, Arnold J.M./0000-0001-9258-9104	Chemical Sciences Division of The Netherlands Organization for Scientific Research (NWO-CW)	Chemical Sciences Division of The Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Chemical Sciences Division of The Netherlands Organization for Scientific Research (NWO-CW).	BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Gumbart J, 2008, J GEN PHYSIOL, V132, P709, DOI 10.1085/jgp.200810062; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nouwen N, 2001, FEBS LETT, V508, P103, DOI 10.1016/S0014-5793(01)03033-2; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Sengupta D, 2009, MOL MEMBR BIOL, V26, P422, DOI 10.3109/09687680903321073; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; Yefimov S, 2008, BIOPHYS J, V94, P2994, DOI 10.1529/biophysj.107.119966; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	27	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23747	23754		10.1074/jbc.M110.124636	http://dx.doi.org/10.1074/jbc.M110.124636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20489195	Green Published, hybrid			2022-12-25	WOS:000280291400025
J	Alvarez-Curto, E; Ward, RJ; Pediani, JD; Milligan, G				Alvarez-Curto, Elisa; Ward, Richard J.; Pediani, John D.; Milligan, Graeme			Ligand Regulation of the Quaternary Organization of Cell Surface M-3 Muscarinic Acetylcholine Receptors Analyzed by Fluorescence Resonance Energy Transfer (FRET) Imaging and Homogeneous Time-resolved FRET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; PHARMACOLOGICAL CHAPERONES; CONFORMATIONAL-CHANGES; GPCR OLIGOMERIZATION; CHOLINERGIC-RECEPTOR; MOLECULAR-BASIS; LIVE CELLS; DIMERIZATION; DIMERS; BINDING	Flp-In-TM T-REx(TM) 293 cells expressing a wild type human M-3 muscarinic acetylcholine receptor construct constitutively and able to express a receptor activated solely by synthetic ligand (RASSL) form of this receptor on demand maintained response to the muscarinic agonist carbachol but developed response to clozapine N-oxide only upon induction of the RASSL. The two constructs co-localized at the plasma membrane and generated strong ratiometric fluorescence resonance energy transfer (FRET) signals consistent with direct physical interactions. Increasing levels of induction of the FRET donor RASSL did not alter wild type receptor FRET-acceptor levels substantially. However, ratiometric FRET was modulated in a bell-shaped fashion with maximal levels of the donor resulting in decreased FRET. Carbachol, but not the antagonist atropine, significantly reduced the FRET signal. Cell surface homogeneous time-resolved FRET, based on SNAP-tag technology and employing wild type and RASSL forms of the human M-3 receptor expressed stably in Flp-In-TM TREx(TM) 293 cells, also identified cell surface dimeric/oligomeric complexes. Now, however, signals were enhanced by appropriate selective agonists. At the wild type receptor, large increases in FRET signal to carbachol and acetylcholine were concentration-dependent with EC50 values consistent with the relative affinities of the two ligands. These studies confirm the capacity of the human M-3 muscarinic acetylcholine receptor to exist as dimeric/oligomeric complexes at the surface of cells and demonstrate that the organization of such complexes can be modified by ligand binding. However, conclusions as to the effect of ligands on such complexes may depend on the approach used.	[Alvarez-Curto, Elisa; Ward, Richard J.; Pediani, John D.; Milligan, Graeme] Univ Glasgow, Fac Biomed & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Mol Pharmacol Grp, 253 Wolfson Link Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	g.milligan@bio.gla.ac.uk	Pediani, John/F-2708-2019; Milligan, Graeme/F-9426-2011	Pediani, John/0000-0001-6615-537X; Milligan, Graeme/0000-0002-6946-3519	Biotechnology and Biosciences Research Council [BB/E006302/1]; Medical Research Council [G0900050]; BBSRC [BB/E006302/1] Funding Source: UKRI; MRC [G0900050] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E006302/1] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biosciences Research Council Grant BB/E006302/1 and the Medical Research Council Grant G0900050.	ALVAREZCURTO E, 2010, G PROTEIN C IN PRESS; Arcemisbehere L, 2010, J BIOL CHEM, V285, P6337, DOI 10.1074/jbc.M109.083477; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; Bouvier M, 2007, NAT METHODS, V4, P3, DOI 10.1038/nmeth0107-3; Bruysters M, 2005, J BIOL CHEM, V280, P34741, DOI 10.1074/jbc.M504165200; Canals M, 2009, BIOCHEM J, V417, P161, DOI 10.1042/BJ20081227; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; del Burgo LS, 2010, EXPERT OPIN DRUG DIS, V5, P461, DOI 10.1517/17460441003720467; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gandia J, 2008, BIOESSAYS, V30, P82, DOI 10.1002/bies.20682; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Granier S, 2009, METHODS MOL BIOL, V552, P253, DOI 10.1007/978-1-60327-317-6_18; Grant M, 2004, J BIOL CHEM, V279, P36179, DOI 10.1074/jbc.M407310200; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Harrison Charlotte, 2006, Journal of Pharmacological and Toxicological Methods, V54, P26, DOI 10.1016/j.vascn.2005.11.001; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Ilien B, 2009, J BIOL CHEM, V284, P19533, DOI 10.1074/jbc.M109.017145; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kang YK, 2003, ARCH PHARM RES, V26, P846, DOI 10.1007/BF02980031; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Ma AWS, 2007, BIOCHEMISTRY-US, V46, P7907, DOI 10.1021/bi6026105; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Nichols CD, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.016.2009; Novi F, 2004, J BIOL CHEM, V279, P7476, DOI 10.1074/jbc.M306818200; Park PSH, 2003, BIOCHEMISTRY-US, V42, P12960, DOI 10.1021/bi034491m; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; WARD RJ, 2010, METHODS MOL IN PRESS; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zeng FY, 2000, NEUROPSYCHOPHARMACOL, V23, pS19, DOI 10.1016/S0893-133X(00)00146-9; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	58	51	51	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23316	23328		10.1074/jbc.M110.122184	http://dx.doi.org/10.1074/jbc.M110.122184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489201	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000279999900065
J	Robertson, PD; Chagot, B; Chazin, WJ; Eichman, BF				Robertson, Patrick D.; Chagot, Benjamin; Chazin, Walter J.; Eichman, Brandt F.			Solution NMR Structure of the C-terminal DNA Binding Domain of Mcm10 Reveals a Conserved MCM Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION ORIGINS; CYCLIN-DEPENDENT KINASES; POLYMERASE ALPHA-PRIMASE; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION; BUDDING YEAST; BIOCHEMICAL-CHARACTERIZATION; CATALYTIC SUBUNIT; PROTEIN FAMILY; CDC23 MCM10	The eukaryotic DNA replication protein Mcm10 associates with chromatin in early S- phase and is required for assembly and function of the replication fork protein machinery. Xenopus laevis (X) Mcm10bindsDNAvia a highly conserved internal domain (ID) and a C- terminal domain (CTD) that is unique to higher eukaryotes. Although the structural basis of the interactions of the ID with DNA and polymerase similar to is known, little information is available for the CTD. Wehave identified the minimalDNAbinding region of the XMcm10- CTD and determined its three- dimensional structure by solution NMR. The CTD contains a globular domain composed of two zinc binding motifs. NMRchemical shift perturbation and mutational analysis show that ssDNA binds only to the N- terminal (CCCH- type) zinc motif, whose structure is unique to Mcm10. The second (CCCC- type) zinc motif is not involved in DNA binding. However, it is structurally similar to the CCCC zinc ribbon in the N- terminal oligomerization domain of eukaryotic and archaeal MCM helicases. NMR analysis of a construct spanning both the ID and CTD reveals that the two DNA binding domains are structurally independent in solution, supporting a modular architecture for vertebrate Mcm10. Our results provide insight in the action of Mcm10 in the replisome and support a model in which it serves as a central scaffold through coupling of interactions with partner proteins and the DNA.	[Chagot, Benjamin; Chazin, Walter J.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Robertson, Patrick D.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Chazin, Walter J.; Eichman, Brandt F.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu; brandt.eichman@vanderbilt.edu	Chagot, Benjamin/AAC-6495-2019; Chagot, Benjamin/H-3258-2011	Chagot, Benjamin/0000-0002-9153-0060; 	National Institutes of Health [GM080570]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080570, R01GM065484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health GrantsGM080570 (to B. F. E.) andGM065484(to W. J. C.) and the Vanderbilt Discovery Grant Program.	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Brosey CA, 2009, J AM CHEM SOC, V131, P6346, DOI 10.1021/ja9013634; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Dalton S, 1997, MOL CELL BIOL, V17, P5867, DOI 10.1128/MCB.17.10.5867; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Eisenberg S, 2009, J BIOL CHEM, V284, P25412, DOI 10.1074/jbc.M109.033175; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Goddard T. D., 2006, SPARKY 3; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Homesley L, 2000, GENE DEV, V14, P913; Hu HT, 2003, J MOL BIOL, V330, P473, DOI 10.1016/S0022-2836(03)00619-3; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee C, 2010, MOL CELL BIOL, V30, P423, DOI 10.1128/MCB.01240-09; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Liu W, 2008, NUCLEIC ACIDS RES, V36, P3235, DOI 10.1093/nar/gkn183; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Lutzmann M, 2005, GENE, V362, P51, DOI 10.1016/j.gene.2005.07.031; MAINE GT, 1984, GENETICS, V106, P365; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Poplawski A, 2001, J BIOL CHEM, V276, P49371, DOI 10.1074/jbc.M108519200; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Warren EM, 2009, J BIOL CHEM, V284, P24662, DOI 10.1074/jbc.M109.020438; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; YAN H, 1991, GENE DEV, V5, P944, DOI 10.1101/gad.5.6.944; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Yoshida K, 2005, BIOCHEM BIOPH RES CO, V331, P669, DOI 10.1016/j.bbrc.2005.03.222; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	57	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22942	22949		10.1074/jbc.M110.131276	http://dx.doi.org/10.1074/jbc.M110.131276			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489205	hybrid, Green Published			2022-12-25	WOS:000279999900028
J	Spedale, G; Mischerikow, N; Heck, AJR; Timmers, HTM; Pijnappel, WWMP				Spedale, Gianpiero; Mischerikow, Nikolai; Heck, Albert J. R.; Timmers, H. T. Marc; Pijnappel, W. W. M. Pim			Identification of Pep4p as the Protease Responsible for Formation of the SAGA-related SLIK Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; MESSENGER-RNA EXPORT; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; IN-VIVO; COACTIVATOR COMPLEX; CATHEPSIN-D; CELL-DEATH; TRANSCRIPTION; RECRUITMENT	The Saccharomyces cerevisiae Spt-Ada-Gcn5 acetyltransferase (SAGA) protein complex is a coactivator for transcription by RNA polymerase II and has various activities, including acetylation and deubuiqitination of histones and recruitment of TATA-binding protein to promoters. The Spt7p subunit is subject to proteolytic cleavage at its C terminus resulting in removal of the Spt8p-binding domain and generation of the SAGA-related SALSA/SAGA-like (SLIK) protein complex. Here, we report identification of the protease responsible for this cleavage. Screening of a protease knock-out collection revealed PEP4 to be required for cleavage of Spt7p within SAGA in vitro. Endogenous formation of truncated Spt7p was abolished in cells lacking PEP4. Purified Pep4p but not catalytic dead mutant Pep4p or unrelated Prc1p protease specifically cleaved Spt7p within SAGA into SLIK-related Spt7p. Interestingly, SAGA lacking Spt8p was more sensitive to Pep4p-mediated truncation of Spt7p, suggesting that Spt8p counteracted its own release from SAGA. Strains mimicking constitutive SLIK formation showed increased resistance to rapamycin treatment, suggesting a role for SLIK in regulating cellular responses to nutrient stress.	[Pijnappel, W. W. M. Pim] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Spedale, Gianpiero; Mischerikow, Nikolai; Heck, Albert J. R.; Timmers, H. T. Marc; Pijnappel, W. W. M. Pim] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Mischerikow, Nikolai; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Mischerikow, Nikolai; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, NL-3584 CH Utrecht, Netherlands; [Heck, Albert J. R.] Ctr Biomed Genet, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Pijnappel, WWMP (corresponding author), Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	w.w.m.pijnappel@umcutrecht.nl	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; Pijnappel, Pim/0000-0002-7042-2482	Netherlands Genomics Initiative [93516050]; Netherlands Proteomics Centre	Netherlands Genomics Initiative; Netherlands Proteomics Centre	This work was financed by Netherlands Genomics Initiative Horizon Program Grant 93516050 and by the Netherlands Proteomics Centre.	Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Coffman JA, 1997, J BACTERIOL, V179, P5609, DOI 10.1128/jb.179.17.5609-5613.1997; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; EISENMANN DM, 1994, GENETICS, V137, P647; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hoke SM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-46; Hoke Stephen Mt, 2007, BMC Biochemistry, V8, P16, DOI 10.1186/1471-2091-8-16; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Marques M, 2006, MICROBIOL-SGM, V152, P3595, DOI 10.1099/mic.0.29040-0; Mason DA, 2005, FEMS YEAST RES, V5, P1237, DOI 10.1016/j.femsyr.2005.07.008; Mischerikow N, 2009, J PROTEOME RES, V8, P5020, DOI 10.1021/pr900449e; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; Pascual-Garcia P, 2009, RNA BIOL, V6, P141, DOI 10.4161/rna.6.2.7793; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Roberg K, 2001, LAB INVEST, V81, P149, DOI 10.1038/labinvest.3780222; Santos-Rosa H, 2009, NAT STRUCT MOL BIOL, V16, P17, DOI 10.1038/nsmb.1534; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; van Oevelen CJC, 2006, J BIOL CHEM, V281, P4523, DOI 10.1074/jbc.M509330200; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang HS, 2008, J BIOL CHEM, V283, P27360, DOI 10.1074/jbc.M803831200; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	47	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22791	22797		10.1074/jbc.M110.108787	http://dx.doi.org/10.1074/jbc.M110.108787			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498363	Green Published, hybrid			2022-12-25	WOS:000279999900011
J	Huc, E; Meniche, X; Benz, R; Bayan, N; Ghazi, A; Tropis, M; Daffe, M				Huc, Emilie; Meniche, Xavier; Benz, Roland; Bayan, Nicolas; Ghazi, Alexandre; Tropis, Marielle; Daffe, Mamadou			O-Mycoloylated Proteins from Corynebacterium AN UNPRECEDENTED POST-TRANSLATIONAL MODIFICATION IN BACTERIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL CHANNEL; OUTER-MEMBRANE; MYCOLIC ACIDS; GLUTAMICUM; IDENTIFICATION; MYCOBACTERIA; ENVELOPE; BIOSYNTHESIS; TREHALOSE; REVEAL	O-Acylation of proteins was known only in a few eukaryotic proteins but never in bacteria. We demonstrate, using a combination of protein chemistry and mass spectrometry, the occurrence of three O-acylated polypeptides in Corynebacterium glutamicum, PorA, PorH, and an unknown small protein. The three polypeptides are O-substituted by mycolic acids, long chain alpha-alkyl and beta-hydroxy fatty acids specifically produced by members of the Corynebacterineae suborder. To date these acids were described only as esterifying trehalose and arabinogalactan, and less frequently glycerol, important components of the highly impermeable outer barrier of Corynebacterineae. We show that the post-translational mycoloylation of PorA occurs at Ser-15 and is necessary for the pore-forming activity of C. glutamicum.	[Huc, Emilie; Meniche, Xavier; Tropis, Marielle; Daffe, Mamadou] IPBS, Dept Mecanismes Mol Infect Mycobacteriennes, CNRS, F-31077 Toulouse 04, France; [Huc, Emilie; Meniche, Xavier; Tropis, Marielle; Daffe, Mamadou] Univ Toulouse 3, F-31062 Toulouse, France; [Meniche, Xavier; Bayan, Nicolas; Ghazi, Alexandre] Univ Paris 11, CNRS, UMR8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Jacobs University	Tropis, M (corresponding author), IPBS, Dept Mecanismes Mol Infect Mycobacteriennes, CNRS, 205 Route Narbonne, F-31077 Toulouse 04, France.	marielle.tropis@ipbs.fr; mamadou.daffe@ipbs.fr	Bayan, Nicolas/AAI-5034-2020; Claustre, Emilie Huc/M-6693-2016	Claustre, Emilie Huc/0000-0002-8856-207X; Bayan, Nicolas/0000-0001-7760-0811; Benz, Roland/0000-0002-9510-9265	CNRS; University of Toulouse (Paul Sabatier); Agence Nationale de la Recherche [ANR-07-BLAN-0363]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Toulouse (Paul Sabatier); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the CNRS, the University of Toulouse (Paul Sabatier), and the Agence Nationale de la Recherche (Grant ANR-07-BLAN-0363).	Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daffe M., 2005, HDB CORYNEBACTERIUM, P121; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hunten P, 2005, BBA-BIOMEMBRANES, V1715, P25, DOI 10.1016/j.bbamem.2005.07.011; Kacem R, 2004, MICROBIOL-SGM, V150, P73, DOI 10.1099/mic.0.26583-0; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lichtinger T, 2001, EUR J BIOCHEM, V268, P462; Lichtinger T, 1998, BIOCHEMISTRY-US, V37, P15024, DOI 10.1021/bi980961e; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365; Schiffler B, 2007, J BACTERIOL, V189, P7709, DOI 10.1128/JB.00864-07; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	23	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21908	21912		10.1074/jbc.C110.133033	http://dx.doi.org/10.1074/jbc.C110.133033			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20508265	Green Published, hybrid			2022-12-25	WOS:000279702200002
J	Li, PF; Jayarama, S; Ganesh, L; Mordi, D; Carr, R; Kanteti, P; Hay, N; Prabhakar, BS				Li, Peifeng; Jayarama, Shankar; Ganesh, Lakshmy; Mordi, David; Carr, Ryan; Kanteti, Prasad; Hay, Nissim; Prabhakar, Bellur S.			Akt-phosphorylated Mitogen-activated Kinase-activating Death Domain Protein (MADD) Inhibits TRAIL-induced Apoptosis by Blocking Fas-associated Death Domain (FADD) Association with Death Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MADD/DENN SPLICE VARIANT; CELL-SURVIVAL; IG20 GENE; CANCER-CELLS; MITOCHONDRIAL-MEMBRANE; NEOPLASTIC-CELLS; EXCHANGE PROTEIN; CARCINOMA CELLS; DENN-SV; BAX	MADD plays an essential role in cancer cell survival. Abrogation of endogenous MADD expression results in significant spontaneous apoptosis and enhanced susceptibility to tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. However, the regulation of MADD function is largely unknown. Here, we demonstrate that endogenous MADDis phosphorylated at three highly conserved sites by Akt, and only the phosphorylated MADD can directly interact with the TRAIL receptor DR4 thereby preventing Fas-associated death domain recruitment. However, in cells susceptible to TRAIL treatment, TRAIL induces a reduction in MADD phosphorylation levels resulting in MADD dissociation from, and Fas-associated death domain association with DR4, which allows death-inducing signaling complex (DISC) formation leading to apoptosis. Thus, the pro-survival function of MADD is dependent upon its phosphorylation by Akt. Because Akt is active in most cancer cells and phosphorylated MADD confers resistance to TRAIL-induced apoptosis, co-targeting AktMADD axis is likely to increase efficacy of TRAIL-based therapies.	[Li, Peifeng; Jayarama, Shankar; Ganesh, Lakshmy; Mordi, David; Carr, Ryan; Kanteti, Prasad; Prabhakar, Bellur S.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Li, Peifeng; Jayarama, Shankar; Ganesh, Lakshmy; Mordi, David; Carr, Ryan; Kanteti, Prasad; Prabhakar, Bellur S.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Hay, Nissim] Univ Illinois, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Prabhakar, BS (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	bprabhak@uic.edu	Li, Peifeng/ABD-5663-2021; Li, Peifeng/AHE-6906-2022	Li, Peifeng/0000-0002-0969-9407; Carr, Ryan/0000-0001-5762-367X; Jayarama, Shankar/0000-0003-2996-0470	National Institutes of Health [5R01CA107506]; NATIONAL CANCER INSTITUTE [R01CA090764, R01CA107506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01CA107506.	Al-Zoubi AM, 2001, J BIOL CHEM, V276, P47202, DOI 10.1074/jbc.M104835200; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Chow VTK, 1996, DNA SEQUENCE, V6, P263, DOI 10.3109/10425179609020873; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Delmas D, 2004, ONCOGENE, V23, P8979, DOI 10.1038/sj.onc.1208086; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Efimova E, 2003, CANCER RES, V63, P8768; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Guo F, 2002, BLOOD, V99, P3419, DOI 10.1182/blood.V99.9.3419; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kurada BRVVSN, 2009, J BIOL CHEM, V284, P13533, DOI 10.1074/jbc.M808554200; Li LC, 2008, CANCER RES, V68, P7352, DOI 10.1158/0008-5472.CAN-07-6311; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Lim KM, 2004, INT J CANCER, V109, P24, DOI 10.1002/ijc.11660; Lim KM, 2002, MOL CARCINOGEN, V35, P110, DOI 10.1002/mc.10082; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Moreau C, 2003, J BIOL CHEM, V278, P19426, DOI 10.1074/jbc.M209472200; Mulherkar N, 2006, ONCOGENE, V25, P6252, DOI 10.1038/sj.onc.1209650; Mulherkar N, 2007, J BIOL CHEM, V282, P11715, DOI 10.1074/jbc.M701085200; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Prabhakar BS, 2008, CLIN CANCER RES, V14, P347, DOI 10.1158/1078-0432.CCR-07-0493; Ramaswamy M, 2004, ONCOGENE, V23, P6083, DOI 10.1038/sj.onc.1207804; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Subramanian M, 2009, J CLIN ENDOCR METAB, V94, P1467, DOI 10.1210/jc.2008-2378; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Way TD, 2004, J BIOL CHEM, V279, P4479, DOI 10.1074/jbc.M305529200; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	56	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22713	22722		10.1074/jbc.M110.105692	http://dx.doi.org/10.1074/jbc.M110.105692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20484047	Green Published, hybrid			2022-12-25	WOS:000279702200082
J	Dong, J; Jiang, GQ; Asmann, YW; Tomaszek, S; Jen, J; Kislinger, T; Wigle, DA				Dong, Jie; Jiang, Guoqian; Asmann, Yan W.; Tomaszek, Sandra; Jen, Jin; Kislinger, Thomas; Wigle, Dennis A.			MicroRNA Networks in Mouse Lung Organogenesis	PLOS ONE			English	Article							EXPRESSION PROFILES; EMBRYONIC LUNG; MESSENGER-RNAS; BINDING-SITES; IDENTIFICATION; CANCER; PATHWAY; TARGETS; ADENOCARCINOMAS; PROLIFERATION	Background: MicroRNAs (miRNAs) are known to be important regulators of both organ development and tumorigenesis. MiRNA networks and their regulation of messenger RNA (mRNA) translation and protein expression in specific biological processes are poorly understood. Methods: We explored the dynamic regulation of miRNAs in mouse lung organogenesis. Comprehensive miRNA and mRNA profiling was performed encompassing all recognized stages of lung development beginning at embryonic day 12 and continuing to adulthood. We analyzed the expression patterns of dynamically regulated miRNAs and mRNAs using a number of statistical and computational approaches, and in an integrated manner with protein levels from an existing mass-spectrometry derived protein database for lung development. Results: In total, 117 statistically significant miRNAs were dynamically regulated during mouse lung organogenesis and clustered into distinct temporal expression patterns. 11,220 mRNA probes were also shown to be dynamically regulated and clustered into distinct temporal expression patterns, with 3 major patterns accounting for 75% of all probes. 3,067 direct miRNA-mRNA correlation pairs were identified involving 37 miRNAs. Two defined correlation patterns were observed upon integration with protein data: 1) increased levels of specific miRNAs directly correlating with downregulation of predicted mRNA targets; and 2) increased levels of specific miRNAs directly correlating with downregulation of translated target proteins without detectable changes in mRNA levels. Of 1345 proteins analyzed, 55% appeared to be regulated in this manner with a direct correlation between miRNA and protein level, but without detectable change in mRNA levels. Conclusion: Systematic analysis of microRNA, mRNA, and protein levels over the time course of lung organogenesis demonstrates dynamic regulation and reveals 2 distinct patterns of miRNA-mRNA interaction. The translation of target proteins affected by miRNAs independent of changes in mRNA level appears to be a prominent mechanism of developmental regulation in lung organogenesis.	[Dong, Jie; Tomaszek, Sandra; Wigle, Dennis A.] Mayo Clin, Div Gen Thorac Surg, Ctr Canc, Rochester, MN 55905 USA; [Jiang, Guoqian; Asmann, Yan W.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Kislinger, Thomas] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Kislinger, Thomas] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada	Mayo Clinic; Mayo Clinic; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Dong, J (corresponding author), Mayo Clin, Div Gen Thorac Surg, Ctr Canc, Rochester, MN 55905 USA.	wigle.dennis@mayo.edu	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540				Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cox B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100151; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dong J, 2009, CANCER BIOL THER, V8, P312, DOI 10.4161/cbt.8.4.7522; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lu Yun, 2008, Proc Am Thorac Soc, V5, P300, DOI 10.1513/pats.200710-162DR; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reymann S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-46; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	54	62	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10854	10.1371/journal.pone.0010854	http://dx.doi.org/10.1371/journal.pone.0010854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520778	gold, Green Submitted, Green Published			2022-12-25	WOS:000278221500038
J	Kapoula, Z; Yang, Q; Bonnet, A; Bourtoire, P; Sandretto, J				Kapoula, Zoi; Yang, Qing; Bonnet, Audrey; Bourtoire, Pauline; Sandretto, Jean			EMDR Effects on Pursuit Eye Movements	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POSTERIOR PARIETAL CORTEX; SMOOTH-PURSUIT; AUTOBIOGRAPHICAL MEMORIES; DESENSITIZATION; SCHIZOPHRENIA; SACCADES; TRACKING; DEFICITS; FMRI	This study aimed to objectivize the quality of smooth pursuit eye movements in a standard laboratory task before and after an Eye Movement Desensitization and Reprocessing (EMDR) session run on seven healthy volunteers. EMDR was applied on autobiographic worries causing moderate distress. The EMDR session was complete in 5 out of the 7 cases; distress measured by SUDS (Subjective Units of Discomfort Scale) decreased to a near zero value. Smooth pursuit eye movements were recorded by an Eyelink II video system before and after EMDR. For the five complete sessions, pursuit eye movement improved after their EMDR session. Notably, the number of saccade intrusions-catch-up saccades (CUS)-decreased and, reciprocally, there was an increase in the smooth components of the pursuit. Such an increase in the smoothness of the pursuit presumably reflects an improvement in the use of visual attention needed to follow the target accurately. Perhaps EMDR reduces distress thereby activating a cholinergic effect known to improve ocular pursuit.	[Kapoula, Zoi; Yang, Qing; Bonnet, Audrey; Bourtoire, Pauline] Hop Europeen Georges Pompidou, Serv Ophtalmol ORL Stomatol, FRE 3154, Lab IRIS,CNRS, Paris, France; [Bonnet, Audrey; Bourtoire, Pauline] Univ Catholique, Ecole Psychol Praticiens, Paris, France; [Sandretto, Jean] EMDR Assoc France, Res Comm, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Kapoula, Z (corresponding author), Hop Europeen Georges Pompidou, Serv Ophtalmol ORL Stomatol, FRE 3154, Lab IRIS,CNRS, Paris, France.	zoi.kapoula@egp.aphp.fr			CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This study is funded by CNRS (www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 1997, BRIT J CLIN PSYCHOL, V36, P209, DOI 10.1111/j.2044-8260.1997.tb01408.x; Armstrong MS, 1996, J BEHAV THER EXP PSY, V27, P21, DOI 10.1016/0005-7916(95)00056-9; Aubert-Khalfa S, 2008, J EMDR PRACT RES, V2, P51, DOI 10.1891/1933-3196.2.1.51; Barrowcliff AL, 2004, J FORENSIC PSYCHI PS, V15, P325, DOI 10.1080/14789940410001673042; Barrowcliff AL, 2003, BRIT J CLIN PSYCHOL, V42, P289, DOI 10.1348/01446650360703393; Basso MA, 2000, J NEUROPHYSIOL, V84, P892, DOI 10.1152/jn.2000.84.2.892; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; BLACK JL, 1984, PERCEPT MOTOR SKILL, V59, P91, DOI 10.2466/pms.1984.59.1.91; Breese CR, 2000, NEUROPSYCHOPHARMACOL, V23, P351, DOI 10.1016/S0893-133X(00)00121-4; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Elofsson UOE, 2008, J ANXIETY DISORD, V22, P622, DOI 10.1016/j.janxdis.2007.05.012; Frazier SH, 1998, AM J PSYCHIAT, V155, P20; FRIEDMAN L, 1992, BIOL PSYCHIAT, V31, P1110, DOI 10.1016/0006-3223(92)90155-S; Goldberg MC, 2002, NEUROPSYCHOLOGIA, V40, P2039, DOI 10.1016/S0028-3932(02)00059-3; Hogberg G, 2007, NORD J PSYCHIAT, V61, P54, DOI 10.1080/08039480601129408; Hong LE, 2003, SCHIZOPHR RES, V63, P39, DOI 10.1016/S0920-9964(02)00388-2; Kapoula Z, 2001, NEUROREPORT, V12, P4041, DOI 10.1097/00001756-200112210-00037; Karoumi B, 2001, PSYCHIAT RES, V101, P209, DOI 10.1016/S0165-1781(01)00227-X; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Lansing K, 2005, J NEUROPSYCH CLIN N, V17, P526, DOI 10.1176/appi.neuropsych.17.4.526; Lee CW, 2008, J ANXIETY DISORD, V22, P801, DOI 10.1016/j.janxdis.2007.08.007; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Levin P, 1999, J ANXIETY DISORD, V13, P159, DOI 10.1016/S0887-6185(98)00045-0; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Macculloch MJ, 1996, BRIT J PSYCHIAT, V169, P571, DOI 10.1192/bjp.169.5.571; Moschner C, 1999, BRAIN, V122, P2147, DOI 10.1093/brain/122.11.2147; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Ross RG, 2002, PSYCHOPHYSIOLOGY, V39, P809, DOI 10.1111/1469-8986.3960809; Sack M, 2008, J ANXIETY DISORD, V22, P1264, DOI 10.1016/j.janxdis.2008.01.007; Shapiro F., 2001, EYE MOVEMENT DESENSI; SHAPIRO F, 1995, EYE MOVEMENT DENSITI; Sherr JD, 2002, BIOL PSYCHIAT, V52, P721, DOI 10.1016/S0006-3223(02)01342-2; Sweeney JA, 1998, BIOL PSYCHIAT, V44, P698, DOI 10.1016/S0006-3223(98)00035-3; Takagi M, 2000, J NEUROPHYSIOL, V83, P2047, DOI 10.1152/jn.2000.83.4.2047; Takarae Y, 2004, BRAIN, V127, P2584, DOI 10.1093/brain/awh307; THYER BA, 1984, J BEHAV THER EXP PSY, V15, P3, DOI 10.1016/0005-7916(84)90115-0; Tian JR, 1996, J NEUROPHYSIOL, V76, P2740, DOI 10.1152/jn.1996.76.4.2740; Tregellas JR, 2005, AM J PSYCHIAT, V162, P391, DOI 10.1176/appi.ajp.162.2.391; Trillenberg P, 2004, CURR OPIN NEUROL, V17, P43, DOI 10.1097/00019052-200402000-00008; van den Hout M, 2001, BRIT J CLIN PSYCHOL, V40, P121; VANGELDER P, 1995, VISION RES, V35, P667, DOI 10.1016/0042-6989(94)00161-E; Wilson DL, 1996, J BEHAV THER EXP PSY, V27, P219, DOI 10.1016/S0005-7916(96)00026-2; WOLPE J, 1991, J BEHAV THER EXP PSY, V22, P39, DOI 10.1016/0005-7916(91)90032-Z; Yang Q, 2004, INVEST OPHTH VIS SCI, V45, P2231, DOI 10.1167/iovs.03-1291	49	11	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10762	10.1371/journal.pone.0010762	http://dx.doi.org/10.1371/journal.pone.0010762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	600VQ	20505828	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017400017
J	Williams, JT; Carpenter, KE; Van Tassell, JL; Hoetjes, P; Toller, W; Etnoyer, P; Smith, M				Williams, Jeffrey T.; Carpenter, Kent E.; Van Tassell, James L.; Hoetjes, Paul; Toller, Wes; Etnoyer, Peter; Smith, Michael			Biodiversity Assessment of the Fishes of Saba Bank Atoll, Netherlands Antilles	PLOS ONE			English	Article								Biodiversity surveys were conducted on Saba Bank, Netherlands Antilles, to assess ichthyofaunal richness and to compare with published surveys of other Caribbean localities. The primary objective was to estimate the total species richness of the Saba Bank ichthyofauna. A variety of sampling techniques was utilized to survey the fish species of both the visually accessible megafauna and the camouflaged and small-sized species comprising the cryptic ichthyofauna. Based on results presented herein, the number of species known on Saba Bank is increased from 42 previously known species to 270 species. Expected species-accumulation curves demonstrate that the current estimate of species richness of fishes for Saba Bank under represents the actual richness, and our knowledge of the ichthyofauna has not plateaued. The total expected fish-species richness may be somewhere between 320 and 411 species. The Saba Bank ichthyofaunal assemblage is compared to fish assemblages found elsewhere in the Caribbean. Despite the absence of shallow or emergent shore habitats like mangroves, Saba Bank ranks as having the eighth highest ichthyofaunal richness of surveyed localities in the Greater Caribbean. Some degree of habitat heterogeneity was evident. Fore-reef, patch-reef, and lagoonal habitats were sampled. Fish assemblages were significantly different between habitats. Species richness was highest on the fore reef, but 11 species were found only at lagoonal sites. A comprehensive, annotated list of the fishes currently known to occur on Saba Bank, Netherland Antilles, is provided and color photographs of freshly collected specimens are presented for 165 of the listed species of Saba Bank fishes to facilitate identification and taxonomic comparison with similar taxa at other localities. Coloration of some species is shown for the first time. Preliminary analysis indicates that at least six undescribed new species were collected during the survey and these are indicated in the annotated list.	[Williams, Jeffrey T.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Fish Div, Suitland, MD USA; [Carpenter, Kent E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Van Tassell, James L.] Amer Museum Nat Hist, Dept Ichthyol, New York, NY 10024 USA; [Hoetjes, Paul] Minist Publ Hlth & Social Dev, Dept Environm & Nat, Curacao, Neth Antilles; [Toller, Wes] Saba Conservat Fdn, Ft Bay, Saba, Neth Antilles; [Etnoyer, Peter] Texas A&M Univ Corpus Christi, Harte Res Inst, Corpus Christi, TX USA; [Smith, Michael] Conservat Int Arlington, Ctr Appl Biodivers Sci, Arlington, VA USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Old Dominion University; American Museum of Natural History (AMNH); Texas A&M University System; Texas A&M University Corpus Christi; Conservation International	Williams, JT (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Fish Div, Suitland, MD USA.	williamsjt@si.edu			Department of Environment and Nature of the Netherlands Antilles; Conservation International	Department of Environment and Nature of the Netherlands Antilles; Conservation International	The Department of Environment and Nature of the Netherlands Antilles and Conservation International provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlke J. E., 1968, FISHES BAHAMAS ADJAC; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CLAVIJO IE, 1980, SPECIAL PUBLICATION; Collette Bruce B., 2003, Aqua (Miradolo Terme), V6, P89; Colwell R. K., 2006, ESTIMATES VERSION 8; Dennis GD, 2005, CARIBB J SCI, V41, P716; Lavett C., 2003, ATOLL RES B, V497, P1, DOI [10.5479/si.00775630.497.1, DOI 10.5479/SI.00775630.497.1]; LONGLEY WH, 1941, CARNEGIE I WASHINGTO, V535; MEESTERS EH, 1996, SUSTAINABLE MA UNPUB; Mejia Luz Stella, 1998, Boletin Ecotropica, V32, P25; Smith-Vaniz W.F., 1999, SPECIAL PUBLICATION, V4; Smith-Vaniz WF, 2006, B MAR SCI, V79, P17; Starck WA, 1968, UNDERSEA BIOL, V1, P5; van der Land J., 1977, FAO FISHERIES REPORT, V200, P469, DOI DOI 10.1371/JOURNAL.PONE.0009207; WILLIAMS JT, 2003, SPECIAL PUBLICATION, V5, P1761	15	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10676	10.1371/journal.pone.0010676	http://dx.doi.org/10.1371/journal.pone.0010676			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505760	gold, Green Published, Green Submitted			2022-12-25	WOS:000278017400007
J	Noren Hooten, N; Abdelmohsen, K; Gorospe, M; Ejiogu, N; Zonderman, AB; Evans, MK				Noren Hooten, Nicole; Abdelmohsen, Kotb; Gorospe, Myriam; Ejiogu, Ngozi; Zonderman, Alan B.; Evans, Michele K.			microRNA Expression Patterns Reveal Differential Expression of Target Genes with Age	PLOS ONE			English	Article							CELLULAR SENESCENCE; LIFE-SPAN; REPLICATIVE SENESCENCE; RECEPTOR; RECOGNITION; SUPPRESSION; P16(INK4A); REDUCTION; PATHWAYS; SUBSETS	Recent evidence supports a role for microRNAs (miRNAs) in regulating the life span of model organisms. However, little is known about how these small RNAs contribute to human aging. Here, we profiled the expression of over 800 miRNAs in peripheral blood mononuclear cells from young and old individuals by real-time RT-PCR analysis. This genome-wide assessment of miRNA expression revealed that the majority of miRNAs studied decreased in abundance with age. We identified nine miRNAs (miR-103, miR-107, miR-128, miR-130a, miR-155, miR-24, miR-221, miR-496, miR-1538) that were significantly lower in older individuals. Among them, five have been implicated in cancer pathogenesis. Predicted targets of several of these miRNAs, including PI3 kinase (PI3K), c-Kit and H2AX, were found to be elevated with advancing age, supporting a possible role for them in the aging process. Furthermore, we found that decreasing the levels of miR-221 was sufficient to cause a corresponding increase in the expression of the predicted target, PI3K. Taken together, these findings demonstrate that changes in miRNA expression occur with human aging and suggest that miRNAs and their predicted targets have the potential to be diagnostic indicators of age or age-related diseases.	[Noren Hooten, Nicole; Abdelmohsen, Kotb; Gorospe, Myriam; Evans, Michele K.] NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA; [Ejiogu, Ngozi; Evans, Michele K.] NIA, Clin Res Branch, NIH, Baltimore, MD 21224 USA; [Zonderman, Alan B.] NIA, Lab Personal & Cognit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Noren Hooten, N (corresponding author), NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA.	evansmi@grc.nia.nih.gov	Ezike, Ngozi/AAL-3075-2021; Noren Hooten, Nicole/J-5498-2019; Huang, H/E-9490-2010; Evans, Michele Kim/AAE-4776-2019; Zonderman, Alan B/A-5807-2013; Abdelmohsen, Kotb/AAX-4191-2020	Noren Hooten, Nicole/0000-0002-1683-3838; Zonderman, Alan B/0000-0003-3530-2319; Abdelmohsen, Kotb/0000-0001-6240-5810; Zonderman, Alan B/0000-0002-6523-4778; Evans, Michele/0000-0002-8546-2831	National Institute of Aging Intramural Research Program at the National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000519, ZIAAG000394, ZIAAG000513] Funding Source: NIH RePORTER	National Institute of Aging Intramural Research Program at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study has been supported in full by National Institute of Aging Intramural Research Program at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BATES DJ, 2009, AGING CELL; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; DEPAOLI P, 1988, CLIN IMMUNOL IMMUNOP, V48, P290, DOI 10.1016/0090-1229(88)90022-0; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LI N, 2009, NEUROBIOL AGING; Liang RQ, 2009, CURR GENOMICS, V10, P184, DOI 10.2174/138920209788185225; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; Marasa BS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000442; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Ohtani N, 2009, CANCER SCI, V100, P792, DOI 10.1111/j.1349-7006.2009.01123.x; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369; UTSUYAMA M, 1992, MECH AGEING DEV, V63, P57, DOI 10.1016/0047-6374(92)90016-7; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x	50	250	261	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10724	10.1371/journal.pone.0010724	http://dx.doi.org/10.1371/journal.pone.0010724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505758	Green Submitted, Green Published, gold			2022-12-25	WOS:000278017300004
J	Prasmickaite, L; Engesaeter, BO; Skrbo, N; Hellenes, T; Kristian, A; Oliver, NK; Suo, ZH; Maelandsmo, GM				Prasmickaite, Lina; Engesaeter, Birgit O.; Skrbo, Nirma; Hellenes, Tina; Kristian, Alexandr; Oliver, Nina K.; Suo, Zhenhe; Maelandsmo, Gunhild M.			Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST CANCERS; EXPRESSION; MARKER; CHEMOTHERAPY; THERAPY; TUMORS	Background: Malignant melanoma is an exceptionally aggressive, drug-resistant and heterogeneous cancer. Recently it has been shown that melanoma cells with high clonogenic and tumourigenic abilities are common, but markers distinguishing such cells from cells lacking these abilities have not been identified. There is therefore no definite evidence that an exclusive cell subpopulation, i.e. cancer stem cells (CSC), exists in malignant melanoma. Rather, it is suggested that multiple cell populations are implicated in initiation and progression of the disease, making it of importance to identify subpopulations with elevated aggressive properties. Methods and Findings: In several other cancer forms, Aldehyde Dehydrogenase (ALDH), which plays a role in stem cell biology and resistance, is a valuable functional marker for identification of cells that show enhanced aggressiveness and drug-resistance. Furthermore, the presence of ALDH(+) cells is linked to poor clinical prognosis in these cancers. By analyzing cell cultures, xenografts and patient biopsies, we showed that aggressive melanoma harboured a large, distinguishable ALDH(+) subpopulation. In vivo, ALDH(+) cells gave rise to ALDH(-) cells, while the opposite conversion was rare, indicating a higher abilities of ALDH(+) cells to reestablish tumour heterogeneity with respect to the ALDH phenotype. However, both ALDH(+) and ALDH(-) cells demonstrated similarly high abilities for clone formation in vitro and tumour initiation in vivo. Furthermore, both subpopulations showed similar sensitivity to the anti-melanoma drugs, dacarbazine and lexatumumab. Conclusions: These findings suggest that ALDH does not distinguish tumour-initiating and/or therapy-resistant cells, implying that the ALDH phenotype is not associated with more-aggressive subpopulations in malignant melanoma, and arguing against ALDH as a "universal'' marker. Besides, it was shown that the ability to reestablish tumour heterogeneity is not necessarily linked to the more aggressive phenotype.	[Prasmickaite, Lina; Engesaeter, Birgit O.; Skrbo, Nirma; Hellenes, Tina; Kristian, Alexandr; Maelandsmo, Gunhild M.] Oslo Univ Hosp, Radiumhosp, Dept Tumour Biol, Oslo, Norway; [Oliver, Nina K.] Oslo Univ Hosp, Radiumhosp, Dept Surg, Oslo, Norway; [Suo, Zhenhe] Oslo Univ Hosp, Radiumhosp, Dept Pathol, Oslo, Norway; [Maelandsmo, Gunhild M.] Univ Tromso, Fac Hlth Sci, Dept Pharm, Tromso, Norway	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso	Prasmickaite, L (corresponding author), Oslo Univ Hosp, Radiumhosp, Dept Tumour Biol, Oslo, Norway.	linap@rr-research.no	Mælandsmo, Gunhild Mari/AFV-4446-2022		South-Eastern Norway Regional Health Authority; Cancer Stem Cell Innovation Center [174938]; Jeanette and Soerenren Bothners Legacy	South-Eastern Norway Regional Health Authority; Cancer Stem Cell Innovation Center; Jeanette and Soerenren Bothners Legacy	This work was supported by South-Eastern Norway Regional Health Authority, Cancer Stem Cell Innovation Center (Grant. No 174938) and Jeanette and Soerenren Bothners Legacy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala SS, 2009, EXPERT REV ANTICANC, V9, P587, DOI [10.1586/era.09.25, 10.1586/ERA.09.25]; Chang B, 2009, MODERN PATHOL, V22, P817, DOI 10.1038/modpathol.2009.35; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Estes RT, 2006, J CELL PHYSIOL, V209, P987, DOI 10.1002/jcp.20808; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Held MA, 2010, CANCER RES, V70, P388, DOI 10.1158/0008-5472.CAN-09-2153; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; MORGAN AC, 1981, HYBRIDOMA, V1, P27, DOI 10.1089/hyb.1.1981.1.27; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Pearce DJ, 2005, STEM CELLS, V23, P752, DOI 10.1634/stemcells.2004-0292; PRASMICKAITE L, 2010, CELL MELANO IN PRESS; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Wakelee HA, 2010, ANN ONCOL, V21, P376, DOI 10.1093/annonc/mdp292; Yang JB, 2009, CANCER RES, V69, P7538, DOI 10.1158/0008-5472.CAN-08-4626	24	60	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10731	10.1371/journal.pone.0010731	http://dx.doi.org/10.1371/journal.pone.0010731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505780	gold, Green Submitted, Green Published			2022-12-25	WOS:000278017300007
J	Papatheodorou, P; Zamboglou, C; Genisyuerek, S; Guttenberg, G; Aktories, K				Papatheodorou, Panagiotis; Zamboglou, Constantinos; Genisyuerek, Selda; Guttenberg, Gregor; Aktories, Klaus			Clostridial Glucosylating Toxins Enter Cells via Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							DIFFICILE TOXIN; INDEPENDENT ENDOCYTOSIS; CHOLERA-TOXIN; LIPID RAFTS; RECEPTOR; INTERNALIZATION; INHIBITION; DYNAMIN; RHO; CYTOTOXICITY	Clostridium difficile toxin A (TcdA) and toxin B (TcdB), C. sordellii lethal toxin (TcsL) and C. novyi alpha-toxin (TcnA) are important pathogenicity factors, which represent the family of the clostridial glucosylating toxins (CGTs). Toxin A and B are associated with antibiotic-associated diarrhea and pseudomembraneous colitis. Lethal toxin is involved in toxic shock syndrome after abortion and alpha-toxin in gas gangrene development. CGTs enter cells via receptor-mediated endocytosis and require an acidified endosome for translocation of the catalytic domain into the cytosol. Here we studied the endocytic processes that mediate cell internalization of the CGTs. Intoxication of cells was monitored by analyzing cell morphology, status of Rac glucosylation in cell lysates and transepithelial resistance of cell monolayers. We found that the intoxication of cultured cells by CGTs was strongly delayed when cells were preincubated with dynasore, a cell-permeable inhibitor of dynamin, or chlorpromazine, an inhibitor of the clathrin-dependent endocytic pathway. Additional evidence about the role of clathrin in the uptake of the prototypical CGT family member toxin B was achieved by expression of a dominant-negative inhibitor of the clathrin-mediated endocytosis (Eps15 DN) or by siRNA against the clathrin heavy chain. Accordingly, cells that expressed dominant-negative caveolin-1 were not protected from toxin B-induced cell rounding. In addition, lipid rafts impairment by exogenous depletion of sphingomyelin did not decelerate intoxication of HeLa cells by CGTs. Taken together, our data indicate that the endocytic uptake of the CGTs involves a dynamin-dependent process that is mainly governed by clathrin.	[Papatheodorou, Panagiotis; Zamboglou, Constantinos; Genisyuerek, Selda; Guttenberg, Gregor; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Freiburg, Germany	University of Freiburg	Papatheodorou, P (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Papatheodorou, Panagiotis/N-7509-2015; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Papatheodorou, Panagiotis/0000-0003-3571-695X	Deutsche Forschungsgemeinschaft [AK6/16-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (AK6/16-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Benmerah A, 1999, J CELL SCI, V112, P1303; BETTE P, 1989, INFECT IMMUN, V57, P2507, DOI 10.1128/IAI.57.8.2507-2513.1989; Blumenthal B, 2007, INFECT IMMUN, V75, P3344, DOI 10.1128/IAI.01937-06; BORIELLO SP, 2005, TOPLEY WILSONS MICRO, P1089; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Fujimoto T, 2000, J CELL SCI, V113, P3509; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HENRIQUES B, 1987, MICROB PATHOGENESIS, V2, P455, DOI 10.1016/0882-4010(87)90052-0; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Ho CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.023; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Just I., 1997, BACTERIAL TOXINS TOO, P159; Kelly CP, 1998, ANNU REV MED, V49, P375; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; KRIVAN HC, 1987, INFECT IMMUN, V55, P1873, DOI 10.1128/IAI.55.8.1873-1877.1987; KUSHNARYOV VM, 1989, INFECT IMMUN, V57, P3914, DOI 10.1128/IAI.57.12.3914-3921.1989; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Matsuda S, 2010, INFECT IMMUN, V78, P603, DOI 10.1128/IAI.00946-09; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mirre C, 1996, AM J PHYSIOL-CELL PH, V271, pC887, DOI 10.1152/ajpcell.1996.271.3.C887; MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548; Na X, 2008, INFECT IMMUN, V76, P2862, DOI 10.1128/IAI.00326-08; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Pothoulakis C, 1996, J CLIN INVEST, V98, P641, DOI 10.1172/JCI118835; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; Schirmer J, 2004, BBA-GEN SUBJECTS, V1673, P66, DOI 10.1016/j.bbagen.2004.03.014; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schraw W, 2002, J BIOL CHEM, V277, P34642, DOI 10.1074/jbc.M203466200; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Trouet D, 2001, BIOCHEM BIOPH RES CO, V284, P461, DOI 10.1006/bbrc.2001.4995; Tsokos M, 2008, INT J LEGAL MED, V122, P35, DOI 10.1007/s00414-007-0163-9; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; VONEICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707, DOI 10.1128/JB.174.20.6707-6710.1992; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192	51	115	118	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10673	10.1371/journal.pone.0010673	http://dx.doi.org/10.1371/journal.pone.0010673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498856	Green Published, Green Submitted, gold			2022-12-25	WOS:000277773700016
J	Roblek, M; Schuchner, S; Huber, V; Ollram, K; Vlcek-Vesely, S; Foisner, R; Wehnert, M; Ogris, E				Roblek, Marko; Schuechner, Stefan; Huber, Veronika; Ollram, Katrin; Vlcek-Vesely, Sylvia; Foisner, Roland; Wehnert, Manfed; Ogris, Egon			Monoclonal Antibodies Specific for Disease-Associated Point-Mutants: Lamin A/C R453W and R482W	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; PARTIAL LIPODYSTROPHY; INTERPHASE NUCLEI; CRYSTAL-STRUCTURE; MUTATIONS; LAMINOPATHIES; CARDIOMYOPATHY; PROTEIN	Background: Disease-linked missense mutations can alter a protein's function with fatal consequences for the affected individual. How a single amino acid substitution in a protein affects its properties, is difficult to study in the context of the cellular proteome, because mutant proteins can often not be traced in cells due to the lack of mutation-specific detection tools. Antibodies, however, with their exquisite epitope specificity permit the detection of single amino acid substitutions but are not available for the vast majority of disease-causing mutant proteins. One of the most frequently missense-mutated human genes is the LMNA gene coding for A-type lamins. Mutations in LMNA cause phenotypically heterogenous, mostly autosomal-dominant inherited diseases, termed laminopathies. The molecular mechanisms underlying the phenotypic heterogeneity of laminopathies, however, are not well understood. Hence, the goal of this study was the development of monoclonal antibodies specific for disease-linked point-mutant A-type lamins. Methodology/Principal Findings: Using two different approaches of antigen presentation, namely KLH-coupled peptides and the display of a complete protein domain fused to the Hepatitis B virus capsid protein, we developed monoclonal antibodies against two disease-associated lamin A/C mutants. Both antibodies display exquisite specificity for the respective mutant proteins. We show that with the help of these novel antibodies it is now possible for the first time to study specifically the properties of the mutant proteins in primary patient cells in the background of wild-type protein. Conclusions: We report here the development of two point-mutant specific antibodies against A-type lamins. While synthetic peptides may be the prime choice of antigen, our results show that a given target sequence may have to be presented in alternative ways to ensure the induction of a mutant-specific immune response. Point-mutant specific antibodies will represent valuable tools for basic and clinical research on a number of hereditary as well as acquired diseases caused by dominant missense mutations.	[Roblek, Marko; Schuechner, Stefan; Huber, Veronika; Ollram, Katrin; Vlcek-Vesely, Sylvia; Foisner, Roland; Ogris, Egon] Med Univ Vienna, Dept Med Biochem, Max Perutz Labs, Vienna, Austria; [Wehnert, Manfed] Ernst Moritz Arndt Univ Greifswald, Inst Human Genet, Greifswald, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Ernst Moritz Arndt Universitat Greifswald	Roblek, M (corresponding author), Med Univ Vienna, Dept Med Biochem, Max Perutz Labs, Vienna, Austria.	egon.ogris@meduniwien.ac.at	Foisner, Roland/AAD-1833-2019	Ogris, Egon/0000-0001-5950-9264; Foisner, Roland/0000-0003-4734-4647	Austrian Science Foundation [FWF L340-B05, FWF L697-B20]; Austrian Science Fund (FWF) [L 697] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported primarily by grants FWF L340-B05 and FWF L697-B20 from the Austrian Science Foundation (http://www.fwf.ac.at/) and to a minor extent by royalty payments from licensing agreements (for the sales of antibodies not used in this study) with the biotechnology companies Millipore Corporation and Santa Cruz Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Benjamin DC, 1995, ADV EXP MED BIOL, V386, P95; Broers JLV, 2005, EXP CELL RES, V304, P582, DOI 10.1016/j.yexcr.2004.11.020; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Dechat T, 1998, EMBO J, V17, P4887, DOI 10.1093/emboj/17.16.4887; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Gotzmann J, 2006, HISTOCHEM CELL BIOL, V125, P33, DOI 10.1007/s00418-005-0050-8; GOTZMANN J, 2004, MOL MECH MUSCULAR DY, P1; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Harlow E., 1988, ANTIBODIES LAB MANUA; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Khan S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-56; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; Magracheva E, 2009, ACTA CRYSTALLOGR F, V65, P665, DOI 10.1107/S1744309109020302; Manilal S, 2004, BBA-GEN SUBJECTS, V1671, P87, DOI 10.1016/j.bbagen.2004.01.008; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; Muchir A, 2004, MUSCLE NERVE, V30, P444, DOI 10.1002/mus.20122; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Nassal M, 2005, EUR J IMMUNOL, V35, P655, DOI 10.1002/eji.200425449; Ostlund C, 2001, J CELL SCI, V114, P4435; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Raharjo WH, 2001, J CELL SCI, V114, P4447; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Vigouroux C, 2001, J CELL SCI, V114, P4459; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Vlcek S, 2007, CURR OPIN CELL BIOL, V19, P298, DOI 10.1016/j.ceb.2007.04.001; Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	50	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10604	10.1371/journal.pone.0010604	http://dx.doi.org/10.1371/journal.pone.0010604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498701	gold, Green Published, Green Submitted			2022-12-25	WOS:000277633500008
J	Garbuzova-Davis, S; Woods, RL; Louis, MK; Zesiewicz, TA; Kuzmin-Nichols, N; Sullivan, KL; Miller, AM; Hernandez-Ontiveros, DG; Sanberg, PR				Garbuzova-Davis, Svitlana; Woods, Robert L., III; Louis, Michael K.; Zesiewicz, Theresa A.; Kuzmin-Nichols, Nicole; Sullivan, Kelly L.; Miller, Amber M.; Hernandez-Ontiveros, Diana G.; Sanberg, Paul R.			Reduction of Circulating Endothelial Cells in Peripheral Blood of ALS Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; VON-WILLEBRAND-FACTOR; SPINAL-CORD; PROGENITOR CELLS; BRAIN-BARRIER; MOTOR-NEURONS; MOUSE MODEL; UP-REGULATION; DISEASE; EXPRESSION	Background: Amyotrophic Lateral Sclerosis (ALS) treatment is complicated by the various mechanisms underlying motor neuron degeneration. Recent studies showed that the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) are compromised in an animal model of ALS due to endothelial cell degeneration. A later study demonstrated a loss of endothelium integrity in the spinal cords of ALS patients. Since circulating endothelial cells (CECs) in the peripheral blood are associated with endothelium damage, being detached dysfunctional endothelial cells, we hypothesized that CEC levels may reflect endothelium condition in ALS patients. Methodology/Principal Findings: CEC levels were estimated in whole blood smears from ALS patients with moderate stage ((M)ALS), severe stage ((S)ALS), and healthy controls by CD146 expression using immunocytochemistry. A significant reduction of CECs was detected in (M)ALS and (S)ALS patients. Conclusions/Significance: CECs did not predict endothelium state in ALS patients; however, endothelial damage and/or impaired endothelium repair may occur in ALS leading to BBB/BSCB dysfunction. Reduced CECs in peripheral blood of ALS patients may indicate different mechanisms of endothelial damage and repair, rather than only detachment of dysfunctional endothelial cells. Although a potential mechanism of CEC reduction is discussed, establishing a reliable indicator of endothelial dysfunction/damage is important for evaluation of BBB/BSCB status in ALS patients during disease progression.	[Garbuzova-Davis, Svitlana; Woods, Robert L., III; Louis, Michael K.; Hernandez-Ontiveros, Diana G.; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Zesiewicz, Theresa A.; Sullivan, Kelly L.; Miller, Amber M.] Univ S Florida, Dept Neurol, Coll Med, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Dept Mol Pharmacol & Physiol, Coll Med, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Dept Pathol & Cell Biol, Coll Med, Tampa, FL 33620 USA; [Sanberg, Paul R.] Univ S Florida, Dept Psychiat, Coll Med, Tampa, FL 33620 USA; [Kuzmin-Nichols, Nicole] Saneron CCEL Therapeut Inc, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Garbuzova-Davis, Svitlana/Q-3687-2019	Sanberg, Paul/0000-0001-9130-4592	Departments of Neurosurgery and Neurology, University of South Florida; Muscular Dystrophy Association [92452]	Departments of Neurosurgery and Neurology, University of South Florida; Muscular Dystrophy Association(Muscular Dystrophy Association)	This research was supported in part by the Departments of Neurosurgery and Neurology, University of South Florida, and by the Muscular Dystrophy Association (Grant # 92452). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO;2-O; Appel S H, 2001, Curr Neurol Neurosci Rep, V1, P303, DOI 10.1007/s11910-001-0081-z; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; AVATA C, 2002, J CLIN NEUROSCI, V9, P113; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cho KJ, 1999, NEUROREPORT, V10, P3939, DOI 10.1097/00001756-199912160-00039; Chong AY, 2006, EUR J HEART FAIL, V8, P167, DOI 10.1016/j.ejheart.2005.06.010; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Consilvio C, 2004, EXP NEUROL, V187, P1, DOI 10.1016/j.expneurol.2003.12.009; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Dome B, 2009, CRIT REV ONCOL HEMAT, V69, P108, DOI 10.1016/j.critrevonc.2008.06.009; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Engelhardt JI, 2005, ACTA NEUROL SCAND, V112, P126, DOI 10.1111/j.1600-0404.2005.00445.x; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; Erdbruegger U, 2006, CLIN CHIM ACTA, V373, P17, DOI 10.1016/j.cca.2006.05.016; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; Garbuzova-Davis S, 2008, AMYOTROPH LATERAL SC, V9, P375, DOI 10.1080/17482960802160990; Goon P, 2009, NEOPLASIA, V11, P771, DOI 10.1593/neo.09490; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; Henkel JS, 2009, NEUROLOGY, V72, P1614, DOI 10.1212/WNL.0b013e3181a41228; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hensley K, 2002, J NEUROCHEM, V82, P365, DOI 10.1046/j.1471-4159.2002.00968.x; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hunting CB, 2005, VOX SANG, V88, P1, DOI 10.1111/j.1423-0410.2005.00589.x; JUNG JE, 2010, MOL NEUROBIOL   0217; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Lee KW, 2005, BLOOD, V105, P526, DOI 10.1182/blood-2004-03-1106; Levine JB, 1999, GLIA, V28, P215; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Nadar SK, 2005, THROMB HAEMOSTASIS, V94, P707; Nicaise C, 2009, BRAIN RES, V1301, P152, DOI 10.1016/j.brainres.2009.09.018; Nicaise C, 2009, ANAT REC, V292, P207, DOI 10.1002/ar.20838; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Rafii S, 2000, J CLIN INVEST, V105, P17, DOI 10.1172/JCI8774; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rule RR, 2010, NEUROLOGY, V74, P821, DOI 10.1212/WNL.0b013e3181d3e2dd; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Woywodt A, 2002, NEPHROL DIAL TRANSPL, V17, P1728, DOI 10.1093/ndt/17.10.1728; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476	54	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10614	10.1371/journal.pone.0010614	http://dx.doi.org/10.1371/journal.pone.0010614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485543	gold, Green Published			2022-12-25	WOS:000277563400017
J	Liu, L; Chen, L; Luo, Y; Chen, WX; Zhou, HY; Xu, BS; Han, XZ; Shen, T; Huang, SL				Liu, Lei; Chen, Long; Luo, Yan; Chen, Wenxing; Zhou, Hongyu; Xu, Baoshan; Han, Xiuzhen; Shen, Tao; Huang, Shile			Rapamycin Inhibits IGF-1 Stimulated Cell Motility through PP2A Pathway	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; RICTOR-MTOR COMPLEX; MAMMALIAN TARGET; SIGNAL-TRANSDUCTION; CATALYTIC SUBUNIT; BINDING PARTNER; KINASE-ACTIVITY; ALPHA4 PROTEIN; TOR PROTEINS; PHOSPHORYLATION	Serine/threonine (Ser/Thr) protein phosphatase 2A (PP2A) has been implicated as a novel component of the mammalian target of rapamycin (mTOR) signaling pathway. Recently we have demonstrated that mTOR regulates cell motility in part through p70 S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E (eIF4E) binding protein 1 (4E-BP1) pathways. Little is known about the role of PP2A in the mTOR-mediated cell motility. Here we show that rapamycin inhibited the basal or insulin-like growth factor 1 (IGF-1)-induced motility of human Ewing sarcoma (Rh1) and rhabdomyosarcoma (Rh30) cells. Treatment of the cells with rapamycin activated PP2A activity, and concurrently inhibited IGF-1 stimulated phosphorylation of Erk1/2. Inhibition of Erk1/2 with PD98059 did not significantly affect the basal mobility of the cells, but dramatically inhibited IGF-1-induced cell motility. Furthermore, inhibition of PP2A with okadaic acid significantly attenuated the inhibitory effect of rapamycin on IGF-1-stimulated phosphorylation of Erk1/2 as well as cell motility. Consistently, expression of dominant negative PP2A conferred resistance to IGF-1-stimulated phosphorylation of Erk1/2 and cell motility. Expression of constitutively active MKK1 also attenuated rapamycin inhibition of IGF-1-stimulated phosphorylation of Erk1/2 and cell motility. The results suggest that rapamycin inhibits cell motility, in part by targeting PP2A-Erk1/2 pathway.	[Liu, Lei; Chen, Long; Luo, Yan; Chen, Wenxing; Zhou, Hongyu; Xu, Baoshan; Han, Xiuzhen; Shen, Tao; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Liu, L (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.	shuan1@lsuhsc.edu	Xu, Baoshan/H-6435-2011; Chen, Wenxing/GSI-9910-2022; Huang, Shile/I-1632-2019; luo, yan/I-5305-2015	Huang, Shile/0000-0002-3239-1072; Xu, Baoshan/0000-0001-8902-1243; Chen, Wenxing/0000-0003-4571-7622	National Institutes of Health (NIH) [CA115414]; American Cancer Society [RSG-08-135-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health (NIH) grant CA115414 (S.H.), and American Cancer Society Award RSG-08-135-01-CNE (S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beevers CS, 2009, CANCER RES, V69, P1000, DOI 10.1158/0008-5472.CAN-08-2367; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; Fasolo A, 2008, EXPERT OPIN INV DRUG, V17, P1717, DOI [10.1517/13543784.17.11.1717, 10.1517/13543784.17.11.1717 ]; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hosoi H, 1999, CANCER RES, V59, P886; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jackson JL, 2003, CLIN EXP METASTAS, V20, P357, DOI 10.1023/A:1024012000009; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Nien WL, 2007, MOL CELL ENDOCRINOL, V263, P10, DOI 10.1016/j.mce.2006.08.015; O'Connor R, 2003, HORM METAB RES, V35, P771; Parameswaran N, 2000, EUR J PHARMACOL, V388, P133, DOI 10.1016/S0014-2999(99)00848-1; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pullar CE, 2003, J BIOL CHEM, V278, P22555, DOI 10.1074/jbc.M300205200; Rhoads JM, 2006, AM J PHYSIOL-GASTR L, V291, pG510, DOI 10.1152/ajpgi.00189.2005; Sakakibara K, 2005, AM J PHYSIOL-HEART C, V288, pH2861, DOI 10.1152/ajpheart.00561.2004; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yumoto N, 2006, MOL CELL BIOCHEM, V285, P165, DOI 10.1007/s11010-005-9075-5	54	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10578	10.1371/journal.pone.0010578	http://dx.doi.org/10.1371/journal.pone.0010578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485667	gold, Green Published, Green Submitted			2022-12-25	WOS:000277563200013
J	Hartmann, C; Muller, N; Blaukat, A; Koch, J; Benhar, I; Wels, WS				Hartmann, C.; Mueller, N.; Blaukat, A.; Koch, J.; Benhar, I.; Wels, W. S.			Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response	ONCOGENE			English	Article						epidermal growth factor receptor; therapeutic antibody; phage display; peptide mimotope	GROWTH-FACTOR RECEPTOR; TUMOR-CELL GROWTH; MONOCLONAL-ANTIBODY; ERBB-2 RECEPTOR; CANCER; DISPLAY; TOXIN; INHIBITION; CARCINOMA; LIBRARIES	Aberrant activation of the epidermal growth factor receptor (EGFR) has been found in human cancers of various origins, and has been implicated in cancer pathogenesis. The therapeutic anti-EGFR antibodies cetuximab and matuzumab inhibit both ligand-induced receptor activation and growth of EGFR-expressing tumor cells. The efficacy of such EGFR-targeted therapies may be further enhanced by induction of functionally equivalent endogenous antibody responses. Here we describe novel peptide sequences selected from random peptide libraries for binding to single-chain antibody fragments of cetuximab or matuzumab. Two of these peptides characterized by KTL and YPLG motifs are recognized equally well by cetuximab and matuzumab, although nonoverlapping epitopes were previously reported for these antibodies. Immunization of experimental animals with synthetic KTL-and YPLG-containing peptides led to induction of antibodies that cross-react with human EGFR, and prevent binding of natural EGFR ligands, ligand-induced receptor activation and tumor cell growth in a manner similar to cetuximab and matuzumab. Our findings show that these peptide mimotopes can induce anti-EGFR antibodies with antitumoral activity, which may have implications for EGFR-specific cancer immunotherapy. Oncogene (2010) 29, 4517-4527; doi: 10.1038/onc.2010.195; published online 31 May 2010	[Hartmann, C.; Mueller, N.; Koch, J.; Wels, W. S.] Chemotherapeut Forschungsinst, D-60596 Frankfurt, Germany; [Blaukat, A.] Merck KGaA, Merck Serono Res, TA Oncol, Darmstadt, Germany; [Benhar, I.] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel	Merck KGaA; EMD Serono Inc.; Tel Aviv University	Wels, WS (corresponding author), Chemotherapeut Forschungsinst, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	wels@em.uni-frankfurt.de		Benhar, Itai/0000-0002-0824-7177; Wels, Winfried/0000-0001-9858-3643	Merck KGaA	Merck KGaA(Merck & Company)	We thank Dr Jens Oliver Funk, Merck KGaA for support of this project; Thorsten Geyer, Georg-Speyer-Haus for preparing plasmid pIB-Tx-scFv(225); Dr John Mendelsohn, MD Anderson Cancer Center, Houston for monoclonal antibody cetuximab; Dr Nancy Hynes, Friedrich Miescher Institute, Basel for 15E anti-EGFR antibody; Christian Brendel, Georg-Speyer-Haus for help with CLSM experiments and Dr Stephen Hyland, Georg-Speyer-Haus and Dr Arne Sutter, Merck KGaA for helpful discussions. This work was supported in part by a grant from Merck KGaA.	Azemar M, 2000, INT J CANCER, V86, P269, DOI 10.1002/(SICI)1097-0215(20000415)86:2<269::AID-IJC18>3.0.CO;2-8; Baselga J, 2005, J CLIN ONCOL, V23, P5568, DOI 10.1200/JCO.2005.07.119; Benhar I, 2000, J MOL BIOL, V301, P893, DOI 10.1006/jmbi.2000.4021; Brandt O, 2009, CURR CHEM BIOL, V3, P171; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Groner B, 2004, CURR MOL MED, V4, P539, DOI 10.2174/1566524043360483; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Leahy DJ, 2008, CANCER CELL, V13, P291, DOI 10.1016/j.ccr.2008.03.010; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Maurer-Gebhard M, 1998, CANCER RES, V58, P2661; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Mayrose I, 2007, NUCLEIC ACIDS RES, V35, P69, DOI 10.1093/nar/gkl975; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; MURTHY U, 1987, ARCH BIOCHEM BIOPHYS, V252, P549, DOI 10.1016/0003-9861(87)90062-2; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Partidos CD, 2000, CURR OPIN MOL THER, V2, P74; Rao S, 2008, BRIT J CANCER, V99, P868, DOI 10.1038/sj.bjc.6604622; Riemer AB, 2005, JNCI-J NATL CANCER I, V97, P1663, DOI 10.1093/jnci/dji373; Riemer AB, 2004, J IMMUNOL, V173, P394, DOI 10.4049/jimmunol.173.1.394; Sato J D, 1983, Mol Biol Med, V1, P511; Schmidt M, 1996, BRIT J CANCER, V74, P853, DOI 10.1038/bjc.1996.448; Schmidt M, 1999, ONCOGENE, V18, P1711, DOI 10.1038/sj.onc.1202489; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Seiden MV, 2007, GYNECOL ONCOL, V104, P727, DOI 10.1016/j.ygyno.2006.10.019; Shomura H, 2004, BRIT J CANCER, V90, P1563, DOI 10.1038/sj.bjc.6601728; WATERFIELD MD, 1982, J CELL BIOCHEM, V20, P149, DOI 10.1002/jcb.240200207; WELS W, 1995, INT J CANCER, V60, P137, DOI 10.1002/ijc.2910600120; WELS W, 1992, CANCER RES, V52, P6310; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	34	28	34	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 12	2010	29	32					4517	4527		10.1038/onc.2010.195	http://dx.doi.org/10.1038/onc.2010.195			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	638AQ	20514015				2022-12-25	WOS:000280862300003
J	Huang, YT; Liu, TH; Chen, YW; Lee, CH; Chen, HH; Huang, TW; Hsu, SH; Lin, SM; Pan, YJ; Lee, CH; Hsu, IC; Tseng, FG; Fu, CC; Pan, RL				Huang, Yun-Tzu; Liu, Tseng-Huang; Chen, Yen-Wei; Lee, Chien-Hsien; Chen, Hsueh-Hua; Huang, Tsu-Wei; Hsu, Shen-Hsing; Lin, Shih-Ming; Pan, Yih-Jiuan; Lee, Ching-Hung; Hsu, Ian C.; Tseng, Fan-Gang; Fu, Chien-Chung; Pan, Rong-Long			Distance Variations between Active Sites of H+-Pyrophosphatase Determined by Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUMPING INORGANIC PYROPHOSPHATASE; ATOMIC-FORCE MICROSCOPY; C-TERMINAL DOMAIN; EVOLUTIONARY CONSERVATION; RADIATION-INACTIVATION; CONFORMATIONAL-CHANGES; MUTAGENESIS; RESIDUES; PURIFICATION; BIOMOLECULES	Homodimeric H+-pyrophosphatase (H+-PPase; EC 3.6.1.1) is a unique enzyme playing a pivotal physiological role in pH homeostasis of organisms. This novel H+-PPase supplies energy at the expense of hydrolyzing metabolic byproduct, pyrophosphate (PPi), for H+ translocation across membrane. The functional unit for the translocation is considered to be a homodimer. Its putative active site on each subunit consists of PPi binding motif, Acidic I and II motifs, and several essential residues. In this investigation structural mapping of these vital regions was primarily determined utilizing single molecule fluorescence resonance energy transfer. Distances between two C termini and also two N termini on homodimeric subunits of H+-PPase are 49.3 +/- 4.0 and 67.2 +/- 5.7 angstrom, respectively. Furthermore, putative PPi binding motifs on individual subunits are found to be relatively far away from each other (70.8 +/- 4.8 angstrom), whereas binding of potassium and substrate analogue led them to closer proximity. Moreover, substrate analogue but not potassium elicits significant distance variations between two Acidic I motifs and two His-622 residues on homodimeric subunits. Taken together, this study provides the first quantitative measurements of distances between various essential motifs, residues, and putative active sites on homodimeric subunits of H+-PPase. A working model is accordingly proposed elucidating the distance variations of dimeric H+-PPase upon substrate binding.	[Huang, Yun-Tzu; Liu, Tseng-Huang; Chen, Yen-Wei; Lee, Chien-Hsien; Hsu, Shen-Hsing; Lin, Shih-Ming; Pan, Yih-Jiuan; Lee, Ching-Hung; Pan, Rong-Long] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Huang, Yun-Tzu; Liu, Tseng-Huang; Chen, Yen-Wei; Lee, Chien-Hsien; Hsu, Shen-Hsing; Lin, Shih-Ming; Pan, Yih-Jiuan; Lee, Ching-Hung; Pan, Rong-Long] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Coll Life Sci, Hsinchu 30013, Taiwan; [Chen, Hsueh-Hua; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu 30013, Taiwan; [Huang, Tsu-Wei; Tseng, Fan-Gang] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan; [Fu, Chien-Chung] Natl Tsing Hua Univ, Inst Nano Engn & Microsyst, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Pan, RL (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan.	rlpan@life.nthu.edu.tw	Fu, ChienChung/E-6137-2013	Tseng, Fan-Gang/0000-0001-7654-6905; Huang, Tsu-Wei/0000-0002-9982-7248	National Science Council, Republic of China [NSC 98-2627-M-007-002, NSC 98-2627-M-007-001, 97-2311-B-007-003-MY3, NSC 98-2627-M-007-003, NSC-98-2627-M-007-004]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Republic of China Grants NSC 98-2627-M-007-002, NSC 98-2627-M-007-001, and 97-2311-B-007-003-MY3 (to R.-L.P.), NSC 98-2627-M-007-003 (to F.-G.T.), and NSC-98-2627-M-007-004 (to C.-C.F.).	Baltscheffsky M, 1999, FEBS LETT, V452, P121, DOI 10.1016/S0014-5793(99)00617-1; Clerc S, 1998, ANAL BIOCHEM, V259, P104, DOI 10.1006/abio.1998.2639; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; EDSTROM RD, 1990, BIOPHYS J, V58, P1437, DOI 10.1016/S0006-3495(90)82489-9; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Ginsburg H, 2002, TRENDS PARASITOL, V18, P483, DOI 10.1016/S1471-4922(02)02350-4; GordonWeeks R, 1996, PLANT PHYSIOL, V111, P195, DOI 10.1104/pp.111.1.195; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Hsiao YY, 2004, BBA-BIOENERGETICS, V1608, P190, DOI 10.1016/j.bbabio.2004.01.001; Hsu SH, 2009, BOT STUD, V50, P291; Ishii Y, 1999, CHEM PHYS, V247, P163, DOI 10.1016/S0301-0104(99)00174-3; KIM EJ, 1995, J BIOL CHEM, V270, P2630, DOI 10.1074/jbc.270.6.2630; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Lin HH, 2005, ARCH BIOCHEM BIOPHYS, V442, P206, DOI 10.1016/j.abb.2005.08.010; Liu TH, 2009, FEBS J, V276, P4381, DOI 10.1111/j.1742-4658.2009.07146.x; Lopez-Marques RL, 2005, BBA-BIOMEMBRANES, V1716, P69, DOI 10.1016/j.bbamem.2005.08.004; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; MAESHIMA M, 1991, EUR J BIOCHEM, V196, P11, DOI 10.1111/j.1432-1033.1991.tb15779.x; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Pohjanjoki P, 1998, BIOCHEMISTRY-US, V37, P1754, DOI 10.1021/bi971771r; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; SARAFIAN V, 1992, BIOCHEM J, V283, P493, DOI 10.1042/bj2830493; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Tzeng CM, 1996, BIOCHEM J, V316, P143, DOI 10.1042/bj3160143; Weiss S, 2000, NAT STRUCT BIOL, V7, P724, DOI 10.1038/78941; Wu CA, 2005, ACTA CRYSTALLOGR D, V61, P1459, DOI 10.1107/S0907444905025667; Yang SH, 2004, BBA-BIOENERGETICS, V1656, P88, DOI 10.1016/j.bbabio.2004.02.001; Yang SJ, 1998, BIOCHEM J, V331, P395, DOI 10.1042/bj3310395; ZHEN RG, 1994, J BIOL CHEM, V269, P23342	34	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23655	23664		10.1074/jbc.M110.134916	http://dx.doi.org/10.1074/jbc.M110.134916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511234	hybrid, Green Published			2022-12-25	WOS:000280291400016
J	Raftos, JE; Whillier, S; Kuchel, PW				Raftos, Julia E.; Whillier, Stephney; Kuchel, Philip W.			Glutathione Synthesis and Turnover in the Human Erythrocyte ALIGNMENT OF A MODEL BASED ON DETAILED ENZYME KINETICS WITH EXPERIMENTAL DATA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSE-MONOPHOSPHATE SHUNT; AMINO-ACID-TRANSPORT; INSIDE-OUT VESICLES; SICKLE-CELL-ANEMIA; GAMMA-GLUTAMYLCYSTEINE; N-ACETYLCYSTEINE; RED-CELL; ELECTROCHEMICAL MODEL; OXIDIZED GLUTATHIONE; MATHEMATICAL-MODEL	The erythrocyte is exposed to reactive oxygen species in the circulation and also to those produced by autoxidation of hemoglobin. Consequently, erythrocytes depend on protection by the antioxidant glutathione. Mathematical models based on realistic kinetic data have provided valuable insights into the regulation of biochemical pathways within the erythrocyte but none have satisfactorily accounted for glutathione metabolism. In the current model, rate equations were derived for the enzyme-catalyzed reactions, and for each equation the nonlinear algebraic relationship between the steady-state kinetic parameters and the unitary rate constants was derived. The model also includes the transport processes that supply the amino acid constituents of glutathione and the export of oxidized glutathione. Values of the kinetic parameters for the individual reactions were measured predominately using isolated enzymes under conditions that differed from the intracellular environment. By comparing the experimental and simulated results, the values of the enzyme-kinetic parameters of the model were refined to yield conformity between model simulations and experimental data. Model output accurately represented the steady-state concentrations of metabolites in erythrocytes suspended in plasma and the changing glutathione concentrations in whole and hemolyzed erythrocytes under specific experimental conditions. Analysis indicated that feedback inhibition of gamma-glutamate-cysteine ligase by glutathione had a limited effect on steady-state glutathione concentrations and was not sufficiently potent to return glutathione concentrations to normal levels in erythrocytes exposed to sustained increases in oxidative load.	[Raftos, Julia E.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Kuchel, Philip W.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Kuchel, Philip W.] Univ Sydney, Ctr Math Biol, Sydney, NSW 2006, Australia	Macquarie University; University of Sydney; University of Sydney	Raftos, JE (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	julia.raftos@mq.edu.au	Whillier, Stephney/AAC-8550-2020	Whillier, Stephney/0000-0002-5093-4376; Kuchel, Philip/0000-0003-4100-7332	Macquarie University; Commonwealth of Australia; Australian Research Council	Macquarie University; Commonwealth of Australia(Australian Government); Australian Research Council(Australian Research Council)	Supported by a Macquarie University Research Development Grant.; Recipient of a Commonwealth of Australia Postgraduate Award.; Recipient of a Discovery Project Grant from the Australian Research Council.	Aguilo A, 2000, J NUTR BIOCHEM, V11, P81, DOI 10.1016/S0955-2863(99)00073-X; AKERBOOM TPM, 1992, BIOCHIM BIOPHYS ACTA, V1103, P115, DOI 10.1016/0005-2736(92)90064-S; BANNAI S, 1984, BIOCHIM BIOPHYS ACTA, V779, P289, DOI 10.1016/0304-4157(84)90014-5; Barbaro MPF, 2005, FREE RADICAL RES, V39, P1111, DOI 10.1080/10715760500250257; BEUTLER E, 1989, GLUTATHIONE CHEM BIO, P291; Blanco RA, 2007, AM J CLIN NUTR, V86, P1016, DOI 10.1093/ajcn/86.4.1016; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; CLELAND WW, 1967, ANNU REV BIOCHEM, V36, P77, DOI 10.1146/annurev.bi.36.070167.000453; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; CORNISHBOWDEN A, 1977, BIOCHEM J, V165, P55, DOI 10.1042/bj1650055; DIMANT E, 1955, J BIOL CHEM, V213, P769; Ellory J.C., 2003, RED CELL MEMBRANE TR, DOI [10.1007/978-3-662-05181-8_12, DOI 10.1007/978-3-662-05181-8_12]; ELLORY JC, 1983, BIOMED BIOCHIM ACTA, V42, pS48; Forni LG, 2005, CRIT CARE, V9, pR591, DOI 10.1186/cc3806; Friesen RW, 2007, J NUTR, V137, P2641; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GRIFFITH OW, 1981, J BIOL CHEM, V256, P4900; GRIMES AJ, 1980, HUMAN RED CELL METAB; HAGENFELDT L, 1978, CLIN CHIM ACTA, V85, P167, DOI 10.1016/0009-8981(78)90236-X; Halliwell B, 2004, FREE RADICALS BIOL M; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; HOLZHUTTER HG, 1985, EUR J BIOCHEM, V149, P101, DOI 10.1111/j.1432-1033.1985.tb08899.x; HSIEH HS, 1975, RED BLOOD CELL, V2, P799; JACKSON RC, 1969, BIOCHEM J, V111, P309, DOI 10.1042/bj1110309; JAFFE ER, 1981, FUNCTION RED BLOOD C, P133; Johnson JM, 2008, CLIN CHIM ACTA, V396, P43, DOI 10.1016/j.cca.2008.06.020; JOSHI A, 1989, J THEOR BIOL, V141, P515, DOI 10.1016/S0022-5193(89)80233-4; Kiessling K, 2000, Hematol J, V1, P243, DOI 10.1038/sj.thj.6200033; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; KING GF, 1985, BIOCHEM J, V227, P833, DOI 10.1042/bj2270833; Klokouzas A, 2001, EUR J BIOCHEM, V268, P6569, DOI 10.1046/j.0014-2956.2001.02611.x; KONDO T, 1980, P NATL ACAD SCI-BIOL, V77, P6359, DOI 10.1073/pnas.77.11.6359; KONDO T, 1987, P NATL ACAD SCI USA, V84, P7373, DOI 10.1073/pnas.84.21.7373; KUCHEL PW, 1982, BIOCHEM MED METAB B, V27, P95, DOI 10.1016/0006-2944(82)90012-6; LEW VL, 1986, J MEMBRANE BIOL, V92, P57, DOI 10.1007/BF01869016; Liu HL, 2005, J NEUROSCI RES, V79, P861, DOI 10.1002/jnr.20424; LOVRIC VA, 1981, MED J AUSTRALIA, V1, P635, DOI 10.5694/j.1326-5377.1981.tb135893.x; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; LUNN G, 1979, BLOOD, V54, P238; MAJERUS PW, 1971, J CLIN INVEST, V50, P1637, DOI 10.1172/JCI106652; MAK IT, 1994, AM J PHYSIOL-CELL PH, V267, pC1366; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mills BJ, 1996, BIOCHEM PHARMACOL, V52, P401, DOI 10.1016/0006-2952(96)00241-9; MINNICH V, 1971, J CLIN INVEST, V50, P507, DOI 10.1172/JCI106519; MULQUINEY P, 2003, MODELLING METABOLISM; Mulquiney PJ, 1999, BIOCHEM J, V342, P597, DOI 10.1042/0264-6021:3420597; Nakayama Y, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-18; Niihara Y, 1997, J LAB CLIN MED, V130, P83, DOI 10.1016/S0022-2143(97)90062-7; Niihara Y, 1998, AM J HEMATOL, V58, P117, DOI 10.1002/(SICI)1096-8652(199806)58:2<117::AID-AJH5>3.0.CO;2-V; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705; Pace BS, 2003, AM J HEMATOL, V73, P26, DOI 10.1002/ajh.10321; PHELPS DT, 1992, AM J RESP CELL MOL, V7, P293, DOI 10.1165/ajrcmb/7.3.293; RAE C, 1990, EUR J BIOCHEM, V193, P83, DOI 10.1111/j.1432-1033.1990.tb19307.x; Raftos JE, 2006, REDOX REP, V11, P9, DOI 10.1179/135100006X100986; RAFTOS JE, 1986, HAEMATOLOGIA, V19, P251; RAFTOS JE, 1990, J GEN PHYSIOL, V95, P1183, DOI 10.1085/jgp.95.6.1183; Raftos JE, 2007, INT J BIOCHEM CELL B, V39, P1698, DOI 10.1016/j.biocel.2007.04.014; RAPOPORT S, 1961, Folia Haematol Int Mag Klin Morphol Blutforsch, V78, P364; RAPOPORT SM, 1988, ROOTS OF MODERN BIOCHEMISTRY, P157; Reed MC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-8; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; Rice-Evans C., 1990, BLOOD CELL BIOCH, P429; Richie JP, 1996, CLIN CHEM, V42, P1100; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; Ristoff E, 2000, BLOOD, V95, P2193; Salvador A, 2003, P NATL ACAD SCI USA, V100, P14463, DOI 10.1073/pnas.2335687100; SCHUSTER R, 1988, BIOSYSTEMS, V22, P19, DOI 10.1016/0303-2647(88)90047-0; SMITH JE, 1980, ENZYME, V25, P236, DOI 10.1159/000459258; SRIVASTA.SK, 1969, J BIOL CHEM, V244, P9; Stein W., 1990, CHANNELS CARRIERS PU; THORBURN DR, 1985, EUR J BIOCHEM, V150, P371, DOI 10.1111/j.1432-1033.1985.tb09030.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tunnicliff G, 2003, J BIOMED SCI, V10, P30, DOI 10.1159/000068084; TUNNICLIFF G, 1994, COMP BIOCHEM PHYS A, V108, P471, DOI 10.1016/0300-9629(94)90329-8; van Thien H, 2004, CLIN NUTR, V23, P59, DOI 10.1016/S0261-5614(03)00089-X; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; WAGNER TC, 1994, ANAL BIOCHEM, V222, P417, DOI 10.1006/abio.1994.1511; Whillier S, 2009, REDOX REP, V14, P115, DOI 10.1179/135100009X392539; WINTER CG, 1964, J BIOL CHEM, V239, P872; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; YOUNG JD, 1980, PROC R SOC SER B-BIO, V209, P355, DOI 10.1098/rspb.1980.0100; Zhang HQ, 2009, ARCH BIOCHEM BIOPHYS, V481, P110, DOI 10.1016/j.abb.2008.10.020	84	59	59	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23557	23567		10.1074/jbc.M109.067017	http://dx.doi.org/10.1074/jbc.M109.067017			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498365	Green Published, hybrid			2022-12-25	WOS:000280291400005
J	Agarwal, V; Asmat, TM; Luo, SS; Jensch, I; Zipfel, PF; Hammerschmidt, S				Agarwal, Vaibhav; Asmat, Tauseef M.; Luo, Shanshan; Jensch, Inga; Zipfel, Peter F.; Hammerschmidt, Sven			Complement Regulator Factor H Mediates a Two-step Uptake of Streptococcus pneumoniae by Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; PNEUMOCOCCAL SURFACE PROTEIN; HEPARIN-BINDING DOMAIN; EPITHELIAL-CELLS; ENDOTHELIAL-CELLS; MYCOBACTERIUM-AVIUM; RHO GTPASES; HOST-CELLS; C-TERMINUS; PSPC	Streptococcus pneumoniae, a human pathogen, recruits complement regulator factor H to its bacterial cell surface. The bacterial PspC protein binds Factor H via short consensus repeats (SCR) 8-11 and SCR19-20. In this study, we define how bacterially bound Factor H promotes pneumococcal adherence to and uptake by epithelial cells or human polymorphonuclear leukocytes (PMNs) via a two-step process. First, pneumococcal adherence to epithelial cells was significantly reduced by heparin and dermatan sulfate. However, none of the glycosaminoglycans affected binding of Factor H to pneumococci. Adherence of pneumococci to human epithelial cells was inhibited by monoclonal antibodies recognizing SCR19-20 of Factor H suggesting that the C-terminal glycosaminoglycan-binding region of Factor H mediates the contact between pneumococci and human cells. Blocking of the integrin CR3 receptor, i.e. CD11b and CD18, of PMNs or CR3-expressing epithelial cells reduced significantly the interaction of pneumococci with both cell types. Similarly, an additional CR3 ligand, Pra1, derived from Candida albicans, blocked the interaction of pneumococci with PMNs. Strikingly, Pra1 inhibited also pneumococcal uptake by lung epithelial cells but not adherence. In addition, invasion of Factor H-coated pneumococci required the dynamics of host-cell actin microfilaments and was affected by inhibitors of protein-tyrosine kinases and phosphatidylinositol 3-kinase. In conclusion, pneumococcal entry into host cells via Factor H is based on a two-step mechanism. The first and initial contact of Factor H-coated pneumococci is mediated by glycosaminoglycans expressed on the surface of human cells, and the second step, pneumococcal uptake, is integrin-mediated and depends on host signaling molecules such as phosphatidylinositol 3-kinase.	[Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Agarwal, Vaibhav; Hammerschmidt, Sven] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Luo, Shanshan; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Zipfel, Peter F.] Univ Jena, D-07745 Jena, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Munich; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Asmat, Tauseef M/Q-3801-2019; Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681	Deutsche Forschungsgemeinschaft [DFG Ha 3125/2-1, 3125/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants DFG Ha 3125/2-1 and 3125/4-1.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; AUSTRIAN R, 1986, J ANTIMICROB CHEMOTH, V18, P35, DOI 10.1093/jac/18.Supplement_A.35; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bermudez LE, 1999, INFECT IMMUN, V67, P4912, DOI 10.1128/IAI.67.9.4912-4916.1999; BERRY L, 1991, AM J RESP CELL MOL, V4, P338, DOI 10.1165/ajrcmb/4.4.338; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Burnham CAD, 2007, FEMS MICROBIOL LETT, V272, P8, DOI 10.1111/j.1574-6968.2007.00768.x; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Cheng ZZ, 2006, MOL IMMUNOL, V43, P972, DOI 10.1016/j.molimm.2005.05.011; Dave S, 2004, J IMMUNOL, V173, P471, DOI 10.4049/jimmunol.173.1.471; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; DiScipio RG, 1998, J IMMUNOL, V160, P4057; Duthy TG, 2002, INFECT IMMUN, V70, P5604, DOI 10.1128/IAI.70.10.5604-5611.2002; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hellwage J, 1997, BIOCHEM J, V326, P321, DOI 10.1042/bj3260321; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; Ingalls RR, 1997, J IMMUNOL, V159, P433; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jarva H, 2004, J IMMUNOL, V172, P3111, DOI 10.4049/jimmunol.172.5.3111; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kazmierczak BI, 2001, CELL MICROBIOL, V3, P85, DOI 10.1046/j.1462-5822.2001.00091.x; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lu L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/jbc.M602404200; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Neeleman C, 1999, INFECT IMMUN, V67, P4517, DOI 10.1128/IAI.67.9.4517-4524.1999; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; RIPOCHE J, 1986, BIOSCIENCE REP, V6, P65, DOI 10.1007/BF01145180; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Saito A, 2005, J BIOCHEM, V137, P225, DOI 10.1093/jb/mvi025; Sangari FJ, 2000, CELL MICROBIOL, V2, P561, DOI 10.1046/j.1462-5822.2000.00080.x; Soloviev DA, 2007, J IMMUNOL, V178, P2038, DOI 10.4049/jimmunol.178.4.2038; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Xu B, 2006, ORG BIOMOL CHEM, V4, P4149, DOI 10.1039/b609143a; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	68	65	68	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23484	23493		10.1074/jbc.M110.142703	http://dx.doi.org/10.1074/jbc.M110.142703			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504767	Green Published, hybrid			2022-12-25	WOS:000279999900080
J	Ohashi, K; Ouchi, N; Higuchi, A; Shaw, RJ; Walsh, K				Ohashi, Koji; Ouchi, Noriyuki; Higuchi, Akiko; Shaw, Reuben J.; Walsh, Kenneth			LKB1 Deficiency in Tie2-Cre-expressing Cells Impairs Ischemia-induced Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; ADIPONECTIN STIMULATES ANGIOGENESIS; ENDOTHELIAL GROWTH-FACTOR; SKELETAL-MUSCLE; GLUCOSE-HOMEOSTASIS; TUMOR-SUPPRESSOR; CANCER CELLS; NO SYNTHASE; EXPRESSION	LKB1 is a tumor suppressor protein whose loss leads to HIF1 alpha-mediated activation of a proangiogenic program in intestinal polyps. LKB1 is also protein kinase regulator of AMP-activated protein kinase (AMPK) signaling, which is essential for endothelial cell responses to tissue ischemia. To discern whether LKB1 signaling is either pro- or antiangiogenic, we investigated ischemia-induced revascularization in mice that were deficient for LKB1 in Tie2-Cre-expressing cells. Whereas homozygous deletion of LKB1 led to embryonic lethality, heterozygous LKB1-knock-out (KO) (Lkb1(flox/+); Tie2(Tg/+)) mice were viable. Unchallenged heterozygous LKB1-KO mice displayed normal capillary density, but the revascularization of hind limb following ischemic surgery was significantly impaired as evaluated by laser Doppler flow and capillary density measurements. Reduction of LKB1 in cultured endothelial cells, using either small interfering RNA or an adenovirus expressing nonfunctional kinase-dead LKB1 protein, attenuated endothelial proliferation, migration, and differentiation into network structures on Matrigel that was accompanied by diminished AMPK phosphorylation at Thr-172. Conversely, adenovirus-mediated LKB1 overexpression (Ad-LKB1) augmented network structure formation, and this was associated with elevated AMPK phosphorylation. The augmented differentiation of endothelial cells into network structures induced by Ad-LKB1 was abrogated by the co-transduction of a dominant negative mutant of AMPK. These observations suggest that the LKB1-AMPK signaling axis in endothelial cells is a positive regulator of the revascularization response to tissue ischemia.	[Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Mol Cardiol, Boston, MA 02118 USA; [Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, Dulbecco Ctr Canc Res, La Jolla, CA 92037 USA	Boston University; Salk Institute	Walsh, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Mol Cardiol, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	OHASHI, Koji/I-7307-2014; OUCHI, Noriyuki/I-7306-2014	Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [AG15052, HL91949, HL81587]; Manpei Suzuki Diabetes Foundation; American Heart Association Scientist Development, Northeast Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091949, P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015052, R37AG015052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; American Heart Association Scientist Development, Northeast Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG15052, HL91949, and HL81587 (to K.W.).; Supported by the Manpei Suzuki Diabetes Foundation.; Supported by an American Heart Association Scientist Development grant, Northeast Affiliate.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Londesborough A, 2008, DEVELOPMENT, V135, P2331, DOI 10.1242/dev.017038; Miyoshi H, 2002, CANCER RES, V62, P2261; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skurk C, 2005, CIRC RES, V96, P308, DOI 10.1161/01.RES.0000156273.30274.f7; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	41	33	34	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22291	22298		10.1074/jbc.M110.123794	http://dx.doi.org/10.1074/jbc.M110.123794			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20489196	hybrid, Green Published			2022-12-25	WOS:000279702200042
J	Fred, RG; Bang-Berthelsen, CH; Mandrup-Poulsen, T; Grunnet, LG; Welsh, N				Fred, Rikard G.; Bang-Berthelsen, Claus H.; Mandrup-Poulsen, Thomas; Grunnet, Lars G.; Welsh, Nils			High Glucose Suppresses Human Islet Insulin Biosynthesis by Inducing miR-133a Leading to Decreased Polypyrimidine Tract Binding Protein-Expression	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; MESSENGER-RNA STABILITY; BETA-CELL DEATH; 3'-UNTRANSLATED REGION; CHRONIC EXPOSURE; GENE-EXPRESSION; RIN-5F CELLS; FATTY-ACIDS; IDENTIFICATION; CYTOKINES	Background: Prolonged periods of high glucose exposure results in human islet dysfunction in vitro. The underlying mechanisms behind this effect of high glucose are, however, unknown. The polypyrimidine tract binding protein (PTB) is required for stabilization of insulin mRNA and the PTB mRNA 3'-UTR contains binding sites for the microRNA molecules miR-133a, miR-124a and miR-146. The aim of this study was therefore to investigate whether high glucose increased the levels of these three miRNAs in association with lower PTB levels and lower insulin biosynthesis rates. Methodology/Principal Findings: Human islets were cultured for 24 hours in the presence of low (5.6 mM) or high glucose (20 mM). Islets were also exposed to sodium palmitate or the proinflammatory cytokines IL-1 beta and IFN-gamma, since saturated free fatty acids and cytokines also cause islet dysfunction. RNA was then isolated for real-time RT-PCR analysis of miR-133a, miR-124a, miR-146, insulin mRNA and PTB mRNA contents. Insulin biosynthesis rates were determined by radioactive labeling and immunoprecipitation. Synthetic miR-133a precursor and inhibitor were delivered to dispersed islet cells by lipofection, and PTB was analyzed by immunoblotting following culture at low or high glucose. Culture in high glucose resulted in increased islet contents of miR-133a and reduced contents of miR-146. Cytokines increased the contents of miR-146. The insulin and PTB mRNA contents were unaffected by high glucose. However, both PTB protein levels and insulin biosynthesis rates were decreased in response to high glucose. The miR-133a inhibitor prevented the high glucose-induced decrease in PTB and insulin biosynthesis, and the miR-133a precursor decreased PTB levels and insulin biosynthesis similarly to high glucose. Conclusion: Prolonged high-glucose exposure down-regulates PTB levels and insulin biosynthesis rates in human islets by increasing miR-133a levels. We propose that this mechanism contributes to hyperglycemia-induced beta-cell dysfunction.	[Fred, Rikard G.; Welsh, Nils] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Bang-Berthelsen, Claus H.; Mandrup-Poulsen, Thomas] Hagedorn Res Inst, Gentofte, Denmark; [Mandrup-Poulsen, Thomas; Grunnet, Lars G.] Univ Copenhagen, Core Unit Med Res Methodol, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Uppsala University; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Karolinska Institutet	Fred, RG (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Nils.Welsh@mcb.uu.se		/0000-0003-4541-2538; Mandrup-Poulsen, Thomas/0000-0002-3215-9273; Fred, Rikard/0000-0002-2273-6719	Swedish Research Council [2006-11590]; Swedish Diabetes Association; Wallenberg Foundation; Family Ernfors Fund; Novo-Nordisk Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Wallenberg Foundation(European Commission); Family Ernfors Fund; Novo-Nordisk Foundation(Novo Nordisk Foundation)	This work was supported in part by the Swedish Research Council (2006-11590), the Swedish Diabetes Association, the Wallenberg Foundation, the Family Ernfors Fund and the Novo-Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen X, 2009, J BIOL CHEM, V284, P5362, DOI 10.1074/jbc.M807523200; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; EIZIRIK DL, 1992, J CLIN INVEST, V90, P1263, DOI 10.1172/JCI115989; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Fred RG, 2009, MOL CELL ENDOCRINOL, V297, P28, DOI 10.1016/j.mce.2008.06.007; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Goto T, 2005, TRANSPL P, V37, P3430, DOI 10.1016/j.transproceed.2005.09.041; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hagerkvist R, 2005, ANN NY ACAD SCI, V1040, P114, DOI 10.1196/annals.1327.014; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kaneto Hideaki, 2005, Am J Ther, V12, P529, DOI 10.1097/01.mjt.0000178773.31525.c2; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lupi R, 2004, AM J PHYSIOL-ENDOC M, V286, pE560, DOI 10.1152/ajpendo.00561.2002; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; Minn AH, 2005, MOL ENDOCRINOL, V19, P794, DOI 10.1210/me.2004-0119; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Rabinovitch A, 1999, DIABETES, V48, P1223, DOI 10.2337/diabetes.48.6.1223; ROBERTSON RP, 1992, J CLIN INVEST, V90, P320, DOI 10.1172/JCI115865; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Tillmar L, 2004, MOL CELL BIOCHEM, V260, P85, DOI 10.1023/B:MCBI.0000026059.56089.e4; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; WELSH M, 1985, J BIOL CHEM, V260, P3590; Wicksteed B, 2001, J BIOL CHEM, V276, P22553, DOI 10.1074/jbc.M011214200; Xiao JN, 2007, J BIOL CHEM, V282, P12363, DOI 10.1074/jbc.C700015200; Zhang J, 2009, CELL DEATH DIFFER, V16, P1460, DOI 10.1038/cdd.2009.87; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584	50	65	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10843	10.1371/journal.pone.0010843	http://dx.doi.org/10.1371/journal.pone.0010843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520763	gold, Green Submitted, Green Published			2022-12-25	WOS:000278221500029
J	Littler, MM; Littler, DS; Brooks, BL				Littler, Mark M.; Littler, Diane S.; Brooks, Barrett L.			Marine Macroalgal Diversity Assessment of Saba Bank, Netherlands Antilles	PLOS ONE			English	Article								Background: Located in the Dutch Windward Islands, Saba Bank is a flat-topped seamount (20-45 m deep in the shallower regions). The primary goals of the survey were to improve knowledge of biodiversity for one of the world's most significant, but little-known, seamounts and to increase basic data and analyses to promote the development of an improved management plan. Methodology/Principal Findings: Our team of three divers used scuba to collect algal samples to depths of 50 m at 17 dive sites. Over 360 macrophyte specimens (12 putative new species) were collected, more than 1,000 photographs were taken in truly exceptional habitats, and three astonishing new seaweed community types were discovered. These included: (1) "Field of Greens'' (N 17 degrees 30.620', W 63 degrees 27.707') dominated by green seaweeds as well as some filamentous reds, (2) "Brown Town'' (N 17 degrees 28.027', W 63 degrees 14.944') dominated by large brown algae, and (3) "Seaweed City'' (N 17 degrees 26.485', W 63 degrees 16.850') with a diversity of spectacular fleshy red algae. Conclusions/Significance: Dives to 30 m in the more two-dimensional interior habitats revealed particularly robust specimens of algae typical of shallower seagrass beds, but here in the total absence of any seagrasses (seagrasses generally do not grow below 20 m). Our preliminary estimate of the number of total seaweed species on Saba Bank ranges from a minimum of 150 to 200. Few filamentous and thin sheet forms indicative of stressed or physically disturbed environments were observed. A more precise number still awaits further microscopic and molecular examinations in the laboratory. The expedition, while intensive, has only scratched the surface of this unique submerged seamount/atoll.	[Littler, Mark M.; Littler, Diane S.; Brooks, Barrett L.] Smithsonian Inst, Dept Bot, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Littler, MM (corresponding author), Smithsonian Inst, Dept Bot, Washington, DC 20560 USA.	littlerm@si.edu	Brooks, Barrett L/C-5306-2008	Brooks, Barrett L/0000-0003-0476-9530; Littler, Dene/0000-0001-5904-1905	Department of Environment and Nature of the Netherlands Antilles; Conservation International; Smithsonian Marine Station at Ft. Pierce (SMSFP)	Department of Environment and Nature of the Netherlands Antilles; Conservation International; Smithsonian Marine Station at Ft. Pierce (SMSFP)	Financial support for this study came from the Department of Environment and Nature of the Netherlands Antilles, Conservation International and the Smithsonian Marine Station at Ft. Pierce (SMSFP Contribution No. 810). The funding sources provided critical assistance in determining dive site locations but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackmore S, 2005, PLANT CONSERVATION: A NATURAL HISTORY APPROACH, P257; Colwell R. K., 2006, ESTIMATES VERSION 8; DAVIS WM, 1926, PUBLICATION AM GEOGR, V2, P212; Klomp Kristi D., 2003, Atoll Research Bulletin, V496, P404; LITTLER DS, 2007, PLANTS LICHENS SABA; Littler M.N., 1993, P 7 INT COR REEF S, V1, P335; Littler MM, 2007, AQUAT CONSERV, V17, P195, DOI 10.1002/aqc.790; LITTLER MM, 1997, B BIOL SOC WASH, V9, P149; MACINTYRE I G, 1975, Caribbean Journal of Science, V15, P11; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; SPENCER JW, 1904, T CAN I, V7, P351; van der Land J., 1977, FAO FISHERIES REPORT, V200, P469, DOI DOI 10.1371/JOURNAL.PONE.0009207; VAUGHAN TW, 1919, BULLETIN US NATL MUS, V103	13	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10677	10.1371/journal.pone.0010677	http://dx.doi.org/10.1371/journal.pone.0010677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505757	Green Published, gold, Green Submitted			2022-12-25	WOS:000278017400008
J	Wehling-Henricks, M; Jordan, MC; Gotoh, T; Grody, WW; Roos, KP; Tidball, JG				Wehling-Henricks, Michelle; Jordan, Maria C.; Gotoh, Tomomi; Grody, Wayne W.; Roos, Kenneth P.; Tidball, James G.			Arginine Metabolism by Macrophages Promotes Cardiac and Muscle Fibrosis in mdx Muscular Dystrophy	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR-BETA; SKELETAL-MUSCLE; TRANSCRIPTIONAL REGULATION; PULMONARY-FUNCTION; MESSENGER-RNAS; EXPRESSION; MOUSE; ARGINASE; SARCOLEMMA	Background: Duchenne muscular dystrophy (DMD) is the most common, lethal disease of childhood. One of 3500 new-born males suffers from this universally-lethal disease. Other than the use of corticosteroids, little is available to affect the relentless progress of the disease, leading many families to use dietary supplements in hopes of reducing the progression or severity of muscle wasting. Arginine is commonly used as a dietary supplement and its use has been reported to have beneficial effects following short-term administration to mdx mice, a genetic model of DMD. However, the long-term effects of arginine supplementation are unknown. This lack of knowledge about the long-term effects of increased arginine metabolism is important because elevated arginine metabolism can increase tissue fibrosis, and increased fibrosis of skeletal muscles and the heart is an important and potentially life-threatening feature of DMD. Methodology: We use both genetic and nutritional manipulations to test whether changes in arginase metabolism promote fibrosis and increase pathology in mdx mice. Our findings show that fibrotic lesions in mdx muscle are enriched with arginase-2-expressing macrophages and that muscle macrophages stimulated with cytokines that activate the M2 phenotype show elevated arginase activity and expression. We generated a line of arginase-2-null mutant mdx mice and found that the mutation reduced fibrosis in muscles of 18-month-old mdx mice, and reduced kyphosis that is attributable to muscle fibrosis. We also observed that dietary supplementation with arginine for 17-months increased mdx muscle fibrosis. In contrast, arginine-2 mutation did not reduce cardiac fibrosis or affect cardiac function assessed by echocardiography, although 17-months of dietary supplementation with arginine increased cardiac fibrosis. Long-term arginine treatments did not decrease matrix metalloproteinase-2 or -9 or increase the expression of utrophin, which have been reported as beneficial effects of short-term treatments. Conclusions/Significance: Our findings demonstrate that arginine metabolism by arginase promotes fibrosis of muscle in muscular dystrophy and contributes to kyphosis. Our findings also show that long-term, dietary supplementation with arginine exacerbates fibrosis of dystrophic heart and muscles. Thus, commonly-practiced dietary supplementation with arginine by DMD patients has potential risk for increasing pathology when performed for long periods, despite reports of benefits acquired with short-term supplementation.	[Wehling-Henricks, Michelle; Tidball, James G.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Jordan, Maria C.; Roos, Kenneth P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Gotoh, Tomomi] Kumamoto Univ, Sch Med, Dept Mol Genet, Kumamoto 860, Japan; [Grody, Wayne W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Grody, Wayne W.; Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Grody, Wayne W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Tidball, James G.] Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kumamoto University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Wehling-Henricks, M (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	jtidball@physci.ucla.edu	Jordan, Maria/HHN-5358-2022; Tidball, James/H-7970-2012	Tidball, James/0000-0003-1202-8038	Muscular Dystrophy Association [4031, 157881, 4006]; National Institutes of Health [R01 AR40343, R01 AR47721]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047721, R01AR054451, R01AR040343] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Muscular Dystrophy Association (4031 and 157881 to JGT; 4006 to MW-H) and the National Institutes of Health (R01 AR40343, R01 AR47721 to JGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; ALBINA JE, 1988, AM J PHYSIOL, V254, pE459, DOI 10.1152/ajpendo.1988.254.4.E459; Bani C, 2008, MUSCLE NERVE, V37, P583, DOI 10.1002/mus.20970; BARBUL A, 1990, SURGERY, V108, P331; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Buga GM, 1996, AM J PHYSIOL-HEART C, V271, pH1988, DOI 10.1152/ajpheart.1996.271.5.H1988; Buyse GM, 2009, EUR HEART J, V30, P116, DOI 10.1093/eurheartj/ehn406; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Chaubourt E, 1999, NEUROBIOL DIS, V6, P499, DOI 10.1006/nbdi.1999.0256; Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Curran JN, 2006, WOUND REPAIR REGEN, V14, P376, DOI 10.1111/j.1743-6109.2006.00151.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Deignan JL, 2006, MOL GENET METAB, V89, P87, DOI 10.1016/j.ymgme.2006.04.007; Endo M, 2003, AM J PHYSIOL-LUNG C, V285, pL313, DOI 10.1152/ajplung.00434.2002; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Forst J, 1999, NEUROMUSCULAR DISORD, V9, P176, DOI 10.1016/S0960-8966(98)00113-8; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; HECKER M, 1995, P NATL ACAD SCI USA, V92, P4671, DOI 10.1073/pnas.92.10.4671; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hrabak A, 1996, FEBS LETT, V390, P203, DOI 10.1016/0014-5793(96)00659-X; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; INKLEY SR, 1974, AM J MED, V56, P297, DOI 10.1016/0002-9343(74)90611-1; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Jung AS, 2006, AM J PHYSIOL-HEART C, V290, pH1756, DOI 10.1152/ajpheart.01104.2005; Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193; KARPATI G, 1986, AM J MED GENET, V25, P653, DOI 10.1002/ajmg.1320250407; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; KUBO M, 1993, PEDIATR CARDIOL, V14, P214, DOI 10.1007/BF00795373; Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MIYOSHI K, 1991, BRIT HEART J, V66, P452; MONTGOMERY AMP, 1993, BIOCHIM BIOPHYS ACTA, V1176, P265, DOI 10.1016/0167-4889(93)90054-S; Moriuchi T, 1993, Tokushima J Exp Med, V40, P83; Morrison J, 2005, AM J PATHOL, V166, P1701, DOI 10.1016/S0002-9440(10)62480-7; NODA M, 1989, ENDOCRINOLOGY, V124, P612, DOI 10.1210/endo-124-2-612; NODA M, 1988, J BIOL CHEM, V263, P13916; NODA M, 1987, J CELL PHYSIOL, V133, P426, DOI 10.1002/jcp.1041330303; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; Passerini L, 2002, NEUROMUSCULAR DISORD, V12, P828, DOI 10.1016/S0960-8966(02)00071-8; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; RIDEAU Y, 1981, MUSCLE NERVE, V4, P155, DOI 10.1002/mus.880040213; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106; Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004; Salimena M, 2004, HISTOCHEM CELL BIOL, V122, P435, DOI 10.1007/s00418-004-0707-8; Satriano J, 2004, AMINO ACIDS, V26, P321, DOI 10.1007/s00726-004-0078-4; Segalat L, 2005, EXP CELL RES, V302, P170, DOI 10.1016/j.yexcr.2004.09.007; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; STAHLEBACKDAHL M, 1994, J CLIN INVEST, V93, P2022, DOI 10.1172/JCI117196; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Steppan J, 2006, P NATL ACAD SCI USA, V103, P4759, DOI 10.1073/pnas.0506589103; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TREASURE CB, 1990, CIRCULATION, V81, P772, DOI 10.1161/01.CIR.81.3.772; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Wehling-Henricks M, 2004, NEUROMUSCULAR DISORD, V14, P483, DOI 10.1016/j.nmd.2004.04.008; Wehling-Henricks M, 2008, HUM MOL GENET, V17, P2280, DOI 10.1093/hmg/ddn129; Witte MB, 2003, WOUND REPAIR REGEN, V11, P419, DOI 10.1046/j.1524-475X.2003.11605.x; Witte MB, 2003, J GASTROINTEST SURG, V7, P378, DOI 10.1016/S1091-255X(02)00431-6; Yamashita T, 2001, J PEDIATR ORTHOPED, V21, P113, DOI 10.1097/01241398-200101000-00022; YANAGISAWA A, 1992, AM HEART J, V124, P1244, DOI 10.1016/0002-8703(92)90407-M	82	85	87	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10763	10.1371/journal.pone.0010763	http://dx.doi.org/10.1371/journal.pone.0010763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505827	Green Published, gold, Green Submitted			2022-12-25	WOS:000278017400018
J	Liu, HS; Zhang, JH; Liu, CY; Wang, IJ; Sieber, M; Chang, J; Jester, JV; Kao, WWY				Liu, Hongshan; Zhang, Jianhua; Liu, Chia-Yang; Wang, I-Jong; Sieber, Martin; Chang, John; Jester, James V.; Kao, Winston W. Y.			Cell Therapy of Congenital Corneal Diseases with Umbilical Mesenchymal Stem Cells: Lumican Null Mice	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; CONFOCAL MICROSCOPY; SKELETAL-MUSCLE; SPINAL-CORD; TRANSPLANTATION; TISSUE; EXPRESSION; KERATOCAN; REPAIR	Background: Keratoplasty is the most effective treatment for corneal blindness, but suboptimal medical conditions and lack of qualified medical personnel and donated cornea often prevent the performance of corneal transplantation in developing countries. Our study aims to develop alternative treatment regimens for congenital corneal diseases of genetic mutation. Methodology/Principal Findings: Human mesenchymal stem cells isolated from neonatal umbilical cords were transplanted to treat thin and cloudy corneas of lumican null mice. Transplantation of umbilical mesenchymal stem cells significantly improved corneal transparency and increased stromal thickness of lumican null mice, but human umbilical hematopoietic stem cells failed to do the same. Further studies revealed that collagen lamellae were re-organized in corneal stroma of lumican null mice after mesenchymal stem cell transplantation. Transplanted umbilical mesenchymal stem cells survived in the mouse corneal stroma for more than 3 months with little or no graft rejection. In addition, these cells assumed a keratocyte phenotype, e. g., dendritic morphology, quiescence, expression of keratocyte unique keratan sulfated keratocan and lumican, and CD34. Moreover, umbilical mesenchymal stem cell transplantation improved host keratocyte functions, which was verified by enhanced expression of keratocan and aldehyde dehydrogenase class 3A1 in lumican null mice. Conclusions/Significance: Umbilical mesenchymal stem cell transplantation is a promising treatment for congenital corneal diseases involving keratocyte dysfunction. Unlike donated corneas, umbilical mesenchymal stem cells are easily isolated, expanded, stored, and can be quickly recovered from liquid nitrogen when a patient is in urgent need.	[Liu, Hongshan; Zhang, Jianhua; Liu, Chia-Yang; Kao, Winston W. Y.] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45221 USA; [Wang, I-Jong] Natl Taiwan Univ, Coll Med, Dept Ophthalmol, Taipei 10764, Taiwan; [Sieber, Martin; Chang, John] Bionet Corp, Taipei, Taiwan; [Jester, James V.] Univ Calif Irvine, Med Ctr, Gavin Herbert Eye Inst, Orange, CA USA	University System of Ohio; University of Cincinnati; National Taiwan University; University of California System; University of California Irvine	Liu, HS (corresponding author), Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45221 USA.	Winston.Kao@UC.Edu		Liu, Chia-yang/0000-0002-8398-5516; Jester, James/0000-0002-9246-0981; Wang, I-Jong/0000-0002-3045-0614	NIH/NEI [EY 011845, EY016663]; Research to Prevent Blindness Inc.; Ohio Lions Eye Res. Foundation; NATIONAL EYE INSTITUTE [R01EY011845, R24EY016663] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); Ohio Lions Eye Res. Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was in part supported by grants NIH/NEI EY 011845, EY016663, Research to Prevent Blindness Inc. and Ohio Lions Eye Res. Foundation. Dr. Martin Sieber and Mr. John Chang are employees of Bionet Corp., Taipei, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except the initial characterizations of the stem cells.	Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen JW, 2005, CELL TISSUE RES, V319, P429, DOI 10.1007/s00441-004-1025-0; Chhabra P, 2009, CURR OPIN ORGAN TRAN, V14, P72, DOI 10.1097/MOT.0b013e328320d2f5; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; Dai LJ, 2009, STEM CELL RES, V2, P16, DOI 10.1016/j.scr.2008.07.005; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Espana EM, 2004, INVEST OPHTH VIS SCI, V45, P2985, DOI 10.1167/iovs.04-0201; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Garg P, 2005, EYE, V19, P1106, DOI 10.1038/sj.eye.6701968; Han M, 2005, OPT EXPRESS, V13, P5791, DOI 10.1364/OPEX.13.005791; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Ikehara S, 2010, CLIN REV ALLERG IMMU, V38, P292, DOI 10.1007/s12016-009-8159-5; Isaikina Ya., 2008, Experimental Oncology, V30, P121; Jester JV, 1999, METHOD ENZYMOL, V307, P230; Jester JV, 2001, VISION RES, V41, P1283, DOI 10.1016/S0042-6989(00)00222-4; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joseph A, 2003, INVEST OPHTH VIS SCI, V44, P4689, DOI 10.1167/iovs.02-0999; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Kassis I, 2006, BONE MARROW TRANSPL, V37, P967, DOI 10.1038/sj.bmt.1705358; Khan Bilal F., 2007, International Ophthalmology Clinics, V47, P61, DOI 10.1097/IIO.0b013e318036bd8b; Kitada M, 2009, HISTOL HISTOPATHOL, V24, P631, DOI 10.14670/HH-24.631; Lasala GP, 2009, HEART LUNG CIRC, V18, P171, DOI 10.1016/j.hlc.2008.09.007; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mobasheri A, 2009, HISTOL HISTOPATHOL, V24, P347, DOI 10.14670/HH-24.347; Moffatt SL, 2005, CLIN EXP OPHTHALMOL, V33, P642, DOI 10.1111/j.1442-9071.2005.01134.x; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Morishige N, 2006, J CATARACT REFR SURG, V32, P1784, DOI 10.1016/j.jcrs.2006.08.027; Myung D, 2008, BIOTECHNOL PROGR, V24, P735, DOI 10.1021/bp070476n; Nadri S, 2008, DIFFERENTIATION, V76, P223, DOI 10.1111/j.1432-0436.2007.00216.x; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; PITTENGER MF, SCIENCE, V284, P143; Popp FC, 2009, TRANSPLANTATION, V87, pS57, DOI 10.1097/TP.0b013e3181a288aa; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Raimondo S, 2006, J ANAT, V208, P3, DOI 10.1111/j.1469-7580.2006.00511.x; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Zakrzewski JL, 2006, NAT MED, V12, P1039, DOI 10.1038/nm1463	54	80	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10707	10.1371/journal.pone.0010707	http://dx.doi.org/10.1371/journal.pone.0010707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502663	Green Published, gold			2022-12-25	WOS:000277845400013
J	Bishay, P; Schmidt, H; Marian, C; Haussler, A; Wijnvoord, N; Ziebell, S; Metzner, J; Koch, M; Myrczek, T; Bechmann, I; Kuner, R; Costigan, M; Dehghani, F; Geisslinger, G; Tegeder, I				Bishay, Philipp; Schmidt, Helmut; Marian, Claudiu; Hauessler, Annett; Wijnvoord, Nina; Ziebell, Simone; Metzner, Julia; Koch, Marco; Myrczek, Thekla; Bechmann, Ingo; Kuner, Rohini; Costigan, Michael; Dehghani, Faramarz; Geisslinger, Gerd; Tegeder, Irmgard			R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; ACTIVATED PROTEIN-KINASE; ACID AMIDE HYDROLASE; DORSAL-ROOT GANGLION; SPINAL-CORD; MICROGLIA CONTRIBUTES; INDUCED HYPERALGESIA; MULTIPLE-SCLEROSIS; PROSTAGLANDIN E-2; GAMMA-SECRETASE	Background: R-flurbiprofen, one of the enantiomers of flurbiprofen racemate, is inactive with respect to cyclooxygenase inhibition, but shows analgesic properties without relevant toxicity. Its mode of action is still unclear. Methodology/Principal Findings: We show that R-flurbiprofen reduces glutamate release in the dorsal horn of the spinal cord evoked by sciatic nerve injury and thereby alleviates pain in sciatic nerve injury models of neuropathic pain in rats and mice. This is mediated by restoring the balance of endocannabinoids (eCB), which is disturbed following peripheral nerve injury in the DRGs, spinal cord and forebrain. The imbalance results from transcriptional adaptations of fatty acid amide hydrolase (FAAH) and NAPE-phospholipase D, i.e. the major enzymes involved in anandamide metabolism and synthesis, respectively. R-flurbiprofen inhibits FAAH activity and normalizes NAPE-PLD expression. As a consequence, R-Flurbiprofen improves endogenous cannabinoid mediated effects, indicated by the reduction of glutamate release, increased activity of the anti-inflammatory transcription factor PPAR gamma and attenuation of microglia activation. Antinociceptive effects are lost by combined inhibition of CB1 and CB2 receptors and partially abolished in CB1 receptor deficient mice. R-flurbiprofen does however not cause changes of core body temperature which is a typical indicator of central effects of cannabinoid-1 receptor agonists. Conclusion: Our results suggest that R-flurbiprofen improves the endogenous mechanisms to regain stability after axonal injury and to fend off chronic neuropathic pain by modulating the endocannabinoid system and thus constitutes an attractive, novel therapeutic agent in the treatment of chronic, intractable pain.	[Bishay, Philipp; Schmidt, Helmut; Marian, Claudiu; Hauessler, Annett; Wijnvoord, Nina; Ziebell, Simone; Metzner, Julia; Myrczek, Thekla; Geisslinger, Gerd; Tegeder, Irmgard] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Bechmann, Ingo] Goethe Univ Frankfurt, Dept Clin Neuroanat, Frankfurt, Germany; [Koch, Marco; Dehghani, Faramarz] Goethe Univ Frankfurt, Dept Expt Neurobiol, Inst Anat, Frankfurt, Germany; [Kuner, Rohini] Univ Heidelberg, Dept Pharmacol, D-6900 Heidelberg, Germany; [Costigan, Michael] Harvard Univ, Sch Med, Boston, MA USA; [Costigan, Michael] Massachusetts Gen Hosp, Neuroplast Res Grp, Dept Anaesthesia, Boston, MA 02114 USA	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Bishay, P (corresponding author), Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	tegeder@em.uni-frankfurt.de	Tegeder, Irmgard/AAM-2266-2020; Kuner, Rohini/AGU-0204-2022; Tegeder, Irmgard/AAM-2246-2020	Tegeder, Irmgard/0000-0001-7524-8025; Tegeder, Irmgard/0000-0001-7524-8025	LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); Else Kroner Fresenius Foundation; PAZ GmbH, Frankfurt; Interdisciplinary Center of Neuroscience Frankfurt, ICNF	LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); Else Kroner Fresenius Foundation; PAZ GmbH, Frankfurt; Interdisciplinary Center of Neuroscience Frankfurt, ICNF	This work was supported by LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF, http://www.liff-ffm.de/liff/mission.php; to IT), Else Kroner Fresenius Foundation (http://www.ekfs.de/de/start.html, to IT), PAZ GmbH, Frankfurt (http://www.paz.de/to GG) and the Interdisciplinary Center of Neuroscience Frankfurt, ICNF (http://www.izn-frankfurt.de/web-content_en/index.html, to IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fowler CJ, 2003, J ENZYM INHIB MED CH, V18, P55, DOI 10.1080/1475636021000049726; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Geisslinger G, 2000, J NEUROCHEM, V74, P2094, DOI 10.1046/j.1471-4159.2000.0742094.x; GEISSLINGER G, 1993, AGENT ACTION SUPPL, V44, P31; Griffin RS, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-105; Hansen HS, 1998, BIOCHEM PHARMACOL, V55, P719, DOI 10.1016/S0006-2952(97)00396-1; Holzer P, 2001, INFLAMM RES, V50, P602, DOI 10.1007/PL00000241; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Jin SX, 2003, J NEUROSCI, V23, P4017; Khasabova IA, 2008, J NEUROSCI, V28, P11141, DOI 10.1523/JNEUROSCI.2847-08.2008; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Ledeboer A, 2005, EUR J NEUROSCI, V22, P1977, DOI 10.1111/j.1460-9568.2005.04379.x; LOTSCH J, 1995, BRIT J CLIN PHARMACO, V40, P339, DOI 10.1111/j.1365-2125.1995.tb04556.x; Ma WY, 2007, EXPERT OPIN THER TAR, V11, P307, DOI 10.1517/14728222.11.3.307; Maione S, 2007, BRIT J PHARMACOL, V150, P766, DOI 10.1038/sj.bjp.0707145; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nyilas R, 2009, EUR J NEUROSCI, V29, P1964, DOI 10.1111/j.1460-9568.2009.06751.x; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Piao ZG, 2006, PAIN, V121, P219, DOI 10.1016/j.pain.2005.12.023; Pollmann W, 2008, CNS DRUGS, V22, P291; Pollock G, 2005, EXP BRAIN RES, V165, P470, DOI 10.1007/s00221-005-2318-6; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; Romero-Sandoval EA, 2008, CURR OPIN INVEST DR, V9, P726; Schmidtko A, 2005, PAIN, V115, P171, DOI 10.1016/j.pain.2005.02.027; SCHMIDTKO A, 2008, PAIN; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Scholz J, 2008, PAIN, V138, P130, DOI 10.1016/j.pain.2007.11.019; Sheng WS, 2009, J NEUROIMMUNE PHARM, V4, P244, DOI 10.1007/s11481-009-9147-5; Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Tegeder I, 2001, FASEB J, V15, P595, DOI 10.1096/fasebj.15.3.595; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Vetter G, 2001, PAIN, V92, P213, DOI 10.1016/S0304-3959(01)00258-5; Wang J, 2006, J BIOL CHEM, V281, P12325, DOI 10.1074/jbc.M512359200; Wilcock GK, 2008, LANCET NEUROL, V7, P483, DOI 10.1016/S1474-4422(08)70090-5; Xu JT, 2007, EXP NEUROL, V204, P355, DOI 10.1016/j.expneurol.2006.11.016	49	66	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10628	10.1371/journal.pone.0010628	http://dx.doi.org/10.1371/journal.pone.0010628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498712	Green Published, gold, Green Submitted			2022-12-25	WOS:000277633500016
J	Brooks, R; Maklakov, A				Brooks, Robert; Maklakov, Alexei			Sex Differences in Obesity Associated with Total Fertility Rate	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; ANTHROPOMETRIC MEASURES; REPRODUCTIVE FACTORS; WEIGHT; PARITY; GENDER	The identification of biological and ecological factors that contribute to obesity may help in combating the spreading obesity crisis. Sex differences in obesity rates are particularly poorly understood. Here we show that the strong female bias in obesity in many countries is associated with high total fertility rate, which is well known to be correlated with factors such as low average income, infant mortality and female education. We also document effects of reduced access to contraception and increased inequality of income among households on obesity rates. These results are consistent with studies that implicate reproduction as a risk factor for obesity in women and that suggest the effects of reproduction interact with socioeconomic and educational factors. We discuss our results in the light of recent research in dietary ecology and the suggestion that insulin resistance during pregnancy is due to historic adaptation to protect the developing foetus during famine. Increased access to contraception and education in countries with high total fertility rate might have the additional benefit of reducing the rates of obesity in women.	[Brooks, Robert] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Maklakov, Alexei] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden	University of New South Wales Sydney; Uppsala University	Brooks, R (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	rob.brooks@unsw.edu.au	Brooks, Robert/A-1251-2008; Maklakov, Alexei/AAS-5968-2021; Maklakov, Alexei A/F-8167-2014	Brooks, Robert/0000-0001-6926-0781; Maklakov, Alexei/0000-0002-5809-1203; 				ARROYO P, 1995, INT J GYNECOL OBSTET, V48, P269, DOI 10.1016/0020-7292(94)02284-6; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Baum CL, 2009, J HEALTH ECON, V28, P635, DOI 10.1016/j.jhealeco.2009.01.004; Bjorkelund C, 1996, INT J OBESITY, V20, P213; Borders TF, 2006, J COMMUN HEALTH, V31, P57, DOI 10.1007/s10900-005-8189-8; BROOKS RC, 2010, OBESITY REV IN PRESS; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Corbett SJ, 2009, AM J HUM BIOL, V21, P587, DOI 10.1002/ajhb.20937; Daly M, 2001, CAN J CRIMINOL, V43, P219; Davis EM, 2009, AM J PUBLIC HEALTH, V99, P294, DOI 10.2105/AJPH.2007.132373; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; FAO, 2008, STAT FOOD INS WORLD; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; HALL MD, 2009, FUNCTIONAL IN PRESS; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; Kim SA, 2007, INT J EPIDEMIOL, V36, P93, DOI 10.1093/ije/dyl252; Koch E, 2008, J EPIDEMIOL COMMUN H, V62, P461, DOI 10.1136/jech.2007.062240; Lutz W, 2009, PHILOS T R SOC B, V364, P3031, DOI 10.1098/rstb.2009.0156; Maklakov AA, 2008, EVOL HUM BEHAV, V29, P444, DOI 10.1016/j.evolhumbehav.2008.08.002; Mansour AA, 2009, EAT WEIGHT DISORD-ST, V14, pE50, DOI 10.1007/BF03327800; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Nesse RM, 2006, SCIENCE, V311, P1071, DOI 10.1126/science.1125956; Newby PK, 2005, INT J OBESITY, V29, P1084, DOI 10.1038/sj.ijo.0802996; Olson CM, 2008, J RURAL HEALTH, V24, P60, DOI 10.1111/j.1748-0361.2008.00138.x; Short RV, 2009, PHILOS T R SOC B, V364, P2971, DOI 10.1098/rstb.2009.0144; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; STUBBS RJ, 1995, INT J OBESITY, V19, pS11; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Wardle J, 2002, AM J PUBLIC HEALTH, V92, P1299, DOI 10.2105/AJPH.92.8.1299; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Wen W, 2003, INT J OBESITY, V27, P933, DOI 10.1038/sj.ijo.0802318; WHO, 2010, WHO GLOB DAT BOD MAS; Wilkinson R, 2009, SPIRIT LEVEL WHY GRE, V1	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10587	10.1371/journal.pone.0010587	http://dx.doi.org/10.1371/journal.pone.0010587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	594UC	20485682	Green Published, gold			2022-12-25	WOS:000277563400005
J	Zhuo, JM; Pratico, D				Zhuo, Jia-Min; Pratico, Domenico			Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						amyloid-beta; APP metabolism; fear-conditioning test	FOLIC-ACID SUPPLEMENTATION; ELEVATED PLASMA HOMOCYSTEINE; PRECURSOR PROTEIN; OXIDATIVE STRESS; PLAQUE-FORMATION; CONTROLLED-TRIAL; RISK-FACTOR; DEMENTIA; MICE; VITAMIN-B-12	Hyperhomocysteine (HHcy) is a risk factor for developing Alzheimer's disease (AD). Previously, we showed that diet-induced HHcy accelerated the AD-like phenotype of a transgenic mouse model, i.e., Tg2576. In the present work, we tested whether an HHcy-lowering strategy in this model would be beneficial. Tg2576 mice received methionine-rich or regular chow diet for 5 mo. Next, while the chow control group was kept on the same regimen, the other mice were randomized into two groups: one was kept on the methionine-rich diet (Met On), the other switched to chow (Met Off). Compared with controls, 5 mo on the methionine-rich diet resulted in HHcy (plasma Hcy level, treated: 12.7 +/- 1.2 mu M vs. control: 3.1 +/- 0.4 mu M) and significant behavioral impairments (% freezing, treated: 2.4 +/- 1.4% vs. control: 19.9 +/- 6.9%). At the end of the study, while the Met On group kept Hcy level elevated, the Met Off group had these values indistinguishable from the controls. The reduction in Hcy levels resulted in a significant improvement of the fear-conditioning performance, and an amelioration of the brain amyloidosis. Our results demonstrate that lowering HHcy in a transgenic AD-mouse model is beneficial since it significantly improves behavior deficits and brain amyloidosis. Our findings provide new biological insights for future clinical trials aimed at lowering this modifiable risk factor in human AD.-Zhuo, J.-M., Pratico, D. Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease. FASEB J. 24, 3895-3902 (2010). www.fasebj.org	[Zhuo, Jia-Min; Pratico, Domenico] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Pratico, D (corresponding author), 706A,MRB,3420 North,Broad St, Philadelphia, PA 19140 USA.	praticod@temple.edu	Zhuo, Jia-Min/M-7546-2014; Pratico, Domenico/ABA-9590-2020	Zhuo, Jia-Min/0000-0001-9199-5485; 	National Institutes of Health [AG-22512]; NATIONAL INSTITUTE ON AGING [R01AG022512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Ms. Ni Meng for technical assistance. This work was funded by a grant from the National Institutes of Health, AG-22512 (to D.P.)	Aisen PS, 2008, JAMA-J AM MED ASSOC, V300, P1774, DOI 10.1001/jama.300.15.1774; Balk EM, 2007, ARCH INTERN MED, V167, P21, DOI 10.1001/archinte.167.1.21; Boldyrev AA, 2007, J ALZHEIMERS DIS, V11, P219; Bryan J, 2002, J NUTR, V132, P1345, DOI 10.1093/jn/132.6.1345; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Firuzi O, 2008, FASEB J, V22, P1169, DOI 10.1096/fj.07-9131.com; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; Fuso A, 2008, MOL CELL NEUROSCI, V37, P731, DOI 10.1016/j.mcn.2007.12.018; Gottfries CG, 1998, J NEURAL TRANSM, V105, P773, DOI 10.1007/s007020050094; Herrmann N, 2002, CAN J PSYCHIAT, V47, P715, DOI 10.1177/070674370204700802; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hvas AM, 2004, J AFFECT DISORDERS, V81, P269, DOI 10.1016/S0165-0327(03)00169-1; Jacobsen DW, 2000, ARTERIOSCL THROM VAS, V20, P1182, DOI 10.1161/01.ATV.20.5.1182; Jakubowski H, 2009, FASEB J, V23, P1721, DOI 10.1096/fj.08-127548; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McCaddon A, 1998, INT J GERIATR PSYCH, V13, P235, DOI 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8; Morris MS, 2003, LANCET NEUROL, V2, P425, DOI 10.1016/S1474-4422(03)00438-1; Morris MS, 2001, AM J CLIN NUTR, V73, P927; Nilsson K, 2001, INT J GERIATR PSYCH, V16, P609, DOI 10.1002/gps.388; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Poirier R, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/006.2007, 10.3389/neuro.08.006.2007]; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Pratico D, 2009, JAMA-J AM MED ASSOC, V301, P1020, DOI 10.1001/jama.2009.211; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Sommer BR, 2003, J GERIATR PSYCH NEUR, V16, P156, DOI 10.1177/0891988703256052; Sung S, 2004, AM J PATHOL, V165, P2197, DOI 10.1016/S0002-9440(10)63269-5; Suszynska J, 2010, J ALZHEIMERS DIS, V19, P1177, DOI 10.3233/JAD-2010-1311; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; Zhang CE, 2009, AM J PATHOL, V174, P1481, DOI 10.2353/ajpath.2009.081036; Zhuo JM, 2010, CURR ALZHEIMER RES, V7, P140, DOI 10.2174/156720510790691326; Zhuo JM, 2010, EXP GERONTOL, V45, P195, DOI 10.1016/j.exger.2009.12.005	41	23	25	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3895	3902		10.1096/fj.10-161828	http://dx.doi.org/10.1096/fj.10-161828			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20519634	Green Published			2022-12-25	WOS:000285005900027
J	Li, CM; Qi, YF; Teng, X; Yang, ZC; Wei, P; Zhang, CS; Tan, L; Zhou, L; Liu, Y; Lai, LH				Li, Chunmei; Qi, Yifei; Teng, Xin; Yang, Zongchang; Wei, Ping; Zhang, Changsheng; Tan, Lei; Zhou, Lu; Liu, Ying; Lai, Luhua			Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIMER INTERFACE; SUBSTRATE-SPECIFICITY; HIV-1 PROTEASE; VIRUS; DIMERIZATION; INHIBITOR; DESIGN; DOMAIN; POLYPROTEIN	The 3C-like proteinase (3CL(pro)) of the severe acute respiratory syndrome (SARS) coronavirus plays a vital role in virus maturation and is proposed to be a key target for drug design against SARS. Various in vitro studies revealed that only the dimer of the matured 3CL(pro) is active. However, as the internally encoded 3CL(pro) gets matured from the replicase polyprotein by autolytic cleavage at both the N-terminal and the C-terminal flanking sites, it is unclear whether the polyprotein also needs to dimerize first for its auto-cleavage reaction. We constructed a large protein containing the cyan fluorescent protein (C), the N-terminal flanking substrate peptide of SARS 3CL(pro) (XX), SARS 3CL(pro) (3CLP), and the yellow fluorescent protein (Y) to study the autoprocessing of 3CL(pro) using fluorescence resonance energy transfer. In contrast to the matured 3CL(pro), the polyprotein, as well as the one-step digested product, 3CLP-Y-His, were shown to be monomeric in gel filtration and analytic ultracentrifuge analysis. However, dimers can still be induced and detected when incubating these large proteins with a substrate analog compound in both chemical cross-linking experiments and analytic ultracentrifuge analysis. We also measured enzyme activity under different enzyme concentrations and found a clear tendency of substrate-induced dimer formation. Based on these discoveries, we conclude that substrate-induced dimerization is essential for the activity of SARS-3CL(pro) in the polyprotein, and a modified model for the 3CL(pro) maturation process was proposed. As many viral proteases undergo a similar maturation process, this model might be generally applicable.	[Liu, Ying; Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Li, Chunmei; Qi, Yifei; Wei, Ping; Zhang, Changsheng; Lai, Luhua] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University	Lai, LH (corresponding author), Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.	lhlai@pku.edu.cn	Teng, Xin/L-7614-2018	Teng, Xin/0000-0002-8354-0090	Ministry of Science and Technology of China; National Natural Science Foundation of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported, in part, by the Ministry of Science and Technology of China and the National Natural Science Foundation of China.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327; CAMERON CE, 1993, J BIOL CHEM, V268, P11711; Chen H, 2006, J BIOL CHEM, V281, P13894, DOI 10.1074/jbc.M510745200; Chen S, 2008, J BIOL CHEM, V283, P554, DOI 10.1074/jbc.M705240200; Darke PL, 1996, J BIOL CHEM, V271, P7445, DOI 10.1074/jbc.271.13.7445; Fan KQ, 2005, BIOCHEM BIOPH RES CO, V329, P934, DOI 10.1016/j.bbrc.2005.02.061; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Hu TC, 2009, VIROLOGY, V388, P324, DOI 10.1016/j.virol.2009.03.034; Huang CK, 2004, BIOCHEMISTRY-US, V43, P4568, DOI 10.1021/bi036022q; Lai LH, 2006, CURR PHARM DESIGN, V12, P4555, DOI 10.2174/138161206779010396; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Marnett AB, 2004, P NATL ACAD SCI USA, V101, P6870, DOI 10.1073/pnas.0401613101; Pinon JD, 1997, VIROLOGY, V230, P309, DOI 10.1006/viro.1997.8503; Schiller JJ, 1998, VIROLOGY, V242, P288, DOI 10.1006/viro.1997.9010; Shan YF, 2004, BIOCHEM BIOPH RES CO, V324, P579, DOI 10.1016/j.bbrc.2004.09.088; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Tang C, 2008, NATURE, V455, P693, DOI 10.1038/nature07342; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tibbles KW, 1996, J VIROL, V70, P1923, DOI 10.1128/JVI.70.3.1923-1930.1996; Wei P, 2006, BIOCHEM BIOPH RES CO, V339, P865, DOI 10.1016/j.bbrc.2005.11.102; Wei P, 2010, ACTA PHYS-CHIM SIN, V26, P1093, DOI 10.3866/PKU.WHXB20100449; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Yang HT, 2006, CURR PHARM DESIGN, V12, P4573, DOI 10.2174/138161206779010369; Zhou L, 2006, J MED CHEM, V49, P3440, DOI 10.1021/jm0602357; Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	30	36	37	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28134	28140		10.1074/jbc.M109.095851	http://dx.doi.org/10.1074/jbc.M109.095851			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20489209	Green Published, hybrid			2022-12-25	WOS:000281404100056
J	Wang, C; Chen, SH; Wang, X; Wang, L; Wallis, AK; Freedman, RB; Wang, CC				Wang, Chao; Chen, Sihong; Wang, Xi; Wang, Lei; Wallis, A. Katrine; Freedman, Robert B.; Wang, Chih-chen			Plasticity of Human Protein Disulfide Isomerase EVIDENCE FOR MOBILITY AROUND THE X-LINKER REGION AND ITS FUNCTIONAL SIGNIFICANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIBONUCLEASE-A; BINDING SITE; B' DOMAIN; THIOREDOXIN; CATALYSIS	Protein disulfide isomerase (PDI), which consists of multiple domains arranged as abb'xa'c, is a key enzyme responsible for oxidative folding in the endoplasmic reticulum. In this work we focus on the conformational plasticity of this enzyme. Proteolysis of native human PDI (hPDI) by several proteases consistently targets sites in the C-terminal half of the molecule (x-linker and a' domain) leaving large fragments in which the N terminus is intact. Fluorescence studies on the W111F/W390F mutant of full-length PDI show that its fluorescence is dominated by Trp-347 in the x-linker which acts as an intrinsic reporter and indicates that this linker can move between "capped" and "uncapped" conformations in which it either occupies or exposes the major ligand binding site on the b' domain of hPDI. Studies with a range of constructs and mutants using intrinsic fluorescence, collision quenching, and extrinsic probe fluorescence (1-anilino-8-naphthalene sulfonate) show that the presence of the a' domain in full-length hPDI moderates the ability of the x-linker to generate the capped conformation (compared with shorter fragments) but does not abolish it. Hence, unlike yeast PDI, the major conformational plasticity of full-length hPDI concerns the mobility of the a' domain "arm" relative to the bb' "trunk" mediated by the x-linker. The chaperone and enzymatic activities of these constructs and mutants are consistent with the interpretation that the reversible interaction of the x-linker with the ligand binding site mediates access of protein substrates to this site.	[Chen, Sihong; Wallis, A. Katrine; Freedman, Robert B.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Chao] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	University of Warwick; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Freedman, RB (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	R.B.Freedman@warwick.ac.uk; chihwang@sun5.ibp.ac.cn	Wang, Chao/AGP-7000-2022	Wang, Lei/0000-0002-5071-5800; Wallis, Katrine/0000-0002-2162-6454; Wang, Chao/0000-0002-3048-8559	Chinese Ministry of Science and Technology [2006CB806508, 2006CB910903]; Chinese Academy of Science [KSCX2-YW-R-119, KSCX2-YW-R-256]; Biotechnology and Biological Sciences Funding Council [BB/D017807, CPA1339]; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/D017807/1] Funding Source: researchfish; BBSRC [BB/D017807/1] Funding Source: UKRI	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Science(Chinese Academy of Sciences); Biotechnology and Biological Sciences Funding Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Chinese Ministry of Science and Technology Grants 2006CB806508 and 2006CB910903, Chinese Academy of Science Grants KSCX2-YW-R-119 and KSCX2-YW-R-256, and Biotechnology and Biological Sciences Funding Council Project Grant BB/D017807 and partnering award CPA1339 (to R. B. F.) and by Wellcome Trust VIP fellowships (to S. C. and A. K. W.).	Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; BIRKS JB, 1970, PHOTOPHYSICS AROMATI, P443; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Chalton DA, 2010, ANAL CHEM, V82, P3073, DOI 10.1021/ac902932c; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Forster ML, 2009, J BIOL CHEM, V284, P13045, DOI 10.1074/jbc.M808352200; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Freedman RB, 1998, BIOL CHEM, V379, P321, DOI 10.1515/bchm.1998.379.3.321; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Lappi AK, 2004, J MOL BIOL, V335, P283, DOI 10.1016/j.jmb.2003.10.051; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; MARTINEZGALISTEO E, 1993, BIOCHIMIE, V75, P803, DOI 10.1016/0300-9084(93)90131-B; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Shin HC, 2000, J MOL BIOL, V300, P995, DOI 10.1006/jmbi.2000.3928; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Wallis AK, 2009, PROTEIN SCI, V18, P2569, DOI 10.1002/pro.270; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651	36	55	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26788	26797		10.1074/jbc.M110.107839	http://dx.doi.org/10.1074/jbc.M110.107839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20516074	Green Published, hybrid			2022-12-25	WOS:000281172700009
J	Inberg, A; Linial, M				Inberg, Alex; Linial, Michal			Protection of Pancreatic beta-Cells from Various Stress Conditions Is Mediated by DJ-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TFII-I; ER STRESS; UP-REGULATION; PROTEIN; ACTIVATION; PROMOTER; FAILURE; NEURONS; BINDING	Pancreatic beta-cells are vulnerable to multiple stresses, leading to dysfunction and apoptotic death. Deterioration in beta-cells function and mass is associated with type 2 diabetes. Comparative two-dimensional gel electrophoresis from pancreatic MIN6 cells that were maintained at varying glucose concentrations was carried out. An induced expression of a protein spot, detected in MIN6 cells experiencing high glucose concentration, was identified by mass spectrometry as the oxidized form of DJ-1. DJ-1 (park7) is a multifunctional protein implicated in familial Parkinsonism and neuroprotection in response to oxidative damage. The DJ-1 protein and its oxidized form were also induced following exposure to oxidative and endoplasmic reticulum stress in MIN6 and beta TC-6 cells and also in mouse pancreatic islets. Suppression of DJ-1 levels by small interfering RNA led to an accelerated cell death, whereas an increase in DJ-1 levels by adenovirus-based infection attenuated cell death induced by H2O2 and thapsigargin in beta-cell lines and mouse pancreatic islets. Furthermore, DJ-1 improved regulated insulin secretion under basal as well as oxidative and endoplasmic reticulum stress conditions in a dose-dependent manner. We identified TFII-I (Gtf2i) as DJ-1 partner in the cytosol, whereas the binding of TFII-I to DJ-1 prevented TFII-I translocation to the nucleus. The outcome was attenuation of the stress response. Our results suggest that DJ-1 together with TFII-I operate in concert to cope with various insults and to sustain pancreatic beta-cell function.	Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Linial, Michal] Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem		michall@cc.huji.ac.il	Linial, Michal/B-9143-2011; Linial, Michal/AAQ-9259-2020	Linial, Michal/0000-0002-9357-4526	Sudarsky Center for Computational Biology; European Commission Framework VII Prospects consortium; ISF [592/07]; Israeli Council for Higher Education	Sudarsky Center for Computational Biology; European Commission Framework VII Prospects consortium; ISF(Israel Science Foundation); Israeli Council for Higher Education	The initial phase of this work was supported by the Sudarsky Center for Computational Biology. This work was supported in part by the European Commission Framework VII Prospects consortium and a grant from ISF 592/07.; Recipient of a Lev-Zion fellowship of the Israeli Council for Higher Education.	Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bonora E, 2008, NUTR METAB CARDIOVAS, V18, P74, DOI 10.1016/j.numecd.2007.05.004; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Inberg A, 2007, PROTEOMICS, V7, P910, DOI 10.1002/pmic.200600547; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim YC, 2009, J NEUROCHEM, V110, P192; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; KNAACK D, 1994, DIABETES, V43, P1413, DOI 10.2337/diabetes.43.12.1413; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Miyazaki S, 2008, J NEUROCHEM, V105, P2418, DOI 10.1111/j.1471-4159.2008.05327.x; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Racek T, 2008, J BIOL CHEM, V283, P34305, DOI 10.1074/jbc.M803925200; Robertson RP, 2009, TRENDS ENDOCRIN MET, V20, P388, DOI 10.1016/j.tem.2009.05.004; Roy AL, 2006, ACS CHEM BIOL, V1, P619, DOI 10.1021/cb6004323; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Tussie-Luna MI, 2002, J BIOL CHEM, V277, P43185, DOI 10.1074/jbc.M207635200; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Zhong N, 2008, HUM MOL GENET, V17, P3357, DOI 10.1093/hmg/ddn230	43	41	43	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25686	25698		10.1074/jbc.M110.109751	http://dx.doi.org/10.1074/jbc.M110.109751			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20516060	Green Published, hybrid			2022-12-25	WOS:000280682400062
J	Sen, S; Talukdar, I; Liu, Y; Tam, J; Reddy, S; Webster, NJG				Sen, Supriya; Talukdar, Indrani; Liu, Ying; Tam, Joseph; Reddy, Sita; Webster, Nicholas J. G.			Muscleblind-like 1 (Mbnl1) Promotes Insulin Receptor Exon 11 Inclusion via Binding to a Downstream Evolutionarily Conserved Intronic Enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY TYPE-2; SPLICING FACTORS; SKELETAL-MUSCLE; CUG REPEATS; PROTEINS; EXPRESSION; MECHANISMS; DISEASE; CELLS	The insulin receptor exists as two isoforms, IR-A and IR-B, which result from alternative splicing of exon 11 in the primary transcript. These two isoforms show a cell-specific distribution, and their relative proportions also vary during development, aging, and in different disease states. We have previously demonstrated that both intron 10 and the alternatively spliced exon 11 contain regulatory sequences that affect insulin receptor splicing both positively and negatively and that these sequences bind the serine/arginine-rich (SR) proteins SRp20 and SF2/ASF and the CELF protein CUG-BP1. In this study, we describe a new intronic splicing element within intron 11 that is highly conserved across species. Using minigenes carrying deletion mutations within intron 11, we demonstrated that this sequence functions as an intronic splicing enhancer. We subsequently used RNA affinity chromatography to identify Mbnl1 as a splicing factor that recognizes this enhancer. By ribonucleoprotein immunoprecipitation, we also established that Mbnl1 binds specifically to the INSR (insulin receptor gene) RNA. Overexpression or knockdown of Mbnl1 in hepatoma and embryonic kidney cells altered the levels of exon 11 inclusion. Finally, we showed that deletion of the intronic enhancer eliminates the ability of Mbnl1 to promote exon inclusion. Collectively, these findings demonstrate a role for Mbnl1 in controlling insulin receptor exon 11 inclusion via binding to a downstream intronic enhancer element.	[Sen, Supriya; Talukdar, Indrani; Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Sen, Supriya; Talukdar, Indrani; Webster, Nicholas J. G.] Vet Affairs San Diego Healthcare Syst, Med Res Serv, San Diego, CA USA; [Liu, Ying; Tam, Joseph] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Reddy, Sita] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Hong Kong; University of Southern California	Webster, NJG (corresponding author), Univ Calif San Diego, Dept Med, Stein Clin Res Bldg 201,0673,9500 Gilman Dr, La Jolla, CA 92093 USA.	nwebster@ucsd.edu	Webster, Nick/AAI-8410-2021; Sen, Supriya/J-1750-2015	Sen, Supriya/0000-0002-0417-9322	Department of Veterans Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047400] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000130] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Review award from the Department of Veterans Affairs.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BROOK, 1992, CELL, V69, P385; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; Hernandez-Sanchez C, 2008, MOL BIOL EVOL, V25, P1043, DOI 10.1093/molbev/msn036; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kosaki A, 1998, J BIOL CHEM, V273, P10331, DOI 10.1074/jbc.273.17.10331; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOSTHAF L, 1991, P NATL ACAD SCI USA, V88, P4728, DOI 10.1073/pnas.88.11.4728; NORGREN S, 1993, DIABETES, V42, P675, DOI 10.2337/diabetes.42.5.675; NORGREN S, 1994, BIOCHEM BIOPH RES CO, V199, P277, DOI 10.1006/bbrc.1994.1225; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; RIO D C, 1992, Current Opinion in Cell Biology, V4, P444, DOI 10.1016/0955-0674(92)90010-A; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Santos AN, 2008, ENDOCRINOLOGY, V149, P515, DOI 10.1210/en.2007-0821; Savkur RS, 2004, AM J HUM GENET, V74, P1309, DOI 10.1086/421528; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; VIDAL H, 1995, DIABETES, V44, P1196, DOI 10.2337/diabetes.44.10.1196; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Webster N J, 1999, Front Horm Res, V25, P1; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	55	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25426	25437		10.1074/jbc.M109.095224	http://dx.doi.org/10.1074/jbc.M109.095224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20519504	hybrid, Green Published			2022-12-25	WOS:000280682400036
J	Guzzo, C; Mat, NFC; Gee, K				Guzzo, Christina; Mat, Nor Fazila Che; Gee, Katrina			Interleukin-27 Induces a STAT1/3-and NF-kappa B-dependent Proinflammatory Cytokine Profile in Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD4(+) T-CELLS; CHEMOKINE RECEPTORS; INTERFERON-GAMMA; IL-10 PRODUCTION; DENDRITIC CELLS; CUTTING EDGE; IL-27; EXPRESSION; INDUCTION; STAT1	IL-27 is a heterodimeric cytokine bridging innate and adaptive immunity by playing a role in the activation of naive T cells and in development of Th1 cells. Additionally, recent evidence supports a role for IL-27 in the activation of monocytic cells. Both pro-inflammatory and anti-inflammatory activities have been attributed to IL-27; however, the role played by IL-27 in the activation of human monocytic cells in terms of cytokine production has not been well described. Our results show that IL-27 is a strong inducer of proinflammatory cytokine and chemokine expression, including enhancement of IL-6, IP- 10, MIP-1 alpha, MIP-1 beta, and TNF-alpha expression in human primary monocytes. Furthermore, we observed that IL-27-induced cytokine and chemokine production was mediated by STAT1, STAT3, and NF-kappa B activation. Understanding how IL-27 exerts its effects on monocytic cells will identify important molecular mechanisms in the regulation of immune responses, particularly in the modulation of monocyte activation.	[Guzzo, Christina; Mat, Nor Fazila Che; Gee, Katrina] Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Gee, K (corresponding author), Queens Univ, Dept Microbiol & Immunol, Rm 739 Botterell Hall, Kingston, ON K7L 3N6, Canada.	kgee@queensu.ca	Gee, Katrina/H-3093-2016; MAT, NOR FAZILA CHE/M-3349-2015	MAT, NOR FAZILA CHE/0000-0002-1698-3633; Guzzo, Christina/0000-0002-3042-0976; Gee, Katrina/0000-0002-7535-2882	Canada Foundation of Innovation; Natural Sciences and Engineering Research Council of Canada; Ontario HIV Treatment Network Studentship; Canadian Institutes of Health Research Vanier Award; Ministry of Higher Education, Malasia; Universiti Sains Malaysia	Canada Foundation of Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario HIV Treatment Network Studentship; Canadian Institutes of Health Research Vanier Award(Canadian Institutes of Health Research (CIHR)); Ministry of Higher Education, Malasia; Universiti Sains Malaysia(Universiti Sains Malaysia)	This work was supported by grants from the Canada Foundation of Innovation and Natural Sciences and Engineering Research Council of Canada.; Supported by an Ontario HIV Treatment Network Studentship and a Canadian Institutes of Health Research Vanier Award.; Supported by the Ministry of Higher Education, Malasia and Universiti Sains Malaysia.	Al-Hanbali M, 2009, NEUROENDOCRINOL LETT, V30, P131; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Bernardino ALF, 2009, J INFECT DIS, V199, P1379, DOI 10.1086/597807; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dagia NM, 2010, AM J PHYSIOL-CELL PH, V298, pC929, DOI 10.1152/ajpcell.00461.2009; Feng XM, 2008, BIOCHEM BIOPH RES CO, V367, P553, DOI 10.1016/j.bbrc.2007.12.154; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Martinasso G, 2010, CANCER LETT, V287, P62, DOI 10.1016/j.canlet.2009.05.036; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Pearson AL, 2008, J NEPHROL, V21, P887; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Robinson CM, 2008, J INFECT DIS, V198, P359, DOI 10.1086/589774; Ruckerl D, 2006, IMMUNOBIOLOGY, V211, P427, DOI 10.1016/j.imbio.2006.05.008; Sato T, 1997, BLOOD, V90, P4749, DOI 10.1182/blood.V90.12.4749.4749_4749_4758; Sheikh F, 2004, J IMMUNOL, V172, P2006, DOI 10.4049/jimmunol.172.4.2006; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Siegernund S, 2007, IMMUNOBIOLOGY, V212, P739, DOI 10.1016/j.imbio.2007.09.004; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Takeda A, 2005, INT IMMUNOL, V17, P889, DOI 10.1093/intimm/dxh268; Veckman V, 2004, J LEUKOCYTE BIOL, V75, P764, DOI 10.1189/jlb.1003461; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Wirtz S, 2005, J IMMUNOL, V174, P2814, DOI 10.4049/jimmunol.174.5.2814; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377	37	81	83	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24404	24411		10.1074/jbc.M110.112599	http://dx.doi.org/10.1074/jbc.M110.112599			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519510	hybrid, Green Published			2022-12-25	WOS:000280542100012
J	Lee, JH; You, J; Dobrota, E; Skalnik, DG				Lee, Jeong-Heon; You, Jinsam; Dobrota, Erika; Skalnik, David G.			Identification and Characterization of a Novel Human PP1 Phosphatase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TARGETING SUBUNIT; CPG-BINDING PROTEIN; C-TERMINAL DOMAIN; HISTONE H3; WD-REPEAT; TRANSCRIPTION TERMINATION; METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; POLYADENYLATION FACTOR; STRUCTURAL BASIS	Mammalian Wdr82 is a regulatory component of the Setd1a and Setd1b histone H3-lysine 4 methyltransferase complexes and is implicated in the tethering of Setd1 complexes to transcriptional start sites of active genes. In the studies reported here, immunoprecipitation and mass spectrometry analyses reveal that Wdr82 additionally associates with multiple protein complexes, including an RNA polymerase II complex, four distinct histone H3-Lys(4) methyltransferase complexes, protein phosphatase 1 (PP1)-associated proteins, a chaperonin-containing Tcp1 complex, and other uncharacterized proteins. Further characterization of the PP1-associated proteins identified a stable multimeric complex composed of regulatory subunits PNUTS, Tox4, and Wdr82 and a PP1 catalytic subunit (denoted as the PTW/PP1 phosphatase complex). The PTW/PP1 complex exhibits in vitro phosphatase activity in a PP1-dependent manner. Analysis of protein-protein interactions reveals that PNUTS mediates phosphatase complex formation by providing a binding platform to each component. The PNUTS and Tox4 subunits are predominantly associated with the PTW/PP1 phosphatase complex in HEK293 cells, and the integrity of this complex remains intact throughout cell cycle progression. Inducible expression of a PP1 interaction-defective form of PNUTS (W401A) or small interfering RNA-mediated depletion of PNUTS in HEK293 cells causes cell cycle arrest at mitotic exit and apoptotic cell death. PNUTS ( W401A) shows normal association with chromosomes but causes defects in the process of chromosome decondensation at late telophase. These data reveal that mammalian Wdr82 functions in a variety of cellular processes and reveal a potential role of the PTW/PP1 phosphatase complex in the regulation of chromatin structure during the transition from mitosis into interphase.	Indiana Univ, Sch Med, Wells Ctr Pediat Res, Sect Pediat Hematol Oncol,Dept Pediat & Biochem, Indianapolis, IN 46202 USA; [You, Jinsam] Monarch LifeSci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Lee, JH (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	jeonglee@iupui.edu			Riley Children's Foundation; Lilly Endowment; National Science Foundation [MCB-0641851]; Showalter Trust	Riley Children's Foundation; Lilly Endowment; National Science Foundation(National Science Foundation (NSF)); Showalter Trust	This work was supported in part by the Riley Children's Foundation, the Lilly Endowment, National Science Foundation Grant MCB-0641851 (to D. G. S.), and a Showalter Trust award (to J.-H. L.).	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Bennett D, 2005, BIOCHEM SOC T, V33, P1444, DOI 10.1042/BST0331444; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cohen PTW, 2002, J CELL SCI, V115, P241; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; De Leon G, 2008, CANCER BIOL THER, V7, P833, DOI 10.4161/cbt.7.6.5839; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; FERNANDEZ A, 1992, J CELL BIOL, V116, P1421, DOI 10.1083/jcb.116.6.1421; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kim YM, 2003, J BIOL CHEM, V278, P13819, DOI 10.1074/jbc.M209621200; Kreivi JP, 1997, FEBS LETT, V420, P57, DOI 10.1016/S0014-5793(97)01485-3; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Landsverk HB, 2005, BIOCHEM J, V390, P709, DOI 10.1042/BJ20050678; Lee H, 2009, PATHOLOGY, V41, P200, DOI 10.1080/00313020802593566; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee SJ, 2007, CELL DEATH DIFFER, V14, P1106, DOI 10.1038/sj.cdd.4402111; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Raha-Chowdhury R, 2005, MOL BRAIN RES, V138, P70, DOI 10.1016/j.molbrainres.2005.04.001; Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Simon VR, 2001, CELL PROLIFERAT, V34, P15, DOI 10.1046/j.1365-2184.2001.00192.x; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Udho E, 2002, BIOCHEM BIOPH RES CO, V297, P463, DOI 10.1016/S0006-291X(02)02236-2; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Vitaliano-Prunier A, 2008, NAT CELL BIOL, V10, P1365, DOI 10.1038/ncb1796; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yi CL, 2006, INT J BIOCHEM CELL B, V38, P1076, DOI 10.1016/j.biocel.2005.12.019	59	73	80	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24466	24476		10.1074/jbc.M110.109801	http://dx.doi.org/10.1074/jbc.M110.109801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516061	hybrid, Green Published			2022-12-25	WOS:000280542100019
J	Sergeeva, OA; Kletke, O; Kragler, A; Poppek, A; Fleischer, W; Schubring, SR; Gorg, B; Haas, HL; Zhu, XR; Lubbert, H; Gisselmann, G; Hatt, H				Sergeeva, Olga A.; Kletke, Olaf; Kragler, Andrea; Poppek, Anja; Fleischer, Wiebke; Schubring, Stephan R.; Goerg, Boris; Haas, Helmut L.; Zhu, Xin-Ran; Luebbert, Hermann; Gisselmann, Guenter; Hatt, Hanns			Fragrant Dioxane Derivatives Identify beta 1-Subunit-containing GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; GENERAL ANESTHETIC ETOMIDATE; A RECEPTOR; EPSILON-SUBUNIT; NEURONS; GAMMA; PROPOFOL; SITES; SLEEP; RAT	Nineteen GABA(A) receptor (GABA(A)R) subunits are known in mammals with only a restricted number of functionally identified native combinations. The physiological role of beta 1-subunit-containing GABA(A)Rs is unknown. Here we report the discovery of a new structural class of GABA(A)R positive modulators with unique beta 1-subunit selectivity: fragrant dioxane derivatives (FDD). At heterologously expressed alpha 1 beta x gamma 2L (x-for 1,2,3) GABAAR FDD were 6 times more potent at beta 1-versus beta 2- and beta 3-containing receptors. Serine at position 265 was essential for the high sensitivity of the beta 1-subunit to FDD and the beta 1N286W mutation nearly abolished modulation; vice versa the mutation beta 3N265S shifted FDD sensitivity toward the beta 1-type. In posterior hypothalamic neurons controlling wakefulness GABA-mediated whole-cell responses and GABAergic synaptic currents were highly sensitive to FDD, in contrast to beta 1-negative cerebellar Purkinje neurons. Immunostaining for the beta 1-subunit and the potency of FDD to modulate GABA responses in cultured hypothalamic neurons was drastically diminished by beta 1-siRNA treatment. In conclusion, with the help of FDDs we reveal a functional expression of beta 1-containing GABA(A)Rs in the hypothalamus, offering a new tool for studies on the functional diversity of native GABA(A)Rs.	[Sergeeva, Olga A.] Univ Dusseldorf, Inst Neurophysiol, D-40001 Dusseldorf, Germany; [Kletke, Olaf; Kragler, Andrea; Poppek, Anja; Gisselmann, Guenter; Hatt, Hanns] Ruhr Univ, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany; [Zhu, Xin-Ran; Luebbert, Hermann] Ruhr Univ, Lehrstuhl Tierphysiol, D-44780 Bochum, Germany; [Goerg, Boris] Univ Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, D-40001 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Ruhr University Bochum; Ruhr University Bochum; Heinrich Heine University Dusseldorf	Sergeeva, OA (corresponding author), Univ Dusseldorf, Inst Neurophysiol, D-40001 Dusseldorf, Germany.	olga.sergeeva@uni-duesseldorf.de	Sergeeva, Olga/AAE-1869-2019	Zhu, Xinran/0000-0003-2352-0853; Kletke, Olaf/0000-0002-7825-1278; Luebbert, Herrmann/0000-0003-3429-5233; Gorg, Boris/0000-0002-4630-9420	Deutsche Forschungsgemeinschaft [SFB 575/TP 1, 3, and 8]; Heisenberg stipend	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg stipend	This work was supported by Deutsche Forschungsgemeinschaft SFB 575/TP 1, 3, and 8 and a Heisenberg stipend (to O.A.S.).	Bateson AN, 2004, SLEEP MED, V5, pS9, DOI 10.1016/S1389-9457(04)90002-0; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Belujon P, 2009, J NEUROPHYSIOL, V102, P2312, DOI 10.1152/jn.00227.2009; Bencsits E, 1999, J BIOL CHEM, V274, P19613, DOI 10.1074/jbc.274.28.19613; Bonin RP, 2008, PHARMACOL BIOCHEM BE, V90, P105, DOI 10.1016/j.pbb.2007.12.011; DREWE JA, 1988, SCIENCE, V241, P1810, DOI 10.1126/science.2459774; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Lam DW, 1998, BRAIN RES, V784, P179, DOI 10.1016/S0006-8993(97)01334-6; Li XQ, 2005, WORLD J GASTROENTERO, V11, P3319, DOI 10.3748/wjg.v11.i21.3319; Mangan PS, 2005, MOL PHARMACOL, V67, P775, DOI 10.1124/mol.104.007385; Meera P, 2009, NEUROPHARMACOLOGY, V56, P155, DOI 10.1016/j.neuropharm.2008.08.011; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Olsen RW, 2004, BIOCHEM PHARMACOL, V68, P1675, DOI 10.1016/j.bcp.2004.07.026; Parmentier R, 2009, J NEUROSCI, V29, P4471, DOI 10.1523/JNEUROSCI.2976-08.2009; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Sergeeva OA, 2005, J NEUROSCI, V25, P88, DOI 10.1523/JNEUROSCI.3209-04.2005; Sergeeva OA, 2002, EUR J NEUROSCI, V16, P1472, DOI 10.1046/j.1460-9568.2002.02221.x; Sergeeva OA, 2007, CELL MOL NEUROBIOL, V27, P669, DOI 10.1007/s10571-007-9153-1; Sergeeva OA, 2006, EUR J NEUROSCI, V24, P1413, DOI 10.1111/j.1460-9568.2006.05027.x; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Sigel Erwin, 2002, Current Topics in Medicinal Chemistry, V2, P833, DOI 10.2174/1568026023393444; Thompson SA, 2004, BRIT J PHARMACOL, V142, P97, DOI 10.1038/sj.bjp.0705689; Ueno S, 1997, J NEUROSCI, V17, P625; VONECONOMO C, 1926, HDB NORMALEN PATHOLO, V17, P591; VOROBJEV VS, 1991, J NEUROSCI METH, V38, P145, DOI 10.1016/0165-0270(91)90164-U; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; WISDEN W, 1992, J NEUROSCI, V12, P1040; Zecharia AY, 2009, J NEUROSCI, V29, P2177, DOI 10.1523/JNEUROSCI.4997-08.2009	37	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23985	23993		10.1074/jbc.M110.103309	http://dx.doi.org/10.1074/jbc.M110.103309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511229	Green Published, hybrid			2022-12-25	WOS:000280291400049
J	Kimura, Y; Kurabe, N; Ikegami, K; Tsutsumi, K; Konishi, Y; Kaplan, OI; Kunitomo, H; Iino, Y; Blacque, OE; Setou, M				Kimura, Yoshishige; Kurabe, Nobuya; Ikegami, Koji; Tsutsumi, Koji; Konishi, Yoshiyuki; Kaplan, Oktay Ismail; Kunitomo, Hirofumi; Iino, Yuichi; Blacque, Oliver E.; Setou, Mitsutoshi			Identification of Tubulin Deglutamylase among Caenorhabditis elegans and Mammalian Cytosolic Carboxypeptidases (CCPs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; BETA-TUBULIN; POLYGLUTAMYLATION; POLYGLYCYLATION; MICROTUBULES; SUBFAMILY; LIGASE; TTLL10	Tubulin polyglutamylation is a reversible post-translational modification, serving important roles in microtubule (MT)-related processes. Polyglutamylases of the tubulin tyrosine ligase-like (TTLL) family add glutamate moieties to specific tubulin glutamate residues, whereas as yet unknown deglutamylases shorten polyglutamate chains. First we investigated regulatory machinery of tubulin glutamylation in MT-based sensory cilia of the roundworm Caenorhabditis elegans. We found that ciliary MTs were polyglutamylated by a process requiring ttll-4. Conversely, loss of ccpp-6 gene function, which encodes one of two cytosolic carboxypeptidases (CCPs), resulted in elevated levels of ciliary MT polyglutamylation. Consistent with a deglutamylase function for ccpp-6, overexpression of this gene in ciliated cells decreased polyglutamylation signals. Similarly, we confirmed that overexpression of murine CCP5, one of two sequence orthologs of nematode ccpp-6, caused a dramatic loss of MT polyglutamylation in cultured mammalian cells. Finally, using an in vitro assay for tubulin glutamylation, we found that recombinantly expressed Myc-tagged CCP5 exhibited deglutamylase biochemical activities. Together, these data from two evolutionarily divergent systems identify C. elegans CCPP-6 and its mammalian ortholog CCP5 as a tubulin deglutamylase.	[Kimura, Yoshishige; Kurabe, Nobuya; Ikegami, Koji; Tsutsumi, Koji; Konishi, Yoshiyuki; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Hamamatsu, Shizuoka 4313192, Japan; [Kaplan, Oktay Ismail; Blacque, Oliver E.] Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Kunitomo, Hirofumi; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan	Hamamatsu University School of Medicine; University College Dublin; University of Tokyo	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Mol Anat, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp	IINO, YUICHI/G-4962-2014; Blacque, Oliver/AAL-8860-2021; Kaplan, Oktay Ismail/F-8531-2015; KUNITOMO, HIROFUMI/G-4963-2014	Kaplan, Oktay Ismail/0000-0002-8733-0920; KUNITOMO, HIROFUMI/0000-0001-7312-7051; Blacque, Oliver/0000-0003-1598-2695	Japan Science and Technology Agency; Japan Society for the Promotion of Science	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a SENTAN grant from the Japan Science and Technology Agency and WAKATE grants from the Japan Society for the Promotion of Science (Grant WAKATE S to M. S. and Grant WAKATE B to Y. Konishi).	ARGARANA CE, 1978, MOL CELL BIOCHEM, V19, P17; AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; BRE MH, 1994, CELL MOTIL CYTOSKEL, V27, P337, DOI 10.1002/cm.970270406; BRENNER S, 1974, GENETICS, V77, P71; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Gagnon C, 1996, J CELL SCI, V109, P1545; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Ikegami K, 2009, FEBS LETT, V583, P1957, DOI 10.1016/j.febslet.2009.05.003; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Nonet ML, 1997, J NEUROSCI, V17, P8061; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Regnard C, 1999, J CELL SCI, V112, P4281; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008	23	74	88	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22934	22939		10.1074/jbc.C110.128280	http://dx.doi.org/10.1074/jbc.C110.128280			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20519502	hybrid, Green Published			2022-12-25	WOS:000279999900027
J	Mizuno, N; Jao, CC; Langen, R; Steven, AC				Mizuno, Naoko; Jao, Christine C.; Langen, Ralf; Steven, Alasdair C.			Multiple Modes of Endophilin-mediated Conversion of Lipid Vesicles into Coated Tubes IMPLICATIONS FOR SYNAPTIC ENDOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIN/AMPHIPHYSIN/RVS BAR DOMAIN; MEMBRANE CURVATURE; STRUCTURAL BASIS; ELECTRON-MICROSCOPY; MICELLE TRANSITION; DYNAMIN; AMPHIPHYSIN; MECHANISM; INVAGINATION; SYNAPTOJANIN	Endophilin A1 is a BAR (Bin/amphiphysin/Rvs) protein abundant in neural synapses that senses and induces membrane curvature, contributing to neck formation in presynaptic endocytic vesicles. To investigate its role in membrane remodeling, we used cryoelectron microscopy to characterize structural changes induced in lipid vesicles by exposure to endophilin. The vesicles convert rapidly to coated tubules whose morphology reflects the local concentration of endophilin. Their diameters and curvature resemble those of synaptic vesicles in situ. Three-dimensional reconstructions of quasicylindrical tubes revealed arrays of BAR dimers, flanked by densities that we equate with amphipathic helices whose folding and membrane insertion were attested by EPR. We also observed the compression of bulbous coated tubes into 70-angstrom-wide cylindrical micelles, which appear to mimic the penultimate (hemi-fission) stage of endocytosis. Our findings suggest that the adaptability of endophilin-lipid interactions underlies dynamic changes of endocytic membranes.	[Mizuno, Naoko; Steven, Alasdair C.] NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Jao, Christine C.; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Southern California	Steven, AC (corresponding author), NIAMS, Struct Biol Res Lab, NIH, Bldg 50,Rm 1517, Bethesda, MD 20892 USA.	stevena@mail.nih.gov	Mizuno, Naoko/AAY-1926-2021	Mizuno, Naoko/0000-0002-1594-2821	NIAMS; National Institutes of Health [GM063915]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Intramural Research Program of NIAMS, National Institutes of Health and by National Institutes of Health Grant GM063915 (to R. L.).	Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Arkhipov A, 2008, BIOPHYS J, V95, P2806, DOI 10.1529/biophysj.108.132563; Arkhipov A, 2009, BIOPHYS J, V97, P2727, DOI 10.1016/j.bpj.2009.08.051; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; CUL H, 2009, BIOPHYS J, V97, P2746; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Yin Y, 2009, STRUCTURE, V17, P882, DOI 10.1016/j.str.2009.03.016	49	41	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23349	23356		10.1074/jbc.M110.143776	http://dx.doi.org/10.1074/jbc.M110.143776			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484046	Green Published, hybrid			2022-12-25	WOS:000279999900068
J	Braun, J; Hoang-Vu, C; Dralle, H; Huettelmaier, S				Braun, J.; Hoang-Vu, C.; Dralle, H.; Huettelmaier, S.			Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas	ONCOGENE			English	Article						ATC; microRNA; TGF beta; EMT; TGFBR1; SMAD2	MESENCHYMAL TRANSITION; MIR-200 FAMILY; E-CADHERIN; CANCER-CELLS; EXPRESSION; ZEB1; METASTASIS; GROWTH; TUMORS; GENES	Anaplastic thyroid carcinomas (ATCs) arise from epithelial thyroid cells by mesenchymal de-/transdifferentiation and rapidly invade the adjacent tissue. Specific microRNA signatures were suggested to distinguish ATCs from normal thyroid tissue and other thyroid carcinomas of follicular origin. Whether distinct microRNA patterns correlate with de-/transdifferentiation and invasion of ATCs remained elusive. We identified two significantly decreased microRNA families that unambiguously distinguish ATCs from papillary and follicular thyroid carcinomas: miR-200 and miR-30. Expression of these microRNAs in mesenchymal ATC-derived cells reduced their invasive potential and induced mesenchymal-epithelial transition (MET) by regulating the expression of MET marker proteins. Supporting the role of transforming growth factor (TGF)beta signaling in modulating MET/epithelial- mesenchymal transition (EMT), expression of SMAD2 and TGFBR1, upregulated in most primary ATCs, was controlled by members of the miR-30 and/or miR-200 families in ATC-derived cells. Inhibition of TGF beta receptor 1 (TGFBR1) in these cells induced MET and reduction of prometastatic miR-21, but caused an increase of the miR-200 family. These findings identify altered microRNA signatures as potent markers for ATCs that promote de-/transdifferentiation (EMT) and invasion of these neoplasias. Hence, TGFBR1 inhibition could have a significant potential for the treatment of ATCs and possibly other invasive tumors. Oncogene (2010) 29, 4237-4244; doi: 10.1038/onc.2010.169; published online 24 May 2010	[Huettelmaier, S.] Univ Halle Wittenberg, Dept Mol Cell Biol, ZAMED, D-06120 Halle, Sachsen Anhalt, Germany; [Hoang-Vu, C.; Dralle, H.] Univ Halle Wittenberg, Dept Gen Visceral & Vasc Surg, D-06120 Halle, Sachsen Anhalt, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Huettelmaier, S (corresponding author), Univ Halle Wittenberg, Dept Mol Cell Biol, ZAMED, Heinrich Damerow Str 1, D-06120 Halle, Sachsen Anhalt, Germany.	stefan.huettelmaier@medizin.uni-halle.de	Hüttelmaier, Stefan/AAQ-1203-2021; Dralle, Henning/ABD-4454-2020	Braun, Juliane/0000-0002-2491-5788	DFG; BMBF [FKZ 01ZZ0404]	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by DFG and BMBF (FKZ 01ZZ0404) funding to Stefan Huttelmaier.	BRABANT G, 1993, CANCER RES, V53, P4987; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guzinska-Ustymowicz K, 2005, WORLD J GASTROENTERO, V11, P1193, DOI 10.3748/wjg.v11.i8.1193; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piek E, 1999, J CELL SCI, V112, P4557; Resnick MB, 1998, MODERN PATHOL, V11, P735; Rocha AS, 2003, HISTOPATHOLOGY, V42, P580, DOI 10.1046/j.1365-2559.2003.01642.x; Safina A, 2007, ONCOGENE, V26, P2407, DOI 10.1038/sj.onc.1210046; Schwertheim S, 2009, HORM METAB RES, V41, P475, DOI 10.1055/s-0029-1215593; Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	26	242	257	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 22	2010	29	29					4237	4244		10.1038/onc.2010.169	http://dx.doi.org/10.1038/onc.2010.169			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20498632				2022-12-25	WOS:000280151500011
J	Patel, CJ; Bhattacharya, J; Butte, AJ				Patel, Chirag J.; Bhattacharya, Jayanta; Butte, Atul J.			An Environment-Wide Association Study (EWAS) on Type 2 Diabetes Mellitus	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; NATIONAL-HEALTH; ALPHA-TOCOPHEROL; RISK-FACTORS; POLYCHLORINATED-BIPHENYLS; SERUM CONCENTRATIONS; SUSCEPTIBILITY LOCI; BETA-CAROTENE; PREVALENCE; EXPOSURE	Background: Type 2 Diabetes (T2D) and other chronic diseases are caused by a complex combination of many genetic and environmental factors. Few methods are available to comprehensively associate specific physical environmental factors with disease. We conducted a pilot Environmental-Wide Association Study (EWAS), in which epidemiological data are comprehensively and systematically interpreted in a manner analogous to a Genome Wide Association Study (GWAS). Methods and Findings: We performed multiple cross-sectional analyses associating 266 unique environmental factors with clinical status for T2D defined by fasting blood sugar (FBG) concentration >= 126 mg/dL. We utilized available Centers for Disease Control (CDC) National Health and Nutrition Examination Survey (NHANES) cohorts from years 1999 to 2006. Within cohort sample numbers ranged from 503 to 3,318. Logistic regression models were adjusted for age, sex, body mass index (BMI), ethnicity, and an estimate of socioeconomic status (SES). As in GWAS, multiple comparisons were controlled and significant findings were validated with other cohorts. We discovered significant associations for the pesticide-derivative heptachlor epoxide (adjusted OR in three combined cohorts of 1.7 for a 1 SD change in exposure amount; p<0.001), and the vitamin c-tocopherol (adjusted OR 1.5; p<0.001). Higher concentrations of polychlorinated biphenyls (PCBs) such as PCB170 (adjusted OR 2.2; p<0.001) were also found. Protective factors associated with T2D included b-carotenes (adjusted OR 0.6; p<0.001). Conclusions and Significance: Despite difficulty in ascertaining causality, the potential for novel factors of large effect associated with T2D justify the use of EWAS to create hypotheses regarding the broad contribution of the environment to disease. Even in this study based on prior collected epidemiological measures, environmental factors can be found with effect sizes comparable to the best loci yet found by GWAS.	[Patel, Chirag J.; Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat & Med, Stanford, CA 94305 USA; [Patel, Chirag J.; Butte, Atul J.] Stanford Univ, Sch Med, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Patel, Chirag J.; Butte, Atul J.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Bhattacharya, Jayanta] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University	Patel, CJ (corresponding author), Stanford Univ, Sch Med, Dept Pediat & Med, Stanford, CA 94305 USA.	abutte@stanford.edu			National Library of Medicine [T15 LM 007033, R01 LM009719]; National Institute on Aging [K02 AG024237]; Lucile Packard Foundation for Children's Health; National Institute of General Medical Sciences [(R01 GM079719]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024237] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033, R01LM009719] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Lucile Packard Foundation for Children's Health; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	C.J.P. was funded by the National Library of Medicine (T15 LM 007033). J. B. was funded in part by the National Institute on Aging (K02 AG024237). A.J.B. was funded in part by the Lucile Packard Foundation for Children's Health, the National Library of Medicine (R01 LM009719), the National Institute of General Medical Sciences (R01 GM079719), and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abahusain MA, 1999, EUR J CLIN NUTR, V53, P630, DOI 10.1038/sj.ejcn.1600825; *ADA, 2009, DIAB INF ALL AB DIAB; *AG TOX SUBST DIS, 2007, HEPT HEPT EP; Arnlov J, 2009, DIABETOLOGIA, V52, P97, DOI 10.1007/s00125-008-1189-3; Burton GW, 1998, AM J CLIN NUTR, V67, P669, DOI 10.1093/ajcn/67.4.669; Campbell S, 2003, CRIT REV ONCOL HEMAT, V47, P249, DOI 10.1016/S1040-8428(03)00042-8; Carpenter David O., 2008, Reviews on Environmental Health, V23, P59; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2022, NAT HLTH NUTR EX SUR; Codru N, 2007, ENVIRON HEALTH PERSP, V115, P1442, DOI 10.1289/ehp.10315; *COMM EWG, HUM TOX PROJ; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; DAVID ED, 2009, EXPT MAN WHAT ONE MA; ERIKSSON J, 1989, NEW ENGL J MED, V321, P337, DOI 10.1056/NEJM198908103210601; Everett CJ, 2007, ENVIRON RES, V103, P413, DOI 10.1016/j.envres.2006.11.002; Ford ES, 1999, AM J EPIDEMIOL, V149, P168, DOI 10.1093/oxfordjournals.aje.a009783; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gong KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r149; Hindorff LA, 2009, CATALOG PUBLISHED GE; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Ioannidis JPA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000247; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; JUDSON RS, 2009, ENV HLTH PERSPECT; Kataja-Tuomola M, 2008, DIABETOLOGIA, V51, P47, DOI 10.1007/s00125-007-0864-0; Kitao Y, 2000, PSYCHIAT GENET, V10, P139, DOI 10.1097/00041444-200010030-00006; Klein BEK, 1996, DIABETES CARE, V19, P827, DOI 10.2337/diacare.19.8.827; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lumley T., 2009, SURVEY ANAL COMPLEX; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Montgomery MP, 2008, AM J EPIDEMIOL, V167, P1235, DOI 10.1093/aje/kwn028; Montonen J, 2004, DIABETES CARE, V27, P362, DOI 10.2337/diacare.27.2.362; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; *OFF WAT REG STAND, 1980, AMB WAT QUAL CRIT HE; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Polidori MC, 2000, DIABETES-METAB RES, V16, P15, DOI 10.1002/(SICI)1520-7560(200001/02)16:1<15::AID-DMRR71>3.3.CO;2-2; *R DEV COR TEAM, 2009, R LANG STAT COMP; Rignell-Hydbom A, 2007, HUM EXP TOXICOL, V26, P447, DOI 10.1177/0960327107076886; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulz LO, 2006, DIABETES CARE, V29, P1866, DOI 10.2337/dc06-0138; Schwartz D, 2007, SCIENCE, V316, P695, DOI 10.1126/science.1141331; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Song YQ, 2009, AM J CLIN NUTR, V90, P429, DOI 10.3945/ajcn.2009.27491; StataCorp, 2007, STAT STAT SOFTW REL; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Toscano William A, 2005, Int J Environ Res Public Health, V2, P4, DOI 10.3390/ijerph2005010004; Uemura H, 2008, ENVIRON RES, V108, P63, DOI 10.1016/j.envres.2008.06.002; Wang L, 2006, AM J EPIDEMIOL, V164, P576, DOI 10.1093/aje/kwj240; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449; Ylonen K, 2003, AM J CLIN NUTR, V77, P1434; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	59	377	388	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10746	10.1371/journal.pone.0010746	http://dx.doi.org/10.1371/journal.pone.0010746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505766	Green Published, gold, Green Submitted			2022-12-25	WOS:000278017300017
J	Seixas, C; Cruto, T; Tavares, A; Gaertig, J; Soares, H				Seixas, Cecilia; Cruto, Teresa; Tavares, Alexandra; Gaertig, Jacek; Soares, Helena			CCT alpha and CCT delta Chaperonin Subunits Are Essential and Required for Cilia Assembly and Maintenance in Tetrahymena	PLOS ONE			English	Article							MICROTUBULE CAPPING STRUCTURES; COMPLEX POLYPEPTIDE-1 INTERACTS; BARDET-BIEDL-SYNDROME; EUKARYOTIC CHAPERONIN; MOLECULAR CHAPERONE; CYTOPLASMIC DYNEIN; CRYSTAL-STRUCTURE; GENE REPLACEMENT; KINESIN-II; PROTEIN	Background: The eukaryotic cytosolic chaperonin CCT is a hetero-oligomeric complex formed by two rings connected back-to-back, each composed of eight distinct subunits (CCT alpha to CCT zeta). CCT complex mediates the folding, of a wide range of newly synthesised proteins including tubulin (alpha, beta and gamma) and actin, as quantitatively major substrates. Methodology/Principal Findings: We disrupted the genes encoding CCT alpha and CCT delta subunits in the ciliate Tetrahymena. Cells lacking the zygotic expression of either CCT alpha or CCT delta showed a loss of cell body microtubules, failed to assemble new cilia and died within 2 cell cycles. We also show that loss of CCT subunit activity leads to axoneme shortening and splaying of tips of axonemal microtubules. An epitope-tagged CCT alpha rescued the gene knockout phenotype and localized primarily to the tips of cilia. A mutation in CCT alpha, G346E, at a residue also present in the related protein implicated in the Bardet Biedel Syndrome, BBS6, also caused defects in cilia and impaired CCT alpha localization in cilia. Conclusions/Significance: Our results demonstrate that the CCT subunits are essential and required for ciliary assembly and maintenance of axoneme structure, especially at the tips of cilia.	[Seixas, Cecilia; Cruto, Teresa; Tavares, Alexandra; Soares, Helena] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Seixas, Cecilia; Gaertig, Jacek] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Soares, Helena] Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Instituto Gulbenkian de Ciencia; University System of Georgia; University of Georgia; Universidade de Lisboa	Seixas, C (corresponding author), CNRS, UMR 5237, Montpellier, France.	mhsoares@fc.ul.pt	Soares, Helena/G-3065-2010; Gaertig, Jacek/F-1553-2010	Soares, Helena/0000-0001-6180-7041; Tavares, Alexandra/0000-0002-5332-3386; Seixas, Ana Cecilia/0000-0002-7364-4320	Fundacao para a Ciencia a Tecnologia [PRAXIS XXI/P/BIA/10097/98, PTDC/BIA-BDE/73163/2006]; NSF [MBC-033965]; IEFP;  [SFRH/BD/5176/2001]	Fundacao para a Ciencia a Tecnologia(Portuguese Foundation for Science and Technology); NSF(National Science Foundation (NSF)); IEFP; 	This work was supported by Fundacao para a Ciencia a Tecnologia grants PRAXIS XXI/P/BIA/10097/98 and PTDC/BIA-BDE/73163/2006 to HS and NSF grant MBC-033965 to JG. CS received a PhD fellowship SFRH/BD/5176/2001; TC and AT received an IEFP fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCH MA, 1995, J CELL SCI, V108, P3541; Brown JM, 2003, MOL BIOL CELL, V14, P3192, DOI 10.1091/mbc.e03-03-0166; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; BRUNS P, 2000, BIOLISTIC TRANSFORMA, P501; Casano C, 2003, J HISTOCHEM CYTOCHEM, V51, P1581, DOI 10.1177/002215540305101202; CassidyHanley D, 1997, GENETICS, V146, P135; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; CREUTZ CE, 1994, J BIOL CHEM, V269, P32035; Cyrne L, 1996, FEBS LETT, V383, P277, DOI 10.1016/0014-5793(96)00240-2; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; DENTLER WL, 1977, J CELL BIOL, V74, P747, DOI 10.1083/jcb.74.3.747; DENTLER WL, 1984, J CELL SCI, V66, P167; DENTLER WL, 1982, CELL MOTIL CYTOSKEL, V2, P549, DOI 10.1002/cm.970020605; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gomez-Puertas P, 2004, J MOL RECOGNIT, V17, P85, DOI 10.1002/jmr.654; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; GOROVSKY MA, 1973, J PROTOZOOL, V20, P19, DOI 10.1111/j.1550-7408.1973.tb05995.x; Grantham J, 2002, CELL STRESS CHAPERON, V7, P235, DOI 10.1379/1466-1268(2002)007<0235:ECCTCP>2.0.CO;2; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Hai B, 1997, P NATL ACAD SCI USA, V94, P1310, DOI 10.1073/pnas.94.4.1310; HAI B, 2000, KNOCKOUT HETEROKARYO, P513; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; KatoMinoura T, 1997, J CELL BIOL, V137, P649, DOI 10.1083/jcb.137.3.649; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim SK, 2009, DEV BIOL, V331, P450, DOI 10.1016/j.ydbio.2009.05.239; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MELKI R, 1993, J CELL BIOL, V122, P1301, DOI 10.1083/jcb.122.6.1301; MILLER JM, 1990, J CELL BIOL, V110, P703, DOI 10.1083/jcb.110.3.703; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ORIAS E, 1976, EXP CELL RES, V102, P127, DOI 10.1016/0014-4827(76)90307-4; Pappenberger G, 2002, J MOL BIOL, V318, P1367, DOI 10.1016/S0022-2836(02)00190-0; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; PORTMAN RW, 1987, J CELL SCI, V87, P85; Roobol A, 1999, J BIOL CHEM, V274, P2408, DOI 10.1074/jbc.274.4.2408; Satouh Y, 2005, MOL BIOL CELL, V16, P626, DOI 10.1091/mbc.e04-09-0784; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seixas C, 2003, EXP CELL RES, V290, P303, DOI 10.1016/S0014-4827(03)00325-2; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; SKRIVER L, 1980, BIOCHEM J, V188, P695, DOI 10.1042/bj1880695; Soares H, 1997, BIOCHEM J, V326, P21, DOI 10.1042/bj3260021; SOARES H, 1994, J BIOL CHEM, V269, P29299; Stephens RE, 1999, CELL MOTIL CYTOSKEL, V44, P274, DOI 10.1002/(SICI)1097-0169(199912)44:4<274::AID-CM5>3.0.CO;2-O; Stephens RE, 1997, MOL BIOL CELL, V8, P2187, DOI 10.1091/mbc.8.11.2187; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Thazhath R, 2002, NAT CELL BIOL, V4, P256, DOI 10.1038/ncb764; URSIC D, 1991, MOL CELL BIOL, V11, P2629, DOI 10.1128/MCB.11.5.2629; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Wagner CT, 2004, J BIOL CHEM, V279, P16223, DOI 10.1074/jbc.M310730200; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Williams NE, 2006, EUKARYOT CELL, V5, P555, DOI 10.1128/EC.5.3.555-567.2006; Williams NE, 1997, J CELL SCI, V110, P1665; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yang C, 2005, MOL BIOL CELL, V16, P637, DOI 10.1091/mbc.E04-09-0787; Yang C, 2008, J CELL BIOL, V180, P403, DOI 10.1083/jcb.200705069	68	19	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10704	10.1371/journal.pone.0010704	http://dx.doi.org/10.1371/journal.pone.0010704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502701	Green Published, gold, Green Submitted			2022-12-25	WOS:000277776500018
J	de Manzano, O; Cervenka, S; Karabanov, A; Farde, L; Ullen, F				de Manzano, Orjan; Cervenka, Simon; Karabanov, Anke; Farde, Lars; Ullen, Fredrik			Thinking Outside a Less Intact Box: Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HUMAN BRAIN; VERBAL CREATIVITY; BINDING; CORTEX; PET; TRANSMISSION; AMPHETAMINE; ASSOCIATION; MODULATION	Several lines of evidence support that dopaminergic neurotransmission plays a role in creative thought and behavior. Here, we investigated the relationship between creative ability and dopamine D2 receptor expression in healthy individuals, with a focus on regions where aberrations in dopaminergic function have previously been associated with psychotic symptoms and a genetic liability to schizophrenia. Scores on divergent thinking tests (Inventiveness battery, Berliner Intelligenz Struktur Test) were correlated with regional D2 receptor densities, as measured by Positron Emission Tomography, and the radioligands [C-11] raclopride and [C-11]FLB 457. The results show a negative correlation between divergent thinking scores and D2 density in the thalamus, also when controlling for age and general cognitive ability. Hence, the results demonstrate that the D2 receptor system, and specifically thalamic function, is important for creative performance, and may be one crucial link between creativity and psychopathology. We suggest that decreased D2 receptor densities in the thalamus lower thalamic gating thresholds, thus increasing thalamocortical information flow. In healthy individuals, who do not suffer from the detrimental effects of psychiatric disease, this may increase performance on divergent thinking tests. In combination with the cognitive functions of higher order cortical networks, this could constitute a basis for the generative and selective processes that underlie real life creativity.	[de Manzano, Orjan; Karabanov, Anke; Ullen, Fredrik] Karolinska Inst, Neuropediat Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [de Manzano, Orjan; Cervenka, Simon; Karabanov, Anke; Farde, Lars; Ullen, Fredrik] Karolinska Inst, Stockholm Brain Inst, Stockholm, Sweden; [Cervenka, Simon; Farde, Lars] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden; [Karabanov, Anke] NINDS, Human Motor Control Unit, NIH, Bethesda, MD 20892 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	de Manzano, O (corresponding author), Karolinska Inst, Neuropediat Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.	orjan.demanzano@ki.se	Cervenka, Simon/Q-2155-2018	Cervenka, Simon/0000-0001-8103-6977; Karabanov, Anke Ninija/0000-0003-1874-393X; de Manzano, Orjan/0000-0002-4632-1112	Swedish Research Council [2006-4733]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Swedish Research Council 2006-4733. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Aalto S, 2009, EUR J NUCL MED MOL I, V36, P475, DOI 10.1007/s00259-008-0969-9; ANDREASEN NC, 1987, AM J PSYCHIAT, V144, P1288; Ball D, 1998, NEUROREPORT, V9, P347, DOI 10.1097/00001756-199801260-00031; Batey M, 2008, PERS INDIV DIFFER, V45, P816, DOI 10.1016/j.paid.2008.08.014; BERGSTROM M, 1981, J COMPUT ASSIST TOMO, V5, P136, DOI 10.1097/00004728-198102000-00027; Buchsbaum MS, 2006, SCHIZOPHR RES, V85, P232, DOI 10.1016/j.schres.2006.03.042; Buchsbaum MS, 1996, AM J PSYCHIAT, V153, P191; Burch GS, 2006, EUR J PERSONALITY, V20, P107, DOI 10.1002/per.572; CAMPBELL DT, 1960, PSYCHOL REV, V67, P380, DOI 10.1037/h0040373; Carson SH, 2003, J PERS SOC PSYCHOL, V85, P499, DOI 10.1037/0022-3514.85.3.499; Cervenka S, 2006, BRAIN, V129, P2017, DOI 10.1093/brain/awl163; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; Christensen P.R., 1960, ALTERNATE USES; Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x; Dibben CRM, 2009, PSYCHOL MED, V39, P381, DOI 10.1017/S0033291708003887; DORFMAN L, 2007, PERSONALITY INDIVIDU, V44, P1382; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Eysenck H., 1995, GENIUS NATURAL HIST; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Floresco SB, 2006, PSYCHOPHARMACOLOGY, V188, P567, DOI 10.1007/s00213-006-0404-5; Folley BS, 2005, SCHIZOPHR RES, V80, P271, DOI 10.1016/j.schres.2005.06.016; FURNHAM A, 2008, PERSONALITY INDIVIDU, V45; Gilbert AR, 2001, AM J PSYCHIAT, V158, P618, DOI 10.1176/appi.ajp.158.4.618; Glenthoj BY, 2006, BIOL PSYCHIAT, V60, P621, DOI 10.1016/j.biopsych.2006.01.010; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; GUSTAFSSON JE, 1984, INTELLIGENCE, V8, P179, DOI 10.1016/0160-2896(84)90008-4; Hall H, 1996, SYNAPSE, V23, P115, DOI 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C; Hirvonen J, 2005, ARCH GEN PSYCHIAT, V62, P371, DOI 10.1001/archpsyc.62.4.371; Hirvonen MM, 2009, PROG NEURO-PSYCHOPH, V33, P630, DOI 10.1016/j.pnpbp.2009.02.021; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jager AO., 1997, TEST BERLINER INTELL; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; KARLSSON JL, 1970, HEREDITAS-GENETISK A, V66, P177; KESSLER RM, 1993, BRAIN RES, V609, P237, DOI 10.1016/0006-8993(93)90878-Q; Kessler RM, 2009, BIOL PSYCHIAT, V65, P1024, DOI 10.1016/j.biopsych.2008.12.029; Kinney DK, 2000, CREATIVITY RES J, V13, P17; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Langer O, 1999, J LABELLED COMPD RAD, V42, P1183; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; McGrew KS, 2009, INTELLIGENCE, V37, P1, DOI 10.1016/j.intell.2008.08.004; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Moises HW, 2001, J NEURAL TRANSM, V108, P115, DOI 10.1007/s007020170102; Montgomery AJ, 2007, J CEREBR BLOOD F MET, V27, P369, DOI 10.1038/sj.jcbfm.9600339; Narendran R, 2009, SYNAPSE, V63, P447, DOI 10.1002/syn.20628; Okauchi T, 2001, SYNAPSE, V41, P87, DOI 10.1002/syn.1063; Olsson H, 2004, NEUROIMAGE, V22, P794, DOI 10.1016/j.neuroimage.2004.02.002; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; POST F, 1994, BRIT J PSYCHIAT, V165, P22, DOI 10.1192/bjp.165.1.22; Post F, 1996, BRIT J PSYCHIAT, V168, P545, DOI 10.1192/bjp.168.5.545; Raven J. C., 1998, RAVENS PROGR MATRICE; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; RICHARDS R, 1988, J ABNORM PSYCHOL, V97, P281, DOI 10.1037/0021-843X.97.3.281; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; SANDELL J, 2000, J LABELLED COMPOUNDS, V43; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sternberg R. J., 2002, HDB CREATIVITY; Suhara T, 2002, ARCH GEN PSYCHIAT, V59, P25, DOI 10.1001/archpsyc.59.1.25; Takahashi H, 2006, BIOL PSYCHIAT, V59, P919, DOI 10.1016/j.biopsych.2006.01.022; Talvik M, 2006, PSYCHIAT RES-NEUROIM, V148, P165, DOI 10.1016/j.pscychresns.2006.05.009; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Weinberger D, 2001, NEUROPSYCHOPHARMACOL, P833; Yasuno F, 2004, AM J PSYCHIAT, V161, P1016, DOI 10.1176/appi.ajp.161.6.1016	66	75	75	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10670	10.1371/journal.pone.0010670	http://dx.doi.org/10.1371/journal.pone.0010670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	597QK	20498850	Green Published, gold, Green Submitted			2022-12-25	WOS:000277773700013
J	Thorek, DLJ; Tsao, PY; Arora, V; Zhou, LL; Eisenberg, RA; Tsourkas, A				Thorek, Daniel L. J.; Tsao, Patricia Y.; Arora, Vaishali; Zhou, Lanlan; Eisenberg, Robert A.; Tsourkas, Andrew			In Vivo, Multimodal Imaging of B Cell Distribution and Response to Antibody Immunotherapy in Mice	PLOS ONE			English	Article							PHASE-II TRIAL; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; DENDRITIC CELLS; RITUXIMAB; DEPLETION; TRACKING; THERAPY; EFFICACY	In Background: B cell depletion immunotherapy has been successfully employed to treat non-Hodgkin's lymphoma. In recent years, increasing attention has been directed towards also using B-cell depletion therapy as a treatment option in autoimmune disorders. However, it appears that the further development of these approaches will depend on a methodology to determine the relation of B-cell depletion to clinical response and how individual patients should be dosed. Thus far, patients have generally been followed by quantification of peripheral blood B cells, but it is not apparent that this measurement accurately reflects systemic B cell dynamics. Methodology/Principal Findings: Cellular imaging of the targeted population in vivo may provide significant insight towards effective therapy and a greater understanding of underlying disease mechanics. Superparamagnetic iron oxide (SPIO) nanoparticles in concert with near infrared (NIR) fluorescent dyes were used to label and track primary C57BL/6 B cells. Following antibody mediated B cell depletion (anti-CD79), NIR-only labeled cells were expeditiously cleared from the circulation and spleen. Interestingly, B cells labeled with both SPIO and NIR were not depleted in the spleen. Conclusions/Significance: Whole body fluorescent tracking of B cells enabled noninvasive, longitudinal imaging of both the distribution and subsequent depletion of B lymphocytes in the spleen. Quantification of depletion revealed a greater than 40% decrease in splenic fluorescent signal-to-background ratio in antibody treated versus control mice. These data suggest that in vivo imaging can be used to follow B cell dynamics, but that the labeling method will need to be carefully chosen. SPIO labeling for tracking purposes, generally thought to be benign, appears to interfere with B cell functions and requires further examination.	[Thorek, Daniel L. J.; Zhou, Lanlan; Tsourkas, Andrew] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Tsao, Patricia Y.; Arora, Vaishali; Eisenberg, Robert A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Thorek, DLJ (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.	atsourk@seas.upenn.edu	Tsourkas, Andrew/A-1074-2007; Tsourkas, Andrew/AAM-8252-2020	Tsourkas, Andrew/0000-0001-7758-1753; Tsourkas, Andrew/0000-0001-7758-1753	Wyeth-Ayerst Pharmaceuticals; Transdisciplinary Program in Translational Medicine and Therapeutics; Department of Defense Office of the Congressionally Directed Medical [W81XWH-07-1-0457]; Lupus Research Institute	Wyeth-Ayerst Pharmaceuticals(Canadian Institutes of Health Research (CIHR)); Transdisciplinary Program in Translational Medicine and Therapeutics; Department of Defense Office of the Congressionally Directed Medical(United States Department of Defense); Lupus Research Institute	This work was supported in part by Wyeth-Ayerst Pharmaceuticals, the Transdisciplinary Program in Translational Medicine and Therapeutics, Department of Defense Office of the Congressionally Directed Medical Research Program (W81XWH-07-1-0457) and the Lupus Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D, 2008, ANN RHEUM DIS, V67, P1724, DOI 10.1136/ard.2007.083162; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Bulte JWM, 2004, BLOOD, V104, P3410, DOI 10.1182/blood-2004-06-2117; Bulte WM, 2005, ACAD RADIOL, V12, pS2; Chen IY, 2009, MOL IMAGING BIOL, V11, P178, DOI 10.1007/s11307-008-0182-z; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Daldrup-Link HE, 2005, EUR RADIOL, V15, P4, DOI 10.1007/s00330-004-2526-7; Dayde D, 2009, BLOOD, V113, P3765, DOI 10.1182/blood-2008-08-175125; De Vita S, 2002, ARTHRITIS RHEUM, V46, P2029, DOI 10.1002/art.10467; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Eisenberg Robert, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P345; Eisenberg R, 2009, J AUTOIMMUN, V32, P223, DOI 10.1016/j.jaut.2009.02.006; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Fu G, 2009, J IMMUNOL METHODS, V350, P194, DOI 10.1016/j.jim.2009.07.009; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Gordan LN, 2005, J CLIN ONCOL, V23, P1096, DOI 10.1200/JCO.2005.12.171; Grillo-Lopez A. J., 2000, Current Pharmaceutical Biotechnology, V1, P1, DOI 10.2174/1389201003379059; Hainsworth JD, 2000, BLOOD, V95, P3052; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Houssiau FA, 2002, ARTHRITIS RHEUM-US, V46, P2121, DOI 10.1002/art.10461; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Leandro MJ, 2002, ANN RHEUM DIS, V61, P883, DOI 10.1136/ard.61.10.883; Levine TD, 2005, ARTHRITIS RHEUM, V52, P601, DOI 10.1002/art.20849; Levine TD, 1999, NEUROLOGY, V52, P1701, DOI 10.1212/WNL.52.8.1701; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Li YM, 2008, J IMMUNOL, V181, P2961, DOI 10.4049/jimmunol.181.5.2961; Li YYY, 2006, MOL IMMUNOL, V43, P613, DOI 10.1016/j.molimm.2005.04.010; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; MELDER RJ, 1994, J IMMUNOL METHODS, V175, P79, DOI 10.1016/0022-1759(94)90333-6; MERRILL JT, 2008, EFFICACY SAFETY RITU; Millington OR, 2007, INFLAMM RES, V56, P391, DOI 10.1007/s00011-007-7017-2; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Pestronk A, 2003, J NEUROL NEUROSUR PS, V74, P485, DOI 10.1136/jnnp.74.4.485; REFF ME, 1994, BLOOD, V83, P435; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Renaud S, 2003, MUSCLE NERVE, V27, P611, DOI 10.1002/mus.10359; Sutter JA, 2008, CLIN IMMUNOL, V126, P282, DOI 10.1016/j.clim.2007.11.012; Tario Joseph D Jr, 2007, Immunol Invest, V36, P861, DOI 10.1080/08820130701712933; Thorek DLJ, 2008, BIOMATERIALS, V29, P3583, DOI 10.1016/j.biomaterials.2008.05.015; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; Valable S, 2007, NEUROIMAGE, V37, pS47, DOI 10.1016/j.neuroimage.2007.05.041; Witzig TE, 2005, J CLIN ONCOL, V23, P1103, DOI 10.1200/JCO.2005.12.052	51	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10655	10.1371/journal.pone.0010655	http://dx.doi.org/10.1371/journal.pone.0010655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498725	gold, Green Published, Green Submitted			2022-12-25	WOS:000277773700007
J	Te, JL; Dozmorov, IM; Guthridge, JM; Nguyen, KL; Cavett, JW; Kelly, JA; Bruner, GR; Harley, JB; Ojwang, JO				Te, Jeannie L.; Dozmorov, Igor M.; Guthridge, Joel M.; Nguyen, Kim L.; Cavett, Joshua W.; Kelly, Jennifer A.; Bruner, Gail R.; Harley, John B.; Ojwang, Joshua O.			Identification of Unique MicroRNA Signature Associated with Lupus Nephritis	PLOS ONE			English	Article							INTERFERON-INDUCIBLE GENE; PERIPHERAL-BLOOD CELLS; ERYTHEMATOSUS PATIENTS; EXPRESSION; ACTIVATION; PATHWAY; PREVALENCE; GENOMICS; DISEASES; PLAYERS	MicroRNAs (miRNA) have emerged as an important new class of modulators of gene expression. In this study we investigated miRNA that are differentially expressed in lupus nephritis. Microarray technology was used to investigate differentially expressed miRNA in peripheral blood mononuclear cells (PBMCs) and Epstein-Barr Virus (EBV)-transformed cell lines obtained from lupus nephritis affected patients and unaffected controls. TaqMan-based stem-loop real-time polymerase chain reaction was used for validation. Microarray analysis of miRNA expressed in both African American (AA) and European American (EA) derived lupus nephritis samples revealed 29 and 50 differentially expressed miRNA, respectively, of 850 tested. There were 18 miRNA that were differentially expressed in both racial groups. When samples from both racial groups and different specimen types were considered, there were 5 primary miRNA that were differentially expressed. We have identified 5 miRNA; hsa-miR-371-5P, hsa-miR-423-5P, hsa-miR-638, hsa-miR-1224-3P and hsa-miR-663 that were differentially expressed in lupus nephritis across different racial groups and all specimen types tested. Hsa-miR371-5P, hsa-miR-1224-3P and hsa-miR-423-5P, are reported here for the first time to be associated with lupus nephritis. Our work establishes EBV-transformed B cell lines as a useful model for the discovery of miRNA as biomarkers for SLE. Based on these findings, we postulate that these differentially expressed miRNA may be potential novel biomarkers for SLE as well as help elucidate pathogenic mechanisms of lupus nephritis. The investigation of miRNA profiles in SLE may lead to the discovery and development of novel methods to diagnosis, treat and prevent SLE.	[Te, Jeannie L.; Dozmorov, Igor M.; Nguyen, Kim L.; Cavett, Joshua W.; Kelly, Jennifer A.; Bruner, Gail R.; Harley, John B.; Ojwang, Joshua O.] Oklahoma Med Res Fdn, Dept Arthrit & Immunol, Oklahoma City, OK 73104 USA; [Guthridge, Joel M.] Oklahoma Med Res Fdn, Dept Clin Immunol, Oklahoma City, OK 73104 USA; [Harley, John B.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Harley, John B.] US Dept Vet Affairs Med Ctr, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Te, JL (corresponding author), Oklahoma Med Res Fdn, Dept Arthrit & Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Joshua-ojwang@omrf.org		Guthridge, Joel/0000-0002-9308-237X; Kelly, Jennifer/0000-0002-3203-2467	National Institutes of Health [0169-04-12-4, NO-1AR62277, PO1-AI 083194, R37-AI 24717, RO1-AR42460, PO1-AR049084, P20 RR020143, R01 AI045050, P30 AR053483, GORDRCC AR053483]; United States Department of Veteran Affairs; Alliance for Lupus Research; Lupus Family Registry and Repository (LFRR); American Cancer Society [IRG-05-066-04]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045050, P01AI083194, R37AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042460, P01AR049084, P30AR053483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veteran Affairs(US Department of Veterans Affairs); Alliance for Lupus Research; Lupus Family Registry and Repository (LFRR); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health (Centers of Biomedical Research Excellence (COBRE) Pilot Grant 0169-04-12-4, NO-1AR62277, PO1-AI 083194, R37-AI 24717, RO1-AR42460, PO1-AR049084, P20 RR020143, R01 AI045050, P30 AR053483, GORDRCC AR053483), the United States Department of Veteran Affairs, the Alliance for Lupus Research, Lupus Family Registry and Repository (LFRR), and the American Cancer Society (IRG-05-066-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Calin GA, 2006, SEMIN ONCOL, V33, P167, DOI 10.1053/j.seminoncol.2006.01.010; COMPTON LJ, 1984, J IMMUNOL, V133, P213; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; FESSEL WJ, 1974, ARCH INTERN MED, V134, P1027, DOI 10.1001/archinte.134.6.1027; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Huang X, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2475; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; Karonitsch T, 2009, ARTHRITIS RHEUM, V60, P1463, DOI 10.1002/art.24449; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Mak A, 2007, LUPUS, V16, P28, DOI 10.1177/0961203306074469; MCCARTY DJ, 1995, ARTHRITIS RHEUM, V38, P1260, DOI 10.1002/art.1780380914; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; NOSSENT JC, 1989, ANN RHEUM DIS, V48, P810, DOI 10.1136/ard.48.10.810; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Vinuesa CG, 2009, INT REV IMMUNOL, V28, P112, DOI 10.1080/08830180902934909	30	161	179	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10344	10.1371/journal.pone.0010344	http://dx.doi.org/10.1371/journal.pone.0010344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485490	Green Submitted, Green Published, gold			2022-12-25	WOS:000277563200001
J	Mai, TV; Gunnarsson, I; Lundberg, S; Svenungsson, E; Wramner, L; Fernstrom, A; Syvanen, AC; Lieu, TD; Jacobson, SH; Padyukov, L				Mai Tuyet Vuong; Gunnarsson, Iva; Lundberg, Sigrid; Svenungsson, Elisabet; Wramner, Lars; Fernstrom, Anderson; Syvanen, Ann-Christine; Lieu Thi Do; Jacobson, Stefan H.; Padyukov, Leonid			Genetic Risk Factors in Lupus Nephritis and IgA Nephropathy - No Support of an Overlap	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ANTI-C1Q ANTIBODIES; PROMOTER REGION; IRF5; ERYTHEMATOSUS; HAPLOTYPE; CLASSIFICATION; POLYMORPHISMS; ASSOCIATION; POPULATION	Background: IgA nephropathy (IgAN) and nephritis in Systemic Lupus Erythematosus (SLE) are two common forms of glomerulonephritis in which genetic findings are of importance for disease development. We have recently reported an association of IgAN with variants of TGFB1. In several autoimmune diseases, particularly in SLE, IRF5, STAT4 genes and TRAF1-C5 locus have been shown to be important candidate genes. The aim of this study was to compare genetic variants from the TGFB1, IRF5, STAT4 genes and TRAF1-C5 locus with susceptibility to IgAN and lupus nephritis in two Swedish cohorts. Patients and Methods: We genotyped 13 single nucleotide polymorphisms (SNPs) in four genetic loci in 1252 DNA samples from patients with biopsy proven IgAN or with SLE (with and without nephritis) and healthy age-and sex-matched controls from the same population in Sweden. Results: Genotype and allelic frequencies for SNPs from selected genes did not differ significantly between lupus nephritis patients and SLE patients without nephritis. In addition, haplotype analysis for seven selected SNPs did not reveal a difference for the SLE patient groups with and without nephritis. Moreover, none of these SPNs showed a significant difference between IgAN patients and healthy controls. IRF5 and STAT4 variants remained significantly different between SLE cases and healthy controls. In addition, the data did not show an association of TRAF1-C5 polymorphism with susceptibility to SLE in this Swedish population. Conclusion: Our data do not support an overlap in genetic susceptibility between patients with IgAN or SLE and reveal no specific importance of SLE associated SNPs for the presence of lupus nephritis.	[Mai Tuyet Vuong; Gunnarsson, Iva; Svenungsson, Elisabet; Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Mai Tuyet Vuong; Jacobson, Stefan H.] Karolinska Inst, Danderyd Hosp, Dept Nephrol, Stockholm, Sweden; [Mai Tuyet Vuong; Lieu Thi Do] Hanoi Med Univ, Dept Internal Med, Hanoi, Vietnam; [Lundberg, Sigrid] Karolinska Univ Hosp, Dept Med, Nephrol Unit, Stockholm, Sweden; [Wramner, Lars] Sahlgrens Univ Hosp, Transplantat Ctr, Gothenburg, Sweden; [Fernstrom, Anderson] Linkoping Univ Hosp, Dept Nephrol, S-58185 Linkoping, Sweden; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Hanoi Medical University; Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Linkoping University; Uppsala University	Mai, TV (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	maituyetvuong@gmail.com	Lundberg, Sigrid/AGM-4891-2022; Lundberg, Sigrid/C-8058-2015; Padyukov, Leonid/A-4890-2009	Lundberg, Sigrid/0000-0003-1224-5200; Padyukov, Leonid/0000-0003-2950-5670; Svenungsson, Elisabet/0000-0003-3396-3244	SIDA Secretariat for Research Cooperation [7500730303, 75007342]; Swedish Research Council for Medicine, Sweden	SIDA Secretariat for Research Cooperation; Swedish Research Council for Medicine, Sweden	The support for the project (7500730303 and 75007342) from SIDA Secretariat for Research Cooperation for the bilateral cooperation between Vietnam and Sweden; Swedish Research Council for Medicine, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basile C, 1998, NEPHROL DIAL TRANSPL, V13, P1891; Bhavnani SK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S3; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gunnarsson I, 1997, NEPHROL DIAL TRANSPL, V12, P2263, DOI 10.1093/ndt/12.11.2263; HAN SW, 2009, J RHEUMATOL; HORINO T, LUPUS; Kozyrev SV, 2007, AUTOIMMUNITY, V40, P591, DOI 10.1080/08916930701510905; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; KURREEMAN FA, 2009, ANN RHEUM DIS; LEE YH, 2008, RHEUMATOL INT; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Maalej A, 2008, SCAND J RHEUMATOL, V37, P414, DOI 10.1080/03009740802256327; Nordmark G, 2009, GENES IMMUN, V10, P68, DOI 10.1038/gene.2008.94; Padyukov L, 2001, IMMUNOGENETICS, V53, P22, DOI 10.1007/s002510000291; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Potlukova E, 2008, SCAND J IMMUNOL, V67, P423, DOI 10.1111/j.1365-3083.2008.02089.x; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Shimane K, 2009, ANN RHEUM DIS, V68, P377, DOI 10.1136/ard.2007.085704; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; SVENUNGSSON E, 2009, ANN RHEUM DIS; VUONG MT, 2009, NEPHROL DIAL TRANSPL	25	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10559	10.1371/journal.pone.0010559	http://dx.doi.org/10.1371/journal.pone.0010559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479942	Green Published, gold, Green Submitted			2022-12-25	WOS:000277467900015
J	Zauner, L; Melroe, GT; Sigrist, JA; Rechsteiner, MP; Dorner, M; Arnold, M; Berger, C; Bernasconi, M; Schaefer, BW; Speck, RF; Nadal, D				Zauner, L.; Melroe, G. T.; Sigrist, J. A.; Rechsteiner, M. P.; Dorner, M.; Arnold, M.; Berger, C.; Bernasconi, M.; Schaefer, B. W.; Speck, R. F.; Nadal, D.			TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification	ONCOGENE			English	Article						TLR9; Burkitt's lymphoma; Epstein-Barr virus; Plasmodium falciparum; histone modification	EPSTEIN-BARR-VIRUS; TOLL-LIKE RECEPTOR-9; NF-KAPPA-B; IMMUNE ACTIVATION; LYTIC CYCLE; CPG DNA; INDUCTION; INFECTION; LATENT; REPLICATION	Endemic Burkitt's lymphoma (BL) is considered to preferentially develop in equatorial Africa because of chronic co-infection with Epstein-Barr virus (EBV) and the malaria pathogen Plasmodium falciparum. The interaction and contribution of both pathogens in the oncogenic process are poorly understood. Earlier, we showed that immune activation with a synthetic Toll-like receptor 9 (TLR9) ligand suppresses the initiation of EBV lytic replication in primary human B cells. In this study we investigate the mechanism involved in the suppression of EBV lytic gene expression in BL cell lines. We show that this suppression is dependent on functional TLR9 and MyD88 signaling but independent of downstream signaling elements, including phosphatidylinositol-3 kinase, mitogen-activated protein kinases and nuclear factor-kappa B. We identified TLR9 triggering resulting in histone modifications to negatively affect the activation of the promoter of EBV's master regulatory lytic gene BZLF1. Finally, we show that P. falciparum hemozoin, a natural TLR9 ligand, suppresses induction of EBV lytic gene expression in a dose-dependent manner. Thus, we provide evidence for a possible interaction between P. falciparum and EBV at the B-cell level and the mechanism involved in suppressing lytic and thereby reinforcing latent EBV that has unique oncogenic potential. Oncogene (2010) 29, 4588-4598; doi: 10.1038/onc.2010.203; published online 31 May 2010	[Zauner, L.; Melroe, G. T.; Sigrist, J. A.; Rechsteiner, M. P.; Dorner, M.; Arnold, M.; Berger, C.; Bernasconi, M.; Nadal, D.] Univ Zurich, Univ Childrens Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Lab Expt Infect Dis & Canc Res, Zurich, Switzerland; [Schaefer, B. W.] Univ Zurich, Univ Childrens Hosp Zurich, Div Oncol, Zurich, Switzerland; [Speck, R. F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University of Zurich; University Zurich Hospital	Nadal, D (corresponding author), Univ Childrens Hosp, Div Infect Dis & Hosp Epidemiol, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	david.nadal@kispi.uzh.ch	Bernasconi, Michele/GOH-1815-2022; Bernasconi, Michele/CAG-2492-2022; Bernasconi, Michele/C-6734-2008; Dorner, Marcus/B-1398-2010; Speck, Roberto F/O-2433-2016	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Schafer, Beat/0000-0001-5988-2915; Speck, Roberto/0000-0002-8453-1137; Dorner, Marcus/0000-0003-0321-4226	Cancer League of the Canton Zurich; Swiss National Foundation [310040-114118]; Oncosuisse; Forschungskredit of the University of Zurich [54192002]	Cancer League of the Canton Zurich; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Oncosuisse; Forschungskredit of the University of Zurich	We thank Jurg Tschopp, Hans-Peter Beck and Sebastian Rusch for providing reagents. This work was supported by grants from the Cancer League of the Canton Zurich, the Swiss National Foundation (no. 310040-114118), Oncosuisse, the Forschungskredit of the University of Zurich (no. 54192002) and UBS donation by a client.	Alazard N, 2003, J VIROL, V77, P8166, DOI 10.1128/JVI.77.14.8166-8172.2003; Ashman RF, 2005, INT IMMUNOL, V17, P411, DOI 10.1093/intimm/dxh222; Berger C, 2001, J MED VIROL, V64, P505, DOI 10.1002/jmv.1078; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; Chene A, 2007, PLOS PATHOG, V3, P826, DOI 10.1371/journal.ppat.0030080; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DIRENZO L, 1994, INT J CANCER, V57, P914, DOI 10.1002/ijc.2910570623; Duramad O, 2005, J IMMUNOL, V174, P5193, DOI 10.4049/jimmunol.174.9.5193; FLEMINGTON EK, 1991, J VIROL, V65, P7073, DOI 10.1128/JVI.65.12.7073-7077.1991; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Heeg K, 2008, INT J MED MICROBIOL, V298, P33, DOI 10.1016/j.ijmm.2007.07.007; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Iwakiri D, 2004, J IMMUNOL, V172, P1561, DOI 10.4049/jimmunol.172.3.1561; Jenkins PJ, 2000, J VIROL, V74, P710, DOI 10.1128/JVI.74.2.710-720.2000; Klein E, 2007, ONCOGENE, V26, P1297, DOI 10.1038/sj.onc.1210240; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Ladell K, 2007, CELL MICROBIOL, V9, P2055, DOI 10.1111/j.1462-5822.2007.00937.x; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; Rechsteiner MP, 2008, J VIROL, V82, P1739, DOI 10.1128/JVI.01723-07; Rechsteiner MP, 2007, J GEN VIROL, V88, P1454, DOI 10.1099/vir.0.82790-0; Rickinson A, 2007, FIELDS VIROLOGY; Rochford R, 2005, NAT REV MICROBIOL, V3, P182, DOI 10.1038/nrmicro1089; Ryan JL, 2004, DIAGN MOL PATHOL, V13, P61, DOI 10.1097/00019606-200406000-00001; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; TOVEY MG, 1978, NATURE, V276, P270, DOI 10.1038/276270a0; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Yi AK, 1999, INT IMMUNOL, V11, P2015, DOI 10.1093/intimm/11.12.2015; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006; ZURHAUSEN H, 1978, NATURE, V272, P373	41	20	22	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 12	2010	29	32					4588	4598		10.1038/onc.2010.203	http://dx.doi.org/10.1038/onc.2010.203			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	638AQ	20514021				2022-12-25	WOS:000280862300009
J	Nambi, S; Basu, N; Visweswariah, SS				Nambi, Subhalaxmi; Basu, Nirmalya; Visweswariah, Sandhya S.			cAMP-regulated Protein Lysine Acetylases in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYLAMINE N-ACETYLTRANSFERASES; ADENYLYL CYCLASES; NUCLEOTIDE PHOSPHODIESTERASE; CHROMATIN PROTEIN; CYCLIC-AMP; BINDING; TUBERCULOSIS; MECHANISM; KINASE; GENE	Cyclic AMP synthesized by Mycobacterium tuberculosis has been shown to play a role in pathogenesis. However, the high levels of intracellular cAMP found in both pathogenic and nonpathogenic mycobacteria suggest that additional and important biological processes are regulated by cAMP in these organisms. We describe here the biochemical characterization of novel cAMP-binding proteins in M. smegmatis and M. tuberculosis (MSMEG_5458 and Rv0998, respectively) that contain a cyclic nucleotide binding domain fused to a domain that shows similarity to the GNAT family of acetyltransferases. We detect protein lysine acetylation in mycobacteria and identify a universal stress protein (USP) as a substrate of MSMEG_5458. Acetylation of a lysine residue in USP is regulated by cAMP, and using a strain deleted for MSMEG_5458, we show that USP is indeed an in vivo substrate for MSMEG_5458. The Rv0998 protein shows a strict cAMP-dependent acetylation of USP, despite a lower affinity for cAMP than MSMEG_5458. Thus, this report not only represents the first demonstration of protein lysine acetylation in mycobacteria but also describes a unique functional interplay between a cyclic nucleotide binding domain and a protein acetyltransferase.	[Nambi, Subhalaxmi; Basu, Nirmalya; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Basu, Nirmalya/0000-0003-3041-2826; Nambi, Subhalaxmi/0000-0001-7104-659X	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Government of India.; Recipient of a Senior Research Fellowship from the Council of Scientific and Industrial Research, Government of India.; Recipient of a Junior Research Fellowship from the Council of Scientific and Industrial Research, Government of India.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; BARZU O, 1994, PROG NUCLEIC ACID RE, V49, P241; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Brent MM, 2009, J BIOL CHEM, V284, P19412, DOI 10.1074/jbc.M109.014951; BUBIS J, 1988, J BIOL CHEM, V263, P9668; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Chang PA, 2010, MOL CELL BIOCHEM, V339, P181, DOI 10.1007/s11010-009-0382-0; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; O'Toole R, 2003, J BACTERIOL, V185, P1543, DOI 10.1128/JB.185.5.1543-1554.2003; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Podobnik M, 2009, J BIOL CHEM, V284, P32846, DOI 10.1074/jbc.M109.049635; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Sim E, 2008, CURR DRUG METAB, V9, P510, DOI 10.2174/138920008784892100; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Vagena E, 2008, CURR DRUG METAB, V9, P628, DOI 10.2174/138920008785821729; Vetting MW, 2008, ACTA CRYSTALLOGR F, V64, P978, DOI 10.1107/S1744309108031679; Vetting MW, 2004, CHEM BIOL, V11, P565, DOI 10.1016/j.chembiol.2004.03.017; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; WEBER IT, 1989, BIOCHEMISTRY-US, V28, P6122, DOI 10.1021/bi00440a059; Yan JS, 2008, J MOL BIOL, V376, P1260, DOI 10.1016/j.jmb.2007.12.070; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu JJ, 2010, PHARMACOL RES, V62, P35, DOI 10.1016/j.phrs.2009.12.006; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	53	86	89	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24313	24323		10.1074/jbc.M110.118398	http://dx.doi.org/10.1074/jbc.M110.118398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507997	hybrid, Green Published			2022-12-25	WOS:000280542100003
J	Peng, YJ; He, WQ; Tang, J; Tao, T; Chen, C; Gao, YQ; Zhang, WC; He, XY; Dai, YY; Zhu, NC; Lv, N; Zhang, CH; Qiao, YN; Zhao, LP; Gao, XA; Zhu, MS				Peng, Ya-Jing; He, Wei-Qi; Tang, Jing; Tao, Tao; Chen, Chen; Gao, Yun-Qian; Zhang, Wen-Cheng; He, Xue-Yan; Dai, Yu-Yuan; Zhu, Nian-Chun; Lv, Ning; Zhang, Cheng-Hai; Qiao, Yan-Ning; Zhao, Li-Ping; Gao, Xiang; Zhu, Min-Sheng			Trio Is a Key Guanine Nucleotide Exchange Factor Coordinating Regulation of the Migration and Morphogenesis of Granule Cells in the Developing Cerebellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; GROWTH-CONE; NEURONAL MIGRATION; GUIDANCE CUES; AXON GUIDANCE; OLFACTORY SYSTEM; IN-VIVO; RAC1; MOTILITY; DOMAIN	Orchestrated regulation of neuronal migration and morphogenesis is critical for neuronal development and establishment of functional circuits, but its regulatory mechanism is incompletely defined. We established and analyzed mice with neural-specific knock-out of Trio, a guanine nucleotide exchange factor with multiple guanine nucleotide exchange factor domains. Knock-out mice showed defective cerebella and severe signs of ataxia. Mutant cerebella had no granule cells in the internal granule cell layer due to aberrant granule cell migration as well as abnormal neurite growth. Trio-deficient granule cells showed reduced extension of neurites and highly branched and misguided processes with perturbed stabilization of actin and microtubules. Trio deletion caused down-regulation of the activation of Rac1, RhoA, and Cdc42, and mutant granule cells appeared to be unresponsive to neurite growth-promoting molecules such as Netrin-1 and Semaphorin 6A. These results suggest that Trio may be a key signal module for the orchestrated regulation of neuronal migration and morphogenesis during cerebellar development. Trio may serve as a signal integrator decoding extrinsic signals to Rho GTPases for cytoskeleton organization.	[Peng, Ya-Jing; He, Wei-Qi; Tang, Jing; Tao, Tao; Chen, Chen; Gao, Yun-Qian; Zhang, Wen-Cheng; He, Xue-Yan; Dai, Yu-Yuan; Zhu, Nian-Chun; Lv, Ning; Zhang, Cheng-Hai; Qiao, Yan-Ning; Gao, Xiang; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Peng, Ya-Jing; He, Wei-Qi; Tang, Jing; Tao, Tao; Chen, Chen; Gao, Yun-Qian; Zhang, Wen-Cheng; He, Xue-Yan; Dai, Yu-Yuan; Zhu, Nian-Chun; Lv, Ning; Zhang, Cheng-Hai; Qiao, Yan-Ning; Gao, Xiang; Zhu, Min-Sheng] Nanjing Univ, Moe Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China; [Zhao, Li-Ping] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Nanjing University; Nanjing University; National Institute of Biological Sciences, Beijing	Zhu, MS (corresponding author), 12 Xue Fu Rd, Nanjing 210061, Peoples R China.	zhums@nju.edu.cn	He, Weiqi/I-7935-2013; Zhang, Wencheng/AAO-8445-2020; Dai, Yuyuan/D-6485-2016; Lv, Ning/V-5706-2019; He, Weiqi/L-2502-2019; He, Xue-Yan/AAK-8453-2021	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; He, Xue-Yan/0000-0001-5423-5997; Chen, Chen/0000-0001-7075-8501; Qiao, Yanning/0000-0002-8092-4662	National Basic Research Program of China (973 Program) [2009CB941602, 2007CB947100, 2005CB522501]; National Natural Science Funding of China [30570911]; Scientific Research Foundation of Graduate School of Nanjing University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Graduate School of Nanjing University(Nanjing University)	This work was supported by the National Basic Research Program of China (973 Program) (Grants 2009CB941602, 2007CB947100, and 2005CB522501), National Natural Science Funding of China (Grant 30570911), and the Scientific Research Foundation of Graduate School of Nanjing University.	Alcantara S, 2000, DEVELOPMENT, V127, P1359; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Backer S, 2007, J NEUROSCI, V27, P10323, DOI 10.1523/JNEUROSCI.1102-07.2007; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bateman J, 2001, J CELL SCI, V114, P1973; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Chen L, 2007, J NEUROSCI, V27, P3884, DOI 10.1523/JNEUROSCI.3509-06.2007; COHENCORY S, 1991, J NEUROSCI, V11, P462; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Donald S, 2008, P NATL ACAD SCI USA, V105, P4483, DOI 10.1073/pnas.0712324105; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hongo T, 2000, BIOL NEONATE, V78, P293, DOI 10.1159/000014282; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kassai H, 2008, EUR J NEUROSCI, V28, P257, DOI 10.1111/j.1460-9568.2008.06343.x; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; Lalli G, 2005, J CELL BIOL, V171, P857, DOI 10.1083/jcb.200507061; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008; Ma XM, 2005, J COMP NEUROL, V482, P333, DOI 10.1002/cne.20404; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Park HT, 2002, BIOESSAYS, V24, P821, DOI 10.1002/bies.10141; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Robertson SP, 2004, CLIN DYSMORPHOL, V13, P123, DOI 10.1097/01.mcd.0000130235.95356.40; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanes DH, 2006, DEV NERVOUS SYSTEM; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yacubova E, 2003, CELL BIOCHEM BIOPHYS, V37, P213; Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	73	57	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24834	24844		10.1074/jbc.M109.096537	http://dx.doi.org/10.1074/jbc.M109.096537			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516067	hybrid, Green Published			2022-12-25	WOS:000280542100056
J	Karousou, E; Kamiryo, M; Skandalis, SS; Ruusala, A; Asteriou, T; Passi, A; Yamashita, H; Hellman, U; Heldin, CH; Heldin, P				Karousou, Eugenia; Kamiryo, Masaru; Skandalis, Spyros S.; Ruusala, Aino; Asteriou, Trias; Passi, Alberto; Yamashita, Hidetoshi; Hellman, Ulf; Heldin, Carl-Henrik; Heldin, Paraskevi			The Activity of Hyaluronan Synthase 2 Is Regulated by Dimerization and Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; MOLECULAR-CLONING; ACTIVATION; BIOSYNTHESIS; EXPRESSION; TRANSPORT; PATHWAY	Hyaluronan is a component of the extracellular matrix, which affects tissue homeostasis. In this study, we investigated the regulatory mechanisms of one of the hyaluronan-synthesizing enzymes, HAS2. Ectopic expression of Flag-and 6myc-HAS2 in COS-1 cells followed by immunoprecipitation and immunoblotting revealed homodimers; after co-transfection with Flag-HAS3, also heterodimers were seen. Furthermore, the expressed HAS2 was ubiquitinated. We identified one acceptor site for ubiquitin on lysine residue 190. Mutation of this residue led to inactivation of the enzymatic activity of HAS2. Interestingly, K190R-mutated HAS2 formed dimers with wt HAS2 and quenched the activity of wt HAS2, thus demonstrating a functional role of the dimeric configuration.	[Hellman, Ulf; Heldin, Carl-Henrik; Heldin, Paraskevi] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Passi, Alberto] Univ Insubria, DSBSC, I-21100 Varese, Italy; [Yamashita, Hidetoshi] Yamagata Univ, Sch Med, Dept Ophthalmol & Visual Sci, Yamagata 9909585, Japan	Ludwig Institute for Cancer Research; Uppsala University; University of Insubria; Yamagata University	Heldin, P (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, Box 595, SE-75124 Uppsala, Sweden.	Evi.Heldin@LICR.uu.se	passi, alberto g/A-1752-2018; Skandalis, Spyros/F-6815-2010	passi, alberto g/0000-0003-3328-3089; Skandalis, Spyros/0000-0003-1156-2896	Swedish Cancer Society; Wenner-Gren Foundation; Mizoutani Foundation for Glycoscience; FEBS	Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Foundation; Mizoutani Foundation for Glycoscience; FEBS	This work was supported in part by grants from the Swedish Cancer Society, Wenner-Gren Foundation, and Mizoutani Foundation for Glycoscience.; Recipient of FEBS Fellowships.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Berdiaki A, 2008, BBA-GEN SUBJECTS, V1780, P194, DOI 10.1016/j.bbagen.2007.10.005; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Ghosh A, 2009, J BIOL CHEM, V284, P18840, DOI 10.1074/jbc.M109.013813; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; HELDIN P, 1992, BIOCHEM J, V283, P165, DOI 10.1042/bj2830165; HELDIN P, 1993, EXP CELL RES, V208, P422, DOI 10.1006/excr.1993.1264; Hellman U, 2000, EXS, V88, P43; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; KLEWES L, 1994, J CELL PHYSIOL, V160, P539, DOI 10.1002/jcp.1041600317; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Recklies AD, 2001, BIOCHEM J, V354, P17, DOI 10.1042/0264-6021:3540017; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Sayo T, 2002, J INVEST DERMATOL, V118, P43, DOI 10.1046/j.0022-202x.2001.01613.x; Schevchenko VA, 1996, MUTAT RES-ENVIR MUTA, V361, P29, DOI 10.1016/S0165-1161(96)90226-5; Schulz T, 2007, J BIOL CHEM, V282, P20999, DOI 10.1074/jbc.M700915200; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Stuhlmeier KM, 2006, WIEN MED WOCHENSCHR, V156, P563, DOI 10.1007/s10354-006-0351-0; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; SUZUKI M, 1995, BIOCHEM J, V307, P817, DOI 10.1042/bj3070817; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997	40	90	90	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23647	23654		10.1074/jbc.M110.127050	http://dx.doi.org/10.1074/jbc.M110.127050			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507985	hybrid, Green Published			2022-12-25	WOS:000280291400015
J	Ladiwala, ARA; Lin, JC; Bale, SS; Marcelino-Cruz, AM; Bhattacharya, M; Dordick, JS; Tessier, PM				Ladiwala, Ali Reza A.; Lin, Jason C.; Bale, Shyam Sundhar; Marcelino-Cruz, Anna Marie; Bhattacharya, Moumita; Dordick, Jonathan S.; Tessier, Peter M.			Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid A beta into Off-pathway Conformers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; POLYGLUTAMINE AGGREGATION NUCLEATION; SMALL-MOLECULE ACTIVATORS; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PRION PROTEIN; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; ASSEMBLY PATHWAYS; STRAIN VARIATION	Misfolded proteins associated with diverse aggregation disorders assemble not only into a single toxic conformer but rather into a suite of aggregated conformers with unique biochemical properties and toxicities. To what extent small molecules can target and neutralize specific aggregated conformers is poorly understood. Therefore, we have investigated the capacity of resveratrol to recognize and remodel five conformers (monomers, soluble oligomers, non-toxic oligomers, fibrillar intermediates, and amyloid fibrils) of the A beta 1-42 peptide associated with Alzheimer disease. We find that resveratrol selectively remodels three of these conformers (soluble oligomers, fibrillar intermediates, and amyloid fibrils) into an alternative aggregated species that is non-toxic, high molecular weight, and unstructured. Surprisingly, resveratrol does not remodel non-toxic oligomers or accelerate A beta monomer aggregation despite that both conformers possess random coil secondary structures indistinguishable from soluble oligomers and significantly different from their beta-sheet rich, fibrillar counterparts. We expect that resveratrol and other small molecules with similar conformational specificity will aid in illuminating the conformational epitopes responsible for A beta-mediated toxicity.	[Dordick, Jonathan S.; Tessier, Peter M.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Tessier, PM (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, 110 8th St, Troy, NY 12180 USA.	tessier@rpi.edu	Tessier, Peter/GPP-3396-2022; Tessier, Peter/I-5730-2013	Tessier, Peter/0000-0002-3220-007X	Alzheimer's Association [NIRG-08-90967]	Alzheimer's Association(Alzheimer's Association)	This work was supported by Alzheimer's Association Grant NIRG-08-90967 (to P. M. T.).	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Amijee H, 2009, J ALZHEIMERS DIS, V17, P33, DOI 10.3233/JAD-2009-1044; Auer S, 2007, HFSP J, V1, P137, DOI 10.2976/1.2760023; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Baxa U, 2005, J STRUCT BIOL, V150, P170, DOI 10.1016/j.jsb.2005.02.007; Bernacki JP, 2009, BIOPHYS J, V96, P2871, DOI 10.1016/j.bpj.2008.12.3903; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Bousset L, 2003, J STRUCT BIOL, V141, P132, DOI 10.1016/S1047-8477(02)00606-8; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DICKINSON AG, 1969, GENET RES, V13, P213, DOI 10.1017/S0016672300002895; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Herbst M, 2006, CURR PHARM DESIGN, V12, P2543, DOI 10.2174/138161206777698828; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hudson SA, 2009, J MOL BIOL, V392, P689, DOI 10.1016/j.jmb.2009.07.031; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lee CH, 2006, J BIOL CHEM, V281, P3463, DOI 10.1074/jbc.M505307200; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PATTISON IH, 1968, RES VET SCI, V9, P408; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Radovan D, 2009, FEBS LETT, V583, P1439, DOI 10.1016/j.febslet.2009.03.059; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Riviere C, 2007, BIOORGAN MED CHEM, V15, P1160, DOI 10.1016/j.bmc.2006.09.069; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott MR, 1997, J VIROL, V71, P9032, DOI 10.1128/JVI.71.12.9032-9044.1997; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Stains CI, 2007, CHEMMEDCHEM, V2, P1674, DOI 10.1002/cmdc.200700140; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Trojanowski JQ, 2001, PARKINSONISM RELAT D, V7, P247, DOI 10.1016/S1353-8020(00)00065-1; Walling HW, 1998, J NEUROSCI RES, V54, P301, DOI 10.1002/(SICI)1097-4547(19981101)54:3<301::AID-JNR1>3.0.CO;2-W; Wang H, 2008, P NATL ACAD SCI USA, V105, P7159, DOI 10.1073/pnas.0801934105; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	94	240	249	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24228	24237		10.1074/jbc.M110.133108	http://dx.doi.org/10.1074/jbc.M110.133108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511235	hybrid, Green Published			2022-12-25	WOS:000280291400072
J	Mrinal, N; Nagaraju, J				Mrinal, Nirotpal; Nagaraju, Javaregowda			Dynamic Repositioning of Dorsal to Two Different kappa B Motifs Controls Its Autoregulation during Immune Response in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED REPRESSION; HOST-DEFENSE; GENES; EMBRYO; ACTIVATION; PATHWAYS; ENHANCER; TOLL; EXPRESSION; CONVERSION	Autoregulation is one of the mechanisms of imparting feedback control on gene expression. Positive autoregulatory feedback results in induction of a gene, and negative feedback leads to its suppression. Here, we report an interesting mechanism of autoregulation operating on Drosophila Rel gene dorsal that can activate as well as repress its expression. Using biochemical and genetic approaches, we show that upon immune challenge Dorsal regulates its activation as well as repression by dynamically binding to two different kappa B motifs, kappa B-I (intronic kappa B) and kappa B-P (promoter kappa B), present in the dorsal gene. Although the kappa B-I motif functions as an enhancer, the kappa B-P motif acts as a transcriptional repressor. Interestingly, Dorsal binding to these two motifs is dynamic; immediately upon immune challenge, Dorsal binds to the kappa B-I leading to auto-activation, whereas at the terminal phase of the immune response, it is removed from the kappa B-I and repositioned at the kappa B-P, resulting in its repression. Furthermore, we show that repression of Dorsal as well as its binding to the kappa B-P depends on the transcription factor AP1. Depletion of AP1 by RNA interference resulted in constitutive expression of Dorsal. In conclusion, this study suggests that during acute phase response dorsal is regulated by following two subcircuits: (i) Dl-kappa B-I for activation and (ii) Dl-AP1-kappa B-P for repression. These two subcircuits are temporally delineated and bring about overall regulation of dorsal during immune response. These results suggest the presence of a previously unknown mechanism of Dorsal autoregulation in immune-challenged Drosophila.	[Mrinal, Nirotpal; Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Nagaraju, J (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Hyderabad 500001, Andhra Pradesh, India.	jnagaraju@cdfd.org.in			Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Supported by a Centre of Excellence grant from Department of Biotechnology, Government of India. To whom correspondence should be addressed. E-mail: jnagaraju@cdfd.org.in.	Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; CHEN SM, 1993, MOL CELL BIOL, V13, P831, DOI 10.1128/MCB.13.2.831; Dushay MS, 1998, AM J HUM GENET, V62, P10, DOI 10.1086/301694; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; GOVIND S, 1991, TRENDS GENET, V7, P119, DOI 10.1016/0168-9525(91)90456-Z; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; IP YT, 1991, CELL, V64, P439; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; KIROV N, 1993, EMBO J, V12, P3193, DOI 10.1002/j.1460-2075.1993.tb05988.x; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Minakhina S, 2006, ONCOGENE, V25, P6749, DOI 10.1038/sj.onc.1209940; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Mrinal N, 2008, J BIOL CHEM, V283, P23376, DOI 10.1074/jbc.M801080200; PAN D, 1992, EMBO J, V11, P1837, DOI 10.1002/j.1460-2075.1992.tb05235.x; Ratnaparkhi GS, 2006, DEVELOPMENT, V133, P4409, DOI 10.1242/dev.02643; RUSHLOW C, 1992, BIOESSAYS, V14, P89, DOI 10.1002/bies.950140204; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Tingvall TO, 2001, P NATL ACAD SCI USA, V98, P3884, DOI 10.1073/pnas.061230198; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003	36	4	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24206	24216		10.1074/jbc.M109.097196	http://dx.doi.org/10.1074/jbc.M109.097196			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504768	Green Published, hybrid			2022-12-25	WOS:000280291400070
J	Olofsson, M; Vallin, A; Jakobsson, S; Wiklund, C				Olofsson, Martin; Vallin, Adrian; Jakobsson, Sven; Wiklund, Christer			Marginal Eyespots on Butterfly Wings Deflect Bird Attacks Under Low Light Intensities with UV Wavelengths	PLOS ONE			English	Article							BICYCLUS-ANYNANA; FEMALE CHOICE; BLUE TITS; ULTRAVIOLET; PREDATION; PATTERNS; LEPIDOPTERA; EVOLUTION; PREY; CUES	Background: Predators preferentially attack vital body parts to avoid prey escape. Consequently, prey adaptations that make predators attack less crucial body parts are expected to evolve. Marginal eyespots on butterfly wings have long been thought to have this deflective, but hitherto undemonstrated function. Methodology/Principal Findings: Here we report that a butterfly, Lopinga achine, with broad-spectrum reflective white scales in its marginal eyespot pupils deceives a generalist avian predator, the blue tit, to attack the marginal eyespots, but only under particular conditions-in our experiments, low light intensities with a prominent UV component. Under high light intensity conditions with a similar UV component, and at low light intensities without UV, blue tits directed attacks towards the butterfly head. Conclusions/Significance: In nature, birds typically forage intensively at early dawn, when the light environment shifts to shorter wavelengths, and the contrast between the eyespot pupils and the background increases. Among butterflies, deflecting attacks is likely to be particularly important at dawn when low ambient temperatures make escape by flight impossible, and when insectivorous birds typically initiate another day's search for food. Our finding that the deflective function of eyespots is highly dependent on the ambient light environment helps explain why previous attempts have provided little support for the deflective role of marginal eyespots, and we hypothesize that the mechanism that we have discovered in our experiments in a laboratory setting may function also in nature when birds forage on resting butterflies under low light intensities.	[Olofsson, Martin; Vallin, Adrian; Jakobsson, Sven; Wiklund, Christer] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Olofsson, M (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	martin.olofsson@zoologi.su.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding: This study was financially supported by the Swedish Research Council to C. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P1345, DOI 10.1098/rspb.1998.0440; BEDNEKOFF PA, 1994, EVOL ECOL, V8, P36, DOI 10.1007/BF01237664; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Blest A. D., 1957, Behaviour, V11, P209, DOI 10.1163/156853956X00048; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; BRAKEFIELD PM, 1992, AVOIDANCE CONCEALMEN, P93; Breuker CJ, 2002, P ROY SOC B-BIOL SCI, V269, P1233, DOI 10.1098/rspb.2002.2005; CHAI P, 1986, BIOL J LINN SOC, V29, P161, DOI 10.1111/j.1095-8312.1986.tb01772.x; Church SC, 1998, P ROY SOC B-BIOL SCI, V265, P1509, DOI 10.1098/rspb.1998.0465; COOPER WE, 1991, CAN J ZOOL, V69, P757, DOI 10.1139/z91-109; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; de Vries P.J., 1988, Journal of Research on the Lepidoptera, V26, P98; Dennis R.L.H., 1986, Nota Lepidopterologica, V9, P39; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; HUTTO RL, 1981, BEHAV ECOL SOCIOBIOL, V9, P195, DOI 10.1007/BF00302937; Kodandaramaiah U, 2009, ANIM BEHAV, V77, P1415, DOI 10.1016/j.anbehav.2009.02.018; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Lyytinen A, 2004, BEHAV ECOL, V15, P982, DOI 10.1093/beheco/arh102; Lyytinen A, 2003, OIKOS, V100, P373, DOI 10.1034/j.1600-0706.2003.11935.x; Lyytinen A, 2001, BEHAV ECOL, V12, P65, DOI 10.1093/oxfordjournals.beheco.a000380; Monteiro A, 2008, BIOESSAYS, V30, P358, DOI 10.1002/bies.20733; Nijhout H. F., 1991, DEV EVOLUTION BUTTER; POWELL RA, 1982, AM NAT, V119, P126, DOI 10.1086/283897; RAWLINS J E, 1978, Journal of the Lepidopterists' Society, V32, P145; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Ruxton G. D., 2004, AVOIDING ATTACK; SHAPIRO AM, 1974, AM NAT, V108, P229, DOI 10.1086/282901; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810; Stevens M, 2007, BIOSCIENCE, V57, P501, DOI 10.1641/B570607; Thery M, 2008, BEHAV ECOL, V19, P627, DOI 10.1093/beheco/arn024; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Vallin A, 2006, BEHAV ECOL SOCIOBIOL, V59, P455, DOI 10.1007/s00265-005-0069-9; Vallin A, 2005, P ROY SOC B-BIOL SCI, V272, P1203, DOI 10.1098/rspb.2004.3034; Vallin A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1419, DOI 10.1007/s00265-007-0374-6; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Vlieger L, 2007, BIOL J LINN SOC, V92, P661, DOI 10.1111/j.1095-8312.2007.00863.x; Wall M, 2007, BIOL J LINN SOC, V91, P719, DOI 10.1111/j.1095-8312.2007.00835.x; WOURMS M K, 1985, Journal of the Lepidopterists' Society, V39, P239; WOURMS MK, 1985, EVOLUTION, V39, P845, DOI 10.1111/j.1558-5646.1985.tb00426.x	40	83	85	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10798	10.1371/journal.pone.0010798	http://dx.doi.org/10.1371/journal.pone.0010798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520736	Green Submitted, Green Published, gold			2022-12-25	WOS:000278034600025
J	de Breij, A; Dijkshoorn, L; Lagendijk, E; van der Meer, J; Koster, A; Bloemberg, G; Wolterbeek, R; van den Broek, P; Nibbering, P				de Breij, Anna; Dijkshoorn, Lenie; Lagendijk, Ellen; van der Meer, Joke; Koster, Abraham; Bloemberg, Guido; Wolterbeek, Ron; van den Broek, Peterhans; Nibbering, Peter			Do Biofilm Formation and Interactions with Human Cells Explain the Clinical Success of Acinetobacter baumannii?	PLOS ONE			English	Article							EPITHELIAL-CELLS; SP NOV.; STRAINS; IDENTIFICATION; HOSPITALS; SURFACES; WIDESPREAD; RESISTANCE; CLONE; PILI	Background: The dramatic increase in antibiotic resistance and the recent manifestation in war trauma patients underscore the threat of Acinetobacter baumannii as a nosocomial pathogen. Despite numerous reports documenting its epidemicity, little is known about the pathogenicity of A. baumannii. The aim of this study was to obtain insight into the factors that might explain the clinical success of A. baumannii. Methodology/Principal Findings: We compared biofilm formation, adherence to and inflammatory cytokine induction by human cells for a large panel of well-described strains of A. baumannii and compared these features to that of other, clinically less relevant Acinetobacter species. Results revealed that biofilm formation and adherence to airway epithelial cells varied widely within the various species, but did not differ among the species. However, airway epithelial cells and cultured human macrophages produced significantly less inflammatory cytokines upon exposure to A. baumannii strains than to strains of A. junii, a species infrequently causing infection. Conclusion/Significance: The induction of a weak inflammatory response may provide a clue to the persistence of A. baumannii in patients.	[de Breij, Anna; Dijkshoorn, Lenie; van den Broek, Peterhans; Nibbering, Peter] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Lagendijk, Ellen] Leiden Univ, Inst Biol, Leiden, Netherlands; [van der Meer, Joke; Koster, Abraham] Leiden Univ, Med Ctr, Sect Elect Microscopy, Dept Mol Cell Biol, Leiden, Netherlands; [Bloemberg, Guido] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [Wolterbeek, Ron] Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Breij, A (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	a.de_breij@lumc.nl	Bloemberg, Guido/AAC-4914-2020					BEACHEY EH, 1988, AM REV RESPIR DIS, V138, P45; Bresser P, 1997, EUR RESPIR J, V10, P2319, DOI 10.1183/09031936.97.10102319; Chu YW, 1999, J CLIN MICROBIOL, V37, P2962, DOI 10.1128/JCM.37.9.2962-2967.1999; Clinical and Laboratory Standards Institute, 2005, M100S15 CLIN LAB STA; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Da Silva G, 2007, CLIN MICROBIOL INFEC, V13, P190, DOI 10.1111/j.1469-0691.2006.01628.x; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 1998, SYST APPL MICROBIOL, V21, P33, DOI 10.1016/S0723-2020(98)80006-4; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Hoffmann MS, 2010, INFECT CONT HOSP EP, V31, P196, DOI 10.1086/650379; HUGH R, 1978, GLUCOSE NONFERMENTIN, P3; Kapetanovic R, 2007, EXPERT OPIN BIOL TH, V7, P907, DOI 10.1517/14712598.7.6.907; Kim D, 2008, J MICROBIOL, V46, P396, DOI 10.1007/s12275-008-0118-y; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Murray CK, 2009, MIL MED, V174, P598, DOI 10.7205/MILMED-D-03-8008; Nemec A, 2004, J MED MICROBIOL, V53, P147, DOI 10.1099/jmm.0.05445-0; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; Nemec A, 2010, INT J SYST EVOL MICR, V60, P896, DOI 10.1099/ijs.0.013656-0; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Qiu HY, 2009, MICROBES INFECT, V11, P946, DOI 10.1016/j.micinf.2009.06.003; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; SEIFERT H, 1993, ZBL BAKT-INT J MED M, V279, P544, DOI 10.1016/S0934-8840(11)80427-5; TJERNBERG I, 1989, APMIS, V97, P595, DOI 10.1111/j.1699-0463.1989.tb00449.x; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Van Looveren M, 2004, CLIN MICROBIOL INFEC, V10, P684, DOI 10.1111/j.1469-0691.2004.00942.x; van Wetering S, 2002, INFLAMM RES, V51, P8, DOI 10.1007/PL00000282; Vaneechoutte M, 1999, RES MICROBIOL, V150, P69, DOI 10.1016/S0923-2508(99)80047-3; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Webster C, 2000, INFECT CONT HOSP EP, V21, P246, DOI 10.1086/503214	33	72	72	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10732	10.1371/journal.pone.0010732	http://dx.doi.org/10.1371/journal.pone.0010732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505779	gold, Green Published, Green Submitted			2022-12-25	WOS:000278017300008
J	Hunt, JH; Wolschin, F; Henshaw, MT; Newman, TC; Toth, AL; Amdam, GV				Hunt, James H.; Wolschin, Florian; Henshaw, Michael T.; Newman, Thomas C.; Toth, Amy L.; Amdam, Gro V.			Differential Gene Expression and Protein Abundance Evince Ontogenetic Bias toward Castes in a Primitively Eusocial Wasp	PLOS ONE			English	Article							HONEY-BEE; PAPER WASP; FLESH FLY; PUPAL DIAPAUSE; OVERWINTERING DIAPAUSE; POLISTES-EXCLAMANS; HSP70 TRANSCRIPTS; JUVENILE-HORMONE; UP-REGULATION; SOCIAL WASPS	Polistes paper wasps are models for understanding conditions that may have characterized the origin of worker and queen castes and, therefore, the origin of paper wasp sociality. Polistes is "primitively eusocial'' by virtue of having context-dependent caste determination and no morphological differences between castes. Even so, Polistes colonies have a temporal pattern in which most female larvae reared by the foundress become workers, and most reared by workers become future-reproductive gynes. This pattern is hypothesized to reflect development onto two pathways, which may utilize mechanisms that regulate diapause in other insects. Using expressed sequence tags (ESTs) for Polistes metricus we selected candidate genes differentially expressed in other insects in three categories: 1) diapause vs. non-diapause phenotypes and/or worker vs. queen differentiation, 2) behavioral subcastes of worker honey bees, and 3) no a priori expectation of a role in worker/gyne development. We also used a non-targeted proteomics screen to test for peptide/protein abundance differences that could reflect larval developmental divergence. We found that foundress-reared larvae (putative worker-destined) and worker-reared larvae (putative gyne-destined) differed in quantitative expression of sixteen genes, twelve of which were associated with caste and/or diapause in other insects, and they also differed in abundance of nine peptides/proteins. Some differentially-expressed genes are involved in diapause regulation in other insects, and other differentially-expressed genes and proteins are involved in the insulin signaling pathway, nutrient metabolism, and caste determination in highly social bees. Differential expression of a gene and a peptide encoding hexameric storage proteins is especially noteworthy. Although not conclusive, our results support hypotheses of 1) larval developmental pathway divergence that can lead to caste bias in adults and 2) nutritional differences as the foundation of the pathway divergence. Finally, the differential expression in Polistes larvae of genes and proteins also differentially expressed during queen vs. worker caste development in honey bees may indicate that regulatory mechanisms of caste outcomes share similarities between primitively eusocial and advanced eusocial Hymenoptera.	[Hunt, James H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Hunt, James H.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Hunt, James H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Hunt, James H.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Wolschin, Florian; Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Wolschin, Florian; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Henshaw, Michael T.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Newman, Thomas C.; Toth, Amy L.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Toth, Amy L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; The National Evolutionary Synthesis Center; Norwegian University of Life Sciences; Arizona State University; Arizona State University-Tempe; Grand Valley State University; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hunt, JH (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	jim_hunt@ncsu.edu	Toth, Amy L/A-9196-2011		US National Science Foundation [0819807, 0803317, 0641431, 0615502]; University of Illinois; National Evolutionary Synthesis Center (NSF) [EF-0905608]; Alexander von Humboldt Foundation; Research Council of Norway [175413, 180504, 185306, 191699]; PEW Foundation [000068-001]; National Institute of Aging (NIA) [P01 AG22500]; Division Of Integrative Organismal Systems [0803317] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); University of Illinois; National Evolutionary Synthesis Center (NSF); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Research Council of Norway(Research Council of Norway); PEW Foundation; National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	JHH, MTH, and ALT received support from the US National Science Foundation (0819807, 0803317, 0641431); JHH received additional support from the University of Illinois Sociogenomics Initiative (Gene E. Robinson, PI) and from the National Evolutionary Synthesis Center (NSF # EF-0905608); FW was supported by a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation; and GVA received support from the Research Council of Norway (175413, 180504, 185306 and 191699), the US National Science Foundation (0615502), the PEW Foundation (000068-001), and the National Institute of Aging (NIA P01 AG22500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM S. MASHHOOD, 1958, PROC ZOOL SOC, V11, P113; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; [Anonymous], 1974, SOCIAL BEHAV BEES; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Batra S. W. T., 1966, Indian Journal of Entomology, V28, P375; Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; BOHM MK, 1972, J INSECT PHYSIOL, V18, P1875, DOI 10.1016/0022-1910(72)90158-8; Cini A, 2009, ANN ZOOL FENN, V46, P423, DOI 10.5735/086.046.0603; CORONA M, 1999, J EXPT BIOL, V202; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Dapporto L, 2005, ANN ZOOL FENN, V42, P135; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; EICKWORT K, 1969, INSECT SOC, V16, P67, DOI 10.1007/BF02224464; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Flannagan RD, 1998, P NATL ACAD SCI USA, V95, P5616, DOI 10.1073/pnas.95.10.5616; GADAGKAR R, 1990, P INDIAN AS-ANIM SCI, V99, P141, DOI 10.1007/BF03186384; GADAGKAR R, 1988, PROC R SOC SER B-BIO, V233, P175, DOI 10.1098/rspb.1988.0017; GADAGKAR R, 1991, ECOL ENTOMOL, V16, P435, DOI 10.1111/j.1365-2311.1991.tb00236.x; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gobbi N, 2006, NATURWISSENSCHAFTEN, V93, P487, DOI 10.1007/s00114-006-0140-z; Greene A., 1991, P263; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hoffman EA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-23; Holldobler B., 1990, pi; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Hunt JH, 2005, SCIENCE, V308, P264, DOI 10.1126/science.1109724; Hunt JH, 2003, J INSECT PHYSIOL, V49, P785, DOI 10.1016/S0022-1910(03)00115-X; Hunt JH, 2002, ECOL ENTOMOL, V27, P467, DOI 10.1046/j.1365-2311.2002.00369.x; Hunt JH, 1999, BIOTROPICA, V31, P192; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Judd TM, 2010, J INSECT PHYSIOL, V56, P42, DOI 10.1016/j.jinsphys.2009.09.002; Judice CC, 2006, INSECT MOL BIOL, V15, P33, DOI 10.1111/j.1365-2583.2005.00605.x; Karsai I, 2002, ENVIRON ENTOMOL, V31, P99, DOI 10.1603/0046-225X-31.1.99; Kawamura K, 1999, DEVELOPMENT, V126, P211; Keeping MG, 2002, J INSECT PHYSIOL, V48, P867, DOI 10.1016/S0022-1910(02)00156-7; Kundu HL., 1967, BIRLA I TECHNOL SCI, V1, P152; Lewis DK, 2002, J INSECT PHYSIOL, V48, P887, DOI 10.1016/S0022-1910(02)00158-0; Liebert AE, 2004, INSECT SOC, V51, P205, DOI 10.1007/s00040-004-0754-0; Marchal P., 1897, Compte Rendu des Seances de la Societe de Biologie, P557; Matsuura M., 1991, P232; Mead F, 2002, ETHOL ECOL EVOL, V14, P111; Noll Fernando B., 2004, American Museum Novitates, V3467, P1, DOI 10.1206/0003-0082(2004)467<0001:EOCINW>2.0.CO;2; O'Donnell S, 1998, ANNU REV ENTOMOL, V43, P323, DOI 10.1146/annurev.ento.43.1.323; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; PARDI L, 1948, PHYSIOL ZOOL, V21, P1; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Pereboom JJM, 2005, P ROY SOC B-BIOL SCI, V272, P1145, DOI 10.1098/rspb.2005.3060; Reeve H.K., 1991, P99; Reeve HK, 2001, MG BEH ECOL, P57; Reeve HK, 1998, P NATL ACAD SCI USA, V95, P13737, DOI 10.1073/pnas.95.23.13737; Rinehart JP, 2000, INSECT BIOCHEM MOLEC, V30, P515, DOI 10.1016/S0965-1748(00)00021-7; Rinehart JP, 2000, INSECT MOL BIOL, V9, P641, DOI 10.1046/j.1365-2583.2000.00230.x; ROSSI AM, 1988, ECOL ENTOMOL, V13, P437, DOI 10.1111/j.1365-2311.1988.tb00376.x; Sim C, 2009, INSECT MOL BIOL, V18, P325, DOI 10.1111/j.1365-2583.2009.00872.x; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; STRASSMANN JE, 1984, INSECT SOC, V31, P291, DOI 10.1007/BF02223613; SULLIVAN JD, 1984, BEHAV ECOL SOCIOBIOL, V15, P249, DOI 10.1007/BF00292986; Sumner S, 2006, P ROY SOC B-BIOL SCI, V273, P19, DOI 10.1098/rspb.2005.3291; Sumner S, 2010, P ROY SOC B-BIOL SCI, V277, P1721, DOI 10.1098/rspb.2009.2289; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Toth AL, 2009, INSECT SOC, V56, P77, DOI 10.1007/s00040-008-1041-2; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Toth AL, 2010, P ROY SOC B-BIOL SCI, V277, P2139, DOI 10.1098/rspb.2010.0090; Van der Horst DJ, 2009, MOL CELL BIOCHEM, V326, P105, DOI 10.1007/s11010-008-0011-3; WENZEL JW, 1992, INSECT SOC, V39, P31, DOI 10.1007/BF01240529; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; West Eberhard M. J., 1969, Miscellaneous Publications Museum of Zoology University of Michigan, VNo. 140, P1; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; Wilson E.O., 1971, INSECT SOC; Winston M.L., 1991, BIOL HONEY BEE; Wolschin F, 2009, J EXP BIOL, V212, P4027, DOI 10.1242/jeb.033845; Wolschin F, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-10; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5; Wolschin F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006394; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0	84	63	64	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10674	10.1371/journal.pone.0010674	http://dx.doi.org/10.1371/journal.pone.0010674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498859	Green Published, gold			2022-12-25	WOS:000277773700017
J	Chao, R; Nevin, L; Agarwal, P; Riemer, J; Bai, XY; Delaney, A; Akana, M; JimenezLopez, N; Bardakjian, T; Schneider, A; Chassaing, N; Schorderet, DF; FitzPatrick, D; Kwok, PY; Ellgaard, L; Gould, DB; Zhang, Y; Malicki, J; Baier, H; Slavotinek, A				Chao, Ryan; Nevin, Linda; Agarwal, Pooja; Riemer, Jan; Bai, Xiaoyang; Delaney, Allen; Akana, Matthew; JimenezLopez, Nelson; Bardakjian, Tanya; Schneider, Adele; Chassaing, Nicolas; Schorderet, Daniel F.; FitzPatrick, David; Kwok, Pui-yan; Ellgaard, Lars; Gould, Douglas B.; Zhang, Yan; Malicki, Jarema; Baier, Herwig; Slavotinek, Anne			A Male with Unilateral Microphthalmia Reveals a Role for TMX3 in Eye Development	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; COPY-NUMBER; CANDIDATE GENES; HEART-DEFECTS; ARRAY-CGH; EXPRESSION; MUTATION; DELETION; PROTEIN; IDENTIFICATION	Anophthalmia and microphthalmia are important birth defects, but their pathogenesis remains incompletely understood. We studied a patient with severe unilateral microphthalmia who had a 2.7 Mb deletion at chromosome 18q22.1 that was inherited from his mother. In-situ hybridization showed that one of the deleted genes, TMX3, was expressed in the retinal neuroepithelium and lens epithelium in the developing murine eye. We re-sequenced TMX3 in 162 patients with anophthalmia or microphthalmia, and found two missense substitutions in unrelated patients: c.116G > A, predicting p.Arg39Gln, in a male with unilateral microphthalmia and retinal coloboma, and c.322G > A, predicting p.Asp108Asn, in a female with unilateral microphthalmia and severe micrognathia. We used two antisense morpholinos targeted against the zebrafish TMX3 orthologue, zgc:110025, to examine the effects of reduced gene expression in eye development. We noted that the morphant larvae resulting from both morpholinos had significantly smaller eye sizes and reduced labeling with islet-1 antibody directed against retinal ganglion cells at 2 days post fertilization. Co-injection of human wild type TMX3 mRNA rescued the small eye phenotype obtained with both morpholinos, whereas co-injection of human TMX3(p.Arg39Gln) mutant mRNA, analogous to the mutation in the patient with microphthalmia and coloboma, did not rescue the small eye phenotype. Our results show that haploinsufficiency for TMX3 results in a small eye phenotype and represents a novel genetic cause of microphthalmia and coloboma. Future experiments to determine if other thioredoxins are important in eye morphogenesis and to clarify the mechanism of function of TMX3 in eye development are warranted.	[Chao, Ryan; JimenezLopez, Nelson; Slavotinek, Anne] Univ Calif San Francisco, Dept Pediat, Div Genet, San Francisco, CA 94143 USA; [Nevin, Linda; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Agarwal, Pooja] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Riemer, Jan; Ellgaard, Lars] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Bai, Xiaoyang; Gould, Douglas B.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Bai, Xiaoyang; Gould, Douglas B.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Bai, Xiaoyang; Akana, Matthew; Kwok, Pui-yan; Gould, Douglas B.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Delaney, Allen] BC Canc Res Ctr, Genome Sci Ctr, Vancouver, BC, Canada; [Akana, Matthew; Kwok, Pui-yan] Univ Calif San Francisco, Dept Dermatol, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bardakjian, Tanya; Schneider, Adele] Albert Einstein Med Ctr, Div Clin Genet, Philadelphia, PA 19141 USA; [Chassaing, Nicolas] Univ Toulouse, Serv Genet Med, Toulouse, France; [Schorderet, Daniel F.] Univ Lausanne, Inst Rech Ophtalmol, Lausanne, Switzerland; [Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [FitzPatrick, David] Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Zhang, Yan; Malicki, Jarema] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Copenhagen; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; British Columbia Cancer Agency; University of California System; University of California San Francisco; Yeshiva University; Universite de Toulouse; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Edinburgh; Harvard University; Harvard Medical School	Chao, R (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Genet, San Francisco, CA 94143 USA.	slavotia@peds.ucsf.edu	Ellgaard, Lars/I-9034-2014; malicki, jarema/G-8611-2014; FitzPatrick, David R/C-7301-2013; Riemer, Jan/B-3340-2012; Riemer, Jan/AAC-1072-2021; Slavotinek, Anne/AAK-6794-2020; Kwok, Pui-Yan/F-7725-2014	Ellgaard, Lars/0000-0002-7018-0137; malicki, jarema/0000-0002-5947-8805; Kwok, Pui-Yan/0000-0002-5087-3059; Riemer, Jan/0000-0002-7574-8457; FitzPatrick, David R./0000-0003-4861-969X	National Institute of Child Health and Development (NICHD) [5R03 HDO49411-02, K08HD053476-01A1]; Sandler Program in Basic Sciences [EY02162]; National Institutes of Health/National Center for Research Resources (NIH/NCRR) University of California San Francisco-Clinical & Translational Science Institute (UCSF-CTSI) [UL1 RR024131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD053476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002162] Funding Source: NIH RePORTER	National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sandler Program in Basic Sciences; National Institutes of Health/National Center for Research Resources (NIH/NCRR) University of California San Francisco-Clinical & Translational Science Institute (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Anne Slavotinek was generously funded by an R03 grant 5R03 HDO49411-02 from the National Institute of Child Health and Development (NICHD) and a K08 grant K08HD053476-01A1 from the same institution. Doug Gould and Xaioyang Bai were funded by the Sandler Program in Basic Sciences, That Man May See, and the core grant (EY02162). This publication was supported by National Institutes of Health/National Center for Research Resources (NIH/NCRR) University of California San Francisco-Clinical & Translational Science Institute (UCSF-CTSI) Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanesov A, 2004, METHODS CELL BIOL, V76, P333; Brown JD, 2009, P NATL ACAD SCI USA, V106, P1462, DOI 10.1073/pnas.0812017106; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Chatterjee B, 2007, MAMM GENOME, V18, P310, DOI 10.1007/s00335-007-9023-7; Davis-Silberman N, 2005, HUM MOL GENET, V14, P2265, DOI 10.1093/hmg/ddi231; DELANEY A, 2008, CURR PROTOC HUM GENE, pCH8; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Giordano E, 2003, MOL GENET GENOMICS, V268, P692, DOI 10.1007/s00438-002-0792-0; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Haugstetter J, 2007, J BIOL CHEM, V282, P33859, DOI 10.1074/jbc.M706442200; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kantarci S, 2006, AM J MED GENET A, V140A, P17, DOI 10.1002/ajmg.a.31025; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Melloy PG, 1998, DEV BIOL, V193, P77, DOI 10.1006/dbio.1997.8787; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Osoegawa K, 2008, J MED GENET, V45, P81, DOI 10.1136/jmg.2007.052191; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Rainger J, 2008, INBORN ERRORS DEV, P94; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Scott DA, 2007, HUM MOL GENET, V16, P424, DOI 10.1093/hmg/ddl475; Sehgal R, 2008, DEV BIOL, V319, P23, DOI 10.1016/j.ydbio.2008.03.041; Slavotinek AM, 2006, EUR J HUM GENET, V14, P999, DOI 10.1038/sj.ejhg.5201652; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Taylor MR, 2005, GENETICS, V170, P263, DOI 10.1534/genetics.104.036434; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Thisse B, 2004, ZFIN DIRECT DATA SUB; Torres MA, 1996, DEVELOPMENT, V122, P3381; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zayed H, 2010, AM J MED GENET A, V152A, P916, DOI 10.1002/ajmg.a.33341	40	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10565	10.1371/journal.pone.0010565	http://dx.doi.org/10.1371/journal.pone.0010565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485507	Green Published, gold, Green Submitted			2022-12-25	WOS:000277563200004
J	Jordao, JF; Ayala-Grosso, CA; Markham, K; Huang, YX; Chopra, R; McLaurin, J; Hynynen, K; Aubert, I				Jordao, Jessica F.; Ayala-Grosso, Carlos A.; Markham, Kelly; Huang, Yuexi; Chopra, Rajiv; McLaurin, JoAnne; Hynynen, Kullervo; Aubert, Isabelle			Antibodies Targeted to the Brain with Image-Guided Focused Ultrasound Reduces Amyloid-beta Plaque Load in the TgCRND8 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							BARRIER; DELIVERY; MICE; IMMUNIZATION; MEMORY; IMMUNOTHERAPY; DISRUPTION; MECHANISMS; DEPOSITION; DEFICITS	Immunotherapy for Alzheimer's disease (AD) relies on antibodies directed against toxic amyloid-beta peptide (A beta), which circulate in the bloodstream and remove A beta from the brain [1,2]. In mouse models of AD, the administration of anti-A beta antibodies directly into the brain, in comparison to the bloodstream, was shown to be more efficient at reducing A beta plaque pathology [3,4]. Therefore, delivering anti-A beta antibodies to the brain of AD patients may also improve treatment efficiency. Transcranial focused ultrasound (FUS) is known to transiently-enhance the permeability of the blood-brain barrier (BBB) [5], allowing intravenously administered therapeutics to enter the brain [6-8]. Our goal was to establish that anti-A beta antibodies delivered to the brain using magnetic resonance imaging-guided FUS (MRIgFUS) [9] can reduce plaque pathology. To test this, TgCRND8 mice [10] received intravenous injections of MRI and FUS contrast agents, as well as anti-A beta antibody, BAM-10. MRIgFUS was then applied transcranially. Within minutes, the MRI contrast agent entered the brain, and BAM-10 was later found bound to A beta plaques in targeted cortical areas. Four days post-treatment, A beta pathology was significantly reduced in TgCRND8 mice. In conclusion, this is the first report to demonstrate that MRIgFUS delivery of anti-A beta antibodies provides the combined advantages of using a low dose of antibody and rapidly reducing plaque pathology.	[Jordao, Jessica F.; Ayala-Grosso, Carlos A.; Markham, Kelly; Huang, Yuexi; Chopra, Rajiv; Hynynen, Kullervo; Aubert, Isabelle] Sunnybrook Res Inst, Toronto, ON, Canada; [Jordao, Jessica F.; McLaurin, JoAnne; Aubert, Isabelle] Univ Toronto, Fac Med, Dept Lab Med & Pathol, Toronto, ON, Canada; [Chopra, Rajiv; Hynynen, Kullervo] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada; [McLaurin, JoAnne] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Ayala-Grosso, Carlos A.] Cent Univ Venezuela, Fac Farm, Unidad Biol Mol, Caracas, Venezuela	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Central Venezuela	Jordao, JF (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.	khynynen@sri.utoronto.ca; isabelle.aubert@sri.utoronto.ca	Ayala-Grosso, Carlos/ABD-5221-2020; Chopra, Rajiv/A-8367-2013; Aubert, Isabelle/AAG-4001-2019	Ayala-Grosso, Carlos/0000-0003-3079-1109; Chopra, Rajiv/0000-0003-3605-6076; Aubert, Isabelle/0000-0001-5163-9961	Sunnybrook Research Institute; Ontario Mental Health Foundation; National Institutes of Health [R21/R33 EB000705]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB000705, R21EB000705] Funding Source: NIH RePORTER	Sunnybrook Research Institute(University of Toronto); Ontario Mental Health Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by Sunnybrook Research Institute (IA), Ontario Mental Health Foundation (IA), National Institutes of Health (KH; R21/R33 EB000705 NIH/NIBIB), and Canadian Institutes of Health Research (IA, JM, JFJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Braakman N, 2006, J MAGN RESON IMAGING, V24, P530, DOI 10.1002/jmri.20675; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chopra R, 2009, MED PHYS, V36, P1867, DOI 10.1118/1.3115680; DaSilva KA, 2009, VACCINE, V27, P1365, DOI 10.1016/j.vaccine.2008.12.044; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Frenkel D, 1998, J NEUROIMMUNOL, V88, P85, DOI 10.1016/S0165-5728(98)00098-8; Hawkes Cheryl A, 2007, Expert Rev Neurother, V7, P1535, DOI 10.1586/14737175.7.11.1535; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2006, J NEUROSURG, V105, P445, DOI 10.3171/jns.2006.105.3.445; Janus C, 2004, NEUROBIOL AGING, V25, P1213, DOI 10.1016/j.neurobiolaging.2003.11.007; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kinoshita M, 2006, BIOCHEM BIOPH RES CO, V340, P1085, DOI 10.1016/j.bbrc.2005.12.112; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Opar A, 2008, NAT REV DRUG DISCOV, V7, P717, DOI 10.1038/nrd2676; Raymond SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002175; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Sheikov N, 2008, ULTRASOUND MED BIOL, V34, P1093, DOI 10.1016/j.ultrasmedbio.2007.12.015; Thakker DR, 2009, P NATL ACAD SCI USA, V106, P4501, DOI 10.1073/pnas.0813404106; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wilcock DM, 2008, J ALZHEIMERS DIS, V15, P555	29	258	268	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10549	10.1371/journal.pone.0010549	http://dx.doi.org/10.1371/journal.pone.0010549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485502	Green Submitted, Green Published, gold			2022-12-25	WOS:000277563200002
J	Forero, MG; Learte, AR; Cartwright, S; Hidalgo, A				Forero, Manuel Guillermo; Learte, Anabel R.; Cartwright, Stephanie; Hidalgo, Alicia			DeadEasy Mito-Glia: Automatic Counting of Mitotic Cells and Glial Cells in Drosophila	PLOS ONE			English	Article								Cell number changes during normal development, and in disease (e.g., neurodegeneration, cancer). Many genes affect cell number, thus functional genetic analysis frequently requires analysis of cell number alterations upon loss of function mutations or in gain of function experiments. Drosophila is a most powerful model organism to investigate the function of genes involved in development or disease in vivo. Image processing and pattern recognition techniques can be used to extract information from microscopy images to quantify automatically distinct cellular features, but these methods are still not very extended in this model organism. Thus cellular quantification is often carried out manually, which is laborious, tedious, error prone or humanly unfeasible. Here, we present DeadEasy Mito-Glia, an image processing method to count automatically the number of mitotic cells labelled with anti-phospho-histone H3 and of glial cells labelled with anti-Repo in Drosophila embryos. This programme belongs to the DeadEasy suite of which we have previously developed versions to count apoptotic cells and neuronal nuclei. Having separate programmes is paramount for accuracy. DeadEasy Mito-Glia is very easy to use, fast, objective and very accurate when counting dividing cells and glial cells labelled with a nuclear marker. Although this method has been validated for Drosophila embryos, we provide an interactive window for biologists to easily extend its application to other nuclear markers and other sample types. DeadEasy MitoGlia is freely available as an ImageJ plug-in, it increases the repertoire of tools for in vivo genetic analysis, and it will be of interest to a broad community of developmental, cancer and neuro-biologists.	[Forero, Manuel Guillermo; Learte, Anabel R.; Cartwright, Stephanie; Hidalgo, Alicia] Univ Birmingham, Sch Biosci, Neurodev Grp, Birmingham, W Midlands, England	University of Birmingham	Forero, MG (corresponding author), Univ Birmingham, Sch Biosci, Neurodev Grp, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	Hidalgo, Alicia/F-5930-2015	Hidalgo, Alicia/0000-0001-8041-5764; Forero, Manuel/0000-0001-9972-8621	Wellcome Trust [073228/Z/03/Z]; EMBO YIP; MRC; Biotechnology and Biological Sciences Research Council [BB/H002278/1] Funding Source: researchfish; BBSRC [BB/H002278/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); EMBO YIP(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Wellcome Trust Equipment Grant 073228/Z/03/Z and EMBO YIP to A. H. and MRC studentship to A. R. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIGA PSU, 2000, MICRON, P363; ANGARITAJAIMES NC, 2009, CYTOM PART A, P768; Can A, 2003, J MICROSC-OXFORD, V211, P67, DOI 10.1046/j.1365-2818.2003.01195.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CONCHELLO JA, 1995, P 1995 IS T SPIE S E, P138; DIMA A, 2002, IEEE T IM PROC, P790; Falcao AX, 2004, IEEE T PATTERN ANAL, V26, P19, DOI 10.1109/TPAMI.2004.1261076; FORERO MG, 2010, CYTOMETRY A; FORERO MG, 2009, PLOS ONE PUBLIC LIB; Griffiths RL, 2004, EMBO J, V23, P2440, DOI 10.1038/sj.emboj.7600258; Guan YQ, 2008, MICROSC RES TECHNIQ, V71, P146, DOI 10.1002/jemt.20536; GUE M, 2005, CYTOMETRY, P18; Harder N, 2007, I S BIOMED IMAGING, P1044, DOI 10.1109/ISBI.2007.357034; Harder N., 2008, WORKSH BIOIM INF BIO; Kervrann C, 2004, J MICROSC-OXFORD, V214, P297, DOI 10.1111/j.0022-2720.2004.01333.x; Li L, 2000, GENE DEV, V14, P147; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; RODENACKER K, 2001, IMAGE ANAL STEREOL, P556; ROERDINK JBT, 1993, J MICROSCOPY; Shimada T, 2005, PHYSICA A, V350, P144, DOI 10.1016/j.physa.2004.11.033; VINCENT L, 1992, P SPIE IMAGE ALGEBRA, V3; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Wahlby C, 2002, ANAL CELL PATHOL, V24, P101; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wahlby C., 2003, ALGORITHMS APPL DIGI; Wu HX, 2005, J MICROSC-OXFORD, V220, P9, DOI 10.1111/j.1365-2818.2005.01508.x	27	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10557	10.1371/journal.pone.0010557	http://dx.doi.org/10.1371/journal.pone.0010557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479944	Green Submitted, Green Published, gold			2022-12-25	WOS:000277467900013
J	Smith, AJ; Lippiat, JD				Smith, Andrew J.; Lippiat, Jonathan D.			Voltage-dependent charge movement associated with activation of the CLC-5 2Cl(-)/1H(+) exchanger	FASEB JOURNAL			English	Article						chloride channel; chloride transport; gating charge; voltage sensor	CHLORIDE CHANNEL; DENTS-DISEASE; PROKARYOTIC HOMOLOG; MOLECULAR-BASIS; CL-CHANNELS; ANION; ANTIPORTER; MUTATIONS; PROTEINS; MOUSE	The family of CLC proteins comprises both Cl- channels and Cl-/H+ exchange transporters with varying degrees of voltage dependence. The human CLC-5 is an electrogenic voltage-dependent 2Cl(-)/1H(+) exchanger that gives rise to strongly outwardly rectifying currents when expressed. We conducted whole-cell recordings from HEK293 cells transiently transfected with either wild-type CLC-5 or a permeation-deficient mutant, E268A. With E268A CLC-5 we recorded transient voltage-dependent currents that represent the gating currents associated with CLC-5 activation and had kinetics that could be described by voltage-dependent forward and reverse transition rates. In extracellular solutions rich in Cl- or Br-, CLC-5 exhibited a gating charge of 1.3, but this was reduced to 0.9 in solutions comprising the impermeant anions aspartate, methanesulfonate, sulfate, or HEPES. Extracellular ion depletion by local perfusion with isotonic mannitol failed to reduce the gating charge further. Lowering intracellular pH from 7.4 to 5.4 did not shift the voltage-dependence of the gating currents, but reducing and increasing intracellular Cl- shifted the charge-voltage relationship to more negative and positive potentials, respectively. Our data suggest that voltage sensing is an intrinsic property of the CLC-5 protein and that permeant anions, particularly Cl-, modulate a voltage-dependent transition to an activated state from which Cl-/H- exchange can occur.-Smith, A. J., Lippiat, J. D. Voltage-dependent charge movement associated with activation of the CLC-5 2Cl(-)/1H(+) exchanger. FASEB J. 24, 3696-3705 (2010). www.fasebj.org	[Smith, Andrew J.; Lippiat, Jonathan D.] Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Lippiat, JD (corresponding author), Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	j.d.lippiat@leeds.ac.uk		Lippiat, Jonathan/0000-0003-3748-7345	Wellcome Trust [076545/Z/05/Z]; BBSRC [BB/D524875/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study is supported by the Wellcome Trust grant number 076545/Z/05/Z. We thank Dr. Malcolm Hunter (University of Leeds) for helpful discussions during the experimental work and for comments on the manuscript.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; de Santiago JA, 2005, J GEN PHYSIOL, V126, P591, DOI 10.1085/jgp.200509310; DEWEER P, 1988, ANNU REV PHYSIOL, V50, P225, DOI 10.1146/annurev.physiol.50.1.225; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gadsby DC, 2004, NATURE, V427, P795, DOI 10.1038/427795a; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hebeisen S, 2003, BIOPHYS J, V84, P2306, DOI 10.1016/S0006-3495(03)75036-X; Jentsch TJ, 2005, CURR OPIN NEUROBIOL, V15, P319, DOI 10.1016/j.conb.2005.05.002; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Ludewig U, 1997, J GEN PHYSIOL, V110, P165, DOI 10.1085/jgp.110.2.165; Ludwig M, 2005, HUM GENET, V117, P228, DOI 10.1007/s00439-005-1303-2; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Peres A, 2004, NEWS PHYSIOL SCI, V19, P80, DOI 10.1152/nips.01504.2003; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Smith AJ, 2009, AM J PHYSIOL-RENAL, V296, pF390, DOI 10.1152/ajprenal.90526.2008; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	34	34	35	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2010	24	10					3696	3705		10.1096/fj.09-150649	http://dx.doi.org/10.1096/fj.09-150649			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20501796	hybrid, Green Published			2022-12-25	WOS:000285005900010
J	Takahashi, N; Kobayashi, R; Kono, T				Takahashi, Nozomi; Kobayashi, Ryota; Kono, Tomohiro			Restoration of Dlk1 and Rtl1 Is Necessary but Insufficient to Rescue Lethality in Intergenic Differentially Methylated Region (IG-DMR)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPRINTED GENE; STEM-CELLS; MOUSE; MOUSE-CHROMOSOME-12; IDENTIFICATION; PLACENTA; DEFECTS; GENOMES; EMBRYO; DOMAIN	In the Dlk1-Dio3 imprinted domain, an intergenic differentially methylated region (IG-DMR) regulates the parental allele-specific expression of imprinted genes. The maternally inherited deletion of IG-DMR (IG-DMR((-/+))) results in perinatal lethality because of the overexpression of paternally expressed genes and repression of maternally expressed noncoding RNAs (ncRNAs), including Gtl2. To better understand the possible contribution of paternally expressed genes to the lethality, we attempted to rescue the lethality of IG-DMR((-/+)) mutants by restoring the paternally expressed genes. Because the paternally inherited Gtl2 deletion (Gtl2((+/-))) induced a decrease in the expression of paternally expressed genes, we crossed female IG-DMR heterozygous mice and male Gtl2 heterozygous mutant mice. The resultant IG-DMR((-/+))/Gtl2((+/-)) double mutant mice had normal expression levels of paternally expressed genes, and none of them showed perinatal lethality; however, most mice showed postnatal lethality with decreased expression of the maternally expressed ncRNAs. Thus, we inferred that paternally expressed genes are necessary for perinatal survivability and that maternally expressed ncRNAs are involved in postnatal lethality.	[Takahashi, Nozomi; Kobayashi, Ryota; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1560054, Japan	Tokyo University of Agriculture	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1560054, Japan.	tomohiro@nodai.ac.jp	liang, yan/H-3894-2011		Ministry of Education, Science, Culture and Sports of Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research on Priority Area and for Scientific Research A from the Ministry of Education, Science, Culture and Sports of Japan (to T. K.).	Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Hatada I, 2001, J BIOCHEM, V130, P187, DOI 10.1093/oxfordjournals.jbchem.a002971; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Schmidt JV, 2000, GENE DEV, V14, P1997; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X	23	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26121	26125		10.1074/jbc.M109.075325	http://dx.doi.org/10.1074/jbc.M109.075325			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20511218	Green Published, hybrid			2022-12-25	WOS:000280921000029
J	Bong, SM; Kwak, GH; Moon, JH; Lee, KS; Kim, HS; Kim, HY; Chi, YM				Bong, Seoung Min; Kwak, Geun-Hee; Moon, Jin Ho; Lee, Ki Seog; Kim, Hong Seok; Kim, Hwa-Young; Chi, Young Min			Structural and Kinetic Analysis of Free Methionine-R-sulfoxide Reductase from Staphylococcus aureus CONFORMATIONAL CHANGES DURING CATALYSIS AND IMPLICATIONS FOR THE CATALYTIC AND INHIBITORY MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE METHIONINE-(R)-SULFOXIDE REDUCTASE; ALZHEIMERS-DISEASE; MOLECULAR-GRAPHICS; GAF DOMAIN; OXIDATION; PEPTIDE; PROTEIN; VIRULENCE; EXPRESSION; REVEALS	Free methionine-R-sulfoxide reductase (fRMsr) reduces free methionine R-sulfoxide back to methionine, but its catalytic mechanism is poorly understood. Here, we have determined the crystal structures of the reduced, substrate-bound, and oxidized forms of fRMsr from Staphylococcus aureus. Our structural and biochemical analyses suggest the catalytic mechanism of fRMsr in which Cys(102) functions as the catalytic residue and Cys(68) as the resolving Cys that forms a disulfide bond with Cys(102).Cys(78), previously thought to be a catalytic Cys, is a non-essential residue for catalytic function. Additionally, our structures provide insights into the enzyme-substrate interaction and the role of active site residues in substrate binding. Structural comparison reveals that conformational changes occur in the active site during catalysis, particularly in the loop of residues 97-106 containing the catalytic Cys(102). We have also crystallized a complex between fRMsr and isopropyl alcohol, which acts as a competitive inhibitor for the enzyme. This isopropyl alcohol-bound structure helps us to understand the inhibitory mechanism of fRMsr. Our structural and enzymatic analyses suggest that a branched methyl group in alcohol seems important for competitive inhibition of the fRMsr due to its ability to bind to the active site.	[Kwak, Geun-Hee; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea; [Bong, Seoung Min; Chi, Young Min] Korea Univ, Coll Life Sci, Div Biotechnol, Seoul 136713, South Korea; [Moon, Jin Ho] Korea Univ, Inst Life Sci & Nat Resources, Seoul 136713, South Korea; [Lee, Ki Seog] Catholic Univ Pusan, Coll Hlth Sci, Dept Clin Lab Sci, Pusan 609757, South Korea; [Kim, Hong Seok] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Yeungnam University; Korea University; Korea University; Catholic University Pusan; University of Texas System; University of Texas Health San Antonio	Kim, HY (corresponding author), Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea.	hykim@ynu.ac.kr; ezeg@korea.ac.kr			Korea University [2009]; Ministry for Health, Welfare, and Family Affairs [A090181]	Korea University; Ministry for Health, Welfare, and Family Affairs	This work was supported by a Korea University Grant 2009 (to Y. M. C.) and by Korea Healthcare Technology R&D Project (Ministry for Health, Welfare, and Family Affairs) Grant A090181 (to H. -Y. K.).	Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Bong SM, 2009, ACTA CRYSTALLOGR F, V65, P1120, DOI 10.1107/S1744309109037105; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwak GH, 2010, BIOCHEM BIOPH RES CO, V395, P412, DOI 10.1016/j.bbrc.2010.04.036; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Minniti AN, 2009, AGING CELL, V8, P690, DOI 10.1111/j.1474-9726.2009.00521.x; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	36	10	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25044	25052		10.1074/jbc.M110.103119	http://dx.doi.org/10.1074/jbc.M110.103119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20504774	Green Published, hybrid			2022-12-25	WOS:000280542100077
J	Lucas, JT; Salimath, BP; Slomiany, MG; Rosenzweig, SA				Lucas, J. T., Jr.; Salimath, B. P.; Slomiany, M. G.; Rosenzweig, S. A.			Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent	ONCOGENE			English	Article						VEGF; invadopodia; cell migration; invasion; HEF1; NEDD9	SQUAMOUS-CELL CARCINOMA; FOCAL ADHESION KINASE; EXTRACELLULAR-MATRIX DEGRADATION; BREAST-CANCER METASTASIS; TYROSINE PHOSPHORYLATION; NECK-CANCER; 11Q13 AMPLIFICATION; FACTOR RECEPTOR; HEAD; CORTACTIN	We previously reported a vascular endothelial growth factor (VEGF) autocrine loop in head and neck squamous cell carcinoma (HNSCC) cell lines, supporting a role for VEGF in HNSCC tumorigenesis. Using a phosphotyrosine proteomics approach, we screened the HNSCC cell line, squamous cell carcinoma-9 for effectors of VEGFR2 signaling. A cluster of proteins involved in cell migration and invasion, including the p130Cas paralog, human enhancer of filamentation 1 (HEF1/Cas-L/Nedd9) was identified. HEF1 silencing and overexpression studies revealed a role for VEGF in regulating cell migration, invasion and matrix metalloproteinase (MMP) expression in a HEF1-dependent manner. Moreover, cells plated on extracellular matrix-coated coverslips showed enhanced invadopodia formation in response to VEGF that was HEF1-dependent. Immunolocalization revealed that HEF1 colocalized to invadopodia with MT1-MMP. Analysis of HNSCC tissue microarrays for HEF1 immunoreactivity revealed a 6.5-fold increase in the odds of having a metastasis with a high HEF1 score compared with a low HEF1 score. These findings suggest that HEF1 may be prognostic for advanced stage HNSCC. They also show for the first time that HEF1 is required for VEGF-mediated HNSCC cell migration and invasion, consistent with HEF1's recent identification as a metastatic regulator. These results support a strategy targeting VEGF: VEGFR2 in HNSCC therapeutics. Oncogene (2010) 29, 4449-4459; doi: 10.1038/onc.2010.185; published online 24 May 2010	[Lucas, J. T., Jr.; Salimath, B. P.; Rosenzweig, S. A.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Slomiany, M. G.] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Rosenzweig, S. A.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Rosenzweig, SA (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, 173 Ashley Ave,MSC 505, Charleston, SC 29425 USA.	rosenzsa@musc.edu	Lucas, John T./K-5243-2013; Rosenzweig, Steven A/O-5062-2018	Lucas, John T./0000-0002-4139-4160; Rosenzweig, Steven/0000-0002-7022-6086	MUSC; PhRMA Foundation; Abney Foundation; Southeastern Pre-Doctoral Training in Clinical Research [T32]; NIH [CA78887, CA134845]; DOD [N6311601MD10004]; American Health Assistance Foundation; NATIONAL CANCER INSTITUTE [R01CA078887, R55CA078887, P30CA138313, R01CA134845] Funding Source: NIH RePORTER	MUSC; PhRMA Foundation; Abney Foundation; Southeastern Pre-Doctoral Training in Clinical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Amanda M Brock for excellent technical assistance, Jennifer Bethard and Dr Kevin Schey (MUSC Mass Spectrometry Facility), the HCC Cell and Molecular Imaging Shared Resource, the HCC Tissue Biorepository and Dr Elizabeth Garrett-Mayer, Director (HCC Biostatistics Shared Resource) for aid and consultations. We are indebted to Drs Terry Day and M Boyd Gillespie for human specimens and Drs Silvio Gutkind and Alfredo Molinolo (NIDCR) for tissue microarrays. This work was supported by a MUSC Summer Health Research Fellowship, a Paul Calabresi Fellowship (PhRMA Foundation), an Abney Foundation Award, the Southeastern Pre-Doctoral Training in Clinical Research T32 (JTL), NIH grants CA78887 and CA134845 (SAR), DOD award (N6311601MD10004) to HCC and the American Health Assistance Foundation (SAR). Portions of this work were presented at the Annual Meeting of the AACR, 2008, San Diego, CA, USA and the Annual Meeting of the Endocrine Society, 2008, San Francisco, CA, USA.	Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Bachelder RE, 2003, CANCER RES, V63, P5230; Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; Bigbee WL, 2007, CLIN CANCER RES, V13, P3107, DOI 10.1158/1078-0432.CCR-07-0746; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Canel M, 2006, CLIN CANCER RES, V12, P3272, DOI 10.1158/1078-0432.CCR-05-1583; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Cooney MM, 2005, CANCER CHEMOTH PHARM, V55, P295, DOI 10.1007/s00280-004-0871-5; Descamps FJ, 2002, LAB INVEST, V82, P1607, DOI 10.1097/01.LAB.0000038556.54069.73; Fashena SJ, 2002, J CELL SCI, V115, P99; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kratchmarova I, 2002, MOL CELL PROTEOMICS, V1, P213, DOI 10.1074/mcp.M200006-MCP200; Kyzas PA, 2005, MODERN PATHOL, V18, P485, DOI 10.1038/modpathol.3800295; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Michi Y, 2000, ORAL ONCOL, V36, P81, DOI 10.1016/S1368-8375(99)00059-7; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Mon NN, 2006, ANN NY ACAD SCI, V1086, P199, DOI 10.1196/annals.1377.019; Nakamoto T, 2000, MOL CELL BIOL, V20, P1649, DOI 10.1128/MCB.20.5.1649-1658.2000; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Patel AM, 1996, ONCOGENE, V12, P31; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Ries L, 2004, SEER CANC STAT REV 1; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Singh MK, 2008, MOL BIOL CELL, V19, P1627, DOI 10.1091/mbc.E07-09-0953; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sloan EK, 2002, CELL MOL LIFE SCI, V59, P1491, DOI 10.1007/s00018-002-8524-5; Slomiany MG, 2007, CANCER LETT, V248, P269, DOI 10.1016/j.canlet.2006.08.004; Slomiany MG, 2006, BIOCHEM BIOPH RES CO, V342, P851, DOI 10.1016/j.bbrc.2006.02.043; Steen H, 2002, J BIOL CHEM, V277, P1031, DOI 10.1074/jbc.M109992200; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Timpson P, 2005, CANCER RES, V65, P3273, DOI 10.1158/0008-5472.CAN-04-2118; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; WEAVER AM, 2008, CANC LETT, V265, P15912; Yu YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003215	58	57	58	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2010	29	31					4449	4459		10.1038/onc.2010.185	http://dx.doi.org/10.1038/onc.2010.185			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	634DG	20498643	Green Accepted			2022-12-25	WOS:000280559100008
J	Chai, GL; Ma, CX; Bao, K; Zheng, LA; Wang, XQ; Sun, ZR; Salo, E; Adell, T; Wu, W				Chai, Guoliang; Ma, Changxin; Bao, Kai; Zheng, Liang; Wang, Xinquan; Sun, Zhirong; Salo, Emili; Adell, Teresa; Wu, Wei			Complete Functional Segregation of Planarian beta-Catenin-1 and-2 in Mediating Wnt Signaling and Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; CRYSTAL-STRUCTURE; PROTEIN INTERACTIONS; ACTIN-BINDING; REGENERATION; PLAKOGLOBIN; ARMADILLO; DISTINCT; PHOSPHORYLATION; MAINTENANCE	beta-Catenin is a bifunctional protein participating in both cell adhesion and canonical Wnt signaling. In cell adhesion, it bridges the transmembrane cadherin and the actin-binding protein alpha-catenin and is essential for adherens junction formation, whereas in canonical Wnt signaling, it shuttles between the cytosol and nucleus and functions as an essential transcriptional activator. Schmidtea mediterranea beta-catenin-1 was identified as a determinant of antero-posterior polarity during body regeneration by mediating Wnt signaling. Here we show that S. mediterranea beta-catenin-2 is specifically expressed in epithelial cells in the gut and pharynx, where it has a putative role in mediating cell adhesion. We show evidence that planarian beta-catenin-1 and -2 have distinct biochemical properties. beta-Catenin-1 can interact with the components of the canonical Wnt signaling pathway but not with alpha-catenin, whereas beta-catenin-2 interacts with cell adhesion molecules, including E-cadherin and alpha-catenin, but not with Wnt signaling components. Consistent with their specific function, beta-catenin-1 is a potent transcriptional activator, whereas beta-catenin-2 has no transcriptional activity. Protein sequence alignment also indicates that the planarian beta-catenin-1 and -2 retain distinct critical residues and motifs, which are in agreement with the differences in their biochemical properties. At last, phylogenetic analysis reveals a probable Platyhelminthes-specific structural and functional segregation from which the monofunctional beta-catenins evolved. Our results thus identify the first two monofunctional beta-catenins in metazoans.	[Salo, Emili; Adell, Teresa] Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain; [Salo, Emili; Adell, Teresa] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain; [Wu, Wei] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Bao, Kai; Sun, Zhirong] Tsinghua Univ, Minist Educ, Bioinformat Lab, Sch Life Sci, Beijing 100084, Peoples R China	University of Barcelona; University of Barcelona; Tsinghua University; Chinese Academy of Sciences; Tsinghua University	Adell, T (corresponding author), Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain.	tadellc@ub.edu; wwu@mail.tsinghua.edu.cn	Salo, Emili/M-3928-2014; Creixell, Teresa Adell/C-5100-2017	Salo, Emili/0000-0001-5460-9223; Creixell, Teresa Adell/0000-0002-5446-1510; Chai, Guoliang/0000-0001-9658-6381	National Natural Science Foundation of China [30670225]; Major Science Programs of China [2006CB943402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science Programs of China	This work was supported by National Natural Science Foundation of China Grant 30670225 and Major Science Programs of China Grant 2006CB943402 (to W. W.).	Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; BUTZ S, 1992, SCIENCE, V257, P1142, DOI 10.1126/science.257.5073.1142-a; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Hartz DT, 1999, AM J DRUG ALCOHOL AB, V25, P207, DOI 10.1081/ADA-100101856; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kobayashi C, 2007, DEV BIOL, V306, P714, DOI 10.1016/j.ydbio.2007.04.010; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Molina MD, 2007, DEV BIOL, V311, P79, DOI 10.1016/j.ydbio.2007.08.019; Natarajan L, 2001, GENETICS, V159, P159; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021	40	24	27	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24120	24130		10.1074/jbc.M110.113662	http://dx.doi.org/10.1074/jbc.M110.113662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511647	Green Published, hybrid			2022-12-25	WOS:000280291400062
J	Tonic, I; Yu, WN; Park, Y; Chen, CC; Hay, N				Tonic, Ivana; Yu, Wan-Ni; Park, Youngku; Chen, Chia-Chen; Hay, Nissim			Akt Activation Emulates Chk1 Inhibition and Bcl2 Overexpression and Abrogates G2 Cell Cycle Checkpoint by Inhibiting BRCA1 Foci	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; KINASE; COMPLEX; 3-KINASE/AKT; SENESCENCE; PATHWAY; REPAIR	Akt is perhaps the most frequently activated oncoprotein in human cancers. Overriding cell cycle checkpoint in combination with the inhibition of apoptosis are two principal requirements for predisposition to cancer. Here we show that the activation of Akt is sufficient to promote these two principal processes, by inhibiting Chk1 activation with concomitant inhibition of apoptosis. These activities of Akt cannot be recapitulated by the knockdown of Chk1 alone or by overexpression of Bcl2. Rather the combination of Chk1 knockdown and Bcl2 overexpression is required to recapitulate Akt activities. Akt was shown to directly phosphorylate Chk1. However, we found that Chk1 mutants in the Akt phosphorylation sites behave like wildtype Chk1 in mediating G2 arrest, suggesting that the phosphorylation of Chk1 by Akt is either dispensable for Chk1 activity or insufficient by itself to exert an effect on Chk1 activity. Here we report a new mechanism by which Akt affects G2 cell cycle arrest. We show that Akt inhibits BRCA1 function that induces G2 cell cycle arrest. Akt prevents the translocation of BRCA1 to DNA damage foci and, thereby, inhibiting the activation of Chk1 following DNA damage.	[Hay, Nissim] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hay, N (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, M-C 669,900 S Ashland Ave, Chicago, IL 60607 USA.	nhay@uic.edu			National Institutes of Health [CA090764, AG016927, AG025953]; ACS-IL [06-24]; NATIONAL CANCER INSTITUTE [R01CA090764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016927, R01AG025953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS-IL; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090764, AG016927, and AG025953 (to N.H.) and by ACS-IL 06-24 (to Y.P.).	Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Altiok S, 1999, J BIOL CHEM, V274, P32274, DOI 10.1074/jbc.274.45.32274; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUEN MS, 2009, NAT REV MOL CELL BIO, V11, P529; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; King FW, 2004, CELL CYCLE, V3, P634; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; PERRY ME, 1993, CURR OPIN GENET DEV, V3, P50, DOI 10.1016/S0959-437X(05)80340-5; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Solyom S, 2010, BREAST CANCER RES TR, V120, P165, DOI 10.1007/s10549-009-0453-7; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Yamane K, 2007, CANCER RES, V67, P6286, DOI 10.1158/0008-5472.CAN-06-2205; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	34	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23790	23798		10.1074/jbc.M110.104372	http://dx.doi.org/10.1074/jbc.M110.104372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20495005	hybrid, Green Published			2022-12-25	WOS:000280291400029
J	Auton, M; Sowa, KE; Smith, SM; Sedlak, E; Vijayan, KV; Cruz, MA				Auton, Matthew; Sowa, Katie E.; Smith, Scott M.; Sedlak, Erik; Vijayan, K. Vinod; Cruz, Miguel A.			Destabilization of the A1 Domain in von Willebrand Factor Dissociates the A1A2A3 Tri-domain and Provokes Spontaneous Binding to Glycoprotein Ib alpha and Platelet Activation under Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VONWILLEBRAND-FACTOR BINDING; CONFORMATIONAL-CHANGE; ADAMTS-13 ACTIVITY; A2 DOMAIN; ADHESION; COLLAGEN; 2B; IDENTIFICATION; AGGREGATION; STABILITY	This study used recombinant A1A2A3 tri-domain proteins to demonstrate that A domain association in von Willebrand factor (VWF) regulates the binding to platelet glycoprotein Ib alpha (GPIb alpha). We performed comparative studies between wild type (WT) A1 domain and the R1450E variant that dissociates the tri-domain complex by destabilizing the A1 domain. Using urea denaturation and differential scanning calorimetry, we demonstrated the destabilization of the A1 domain structure concomitantly results in a reduced interaction among the three A domains. This dissociation results in spontaneous binding of R1450E to GPIb alpha without ristocetin with an apparent K-D of 85 +/- 34 nM, comparable with that of WT (36 +/- 12 nM) with ristocetin. The mutant blocked 100% ristocetin-induced platelet agglutination, whereas WT failed to inhibit. The mutant enhanced shear-induced platelet aggregation at 500 and 5000 s(-1) shear rates, reaching 42 and 66%, respectively. Shear-induced platelet aggregation did not exceed 18% in the presence of WT. A1A2A3 variants were added before perfusion over a fibrin(ogen)-coated surface. At 1500 s(-1), platelets from blood containing WT adhered <10% of the surface area, whereas the mutant induced platelets to rapidly bind, covering 100% of the fibrin(ogen) surface area. Comparable results were obtained with multimeric VWF when ristocetin (0.5 mg/ml) was added to blood before perfusion. EDTA or antibodies against GPIb alpha and alpha IIb beta 3 blocked the effect of the mutant and ristocetin on platelet activation/adhesion. Therefore, the termination of A domain association within VWF in solution results in binding to GPIba and platelet activation under high shear stress.	[Auton, Matthew; Sowa, Katie E.; Smith, Scott M.; Sedlak, Erik; Vijayan, K. Vinod; Cruz, Miguel A.] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Cruz, MA (corresponding author), Baylor Coll Med, Thrombosis Res Sect, Dept Med, 1 Baylor Plaza,N1319, Houston, TX 77030 USA.	miguelc@bcm.tmc.edu	Auton, Matthew/A-2960-2008	Auton, Matthew/0000-0002-4446-6932; Sedlak, Erik/0000-0003-1290-5774	National Institutes of Health [HL72886]; Mary R. Gibson Foundation; Alkek Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary R. Gibson Foundation; Alkek Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL72886 (to M. A. C.). This work was also supported by the Mary R. Gibson Foundation and Alkek Foundation.	Ajzenberg N, 2000, BLOOD, V95, P3796; Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; Auton M, 2009, BIOPHYS J, V97, P618, DOI 10.1016/j.bpj.2009.05.009; AZUMA H, 1993, THROMB HAEMOSTASIS, V69, P192; Borthakur G, 2003, J THROMB HAEMOST, V1, P1288, DOI 10.1046/j.1538-7836.2003.00156.x; CHOW TW, 1992, BLOOD, V80, P113; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; Cruz MA, 2005, BLOOD, V105, P1986, DOI 10.1182/blood-2004-04-1365; Cruz MA, 2003, THROMB HAEMOSTASIS, V90, P1204, DOI 10.1160/TH03-06-0398; CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822; de Romeuf C, 1998, THROMB HAEMOSTASIS, V79, P211; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; ENDENBURG SC, 1995, BLOOD, V86, P4158, DOI 10.1182/blood.V86.11.4158.bloodjournal86114158; ENDENBURG SC, 1993, BLOOD COAGUL FIBRIN, V4, P139, DOI 10.1097/00001721-199304010-00024; Federici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280; Gardiner EE, 2010, PLATELETS, V21, P244, DOI 10.3109/09537101003695339; Goto S, 1998, J CLIN INVEST, V101, P479, DOI 10.1172/JCI973; IKEDA Y, 1993, THROMB HAEMOSTASIS, V69, P496; Keuren JFW, 2004, BLOOD, V103, P1741, DOI 10.1182/blood-2003-07-2267; Lankhof H, 1996, THROMB HAEMOSTASIS, V75, P950; Lyubarev AE, 1998, BIOCHEMISTRY-MOSCOW+, V63, P434; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; Mazzucato M, 1999, J BIOL CHEM, V274, P3033, DOI 10.1074/jbc.274.5.3033; Mazzucato M, 2002, BLOOD, V100, P2793, DOI 10.1182/blood-2002-02-0514; Miura S, 1999, BRIT J HAEMATOL, V105, P1092, DOI 10.1046/j.1365-2141.1999.01454.x; MOHRI H, 1989, J BIOL CHEM, V264, P17361; MOHRI H, 1988, J BIOL CHEM, V263, P17901; Morales LD, 2006, J THROMB HAEMOST, V4, P417, DOI 10.1111/j.1538-7836.2006.01742.x; Nakayama T, 2002, J BIOL CHEM, V277, P22063, DOI 10.1074/jbc.M201327200; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Sedlak E, 2008, BIOPHYS J, V94, P1384, DOI 10.1529/biophysj.107.113696; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; SHELTONINLOES BB, 1986, BIOCHEMISTRY-US, V25, P3164, DOI 10.1021/bi00359a014; Tsai HM, 1997, BLOOD, V89, P1954, DOI 10.1182/blood.V89.6.1954; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Whitelock JL, 2004, J THROMB HAEMOST, V2, P485, DOI 10.1111/j.1538-7836.2004.00601.x; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zaidi TN, 1996, BLOOD, V88, P2967, DOI 10.1182/blood.V88.8.2967.bloodjournal8882967; Zhang JN, 2003, THROMB HAEMOSTASIS, V90, P672, DOI 10.1160/TH03-03-0145; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106	42	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22829	22837		10.1074/jbc.M110.103358	http://dx.doi.org/10.1074/jbc.M110.103358			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498367	hybrid, Green Published			2022-12-25	WOS:000279999900015
J	Lacal, J; Alfonso, C; Liu, XX; Parales, RE; Morel, B; Conejero-Lara, F; Rivas, G; Duque, E; Ramos, JL; Krell, T				Lacal, Jesus; Alfonso, Carlos; Liu, Xianxian; Parales, Rebecca E.; Morel, Bertrand; Conejero-Lara, Francisco; Rivas, German; Duque, Estrella; Ramos, Juan L.; Krell, Tino			Identification of a Chemoreceptor for Tricarboxylic Acid Cycle Intermediates DIFFERENTIAL CHEMOTACTIC RESPONSE TOWARDS RECEPTOR LIGANDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC-ACIDS; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; BINDING DOMAIN; RHIZOSPHERE; CLONING; CITRATE; COLONIZATION; PREDICTION	We report the identification of McpS as the specific chemoreceptor for 6 tricarboxylic acid (TCA) cycle intermediates and butyrate in Pseudomonas putida. The analysis of the bacterial mutant deficient in mcpS and complementation assays demonstrate that McpS is the only chemoreceptor of TCA cycle intermediates in the strain under study. TCA cycle intermediates are abundantly present in root exudates, and taxis toward these compounds is proposed to facilitate the access to carbon sources. McpS has an unusually large ligand-binding domain (LBD) that is un-annotated in InterPro and is predicted to contain 6 helices. The ligand profile of McpS was determined by isothermal titration calorimetry of purified recombinant LBD (McpS-LBD). McpS recognizes TCA cycle intermediates but does not bind very close structural homologues and derivatives like maleate, aspartate, or tricarballylate. This implies that functional similarity of ligands, such as being part of the same pathway, and not structural similarity is the primary element, which has driven the evolution of receptor specificity. The magnitude of chemotactic responses toward these 7 chemoattractants, as determined by qualitative and quantitative chemotaxis assays, differed largely. Ligands that cause a strong chemotactic response (malate, succinate, and fumarate) were found by differential scanning calorimetry to increase significantly the midpoint of protein unfolding (T-m) and unfolding enthalpy (Delta H) of McpS-LBD. Equilibrium sedimentation studies show that malate, the chemoattractant that causes the strongest chemotactic response, stabilizes the dimeric state of McpS-LBD. In this respect clear parallels exist to the Tar receptor and other eukaryotic receptors, which are discussed.	[Lacal, Jesus; Duque, Estrella; Ramos, Juan L.; Krell, Tino] CSIC, Estn Expt Zaidin, Environm Protect Dept, E-18008 Granada, Spain; [Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Liu, Xianxian; Parales, Rebecca E.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Morel, Bertrand; Conejero-Lara, Francisco] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; [Morel, Bertrand; Conejero-Lara, Francisco] Univ Granada, Fac Ciencias, Inst Biotecnol, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of California System; University of California Davis; University of Granada; University of Granada	Krell, T (corresponding author), CSIC, Estn Expt Zaidin, Environm Protect Dept, Prof Albareda 1, E-18008 Granada, Spain.	tino.krell@eez.csic.es	Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Lacal Romero, Jesus/G-8041-2015; Lara, Francisco Conejero/F-2962-2016; Lacal, Jesus/B-1511-2019; Krell, Tino/G-7296-2015	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Lacal Romero, Jesus/0000-0002-2751-7291; Lara, Francisco Conejero/0000-0002-8282-2168; Lacal, Jesus/0000-0002-2751-7291; Krell, Tino/0000-0002-9040-3166; Morel, Bertrand/0000-0002-2708-8589; Ramos, Juan L./0000-0002-8731-7435; Duque, Estrella/0000-0002-4857-8974	Spanish Ministry of Science and Education [CICYT BIO-2006-05668, BFU 2005-0487-C02-02, CSD 2007-00010, BIO2008-04478-C03-03]; Junta de Andalucia [CIV344, CIV1912, P09-RNM-4509]; BBVA foundation	Spanish Ministry of Science and Education(Spanish Government); Junta de Andalucia(Junta de Andalucia); BBVA foundation(BBVA Foundation)	This work was supported by Spanish Ministry of Science and Education Grants CICYT BIO-2006-05668, BFU 2005-0487-C02-02, CSD 2007-00010, and BIO2008-04478-C03-03, Junta de Andalucia Grant CIV344 (to J.L.R.), CIV1912 and P09-RNM-4509 (to T. K.), and the BBVA foundation.	Alvarez-Ortega C, 2007, APPL ENVIRON MICROB, V73, P7793, DOI 10.1128/AEM.01898-07; Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; BIEMANN HP, 1994, BIOCHEMISTRY-US, V33, P629, DOI 10.1021/bi00169a002; Bjorkman AM, 2001, J BIOL CHEM, V276, P2808, DOI 10.1074/jbc.M009593200; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; Busch A, 2007, P NATL ACAD SCI USA, V104, P13774, DOI 10.1073/pnas.0701547104; Chaudhry C, 2009, P NATL ACAD SCI USA, V106, P12329, DOI 10.1073/pnas.0904175106; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; DUQUE E, 2007, PSEUDOMONAS, V5; Garcia JAL, 2001, PHYTOCHEM ANALYSIS, V12, P305, DOI 10.1002/pca.596; Guazzaroni ME, 2007, J BIOL CHEM, V282, P16308, DOI 10.1074/jbc.M610032200; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; HUGDAHL MB, 1988, INFECT IMMUN, V56, P1560, DOI 10.1128/IAI.56.6.1560-1566.1988; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; JOHNSON JF, 1994, PLANT PHYSIOL, V85, P315; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Kato J, 2008, J BIOSCI BIOENG, V106, P1, DOI 10.1263/jbb.106.1; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Levit MN, 2002, J BIOL CHEM, V277, P36760, DOI 10.1074/jbc.M204325200; Liao H, 2006, PLANT PHYSIOL, V141, P674, DOI 10.1104/pp.105.076497; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; LIPTON DS, 1987, PLANT PHYSIOL, V85, P315, DOI 10.1104/pp.85.2.315; Liu XX, 2009, J BACTERIOL, V191, P2909, DOI 10.1128/JB.01708-08; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; MILLIGAN DL, 1993, J BIOL CHEM, V268, P19991; MINTON AP, 1996, MODERN ANAL ULTRACEN, P81; Molina L, 2000, SOIL BIOL BIOCHEM, V32, P315, DOI 10.1016/S0038-0717(99)00156-X; Murphy OJ, 2001, BIOCHEMISTRY-US, V40, P1358, DOI 10.1021/bi0015109; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Ottemann KM, 1998, BIOCHEMISTRY-US, V37, P7062, DOI 10.1021/bi980305e; Parales RE, 2000, APPL ENVIRON MICROB, V66, P4098, DOI 10.1128/AEM.66.9.4098-4104.2000; REINHOLD B, 1985, J BACTERIOL, V162, P190, DOI 10.1128/JB.162.1.190-195.1985; ROBINSON JB, 1993, J BACTERIOL, V175, P2284, DOI 10.1128/JB.175.8.2284-2291.1993; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Spink CH, 2008, METHOD CELL BIOL, V84, P115, DOI 10.1010/S0091-679X(07)84005-2; Stock J, 1996, CURR BIOL, V6, P825, DOI 10.1016/S0960-9822(02)00605-X; Tikhonov D B, 2009, Neurosci Behav Physiol, V39, P763, DOI 10.1007/s11055-009-9195-6; Ulrich LE, 2005, BIOINFORMATICS, V21, P45, DOI 10.1093/bioinformatics/bti1204; Vaknin A, 2008, J MOL BIOL, V382, P573, DOI 10.1016/j.jmb.2008.07.026; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Vilchez S, 2000, J BACTERIOL, V182, P91, DOI 10.1128/JB.182.1.91-99.2000; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Warner JB, 2002, MICROBIOL-SGM, V148, P3405, DOI 10.1099/00221287-148-11-3405; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; YAMAMOTO K, 1993, P NATL ACAD SCI USA, V90, P217, DOI 10.1073/pnas.90.1.217; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Yu EW, 2001, P NATL ACAD SCI USA, V98, P9517, DOI 10.1073/pnas.161239298; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002; Zhulin IB, 2003, J BACTERIOL, V185, P285, DOI 10.1128/JB.185.1.285-294.2003; Zhulin IB, 2001, ADV MICROB PHYSIOL, V45, P157, DOI 10.1016/S0065-2911(01)45004-1	58	77	79	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23124	23134		10.1074/jbc.M110.110403	http://dx.doi.org/10.1074/jbc.M110.110403			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498372	Green Published, hybrid			2022-12-25	WOS:000279999900047
J	Basu, D; Nguyen, TTK; Montone, KT; Zhang, G; Wang, LP; Diehl, JA; Rustgi, AK; Lee, JT; Weinstein, GS; Herlyn, M				Basu, D.; Nguyen, T-T K.; Montone, K. T.; Zhang, G.; Wang, L-P; Diehl, J. A.; Rustgi, A. K.; Lee, J. T.; Weinstein, G. S.; Herlyn, M.			Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity	ONCOGENE			English	Article						epithelial to mesenchymal transition; squamous cell carcinoma; head and neck; chemotherapy resistance; tumor heterogeneity	CANCER CELLS; TRANSITION PHENOTYPE; ACQUIRED-RESISTANCE; EGFR INHIBITORS; COPY NUMBER; HEAD; SENSITIVITY; SNAIL; LINES; EXPRESSION	Variable drug responses among malignant cells within individual tumors may represent a barrier to their eradication using chemotherapy. Carcinoma cells expressing mesenchymal markers resist conventional and epidermal growth factor receptor (EGFR)-targeted chemotherapy. In this study, we evaluated whether mesenchymal-like sub-populations within human squamous cell carcinomas (SCCs) with predominantly epithelial features contribute to overall therapy resistance. We identified a mesenchymal-like subset expressing low E-cadherin (Ecad-lo) and high vimentin within the upper aerodigestive tract SCCs. This subset was both isolated from the cell lines and was identified in xenografts and primary clinical specimens. The Ecad-lo subset contained more low-turnover cells, correlating with resistance to the conventional chemotherapeutic paclitaxel in vitro. Epidermal growth factor induced less stimulation of the mitogen-activated protein kinase and phosphatidylinositol-3-kinase pathways in Ecad-lo cells, which was likely due to lower EGFR expression in this subset and correlated with in vivo resistance to the EGFR-targeted antibody, cetuximab. The Ecad-lo and high E-cadherin subsets were dynamic in phenotype, showing the capacity to repopulate each other from single-cell clones. Taken together, these results provide evidence for a low-turnover, mesenchymal-like sub-population in SCCs with diminished EGFR pathway function and intrinsic resistance to conventional and EGFR-targeted chemotherapies. Oncogene ( 2010) 29, 4170-4182; doi: 10.1038/onc.2010.170; published online 24 May 2010	[Basu, D.; Nguyen, T-T K.; Zhang, G.; Lee, J. T.; Herlyn, M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Basu, D.; Weinstein, G. S.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Basu, D.] Vet Adm Med Ctr, Philadelphia, PA 19104 USA; [Montone, K. T.; Wang, L-P] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Diehl, J. A.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Rustgi, A. K.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Basu, D (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	devraj.basu@uphs.upenn.edu; herlynm@wistar.org	Zhang, Gao/D-3471-2017		NIH [NCI P01 CA098101]; Wistar Cancer Center [P30 CA10815]; American Cancer Society [IRG-78-002-30]; Philadelphia VA Medical Center; NATIONAL CANCER INSTITUTE [P01CA098101, P30CA010815, P30CA016520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar Cancer Center; American Cancer Society(American Cancer Society); Philadelphia VA Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Fredrick Keeny in the Wistar Institute Microscopy Core for assistance with digital image processing and Ademi Santiago-Walker, PhD for critical review of the paper. This work is supported by grants from the NIH (NCI P01 CA098101 to M Herlyn, A Rustgi and D Basu), the Wistar Cancer Center Core Grant (P30 CA10815), and the American Cancer Society (IRG-78-002-30 to D Basu). This work is also supported in part with resources and use of facilities at the Philadelphia VA Medical Center.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bianco R, 2005, ENDOCR-RELAT CANCER, V12, pS159, DOI 10.1677/erc.1.00999; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Cooper JB, 2009, HEAD NECK-J SCI SPEC, V31, P1086, DOI 10.1002/hed.21109; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Ghoul A, 2009, CANCER RES, V69, P4260, DOI 10.1158/0008-5472.CAN-08-2837; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Haddad Y, 2009, CLIN CANCER RES, V15, P532, DOI 10.1158/1078-0432.CCR-08-1733; Herbst RS, 2005, J CLIN ONCOL, V23, P5578, DOI 10.1200/JCO.2005.07.120; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kawaguchi Y, 2007, BRIT J CANCER, V97, P494, DOI 10.1038/sj.bjc.6603885; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; MANCANIELLO D, 2008, CURR PROTOC CYTOM, P168; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Opitz OG, 1998, J BIOL CHEM, V273, P23912, DOI 10.1074/jbc.273.37.23912; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shrader M, 2007, MOL CANCER THER, V6, P277, DOI 10.1158/1535-7163.MCT-06-0513; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strauss R, 2009, CANCER RES, V69, P5115, DOI 10.1158/0008-5472.CAN-09-0645; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Temam S, 2007, J CLIN ONCOL, V25, P2164, DOI 10.1200/JCO.2006.06.6605; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	47	43	45	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2010	29	29					4170	4182		10.1038/onc.2010.170	http://dx.doi.org/10.1038/onc.2010.170			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20498638	Green Accepted			2022-12-25	WOS:000280151500005
J	Douw, L; de Groot, M; van Dellen, E; Heimans, JJ; Ronner, HE; Stam, CJ; Reijneveld, JC				Douw, Linda; de Groot, Marjolein; van Dellen, Edwin; Heimans, Jan J.; Ronner, Hanneke E.; Stam, Cornelis J.; Reijneveld, Jaap C.			'Functional Connectivity' Is a Sensitive Predictor of Epilepsy Diagnosis after the First Seizure	PLOS ONE			English	Article							GENERALIZED SYNCHRONIZATION; EEG; ABNORMALITIES; MAGNETOENCEPHALOGRAPHY; LIKELIHOOD; DISEASE	Background: Although epilepsy affects almost 1% of the world population, diagnosis of this debilitating disease is still difficult. The EEG is an important tool for epilepsy diagnosis and classification, but the sensitivity of interictal epileptiform discharges (IEDs) on the first EEG is only 30-50%. Here we investigate whether using 'functional connectivity' can improve the diagnostic sensitivity of the first interictal EEG in the diagnosis of epilepsy. Methodology/Principal Findings: Patients were selected from a database with 390 standard EEGs of patients after a first suspected seizure. Patients who were later diagnosed with epilepsy (i.e. >= two seizures) were compared to matched non-epilepsy patients (with a minimum follow-up of one year). The synchronization likelihood (SL) was used as an index of functional connectivity of the EEG, and average SL per patient was calculated in seven frequency bands. In total, 114 patients were selected. Fifty-seven patients were diagnosed with epilepsy (20 had IEDs on their EEG) and 57 matched patients had other diagnoses. Epilepsy patients had significantly higher SL in the theta band than non-epilepsy patients. Furthermore, theta band SL proved to be a significant predictor of a diagnosis of epilepsy. When only those epilepsy patients without IEDs were considered (n = 74), theta band SL could predict diagnosis with specificity of 76% and sensitivity of 62%. Conclusion/Significance: Theta band functional connectivity may be a useful diagnostic tool in diagnosing epilepsy, especially in those patients who do not show IEDs on their first EEG. Our results indicate that epilepsy diagnosis could be improved by using functional connectivity.	[Douw, Linda; de Groot, Marjolein; van Dellen, Edwin; Heimans, Jan J.; Reijneveld, Jaap C.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Ronner, Hanneke E.; Stam, Cornelis J.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Douw, L (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands.	l.douw@vumc.nl	van Dellen, Edwin/AAU-6245-2020; van Dellen, Edwin/AAL-6605-2020; van Dellen, Edwin/ABC-1501-2020	van Dellen, Edwin/0000-0003-1828-5959; van Dellen, Edwin/0000-0003-1828-5959; Douw, Linda/0000-0001-7058-4062; Stam, Cornelis/0000-0001-9163-7274	Dutch Epilepsy Foundation; UCB Pharma	Dutch Epilepsy Foundation; UCB Pharma(UCB Pharma SA)	L. Douw and E. van Dellen have projects sponsored by the Dutch Epilepsy Foundation, while M. de Groot is sponsored by UCB Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi A, 2008, BRAIN RES, V1188, P207, DOI 10.1016/j.brainres.2007.10.048; Bartolomei F, 2006, ANN NEUROL, V59, P128, DOI 10.1002/ana.20710; BETTUS G, 2008, EPILEPSY RES; Bosma I, 2008, NEURO-ONCOLOGY, V10, P734, DOI 10.1215/15228517-2008-034; GREGORY RP, 1993, ELECTROEN CLIN NEURO, V86, P75, DOI 10.1016/0013-4694(93)90069-8; HORSTMANN MT, 2009, CLIN NEUROPHYSIOL; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; MARSAN CA, 1970, EPILEPSIA, V11, P361, DOI 10.1111/j.1528-1157.1970.tb03903.x; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Mormann F, 2003, EPILEPSY RES, V53, P173, DOI 10.1016/S0920-1211(03)00002-0; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Righi M, 2008, BRAIN TOPOGR, V21, P43, DOI 10.1007/s10548-008-0057-2; ROBIN JJ, 1978, AVIAT SPACE ENVIR MD, V49, P732; Rosso OA, 2009, J NEUROSCI METH, V177, P461, DOI 10.1016/j.jneumeth.2008.10.017; RULKOV NF, 1995, PHYS REV E, V51, P980, DOI 10.1103/PhysRevE.51.980; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stoffers D, 2008, NEUROIMAGE, V41, P212, DOI 10.1016/j.neuroimage.2008.02.027; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343; Zucconi M, 2005, NEUROL SCI, V26, pS199, DOI 10.1007/s10072-005-0487-5	28	82	83	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10839	10.1371/journal.pone.0010839	http://dx.doi.org/10.1371/journal.pone.0010839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520774	Green Published, gold			2022-12-25	WOS:000278221500025
J	He, GX; Xie, YG; Wang, LX; Borgdorff, MW; van der Werf, MJ; Fan, JH; Yan, XL; Li, FB; Zhang, XZ; Zhao, YL; van den Hof, S				He, Guang Xue; Xie, Yan Guang; Wang, Li Xia; Borgdorff, Martien W.; van der Werf, Marieke J.; Fan, Ji Huan; Yan, Xing Lu; Li, Fa Bin; Zhang, Xue Zhi; Zhao, Yan Lin; van den Hof, Susan			Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment	PLOS ONE			English	Article							TREATMENT OUTCOMES; CHINA; COUNTRIES	Background: In 2004, an anti-tuberculosis (TB) drug resistance survey in Heilongjiang province, China, enrolled 1574 (79%) new and 421 (21%) retreatment patients. Multi-drug resistant (MDR) TB was detected in 7.2% of new and 30.4% of retreatment patients. All received treatment with standardized first-line drug (FLD) regimens. Methodology/Principal Findings: We report treatment outcomes of the 2004 cohort, and long-term outcomes as assessed in the second half of 2008. The reported cure rate for MDR-TB patients was 83% (94/113) among new and 66% (85/128) among retreatment patients (P<0.001). Ten of the 241 MDR-TB patients died during treatment. Of the remaining 231, 129 (56%) could be traced in 2008. The overall recurrence rates among new and retreatment cases were 46% and 66%, respectively (P=0.03). The overall death rates among new and retreatment cases were 25% and 46%, respectively (P=0.02). Forty percent of the traced new cases and 24% of the retreatment cases were alive and without recurrent TB (P=0.01). Of the 16 patients who failed or defaulted from treatment in 2004, only two patients were not re-diagnosed with TB by 2008. Of the 111 (86%) patients with an initial successful treatment outcome 63 (57%) had developed recurrent TB, 40 (36%) had died, 27 (24%) of them died of TB. The follow-up period of four years precluded follow-up of all patients. In a highly conservative sensitivity analysis in which we assumed that all non-included patients were alive and did not have recurrent TB, the recurrence and death rate were 33% and 21%. Conclusions/Significance: Documentation of cure based on conventional smear microscopy was a poor predictor of long term outcomes. MDR-TB patients in Heilongjiang province in China had high recurrence and death rates four years after treatment with standardized FLD regimens, reinforcing the need for early diagnosis and treatment of MDR-TB, including assessment of treatment outcomes with more sensitive laboratory methods.	[He, Guang Xue; Wang, Li Xia] China Ctr Dis Control & Prevent China CDC, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [He, Guang Xue; Borgdorff, Martien W.; van der Werf, Marieke J.; van den Hof, Susan] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Xie, Yan Guang; Yan, Xing Lu; Li, Fa Bin; Zhang, Xue Zhi] Heilongjiang Prov Ctr TB Control & Prevent, Harbin, Heilongjiang, Peoples R China; [van der Werf, Marieke J.; van den Hof, Susan] KNCV TB Fdn, The Hague, Netherlands; [Fan, Ji Huan] Peking Union Med Coll, Sch Publ Hlth, Beijing 100021, Peoples R China; [Zhao, Yan Lin] China Ctr Dis Control & Prevent China CDC, Natl TB Reference Lab, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; University of Amsterdam; Academic Medical Center Amsterdam; KNCV Tuberculosis Foundation; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention	He, GX (corresponding author), China Ctr Dis Control & Prevent China CDC, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.	vandenhofs@kncvtbc.nl		van der Werf, Marieke J./0000-0001-8021-1358	China Global Fund TB Program [07-053, 07-059]; China National Key Project [2008ZX10003-009, 2009ZX10004-714]	China Global Fund TB Program; China National Key Project	Funding: This research project received funding through the China Global Fund TB Program (07-053, 059) and the China National Key Project (2008ZX10003-009, 2009ZX10004-714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN Y, 2007, J CHINESE ANTITUBERC, V29, P475; Bonnet M, 2005, INT J TUBERC LUNG D, V9, P1147; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P1176; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; Cheng MH, 2009, LANCET, V373, P1328, DOI 10.1016/S0140-6736(09)60757-1; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; GAO WW, 2008, J CHINESE ANTITUBERC, V30, P114; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; LI B, 2003, J CHINESE ANTITUBERC, V25, P343; LI Q, 2000, CHINESE J TUBERCULOS, V23, P718; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Ohkado A, 2006, INT J TUBERC LUNG D, V10, P283; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sun ZG, 2008, J CLIN MICROBIOL, V46, P4075, DOI 10.1128/JCM.00822-08; Wang Guo-jie, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P527; WANG SM, 2005, J CHINESE ANTITUBERC, V27, P370; *WHO, 2008, WHOHTMTB2008394; *WHO INT UN TUB LU, 2000, 2 WHO INT UN TUB LUN; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization and International Union against Tuberculosis and Lung Disease, 1997, WHOTB96216; XIE YG, 2005, J CHINESE ANTITUBERC, V30, P395	29	29	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10799	10.1371/journal.pone.0010799	http://dx.doi.org/10.1371/journal.pone.0010799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520720	Green Submitted, Green Published, gold			2022-12-25	WOS:000278034600026
J	Nelson, DM; Cann, IKO; Altermann, E; Mackie, RI				Nelson, David M.; Cann, Isaac K. O.; Altermann, Eric; Mackie, Roderick I.			Phylogenetic Evidence for Lateral Gene Transfer in the Intestine of Marine Iguanas	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; RUMEN; GENOME; MICROBIOTA; DIGESTION; LIZARDS; SHEEP; TREES; NOV.	Background: Lateral gene transfer (LGT) appears to promote genotypic and phenotypic variation in microbial communities in a range of environments, including the mammalian intestine. However, the extent and mechanisms of LGT in intestinal microbial communities of non-mammalian hosts remains poorly understood. Methodology/Principal Findings: We sequenced two fosmid inserts obtained from a genomic DNA library derived from an agar-degrading enrichment culture of marine iguana fecal material. The inserts harbored 16S rRNA genes that place the organism from which they originated within Clostridium cluster IV, a well documented group that habitats the mammalian intestinal tract. However, sequence analysis indicates that 52% of the protein-coding genes on the fosmids have top BLASTX hits to bacterial species that are not members of Clostridium cluster IV, and phylogenetic analysis suggests that at least 10 of 44 coding genes on the fosmids may have been transferred from Clostridium cluster XIVa to cluster IV. The fosmids encoded four transposase-encoding genes and an integrase-encoding gene, suggesting their involvement in LGT. In addition, several coding genes likely involved in sugar transport were probably acquired through LGT. Conclusion: Our phylogenetic evidence suggests that LGT may be common among phylogenetically distinct members of the phylum Firmicutes inhabiting the intestinal tract of marine iguanas.	[Nelson, David M.] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA; [Nelson, David M.; Cann, Isaac K. O.; Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cann, Isaac K. O.; Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Altermann, Eric] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand	University System of Maryland; University of Maryland Center for Environmental Science; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; AgResearch - New Zealand	Nelson, DM (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA.	dmnelson@al.umces.edu; r-mackie@illinois.edu	Nelson, David/AAP-9412-2020; Nelson, David M/D-5596-2009	Nelson, David/0000-0003-2755-5535; Nelson, David M/0000-0003-2755-5535; Altermann, Eric/0000-0003-1376-1549	National Science Foundation [0238422]; Institute for Genomic Biology; United States Department of Agriculture [2008-35107-18664]	National Science Foundation(National Science Foundation (NSF)); Institute for Genomic Biology; United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding: Support for this research was provided by National Science Foundation grant #0238422 (R. I. M. and I.K.O.C.), a postdoctoral fellowship from the Institute for Genomic Biology (D.M.N.), and United States Department of Agriculture grant #2008-35107-18664 (D.M.N.). E. A. is a current employee of AgResearch Limited (www.agresearch.co.nz), a New Zealand Crown Research Institute. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Azcarate-Peril MA, 2008, APPL ENVIRON MICROB, V74, P4610, DOI 10.1128/AEM.00054-08; BROWNE J, 1989, VOYAGE BEAGLE C DARW; Carlier JP, 2010, INT J SYST EVOL MICR, V60, P585, DOI 10.1099/ijs.0.016725-0; Eliot AC, 2008, CHEM BIOL, V15, P765, DOI 10.1016/j.chembiol.2008.07.010; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gilbert JA, 2008, ISME J, V2, P790, DOI 10.1038/ismej.2008.49; Gophna U., 2009, MICROBE, V4, P549; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lino T, 2007, INT J SYST EVOL MICR, V57, P1840, DOI 10.1099/ijs.0.64717-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mackie RI, 2004, PHYSIOL BIOCHEM ZOOL, V77, P127, DOI 10.1086/383498; Mackie RI, 2003, APPL ENVIRON MICROB, V69, P6808, DOI 10.1128/AEM.69.11.6808-6815.2003; Mackie RI, 1997, GASTROINTESTINAL MIC; MACKIE RI, 2008, 4 COMP PHYSL BIOCH M, P193; Nei M., 2000, MOL EVOLUTION PHYLOG; Nesbo CL, 2005, ENVIRON MICROBIOL, V7, P2011, DOI 10.1111/j.1462-2920.2005.00918.x; ORPIN CG, 1985, J APPL BACTERIOL, V58, P585, DOI 10.1111/j.1365-2672.1985.tb01715.x; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wikelski M, 2000, NATURE, V403, P37, DOI 10.1038/47396; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	33	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10785	10.1371/journal.pone.0010785	http://dx.doi.org/10.1371/journal.pone.0010785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520734	gold, Green Published, Green Submitted			2022-12-25	WOS:000278034600012
J	Banu, S; Hossain, A; Uddin, MKM; Uddin, MR; Ahmed, T; Khatun, R; Mahmud, AM; Hyder, KA; Lutfor, AB; Karim, MS; Zaman, K; Khan, MAI; Barua, PC; Luby, SP				Banu, Sayera; Hossain, Arman; Uddin, Mohammad Khaja Mafij; Uddin, Muhammad Reaj; Ahmed, Tahmeed; Khatun, Razia; Mahmud, Asif Mujtaba; Hyder, Khurshid Alam; Lutfor, Afzalunnessa Binte; Karim, Md. Sirajul; Zaman, Khalequ; Khan, Md. Ashraful Islam; Barua, Pravat Chandra; Luby, Stephen P.			Pulmonary Tuberculosis and Drug Resistance in Dhaka Central Jail, the Largest Prison in Bangladesh	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; THAI PRISONS; SMEAR; TRANSMISSION; POPULATION; PCR	Background: There are limited data on TB among prison inmates in Bangladesh. The aim of the study was to determine the prevalence of pulmonary tuberculosis (TB), its drug resistance and risk factors in Dhaka Central Jail, the largest prison in Bangladesh. Methods: Cross sectional survey with, active screening of a total number of 11,001 inmates over a period of 2 years. Sputum samples from TB suspects were taken for acid-fast bacilli (AFB) microscopy, culture and drug susceptibility testing. Results: Among 1,781 TB suspects 245 (13.8%) were positive for AFB on microscopy and/or culture. The prevalence rate of sputum-positive pulmonary TB was 2,227/100,000. Fifty three cases (21.6% of 245 cases) were AFB- negative on microscopy but were found positive on culture. Resistance to isoniazid, rifampicin, streptomycin and ethambutol was 11.4%, 0.8%, 22.4% and 6.5% respectively. No multidrug resistance was observed. The main risk factors of TB in prison were exposure to TB patients (adjusted odds ratio 3.16, 95% CI 2.36-4.21), previous imprisonment (1.86, 1.38-2.50), longer duration of stay in prison (17.5 months for TB cases; 1.004, 1.001-1.006) and low body mass index which is less than 18.5 kg/m(2) (5.37, 4.02-7.16). Conclusions: The study results revealed a very high prevalence of TB in the prison population in Dhaka Central Jail. Entry examinations and active symptom screening among inmates are important to control TB transmission inside the prison. Identifying undiagnosed smear-negative TB cases remains a challenge to combat this deadly disease in this difficult setting.	[Banu, Sayera; Hossain, Arman; Uddin, Mohammad Khaja Mafij; Uddin, Muhammad Reaj; Ahmed, Tahmeed; Khatun, Razia; Zaman, Khalequ; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Mahmud, Asif Mujtaba] Natl Inst Dis Chest & Hosp, Dhaka, Bangladesh; [Hyder, Khurshid Alam] WHO, Dhaka, Bangladesh; [Lutfor, Afzalunnessa Binte] Sir Salimullah Med Coll, Dept Microbiol, Dhaka, Bangladesh; [Karim, Md. Sirajul] Savar Cantonment, ADMS, Dhaka, Bangladesh; [Khan, Md. Ashraful Islam] Directorate Prisons, Dhaka, Bangladesh; [Barua, Pravat Chandra] Directorate Gen Hlth Serv, Natl TB Control Programme, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); World Health Organization; Sir Salimullah Medical College	Banu, S (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	sbanu@icddrb.org		Banu, Sayera/0000-0002-5121-1962	Government of Bangladesh through IHP-HNPRP; International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)	Government of Bangladesh through IHP-HNPRP; International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)	This work was supported by grants from the Government of Bangladesh through IHP-HNPRP and International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). The Centre is supported by agencies and countries that share its concern for the health problems of developing countries. The authors gratefully acknowledge these donors for their support and commitment to the Centre's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chaves F, 1997, AM J RESP CRIT CARE, V155, P719, DOI 10.1164/ajrccm.155.2.9032218; CHEVALLAY B, 1983, SCHWEIZ MED WSCHR, V113, P261; Chiang CY, 2002, J FORMOS MED ASSOC, V101, P537; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; CONINX R, 1995, LANCET, V346, P1238, DOI 10.1016/S0140-6736(95)92952-5; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Coninx R, 1998, BRIT MED J, V316, P1423, DOI 10.1136/bmj.316.7142.1423; Drobniewski F, 2002, EMERG INFECT DIS, V8, P1320, DOI 10.3201/eid0811.020507; Garcia-Quintanilla A, 2002, J CLIN MICROBIOL, V40, P4646, DOI 10.1128/JCM.40.12.4646-4651.2002; Karyadi E, 2000, J NUTR, V130, P2953, DOI 10.1093/jn/130.12.2953; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; Munyati SS, 2005, CLIN INFECT DIS, V40, P1818, DOI 10.1086/429912; ONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363; Pleumpanupat W, 2003, INT J TUBERC LUNG D, V7, P472; Rao N. A., 2004, JPMA Journal of the Pakistan Medical Association, V54, P413; SAHA K, 1989, EUR J CLIN NUTR, V43, P117; Sanchez AR, 2007, CAD SAUDE PUBLICA, V23, P545, DOI 10.1590/S0102-311X2007000300013; Shah S A, 2003, East Mediterr Health J, V9, P667; Sretrirutchai S, 2002, INT J TUBERC LUNG D, V6, P208; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Tueller C, 2005, EUR RESPIR J, V26, P767, DOI 10.1183/09031936.05.00046105; VALWAY SE, 1994, J INFECT DIS, V170, P151, DOI 10.1093/infdis/170.1.151; Zaman K, 2006, EPIDEMIOL INFECT, V134, P1052, DOI 10.1017/S0950268806006108; 2003, INDIAN J ALLERGY AST, V17, P67	25	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10759	10.1371/journal.pone.0010759	http://dx.doi.org/10.1371/journal.pone.0010759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505826	gold, Green Published, Green Submitted			2022-12-25	WOS:000278017400015
J	Diehnelt, CW; Shah, M; Gupta, N; Belcher, PE; Greving, MP; Stafford, P; Johnston, SA				Diehnelt, Chris W.; Shah, Miti; Gupta, Nidhi; Belcher, Paul E.; Greving, Matthew P.; Stafford, Phillip; Johnston, Stephen Albert			Discovery of High-Affinity Protein Binding Ligands - Backwards	PLOS ONE			English	Article							PHAGE DISPLAY; GENERATION; ANTIBODIES; REAGENTS; PEPTIDES; SPECIFICITY; MICROARRAYS; MOLECULES; LIBRARIES; SELECTION	Background: There is a pressing need for high-affinity protein binding ligands for all proteins in the human and other proteomes. Numerous groups are working to develop protein binding ligands but most approaches develop ligands using the same strategy in which a large library of structured ligands is screened against a protein target to identify a high-affinity ligand for the target. While this methodology generates high-affinity ligands for the target, it is generally an iterative process that can be difficult to adapt for the generation of ligands for large numbers of proteins. Methodology/Principal Findings: We have developed a class of peptide-based protein ligands, called synbodies, which allow this process to be run backwards - i.e. make a synbody and then screen it against a library of proteins to discover the target. By screening a synbody against an array of 8,000 human proteins, we can identify which protein in the library binds the synbody with high affinity. We used this method to develop a high-affinity synbody that specifically binds AKT1 with a K-d<5 nM. It was found that the peptides that compose the synbody bind AKT1 with low micromolar affinity, implying that the affinity and specificity is a product of the bivalent interaction of the synbody with AKT1. We developed a synbody for another protein, ABL1 using the same method. Conclusions/Significance: This method delivered a high-affinity ligand for a target protein in a single discovery step. This is in contrast to other techniques that require subsequent rounds of mutational improvement to yield nanomolar ligands. As this technique is easily scalable, we believe that it could be possible to develop ligands to all the proteins in any proteome using this approach.	[Diehnelt, Chris W.; Shah, Miti; Gupta, Nidhi; Belcher, Paul E.; Stafford, Phillip; Johnston, Stephen Albert] Arizona State Univ, Ctr Innovat Med, Tempe, AZ 85287 USA; [Greving, Matthew P.] Arizona State Univ, Biodesign Inst, Ctr BioOpt Nanotechnol, Tempe, AZ USA; [Johnston, Stephen Albert] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Diehnelt, CW (corresponding author), Arizona State Univ, Ctr Innovat Med, Tempe, AZ 85287 USA.	stephen.johnston@asu.edu	Diehnelt, Chris/AAT-9271-2020	Diehnelt, Chris/0000-0003-4565-9338	Arizona Translational Research Initiative Funds	Arizona Translational Research Initiative Funds	The Arizona Translational Research Initiative Funds to S.A.J. and C.W.D supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PS, 2002, J AM CHEM SOC, V124, P13067, DOI 10.1021/ja0208355; Blow N, 2007, NATURE, V447, P741, DOI 10.1038/447741a; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; EGLER C, 2009, J MOL RECOGNIT, V5, P5; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Gilbreth RN, 2008, J MOL BIOL, V381, P407, DOI 10.1016/j.jmb.2008.06.014; Haab BB, 2006, MOL CELL PROTEOMICS, V5, P1996, DOI 10.1074/mcp.T600020-MCP200; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kijanka G, 2009, J IMMUNOL METHODS, V340, P132, DOI 10.1016/j.jim.2008.10.008; Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910; Oyama T, 2003, CANCER LETT, V202, P219, DOI 10.1016/j.canlet.2003.08.011; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Ramachandran N, 2008, NAT METHODS, V5, P535, DOI 10.1038/NMETH.1210; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Safsten P, 2006, ANAL BIOCHEM, V353, P181, DOI 10.1016/j.ab.2006.01.041; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Shrivastava A, 2005, PROTEIN ENG DES SEL, V18, P417, DOI 10.1093/protein/gzi049; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Uhlen M, 2008, NAT METHODS, V5, P854, DOI 10.1038/nmeth1008-854; Uhlen M, 2007, MOL CELL PROTEOMICS, V6, P1455; Uhlen M, 2009, J MOL RECOGNIT, V22, P57, DOI 10.1002/jmr.891; Vagner J, 2004, BIOORG MED CHEM LETT, V14, P211, DOI 10.1016/j.bmcl.2003.09.079; Williams BAR, 2009, J AM CHEM SOC, V131, P17233, DOI 10.1021/ja9051735	33	19	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10728	10.1371/journal.pone.0010728	http://dx.doi.org/10.1371/journal.pone.0010728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502719	Green Published, gold, Green Submitted			2022-12-25	WOS:000277845400028
J	Tobler, A; Nijhout, HF				Tobler, Alexandra; Nijhout, H. Frederik			A Switch in the Control of Growth of the Wing Imaginal Disks of Manduca sexta	PLOS ONE			English	Article							INSULIN-LIKE PEPTIDES; SILKWORM BOMBYX-MORI; INSECT BODY-SIZE; TOBACCO HORNWORM; JUVENILE-HORMONE; PROTHORACICOTROPIC HORMONE; DROSOPHILA-MELANOGASTER; FAT-BODY; ECDYSTEROID TITER; STATIC ALLOMETRY	Background: Insulin and ecdysone are the key extrinsic regulators of growth for the wing imaginal disks of insects. In vitro tissue culture studies have shown that these two growth regulators act synergistically: either factor alone stimulates only limited growth, but together they stimulate disks to grow at a rate identical to that observed in situ. It is generally thought that insulin signaling links growth to nutrition, and that starvation stops growth because it inhibits insulin secretion. At the end of larval life feeding stops but the disks continue to grow, so at that time disk growth has become uncoupled from nutrition. We sought to determine at exactly what point in development this uncoupling occurs. Methodology: Growth and cell proliferation in the wing imaginal disks and hemolymph carbohydrate concentrations were measured at various stages in the last larval instar under experimental conditions of starvation, ligation, rescue, and hormone treatment. Principal Findings: Here we show that in the last larval instar of M. sexta, the uncoupling of nutrition and growth occurs as the larva passes the critical weight. Before this time, starvation causes a decline in hemolymph glucose and trehalose and a cessation of wing imaginal disks growth, which can be rescued by injections of trehalose. After the critical weight the trehalose response to starvation disappears, and the expression of insulin becomes decoupled from nutrition. After the critical weight the wing disks loose their sensitivity to repression by juvenile hormone, and factors from the abdomen, but not the brain, are required to drive continued growth. Conclusions: During the last larval instar imaginal disk growth becomes decoupled from somatic growth at the time that the endocrine events of metamorphosis are initiated. These regulatory changes ensure that disk growth continues uninterrupted when the nutritive and endocrine signals undergo the drastic changes associated with metamorphosis.	[Tobler, Alexandra; Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC USA	Duke University	Tobler, A (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN USA.	hfn@duke.edu			National Science Foundation [IOS-0641144, IOS-0744952]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grants IOS-0641144 and IOS-0744952 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER FC, 1987, INSECT BIOCHEM, V17, P989, DOI 10.1016/0020-1790(87)90108-9; Beadle GW, 1938, BIOL BULL-US, V75, P447, DOI 10.2307/1537573; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BOLLENBACHER WE, 1981, GEN COMP ENDOCR, V44, P302, DOI 10.1016/0016-6480(81)90005-8; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Browder M.H., 2001, Journal of Insect Science (Tucson), V1, pUnpaginated; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; CYMBOROWSKI B, 1982, J INSECT PHYSIOL, V28, P129, DOI 10.1016/0022-1910(82)90120-2; D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698; DAI JD, 1994, INVERTEBR REPROD DEV, V26, P187, DOI 10.1080/07924259.1994.9672417; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; DAVIS KT, 1977, SCIENCE, V196, P438, DOI 10.1126/science.403606; DOMINICK OS, 1985, J EXP BIOL, V117, P45; DUTKOWSKI AB, 1974, J INSECT PHYSIOL, V20, P743, DOI 10.1016/0022-1910(74)90194-2; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Iwami M, 1996, INSECT BIOCHEM MOLEC, V26, P25, DOI 10.1016/0965-1748(95)00057-7; JESUDASON P, 1990, INSECT BIOCHEM, V20, P593, DOI 10.1016/0020-1790(90)90071-2; KATO Y, 1987, DEVELOPMENT, V100, P227; KIMURAKAWAKAMI M, 1992, GEN COMP ENDOCR, V86, P257, DOI 10.1016/0016-6480(92)90109-W; Kremen C, 1998, J INSECT PHYSIOL, V44, P287, DOI 10.1016/S0022-1910(97)00121-2; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masumura M, 2000, GEN COMP ENDOCR, V118, P393, DOI 10.1006/gcen.1999.7438; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2009, DEVELOPMENT, V136, P2345, DOI 10.1242/dev.032672; NAGASAWA H, 1986, P NATL ACAD SCI USA, V83, P5840, DOI 10.1073/pnas.83.16.5840; NIJHOUT F, 1994, INSECT HORMONES, P267; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43; Nijhout HF, 2007, DEV BIOL, V302, P569, DOI 10.1016/j.ydbio.2006.10.023; NIJHOUT HF, 1975, BIOL BULL-US, V149, P568, DOI 10.2307/1540387; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; ROUNTREE DB, 1986, J EXP BIOL, V120, P41; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shafiei M, 2001, PHYSIOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-3032.2001.00231.x; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Smagghe G, 2001, IN VITRO CELL DEV-AN, V37, P90, DOI 10.1290/1071-2690(2001)037<0090:IVAIVE>2.0.CO;2; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; WATSON RD, 1988, MOL CELL ENDOCRINOL, V57, P251, DOI 10.1016/0303-7207(88)90081-0; Wigglesworth V. B., 1965, PRINCIPLES INSECT PH; WOLFGANG WJ, 1986, DEV BIOL, V113, P305, DOI 10.1016/0012-1606(86)90166-1; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	52	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10723	10.1371/journal.pone.0010723	http://dx.doi.org/10.1371/journal.pone.0010723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502707	gold, Green Published, Green Submitted			2022-12-25	WOS:000277845400025
J	Appler, KK; Brown, AN; Stewart, BS; Behr, MJ; Demarest, VL; Wong, SJ; Bernard, KA				Appler, Kim K.; Brown, Ashley N.; Stewart, Barbara S.; Behr, Melissa J.; Demarest, Valerie L.; Wong, Susan J.; Bernard, Kristen A.			Persistence of West Nile Virus in the Central Nervous System and Periphery of Mice	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; VIREMIC BLOOD-DONORS; NEW-YORK; CEREBROSPINAL-FLUID; FUNCTIONAL OUTCOMES; GOLDEN-HAMSTER; UNITED-STATES; FOLLOW-UP; IN-VIVO; INFECTION	Most acute infections with RNA viruses are transient and subsequently cleared from the host. Recent evidence, however, suggests that the RNA virus, West Nile virus (WNV), not only causes acute disease, but can persist long term in humans and animal models. Our goal in this study was to develop a mouse model of WNV persistence. We inoculated immunocompetent mice subcutaneously (s.c.) with WNV and examined their tissues for infectious virus and WNV RNA for 16 months (mo) post-inoculation (p.i.). Infectious WNV persisted for 1 mo p.i. in all mice and for 4 mo p.i. in 12% of mice, and WNV RNA persisted for up to 6 mo p.i. in 12% of mice. The frequency of persistence was tissue dependent and was in the following order: skin, spinal cord, brain, lymphoid tissues, kidney, and heart. Viral persistence occurred in the face of a robust antibody response and in the presence of inflammation in the brain. Furthermore, persistence in the central nervous system (CNS) and encephalitis were observed even in mice with subclinical infections. Mice were treated at 1 mo p.i. with cyclophosphamide, and active viral replication resulted, suggesting that lymphocytes are functional during viral persistence. In summary, WNV persisted in the CNS and periphery of mice for up to 6 mo p.i. in mice with subclinical infections. These results have implications for WNV-infected humans. In particular, immunosuppressed patients, organ transplantation, and long term sequelae may be impacted by WNV persistence.	[Appler, Kim K.; Brown, Ashley N.; Stewart, Barbara S.; Behr, Melissa J.; Demarest, Valerie L.; Wong, Susan J.; Bernard, Kristen A.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA; [Brown, Ashley N.; Stewart, Barbara S.; Behr, Melissa J.; Wong, Susan J.; Bernard, Kristen A.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Appler, KK (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.	kbernard@vetmed.wisc.edu		Brown, Ashley/0000-0001-9993-5241	National Institute of Allergy and Infectious Disease, National Institutes of Health [N01-AI25490]; NIH/NIAID (Northeast Biodefense Center) [U54-AI057158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025490, U54AI057158] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID (Northeast Biodefense Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health, under contract N01-AI25490. The biosafety level-3 (BSL-3) vivarium at the Wadsworth Center was used, which is funded in part as a core facility by NIH/NIAID U54-AI057158 (Northeast Biodefense Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; Briese T, 1999, LANCET, V354, P1650; Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6; Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033; BURKE DS, 1985, J INFECT DIS, V151, P1093, DOI 10.1093/infdis/151.6.1093; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287; Cao NJY, 2005, J NEUROL SCI, V236, P73, DOI 10.1016/j.jns.2005.05.007; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x; DeSalvo D, 2004, TRANSPLANTATION, V77, P466, DOI 10.1097/01.TP.0000101434.98873.CB; Gottfried K, 2005, SOUTH MED J, V98, P603, DOI 10.1097/01.SMJ.0000155633.43244.AC; Haaland KY, 2006, EMERG INFECT DIS, V12, P1260, DOI 10.3201/eid1708.060097; Halford WP, 2000, J VIROL, V74, P5957, DOI 10.1128/JVI.74.13.5957-5967.2000; Kapoor H, 2004, J CLIN VIROL, V31, P289, DOI 10.1016/j.jcv.2004.05.017; Kauffman EB, 2003, J CLIN MICROBIOL, V41, P3661, DOI 10.1128/JCM.41.8.3661-3667.2003; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lim PY, 2010, VIROLOGY, V400, P93, DOI 10.1016/j.virol.2010.01.029; Loeb M, 2008, ANN INTERN MED, V149, P232, DOI 10.7326/0003-4819-149-4-200808190-00004; MATHUR A, 1986, J GEN VIROL, V67, P381, DOI 10.1099/0022-1317-67-2-381; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; Ostlund EN, 2001, EMERG INFECT DIS, V7, P665; Ou Alan C, 2005, J La State Med Soc, V157, P42; Patnaik JL, 2006, EMERG INFECT DIS, V12, P1129, DOI 10.3201/eid1207.051399; PEARCE BD, 1994, J VIROL, V68, P5483, DOI 10.1128/JVI.68.9.5483-5495.1994; Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004; POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128; Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07; Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005; RAVI V, 1993, J MED VIROL, V40, P326, DOI 10.1002/jmv.1890400412; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918; Sejvar JJ, 2008, J NEUROPSYCHOL, V2, P477, DOI 10.1348/174866407X218312; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320; Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010; Wong SJ, 2004, J CLIN MICROBIOL, V42, P65, DOI 10.1128/JCM.42.1.65-72.2004; Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003; Xiao SY, 2001, EMERG INFECT DIS, V7, P714	49	72	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10649	10.1371/journal.pone.0010649	http://dx.doi.org/10.1371/journal.pone.0010649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498839	Green Submitted, gold, Green Published			2022-12-25	WOS:000277771600013
J	Hwang, JH; Voortman, J; Giovannetti, E; Steinberg, SM; Leon, LG; Kim, YT; Funel, N; Park, JK; Kim, MA; Kang, GH; Kim, SW; Del Chiaro, M; Peters, GJ; Giaccone, G				Hwang, Jin-Hyeok; Voortman, Johannes; Giovannetti, Elisa; Steinberg, Seth M.; Leon, Leticia G.; Kim, Yong-Tae; Funel, Niccola; Park, Joo Kyung; Kim, Min A.; Kang, Gyeong Hoon; Kim, Sun-Whe; Del Chiaro, Marco; Peters, Godefridus J.; Giaccone, Giuseppe			Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-SUPPRESSOR GENE; HUMAN CHOLANGIOCARCINOMA; DUCTAL ADENOCARCINOMA; PROGNOSTIC MARKERS; ACTIVATED AKT; EXPRESSION; CELLS; GEMCITABINE; SURVIVAL	Background: Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis. The high risk of recurrence following surgical resection provides the rationale for adjuvant therapy. However, only a subset of patients benefit from adjuvant therapy. Identification of molecular markers to predict treatment outcome is therefore warranted. The aim of the present study was to evaluate whether expression of novel candidate biomarkers, including microRNAs, can predict clinical outcome in PDAC patients treated with adjuvant therapy. Methodology/Principal Findings: Formalin-fixed paraffin embedded specimens from a cohort of 82 resected Korean PDAC cases were analyzed for protein expression by immunohistochemistry and for microRNA expression using quantitative Real-Time PCR. Cox proportional hazards model analysis in the subgroup of patients treated with adjuvant therapy (N = 52) showed that lower than median miR-21 expression was associated with a significantly lower hazard ratio (HR) for death (HR = 0.316; 95% CI = 0.166-0.600; P = 0.0004) and recurrence (HR = 0.521; 95% CI = 0.280-0.967; P = 0.04). MiR-21 expression status emerged as the single most predictive biomarker for treatment outcome among all 27 biological and 9 clinicopathological factors evaluated. No significant association was detected in patients not treated with adjuvant therapy. In an independent validation cohort of 45 frozen PDAC tissues from Italian cases, all treated with adjuvant therapy, lower than median miR-21 expression was confirmed to be correlated with longer overall as well as disease-free survival. Furthermore, transfection with anti-miR-21 enhanced the chemosensitivity of PDAC cells. Conclusions Significance: Low miR-21 expression was associated with benefit from adjuvant treatment in two independent cohorts of PDAC cases, and anti-miR-21 increased anticancer drug activity in vitro. These data provide evidence that miR-21 may allow stratification for adjuvant therapy, and represents a new potential target for therapy in PDAC.	[Hwang, Jin-Hyeok; Voortman, Johannes; Giaccone, Giuseppe] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Hwang, Jin-Hyeok] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Hwang, Jin-Hyeok; Kim, Yong-Tae; Park, Joo Kyung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Voortman, Johannes; Giovannetti, Elisa; Leon, Leticia G.; Peters, Godefridus J.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Giovannetti, Elisa] Univ Pisa, Dept Internal Med, Pisa, Italy; [Steinberg, Seth M.] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA; [Funel, Niccola; Del Chiaro, Marco] Hosp Pisa, Div Chirurg Gen & Trapianti Urem & Diabet, Pisa, Italy; [Kim, Min A.; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Sun-Whe] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 151, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Pisa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU)	Hwang, JH (corresponding author), NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA.	giacconeg@mail.nih.gov	giovannetti, elisa/F-4261-2011; Hwang, Jin-Hyeok/J-5735-2012; Kim, Yong-Tae/E-4148-2012; Kim, Sun-Whe/J-2741-2012; Giaccone, Giuseppe/E-8297-2017; Voortman, J/AAO-1289-2020; Kang, Gyeong Hoon/F-1051-2010; Peters, Godefridus J/C-7562-2013	giovannetti, elisa/0000-0002-7565-7504; Giaccone, Giuseppe/0000-0002-5023-7562; Kang, Gyeong Hoon/0000-0003-2380-6675; Funel, Niccola/0000-0002-5028-2363; Peters, Godefridus J/0000-0002-5447-2877	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIDSC007202, ZIABC011269] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	In part funded by the National Institutes of Health, National Cancer Institute intramural program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese JL, 2008, JAMA-J AM MED ASSOC, V299, P1066, DOI 10.1001/jama.299.9.1066; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco C, 2006, CLIN CANCER RES, V12, P7099, DOI 10.1158/1078-0432.CCR-06-0833; Boeck S, 2007, ONCOLOGY-BASEL, V72, P314, DOI 10.1159/000113054; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Chadha KS, 2006, ANN SURG ONCOL, V13, P933, DOI 10.1245/ASO.2006.07.011; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; COX DR, 1972, J R STAT SOC B, V34, P187; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Funel N, 2008, LAB INVEST, V88, P773, DOI 10.1038/labinvest.2008.40; Garcea G, 2005, EUR J CANCER, V41, P2213, DOI 10.1016/j.ejca.2005.04.044; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Hampton T, 2007, JAMA-J AM MED ASSOC, V297, P937, DOI 10.1001/jama.297.9.937; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hruban RH, 2001, CANCER J, V7, P251; Itakura J, 1997, CLIN CANCER RES, V3, P1309; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jimeno A, 2006, MOL CANCER THER, V5, P787, DOI 10.1158/1535-7163.MCT-06-0005; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katz MHG, 2008, CA-CANCER J CLIN, V58, P111, DOI 10.3322/CA.2007.0012; Leon LG, 2008, CHEMMEDCHEM, V3, P1740, DOI 10.1002/cmdc.200800212; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marchesi F, 2008, CANCER RES, V68, P9060, DOI 10.1158/0008-5472.CAN-08-1810; Mardin W, 2009, ANN SURG ONCOL, V16, P3183, DOI 10.1245/s10434-009-0623-1; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Neoptolemos J, 2009, J CLIN ONCOL, V27; Neuhaus P, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.lba4504; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Salek C, 2009, ANTICANCER RES, V29, P1803; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Tonini G, 2007, EXPERT OPIN THER TAR, V11, P1553, DOI 10.1517/14728222.11.12.1553; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004; Zhang WM, 2008, ELECTROCHEM COMMUN, V10, P519, DOI 10.1016/j.elecom.2008.01.032; Zuckerman DS, 2008, CANCER-AM CANCER SOC, V112, P243, DOI 10.1002/cncr.23174	65	235	251	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10630	10.1371/journal.pone.0010630	http://dx.doi.org/10.1371/journal.pone.0010630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498843	Green Published, Green Submitted, gold			2022-12-25	WOS:000277771600004
J	Reuter, K; Pittelkow, M; Bursy, J; Heine, A; Craan, T; Bremer, E				Reuter, Klaus; Pittelkow, Marco; Bursy, Jan; Heine, Andreas; Craan, Tobias; Bremer, Erhard			Synthesis of 5-Hydroxyectoine from Ectoine: Crystal Structure of the Non-Heme Iron(II) and 2-Oxoglutarate-Dependent Dioxygenase EctD	PLOS ONE			English	Article							COMPATIBLE SOLUTE ECTOINE; LATERAL GENE-TRANSFER; PROLINE 4-HYDROXYLASE; ESCHERICHIA-COLI; HYDROXYECTOINE; BACTERIA; GROWTH; STABILIZATION; BIOSYNTHESIS; OXYGENASES	As a response to high osmolality, many microorganisms synthesize various types of compatible solutes. These organic osmolytes aid in offsetting the detrimental effects of low water activity on cell physiology. One of these compatible solutes is ectoine. A sub-group of the ectoine producer's enzymatically convert this tetrahydropyrimidine into a hydroxylated derivative, 5-hydroxyectoine. This compound also functions as an effective osmostress protectant and compatible solute but it possesses properties that differ in several aspects from those of ectoine. The enzyme responsible for ectoine hydroxylation (EctD) is a member of the non-heme iron(II)-containing and 2-oxoglutarate-dependent dioxygenases (EC 1.14.11). These enzymes couple the decarboxylation of 2-oxoglutarate with the formation of a high-energy ferryl-oxo intermediate to catalyze the oxidation of the bound organic substrate. We report here the crystal structure of the ectoine hydroxylase EctD from the moderate halophile Virgibacillus salexigens in complex with Fe3+ at a resolution of 1.85 A. Like other non-heme iron(II) and 2-oxoglutarate dependent dioxygenases, the core of the EctD structure consists of a double-stranded beta-helix forming the main portion of the active-site of the enzyme. The positioning of the iron ligand in the active-site of EctD is mediated by an evolutionarily conserved 2-His-1-carboxylate iron-binding motif. The side chains of the three residues forming this iron-binding site protrude into a deep cavity in the EctD structure that also harbours the 2-oxoglutarate co-substrate-binding site. Database searches revealed a widespread occurrence of EctD-type proteins in members of the Bacteria but only in a single representative of the Archaea, the marine crenarchaeon Nitrosopumilus maritimus. The EctD crystal structure reported here can serve as a template to guide further biochemical and structural studies of this biotechnologically interesting enzyme family.	[Reuter, Klaus; Heine, Andreas; Craan, Tobias] Univ Marburg, Dept Pharm, Inst Pharmaceut Chem, Marburg, Germany; [Pittelkow, Marco; Bursy, Jan; Bremer, Erhard] Univ Marburg, Dept Biol, Microbiol Lab, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Reuter, K (corresponding author), Univ Marburg, Dept Pharm, Inst Pharmaceut Chem, Marburg, Germany.	reuterk@staff.uni-marburg.de; bremer@staff.uni-marburg.de		Reuter, Klaus/0000-0003-3673-7971	Philipps-University Marburg; Max-Planck-Institute for Terrestrial Microbiology (Marburg); Fonds der Chemischen Industrie; LOEWE Center for Synthetic Microbiology (Marburg); Bundesministerium fur Bildung und Forschung (BMBF) [05ES3XBA/5]	Philipps-University Marburg; Max-Planck-Institute for Terrestrial Microbiology (Marburg); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); LOEWE Center for Synthetic Microbiology (Marburg); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Philipps-University Marburg (to KR and EB), the Max-Planck-Institute for Terrestrial Microbiology (Marburg) (to EB), the Fonds der Chemischen Industrie and the LOEWE Center for Synthetic Microbiology (Marburg) (to EB). The travel costs to the BESSY II synchrotron in Berlin were covered by a grant to AH from the Bundesministerium fur Bildung und Forschung (BMBF support code: 05ES3XBA/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bestvater Thorsten, 2008, Saline Syst, V4, P12, DOI 10.1186/1746-1448-4-12; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; BRANDEN C, 1999, INTRO PROTEIN STRUCT, P77; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Calderon MI, 2004, MICROBIOL-SGM, V150, P3051, DOI 10.1099/mic.0.27122-0; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; da Costa M. S., 1998, V61, P117; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Flashman E, 2007, NAT CHEM BIOL, V3, P86, DOI 10.1038/nchembio0207-86; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Hanekop N, 2007, J MOL BIOL, V374, P1237, DOI 10.1016/j.jmb.2007.09.071; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Helmetag V, 2009, FEBS J, V276, P3669, DOI 10.1111/j.1742-4658.2009.07085.x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JEBBAR M, 1992, J BACTERIOL, V174, P5027, DOI 10.1128/JB.174.15.5027-5035.1992; Jebbar M, 1997, FEMS MICROBIOL LETT, V154, P325, DOI 10.1111/j.1574-6968.1997.tb12663.x; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kanapathipillai M, 2008, BIOCHEM BIOPH RES CO, V365, P808, DOI 10.1016/j.bbrc.2007.11.074; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Knapp S, 1999, EXTREMOPHILES, V3, P191, DOI 10.1007/s007920050116; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lawrence CC, 1996, BIOCHEM J, V313, P185, DOI 10.1042/bj3130185; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Lo CC, 2009, MICROBIOL MOL BIOL R, V73, P594, DOI 10.1128/MMBR.00024-09; Louis P, 1997, MICROBIOL-UK, V143, P1141, DOI 10.1099/00221287-143-4-1141; Malin G, 1996, J BACTERIOL, V178, P385, DOI 10.1128/jb.178.2.385-395.1996; Manzanera M, 2002, APPL ENVIRON MICROB, V68, P4328, DOI 10.1128/AEM.68.9.4328-4333.2002; McDonough MA, 2005, J BIOL CHEM, V280, P41101, DOI 10.1074/jbc.M507528200; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moghaieb REA, 2006, PLANT CELL ENVIRON, V29, P173, DOI 10.1111/j.1365-3040.2005.01410.x; Mustakhimov II, 2010, J BACTERIOL, V192, P410, DOI 10.1128/JB.00553-09; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Purpero V, 2007, J BIOL INORG CHEM, V12, P587, DOI 10.1007/s00775-007-0231-0; Reshetnikov AS, 2006, ARCH MICROBIOL, V184, P286, DOI 10.1007/s00203-005-0042-z; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; Sabirova JS, 2008, FEMS MICROBIOL LETT, V285, P89, DOI 10.1111/j.1574-6968.2008.01222.x; Saum SH, 2008, ENVIRON MICROBIOL, V10, P716, DOI 10.1111/j.1462-2920.2007.01494.x; Schiraldi C, 2006, RES MICROBIOL, V157, P693, DOI 10.1016/j.resmic.2006.03.004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schnoor M, 2004, BIOCHEM BIOPH RES CO, V322, P867, DOI 10.1016/j.bbrc.2004.07.200; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Shibasaki T, 1999, APPL ENVIRON MICROB, V65, P4028; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; SYDLIK U, 2009, AM J RESP C IN PRESS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wei L, 2009, PATHOBIOLOGY, V76, P212, DOI 10.1159/000218338; Welford RWD, 2005, FEBS LETT, V579, P5170, DOI 10.1016/j.febslet.2005.08.033; You Z, 2007, J BIOL CHEM, V282, P36552, DOI 10.1074/jbc.M706358200	75	47	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10647	10.1371/journal.pone.0010647	http://dx.doi.org/10.1371/journal.pone.0010647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498719	Green Submitted, Green Published, gold			2022-12-25	WOS:000277771600011
J	Olsen, M; Siegelmann-Danieli, N; Siegelmann, HT				Olsen, Megan; Siegelmann-Danieli, Nava; Siegelmann, Hava T.			Dynamic Computational Model Suggests That Cellular Citizenship Is Fundamental for Selective Tumor Apoptosis	PLOS ONE			English	Article							CANCER; THERAPY; CELLS; MORPHOLOGY; HALLMARKS; DEATH	Computational models in the field of cancer research have focused primarily on estimates of biological events based on laboratory generated data. We introduce a novel in-silico technology that takes us to the next level of prediction models and facilitates innovative solutions through the mathematical system. The model's building blocks are cells defined phenotypically as normal or tumor, with biological processes translated into equations describing the life protocols of the cells in a quantitative and stochastic manner. The essentials of communication in a society composed of normal and tumor cells are explored to reveal "protocols" for selective tumor eradication. Results consistently identify "citizenship properties" among cells that are essential for the induction of healing processes in a healthy system invaded by cancer. These properties act via inter-cellular communication protocols that can be optimized to induce tumor eradication along with system recovery. Within the computational systems, the protocols universally succeed in removing a wide variety of tumors defined by proliferation rates, initial volumes, and apoptosis resistant phenotypes; they show high adaptability for biological details and allow incorporation of population heterogeneity. These protocols work as long as at least 32% of cells obey extra-cellular commands and at least 28% of cancer cells report their deaths. This low percentage implies that the protocols are resilient to the suboptimal situations often seen in biological systems. We conclude that our in-silico model is a powerful tool to investigate, to propose, and to exercise logical anti-cancer solutions. Functional results should be confirmed in a biological system and molecular findings should be loaded into the computational model for the next level of directed experiments.	[Olsen, Megan; Siegelmann, Hava T.] Univ Massachusetts, Dept Comp Sci, Amherst, MA 01003 USA; [Siegelmann-Danieli, Nava] CommuniSef Com, Tel Aviv, Israel; [Siegelmann-Danieli, Nava] Maccabi Hlth Serv, Tel Aviv, Israel	University of Massachusetts System; University of Massachusetts Amherst	Olsen, M (corresponding author), Univ Massachusetts, Dept Comp Sci, Amherst, MA 01003 USA.	hava@cs.umass.edu	Olsen, Megan/AAV-6775-2021	Olsen, Megan/0000-0003-0187-997X	Department of Homeland Security; NSF [0501432]	Department of Homeland Security(United States Department of Homeland Security (DHS)); NSF(National Science Foundation (NSF))	This work was partially funded by a Department of Homeland Security Fellowship (http://www.orau.gov/dhsed/), and an NSF grant ECCS 0501432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LH, 2006, BRIT J CANCER, V95, P1136, DOI 10.1038/sj.bjc.6603310; Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Apetoh L, 2008, CANCER RES, V68, P4026, DOI 10.1158/0008-5472.CAN-08-0427; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Barkai N, 2007, MOL CELL, V28, P755, DOI 10.1016/j.molcel.2007.11.013; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Eng C, 2009, CANCER RES, V69, P6759, DOI 10.1158/0008-5472.CAN-09-0985; Fuldo S, 2007, EXPERT REV ANTICANC, V7, P1255, DOI 10.1586/14737140.7.9.1255; Galam S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051907; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hess CJ, 2007, J CLIN ONCOL, V25, P1209, DOI 10.1200/JCO.2006.08.4061; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Kim R, 2006, EJSO-EUR J SURG ONC, V32, P269, DOI 10.1016/j.ejso.2005.12.006; McConkey DJ, 2007, ADV EXP MED BIOL, V608, P31; Olsen MM, 2008, ARTIF INTELL, V172, P884, DOI 10.1016/j.artint.2007.10.015; Pert C., 1999, MOL EMOTION SCI MIND; Pettet GJ, 2001, B MATH BIOL, V63, P231, DOI 10.1006/bulm.2000.0217; PULTACK IF, 2001, CLIN CANCER RES, V7, P1362; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Simpson MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021918; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034	26	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10637	10.1371/journal.pone.0010637	http://dx.doi.org/10.1371/journal.pone.0010637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498709	gold, Green Published			2022-12-25	WOS:000277633500021
J	Chiriva-Internati, M; Yu, YF; Mirandola, L; Jenkins, MR; Chapman, C; Cannon, M; Cobos, E; Kast, WM				Chiriva-Internati, Maurizio; Yu, Yuefei; Mirandola, Leonardo; Jenkins, Marjorie R.; Chapman, Caroline; Cannon, Martin; Cobos, Everardo; Kast, W. Martin			Cancer Testis Antigen Vaccination Affords Long-Term Protection in a Murine Model of Ovarian Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; SPERM PROTEIN-17 SP17; DENDRITIC CELLS; MULTIPLE-MYELOMA; SUITABLE TARGET; SELF-ANTIGEN; TH17 CELLS; IN-VIVO; IMMUNOTHERAPY; CPG	Sperm protein (Sp17) is an attractive target for ovarian cancer (OC) vaccines because of its over-expression in primary as well as in metastatic lesions, at all stages of the disease. Our studies suggest that a Sp17-based vaccine can induce an enduring defense against OC development in C57BL/6 mice with ID8 cells, following prophylactic and therapeutic treatments. This is the first time that a mouse counterpart of a cancer testis antigen (Sp17) was shown to be expressed in an OC mouse model, and that vaccination against this antigen significantly controlled tumor growth. Our study shows that the CpG-adjuvated Sp17 vaccine overcomes the issue of immunologic tolerance, the major barrier to the development of effective immunotherapy for OC. Furthermore, this study provides a better understanding of OC biology by showing that Th-17 cells activation and contemporary immunosuppressive T-reg cells inhibition is required for vaccine efficacy. Taken together, these results indicate that prophylactic and therapeutic vaccinations can induce long-standing protection against OC and delay tumor growth, suggesting that this strategy may provide additional treatments of human OC and the prevention of disease onset in women with a family history of OC.	[Chiriva-Internati, Maurizio; Yu, Yuefei; Mirandola, Leonardo; Jenkins, Marjorie R.; Cobos, Everardo] Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA; [Chiriva-Internati, Maurizio; Yu, Yuefei; Mirandola, Leonardo; Jenkins, Marjorie R.; Cobos, Everardo] SW Canc Treatment & Res Ctr, Lubbock, TX USA; [Jenkins, Marjorie R.] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Amarillo, TX USA; [Jenkins, Marjorie R.] Texas Tech Univ, Hlth Sci Ctr, Dept Obstet & Gynecol, Amarillo, TX USA; [Jenkins, Marjorie R.] Texas Tech Univ, Hlth Sci Ctr, Laura W Bush Inst Womens Hlth, Amarillo, TX USA; [Jenkins, Marjorie R.] Texas Tech Univ, Hlth Sci Ctr, Ctr Womens Hlth & Gender Based Med, Amarillo, TX USA; [Chapman, Caroline] Univ Nottingham, Div Breast Surg, Nottingham NG7 2RD, England; [Cannon, Martin] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Kast, W. Martin] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Kast, W. Martin] Univ So Calif, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Kast, W. Martin] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Gynecol & Urol, Los Angeles, CA 90033 USA; [Kast, W. Martin] Univ Hawaii Manoa, Canc Res Ctr Hawaii, Honolulu, HI 96822 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Nottingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Southern California; University of Southern California; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa	Chiriva-Internati, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA.	maurizio.chiriva@ttuhsc.edu	Chapman, Caroline/B-7503-2012; Mirandola, Leonardo/B-1575-2013	cobos, everardo/0000-0001-5799-0074; Kast, W Martin/0000-0003-2321-3159	Billy and Ruby Power Endowment for Cancer Research; Laura W. Bush Institute for Women's Health; Center for Women's Health; Gender-Based Medicine	Billy and Ruby Power Endowment for Cancer Research; Laura W. Bush Institute for Women's Health; Center for Women's Health; Gender-Based Medicine	This project was supported by the Billy and Ruby Power Endowment for Cancer Research and Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Benatar T, 2008, CANCER IMMUNOL IMMUN, V57, P1757, DOI 10.1007/s00262-008-0502-9; Benencia F, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-21; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Cannon MJ, 2009, EXPERT OPIN BIOL TH, V9, P677, DOI 10.1517/14712590902932897; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Chiriva-Internati M, 2003, BLOOD, V102, P3100, DOI 10.1182/blood-2002-11-3580; Chiriva-Internati M, 2002, CANCER-AM CANCER SOC, V94, P2447, DOI 10.1002/cncr.10506; Chiriva-Internati M, 2002, BLOOD, V100, P961, DOI 10.1182/blood-2002-02-0408; Chiriva-Internati M, 2001, EUR J IMMUNOL, V31, P2277, DOI 10.1002/1521-4141(200108)31:8<2277::AID-IMMU2277>3.0.CO;2-Z; Chiriva-Internati M, 2008, J IMMUNOTHER, V31, P693, DOI 10.1097/CJI.0b013e31818283d5; Chiriva-Internati M, 2007, J IMMUNOL METHODS, V321, P86, DOI 10.1016/j.jim.2007.01.010; Coukos G, 2002, BEST PRACT RES CL OB, V16, P597, DOI 10.1053/beog.2002.9305; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dadabayev AR, 2005, AM J HEMATOL, V80, P6, DOI 10.1002/ajh.20415; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Foster T, 2009, GYNECOL ONCOL, V115, P290, DOI 10.1016/j.ygyno.2009.07.026; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Giuntoli RL, 2009, ANTICANCER RES, V29, P2875; Grizzi F, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-23; Grizzi F, 2004, J HISTOCHEM CYTOCHEM, V52, P549, DOI 10.1177/002215540405200414; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Holtz DO, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-2; Hwu P, 2002, J IMMUNOTHER, V25, P189, DOI 10.1097/00002371-200205000-00001; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jin B, 2007, IMMUNOLOGY, V122, P15, DOI 10.1111/j.1365-2567.2007.02607.x; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Leveque L, 2009, J IMMUNOTHER, V32, P101, DOI 10.1097/CJI.0b013e318195b59e; Markiewicz MA, 2004, CANCER INVEST, V22, P417, DOI 10.1081/CNV-200029072; Mendez S, 2003, INFECT IMMUN, V71, P5121, DOI 10.1128/IAI.71.9.5121-5129.2003; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Munn DH, 2009, BLOOD, V114, P1134, DOI 10.1182/blood-2009-06-224246; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Narod SA, 2002, JNCI-J NATL CANCER I, V94, P1773, DOI 10.1093/jnci/94.23.1773; Noben-Trauth N, 2002, EUR J IMMUNOL, V32, P1428, DOI 10.1002/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0; ORAND MG, 1988, DEV BIOL, V129, P231, DOI 10.1016/0012-1606(88)90177-7; Oumouna M, 2005, J VIROL, V79, P2024, DOI 10.1128/JVI.79.4.2024-2032.2005; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Radhakrishnan S, 2008, J IMMUNOL, V181, P3137, DOI 10.4049/jimmunol.181.5.3137; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Russo A, 2009, CRIT REV ONCOL HEMAT, V69, P28, DOI 10.1016/j.critrevonc.2008.06.003; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Sprent J, 2000, PHILOS T R SOC B, V355, P317, DOI 10.1098/rstb.2000.0568; Straughn JM, 2004, INT J CANCER, V108, P805, DOI 10.1002/ijc.11617; Sun SQ, 2000, SPRINGER SEMIN IMMUN, V22, P77, DOI 10.1007/s002810000028; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; Verthelyi D, 2003, TRENDS IMMUNOL, V24, P519, DOI 10.1016/S1471-4906(03)00243-6; Wagner H, 2009, ADV DRUG DELIVER REV, V61, P243, DOI 10.1016/j.addr.2008.12.010; Wen Y, 2001, BIOCHEM J, V357, P25, DOI 10.1042/0264-6021:3570025; Zhou H, 2005, BLOOD, V106, P2026, DOI 10.1182/blood-2005-03-0969; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	59	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10471	10.1371/journal.pone.0010471	http://dx.doi.org/10.1371/journal.pone.0010471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485677	Green Submitted, Green Published, gold			2022-12-25	WOS:000277563400001
J	Fraser, ON; Bugnyar, T				Fraser, Orlaith N.; Bugnyar, Thomas			Do Ravens Show Consolation? Responses to Distressed Others	PLOS ONE			English	Article							POST-CONFLICT BEHAVIOR; POSTCONFLICT 3RD-PARTY AFFILIATION; MACAQUES MACACA-FASCICULARIS; CHIMPANZEES PAN-TROGLODYTES; WILD CHIMPANZEES; COMMON RAVENS; RECONCILIATION; EMPATHY; INTELLIGENCE; AGGRESSION	Background: Bystander affiliation (post-conflict affiliation from an uninvolved bystander to the conflict victim) may represent an expression of empathy in which the bystander consoles the victim to alleviate the victim's distress ("consolation''). However, alternative hypotheses for the function of bystander affiliation also exist. Determining whether ravens spontaneously offer consolation to distressed partners may not only help us to understand how animals deal with the costs of aggressive conflict, but may also play an important role in the empathy debate. Methodology/Principal findings: This study investigates the post-conflict behavior of ravens, applying the predictive framework for the function of bystander affiliation for the first time in a non-ape species. We found weak evidence for reconciliation (post-conflict affiliation between former opponents), but strong evidence for both bystander affiliation and solicited bystander affiliation (post-conflict affiliation from the victim to a bystander). Bystanders involved in both interactions were likely to share a valuable relationship with the victim. Bystander affiliation offered to the victim was more likely to occur after intense conflicts. Renewed aggression was less likely to occur after the victim solicited affiliation from a bystander. Conclusions/Significance: Our findings suggest that in ravens, bystanders may console victims with whom they share a valuable relationship, thus alleviating the victims' post-conflict distress. Conversely victims may affiliate with bystanders after a conflict in order to reduce the likelihood of renewed aggression. These results stress the importance of relationship quality in determining the occurrence and function of post-conflict interactions, and show that ravens may be sensitive to the emotions of others.	[Fraser, Orlaith N.; Bugnyar, Thomas] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Bugnyar, Thomas] Konrad Lorenz Forschungstelle, Grunau, Austria	University of Vienna	Fraser, ON (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	orlaith.fraser@univie.ac.at			European Science Foundation [I-105-G11]; FWF (Fonds zur Foerderung der wissenschaftlichen Forschung) [Y366-B17]; Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish	European Science Foundation(European Science Foundation (ESF)European Commission); FWF (Fonds zur Foerderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the European Science Foundation (COCOR: I-105-G11; http://www.esf.org) and the FWF (Fonds zur Foerderung der wissenschaftlichen Forschung; START: Y366-B17; http://www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2002, BEHAV BRAIN SCI, V25, P21, DOI 10.1017/S0140525X02230010; [Anonymous], 2007, LME4 LINEAR MIXED EF; Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; ARNOLD K, PRIMATES PE IN PRESS; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Aureli F, 2002, BEHAV BRAIN SCI, V25, P23, DOI 10.1017/S0140525X02250013; AURELI F, 1991, ETHOLOGY, V89, P101; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F., 2000, NATURAL CONFLICT RES; Boarman W. I., 1999, BIRDS N AM, V476; Bugnyar T, 2007, CURR BIOL, V17, P1804, DOI 10.1016/j.cub.2007.09.048; Bugnyar T, 2006, ANIM COGN, V9, P369, DOI 10.1007/s10071-006-0035-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; CHENEY DL, 1989, BEHAVIOUR, V110, P258, DOI 10.1163/156853989X00501; Cheney DL, 1997, ANIM BEHAV, V54, P409, DOI 10.1006/anbe.1996.0438; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cords M., 2000, NATURAL CONFLICT RES, P177; Dall SRX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004530; Dally J, 2006, J ORNITHOL, V147, P154; de Waal FBM, 2005, P NATL ACAD SCI USA, V102, P11140, DOI 10.1073/pnas.0503935102; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; De Waal Frans B. M., 1996, P80; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; Fraser Orlaith N, 2009, Commun Integr Biol, V2, P285; HEINRICH B, 1994, CONDOR, V96, P545, DOI 10.2307/1369334; Heinrich B, 2007, SCI AM, V296, P64, DOI 10.1038/scientificamerican0407-64; Judge PG, 2005, ANIM BEHAV, V69, P1345, DOI 10.1016/j.anbehav.2004.08.016; JUDGE PG, 1991, AM J PRIMATOL, V23, P225, DOI 10.1002/ajp.1350230403; Kazem Anahita J. N., 2006, P191; KOSKI SE, EUR J DEV P IN PRESS; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; Kutsukake N, 2004, PRIMATES, V45, P157, DOI 10.1007/s10329-004-0082-z; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; MARZLUFF JM, 1991, ANIM BEHAV, V42, P755, DOI 10.1016/S0003-3472(05)80121-6; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; Penn DC, 2007, PHILOS T R SOC B, V362, P731, DOI 10.1098/rstb.2006.2023; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; *R DEV COR TEAM, 2009, R LANG STAT COMP VIE; Ratcliffe DA., 1997, RAVEN; ROMERO T, J COMP PSCY IN PRESS; Schino G, 2004, J COMP PSYCHOL, V118, P340, DOI 10.1037/0735-7036.118.3.340; Seed A, 2009, ETHOLOGY, V115, P401, DOI 10.1111/j.1439-0310.2009.01644.x; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; VONBLOTZHEIM UNG, 1993, HDB VOGEL MITTELEURO, V13, P600; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Wascher CAF, 2008, P ROY SOC B-BIOL SCI, V275, P1653, DOI 10.1098/rspb.2008.0146; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Wittig RM, 2003, BEHAV ECOL SOCIOBIOL, V54, P491, DOI 10.1007/s00265-003-0654-8; WITTIG RM, MIND CHIMPA IN PRESS; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203	63	89	91	30	211	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10605	10.1371/journal.pone.0010605	http://dx.doi.org/10.1371/journal.pone.0010605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485685	Green Published, gold			2022-12-25	WOS:000277563400012
J	Funaioli, T; Cavazza, M; Zandomeneghi, M; Pietra, F				Funaioli, Tiziana; Cavazza, Marino; Zandomeneghi, Maurizio; Pietra, Francesco			On the Chiroptical Behavior of Conjugated Multichromophoric Compounds of a New Pseudoaromatic Class: Bicolchicides and Biisocolchicides	PLOS ONE			English	Article							ELECTRONIC CIRCULAR-DICHROISM; OPTICAL-PROPERTIES; CRYSTAL-STRUCTURE; SOLVATION; SPECTRA; MUTAROTATION; ABSORPTION; COLCHICINE; CHARGE	Background: It is well known that, stemming from the mutual interplay between chromophores, circular dichroism (CD) is a powerful technique to deal with structural problems for both the small organic molecule and the biopolymer. However, quantitative interpretations of the spectroscopic and structural terms that give rise to the exciton couplet are usually presented for ideal cases, or a few CD bands only are taken into account, overlooking the role of the solvent medium. Methodology/Principal Findings: Circular dichroism and UV absorption spectra were carried out for colchicide (3) and isocolchicide (6), as well as their coupling products, 10,10'-bicolchicide (2) and 9,9'-biisocolchicide (5), in both hydrogen bonding and non hydrogen bonding solvents, as well as MeCN/H2O mixtures. A dramatic control by the solvent emerged, as even tiny changes in the composition of solvent mixtures, at ca 1 water molar fraction, induced a dramatic modification of their CD bands. A mutarotation phenomenon - long known for isocolchicine (8) - was also observed for 5, and can be attributed to the interconversion between atropisomers (R-a,7S),(R-a,7'S)-5a and (R-a,7S),(S-a,7'S)-5b. Conclusions/Significance: Our data show that with molecules built on two structurally identical moieties which embody both hydrophilic and hydrophobic groups, even tiny changes in the composition of solvent mixtures cause a dramatic modification of the CD bands. Their analysis arrives at a qualitative rationalization of the observed CD couplets from the coupling of high energy transitions, while attempts at a quantitative interpretation of these phenomena through time-dependent density functional theory allowed to reproduce satisfactorily the CD spectrum in the 300-450 nm region only. Failure with higher energies probably reflects currently inadequate specific theoretical treatments of the solvent medium.	[Funaioli, Tiziana; Cavazza, Marino; Zandomeneghi, Maurizio] Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy; [Pietra, Francesco] Accademia Lucchese Sci, Lettere, Lucca, Italy; [Pietra, Francesco] Accademia Lucchese Sci, Arti, Lucca, Italy	University of Pisa	Funaioli, T (corresponding author), Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.	tiziana@dcci.unipi.it			University of Pisa; MIUR-PRIN	University of Pisa; MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the University of Pisa and by MIUR-PRIN 2006-2007 (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Berova N, 2007, CHEM SOC REV, V36, P914, DOI 10.1039/b515476f; BRUHN T, 2009, SPECDIS VERSION 1 45; BUSHNELL JE, 2004, XANNEAL VERSION 0 7; Caricato M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2183309; Cavazza M, 2000, TETRAHEDRON LETT, V41, P9129, DOI 10.1016/S0040-4039(00)01631-2; Cavazza M, 1997, SYNTHETIC COMMUN, V27, P3405, DOI 10.1080/00397919708005641; Cramer CJ, 2008, ACCOUNTS CHEM RES, V41, P760, DOI 10.1021/ar800019z; Crawford TD, 2007, J PHYS CHEM A, V111, P12057, DOI 10.1021/jp075046u; DANIELI B, 1985, HELV CHIM ACTA, V68, P2173, DOI 10.1002/hlca.19850680812; DEVOE H, 1965, J CHEM PHYS, V43, P3199, DOI 10.1063/1.1697294; DEVOE H, 1964, J CHEM PHYS, V41, P393, DOI 10.1063/1.1725879; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Florian J, 1999, J PHYS CHEM B, V103, P10282, DOI 10.1021/jp992041r; Frenkel J, 1931, PHYS REV, V37, P17, DOI 10.1103/PhysRev.37.17; GAFFIELD W, 1984, J CHEM SOC CHEM COMM, P610, DOI 10.1039/c39840000610; Gawronski J, 2004, CURR ORG CHEM, V8, P65, DOI 10.2174/1385272043486052; GILBERT K, 2006, STERIC ENERGY MINIMI; Goerigk L, 2009, J PHYS CHEM A, V113, P767, DOI 10.1021/jp807366r; Harada N., 1983, CIRCULAR DICHROIC SP; Kendall RA, 2000, COMPUT PHYS COMMUN, V128, P260, DOI 10.1016/S0010-4655(00)00065-5; Klamt A, 1996, J CHEM PHYS, V105, P9972, DOI 10.1063/1.472829; Kuhne TD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.066401; KUYPER LF, 1991, J PHYS CHEM-US, V95, P6661, DOI 10.1021/j100170a052; LESSINGER L, 1978, ACTA CRYSTALLOGR B, V34, P1556, DOI 10.1107/S056774087800607X; LESSINGER L, 1978, ACTA CRYSTALLOGR B, V34, P578, DOI 10.1107/S0567740878003568; Major DT, 2006, J AM CHEM SOC, V128, P16345, DOI 10.1021/ja066334r; Petrenko T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770706; Pietra F, 2007, J PHYS ORG CHEM, V20, P1102, DOI 10.1002/poc.1263; RAPOPORT H, 1956, J AM CHEM SOC, V78, P2455, DOI 10.1021/ja01592a030; SEMMELHACK MF, 1971, J AM CHEM SOC, V93, P5908, DOI 10.1021/ja00751a062; Superchi S, 2004, CHIRALITY, V16, P422, DOI 10.1002/chir.20056; Venables DS, 1998, J CHEM PHYS, V108, P4935, DOI 10.1063/1.475902; VERACINI CA, 1972, J CHEM SOC CHEM COMM, P1262, DOI 10.1039/c39720001262; ZANDOMENEGHI M, 1979, J PHYS CHEM-US, V83, P2926, DOI 10.1021/j100485a024; Zhao Y, 2006, J CHEM THEORY COMPUT, V2, P364, DOI 10.1021/ct0502763	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10617	10.1371/journal.pone.0010617	http://dx.doi.org/10.1371/journal.pone.0010617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485544	Green Submitted, gold, Green Published			2022-12-25	WOS:000277563400020
J	Zhang, YY; Yang, SL; Liu, M; Song, CX; Wu, N; Ling, PX; Chu, E; Lin, XK				Zhang, Yuyan; Yang, Shaoli; Liu, Ming; Song, Chunxia; Wu, Ning; Ling, Peixue; Chu, Edward; Lin, Xiukun			Interaction between Thymidylate Synthase and Its Cognate mRNA in Zebrafish Embryos	PLOS ONE			English	Article							BINDING; PROTEIN; AUTOREGULATION; DEGRADATION; EXPRESSION; INDUCTION; MECHANISM; RESIDUES; CANCER; CELLS	Thymidylate synthase (TS), which catalyzes the de novo synthesis of dUMP, is an important target for cancer therapy. In this report, the effects of 5-fluorouracil (5-FU) and ZD1694 on the regulation of TS gene expression were evaluated in zebrafish embryos. Our results revealed that the expression of TS was increased by about six-fold when embryos were treated with 1.0 mu M 5-FU and there was a greater than 10-fold increase in the TS protein level after treatment with 0.4 mu M ZD1694. Northern blot analysis confirmed that expression of TS mRNA was identical in treated or untreated embryos. Gel shift and immunoprecipitation assays revealed that zebrafish TS was specifically bound with its cognate mRNA in vitro and in vivo. We identified a 20 nt RNA sequence, TS:N20, localized to the 5'-UTR of TS mRNA, which corresponded to nt 13-32; TS:N20 bound to the TS protein with an affinity similar to that of the full-length TS mRNA. The MFold program predicted that TS:N20 formed a stable stem-loop structure similar to that of the cis-acting element found in human TS mRNA. Variant RNAs with either a deletion or mutation in the core motif of TS:N20 were unable to bind to the TS protein. In vitro translation experiments, using the rabbit lysate system, confirmed that zebrafish TS mRNA translation was significantly repressed when an excess amount of TS protein was included in the system. Additionally, a TS stability experiment confirmed that treatment of zebrafish embryos with 5-FU could increase the TS stability significantly, and the half life of TS protein was about 2.7 times longer than in untreated embryos. Our study revealed a structural requirement for the interaction of TS RNA with TS protein. These findings also demonstrated that the increase in TS protein induced by 5-FU occurs at the post-transcriptional level and that increased stability and translation efficiency both contributed to the increase in TS protein levels induced by TS inhibitors.	[Zhang, Yuyan; Yang, Shaoli; Liu, Ming; Song, Chunxia; Wu, Ning; Lin, Xiukun] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Chu, Edward] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; [Zhang, Yuyan; Wu, Ning] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Ling, Peixue] Inst Biopharmaceut Shandong Prov, Jinan, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Yale University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YY (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	linxiukun@yahoo.com		Ling, Peixue/0000-0002-2783-7463; Lin, Xiukun/0000-0002-0306-4953	Department of Sci and Technology of Shandong Province [2007GG1005002]; Chinese Academy of Sciences [KSCX2-YW-104, KZCX2-YW-209]	Department of Sci and Technology of Shandong Province; Chinese Academy of Sciences(Chinese Academy of Sciences)	Supported by the Innovative Project of the Department of Sci and Technology of Shandong Province (No#.2007GG1005002). This work was also supported in part by the innovative projects of Chinese Academy of Sciences (No#KSCX2-YW-104 and KZCX2-YW-209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SH, 2004, BBA-PROTEINS PROTEOM, V1696, P15, DOI 10.1016/j.bbapap.2003.09.005; Chu E, 1996, BIOESSAYS, V18, P191, DOI 10.1002/bies.950180306; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; CHU E, 1995, MOL CELL BIOL, V15, P179, DOI 10.1128/MCB.15.1.179; CHU E, 1994, J BIOL CHEM, V269, P20289; CHU E, 1993, P NATL ACAD SCI USA, V90, P517, DOI 10.1073/pnas.90.2.517; DANBERG PV, 1997, BIOCHIM BIOPHYS ACTA, V473, P73; DOOLEY K, 2002, CURR OPIN GENE DEV, V10, P252; Du CQ, 2006, J BIOCHEM, V139, P913, DOI 10.1093/jb/mvj100; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Ju JF, 1999, P NATL ACAD SCI USA, V96, P3769, DOI 10.1073/pnas.96.7.3769; KEYOMARSI K, 1988, J BIOL CHEM, V263, P14402; Khaladkar M, 2007, NUCLEIC ACIDS RES, V35, pW300, DOI 10.1093/nar/gkm253; Kitchens ME, 1999, J BIOL CHEM, V274, P12544, DOI 10.1074/jbc.274.18.12544; Krarnarova TV, 2008, BBA-BIOENERGETICS, V1777, P747, DOI 10.1016/j.bbabio.2008.05.446; LIN X, 2000, NUCLEIC ACIDS RES, V28, P4622; Lin XK, 2003, NUCLEIC ACIDS RES, V31, P4882, DOI 10.1093/nar/gkg678; Lin XK, 2000, NUCLEIC ACIDS RES, V28, P1381, DOI 10.1093/nar/28.6.1381; Liu J, 2002, BBA-MOL BASIS DIS, V1587, P174, DOI 10.1016/S0925-4439(02)00080-7; Mathews David H, 2007, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1102s28; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Sanchez-Diaz Patricia, 2006, RNA Biol, V3, P101; SWAIN SM, 1989, J CLIN ONCOL, V7, P890, DOI 10.1200/JCO.1989.7.7.890; Tai NW, 2004, FRONT BIOSCI-LANDMRK, V9, P2521, DOI 10.2741/1413; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	28	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10618	10.1371/journal.pone.0010618	http://dx.doi.org/10.1371/journal.pone.0010618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485548	Green Submitted, Green Published, gold			2022-12-25	WOS:000277563400021
J	Mackenzie, G; Ceesay, SJ; Hill, PC; Walther, M; Bojang, KA; Satoguina, J; Enwere, G; D'Alessandro, U; Saha, D; Ikumapayi, UNA; O'Dempsey, T; Mabey, DCW; Corrah, T; Conway, DJ; Adegbola, RA; Greenwood, BM				Mackenzie, Grant; Ceesay, Serign J.; Hill, Philip C.; Walther, Michael; Bojang, Kalifa A.; Satoguina, Judith; Enwere, Godwin; D'Alessandro, Umberto; Saha, Debasish; Ikumapayi, Usman N. A.; O'Dempsey, Tim; Mabey, David C. W.; Corrah, Tumani; Conway, David J.; Adegbola, Richard A.; Greenwood, Brian M.			A Decline in the Incidence of Invasive Non-Typhoidal Salmonella Infection in the Gambia Temporally Associated with a Decline in Malaria Infection	PLOS ONE			English	Article							PNEUMOCOCCAL DISEASE; WEST-AFRICA; MALAWIAN CHILDREN; KENYAN CHILDREN; BACTEREMIA; COMMUNITY; PNEUMONIA; MORTALITY; EFFICACY; VACCINE	Background: Malaria is a risk factor for invasive non-typhoidal Salmonella (NTS) infection in children. In the last 10 years, indices of malaria infection in The Gambia have fallen substantially. Methods: We compared temporal trends of childhood malaria and NTS infection in two Gambian locations. In Fajara, on the coast, the incidence of NTS infection at three time points between 1979 and 2005 was compared to the percentage of malaria positive outpatient thick blood films and the percentage of admissions associated with malaria over time. In Basse, in the eastern part of the country, the incidence of NTS infection at three time points between 1989 and 2008 was compared to the prevalence of malaria parasitaemia at four time points between 1992 and 2008. Results: The estimated incidence of NTS infection in Fajara fell from 60 (1979-1984) to 10 (2003-05) cases per 100,000 person years. The proportion of outpatients in Fajara with suspected malaria who were parasitaemic fell from 33% (1999) to 6% (2007) while the proportion of admissions associated with malaria fell from 14.5% (1999) to 5% (2007). In Basse, the estimated incidence of NTS infection fell from 105 (1989-1991) to 29 (2008) cases per 100,000 person years while the prevalence of malaria parasitaemia fell from 45% (1992) to 10% (2008). The incidence of pneumococcal bacteraemia in Fajara and Basse did not fall over the study period. Conclusions: These data support an association between malaria and NTS infection. Reductions in malaria infection may be associated with reduced rates of invasive childhood NTS infection.	[Mackenzie, Grant; Ceesay, Serign J.; Walther, Michael; Bojang, Kalifa A.; Satoguina, Judith; Saha, Debasish; Ikumapayi, Usman N. A.; Corrah, Tumani; Conway, David J.; Adegbola, Richard A.] Med Res Council United Kingdom Gambia, Fajara, Gambia; [Hill, Philip C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand; [Enwere, Godwin] Program Appropriate Technol Hlth, Meningitis Vaccine Program, Ferney Voltaire, France; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [O'Dempsey, Tim] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Mabey, David C. W.; Greenwood, Brian M.] London Sch Hyg & Trop Med, London WC1, England; [Adegbola, Richard A.] Bill & Melinda Gates Fdn, Seattle, WA USA	University of London; London School of Hygiene & Tropical Medicine; University of Otago; Institute of Tropical Medicine (ITM); Liverpool School of Tropical Medicine; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; Bill & Melinda Gates Foundation	Mackenzie, G (corresponding author), Med Res Council United Kingdom Gambia, Fajara, Gambia.	gmackenzie@mrc.gm	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Mabey, David/0000-0002-0031-8276; Bojang, Kalifa/0000-0001-7506-0938; Mackenzie, Grant/0000-0002-4994-2627; Conway, David/0000-0002-8711-3037	Medical Research Council Fajara Clinical Service [MRC(UK)]; URR Salmonella disease epidemiology	Medical Research Council Fajara Clinical Service [MRC(UK)]; URR Salmonella disease epidemiology	Financial support for the studies which contributed data was as follows: Medical Research Council Fajara Clinical Service [MRC(UK)], URR Salmonella disease epidemiology 1989-91 [MRC(UK), United States Agency for International Development] and 2008 (GAVI's PneumoADIP), Hib vaccine trial (World Health Organization, USAID, The United Nations Children's Fund, United Nations Development Programme), Pneumococcal vaccine trial (National Institutes of Health, WHO, PATH, USAID, Wyeth), Insecticide Treated Net evaluation (UNDP, World Bank, WHO), Malaria vaccine trial [MRC(UK)], Malaria prevalence survey 2008 [MRC(UK)]. The authors thank MRC(UK) The Gambia for the administrative and infrastructure support which made possible all the studies which contributed to this report. The funders of the different studies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bojang KA, 1998, VACCINE, V16, P62, DOI 10.1016/S0264-410X(97)00159-X; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; *GAMB BUR STAT, 2002, GAMB MULT IND CLUST; *GAMB BUR STAT, 1998, GAMB MULT IND CLUST; Gambia Bureau of Statistics, 2007, GAMB MULT IND CLUST; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; GREEN SDR, 1993, ANN TROP PAEDIATR, V13, P45, DOI 10.1080/02724936.1993.11747624; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; NESBITT A, 1989, J TROP PEDIATRICS, V35, P35, DOI 10.1093/tropej/35.1.35; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Poskitt EME, 1999, ARCH DIS CHILD, V80, P115, DOI 10.1136/adc.80.2.115; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Usen S, 1998, PEDIATR INFECT DIS J, V17, P23, DOI 10.1097/00006454-199801000-00006; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010	24	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10568	10.1371/journal.pone.0010568	http://dx.doi.org/10.1371/journal.pone.0010568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485496	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000277563200005
J	Shimbo, T; Tanemura, A; Yamazaki, T; Tamai, K; Katayama, I; Kaneda, Y				Shimbo, Takashi; Tanemura, Atsushi; Yamazaki, Takehiko; Tamai, Katsuto; Katayama, Ichiro; Kaneda, Yasufumi			Serum Anti-BPAG1 Auto-Antibody Is a Novel Marker for Human Melanoma	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; BULLOUS PEMPHIGOID ANTIGEN-1; TUMOR-ASSOCIATED ANTIGENS; PHAGE-DISPLAY SELECTION; T-CELLS; AUTOIMMUNE-DISEASE; VITILIGO; GENE; IDENTIFICATION; INTERFERON	Malignant melanoma is one of the most aggressive types of tumor. Because malignant melanoma is difficult to treat once it has metastasized, early detection and treatment are essential. The search for reliable biomarkers of early-stage melanoma, therefore, has received much attention. By using a novel method of screening tumor antigens and their auto-antibodies, we identified bullous pemphigoid antigen 1 (BPAG1) as a melanoma antigen recognized by its auto-antibody. BPAG1 is an auto-antigen in the skin disease bullous pemphigoid (BP) and anti-BPAG1 auto-antibodies are detectable in sera from BP patients and are used for BP diagnosis. However, BPAG1 has been viewed as predominantly a keratinocyte-associated protein and a relationship between BPAG1 expression and melanoma has not been previously reported. In the present study, we show that bpag1 is expressed in the mouse F10 melanoma cell line in vitro and F10 melanoma tumors in vivo and that BPAG1 is expressed in human melanoma cell lines (A375 and G361) and normal human melanocytes. Moreover, the levels of anti-BPAG1 auto-antibodies in the sera of melanoma patients were significantly higher than in the sera of healthy volunteers (p<0.01). Furthermore, anti-BPAG1 auto-antibodies were detected in melanoma patients at both early and advanced stages of disease. Here, we report anti-BPAG1 auto-antibodies as a promising marker for the diagnosis of melanoma, and we discuss the significance of the detection of such auto-antibodies in cancer biology and patients.	[Shimbo, Takashi; Yamazaki, Takehiko; Tamai, Katsuto; Kaneda, Yasufumi] Osaka Univ, Div Gene Therapy Sci, Grad Sch Med, Osaka, Japan; [Tanemura, Atsushi; Katayama, Ichiro] Osaka Univ, Dept Dermatol, Grad Sch Med, Osaka, Japan	Osaka University; Osaka University	Shimbo, T (corresponding author), Osaka Univ, Div Gene Therapy Sci, Grad Sch Med, Osaka, Japan.	kaneday@gts.med.osaka-u.ac.jp			Biomedical Cluster Kansai; Ministry of Education, Culture, Sports, Science and Technology	Biomedical Cluster Kansai; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is supported by the Biomedical Cluster Kansai project, which is promoted by the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosserhoff AK, 2006, CLIN CHIM ACTA, V367, P28, DOI 10.1016/j.cca.2005.10.029; Brochez L, 2000, BRIT J DERMATOL, V143, P256, DOI 10.1046/j.1365-2133.2000.03649.x; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; BYSTRYN JC, 1989, CLIN DERMATOL, V7, P136, DOI 10.1016/0738-081X(89)90063-1; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Ehlken H, 2004, INT J CANCER, V108, P307, DOI 10.1002/ijc.11537; Forgber M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005199; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Huang SKS, 1998, J INVEST DERMATOL, V111, P662, DOI 10.1046/j.1523-1747.1998.00354.x; Ikuta Y, 2005, CLIN CANCER RES, V11, P8079, DOI 10.1158/1078-0432.CCR-05-1074; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kasperkiewicz M, 2007, CLIN REV ALLERG IMMU, V33, P67, DOI 10.1007/s12016-007-0030-y; Kawakami Y, 1997, IMMUNOL RES, V16, P313, DOI 10.1007/BF02786397; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Krag DN, 2006, CANCER RES, V66, P7724, DOI 10.1158/0008-5472.CAN-05-4441; LABIB RS, 1986, J IMMUNOL, V136, P1231; Lee CW, 2000, BRIT J DERMATOL, V143, P821, DOI 10.1046/j.1365-2133.2000.03838.x; Lee Lewis, 2007, V136, P369; Li G, 2004, CANCER IMMUNOL IMMUN, V53, P139, DOI 10.1007/s00262-003-0471-y; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; MUTASIM DF, 1985, J INVEST DERMATOL, V84, P47, DOI 10.1111/1523-1747.ep12274684; Nakatsura T, 2004, CLIN CANCER RES, V10, P6612, DOI 10.1158/1078-0432.CCR-04-0348; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Okumura M, 2002, J BIOL CHEM, V277, P6682, DOI 10.1074/jbc.M109209200; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Ram M, 2007, ANN NY ACAD SCI, V1110, P410, DOI 10.1196/annals.1423.043; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; Sun YJ, 2009, J IMMUNOL METHODS, V347, P46, DOI 10.1016/j.jim.2009.06.002; Tanaka M, 2010, INT J CANCER, V126, P1982, DOI 10.1002/ijc.24965; Wei WZ, 2005, CANCER RES, V65, P8471, DOI 10.1158/0008-5472.CAN-05-0934; Young KG, 2007, CELL MOTIL CYTOSKEL, V64, P897, DOI 10.1002/cm.20235	39	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10566	10.1371/journal.pone.0010566	http://dx.doi.org/10.1371/journal.pone.0010566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479946	Green Submitted, gold, Green Published			2022-12-25	WOS:000277467900018
J	Luig, C; Kother, K; Dudek, SE; Gaestel, M; Hiscott, J; Wixler, V; Ludwig, S				Luig, Christina; Koether, Katharina; Dudek, Sabine Eva; Gaestel, Matthias; Hiscott, John; Wixler, Viktor; Ludwig, Stephan			MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR	FASEB JOURNAL			English	Article						MAPKAPK; tetrameric protein complex	DOUBLE-STRANDED-RNA; RAS SIGNALING PATHWAY; TUMOR-NECROSIS-FACTOR; P58(IPK); MK2; STABILIZATION; BIOSYNTHESIS; EXPRESSION; INDUCTION; ONCOLYSIS	Influenza viruses have to overcome the type I interferon induced antiviral response to successfully propagate in target cells. A major antiviral factor induced by interferons is the protein kinase R (PKR) that is further activated by dsRNA and phosphorylates the eukaryotic initiation factor 2 (eIF2 alpha). This results in inhibition of protein translation thereby limiting viral replication. Here we describe a novel mechanism by which influenza A viruses escape the antiviral action of PKR. We demonstrate that the mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) MK2 and MK3 are activated on virus infection and, in their active form, directly interact with the repressor of the inhibitor of PKR p88(rIPK). This leads to recruitment of a tetrameric protein complex consisting of p88(rIPK), the inhibitor of PKR p58(IPK) and PKR itself, and finally results in inhibition of the kinase. The importance of MKs for influenza virus propagation was further underscored by demonstrating reduced viral progeny in cells genetically deficient in MK2 or MK3 genes as well as in highly proliferating tumor cells, in which expression of MKs was diminished by specific small interfering RNA. Accordingly, knockdown of MKs resulted in enhanced phosphorylation of PKR and its substrate eIF2 alpha.-Luig, C., Kother, K., Dudek, S. E., Gaestel, M., Hiscott, J., Wixler, V., Ludwig, S. MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR. FASEB J. 24, 4068-4077 (2010). www.fasebj.org	[Luig, Christina; Koether, Katharina; Dudek, Sabine Eva; Wixler, Viktor; Ludwig, Stephan] Univ Munster, Inst Mol Virol, D-48149 Munster, Germany; [Luig, Christina; Koether, Katharina; Dudek, Sabine Eva; Wixler, Viktor; Ludwig, Stephan] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-3000 Hannover, Germany; [Hiscott, John] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	University of Munster; University of Munster; Hannover Medical School; Lady Davis Institute; McGill University	Ludwig, S (corresponding author), Univ Munster, Inst Mol Virol, Von Esmarch Str 56, D-48149 Munster, Germany.	ludwigs@uni-muenster.de	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; Ludwig, Stephan/0000-0003-4490-3052	German Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft (DFG) [GRK1409]; Interdisciplinary Clinical Research Centre (IZKF) of the University of Munster	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Clinical Research Centre (IZKF) of the University of Munster	The authors thank Michael Gale (Department of Immunology, University of Washington School of Medicine, Seattle, WA, USA) for providing the pCMVflag-p58<SUP>rIPK</SUP> plasmid. This work was supported by the Graduate School GRK1409 from the Deutsche Forschungsgemeinschaft (DFG); the Interdisciplinary Clinical Research Centre (IZKF) of the University of Munster; and the FluResearchNet, funded by the German Ministry of Education and Research (BMBF).	Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Farassati F, 2001, NAT CELL BIOL, V3, P745, DOI 10.1038/35087061; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gale M, 1998, MOL CELL BIOL, V18, P859, DOI 10.1128/MCB.18.2.859; Gale M, 2002, BIOCHEMISTRY-US, V41, P11878, DOI 10.1021/bi020397e; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, BIOCHEM SOC T, V30, P959, DOI 10.1042/BST0300959; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ludwig S, 1996, MOL CELL BIOL, V16, P6687; Ludwig S, 2004, FEBS LETT, V561, P37, DOI 10.1016/S0014-5793(04)00108-5; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Ludwig S, 2001, J BIOL CHEM, V276, P10990, DOI 10.1074/jbc.M009902200; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; Mizumura K, 2003, CLIN EXP ALLERGY, V33, P1244, DOI 10.1046/j.1365-2222.2003.01750.x; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Olschlager V, 2004, ONCOGENE, V23, P6639, DOI 10.1038/sj.onc.1207883; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Polyak SJ, 1996, J BIOL CHEM, V271, P1702, DOI 10.1074/jbc.271.3.1702; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Smith KD, 2006, J VIROL, V80, P1110, DOI 10.1128/JVI.80.3.1110-1120.2006; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Tan SL, 1998, MOL CELL BIOL, V18, P2431, DOI 10.1128/MCB.18.5.2431; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zakowski V, 2004, EXP CELL RES, V299, P101, DOI 10.1016/j.yexcr.2004.05.027	33	25	26	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					4068	4077		10.1096/fj.10-158766	http://dx.doi.org/10.1096/fj.10-158766			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20484669				2022-12-25	WOS:000285005900042
J	Duriseti, S; Goetz, DH; Hostetter, DR; LeBeau, AM; Wei, Y; Craik, CS				Duriseti, Sai; Goetz, David H.; Hostetter, Daniel R.; LeBeau, Aaron M.; Wei, Ying; Craik, Charles S.			Antagonistic Anti-urokinase Plasminogen Activator Receptor (uPAR) Antibodies Significantly Inhibit uPAR-mediated Cellular Signaling and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; IN-VITRO; CELLS; METASTASIS; VITRONECTIN; PROGRESSION; ALPHA-5-BETA-1; IDENTIFICATION; ADHESION; INVASION	Interactions between urokinase plasminogen activator receptor (uPAR) and its various ligands regulate tumor growth, invasion, and metastasis. Antibodies that bind specific uPAR epitopes may disrupt these interactions, thereby inhibiting these processes. Using a highly diverse and naive human fragment of the antigen binding (Fab) phage display library, we identified 12 unique human Fabs that bind uPAR. Two of these antibodies compete against urokinase plasminogen activator (uPA) for uPAR binding, whereas a third competes with beta 1 integrins for uPAR binding. These competitive antibodies inhibit uPAR-dependent cell signaling and invasion in the non-small cell lung cancer cell line, H1299. Additionally, the integrin-blocking antibody abrogates uPAR/beta 1 integrin-mediated H1299 cell adhesion to fibronectin and vitronectin. This antibody and one of the uPAR/uPA antagonist antibodies shows a significant combined effect in inhibiting cell invasion through Matrigel/Collagen I or Collagen I matrices. Our results indicate that these antagonistic antibodies have potential for the detection and treatment of uPAR-expressing tumors.	[Wei, Ying] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Wei, Ying] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Duriseti, Sai] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Goetz, David H.; Hostetter, Daniel R.; LeBeau, Aaron M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wei, Y (corresponding author), HSE 201,514 Parnassus Ave, San Francisco, CA 94143 USA.	ying.wei@ucsf.edu; craik@cgl.ucsf.edu			National Institutes of Health [5T32GM008284-22, CA128765, GM073210, CA125564]; Leukemia and Lymphoma Society [5552-06]; NATIONAL CANCER INSTITUTE [R01CA125564, R01CA128765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210, T32GM008284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5T32GM008284-22 (to S. D.), CA128765 and GM073210 (to C. S. C.), and CA125564 and CA125564 (to Y. W. and Harold A. Chapman). This work was also supported by Leukemia and Lymphoma Society Fellowship 5552-06 (to D. R. H.).	Alfano D, 2005, THROMB HAEMOSTASIS, V93, P205, DOI 10.1160/TH04-09-0592; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259; Carriero MV, 1999, CANCER RES, V59, P5307; Chaurasia P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004617; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Dass CR, 2008, CANCER BIOL THER, V7, P1262, DOI 10.4161/cbt.7.8.6265; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Gaultier A, 2010, MATRIX BIOL, V29, P22, DOI 10.1016/j.matbio.2009.08.003; GYETKO MR, 1994, J CLIN INVEST, V93, P1380, DOI 10.1172/JCI117114; He Y, 2007, CLIN CANCER RES, V13, P3115, DOI 10.1158/1078-0432.CCR-06-2088; HolstHansen C, 1996, CLIN EXP METASTAS, V14, P297; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kogianni G, 2009, EUR J CANCER, V45, P685, DOI 10.1016/j.ejca.2008.11.023; Lakka SS, 2001, CLIN CANCER RES, V7, P1087; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mazar AP, 2008, CLIN CANCER RES, V14, P5649, DOI 10.1158/1078-0432.CCR-07-4863; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Okumura Y, 1997, FEBS LETT, V402, P181, DOI 10.1016/S0014-5793(96)01523-2; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SCHNAPER HW, 1995, J CELL PHYSIOL, V165, P107, DOI 10.1002/jcp.1041650114; Sitrin RG, 2000, J IMMUNOL, V165, P3341, DOI 10.4049/jimmunol.165.6.3341; Solberg H, 2001, J HISTOCHEM CYTOCHEM, V49, P237, DOI 10.1177/002215540104900211; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tang CH, 2008, J CELL SCI, V121, P3747, DOI 10.1242/jcs.029769; Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Tyndall JDA, 2008, RECENT PAT ANTI-CANC, V3, P1, DOI 10.2174/157489208783478711; van der Pluijm G, 2001, AM J PATHOL, V159, P971, DOI 10.1016/S0002-9440(10)61773-7; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200	35	47	52	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26878	26888		10.1074/jbc.M109.077677	http://dx.doi.org/10.1074/jbc.M109.077677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20501655	hybrid, Green Published			2022-12-25	WOS:000281172700019
J	Maun, HR; Wen, XH; Lingel, A; de Sauvage, FJ; Lazarus, RA; Scales, SJ; Hymowitz, SG				Maun, Henry R.; Wen, Xiaohui; Lingel, Andreas; de Sauvage, Frederic J.; Lazarus, Robert A.; Scales, Suzie J.; Hymowitz, Sarah G.			Hedgehog Pathway Antagonist 5E1 Binds Hedgehog at the Pseudo-active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SONIC HEDGEHOG; ANIMAL DEVELOPMENT; CRYSTAL-STRUCTURE; ANTIBODY; PROTEIN; CANCER; CDO; COMPLEX; DIFFERENTIATION; REQUIREMENT	Proper hedgehog (Hh) signaling is crucial for embryogenesis and tissue regeneration. Dysregulation of this pathway is associated with several types of cancer. The monoclonal antibody 5E1 is a Hh pathway inhibitor that has been extensively used to elucidate vertebrate Hh biology due to its ability to block binding of the three mammalian Hh homologs to the receptor, Patched1 (Ptc1). Here, we engineered a murine: human chimeric 5E1 (ch5E1) with similar Hh-binding properties to the original murine antibody. Using biochemical, biophysical, and x-ray crystallographic studies, we show that, like the regulatory receptors Cdon and Hedgehog-interacting protein (Hhip), ch5E1 binding to Sonic hedgehog (Shh) is enhanced by calcium ions. In the presence of calcium and zinc ions, the ch5E1 binding affinity increases 10-20-fold to tighter than 1 nM primarily because of a decrease in the dissociation rate. The co-crystal structure of Shh bound to the Fab fragment of ch5E1 reveals that 5E1 binds at the pseudo-active site groove of Shh with an epitope that largely overlaps with the binding site of its natural receptor antagonist Hhip. Unlike Hhip, the side chains of 5E1 do not directly coordinate the Zn2+ cation in the pseudo-active site, despite the modest zinc-dependent increase in 5E1 affinity for Shh. Furthermore, to our knowledge, the ch5E1 Fab-Shh complex represents the first structure of an inhibitor antibody bound to a metalloprotease fold.	[Hymowitz, Sarah G.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Wen, Xiaohui; de Sauvage, Frederic J.; Scales, Suzie J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Hymowitz, SG (corresponding author), Genentech Inc, Dept Biol Struct, 1 DNA Way, San Francisco, CA 94080 USA.	hymowitz@gene.com	Lingel, Andreas/AAP-5078-2021; Scales, Suzie J./H-4507-2019; de Sauvage, Frederic/ABE-8400-2020	Scales, Suzie J./0000-0003-2544-0283; de Sauvage, Frederic/0000-0002-5275-2584	National Institutes of Health; NIGMS; United States Department of Energy	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE))	We thank Kurt Schroeder for growing the mouse 5E1 hybridoma; Wendy Sandoval for N-terminally sequencing 5E1; Yongmei Chen and Yan Wu for making the ch5E1 mammalian expression construct; George Dutina, Mark Nagel, and Erin Harrod for expressing and purifying ch5E1; Richard Vandlen for isolation of ch5E1 Fab; Hua Tian for the mouse embryo; Steven Russell for atomic absorption spectroscopy, and Christine Yu for mounting and characterizing the crystals. We also gratefully acknowledge our collaborators at Curis, Inc. (Cambridge, MA), for providing the mouse 5E1 hybridoma. ALS beamline 5.0.1 and the Berkeley Center for Structural Biology are supported by the National Institutes of Health, NIGMS, and United States Department of Energy.	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Arnaud J, 2008, CLIN CHEM, V54, P1892, DOI 10.1373/clinchem.2008.108142; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; BOROWSKI M, 1986, J BIOL CHEM, V261, P4969; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Day ES, 1999, BIOCHEMISTRY-US, V38, P14868, DOI 10.1021/bi9910068; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Farady CJ, 2008, J MOL BIOL, V380, P351, DOI 10.1016/j.jmb.2008.05.009; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; HORN IR, 1995, J BIOL CHEM, V270, P11770, DOI 10.1074/jbc.270.20.11770; Huang MD, 2004, J BIOL CHEM, V279, P14338, DOI 10.1074/jbc.M314011200; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kang JS, 1997, J CELL BIOL, V138, P203, DOI 10.1083/jcb.138.1.203; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; KOBAYASHI K, 1991, J BIOCHEM-TOKYO, V109, P551, DOI 10.1093/oxfordjournals.jbchem.a123418; Koyama E, 2003, DEV DYNAM, V226, P149, DOI 10.1002/dvdy.10217; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; MAUN HR, 2010, BIOL CHEM IN PRESS; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Peng LF, 2009, BIOORG MED CHEM LETT, V19, P6319, DOI 10.1016/j.bmcl.2009.09.089; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; PRICKETT KS, 1989, BIOTECHNIQUES, V7, P580; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Stanton BZ, 2009, NAT CHEM BIOL, V5, P154, DOI 10.1038/nchembio.142; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; WARD SL, 1992, MOL IMMUNOL, V29, P83, DOI 10.1016/0161-5890(92)90160-Y; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhou TQ, 2005, P NATL ACAD SCI USA, V102, P14575, DOI 10.1073/pnas.0507267102	61	103	107	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26570	26580		10.1074/jbc.M110.112284	http://dx.doi.org/10.1074/jbc.M110.112284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20504762	Green Published, hybrid			2022-12-25	WOS:000280921000073
J	Kim, CH; Shin, YP; Noh, MY; Jo, YH; Han, YS; Seong, YS; Lee, IH				Kim, Chong Han; Shin, Yong Pyo; Noh, Mi Young; Jo, Yong Hun; Han, Yeon Soo; Seong, Yeon Sun; Lee, In Hee			An Insect Multiligand Recognition Protein Functions as an Opsonin for the Phagocytosis of Microorganisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; GREAT WAX MOTH; GALLERIA-MELLONELLA; APOLIPOPHORIN-III; INNATE IMMUNITY; CDNA CLONING; PATTERN-RECOGNITION; LIPOTEICHOIC ACID; HOST-DEFENSE; BOMBYX-MORI	We characterize a novel pathogen recognition protein obtained from the lepidopteran Galleria mellonella. This protein recognizes Escherichia coli, Micrococcus luteus, and Candida albicans via specific binding to lipopolysaccharides, lipoteichoic acid, and beta-1,3-glucan, respectively. As a multiligand receptor capable of coping with a broad variety of invading pathogens, it is constitutively produced in the fat body, midgut, and integument but not in the hemocytes and is secreted into the hemolymph. The protein was confirmed to be relevant to cellular immune response and to further function as an opsonin that promotes the uptake of invading microorganisms into hemocytes. Our data reveal that the mechanism by which a multiligand receptor recognizes microorganisms contributes substantially to their phagocytosis by hemocytes. A better understanding of an opsonin with the required repertoire for detecting diverse invaders might provide us with critical insights into the mechanisms underlying insect phagocytosis.	[Kim, Chong Han; Shin, Yong Pyo; Lee, In Hee] Hoseo Univ, Dept Biotechnol, Asan 336795, Chungnam, South Korea; [Noh, Mi Young; Jo, Yong Hun; Han, Yeon Soo] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Agr Biol, Kwangju 500257, South Korea; [Seong, Yeon Sun] Dankook Univ, Coll Med, Dept Biochem, Cheonan 330714, Chungnam, South Korea	Hoseo University; Chonnam National University; Dankook University	Lee, IH (corresponding author), Hoseo Univ, Dept Biotechnol, Asan 336795, Chungnam, South Korea.	leeih@hoseo.edu	SEONG, YEON-SUN/B-2485-2016	SEONG, YEON-SUN/0000-0002-4743-8048	National Research Foundation of Korea [NRF 2009-007/968]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grant NRF 2009-007/968.	Boman HG, 1998, SCAND J IMMUNOL, V48, P15; Costa SCP, 2005, J INSECT PHYSIOL, V51, P39, DOI 10.1016/j.jinsphys.2004.10.014; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Frobius AC, 2000, EUR J BIOCHEM, V267, P2046, DOI 10.1046/j.1432-1327.2000.01207.x; Halwani AE, 2000, J INVERTEBR PATHOL, V76, P233, DOI 10.1006/jipa.2000.4978; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Iimura Y, 1998, ARCH INSECT BIOCHEM, V38, P119, DOI 10.1002/(SICI)1520-6327(1998)38:3&lt;119::AID-ARCH2&gt;3.0.CO;2-N; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kim CH, 2004, MOL CELLS, V17, P262; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lee YS, 2004, INSECT MOL BIOL, V13, P65, DOI 10.1111/j.1365-2583.2004.00462.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ling EJ, 2009, INSECT BIOCHEM MOLEC, V39, P263, DOI 10.1016/j.ibmb.2008.12.006; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Nagai T, 2000, J BIOL CHEM, V275, P29264, DOI 10.1074/jbc.M002556200; Park SY, 2005, DEV COMP IMMUNOL, V29, P43, DOI 10.1016/j.dci.2004.06.001; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Scott MG, 1999, INFECT IMMUN, V67, P6445; Shrivastava B, 2003, INSECT BIOCHEM MOLEC, V33, P1025, DOI 10.1016/S0965-1748(03)00117-6; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Wang XG, 2006, CELL MICROBIOL, V8, P1581, DOI 10.1111/j.1462-5822.2006.00732.x; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2002, EUR J BIOCHEM, V269, P1827, DOI 10.1046/j.1432-1033.2002.02830.x; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200	34	22	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25243	25250		10.1074/jbc.M110.134940	http://dx.doi.org/10.1074/jbc.M110.134940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20519517	hybrid, Green Published			2022-12-25	WOS:000280682400017
J	Mattiello, T; Fiore, G; Brown, ER; d'Ischia, M; Palumbo, A				Mattiello, Teresa; Fiore, Gabriella; Brown, Euan R.; d'Ischia, Marco; Palumbo, Anna			Nitric Oxide Mediates the Glutamate-dependent Pathway for Neurotransmission in Sepia officinalis Chromatophore Organs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; RYANODINE RECEPTOR; SYNTHASE; LOCALIZATION; RELEASE; CALCIUM; DONORS; SQUID; STIMULATION; SKELETAL	Chromatophore organs are complex and unique structures responsible for the variety of body coloration patterns used by cephalopods to communicate and camouflage. They are formed by a pigment-containing cytoelastic sacculus, surrounded by muscle fibers directly innervated from the brain. Muscle contraction and relaxation are responsible for expansion and retraction of the pigment-containing cell. Their functioning depends on glutamate and Phe-Met-Arg-Phe-NH2-related peptides, which induce fast and slow cell expansion, respectively, and 5-hydroxytryptamine, which induces retraction. Apart from these three substances and acetylcholine, which acts presynaptically, no other neuroactive compounds have so far been found to be involved in the neuroregulation of chromatophore physiology, and the detailed signaling mechanisms are still little understood. Herein, we disclose the role of nitric oxide (NO) as mediator in one of the signaling pathways by which glutamate activates body patterning. NO and nitric-oxide synthase have been detected in pigment and muscle fibers of embryo, juvenile, and adult chromatophore organs from Sepia officinalis. NO-mediated Sepia chromatophore expansion operates at slower rate than glutamate and involves cGMP, cyclic ADP-ribose, and ryanodine receptor activation. These results demonstrate for the first time that NO is an important messenger in the long term maintenance of the body coloration patterns in Sepia.	Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, I-80121 Naples, Italy; [Brown, Euan R.] Stn Zool Anton Dohrn, Lab Anim Physiol & Evolut, I-80121 Naples, Italy; [d'Ischia, Marco] Univ Naples Federico II, Dept Organ Chem & Biochem, I-80126 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II		palumbo@szn.it	d'Ischia, Marco/C-9837-2011; Brown, Euan Robert/I-2389-2019; Brown, Euan R/A-5558-2008	d'Ischia, Marco/0000-0002-7184-0029; Brown, Euan Robert/0000-0002-5995-834X; Brown, Euan R/0000-0002-5995-834X; Palumbo, Anna/0000-0002-5972-5589				Campbell RK, 2007, AM J PHYSIOL-GASTR L, V292, pG1543, DOI 10.1152/ajpgi.00111.2006; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Chao DS, 1996, METHOD ENZYMOL, V268, P488; Davidson SK, 2004, CELL MICROBIOL, V6, P1139, DOI 10.1111/j.1462-5822.2004.00429.x; Di Cosmo A, 2000, J COMP NEUROL, V428, P411, DOI 10.1002/1096-9861(20001218)428:3<411::AID-CNE3>3.0.CO;2-#; Di Cristo C, 2007, EUR J NEUROSCI, V26, P1599, DOI 10.1111/j.1460-9568.2007.05765.x; DUBAS F, 1986, J EXP BIOL, V121, P1; Fiore G, 2004, BIOCHEM J, V378, P785, DOI 10.1042/BJ20031864; FLOREY E, 1969, AM ZOOL, V9, P429; FOX HM, 1960, NATURE ANIMAL COLOUR, P50; Halm MP, 2003, COMP BIOCHEM PHYS C, V134, P139, DOI 10.1016/S1532-0456(02)00223-5; Han Q, 2003, INSECT MOL BIOL, V12, P483, DOI 10.1046/j.1365-2583.2003.00433.x; Hanlon R, 2007, CURR BIOL, V17, pR400, DOI 10.1016/j.cub.2007.03.034; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; LEMAIRE J, 1970, Bulletin de la Societe Zoologique de France, V95, P773; Li Q, 2009, NITRIC OXIDE-BIOL CH, V21, P69, DOI 10.1016/j.niox.2009.04.001; Lima PA, 2003, EUR J NEUROSCI, V17, P507, DOI 10.1046/j.1460-9568.2003.02477.x; LIMA PA, 1997, J PHYSL, pP2; LIMA PA, 1998, J PHYSL, pP127; Loi PK, 1997, J EXP BIOL, V200, P1483; Loi PK, 1996, J EXP BIOL, V199, P1177; Lopez AS, 2006, IMMUNOL LETT, V106, P163, DOI 10.1016/j.imlet.2006.05.008; Messenger JB, 2001, BIOL REV, V76, P473, DOI 10.1017/S1464793101005772; Packard A., 1977, Symposia of the Zoological Society of London, P191; Palumbo A, 1999, J NEUROCHEM, V73, P1254, DOI 10.1046/j.1471-4159.1999.0731254.x; Palumbo A, 2000, J BIOL CHEM, V275, P16885, DOI 10.1074/jbc.M909509199; Palumbo A, 2007, ADV EXP BIOL, V1, P45, DOI 10.1016/S1872-2423(07)01002-2; Ramamurthi A, 1997, CHEM RES TOXICOL, V10, P408, DOI 10.1021/tx960183w; ROBERTSON JD, 1994, P ROY SOC B-BIOL SCI, V256, P269, DOI 10.1098/rspb.1994.0080; Robertson JD, 1996, P ROY SOC B-BIOL SCI, V263, P1739, DOI 10.1098/rspb.1996.0254; Schipp R., 1999, Invertebrate Neuroscience, V4, P9, DOI 10.1007/s101580050002; Schmidt K, 1997, N-S ARCH PHARMACOL, V355, P457, DOI 10.1007/PL00004969; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Thomas SR, 2007, J BIOL CHEM, V282, P23778, DOI 10.1074/jbc.M700669200; Tu YJ, 2000, BRAIN RES, V865, P211, DOI 10.1016/S0006-8993(00)02222-8; Welshhans K, 2007, EUR J NEUROSCI, V26, P1537, DOI 10.1111/j.1460-9568.2007.05768.x; Willmott N, 1996, J BIOL CHEM, V271, P3699; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234	41	21	21	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24154	24163		10.1074/jbc.M109.083428	http://dx.doi.org/10.1074/jbc.M109.083428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516065	hybrid, Green Published			2022-12-25	WOS:000280291400065
J	Kultti, A; Karna, R; Rilla, K; Nurminen, P; Koli, E; Makkonen, KM; Si, JT; Tammi, MI; Tammi, RH				Kultti, Anne; Karna, Riikka; Rilla, Kirsi; Nurminen, Pertti; Koli, Elina; Makkonen, Katri M.; Si, Jutong; Tammi, Markku I.; Tammi, Raija H.			Methyl-beta-cyclodextrin Suppresses Hyaluronan Synthesis by Down-regulation of Hyaluronan Synthase 2 through Inhibition of Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LIPID RAFTS; CHOLESTEROL CONTENT; EPIDERMAL-KERATINOCYTES; DERMAL FIBROBLASTS; TGF-BETA; STREPTOCOCCUS-EQUISIMILIS; DIFFERENTIAL REGULATION; ACTIVATES HYALURONAN; GENE-EXPRESSION	Hyaluronan synthases (HAS1-3) are integral plasma membrane proteins that synthesize hyaluronan, a cell surface and extracellular matrix polysaccharide necessary for many biological processes. It has been shown that HAS is partly localized in cholesterol-rich lipid rafts of MCF-7 cells, and cholesterol depletion with methyl-beta-cyclodextrin (M beta CD) suppresses hyaluronan secretion in smooth muscle cells. However, the mechanism by which cholesterol depletion inhibits hyaluronan production has remained unknown. We found that cholesterol depletion from MCF-7 cells by M beta CD inhibits synthesis but does not decrease the molecular mass of hyaluronan, suggesting no major influence on HAS stability in the membrane. The inhibition of hyaluronan synthesis was not due to the availability of HASsubstrates UDP-GlcUA and UDP-GlcNAc. Instead, M beta CD specifically down-regulated the expression of HAS2 but not HAS1 or HAS3. Screening of signaling proteins after M beta CD treatment revealed that phosphorylation of Akt and its downstream target p70S6 kinase, both members of phosphoinositide 3-kinase-Akt pathway, were inhibited. Inhibitors of this pathway suppressed hyaluronan synthesis and HAS2 expression in MCF-7 cells, suggesting that the reduced hyaluronan synthesis by M beta CD is due to down-regulation of HAS2, mediated by the phosphoinositide 3-kinase-Akt-mTOR-p70S6K pathway.	[Kultti, Anne; Karna, Riikka; Rilla, Kirsi; Nurminen, Pertti; Koli, Elina; Makkonen, Katri M.; Tammi, Markku I.; Tammi, Raija H.] Univ Eastern Finland, Inst Biomed, FIN-70211 Kuopio, Finland; [Makkonen, Katri M.] Univ Eastern Finland, Dept Biosci, FIN-70211 Kuopio, Finland; [Si, Jutong] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Eastern Finland; University of Eastern Finland; Fred Hutchinson Cancer Center	Kultti, A (corresponding author), POB 1627, FIN-70211 Kuopio, Finland.	anne.kultti@uef.fi	Tammi, Markku/AAQ-7878-2021	Rilla, Kirsi/0000-0002-7862-5727	Academy of Finland [107173, 108484]; Sigrid Juselius Foundation; Finnish Cancer Foundations; The Mizutani Foundation; Finnish Cultural Foundation; The North Savo Cancer Foundation; Emil Aaltonen Foundation; Kuopio University Foundation; Paavo Koistinen Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Foundations; The Mizutani Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); The North Savo Cancer Foundation; Emil Aaltonen Foundation; Kuopio University Foundation; Paavo Koistinen Foundation	This work was supported by Academy of Finland Grants 107173 and 108484 (to M. I. T.), grants from the Sigrid Juselius Foundation (to M. I. T. and R. H. T.), Finnish Cancer Foundations (to R. H. T.), The Mizutani Foundation (to M. I. T.), Finnish Cultural Foundation (to A. K.), The North Savo Cancer Foundation (to A. K.), Emil Aaltonen Foundation (to A. K.), Kuopio University Foundation (to A. K.), and Paavo Koistinen Foundation (to A. K.).	Barnes K, 2004, BIOCHEM J, V378, P343, DOI 10.1042/BJ20031186; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Christian AE, 1997, J LIPID RES, V38, P2264; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Dattilo JB, 1998, ANN VASC SURG, V12, P168, DOI 10.1007/s100169900136; David-Raoudi M, 2009, ARTHRITIS RHEUM-US, V60, P760, DOI 10.1002/art.24302; dos Santos SM, 2007, BIOCHEM BIOPH RES CO, V354, P216, DOI 10.1016/j.bbrc.2006.12.202; Evanko SP, 1998, AM J PATHOL, V152, P533; GERTLER MM, 1950, CIRCULATION, V2, P205, DOI 10.1161/01.CIR.2.2.205; Glazer HP, 2009, CELL CYCLE, V8, P1738, DOI 10.4161/cc.8.11.8619; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Grosse PY, 1998, BRIT J CANCER, V78, P1165, DOI 10.1038/bjc.1998.648; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jans R, 2004, J INVEST DERMATOL, V123, P564, DOI 10.1111/j.0022-202X.2004.23221.x; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kakizaki I, 2002, EUR J BIOCHEM, V269, P5066, DOI 10.1046/j.1432-1033.2002.03217.x; Kaneko E, 2000, CORONARY ARTERY DIS, V11, P599, DOI 10.1097/00019501-200012000-00005; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Liao PL, 2009, TOXICOL LETT, V190, P172, DOI 10.1016/j.toxlet.2009.07.012; Liu P, 2004, AM J PHYSIOL-CELL PH, V286, pC317, DOI 10.1152/ajpcell.00073.2003; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Monslow J, 2004, J BIOL CHEM, V279, P20576, DOI 10.1074/jbc.M312666200; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Motoyama K, 2009, EUR J PHARM SCI, V38, P249, DOI 10.1016/j.ejps.2009.07.010; Oguchi T, 2004, CONNECT TISSUE RES, V45, P197, DOI 10.1080/03008200490523031; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Pummill PE, 2003, J BIOL CHEM, V278, P19808, DOI 10.1074/jbc.M301097200; Qi MS, 2009, J CELL BIOCHEM, V106, P1031, DOI 10.1002/jcb.22081; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; Sakr SW, 2008, J BIOL CHEM, V283, P36195, DOI 10.1074/jbc.M807772200; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; STEHBENS WE, 1975, LANCET, V1, P724; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Stuhlmeier KM, 2005, J IMMUNOL, V174, P7376, DOI 10.4049/jimmunol.174.11.7376; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Stuhlmeier KM, 2004, RHEUMATOLOGY, V43, P164, DOI 10.1093/rheumatology/keh014; Swyer GIM, 1942, CANCER RES, V2, P372; Tlapak-Simmons VL, 2004, BIOCHEMISTRY-US, V43, P9234, DOI 10.1021/bi049468v; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; TRISCOTT MX, 1986, J BIOL CHEM, V261, P6004; Tuluc F, 2003, INT IMMUNOPHARMACOL, V3, P1775, DOI 10.1016/j.intimp.2003.08.002; Uchiyama T, 2005, BIOCHEM BIOPH RES CO, V327, P927, DOI 10.1016/j.bbrc.2004.12.092; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Weigel PH, 2006, J BIOL CHEM, V281, P36542, DOI 10.1074/jbc.M606529200; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Zhang W, 2000, BIOCHEM J, V349, P91, DOI 10.1042/0264-6021:3490091; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; ZILVERSMIT DB, 1975, AM J CARDIOL, V35, P559, DOI 10.1016/0002-9149(75)90840-1	67	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22899	22908		10.1074/jbc.M109.088435	http://dx.doi.org/10.1074/jbc.M109.088435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501660	Green Published, hybrid			2022-12-25	WOS:000279999900023
J	Nicolaes, GAF; Bock, PE; Segers, K; Wildhagen, KCAA; Dahlback, B; Rosing, J				Nicolaes, Gerry A. F.; Bock, Paul E.; Segers, Kenneth; Wildhagen, Karin C. A. A.; Dahlback, Bjorn; Rosing, Jan			Inhibition of Thrombin Formation by Active Site Mutated (S360A) Activated Protein C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR VA; PEPTIDE-BOND CLEAVAGES; BLOOD-COAGULATION; FACTOR-XA; FACTOR VIIIA; ANTICOAGULANT ACTIVITY; SUBSTRATE-SPECIFICITY; MEDIATED CLEAVAGES; FACTOR VA(R506Q); BINDING-SITE	Activated protein C (APC) down-regulates thrombin formation through proteolytic inactivation of factor Va (FVa) by cleavage at Arg(506) and Arg(306) and of factor VIIIa (FVIIIa) by cleavage at Arg(336) and Arg(562). To study substrate recognition by APC, active site-mutated APC (APC(S360A)) was used, which lacks proteolytic activity but exhibits anticoagulant activity. Experiments in model systems and in plasma show that APC(S360A), and not its zymogen protein C(S360A), expresses anticoagulant activities by competing with activated coagulation factors X and IX for binding to FVa and FVIIIa, respectively. APC(S360A) bound to FVa with a K-D of 0.11 +/- 0.05 nM and competed with active site-labeled Oregon Green activated coagulation factor X for binding to FVa. The binding of APC(S360A) to FVa was not affected by protein S but was inhibited by prothrombin. APC(S360A) binding to FVa was critically dependent upon the presence of Arg(506) and not Arg(306) and additionally required an active site accessible to substrates. Inhibition of FVIIIa activity by APC(S360A) was > 100-fold less efficient than inhibition of FVa. Our results show that despite exosite interactions near the Arg(506) cleavage site, binding of APC(S360A) to FVa is almost completely dependent on Arg(506) interacting with APC(S360A) to form a nonproductive Michaelis complex. Because docking of APC to FVa and FVIIIa constitutes the first step in the inactivation of the cofactors, we hypothesize that the observed anticoagulant activity may be important for in vivo regulation of thrombin formation.	[Nicolaes, Gerry A. F.; Segers, Kenneth; Wildhagen, Karin C. A. A.; Rosing, Jan] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; [Bock, Paul E.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA; [Dahlback, Bjorn] Lund Univ, Dept Lab Med, Wallenberg Lab, Univ Hosp, SE-20502 Malmo, Sweden	Maastricht University; Vanderbilt University; Lund University; Skane University Hospital	Nicolaes, GAF (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands.	G.Nicolaes@bioch.unimaas.nl	Nicolaes, Gerry A.F./A-8421-2016	Nicolaes, Gerry A.F./0000-0002-2482-0412; Dahlback, Bjorn/0000-0003-1546-0328	National Institutes of Health [RO1 HL038779]; Netherlands Organization for Scientific Research [916-046-330]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL038779 (to P. E. B.). This work was also supported by VIDI Grant 916-046-330 from the Netherlands Organization for Scientific Research (to G. A. F. N.).	Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; Bradford HN, 2010, J BIOL CHEM, V285, P328, DOI 10.1074/jbc.M109.070334; BROEKMANS AW, 1983, NEW ENGL J MED, V309, P340, DOI 10.1056/NEJM198308113090604; Cawthern KM, 1998, BLOOD, V91, P4581, DOI 10.1182/blood.V91.12.4581.412k12_4581_4592; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Friedrich U, 2001, J BIOL CHEM, V276, P23105, DOI 10.1074/jbc.M103138200; FRIEDRICH U, 1994, THROMB HAEMOSTASIS, V72, P567; Gailani D, 2001, BLOOD, V97, P3117, DOI 10.1182/blood.V97.10.3117; Gale AJ, 1997, PROTEIN SCI, V6, P132; Gale AJ, 2000, BLOOD, V96, P585; Gale AJ, 2002, J BIOL CHEM, V277, P28836, DOI 10.1074/jbc.M204363200; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; JOSSO F, 1965, THROMB DIATH HAEMOST, VS, P35; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Lu GM, 2005, J BIOL CHEM, V280, P15471, DOI 10.1074/jbc.M500881200; Manithody C, 2003, BLOOD, V101, P4802, DOI 10.1182/blood-2003-01-0126; MARLAR RA, 1989, J PEDIATR-US, V114, P528, DOI 10.1016/S0022-3476(89)80688-2; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; Nicolaes GAF, 2004, EUR J BIOCHEM, V271, P2724, DOI 10.1111/j.1432-1033.2004.04201.x; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Nicolaes GAF, 1999, BIOCHEMISTRY-US, V38, P13584, DOI 10.1021/bi991165r; Nicolaes Gerry A F, 2003, Semin Vasc Med, V3, P33, DOI 10.1055/s-2003-38331; Norstrom EA, 2006, J BIOL CHEM, V281, P31486, DOI 10.1074/jbc.M606441200; O'Brien LM, 2000, BLOOD, V95, P1714, DOI 10.1182/blood.V95.5.1714.005k40_1714_1720; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Segers K, 2008, J BIOL CHEM, V283, P22573, DOI 10.1074/jbc.M801724200; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; SHEN L, 1994, J BIOL CHEM, V269, P18735; Shen L, 1998, J BIOL CHEM, V273, P31086, DOI 10.1074/jbc.273.47.31086; Sun YH, 2003, BLOOD, V101, P2277, DOI 10.1182/blood-2002-06-1691; Tran S, 2008, J BIOL CHEM, V283, P6648, DOI 10.1074/jbc.M708036200; VARADI K, 1995, THROMB HAEMOSTASIS, V73, P730; Villoutreix BO, 2001, J COMPUT AID MOL DES, V15, P13, DOI 10.1023/A:1011158717139; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Yegneswaran S, 2007, J BIOL CHEM, V282, P28353, DOI 10.1074/jbc.M704316200; Yegneswaran S, 2009, THROMB HAEMOSTASIS, V101, P55, DOI 10.1160/TH08-07-0491	49	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22888	22898		10.1074/jbc.M110.131029	http://dx.doi.org/10.1074/jbc.M110.131029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484050	hybrid, Green Published			2022-12-25	WOS:000279999900022
J	Plafker, KS; Nguyen, L; Barneche, M; Mirza, S; Crawford, D; Plafker, SM				Plafker, Kendra S.; Nguyen, Linda; Barneche, Mark; Mirza, Saima; Crawford, David; Plafker, Scott M.			The Ubiquitin-conjugating Enzyme UbcM2 Can Regulate the Stability and Activity of the Antioxidant Transcription Factor Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-DEPENDENT TRANSCRIPTION; OXIDATIVE STRESS; RESPONSE ELEMENT; NUCLEAR IMPORT; PROTEASOMAL DEGRADATION; INDUCIBLE EXPRESSION; GENE-EXPRESSION; SENSOR KEAP1; PLASMID DNA; E3 LIGASE	The transcription factor nuclear factor E2-related factor 2 (Nrf2) induces the expression of antioxidant gene products that neutralize reactive oxygen species and restore redox homeostasis. Nrf2 is constitutively degraded by the ubiquitin proteolytic system in unperturbed cells, but this turnover is arrested in response to oxidative stress, thereby leading to Nrf2 accumulation. Yet, a mechanistic understanding of how Nrf2 stabilization and transcriptional activation are coupled remains to be determined. We have discovered that the ubiquitin-conjugating enzyme UbcM2 is a novel regulator of Nrf2. Recombinant Nrf2 and UbcM2 form a complex upon alkylation of a non-catalytic cysteine in UbcM2, Cys-136. Substitution of this cysteine with a phenylalanine (C136F) to mimic cysteine oxidation/alkylation results in constitutive binding of UbcM2 to Nrf2 and an increased half-life of the transcription factor in vivo. We provide evidence that UbcM2 and Nrf2 form a nuclear complex utilizing the DNA binding, Neh1 domain, of Nrf2. Finally, we demonstrate that UbcM2 can enhance the transcriptional activity of endogenous Nrf2 and that Cys-136 and the active-site cysteine, Cys-145, jointly contribute to this regulation. Collectively, these data identify UbcM2 as a novel component of the Nrf2 regulatory circuit and position cysteine 136 as a putative redox sensor in this signaling pathway. This work implicates UbcM2 in the restoration of redox homeostasis following oxidative stress.	[Plafker, Kendra S.; Nguyen, Linda; Barneche, Mark; Mirza, Saima; Crawford, David; Plafker, Scott M.] Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Crawford, David] Univ Oklahoma, Dept Pediat, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Plafker, SM (corresponding author), Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, 940 Stanton L Young Blvd,BMSB 538, Oklahoma City, OK 73104 USA.	scott-plafker@ouhsc.edu			National Center for Research Resources, National Institutes of Health [P20RR024215]; American Health Assistance Foundation [M2009095]; Oklahoma Center for the Advancement of Science and Technology [HR08-076]; Karl Kirchgessner Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Health Assistance Foundation(BrightFocus Foundation); Oklahoma Center for the Advancement of Science and Technology; Karl Kirchgessner Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR024215 from the National Center for Research Resources (title: Mentoring Diabetes Research in Oklahoma). Additional funding (to S. M. P.) in support of this work was kindly provided by the American Health Assistance Foundation (Grant M2009095), The Oklahoma Center for the Advancement of Science and Technology (Grant HR08-076), and a Karl Kirchgessner Foundation Vision Research Grant.	ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Guo YG, 2008, BIOCHEM BIOPH RES CO, V374, P570, DOI 10.1016/j.bbrc.2008.07.064; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jeong WS, 2005, J BIOCHEM MOL BIOL, V38, P167; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi S, 2004, J MOL ENDOCRINOL, V32, P69, DOI 10.1677/jme.0.0320069; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Pan X, 2006, BIOCHEM BIOPH RES CO, V344, P727, DOI 10.1016/j.bbrc.2006.03.194; Plafker KS, 2009, BIOCHEMISTRY-US, V48, P3527, DOI 10.1021/bi801971m; Plafker KS, 2008, INVEST OPHTH VIS SCI, V49, P5611, DOI 10.1167/iovs.08-1698; Plafker SM, 2000, EMBO J, V19, P5502, DOI 10.1093/emboj/19.20.5502; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Poukka H, 1999, J BIOL CHEM, V274, P19441, DOI 10.1074/jbc.274.27.19441; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yokota K, 2007, J BIOL CHEM, V282, P1998, DOI 10.1074/jbc.M607741200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	49	43	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23062	23072		10.1074/jbc.M110.121913	http://dx.doi.org/10.1074/jbc.M110.121913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484052	Green Published, hybrid			2022-12-25	WOS:000279999900041
J	Sidhu, SS; Nawroth, R; Retz, M; Lemjabbar-Alaoui, H; Dasari, V; Basbaum, C				Sidhu, S. S.; Nawroth, R.; Retz, M.; Lemjabbar-Alaoui, H.; Dasari, V.; Basbaum, C.			EMMPRIN regulates the canonical Wnt/beta-catenin signaling pathway, a potential role in accelerating lung tumorigenesis	ONCOGENE			English	Article						CD147; EMMPRIN; beta-catenin; Wnt; lung cancer	MATRIX-METALLOPROTEINASE INDUCER; FAMILIAL ADENOMATOUS POLYPOSIS; BETA-CATENIN; COLORECTAL-CANCER; GROWTH-FACTOR; STEM-CELLS; WNT; EXPRESSION; CD147; ACTIVATION	Advances in the field of tumor biology have identified that tumor cells co-opt developmental signaling pathways of embryonic stem cells and thus gain the ability to proliferate, differentiate and alter cell-cell interactions. One such pathway is the Wnt/beta-catenin signaling pathway. High levels of EMMPRIN expression have been shown to correlate with poor prognosis and metastasis in a broad range of tumors. Although a variety of functions are attributed to EMMPRIN in tumorigenesis, the specific mechanism(s) through which it can exert its effects have not been elucidated, until now. In this study, we identify EMMPRIN as a novel regulator of the canonical Wnt/beta-catenin signaling pathway in lung cancer. Increasing EMMPRIN expression levels in lung cancer epithelial cells upregulated the beta-catenin signaling pathway and silencing EMMPRIN inhibited beta-catenin signaling, cell migration, proliferation, anchorage-independent growth and tumor growth in a mouse tumor xenograft model. These results provide a compelling rationale for targeting EMMPRIN for anticancer therapies. Understanding the molecular mechanisms driving EMMPRIN-induced lung tumorigenesis will provide enormous benefits in developing new therapeutic treatments for this and other forms of cancer. Oncogene ( 2010) 29, 4145-4156; doi: 10.1038/onc.2010.166; published online 31 May 2010	[Sidhu, S. S.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care, San Francisco, CA 94143 USA; [Sidhu, S. S.] Univ Calif San Francisco, Dept Med, Div Allergy Immunol, San Francisco, CA 94143 USA; [Sidhu, S. S.; Nawroth, R.; Retz, M.; Lemjabbar-Alaoui, H.; Dasari, V.; Basbaum, C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Sidhu, S. S.; Nawroth, R.; Retz, M.; Lemjabbar-Alaoui, H.; Dasari, V.; Basbaum, C.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Nawroth, R.; Retz, M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-8000 Munich, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Technical University of Munich	Sidhu, SS (corresponding author), Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care, HSE 1350,513 Parnassus Ave, San Francisco, CA 94143 USA.	ssidhu@ucsf.edu		Sidhu, Sukhvinder/0000-0002-2999-4358	National Institutes of Health [PPG P01 HL024136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (PPG P01 HL024136). The authors would like to thank Anatol Sucher for technical support and Dr Zena Werb for critical reading of the paper. The authors also dedicate this paper to the memory of Dr Carol Basbaum (mentor and friend).	Als AB, 2007, CLIN CANCER RES, V13, P4407, DOI 10.1158/1078-0432.CCR-07-0109; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Betsuyaku T, 2003, AM J RESP CRIT CARE, V168, P222, DOI 10.1164/rccm.200301-103OC; BISWAS C, 1995, CANCER RES, V55, P434; Bonner AE, 2003, J MED GENET, V40, P408, DOI 10.1136/jmg.40.6.408; Boon EMJ, 2004, BRIT J CANCER, V90, P224, DOI 10.1038/sj.bjc.6601505; Caudroy S, 1999, J HISTOCHEM CYTOCHEM, V47, P1575, DOI 10.1177/002215549904701209; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Daniel VC, 2006, RESPIROLOGY, V11, P234, DOI 10.1111/j.1440-1843.2006.00838.x; Davidson B, 2003, CLIN EXP METASTAS, V20, P161, DOI 10.1023/A:1022696012668; Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Fadool JM, 1996, BIOCHEM BIOPH RES CO, V229, P280, DOI 10.1006/bbrc.1996.1793; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Guo HM, 1997, J BIOL CHEM, V272, P24; Huang ZQ, 2008, BIOCHEM BIOPH RES CO, V374, P517, DOI 10.1016/j.bbrc.2008.07.058; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; Koornstra JJ, 2005, CANCER EPIDEM BIOMAR, V14, P1608, DOI 10.1158/1055-9965.EPI-05-0112; Lemjabbar H, 2003, J BIOL CHEM, V278, P26202, DOI 10.1074/jbc.M207018200; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lowy AM, 2006, CANCER RES, V66, P4734, DOI 10.1158/0008-5472.CAN-05-4268; McEntee MF, 1999, CARCINOGENESIS, V20, P635, DOI 10.1093/carcin/20.4.635; Millimaggi D, 2007, NEOPLASIA, V9, P349, DOI 10.1593/neo.07133; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Nawroth R, 2008, UROLOGE, V47, P1152, DOI 10.1007/s00120-008-1828-9; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Reimers N, 2004, CLIN CANCER RES, V10, P3422, DOI 10.1158/1078-0432.CCR-03-0610; Renno T, 2002, J IMMUNOL, V168, P4946, DOI 10.4049/jimmunol.168.10.4946; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Riethdorf S, 2006, INT J CANCER, V119, P1800, DOI 10.1002/ijc.22062; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sidhu SS, 2004, ONCOGENE, V23, P956, DOI 10.1038/sj.onc.1207070; Sienel W, 2008, MODERN PATHOL, V21, P1130, DOI 10.1038/modpathol.2008.102; Soon LL, 2003, J BIOL CHEM, V278, P11465, DOI 10.1074/jbc.M210945200; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Sun JX, 2001, CANCER RES, V61, P2276; Taketo MM, 2004, NAT GENET, V36, P320, DOI 10.1038/ng0404-320; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tang W, 2004, J BIOL CHEM, V279, P11112, DOI 10.1074/jbc.M312947200; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Tang Y, 2006, MOL CANCER RES, V4, P371, DOI 10.1158/1541-7786.MCR-06-0042; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; Wang WJ, 2008, CHEMOTHERAPY, V54, P291, DOI 10.1159/000151225; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yang JM, 2006, J BIOL CHEM, V281, P9719, DOI 10.1074/jbc.M508421200; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Yurchenko V, 2005, J BIOL CHEM, V280, P17013, DOI 10.1074/jbc.M412851200	63	51	55	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2010	29	29					4145	4156		10.1038/onc.2010.166	http://dx.doi.org/10.1038/onc.2010.166			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20514014				2022-12-25	WOS:000280151500003
J	Fotheringham, JA; Mazzucca, S; Raab-Traub, N				Fotheringham, J. A.; Mazzucca, S.; Raab-Traub, N.			Epstein-Barr virus latent membrane protein-2A-induced Delta Np63 alpha expression is associated with impaired epithelial-cell differentiation	ONCOGENE			English	Article						Epstein-Barr virus; nasopharyngeal carcinoma; differentiation; p63; latent membrane protein 2A	NASOPHARYNGEAL CARCINOMA; PROTEIN 2A; KERATINOCYTE DIFFERENTIATION; UBIQUITIN LIGASE; STEM-CELLS; PY MOTIFS; P63; LMP2A; TRANSCRIPTION; DEGRADATION	Epstein-Barr virus (EBV) is an oncogenic gamma-herpes virus associated with malignancies that develop in both lymphoid and epithelial cells including nasopharyngeal carcinoma (NPC). The EBV protein, latent membrane protein 2A (LMP2A), is expressed in NPC and can modulate epithelial proliferation, transformation and differentiation, and as such may promote malignancy. A key regulator of epithelial-cell differentiation is the transcription factor p63, a member of the p53 family. This study examines the potential contribution of p63 to LMP2A-mediated inhibition of epithelial-cell differentiation. Stable expression of LMP2A increased the protein level and stability of the Delta Np63 alpha isoform and in two epithelial cell lines, LMP2A interacted with Delta Np63 alpha under stable-and transient-expression systems. LMP2A and Delta Np63 alpha were localized to the cytoplasm and nuclear membrane and co-immunoprecipitated in the same fractions. Following induction of epithelial-cell differentiation by calcium, expression of differentiation markers was impaired in both Delta Np63 alpha- and LMP2A-expressing cells. Induction of p63 alpha, association of p63 alpha with LMP2A and impairment of differentiation required the PY and immunoreceptor tyrosine-based activation motif (ITAM) signaling motif of LMP2A. By associating with and being regulated by LMP2A, Delta Np63 alpha may function as a unique regulator of LMP2A effects on epithelial differentiation and contribute to EBV-associated epithelial cancers. Oncogene (2010) 29, 4287-4296; doi:10.1038/onc.2010.175; published online 24 May 2010	[Fotheringham, J. A.; Mazzucca, S.; Raab-Traub, N.] Univ N Carolina, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Raab-Traub, N (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA.	nrt@med.unc.edu	Ariel, Pablo/AGJ-4118-2022	Mazzucca, Stephanie/0000-0001-6908-0780	National Institutes of Health [CA19014, CA32979, CA103634]; NATIONAL CANCER INSTITUTE [P01CA019014, R01CA032979, R01CA103634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge Dr M Oren for providing the Delta Np63 alpha plasmid and Dr R Longnecker for providing the LMP2A PY mutant. Funding for this study was provided by the National Institutes of Health grants CA19014, CA32979 and CA103634.	Bamberger C, 2002, J INVEST DERMATOL, V118, P133, DOI 10.1046/j.0022-202x.2001.01649.x; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Bultema R, 2009, ONCOGENE, V28, P1471, DOI 10.1038/onc.2008.492; BUSSON P, 1992, J VIROL, V66, P3257, DOI 10.1128/JVI.66.5.3257-3262.1992; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Fukuda M, 2007, J VIROL, V81, P9299, DOI 10.1128/JVI.00537-07; Guo C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-23; Ikeda A, 2003, J VIROL, V77, P5529, DOI 10.1128/JVI.77.9.5529-5534.2003; Ikeda M, 2000, VIROLOGY, V268, P178, DOI 10.1006/viro.1999.0166; Ikeda M, 2001, J VIROL, V75, P5711, DOI 10.1128/JVI.75.12.5711-5718.2001; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Li YC, 2009, MOL CELL BIOL, V29, P3953, DOI 10.1128/MCB.00449-09; Longnecker R, 2000, EXP CELL RES, V257, P332, DOI 10.1006/excr.2000.4900; Medawar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003441; Melino G, 2006, CELL CYCLE, V5, P1735; Merchant M, 2001, Int Rev Immunol, V20, P805, DOI 10.3109/08830180109045591; Morrison JA, 2005, J VIROL, V79, P2375, DOI 10.1128/JVI.79.4.2375-2382.2005; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Ogawa E, 2008, J BIOL CHEM, V283, P34241, DOI 10.1074/jbc.M804101200; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Raab-Traub N, 1992, Semin Cancer Biol, V3, P297; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; RAABTRAUB N, 1992, INFECT AGENT DIS, V1, P173; Rossi M, 2006, CELL CYCLE, V5, P1816, DOI 10.4161/cc.5.16.2861; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Testoni B, 2006, NUCLEIC ACIDS RES, V34, P928, DOI 10.1093/nar/gkj477; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Wu GJ, 2003, CANCER RES, V63, P2351; Yip YL, 2008, INT J ONCOL, V33, P713, DOI 10.3892/ijo_00000057; Young L S, 1992, Semin Cancer Biol, V3, P273	35	32	32	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2010	29	30					4287	4296		10.1038/onc.2010.175	http://dx.doi.org/10.1038/onc.2010.175			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20498633	Green Accepted, Green Submitted			2022-12-25	WOS:000280547900005
J	Haller, BK; Brave, A; Wallgard, E; Roswall, P; Sunkari, VG; Mattson, U; Hallengard, D; Catrina, SB; Hellstrom, M; Pietras, K				Haller, B. K.; Brave, A.; Wallgard, E.; Roswall, P.; Sunkari, V. G.; Mattson, U.; Hallengard, D.; Catrina, S-B; Hellstrom, M.; Pietras, K.			Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma	ONCOGENE			English	Article						angiogenesis; DNA vaccination; breast cancer; Delta-like ligand 4; endothelial tip cell	INHIBITS TUMOR-GROWTH; CANCER VACCINES; DLL4; ANGIOGENESIS; BLOCKADE; EXPRESSION; CHALLENGE; PROTECTS; TRIAL; COLON	The Notch ligand delta-like ligand 4 (DLL4) is an essential component expressed by endothelial tip cells during angiogenic sprouting. We have described a conceptually novel therapeutic strategy for targeting tumor angiogenesis and endothelial tip cells based on DNA vaccination against DLL4. Immunization with DLL4-encoding plasmid DNA by in vivo electroporation severely retarded the growth of orthotopically implanted mammary carcinomas in mice by induction of a nonproductive angiogenic response. Mechanistically, vaccination brought about a break in tolerance against the self-antigen, DLL4, as evidenced by the production of inhibitory and inherently therapeutic antibodies against mouse DLL4. Importantly, no evidence for a delayed wound healing response, or for toxicity associated with pharmacological blockade of DLL4 signaling, was noted in mice immunized with the DLL4 vaccine. We have thus developed a well-tolerated DNA vaccination strategy targeting the endothelial tip cells and the antigen DLL4 with proven therapeutic efficacy in mouse models of mammary carcinoma; a disease that has been reported to dramatically induce the expression of DLL4. Conceivably, induction of immunity toward principal mediators of pathological angiogenesis could provide protection against recurrent malignant disease in the adjuvant setting. Oncogene (2010) 29, 4276-4286; doi: 10.1038/onc.2010.176; published online 24 May 2010	[Wallgard, E.; Roswall, P.; Pietras, K.] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Haller, B. K.; Brave, A.; Hallengard, D.] Swedish Inst Infect Dis Control, Dept Virol, Stockholm, Sweden; [Haller, B. K.; Brave, A.; Hallengard, D.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Sunkari, V. G.; Catrina, S-B] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Mattson, U.; Hellstrom, M.] Bioinvent Int, Lund, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska Institutet	Pietras, K (corresponding author), Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, House A4,Level 4,Scheeles Vag 2, SE-17177 Stockholm, Sweden.	kristian.pietras@ki.se	Pietras, Kristian/ABG-2097-2021; Pietras, Kristian/ABE-8727-2020	Pietras, Kristian/0000-0001-6738-4705; Haller, Kristian/0000-0002-9060-0928; Catrina, Sergiu/0000-0002-6914-3902; Sunkari, Vivekananda/0000-0003-4599-5120; Hellstrom, Mats/0000-0002-7088-9533	Swedish Cancer Society; Swedish Research Council; Karolinska Institutet Cancer network; Ake Wiberg's foundation; Jeansson's foundation; Swedish National Board of Health and Welfare; Alex and Eva Wallstrom foundation; Magn. Bergvall foundation; Karolinska Institute Research foundations	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet Cancer network; Ake Wiberg's foundation; Jeansson's foundation; Swedish National Board of Health and Welfare; Alex and Eva Wallstrom foundation; Magn. Bergvall foundation; Karolinska Institute Research foundations(Karolinska Institutet)	We are grateful to Cyto Pulse Sciences, Inc., Glen Burnie, MD, USA for providing the technology for in vivo electroporation. This study was supported by grants to KP from the Swedish Cancer Society (Young Investigator Award and project grant), the Swedish Research Council (including a Linnaeus grant for the STARGET consortium), by a strategic grant from the Karolinska Institutet Cancer network, Ake Wiberg's foundation and Jeansson's foundation. BKH recieved support from the The Swedish National Board of Health and Welfare, The Alex and Eva Wallstrom foundation, The Magn. Bergvall foundation and Karolinska Institute Research foundations.	Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bergman PJ, 2003, CLIN CANCER RES, V9, P1284; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Holmgren L, 2006, P NATL ACAD SCI USA, V103, P9208, DOI 10.1073/pnas.0603110103; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Jubb AM, 2009, BRIT J CANCER, V101, P1749, DOI 10.1038/sj.bjc.6605368; Jubb AM, 2010, AM J PATHOL, V176, P2019, DOI 10.2353/ajpath.2010.090908; Kaplan CD, 2006, VACCINE, V24, P6994, DOI 10.1016/j.vaccine.2006.04.071; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Liu MA, 2006, HUM GENE THER, V17, P1051, DOI 10.1089/hum.2006.17.1051; Niethammer AG, 2002, NAT MED, V8, P1369, DOI 10.1038/nm794; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Pejawar-Gaddy S, 2008, CRIT REV ONCOL HEMAT, V67, P93, DOI 10.1016/j.critrevonc.2008.02.010; Plum SM, 2004, IMMUNOPHARM IMMUNOT, V26, P29, DOI 10.1081/IPH-120029942; Pourgholami Mohammad H., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P343, DOI 10.2174/187152508785909528; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Schlom J, 2007, CLIN CANCER RES, V13, P3776, DOI 10.1158/1078-0432.CCR-07-0588; Segarra M, 2008, BLOOD, V112, P1904, DOI 10.1182/blood-2007-11-126045; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Ullenhag GJ, 2004, CLIN CANCER RES, V10, P3273, DOI 10.1158/1078-0432.CCR-03-0706; Wei WZ, 1999, INT J CANCER, V81, P748, DOI 10.1002/(SICI)1097-0215(19990531)81:5<748::AID-IJC14>3.0.CO;2-6; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751	27	25	27	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2010	29	30					4276	4286		10.1038/onc.2010.176	http://dx.doi.org/10.1038/onc.2010.176			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	633ZV	20498640				2022-12-25	WOS:000280547900004
J	Zhao, KY; Wright, M; Kimball, J; Eizenga, G; McClung, A; Kovach, M; Tyagi, W; Ali, ML; Tung, CW; Reynolds, A; Bustamante, CD; McCouch, SR				Zhao, Keyan; Wright, Mark; Kimball, Jennifer; Eizenga, Georgia; McClung, Anna; Kovach, Michael; Tyagi, Wricha; Ali, Md. Liakat; Tung, Chih-Wei; Reynolds, Andy; Bustamante, Carlos D.; McCouch, Susan R.			Genomic Diversity and Introgression in O. sativa Reveal the Impact of Domestication and Breeding on the Rice Genome	PLOS ONE			English	Article							ORYZA-SATIVA; POPULATION-STRUCTURE; NUCLEOTIDE-BINDING; LINKAGE DISEQUILIBRIUM; MAGNAPORTHE-ORYZAE; GENETIC DIVERSITY; GREEN-REVOLUTION; CULTIVATED RICE; AMYLOSE CONTENT; REPEAT PROTEIN	Background: The domestication of Asian rice (Oryza sativa) was a complex process punctuated by episodes of introgressive hybridization among and between subpopulations. Deep genetic divergence between the two main varietal groups (Indica and Japonica) suggests domestication from at least two distinct wild populations. However, genetic uniformity surrounding key domestication genes across divergent subpopulations suggests cultural exchange of genetic material among ancient farmers. Methodology/Principal Findings: In this study, we utilize a novel 1,536 SNP panel genotyped across 395 diverse accessions of O. sativa to study genome-wide patterns of polymorphism, to characterize population structure, and to infer the introgression history of domesticated Asian rice. Our population structure analyses support the existence of five major subpopulations (indica, aus, tropical japonica, temperate japonica and GroupV) consistent with previous analyses. Our introgression analysis shows that most accessions exhibit some degree of admixture, with many individuals within a population sharing the same introgressed segment due to artificial selection. Admixture mapping and association analysis of amylose content and grain length illustrate the potential for dissecting the genetic basis of complex traits in domesticated plant populations. Conclusions/Significance: Genes in these regions control a myriad of traits including plant stature, blast resistance, and amylose content. These analyses highlight the power of population genomics in agricultural systems to identify functionally important regions of the genome and to decipher the role of human-directed breeding in refashioning the genomes of a domesticated species.	[Zhao, Keyan; Wright, Mark; Reynolds, Andy; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Zhao, Keyan; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kimball, Jennifer; Kovach, Michael; Tyagi, Wricha; Tung, Chih-Wei; McCouch, Susan R.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Eizenga, Georgia; McClung, Anna] ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA; [Ali, Md. Liakat] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA	Cornell University; Stanford University; Cornell University; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville	Zhao, KY (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	cdbustam@stanford.edu; srm4@cornell.edu		Kimball, Jennifer/0000-0002-1210-8161; Zhao, Keyan/0000-0002-8800-2304; Wright, Mark/0000-0001-8036-1161; Bustamante, Carlos D./0000-0002-4187-7920; TUNG, CHIH-WEI/0000-0001-5337-0177	National Science Foundation [0606461]; University of Arkansas at the Rice Research and Extension Center, Stuttgart, AR	National Science Foundation(National Science Foundation (NSF)); University of Arkansas at the Rice Research and Extension Center, Stuttgart, AR	Funding: This research was funded by National Science Foundation grant #0606461; http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Teresa Hancock and Daniel Wood, supported by this grant through the University of Arkansas at the Rice Research and Extension Center, Stuttgart, AR for their outstanding technical assistance collecting phenotypic information and managing the seed stocks. We thank Weiwei Zhai from Beijing Institute of Genomics for comments and suggestions on the manuscript. We acknowledge the assistance of Melissa Jia in the Genomics Core Facility at the Dale Bumpers National Rice Research Center, Stuttgart, AR for running the grain quality markers. We thank Ken McNally and Jan Leach of the OryzaSNP project for early access to the OryzaSNP data. We are grateful to Lois Swales for help formatting the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; BOLLICH CN, 1985, CROP SCI, V25, P883, DOI 10.2135/cropsci1985.0011183X002500050038x; BOLLICH CN, 1993, CROP SCI, V33, P877, DOI 10.2135/cropsci1993.0011183X003300040056x; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chang TT, 2002, W CROP SCI, P3; Chen MH, 2008, J CEREAL SCI, V47, P536, DOI 10.1016/j.jcs.2007.06.013; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Falush D, 2003, GENETICS, V164, P1567; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Garris AJ, 2003, GENETICS, V165, P759; Gibbons JW, 2006, CROP SCI, V46, P2317, DOI 10.2135/cropsci2006.03.0173; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Huang XH, 2008, PLANT PHYSIOL, V148, P25, DOI 10.1104/pp.108.121491; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jia YL, 2004, PHYTOPATHOLOGY, V94, P296, DOI 10.1094/PHYTO.2004.94.3.296; Jia YL, 2003, PHYTOPATHOLOGY, V93, P1452, DOI 10.1094/PHYTO.2003.93.11.1452; Jia YL, 2002, CROP SCI, V42, P2145, DOI 10.2135/cropsci2002.2145; Kashiwagi T, 2004, PLANT PHYSIOL, V134, P676, DOI 10.1104/pp.103.029355; KHUSH GS, 2003, IRRI DISCUSSION PAPE, P1; KHUSH GS, 2006, IRRI DISCUSSION PAPE, V46; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Kim SI, 2009, SABRAO J BREED GENET, V41, P25; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Kovach MJ, 2009, P NATL ACAD SCI USA, V106, P14444, DOI 10.1073/pnas.0904077106; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Lin F, 2007, GENETICS, V177, P1871, DOI 10.1534/genetics.107.080648; Linscombe SD, 2000, CROP SCI, V40, P294, DOI 10.2135/cropsci2000.0007rcv; Liu L, 2007, ANTIQUITY, V81, P886, DOI 10.1017/S0003598X00095983; Mackill DJ, 2002, W CROP SCI, P87; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; McClung AM, 1997, CROP SCI, V37, P629, DOI 10.2135/cropsci1997.0011183X003700020058x; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Moldenhauer KAK, 2007, CROP SCI, V47, P447, DOI 10.2135/cropsci2006.06.0418; MOLDENHAUER KAK, 1990, CROP SCI, V30, P747, DOI 10.2135/cropsci1990.0011183X003000030065x; Ni J, 2002, CROP SCI, V42, P601, DOI 10.2135/cropsci2002.0601; Pritchard JK, 2000, GENETICS, V155, P945; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Rakshit S, 2007, THEOR APPL GENET, V114, P731, DOI 10.1007/s00122-006-0473-1; RASAMIVELONA A, 1995, CROP SCI, V35, P1365, DOI 10.2135/cropsci1995.0011183X003500050017x; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Song ZP, 2006, EVOL ECOL, V20, P501, DOI 10.1007/s10682-006-9113-0; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; WANG GL, 1994, GENETICS, V136, P1421; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; WANG ZY, 1989, GENOME, V32, P1113, DOI 10.1139/g89-563; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WEIR BS, 1996, GENETIC DATA ANAL, V2, P161; WRIGHT MH, BIOINFORMAT IN PRESS; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yamanaka S, 2004, THEOR APPL GENET, V108, P1200, DOI 10.1007/s00122-003-1564-x; Yan WG, 2009, MOL BREEDING, V24, P277, DOI 10.1007/s11032-009-9290-y; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Yano M, 2009, CURR OPIN PLANT BIOL, V12, P103, DOI 10.1016/j.pbi.2009.01.001; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	79	206	216	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10780	10.1371/journal.pone.0010780	http://dx.doi.org/10.1371/journal.pone.0010780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520727	Green Published, gold, Green Submitted			2022-12-25	WOS:000278034600010
J	Bressler, J; Kao, WHL; Pankow, JS; Boerwinkle, E				Bressler, Jan; Kao, W. H. Linda; Pankow, James S.; Boerwinkle, Eric			Risk of Type 2 Diabetes and Obesity Is Differentially Associated with Variation in FTO in Whites and African-Americans in the ARIC Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FAT MASS; GENETIC-VARIANTS; POLYMORPHISMS; IGF2BP2; CHINESE; SLC30A8; CDKAL1; REPLICATION; CHOLESTEROL	Single nucleotide polymorphisms (SNPs) in the fat mass and obesity associated (FTO) gene are associated with body mass index (BMI) in populations of European descent. The FTO rs9939609 variant, first detected in a genome-wide association study of diabetes, conferred an increased disease risk that was abolished after adjustment for BMI, suggesting that the association may be due to variation in adiposity. The relationship between diabetes, four previously identified FTO polymorphisms that span a 19.6-kb genomic region, and obesity was therefore evaluated in the biracial population-based Atherosclerosis Risk in Communities Study with the goal of further refining the association by comparing results between the two ethnic groups. The prevalence of diabetes and obesity (BMI >= 30 kg/m(2)) was established at baseline, and diabetes was determined by either self-report, a fasting glucose level >= 126 mg/dL, or non-fasting glucose >= 200 mg/dL. There were 1,004 diabetes cases and 10,038 non-cases in whites, and 670 cases and 2,780 non-cases in African-Americans. Differences in mean BMI were assessed by a general linear model, and multivariable logistic regression was used to predict the risk of diabetes and obesity. For white participants, the FTO rs9939609 A allele was associated with an increased risk of diabetes (odds ratio (OR) = 1.19, p < 0.001) and obesity (OR = 1.22, p < 0.001) under an additive genetic model that was similar for all of the SNPs analyzed. In African-Americans, only the rs1421085 C allele was a determinant of obesity risk (OR = 1.17, p = 0.05), but was found to be protective against diabetes (OR = 0.79, p = 0.03). Adjustment for BMI did not eliminate any of the observed associations with diabetes. Significant statistical interaction between race and the FTO variants suggests that the effect on diabetes susceptibility may be context dependent.	[Bressler, Jan; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Pankow, James S.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston	Bressler, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA.	Eric.Boerwinkle@uth.tmc.edu		Pankow, James/0000-0001-7076-483X	National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055019, N01HC055020, N01HC055021, N01HC055022, N01HC055018, N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055019, R41HL055018, R42HL055018] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Cheng CY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000490; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Hunt SC, 2008, OBESITY, V16, P902, DOI 10.1038/oby.2007.126; Lee YH, 2008, J HUM GENET, V53, P991, DOI 10.1007/s10038-008-0341-8; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Song YQ, 2008, OBESITY, V16, P2472, DOI 10.1038/oby.2008.408; STERN MP, 1986, ARTERIOSCLEROSIS, V6, P123, DOI 10.1161/01.ATV.6.2.123; Tan JT, 2008, DIABETES, V57, P2851, DOI 10.2337/db08-0214; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wing MR, 2009, HUM GENET, V125, P615, DOI 10.1007/s00439-009-0656-3; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; 1998, OBES RES, V51, P209	38	62	63	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10521	10.1371/journal.pone.0010521	http://dx.doi.org/10.1371/journal.pone.0010521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20502638	Green Published, Green Submitted, gold			2022-12-25	WOS:000278017300001
J	Sawai, H; Kim, HL; Kuno, K; Suzuki, S; Gotoh, H; Takada, M; Takahata, N; Satta, Y; Akishinonomiya, F				Sawai, Hiromi; Kim, Hie Lim; Kuno, Kaori; Suzuki, Sayaka; Gotoh, Hideo; Takada, Masaru; Takahata, Naoyuki; Satta, Yoko; Akishinonomiya, Fumihito			The Origin and Genetic Variation of Domestic Chickens with Special Reference to Junglefowls Gallus g. gallus and G. varius	PLOS ONE			English	Article							CONTROL REGION; DNA-SEQUENCES; MODERN HUMANS; GENUS GALLUS; EVOLUTION; BIRDS; DIVERGENCE; GENOME; HYBRIDIZATION; REVEALS	It is postulated that chickens (Gallus gallus domesticus) became domesticated from wild junglefowls in Southeast Asia nearly 10,000 years ago. Based on 19 individual samples covering various chicken breeds, red junglefowl (G. g. gallus), and green junglefowl (G. varius), we address the origin of domestic chickens, the relative roles of ancestral polymorphisms and introgression, and the effects of artificial selection on the domestic chicken genome. DNA sequences from 30 introns at 25 nuclear loci are determined for both diploid chromosomes from a majority of samples. The phylogenetic analysis shows that the DNA sequences of chickens, red and green junglefowls formed reciprocally monophyletic clusters. The Markov chain Monte Carlo simulation further reveals that domestic chickens diverged from red junglefowl 58,000 +/- 16,000 years ago, well before the archeological dating of domestication, and that their common ancestor in turn diverged from green junglefowl 3.6 million years ago. Several shared haplotypes nonetheless found between green junglefowl and chickens are attributed to recent unidirectional introgression of chickens into green junglefowl. Shared haplotypes are more frequently found between red junglefowl and chickens, which are attributed to both introgression and ancestral polymorphisms. Within each chicken breed, there is an excess of homozygosity, but there is no significant reduction in the nucleotide diversity. Phenotypic modifications of chicken breeds as a result of artificial selection appear to stem from ancestral polymorphisms at a limited number of genetic loci.	[Sawai, Hiromi; Kim, Hie Lim; Kuno, Kaori; Suzuki, Sayaka; Satta, Yoko; Akishinonomiya, Fumihito] Grad Univ Adv Studies Sokendai, Hayama Ctr Adv Studies, Kanagawa, Japan; [Gotoh, Hideo] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Takada, Masaru] Res Inst Evolutionary Biol, Setagaya Ku, Tokyo, Japan	Graduate University for Advanced Studies - Japan; National Institute of Agrobiological Sciences - Japan	Sawai, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan.	sattayk@soken.ac.jp	Kim, Hie Lim/E-7393-2017	Kim, Hie Lim/0000-0003-3080-9524; Satta, Yoko/0000-0002-5305-493X	Japan Society for Promotion of Science [16107001]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant (no. 16107001) from the Japan Society for Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Avise JC, 1993, MOL MARKERS NATURAL; Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Brodkorb P., 1964, Bulletin of the Florida State Museum Biological Sciences, V8, P195; DANFORTH C. H., 1958, JOUR HEREDITY, V49, P167; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Dimcheff DE, 2002, MOL PHYLOGENET EVOL, V24, P203, DOI 10.1016/S1055-7903(02)00230-0; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; FUMIHITO A, 1995, P NATL ACAD SCI USA, V92, P11053, DOI 10.1073/pnas.92.24.11053; Giuffra E, 2000, GENETICS, V154, P1785; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Hedges SB, 2003, TRENDS GENET, V19, P200, DOI 10.1016/S0168-9525(03)00053-2; HELMBYCHOWSKI KM, 1986, P NATL ACAD SCI USA, V83, P688, DOI 10.1073/pnas.83.3.688; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; JUKES T H, 1969, P21; Kanginakudru S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-174; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Komiyama T, 2004, GENE, V333, P91, DOI 10.1016/j.gene.2004.02.035; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; MOREJOHN GV, 1968, EVOLUTION, V22, P576, DOI 10.1111/j.1558-5646.1968.tb03993.x; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M., 2000, MOL EVOLUTION PHYLOG; Nishibori M, 2005, ANIM GENET, V36, P367, DOI 10.1111/j.1365-2052.2005.01318.x; PRAGER EM, 1974, J MOL EVOL, V3, P243, DOI 10.1007/BF01796041; Pritchard JK, 2000, GENETICS, V155, P945; QUINN TW, 1993, J MOL EVOL, V37, P417; Randi E, 1998, J MOL EVOL, V47, P449, DOI 10.1007/PL00006402; Rannala B, 2003, GENETICS, V164, P1645; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STEINER H, 1945, VEREBUNGFORSCB SOCIA, V20, P236; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; Takahata N, 2007, GENETICS, V176, P1, DOI 10.1534/genetics.104.75135; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Tuinen M, 2004, MOL PHYLOGENET EVOL, V30, P74, DOI 10.1016/S1055-7903(03)00164-7; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156	44	66	69	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10639	10.1371/journal.pone.0010639	http://dx.doi.org/10.1371/journal.pone.0010639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502703	Green Published, Green Submitted, gold			2022-12-25	WOS:000277845400003
J	Tian, SB; Haney, RA; Feder, ME				Tian, Sibo; Haney, Robert A.; Feder, Martin E.			Phylogeny Disambiguates the Evolution of Heat-Shock cis-Regulatory Elements in Drosophila	PLOS ONE			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; MORPHOLOGICAL EVOLUTION; DUPLICATE GENES; HSP26 GENE; IN-VIVO; PROMOTER; SEQUENCE; MELANOGASTER; EXPRESSION	Heat-shock genes have a well-studied control mechanism for their expression that is mediated through cis-regulatory motifs known as heat-shock elements (HSEs). The evolution of important features of this control mechanism has not been investigated in detail, however. Here we exploit the genome sequencing of multiple Drosophila species, combined with a wealth of available information on the structure and function of HSEs in D. melanogaster, to undertake this investigation. We find that in single-copy heat shock genes, entire HSEs have evolved or disappeared 14 times, and the phylogenetic approach bounds the timing and direction of these evolutionary events in relation to speciation. In contrast, in the multicopy gene Hsp70, the number of HSEs is nearly constant across species. HSEs evolve in size, position, and sequence within heat-shock promoters. In turn, functional significance of certain features is implicated by preservation despite this evolutionary change; these features include tail-to-tail arrangements of HSEs, gapped HSEs, and the presence or absence of entire HSEs. The variation among Drosophila species indicates that the cis-regulatory encoding of responsiveness to heat and other stresses is diverse. The broad dimensions of variation uncovered are particularly important as they suggest a substantial challenge for functional studies.	[Tian, Sibo; Haney, Robert A.; Feder, Martin E.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Tian, SB (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	robert.a.haney@gmail.com		Tian, Sibo/0000-0001-5018-4854; Haney, Robert/0000-0002-3742-3395	National Science Foundation [IOB06-41278]	National Science Foundation(National Science Foundation (NSF))	Supported by the National Science Foundation (IOB06-41278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; AMIN J, 1985, MOL CELL BIOL, V5, P197, DOI 10.1128/MCB.5.1.197; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Bauer DC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-220; Besnard G, 2009, MOL BIOL EVOL, V26, P1909, DOI 10.1093/molbev/msp103; Bettencourt BR, 2002, J MOL EVOL, V54, P569, DOI 10.1007/s00239-001-0044-7; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; BONNER JJ, 1994, MOL CELL BIOL, V14, P501, DOI 10.1128/MCB.14.1.501; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; COHEN RS, 1985, CELL, V43, P737, DOI 10.1016/0092-8674(85)90247-8; Crocker J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000276; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dermitzakis ET, 2003, MOL BIOL EVOL, V20, P703, DOI 10.1093/molbev/msg077; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FERNANDES M, 1994, NUCLEIC ACIDS RES, V22, P167, DOI 10.1093/nar/22.2.167; Fernandes M, 1995, NUCLEIC ACIDS RES, V23, P4799, DOI 10.1093/nar/23.23.4799; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Georgel PT, 2005, BIOCHEM CELL BIOL, V83, P555, DOI 10.1139/O05-060; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Guo LH, 2008, PLANT CELL PHYSIOL, V49, P1306, DOI 10.1093/pcp/pcn105; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Haney RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008486; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; Hashikawa N, 2004, MOL CELL BIOL, V24, P3648, DOI 10.1128/MCB.24.9.3648-3659.2004; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jost R, 2007, BIOTECHNIQUES, V43, P206, DOI 10.2144/000112534; Kellett M, 2005, GENOME, V48, P226, DOI [10.1139/g04-113, 10.1139/G04-113]; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000330; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lardenois A, 2006, NUCLEIC ACIDS RES, V34, pW578, DOI 10.1093/nar/gkl193; Large AT, 2009, BIOCHEM SOC T, V37, P46, DOI 10.1042/BST0370046; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; LINDQUIST S, 1980, DEV BIOL, V77, P463, DOI 10.1016/0012-1606(80)90488-1; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lis J.T., 1990, STRESS PROTEINS BIOL, P411; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Macario AJL, 2006, J MOL EVOL, V63, P74, DOI 10.1007/s00239-005-6207-1; Matute DR, 2009, EVOLUTION, V63, P595, DOI 10.1111/j.1558-5646.2008.00588.x; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; MESTRIL R, 1985, EMBO J, V4, P2971, DOI 10.1002/j.1460-2075.1985.tb04031.x; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; [ NRC] National Research Council Committee on Defining and Advancing the Conceptual Basis of Biological Sciences in the 21st Century, 2008, ROL THEOR ADV 21 CEN; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; Schmid CD, 2004, NUCLEIC ACIDS RES, V32, pD82, DOI 10.1093/nar/gkh122; Singh B, 2009, MOL GENET GENOMICS, V281, P361, DOI 10.1007/s00438-008-0417-3; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Takemori Y, 2009, BIOCHEM J, V424, P253, DOI 10.1042/BJ20090922; THOMAS GH, 1988, EMBO J, V7, P2191, DOI 10.1002/j.1460-2075.1988.tb03058.x; VUISTER GW, 1994, NAT STRUCT BIOL, V1, P605, DOI 10.1038/nsb0994-605; Wilczynski B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-82; Wittkopp PJ, 2006, HEREDITY, V97, P139, DOI 10.1038/sj.hdy.6800869; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu WS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-439; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; Zhang Zhaolei, 2003, J Biol, V2, P11, DOI 10.1186/1475-4924-2-11; Zhao YM, 2007, MOL CELL BIOCHEM, V306, P1, DOI 10.1007/s11010-007-9547-x	76	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10669	10.1371/journal.pone.0010669	http://dx.doi.org/10.1371/journal.pone.0010669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498853	Green Submitted, Green Published, gold			2022-12-25	WOS:000277773700012
J	Rodriguez-Noriega, E; Gonzalez-Diaz, E; Morfin-Otero, R; Gomez-Abundis, GF; Briseno-Ramirez, J; Perez-Gomez, HR; Lopez-Gatell, H; Alpuche-Aranda, CM; Ramirez, E; Lopez, I; Iguala, M; Chapela, IB; Zavala, EP; Hernandez, M; Stuart, TL; Villarino, ME; Widdowson, MA; Waterman, S; Uyeki, T; Azziz-Baumgartner, E				Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Morfin-Otero, Rayo; Gomez-Abundis, Gerardo F.; Briseno-Ramirez, Jaime; Raul Perez-Gomez, Hector; Lopez-Gatell, Hugo; Alpuche-Aranda, Celia M.; Ramirez, Ernesto; Lopez, Irma; Iguala, Miguel; Bojorquez Chapela, Ietza; Palacios Zavala, Ethel; Hernandez, Mauricio; Stuart, Tammy L.; Villarino, Margarita Elsa; Widdowson, Marc-Alain; Waterman, Steve; Uyeki, Timothy; Azziz-Baumgartner, Eduardo		Hosp Civil Guadalajara	Hospital Triage System for Adult Patients Using an Influenza-Like Illness Scoring System during the 2009 Pandemic-Mexico	PLOS ONE			English	Article							A H1N1 VIRUS; SURGE CAPACITY; UNITED-STATES; CRITICAL-CARE; PNEUMONIA; DISASTER	Background: Pandemic influenza A (H1N1) virus emerged during 2009. To help clinicians triage adults with acute respiratory illness, a scoring system for influenza-like illness (ILI) was implemented at Hospital Civil de Guadalajara, Mexico. Methods: A medical history, laboratory and radiology results were collected on emergency room (ER) patients with acute respiratory illness to calculate an ILI-score. Patients were evaluated for admission by their ILI-score and clinicians' assessment of risk for developing complications. Nasal and throat swabs were collected from intermediate and high-risk patients for influenza testing by RT-PCR. The disposition and ILI-score of those oseltamivir-treated versus untreated, clinical characteristics of 2009 pandemic influenza A (H1N1) patients versus test-negative patients were compared by Pearson's X(2), Fisher's Exact, and Wilcoxon rank-sum tests. Results: Of 1840 ER patients, 230 were initially hospitalized (mean ILI-score = 15), and the rest were discharged, including 286 ambulatory patients given oseltamivir (median ILI-score = 11), and 1324 untreated (median ILI-score = 5). Fourteen (1%) untreated patients returned, and 3 were hospitalized on oseltamivir (median ILI-score = 19). Of 371 patients tested by RTPCR, 104 (28%) had pandemic influenza and 42 (11%) had seasonal influenza A detected. Twenty (91%) of 22 imaged hospitalized pandemic influenza patients had bilateral infiltrates compared to 23 (38%) of 61 imaged hospital test-negative patients (p<0.001). One patient with confirmed pandemic influenza presented 6 days after symptom onset, required mechanical ventilation, and died. Conclusions: The triaging system that used an ILI-score complimented clinicians' judgment of who needed oseltamivir and inpatient care and helped hospital staff manage a surge in demand for services.	[Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Morfin-Otero, Rayo; Briseno-Ramirez, Jaime; Raul Perez-Gomez, Hector] Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico; [Rodriguez-Noriega, Eduardo; Morfin-Otero, Rayo; Gomez-Abundis, Gerardo F.; Briseno-Ramirez, Jaime; Raul Perez-Gomez, Hector] Univ Guadalajara, Inst Patol Infecciosa & Expt, Ctr Univ Ciencias Salud, Guadalajara 44430, Jalisco, Mexico; [Lopez-Gatell, Hugo; Bojorquez Chapela, Ietza; Palacios Zavala, Ethel; Hernandez, Mauricio] Mexico Minist Hlth, Direcc Gen Epidemiol, Mexico City, DF, Mexico; [Alpuche-Aranda, Celia M.; Ramirez, Ernesto; Lopez, Irma; Iguala, Miguel] Natl Publ Hlth Lab, Mexico City, DF, Mexico; [Stuart, Tammy L.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Villarino, Margarita Elsa; Widdowson, Marc-Alain; Waterman, Steve; Uyeki, Timothy; Azziz-Baumgartner, Eduardo] US Ctr Dis Control & Prevent, Atlanta, GA USA	Universidad de Guadalajara; Public Health Agency of Canada; Centers for Disease Control & Prevention - USA	Rodriguez-Noriega, E (corresponding author), Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico.	eha9@cdc.gov	Gonzalez-Diaz, Esteban/GVU-0915-2022; Morfín-Otero, Rayo/AAR-8027-2021	Gonzalez-Diaz, Esteban/0000-0002-9743-3739; Morfín-Otero, Rayo/0000-0001-9576-1950; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Widdowson, Marc-Alain/0000-0002-0682-6933; RAMIREZ-GONZALEZ, JOSE ERNESTO/0000-0003-0477-2211				Azziz-Baumgartner E, 2009, INFLUENZA OTHER RESP, V3, P189, DOI 10.1111/j.1750-2659.2009.00091.x; *CDC, 2009, INT GUID ANT REC PAT; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Cordova J. A., 2009, Morbidity and Mortality Weekly Report, V58, P585; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; *DEP HLTH BRIT INF, 2007, THORAX, V62, pS1; Glaser CA, 2002, EMERG INFECT DIS, V8, P569, DOI 10.3201/eid0806.010370; Hak E, 2004, J INFECT DIS, V189, P450, DOI 10.1086/381165; HANCOCK K, 2009, NEW ENGL J MED, V361, P1; Ho Y-S., 2009, J ENV PROTECTION SCI, V3, P111; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Nguyen-Van-Tam JS, 2003, VACCINE, V21, P1762, DOI 10.1016/S0264-410X(03)00069-0; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Powell T, 2008, DISASTER MED PUBLIC, V2, P20, DOI 10.1097/DMP.0b013e3181620794; *PUBL HLTH AG CAN, 2008, CAN INFL PLAN HLTH S; Rubinson L, 2008, CHEST, V133, p32S, DOI 10.1378/chest.07-2691; Schull MJ, 2006, ACAD EMERG MED, V13, P1228, DOI [10.1197/j.aem.2006.04.011, 10.1111/j.1553-2712.2006.tb01653.x]; Singanayagam A, 2009, QJM-INT J MED, V102, P379, DOI 10.1093/qjmed/hcp027; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; *US DEP HHS, HHS PAND INFL PLA S5; World Health Organization, 2022, PAND INFL PREP RESP; [No title captured]	25	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10658	10.1371/journal.pone.0010658	http://dx.doi.org/10.1371/journal.pone.0010658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498718	Green Published, gold, Green Submitted			2022-12-25	WOS:000277771600019
J	Birky, CW; Adams, J; Gemmel, M; Perry, J				Birky, C. William, Jr.; Adams, Joshua; Gemmel, Marlea; Perry, Julia			Using Population Genetic Theory and DNA Sequences for Species Detection and Identification in Asexual Organisms	PLOS ONE			English	Article							DIVERSIFICATION; DIVERSITY; MODEL	Background: It is widely agreed that species are fundamental units of biology, but there is little agreement on a definition of species or on an operational criterion for delimiting species that is applicable to all organisms. Methodology/Principal Findings: We focus on asexual eukaryotes as the simplest case for investigating species and speciation. We describe a model of speciation in asexual organisms based on basic principles of population and evolutionary genetics. The resulting species are independently evolving populations as described by the evolutionary species concept or the general lineage species concept. Based on this model, we describe a procedure for using gene sequences from small samples of individuals to assign them to the same or different species. Using this method of species delimitation, we demonstrate the existence of species as independent evolutionary units in seven groups of invertebrates, fungi, and protists that reproduce asexually most or all of the time. Conclusions/Significance: This wide evolutionary sampling establishes the general existence of species and speciation in asexual organisms. The method is well suited for measuring species diversity when phenotypic data are insufficient to distinguish species, or are not available, as in DNA barcoding and environmental sequencing. We argue that it is also widely applicable to sexual organisms.	[Birky, C. William, Jr.; Adams, Joshua; Gemmel, Marlea; Perry, Julia] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Birky, C. William, Jr.] Univ Arizona, Grad Interdisciplinary Program Genet, Tucson, AZ USA	University of Arizona; University of Arizona	Birky, CW (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	birky@u.arizona.edu						Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Avise John C., 1994, pi; Barraclough TG, 2003, EVOLUTION, V57, P2166; Birky CW, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P201, DOI 10.1007/978-90-481-2770-2_10; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Birky CW, 1996, GENETICS, V144, P427; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Coyne JA, 2004, SPECIATION; Darwin C., 1872, P458; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; DONNER J, 1965, ORDNUNG BDELLOIDEA; DONNER J, 1966, ROTIFERS; Fontaneto D, 2008, J EVOLUTION BIOL, V21, P580, DOI 10.1111/j.1420-9101.2007.01472.x; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Grimsley N, 2010, MOL BIOL EVOL, V27, P47, DOI 10.1093/molbev/msp203; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Gustafsson DR, 2009, MOL PHYLOGENET EVOL, V51, P182, DOI 10.1016/j.ympev.2008.12.016; Hall B.G., 2004, PHYLOGENETIC TREES M; Harrison RG, 1998, ENDLESS FORMS, P19; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HIGGS PG, 1992, J MOL EVOL, V35, P454, DOI 10.1007/BF00171824; Highton R, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P215; HOWARD DJ, 1999, ENDLESS FORMS; KNOWLTON N, 1993, SCIENCE, V260, P1629, DOI 10.1126/science.8503007; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Marrone F, 2010, HYDROBIOLOGIA, V644, P115, DOI 10.1007/s10750-010-0101-6; Melone G, 2005, HYDROBIOLOGIA, V546, P197, DOI 10.1007/s10750-005-4197-z; NEI M, 2000, MOL EVOLUTION PHYLOG; Nei M, 1987, MOL EVOLUTIONARY GEN; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ricci C, 2000, HYDROBIOLOGIA, V418, P73, DOI 10.1023/A:1003840216827; Rodriguez F, 2005, ENVIRON MICROBIOL, V7, P853, DOI 10.1111/j.1462-2920.2005.00758.x; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Scheckenbach F, 2005, AQUAT MICROB ECOL, V38, P239, DOI 10.3354/ame038239; Segers H, 2005, HYDROBIOLOGIA, V546, P141, DOI 10.1007/s10750-005-4111-8; Segers H, 2002, J NAT HIST, V36, P631, DOI 10.1080/002229302317339707; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Templeton A.R., 1989, P3; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Wheeler QD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P55; Wiley EO, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P70	52	90	91	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10609	10.1371/journal.pone.0010609	http://dx.doi.org/10.1371/journal.pone.0010609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498705	Green Published, Green Submitted, gold			2022-12-25	WOS:000277633500009
J	Goldstone, S; Reyes, C; Gay, G; Courtheoux, T; Dubarry, M; Tournier, S; Gachet, Y				Goldstone, Sherilyn; Reyes, Celine; Gay, Guillaume; Courtheoux, Thibault; Dubarry, Marion; Tournier, Sylvie; Gachet, Yannick			Tip1/CLIP-170 Protein Is Required for Correct Chromosome Poleward Movement in Fission Yeast	PLOS ONE			English	Article							MITOTIC SPINDLE; SACCHAROMYCES-CEREVISIAE; MICROTUBULE ATTACHMENT; DISTINCT MECHANISMS; BINDING PROTEIN; DYNAMICS; CLIP-170; CHECKPOINT; ANAPHASE; KINETOCHORE	The plus-end microtubule binding proteins (+TIPs) play an important role in the regulation of microtubule stability and cell polarity during interphase. In S. pombe, the CLIP-170 like protein Tip1, together with the kinesin Tea2, moves along the microtubules towards their plus ends. Tip1 also requires the EB1 homolog Mal3 to localize to the microtubule tips. Given the requirement for Tip1 for microtubule stability, we have investigated its role during spindle morphogenesis and chromosome movement. Loss of Tip1 affects metaphase plate formation and leads to the activation of the spindle assembly checkpoint. In the absence of Tip1 we also observed the appearance of lagging chromosomes, which do not influence the normal rate of spindle elongation. Our results suggest that S. pombe Tip1/CLIP170 is directly or indirectly required for correct chromosome poleward movement independently of Mal3/EB1.	[Goldstone, Sherilyn; Reyes, Celine; Gay, Guillaume; Courtheoux, Thibault; Dubarry, Marion; Tournier, Sylvie; Gachet, Yannick] Univ Toulouse, CNRS, LBCMCP, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Goldstone, S (corresponding author), Univ Toulouse, CNRS, LBCMCP, Toulouse, France.	tournier@cict.fr; gachet@cict.fr	Gachet, Yannick/AAK-5363-2021	Dubarry, Marion/0000-0001-5648-5770; Gay, Guillaume/0000-0002-5444-5246	Fondation pour la Recherche Medicale; La ligue contre le cancer	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); La ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported partially by a post-doctoral fellowship from the Fondation pour la Recherche Medicale. T. C. is supported by a fellowship from La ligue contre le cancer. L'Association de la Recherche sur le Cancer (ARC) provided some part of the microscopy equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2006, CELL CYCLE, V5, P27, DOI 10.4161/cc.5.1.2262; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Courtheoux T, 2007, BIOL CELL, V99, P627, DOI 10.1042/BC20070047; Courtheoux T, 2009, J CELL BIOL, V187, P399, DOI 10.1083/jcb.200902093; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Dzhindzhev NS, 2005, J CELL SCI, V118, P3781, DOI 10.1242/jcs.02504; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Gachet Y, 2004, EMBO J, V23, P1289, DOI 10.1038/sj.emboj.7600156; Gachet Y, 2008, MOL BIOL CELL, V19, P1646, DOI 10.1091/mbc.E07-09-0910; Gachet Y, 2006, YEAST, V23, P1015, DOI 10.1002/yea.1410; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; Grancell A, 1998, CURR BIOL, V8, pR382, DOI 10.1016/S0960-9822(98)70243-X; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Grishchuk EL, 2007, MOL BIOL CELL, V18, P2216, DOI 10.1091/mbc.E06-11-0987; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Javerzat JP, 1996, NUCLEIC ACIDS RES, V24, P4676, DOI 10.1093/nar/24.23.4676; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Maekawa H, 2004, DEV CELL, V6, P746, DOI 10.1016/j.devcel.2004.05.017; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; Miller RK, 2006, CURR TOP DEV BIOL, V76, P49, DOI 10.1016/S0070-2153(06)76002-1; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Molk JN, 2006, J CELL BIOL, V172, P27, DOI 10.1083/jcb.200510032; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Pidoux AL, 2000, J CELL SCI, V113, P4177; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Tanaka K, 2009, CANCER SCI, V100, P1158, DOI 10.1111/j.1349-7006.2009.01178.x; Tanenbaum ME, 2006, EMBO J, V25, P45, DOI 10.1038/sj.emboj.7600916; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tolic-Norrelykke IM, 2004, CURR BIOL, V14, P1181, DOI 10.1016/j.cub.2004.06.029; Tournier S, 2004, MOL BIOL CELL, V15, P3345, DOI 10.1091/mbc.E04-03-0256; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wolyniak MJ, 2006, MOL BIOL CELL, V17, P2789, DOI 10.1091/mbc.E05-09-0892; Wuhr M, 2008, CURR BIOL, V18, pR912, DOI 10.1016/j.cub.2008.08.043	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10634	10.1371/journal.pone.0010634	http://dx.doi.org/10.1371/journal.pone.0010634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498706	Green Published, Green Submitted, gold			2022-12-25	WOS:000277633500019
J	Kabir, MM; Dimitri, H; Sanders, P; Antic, R; Nalivaiko, E; Abbott, D; Baumert, M				Kabir, Muammar M.; Dimitri, Hany; Sanders, Prashanthan; Antic, Ral; Nalivaiko, Eugene; Abbott, Derek; Baumert, Mathias			Cardiorespiratory Phase-Coupling Is Reduced in Patients with Obstructive Sleep Apnea	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MYOCARDIAL-INFARCTION; SPECTRAL-ANALYSIS; BLOOD-PRESSURE; TIME-DOMAIN; SYNCHRONIZATION; SYSTEM; RESPIRATION; MODULATION; DYNAMICS	Cardiac and respiratory rhythms reveal transient phases of phase-locking which were proposed to be an important aspect of cardiorespiratory interaction. The aim of this study was to quantify cardio-respiratory phase-locking in obstructive sleep apnea (OSA). We investigated overnight polysomnography data of 248 subjects with suspected OSA. Cardiorespiratory phase-coupling was computed from the R-R intervals of body surface ECG and respiratory rate, calculated from abdominal and thoracic sensors, using Hilbert transform. A significant reduction in phase-coupling was observed in patients with severe OSA compared to patients with no or mild OSA. Cardiorespiratory phase-coupling was also associated with sleep stages and was significantly reduced during rapid-eye-movement (REM) sleep compared to slow-wave (SW) sleep. There was, however, no effect of age and BMI on phase coupling. Our study suggests that the assessment of cardiorespiratory phase coupling may be used as an ECG based screening tool for determining the severity of OSA.	[Kabir, Muammar M.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Ctr Biomed Engn, Adelaide, SA, Australia; [Dimitri, Hany; Sanders, Prashanthan] Univ Adelaide, Cardiovasc Res Ctr, Sch Med, Adelaide, SA, Australia; [Antic, Ral] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia; [Nalivaiko, Eugene] Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia; [Baumert, Mathias] Univ Adelaide, Sch Med, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; Royal Adelaide Hospital; University of Newcastle; University of Adelaide	Kabir, MM (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Ctr Biomed Engn, Adelaide, SA, Australia.	muammar.kabir@adelaide.edu.au	Baumert, Mathias/A-8324-2008; Kabir, Muammar/C-1210-2010; Abbott, Derek/E-8352-2011; Sanders, Prashanthan/D-7641-2013	Baumert, Mathias/0000-0003-2984-2167; Abbott, Derek/0000-0002-0945-2674; Sanders, Prashanthan/0000-0003-3803-8429; Nalivaiko, Eugene/0000-0002-6449-8181	Australian Research Council [DP0663345]	Australian Research Council(Australian Research Council)	The research was supported by the Australian Research Council (grant #DP0663345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin M, 2004, TEX HEART I J, V31, P132; Bartsch R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.054102; Baumert M, 2008, SLEEP, V31, P959; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bettermann Henrik, 2002, BMC Physiol, V2, P18, DOI 10.1186/1472-6793-2-18; Brandenberger G, 2005, AUTON NEUROSCI-BASIC, V121, P81, DOI 10.1016/j.autneu.2005.06.002; Busetto L, 2005, CHEST, V128, P618, DOI 10.1378/chest.128.2.618; CASOLO GC, 1992, CIRCULATION, V85, P2073, DOI 10.1161/01.CIR.85.6.2073; Censi F, 2000, MED BIOL ENG COMPUT, V38, P416, DOI 10.1007/BF02345011; Coruzzi P, 2006, CHEST, V130, P1362, DOI 10.1378/chest.130.5.1362; Cysarz D, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-44; FERGUSON KA, 1995, CHEST, V108, P375, DOI 10.1378/chest.108.2.375; Gottesmann C, 1999, PROG NEUROBIOL, V59, P469, DOI 10.1016/S0301-0082(99)00014-3; Guyton A.C., 2006, TXB MED PHYSL, P739; Hamann C, 2009, CHAOS, V19, DOI 10.1063/1.3096415; HAYANO J, 1994, AM J PHYSIOL, V267, pH33, DOI 10.1152/ajpheart.1994.267.1.H33; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Hoffmann J, 1996, PACE, V19, P1841, DOI 10.1111/j.1540-8159.1996.tb03237.x; Hoyer D, 2002, MED ENG PHYS, V24, P33, DOI 10.1016/S1350-4533(01)00120-5; Hoyer D, 1997, IEEE ENG MED BIOL, V16, P97, DOI 10.1109/51.637123; Javorka M, 2008, CLIN NEUROPHYSIOL, V119, P1071, DOI 10.1016/j.clinph.2007.12.017; Kenwright DA, 2008, EUR PHYS J B, V65, P425, DOI 10.1140/epjb/e2008-00199-4; Kotani K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051923; Leder U, 2000, Z KARDIOL, V89, P630, DOI 10.1007/s003920070214; Lotric MB, 2000, PHYSICA A, V283, P451, DOI 10.1016/S0378-4371(00)00204-1; Mangin L, 2009, AM J PHYSIOL-REG I, V296, pR1088, DOI 10.1152/ajpregu.90862.2008; MEERSMAN RE, 1992, EUR J APPL PHYSL, V64, P434; MOSER M, 1994, CIRCULATION, V90, P1078, DOI 10.1161/01.CIR.90.2.1078; Mrowka R, 2000, INT J BIFURCAT CHAOS, V10, P2479, DOI 10.1142/S0218127400001754; Nalivaiko E, 2007, AM J PHYSIOL-REG I, V292, pR1320, DOI 10.1152/ajpregu.00642.2006; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Narkiewicz K, 2003, ACTA PHYSIOL SCAND, V177, P385, DOI 10.1046/j.1365-201X.2003.01091.x; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; Penzel T, 2003, NEUROPSYCHOPHARMACOL, V28, pS48, DOI 10.1038/sj.npp.1300146; Pereda E, 2005, IEEE T BIO-MED ENG, V52, P578, DOI 10.1109/TBME.2005.844022; PIZZUTI GP, 1985, J BIOMED ENG, V7, P247, DOI 10.1016/0141-5425(85)90027-5; Rechtschaffen A, 1968, MANUAL STANDARIZED T; Roche F, 2002, PACE, V25, P1192, DOI 10.1046/j.1460-9592.2002.01192.x; Roche F, 1999, CIRCULATION, V100, P1411, DOI 10.1161/01.CIR.100.13.1411; Sandercock GRH, 2006, PACE, V29, P892, DOI 10.1111/j.1540-8159.2006.00457.x; Schafer C, 1999, PHYS REV E, V60, P857, DOI 10.1103/PhysRevE.60.857; Schafer C, 1998, NATURE, V392, P239, DOI 10.1038/32567; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; SNYDER F, 1964, J APPL PHYSIOL, V19, P417, DOI 10.1152/jappl.1964.19.3.417; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Song HS, 2003, APPL PSYCHOPHYS BIOF, V28, P13, DOI 10.1023/A:1022312815649; Stefanovska A, 2000, PHYS REV LETT, V85, P4831, DOI 10.1103/PhysRevLett.85.4831; Toledo E, 2002, MED ENG PHYS, V24, P45, DOI 10.1016/S1350-4533(01)00114-X; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Tzeng YC, 2007, AM J PHYSIOL-HEART C, V292, pH1967, DOI 10.1152/ajpheart.01049.2006; Tzeng YC, 2003, EXP PHYSIOL, V88, P775, DOI 10.1113/eph8802606; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Varady P, 2003, IEEE T INSTRUM MEAS, V52, P2, DOI 10.1109/TIM.2003.809095; Wiklund U, 2000, CLIN PHYSIOL, V20, P234; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	55	46	48	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10602	10.1371/journal.pone.0010602	http://dx.doi.org/10.1371/journal.pone.0010602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485528	Green Published, gold, Green Submitted			2022-12-25	WOS:000277633500007
J	Squarize, CH; Castilho, RM; Bugge, TH; Gutkind, JS				Squarize, Cristiane H.; Castilho, Rogerio M.; Bugge, Thomas H.; Gutkind, J. Silvio			Accelerated Wound Healing by mTOR Activation in Genetically Defined Mouse Models	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; RENAL-ALLOGRAFT REJECTION; CHROMOSOME-10 PTEN; CANCER; SIROLIMUS; TARGET; DISEASE; PROLIFERATION; PHOSPHATASE; MECHANISMS	Background: The management of slow or non-healing ulcerations constitutes an increasing clinical challenge in the developed world because of the ageing of the population and the pandemic rise in type II diabetes. Recent studies suggest that molecular circuitries deployed by tumor cells to promote cancerous growth may also contribute to tissue regeneration. Here, we exploited this emerging information to search for novel molecular targets to accelerate wound healing. Methodology/Principal Findings: We found that the activation of the PI3K-Akt-mTOR pathway, whose aberrant function is a frequent event in human neoplasia, represents an integral component of the normal wound healing process. By the use of genetically defined approaches, including the epithelial-specific ablation of Pten and Tsc1, we show that mTOR activation can dramatically increase epithelial cell proliferation, migration, and cutaneous wound healing, while pharmacological inhibition of mTOR with rapamycin delays wound closure. Conclusions/Significance: Overall, our findings indicate that the transient pharmacologic activation of the PI3K-Akt-mTOR signaling axis may represent a novel clinical intervention strategy to accelerate the healing of debilitating and life-threatening wounds.	[Squarize, Cristiane H.; Castilho, Rogerio M.; Bugge, Thomas H.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Squarize, Cristiane H.; Castilho, Rogerio M.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Div Oral Pathol Med Radiol, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Michigan System; University of Michigan	Squarize, CH (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA.	sg39v@nih.gov	Castilho, Rogerio M/E-4987-2010; Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009	Castilho, Rogerio M/0000-0001-5358-612X; Gutkind, J. Silvio/0000-0002-5150-4482; Squarize, Cristiane/0000-0002-6782-3429	NIH, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558] Funding Source: NIH RePORTER	NIH, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the Intramural Research Program of NIH, National Institute of Dental and Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Campistol JM, 2009, TRANSPL INT, V22, P681, DOI 10.1111/j.1432-2277.2009.00858.x; Castilho RM, 2007, ONCOGENE, V26, P5078, DOI 10.1038/sj.onc.1210322; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Comer FI, 2007, CELL, V128, P239, DOI 10.1016/j.cell.2007.01.010; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kaposztas Z, 2008, TRANSPL P, V40, P1744, DOI [10.1016/j.transproceed.2007.11.072, 10.1016/j.transproceed.2008.10.019]; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Knight RJ, 2007, CLIN TRANSPLANT, V21, P460, DOI 10.1111/j.1399-0012.2007.00668.x; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mathew TH, 2006, J CLIN PHARMACOL, V46, P76, DOI 10.1177/0091270005282628; Meikle L, 2005, HUM MOL GENET, V14, P429, DOI 10.1093/hmg/ddi039; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Romer J, 1996, NAT MED, V2, P725, DOI 10.1038/nm0796-725a; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; SARRET Y, 1992, J INVEST DERMATOL, V98, P12, DOI 10.1111/1523-1747.ep12493517; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schmid AC, 2004, BIOCHEM SOC T, V32, P348, DOI 10.1042/BST0320348; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Squarize CH, 2008, CANCER RES, V68, P7066, DOI 10.1158/0008-5472.CAN-08-0922; Zhao M, 2007, BRIT J PHARMACOL, V152, P1141, DOI 10.1038/sj.bjp.0707503	42	128	134	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10643	10.1371/journal.pone.0010643	http://dx.doi.org/10.1371/journal.pone.0010643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498714	Green Submitted, Green Published, gold			2022-12-25	WOS:000277633500022
J	Massaad, CA; Amin, SK; Hu, LY; Mei, Y; Klann, E; Pautler, RG				Massaad, Cynthia A.; Amin, Samir K.; Hu, Lingyun; Mei, Yuan; Klann, Eric; Pautler, Robia G.			Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AMYLOID-BETA PROTEIN; OXIDATIVE STRESS; MEMORY DEFICITS; DISMUTASE; TAU; PHOSPHORYLATION; BRAIN; OVEREXPRESSION; DYSFUNCTION	Background: Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive decline in cognitive functions and the deposition of aggregated amyloid beta (A beta) into senile plaques and the protein tau into tangles. In addition, a general state of oxidation has long been known to be a major hallmark of the disease. What is not known however, are the mechanisms by which oxidative stress contributes to the pathology of AD. Methodology/Principal Findings: In the current study, we used a mouse model of AD and genetically boosted its ability to quench free radicals of specific mitochondrial origin. We found that such manipulation conferred to the AD mice protection against vascular as well as neuronal deficits that typically affect them. We also found that the vascular deficits are improved via antioxidant modulation of the endothelial nitric oxide synthase, an enzyme primarily responsible for the production of nitric oxide, while neuronal deficits are improved via modulation of the phosphorylation status of the protein tau, which is a neuronal cytoskeletal stabilizer. Conclusions/Significance: These findings directly link free radicals of specific mitochondrial origin to AD-associated vascular and neuronal pathology.	[Massaad, Cynthia A.; Amin, Samir K.; Hu, Lingyun; Mei, Yuan; Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Mei, Yuan] Rice Univ, Dept Cognit Sci, Houston, TX USA; [Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA	Baylor College of Medicine; Rice University; New York University	Massaad, CA (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	rpautler@bcm.edu			National Institutes of Health, National Institute on Aging [AG029977]; Wendler Research Fund; National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS034007, NS047384]; Alzheimers Association Investigator Initiated Research [05-15221]; National Institutes of Health, National Heart, Lung and Blood Institute [T32HL07676]; American Health Assistance Foundation, Alzheimer Disease Research [A2008-600]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034007, R01NS034007, R37NS034007, R01NS047384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029977] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wendler Research Fund; National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimers Association Investigator Initiated Research(Alzheimer's Association); National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Health Assistance Foundation, Alzheimer Disease Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health, National Institute on Aging Grant AG029977 and The Wendler Research Fund (to R. G. P.), the National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS034007 and NS047384, and Alzheimers Association Investigator Initiated Research Grant 05-15221 (to E. K.); the National Institutes of Health, National Heart, Lung and Blood Institute Grant T32HL07676 and the American Health Assistance Foundation, Alzheimer Disease Research Grant A2008-600 (to C. A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADORO G, 2009, NEUROBIOL AGING; Anantharaman M, 2006, AM J PATHOL, V168, P1608, DOI 10.2353/ajpath.2006.051223; Behl C, 2005, SUB CELL BIOCHEM, V38, P65; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Butterfield DA, 2002, J ALZHEIMERS DIS, V4, P193, DOI 10.3233/JAD-2002-4309; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Christie R, 2001, AM J PATHOL, V158, P1065, DOI 10.1016/S0002-9440(10)64053-9; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HANSSON O, 2007, NEUROBIOL AGING; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Ho YS, 1998, AM J RESP CELL MOL, V18, P538, DOI 10.1165/ajrcmb.18.4.2959; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003; Iadecola C, 2003, ARTERIOSCL THROM VAS, V23, P1951, DOI 10.1161/01.ATV.0000102660.99744.85; Ittner LM, 2009, J BIOL CHEM, V284, P20909, DOI 10.1074/jbc.M109.014472; Jeynes B, 2009, NEUROSCI LETT, V463, P244, DOI 10.1016/j.neulet.2009.07.091; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Massaad CA, 2009, P NATL ACAD SCI USA, V106, P13576, DOI 10.1073/pnas.0902714106; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; MONCADA S, 1991, PHARMACOL REV, V43, P109; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shah SB, 2009, NEUROBIOL DIS, V36, P11, DOI 10.1016/j.nbd.2009.05.016; Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith KDB, 2007, NEUROIMAGE, V35, P1401, DOI 10.1016/j.neuroimage.2007.01.046; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Orduna MT, 2009, J PINEAL RES, V46, P262, DOI 10.1111/j.1600-079X.2008.00656.x; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804	56	55	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10561	10.1371/journal.pone.0010561	http://dx.doi.org/10.1371/journal.pone.0010561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479943	gold, Green Published, Green Submitted			2022-12-25	WOS:000277467900016
J	Trajtenberg, F; Grana, M; Ruetalo, N; Botti, H; Buschiazzo, A				Trajtenberg, Felipe; Grana, Martin; Ruetalo, Natalia; Botti, Horacio; Buschiazzo, Alejandro			Structural and Enzymatic Insights into the ATP Binding and Autophosphorylation Mechanism of a Sensor Histidine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; DOMAIN; CHEA; PHOSPHORYLATION; DEPHOSPHORYLATION; SPECIFICITY; CATALYSIS	DesK is a sensor histidine kinase (HK) that allows Bacillus subtilis to respond to cold shock, triggering the adaptation of membrane fluidity via transcriptional control of a fatty acid desaturase. It belongs to the HK family HPK7, which includes the nitrogen metabolism regulators NarX/Q and the antibiotic sensor LiaS among other important sensor kinases. Structural information on different HK families is still scarce and several questions remain, particularly concerning the molecular features that determine HK specificity during its catalytic autophosphorylation and subsequent response-regulator phosphotransfer reactions. To analyze the ATP-binding features of HPK7 HKs and dissect their mechanism of autophosphorylation at the molecular level, we have studied DesK in complex with ATP using high resolution structural approaches in combination with biochemical studies. We report the first crystal structure of an HK in complex with its natural nucleotidic substrate. The general fold of the ATP-binding domain of DesK is conserved, compared with well studied members of other families. Yet, DesK displays a far more compact structure at the ATP-binding pocket: the ATP lid loop is much shorter with no secondary structural organization and becomes ordered upon ATP loading. Sequence conservation mapping onto the molecular surface, semi-flexible protein-protein docking simulations, and structure-based point mutagenesis allow us to propose a specific domain-domain geometry during autophosphorylation catalysis. Supporting our hypotheses, we have been able to trap an autophosphorylating intermediate state, by protein engineering at the predicted domain-domain interaction surface.	[Trajtenberg, Felipe; Ruetalo, Natalia; Botti, Horacio; Buschiazzo, Alejandro] Inst Pasteur Montevideo, Unit Prot Crystallog, Montevideo 11400, Uruguay; [Grana, Martin] Inst Pasteur Montevideo, Unit Bioinformat, Montevideo 11400, Uruguay; [Buschiazzo, Alejandro] Inst Pasteur, Dept Struct Biol & Chem, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Buschiazzo, A (corresponding author), Inst Pasteur Montevideo, Unit Prot Crystallog, Mataojo 2020, Montevideo 11400, Uruguay.	alebus@pasteur.edu.uy	Buschiazzo, Alejandro/W-1095-2018	Buschiazzo, Alejandro/0000-0002-2509-6526; Trajtenberg, Felipe/0000-0003-0427-5549; Grana, Martin/0000-0003-1182-8236	Agencia Nacional de Investigacion e Innovacion, Uruguay (ANII) [FCE2007_219, FCE2007_377]; Agence Nationale de la Recherche, France [ANR-06-PCVI-0009-01]	Agencia Nacional de Investigacion e Innovacion, Uruguay (ANII); Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was supported in part by Grants FCE2007_219 (to A.B.) and FCE2007_377 (to M.G.) from the Agencia Nacional de Investigacion e Innovacion, Uruguay (ANII) and Grant ANR-06-PCVI-0009-01 (to A.B.) from the Agence Nationale de la Recherche, France.	Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Albanesi D, 2004, J BACTERIOL, V186, P2655, DOI 10.1128/JB.186.9.2655-2663.2004; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cai SJ, 2003, J MOL BIOL, V329, P495, DOI 10.1016/S0022-2836(03)00446-7; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cybulski LE, 2004, J BIOL CHEM, V279, P39340, DOI 10.1074/jbc.M405150200; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dehner A, 2003, CHEMBIOCHEM, V4, P870, DOI 10.1002/cbic.200300658; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Espenson J. H, 1995, CHEM KINETICS REACTI, P15; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; HULTQUIST DE, 1966, BIOCHEMISTRY-US, V5, P322, DOI 10.1021/bi00865a041; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kotting C, 2006, P NATL ACAD SCI USA, V103, P13911, DOI 10.1073/pnas.0604128103; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lindsley JE, 2000, METH MOL B, V95, P57; Lott JS, 2006, J BIOL CHEM, V281, P22131, DOI 10.1074/jbc.M603062200; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Marina A, 2001, J BIOL CHEM, V276, P41182, DOI 10.1074/jbc.M106080200; Markowitz Victor M., 2007, V395, P35; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; Noriega CE, 2008, J BACTERIOL, V190, P3869, DOI 10.1128/JB.00092-08; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Scaramozzino F, 2009, J BACTERIOL, V191, P687, DOI 10.1128/JB.01184-08; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; Siryaporn A, 2008, MOL MICROBIOL, V70, P494, DOI 10.1111/j.1365-2958.2008.06426.x; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; TAWA P, 1994, BIOCHEMISTRY-US, V33, P7917, DOI 10.1021/bi00191a019; TAWA P, 1994, J BACTERIOL, V176, P4210, DOI 10.1128/jb.176.14.4210-4218.1994; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Wolanin PM, 2002, GENOME BIOL, V3; Zhang J, 2005, J AM CHEM SOC, V127, P11709, DOI 10.1021/ja051199o	43	40	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24892	24903		10.1074/jbc.M110.147843	http://dx.doi.org/10.1074/jbc.M110.147843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507988	hybrid, Green Published			2022-12-25	WOS:000280542100062
J	Cassano, S; Agnese, S; D'Amato, V; Papale, M; Garbi, C; Castagnola, P; Ruocco, MR; Castellano, I; De Vendittis, E; Santillo, M; Amente, S; Porcellini, A; Avvedimento, EV				Cassano, Silvana; Agnese, Savina; D'Amato, Valentina; Papale, Massimo; Garbi, Corrado; Castagnola, Patrizio; Ruocco, Maria Rosaria; Castellano, Immacolata; De Vendittis, Emmanuele; Santillo, Mariarosaria; Amente, Stefano; Porcellini, Antonio; Avvedimento, Enrico Vittorio			Reactive Oxygen Species, Ki-Ras, and Mitochondrial Superoxide Dismutase Cooperate in Nerve Growth Factor-induced Differentiation of PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX REGULATION; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; HYDROGEN-PEROXIDE; NADPH OXIDASE; PROTEIN; ACTIVATION; MICROTUBULES; EXPRESSION; RECEPTORS	Nerve growth factor (NGF) induces terminal differentiation in PC12, a pheochromocytoma-derived cell line. NGF binds a specific receptor on the membrane and triggers the ERK1/2 cascade, which stimulates the transcription of neural genes. We report that NGF significantly affects mitochondrial metabolism by reducing mitochondrial-produced reactive oxygen species and stabilizing the electrochemical gradient. This is accomplished by stimulation of mitochondrial manganese superoxide dismutase (MnSOD) both transcriptionally and post-transcriptionally via Ki-Ras and ERK1/2. Activation of MnSOD is essential for completion of neuronal differentiation because 1) expression of MnSOD induces the transcription of a neuronal specific promoter and neurite outgrowth, 2) silencing of endogenous MnSOD by small interfering RNA significantly reduces transcription induced by NGF, and 3) a Ki-Ras mutant in the polylysine stretch at the COOH terminus, unable to stimulate MnSOD, fails to induce complete differentiation. Overexpression of MnSOD restores differentiation in cells expressing this mutant. ERK1/2 is also downstream of MnSOD, as a SOD mimetic drug stimulates ERK1/2 with the same kinetics of NGF and silencing of MnSOD reduces NGF-induced late ERK1/2. Long term activation of ERK1/2 by NGF requires SOD activation, low levels of hydrogen peroxide, and the integrity of the microtubular cytoskeleton. Confocal immunofluorescence shows that NGF stimulates the formation of a complex containing membrane-bound Ki-Ras, microtubules, and mitochondria. We propose that active NGF receptor induces association of mitochondria with plasma membrane. Local activation of ERK1/2 by Ki-Ras stimulates mitochondrial SOD, which reduces reactive oxygen species and produces H(2)O(2). Low and spatially restricted levels of H(2)O(2) induce and maintain long term ERK1/2 activity and ultimately differentiation of PC12 cells.	[Cassano, Silvana; Agnese, Savina; D'Amato, Valentina; Papale, Massimo; Garbi, Corrado; Avvedimento, Enrico Vittorio] Univ Naples Federico 2, CNR, Ist Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Mol & Cellulare, I-80131 Naples, Italy; [Santillo, Mariarosaria] Univ Naples Federico 2, Dipartimento Neurosci, Sez Fisiol, I-80131 Naples, Italy; [Ruocco, Maria Rosaria; Castellano, Immacolata; De Vendittis, Emmanuele] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; [Amente, Stefano] Univ Naples Federico 2, Dipartimento Biol Strutturale & Funz, I-80126 Naples, Italy; [Porcellini, Antonio] Univ Molise, Dipartimento Sci Salute, I-86100 Campobasso, Italy; [Castagnola, Patrizio] Ist Nazl Ric Canc, I-16132 Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Molise; University of Genoa; IRCCS AOU San Martino IST	Avvedimento, EV (corresponding author), Univ Naples Federico 2, CNR, Ist Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Mol & Cellulare, Via S Pansini,5, I-80131 Naples, Italy.	avvedim@unina.it	Castagnola, Patrizio/H-2029-2012; Porcellini, Antonio/E-1900-2011; Papale, Massimo/AAQ-2370-2020; Castellano, Immacolata/AAD-5523-2019; Amente, Stefano/AAU-7605-2020; Porcellini, Antonio/AAC-6097-2019	Castagnola, Patrizio/0000-0003-2008-9199; Porcellini, Antonio/0000-0001-6882-9518; Papale, Massimo/0000-0002-8278-5045; Amente, Stefano/0000-0003-0612-6096; CASSANO, SILVANA/0000-0001-9868-7936; Castellano, Immacolata/0000-0002-4274-6738	Associazione Italiana per la Ricerca sul Cancro; Ministero Italiano per l'Universita e la Ricerca Scientifica; Fondo per gli Investimenti della Ricerca di Base; Ministero della Salute	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano per l'Universita e la Ricerca Scientifica; Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministero della Salute(Ministry of Health, Italy)	This work was supported in part by the Associazione Italiana per la Ricerca sul Cancro, Ministero Italiano per l'Universita e la Ricerca Scientifica, Fondo per gli Investimenti della Ricerca di Base, and Project "Colon," Ministero della Salute, FSN 2004.	Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bumeister R, 2004, CURR BIOL, V14, P439, DOI 10.1016/j.cub.2004.02.037; Cassano S, 1999, J BIOL CHEM, V274, P32574, DOI 10.1074/jbc.274.46.32574; Castellano I, 2009, BIOPOLYMERS, V91, P1215, DOI 10.1002/bip.21208; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Cuda G, 2002, CIRCULATION, V105, P968, DOI 10.1161/hc0802.104324; DAMON DH, 1990, J CELL BIOL, V110, P1333, DOI 10.1083/jcb.110.4.1333; Ding AH, 1996, J EXP MED, V183, P1899, DOI 10.1084/jem.183.4.1899; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Fukano T, 2007, CELL STRUCT FUNCT, V32, P9, DOI 10.1247/csf.06019; Gadjev I, 2008, INT REV CEL MOL BIO, V270, P87, DOI 10.1016/S1937-6448(08)01403-2; Galeotti T, 2005, BIOMED PHARMACOTHER, V59, P197, DOI 10.1016/j.biopha.2005.03.002; Ginsberg MD, 2003, J MOL BIOL, V327, P885, DOI 10.1016/S0022-2836(03)00173-6; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; Hu YM, 2005, J BIOL CHEM, V280, P39485, DOI 10.1074/jbc.M503296200; Ibi M, 2006, FREE RADICAL BIO MED, V40, P1785, DOI 10.1016/j.freeradbiomed.2006.01.009; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; JANSSENTIMMEN U, 1989, GENE, V80, P325, DOI 10.1016/0378-1119(89)90296-5; Kemmerling U, 2007, CELL CALCIUM, V41, P491, DOI 10.1016/j.ceca.2006.10.001; Kim JW, 2008, BIOCHEM PHARMACOL, V76, P1577, DOI 10.1016/j.bcp.2008.08.007; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Lazarovici P, 1997, J BIOL CHEM, V272, P11026, DOI 10.1074/jbc.272.17.11026; MARCHISIO PC, 1993, EXP CELL RES, V205, P205, DOI 10.1006/excr.1993.1078; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MorishimaKawashima M, 1996, MOL BIOL CELL, V7, P893, DOI 10.1091/mbc.7.6.893; Muller M, 2005, EXP CELL RES, V303, P114, DOI 10.1016/j.yexcr.2004.09.025; PETER P, 2006, BIOCHIMIE, P123; Prior IA, 2001, J CELL SCI, V114, P1603; Ranganathan AC, 2001, J BIOL CHEM, V276, P14264, DOI 10.1074/jbc.M100199200; SAMPATH D, 1994, J NEUROCHEM, V62, P2476; Santillo M, 2001, CURR BIOL, V11, P614, DOI 10.1016/S0960-9822(01)00159-2; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Takii Y, 2003, ELECTROCHIM ACTA, V48, P3381, DOI 10.1016/S0013-4686(03)00408-0; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Wright JH, 1997, MOL BIOL CELL, V8, P1575, DOI 10.1091/mbc.8.8.1575; Wu CB, 2007, TRAFFIC, V8, P1503, DOI 10.1111/j.1600-0854.2007.00636.x; Zhou ZX, 2000, J HISTOCHEM CYTOCHEM, V48, P585, DOI 10.1177/002215540004800502	50	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24141	24153		10.1074/jbc.M109.098525	http://dx.doi.org/10.1074/jbc.M109.098525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20495008	Green Published			2022-12-25	WOS:000280291400064
J	Guo, X; Xu, KF; Zhang, JF; Li, HG; Zhang, WY; Wang, HA; Lange, AJ; Chen, YE; Huo, YQ; Wu, CD				Guo, Xin; Xu, Kefeng; Zhang, Jifeng; Li, Honggui; Zhang, Weiyu; Wang, Huan; Lange, Alex J.; Chen, Y. Eugene; Huo, Yuqing; Wu, Chaodong			Involvement of Inducible 6-Phosphofructo-2-kinase in the Anti-diabetic Effect of Peroxisome Proliferator-activated Receptor gamma Activation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADIPOSE-TISSUE; INSULIN-RESISTANCE; PPAR-GAMMA; OBESITY; ADIPOCYTES; ROSIGLITAZONE; EXPRESSION; LIVER; FAT; DISRUPTION	PFKFB3 is the gene that codes for the inducible isoform of 6-phosphofructo-2-kinase (iPFK2), a key regulatory enzyme of glycolysis. As one of the targets of peroxisome proliferator-activated receptor gamma (PPAR gamma), PFKFB3/iPFK2 is up-regulated by thiazolidinediones. In the present study, using PFKFB3/iPFK2-disrupted mice, the role of PFKFB3/iPFK2 in the anti-diabetic effect of PPAR gamma activation was determined. In wild-type littermate mice, PPAR gamma activation (i.e. treatment with rosiglitazone) restored euglycemia and reversed high fat diet-induced insulin resistance and glucose intolerance. In contrast, PPAR gamma activation did not reduce high fat diet-induced hyperglycemia and failed to reverse insulin resistance and glucose intolerance in PFKFB3(+/-) mice. The lack of anti-diabetic effect in PFKFB3(+/-) mice was associated with the inability of PPAR gamma activation to suppress adipose tissue lipolysis and proinflammatory cytokine production, stimulate visceral fat accumulation, enhance adipose tissue insulin signaling, and appropriately regulate adipokine expression. Similarly, in cultured 3T3-L1 adipocytes, knockdown of PFKFB3/iPFK2 lessened the effect of PPAR gamma activation on stimulating lipid accumulation. Furthermore, PPAR gamma activation did not suppress inflammatory signaling in PFKFB3/iPFK2-knockdown adipocytes as it did in control adipocytes. Upon inhibition of excessive fatty acid oxidation in PFKFB3/iPFK2-knockdown adipocytes, PPAR gamma activation was able to significantly reverse inflammatory signaling and proinflammatory cytokine expression and restore insulin signaling. Together, these data demonstrate that PFKFB3/iPFK2 is critically involved in the anti-diabetic effect of PPAR gamma activation.	[Guo, Xin; Li, Honggui; Wu, Chaodong] Texas A&M Univ, Intercollegiate Fac Nutr, Dept Nutr & Food Sci, College Stn, TX 77843 USA; [Xu, Kefeng] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Ctr Cardiovasc, Dept Internal Med, Ann Arbor, MI 48105 USA; [Zhang, Weiyu; Wang, Huan; Huo, Yuqing] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Lange, Alex J.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Huo, Yuqing] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Texas A&M University System; Texas A&M University College Station; Morehouse School of Medicine; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Peking University	Chen, YE (corresponding author), 1150 W Med Ctr Dr,MSRB 3 7301E, Ann Arbor, MI 48015 USA.	echenum@med.umich.edu; yuqing@umn.edu; cdwu@tamu.edu			National Institutes of Health [HL78679, HL080569, HL68878, HL89544, HL75397]; American Diabetes Association [1-10-BS-76, 1-10-JF-54]; American Heart Association [0835237N, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, R01HL068878, R01HL078679, R01HL080569, R01HL075397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78679 and HL080569 (to Y.H.) and HL68878, HL89544, and HL75397 (to Y.E.C.). This work was also supported by American Diabetes Association Grants 1-10-BS-76 (to Y.H.) and 1-10-JF-54 (to C.W.).; Supported by American Heart Association National Career Development Grant 0835237N.; An established investigator of the American Heart Association ( Grant 0840025N).	Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Berger JJ, 1999, J APPL PHYSIOL, V87, P227, DOI 10.1152/jappl.1999.87.1.227; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Chesney J, 2005, BIOCHEM BIOPH RES CO, V331, P139, DOI 10.1016/j.bbrc.2005.02.193; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Devine JH, 1999, J BIOL CHEM, V274, P13604, DOI 10.1074/jbc.274.19.13604; Diaz-Delfin J, 2007, DIABETES, V56, P1865, DOI 10.2337/db06-1293; Duplus E, 2003, BIOCHIMIE, V85, P1257, DOI 10.1016/j.biochi.2003.10.016; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Forest C, 2003, BIOCHEM SOC T, V31, P1125; Franckhauser S, 2006, DIABETES, V55, P273, DOI 10.2337/diabetes.55.02.06.db05-0482; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Grundy Scott M, 2006, Nat Rev Drug Discov, V5, P295, DOI 10.1038/nrd2005; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Kolak M, 2007, J CLIN ENDOCR METAB, V92, P720, DOI 10.1210/jc.2006-1465; Krentz AJ, 2000, BMJ-BRIT MED J, V321, P252, DOI 10.1136/bmj.321.7256.252; Lebovitz HE, 2001, J CLIN ENDOCR METAB, V86, P280, DOI 10.1210/jc.86.1.280; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Permana PA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1076, DOI 10.1152/ajpendo.91013.2008; Phillips LS, 2001, DIABETES CARE, V24, P308, DOI 10.2337/diacare.24.2.308; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tan GD, 2003, NAT MED, V9, P811, DOI 10.1038/nm0703-811; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2004, ENDOCRINOLOGY, V145, P2214, DOI 10.1210/en.2003-1580; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	54	34	34	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23711	23720		10.1074/jbc.M110.123174	http://dx.doi.org/10.1074/jbc.M110.123174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498376	Green Published, hybrid			2022-12-25	WOS:000280291400021
J	Ishikura, S; Weissman, AM; Bonifacino, JS				Ishikura, Shuhei; Weissman, Allan M.; Bonifacino, Juan S.			Serine Residues in the Cytosolic Tail of the T-cell Antigen Receptor alpha-Chain Mediate Ubiquitination and Endoplasmic Reticulum-associated Degradation of the Unassembled Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; LIGASE; PROTEASOME; SUBUNIT; HRD1; UBIQUITYLATION; DESTRUCTION; PROMOTES; LYSINE	The T-cell antigen receptor (TCR) alpha-chain (TCR alpha) is a type I integral membrane protein that becomes ubiquitinated and targeted to the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway when it fails to assemble into the heteromeric TCR complex. Remarkably, TCR alpha has a cytosolic tail of only five amino acid residues (i.e. RLWSS), none of which is the conventional ubiquitin acceptor, lysine. Herein we report that substitution of two conserved serine residues in the cytosolic tail of TCR alpha to alanine decreased ubiquitination, whereas placement of additional serine residues enhanced it. Moreover, replacement of the cytosolic serine residues by other ubiquitinatable residues (i.e. cysteine, threonine, or lysine) allowed ubiquitination to take place. Serine-dependent ubiquitination perfectly correlated with targeting of TCR alpha for ERAD. We also found that this ubiquitination was mediated by the ER-localized ubiquitin ligase, HRD1. These findings indicate that serine-dependent, HRD1-mediated ubiquitination targets TCR alpha to the ERAD pathway.	[Ishikura, Shuhei; Bonifacino, Juan S.] Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, Bethesda, MD 20892 USA; [Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bonifacino, JS (corresponding author), 9000 Rockville Pike, Bethesda, MD 20892 USA.	juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP); NICHD and NCI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008909] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008834] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC009392] Funding Source: NIH RePORTER	National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD and NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP) and the Intramural Programs of NICHD and NCI.	Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; CHEN C, 1988, J CELL BIOL, V107, P2149, DOI 10.1083/jcb.107.6.2149; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; HOU D, 1994, J BIOL CHEM, V269, P14244; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee SJ, 1998, EXP MOL MED, V30, P159, DOI 10.1038/emm.1998.23; Lenk U, 2002, J CELL SCI, V115, P3007; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Omura T, 2006, J NEUROCHEM, V99, P1456, DOI 10.1111/j.1471-4159.2006.04155.x; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	48	66	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23916	23924		10.1074/jbc.M110.127936	http://dx.doi.org/10.1074/jbc.M110.127936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519503	Green Published, hybrid			2022-12-25	WOS:000280291400042
J	Li, XF; Zhang, R; Zhang, HF; He, Y; Ji, WD; Min, W; Boggon, TJ				Li, Xiaofeng; Zhang, Rong; Zhang, Haifeng; He, Yun; Ji, Weidong; Min, Wang; Boggon, Titus J.			Crystal Structure of CCM3, a Cerebral Cavernous Malformation Protein Critical for Vascular Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAXILLIN LD MOTIFS; 2-HIT MECHANISM; MUTATIONS; GENE; KRIT1; PATHOGENESIS; DOMAIN; TOOL	CCM3 mutations are associated with cerebral cavernous malformation (CCM), a disease affecting 0.1-0.5% of the human population. CCM3 (PDCD10, TFAR15) is thought to form a CCM complex with CCM1 and CCM2; however, the molecular basis for these interactions is not known. We have determined the 2.5 angstrom crystal structure of CCM3. This structure shows an all alpha-helical protein containing two domains, an N-terminal dimerization domain with a fold not previously observed, and a C-terminal focal adhesion targeting (FAT)-homology domain. We show that CCM3 binds CCM2 via this FAT-homology domain and that mutation of a highly conserved FAK-like hydrophobic pocket (HP1) abrogates CCM3-CCM2 interaction. This CCM3 FAT-homology domain also interacts with paxillin LD motifs using the same surface, and partial CCM3 co-localization with paxillin in cells is lost on HP1 mutation. Disease-related CCM3 truncations affect the FAT-homology domain suggesting a role for the FAT-homology domain in the etiology of CCM.	[Zhang, Haifeng; He, Yun; Ji, Weidong; Min, Wang] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University; Yale University	Min, W (corresponding author), Yale Univ, Sch Med, Dept Pathol, 10 Amistad St,401B, New Haven, CT 06520 USA.	wang.min@yale.edu; titus.boggon@yale.edu	Li, Xiaofeng/F-3735-2011; ji, weidong/AAX-7397-2020		National Institutes of Health [R01 HL077357, HL085789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077357, R01HL085789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL077357 and HL085789 (to W. M.) and by startup funds (to T.J.B.).	Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kim BH, 2009, NUCLEIC ACIDS RES, V37, pW532, DOI 10.1093/nar/gkp328; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83	35	67	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24099	24107		10.1074/jbc.M110.128470	http://dx.doi.org/10.1074/jbc.M110.128470			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20489202	Green Published, hybrid			2022-12-25	WOS:000280291400060
J	Minajigi, A; Francklyn, CS				Minajigi, Anand; Francklyn, Christopher S.			Aminoacyl Transfer Rate Dictates Choice of Editing Pathway in Threonyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; QUALITY-CONTROL; ACTIVE-SITE; ZINC ION; MECHANISM; DISCRIMINATION; ACIDS; MISTRANSLATION; PHENYLALANINE	Aminoacyl-tRNA synthetases hydrolyze aminoacyl adenylates and aminoacyl-tRNAs formed from near-cognate amino acids, thereby increasing translational fidelity. The contributions of pre- and post-transfer editing pathways to the fidelity of Escherichia coli threonyl-tRNA synthetase (ThrRS) were investigated by rapid kinetics. In the pre- steady state, asymmetric activation of cognate threonine and noncognate serine was observed in the active sites of dimeric ThrRS, with similar rates of activation. In the absence of tRNA, seryl-adenylate was hydrolyzed 29-fold faster by the ThrRS catalytic domain than threonyl-adenylate. The rate of seryl transfer to cognate tRNA was only 2-fold slower than threonine. Experiments comparing the rate of ATP consumption to the rate of aminoacyl-tRNA(AA) formation demonstrated that pre- transfer hydrolysis contributes to proofreading only when the rate of transfer is slowed significantly. Thus, the relative contributions of pre- and post-transfer editing in ThrRS are subject to modulation by the rate of aminoacyl transfer.	[Francklyn, Christopher S.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA; Univ Vermont, Cell & Mol Biol Program, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Francklyn, CS (corresponding author), Univ Vermont, Dept Biochem, Coll Med, Hlth Sci Complex,89 Beaumont Ave, Burlington, VT 05405 USA.	Christopher.Francklyn@uvm.edu			National Institutes of Health, NIGMS [GM54899]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054899] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54899 from NIGMS.	Ambrogelly A, 2005, FEBS LETT, V579, P6017, DOI 10.1016/j.febslet.2005.09.025; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Bovee ML, 2003, BIOCHEMISTRY-US, V42, P15102, DOI 10.1021/bi0355701; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; FERSHT A, 1999, STRUCTURE MECH PROTE, P377; FERSHT AR, 1981, PROC R SOC SER B-BIO, V212, P351, DOI 10.1098/rspb.1981.0044; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Francklyn CS, 2008, BIOCHEMISTRY-US, V47, P11695, DOI 10.1021/bi801500z; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Guth E, 2009, J BIOL CHEM, V284, P20753, DOI 10.1074/jbc.M109.021311; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hauenstein SI, 2008, J BIOL CHEM, V283, P21997, DOI 10.1074/jbc.M801838200; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; LIN SX, 1983, BIOCHEMISTRY-US, V22, P681, DOI 10.1021/bi00272a024; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling J, 2007, RNA, V13, P1881, DOI 10.1261/rna.684107; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Pauling L., 1957, FESTSCHRIFT ARTHUR S, P597; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, METHODS, V44, P119, DOI 10.1016/j.ymeth.2007.10.009; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Waas WF, 2007, BIOCHEMISTRY-US, V46, P12062, DOI 10.1021/bi7007454; YAMANE T, 1977, P NATL ACAD SCI USA, V74, P2246, DOI 10.1073/pnas.74.6.2246; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582	44	45	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23810	23817		10.1074/jbc.M110.105320	http://dx.doi.org/10.1074/jbc.M110.105320			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504770	Green Published, hybrid			2022-12-25	WOS:000280291400031
J	Gable, K; Gupta, SD; Han, GS; Niranjanakumari, S; Harmon, JM; Dunn, TM				Gable, Kenneth; Gupta, Sita D.; Han, Gongshe; Niranjanakumari, Somashekarappa; Harmon, Jeffrey M.; Dunn, Teresa M.			A Disease-causing Mutation in the Active Site of Serine Palmitoyltransferase Causes Catalytic Promiscuity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SENSORY NEUROPATHY; AFFINITY-PEPTIDE CHROMATOGRAPHY; SPHINGOLIPID BIOSYNTHESIS; BASE SYNTHESIS; SUBUNIT; YEAST; SPTLC1; ACCUMULATION; PURIFICATION; PROTEIN	The autosomal dominant peripheral sensory neuropathy HSAN1 results from mutations in the LCB1 subunit of serine palmitoyltransferase (SPT). Serum from patients and transgenic mice expressing a disease-causing mutation (C133W) contain elevated levels of 1-deoxysphinganine (1-deoxySa), which presumably arise from inappropriate condensation of alanine with palmitoyl-CoA. Mutant heterodimeric SPT is catalytically inactive. However, mutant heterotrimeric SPT has similar to 10-20% of wild-type activity and supports growth of yeast cells lacking endogenous SPT. In addition, long chain base profiling revealed the synthesis of significantly more 1-deoxySa in yeast and mammalian cells expressing the heterotrimeric mutant enzyme than in cells expressing wild-type enzyme. Wild-type and mutant enzymes had similar affinities for serine. Surprisingly, the enzymes also had similar affinities for alanine, indicating that the major affect of the C133W mutation is to enhance activation of alanine for condensation with the acyl-CoA substrate. In vivo synthesis of 1-deoxySa by the mutant enzyme was proportional to the ratio of alanine to serine in the growth media, suggesting that this ratio can be used to modulate the relative synthesis of sphinganine and 1-deoxySa. By expressing SPT as a single-chain fusion protein to ensure stoichiometric expression of all three subunits, we showed that GADD153, a marker for endoplasmic reticulum stress, was significantly elevated in cells expressing mutant heterotrimers. GADD153 was also elevated in cells treated with 1-deoxySa. Taken together, these data indicate that the HSAN1 mutations perturb the active site of SPT resulting in a gain of function that is responsible for the HSAN1 phenotype.	[Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20184 USA; [Harmon, Jeffrey M.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20184 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Dunn, TM (corresponding author), 4301 Jones Bridge Rd, Bethesda, MD 20184 USA.	tdunn@usuhs.mil		Harmon, Jeffrey/0000-0001-7833-931X	National Institutes of Health [NS47717]; USPHS, National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)United States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS47717 (to T.M.D.) from the USPHS, National Institute of Neurological Disorders and Stroke.	Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Dedov VN, 2004, BBA-MOL BASIS DIS, V1688, P168, DOI 10.1016/j.bbadis.2003.12.005; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Gupta SD, 2009, J LIPID RES, V50, P1630, DOI 10.1194/jlr.M800580-JLR200; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada Kentaro, 2003, Methods Mol Biol, V228, P163, DOI 10.1385/1-59259-400-X:163; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hornemann T, 2009, NEUROGENETICS, V10, P135, DOI 10.1007/s10048-008-0168-7; Luheshi LM, 2009, FEBS LETT, V583, P2581, DOI 10.1016/j.febslet.2009.06.030; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Nakamura T, 2009, APOPTOSIS, V14, P455, DOI 10.1007/s10495-008-0301-y; Nicholson GA, 2001, AM J HUM GENET, V69, P655, DOI 10.1086/323252; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Raman MCC, 2009, J BIOL CHEM, V284, P17328, DOI 10.1074/jbc.M109.008680; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	27	78	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22844	22850		10.1074/jbc.M110.122259	http://dx.doi.org/10.1074/jbc.M110.122259			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504773	Green Published, hybrid			2022-12-25	WOS:000279999900017
J	Stefanini, I; Trabocchi, A; Marchi, E; Guarna, A; Cavalieri, D				Stefanini, Irene; Trabocchi, Andrea; Marchi, Emmanuela; Guarna, Antonio; Cavalieri, Duccio			A Systems Biology Approach to Dissection of the Effects of Small Bicyclic Peptidomimetics on a Panel of Saccharomyces cerevisiae Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL GENOMICS; BIOACTIVE COMPOUNDS; SMALL MOLECULES; TARTARIC ACID; YEAST; ENANTIOPURE; EXPRESSION; GENETICS; MUTATION; LIBRARY	In recent years, an approach called "chemical genetics" has been adopted in drug research to discover and validate new targets and to identify and optimize leads by high throughput screening. In this work, we tested the ability of a library of small peptidomimetics to induce phenotypic effects with functional implications on a panel of strains of the budding yeast Saccharomyces cerevisiae, both wild type and mutants, for respiratory function and multidrug resistance. Further elucidation of the function of these peptidomimetics was assessed by testing the effects of the compound with the most prominent inhibitory activity, 089, on gene expression using DNA microarrays. Pathway analysis showed the involvement of such a molecule in inducing oxidative damage through alterations in mitochondrial functions. Transcriptional experiments were confirmed by increased levels of ROS and activation of mitochondrial membrane potential. Our results demonstrate the influence of a functional HAP1 gene in the performance of S. cerevisiae as a model system.	[Stefanini, Irene; Marchi, Emmanuela; Cavalieri, Duccio] Univ Florence, Dept Pharmacol Mario Aiazzi Mancini, I-50139 Florence, Italy; [Trabocchi, Andrea; Guarna, Antonio] Univ Florence, Dept Chem Ugo Schiff, I-50139 Florence, Italy	University of Florence; University of Florence	Trabocchi, A (corresponding author), Via Lastruccia 13, I-50019 Florence, Italy.	andrea.trabocchi@unifi.it; duccio.cavalieri@unifi.it	Stefanini, Irene/V-5673-2017; Trabocchi, Andrea/H-7942-2014; CAVALIERI, DUCCIO/T-3097-2017	Stefanini, Irene/0000-0002-5629-9174; Trabocchi, Andrea/0000-0003-1774-9301; CAVALIERI, DUCCIO/0000-0001-6426-5719	Network of Excellence in Nutrigenomics (NuGO) [FOOD-CT-2004-506360]; European Union [LSHB-CT-2004-512074]; Network of Excellence DC-THERA [242220]; Fondazione RomaMinistero dell'Istruzione, dell'Universita e della Ricerca Programmi di ricerca di Rilevante Interesse Nazionale [519MIUR060]; Consorzio Interuniversitario Nazionale "Metodologie e Processi Innovativi di Sintesi"	Network of Excellence in Nutrigenomics (NuGO); European Union(European Commission); Network of Excellence DC-THERA; Fondazione RomaMinistero dell'Istruzione, dell'Universita e della Ricerca Programmi di ricerca di Rilevante Interesse Nazionale; Consorzio Interuniversitario Nazionale "Metodologie e Processi Innovativi di Sintesi"	This work was supported by Network of Excellence in Nutrigenomics (NuGO) Grant FOOD-CT-2004-506360, European Union Grant LSHB-CT-2004-512074, the Network of Excellence DC-THERA (Dendritic Cells for Novel Immunotherapies), SYBARIS Grant Agreement 242220, Fondazione Roma, Consorzio Interuniversitario Nazionale "Metodologie e Processi Innovativi di Sintesi" and Ministero dell'Istruzione, dell'Universita e della Ricerca Programmi di ricerca di Rilevante Interesse Nazionale Grant 519MIUR060.	Beltrame L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004128; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brenner C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-240; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Cavalieri D, 2007, BIOINFORMATICS, V23, P2631, DOI 10.1093/bioinformatics/btm333; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; GANTE J, 1994, ANGEW CHEM INT EDIT, V33, P1699, DOI 10.1002/anie.199416991; Giaever G, 2003, TRENDS PHARMACOL SCI, V24, P444, DOI 10.1016/S0165-6147(03)00225-6; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Guarna A, 2002, TETRAHEDRON, V58, P9865, DOI 10.1016/S0040-4020(02)01297-8; Guarna A, 1999, J ORG CHEM, V64, P7347, DOI 10.1021/jo9904967; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Hoon S, 2008, TRENDS PHARMACOL SCI, V29, P499, DOI 10.1016/j.tips.2008.07.006; Huang J, 2004, P NATL ACAD SCI USA, V101, P16594, DOI 10.1073/pnas.0407117101; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lo MMC, 2004, J AM CHEM SOC, V126, P16077, DOI 10.1021/ja045089d; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Machetti F, 2007, J COMB CHEM, V9, P454, DOI 10.1021/cc060120o; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Resnick MA, 2000, MUTAT RES-FUND MOL M, V451, P1, DOI 10.1016/S0027-5107(00)00036-1; Romualdi C, 2005, NUCLEIC ACIDS RES, V33, pW644, DOI 10.1093/nar/gki497; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Spring DR, 2005, CHEM SOC REV, V34, P472, DOI 10.1039/b312875j; Stockwell BR, 2000, TRENDS BIOTECHNOL, V18, P449, DOI 10.1016/S0167-7799(00)01499-2; Tamura KI, 2004, J BIOSCI BIOENG, V98, P159, DOI 10.1016/S1389-1723(04)00260-9; Trabocchi A, 2006, SYNLETT, P331, DOI 10.1055/s-2006-926249; Trabocchi A, 2002, J ORG CHEM, V67, P7483, DOI 10.1021/jo0202132; Verkman AS, 2004, AM J PHYSIOL-CELL PH, V286, pC465, DOI 10.1152/ajpcell.00397.2003; Zheng X. F. Steven, 2002, Current Issues in Molecular Biology, V4, P33; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	37	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23475	23483		10.1074/jbc.M110.125153	http://dx.doi.org/10.1074/jbc.M110.125153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501664	Green Published, hybrid			2022-12-25	WOS:000279999900079
J	Lecomte, S; Desmots, F; Le Masson, F; Le Goff, P; Michel, D; Christians, ES; Le Drean, Y				Lecomte, S.; Desmots, F.; Le Masson, F.; Le Goff, P.; Michel, D.; Christians, E. S.; Le Drean, Y.			Roles of heat shock factor 1 and 2 in response to proteasome inhibition: consequence on p53 stability	ONCOGENE			English	Article						heat shock factor; MG132; proteasome; gankyrin; p53	TRANSCRIPTION FACTOR-1; EXPRESSION; GENE; ACTIVATION; STRESS; SYSTEM; DISRUPTION; RESISTANCE; APOPTOSIS; PROTEINS	A single heat shock factor (HSF), mediating the heat shock response, exists from yeast to Drosophila, whereas several related HSFs have been found in mammals. This raises the question of the specific or redundant functions of the different members of the HSF family and in particular of HSF1 and HSF2, which are both ubiquitously expressed. Using immortalized mouse embryonic fibroblasts (iMEFs) derived from wild-type, Hsf1(-/-), Hsf2(-/-) or double-mutant mice, we observed the distinctive behaviors of these mutants with respect to proteasome inhibition. This proteotoxic stress reduces to the same extent the viability of Hsf1(-/-)- and Hsf2(-/-)-deficient cells, but through different underlying mechanisms. Contrary to Hsf2(-/-) cells, Hsf1(-/-) cells are unable to induce pro-survival heat shock protein expression. Conversely, proteasome activity is lower in Hsf2(-/-) cells and the expression of some proteasome subunits, such as Psmb5 and gankyrin, is decreased. As gankyrin is an oncoprotein involved in p53 degradation, we analyzed the status of p53 in HSF-deficient iMEFs and observed that it was strongly stabilized in Hsf2(-/-) cells. This study points a new role for HSF2 in the regulation of protein degradation and suggests that pan-HSF inhibitors could be valuable tools to reduce chemoresistance to proteasome inhibition observed in cancer therapy. Oncogene ( 2010) 29, 4216-4224; doi: 10.1038/onc.2010.171; published online 24 May 2010	[Lecomte, S.; Desmots, F.; Le Goff, P.; Michel, D.; Le Drean, Y.] Univ Rennes 1, IFR Genom Fonct Agron & Sante 140, CNRS, UMR 6026, F-35042 Rennes, France; [Le Masson, F.; Christians, E. S.] Univ Toulouse 3, CNRS, UMR 5547, Ctr Dev Biol, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Le Drean, Y (corresponding author), Univ Rennes 1, IFR Genom Fonct Agron & Sante 140, CNRS, UMR 6026, Bat 13,Campus Beaulieu, F-35042 Rennes, France.	yves.le-drean@univ-rennes1.fr	Le Dréan, Yves/L-4822-2015; LE GOFF, PASCALE/K-1842-2015; Lecomte, Sylvain/K-1745-2015	LE GOFF, PASCALE/0000-0002-3931-2197; 	Canceropole Grand Ouest; CNRS; French Ministry of Higher Education and Research (MENRT); 'Association pour la Recherche sur le Cancer' (ARC)	Canceropole Grand Ouest; CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Higher Education and Research (MENRT); 'Association pour la Recherche sur le Cancer' (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by Canceropole Grand Ouest and CNRS. SL and FLM were supported by a fellowship from the French Ministry of Higher Education and Research (MENRT), and FD by a fellowship from the 'Association pour la Recherche sur le Cancer' (ARC). We thank Dr V Mezger (UMR CNRS 7216, Paris, France) for the gift of immortalized MEFs, and V Noel for the help in in silico analysis. We also thank Frederic Percevault for the establishment of a stable clone expressing HSF2 from Hsf2<SUP>-/-</SUP> iMEFs.	Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bush KT, 1997, J BIOL CHEM, V272, P9086; Busse A, 2008, CANCER, V112, P659, DOI 10.1002/cncr.23224; Cantalupo PG, 2009, VIROLOGY, V386, P183, DOI 10.1016/j.virol.2008.12.038; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Fuchs D, 2008, J CELL BIOCHEM, V103, P270, DOI 10.1002/jcb.21405; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Homma S, 2007, J NEUROSCI, V27, P7974, DOI 10.1523/JNEUROSCI.0006-07.2007; Jin XJ, 2009, J CELL BIOCHEM, V107, P504, DOI 10.1002/jcb.22151; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; McMillan DR, 2002, MOL CELL BIOL, V22, P8005, DOI 10.1128/MCB.22.22.8005-8014.2002; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pipas JM, 2001, SEMIN CANCER BIOL, V11, P23, DOI 10.1006/scbi.2000.0343; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Pirkkala L, 2000, MOL CELL BIOL, V20, P2670, DOI 10.1128/MCB.20.8.2670-2675.2000; Ruckrich T, 2009, LEUKEMIA, V23, P1098, DOI 10.1038/leu.2009.8; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Sato Y, 2009, BIOCHEM BIOPH RES CO, V378, P795, DOI 10.1016/j.bbrc.2008.11.125; Schwartz AL, 1999, ANNU REV MED, V50, P57; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Taylor DM, 2005, CELL STRESS CHAPERON, V10, P230, DOI 10.1379/CSC-119R.1; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tsirigotis M, 2001, BIOTECHNIQUES, V31, P120, DOI 10.2144/01311rr03; Twombly R, 2003, J NATL CANCER I, V95, P845, DOI 10.1093/jnci/95.12.845; Wilkerson DC, 2007, CELL STRESS CHAPERON, V12, P283, DOI 10.1379/CSC-250.1; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yamamoto N, 2009, FEBS J, V276, P1962, DOI 10.1111/j.1742-4658.2009.06923.x; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692	45	31	32	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2010	29	29					4216	4224		10.1038/onc.2010.171	http://dx.doi.org/10.1038/onc.2010.171			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20498630	Green Submitted			2022-12-25	WOS:000280151500009
J	Wu, Q; Sahasrabudhe, RM; Luo, LZ; Lewis, DW; Gollin, SM; Saunders, WS				Wu, Q.; Sahasrabudhe, R. M.; Luo, L. Z.; Lewis, D. W.; Gollin, S. M.; Saunders, W. S.			Deficiency in myosin light-chain phosphorylation causes cytokinesis failure and multipolarity in cancer cells	ONCOGENE			English	Article						cytokinesis; myosin light-chain kinase; multinucleation; multipolar spindles; myosin phosphatase; myosin regulatory light chain	RHO-ASSOCIATED KINASE; SMOOTH-MUSCLE MYOSIN; CHROMOSOMAL INSTABILITY; CLEAVAGE FURROW; CITRON-KINASE; CENTROSOME; LINES; CONSEQUENCES; PHOSPHATASE; INVASION	Cancer cells often have unstable genomes and increased centrosome and chromosome numbers, which are an important part of malignant transformation in the most recent model of tumorigenesis. However, very little is known about divisional failures in cancer cells that may lead to chromosomal and centrosomal amplifications. In this study, we show that cancer cells often failed at cytokinesis because of decreased phosphorylation of the myosin regulatory light chain (MLC), a key regulatory component of cortical contraction during division. Reduced MLC phosphorylation was associated with high expression of myosin phosphatase and/or reduced myosin light-chain kinase levels. Furthermore, expression of phosphomimetic MLC largely prevented cytokinesis failure in the tested cancer cells. When myosin light-chain phosphorylation was restored to normal levels by phosphatase knockdown, multinucleation and multipolar mitosis were markedly reduced, resulting in enhanced genome stabilization. Furthermore, both overexpression of myosin phosphatase or inhibition of the myosin light-chain kinase in nonmalignant cells could recapitulate some of the mitotic defects of cancer cells, including multinucleation and multipolar spindles, indicating that these changes are sufficient to reproduce the cytokinesis failures we see in cancer cells. These results for the first time define the molecular defects leading to divisional failure in cancer cells. Oncogene ( 2010) 29, 4183-4193; doi: 10.1038/onc.2010.165; published online 24 May 2010	[Wu, Q.; Sahasrabudhe, R. M.; Saunders, W. S.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Luo, L. Z.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Lewis, D. W.; Gollin, S. M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Lewis, D. W.; Gollin, S. M.; Saunders, W. S.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; City of Hope; Beckman Research Institute of City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Saunders, WS (corresponding author), Univ Pittsburgh, Dept Biol Sci, 258 Crawford Hall, Pittsburgh, PA 15260 USA.	wsaund@pitt.edu		Luo, Li/0000-0002-8680-4119; Gollin, Susanne/0000-0001-5438-6808	NIH [R01DE016086, R01DE14729, P30CA47904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014729] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr David J Hartshorne (University of Arizona) for kindly providing the UPCI:SCC103 cell line and HEK293 with the MYPT1 expression cell line, respectively. We are also grateful to Dr Jeffrey D Hildebrand (University of Pittsburgh), Dr Anne R Bresnick (Albert Einstein College of Medicine), Dr Kathleen Kelly (National Cancer Institute), Dr David J Hartshorne (University of Arizona) and Dr James T Stull (University of Texas Southwestern Medical Center) for plasmids and antibodies. We also thank Dr Xiaojing Wang (University of Pittsburgh) for helpful discussions regarding statistical analysis and Dr Jian Huang (University of Texas Southwestern Medical Center) for helpful suggestions about urea glycerol electrophoresis. This study was supported in part by NIH grants R01DE016086 to WSS and SMG and R01DE14729 to SMG and WSS. Cytogenetic analyses were carried out in the UPCI Cytogenetics Facility, supported in part by NIH grant P30CA47904 to Ronald B Herberman/SMG.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Eda M, 2001, J CELL SCI, V114, P3273; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Gu LZ, 2006, EUR J CANCER, V42, P948, DOI 10.1016/j.ejca.2005.12.017; IKEBE M, 1988, J BIOL CHEM, V263, P6432; IKEBE M, 1985, J BIOL CHEM, V260, P27; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Kaneko K, 2002, PANCREAS, V24, P34, DOI 10.1097/00006676-200201000-00005; King RW, 2008, BBA-REV CANCER, V1786, P4, DOI 10.1016/j.bbcan.2008.07.007; Komatsu S, 2000, J BIOL CHEM, V275, P34512, DOI 10.1074/jbc.M003019200; Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633; Lemez P, 1998, LEUKEMIA RES, V22, P581, DOI 10.1016/S0145-2126(97)00177-X; Lothschutz D, 2002, INFLAMM RES, V51, P416, DOI 10.1007/PL00000323; Lucero A, 2006, MOL BIOL CELL, V17, P4093, DOI 10.1091/mbc.E06-02-0119; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; PARK SH, 1995, CANCER GENET CYTOGEN, V83, P127, DOI 10.1016/0165-4608(95)00040-V; Poperechnaya A, 2000, J CELL BIOL, V151, P697, DOI 10.1083/jcb.151.3.697; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Schenker T, 1998, EXP CELL RES, V239, P161, DOI 10.1006/excr.1997.3896; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; SHACKNEY SE, 1989, CANCER RES, V49, P3344; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Silverman-Gavrila RV, 2001, CELL MOTIL CYTOSKEL, V50, P180, DOI 10.1002/cm.10006; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Takanishi DM, 1996, ARCH SURG-CHICAGO, V131, P587; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tohtong R, 2003, PROSTATE CANCER P D, V6, P212, DOI 10.1038/sj.pcan.4500663; VANELDIK LJ, 1984, MOL CELL BIOL, V4, P2224, DOI 10.1128/MCB.4.10.2224; Wang Q, 2004, DNA CELL BIOL, V23, P475, DOI 10.1089/1044549041562276; White JS, 2007, ORAL ONCOL, V43, P701, DOI 10.1016/j.oraloncology.2006.09.001; WORD RA, 1991, AM J PHYSIOL, V260, pC861, DOI 10.1152/ajpcell.1991.260.4.C861; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025	36	33	34	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2010	29	29					4183	4193		10.1038/onc.2010.165	http://dx.doi.org/10.1038/onc.2010.165			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20498637	Green Accepted			2022-12-25	WOS:000280151500006
J	Heublein, S; Kazi, S; Ogmundsdottir, MH; Attwood, EV; Kala, S; Boyd, CAR; Wilson, C; Goberdhan, DCI				Heublein, S.; Kazi, S.; Oegmundsdottir, M. H.; Attwood, E. V.; Kala, S.; Boyd, C. A. R.; Wilson, C.; Goberdhan, D. C. I.			Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation	ONCOGENE			English	Article						SLC36; PAT; mTORC1; amino-acid sensing; transporter; transceptor	XENOPUS-LAEVIS OOCYTES; PI3K PATHWAY; RAG GTPASES; CANCER; GROWTH; RAPAMYCIN; KINASE; TARGET; LOCALIZATION; METABOLISM	The phosphoinositide3-kinase (PI3K)/Akt and downstream mammalian target of rapamycin complex 1 (mTORC1) signalling cascades promote normal growth and are frequently hyperactivated in tumour cells. mTORC1 is also regulated by local nutrients, particularly amino acids, but the mechanisms involved are poorly understood. Unexpectedly, members of the proton-assisted amino-acid transporter (PAT or SLC36) family emerged from in vivo genetic screens in Drosophila as transporters with uniquely potent effects on mTORC1-mediated growth. In this study, we show the two human PATs that are widely expressed in normal tissues and cancer cell lines, namely PAT1 and PAT4, behave similarly to fly PATs when expressed in Drosophila. Small interfering RNA knockdown shows that these molecules are required for the activation of mTORC1 targets and for proliferation in human MCF-7 breast cancer and HEK-293 embryonic kidney cell lines. Furthermore, activation of mTORC1 in starved HEK-293 cells stimulated by amino acids requires PAT1 and PAT4, and is elevated in PAT1-overexpressing cells. Importantly, in HEK-293 cells, PAT1 is highly concentrated in intracellular compartments, including endosomes, wherein mTOR shuttles upon amino-acid stimulation. Therefore our data are consistent with a model in which PATs modulate the activity of mTORC1 not by transporting amino acids into the cell but by modulating the intracellular response to amino acids. Oncogene (2010) 29, 4068-4079; doi:10.1038/onc.2010.177; published online 24 May 2010	[Heublein, S.; Kazi, S.; Oegmundsdottir, M. H.; Attwood, E. V.; Kala, S.; Boyd, C. A. R.; Wilson, C.; Goberdhan, D. C. I.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Oxford	Goberdhan, DCI (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Le Gros Clark Bldg,S Parks Rd, Oxford OX1 3QX, England.	deborah.goberdhan@dpag.ox.ac.uk			Cancer Research-UK [C19591/A9093, C191591/A6181, C7713/A6174]; Studienstiftung des deutschen Volkes; Max Weber Programm Bayern; University of Oxford; Newton Abraham Studentship and Overseas Research	Cancer Research-UK(Cancer Research UK); Studienstiftung des deutschen Volkes; Max Weber Programm Bayern; University of Oxford; Newton Abraham Studentship and Overseas Research	We thank Toshiro Aigaki, Hugo Bellen and the Bloomington Stock Centre for fly strains, Robert Edwards (UCSF) for generously providing the PAT1 antisera and Vuk Stambolic (Toronto) for the GFP-Rheb construct. We are grateful to Dr David Meredith (Oxford Brookes University) for helpful discussion and to Bass Hassan and Claudia Buehnemann for comments on the paper. This work was supported by Cancer Research-UK grants (C19591/A9093, C191591/A6181 and C7713/A6174), funding from the Studienstiftung des deutschen Volkes and the Max Weber Programm Bayern to SH and a University of Oxford, Newton Abraham Studentship and Overseas Research Student Award to MHO.	Atkins MB, 2009, NAT REV DRUG DISCOV, V8, P535, DOI 10.1038/nrd2924; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bermingham JR, 2004, MAMM GENOME, V15, P114, DOI 10.1007/s00335-003-2319-3; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chen Z, 2003, J PHYSIOL-LONDON, V546, P349, DOI 10.1113/jphysiol.2002.026500; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; Cohen A, 2009, CELL, V136, P399, DOI 10.1016/j.cell.2009.01.021; Deves R, 2000, J MEMBRANE BIOL, V173, P165, DOI 10.1007/s002320001017; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Goberdhan DCI, 2009, BIOCHEM SOC T, V37, P248, DOI 10.1042/BST0370248; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hafen E, 2004, SWISS MED WKLY, V134, P711; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim RH, 2006, BRIT J CANCER, V94, P620, DOI 10.1038/sj.bjc.6602994; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Panitsas KE, 2006, PFLUG ARCH EUR J PHY, V452, P53, DOI 10.1007/s00424-005-0002-0; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Reynolds B, 2007, BIOCHEM SOC T, V35, P1215, DOI 10.1042/BST0351215; Rubio-Aliaga I, 2004, J BIOL CHEM, V279, P2754, DOI 10.1074/jbc.M305556200; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Wreden CC, 2003, J NEUROSCI, V23, P1265, DOI 10.1523/JNEUROSCI.23-04-01265.2003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zinzalla V, 2008, NATURE, V454, P287, DOI 10.1038/454287a	48	111	116	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 15	2010	29	28					4068	4079		10.1038/onc.2010.177	http://dx.doi.org/10.1038/onc.2010.177			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20498635	Green Accepted			2022-12-25	WOS:000279892400007
J	Nowack, J; Mzilikazi, N; Dausmann, KH				Nowack, Julia; Mzilikazi, Nomakwezi; Dausmann, Kathrin H.			Torpor on Demand: Heterothermy in the Non-Lemur Primate Galago moholi	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; MICROCEBUS-MURINUS; BODY-TEMPERATURE; HIBERNATION; THERMOREGULATION; MADAGASCAR; BATS; METABOLISM; EVOLUTION; SEX	Background: Hibernation and daily torpor are energy-and water-saving adaptations employed to survive unfavourable periods mostly in temperate and arctic environments, but also in tropical and arid climates. Heterothermy has been found in a number of mammalian orders, but within the primates so far it seems to be restricted to one family of Malagasy lemurs. As currently there is no evidence of heterothermy of a primate outside of Madagascar, the aim of our study was to investigate whether small primates from mainland Africa are indeed always homeothermic despite pronounced seasonal changes in weather and food availability. Methodology/Principal Findings: One of the nearest relatives of Malagasy lemurs, the African lesser bushbaby, Galago moholi, which inhabits a highly seasonal habitat with a hot wet-season and a cold dry-season with lower food abundance, was investigated to determine whether it is capable of heterothermy. We measured skin temperature of free-ranging individuals throughout the cool dry season using temperature-sensitive collars as well as metabolic rate in captured individuals. Torpor was employed by 15% of 20 animals. Only one of these animals displayed heterothermy in response to natural availability of food and water, whereas the other animals became torpid without access to food and water. Conclusions/Significance: Our results show that G. moholi are physiologically capable of employing torpor. However they do not use it as a routine behaviour, but only under adverse conditions. This reluctance is presumably a result of conflicting selective pressures for energy savings versus other ecological and evolutionary forces, such as reproduction or territory defence. Our results support the view that heterothermy in primates evolved before the division of African and Malagasy Strepsirhini, with the possible implication that more primate species than previously thought might still have the potential to call upon this possibility, if the situation necessitates it.	[Nowack, Julia; Dausmann, Kathrin H.] Univ Hamburg, Dept Anim Ecol & Conservat, Bioctr Grindel, Hamburg, Germany; [Mzilikazi, Nomakwezi] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa	University of Hamburg; Nelson Mandela University	Nowack, J (corresponding author), Univ Hamburg, Dept Anim Ecol & Conservat, Bioctr Grindel, Hamburg, Germany.	julia.nowack@uni-hamburg.de	Mzilikazi, Nomakwezi/K-4964-2012; Dausmann, Kathrin/E-9270-2017	Mzilikazi, Nomakwezi/0000-0002-0038-7431	German Academic Exchange Service (DAAD); German Research Foundation (DFG) [DA1013/3-1]; National Research Foundation (NRF) [66025]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG)); National Research Foundation (NRF)	Funding: This study was supported by the German Academic Exchange Service (DAAD; URL:/www.daad.de), the German Research Foundation (DFG; URL:www.dfg.de) (DA1013/3-1) and the National Research Foundation (NRF; URL:www.nrf.ac.za)(66025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay RMR, 1996, J MAMMAL, V77, P1102, DOI 10.2307/1382791; Bartels W, 1998, J COMP PHYSIOL B, V168, P233, DOI 10.1007/s003600050141; Bonaccorso FJ, 1997, J MAMMAL, V78, P1073, DOI 10.2307/1383050; Cossins AR, 1996, NATURE, V382, P582, DOI 10.1038/382582a0; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Dausmann K. H., 2008, HYPOMETABOLISM ANIMA, P327; Dausmann KH, 2005, J COMP PHYSIOL B, V175, P147, DOI 10.1007/s00360-004-0470-0; Dausmann KH, 2005, J THERM BIOL, V30, P195, DOI 10.1016/j.jtherbio.2004.11.003; DAUSMANN KK, 2004, NATURE, V429; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; GEISER F, 1988, PHYSIOL ZOOL, V61, P442, DOI 10.1086/physzool.61.5.30161266; Geiser F, 1998, CLIN EXP PHARMACOL P, V25, P736, DOI 10.1111/j.1440-1681.1998.tb02287.x; GEISER F, 1988, OECOLOGIA, V77, P395, DOI 10.1007/BF00378050; Geiser Fritz, 2004, Australian Mammalogy, V26, P125; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; HELDMAIER G, 2004, RESP PHYSL NEUROBIOL, V141; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; KNOX CM, 1989, S AFR J ZOOL, V24, P89; Kobbe S, 2009, NATURWISSENSCHAFTEN, V96, P1221, DOI 10.1007/s00114-009-0580-3; Kortner G, 2000, OECOLOGIA, V123, P350, DOI 10.1007/s004420051021; Kortner G, 2009, NATURWISSENSCHAFTEN, V96, P525, DOI 10.1007/s00114-008-0492-7; LEWIS SE, 1993, CAN J ZOOL, V71, P1429, DOI 10.1139/z93-197; Lovegrove BG, 1998, J COMP PHYSIOL B, V168, P303, DOI 10.1007/s003600050150; Masters JC, 2007, J BIOGEOGR, V34, P21, DOI 10.1111/j.1365-2699.2006.01569.x; McKechnie A. E., 2006, ACTA ZOOL SINICA, V52, P409; MULLER EF, 1985, FOLIA PRIMATOL, V44, P216, DOI 10.1159/000156215; Mzilikazi N, 2006, FOLIA PRIMATOL, V77, P465, DOI 10.1159/000095392; Ortmann S, 1997, NATURWISSENSCHAFTEN, V84, P28, DOI 10.1007/s001140050344; RACEY PA, 1981, J REPROD FERTIL, V61, P123; Schmid J, 1998, BEHAV ECOL SOCIOBIOL, V43, P125, DOI 10.1007/s002650050474; Schmid J, 2000, OECOLOGIA, V123, P175, DOI 10.1007/s004420051003; Schmid J, 2000, J COMP PHYSIOL B, V170, P59, DOI 10.1007/s003600050008; Schulke O, 2007, ACTA ETHOL, V10, P13, DOI 10.1007/s10211-006-0023-5; Turbill C, 2003, J THERM BIOL, V28, P223, DOI 10.1016/S0306-4565(02)00067-0; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120	35	49	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10797	10.1371/journal.pone.0010797	http://dx.doi.org/10.1371/journal.pone.0010797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520735	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000278034600024
J	Susa, M; Iyer, AK; Ryu, K; Choy, E; Hornicek, FJ; Mankin, H; Milane, L; Amiji, MM; Duan, Z				Susa, Michiro; Iyer, Arun K.; Ryu, Keinosuke; Choy, Edwin; Hornicek, Francis J.; Mankin, Henry; Milane, Lara; Amiji, Mansoor M.; Duan, Zhenfeng			Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE; OVARIAN-CARCINOMA; CYCLOSPORINE-A; CANCER CELLS; SOLID TUMOR; STEM-CELLS; REVERSAL; DOXORUBICIN; GENE	Background: The use of neo-adjuvant chemotherapy in treating osteosarcoma has improved patients' average 5 year survival rate from 20% to 70% in the past 30 years. However, for patients who progress after chemotherapy, its effectiveness diminishes due to the emergence of multi-drug resistance (MDR) after prolonged therapy. Methodology/Principal Findings: In order to overcome both the dose-limiting side effects of conventional chemotherapeutic agents and the therapeutic failure resulting from MDR, we designed and evaluated a novel drug delivery system for MDR1 siRNA delivery. Novel biocompatible, lipid-modified dextran-based polymeric nanoparticles were used as the platform for MDR1 siRNA delivery; and the efficacy of combination therapy with this system was evaluated. In this study, multi-drug resistant osteosarcoma cell lines (KHOSR2 and U-2OS(R2)) were treated with the MDR1 siRNA nanocarriers and MDR1 protein (P-gp) expression, drug retention, and immunofluoresence were analyzed. Combination therapy of the MDR1 siRNA loaded nanocarriers with increasing concentrations of doxorubicin was also analyzed. We observed that MDR1 siRNA loaded dextran nanoparticles efficiently suppresses P-gp expression in the drug resistant osteosarcoma cell lines. The results also demonstrated that this approach may be capable of reversing drug resistance by increasing the amount of drug accumulation in MDR cell lines. Conclusions/Significance: Lipid-modified dextran-based polymeric nanoparticles are a promising platform for siRNA delivery. Nanocarriers loaded with MDR1 siRNA are a potential treatment strategy for reversing MDR in osteosarcoma.	[Susa, Michiro; Ryu, Keinosuke; Hornicek, Francis J.; Duan, Zhenfeng] Massachusetts Gen Hosp, Dept Orthopaed, Boston, MA USA; [Susa, Michiro; Ryu, Keinosuke; Choy, Edwin; Hornicek, Francis J.; Mankin, Henry; Duan, Zhenfeng] Massachusetts Gen Hosp, Sarcoma Biol Lab, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA USA; [Iyer, Arun K.; Milane, Lara; Amiji, Mansoor M.] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Northeastern University	Susa, M (corresponding author), Massachusetts Gen Hosp, Dept Orthopaed, Boston, MA USA.	zduan@partners.org	Duan, Zhenfeng/AAK-5587-2020; Susa, Michiro/L-2291-2013; Amiji, Mansoor M/AAK-1531-2020; Amiji, Mansoor M/A-4365-2014; Iyer, Arun K/G-9072-2017; Iyer, Arun/O-6688-2019	Amiji, Mansoor M/0000-0001-6170-881X; Iyer, Arun K/0000-0002-4428-0222; Iyer, Arun/0000-0002-4428-0222; Choy, Edwin/0000-0001-9896-8084	National Cancer Institute, National Institutes of Health (Nanotechnology Platform Partnership) [R01-CA119617]; Sarcoma Foundation of America; Gattegno and Wechsler funds; NATIONAL CANCER INSTITUTE [R01CA119617] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (Nanotechnology Platform Partnership)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sarcoma Foundation of America; Gattegno and Wechsler funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported, in part, by a grant from the National Cancer Institute, National Institutes of Health (Nanotechnology Platform Partnership), R01-CA119617. Dr. Duan is supported, in part, through a grant from Sarcoma Foundation of America. Support has also been provided by the Gattegno and Wechsler funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLAMY WT, 1994, ADV CLIN CHEM, V31, P1, DOI 10.1016/S0065-2423(08)60332-7; BROXTERMAN HJ, 1990, PEZCOLLER FDN S, V1, P309; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Chou AJ, 2006, EXPERT REV ANTICANC, V6, P1075, DOI 10.1586/14737140.6.7.1075; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Duan ZF, 2004, MOL CANCER THER, V3, P833; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fletcher CDM, 2002, WHO CLASSIFICATION T; FORD JM, 1990, CANCER RES, V50, P1748; Golzio M, 2007, GENE THER, V14, P752, DOI 10.1038/sj.gt.3302920; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HINDENBURG AA, 1987, CANCER RES, V47, P1421; Horwitz Susan Band, 1993, Journal of the National Cancer Institute Monographs, V0, P55; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Kaye SB, 2008, J CLIN ONCOL, V26, P2616, DOI 10.1200/JCO.2008.16.2123; KEIZER HG, 1989, CANCER RES, V49, P2988; KLIMECKI WT, 1994, BLOOD, V83, P2451; Kolitz JE, 2004, J CLIN ONCOL, V22, P4290, DOI 10.1200/JCO.2004.11.106; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Labroille G, 1998, CYTOMETRY, V32, P86, DOI 10.1002/(SICI)1097-0320(19980601)32:2<86::AID-CYTO3>3.0.CO;2-C; LICHT T, 1994, ANN HEMATOL, V69, P159, DOI 10.1007/BF02215949; Lourda M, 2007, INT J CANCER, V120, P611, DOI 10.1002/ijc.22327; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Martwiset S, 2006, LANGMUIR, V22, P8192, DOI 10.1021/la061064b; MATSUMURA Y, 1986, CANCER RES, V46, P6387; MICKISCH GH, 1991, P NATL ACAD SCI USA, V88, P547, DOI 10.1073/pnas.88.2.547; Minko T, 2000, INT J CANCER, V86, P108, DOI 10.1002/(SICI)1097-0215(20000401)86:1<108::AID-IJC17>3.0.CO;2-8; Minko T, 1999, J CONTROL RELEASE, V59, P133, DOI 10.1016/S0168-3659(98)00186-2; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Pereswetoff-Morath L, 1998, ADV DRUG DELIVER REV, V29, P185, DOI 10.1016/S0169-409X(97)00069-0; Sahoo SK, 2005, MOL PHARMACEUT, V2, P373, DOI 10.1021/mp050032z; SCHURR E, 1989, CANCER RES, V49, P2729; SCHUURHUIS GJ, 1989, J NATL CANCER I, V81, P1887, DOI 10.1093/jnci/81.24.1887; Schwartz CL, 2007, J CLIN ONCOL, V25, P2057, DOI 10.1200/JCO.2006.07.7776; Shen YC, 2001, MOL PHARMACOL, V60, P1083, DOI 10.1124/mol.60.5.1083; Sikic BI, 1997, SEMIN HEMATOL, V34, P40; Smeets M, 1997, BRIT J HAEMATOL, V96, P346, DOI 10.1046/j.1365-2141.1997.d01-2024.x; Sonneveld P, 2001, BRIT J HAEMATOL, V115, P895, DOI 10.1046/j.1365-2141.2001.03171.x; SUGAWARA I, 1988, CANCER RES, V48, P1926; Susa M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-399; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TWENTYMAN PR, 1991, EUR J CANCER, V27, P1639, DOI 10.1016/0277-5379(91)90435-G; van Vlerken LE, 2007, PHARM RES-DORDR, V24, P1405, DOI 10.1007/s11095-007-9284-6; VANDERVALK P, 1990, ANN ONCOL, V1, P56; WILLINGHAM MC, 1986, CANCER RES, V46, P5941; Zhang H, 2009, POLYM COMPOSITE, V30, P1243, DOI 10.1002/pc.20684; ZHANG Y, 2003, J POLYM SCI A, V41, P386	48	119	126	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10764	10.1371/journal.pone.0010764	http://dx.doi.org/10.1371/journal.pone.0010764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520719	gold, Green Published, Green Submitted			2022-12-25	WOS:000278034600001
J	Hao, GF; Yang, GF				Hao, Ge-Fei; Yang, Guang-Fu			The Role of Phe82 and Phe351 in Auxin-Induced Substrate Perception by TIR1 Ubiquitin Ligase: A Novel Insight from Molecular Dynamics Simulations	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; PARTICLE MESH EWALD; BOX PROTEIN TIR1; AUX/IAA PROTEINS; PLANT-GROWTH; SOLVENT MODELS; FREE-ENERGIES; BINDING; DEGRADATION; ARABIDOPSIS	It is well known that Auxin plays a key role in controlling many aspects of plant growth and development. Crystal structures of Transport inhibitor response 1 (TIR1), a true receptor of auxin, were very recently determined for TIR1 alone and in complexes with auxin and different synthetic analogues and an Auxin/Indole-3-Acetic Acid (Aux/IAA) substrate peptide. However, the dynamic conformational changes of the key residues of TIR1 that take place during the auxin and substrate perception by TIR1 and the detailed mechanism of these changes are still unclear. In the present study, various computational techniques were integrated to uncover the detailed molecular mechanism of the auxin and Aux/IAA perception process; these simulations included molecular dynamics (MD) simulations on complexes and the free enzyme, the molecular mechanics Poisson Boltzmann surface area (MM-PBSA) calculations, normal mode analysis, and hydrogen bond energy (HBE) calculations. The computational simulation results provided a reasonable explanation for the structure-activity relationships of auxin and its synthetic analogues in view of energy. In addition, a more detailed model for auxin and Aux/IAA perception was also proposed, indicating that Phe82 and Phe351 played a pivotal role in Aux/IAA perception. Upon auxin binding, Phe82 underwent conformational changes to accommodate the subsequent binding of Aux/IAA. As a result, auxin enhances the TIR1-Aux/IAA interactions by acting as a "molecular glue''. Besides, Phe351 acts as a "fastener'' to further improve the substrate binding. The structural and mechanistic insights obtained from the present study will provide valuable clues for the future design of promising auxin analogues.	[Hao, Ge-Fei; Yang, Guang-Fu] Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan, Peoples R China	Central China Normal University	Hao, GF (corresponding author), Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan, Peoples R China.	gfyang@mail.ccnu.edu.cn			National Basic Research Program of China [2010CB126103]; NSFC [20925206, 20932005]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	The research was supported in part by the National Basic Research Program of China (No. 2010CB126103) and the NSFC (No. 20925206 and 20932005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Bertosa B, 2008, BIOPHYS J, V94, P27, DOI 10.1529/biophysj.107.109025; Callis J, 2005, NATURE, V435, P436, DOI 10.1038/435436b; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 2004, AMBER8; COLEMAN TG, 1977, ANN BIOMED ENG, V5, P322, DOI 10.1007/BF02367312; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Henriques R, 2009, CURR OPIN PLANT BIOL, V12, P49, DOI 10.1016/j.pbi.2008.10.009; Hoecker U, 2005, CURR OPIN PLANT BIOL, V8, P469, DOI 10.1016/j.pbi.2005.07.002; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jones AM, 1998, SCIENCE, V282, P2201, DOI 10.1126/science.282.5397.2201; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Perrot-Rechenmann C, 2005, VITAM HORM, V72, P203, DOI 10.1016/S0083-6729(04)72006-3; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Taiz L, 2006, PLANT PHYSL ONLINE; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tao LZ, 2002, PLANT CELL, V14, P2745, DOI 10.1105/tpc.006320; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Woodward AW, 2005, PLANT CELL, V17, P2425, DOI 10.1105/tpc.105.036236; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	50	21	23	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10742	10.1371/journal.pone.0010742	http://dx.doi.org/10.1371/journal.pone.0010742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505777	gold, Green Submitted, Green Published			2022-12-25	WOS:000278017300015
J	Narayanan, S; Silva, R; Peruzzi, G; Alvarez, Y; Simhadri, VR; Debell, K; Coligan, JE; Borrego, F				Narayanan, Sriram; Silva, Rodolfo; Peruzzi, Giovanna; Alvarez, Yelina; Simhadri, Venkateswara R.; Debell, Karen; Coligan, John E.; Borrego, Francisco			Human Th1 Cells That Express CD300a Are Polyfunctional and After Stimulation Up-Regulate the T-Box Transcription Factor Eomesodermin	PLOS ONE			English	Article							RECEPTOR IRP60 CD300A; IFN-GAMMA PRODUCTION; INHIBITORY RECEPTOR; INTERFERON-GAMMA; HELPER LYMPHOCYTES; LEISHMANIA-MAJOR; DENDRITIC CELLS; BET; DIFFERENTIATION; EFFECTOR	Human naive CD4 T cells express low levels of the immunomodulatory receptor CD300a, whereas effector/memory CD4 cells can be either CD300a(+) or CD300a(-). This suggested that CD300a expression could define a specific subset within the effector/memory CD4 T cell subpopulations. In fact, ex vivo analysis of the IFN-gamma producing CD4 T cells showed that they are enriched in the CD300a(+) subset. Moreover, stimulated CD4 T cells producing TNF-alpha and IL-2 besides IFN-gamma (polyfunctional) are predominantly CD300a(+). In addition to producing markedly higher levels of Th1-associated cytokines, the stimulated CD300a(+) CD4 T cells are distinguished by a striking up-regulation of the T-box transcription factor eomesodermin (Eomes), whereas T-bet is up-regulated in both CD300a+ and CD300a(-) activated CD4 T cells to similar levels. The pleiotropic cytokine TGF-beta 1 has a determinant role in dictating the development of this Th1 subset, as its presence inhibits the expression of CD300a and down-regulates the expression of Eomes and IFN-gamma. We conclude that CD300a+ human Th1 cells tend to be polyfunctional and after stimulation up-regulate Eomes.	[Narayanan, Sriram; Silva, Rodolfo; Peruzzi, Giovanna; Alvarez, Yelina; Coligan, John E.] NIAID, Receptor Cell Biol Sect, Immunogenet Lab, NIH, Rockville, MD USA; [Simhadri, Venkateswara R.; Debell, Karen; Borrego, Francisco] US FDA, Ctr Biol Evaluat & Res, Lab Mol & Dev Immunol, Div Monoclonal Antibodies, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA)	Narayanan, S (corresponding author), NIAID, Receptor Cell Biol Sect, Immunogenet Lab, NIH, Rockville, MD USA.	Francisco.Borrego@fda.hhs.gov		Peruzzi, Giovanna/0000-0002-6517-9107; Narayanan, Sriram/0000-0002-6484-2800; Borrego, Francisco/0000-0002-3105-981X	Food and Drug Administration (FDA); National Institute of Allergy and Infectious Diseases (NIAID)	Food and Drug Administration (FDA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural programs of Food and Drug Administration (FDA) and the National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Alvarez Y, 2008, MOL IMMUNOL, V45, P253, DOI 10.1016/j.molimm.2007.05.006; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Clark GJ, 2007, J LEUKOCYTE BIOL, V82, P1126, DOI 10.1189/jlb.0107035; Clark GJ, 2009, IMMUNOBIOLOGY, V214, P730, DOI 10.1016/j.imbio.2009.06.004; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Georas SN, 2005, EUR RESPIR J, V26, P1119, DOI 10.1183/09031936.05.00006005; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ju XS, 2008, BLOOD, V112, P1184, DOI 10.1182/blood-2007-12-127951; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Smeltz RB, 2005, IMMUNOLOGY, V114, P484, DOI 10.1111/j.1365-2567.2005.02115.x; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tang J, 2007, J IMMUNOL, V178, P5578, DOI 10.4049/jimmunol.178.9.5578; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	55	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10636	10.1371/journal.pone.0010636	http://dx.doi.org/10.1371/journal.pone.0010636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498708	Green Published, Green Submitted, gold			2022-12-25	WOS:000277633500020
J	Khurshid, N; Hameed, LS; Mohanasundaram, S; Iyengar, S				Khurshid, Nazia; Hameed, L. Shahul; Mohanasundaram, Sivaraj; Iyengar, Soumya			Opioid modulation of cell proliferation in the ventricular zone of adult zebra finches (Taenopygia guttata)	FASEB JOURNAL			English	Article						song control system; naloxone; met-enkephalin	MESSENGER-RNA EXPRESSION; VOCAL CONTROL-SYSTEM; FEMALE CANARY BRAIN; NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; SUBGRANULAR ZONE; RAT HIPPOCAMPUS; NEURONAL RECRUITMENT; GENE-EXPRESSION	Besides modulating pain, stress, physiological functions, motivation, and reward, the opioid system has been implicated in developmental and adult mammalian neurogenesis and gliogenesis. In adult male songbirds including zebra finches, neurons generated from the ventricular zone (VZ) of the lateral ventricles are incorporated throughout the telencephalon, including the song control nuclei, HVC, and area X. Although the endogenous opioid met-enkephalin is present in neurons adjacent to the VZ and is upregulated in song control regions during singing, it is not known whether the opioid system can modulate adult neurogenesis/gliogenesis in zebra finches. We used quantitative RT-PCR and in situ hybridization to demonstrate that mu- and delta-opioid receptors are expressed by the VZ of adult male zebra finches. Treating cultured VZ cells from male birds with the opioid antagonist naloxone led to an increase in cell proliferation measured by 5-bromo-2-deoxyuridine incorporation, whereas administering met-enkephalin had the opposite effect, compared with saline-treated cultures. Systemically administering naloxone (2.5 mg/kg body wt) to adult male zebra finches for 4 d also led to a significant increase in cell proliferation in the ventral VZ of these birds, compared with saline-treated controls. Our results show that cell proliferation is augmented by naloxone in the VZ adjacent to the anterior commissure, suggesting that the endogenous opioids modulate adult neurogenesis/gliogenesis by inhibiting cell proliferation in songbirds.-Khurshid, N., Hameed, L. S., Mohanasundaram, S., Iyengar, S. Opioid modulation of cell proliferation in the ventricular zone of adult zebra finches (Taenopygia guttata). FASEB J. 24, 3681-3695 (2010). www.fasebj.org	[Khurshid, Nazia; Hameed, L. Shahul; Mohanasundaram, Sivaraj; Iyengar, Soumya] Natl Brain Res Ctr, Div Syst Neurosci, Manesar, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Iyengar, S (corresponding author), Deemed Univ, Natl Brain Res Ctr, NH-8, Gurgaon 122050, Haryana, India.	soumya@nbrc.ac.in	Sundaram, Sivaraj/AAB-5852-2022; Sundaram, Sivaraj Mohana/R-9681-2019	Sundaram, Sivaraj Mohana/0000-0003-2120-9420	Department of Biotechnology, India [BT/PR6615/MED/14/857/2005]; NBRC (Manesar, India)	Department of Biotechnology, India(Department of Biotechnology (DBT) India); NBRC (Manesar, India)	The authors gratefully acknowledge the expert technical support provided by Shalini Sharma, Naveen Jayaprakash, and Khader Valli (NBRC). The authors also thank Uzma Saeed (NBRC) and two anonymous reviewers for their insightful comments which helped improve this manuscript. This study was supported by a grant from the Department of Biotechnology, India (BT/PR6615/MED/14/857/2005; to S.I.), and funds from NBRC (Manesar, India).	Adar E, 2008, J NEUROSCI, V28, P5394, DOI 10.1523/JNEUROSCI.5706-07.2008; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; ARAI O, 1995, NEUROSCI LETT, V198, P135, DOI 10.1016/0304-3940(95)11989-A; Arguello AA, 2008, NEUROSCIENCE, V157, P70, DOI 10.1016/j.neuroscience.2008.08.064; Barkan S, 2007, DEV NEUROBIOL, V67, P687, DOI 10.1002/dneu.20379; Barnea A, 2006, BEHAV BRAIN RES, V167, P63, DOI 10.1016/j.bbr.2005.08.018; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; BERKOWITZ BA, 1975, CLIN PHARMACOL THER, V17, P629; Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; BOTTJER SW, 1995, BRAIN BEHAV EVOLUT, V45, P153, DOI 10.1159/000113547; BOULDER C, 1970, ANAT REC, V166, P257; BROWN SD, 1993, J NEUROSCI, V13, P2024; Bungo T, 2005, PHYSIOL BEHAV, V85, P519, DOI 10.1016/j.physbeh.2005.05.015; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Charvet CJ, 2008, BRAIN BEHAV EVOLUT, V72, P295, DOI 10.1159/000184744; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Chen YL, 2008, CURR MED CHEM, V15, P772, DOI 10.2174/092986708783955518; CSILLAG A, 1990, J COMP NEUROL, V302, P543, DOI 10.1002/cne.903020310; De Vries TJ, 2002, J NEUROSCI, V22, P3321; Deviche P, 1997, BRAIN RES, V757, P276, DOI 10.1016/S0006-8993(97)00298-9; DeWulf V, 2005, J COMP NEUROL, V481, P70, DOI 10.1002/cne.20352; DeWulf V, 2002, J NEUROSCI, V22, P4080, DOI 10.1523/JNEUROSCI.22-10-04080.2002; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fields HL, 2007, REGION ANESTH PAIN M, V32, P242, DOI 10.1016/j.rapm.2007.01.001; Fischer SJ, 2008, NEUROSCIENCE, V151, P1217, DOI 10.1016/j.neuroscience.2007.11.035; FORD DH, 1979, ACTA NEUROL SCAND, V59, P248; Freeman FM, 2000, LEARN MEMORY, V7, P213, DOI 10.1101/lm.7.4.213; Ganapathy V, 2005, AAPS J, V7, pE852, DOI 10.1208/aapsj070482; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; GOLDMAN SA, 1985, DEV BRAIN RES, V22, P237, DOI 10.1016/0165-3806(85)90175-0; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; GULLEDGE CC, 1995, J COMP NEUROL, V356, P408, DOI 10.1002/cne.903560308; Gulledge CC, 1999, J COMP NEUROL, V404, P505; HAMMER RP, 1993, MOL BRAIN RES, V19, P129, DOI 10.1016/0169-328X(93)90157-K; Hauser KF, 2000, EUR J NEUROSCI, V12, P1281, DOI 10.1046/j.1460-9568.2000.01015.x; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; Holmes MM, 2002, BEHAV NEUROSCI, V116, P160, DOI 10.1037//0735-7044.116.1.160; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Hu SX, 2002, NEUROPHARMACOLOGY, V42, P829, DOI 10.1016/S0028-3908(02)00030-8; Hurley P, 2008, BRAIN BEHAV EVOLUT, V71, P263, DOI 10.1159/000127046; Jiang JW, 1998, J NEUROBIOL, V36, P1, DOI 10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6; Kahn L, 2005, EUR J NEUROSCI, V21, P493, DOI 10.1111/j.1460-9568.2005.03883.x; Katz A, 2008, EUR J NEUROSCI, V28, P99, DOI 10.1111/j.1460-9568.2008.06303.x; KEMENADE V, 2009, ANN NY ACAD SCI, V1163, P528; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Khurshid N, 2010, BEHAV BRAIN RES, V208, P359, DOI 10.1016/j.bbr.2009.12.003; Khurshid N, 2009, J CHEM NEUROANAT, V37, P158, DOI 10.1016/j.jchemneu.2008.12.001; Kim E, 2006, J BIOL CHEM, V281, P33749, DOI 10.1074/jbc.M603862200; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Law PY, 1997, MOL PHARMACOL, V51, P152, DOI 10.1124/mol.51.1.152; Leslie FM, 1998, CAN J PHYSIOL PHARM, V76, P284, DOI 10.1139/cjpp-76-3-284; Li X, 1996, J MOL EVOL, V43, P179, DOI 10.1007/BF02338825; Li Y, 2009, BIOCHEM BIOPH RES CO, V378, P857, DOI 10.1016/j.bbrc.2008.12.001; Lipkind D, 2002, BEHAV BRAIN RES, V133, P31, DOI 10.1016/S0166-4328(01)00416-8; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lowery JJ, 2007, CHEM BIOL DRUG DES, V69, P41, DOI 10.1111/j.1747-0285.2007.00462.x; Lu M, 2008, J NEUROSCI METH, V167, P376, DOI 10.1016/j.jneumeth.2007.08.015; Lucas NN, 2009, NEUROREPORT, V20, P1066, DOI 10.1097/WNR.0b013e32832e0c2b; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mandyam CD, 2004, J NEUROSCI RES, V76, P783, DOI 10.1002/jnr.20090; MINAMI M, 1995, FEBS LETT, V364, P23, DOI 10.1016/0014-5793(95)00340-F; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; NGAI SH, 1976, ANESTHESIOLOGY, V44, P398, DOI 10.1097/00000542-197605000-00008; NORDEEN KW, 1988, NATURE, V334, P149, DOI 10.1038/334149a0; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Olmstead MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004410; OLSON GA, 1992, PEPTIDES, V13, P1247, DOI 10.1016/0196-9781(92)90036-3; Persson AI, 2003, EUR J NEUROSCI, V17, P1159, DOI 10.1046/j.1460-9568.2003.02538.x; Przewlocki R, 2004, EUR J PHARMACOL, V500, P331, DOI 10.1016/j.ejphar.2004.07.036; Pytte CL, 2007, DEV NEUROBIOL, V67, P1699, DOI 10.1002/dneu.20520; Ra SM, 2002, NEUROSCI LETT, V333, P123, DOI 10.1016/S0304-3940(02)01031-5; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; RASIKA S, 1994, P NATL ACAD SCI USA, V91, P7854, DOI 10.1073/pnas.91.17.7854; REINER A, 1989, J COMP NEUROL, V280, P359, DOI 10.1002/cne.902800304; Reznikov K, 1999, EUR J NEUROSCI, V11, P2711, DOI 10.1046/j.1460-9568.1999.00680.x; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sargeant TJ, 2008, J NEUROCHEM, V107, P883, DOI 10.1111/j.1471-4159.2008.05671.x; Sargeant TJ, 2007, BRAIN RES, V1175, P28, DOI 10.1016/j.brainres.2007.07.091; Scott BB, 2007, J COMP NEUROL, V502, P202, DOI 10.1002/cne.21296; Scotto-Lomassese S, 2007, EUR J NEUROSCI, V25, P1663, DOI 10.1111/j.1460-9568.2007.05418.x; SEATRIZ JV, 1993, BRAIN RES BULL, V30, P523, DOI 10.1016/0361-9230(93)90078-P; Stefano GB, 2008, NEUROCHEM RES, V33, P1933, DOI 10.1007/s11064-008-9674-0; Stevens Craig W., 2005, P13; Stiene-Martin A, 2001, GLIA, V36, P78, DOI 10.1002/glia.1097; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Tegeder I, 2004, PHARMACOL REV, V56, P351, DOI 10.1124/pr.56.3.2; Tekumalla PK, 2002, J NEUROBIOL, V51, P323, DOI 10.1002/neu.10053; Tripathi A, 2008, NEUROSCI RES, V61, P257, DOI 10.1016/j.neures.2008.03.002; Vaidya V. A., 2007, CNS & Neurological Disorders-Drug Targets, V6, P358, DOI 10.2174/187152707783220910; Vaidya Vidita A, 2007, Expert Rev Neurother, V7, P853, DOI 10.1586/14737175.7.7.853; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Wang WW, 1995, P NATL ACAD SCI USA, V92, P12436, DOI 10.1073/pnas.92.26.12436; Wang X, 2006, PHARMACOGENOMICS J, V6, P255, DOI 10.1038/sj.tpj.6500375; Wilbrecht L, 2004, ANN NY ACAD SCI, V1016, P659, DOI 10.1196/annals.1298.024; Xi ZX, 2002, ALCOHOL ALCOHOLISM, V37, P485, DOI 10.1093/alcalc/37.5.485; Zagon IS, 2005, NEUROPEPTIDES, V39, P495, DOI 10.1016/j.npep.2005.07.001; ZAGON IS, 1987, BRAIN RES, V412, P68, DOI 10.1016/0006-8993(87)91440-5; ZAGON IS, 1977, PHARMACOLOGY, V15, P302, DOI 10.1159/000136703; ZAGON IS, 1991, BRAIN RES, V542, P318, DOI 10.1016/0006-8993(91)91585-O	117	10	10	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3681	3695		10.1096/fj.09-146746	http://dx.doi.org/10.1096/fj.09-146746			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20495180				2022-12-25	WOS:000285005900009
J	Guan, Y; Omueti-Ayoade, K; Mutha, SK; Hergenrother, PJ; Tapping, RI				Guan, Yue; Omueti-Ayoade, Katherine; Mutha, Sarita K.; Hergenrother, Paul J.; Tapping, Richard I.			Identification of Novel Synthetic Toll-like Receptor 2 Agonists by High Throughput Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; MICROBIAL LIPOPROTEINS; BACTERIAL LIPOPROTEINS; ADJUVANT; VACCINE; RECOGNITION; LIPOPEPTIDE; RESPONSES; TLR; DISCRIMINATION	Toll-like receptors (TLRs) play a central role in host defense by inducing inflammatory and adaptive immune responses following infection. Drugs that target TLRs are of considerable interest as potential inflammatory regulators, vaccine adjuvants, and novel immunotherapeutics. TLR2, in cooperation with either TLR1 or TLR6, mediates responses to a wide variety of microbial products as well as products of host tissue damage. In an effort to understand the structural basis of TLR2 recognition and uncover novel TLR2 agonists, a synthetic chemical library of 24,000 compounds was screened using an IL-8-driven luciferase reporter in cells expressing these human receptors. The screening yielded several novel TLR2-dependent activators that utilize TLR1, TLR6, or both as co-receptors. These novel small molecule compounds are aromatic in nature and structurally unrelated to any known TLR2 agonists. The three most potent compounds do not exhibit synergistic activity, nor do they act as pseudoantagonists toward natural TLR2 activators. Interestingly, two of the compounds exhibit species specificity and are inactive toward murine peritoneal macrophages. Mutational analysis reveals that although the central extracellular region of TLR1 is required for stimulation, there are subtle differences in the mechanism of stimulation mediated by the synthetic compounds in comparison with natural lipoprotein agonists. The three most potent compounds activate cells in the nanomolar range and stimulate cytokine production from human peripheral blood monocytes. Our results confirm the utility of high throughput screens to uncover novel synthetic TLR2 agonists that may be of therapeutic benefit.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Tapping, Richard I.] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Mutha, Sarita K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Hergenrother, Paul J.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tapping, RI (corresponding author), B103 CLSL,MC110,601 S Goodwin Ave, Urbana, IL 61801 USA.	tapping@illinois.edu		, Katherine/0000-0002-8822-6607	National Institutes of Health [AI052344]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052344, R21AI052344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI052344 (to R.I.T.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; FEARON DT, 1997, NATURE, V388, P323; Gallorini S, 2009, P NATL ACAD SCI USA, V106, P17481, DOI 10.1073/pnas.0903313106; Grabiec A, 2004, J BIOL CHEM, V279, P48004, DOI 10.1074/jbc.M405311200; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hauguel TM, 2008, FRONT BIOSCI-LANDMRK, V13, P2806, DOI 10.2741/2887; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Liang S, 2009, VACCINE, V27, P4302, DOI 10.1016/j.vaccine.2009.05.027; Liang S, 2009, J IMMUNOL, V182, P2978, DOI 10.4049/jimmunol.0803737; Liu XP, 2008, VACCINE, V26, P786, DOI 10.1016/j.vaccine.2007.11.080; Makkouk A, 2009, IMMUNOPHARM IMMUNOT, V31, P331, DOI 10.1080/08923970902802926; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Monie TP, 2009, IMMUNOL REV, V227, P161, DOI 10.1111/j.1600-065X.2008.00735.x; Moyle PM, 2008, CURR MED CHEM, V15, P506, DOI 10.2174/092986708783503249; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; PAZZAGLI M, 1992, ANAL BIOCHEM, V204, P315, DOI 10.1016/0003-2697(92)90245-3; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tapping RI, 2009, SEMIN IMMUNOL, V21, P175, DOI 10.1016/j.smim.2009.05.003; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1	39	42	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23755	23762		10.1074/jbc.M110.116046	http://dx.doi.org/10.1074/jbc.M110.116046			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504771	Green Published, hybrid			2022-12-25	WOS:000280291400026
J	Suzuki, S; Yokoyama, U; Abe, T; Kiyonari, H; Yamashita, N; Kato, Y; Kurotani, R; Sato, M; Okumura, S; Ishikawa, Y				Suzuki, Sayaka; Yokoyama, Utako; Abe, Takaya; Kiyonari, Hiroshi; Yamashita, Naoya; Kato, Yuko; Kurotani, Reiko; Sato, Motohiko; Okumura, Satoshi; Ishikawa, Yoshihiro			Differential Roles of Epac in Regulating Cell Death in Neuronal and Myocardial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEIN BIM; INDUCED APOPTOSIS; 3-NITROPROPIONIC ACID; HYDROGEN-PEROXIDE; GENE-EXPRESSION; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; CARDIAC MYOCYTES; PDE4 INHIBITOR; UP-REGULATION	Cell survival and death play critical roles in tissues composed of post-mitotic cells. Cyclic AMP (cAMP) has been known to exert a distinct effect on cell susceptibility to apoptosis, protecting neuronal cells and deteriorating myocardial cells. These effects are primarily studied using protein kinase A activation. In this study we show the differential roles of Epac, an exchange protein activated by cAMP and a new effector molecule of cAMP signaling, in regulating apoptosis in these cell types. Both stimulation of Epac by 8-p-methoxyphenylthon-2'-O-methyl-cAMP and overexpression of Epac significantly increased DNA fragmentation and TUNEL (terminal deoxynucleotidyltransferase-mediated biotin nick end-labeling)-positive cell counts in mouse cortical neurons but not in cardiac myocytes. In contrast, stimulation of protein kinase A increased apoptosis in cardiac myocytes but not in neuronal cells. In cortical neurons the expression of the Bcl-2 interacting member protein (Bim) was increased by stimulation of Epac at the transcriptional level and was decreased in mice with genetic disruption of Epac1. Epac-induced neuronal apoptosis was attenuated by the silencing of Bim. Furthermore, Epac1 disruption in vivo abolished the 3-nitropropionic acid-induced neuronal apoptosis that occurs in wild-type mice. These results suggest that Epac induces neuron-specific apoptosis through increasing Bim expression. Because the disruption of Epac exerted a protective effect on neuronal apoptosis in vivo, the inhibition of Epac may be a consideration in designing a therapeutic strategy for the treatment of neurodegenerative diseases.	[Yokoyama, Utako] Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Yamashita, Naoya] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Cardiovasc Res Inst, Dept Cell Biol, Newark, NJ 07103 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Dept Mol Med, Newark, NJ 07103 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	Yokohama City University; Yokohama City University; RIKEN; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yokoyama, U (corresponding author), Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	utako@yokohama-cu.ac.jp	Yokoyama, Utako/AAD-1404-2022; Kiyonari, Hiroshi/N-7936-2015	Yokoyama, Utako/0000-0003-1803-0155; 	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Yokohama Foundation for Advanced Medical Science; Kanae Foundation for the Promotion for Medical Science; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation; Sumitomo Foundation; Japan Heart Foundation; Kowa Life Science Foundation; Cosmetology Research Foundation; Uehara Memorial Foundation; Kitsuen Research Foundation; Japan Space Forum	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Foundation for Advanced Medical Science; Kanae Foundation for the Promotion for Medical Science; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Japan Heart Foundation; Kowa Life Science Foundation; Cosmetology Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Kitsuen Research Foundation; Japan Space Forum	This work was supported by a grant-in-aid for Scientific Research (KAKENHI) (to U. Y. and S. S.) and by grants from the Ministry of Health, Labor, and Welfare (to Y. I.), the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y. I.), the Yokohama Foundation for Advanced Medical Science (to U. Y.), the Kanae Foundation for the Promotion for Medical Science (to U. Y.), the Miyata Cardiology Research Promotion Funds (to U. Y.), the Takeda Science Foundation (to U. Y.), the Sumitomo Foundation (to U. Y.), the Japan Heart Foundation Research Grant (to U. Y.), the Kowa Life Science Foundation (to U. Y.), the Cosmetology Research Foundation (to Y. I.), the Uehara Memorial Foundation (to U. Y.), the Kitsuen Research Foundation (to Y. I.), and the Japan Space Forum (to Y. I.).	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Biju MP, 2005, AM J PHYSIOL-RENAL, V289, pF1217, DOI 10.1152/ajprenal.00233.2005; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Cai BB, 2008, APOPTOSIS, V13, P803, DOI 10.1007/s10495-008-0218-5; Chae IH, 2004, CLIN CHIM ACTA, V341, P83, DOI 10.1016/j.cccn.2003.11.009; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Communal C, 2005, ARCH MAL COEUR VAISS, V98, P236; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dong JW, 2003, CELL RES, V13, P385, DOI 10.1038/sj.cr.7290184; Geng YJ, 1999, CIRC RES, V84, P34; Grandoch M, 2009, J LEUKOCYTE BIOL, V86, P847, DOI 10.1189/jlb.0109048; Guo JF, 2009, CIRC RES, V104, P660, DOI 10.1161/CIRCRESAHA.108.186288; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Hoyt KR, 1997, NEUROCHEM RES, V22, P333, DOI 10.1023/A:1022403224901; Huang C, 2009, BRAIN RES, V1257, P75, DOI 10.1016/j.brainres.2008.11.088; ISHIKAWA N, 1992, J BIOL CHEM, V267, P14366; Iwatsubo K, 2004, J BIOL CHEM, V279, P40938, DOI 10.1074/jbc.M314238200; Iwatsubo K, 2007, AM J PHYSIOL-CELL PH, V293, pC1498, DOI 10.1152/ajpcell.00088.2007; Jonakait GM, 2009, BRAIN RES, V1285, P30, DOI 10.1016/j.brainres.2009.06.037; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kobayashi Y, 1997, BRAIN RES, V778, P309, DOI 10.1016/S0006-8993(97)01072-X; Kwak HJ, 2008, CELL SIGNAL, V20, P803, DOI 10.1016/j.cellsig.2007.12.011; Kwon G, 2004, J BIOL CHEM, V279, P8938, DOI 10.1074/jbc.M310330200; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Mandavilli BS, 2005, MOL BRAIN RES, V133, P215, DOI 10.1016/j.molbrainres.2004.10.033; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; McPhee I, 2005, BIOCHEM SOC T, V33, P1330, DOI 10.1042/BST0331330; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Murray AJ, 2008, MOL CELL NEUROSCI, V38, P578, DOI 10.1016/j.mcn.2008.05.006; O'Driscoll C, 2007, J NEUROCHEM, V103, P860, DOI 10.1111/j.1471-4159.2007.04827.x; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pandey M, 2008, J NEUROCHEM, V104, P420, DOI 10.1111/j.1471-4159.2007.04996.x; Parvathenani LK, 2000, NEUROREPORT, V11, P2293, DOI 10.1097/00001756-200007140-00045; Porat S, 1999, ANN NY ACAD SCI, V893, P372, DOI 10.1111/j.1749-6632.1999.tb07858.x; Pugh PC, 2006, MOL CELL NEUROSCI, V31, P586, DOI 10.1016/j.mcn.2005.11.012; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Tiwari S, 2004, BLOOD, V103, P2661, DOI 10.1182/blood-2003-06-2154; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang CY, 2007, J PHYSIOL-LONDON, V584, P191, DOI 10.1113/jphysiol.2007.135616; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; WHITTEMORE ER, 1995, NEUROSCIENCE, V67, P921, DOI 10.1016/0306-4522(95)00108-U; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2008, AM J PHYSIOL-HEART C, V295, pH1547, DOI 10.1152/ajpheart.01317.2007; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	53	61	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24248	24259		10.1074/jbc.M109.094581	http://dx.doi.org/10.1074/jbc.M109.094581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516079	Green Published, hybrid			2022-12-25	WOS:000280291400074
J	Nie, J; Xie, P; Liu, L; Xing, GC; Chang, ZJ; Yin, YX; Tian, CY; He, FC; Zhang, LQ				Nie, Jing; Xie, Ping; Liu, Lin; Xing, Guichun; Chang, Zhijie; Yin, Yuxin; Tian, Chunyan; He, Fuchu; Zhang, Lingqiang			Smad Ubiquitylation Regulatory Factor 1/2 (Smurf1/2) Promotes p53 Degradation by Stabilizing the E3 Ligase MDM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; ARF TUMOR-SUPPRESSOR; NEGATIVE REGULATOR; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; PATHWAY; DOMAIN; RESCUE; INHIBITION; DELETION	The tumor suppressor p53 protein is tightly regulated by a ubiquitin-proteasomal degradation mechanism. Several E3 ubiquitin ligases, including MDM2 (mouse double minute 2), have been reported to play an essential role in the regulation of p53 stability. However, it remains unclear how the activity of these E3 ligases is regulated. Here, we show that the HECT-type E3 ligase Smurf1/2 (Smad ubiquitylation regulatory factor 1/2) promotes p53 degradation by enhancing the activity of the E3 ligase MDM2. We provide evidence that the role of Smurf1/2 on the p53 stability is not dependent on the E3 activity of Smurf1/2 but rather is dependent on the activity of MDM2. We find that Smurf1/2 stabilizes MDM2 by enhancing the heterodimerization of MDM2 with MDMX, during which Smurf1/2 interacts with MDM2 and MDMX. We finally provide evidence that Smurf1/2 regulates apoptosis through p53. To our knowledge, this is the first report to demonstrate that Smurf1/2 functions as a factor to stabilize MDM2 protein rather than as a direct E3 ligase in regulation of p53 degradation.	[Nie, Jing; Xie, Ping; Xing, Guichun; Chang, Zhijie; Tian, Chunyan; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Nie, Jing; Xie, Ping; Chang, Zhijie; He, Fuchu] Tsinghua Univ, Sch Life Sci, Beijing 100842, Peoples R China; [Liu, Lin] Gen Hosp Chinese Peoples Liberat Army, Inst Gen Surg, Beijing 100853, Peoples R China; [Yin, Yuxin] Peking Univ, Dept Pathol, Sch Basic Med Sci, Beijing 100191, Peoples R China	Academy of Military Medical Sciences - China; Tsinghua University; Peking University	Tian, CY (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China.	tiancy@nic.bmi.ac.cn; hefc@nic.bmi.ac.cn; zhanglq@nic.bmi.ac.cn	Chang, Zhijie/AAH-8109-2019	Tian, Chunyan/0000-0003-1589-293X; Chang, Zhijie/0000-0003-1567-3227	National Basic Research Program [2007CB914601, 2006CB910802, 2009CB918402, 2010CB912202]; National Natural Science Foundation [30830029, 30800177]; National Key Technologies R&D Program for New Drugs [2009ZX09503-002, 2009ZX09301-002]; State Key Laboratory of Proteomics [K200802]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program); State Key Laboratory of Proteomics	The work was supported by National Basic Research Program Grants 2007CB914601, 2006CB910802, 2009CB918402, and 2010CB912202, National Natural Science Foundation Project Grants 30830029 and 30800177, National Key Technologies R&D Program for New Drugs Grants 2009ZX09503-002 and 2009ZX09301-002, and State Key Laboratory of Proteomics Grant K200802.	Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chang YC, 1998, CELL GROWTH DIFFER, V9, P79; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finch RA, 2002, CANCER RES, V62, P3221; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; LANE DP, 1992, NATURE, V358, P16; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Suzuki A, 2008, CANCER SCI, V99, P986, DOI 10.1111/j.1349-7006.2008.00779.x; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang W, 2008, CELL CYCLE, V7, P670, DOI 10.4161/cc.7.5.5701; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	49	64	66	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22816	22828		10.1074/jbc.M110.126920	http://dx.doi.org/10.1074/jbc.M110.126920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484049	hybrid, Green Published			2022-12-25	WOS:000279999900014
J	Zhang, YQ; Kubiseski, TJ				Zhang, Yuqian; Kubiseski, Terrance J.			Caenorhabditis elegans wsp-1 Regulation of Synaptic Function at the Neuromuscular Junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROENDOCRINE CELLS; RHO-GTPASES; N-WASP; ACTIN; PROTEIN; CYTOSKELETAL; EXOCYTOSIS; VESICLES	The Rho GTPase members and their effector proteins, such as the Wiskott-Aldrich syndrome protein (WASP), play critical roles in regulating actin dynamics that affect cell motility, endocytosis, cell division, and transport. It is well established that Caenorhabditis elegans wsp-1 plays an essential role in embryonic development. We were interested in the role of the C. elegans protein WSP-1 in the adult nematode. In this report, we show that a deletion mutant of wsp-1 exhibits a strong sensitivity to the neuromuscular inhibitor aldicarb. Transgenic rescue experiments demonstrated that neuronal expression of WSP-1 rescued this phenotype and that it required a functional WSP-1 Cdc42/Rac interactive binding domain. WSP-1-GFP fusion protein was found localized presynaptically, immediately adjacent to the synaptic protein RAB-3. Strong genetic interactions with wsp-1 and other genes involved in different stages of synaptic transmission were observed as the wsp-1(gm324) mutation suppresses the aldicarb resistance seen in unc-13(e51), unc-11(e47), and snt-1 (md290) mutants. These results provide genetic and pharmacological evidence that WSP-1 plays an essential role to stabilize the actin cytoskeleton at the neuronal active zone of the neuromuscular junction to restrain synaptic vesicle release.	[Zhang, Yuqian; Kubiseski, Terrance J.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Kubiseski, Terrance J.] York Univ, Dept Neurosci, N York, ON M3J 1P3, Canada	York University - Canada; York University - Canada	Kubiseski, TJ (corresponding author), York Univ, Dept Biol, 4700 Keele St, N York, ON M3J 1P3, Canada.	tkubises@yorku.ca		Kubiseski, Terrance/0000-0001-9388-8608	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada.	Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; BRENNER S, 1974, GENETICS, V77, P71; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Halpain S, 2003, NAT NEUROSCI, V6, P101, DOI 10.1038/nn0203-101; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Locke CJ, 2008, JOVE-J VIS EXP, V18, P837, DOI DOI 10.3791/837; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Ramesh N, 2009, IMMUNOL RES, V44, P99, DOI 10.1007/s12026-008-8086-1; Richmond Janet, 2005, WormBook, P1; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Shakir MA, 2008, GENETICS, V179, P1957, DOI 10.1534/genetics.108.088963; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Soderling SH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.255pe5; Tal T, 2002, DEV BIOL, V243, P260, DOI 10.1006/dbio.2002.0571; van der Linden AM, 2001, GENETICS, V158, P221; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676	28	6	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23038	23044		10.1074/jbc.M109.096164	http://dx.doi.org/10.1074/jbc.M109.096164			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501656	Green Published, hybrid			2022-12-25	WOS:000279999900038
J	de Oca, PM; Malarde, V; Proust, R; Dautry-Varsat, A; Gesbert, F				Montes de Oca B, Pavel; Malarde, Valerie; Proust, Richard; Dautry-Varsat, Alice; Gesbert, Franck			Ectodomain Shedding of Interleukin-2 Receptor beta and Generation of an Intracellular Functional Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; REGULATED INTRAMEMBRANE PROTEOLYSIS; CELL-LINE; IL-2 RECEPTOR; GAMMA-CHAIN; CLEAVAGE; ENDOCYTOSIS; LEUKEMIA; PROTEIN; NOTCH	Interleukin-2 (IL-2) regulates different functions of various lymphoid cell subsets. These are mediated by its binding to the IL-2 receptor (IL-2R) composed of three subunits (IL2-R alpha, -beta, and -gamma(c)). IL-2R beta is responsible for the activation of several signaling pathways. Ectodomain shedding of membrane receptors is thought to be an important mechanism for down-regulation of cell surface receptor abundance but is also emerging as a mechanism that cell membrane-associated molecules require for proper action in vivo. Here, we demonstrate that IL-2R beta is cleaved in cell lines of different origin, including T cells, generating an intracellular 37-kDa fragment (37 beta ic) that comprises the full intracellular C-terminal and transmembrane domains. Ectodomain shedding of IL-2R beta decreases in a mutant deleted of the juxtamembrane region, where cleavage is predicted to occur, and is inhibited by tissue inhibitor of metalloproteases-3. 37 beta ic is tyrosine-phosphorylated and associates with STAT-5, a canonic signal transducer of IL-2R. Finally, lymphoid cell transfection with a truncated form of IL-2R beta mimicking 37 beta ic increases their proliferation. These data indicate that IL-2R beta is subject to ectodomain shedding generating an intracellular fragment biologically functional, because (i) it is phosphorylated, (ii) it associates with STAT5A, and (iii) it increases cell proliferation.	[Gesbert, Franck] Univ Paris 11, INSERM, UMR S1004, F-94807 Villejuif, France; [Montes de Oca B, Pavel; Malarde, Valerie; Dautry-Varsat, Alice; Gesbert, Franck] Inst Pasteur, CNRS, URA2582, F-75015 Paris, France; [Montes de Oca B, Pavel] Inst Nacl Neurol & Neurocirug, Excitatory Amino Acids Lab, Mexico City 14269, DF, Mexico; [Proust, Richard; Gesbert, Franck] Univ Paris 11, Inst Andre Lwoff, UMR S1004, F-94807 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay	Gesbert, F (corresponding author), Univ Paris 11, INSERM, UMR S1004, 14 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	franck.gesbert@u-psud.fr			Action Concertee; Iniciative Biologie Cellulaire; Moleculaire et Structurale; Institut Pasteur	Action Concertee; Iniciative Biologie Cellulaire; Moleculaire et Structurale; Institut Pasteur(European Commission)	This work was supported in part by Action Concertee, Iniciative Biologie Cellulaire, Moleculaire et Structurale.; Supported by Joshi (2005-2006) and Cantarini (2006-2007) fellowships for postdoctoral studies from Institut Pasteur. To whom correspondence may be addressed: Excitatory Amino Acids Laboratory, Instituto Nacional de Neurologia y Neurocirugia, D.F., 14269, Mexico. Tel.: 52-55-5606-3822 (ext. 2013 or 5059); Fax: 52-55-5528-8036; E-mail: pavel73@hotmail.com.	Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Delespine-Carmagnat M, 2000, EUR J IMMUNOL, V30, P59, DOI 10.1002/1521-4141(200001)30:1<59::AID-IMMU59>3.0.CO;2-1; Diaz-Rodriguez E, 1999, EUR J NEUROSCI, V11, P1421, DOI 10.1046/j.1460-9568.1999.00552.x; EVANS GA, 1994, J BIOL CHEM, V269, P23407; FernandezBotran R, 1996, ADV IMMUNOL, V63, P269, DOI 10.1016/S0065-2776(08)60858-5; Fujimura S, 2004, INT J ONCOL, V25, P437; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Gesbert F, 2004, CURR TOP MICROBIOL, V286, P119; Gesbert F, 1998, J BIOL CHEM, V273, P18273, DOI 10.1074/jbc.273.29.18273; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Herman C, 1998, J IMMUNOL, V160, P2478; HONDA M, 1990, J IMMUNOL, V145, P4131; HORI T, 1987, BLOOD, V70, P1069; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; KAWAHARA A, 1994, MOL CELL BIOL, V14, P5433, DOI 10.1128/MCB.14.8.5433; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maasho K, 2004, J IMMUNOL METHODS, V284, P133, DOI 10.1016/j.jim.2003.10.010; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Meissner U, 2001, BLOOD, V97, P183; Michihara A, 2005, BIOL PHARM BULL, V28, P947, DOI 10.1248/bpb.28.947; Mori N, 2002, BLOOD, V99, P1341, DOI 10.1182/blood.V99.4.1341; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pise-Masison CA, 2002, CANCER RES, V62, P3562; Polavarapu R, 2008, AM J PATHOL, V172, P1355, DOI 10.2353/ajpath.2008.070975; Robertson MJ, 1996, EXP HEMATOL, V24, P406; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Wang XD, 2002, J BIOL CHEM, V277, P50510, DOI 10.1074/jbc.M208738200; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wilhelmsen K, 2004, MOL CELL BIOL, V24, P454, DOI 10.1128/MCB.24.1.454-464.2004; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	46	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22050	22058		10.1074/jbc.M109.093088	http://dx.doi.org/10.1074/jbc.M109.093088			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20495002	hybrid, Green Published			2022-12-25	WOS:000279702200017
J	Chaturvedi, V; Springer, DJ; Behr, MJ; Ramani, R; Li, XJ; Peck, MK; Ren, P; Bopp, DJ; Wood, B; Samsonoff, WA; Butchkoski, CM; Hicks, AC; Stone, WB; Rudd, RJ; Chaturvedi, S				Chaturvedi, Vishnu; Springer, Deborah J.; Behr, Melissa J.; Ramani, Rama; Li, Xiaojiang; Peck, Marcia K.; Ren, Ping; Bopp, Dianna J.; Wood, Britta; Samsonoff, William A.; Butchkoski, Calvin M.; Hicks, Alan C.; Stone, Ward B.; Rudd, Robert J.; Chaturvedi, Sudha			Morphological and Molecular Characterizations of Psychrophilic Fungus Geomyces destructans from New York Bats with White Nose Syndrome (WNS)	PLOS ONE			English	Article							DIVERSITY; INFECTION; PANNORUM; RESPONSES	Background: Massive die-offs of little brown bats (Myotis lucifugus) have been occurring since 2006 in hibernation sites around Albany, New York, and this problem has spread to other States in the Northeastern United States. White cottony fungal growth is seen on the snouts of affected animals, a prominent sign of White Nose Syndrome (WNS). A previous report described the involvement of the fungus Geomyces destructans in WNS, but an identical fungus was recently isolated in France from a bat that was evidently healthy. The fungus has been recovered sparsely despite plentiful availability of afflicted animals. Methodology/Principal Findings: We have investigated 100 bat and environmental samples from eight affected sites in 2008. Our findings provide strong evidence for an etiologic role of G. destructans in bat WNS. (i) Direct smears from bat snouts, Periodic Acid Schiff-stained tissue sections from infected tissues, and scanning electron micrographs of bat tissues all showed fungal structures similar to those of G. destructans. (ii) G. destructans DNA was directly amplified from infected bat tissues, (iii) Isolations of G. destructans in cultures from infected bat tissues showed 100% DNA match with the fungus present in positive tissue samples. (iv) RAPD patterns for all G. destructans cultures isolated from two sites were indistinguishable. (v) The fungal isolates showed psychrophilic growth. (vi) We identified in vitro proteolytic activities suggestive of known fungal pathogenic traits in G. destructans. Conclusions/Significance: Further studies are needed to understand whether G. destructans WNS is a symptom or a trigger for bat mass mortality. The availability of well-characterized G. destructans strains should promote an understanding of bat-fungus relationships, and should aid in the screening of biological and chemical control agents.	[Chaturvedi, Vishnu; Springer, Deborah J.; Ramani, Rama; Li, Xiaojiang; Peck, Marcia K.; Ren, Ping; Chaturvedi, Sudha] New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY USA; [Chaturvedi, Vishnu; Springer, Deborah J.; Ramani, Rama; Chaturvedi, Sudha] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY USA; [Bopp, Dianna J.] New York State Dept Hlth, Wadsworth Ctr, Bacteriol Lab, Albany, NY USA; [Wood, Britta; Rudd, Robert J.] New York State Dept Hlth, Wadsworth Ctr, Rabies Lab, Albany, NY USA; [Butchkoski, Calvin M.] Penn Game Commiss, Harrisburg, PA USA; [Hicks, Alan C.] Bur Wildlife, New York State Dept Environm Conservat, Albany, NY USA; [Stone, Ward B.] New York State Dept Environm Conservat, Wildlife Pathol Unit, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; Wadsworth Center	Chaturvedi, V (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY USA.	vishnu@wadsworth.org	Ramani, Rama/AAS-2019-2020	Chaturvedi, Vishnu/0000-0002-3922-9676; Ren, Ping/0000-0002-4022-6667	Clinical Laboratory Reference System of the Wadsworth Center	Clinical Laboratory Reference System of the Wadsworth Center	Funding: This study was supported with funds available as part of the Clinical Laboratory Reference System of the Wadsworth Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baptista-Rosas RC, 2007, ANN NY ACAD SCI, V1111, P35, DOI 10.1196/annals.1406.003; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chaturvedi V, 2002, INFECT IMMUN, V70, P5225, DOI 10.1128/IAI.70.9.5225-5235.2002; CHATURVEDI VP, 1984, SABOURAUDIA, V22, P185; Christen-Zaech S, 2008, J AM ACAD DERMATOL, V58, pS112, DOI 10.1016/j.jaad.2007.04.019; Connell L, 2008, MICROB ECOL, V56, P448, DOI 10.1007/s00248-008-9363-1; Courtin F, 2010, VET PATHOL, V47, P214, DOI 10.1177/0300985809358614; De Bernardis F, 1999, J CLIN MICROBIOL, V37, P3481, DOI 10.1128/JCM.37.11.3481-3486.1999; De Hoog G. S., 2000, ATLAS CLIN FUNGI; DeBlase A. F., 1965, Journal of Mammalogy, V46, P96, DOI 10.2307/1377821; Dyavaiah Madhu, 2007, BMC Ophthalmol, V7, P1, DOI 10.1186/1471-2415-7-1; Erne JB, 2007, JAVMA-J AM VET MED A, V230, P537, DOI 10.2460/javma.230.4.537; Franco M, 2000, MED MYCOL, V38, P185, DOI 10.1080/714030941; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Gente S, 2006, J IND MICROBIOL BIOT, V33, P1019, DOI 10.1007/s10295-006-0130-3; Gianni C, 2003, MYCOSES, V46, P430, DOI 10.1046/j.1439-0507.2003.00897.x; Gilichinsky D, 2005, FEMS MICROBIOL ECOL, V53, P117, DOI 10.1016/j.femsec.2005.02.003; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; GRIFFIN DONALD R., 1940, JOUR MAMMAL, V21, P181, DOI 10.2307/1374974; HATTEN BA, 1970, J IMMUNOL, V105, P872; HICKS AC, 2002, HIST STATUS BEHAV HI, P35; Johnson SA, 1998, AM MIDL NAT, V139, P255, DOI 10.1674/0003-0031(1998)139[0255:OWLOIB]2.0.CO;2; Julg B, 2008, J TRAVEL MED, V15, P133, DOI 10.1111/j.1708-8305.2008.00193.x; KELLY T, 2008, NY TIMES; Kerth Gerald, 2003, Acta Ethologica, V5, P107; KLEIN BS, 1986, NEW ENGL J MED, V314, P529, DOI 10.1056/NEJM198602273140901; Kunz TH, 2003, BAT ECOLOGY, P3; Kurtz CC, 2007, DEV COMP IMMUNOL, V31, P415, DOI 10.1016/j.dci.2006.07.003; Kwon-Chung K.J., 1992, MED MYCOL; Lampo M, 2000, AM J TROP MED HYG, V62, P718, DOI 10.4269/ajtmh.2000.62.718; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Malosso E, 2006, POLAR BIOL, V29, P552, DOI 10.1007/s00300-005-0088-z; Marshall WA, 1998, MICROBIAL ECOL, V36, P212, DOI 10.1007/s002489900108; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Moller C, 1996, J IND MICROBIOL BIOT, V17, P359, DOI 10.1007/BF01574767; Murtagh GJ, 2002, MYCOL RES, V106, P1277, DOI 10.1017/S0953756202006615; PRICE MF, 1982, SABOURAUDIA, V20, P7; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Rice AV, 2006, MYCOLOGIA, V98, P307, DOI 10.3852/mycologia.98.2.307; Robinson CH, 2001, NEW PHYTOL, V151, P341, DOI 10.1046/j.1469-8137.2001.00177.x; Ruisi Serena, 2007, Reviews in Environmental Science and Bio/Technology, V6, P127, DOI 10.1007/s11157-006-9107-y; Samson R., 2004, INTRO FOOD AIRBORNE; Schmidt SK, 2008, MICROB ECOL, V56, P681, DOI 10.1007/s00248-008-9387-6; SCHOENBORN C, 1970, Mykosen, V13, P253; SCOTT DW, 2000, MULLER KIRKS SMALL A; Symonds EP, 2008, MYCOPATHOLOGIA, V166, P143, DOI 10.1007/s11046-008-9135-y; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ter Hofstede HM, 2005, J ZOOL, V266, P333, DOI 10.1017/S095283690500693X; TRIMARCHI CV, 1977, J WILDLIFE DIS, V13, P366, DOI 10.7589/0090-3558-13.4.366; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; ZAMORA JRC, 1977, MYCOPATHOLOGIA, V60, P157; Zelenkova Hana, 2006, Acta Dermatovenerol Croat, V14, P21	57	73	75	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10783	10.1371/journal.pone.0010783	http://dx.doi.org/10.1371/journal.pone.0010783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520731	Green Published, Green Submitted, gold			2022-12-25	WOS:000278034600011
J	de Leon, AD; Cronkhite, JT; Katzenstein, ALA; Godwin, JD; Raghu, G; Glazer, CS; Rosenblatt, RL; Girod, CE; Garrity, ER; Xing, C; Garcia, CK				de Leon, Alberto Diaz; Cronkhite, Jennifer T.; Katzenstein, Anna-Luise A.; Godwin, J. David; Raghu, Ganesh; Glazer, Craig S.; Rosenblatt, Randall L.; Girod, Carlos E.; Garrity, Edward R.; Xing, Chao; Garcia, Christine Kim			Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations	PLOS ONE			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; RNA COMPONENT; CELLS; HAPLOINSUFFICIENCY; ANTICIPATION; FAMILIES; GENE	Background: Telomerase is an enzyme that catalyzes the addition of nucleotides on the ends of chromosomes. Rare loss of function mutations in the gene that encodes the protein component of telomerase (TERT) have been described in patients with idiopathic pulmonary fibrosis (IPF). Here we examine the telomere lengths and pulmonary fibrosis phenotype seen in multiple kindreds with heterozygous TERT mutations. Methods and Findings: We have identified 134 individuals with heterozygous TERT mutations from 21 unrelated families. Available medical records, surgical lung biopsies and radiographs were evaluated retrospectively. Genomic DNA isolated from circulating leukocytes has been used to measure telomere lengths with a quantitative PCR assay. We find that telomere lengths of TERT mutation carriers decrease in an age-dependent manner and show progressive shortening with successive generations of mutation inheritance. Family members without TERT mutations have a shorter mean telomere length than normal, demonstrating epigenetic inheritance of shortened telomere lengths in the absence of an inherited TERT mutation. Pulmonary fibrosis is an age-dependent phenotype not seen in mutation carriers less than 40 years of age but found in 60% of men 60 years or older; its development is associated with environmental exposures including cigarette smoking. A radiographic CT pattern of usual interstitial pneumonia (UIP), which is consistent with a diagnosis of IPF, is seen in 74% of cases and a pathologic pattern of UIP is seen in 86% of surgical lung biopsies. Pulmonary fibrosis associated with TERT mutations is progressive and lethal with a mean survival of 3 years after diagnosis. Overall, TERT mutation carriers demonstrate reduced life expectancy, with a mean age of death of 58 and 67 years for males and females, respectively. Conclusions: A subset of pulmonary fibrosis, like dyskeratosis congenita, bone marrow failure, and liver disease, represents a "telomeropathy" caused by germline mutations in telomerase and characterized by short telomere lengths. Family members within kindreds who do not inherit the TERT mutation have shorter telomere lengths than controls, demonstrating epigenetic inheritance of a shortened parental telomere length set-point.	[de Leon, Alberto Diaz; Cronkhite, Jennifer T.; Xing, Chao; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Glazer, Craig S.; Rosenblatt, Randall L.; Girod, Carlos E.; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Pulm & Crit Care Med, Dallas, TX 75390 USA; [Katzenstein, Anna-Luise A.] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY USA; [Godwin, J. David] Univ Washington, Med Ctr, Dept Radiol, Seattle, WA 98195 USA; [Raghu, Ganesh] Univ Washington, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Garrity, Edward R.] Univ Chicago, Dept Internal Med, Div Pulm & Crit Care Med, Chicago, IL 60637 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago	de Leon, AD (corresponding author), Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	Christine.garcia@utsouthwestern.edu		Xing, Chao/0000-0002-1838-0502	National Institutes of Health [K23RR020632, R01HL093096]; Doris Duke Charitable Foundation; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR020632] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health grants K23RR020632 and R01HL093096, the Doris Duke Charitable Foundation and the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; ALTER BP, 2007, BLOOD; American Thoracic Society, 2002, AM J RESP CRIT CARE, V165, P277, DOI DOI 10.1164/ajrccm.165.2.ats01; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; ARMANIOS M, 2009, AM J HUM GENET; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Du HY, 2009, BLOOD, V113, P309, DOI 10.1182/blood-2008-07-166421; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GARCIA CK, 2007, NUCL ACIDS RES; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Marciniak RA, 2000, TRENDS GENET, V16, P193, DOI 10.1016/S0168-9525(00)01984-3; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; NORDFJALL K, 2009, EUR J HUM GENET; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; WALNE AJ, 2007, HUM MOL GENET; Wright WE, 1996, DEV GENET, V18, P173; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	34	235	236	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10680	10.1371/journal.pone.0010680	http://dx.doi.org/10.1371/journal.pone.0010680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502709	Green Published, gold, Green Submitted			2022-12-25	WOS:000277845400005
J	Paule, B; Bastien, L; Deslandes, E; Cussenot, O; Podgorniak, MP; Allory, Y; Naimi, B; Porcher, R; de La Taille, A; Menashi, S; Calvo, F; Mourah, S				Paule, Bernard; Bastien, Laurence; Deslandes, Emmanuelle; Cussenot, Olivier; Podgorniak, Marie-Pierre; Allory, Yves; Naimi, Benyoussef; Porcher, Raphael; de La Taille, Alexandre; Menashi, Suzanne; Calvo, Fabien; Mourah, Samia			Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas	PLOS ONE			English	Article							ANGIOGENESIS; SORAFENIB; RECEPTORS; EFFICACY; BIOLOGY; PLASMA; TRIAL; VEGF	Background: Angiogenesis is the target of several agents in the treatment of malignancies, including renal cell carcinoma (RCC). There is a real need for surrogate biomarkers that can predict selection of patients who may benefit from antiangiogenic therapies, prediction of disease outcome and which may improve the knowledge regarding mechanism of action of these treatments. Tyrosine kinase inhibitors (TKI) have proven efficacy in metastatic RCC (mRCC). However, the molecular mechanisms underlying the clinical response to these drugs remain unclear. Methodology/Principal Findings: The present study aimed to identify molecular biomarkers associated with the response to sunitinib, a Tyrosine kinase inhibitor. To evaluate this relationship, primary tumors from 23 metastatic RCC patients treated by sunitinib were analyzed for a panel of 16 biomarkers involved in tumor pathways targeted by sunitinib, using real-time quantitative reverse-transcriptase PCR. Nine of the 23 patients (39%) responded to sunitinib. Among transcripts analyzed, only the levels of vascular endothelial growth factor (VEGF) soluble isoforms (VEGF(121) and VEGF(165)) were associated with the response to sunitinib (P = 0.04 for both). Furthermore, the ratio of VEGF soluble isoforms (VEGF(121)/VEGF(165)) was significantly associated with prognosis (P = 0.02). Conclusions: This preliminary study provides a promising tool that might help in the management of metastatic RCC, and could be extended to other tumors treated by TKI.	[Paule, Bernard; Naimi, Benyoussef; Calvo, Fabien; Mourah, Samia] INSERM, UMRS 940, Paris, France; [Paule, Bernard; Bastien, Laurence; Allory, Yves; de La Taille, Alexandre] Hop Henri Mondor, AP HP, Dept Urol, INSERM,U841Eq07, Creteil, France; [Deslandes, Emmanuelle; Porcher, Raphael] Univ Paris 07, Hop St Louis, AP HP, INSERM,Dept Biostat & Med Data Proc,U717, Paris, France; [Cussenot, Olivier] Hop Tenon, AP HP, Dept Urol, F-75970 Paris, France; [Cussenot, Olivier] CeRePP Natl Grp, Paris, France; [Podgorniak, Marie-Pierre; Calvo, Fabien; Mourah, Samia] Hop St Louis, AP HP, Pharmacol Lab, Paris, France; [Menashi, Suzanne] Univ Paris Est, CNRS, UMR 7149, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Paule, B (corresponding author), INSERM, UMRS 940, Paris, France.	samia.mourah@sls.aphp.fr	de la taille, Alex/ABE-8422-2021	cussenot, olivier/0000-0002-9912-0533; Boutmy, Emmanuelle/0000-0001-9657-9376; calvo, fabien/0000-0002-0298-7633; Porcher, Raphael/0000-0002-5277-4679	Pfizer France	Pfizer France(Pfizer)	This work has been performed with the collaboration of INSERM-U716, Laboratory of Pharmacology of Hopital Saint-Louis and University Paris 7, and the support of Pfizer France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi002; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Choueiri TK, 2008, J CLIN ONCOL, V26, P127, DOI 10.1200/JCO.2007.13.3223; Eisen T, 2008, JNCI-J NATL CANCER I, V100, P1454, DOI 10.1093/jnci/djn319; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kontovinis LF, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-82; Loupakis F, 2007, J CLIN ONCOL, V25, P1816, DOI 10.1200/JCO.2006.10.3051; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Rini BI, 2008, J CLIN ONCOL, V26, P3743, DOI 10.1200/JCO.2007.15.5416; Rivet J, 2008, CANCER, V112, P433, DOI 10.1002/cncr.23186; Rixe O, 2007, ANN ONCOL, V18, P1117, DOI 10.1093/annonc/mdm184; TAKAHASHI A, 1994, CANCER RES, V54, P4233; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tomisawa M, 1999, EUR J CANCER, V35, P133, DOI 10.1016/S0959-8049(98)00278-0; Tsuchiya N, 2001, TOHOKU J EXP MED, V195, P101, DOI 10.1620/tjem.195.101	18	39	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10715	10.1371/journal.pone.0010715	http://dx.doi.org/10.1371/journal.pone.0010715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502715	Green Published, Green Submitted, gold			2022-12-25	WOS:000277845400017
J	Dieterle, MG; Wiest, AE; Plamann, M; McCluskey, K				Dieterle, Michael G.; Wiest, Aric E.; Plamann, Mike; McCluskey, Kevin			Characterization of the Temperature-Sensitive Mutations un-7 and png-1 in Neurospora crassa	PLOS ONE			English	Article							GENOME; CHROMOSOME; CLONING	The model filamentous fungus Neurospora crassa has been studied for over fifty years and many temperature-sensitive mutants have been generated. While most of these have been mapped genetically, many remain anonymous. The mutation in the N. crassa temperature-sensitive lethal mutant un-7 was identified by a complementation based approach as being in the open reading frame designated NCU00651 on linkage group I. Other mutations in this gene have been identified that lead to a temperature-sensitive morphological phenotype called png-1. The mutations underlying un-7 result in a serine to phenylalanine change at position 273 and an isoleucine to valine change at position 390, while the mutation in png-1 was found to result in a serine to leucine change at position 279 although there were other conservative changes in this allele. The overall morphology of the strain carrying the un-7 mutation is compared to strains carrying the png-1 mutation and these mutations are evaluated in the context of other temperature-sensitive mutants in Neurospora.	[Dieterle, Michael G.; Wiest, Aric E.; Plamann, Mike; McCluskey, Kevin] Univ Missouri Kansas City, Sch Biol Sci, Fungal Genet Stock Ctr, Kansas City, MO 64110 USA; [Dieterle, Michael G.] Pembroke Hill Sch, Kansas City, MO USA	University of Missouri System; University of Missouri Kansas City	Dieterle, MG (corresponding author), Univ Missouri Kansas City, Sch Biol Sci, Fungal Genet Stock Ctr, Kansas City, MO 64110 USA.	mccluskeyk@umkc.edu		Dieterle, Michael/0000-0002-3109-6151	US National Science Foundation [0742713]; Direct For Biological Sciences [0742713] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The Fungal Genetics Stock Center is supported by the US National Science Foundation grant number 0742713 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; INOUE H, 1970, JPN J GENET, V45, P357, DOI 10.1266/jjg.45.357; Kelkar HS, 2001, GENETICS, V157, P979; Kinney M., 2009, FUNGAL GENETICS REPO, V56, P6; LOO MW, 1981, MOL CELL BIOL, V1, P199, DOI 10.1128/MCB.1.3.199; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; McCluskey K., 2007, FUNGAL GENET NEWSL, V54, P9; PERKINS DD, 2002, FUNGAL GENET NEWSL S, V49, P199; Schmidhauser TJ, 1997, FUNGAL GENET BIOL, V21, P323, DOI 10.1006/fgbi.1997.0974; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Videira A, 2009, MICROBIOL-SGM, V155, P3134, DOI 10.1099/mic.0.029710-0; Vogel H.J., 1956, MICROB GENET B, V13, P42; VOLLMER SJ, 1986, P NATL ACAD SCI USA, V83, P4869, DOI 10.1073/pnas.83.13.4869; Wiest A., 2008, FUNGAL GENETICS REPO, V55, P37; Zhang Z, 2010, FUNGAL GENET BIOL, V47, P199, DOI 10.1016/j.fgb.2009.12.001; Zhao G, 2009, GLYCOBIOLOGY, V19, P118, DOI 10.1093/glycob/cwn108	20	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10703	10.1371/journal.pone.0010703	http://dx.doi.org/10.1371/journal.pone.0010703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502699	gold, Green Published, Green Submitted			2022-12-25	WOS:000277776500017
J	Zacchi, LF; Selmecki, AM; Berman, J; Davis, DA				Zacchi, Lucia F.; Selmecki, Anna M.; Berman, Judith; Davis, Dana A.			Low Dosage of Histone H4 Leads to Growth Defects and Morphological Changes in Candida albicans	PLOS ONE			English	Article							MITOTIC CHROMOSOME TRANSMISSION; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CELL-CYCLE; DROSOPHILA-MELANOGASTER; WIDESPREAD ANEUPLOIDY; NUCLEOSOME DEPLETION; COLONY MORPHOLOGY; ESCHERICHIA-COLI; FUNGAL PATHOGEN	Chromatin function depends on adequate histone stoichiometry. Alterations in histone dosage affect transcription and chromosome segregation, leading to growth defects and aneuploidies. In the fungal pathogen Candida albicans, aneuploidy formation is associated with antifungal resistance and pathogenesis. Histone modifying enzymes and chromatin remodeling proteins are also required for pathogenesis. However, little is known about the mechanisms that generate aneuploidies or about the epigenetic mechanisms that shape the response of C. albicans to the host environment. Here, we determined the impact of histone H4 deficit in the growth and colony morphology of C. albicans. We found that C. albicans requires at least two of the four alleles that code for histone H4 (HHF1 and HHF22) to grow normally. Strains with only one histone H4 allele show a severe growth defect and unstable colony morphology, and produce faster-growing, morphologically stable suppressors. Segmental or whole chromosomal trisomies that increased wild-type histone H4 copy number were the preferred mechanism of suppression. This is the first study of a core nucleosomal histone in C. albicans, and constitutes the prelude to future, more detailed research on the function of histone H4 in this important fungal pathogen.	[Zacchi, Lucia F.; Berman, Judith; Davis, Dana A.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Selmecki, Anna M.; Berman, Judith] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zacchi, LF (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	dadavis@umn.edu	Berman, Judith/AAS-5115-2021; Berman, Judith/ABA-8528-2021; Zacchi, Lucia/F-7494-2016; Zacchi, Lucia/N-6484-2019	Berman, Judith/0000-0002-8577-0084; Zacchi, Lucia/0000-0001-6217-1380; Zacchi, Lucia/0000-0001-6217-1380; Selmecki, Anna/0000-0003-3298-2400	Burroughs Wellcome Fund; NIH [R01 AI0624273]; Microbial and Plant Genomics Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062427] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microbial and Plant Genomics Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Investigators in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund to D. A. D., NIH R01 AI0624273 to J.B. and Microbial and Plant Genomics Institute of MN Integrative Fellowship to A. M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Arbour M, 2009, FEMS YEAST RES, V9, P1070, DOI 10.1111/j.1567-1364.2009.00563.x; ASAKURA K, 1991, J GEN MICROBIOL, V137, P2531, DOI 10.1099/00221287-137-11-2531; Au WC, 2008, GENETICS, V179, P263, DOI 10.1534/genetics.108.088518; Ausio J, 2001, BIOCHEM CELL BIOL, V79, P693, DOI 10.1139/bcb-79-6-693; BARTON RC, 1994, J BACTERIOL, V176, P756, DOI 10.1128/jb.176.3.756-763.1994; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; Calderone RA., 2002, CANDIDA CANDIDIASIS; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Chang CH, 1997, J BIOL CHEM, V272, P23427, DOI 10.1074/jbc.272.37.23427; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; CHOE J, 1985, MOL CELL BIOL, V5, P3261, DOI 10.1128/MCB.5.11.3261; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Davis DA, 2002, GENETICS, V162, P1573; Diogo D, 2009, FUNGAL GENET BIOL, V46, P159, DOI 10.1016/j.fgb.2008.11.005; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; DURRIN LK, 1992, MOL CELL BIOL, V12, P1621, DOI 10.1128/MCB.12.4.1621; Forche A, 2005, EUKARYOT CELL, V4, P156, DOI 10.1128/EC.4.1.156-165.2005; Forche A, 2009, GENETICS, V182, P799, DOI 10.1534/genetics.109.103325; FRETZIN S, 1991, GENE, V107, P341, DOI 10.1016/0378-1119(91)90337-B; Ganley ARD, 2009, MOL CELL, V35, P683, DOI 10.1016/j.molcel.2009.07.012; Garcia-Sanchez S, 2005, MOL BIOL CELL, V16, P2913, DOI 10.1091/mbc.E05-01-0071; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; Hanlon SE, 2003, GENETICS, V164, P1333; Hnisz D, 2009, MOL MICROBIOL, V74, P1, DOI 10.1111/j.1365-2958.2009.06772.x; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; IWAGUCHI SI, 1992, J GEN MICROBIOL, V138, P1177, DOI 10.1099/00221287-138-6-1177; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; Klar AJS, 2001, GENETICS, V158, P919; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Legrand M, 2004, MOL MICROBIOL, V52, P1451, DOI 10.1111/j.1365-2958.2004.04068.x; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Libuda DE, 2006, NATURE, V443, P1003, DOI 10.1038/nature05205; Lu Y, 2008, MOL BIOL CELL, V19, P4260, DOI 10.1091/mbc.E08-02-0173; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; MAGEE PT, 1992, J CLIN MICROBIOL, V30, P2674, DOI 10.1128/JCM.30.10.2674-2679.1992; Mao XM, 2006, FEBS LETT, V580, P2615, DOI 10.1016/j.febslet.2006.04.009; MATSUMOTO S, 1985, EMBO J, V4, P3531, DOI 10.1002/j.1460-2075.1985.tb04113.x; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; MOORE GD, 1983, GENETICS, V105, P327; MORAN L, 1990, GENE DEV, V4, P752, DOI 10.1101/gad.4.5.752; NORRIS D, 1987, MOL CELL BIOL, V7, P3473, DOI 10.1128/MCB.7.10.3473; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Perepnikhatka V, 1999, J BACTERIOL, V181, P4041, DOI 10.1128/JB.181.13.4041-4049.1999; Pfaller MA, 1998, DIAGN MICR INFEC DIS, V31, P327, DOI 10.1016/S0732-8893(97)00240-X; Pfaller MA, 2001, J CLIN MICROBIOL, V39, P3254, DOI 10.1128/JCM.39.9.3254-3259.2001; Prado F, 2005, MOL CELL BIOL, V25, P1526, DOI 10.1128/MCB.25.4.1526-1536.2005; PRUSS D, 1995, BIOESSAYS, V17, P161, DOI 10.1002/bies.950170211; Raman SB, 2006, MOL MICROBIOL, V60, P697, DOI 10.1111/j.1365-2958.2006.05121.x; Rustchenko E, 2007, FEMS YEAST RES, V7, P2, DOI 10.1111/j.1567-1364.2006.00150.x; RUSTCHENKO EP, 1993, J BACTERIOL, V175, P7189, DOI 10.1128/JB.175.22.7189-7199.1993; RUSTCHENKO EP, 1994, J BACTERIOL, V176, P3231, DOI 10.1128/jb.176.11.3231-3241.1994; RUSTCHENKOBULGAC EP, 1990, J BACTERIOL, V172, P1276, DOI 10.1128/jb.172.3.1276-1283.1990; Sanyal K, 2002, P NATL ACAD SCI USA, V99, P12969, DOI 10.1073/pnas.162488299; SAUNDERS MJ, 1990, MOL CELL BIOL, V10, P5721, DOI 10.1128/MCB.10.11.5721; SELLAM A, 2005, MOL MICROBIOL, V55, P1553; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; SLUTSKY B, 1985, SCIENCE, V230, P666, DOI 10.1126/science.3901258; SMITH MM, 1983, J MOL BIOL, V169, P663, DOI 10.1016/S0022-2836(83)80164-8; Smith MM, 1996, MOL CELL BIOL, V16, P1017; SMITH MM, 1988, J CELL BIOL, V106, P557, DOI 10.1083/jcb.106.3.557; Smith WL, 2002, ANTIMICROB AGENTS CH, V46, P3532, DOI 10.1128/AAC.46.11.3532-3539.2002; SOLL DR, 1988, J CLIN MICROBIOL, V26, P1448, DOI 10.1128/JCM.26.8.1448-1459.1988; SOLL DR, 1987, J CLIN MICROBIOL, V25, P1611, DOI 10.1128/JCM.25.9.1611-1622.1987; SOLL DR, 1989, J CLIN MICROBIOL, V27, P681, DOI 10.1128/JCM.27.4.681-690.1989; Srikantha T, 2001, J BACTERIOL, V183, P4614, DOI 10.1128/JB.183.15.4614-4625.2001; STEIN G S, 1992, Current Opinion in Cell Biology, V4, P166, DOI 10.1016/0955-0674(92)90028-B; SUZUKI T, 1989, J GEN MICROBIOL, V135, P425; SVAREN J, 1993, CURR OPIN GENET DEV, V3, P219, DOI 10.1016/0959-437X(93)90026-L; Takayama Y, 2007, NUCLEIC ACIDS RES, V35, P3223, DOI 10.1093/nar/gkm213; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Tsui KC, 1997, GENETICS, V145, P647; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Venditti S, 1999, MOL GEN GENET, V262, P367, DOI 10.1007/s004380051095; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WELLS JRE, 1989, HISTONES OTHER BASIC; WICKES B, 1991, INFECT IMMUN, V59, P2480, DOI 10.1128/IAI.59.7.2480-2484.1991; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Wu W, 2005, GENETICS, V169, P1311, DOI 10.1534/genetics.104.033167; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	99	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10629	10.1371/journal.pone.0010629	http://dx.doi.org/10.1371/journal.pone.0010629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498713	gold, Green Published, Green Submitted			2022-12-25	WOS:000277633500017
J	Hu, B; Du, J; Zou, RY; Yuan, YJ				Hu, Bo; Du, Jin; Zou, Rui-yang; Yuan, Ying-jin			An Environment-Sensitive Synthetic Microbial Ecosystem	PLOS ONE			English	Article							COMMUNICATION; BIOLOGY; ANTIBIOTICS; DIVERSITY; GENOMICS; NETWORK; DESIGN; SYSTEM; GENES; VIEW	Microbial ecosystems have been widely used in industrial production, but the inter-relationships of organisms within them haven't been completely clarified due to complex composition and structure of natural microbial ecosystems. So it is challenging for ecologists to get deep insights on how ecosystems function and interplay with surrounding environments. But the recent progresses in synthetic biology show that construction of artificial ecosystems where relationships of species are comparatively clear could help us further uncover the meadow of those tiny societies. By using two quorum-sensing signal transduction circuits, this research designed, simulated and constructed a synthetic ecosystem where various population dynamics formed by changing environmental factors. Coherent experimental data and mathematical simulation in our study show that different antibiotics levels and initial cell densities can result in correlated population dynamics such as extinction, obligatory mutualism, facultative mutualism and commensalism. This synthetic ecosystem provides valuable information for addressing questions in ecology and may act as a chassis for construction of more complex microbial ecosystems.	[Hu, Bo] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; Tianjin Univ, Dept Pharmaceut Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Hu, B (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn			National Science Fund of China for Distinguished Young Scholars [20425620]; Key Program Grant [20736006]; National Basic Research Program of China ('973' Program) [2007CB714301]	National Science Fund of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Program Grant; National Basic Research Program of China ('973' Program)(National Basic Research Program of China)	The authors are very grateful for BioBrick Foundation for providing biobrick and also thank the financial support from the National Science Fund of China for Distinguished Young Scholars Grant (Project No. 20425620), Key Program Grant (Project No. 20736006), the National Basic Research Program of China ('973' Program: 2007CB714301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Banning NC, 2008, APPL SOIL ECOL, V40, P109, DOI 10.1016/j.apsoil.2008.03.011; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bertin PN, 2008, MICROBIOL-SGM, V154, P347, DOI 10.1099/mic.0.2007/011791-0; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Chin JW, 2006, NAT CHEM BIOL, V2, P304, DOI 10.1038/nchembio789; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100040; Costanzo SD, 2005, MAR POLLUT BULL, V51, P218, DOI 10.1016/j.marpolbul.2004.10.038; Dunham MJ, 2007, P NATL ACAD SCI USA, V104, P1741, DOI 10.1073/pnas.0611067104; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Foerstner KU, 2006, PHILOS T R SOC B, V361, P519, DOI 10.1098/rstb.2005.1809; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Haseltine EL, 2007, ANNU REV BIOPH BIOM, V36, P1, DOI 10.1146/annurev.biophys.36.040306.132600; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kalia VC, 2008, J IND MICROBIOL BIOT, V35, P403, DOI 10.1007/s10295-007-0300-y; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Marguet P, 2007, J R SOC INTERFACE, V4, P607, DOI 10.1098/rsif.2006.0206; Maru Y, 2009, CENT EUR J BIOL, V4, P1, DOI 10.2478/s11535-008-0063-0; MORAN AC, 2008, ENVIRON TOXICOL CHEM, V3, P1; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Paerl HW, 2003, ENVIRON MICROBIOL, V5, P1025, DOI 10.1046/j.1462-2920.2003.00504.x; Pappas KM, 2004, MOL MICROBIOL, V53, P755, DOI 10.1111/j.1365-2958.2004.04212.x; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rittmann BE, 2008, BIOTECHNOL BIOENG, V100, P203, DOI 10.1002/bit.21875; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schmidt TM, 2006, INT MICROBIOL, V9, P217; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Williams HTP, 2008, P NATL ACAD SCI USA, V105, P10432, DOI 10.1073/pnas.0800244105; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	47	40	47	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10619	10.1371/journal.pone.0010619	http://dx.doi.org/10.1371/journal.pone.0010619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485551	Green Published, Green Submitted, gold			2022-12-25	WOS:000277563400022
J	McCormick, MI; Ryen, CA; Munday, PL; Walker, SPW				McCormick, Mark I.; Ryen, Christopher A.; Munday, Philip L.; Walker, Stefan P. W.			Differing Mechanisms Underlie Sexual Size-Dimorphism in Two Populations of a Sex-Changing Fish	PLOS ONE			English	Article							CORAL-REEF FISH; SETTLEMENT-MARKS; MATING SYSTEMS; SOCIAL-CONTROL; GROWTH; EVOLUTION; DENSITY; TEMPERATURE; PERSPECTIVE; PERFORMANCE	Variability in the density of groups within a patchy environment lead to differences in interaction rates, growth dynamics and social organization. In protogynous hermaphrodites there are hypothesised trade-offs among sex-specific growth, reproductive output and mortality. When differences in density lead to changes to social organization the link between growth and the timing of sex-change is predicted to change. The present study explores this prediction by comparing the social organisation and sex-specific growth of two populations of a protogynous tropical wrasse, Halichoeres miniatus, which differ in density. At a low density population a strict harem structure was found, where males maintained a tight monopoly of access and spawning rights to females. In contrast, at a high density population a loosely organised system prevailed, where females could move throughout multiple male territories. Otolith microstructure revealed the species to be annual and deposit an otolith check associated with sex-change. Growth trajectories suggested that individuals that later became males in both populations underwent a growth acceleration at sex-change. Moreover, in the high density population, individuals that later became males were those individuals that had the largest otolith size at hatching and consistently deposited larger increments throughout early larval, juvenile and female life. This study demonstrates that previous growth history and growth rate changes associated with sex change can be responsible for the sexual dimorphism typically found in sex-changing species, and that the relative importance of these may be socially constrained.	[McCormick, Mark I.; Ryen, Christopher A.; Munday, Philip L.; Walker, Stefan P. W.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Sch Marine & Trop Biol, Townsville, Qld, Australia	James Cook University	McCormick, MI (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Sch Marine & Trop Biol, Townsville, Qld, Australia.	mark.mccormick@jcu.edu.au	Walker, Stefan/A-7238-2010; Munday, Philip L/F-5443-2011; McCormick, Mark I/J-8301-2014	Munday, Philip L/0000-0001-9725-2498; McCormick, Mark I/0000-0001-9289-1645	JCU; Australian Museum; Merit Research Grant; Australian Research Council Centre of Excellence for Coral Reef Studies [CE0561432]	JCU; Australian Museum; Merit Research Grant; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	Research was funded by a JCU Doctoral Research Merit Grant and a Lizard Island Doctoral fellowship (Australian Museum) to S.P.W.W., a Merit Research Grant to M.I.M. and the Australian Research Council Centre of Excellence for Coral Reef Studies (CE0561432; www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2001, J FISH BIOL, V59, P183, DOI 10.1111/j.1095-8649.2001.tb02350.x; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; Buston PM, 2006, OECOLOGIA, V149, P362, DOI 10.1007/s00442-006-0442-z; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; Campana Steven E., 1992, Canadian Special Publication of Fisheries and Aquatic Sciences, V117, P73; CHAMBERS RC, 1994, RECENT DEV FISH OTOL, P764; CHARNOV E L, 1982; Choat J. Howard, 2002, P57; Edeline E, 2010, P ROY SOC B-BIOL SCI, V277, P843, DOI 10.1098/rspb.2009.1724; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fey DP, 2006, J FISH BIOL, V69, P794, DOI 10.1111/j.1095-8649.2006.01151.x; FRICKE HW, 1980, ANIM BEHAV, V28, P561, DOI 10.1016/S0003-3472(80)80065-0; Frisch AJ, 2007, HORM BEHAV, V52, P540, DOI 10.1016/j.yhbeh.2007.07.008; Gagliano M, 2007, P R SOC B, V274, P1575, DOI 10.1098/rspb.2007.0242; Gagliano M, 2009, OECOLOGIA, V160, P657, DOI 10.1007/s00442-009-1335-8; Green BS, 2005, MAR ECOL PROG SER, V289, P263, DOI 10.3354/meps289263; Gust N, 2004, CAN J FISH AQUAT SCI, V61, P205, DOI 10.1139/F03-160; Gust N, 2002, MAR BIOL, V140, P1039, DOI 10.1007/s00227-001-0773-6; Hoey A. S., 2006, P 10 INT COR REEFS S, P420; Hoey J, 2007, CORAL REEFS, V26, P603, DOI 10.1007/s00338-007-0246-6; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Iwasa Y, 1991, BEHAV ECOL, V2, P56, DOI 10.1093/beheco/2.1.56; Johnstone RA, 1999, P ROY SOC B-BIOL SCI, V266, P275, DOI 10.1098/rspb.1999.0633; KIMURA S, 1993, JPN J ICHTHYOL, V39, P371, DOI 10.1007/BF02905137; Lindgren B, 2005, J EVOLUTION BIOL, V18, P820, DOI 10.1111/j.1420-9101.2004.00875.x; Lorenzi V, 2006, BEHAV ECOL SOCIOBIOL, V59, P715, DOI 10.1007/s00265-005-0101-0; LUTNESKY MMF, 1994, BEHAV ECOL, V5, P375, DOI 10.1093/beheco/5.4.375; Moller AP, 2009, BIOL REV, V84, P567, DOI 10.1111/j.1469-185X.2009.00087.x; Munday PL, 2009, CORAL REEFS, V28, P623, DOI 10.1007/s00338-009-0499-3; Munday PL, 2006, P ROY SOC B-BIOL SCI, V273, P2845, DOI 10.1098/rspb.2006.3666; Munday PL, 2004, CAN J FISH AQUAT SCI, V61, P323, DOI 10.1139/F04-057; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; PETERSEN CW, 1990, BEHAVIOUR, V113, P57, DOI 10.1163/156853990X00437; Polo V, 2007, J ANIM ECOL, V76, P866, DOI 10.1111/j.1365-2656.2007.01270.x; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; ROBERTSON DR, 1977, Z TIERPSYCHOL, V45, P298; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007; RYEN CA, 2008, SEX SPECIFIC GROWTH; SADOVY Y, 1987, COPEIA, P136, DOI 10.2307/1446046; Sakai Y, 2002, J ETHOL, V20, P101, DOI 10.1007/s10164-002-0060-0; Shapiro D.Y., 1984, P103; SHUSTER SM, 2003, MG BEH ECOL, pR7; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Tibbetts EA, 2008, P ROY SOC B-BIOL SCI, V275, P2201, DOI 10.1098/rspb.2008.0477; Walker SPW, 2007, J FISH BIOL, V71, P1347, DOI 10.1111/j.1095-8649.2007.01595.x; Walker SPW, 2004, MAR ECOL PROG SER, V266, P201, DOI 10.3354/meps266201; Walker SPW, 2009, BIOL LETTERS, V5, P73, DOI 10.1098/rsbl.2008.0555; WARNER RR, 1980, EVOLUTION, V34, P508, DOI 10.1111/j.1558-5646.1980.tb04840.x; WARNER RR, 1984, AM SCI, V72, P128; WARNER RR, 1980, ECOLOGY, V61, P772, DOI 10.2307/1936747; WARNER RR, 1991, BIOL BULL-US, V181, P199, DOI 10.2307/1542090; WARNER RR, 1988, TRENDS ECOL EVOL, V3, P133, DOI 10.1016/0169-5347(88)90176-0; Williams D. McB, 1991, ECOLOGY FISHES CORAL, P437; Wilson DT, 1997, MAR ECOL PROG SER, V153, P259, DOI 10.3354/meps153259; Wilson DT, 1999, MAR BIOL, V134, P29, DOI 10.1007/s002270050522; Wong MYL, 2007, P ROY SOC B-BIOL SCI, V274, P1093, DOI 10.1098/rspb.2006.0284	59	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10616	10.1371/journal.pone.0010616	http://dx.doi.org/10.1371/journal.pone.0010616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485547	Green Published, gold, Green Accepted			2022-12-25	WOS:000277563400019
J	Charurat, M; Oyegunle, M; Benjamin, R; Habib, A; Eze, E; Ele, P; Ibanga, I; Ajayi, S; Eng, M; Mondal, P; Gebi, U; Iwu, E; Etiebet, MA; Abimiku, A; Dakum, P; Farley, J; Blattner, W				Charurat, Man; Oyegunle, Modupe; Benjamin, Renata; Habib, Abdulrazaq; Eze, Emeka; Ele, Prince; Ibanga, Iquo; Ajayi, Samuel; Eng, Maria; Mondal, Prosanta; Gebi, Usman; Iwu, Emilia; Etiebet, Mary-Ann; Abimiku, Alash'le; Dakum, Patrick; Farley, John; Blattner, William			Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors	PLOS ONE			English	Article							HIV-INFECTED ADULTS; FOLLOW-UP; SOUTH-AFRICA; HIV-1-INFECTED PATIENTS; IMPROVE ADHERENCE; INCOME COUNTRIES; LACTIC-ACIDOSIS; 1ST YEAR; STAVUDINE; UGANDA	Background: Substantial resources and patient commitment are required to successfully scale-up antiretroviral therapy (ART) and provide appropriate HIV management in resource-limited settings. We used pharmacy refill records to evaluate risk factors for loss to follow-up (LTFU) and non-adherence to ART in a large treatment cohort in Nigeria. Methods and Findings: We reviewed clinic records of adult patients initiating ART between March 2005 and July 2006 at five health facilities. Patients were classified as LTFU if they did not return > 60 days from their expected visit. Pharmacy refill rates were calculated and used to assess non-adherence. We identified risk factors associated with LTFU and non-adherence using Cox and Generalized Estimating Equation (GEE) regressions, respectively. Of 5,760 patients initiating ART, 26% were LTFU. Female gender (p < 0.001), post-secondary education (p = 0.03), and initiating treatment with zidovudine-containing (p = 0.004) or tenofovir-containing (p = 0.05) regimens were associated with decreased risk of LTFU, while patients with only primary education (p = 0.02) and those with baseline CD4 counts (cell/ml(3)) > 350 and < 100 were at a higher risk of LTFU compared to patients with baseline CD4 counts of 100-200. The adjusted GEE analysis showed that patients aged < 35 years (p = 0.005), who traveled for > 2 hours to the clinic (p = 0.03), had total ART duration of > 6 months (p < 0.001), and CD4 counts > 200 at ART initiation were at a higher risk of non-adherence. Patients who disclosed their HIV status to spouse/family (p = 0.01) and were treated with tenofovir-containing regimens (p < 0.001) were more likely to be adherent. Conclusions: These findings formed the basis for implementing multiple pre-treatment visit preparation that promote disclosure and active community outreaching to support retention and adherence. Expansion of treatment access points of care to communities to diminish travel time may have a positive impact on adherence.	[Charurat, Man; Oyegunle, Modupe; Benjamin, Renata; Eng, Maria; Mondal, Prosanta; Etiebet, Mary-Ann; Abimiku, Alash'le; Dakum, Patrick; Farley, John; Blattner, William] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Habib, Abdulrazaq] Aminu Kano Teaching Hosp, Kano, Nigeria; [Eze, Emeka] Univ Benin, Teaching Hosp, Benin, Edo State, Nigeria; [Ele, Prince] Nnamdi Azikwe Univ, Teaching Hosp, Nnewi, Anambra State, Nigeria; [Ibanga, Iquo] Univ Calabar, Teaching Hosp, Calabar, Cross River Sta, Nigeria; [Ajayi, Samuel] Univ Abuja, Teaching Hosp, Abuja, Federal Capital, Nigeria; [Gebi, Usman; Iwu, Emilia; Etiebet, Mary-Ann; Dakum, Patrick] Inst Human Virol Nigeria, Abuja, Federal Capital, Nigeria; [Iwu, Emilia] Univ Maryland, Sch Nursing, Dept Family & Community Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Benin; University of Calabar; University System of Maryland; University of Maryland Baltimore	Charurat, M (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	mcharurat@ihv.umaryland.edu		Gebi, Usman/0000-0002-1395-4650; Benjamin, Renata/0000-0001-6406-4247	U.S. Centers for Disease Control and Prevention [PS000651]; The U.S. National Institutes of Health's Fogarty AIDS International Training Research Program [D43 TW001041]; International Epidemiologic Database to evaluate AIDS [U01AI069919]; FOGARTY INTERNATIONAL CENTER [D43TW001041] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U2GPS000651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); The U.S. National Institutes of Health's Fogarty AIDS International Training Research Program; International Epidemiologic Database to evaluate AIDS; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The AIDS Care and Treatment in Nigeria (ACTION) project is supported by the U.S. Centers for Disease Control and Prevention (Cooperative Agreement No. PS000651). This publication content is solely the responsibility of the authors and does not necessarily represent the official views of the CDC. This on-going project is jointly implemented by the Institute of Human Virology of the University of Maryland School of Medicine, Institute of Human Virology Nigeria, the Nigerian Federal Ministry of Health, and local partner treatment facilities. The U.S. National Institutes of Health's Fogarty AIDS International Training Research Program (AITRP, D43 TW001041) and the International Epidemiologic Database to evaluate AIDS (IeDEA, U01AI069919) provided research training support for this analysis.	[Anonymous], 2008, EP FACT SHEET HIV AI; Bajunirwe Francis, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P139, DOI 10.1177/1545109709332470; Bell DJ, 2007, JAIDS-J ACQ IMM DEF, V45, P560, DOI 10.1097/QAI.0b013e3180decadb; Birbeck GL, 2009, AM J TROP MED HYG, V80, P669, DOI 10.4269/ajtmh.2009.80.669; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Crane JT, 2006, AIDS BEHAV, V10, P437, DOI 10.1007/s10461-006-9080-z; Cui J, 2009, AM J EPIDEMIOL, V169, P113, DOI 10.1093/aje/kwn292; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; FARLEY J, 2007, ADHERENCE ASSESSMENT; *FMOH, 2005, GUID US ANT DRUGS NI; Grossberg Robert, 2007, Curr HIV/AIDS Rep, V4, P187, DOI 10.1007/s11904-007-0027-4; Horton NJ, 1999, STAT MED, V18, P213, DOI 10.1002/(SICI)1097-0258(19990130)18:2<213::AID-SIM999>3.0.CO;2-E; Idoko JA, 2007, INT J STD AIDS, V18, P760, DOI 10.1258/095646207782212252; Joly V, 2002, AIDS, V16, P2447, DOI 10.1097/00002030-200212060-00010; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Krebs DW, 2008, AIDS CARE, V20, P311, DOI 10.1080/09540120701594776; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Miller KD, 2000, ANN INTERN MED, V133, P192, DOI 10.7326/0003-4819-133-3-200008010-00010; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mokrzycki MH, 2000, CLIN INFECT DIS, V30, P198, DOI 10.1086/313594; Muyingo SK, 2008, JAIDS-J ACQ IMM DEF, V48, P468, DOI 10.1097/QAI.0b013e31817dc3fd; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Nachega Jean B, 2009, Curr HIV/AIDS Rep, V6, P121, DOI 10.1007/s11904-009-0017-9; Nacher M, 2006, AM J TROP MED HYG, V74, P915, DOI 10.4269/ajtmh.2006.74.915; Navario P, 2009, LANCET, V374, P184, DOI 10.1016/S0140-6736(09)61312-X; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Pearson CR, 2007, JAIDS-J ACQ IMM DEF, V46, P238, DOI 10.1097/QAI.0b013e318153f7ba; Reliquet V, 2001, HIV Med, V2, P92, DOI 10.1046/j.1468-1293.2001.00066.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Scarsella A, 2002, ADV THER, V19, P1, DOI 10.1007/BF02850013; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Unge C, 2009, JAIDS-J ACQ IMM DEF, V50, P397, DOI 10.1097/QAI.0b013e318194618e; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; Vriesendorp R, 2007, EUR J CLIN PHARMACOL, V63, P1115, DOI 10.1007/s00228-007-0369-2; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Williams AB, 2006, JAIDS-J ACQ IMM DEF, V42, P314, DOI 10.1097/01.qai.0000221681.60187.88; World Health Organization, 2006, ANT THER HIV INF AD; Wouters E, 2009, AIDS PATIENT CARE ST, V23, P357, DOI 10.1089/apc.2008.0201	49	98	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10584	10.1371/journal.pone.0010584	http://dx.doi.org/10.1371/journal.pone.0010584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485670	gold, Green Published, Green Submitted			2022-12-25	WOS:000277563200017
J	Zeeuwen, PLJM; van Vlijmen-Willems, IMJJ; Cheng, T; Rodijk-Olthuis, D; Hitomi, K; Hara-Nishimura, I; John, S; Smyth, N; Reinheckel, T; Hendriks, WJAJ; Schalkwijk, J				Zeeuwen, Patrick L. J. M.; van Vlijmen-Willems, Ivonne M. J. J.; Cheng, Tsing; Rodijk-Olthuis, Diana; Hitomi, Kiyotaka; Hara-Nishimura, Ikuko; John, Susan; Smyth, Neil; Reinheckel, Thomas; Hendriks, Wiljan J. A. J.; Schalkwijk, Joost			The cystatin M/E-cathepsin L balance is essential for tissue homeostasis in epidermis, hair follicles, and cornea	FASEB JOURNAL			English	Article						differentiation; proteases; skin barrier; trans-glutaminases; mouse models	OF-FUNCTION MUTATIONS; DEFICIENT MICE; CROSS-LINKING; PROTEINASE-INHIBITOR; EPITHELIAL-CELLS; REACTIVE-SITE; TRANSGLUTAMINASE; ICHTHYOSIS; GENE; DIFFERENTIATION	Cystatin M/E (CST6) is a nonredundant, epithelium-specific protease inhibitor with a presumed role in epidermal differentiation and tumor suppression. We have previously reported that cystatin M/E deficiency in Cst6(-/-) mice causes neonatal lethality because of excessive transepidermal water loss. Biochemical evidence suggests that cystatin M/E controls the activity of legumain, cathepsin L, cathepsin V, and transglutaminase-3. Using a genetic approach we sought to define the role of cystatin M/E in epithelial biology by identification of its target proteases and their downstream functions. Ablation of cathepsin L in a Cst6(-/-) background (Cst6(-/-) Ctsl(-/-) double-knockout mice) restored viability and resulted in normalization of stratum corneum morphology. Ablation of legumain or transglutaminase-3 in Cst6(-/-) mice, however, did not rescue the lethal phenotype. Intriguingly, both Cst6(-/-) Ctsl(-/-) and Cst6(-/-) Ctsl(+/-) mice were viable, but the absence of cystatin M/E caused scarring alopecia in adult animals. In the cornea of Cst6(-/-) Ctsl(+/-) mice, we observed keratitis, hyperplasia, and transition to a cornified epithelium. Evidence is provided that activation of cathepsin D and transglutaminase-1 are downstream events, dependent of cathepsin L activity. We conclude that a tightly regulated balance between cathepsin L and cystatin M/E is essential for tissue integrity in epidermis, hair follicles, and corneal epithelium.-Zeeuwen, P. L. J. M., van Vlijmen-Willems, I. M. J. J., Cheng, T., Rodijk-Olthuis, D., Hitomi, K., Hara-Nishimura, I., John, S., Smyth, N., Reinheckel, T., Hendriks, W. J. A. J., Schalkwijk, J. The cystatin M/E-cathepsin L balance is essential for tissue homeostasis in epidermis, hair follicles and cornea. FASEB J. 24, 3744-3755 (2010). www.fasebj.org	[Zeeuwen, Patrick L. J. M.; van Vlijmen-Willems, Ivonne M. J. J.; Cheng, Tsing; Rodijk-Olthuis, Diana; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Dermatol, NL-6500 HB Nijmegen, Netherlands; [Hendriks, Wiljan J. A. J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6500 HB Nijmegen, Netherlands; [Hitomi, Kiyotaka] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Hara-Nishimura, Ikuko] Kyoto Univ, Dept Bot, Grad Sch Sci, Kyoto, Japan; [John, Susan; Smyth, Neil] Univ Cologne, Ctr Biochem, Cologne, Germany; [John, Susan; Smyth, Neil] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Nagoya University; Kyoto University; University of Cologne; University of Cologne; University of Freiburg	Zeeuwen, PLJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Dermatol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.zeeuwen@ncmls.ru.nl	Reinheckel, Thomas/AAL-9761-2021; Schalkwijk, Joost/N-1774-2013; Schalkwijk, Joost/R-7509-2019; Hendriks, Wiljan/Q-4325-2019; Hendriks, Wiljan J.A.J./A-5214-2013; Zeeuwen, Patrick/N-1779-2013; van Vlijmen-Willems, Ivonne MJJ/P-5336-2015	Reinheckel, Thomas/0000-0001-9866-9105; Schalkwijk, Joost/0000-0002-1308-1319; Hendriks, Wiljan/0000-0001-9481-8281; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Zeeuwen, Patrick/0000-0002-6878-2438; van Vlijmen-Willems, Ivonne MJJ/0000-0002-3522-2573; Smyth, Neil/0000-0002-3734-2149; Cheng, Tsing/0000-0001-5191-3289	ZonMW, the Netherlands Organization for Health Research and Development [916.56.117]	ZonMW, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This paper is dedicated to the memory of Dr. Rosanne van Lingen (1979-2010), Department of Dermatology, Radboud University Nijmegen Medical Centre. The authors thank Debby Smits for assistance with the animal experiments. This work was supported by VENI-grant 916.56.117 from ZonMW, the Netherlands Organization for Health Research and Development (to P.L.J.M.Z.). This study was in part funded by the Alternatives to Animal Experiments program of ZonMW (to J.S. and P.L.J.M.Z.).	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; CHENG T, 2009, THESIS RADBOUD U NIJ; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Egberts F, 2004, J CELL SCI, V117, P2295, DOI 10.1242/jcs.01075; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Hiiragi T, 1999, J BIOL CHEM, V274, P34148, DOI 10.1074/jbc.274.48.34148; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; JOHN S, 2006, THESIS U COLOGNE GER; KIRSCHKE H, 2004, HDB PROTEOLYTIC ENZY, P1097; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Mirmirani P, 2005, J AM ACAD DERMATOL, V52, P637, DOI 10.1016/j.jaad.2004.07.069; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakamura T, 2001, INVEST OPHTH VIS SCI, V42, P549; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Sugimura Y, 2008, FEBS J, V275, P5667, DOI 10.1111/j.1742-4658.2008.06692.x; Sundberg JP, 1997, AM J PATHOL, V151, P293; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Wille A, 2004, BIOL CHEM, V385, P665, DOI 10.1515/BC.2004.082; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126; Zeeuwen PLJM, 2007, J INVEST DERMATOL, V127, P120, DOI 10.1038/sj.jid.5700480; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388; Zeeuwen PLJM, 1997, J BIOL CHEM, V272, P20471, DOI 10.1074/jbc.272.33.20471; Zeeuwen PLJM, 2004, HUM MOL GENET, V13, P1069, DOI 10.1093/hmg/ddh115; Zeeuwen PLJM, 2002, HUM MOL GENET, V11, P2867, DOI 10.1093/hmg/11.23.2867; Zeeuwen PLJM, 2001, J INVEST DERMATOL, V116, P693, DOI 10.1046/j.1523-1747.2001.01309.x	38	29	32	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2010	24	10					3744	3755		10.1096/fj.10-155879	http://dx.doi.org/10.1096/fj.10-155879			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20495178				2022-12-25	WOS:000285005900014
J	DiNatale, BC; Schroeder, JC; Francey, LJ; Kusnadi, A; Perdew, GH				DiNatale, Brett C.; Schroeder, Jennifer C.; Francey, Lauren J.; Kusnadi, Ann; Perdew, Gary H.			Mechanistic Insights into the Events That Lead to Synergistic Induction of Interleukin 6 Transcription upon Activation of the Aryl Hydrocarbon Receptor and Inflammatory Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; AH RECEPTOR; CELL-LINE; BREAST-CARCINOMA; PROSTATE-CANCER; AUTOCRINE LOOP; GROWTH-FACTOR; KINASE-ALPHA; IKK-ALPHA	The aryl hydrocarbon receptor (AHR) is the ligand-activated transcription factor responsible for mediating the toxicological effects of dioxin and xenobiotic metabolism. However, recent evidence has implicated the AHR in additional, nonmetabolic physiological processes, including immune regulation. Certain tumor cells are largely nonresponsive to cytokine-mediated induction of the pro-survival cytokine interleukin (IL) 6. We have demonstrated that multiple nonresponsive tumor lines are able to undergo synergistic induction of IL6 following combinatorial treatment with IL1 beta and the AHR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin. Such data implicate the AHR in tumor expansion, although the mechanistic basis for the AHR-dependent synergistic induction of IL6 has not been determined. Here, we demonstrate that ligand-activated AHR is involved in priming the IL6 promoter through binding to nonconsensus dioxin response elements located upstream of the IL6 start site. Such binding appears to render the promoter more permissive to IL1 beta-induced binding of NF-kappa B components. The nature of the AHR-dependent increases in IL6 promoter transcriptional potential has been shown to involve a reorganization of repressive complexes as exemplified by the presence of HDAC1 and HDAC3. Dismissal of these HDACs correlates with post-translational modifications of promoter-bound NF-kappa B components in a time-dependent manner. Thus the AHR plays a role in derepressing the IL6 promoter, leading to synergistic IL6 expression in the presence of inflammatory signals. These observations may explain the association between enhanced expression of AHR and tumor aggressiveness. It is likely that AHR-mediated priming is not restricted to the IL6 promoter and may contribute to the expression of a variety of genes, which do not have consensus dioxin response elements.	[Perdew, Gary H.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Perdew, GH (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA.	ghp2@psu.edu		Francey, Lauren J/0000-0002-9700-2277				Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Armenante F, 1999, NUCLEIC ACIDS RES, V27, P4483, DOI 10.1093/nar/27.22.4483; Asgeirsson KS, 1998, CYTOKINE, V10, P720, DOI 10.1006/cyto.1998.0349; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Badache A, 2001, CANCER RES, V61, P383; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bunger MK, 2008, TOXICOL SCI, V106, P83, DOI 10.1093/toxsci/kfn149; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chiaro CR, 2007, MOL PHARMACOL, V72, P1369, DOI 10.1124/mol.107.038968; Conze D, 2001, CANCER RES, V61, P8851; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Denison MS, 1998, TARG ORG T, P3; DINATALE BC, 2010, CYTOTECHNOL IN PRESS; Faggioli L, 1996, EUR J BIOCHEM, V239, P624, DOI 10.1111/j.1432-1033.1996.0624u.x; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Gillesby BE, 1997, BIOCHEMISTRY-US, V36, P6080, DOI 10.1021/bi962131b; Gloire G, 2007, J BIOL CHEM, V282, P21308, DOI 10.1074/jbc.M610728200; Gouedard C, 2004, MOL CELL BIOL, V24, P5209, DOI 10.1128/MCB.24.12.5209-5222.2004; Hershko DD, 2002, AM J PHYSIOL-REG I, V283, pR1140, DOI 10.1152/ajpregu.00161.2002; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Ishida M, 2010, CARCINOGENESIS, V31, P287, DOI 10.1093/carcin/bgp222; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kobayashi S, 2008, RHEUMATOLOGY, V47, P1317, DOI 10.1093/rheumatology/ken259; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Ndlovu MN, 2009, MOL CELL BIOL, V29, P5488, DOI 10.1128/MCB.01657-08; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Safe S, 1998, TOXICOL LETT, V103, P343; Safe S, 1995, Arch Toxicol Suppl, V17, P99; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Sasser AK, 2007, CANCER LETT, V254, P255, DOI 10.1016/j.canlet.2007.03.012; Schnekenburger M, 2007, BBA-GENE STRUCT EXPR, V1769, P569, DOI 10.1016/j.bbaexp.2007.07.002; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; Vogel CFA, 2007, BIOCHEM BIOPH RES CO, V363, P722, DOI 10.1016/j.bbrc.2007.09.032; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xu Y, 2008, MOL CANCER THER, V7, P2367, DOI 10.1158/1535-7163.MCT-08-0238; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y	51	82	87	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24388	24397		10.1074/jbc.M110.118570	http://dx.doi.org/10.1074/jbc.M110.118570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20511231	Green Published, hybrid			2022-12-25	WOS:000280542100010
J	Markovics, JA; Araya, J; Cambier, S; Jablons, D; Hill, A; Wolters, PJ; Nishimura, SL				Markovics, Jennifer A.; Araya, Jun; Cambier, Stephanie; Jablons, David; Hill, Arthur; Wolters, Paul J.; Nishimura, Stephen L.			Transcription of the Transforming Growth Factor beta Activating Integrin beta 8 Subunit Is Regulated by SP3, AP-1, and the p38 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING; C-JUN; GENE; EXPRESSION; PROMOTER; BINDING; PROTEIN; ALPHA; ALPHA-V-BETA-8; FAMILY	Integrin alpha v beta 8 is a critical regulator of transforming growth factor beta activation in vasculogenesis during development, immune regulation, and endothelial/ epithelial-mesenchymal homeostasis. Recent studies have suggested roles for integrin beta 8 in the pathogenesis of chronic obstructive pulmonary disease, brain arteriovenous malformations, and select cancers (Araya, J., Cambier, S., Markovics, J. A., Wolters, P., Jablons, D., Hill, A., Finkbeiner, W., Jones, K., Broaddus, V. C., Sheppard, D., Barzcak, A., Xiao, Y., Erle, D. J., and Nishimura, S. L. (2007) J. Clin. Invest. 117, 3551- 3562; Su, H., Kim, H., Pawlikowska, L., Kitamura, H., Shen, F., Cambier, S., Markovics, J., Lawton, M. T., Sidney, S., Bollen, A. W., Kwok, P. Y., Reichardt, L., Young, W. L., Yang, G. Y., and Nishimura, S. L. (2010) Am. J. Pathol. 176, 1018- 1027; Culhane, A. C., and Quackenbush, J. (2009) Cancer Res. 69, 7480-7485; Cambier, S., Mu, D. Z., O-Connell, D., Boylen, K., Travis, W., Liu, W. H., Broaddus, V. C., and Nishimura, S. L. (2000) Cancer Res. 60, 7084-7093). Here we report the first identification and characterization of the promoter for ITGB8. We show that a SP binding site and a cyclic AMP response element (CRE) in the ITGB8 core promoter are required for its expression and that Sp1, Sp3, and several AP-1 transcription factors form a complex that binds to these sites in a p38-dependent manner. Furthermore, we demonstrate the requirement for Sp3, ATF-2, and p38 for the transcription and protein expression of integrin beta 8. Additionally, reduction of SP3 or inhibition of p38 blocks alpha v beta 8-mediated transforming growth factor beta activation. These results place integrin beta 8 expression and activity under the control of ubiquitous transcription factors in a stress-activated and pro-inflammatory pathway.	[Markovics, Jennifer A.; Araya, Jun; Cambier, Stephanie; Nishimura, Stephen L.] Univ Calif San Francisco, Sch Med, Dept Pathol, Div Pulm, San Francisco, CA 94143 USA; [Jablons, David; Hill, Arthur] Univ Calif San Francisco, Sch Med, Dept Surg, Div Pulm, San Francisco, CA 94143 USA; [Wolters, Paul J.] Univ Calif San Francisco, Sch Med, Dept Med, Div Pulm, San Francisco, CA 94143 USA; [Wolters, Paul J.] Univ Calif San Francisco, Sch Med, Lung Biol Ctr, Div Pulm, San Francisco, CA 94143 USA; [Araya, Jun] Jikei Univ, Sch Med, Div Resp Dis, Dept Internal Med, Tokyo 1058461, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Jikei University	Nishimura, SL (corresponding author), UCSF SFGH Bldg 3,Rm 211,1001 Potrero Ave, San Francisco, CA 94110 USA.	stephen.nishimura@ucsf.edu			National Institutes of Health [HL090662, HL63993, NS04415]; University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063993, R01HL090662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL090662, HL63993, and NS04415 (to S. L. N.).; Supported by a grant from the Resource Allocation Program at the University of California San Francisco.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Angel P, 2002, BIOCHEM PHARMACOL, V64, P949, DOI 10.1016/S0006-2952(02)01158-9; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Araya J, 2006, AM J PATHOL, V169, P405, DOI 10.2353/ajpath.2006.060049; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Bajic VB, 2002, BIOINFORMATICS, V18, P198, DOI 10.1093/bioinformatics/18.1.198; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Block KL, 1996, BLOOD, V88, P2071, DOI 10.1182/blood.V88.6.2071.bloodjournal8862071; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Brudno M, 2007, NUCLEIC ACIDS RES, V35, pW669, DOI 10.1093/nar/gkm279; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cambier S, 2000, CANCER RES, V60, P7084; Citron BA, 2008, J NEUROSCI RES, V86, P2499, DOI 10.1002/jnr.21695; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; CULHANE AC, 2009, J CANC RES, V69, P7480; Czyz M, 1999, EUR J BIOCHEM, V265, P638, DOI 10.1046/j.1432-1327.1999.00754.x; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Finkbeiner WE., 1997, LUNG SCI FDN, P415; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Fujita N, 2004, METHODS, V33, P81, DOI 10.1016/j.ymeth.2003.10.022; Gingras ME, 2009, INVEST OPHTH VIS SCI, V50, P57, DOI 10.1167/iovs.08-2059; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hale KK, 1999, J IMMUNOL, V162, P4246; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Huang XZ, 2000, MOL CELL BIOL, V20, P755, DOI 10.1128/MCB.20.3.755-759.2000; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001; Jackson Paul F., 2002, Current Topics in Medicinal Chemistry, V2, P1011, DOI 10.2174/1568026023393372; Jarad G, 2002, J BIOL CHEM, V277, P47826, DOI 10.1074/jbc.M204901200; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Katabami K, 2006, J CELL BIOCHEM, V97, P530, DOI 10.1002/jcb.20663; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KITABAYASHI I, 1995, EMBO J, V14, P3496, DOI 10.1002/j.1460-2075.1995.tb07356.x; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kruger I, 2007, DEV DYNAM, V236, P2235, DOI 10.1002/dvdy.21222; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Lakhe-Reddy S, 2006, J BIOL CHEM, V281, P19688, DOI 10.1074/jbc.M601110200; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; LoGrasso PV, 1997, BIOCHEMISTRY-US, V36, P10422, DOI 10.1021/bi9706778; Lu N, 2010, MATRIX BIOL, V29, P166, DOI 10.1016/j.matbio.2009.11.003; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; MOYLE M, 1991, J BIOL CHEM, V266, P19650; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Noti JD, 1997, J BIOL CHEM, V272, P24038, DOI 10.1074/jbc.272.38.24038; Noti JD, 2000, J BIOL CHEM, V275, P8959, DOI 10.1074/jbc.275.12.8959; OHLER U, 2000, P PAC S BIOCOMPUT, V5, P380; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Reimold AM, 2001, INT IMMUNOL, V13, P241, DOI 10.1093/intimm/13.2.241; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Shi W, 2007, PHYSIOL GENOMICS, V31, P374, DOI 10.1152/physiolgenomics.00085.2006; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takaoka AS, 1998, J BIOL CHEM, V273, P33848, DOI 10.1074/jbc.273.50.33848; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Woo IS, 2002, INT J ONCOL, V20, P527; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Ye JP, 1996, MOL CELL BIOL, V16, P6178; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; Zhu JW, 2002, DEVELOPMENT, V129, P2891; Zutter MM, 1999, BLOOD, V93, P1600, DOI 10.1182/blood.V93.5.1600.405k04_1600_1611	81	24	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24695	24706		10.1074/jbc.M110.113977	http://dx.doi.org/10.1074/jbc.M110.113977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519498	hybrid, Green Published			2022-12-25	WOS:000280542100042
J	Chang, HK; Lee, JR; Liu, TA; Suen, CS; Arreola, J; Shieh, RC				Chang, Hsueh-Kai; Lee, Jay-Ron; Liu, Tai-An; Suen, Ching-Shu; Arreola, Jorge; Shieh, Ru-Chi			The Extracellular K+ Concentration Dependence of Outward Currents through Kir2.1 Channels Is Regulated by Extracellular Na+ and Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER POTASSIUM CHANNELS; GUINEA-PIG; ANOMALOUS RECTIFICATION; VENTRICULAR MYOCYTES; INWARD RECTIFICATION; MYOCARDIAL ISCHEMIA; SODIUM-CHANNELS; PORE REGION; BLOCK; INACTIVATION	It has been known for more than three decades that outward Kir currents (I-K1) increase with increasing extracellular K+ concentration ([K+](o)). Although this increase in I-K1 can have significant impacts under pathophysiological cardiac conditions, where [K+](o) can be as high as 18 mM and thus predispose the heart to re-entrant ventricular arrhythmias, the underlying mechanism has remained unclear. Here, we show that the steep [K+](o) dependence of Kir2.1-mediated outward I-K1 was due to [K+](o)-dependent inhibition of outward I-K1 by extracellular Na+ and Ca2+. This could be accounted for by Na+/Ca2+ inhibition of I-K1 through screening of local negative surface charges. Consistent with this, extracellular Na+ and Ca2+ reduced the outward single-channel current and did not increase open-state noise or decrease the mean open time. In addition, neutralizing negative surface charges with a carboxylate esterifying agent inhibited outward I-K1 in a similar [K+](o)-dependent manner as Na+/Ca2(+). Site-directed mutagenesis studies identified Asp(114) and Glu(153) as the source of surface charges. Reducing K+ activation and surface electrostatic effects in an R148Y mutant mimicked the action of extracellular Na+ and Ca2+, suggesting that in addition to exerting a surface electrostatic effect, Na+ and Ca2+ might inhibit outward I-K1 by inhibiting K+ activation. This study identified interactions of K+ with Na+ and Ca2+ that are important for the [K+](o) dependence of Kir2.1-mediated outward I-K1.	[Arreola, Jorge] Autonomous Univ San Luis Potosi, Inst Phys, San Luis Potosi 78290, Mexico; [Chang, Hsueh-Kai; Lee, Jay-Ron; Liu, Tai-An; Suen, Ching-Shu; Shieh, Ru-Chi] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Universidad Autonoma de San Luis Potosi; Academia Sinica - Taiwan	Arreola, J (corresponding author), Autonomous Univ San Luis Potosi, Inst Phys, San Luis Potosi 78290, Mexico.	arreola@dec1.ifisica.uaslp.mx; ruchi@ibms.sinica.edu.tw	ARREOLA, JORGE/HGE-4524-2022; Arreola, Jorge/B-1042-2009	ARREOLA, JORGE/0000-0002-5354-3709; 	Academia Sinica in Taiwan; National Science Council of Taiwan [98-2320-B001-009-MY3]	Academia Sinica in Taiwan(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica in Taiwan and National Science Council of Taiwan Grant 98-2320-B001-009-MY3.	Alagem N, 2001, J PHYSIOL-LONDON, V534, P381, DOI 10.1111/j.1469-7793.2001.00381.x; BIERMANS G, 1987, PFLUG ARCH EUR J PHY, V410, P604, DOI 10.1007/BF00581320; Carabelli V, 2001, J PHYSIOL-LONDON, V532, P73, DOI 10.1111/j.1469-7793.2001.0073g.x; CHANDLER WK, 1965, J PHYSIOL-LONDON, V180, P821, DOI 10.1113/jphysiol.1965.sp007733; Claydon TW, 2004, BIOPHYS J, V87, P2407, DOI 10.1529/biophysj.103.039073; D'Avanzo N, 2005, J GEN PHYSIOL, V125, P493, DOI 10.1085/jgp.200409175; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; DUDLEY SC, 1993, J GEN PHYSIOL, V101, P651, DOI 10.1085/jgp.101.5.651; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; HAGIWARA S, 1979, J PHYSIOL-LONDON, V292, P251, DOI 10.1113/jphysiol.1979.sp012849; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARVEY RD, 1988, J GEN PHYSIOL, V91, P593, DOI 10.1085/jgp.91.4.593; Hayashi M, 2007, PFLUG ARCH EUR J PHY, V455, P455, DOI 10.1007/s00424-007-0309-0; Hilgemann Donald W., 1995, P307; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HIRCHE H, 1980, J MOL CELL CARDIOL, V12, P579, DOI 10.1016/0022-2828(80)90016-4; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; ISHIHARA K, 1989, J PHYSIOL-LONDON, V419, P297, DOI 10.1113/jphysiol.1989.sp017874; ISHIHARA K, 1994, J MEMBRANE BIOL, V142, P55; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; KLEBER AG, 1984, J MOL CELL CARDIOL, V16, P389, DOI 10.1016/S0022-2828(84)80610-0; Kubo Y, 1996, RECEPTOR CHANNEL, V4, P73; LEECH CA, 1981, J PHYSIOL-LONDON, V319, P295, DOI 10.1113/jphysiol.1981.sp013909; Lopatin AN, 1996, J GEN PHYSIOL, V108, P105, DOI 10.1085/jgp.108.2.105; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MATSUDA H, 1993, J PHYSIOL-LONDON, V460, P311, DOI 10.1113/jphysiol.1993.sp019473; Matsuda H, 2003, J PHYSIOL-LONDON, V548, P361, DOI 10.1113/jphysiol.2003.038844; MATSUDA H, 1984, J PHYSIOL-LONDON, V357, P553, DOI 10.1113/jphysiol.1984.sp015517; Murata Y, 2002, J PHYSIOL-LONDON, V544, P665, DOI 10.1113/jphysiol.2002.030650; OHMORI H, 1978, J PHYSIOL-LONDON, V281, P77, DOI 10.1113/jphysiol.1978.sp012410; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PENNEFATHER P, 1992, BIOPHYS J, V61, P448, DOI 10.1016/S0006-3495(92)81850-7; Shieh RC, 1999, J BIOL CHEM, V274, P17424, DOI 10.1074/jbc.274.25.17424; SIGWORTH FJ, 1980, NATURE, V283, P293, DOI 10.1038/283293a0; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; STANDEN NB, 1979, J PHYSIOL-LONDON, V294, P497, DOI 10.1113/jphysiol.1979.sp012943; STANFIELD PR, 1994, J PHYSIOL-LONDON, V475, P1; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568	44	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23113	23123		10.1074/jbc.M110.121186	http://dx.doi.org/10.1074/jbc.M110.121186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20495007	Green Published, hybrid			2022-12-25	WOS:000279999900046
J	Krupenko, NI; Dubard, ME; Strickland, KC; Moxley, KM; Oleinik, NV; Krupenko, SA				Krupenko, Natalia I.; Dubard, Marianne E.; Strickland, Kyle C.; Moxley, Kelly M.; Oleinik, Natalia V.; Krupenko, Sergey A.			ALDH1L2 Is the Mitochondrial Homolog of 10-Formyltetrahydrofolate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; SERINE HYDROXYMETHYLTRANSFERASES; C-1-TETRAHYDROFOLATE SYNTHASE; TRIFUNCTIONAL ENZYME; HYDROLASE; EXPRESSION; PROTEIN; LIVER; PURIFICATION; SYNTHETASE	Cytosolic 10-formyltetrahydrofolate dehydrogenase (FDH, ALDH1L1) is an abundant enzyme of folate metabolism. It converts 10-formyltetrahydrofolate to tetrahydrofolate and CO2 in an NADP(+)-dependent reaction. We have identified a gene at chromosome locus 12q24.11 of the human genome, the product of which has 74% sequence similarity with cytosolic FDH. This protein has an extra N-terminal sequence of 22 amino acid residues, predicted to be a mitochondrial translocation signal. Transfection of COS-7 or A549 cell lines with a construct in which green fluorescent protein was introduced between the leader sequence and the rest of the putative mitochondrial FDH (mtFDH) has demonstrated mitochondrial localization of the fusion protein, suggesting that the identified gene encodes a mitochondrial enzyme. Purified pig liver mtFDH displayed dehydrogenase/hydrolase activities similar to cytosolic FDH. Real-time PCR performed on an array of human tissues has shown that although cytosolic FDH mRNA is highest in liver, kidney, and pancreas, mtFDH mRNA is most highly expressed in pancreas, heart, and brain. In contrast to the cytosolic enzyme, which is not detectable in cancer cells, the presence of mtFDH was demonstrated in several human cancer cell lines by conventional and real-time PCR and by Western blot. Analysis of genomes of different species indicates that the mitochondrial enzyme is a later evolutionary product when compared with the cytosolic enzyme. We propose that this novel mitochondrial enzyme is a likely source of CO2 production from 10-formyltetrahydrofolate in mitochondria and plays an essential role in the distribution of one-carbon groups between the cytosolic and mitochondrial compartments of the cell.	[Krupenko, Natalia I.; Dubard, Marianne E.; Strickland, Kyle C.; Moxley, Kelly M.; Oleinik, Natalia V.; Krupenko, Sergey A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Krupenko, SA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu	Strickland, Kyle/Q-7135-2019	Strickland, Kyle/0000-0003-1636-5277	National Institutes of Health [DK54388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54388 (to S.A.K.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BARLOWE C K, 1988, Biofactors, V1, P171; CHAMPION KM, 1994, P NATL ACAD SCI USA, V91, P11338, DOI 10.1073/pnas.91.24.11338; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; Chumanevich AA, 2004, J BIOL CHEM, V279, P14355, DOI 10.1074/jbc.M313934200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COOK RJ, 1991, J BIOL CHEM, V266, P4965; COOK RJ, 1982, BIOCHEMISTRY-US, V21, P4427, DOI 10.1021/bi00261a036; Donato H, 2007, J BIOL CHEM, V282, P34159, DOI 10.1074/jbc.M707627200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2001, BBA-MOL CELL RES, V1541, P114, DOI 10.1016/S0167-4889(01)00145-8; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Fox JT, 2009, J BIOL CHEM, V284, P31085, DOI 10.1074/jbc.M109.035576; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gregory JF, 2002, ANNU REV NUTR, V22, P199, DOI 10.1146/annurev.nutr.22.120701.083554; HUM DW, 1988, J BIOL CHEM, V263, P15946; HUM DW, 1991, PROTEIN ENG, V4, P493, DOI 10.1093/protein/4.4.493; Kisliuk RL, 1999, CANC DRUG DISC DEV, P13; KREBS HA, 1976, BIOCHEM J, V158, P341, DOI 10.1042/bj1580341; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; KRUPENKO SA, 1995, J BIOL CHEM, V270, P519, DOI 10.1074/jbc.270.2.519; Krupenko SA, 2001, J BIOL CHEM, V276, P24030, DOI 10.1074/jbc.M009257200; KRUPENKO SA, 1995, BIOCHEM J, V306, P651, DOI 10.1042/bj3060651; KRUPENKO SA, 1995, PROTEIN EXPRES PURIF, V6, P457, DOI 10.1006/prep.1995.1061; Krupenko SA, 1999, J BIOL CHEM, V274, P35777, DOI 10.1074/jbc.274.50.35777; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEMASTERS JJ, 1984, J BIOL CHEM, V259, P3058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MASUDA T, 1987, J BIOCHEM, V101, P643, DOI 10.1093/jb/101.3.643; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Patel H, 2002, ARCH BIOCHEM BIOPHYS, V403, P145, DOI 10.1016/S0003-9861(02)00203-5; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Reuland SN, 2006, PROTEIN SCI, V15, P1076, DOI 10.1110/ps.052062806; Reuland SN, 2003, J BIOL CHEM, V278, P22894, DOI 10.1074/jbc.M302948200; Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886; Strickland KC, 2010, J BIOL CHEM, V285, P1627, DOI 10.1074/jbc.M109.080556; TEPHLY TR, 1992, TOXICOL APPL PHARM, V116, P142, DOI 10.1016/0041-008X(92)90155-L; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VILLAR E, 1985, J BIOL CHEM, V260, P2245; Wagner C, 1995, FOLATE HLTH DIS, P23; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	56	66	68	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23054	23061		10.1074/jbc.M110.128843	http://dx.doi.org/10.1074/jbc.M110.128843			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498374	Green Published, hybrid			2022-12-25	WOS:000279999900040
J	Ibrahim, N; Unwin, DM; Martill, DM; Baidder, L; Zouhri, S				Ibrahim, Nizar; Unwin, David M.; Martill, David M.; Baidder, Lahssen; Zouhri, Samir			A New Pterosaur (Pterodactyloidea: Azhdarchidae) from the Upper Cretaceous of Morocco	PLOS ONE			English	Article							GIANT PTEROSAUR; CHINA; INFORMATION; PHYLOGENY; KAZAKSTAN; DINOSAURS; DEPOSITS; REMAINS; RUSSIA; SAHARA	The Kem Kem beds in South Eastern Morocco contain a rich early Upper (or possibly late Lower) Cretaceous vertebrate assemblage. Fragmentary remains, predominantly teeth and jaw tips, represent several kinds of pterosaur although only one species, the ornithocheirid Coloborhynchus moroccensis, has been named. Here, we describe a new azhdarchid pterosaur, Alanqa saharica nov. gen. nov. sp., based on an almost complete well preserved mandibular symphysis from Aferdou N'Chaft. We assign additional fragmentary jaw remains, some of which have been tentatively identified as azhdarchid and pteranodontid, to this new taxon which is distinguished from other azhdarchids by a remarkably straight, elongate, lance-shaped mandibular symphysis that bears a pronounced dorsal eminence near the posterior end of its dorsal (occlusal) surface. Most remains, including the holotype, represent individuals of approximately three to four meters in wingspan, but a fragment of a large cervical vertebra, that probably also belongs to A. saharica, suggests that wingspans of six meters were achieved in this species. The Kem Kem beds have yielded the most diverse pterosaur assemblage yet reported from Africa and provide the first clear evidence for the presence of azhdarchids in Gondwana at the start of the Late Cretaceous. This, the relatively large size achieved by Alanqa, and the additional evidence of variable jaw morphology in azhdarchids provided by this taxon, indicates a longer and more complex history for this clade than previously suspected.	[Ibrahim, Nizar] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Unwin, David M.] Univ Leicester, Sch Museum Studies, Leicester, Leics, England; [Martill, David M.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Baidder, Lahssen; Zouhri, Samir] Univ Hassan 2, Lab Geosci, Casablanca, Morocco	University College Dublin; University of Leicester; University of Portsmouth; Hassan II University of Casablanca	Ibrahim, N (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.	Nizar.Ibrahim@ucd.ie	Zouhri, Samir/T-7894-2019	Zouhri, Samir/0000-0002-3811-9977; BAIDDER, Lahssen/0000-0001-5318-7102; Ibrahim, Nizar/0000-0001-5839-6798; Martill, David/0000-0002-3208-5702	Ad Astra Research Scholarship; University of Portsmouth	Ad Astra Research Scholarship; University of Portsmouth	This research was supported by an Ad Astra Research Scholarship awarded to NI (http://www.ucd.ie/), financial support from the University of Portsmouth to DMM (http://www.port.ac.uk/), contributions from members of the December 2008 expedition to Morocco [Robert Loveridge, Richard Hing, Darren Naish] and a New Blood grant awarded to DMU by Leicester University (http://www.le.ac.uk/ms/contactus/davidunwin.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan Martin, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V5, P19; Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Averianov A, 2008, PALEONTOL J+, V42, P634, DOI 10.1134/S0031030108060099; Averianov AO, 2007, PALEONTOL J+, V41, P189, DOI 10.1134/S0031030107020098; Averianov AO, 2004, PALEONTOL J+, V38, P426; Bakhurina Natalia N., 1995, Historical Biology, V10, P197; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Bennett S. Christopher, 2003, Palaeontologische Zeitschrift, V77, P61; Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; Benton MJ, 2000, PALAEOGEOGR PALAEOCL, V157, P227, DOI 10.1016/S0031-0182(99)00167-4; BLACKBEARD M, 2007, J VERT PALEONTOL S, V23, P49; BLACKBURN D, 2002, J VERT PALEONTOL S, V22, pA27; Bogoliubov N. N., 1914, Ann geol miner Novo-Alexandria, V16, P1; BUFFETAUT E, 1994, CR ACAD SCI II, V319, P1563; Buffetaut E, 1997, GEOL MAG, V134, P553, DOI 10.1017/S0016756897007449; Cai Zhengquan, 1994, Vertebrata Palasiatica, V32, P181; Catuneanu O, 2006, SEDIMENT GEOL, V190, P121, DOI 10.1016/j.sedgeo.2006.05.010; Cavin L, 1999, GEOL MIJNBOUW-N J G, V78, P261, DOI 10.1023/A:1003810123806; Codorniu Laura, 2007, P143; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; Dal Sasso Cristiano, 2003, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V144, P281; FERRANDINI M, 1985, B SOC GEOL FR, V1, P559; Frey Eberhard, 2006, Oryctos, V6, P19; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Frey Eberhard, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P221; Kaup J, 1834, ISIS, V3, P311; Keller JT, 1996, CEPHALALGIA, V16, P3, DOI 10.1046/j.1468-2982.1996.1601003.x; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 1996, J VERTEBR PALEONTOL, V16, P222, DOI 10.1080/02724634.1996.10011310; Kellner AWA, 2002, SCIENCE, V297, P389, DOI 10.1126/science.1073186; Kellner AWA, 1997, J PALEONTOL, V71, P525, DOI 10.1017/S0022336000039548; KELLNER AWA, 2007, SURVEY PTEROSAURS AF, P257; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Knoll Fabien, 2000, Annales de Paleontologie, V86, P157, DOI 10.1016/S0753-3969(00)80006-3; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Lavocat R, 1949, CR HEBD ACAD SCI, V7, P125; LAVOCAT R, 1954, NOTES MEM SERV GEOL, V116, P147; LEFRANC JP, 1990, J AFR EARTH SCI, V10, P27, DOI 10.1016/0899-5362(90)90047-I; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lu JC, 2008, NATURWISSENSCHAFTEN, V95, P891, DOI 10.1007/s00114-008-0397-5; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Mader Bryn J., 1997, Journal of Vertebrate Paleontology, V17, p62A; Mader Bryn J., 1999, Boletim do Museu Nacional Nova Serie Geologia, V45, P1; Martill David M., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V207, P57; Martill DM, 1999, GEOL MIJNBOUW, V78, P315, DOI 10.1023/A:1003843115145; MARTILL DM, 1998, 3 EUR WORKSH VERT PA, P49; MONTEILLET J, 1982, CR ACAD SCI II, V295, P409; MURRY PA, 1991, J PALEONTOL, V65, P167, DOI 10.1017/S0022336000020291; NESOV LA, 1984, PALEONTOL ZH, P47; Ntamak-Nida M.J., 2006, Africa Geoscience Review, V13, P385; Osi A, 2005, ACTA PALAEONTOL POL, V50, P777; Owen R., 1859, MONOGRAPHS PALAEONTO, V1859, P1; OWEN R, 1874, MONOGRAPHS PALAEONTO, P1; Padian Kevin, 1993, Journal of Vertebrate Paleontology, V13, p52A; PEREDASUBERBIOL.X, 2003, GEOLOGICAL SOC LONDO, V217, P80; Plieninger F, 1901, PALAEONTOGRAPHICA, V48, P65; Plieninger Felix, 1907, Palaeontographica Stuttgart, V53; RECK H, 1931, CENTRALBLATT MINER B, P321; Rodrigues T, 2006, J VERTEBR PALEONTOL, V26, p116A; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; SAYAO JM, 2001, B RES C BRAS PAL RIO, P145; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; SWINTON WE, 1984, B SOC BELG GEOL, V77, P234; Taquet P, 1998, CR ACAD SCI II A, V327, P347, DOI 10.1016/S1251-8050(98)80054-2; Unwin D.M., 2007, FOSSILS CRATO FORMAT, P475; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 1997, Historical Biology, V12, P199; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Unwin David M., 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P121; Vullo R, 2009, J VERTEBR PALEONTOL, V29, P277, DOI 10.1080/02724634.2009.10010380; Wang Xiao-Lin, 2003, Vertebrata Palasiatica, V41, P34; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Witton MP, 2009, CRETACEOUS RES, V30, P1293, DOI 10.1016/j.cretres.2009.07.006; Witton MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002271; Witton MP, 2008, PALAEONTOLOGY, V51, P1289, DOI 10.1111/j.1475-4983.2008.00811.x	77	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10875	10.1371/journal.pone.0010875	http://dx.doi.org/10.1371/journal.pone.0010875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520782	Green Submitted, Green Published, gold			2022-12-25	WOS:000278221500040
J	Gross, DA; Snapp, EL; Silver, DL				Gross, David A.; Snapp, Erik L.; Silver, David L.			Structural Insights into Triglyceride Storage Mediated by Fat Storage-Inducing Transmembrane (FIT) Protein 2	PLOS ONE			English	Article							LIPID DROPLET PROTEINS; MEMBRANE TOPOLOGY; DIACYLGLYCEROL ACYLTRANSFERASE; METABOLISM; FAMILY; FLUORESCENCE; LIPOLYSIS; GENES	Fat storage-Inducing Transmembrane proteins 1 & 2 (FIT1/FITM1 and FIT2/FITM2) belong to a unique family of evolutionarily conserved proteins localized to the endoplasmic reticulum that are involved in triglyceride lipid droplet formation. FIT proteins have been shown to mediate the partitioning of cellular triglyceride into lipid droplets, but not triglyceride biosynthesis. FIT proteins do not share primary sequence homology with known proteins and no structural information is available to inform on the mechanism by which FIT proteins function. Here, we present the experimentally-solved topological models for FIT1 and FIT2 using N-glycosylation site mapping and indirect immunofluorescence techniques. These methods indicate that both proteins have six-transmembrane-domains with both N- and C-termini localized to the cytosol. Utilizing this model for structure-function analysis, we identified and characterized a gain-of-function mutant of FIT2 (FLL(157-9)AAA) in transmembrane domain 4 that markedly augmented the total number and mean size of lipid droplets. Using limited-trypsin proteolysis we determined that the FLL(157-9)AAA mutant has enhanced trypsin cleavage at K86 relative to wild-type FIT2, indicating a conformational change. Taken together, these studies indicate that FIT2 is a 6 transmembrane domain-containing protein whose conformation likely regulates its activity in mediating lipid droplet formation.	[Gross, David A.; Silver, David L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Snapp, Erik L.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gross, DA (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	david.silver@einstein.yu.edu	Snapp, Erik Lee/H-7152-2019	Snapp, Erik Lee/0000-0001-9482-2272; Silver, David/0000-0002-7289-9890	NIH, Diabetes Research and Training Center at Einstein [DK020541]; NIH [T32 GM007491]; National Institute of General Medical Sciences and National Institute on Aging [1R01GM086530, 1R21AG032544]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288, R01GM086530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032544] Funding Source: NIH RePORTER	NIH, Diabetes Research and Training Center at Einstein(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences and National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported in part by a pilot and feasibility grant NIH DK020541 through the Diabetes Research and Training Center at Einstein (to D. L. S.) and an NIH Training Program in Cellular and Molecular Biology and Genetics, T32 GM007491 (to D. A. G.), and grants from National Institute of General Medical Sciences and National Institute on Aging 1R01GM086530 and 1R21AG032544 (to E. L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Fei WH, 2008, EUKARYOT CELL, V7, P401, DOI 10.1128/EC.00386-07; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Traini M, 2009, CURR OPIN LIPIDOL, V20, P147, DOI 10.1097/MOL.0b013e32832956c7; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	24	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10796	10.1371/journal.pone.0010796	http://dx.doi.org/10.1371/journal.pone.0010796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520733	gold, Green Published			2022-12-25	WOS:000278034600020
J	Rausenberger, J; Hussong, A; Kircher, S; Kirchenbauer, D; Timmer, J; Nagy, F; Schafer, E; Fleck, C				Rausenberger, Julia; Hussong, Andrea; Kircher, Stefan; Kirchenbauer, Daniel; Timmer, Jens; Nagy, Ferenc; Schaefer, Eberhard; Fleck, Christian			An Integrative Model for Phytochrome B Mediated Photomorphogenesis: From Protein Dynamics to Physiology	PLOS ONE			English	Article							SINAPIS-ALBA L; PLANT PHOTORECEPTORS PHYTOCHROME; GFP FUSION PROTEIN; TRANSGENIC ARABIDOPSIS; SIGNAL-TRANSDUCTION; TERMINAL-DOMAIN; RED-LIGHT; IN-VIVO; IRRADIANCE; SEEDLINGS	Background: Plants have evolved various sophisticated mechanisms to respond and adapt to changes of abiotic factors in their natural environment. Light is one of the most important abiotic environmental factors and it regulates plant growth and development throughout their entire life cycle. To monitor the intensity and spectral composition of the ambient light environment, plants have evolved multiple photoreceptors, including the red/far-red light-sensing phytochromes. Methodology/Principal Findings: We have developed an integrative mathematical model that describes how phytochrome B (phyB), an essential receptor in Arabidopsis thaliana, controls growth. Our model is based on a multiscale approach and connects the mesoscopic intracellular phyB protein dynamics to the macroscopic growth phenotype. To establish reliable and relevant parameters for the model phyB regulated growth we measured: accumulation and degradation, dark reversion kinetics and the dynamic behavior of different nuclear phyB pools using in vivo spectroscopy, western blotting and Fluorescence Recovery After Photobleaching (FRAP) technique, respectively. Conclusions/Significance: The newly developed model predicts that the phyB-containing nuclear bodies (NBs) (i) serve as storage sites for phyB and (ii) control prolonged dark reversion kinetics as well as partial reversibility of phyB Pfr in extended darkness. The predictive power of this mathematical model is further validated by the fact that we are able to formalize a basic photobiological observation, namely that in light-grown seedlings hypocotyl length depends on the total amount of phyB. In addition, we demonstrate that our theoretical predictions are in excellent agreement with quantitative data concerning phyB levels and the corresponding hypocotyl lengths. Hence, we conclude that the integrative model suggested in this study captures the main features of phyB-mediated photomorphogenesis in Arabidopsis.	[Rausenberger, Julia; Fleck, Christian] Univ Freiburg, Ctr Biol Syst Anal, Freiburg, Germany; [Rausenberger, Julia; Hussong, Andrea; Kircher, Stefan; Kirchenbauer, Daniel; Schaefer, Eberhard] Univ Freiburg, Inst Biol 2, D-7800 Freiburg, Germany; [Timmer, Jens; Fleck, Christian] Univ Freiburg, Inst Phys, Freiburg, Germany; [Timmer, Jens; Nagy, Ferenc] Univ Freiburg, Freiburg Inst Adv Studies, Freiburg, Germany; [Nagy, Ferenc] Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [Nagy, Ferenc] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Edinburgh	Rausenberger, J (corresponding author), ETH, Dept Biosyst Sci & Engn, Basel, Switzerland.	eberhard.schaefer@biologie.uni-freiburg.de; christian.fleck@fdm.uni-freiburg.de	Nagy, Ferenc/D-3532-2015; Fleck, Christian/D-1620-2012	Nagy, Ferenc/0000-0002-6157-9269; Fleck, Christian/0000-0002-6371-4495; Kircher, Stefan/0000-0002-8351-567X	International Graduate School Signal Systems in Plant Model Organisms (DFG) [GRK1305]; Deutsche Forschungsgemeinschaft [SFB 592]; BMBF [0313921]; German Federal and State Governments; Howard Hughes International	International Graduate School Signal Systems in Plant Model Organisms (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); German Federal and State Governments; Howard Hughes International	The work was supported by the International Graduate School Signal Systems in Plant Model Organisms (DFG grant no. GRK1305 for JR), the Deutsche Forschungsgemeinschaft (SFB 592 for AH, SK, ES), BMBF FRISYS 0313921 (for CF and JR), and by the Excellence Initiative of the German Federal and State Governments (for JT and FN). Work in Hungary was supported by a Howard Hughes International Scholar grant to FN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; BACKMAN G, 1943, WACHSTUM ORG; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; BEGGS CJ, 1980, PLANT PHYSIOL, V66, P615, DOI 10.1104/pp.66.4.615; BRIGGS WR, 2006, PHOTOMORPHOGENESIS P, P223; Cashmoore AR, 2006, PHOTOMORPHOGENESIS P, P199; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen M, 2003, P NATL ACAD SCI USA, V100, P14493, DOI 10.1073/pnas.1935989100; Chen M, 2008, CURR OPIN PLANT BIOL, V11, P503, DOI 10.1016/j.pbi.2008.06.012; DOWNS R. J., 1957, BOT GAZ, V118, P199, DOI 10.1086/335946; Downson-Day MJ, 1999, PLANT J, V17, P63; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Eichenberg K, 2000, PLANT CELL ENVIRON, V23, P311, DOI 10.1046/j.1365-3040.2000.00550.x; Gil P, 2000, PLANT J, V22, P135, DOI 10.1046/j.1365-313x.2000.00730.x; Gross J, 1984, TECHNIQUES PHOTOMORP, P131; Hennig L, 1999, PLANT PHYSIOL, V121, P571, DOI 10.1104/pp.121.2.571; Hennig L, 1999, PLANTA, V208, P257, DOI 10.1007/s004250050557; Hennig L, 2000, PLANT CELL ENVIRON, V23, P727, DOI 10.1046/j.1365-3040.2000.00587.x; Hirschfeld M, 1998, GENETICS, V149, P523; HOCK B, 1965, PLANTA, V65, P1, DOI 10.1007/BF00385175; Huq E, 2003, PLANT J, V35, P660, DOI 10.1046/j.1365-313X.2003.01836.x; Johnson C. B., 1979, Plant, Cell and Environment, V2, P259, DOI 10.1111/j.1365-3040.1979.tb00077.x; Khan J, 2007, EJC SUPPL, V5, P12, DOI 10.1016/S1359-6349(08)70024-7; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kretsch T, 2000, PLANT J, V22, P177, DOI 10.1046/j.1365-313x.2000.00715.x; KUNKEL T, 1995, J BIOL CHEM, V270, P20193, DOI 10.1074/jbc.270.34.20193; LAGARIAS JC, 1987, PHOTOCHEM PHOTOBIOL, V46, P5, DOI 10.1111/j.1751-1097.1987.tb04729.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Muller TG, 2002, MATH BIOSCI, V177, P147, DOI 10.1016/S0025-5564(01)00098-0; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Nozue K, 2006, PLANT CELL ENVIRON, V29, P396, DOI 10.1111/j.1365-3040.2005.01489.x; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Quail P.H., 2000, PHOTOMORPHOGENESIS P, P335, DOI [10.1007/1-4020-3811-9_17, DOI 10.1007/1-4020-3811-9_17]; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; QUAIL PH, 1983, ENCY PLANT PHYSL A, V16, P178; Sch_afer E, 2006, PHOTOMORPHOGENESIS P, V3; SCHAFER E, 1974, J MATH BIOL, V1, P9, DOI 10.1007/BF02339485; SCHAFER E, 1975, J MATH BIOL, V2, P41, DOI 10.1007/BF00276015; SCHAFER E, 1976, PHOTOCHEM PHOTOBIOL, V24, P567, DOI 10.1111/j.1751-1097.1976.tb06874.x; SCHAFER E, 2006, PHOTOMORPHOGENESIS P, P13; SCHAFER E, 1977, OPTISCHE STRAHLUNGSQ, P249; SCHMIDT W, 1973, PLANTA, V111, P329, DOI 10.1007/BF00385552; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Ulm R, 2006, PHOTOMORPHOGENESIS P, P279, DOI [10.1007/14020-38119_14, DOI 10.1007/14020-38119_14]; WAGNER D, 1991, PLANT CELL, V3, P1275, DOI 10.1105/tpc.3.12.1275; WAGNER D, 1995, P NATL ACAD SCI USA, V92, P8596, DOI 10.1073/pnas.92.19.8596; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437	55	76	79	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10721	10.1371/journal.pone.0010721	http://dx.doi.org/10.1371/journal.pone.0010721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502669	Green Published, Green Submitted, gold			2022-12-25	WOS:000277845400023
J	Sim, S; Dimopoulos, G				Sim, Shuzhen; Dimopoulos, George			Dengue Virus Inhibits Immune Responses in Aedes aegypti Cells	PLOS ONE			English	Article							ANTIVIRAL RESPONSE; TOLL PATHWAY; PROTEIN; EXPRESSION; INSECT; ACTIVATION; BINDING; NS5; IMD	The ability of many viruses to manipulate the host antiviral immune response often results in complex host-pathogen interactions. In order to study the interaction of dengue virus (DENV) with the Aedes aegypti immune response, we have characterized the DENV infection-responsive transcriptome of the immune-competent A. aegypti cell line Aag2. As in mosquitoes, DENV infection transcriptionally activated the cell line Toll pathway and a variety of cellular physiological systems. Most notably, however, DENV infection down-regulated the expression levels of numerous immune signaling molecules and antimicrobial peptides (AMPs). Functional assays showed that transcriptional induction of AMPs from the Toll and IMD pathways in response to bacterial challenge is impaired in DENV-infected cells. In addition, Escherichia coli, a Gram-negative bacteria species, grew better when co-cultured with DENV-infected cells than with uninfected cells, suggesting a decreased production of AMPs from the IMD pathway in virus-infected cells. Pre-stimulation of the cell line with Gram-positive bacteria prior to DENV infection had no effect on DENV titers, while pre-stimulation with Gram-negative bacteria resulted in an increase in DENV titers. These results indicate that DENV is capable of actively suppressing immune responses in the cells it infects, a phenomenon that may have important consequences for virus transmission and insect physiology.	[Sim, Shuzhen; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sim, S (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	gdimopou@jhsph.edu		Dimopoulos, George/0000-0001-6755-8111	National Institutes of Health/National Institute for Allergy and Infectious Disease [R01AI061576, RO1AI059492, RO1AI078997]; Johns Hopkins School of Public Health; Johns Hopkins Malaria Research Institute; Agency for Science, Technology and Research (A*STAR), Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059492, R01AI061576, R01AI078997] Funding Source: NIH RePORTER	National Institutes of Health/National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins School of Public Health; Johns Hopkins Malaria Research Institute; Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the National Institutes of Health/National Institute for Allergy and Infectious Disease R01AI061576, RO1AI059492, RO1AI078997, the Johns Hopkins School of Public Health, and the Johns Hopkins Malaria Research Institute. SS is supported by the Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x; Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005; Kile BT, 2001, CELL MOL LIFE SCI, V58, P1627, DOI 10.1007/PL00000801; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200; Lin CW, 2008, VIRUS RES, V137, P49, DOI 10.1016/j.virusres.2008.05.015; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nasirudeen AMA, 2009, J MED VIROL, V81, P1069, DOI 10.1002/jmv.21486; Nasr NM, 2003, J INVERTEBR PATHOL, V82, P162, DOI 10.1016/S0022-2011(03)00030-2; PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6; Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; *WHO, 2009, 117 WHO; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Yang IV, 2002, GENOME BIOL, V3; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	36	119	119	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10678	10.1371/journal.pone.0010678	http://dx.doi.org/10.1371/journal.pone.0010678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502529	Green Submitted, gold, Green Published			2022-12-25	WOS:000277776500002
J	Spicer, E; Suckert, C; Al-Attar, H; Marsden, M				Spicer, Erin; Suckert, Catherine; Al-Attar, Hyder; Marsden, Mungo			Integrin alpha 5 beta 1 Function Is Regulated by XGIPC/kermit2 Mediated Endocytosis during Xenopus laevis Gastrulation	PLOS ONE			English	Article							EMBRYONIC-CELL ADHESION; PDZ DOMAIN PROTEIN; INTERACTING PROTEIN; MESODERM INDUCTION; DNA-REPLICATION; SMALL GTPASE; FIBRONECTIN; RECEPTOR; GIPC; MIGRATION	During Xenopus gastrulation alpha 5 beta 1 integrin function is modulated in a temporally and spatially restricted manner, however, the regulatory mechanisms behind this regulation remain uncharacterized. Here we report that XGIPC/kermit2 binds to the cytoplasmic domain of the alpha 5 subunit and regulates the activity of alpha 5 beta 1 integrin. The interaction of kermit2 with alpha 5 beta 1 is essential for fibronectin (FN) matrix assembly during the early stages of gastrulation. We further demonstrate that kermit2 regulates alpha 5 beta 1 integrin endocytosis downstream of activin signaling. Inhibition of kermit2 function impairs cell migration but not adhesion to FN substrates indicating that integrin recycling is essential for mesoderm cell migration. Furthermore, we find that the alpha 5 beta 1 integrin is colocalized with kermit2 and Rab 21 in embryonic and XTC cells. These data support a model where region specific mesoderm induction acts through kermit2 to regulate the temporally and spatially restricted changes in adhesive properties of the alpha 5 beta 1 integrin through receptor endocytosis.	[Spicer, Erin; Suckert, Catherine; Al-Attar, Hyder; Marsden, Mungo] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Spicer, E (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	mmarsden@uwaterloo.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding provided by NSERC Discovery grant to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Booth RA, 2002, J BIOL CHEM, V277, P6719, DOI 10.1074/jbc.M108033200; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; Burke DJ, 2000, CURR OPIN GENET DEV, V10, P26, DOI 10.1016/S0959-437X(99)00040-4; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Cohen MW, 2000, J NEUROSCI, V20, P4912; Cousin H, 2008, DEV BIOL, V319, P86, DOI 10.1016/j.ydbio.2008.04.007; Davidson LA, 2002, DEV BIOL, V242, P109, DOI 10.1006/dbio.2002.0537; DeSimone DW, 2007, METHOD ENZYMOL, V426, P403, DOI 10.1016/S0076-6879(07)26017-3; DESIMONE DW, 1991, METHOD CELL BIOL, V36, P527; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Favre-Bonvin A, 2005, J VIROL, V79, P4229, DOI 10.1128/JVI.79.7.4229-4237.2005; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; GAWANTKA V, 1994, MECH DEVELOP, V47, P199, DOI 10.1016/0925-4773(94)90039-6; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hens MD, 2002, BIOCHEM BIOPH RES CO, V298, P364, DOI 10.1016/S0006-291X(02)02459-2; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katoh M, 2002, INT J MOL MED, V9, P585; LEE G, 1984, CELL, V36, P729, DOI 10.1016/0092-8674(84)90353-2; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Liu TF, 2001, J BIOL CHEM, V276, P35768, DOI 10.1074/jbc.M103585200; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Marsden M, 2001, DEVELOPMENT, V128, P3635; Memmo LM, 1998, J CELL SCI, V111, P425; Na J, 2003, J CELL SCI, V116, P2333, DOI 10.1242/jcs.00445; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Pera EM, 2001, DEV CELL, V1, P655, DOI 10.1016/S1534-5807(01)00069-7; PijuanThompson V, 1997, J BIOL CHEM, V272, P2736, DOI 10.1074/jbc.272.5.2736; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; Ramis JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000213; Ramos JW, 1996, J CELL BIOL, V134, P227, DOI 10.1083/jcb.134.1.227; Ramos JW, 1996, DEVELOPMENT, V122, P2873; SAEGUSA J, 2009, J BIOL CHEM; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; SIVE HL, 2000, EARLY DEV XENOPUS LA, V9, P338; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SMITH JC, 1990, DEVELOPMENT, V108, P229; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Tan C, 2001, DEVELOPMENT, V128, P3665; Tani TT, 2001, J BIOL CHEM, V276, P36535, DOI 10.1074/jbc.M105785200; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; WINKLBAUER R, 1988, DEV BIOL, V130, P175, DOI 10.1016/0012-1606(88)90424-1; Winklbauer R, 1996, DEV BIOL, V177, P413, DOI 10.1006/dbio.1996.0174; WINKLBAUER R, 1990, DEV BIOL, V142, P155, DOI 10.1016/0012-1606(90)90159-G; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547; Yi ZH, 2007, J NEUROSCI, V27, P11663, DOI 10.1523/JNEUROSCI.3252-07.2007	61	15	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10665	10.1371/journal.pone.0010665	http://dx.doi.org/10.1371/journal.pone.0010665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498857	gold, Green Submitted, Green Published			2022-12-25	WOS:000277773700009
J	Assies, J; Pouwer, F; Lok, A; Mocking, RJT; Bockting, CLH; Visser, I; Abeling, NGGM; Duran, M; Schene, AH				Assies, Johanna; Pouwer, Francois; Lok, Anja; Mocking, Roel J. T.; Bockting, Claudi L. H.; Visser, Ieke; Abeling, Nico G. G. M.; Duran, Marinus; Schene, Aart H.			Plasma and Erythrocyte Fatty Acid Patterns in Patients with Recurrent Depression: A Matched Case-Control Study	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR MORTALITY; OXIDATIVE STRESS; DISORDER; MOOD; OMEGA-3-FATTY-ACIDS; DESATURASE; BIPOLAR; CORTEX; BLOOD	Background: The polyunsaturated fatty acid (PUFA) composition of (nerve) cell membranes may be involved in the pathophysiology of depression. Studies so far, focussed mainly on omega-3 and omega-6 PUFAs. In the present study, saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs) and PUFAs of the omega-3, -6 and -9 series in plasma and erythrocytes of patients with recurrent major depressive disorder (MDD-R) were compared with controls. Methodology and Principal Findings: We carried out a case-control study. The sample consisted of 137 patients with MDD-R and 65 matched non-depressed controls. In plasma and erythrocytes of patients with MDD-R the concentrations of most of the SFAs and MUFAs, and additionally erythrocyte PUFAs, all with a chain length >20 carbon (C) atoms, were significantly lower than in the controls. In contrast, the concentrations of most of the shorter chain members (<= 18C) of the SFAs and MUFAs were significantly higher in the patients. Estimated activities of several elongases in plasma of patients were significantly altered, whereas delta-9 desaturase activity for C14:0 and C18:0 was significantly higher. Conclusions/Significance: The fatty acid status of patients with MDD-R not only differs with regard to omega-3 and omega-6 PUFAs, but also concerns other fatty acids. These alterations may be due to: differences in diet, changes in synthesizing enzyme activities, higher levels of chronic (oxidative) stress but may also result from adaptive strategies by providing protection against enhanced oxidative stress and production of free radicals.	[Assies, Johanna; Lok, Anja; Mocking, Roel J. T.; Visser, Ieke; Schene, Aart H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Program Mood Disorders, NL-1105 AZ Amsterdam, Netherlands; [Pouwer, Francois] Tilburg Univ, Dept Med Psychol & Neuropsychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands; [Bockting, Claudi L. H.] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Visser, Ieke] PsyQ Mental Heath Care, Zaandam, Netherlands; [Abeling, Nico G. G. M.; Duran, Marinus] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Tilburg University; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	Assies, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Program Mood Disorders, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.assies@amc.uva.nl	Schene, A.H./H-8085-2014; Mocking, Roel JT/H-8131-2012; Bockting, Claudi L/K-3768-2019	Schene, A.H./0000-0002-1756-3235; Mocking, Roel JT/0000-0003-3543-3810; Bockting, Claudi L/0000-0002-9220-9244; Pouwer, Frans/0000-0002-8172-9818	Health Research Development Counsel (ZonMw); Department Prevention Program; National Foundation for Mental Health (Fonds Psychische Gezondheid)	Health Research Development Counsel (ZonMw)(Netherlands Organization for Health Research and Development); Department Prevention Program; National Foundation for Mental Health (Fonds Psychische Gezondheid)	This study was granted by the Health Research Development Counsel (ZonMw), Department Prevention Program and National Foundation for Mental Health (Fonds Psychische Gezondheid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Bull World Health Organ, V78, P413; Appleton KM, 2008, NUTR RES REV, V21, P13, DOI 10.1017/S0954422408998620; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Assies J, 2001, BIOL PSYCHIAT, V49, P510, DOI 10.1016/S0006-3223(00)00986-0; ASSIES J, 2003, PROSTAGLANDINS LEUKO, V70, P151; Astorg P, 2009, PROSTAG LEUKOTR ESS, V81, P265, DOI 10.1016/j.plefa.2009.06.002; BENSACHAR D, 2008, PLOS; Bockting CLH, 2005, J CONSULT CLIN PSYCH, V73, P647, DOI 10.1037/0022-006X.73.4.647; Carver JD, 2001, BRAIN RES BULL, V56, P79, DOI 10.1016/S0361-9230(01)00551-2; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Cole GM, 2009, PROSTAG LEUKOTR ESS, V81, P213, DOI 10.1016/j.plefa.2009.05.015; Dacremont G, 1995, J INHERIT METAB DIS, V18, P76, DOI 10.1007/BF00711430; Dodd S, 2008, INT J NEUROPSYCHOPH, V11, P179; First M. D., 1996, USERS GUIDE STRUCTUR; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; Hakkaart-van Roijen L, 2002, MANUAL TRIMBOS IMTA; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; JACOBSSON A, 2006, PROGR LIP RES, V45, P15; Jokinen J, 2009, J AFFECT DISORDERS, V116, P88, DOI 10.1016/j.jad.2008.10.025; Kume A, 2008, DIABETES RES CLIN PR, V80, P259, DOI 10.1016/j.diabres.2007.12.014; Liou YA, 2009, PROSTAG LEUKOTR ESS, V80, P201, DOI 10.1016/j.plefa.2009.02.003; McIntyre RS, 2009, CURR DIABETES REP, V9, P51, DOI 10.1007/s11892-009-0010-0; McNamara RK, 2007, BIOL PSYCHIAT, V62, P17, DOI 10.1016/j.biopsych.2006.08.026; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; McNamara RK, 2009, PROSTAG LEUKOTR ESS, V81, P223, DOI 10.1016/j.plefa.2009.05.017; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Severus WE, 2001, HARVARD REV PSYCHIAT, V9, P280, DOI 10.1093/hrp/9.6.280; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Sobczak S, 2004, PSYCHOL MED, V34, P103, DOI 10.1017/S0033291703001090; Vogelzangs N, 2007, PSYCHONEUROENDOCRINO, V32, P151, DOI 10.1016/j.psyneuen.2006.11.009; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Zak A, 2007, TOHOKU J EXP MED, V212, P359, DOI 10.1620/tjem.212.359	41	96	99	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10635	10.1371/journal.pone.0010635	http://dx.doi.org/10.1371/journal.pone.0010635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498721	Green Published, gold, Green Submitted			2022-12-25	WOS:000277771600005
J	Gotz, A; Eylert, E; Eisenreich, W; Goebel, W				Goetz, Andreas; Eylert, Eva; Eisenreich, Wolfgang; Goebel, Werner			Carbon Metabolism of Enterobacterial Human Pathogens Growing in Epithelial Colorectal Adenocarcinoma (Caco-2) Cells	PLOS ONE			English	Article							PHOSPHATE-TRANSPORT-SYSTEM; SHIGELLA-FLEXNERI 2A; ESCHERICHIA-COLI; GENOME SEQUENCE; VIRULENCE; GLUCOSE; INFECTION; MUTANTS; GENE; SUGAR	Analysis of the genome sequences of the major human bacterial pathogens has provided a large amount of information concerning their metabolic potential. However, our knowledge of the actual metabolic pathways and metabolite fluxes occurring in these pathogens under infection conditions is still limited. In this study, we analysed the intracellular carbon metabolism of enteroinvasive Escherichia coli (EIEC HN280 and EIEC 4608-58) and Salmonella enterica Serovar Typhimurium (Stm 14028) replicating in epithelial colorectal adenocarcinoma cells (Caco-2). To this aim, we supplied [U-C-13(6)]glucose to Caco-2 cells infected with the bacterial strains or mutants thereof impaired in the uptake of glucose, mannose and/or glucose 6-phosphate. The C-13-isotopologue patterns of protein-derived amino acids from the bacteria and the host cells were then determined by mass spectrometry. The data showed that EIEC HN280 growing in the cytosol of the host cells, as well as Stm 14028 replicating in the Salmonella-containing vacuole (SCV) utilised glucose, but not glucose 6-phosphate, other phosphorylated carbohydrates, gluconate or fatty acids as major carbon substrates. EIEC 4608-58 used C-3-compound(s) in addition to glucose as carbon source. The labelling patterns reflected strain-dependent carbon flux via glycolysis and/or the Entner-Doudoroff pathway, the pentose phosphate pathway, the TCA cycle and anapleurotic reactions between PEP and oxaloacetate. Mutants of all three strains impaired in the uptake of glucose switched to C-3-substrate(s) accompanied by an increased uptake of amino acids (and possibly also other anabolic monomers) from the host cell. Surprisingly, the metabolism of the host cells, as judged by the efficiency of C-13-incorporation into host cell amino acids, was not significantly affected by the infection with either of these intracellular pathogens.	[Goetz, Andreas; Goebel, Werner] Univ Wurzburg, Biozentrum, Lehrstuhl Mikrobiol, Wurzburg, Germany; [Eylert, Eva; Eisenreich, Wolfgang] Tech Univ Munich, Ctr Isotopol Profiling, Lehrstuhl Biochem, D-8046 Garching, Germany; [Goebel, Werner] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany	University of Wurzburg; Technical University of Munich; University of Munich	Gotz, A (corresponding author), Univ Wurzburg, Biozentrum, Lehrstuhl Mikrobiol, Wurzburg, Germany.	wolfgang.eisenreich@ch.tum.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Goebel, Werner/0000-0003-4851-2083	Deutsche Forschungsgemeinschaft [SPP1316, SFB479, TR34]; Network of Excellence EuroPathoGenomics (NoE EPG); GCWN [1141 W1/4rzburg/Nice]; Franco-German University [ED-31-04]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Network of Excellence EuroPathoGenomics (NoE EPG); GCWN; Franco-German University	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SPP1316, SFB479 and TR34) and the Network of Excellence EuroPathoGenomics (NoE EPG). A.G. was supported by the International DFG Research Training Group 1141 W1/4rzburg/Nice (GCWN) and the Franco-German University (ED-31-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Cersini A, 2003, INFECT IMMUN, V71, P7002, DOI 10.1128/IAI.71.12.7002-7013.2003; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; DIETZ GW, 1976, ADV ENZYMOL RAMB, V44, P237; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; ERNI B, 1989, FEMS MICROBIOL LETT, V63, P13, DOI 10.1016/0168-6445(89)90004-1; ERNI B, 1986, J BIOL CHEM, V261, P6398; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; GOTZ A, 2010, MICROBIOLOGY; ISLAND MD, 1992, J BACTERIOL, V174, P2754, DOI 10.1128/JB.174.9.2754-2762.1992; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Khoursandi S, 2004, AM J PHYSIOL-CELL PH, V287, pC1041, DOI 10.1152/ajpcell.00197.2004; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4; Mercado-Lubo R, 2009, INFECT IMMUN, V77, P1397, DOI 10.1128/IAI.01335-08; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07; NICOLETTI M, 1988, J CLIN MICROBIOL, V26, P524, DOI 10.1128/JCM.26.3.524-529.1988; Nikel PI, 2009, J BACTERIOL, V191, P5538, DOI 10.1128/JB.00174-09; Noriega FR, 1996, INFECT IMMUN, V64, P3055, DOI 10.1128/IAI.64.8.3055-3061.1996; PAPPENHEIMER JR, 1993, AM J PHYSIOL, V265, pG409, DOI 10.1152/ajpgi.1993.265.3.G409; Porco A, 1997, J BACTERIOL, V179, P1584, DOI 10.1128/jb.179.5.1584-1590.1997; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Romisch-Margl W, 2007, PHYTOCHEMISTRY, V68, P2273, DOI 10.1016/j.phytochem.2007.03.034; Runyen-Janecky LJ, 2002, INFECT IMMUN, V70, P4379, DOI 10.1128/IAI.70.8.4379-4388.2002; Rupp J, 2007, CELL MICROBIOL, V9, P2181, DOI 10.1111/j.1462-5822.2007.00948.x; SANSONETTI PJ, 1982, ANN INST PASTEUR MIC, VA133, P351; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Shaikh AS, 2010, BIOTECHNOL PROGR, V26, P52, DOI 10.1002/btpr.325; Tsolis RM, 2008, NAT REV MICROBIOL, V6, P883, DOI 10.1038/nrmicro2012; Vazquez-Torres A, 2000, CURR OPIN MICROBIOL, V3, P54, DOI 10.1016/S1369-5274(99)00051-X; Verhamme DT, 2001, MICROBIOL-SGM, V147, P3345, DOI 10.1099/00221287-147-12-3345; Wittmann C, 2007, J BIOTECHNOL, V132, P375, DOI 10.1016/j.jbiotec.2007.07.495; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zamboni N, 2009, CURR OPIN MICROBIOL, V12, P553, DOI 10.1016/j.mib.2009.08.003; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zhao J, 2004, APPL MICROBIOL BIOT, V64, P91, DOI 10.1007/s00253-003-1458-5	51	46	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10586	10.1371/journal.pone.0010586	http://dx.doi.org/10.1371/journal.pone.0010586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485672	Green Published, Green Submitted, gold			2022-12-25	WOS:000277563200018
J	Johns, MC; Eick, AA; Blazes, DL; Lee, SE; Perdue, CL; Lipnick, R; Vest, KG; Russell, KL; DeFraites, RF; Sanchez, JL				Johns, Matthew C.; Eick, Angelia A.; Blazes, David L.; Lee, Seung-eun; Perdue, Christopher L.; Lipnick, Robert; Vest, Kelly G.; Russell, Kevin L.; DeFraites, Robert F.; Sanchez, Jose L.			Seasonal Influenza Vaccine and Protection against Pandemic (H1N1) 2009-Associated Illness among US Military Personnel	PLOS ONE			English	Article							T-CELL RESPONSES; AVIAN INFLUENZA; PREEXISTING IMMUNITY; ANTIBODY-RESPONSES; RISK-FACTORS; A H1N1; LIVE; VIRUS; TRIVALENT; INFECTION	Introduction: A novel A/H1N1 virus is the cause of the present influenza pandemic; vaccination is a key countermeasure, however, few data assessing prior seasonal vaccine effectiveness (VE) against the pandemic strain of H1N1 (pH1N1) virus are available. Materials and Methods: Surveillance of influenza-related medical encounter data of active duty military service members stationed in the United States during the period of April-October 2009 with comparison of pH1N1-confirmed cases and location and date-matched controls. Crude odds ratios (OR) and VE estimates for immunized versus non-immunized were calculated as well as adjusted OR (AOR) controlling for sex, age group, and history of prior influenza vaccination. Separate stratified VE analyses by vaccine type (trivalent inactivated [TIV] or live attenuated [LAIV]), age groups and hospitalization status were also performed. For the period of April 20 to October 15, 2009, a total of 1,205 cases of pH1N1-confirmed cases were reported, 966 (80%) among males and over one-half (58%) under 25 years of age. Overall VE for service members was found to be 45% (95% CI, 33 to 55%). Immunization with prior season's TIV (VE = 44%, 95% CI, 32 to 54%) as well as LAIV (VE = 24%, 95% CI, 6 to 38%) were both found to be associated with protection. Of significance, VE against a severe disease outcome was higher (VE = 62%, 95% CI, 14 to 84%) than against milder outcomes (VE = 42%, 95% CI, 29 to 53%). Conclusion: A moderate association with protection against clinically apparent, laboratory-confirmed Pandemic (H1N1) 2009-associated illness was found for immunization with either TIV or LAIV 2008-09 seasonal influenza vaccines. This association with protection was found to be especially apparent for severe disease as compared to milder outcome, as well as in the youngest and older populations. Prior vaccination with seasonal influenza vaccines in 2004-08 was also independently associated with protection.	[Johns, Matthew C.; Blazes, David L.; Vest, Kelly G.; Russell, Kevin L.; Sanchez, Jose L.] Armed Forces Hlth Surveillance Ctr, Div GEIS Operat, Silver Spring, MD USA; [Eick, Angelia A.; Lee, Seung-eun] Armed Forces Hlth Surveillance Ctr, Henry M Jackson Fdn Adv Mil Med, Silver Spring, MD USA; [Perdue, Christopher L.; Lipnick, Robert] Armed Forces Hlth Surveillance Ctr, Div Commun Stand & Training, Silver Spring, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Johns, MC (corresponding author), Armed Forces Hlth Surveillance Ctr, Div GEIS Operat, Silver Spring, MD USA.	matthew.c.johns@us.army.mil		Mulvihill, Daniel/0000-0003-2502-5274; Geeves, Michael/0000-0002-9364-8898	US Military; BBSRC [BB/F011784/1] Funding Source: UKRI	US Military; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the baseline funding of the US Military's Defense Health Program for the Armed Forces Health Surveillance Center (AFHSC). No non-government funding was accepted for this effort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFHSC, 2009, TRI SERV REP EV GUID; Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Bernstein DI, 2003, PEDIATR INFECT DIS J, V22, P28, DOI 10.1097/00006454-200301000-00010; Block SL, 2007, ANTIMICROB AGENTS CH, V51, P4001, DOI 10.1128/AAC.00517-07; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; *CDC, 2010, ADV COMM IMM PRACT P; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Cohen J, 2010, SCIENCE, V327, P1563, DOI 10.1126/science.327.5973.1563; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Eick AA, 2009, VACCINE, V27, P3568, DOI 10.1016/j.vaccine.2009.03.088; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Goy K, 2008, INFLUENZA OTHER RESP, V2, P115, DOI 10.1111/j.1750-2659.2008.00046.x; Grabenstein JD, 2006, EPIDEMIOL REV, V28, P3, DOI 10.1093/epirev/mxj003; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Loeb M, 2010, EMERG INFECT DIS, V16, P719, DOI 10.3201/eid1604.091588; Martinez O, 2009, INT REV IMMUNOL, V28, P69, DOI 10.1080/08830180802593540; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; RUSSELL KL, 2006, TXB MILITARY MED REC, P227; Skowronski DM, 2008, J INFECT DIS, V197, P490, DOI 10.1086/524146; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; *WHO, 2009, AD HOC POL ADV WORK; WHO, 2009, SUMM REP HIGH LEV CO; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	55	65	66	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10722	10.1371/journal.pone.0010722	http://dx.doi.org/10.1371/journal.pone.0010722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502705	Green Published, gold, Green Submitted			2022-12-25	WOS:000277845400024
